PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gupta, S; Chai, J; Cheng, J; D'Mello, R; Chance, MR; Fu, D				Gupta, Sayan; Chai, Jin; Cheng, Jie; D'Mello, Rhijuta; Chance, Mark R.; Fu, Dax			Visualizing the kinetic power stroke that drives proton-coupled zinc(II) transport	NATURE			English	Article							MASS-SPECTROMETRY; METAL-BINDING; YIIP; SPECIFICITY; SELECTIVITY; MECHANISM; DYNAMICS; VESICLES; FAMILY; FIEF	The proton gradient is a principal energy source for respiration-dependent active transport, but the structural mechanisms of proton-coupled transport processes are poorly understood. YiiP is a proton-coupled zinc transporter found in the cytoplasmic membrane of Escherichia coli. Its transport site receives protons from water molecules that gain access to its hydrophobic environment and transduces the energy of an inward proton gradient to drive Zn(II) efflux(1,2). This membrane protein is a well characterized member3- 7 of the family of cation diffusion facilitators that occurs at all phylogenetic levels(8-10). Here we show, using X-ray-mediated hydroxyl radical labelling of YiiP and mass spectrometry, that Zn( II) binding triggers a highly localized, all-or-nothing change of water accessibility to the transport site and an adjacent hydrophobic gate. Milli-secondtime-resolved dynamics reveal a concerted and reciprocal pattern of accessibility changes along a trans membrane helix, suggesting a rigid-body helical re-orientation linked to Zn( II) binding that triggers the closing of the hydrophobic gate. The gated water access to the transport site enables a stationary proton gradient to facilitate the conversion of zinc-binding energy to the kinetic power stroke of a vectorial zinc transport. The kinetic details provide energetic insights intoaproton-coupled active-transport reaction.	[Gupta, Sayan; Cheng, Jie; D'Mello, Rhijuta] Case Western Reserve Univ, Ctr Synchrotron Biosci, Cleveland, OH 44109 USA; [Gupta, Sayan; D'Mello, Rhijuta; Chance, Mark R.] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44109 USA; [Chai, Jin; Fu, Dax] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Cheng, Jie; Fu, Dax] Johns Hopkins Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Case Western Reserve University; Case Western Reserve University; United States Department of Energy (DOE); Brookhaven National Laboratory; Johns Hopkins University; Johns Hopkins Medicine	Fu, D (corresponding author), Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA.	mrc16@case.edu; dfu3@jhmi.edu		Fu, Dax/0000-0002-2663-1316; chai, jin/0000-0002-4760-5811	National Institutes of Health [R01GM065137]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DOE) [DE-AC02-98CH10886]; Physical Biosciences Program, Office of Basic Energy Sciences of the DOE; National Institute for Biomedical Imaging and Bioengineering [P30-EB-09998, R01-EB-09688]; DOE [DE-AC02-98CH10886]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009688, P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DOE)(United States Department of Energy (DOE)); Physical Biosciences Program, Office of Basic Energy Sciences of the DOE; National Institute for Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We dedicate this work to the memory of Peter C. Maloney, who read and commented on a version of the manuscript. This work was supported in part by the National Institutes of Health under grant R01GM065137(to D.F.), the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DOE) under contract DE-AC02-98CH10886 (to D.F.); D.F. is primarily supported by the Physical Biosciences Program, Office of Basic Energy Sciences of the DOE and the National Institute for Biomedical Imaging and Bioengineering under grants P30-EB-09998 and R01-EB-09688 (to M.R.C.). The National Synchrotron Light Source at Brookhaven National Laboratory is supported by the DOE under contract DE-AC02-98CH10886.	Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Chao Y, 2004, J BIOL CHEM, V279, P12043, DOI 10.1074/jbc.M313510200; Chao Y, 2004, J BIOL CHEM, V279, P17173, DOI 10.1074/jbc.M400208200; Coudray N, 2013, P NATL ACAD SCI USA, V110, P2140, DOI 10.1073/pnas.1215455110; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Gupta S, 2007, J SYNCHROTRON RADIAT, V14, P233, DOI 10.1107/S0909049507013118; Gupta S, 2012, P NATL ACAD SCI USA, V109, P14882, DOI 10.1073/pnas.1209060109; Gupta S, 2010, STRUCTURE, V18, P839, DOI 10.1016/j.str.2010.04.012; Hinds BJ, 2004, SCIENCE, V303, P62, DOI 10.1126/science.1092048; Hoch E, 2012, P NATL ACAD SCI USA, V109, P7202, DOI 10.1073/pnas.1200362109; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kaur P, 2009, ANAL CHEM, V81, P8141, DOI 10.1021/ac9013644; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Lin HL, 2009, BIOCHEM J, V422, P273, DOI 10.1042/BJ20090853; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Podar D, 2012, J BIOL CHEM, V287, P3185, DOI 10.1074/jbc.M111.305649; Ralston CY, 2000, METHOD ENZYMOL, V317, P353; RAMOS S, 1976, P NATL ACAD SCI USA, V73, P1892, DOI 10.1073/pnas.73.6.1892; Takamoto K, 2006, ANNU REV BIOPH BIOM, V35, P251, DOI 10.1146/annurev.biophys.35.040405.102050; Wei YN, 2006, J BIOL CHEM, V281, P23492, DOI 10.1074/jbc.M602254200; Wei YN, 2005, J BIOL CHEM, V280, P33716, DOI 10.1074/jbc.M506107200; Wei YN, 2004, J BIOL CHEM, V279, P39251, DOI 10.1074/jbc.M407044200; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047	27	88	90	4	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					101	+		10.1038/nature13382	http://dx.doi.org/10.1038/nature13382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043033	Green Accepted			2022-12-01	WOS:000339908000040
J	Harjunmaa, E; Seidel, K; Hakkinen, T; Renvoise, E; Corfe, IJ; Kallonen, A; Zhang, ZQ; Evans, AR; Mikkola, ML; Salazar-Ciudad, I; Klein, OD; Jernvall, J				Harjunmaa, Enni; Seidel, Kerstin; Hakkinen, Teemu; Renvoise, Elodie; Corfe, Ian J.; Kallonen, Aki; Zhang, Zhao-Qun; Evans, Alistair R.; Mikkola, Marja L.; Salazar-Ciudad, Isaac; Klein, Ophir D.; Jernvall, Jukka			Replaying evolutionary transitions from the dental fossil record	NATURE			English	Article							MAMMALIAN TEETH; PATTERNS; ECTODYSPLASIN; MOLECULES; RADIATION; DYNAMICS; GENES; MODEL; TREES	The evolutionary relationships of extinct species are ascertained primarily through the analysis of morphological characters. Character inter-dependencies can have a substantial effect on evolutionary interpretations, but the developmental underpinnings of character inter-dependence remain obscure because experiments frequently do not provide detailed resolution of morphological characters. Here we show experimentally and computationally how gradual modification of development differentially affects characters in the mouse dentition. We found that intermediate phenotypes could be produced by gradually adding ectodysplas in A (EDA) protein in culture to tooth explants carrying a null mutation in the tooth-patterning gene Eda. By identifying development-based character inter-dependencies, we show how to predict morphological patterns of teeth among mammalian species. Finally, in vivo inhibition of sonic hedgehog signalling in Eda null teeth enabled us to reproduce characters deep in the rodent ancestry. Taken together, evolutionarily informative transitions can be experimentally reproduced, thereby providing development-based expectations for character-state transitions used in evolutionary studies.	[Harjunmaa, Enni; Hakkinen, Teemu; Renvoise, Elodie; Corfe, Ian J.; Mikkola, Marja L.; Salazar-Ciudad, Isaac; Jernvall, Jukka] Univ Helsinki, Inst Biotechnol, Dev Biol Program, FIN-00014 Helsinki, Finland; [Seidel, Kerstin; Klein, Ophir D.] Univ Calif San Francisco, Program Craniofacial & Mesenchymal Biol, San Francisco, CA 94114 USA; [Seidel, Kerstin; Klein, Ophir D.] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94114 USA; [Kallonen, Aki] Univ Helsinki, Dept Phys, Div Mat Phys, FIN-00014 Helsinki, Finland; [Zhang, Zhao-Qun] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China; [Evans, Alistair R.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Evans, Alistair R.] Museum Victoria, Melbourne, Vic 3001, Australia; [Salazar-Ciudad, Isaac] Univ Autonoma Barcelona, Dept Genet & Microbiol, Genom Bioinformat & Evolut Group, Cerdanyola Del Valles 08193, Spain; [Klein, Ophir D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94114 USA; [Klein, Ophir D.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94114 USA	University of Helsinki; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Helsinki; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Monash University; Museum Victoria; Autonomous University of Barcelona; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jernvall, J (corresponding author), Univ Helsinki, Inst Biotechnol, Dev Biol Program, POB 56, FIN-00014 Helsinki, Finland.	ophir.klein@ucsf.edu; jernvall@fastmail.fm	Evans, Alistair R/D-4239-2011; Salazar-Ciudad, Isaac/R-2238-2018; Corfe, Ian/GSN-6109-2022	Evans, Alistair R/0000-0002-4078-4693; Salazar Ciudad, Isaac/0000-0003-1607-0962; Klein, Ophir/0000-0002-6254-7082; Corfe, Ian/0000-0002-1824-755X	Academy of Finland; NIH/NIDCR [R01-DE021420]; NIH [DP2-OD007191]; Australian Research Council; MST [2012CB821904]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K99DE024214, R01DE021420] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007191] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); MST; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Fortelius, J. Eronen, I. Thesleff, P. Munne for discussions; S. Alto, M. Makinen, R. Santalahti, R. Savolainen, and M. Christensen for technical assistance; P. Schneider for the Fc-EDA-A1-protein; F. de Sauvage for HhAntag compound; Hou Yemao for tomography; and the Finnish Museum of Natural History (Helsinki, Finland), Museum of Natural History (Stockholm, Sweden), and Museum fur Naturkunde (Berlin, Germany) for specimen loans. This work was supported by the Academy of Finland to J.J., M.M., I.S.-C., R01-DE021420 (NIH/NIDCR) and an NIH Director's New Innovator Award DP2-OD007191 to O.D.K., an Australian Research Council Future Fellowship to A.R.E, and the Major Basic Research Projects (2012CB821904) of MST to Z.-Q.Z. Data are presented in the Supplementary and Extended Data Tables, available in the MorphoBrowser database (http://morphobrowser.biocenter.helsinki.fi/) and from the authors, and models can be accessed at (http://www.biocenter.helsinki.fi/bi/evodevo/toothmaker.html).	Arthur W., 2011, EVOLUTION DEV APPROA; Asher RJ, 2005, SCIENCE, V307, P1091, DOI 10.1126/science.1107808; Bhullar BAS, 2012, NATURE, V487, P223, DOI 10.1038/nature11146; BUTLER PM, 1990, BIOL REV, V65, P529, DOI 10.1111/j.1469-185X.1990.tb01237.x; Cho SW, 2011, DEVELOPMENT, V138, P1807, DOI 10.1242/dev.056051; Doyle JJ, 1997, SYST BIOL, V46, P537, DOI 10.2307/2413695; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; FELSENSTEIN J, 1973, SYST ZOOL, V22, P240, DOI 10.2307/2412304; Fliniaux I, 2008, DEV BIOL, V320, P60, DOI 10.1016/j.ydbio.2008.04.023; Gaide O, 2003, NAT MED, V9, P614, DOI 10.1038/nm861; Goswami Anjali, 2010, P141; GRUNEBERG H, 1965, J EMBRYOL EXP MORPH, V14, P137; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Harjunmaa E, 2012, NATURE, V483, P324, DOI 10.1038/nature10876; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P14444, DOI 10.1073/pnas.97.26.14444; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Antonanzas RL, 2009, ZOOL J LINN SOC-LOND, V156, P664, DOI 10.1111/j.1096-3642.2008.00494.x; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo ZX, 2007, NATURE, V450, P93, DOI 10.1038/nature06221; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; Mauldin EA, 2009, AM J MED GENET A, V149A, P2045, DOI 10.1002/ajmg.a.32916; Meng Jin, 2001, Journal of Mammalian Evolution, V8, P1, DOI 10.1023/A:1011328616715; Narhi K, 2010, METHODS MOL BIOL, V666, P253, DOI 10.1007/978-1-60761-820-1_16; O'Keefe FR, 2001, SYST BIOL, V50, P657, DOI 10.1080/106351501753328794; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Osborn J.W., 1973, Breviora, VNo. 399, P1; Polly PD, 2008, EVOL BIOL, V35, P83, DOI 10.1007/s11692-008-9020-0; Rice SH, 2008, ANN NY ACAD SCI, V1133, P67, DOI 10.1196/annals.1438.002; Rodrigues HG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3504; Salazar-Ciudad I, 2013, NATURE, V497, P361, DOI 10.1038/nature12142; Salazar-Ciudad I, 2010, NATURE, V464, P583, DOI 10.1038/nature08838; Santana SE, 2011, FUNCT ECOL, V25, P839, DOI 10.1111/j.1365-2435.2011.01832.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Van Valkenburgh B, 1999, ANNU REV EARTH PL SC, V27, P463, DOI 10.1146/annurev.earth.27.1.463; VANVALEN L, 1970, DEV BIOL, V23, P456, DOI 10.1016/0012-1606(70)90110-7; Wake D.B., 1989, Geobios Memoire Special (Villeurbanne), P369; Wessels W., 2009, GEOL ULTRAIECTINA, V307; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	43	75	78	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					44	+		10.1038/nature13613	http://dx.doi.org/10.1038/nature13613			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25079326	Green Accepted			2022-12-01	WOS:000339908000027
J	Hovenden, MJ; Newton, PCD; Wills, KE				Hovenden, Mark J.; Newton, Paul C. D.; Wills, Karen E.			Seasonal not annual rainfall determines grassland biomass response to carbon dioxide	NATURE			English	Article							ELEVATED CO2; CLIMATE-CHANGE; NITROGEN INTERACTIONS; WATER RELATIONS; ECOSYSTEMS; PRODUCTIVITY; LIMITATION; RANGELANDS; LESSONS; TRENDS	The rising atmospheric concentration of carbon dioxide (CO2) should stimulate ecosystem productivity, but to what extent is highly uncertain, particularly when combined with changing temperature and precipitation(1). Ecosystem response to CO2 is complicated by biogeochemical feedbacks(2) but must be understood if carbon storage and associated dampening of climate warming are to be predicted(3). Feedbacks through the hydrological cycle are particularly important(4) and the physiology is well known; elevated CO2 reduces stomatal conductance and increases plant water use efficiency (the amount of water required to produce a unit of plant dry matter)(5). The CO2 response should consequently be strongest when water is limiting(6); although this has been shown in some experiments(7), it is absent frommany(8-11). Here we show that large annual variation in the stimulation of above-ground biomass by elevated CO2 in a mixed C-3/C-4 temperate grassland can be predicted accurately using seasonal rainfall totals; summer rainfall had a positive effect but autumn and spring rainfall had negative effects on the CO2 response. Thus, the elevated CO2 effect mainly depended upon the balance between summer and autumn/spring rainfall. This is partly because high rainfall during cool, moist seasons leads to nitrogen limitation, reducing or even preventing biomass stimulation by elevated CO2. Importantly, the prediction held whether plots were warmed by 2 degrees C or left unwarmed, and was similar for C-3 plants and total biomass, allowing us to make a powerful generalization about ecosystem responses to elevated CO2. This new insight is particularly valuable because climate projections predict large changes in the timing of rainfall, even where annual totals remain static(12). Our findings will help resolve apparent differences in the outcomes of CO2 experiments and improve the formulation and interpretation of models that are insensitive to differences in the seasonal effects of rainfall on the CO2 response(7,13,14).	[Hovenden, Mark J.; Wills, Karen E.] Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia; [Newton, Paul C. D.] AgResearch, Land & Environm Management, Palmerston North 4474, New Zealand	University of Tasmania; AgResearch - New Zealand	Hovenden, MJ (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia.	Mark.Hovenden@utas.edu.au	Wills, Karen/M-2652-2019; Wills, Karen E/H-4390-2012; Hovenden, Mark/A-1323-2008	Wills, Karen/0000-0003-3897-2908; Wills, Karen E/0000-0003-3897-2908; Hovenden, Mark/0000-0001-7208-9700	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by grants from the Australian Research Council Discovery Projects scheme. We thank the Australian Department of Defence for access to the Pontville Small Arms Range Complex. J. Vander Schoor, A. Williams, J. Janes, J. Buettel and M. Porter provided technical assistance. R. Mallett assisted with statistical analyses and L. Barmuta provided advice on multimodel inference.	[Anonymous], 2011, R LANG ENV STAT COMP; Borken W, 2009, GLOBAL CHANGE BIOL, V15, P808, DOI 10.1111/j.1365-2486.2008.01681.x; Burnham KP., 2002, MODEL SELECTION MULT, V2; De Kauwe MG, 2013, GLOBAL CHANGE BIOL, V19, P1759, DOI 10.1111/gcb.12164; Derner JD, 2003, GLOBAL CHANGE BIOL, V9, P452, DOI 10.1046/j.1365-2486.2003.00579.x; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Grunzweig JM, 2001, OECOLOGIA, V128, P251, DOI 10.1007/s004420100657; Hovenden MJ, 2006, AUST J BOT, V54, P1, DOI 10.1071/BT04194; K/rner C., 2007, TERRESTRIAL ECOSYSTE, P9, DOI [10.1007/978-3-540-32730-1_2, DOI 10.1007/978-3-540-32730-1_2]; Knapp AK, 2001, ECOSYSTEMS, V4, P19, DOI 10.1007/s100210000057; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Leuzinger S, 2010, GLOBAL CHANGE BIOL, V16, P246, DOI 10.1111/j.1365-2486.2009.01937.x; Marissink M, 2002, AGR ECOSYST ENVIRON, V93, P107, DOI 10.1016/S0167-8809(01)00356-5; Matthews HD, 2007, GLOBAL CHANGE BIOL, V13, P1068, DOI 10.1111/j.1365-2486.2007.01343.x; McMurtrie RE, 2008, FUNCT PLANT BIOL, V35, P521, DOI 10.1071/FP08128; Morgan JA, 2004, OECOLOGIA, V140, P11, DOI 10.1007/s00442-004-1550-2; Morgan JA, 2004, ECOL APPL, V14, P208, DOI 10.1890/02-5213; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; Norby RJ, 2011, ANNU REV ECOL EVOL S, V42, P181, DOI 10.1146/annurev-ecolsys-102209-144647; Nowak RS, 2004, NEW PHYTOL, V162, P253, DOI 10.1111/j.1469-8137.2004.01033.x; Osanai Y, 2012, PLANT SOIL, V350, P365, DOI 10.1007/s11104-011-0920-x; Peters GP, 2013, NAT CLIM CHANGE, V3, P4, DOI 10.1038/nclimate1783; Piao SL, 2013, GLOBAL CHANGE BIOL, V19, P2117, DOI 10.1111/gcb.12187; Polley HW, 2013, RANGELAND ECOL MANAG, V66, P493, DOI 10.2111/REM-D-12-00068.1; Quinn G.P., 2002, EXPT DESIGN DATA ANA; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Reich PB, 2006, ANNU REV ECOL EVOL S, V37, P611, DOI 10.1146/annurev.ecolsys.37.091305.110039; Reich PB, 2013, NAT CLIM CHANGE, V3, P278, DOI [10.1038/nclimate1694, 10.1038/NCLIMATE1694]; Singh D, 2013, J GEOPHYS RES-ATMOS, V118, P7063, DOI 10.1002/jgrd.50543; Sokolov AP, 2008, J CLIMATE, V21, P3776, DOI 10.1175/2008JCLI2038.1; Solomon S., 2007, ADV CLIM CHANG RES; Soussana JF, 2007, GRASS FORAGE SCI, V62, P127, DOI 10.1111/j.1365-2494.2007.00577.x; Webb NP, 2012, CLIMATIC CHANGE, V112, P925, DOI 10.1007/s10584-011-0236-0	34	107	115	6	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					583	+		10.1038/nature13281	http://dx.doi.org/10.1038/nature13281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	24870242				2022-12-01	WOS:000339566300033
J	Canaud, G; Bienaime, F; Tabarin, F; Bataillon, G; Seilhean, D; Noel, LH; Dragon-Durey, MA; Snanoudj, R; Friedlander, G; Halbwachs-Mecarelli, L; Legendre, C; Terzi, F				Canaud, Guillaume; Bienaime, Frank; Tabarin, Fanny; Bataillon, Guillaume; Seilhean, Danielle; Noel, Laure-Helene; Dragon-Durey, Marie-Agnes; Snanoudj, Renaud; Friedlander, Gerard; Halbwachs-Mecarelli, Lise; Legendre, Christophe; Terzi, Fabiola			Inhibition of the mTORC Pathway in the Antiphospholipid Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTIBODY-MEDIATED REJECTION; POLYCYSTIC KIDNEY-DISEASE; SMOOTH-MUSCLE-CELLS; ANTI-BETA(2)-GLYCOPROTEIN-I ANTIBODIES; SYNDROME NEPHROPATHY; RAPAMYCIN; VASCULOPATHY; BETA(2)-GLYCOPROTEIN-I; ANGIOPLASTY	BACKGROUND Although thrombosis is considered the cardinal feature of the antiphospholipid syndrome, chronic vascular lesions are common, particularly in patients with life-threatening complications. In patients who require transplantation, vascular lesions often recur. The molecular pathways involved in the vasculopathy of the antiphospholipid syndrome are unknown, and adequate therapies are lacking. METHODS We used double immunostaining to evaluate pathway activation in the mammalian target of rapamycin complex (mTORC) and the nature of cell proliferation in the vessels of patients with primary or secondary antiphospholipid syndrome nephropathy. We also evaluated autopsy specimens from persons who had catastrophic antiphospholipid syndrome. The molecular pathways through which antiphospholipid antibodies modulate the mTORC pathway were evaluated in vitro, and potential pharmacologic inhibitors were also tested in vitro. Finally, we studied the effect of sirolimus in kidney-transplant recipients with the antiphospholipid syndrome. RESULTS The vascular endothelium of proliferating intrarenal vessels from patients with antiphospholipid syndrome nephropathy showed indications of activation of the mTORC pathway. In cultured vascular endothelial cells, IgG antibodies from patients with the antiphospholipid syndrome stimulated mTORC through the phosphatidy-l-inositol 3-kinase (PI3K)-AKT pathway. Patients with antiphospholipid syndrome nephropathy who required transplantation and were receiving sirolimus had no recurrence of vascular lesions and had decreased vascular proliferation on biopsy as compared with patients with antiphospholipid antibodies who were not receiving sirolimus. Among 10 patients treated with sirolimus, 7 (70%) had a functioning renal allograft 144 months after transplantation versus 3 of 27 untreated patients (11%). Activation of mTORC was also found in the vessels of autopsy specimens from patients with catastrophic antiphospholipid syndrome. CONCLUSIONS Our results suggest that the mTORC pathway is involved in the vascular lesions associated with the antiphospholipid syndrome.	[Canaud, Guillaume; Bienaime, Frank; Tabarin, Fanny; Friedlander, Gerard; Halbwachs-Mecarelli, Lise; Legendre, Christophe; Terzi, Fabiola] Univ Paris 05, INSERM, U1151, Inst Necker Enfants Malad,Sorbone Paris Cite, Paris, France; [Canaud, Guillaume; Snanoudj, Renaud; Legendre, Christophe] Hop Necker Enfants Malad, Serv Nephrol Transplantat Adultes, F-75015 Paris, France; [Bienaime, Frank; Friedlander, Gerard] Hop Necker Enfants Malad, Serv Explorat Fonct, F-75015 Paris, France; [Noel, Laure-Helene] Hop Necker Enfants Malad, Serv Anat & Cytol Pathol, F-75015 Paris, France; [Dragon-Durey, Marie-Agnes] Hop Necker Enfants Malad, Serv Immunol Biol, F-75015 Paris, France; [Bataillon, Guillaume; Seilhean, Danielle] Univ Paris 06, Hop Europeen Georges Pompidou, Hop Pitie Salpetriere, AP HP, Paris, France; [Bataillon, Guillaume; Seilhean, Danielle] Univ Paris 06, Neuropathol Lab, Hop Pitie Salpetriere, AP HP, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Terzi, F (corresponding author), Hop Necker Enfants Malad, INSERM, U1151, 6eme Etage,149 Rue Sevres, F-75015 Paris, France.	fabiola.terzi@inserm.fr	Snanoudj, Renaud/AAK-1294-2020; , Dragon-Durey/AGM-3653-2022	Snanoudj, Renaud/0000-0002-6657-6235; Friedlander, Gerard/0000-0002-6854-4261; Dragon-Durey, Marie-Agnes/0000-0002-5809-8122; Bienaime, Frank/0000-0002-8666-2042	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	Funded by INSERM and others.	ALARCONSEGOVIA D, 1989, J RHEUMATOL, V16, P762; Allen KL, 2012, BLOOD, V119, P884, DOI 10.1182/blood-2011-03-344671; Basu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023919; Bayliss J, 2008, TRANSPLANTATION, V86, P991, DOI 10.1097/TP.0b013e318186d734; Canaud G, 2013, AM J TRANSPLANT, V13, P2179, DOI 10.1111/ajt.12319; Canaud G, 2010, AM J TRANSPLANT, V10, P1701, DOI 10.1111/j.1600-6143.2010.03152.x; Canaud G, 2013, NAT MED, V19, P1288, DOI 10.1038/nm.3313; Daugas E, 2002, J AM SOC NEPHROL, V13, P42, DOI 10.1681/ASN.V13142; de Laat B, 2006, BLOOD, V107, P1916, DOI 10.1182/blood-2005-05-1943; Eisen HJ, 2003, NEW ENGL J MED, V349, P847, DOI 10.1056/NEJMoa022171; Espinosa G, 2009, CURR OPIN PULM MED, V15, P413, DOI 10.1097/MCP.0b013e32832d0463; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Gallo R, 1999, CIRCULATION, V99, P2164, DOI 10.1161/01.CIR.99.16.2164; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Heydarkhan-Hagvall S, 2003, J CELL BIOCHEM, V89, P1250, DOI 10.1002/jcb.10583; HUGHSON MD, 1995, HUM PATHOL, V26, P716, DOI 10.1016/0046-8177(95)90218-X; Ivey ME, 2008, ATHEROSCLEROSIS, V199, P237, DOI 10.1016/j.atherosclerosis.2008.03.006; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Lepin EJ, 2006, AM J TRANSPLANT, V6, P1560, DOI 10.1111/j.1600-6143.2006.01355.x; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; Long BR, 2008, HEMATOL ONCOL CLIN N, V22, P79, DOI 10.1016/j.hoc.2007.10.002; MAJESKY MW, 1991, J CLIN INVEST, V88, P904, DOI 10.1172/JCI115393; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Nochy D, 1999, J AM SOC NEPHROL, V10, P507; Poulton K, 2012, SEMIN ARTHRITIS RHEU, V41, P720, DOI 10.1016/j.semarthrit.2011.09.004; Qi YX, 2011, P NATL ACAD SCI USA, V108, P1908, DOI 10.1073/pnas.1019219108; Ramesh S, 2011, J CLIN INVEST, V121, P120, DOI 10.1172/JCI39828; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Shi T, 2006, ARTHRITIS RHEUM-US, V54, P2558, DOI 10.1002/art.21968; Sousa JE, 2001, CIRCULATION, V104, P2007, DOI 10.1161/hc4201.098056; Stylianou K, 2011, NEPHROL DIAL TRANSPL, V26, P498, DOI 10.1093/ndt/gfq496; Tektonidou MG, 2004, ARTHRITIS RHEUM-US, V50, P2569, DOI 10.1002/art.20433; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; WARNER LM, 1994, ARTHRITIS RHEUM, V37, P289, DOI 10.1002/art.1780370219; Zhang X, 2009, AM J TRANSPLANT, V9, P2459, DOI 10.1111/j.1600-6143.2009.02819.x	37	193	204	2	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					303	312		10.1056/NEJMoa1312890	http://dx.doi.org/10.1056/NEJMoa1312890			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7TY	25054716				2022-12-01	WOS:000339339800007
J	Vachieri, SG; Xiong, XL; Collins, PJ; Walker, PA; Martin, SR; Haire, LF; Zhang, Y; McCauley, JW; Gamblin, SJ; Skehel, JJ				Vachieri, Sebastien G.; Xiong, Xiaoli; Collins, Patrick J.; Walker, Philip A.; Martin, Stephen R.; Haire, Lesley F.; Zhang, Ying; McCauley, John W.; Gamblin, Steven J.; Skehel, John J.			Receptor binding by H10 influenza viruses	NATURE			English	Article							A VIRUS; HEMAGGLUTININ; H5; SPECIFICITY; COMPLEXES; EPITHELIUM; EVOLUTION; SELECTION; CELL; H7	H10N8 follows H7N9 and H5N1 as the latest in a line of avian influenza viruses that cause serious disease in humans and have become a threat to public health(1). Since December 2013, three human cases of H10N8 infection have been reported, two of whom are known to have died. To gather evidence relating to the epidemic potential of H10 we have determined the structure of the haemagglutinin of a previously isolated avian H10 virus and we present here results relating especially to its receptor-binding properties, as these are likely to be major determinants of virus transmissibility. Our results show, first, that the H10 virus possesses high avidity for human receptors and second, from the crystal structure of the complex formed by avian H10 haemagglutinin with human receptor, it is clear that the conformation of the bound receptor has characteristics of both the 1918 H1N1 pandemic virus(2) and the human H7 viruses isolated from patients in 2013 (ref. 3). We conclude that avian H10N8 virus has sufficient avidity for human receptors to account for its infection of humans but that its preference for avian receptors should make avian receptor-rich human airway mucins(4) an effective block to widespread infection. In terms of surveillance, particular attention will be paid to the detection of mutations in the receptor-binding site of the H10 haemagglutinin that decrease its avidity for avian receptor, and could enable it to be more readily transmitted between humans.	[Vachieri, Sebastien G.; Xiong, Xiaoli; Collins, Patrick J.; Walker, Philip A.; Martin, Stephen R.; Haire, Lesley F.; Zhang, Ying; McCauley, John W.; Gamblin, Steven J.; Skehel, John J.] MRC Natl Inst Med Res, London NW7 1AA, England	MRC National Institute for Medical Research	Gamblin, SJ (corresponding author), MRC Natl Inst Med Res, Mill Hill, London NW7 1AA, England.	sgambli@nimr.mrc.ac.uk; skeheljj@nimr.mrc.ac.uk		Gamblin, Steve/0000-0001-5331-639X; Xiong, Xiaoli/0000-0002-4632-9122	Medical Research Council [U117584222, U117570592, U117585868]; MRC [MC_U117512723, G0600522, MC_U117585868] Funding Source: UKRI; Medical Research Council [MC_U117512723, G0600522, MC_U117585868] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank N. Bovin for gifts of sulphated sialoside. We greatly acknowledge Diamond Light Source for access to synchrotron time under proposal 7707. This work was funded by the Medical Research Council through programmes U117584222, U117570592 and U117585868.	Chen H., 2014, LANCET; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gambaryan AS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-85; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Ha Y, 2003, VIROLOGY, V309, P209, DOI 10.1016/S0042-6822(03)00068-0; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Keawcharoen J, 2010, VACCINE, V28, P5803, DOI 10.1016/j.vaccine.2010.06.072; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich M, 2007, VIROLOGY, V361, P384, DOI 10.1016/j.virol.2006.11.030; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Otwinowski Z., 1993, P CCP4 STUDY WEEKEND, P556; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; ROGERS GN, 1985, J BIOL CHEM, V260, P7362; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Shi Y, 2013, SCIENCE, V342, P243, DOI 10.1126/science.1242917; SKEHEL JJ, 1971, VIROLOGY, V44, P396, DOI 10.1016/0042-6822(71)90270-4; Xiong X, 2013, VIRUS RES, V178, P12, DOI 10.1016/j.virusres.2013.08.007; Xiong XL, 2013, NATURE, V499, P496, DOI 10.1038/nature12372; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144; Xu R, 2012, J VIROL, V86, P982, DOI 10.1128/JVI.06322-11; Xu R, 2011, J VIROL, V85, P5172, DOI 10.1128/JVI.02430-10; Zhang W, 2013, SCIENCE, V340, P1463, DOI 10.1126/science.1236787	27	62	65	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					475	+		10.1038/nature13443	http://dx.doi.org/10.1038/nature13443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	24870229				2022-12-01	WOS:000339335700048
J	Choulet, F; Alberti, A; Theil, S; Glover, N; Barbe, V; Daron, J; Pingault, L; Sourdille, P; Couloux, A; Paux, E; Leroy, P; Mangenot, S; Guilhot, N; Le Gouis, J; Balfourier, F; Alaux, M; Jamilloux, V; Poulain, J; Durand, C; Bellec, A; Gaspin, C; Safar, J; Dolezel, J; Rogers, J; Vandepoele, K; Aury, JM; Mayer, K; Berges, H; Quesneville, H; Wincker, P; Feuillet, C				Choulet, Frederic; Alberti, Adriana; Theil, Sebastien; Glover, Natasha; Barbe, Valerie; Daron, Josquin; Pingault, Lise; Sourdille, Pierre; Couloux, Arnaud; Paux, Etienne; Leroy, Philippe; Mangenot, Sophie; Guilhot, Nicolas; Le Gouis, Jacques; Balfourier, Francois; Alaux, Michael; Jamilloux, Veronique; Poulain, Julie; Durand, Celine; Bellec, Arnaud; Gaspin, Christine; Safar, Jan; Dolezel, Jaroslav; Rogers, Jane; Vandepoele, Klaas; Aury, Jean-Marc; Mayer, Klaus; Berges, Helene; Quesneville, Hadi; Wincker, Patrick; Feuillet, Catherine			Structural and functional partitioning of bread wheat chromosome 3B	SCIENCE			English	Article							TRANSPOSABLE ELEMENTS; GENE DUPLICATION; GENOME SEQUENCE; COMPLEX GENOMES; DRAFT GENOME; EVOLUTION; RECOMBINATION; DIVERSITY; MAP; KARYOTYPE	We produced a reference sequence of the 1-gigabase chromosome 3B of hexaploid bread wheat. By sequencing 8452 bacterial artificial chromosomes in pools, we assembled a sequence of 774 megabases carrying 5326 protein-coding genes, 1938 pseudogenes, and 85% of transposable elements. The distribution of structural and functional features along the chromosome revealed partitioning correlated with meiotic recombination. Comparative analyses indicated high wheat-specific inter-and intrachromosomal gene duplication activities that are potential sources of variability for adaption. In addition to providing a better understanding of the organization, function, and evolution of a large and polyploid genome, the availability of a high-quality sequence anchored to genetic maps will accelerate the identification of genes underlying important agronomic traits.	[Choulet, Frederic; Theil, Sebastien; Glover, Natasha; Daron, Josquin; Pingault, Lise; Sourdille, Pierre; Paux, Etienne; Leroy, Philippe; Guilhot, Nicolas; Le Gouis, Jacques; Balfourier, Francois; Feuillet, Catherine] INRA, UMR1095, 5 Chemin Beaulieu, F-63039 Clermont Ferrand, France; [Choulet, Frederic; Theil, Sebastien; Glover, Natasha; Daron, Josquin; Pingault, Lise; Sourdille, Pierre; Paux, Etienne; Leroy, Philippe; Guilhot, Nicolas; Le Gouis, Jacques; Balfourier, Francois; Feuillet, Catherine] Univ Blaise Pascal, UMR1095, F-63039 Clermont Ferrand, France; [Alberti, Adriana; Barbe, Valerie; Couloux, Arnaud; Mangenot, Sophie; Poulain, Julie; Durand, Celine; Aury, Jean-Marc; Wincker, Patrick] Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Genom, F-91000 Evry, France; [Alaux, Michael; Jamilloux, Veronique; Quesneville, Hadi] INRA Versailles, Res Unit Genom Info, UR1164, INRA, F-78026 Versailles, France; [Bellec, Arnaud; Berges, Helene] INRA, UPR 1258, Ctr Natl Ressources Genom Vegetales, F-31326 Castanet Tolosan, France; [Gaspin, Christine] INRA, Biometrie & Intelligence Artificielle, F-31326 Castanet Tolosan, France; [Safar, Jan; Dolezel, Jaroslav] Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, CZ-78371 Olomouc, Czech Republic; [Rogers, Jane] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Vandepoele, Klaas] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Vandepoele, Klaas] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Mayer, Klaus] Helmholtz Zentrum Muenchen, Inst Bioinformat & Syst Biol, Munich Informat Ctr Prot Sequences, D-85764 Neuherberg, Germany; [Wincker, Patrick] CNRS, UMR 8030, F-91000 Evry, France; [Wincker, Patrick] Univ Evry, CP5706 Evry, Evry, France	INRAE; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); CEA; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; The Genome Analysis Centre (TGAC); Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Choulet, F (corresponding author), INRA, UMR1095, 5 Chemin Beaulieu, F-63039 Clermont Ferrand, France.	frederic.choulet@clermont.inra.fr	Gaspin, Christine/B-6756-2015; Alberti, Adriana/E-7142-2017; Vandepoele, Klaas/E-7514-2010; Alberti, Adriana/AAZ-2013-2021; Sourdille, Pierre/CAF-2780-2022; Quesneville, Hadi/AAG-1048-2020; Safar, Jan/G-1038-2014; Aury, Jean-Marc/N-1621-2019; Pingault, Lise/AAQ-8602-2020; Dolezel, Jaroslav/B-7716-2008; Mayer, Klaus FX/M-7941-2015	Alberti, Adriana/0000-0003-3372-9423; Vandepoele, Klaas/0000-0003-4790-2725; Alberti, Adriana/0000-0003-3372-9423; Quesneville, Hadi/0000-0003-3001-4908; Aury, Jean-Marc/0000-0003-1718-3010; Pingault, Lise/0000-0002-6149-1267; Dolezel, Jaroslav/0000-0002-6263-0492; Mayer, Klaus FX/0000-0001-6484-1077; Sourdille, Pierre/0000-0002-1027-2224; Paux, Etienne/0000-0002-3094-7129; BERGES, Helene/0000-0002-5492-1062; Poulain, Julie/0000-0002-8744-3116; Jamilloux, Veronique/0000-0002-6898-4910; Daron, Josquin/0000-0003-3914-5998; Alaux, Michael/0000-0001-9356-4072; Couloux, Arnaud/0000-0003-2356-0062; Choulet, Frederic/0000-0003-1788-7288	French National Research Agency [ANR-09-GENM-025 3BSEQ]; France Agrimer; INRA BAP Biologie et Amelioration des Plantes division; European Commission research training program Marie-Curie Actions (FP7-MC-IIF-NoncollinearGenes); French Ministry of Research; Region Auvergne; Ghent University Multidisciplinary Research Partnership ["Bioinformatics: From nucleotides to networks"] [01MR0310W]; Czech Science Foundation [P501/12/G090]; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193] Funding Source: researchfish; BBSRC [BBS/E/T/000PR6193] Funding Source: UKRI	French National Research Agency(French National Research Agency (ANR)); France Agrimer; INRA BAP Biologie et Amelioration des Plantes division; European Commission research training program Marie-Curie Actions (FP7-MC-IIF-NoncollinearGenes); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Region Auvergne(Region Auvergne-Rhone-Alpes); Ghent University Multidisciplinary Research Partnership ["Bioinformatics: From nucleotides to networks"](Ghent University); Czech Science Foundation(Grant Agency of the Czech Republic); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the scientific advisory board (P. Schnable, S. Rounsley, D. Ware, J. Rogers, and K. Eversole) of the 3BSEQ project for fruitful discussions; K. Eversole for critical reading and editing of the manuscript; H. Rimbert, N. Cubizolles, and E. Rey for SNP marker discovery and genotyping; M. Kubalakova and J. Vrana for assistance with the preparation of DNA amplified from flow-sorted chromosome 3B; L. Couderc, A. Keliet, and S. Reboux for their support in database and system administration; and C. Poncet and the "Plateforme GENTYANE" for SNP genotyping. This work was supported by a grant from the French National Research Agency (ANR-09-GENM-025 3BSEQ), a grant from France Agrimer, and a grant (project DL-BLE) from the INRA BAP Biologie et Amelioration des Plantes division. N. G. is funded by a grant from the European Commission research training program Marie-Curie Actions (FP7-MC-IIF-NoncollinearGenes). J. Daron is funded by a grant from the French Ministry of Research. L. P. is funded by a grant from the Region Auvergne. K. V. is supported by the Ghent University Multidisciplinary Research Partnership ["Bioinformatics: From nucleotides to networks" (Project 01MR0310W)]. J. Dolezel is supported by the Czech Science Foundation (award no. P501/12/G090). The chromosome 3B BAC library and the pools of the MTP BAC clones are available upon request under a materials transfer agreement at the French Plant Genomic Center, INRA-Centre National de Ressources Genomiques Vegetales. Annotation data and browser are available at https://urgi.versailles.inra.fr/gb2/gbrowse/wheat_annot_3B. Sequences and annotations of the reference pseudomolecule and unassigned scaffolds have been deposited in ENA (project PRJEB4376) under accession numbers HG670306 and CBUC010000001 to CBUC010001450, respectively. RNA-Seq data were deposited under accession number ERP004714.	Akhunov ED, 2003, P NATL ACAD SCI USA, V100, P10836, DOI 10.1073/pnas.1934431100; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; Baucom RS, 2009, GENOME RES, V19, P243, DOI 10.1101/gr.083360.108; Bhat PR, 2007, NUCLEIC ACIDS RES, V35, P2936, DOI 10.1093/nar/gkm148; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Charles M, 2008, GENETICS, V180, P1071, DOI 10.1534/genetics.108.092304; Chen J., 2012, PARAMETRIC STATISTIC; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; Dolezel J, 2007, CHROMOSOME RES, V15, P51, DOI 10.1007/s10577-006-1106-x; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Evans J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079192; Feuillet C, 2011, TRENDS PLANT SCI, V16, P77, DOI 10.1016/j.tplants.2010.10.005; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; GILL BS, 1991, GENOME, V34, P830, DOI 10.1139/g91-128; Goffinet B, 2000, GENETICS, V155, P463; Gottlieb A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054101; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Leroy P, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00005; Li BC, 2013, PLANT J, V73, P952, DOI 10.1111/tpj.12086; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Lu C, 2012, MOL BIOL EVOL, V29, P1005, DOI 10.1093/molbev/msr282; LUKASZEWSKI AJ, 1993, THEOR APPL GENET, V86, P121, DOI 10.1007/BF00223816; Marx V, 2013, NATURE, V501, P263, DOI 10.1038/501261a; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Murat F, 2010, GENOME RES, V20, P1545, DOI 10.1101/gr.109744.110; Pan QC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052777; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Paux E, 2010, PLANT BIOTECHNOL J, V8, P196, DOI 10.1111/j.1467-7652.2009.00477.x; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Rustenholz C, 2011, PLANT PHYSIOL, V157, P1596, DOI 10.1104/pp.111.183921; Safar J, 2004, PLANT J, V39, P960, DOI 10.1111/j.1365-313X.2004.02179.x; Saintenac C, 2009, GENETICS, V181, P393, DOI 10.1534/genetics.108.097469; Sakuno T, 2009, NATURE, V458, P852, DOI 10.1038/nature07876; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sekhon RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061005; Sergeeva EM, 2010, MOL GENET GENOMICS, V284, P11, DOI 10.1007/s00438-010-0544-5; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Wicker T, 2010, GENOME RES, V20, P1229, DOI 10.1101/gr.107284.110; Wilson ID, 2004, PLANT BIOTECHNOL J, V2, P495, DOI 10.1111/j.1467-7652.2004.00096.x; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yan HH, 2008, PLOS BIOL, V6, P2563, DOI 10.1371/journal.pbio.0060286; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang H, 2012, CHROMOSOME RES, V20, P403, DOI 10.1007/s10577-012-9284-1; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	56	386	406	1	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194			SI				1249721	10.1126/science.1249721	http://dx.doi.org/10.1126/science.1249721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR2MB	25035497	Green Submitted			2022-12-01	WOS:000343420300001
J	Maldarelli, F; Wu, X; Su, L; Simonetti, FR; Shao, W; Hill, S; Spindler, J; Ferris, AL; Mellors, JW; Kearney, MF; Coffin, JM; Hughes, SH				Maldarelli, F.; Wu, X.; Su, L.; Simonetti, F. R.; Shao, W.; Hill, S.; Spindler, J.; Ferris, A. L.; Mellors, J. W.; Kearney, M. F.; Coffin, J. M.; Hughes, S. H.			Specific HIV integration sites are linked to clonal expansion and persistence of infected cells	SCIENCE			English	Article							CD4(+) T-CELLS; ANTIRETROVIRAL THERAPY; RESERVOIR; GENES; CURE; IDENTIFICATION; LYMPHOMAS; DYNAMICS; DNA	The persistence of HIV-infected cells in individuals on suppressive combination antiretroviral therapy (cART) presents a major barrier for curing HIV infections. HIV integrates its DNA into many sites in the host genome; we identified 2410 integration sites in peripheral blood lymphocytes of five infected individuals on cART. About 40% of the integrations were in clonally expanded cells. Approximately 50% of the infected cells in one patient were from a single clone, and some clones persisted for many years. There were multiple independent integrations in several genes, including MKL2 and BACH2; many of these integrations were in clonally expanded cells. Our findings show that HIV integration sites can play a critical role in expansion and persistence of HIV-infected cells.	[Maldarelli, F.; Simonetti, F. R.; Hill, S.; Spindler, J.; Ferris, A. L.; Kearney, M. F.; Hughes, S. H.] NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA; [Wu, X.; Su, L.; Shao, W.] Leidos Biomed Res, Frederick, MD 21702 USA; [Simonetti, F. R.] Univ Milan, Dept Biomed & Clin Sci L Sacco, I-20122 Milan, Italy; [Mellors, J. W.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA; [Coffin, J. M.] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Milan; Luigi Sacco Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tufts University	Hughes, SH (corresponding author), NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA.	hughesst@mail.nih.gov	Maldarelli, Frank/O-2428-2016; Kearney, Mary/AAU-8132-2020	Kearney, Mary/0000-0003-3839-6576	Federal funds from the National Cancer Institute, an NIH; National Cancer Institute [HSSN261200800001E, 25XS119]; American Cancer Society; F. M. Kirby Foundation; NATIONAL CANCER INSTITUTE [ZIABC011426, R37CA089441, R01CA089441] Funding Source: NIH RePORTER	Federal funds from the National Cancer Institute, an NIH; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); F. M. Kirby Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are indebted to the study participants and to the clinical staff of the National Institute of Allergy and Infectious Diseases/Critical Care Medicine Department clinic who cared for them. We thank C. Lane, H. Malech, H. Imamichi, S. Matsushita, and L. Frenkel for stimulating discussions. We are grateful to J. Meyer and A. Kane for help with the figures and T. Burdette for help in preparing the manuscript. The data presented in this work is tabulated in the main paper and in the supplementary materials. The integration sites are compiled in table S3; the data can also be accessed using the National Center for Biotechnology Information accession no. PRJNA241020. Funding for this research was provided with Federal funds from the National Cancer Institute, an NIH Bench to Bedside award (F. M.), and by funds from the National Cancer Institute under contract HSSN261200800001E (X. W. and L. S.). J. M. C. was supported by a Research Professorship from the American Cancer Society with additional support from the F. M. Kirby Foundation and by funding from the National Cancer Institute (Leidos contract 25XS119). J. W. M. was supported by funding from the National Cancer Institute (Leidos contract 25XS119). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.	Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Berry CC, 2012, BIOINFORMATICS, V28, P755, DOI 10.1093/bioinformatics/bts004; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Coffin J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012526; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; De Ravin S. S., 2014, J VIROL; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Flucke U, 2013, HISTOPATHOLOGY, V62, P925, DOI 10.1111/his.12100; Gillet NA, 2011, BLOOD, V117, P3113, DOI 10.1182/blood-2010-10-312926; Han YF, 2004, J VIROL, V78, P6122, DOI 10.1128/JVI.78.12.6122-6133.2004; HERNDIER BG, 1992, BLOOD, V79, P1768; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hu GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3830; Ikeda T, 2007, J INFECT DIS, V195, P716, DOI 10.1086/510915; Imamichi H., 2014, AIDS; Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110; Katano H, 2007, MICROBES INFECT, V9, P1581, DOI 10.1016/j.micinf.2007.09.008; Kearney MF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004010; Kobayashi S, 2011, GENE CHROMOSOME CANC, V50, P207, DOI 10.1002/gcc.20845; Liu JH, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-2; Mack KD, 2003, JAIDS-J ACQ IMM DEF, V33, P308, DOI 10.1097/00126334-200307010-00004; Muehlich S, 2012, ONCOGENE, V31, P3913, DOI 10.1038/onc.2011.560; Palmer S, 2011, J INTERN MED, V270, P550, DOI 10.1111/j.1365-2796.2011.02457.x; Rosenberg N., 1997, P475; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; SHIRAMIZU B, 1994, CANCER RES, V54, P2069; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0	29	531	539	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					179	183		10.1126/science.1254194	http://dx.doi.org/10.1126/science.1254194			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	24968937	Green Accepted			2022-12-01	WOS:000339409900044
J	Iversen, L; Tu, HL; Lin, WC; Christensen, SM; Abel, SM; Iwig, J; Wu, HJ; Gureasko, J; Rhodes, C; Petit, RS; Hansen, SD; Thill, P; Yu, CH; Stamou, D; Chakraborty, AK; Kuriyan, J; Groves, JT				Iversen, Lars; Tu, Hsiung-Lin; Lin, Wan-Chen; Christensen, Sune M.; Abel, Steven M.; Iwig, Jeff; Wu, Hung-Jen; Gureasko, Jodi; Rhodes, Christopher; Petit, Rebecca S.; Hansen, Scott D.; Thill, Peter; Yu, Cheng-Han; Stamou, Dimitrios; Chakraborty, Arup K.; Kuriyan, John; Groves, Jay T.			Ras activation by SOS: Allosteric regulation by altered fluctuation dynamics	SCIENCE			English	Article							SINGLE-MOLECULE; SIGNAL-TRANSDUCTION; ENZYME CATALYSIS; PLASMA-MEMBRANE; HISTONE DOMAIN; SEVENLESS; CELL; PROTEINS; TIME; AUTOINHIBITION	Activation of the small guanosine triphosphatase H-Ras by the exchange factor Son of Sevenless (SOS) is an important hub for signal transduction. Multiple layers of regulation, through protein and membrane interactions, govern activity of SOS. We characterized the specific activity of individual SOS molecules catalyzing nucleotide exchange in H-Ras. Single-molecule kinetic traces revealed that SOS samples a broad distribution of turnover rates through stochastic fluctuations between distinct, long-lived (more than 100 seconds), functional states. The expected allosteric activation of SOS by Ras-guanosine triphosphate (GTP) was conspicuously absent in the mean rate. However, fluctuations into highly active states were modulated by Ras-GTP. This reveals a mechanism in which functional output may be determined by the dynamical spectrum of rates sampled by a small number of enzymes, rather than the ensemble average.	[Iversen, Lars; Tu, Hsiung-Lin; Lin, Wan-Chen; Christensen, Sune M.; Wu, Hung-Jen; Petit, Rebecca S.; Hansen, Scott D.; Kuriyan, John; Groves, Jay T.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA; [Abel, Steven M.; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Iwig, Jeff; Gureasko, Jodi; Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Rhodes, Christopher] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Thill, Peter; Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Yu, Cheng-Han; Groves, Jay T.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Stamou, Dimitrios] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Stamou, Dimitrios] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] Ragon Inst Massachusetts Gen Hosp MIT & Harvard, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Kuriyan, John; Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Kuriyan, John; Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Groves, Jay T.] Berkeley Educ Alliance Res Singapore, Singapore 138602, Singapore	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); National University of Singapore; University of Copenhagen; University of Copenhagen; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Groves, JT (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA.	jtgroves@lbl.gov	Yu, Cheng-han/K-8732-2013; Tu, Hsiung-Lin/B-6814-2018; Iversen, Lars/C-5298-2011; Stamou, Dimitrios/D-5042-2016; Wu, Hung-Jen/H-3769-2016	Yu, Cheng-han/0000-0002-8821-8877; Tu, Hsiung-Lin/0000-0003-1125-1879; Iversen, Lars/0000-0002-1314-130X; Stamou, Dimitrios/0000-0001-8456-8995; Wu, Hung-Jen/0000-0003-3082-7431; Christensen, Sune/0000-0001-9650-6660; Abel, Steven/0000-0003-0491-8647	NIH [P01 AI091580]; Danish Council for Independent Research, Natural Sciences; Mechanobiology Institute, National University of Singapore; Berkeley Education Alliance for Research in Singapore; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI091580] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Mechanobiology Institute, National University of Singapore(National University of Singapore); Berkeley Education Alliance for Research in Singapore; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Major support was provided by NIH P01 AI091580. Additional support was provided by the Danish Council for Independent Research, Natural Sciences (L. I., S. M. C., and D. S.), by the Mechanobiology Institute, National University of Singapore (C.-H.Y. and J.T.G.), and by the Berkeley Education Alliance for Research in Singapore (J.T.G.). L. I., H.-L. T., W.-C. L., and J.T.G. planned and designed the research; H.-L. T. and L. I. performed experiments and analyzed data; S. M. C. and W.-C. L. assisted with experiments; H.-L. T., S. M. C., and H.-J.W. developed algorithms for data analysis; H.-L. T., S. M. A., and P. T. performed stochastic simulations; J.I., J.G., and S. D. H. prepared proteins; C.-H.Y., C. R., and R. S. P. prepared patterned substrates; L. I., H.-L. T., and J.T.G. wrote the manuscript; J.T.G. supervised the project. All authors commented on the manuscript.	ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; English BP, 2006, NAT CHEM BIOL, V2, P87, DOI 10.1038/nchembio759; Ensign DL, 2010, J PHYS CHEM B, V114, P280, DOI 10.1021/jp906786b; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Grecco HE, 2011, CELL, V144, P897, DOI 10.1016/j.cell.2011.01.029; Groves JT, 2008, ANNU REV BIOMED ENG, V10, P311, DOI 10.1146/annurev.bioeng.10.061807.160431; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Guldenhaupt J, 2012, BIOPHYS J, V103, P1585, DOI 10.1016/j.bpj.2012.08.043; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Gureasko J, 2010, P NATL ACAD SCI USA, V107, P3430, DOI 10.1073/pnas.0913915107; Harding AS, 2008, TRENDS CELL BIOL, V18, P364, DOI 10.1016/j.tcb.2008.05.006; Hartman NC, 2011, CURR OPIN CELL BIOL, V23, P370, DOI 10.1016/j.ceb.2011.05.003; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Jun JE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00239; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Manza BN, 2011, P NATL ACAD SCI USA, V108, P9089, DOI 10.1073/pnas.1018771108; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Min W, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198302; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; O'Donoghue GP, 2013, ELIFE, V2, DOI 10.7554/eLife.00778; Prakash MK, 2007, P NATL ACAD SCI USA, V104, P15982, DOI 10.1073/pnas.0707859104; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; Yadav KK, 2010, P NATL ACAD SCI USA, V107, P3436, DOI 10.1073/pnas.0914315107; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	43	83	85	2	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					50	54		10.1126/science.1250373	http://dx.doi.org/10.1126/science.1250373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994643	Green Accepted			2022-12-01	WOS:000338284400045
J	Pekkurnaz, G; Trinidad, JC; Wang, XN; Kong, D; Schwarz, TL				Pekkurnaz, Gulcin; Trinidad, Jonathan C.; Wang, Xinnan; Kong, Dong; Schwarz, Thomas L.			Glucose Regulates Mitochondrial Motility via Milton Modification by O-GlcNAc Transferase	CELL			English	Article							AXONAL-TRANSPORT; PHOSPHORYLATION; PROTEIN; BRAIN; GLYCOSYLATION; DYNAMICS; NEURONS; IDENTIFICATION; GLCNACYLATION; LOCALIZATION	Cells allocate substantial resources toward monitoring levels of nutrients that can be used for ATP generation by mitochondria. Among the many specialized cell types, neurons are particularly dependent on mitochondria due to their complex morphology and regional energy needs. Here, we report a molecular mechanism by which nutrient availability in the form of extracellular glucose and the enzyme O-GlcNAc Transferase (OGT), whose activity depends on glucose availability, regulates mitochondrial motility in neurons. Activation of OGT diminishes mitochondrial motility. We establish the mitochondrial motor-adaptor protein Milton as a required substrate for OGT to arrest mitochondrial motility by mapping and mutating the key O-GlcNAcylated serine residues. We find that the GlcNAcylation state of Milton is altered by extracellular glucose and that OGT alters mitochondrial motility in vivo. Our findings suggest that, by dynamically regulating Milton GlcNAcylation, OGT tailors mitochondrial dynamics in neurons based on nutrient availability.	[Pekkurnaz, Gulcin; Schwarz, Thomas L.] Harvard Univ, Boston Childrens Hosp, F M Kirby Neurobiol Ctr, Sch Med, Boston, MA 02115 USA; [Pekkurnaz, Gulcin; Schwarz, Thomas L.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Trinidad, Jonathan C.] Indiana Univ, Dept Chem, Biol Mass Spectrometry Facil, Bloomington, IN 47405 USA; [Wang, Xinnan] Stanford Univ, Dept Neurosurg, Stanford, CA 94304 USA; [Kong, Dong] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Endocrinol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Indiana University System; Indiana University Bloomington; Stanford University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Schwarz, TL (corresponding author), Harvard Univ, Boston Childrens Hosp, F M Kirby Neurobiol Ctr, Sch Med, Boston, MA 02115 USA.	thomas.schwarz@childrens.harvard.edu	Trinidad, Jonathan/GWR-2077-2022	Pekkurnaz, Gulcin/0000-0002-7388-6178	IDDRC Molecular Genetics and Imaging Cores [P30HD18655]; Ellison Medical Foundation;  [K01DK094943];  [P30DK46200];  [5R01GM069808-08]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, K01DK094943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069808] Funding Source: NIH RePORTER	IDDRC Molecular Genetics and Imaging Cores; Ellison Medical Foundation(Lawrence Ellison Foundation); ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge the gift of plasmid constructs from Drs. P. Aspenstrom for myc-hMiro1/2; G. Hajnoczky for Mito-DsRed; G. W. Hart for OGT and Xpress-hMilton1; X. Yang for eGFP-OGT; H. T. Cline for Syp-CFP; M. Sahin for scrambled shRNA; M. J. Reginato for OGT shRNA; K. J. Verhey for KHC-mCit; and M. Greenberg for pEGFP-N1. We thank S. Vasquez, K. Pereira, K. Apaydin, and Dr. M. Sahin's laboratory for assistance with primary hippocampal neuron cultures; X. Ho, E. Ling, and Y. Guo for technical assistance; L. Ding from Harvard NeuroDiscovery Center, Enhanced Neuroimaging Core for assistance with development of Kymolyzer; the IDDRC Molecular Genetics and Imaging Cores (grant number P30HD18655). We also thank Drs. M. Banghart, R. Cartoni, M. A. Cronin, B. Lowell, G. Yellen, and M. Tantama and A. Nasser and M. Hamilton for support and valuable input. D. K. was supported by K01DK094943 and P30DK46200. This work was supported by 5R01GM069808-08 and the Ellison Medical Foundation.	Akimoto Y, 2003, BRAIN RES, V966, P194, DOI 10.1016/S0006-8993(02)04158-6; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; Dash MB, 2013, J NEUROCHEM, V124, P79, DOI 10.1111/jnc.12063; Fort AG, 2011, J BIOL CHEM, V286, P22875, DOI 10.1074/jbc.M111.219709; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hou BH, 2011, NAT PROTOC, V6, P1818, DOI 10.1038/nprot.2011.392; Huang CW, 2007, J NEUROSCI RES, V85, P1468, DOI 10.1002/jnr.21284; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Ji S, 2011, AMINO ACIDS, V40, P809, DOI 10.1007/s00726-010-0698-9; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Li Y, 2009, J CELL BIOL, V185, P1065, DOI 10.1083/jcb.200811033; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; Lopez-Domenech G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1829; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Matthews JA, 2007, MOL CELL BIOCHEM, V298, P109, DOI 10.1007/s11010-006-9358-5; Nie DY, 2012, METHODS MOL BIOL, V821, P393, DOI 10.1007/978-1-61779-430-8_25; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Park JH, 2003, DEVELOPMENT, V130, P2645, DOI 10.1242/dev.00503; Pathak D, 2010, J NEUROSCI, V30, P8984, DOI 10.1523/JNEUROSCI.1621-10.2010; Peppiatt C, 2004, NATURE, V431, P137, DOI 10.1038/431137a; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Pozo KBK, 2011, BBA-MOL CELL RES, V1813, P269, DOI 10.1016/j.bbamcr.2010.10.011; Ruan HB, 2013, TRENDS ENDOCRIN MET, V24, P301, DOI 10.1016/j.tem.2013.02.002; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; SILVER IA, 1994, J NEUROSCI, V14, P5068; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Tallent MK, 2009, J BIOL CHEM, V284, P174, DOI 10.1074/jbc.M807431200; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; van Spronsen M, 2013, NEURON, V77, P485, DOI 10.1016/j.neuron.2012.11.027; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wang XN, 2009, METHOD ENZYMOL, V457, P319, DOI 10.1016/S0076-6879(09)05018-6; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Weisova P, 2009, J NEUROSCI, V29, P2997, DOI 10.1523/JNEUROSCI.0354-09.2009; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278	50	169	172	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					54	68		10.1016/j.cell.2014.06.007	http://dx.doi.org/10.1016/j.cell.2014.06.007			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995978	Green Accepted, Bronze			2022-12-01	WOS:000340943100007
J	Phillippe, M				Phillippe, Mark			Cell-free Fetal DNA - A Trigger for Parturition	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MATERNAL PLASMA; PRENATAL-DIAGNOSIS		Massachusetts Gen Hosp, Dept Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Phillippe, M (corresponding author), Massachusetts Gen Hosp, Dept Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA.							[Anonymous], 1998, AM J HUM GENET, V62, P768; Birch L, 2005, CLIN CHEM, V51, P312, DOI 10.1373/clinchem.2004.042713; Khosrotehrani K, 2004, HUM REPROD, V19, P2460, DOI 10.1093/humrep/deh445; Leung TN, 1999, LANCET, V354, P780; Majer S, 2007, PRENATAL DIAG, V27, P1219, DOI 10.1002/pd.1875; Mitsunaga F, 2010, EXP ANIM TOKYO, V59, P255, DOI 10.1538/expanim.59.255; Scharfe-Nugent A, 2012, J IMMUNOL, V188, P5706, DOI 10.4049/jimmunol.1103454	7	50	54	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					2534	2536		10.1056/NEJMcibr1404324	http://dx.doi.org/10.1056/NEJMcibr1404324			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KY	24963574				2022-12-01	WOS:000337804400014
J	Yong, E				Yong, Ed			FIRST RESPONSE Race against time	NATURE			English	Editorial Material																		Fassbender K, 2003, STROKE, V34, pE44, DOI 10.1161/01.STR.0000075573.22885.3B; Fassbender K, 2013, LANCET NEUROL, V12, P585, DOI 10.1016/S1474-4422(13)70100-5; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Silke W., 2012, LANCET NEUROL, V11, P397	4	5	5	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S5	S5		10.1038/510S5a	http://dx.doi.org/10.1038/510S5a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ6LK	24964025				2022-12-01	WOS:000337806300004
J	Ahrends, R; Ota, A; Kovary, KM; Kudo, T; Park, BO; Teruel, MN				Ahrends, Robert; Ota, Asuka; Kovary, Kyle M.; Kudo, Takamasa; Park, Byung Ouk; Teruel, Mary N.			Controlling low rates of cell differentiation through noise and ultrahigh feedback	SCIENCE			English	Article							PPAR-GAMMA; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; STEM-CELLS; DEDIFFERENTIATION; ADIPOGENESIS; EXPRESSION; DYNAMICS; BIOLOGY; BINDING	Mammalian tissue size is maintained by slow replacement of de-differentiating and dying cells. For adipocytes, key regulators of glucose and lipid metabolism, the renewal rate is only 10% per year. We used computational modeling, quantitative mass spectrometry, and single-cell microscopy to show that cell-to-cell variability, or noise, in protein abundance acts within a network of more than six positive feedbacks to permit pre-adipocytes to differentiate at very low rates. This reconciles two fundamental opposing requirements: High cell-to-cell signal variability is needed to generate very low differentiation rates, whereas low signal variability is needed to prevent differentiated cells from de-differentiating. Higher eukaryotes can thus control low rates of near irreversible cell fate decisions through a balancing act between noise and ultrahigh feedback connectivity.	[Ahrends, Robert; Ota, Asuka; Kovary, Kyle M.; Kudo, Takamasa; Park, Byung Ouk; Teruel, Mary N.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Teruel, MN (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	mteruel@stanford.edu		Kovary, Kyle/0000-0002-7616-2968; Teruel, Mary/0000-0002-2854-3598; Ahrends, Robert/0000-0003-0232-3375	Stanford University New Faculty Startup Funds; NIH [P50GM107615]; Deutsche Forschungsgemeinschaft Fellowship [AH 220/1-1]; American Heart Association Fellowship [13POST17090092]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER	Stanford University New Faculty Startup Funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft Fellowship(German Research Foundation (DFG)); American Heart Association Fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Meyer, S. Collins, G. Anderson, S. Spencer, together with members of the Teruel lab, for thoughtful comments and discussions. This work is supported by Stanford University New Faculty Startup Funds and NIH P50GM107615 (M.N.T.), Deutsche Forschungsgemeinschaft Fellowship AH 220/1-1 (R. A.), and American Heart Association Fellowship 13POST17090092 (A.O.).	Abell E, 2011, P NATL ACAD SCI USA, V108, P14485, DOI 10.1073/pnas.1018266108; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Berry DC, 2013, DEVELOPMENT, V140, P3939, DOI 10.1242/dev.080549; Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Kim HE, 2013, BIOCHEM J, V453, P49, DOI 10.1042/BJ20121598; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; Palani S, 2012, CELL REP, V1, P215, DOI 10.1016/j.celrep.2012.01.007; Park BO, 2012, CELL REP, V2, P976, DOI 10.1016/j.celrep.2012.08.038; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Poloni A, 2012, STEM CELLS, V30, P965, DOI 10.1002/stem.1067; Reiff T, 2010, J NEUROSCI, V30, P905, DOI 10.1523/JNEUROSCI.5368-09.2010; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Tchoukalova YD, 2004, AM J PHYSIOL-REG I, V287, pR1132, DOI 10.1152/ajpregu.00337.2004; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trunnell NB, 2011, MOL CELL, V41, P263, DOI 10.1016/j.molcel.2011.01.012; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	29	56	56	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1384	1389		10.1126/science.1252079	http://dx.doi.org/10.1126/science.1252079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948735	Green Accepted			2022-12-01	WOS:000337531700037
J	Weedon-Fekjaer, H; Romundstad, PR; Vatten, LJ				Weedon-Fekjaer, Harald; Romundstad, Pal R.; Vatten, Lars J.			Modern mammography screening and breast cancer mortality: population study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NORWAY; REGISTRY; QUALITY; TRENDS; IMPACT	Objective To evaluate the effectiveness of contemporary mammography screening using individual information about screening history and breast cancer mortality from public screening programmes. Design Prospective cohort study of Norwegian women who were followed between 1986 and 2009. Within that period (1995-2005), a national mammography screening programme was gradually implemented, with biennial invitations sent to women aged 50-69 years. Participants All Norwegian women aged 50-79 between 1986 and 2009. Main outcome measures Multiple Poisson regression analysis was used to estimate breast cancer mortality rate ratios comparing women who were invited to screening (intention to screen) with women who were not invited, with a clear distinction between cases of breast cancer diagnosed before (without potential for screening effect) and after (with potential for screening effect) the first invitation for screening. We took competing causes of death into account by censoring women from further follow-up who died from other causes. Based on the observed mortality reduction combined with the all cause and breast cancer specific mortality in Norway in 2009, we used the CISNET (Cancer Intervention and Surveillance Modeling Network) Stanford simulation model to estimate how many women would need to be invited to biennial mammography screening in the age group 50-69 years to prevent one breast cancer death during their lifetime. Results During 15 193 034 person years of observation (1986-2009), deaths from breast cancer occurred in 1175 women with a diagnosis after being invited to screening and 8996 women who had not been invited before diagnosis. After adjustment for age, birth cohort, county of residence, and national trends in deaths from breast cancer, the mortality rate ratio associated with being invited to mammography screening was 0.72 (95% confidence interval 0.64 to 0.79). To prevent one death from breast cancer, 368 (95% confidence interval 266 to 508) women would need to be invited to screening. Conclusion Invitation to modern mammography screening may reduce deaths from breast cancer by about 28%.	[Weedon-Fekjaer, Harald; Romundstad, Pal R.; Vatten, Lars J.] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7491 Trondheim, Norway; [Weedon-Fekjaer, Harald] Univ Oslo, Oslo Ctr Biostat & Epidemiol, Dept Biostat, Oslo, Norway; [Weedon-Fekjaer, Harald] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Res Support Serv, Oslo, Norway; [Vatten, Lars J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health	Weedon-Fekjaer, H (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7491 Trondheim, Norway.	harald.weedon-fekjar@medisin.uio.no	Weedon-Fekjær, Harald/B-6900-2008; Vatten, Lars/AFK-2073-2022; Vatten, Lars/AAF-9380-2022	Weedon-Fekjær, Harald/0000-0002-9109-0034; Romundstad, Pal Richard/0000-0003-2061-4336	Norwegian Research Council [189503]; NATIONAL CANCER INSTITUTE [U01CA152958] Funding Source: NIH RePORTER	Norwegian Research Council(Research Council of NorwayEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Norwegian Research Council (reference No 189503).	Ancelle-Park R, 2012, J MED SCREEN, V19, P5, DOI 10.1258/jms.2012.012077; [Anonymous], 1988, NEW ENGL J MED, V319, P1681; [Anonymous], IARC HDB CANC PREV H; Ascunce EN, 2007, J MED SCREEN, V14, P14, DOI 10.1258/096914107780154558; Autier P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4411; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; CISNET. Cancer Intervention and Surveillance Modeling Network, 2012, CANC INT SURV MOD NE; Clarke M, 1998, LANCET, V351, P1451; Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017; Falk RS, 2013, INT J CANCER, V133, P705, DOI 10.1002/ijc.28052; Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Hakama M, 1997, BRIT MED J, V314, P864; Hofvind S, 2008, JNCI-J NATL CANCER I, V100, P1082, DOI 10.1093/jnci/djn224; Hofvind S, 2013, CANCER-AM CANCER SOC, V119, P3106, DOI 10.1002/cncr.28174; Jorgensen KJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1241; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; Lynge E, 2011, ACTA ONCOL, V50, P1062, DOI 10.3109/0284186X.2011.599339; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Moss SM, 2012, J MED SCREEN, V19, P26, DOI 10.1258/jms.2012.012079; Njor S, 2012, J MED SCREEN, V19, P33, DOI 10.1258/jms.2012.012080; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Olsen AH, 2005, BMJ-BRIT MED J, V330, P220, DOI 10.1136/bmj.38313.639236.82; Olsen AH, 2007, EPIDEMIOLOGY, V18, P487, DOI 10.1097/EDE.0b013e318060cbbd; Olsen AH, 2013, INT J CANCER, V132, P208, DOI 10.1002/ijc.27609; Paci E, 2002, EUR J CANCER, V38, P568, DOI 10.1016/S0959-8049(01)00382-3; Plevritis Sylvia K, 2006, J Natl Cancer Inst Monogr, P86, DOI 10.1093/jncimonographs/lgj012; Sorum R, 2010, BREAST, V19, P499, DOI 10.1016/j.breast.2010.05.014; Weedon-Fekjaer H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e299; Welch HG, 2010, NEW ENGL J MED, V363, P1276, DOI 10.1056/NEJMe1008369	31	92	99	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2014	348								g3701	10.1136/bmj.g3701	http://dx.doi.org/10.1136/bmj.g3701			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6LA	24951459	Green Published, hybrid			2022-12-01	WOS:000337804900001
J	Goldacre, B; Godlee, F; Heneghan, C; Tovey, D; Lehman, R; Chalmers, I; Barbour, V; Brown, T				Goldacre, Ben; Godlee, Fiona; Heneghan, Carl; Tovey, David; Lehman, Richard; Chalmers, Iain; Barbour, Virginia; Brown, Tracey			OPEN DATA CAMPAIGN Open letter: European Medicines Agency should remove barriers to access clinical trial data	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Goldacre, Ben] London Sch Hyg & Trop Med, London, England; [Heneghan, Carl] Ctr Evidence based Med, Oxford, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Goldacre, B (corresponding author), London Sch Hyg & Trop Med, London, England.			Barbour, Virginia/0000-0002-2358-2440; Brown, Tracey/0000-0002-8112-6873; Goldacre, Ben/0000-0002-5127-4728					0	7	7	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2014	348								g3768	10.1136/bmj.g3768	http://dx.doi.org/10.1136/bmj.g3768			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7CE	24906718	Bronze, Green Published			2022-12-01	WOS:000337038000010
J	Segawa, K; Kurata, S; Yanagihashi, Y; Brummelkamp, TR; Matsuda, F; Nagata, S				Segawa, Katsumori; Kurata, Sachiko; Yanagihashi, Yuichi; Brummelkamp, Thijn R.; Matsuda, Fumihiko; Nagata, Shigekazu			Caspase-mediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure	SCIENCE			English	Article							AMINOPHOSPHOLIPID TRANSLOCASE; CELL-DEATH; LYMPHOCYTES; PROTEIN; IDENTIFICATION; P-4-ATPASES; CLEARANCE; P4-ATPASE; TRANSPORT; MEMBRANES	Phospholipids are asymmetrically distributed in the plasma membrane. This asymmetrical distribution is disrupted during apoptosis, exposing phosphatidylserine (PtdSer) on the cell surface. Using a haploid genetic screen in human cells, we found that ATP11C (adenosine triphosphatase type 11C) and CDC50A (cell division cycle protein 50A) are required for aminophospholipid translocation from the outer to the inner plasma membrane leaflet; that is, they display flippase activity. ATP11C contained caspase recognition sites, and mutations at these sites generated caspase-resistant ATP11C without affecting its flippase activity. Cells expressing caspase-resistant ATP11C did not expose PtdSer during apoptosis and were not engulfed by macrophages, which suggests that inactivation of the flippase activity is required for apoptotic PtdSer exposure. CDC50A-deficient cells displayed PtdSer on their surface and were engulfed by macrophages, indicating that PtdSer is sufficient as an "eat me" signal.	[Segawa, Katsumori; Kurata, Sachiko; Yanagihashi, Yuichi; Nagata, Shigekazu] Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan; [Brummelkamp, Thijn R.] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto 6068501, Japan; [Nagata, Shigekazu] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kyoto 6068501, Japan	Kyoto University; Netherlands Cancer Institute; Kyoto University; Japan Science & Technology Agency (JST)	Nagata, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.	snagata@mfour.med.kyoto-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426	Ministry of Education, Science, Sports, and Culture, Japan; Grants-in-Aid for Scientific Research [22000013] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank B. H. Cochran for KBM7 cells, K. Higasa and M. Shimizu for help in next-generation sequencing, K. Okamoto-Furuta and H. Kohda for support in electron microscope analysis, and M. Fujii for secretarial assistance. This work was supported in part by grants-in-aid from the Ministry of Education, Science, Sports, and Culture, Japan. Kyoto University has filed a patent entitled "Method of screening agents for the treatment or prevention of cancer or apoptosis-related diseases" (inventors, Shigekazu Nagata, Katsumori Segawa; reference number: 61/978415). Plasmids encoding human ATP11C or CDC50A, human KBM7 cells lacking ATP11C or CDC50A, and mouse W3 cell lines lacking ATP11C or CDC50A are all available under material transfer agreements. T. R. B. is a co-founder, shareholder, and member of the scientific advisory board of Haplogen, an early-phase biotech company based on haploid genetics.	Bratton DL, 1997, J BIOL CHEM, V272, P26159, DOI 10.1074/jbc.272.42.26159; Brown GC, 2012, TRENDS BIOCHEM SCI, V37, P325, DOI 10.1016/j.tibs.2012.05.002; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Chen BH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001235; Chen R, 2011, J IMMUNOL, V186, P3215, DOI 10.4049/jimmunol.1002710; Coleman JA, 2013, BBA-MOL CELL BIOL L, V1831, P555, DOI 10.1016/j.bbalip.2012.10.006; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daleke DL, 2000, BBA-MOL CELL BIOL L, V1486, P108, DOI 10.1016/S1388-1981(00)00052-4; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; Elliott JI, 2005, NAT CELL BIOL, V7, P808, DOI 10.1038/ncb1279; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Segawa K, 2011, P NATL ACAD SCI USA, V108, P19246, DOI 10.1073/pnas.1114799108; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Siggs OM, 2011, P NATL ACAD SCI USA, V108, P7890, DOI 10.1073/pnas.1104631108; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Tanaka K, 2011, J BIOCHEM, V149, P131, DOI 10.1093/jb/mvq140; Tanaka M, 1997, J IMMUNOL, V158, P2303; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011	30	314	315	0	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1164	1168		10.1126/science.1252809	http://dx.doi.org/10.1126/science.1252809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904167	Green Published			2022-12-01	WOS:000336791200049
J	Bauer, BW; Shemesh, T; Chen, Y; Rapoport, TA				Bauer, Benedikt W.; Shemesh, Tom; Chen, Yu; Rapoport, Tom A.			A "Push and Slide" Mechanism Allows Sequence-Insensitive Translocation of Secretory Proteins by the SecA ATPase	CELL			English	Article							POLYPEPTIDE TRANSLOCATION; SECYEG COMPLEX; CHANNEL; MEMBRANE; MACHINE; BINDING; MEDIATE; PORE; MOTIONS; REVEAL	In bacteria, most secretory proteins are translocated across the plasma membrane by the interplay of the SecA ATPase and the SecY channel. How SecA moves a broad range of polypeptide substrates is only poorly understood. Here we show that SecA moves polypeptides through the SecY channel by a "push and slide" mechanism. In its ATP-bound state, SecA interacts through a two-helix finger with a subset of amino acids in a substrate, pushing them into the channel. A polypeptide can also passively slide back and forth when SecA is in the predominant ADP-bound state or when SecA encounters a poorly interacting amino acid in its ATP-bound state. SecA performs multiple rounds of ATP hydrolysis before dissociating from SecY. The proposed push and slide mechanism is supported by a mathematical model and explains how SecA allows translocation of a wide range of polypeptides. This mechanism may also apply to hexameric polypeptide-translocating ATPases.	[Bauer, Benedikt W.; Shemesh, Tom; Chen, Yu; Rapoport, Tom A.] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA; [Bauer, Benedikt W.; Shemesh, Tom; Chen, Yu; Rapoport, Tom A.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu			Boehringer Ingelheim Fonds; NIH [GM052586]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER	Boehringer Ingelheim Fonds(Boehringer Ingelheim); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Karl Erlandson and Stephanie Miller for providing preliminary data, the Institute of Chemistry and Cell Biology for providing access to the plate reader, Alexander Stein for helpful suggestions, and Thomas Guttler, Alexander Stein, and Long Li for critical reading of the manuscript. B. W. B. is the recipient of a fellowship from the Boehringer Ingelheim Fonds. T. A. R. is supported by NIH grant GM052586 and is a Howard Hughes Medical Institute Investigator.	Alami M, 2007, EMBO J, V26, P1995, DOI 10.1038/sj.emboj.7601661; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; Erlandson KJ, 2008, J BIOL CHEM, V283, P15709, DOI 10.1074/jbc.M710356200; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; HENDRICK JP, 1991, J BIOL CHEM, V266, P24596; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; Kraut DA, 2013, J BIOL CHEM, V288, P34729, DOI 10.1074/jbc.M113.512533; Kusters I, 2010, METHODS MOL BIOL, V619, P131, DOI 10.1007/978-1-60327-412-8_8; Liebermeister W, 2001, J MOL BIOL, V305, P643, DOI 10.1006/jmbi.2000.4302; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-402312, 10.1146/annurev-biophys-050511-102312]; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Robson A, 2009, P NATL ACAD SCI USA, V106, P5111, DOI 10.1073/pnas.0809592106; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Too PHM, 2013, J BIOL CHEM, V288, P13243, DOI 10.1074/jbc.M113.452524; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Whitehouse S, 2012, J CELL BIOL, V199, P919, DOI 10.1083/jcb.201205191; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zimmer J, 2009, J MOL BIOL, V394, P606, DOI 10.1016/j.jmb.2009.10.024	26	77	77	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1416	1429		10.1016/j.cell.2014.03.063	http://dx.doi.org/10.1016/j.cell.2014.03.063			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906156	Green Accepted, Bronze			2022-12-01	WOS:000340881400017
J	Kohout, AL; Williams, MJM; Dean, SM; Meylan, MH				Kohout, A. L.; Williams, M. J. M.; Dean, S. M.; Meylan, M. H.			Storm-induced sea-ice breakup and the implications for ice extent	NATURE			English	Article							OCEAN WAVES; ATTENUATION; TRENDS; ZONE; CLIMATE	The propagation of large, storm-generated waves through sea ice has so far not been measured, limiting our understanding of how ocean waves break sea ice. Without improved knowledge of ice breakup, we are unable to understand recent changes, or predict future changes, in Arctic and Antarctic sea ice. Here we show that storm-generated ocean waves propagating through Antarctic sea ice are able to transport enough energy to break sea ice hundreds of kilometres from the ice edge. Our results, which are based on concurrent observations at multiple locations, establish that large waves break sea ice much farther from the ice edge than would be predicted by the commonly assumed exponential decay(1-3). We observed the wave height decay to be almost linear for large waves-those with a significant wave height greater than three metres-and to be exponential only for small waves. This implies a more prominent role for large ocean waves in sea-ice breakup and retreat than previously thought. We examine the wider relevance of this by comparing observed Antarctic sea-ice edge positions with changes in modelled significant wave heights for the Southern Ocean between 1997 and 2009, and find that the retreat and expansion of the sea-ice edge correlate with mean significant wave height increases and decreases, respectively. This includes capturing the spatial variability in sea-ice trends found in the Ross and Amundsen-Bellingshausen seas. Climate models fail to capture recent changes in sea ice in both polar regions(4,5). Our results suggest that the incorporation of explicit or parameterized interactions between ocean waves and sea ice may resolve this problem.	[Kohout, A. L.] Natl Inst Water & Atmospher Res, Christchurch 8011, New Zealand; [Williams, M. J. M.; Dean, S. M.] Natl Inst Water & Atmospher Res, Wellington 6021, New Zealand; [Meylan, M. H.] Univ Newcastle, Newcastle, NSW 2308, Australia	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Newcastle	Kohout, AL (corresponding author), Natl Inst Water & Atmospher Res, Christchurch 8011, New Zealand.	alison.kohout@niwa.co.nz	Dean, Sam/F-7711-2011; Meylan, Michael/A-7341-2010; Williams, Michael/H-9674-2014	Dean, Sam/0000-0001-6338-4601; Meylan, Michael/0000-0002-3164-1367; 	New Zealand Foundation of Research Science and Technology; Marsden Fund Council; NIWA, under National Climate Centre Climate Systems programme; Antarctic Climate and Ecosystems Cooperative Research Centre; Australian Antarctic Science project [4073]	New Zealand Foundation of Research Science and Technology(New Zealand Foundation for Research, Science and Technology); Marsden Fund Council(Royal Society of New ZealandMarsden Fund (NZ)); NIWA, under National Climate Centre Climate Systems programme; Antarctic Climate and Ecosystems Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Antarctic Science project	We thank Inprod Pty Ltd for instrument design and construction; M. Doble, V. Squire and T. Haskell for contributions toward instrument design; T. Toyota for the provision of ice floe size and ice thickness data; the captain and crew of RSV Aurora Australis and the second Sea Ice Physics and Ecosystem Experiment (SIPEX II) for their assistance in deploying the waves-in-ice instruments; and V. Squire, T. Toyota, L. Bennetts and T. Williams for contributions toward interpretation and editing. The work was funded by a New Zealand Foundation of Research Science and Technology Postdoctoral award to A. L. K.; the Marsden Fund Council, administered by the Royal Society of New Zealand; NIWA, through core funding under the National Climate Centre Climate Systems programme; the Antarctic Climate and Ecosystems Cooperative Research Centre; and Australian Antarctic Science project 4073.	[Anonymous], 2017, NOAANSIDC CLIMATE DA; [Anonymous], GEOPHYS RES LETT, DOI [10.1029/2007/GL029703, DOI 10.1029/2007GL029703]; Chawla A, 2013, OCEAN MODEL, V70, P189, DOI 10.1016/j.ocemod.2012.07.005; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Doble MJ, 2013, OCEAN MODEL, V70, P166, DOI 10.1016/j.ocemod.2013.05.012; Dobrynin M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052843; Downer J, 2001, ANN GLACIOL, V33, P345, DOI 10.3189/172756401781818923; Dumont D, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006682; Earle M. D., 1996, 9601 NDBC US DEP COM; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Holland PR, 2012, NAT GEOSCI, V5, P872, DOI [10.1038/NGEO1627, 10.1038/ngeo1627]; Kaleschke L, 2001, CAN J REMOTE SENS, V27, P526, DOI 10.1080/07038992.2001.10854892; Kaleschke L., 2006, SEA ICE CONCENTRATIO; Kohout AL, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004434; Kohout A. L., 2013, WAVES IN ICE OBSERVA; Komen G. J., 1994, DYNAMICS MODELLING O, P232; LIU AK, 1992, ATMOS OCEAN, V30, P192, DOI 10.1080/07055900.1992.9649437; LONGUETHIGGINS MS, 1952, J MAR RES, V11, P245; Marko J. R., 2003, J GEOPHYS RES, V108, pC9; Parkinson CL, 2012, CRYOSPHERE, V6, P871, DOI 10.5194/tc-6-871-2012; Peng G, 2013, EARTH SYST SCI DATA, V5, P311, DOI 10.5194/essd-5-311-2013; Prinsenberg SJ, 2011, ANN GLACIOL, V52, P35, DOI 10.3189/172756411795931688; Shackleton E. H., 1982, S STORY SHACKLETONS, V103; Spreen G, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2005JC003384; Squire VA, 2007, COLD REG SCI TECHNOL, V49, P110, DOI 10.1016/j.coldregions.2007.04.007; SQUIRE VA, 1980, NATURE, V283, P365, DOI 10.1038/283365a0; SQUIRE VA, 1995, ANNU REV FLUID MECH, V27, P115, DOI 10.1146/annurev.fl.27.010195.000555; Toyota T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024556; Tucker M.J., 2001, WAVES OCEAN ENG; Turner J, 2013, J CLIMATE, V26, P1473, DOI 10.1175/JCLI-D-12-00068.1; WADHAMS P, 1988, J GEOPHYS RES-OCEANS, V93, P6799, DOI 10.1029/JC093iC06p06799; Wadhams P., 2002, ICE OCEAN, P202; Williams TD, 2013, OCEAN MODEL, V71, P92, DOI 10.1016/j.ocemod.2013.05.011; Young IR, 2011, SCIENCE, V332, P451, DOI 10.1126/science.1197219	34	189	195	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					604	+		10.1038/nature13262	http://dx.doi.org/10.1038/nature13262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870546				2022-12-01	WOS:000336457100046
J	Capewell, S				Capewell, Simon			PERSONAL VIEW Sugar sweetened drinks should carry obesity warnings	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONSUMPTION; TOBACCO; ADULTS; FOOD		Univ Liverpool, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Capewell, S (corresponding author), Univ Liverpool, Liverpool L69 3BX, Merseyside, England.	Capewell@liverpool.ac.uk						Academy of Medical Royal Colleges, 2013, MEAS MED PROF PRESCR; [Anonymous], BBC NEWS; Capewell S, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d287; Chantler C, 2014, INDEPENDENT REV STAN; Cochrane Library, 2011, TREATM OB; Credit Suisse Research Institute, 2013, SUG CONS CROSSR; DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229; Editorial, 2011, LANCET, V378, P741; Finlex, RAD IND MIN REG LAB; Hennessy M., 2014, FOOD NAVIGATOR  0424; Joossens L, 2006, TOB CONTROL, V15, P247, DOI 10.1136/tc.2005.015347; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; National Institute for Health and Care Excellence, 2010, PREV CARD DIS; Ng SW, 2012, BRIT J NUTR, V108, P536, DOI 10.1017/S0007114511006465; Quinn I, 2014, GROCER          0510; Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8; Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563	17	4	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2014	348								g3428	10.1136/bmj.g3428	http://dx.doi.org/10.1136/bmj.g3428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EB	24870354				2022-12-01	WOS:000336741400010
J	Whelan, R; Watts, R; Orr, CA; Althoff, RR; Artiges, E; Banaschewski, T; Barker, GJ; Bokde, ALW; Buchel, C; Carvalho, FM; Conrod, PJ; Flor, H; Fauth-Buhler, M; Frouin, V; Gallinat, J; Gan, G; Gowland, P; Heinz, A; Ittermann, B; Lawrence, C; Mann, K; Martinot, JL; Nees, F; Ortiz, N; Paillere-Martinot, ML; Paus, T; Pausova, Z; Rietschel, M; Robbins, TW; Smolka, MN; Strohle, A; Schumann, G; Garavan, H				Whelan, Robert; Watts, Richard; Orr, Catherine A.; Althoff, Robert R.; Artiges, Eric; Banaschewski, Tobias; Barker, Gareth J.; Bokde, Arun L. W.; Buechel, Christian; Carvalho, Fabiana M.; Conrod, Patricia J.; Flor, Herta; Fauth-Buehler, Mira; Frouin, Vincent; Gallinat, Juergen; Gan, Gabriela; Gowland, Penny; Heinz, Andreas; Ittermann, Bernd; Lawrence, Claire; Mann, Karl; Martinot, Jean-Luc; Nees, Frauke; Ortiz, Nick; Paillere-Martinot, Marie-Laure; Paus, Tomas; Pausova, Zdenka; Rietschel, Marcella; Robbins, Trevor W.; Smolka, Michael N.; Stroehle, Andreas; Schumann, Gunter; Garavan, Hugh		IMAGEN Consortium	Neuropsychosocial profiles of current and future adolescent alcohol misusers	NATURE			English	Article							SUBSTANCE USE; BRAIN; RISK; REINFORCEMENT; ENDOPHENOTYPES; RELIABILITY; IMPULSIVITY; DYSFUNCTION; INHIBITION; DEPENDENCE	A comprehensive account of the causes of alcohol misuse must accommodate individual differences in biology, psychology and environment, and must disentangle cause and effect. Animal models(1) can demonstrate the effects of neurotoxic substances; however, they provide limited insight into the psycho-social and higher cognitive factors involved in the initiation of substance use and progression to misuse. One can search for pre-existing risk factors by testing for endophenotypic biomarkers(2) in non-using relatives; however, these relatives may have personality or neural resilience factors that protect them from developing dependence(3). A longitudinal study has potential to identify predictors of adolescent substance misuse, particularly if it can incorporate a wide range of potential causal factors, both proximal and distal, and their influence on numerous social, psychological and biological mechanisms(4). Here we apply machine learning to a wide range of data from a large sample of adolescents (n = 692) to generate models of current and future adolescent alcohol misuse that incorporate brain structure and function, individual personality and cognitive differences, environmental factors (including gestational cigarette and alcohol exposure), life experiences, and candidate genes. These models were accurate and generalized to novel data, and point to life experiences, neurobiological differences and personality as important antecedents of binge drinking. By identifying the vulnerability factors underlying individual differences in alcohol misuse, these models shed light on the aetiology of alcohol misuse and suggest targets for prevention.	[Whelan, Robert; Ortiz, Nick; Garavan, Hugh] Univ Vermont, Dept Psychiat, Burlington, VT 05401 USA; [Whelan, Robert] Natl Univ Ireland Univ Coll Dublin, Dept Psychol, Dublin 4, Ireland; [Watts, Richard] Univ Vermont, Dept Radiol, Burlington, VT 05401 USA; [Orr, Catherine A.] Univ Vermont, Vermont Ctr Children Youth & Families, Burlington, VT 05401 USA; [Althoff, Robert R.] Univ Vermont, Dept Pediat, Burlington, VT 05401 USA; [Althoff, Robert R.; Garavan, Hugh] Univ Vermont, Dept Psychol, Burlington, VT 05401 USA; [Artiges, Eric; Martinot, Jean-Luc] Univ Paris 11, CEA, INSERM, Imaging & Psychiat U1000, F-91400 Orsay, France; [Artiges, Eric] Orsay Hosp, Dept Psychiat, F-91400 Orsay, France; [Banaschewski, Tobias; Flor, Herta; Fauth-Buehler, Mira; Mann, Karl; Nees, Frauke; Rietschel, Marcella] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Cognit & Clin Neurosci, D-68159 Mannheim, Germany; [Barker, Gareth J.; Carvalho, Fabiana M.; Conrod, Patricia J.; Schumann, Gunter] Kings Coll London, Inst Psychiat, London SE5 8AF, England; [Bokde, Arun L. W.; Garavan, Hugh] Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland; [Buechel, Christian; Gallinat, Juergen] Univ Klinikum Hamburg Eppendorf, Dept Syst Neurosci, D-20246 Hamburg, Germany; [Buechel, Christian] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Conrod, Patricia J.] Univ Montreal, CHU Ste Justine Hosp, Dept Psychiat, Montreal, PQ H3T 1C5, Canada; [Fauth-Buehler, Mira] Heidelberg Univ, Dept Addict Behav & Addict Med, D-68159 Mannheim, Germany; [Frouin, Vincent] 14 CEA, DSV, I2BM, F-91191 Gif Sur Yvette, France; [Gallinat, Juergen; Heinz, Andreas; Paillere-Martinot, Marie-Laure; Stroehle, Andreas] Charite, Dept Psychiat & Psychotherapy, D-10117 Berlin, Germany; [Gan, Gabriela; Smolka, Michael N.] Tech Univ Dresden, Dept Psychiat, D-01062 Dresden, Germany; [Gan, Gabriela; Smolka, Michael N.] Tech Univ Dresden, Neuroimaging Ctr, D-01062 Dresden, Germany; [Gowland, Penny] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; [Ittermann, Bernd] Phys Tech Bundesanstalt PTB, D-10587 Berlin, Germany; [Lawrence, Claire] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; [Martinot, Jean-Luc; Paillere-Martinot, Marie-Laure] Univ Paris 05, AP HP, Dept Adolescent Psychopathol & Med, F-75006 Paris, France; [Ortiz, Nick] Univ Vermont, Neurosci Grad Program, Burlington, VT 05401 USA; [Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON M5R 0A3, Canada; [Paus, Tomas] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Pausova, Zdenka] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 0A4, Canada; [Robbins, Trevor W.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 1TN, England; [Robbins, Trevor W.] Univ Cambridge, Dept Psychol, Cambridge CB2 1TN, England; [Schumann, Gunter] MRC Social Genet & Dev Psychiat SGDP Ctr, London WC2R 2LS, England	University of Vermont; University College Dublin; University of Vermont; University of Vermont; University of Vermont; University of Vermont; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of London; King's College London; Trinity College Dublin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Stanford University; Universite de Montreal; Ruprecht Karls University Heidelberg; CEA; UDICE-French Research Universities; Universite Paris Saclay; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden; Technische Universitat Dresden; University of Nottingham; Physikalisch-Technische Bundesanstalt (PTB); University of Nottingham; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; University of Vermont; University of Toronto; University Toronto Affiliates; Baycrest; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Cambridge; University of Cambridge	Whelan, R (corresponding author), Univ Vermont, Dept Psychiat, Burlington, VT 05401 USA.	Robert.whelan@ucd.ie; Hugh.garavan@uvm.edu	Smolka, Michael/B-4865-2011; Artiges, Eric/C-2815-2019; Williams, Steve C/D-6979-2011; Ströhle, Andreas/E-4286-2012; Vollstädt-Klein, Sabine/C-6744-2012; Poustka, Luise/D-9299-2017; Nees, Frauke/AAZ-2150-2020; Robbins, Trevor W/A-7551-2008; Artiges, Eric/AAT-7219-2021; Barker, Gareth J/C-9616-2009; Stacey, David/AFX-6013-2022; Heinz, Andreas/ABB-7736-2020; Whelan, Robert/E-5365-2010; Lawrence, Claire/P-1058-2018; Conrod, Patricia J/P-4187-2018; Banaschewski, Tobias/ABE-5985-2020; Martinot, Jean-Luc/N-3704-2018; Jia, Tianye/AAC-3925-2019; Rapp, Michael/ABB-7573-2020; Gowland, Penny A./I-9016-2012	Smolka, Michael/0000-0001-5398-5569; Artiges, Eric/0000-0003-4461-7646; Williams, Steve C/0000-0003-4299-1941; Vollstädt-Klein, Sabine/0000-0002-6210-672X; Artiges, Eric/0000-0003-4461-7646; Barker, Gareth J/0000-0002-5214-7421; Stacey, David/0000-0002-9392-9235; Heinz, Andreas/0000-0001-5405-9065; Whelan, Robert/0000-0002-2790-7281; Lawrence, Claire/0000-0001-6787-9716; Banaschewski, Tobias/0000-0003-4595-1144; Jia, Tianye/0000-0001-5399-2953; Rapp, Michael/0000-0003-0106-966X; Gowland, Penny A./0000-0002-4900-4817; Robbins, Trevor/0000-0003-0642-5977; Gan, Gabriela/0000-0001-6589-6168; MIRANDA, RUBEN/0000-0002-9445-7348; Bokde, Arun/0000-0003-0114-4914; Flor, Herta/0000-0003-4809-5398; Nees, Frauke/0000-0002-7796-8234	European Union [LSHM-CT- 2007-037286]; FP7 projects IMAGEMEND [602450]; MATRICS [603016]; Innovative Medicine Initiative Project EU-AIMS [115300-2]; Medical Research Council Programme Grant "Developmental pathways into adolescent substance abuse" [93558]; Swedish funding agency FORMAS; Medical Research Council; Wellcome Trust (Behavioural and Clinical Neuroscience Institute, University of Cambridge); National Institute for Health Research (NIHR) Biomedical Research Centre at South London; Maudsley NHS Foundation Trust; King's College London; Bundesministerium fur Bildung und Forschung (BMBF) [01GS08152, 01EV0711, eMED SysAlc 01ZX1311A]; Deutsche Forschungsgemeinschaft (DFG) [SP 383/5-1, SM 80/7-1, SFB 940/1, FOR 1617]; French MILDT (Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie); CENIR (Centre de NeuroImagerie de Recherche) within the ICM institute; National Institute of Mental Health [MH082116]; National Institutes of Health Center of Biomedical Research Excellence award from the National Institute of General Medical Sciences [P20GM103644]; Tobacco Centers of Regulatory Science award [P50DA036114]; NASA at University of Vermont [NNX 06AC88G]; MRC [G0901858] Funding Source: UKRI; Medical Research Council [G0001354, G0901858, G0001354B, G1000183B] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH082116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA036114] Funding Source: NIH RePORTER	European Union(European Commission); FP7 projects IMAGEMEND; MATRICS; Innovative Medicine Initiative Project EU-AIMS; Medical Research Council Programme Grant "Developmental pathways into adolescent substance abuse"(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish funding agency FORMAS; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust (Behavioural and Clinical Neuroscience Institute, University of Cambridge); National Institute for Health Research (NIHR) Biomedical Research Centre at South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; King's College London(General Electric); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); French MILDT (Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie); CENIR (Centre de NeuroImagerie de Recherche) within the ICM institute; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health Center of Biomedical Research Excellence award from the National Institute of General Medical Sciences; Tobacco Centers of Regulatory Science award; NASA at University of Vermont; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work received support from the following sources: the European Union-funded FP6 Integrated Project IMAGEN (Reinforcement-related behaviour in normal brain function and psychopathology) (LSHM-CT- 2007-037286), the FP7 projects IMAGEMEND(602450; IMAging GEnetics for MENtal Disorders) and MATRICS (603016), the Innovative Medicine Initiative Project EU-AIMS (115300-2), a Medical Research Council Programme Grant "Developmental pathways into adolescent substance abuse" (93558), the Swedish funding agency FORMAS, the Medical Research Council and the Wellcome Trust (Behavioural and Clinical Neuroscience Institute, University of Cambridge), the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, the Bundesministerium fur Bildung und Forschung (BMBF grants 01GS08152; 01EV0711; eMED SysAlc 01ZX1311A; Forschungsnetz AERIAL), the Deutsche Forschungsgemeinschaft (DFG): Reinhart-Koselleck Award SP 383/5-1 and grants SM 80/7-1, SFB 940/1, FOR 1617), the French MILDT (Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie), the CENIR (Centre de NeuroImagerie de Recherche, Pr. S. Lehericy) within the ICM institute, the National Institute of Mental Health(MH082116), a National Institutes of Health Center of Biomedical Research Excellence award P20GM103644 from the National Institute of General Medical Sciences and the Tobacco Centers of Regulatory Science award P50DA036114. The authors acknowledge the Vermont Advanced Computing Core which is supported by NASA (NNX 06AC88G), at the University of Vermont for providing high performance computing resources that have contributed to the research results reported within this paper.	Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Castellanos-Ryan N, 2013, ALCOHOL CLIN EXP RES, V37, pE281, DOI 10.1111/j.1530-0277.2012.01931.x; Cloninger C. R., 1999, TEMPERAMENT CHARACTE; CLONINGER CR, 1987, SCIENCE, V236, P410, DOI 10.1126/science.2882604; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Conrod PJ, 2008, J CHILD PSYCHOL PSYC, V49, P181, DOI [10.1111/j-1469-7610.2007.01826.x, 10.1111/j.1469-7610.2007.01826.x]; COSTA PT, 1995, J PERS ASSESS, V64, P21, DOI 10.1207/s15327752jpa6401_2; Crews FT, 2000, ALCOHOL CLIN EXP RES, V24, P1712, DOI 10.1111/j.1530-0277.2000.tb01973.x; Dube S. R., 2006, Journal of Adolescent Health, V38, DOI 10.1016/j.jadohealth.2005.06.006; Ersche KD, 2012, AM J PSYCHIAT, V169, P926, DOI 10.1176/appi.ajp.2012.11091421; Ersche KD, 2012, SCIENCE, V335, P601, DOI 10.1126/science.1214463; Ghahremani DG, 2013, J ADOLESCENT HEALTH, V53, P139, DOI 10.1016/j.jadohealth.2013.02.010; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Gottfredson Denise C, 2003, Prev Sci, V4, P27, DOI 10.1023/A:1021782710278; Grant BF, 2001, J SUBST ABUSE, V13, P493, DOI 10.1016/S0899-3289(01)00096-7; Grant JD, 2006, PSYCHOL MED, V36, P109, DOI 10.1017/S0033291705006045; Grosbras MH, 2006, CEREB CORTEX, V16, P1087; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hibell B, 1997, 1995 ESPAD REPORT AL; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; NEWCOMB MD, 1981, J HEALTH SOC BEHAV, V22, P400, DOI 10.2307/2136681; Nigg JT, 2006, J AM ACAD CHILD PSY, V45, P468, DOI 10.1097/01.chi.0000199028.76452.a9; Norman AL, 2011, DRUG ALCOHOL DEPEN, V119, P216, DOI 10.1016/j.drugalcdep.2011.06.019; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; Pausova Z, 2007, HUM BRAIN MAPP, V28, P502, DOI 10.1002/hbm.20402; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Rietschel M, 2013, ANN NY ACAD SCI, V1282, P39, DOI 10.1111/j.1749-6632.2012.06794.x; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; Schumann G, 2010, MOL PSYCHIATR, V15, P1128, DOI 10.1038/mp.2010.4; Stacey D, 2012, P NATL ACAD SCI USA, V109, P21128, DOI 10.1073/pnas.1211844110; Swendsen J, 2012, ARCH GEN PSYCHIAT, V69, P390, DOI 10.1001/archgenpsychiatry.2011.1503; Tyndale RF, 2003, ANN MED, V35, P94, DOI 10.1080/07853890310010014; Volkow ND, 2006, ARCH GEN PSYCHIAT, V63, P999, DOI 10.1001/archpsyc.63.9.999; Wechsler D., 2003, WECHSLER INTELLIGENC, V4th; Whelan R, 2014, BIOL PSYCHIAT, V75, P746, DOI 10.1016/j.biopsych.2013.05.014; Whelan R, 2012, NAT NEUROSCI, V15, P920, DOI 10.1038/nn.3092; Woicik PA, 2009, ADDICT BEHAV, V34, P1042, DOI 10.1016/j.addbeh.2009.07.001; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	43	285	291	10	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					185	+		10.1038/nature13402	http://dx.doi.org/10.1038/nature13402			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM9KO	25043041	Green Accepted, Green Submitted			2022-12-01	WOS:000340200700030
J	Liu, Y; Jesus, AA; Marrero, B; Yang, D; Ramsey, SE; Sanchez, GAM; Tenbrock, K; Wittkowski, H; Jones, OY; Kuehn, HS; Lee, CCR; DiMattia, MA; Cowen, EW; Gonzalez, B; Palmer, I; DiGiovanna, JJ; Biancotto, A; Kim, H; Tsai, WL; Trier, AM; Huang, Y; Stone, DL; Hill, S; Kim, HJ; St Hilaire, C; Gurprasad, S; Plass, N; Chapelle, D; Horkayne-Szakaly, I; Foell, D; Barysenka, A; Candotti, F; Holland, SM; Hughes, JD; Mehmet, H; Issekutz, AC; Raffeld, M; McElwee, J; Fontana, JR; Minniti, CP; Moir, S; Kastner, DL; Gadina, M; Steven, AC; Wingfield, PT; Brooks, SR; Rosenzweig, SD; Fleisher, TA; Deng, Z; Boehm, M; Paller, AS; Goldbach-Mansky, R				Liu, Y.; Jesus, A. A.; Marrero, B.; Yang, D.; Ramsey, S. E.; Sanchez, G. A. Montealegre; Tenbrock, K.; Wittkowski, H.; Jones, O. Y.; Kuehn, H. S.; Lee, C. -C. R.; DiMattia, M. A.; Cowen, E. W.; Gonzalez, B.; Palmer, I.; DiGiovanna, J. J.; Biancotto, A.; Kim, H.; Tsai, W. L.; Trier, A. M.; Huang, Y.; Stone, D. L.; Hill, S.; Kim, H. J.; St Hilaire, C.; Gurprasad, S.; Plass, N.; Chapelle, D.; Horkayne-Szakaly, I.; Foell, D.; Barysenka, A.; Candotti, F.; Holland, S. M.; Hughes, J. D.; Mehmet, H.; Issekutz, A. C.; Raffeld, M.; McElwee, J.; Fontana, J. R.; Minniti, C. P.; Moir, S.; Kastner, D. L.; Gadina, M.; Steven, A. C.; Wingfield, P. T.; Brooks, S. R.; Rosenzweig, S. D.; Fleisher, T. A.; Deng, Z.; Boehm, M.; Paller, A. S.; Goldbach-Mansky, R.			Activated STING in a Vascular and Pulmonary Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MONOGENIC AUTOINFLAMMATORY DISEASES; FAMILIAL CHILBLAIN LUPUS; CYCLIC GMP-AMP; I INTERFERON; PROTEASOME SUBUNIT; INBORN-ERRORS; DNA; SENSOR; LIPODYSTROPHY; EXPRESSION	BACKGROUND The study of autoinflammatory diseases has uncovered mechanisms underlying cytokine dysregulation and inflammation. METHODS We analyzed the DNA of an index patient with early-onset systemic inflammation, cutaneous vasculopathy, and pulmonary inflammation. We sequenced a candidate gene, TMEM173, encoding the stimulator of interferon genes (STING), in this patient and in five unrelated children with similar clinical phenotypes. Four children were evaluated clinically and immunologically. With the STING ligand cyclic guanosine monophosphate-adenosine monophosphate (cGAMP), we stimulated peripheral-blood mononuclear cells and fibroblasts from patients and controls, as well as commercially obtained endothelial cells, and then assayed transcription of IFNB1, the gene encoding interferon-beta, in the stimulated cells. We analyzed IFNB1 reporter levels in HEK293T cells cotransfected with mutant or nonmutant STING constructs. Mutant STING leads to increased phosphorylation of signal transducer and activator of transcription 1 (STAT1), so we tested the effect of Janus kinase (JAK) inhibitors on STAT1 phosphorylation in lymphocytes from the affected children and controls. RESULTS We identified three mutations in exon 5 of TMEM173 in the six patients. Elevated transcription of IFNB1 and other gene targets of STING in peripheral-blood mononuclear cells from the patients indicated constitutive activation of the pathway that cannot be further up-regulated with stimulation. On stimulation with cGAMP, fibroblasts from the patients showed increased transcription of IFNB1 but not of the genes encoding interleukin-1 (IL1), interleukin-6 (IL6), or tumor necrosis factor (TNF). HEK293T cells transfected with mutant constructs show elevated IFNB1 reporter levels. STING is expressed in endothelial cells, and exposure of these cells to cGAMP resulted in endothelial activation and apoptosis. Constitutive up-regulation of phosphorylated STAT1 in patients' lymphocytes was reduced by JAK inhibitors. CONCLUSIONS STING-associated vasculopathy with onset in infancy (SAVI) is an autoinflammatory disease caused by gain-of-function mutations in TMEM173.	[Liu, Y.; Jesus, A. A.; Marrero, B.; Sanchez, G. A. Montealegre; DiMattia, M. A.; Palmer, I.; Kim, H.; Tsai, W. L.; Trier, A. M.; Huang, Y.; Plass, N.; Chapelle, D.; Gadina, M.; Steven, A. C.; Wingfield, P. T.; Brooks, S. R.; Deng, Z.; Goldbach-Mansky, R.] NIAMSD, NIH, Bethesda, MD 20892 USA; [Lee, C. -C. R.; Cowen, E. W.; DiGiovanna, J. J.; Raffeld, M.] NCI, NIH, Bethesda, MD 20892 USA; [Yang, D.; Biancotto, A.; St Hilaire, C.; Fontana, J. R.; Minniti, C. P.; Boehm, M.] NHLBI, NIH, Bethesda, MD 20892 USA; [Kuehn, H. S.; Gurprasad, S.; Rosenzweig, S. D.; Fleisher, T. A.] NIH, Dept Lab Med, Bethesda, MD 20892 USA; [Stone, D. L.; Candotti, F.; Kastner, D. L.] NHGRI, NIH, Bethesda, MD 20892 USA; [Hill, S.] NIH, Dept Radiol & Imaging Serv, Bethesda, MD 20892 USA; [Kim, H. J.] Natl Inst Deafness & Other Commun Disorders, NIH, Bethesda, MD USA; [Holland, S. M.; Moir, S.] NIAID, NIH, Bethesda, MD 20892 USA; [Jones, O. Y.; Horkayne-Szakaly, I.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Ramsey, S. E.; Issekutz, A. C.] Dalhousie Univ, Halifax, NS, Canada; [Tenbrock, K.] Rhein Westfal TH Aachen, D-52062 Aachen, Germany; [Wittkowski, H.; Foell, D.; Barysenka, A.] Univ Hosp Muenster, Munster, Germany; [Gonzalez, B.] Hosp Ninos Luis Calvo Mackenna, Santiago, Chile; [Hughes, J. D.; Mehmet, H.; McElwee, J.] Merck Res Labs, Boston, MA USA; [Paller, A. S.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Walter Reed National Military Medical Center; Dalhousie University; RWTH Aachen University; University of Munster; Universidad de Chile; Merck & Company; Northwestern University; Feinberg School of Medicine	Goldbach-Mansky, R (corresponding author), NIAMSD, NIH Bldg 10,Rm 6D-47B,10 Ctr Dr, Bethesda, MD 20892 USA.	goldbacr@mail.nih.gov	Goldbach-Mansky, Raphaela/N-5917-2017; Moir, Susan/AAC-3676-2020; Gadina, Massimo/R-4195-2019; Minniti, Caterina/AAX-3187-2021; Lee, Chyi-Chia Richard/AAO-1149-2020; St. Hilaire, Cynthia/R-8205-2017; biancotto, angelique/C-4632-2011; Lee, Chyi-Chia/I-1938-2013	St. Hilaire, Cynthia/0000-0003-1871-6915; biancotto, angelique/0000-0003-2271-009X; Wingfield, Paul/0000-0002-9515-4752; Trier, Anna/0000-0001-7957-2180; Lee, Chyi-Chia/0000-0002-5306-7781; Paller, Amy/0000-0001-6187-6549; Candotti, Fabio/0000-0001-6399-6042; DiGiovanna, John J./0000-0002-2750-2313; Kim, Hanna/0000-0002-0595-6533	National Institute of Arthritis and Musculoskeletal and Skin Diseases; NATIONAL CANCER INSTITUTE [ZICBC011087, ZIDBC011317] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006079, ZIAHL006077] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000825, ZIAAI001122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041138, ZIHAR041173, ZICAR041181, ZIAAR027015, ZIDAR041180] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases.	Agarwal AK, 2010, AM J HUM GENET, V87, P866, DOI 10.1016/j.ajhg.2010.10.031; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Arima K, 2011, P NATL ACAD SCI USA, V108, P14914, DOI 10.1073/pnas.1106015108; Beuthien W, 2005, CLIN RHEUMATOL, V24, P507, DOI 10.1007/s10067-005-1093-x; Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491; Casanova JL, 2012, IMMUNITY, V36, P515, DOI 10.1016/j.immuni.2012.03.016; Clark JD, 2014, J MED CHEM; Crow YJ, 2013, HAND CLINIC, V113, P1629, DOI 10.1016/B978-0-444-59565-2.00031-9; Crow YJ, 2011, ANN NY ACAD SCI, V1238, P91, DOI 10.1111/j.1749-6632.2011.06220.x; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Goldbach-Mansky R, 2012, CLIN EXP IMMUNOL, V167, P391, DOI 10.1111/j.1365-2249.2011.04533.x; GOODWIN JN, 1974, ARCH SURG-CHICAGO, V108, P780; Graf J, 2013, CURR OPIN RHEUMATOL, V25, P50, DOI 10.1097/BOR.0b013e32835b4449; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kitamura A, 2011, J CLIN INVEST, V121, P4150, DOI 10.1172/JCI58414; Kondo T, 2013, P NATL ACAD SCI USA, V110, P2969, DOI 10.1073/pnas.1222694110; Lee-Kirsch MA, 2006, AM J HUM GENET, V79, P731, DOI 10.1086/507848; Liu Y, 2012, ARTHRITIS RHEUM-US, V64, P895, DOI 10.1002/art.33368; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; O'Shea JJ, 2013, NEW ENGL J MED, V368, P161, DOI 10.1056/NEJMra1202117; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Rani MRS, 2007, J LEUKOCYTE BIOL, V82, P1353, DOI 10.1189/jlb.0507273; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rongioletti F, 1999, BRIT J DERMATOL, V140, P948, DOI 10.1046/j.1365-2133.1999.02833.x; Rosengren S, 2012, ANN RHEUM DIS, V71, P440, DOI 10.1136/ard.2011.150284; Ruiz-Irastorza G, 2010, LANCET, V376, P1498, DOI 10.1016/S0140-6736(10)60709-X; Sanchez GAM, 2013, RHEUM DIS CLIN N AM, V39, P701, DOI 10.1016/j.rdc.2013.08.001; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Szilasiova J, 2009, CLIN NEUROPHARMACOL, V32, P301, DOI 10.1097/WNF.0b013e3181a2b5fd; Thornsberry LA, 2013, J AM ACAD DERMATOL, V69, P450, DOI 10.1016/j.jaad.2013.01.043; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; van Boxel-Dezaire AHH, 2010, J IMMUNOL, V185, P5888, DOI 10.4049/jimmunol.0902314; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	42	725	761	7	130	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2014	371	6					507	518		10.1056/NEJMoa1312625	http://dx.doi.org/10.1056/NEJMoa1312625			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5LE	25029335	Green Accepted			2022-12-01	WOS:000339899100005
J	Reese, TA; Wakeman, BS; Choi, HS; Hufford, MM; Huang, SC; Zhang, X; Buck, MD; Jezewski, A; Kambal, A; Liu, CY; Goel, G; Murray, PJ; Xavier, RJ; Kaplan, MH; Renne, R; Speck, SH; Artyomov, MN; Pearce, EJ; Virgin, HW				Reese, T. A.; Wakeman, B. S.; Choi, H. S.; Hufford, M. M.; Huang, S. C.; Zhang, X.; Buck, M. D.; Jezewski, A.; Kambal, A.; Liu, C. Y.; Goel, G.; Murray, P. J.; Xavier, R. J.; Kaplan, M. H.; Renne, R.; Speck, S. H.; Artyomov, M. N.; Pearce, E. J.; Virgin, H. W.			Helminth infection reactivates latent gamma-herpesvirus via cytokine competition at a viral promoter	SCIENCE			English	Article							MURINE GAMMAHERPESVIRUS 68; SWITCH GENE 50; B-CELLS; MACROPHAGES; INTERFERON; VIRUS; TRANSACTIVATOR; PROLIFERATION; ESTABLISHMENT; INFLAMMATION	Mammals are coinfected by multiple pathogens that interact through unknown mechanisms. We found that helminth infection, characterized by the induction of the cytokine interleukin-4 (IL-4) and the activation of the transcription factor Stat6, reactivated murine gamma-herpesvirus infection in vivo. IL-4 promoted viral replication and blocked the antiviral effects of interferon-gamma (IFN gamma) by inducing Stat6 binding to the promoter for an important viral transcriptional transactivator. IL-4 also reactivated human Kaposi's sarcoma-associated herpesvirus from latency in cultured cells. Exogenous IL-4 plus blockade of IFN gamma reactivated latent murine gamma-herpesvirus infection in vivo, suggesting a "two-signal" model for viral reactivation. Thus, chronic herpesvirus infection, a component of the mammalian virome, is regulated by the counterpoised actions of multiple cytokines on viral promoters that have evolved to sense host immune status.	[Reese, T. A.; Huang, S. C.; Zhang, X.; Buck, M. D.; Jezewski, A.; Kambal, A.; Liu, C. Y.; Artyomov, M. N.; Pearce, E. J.; Virgin, H. W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Wakeman, B. S.; Speck, S. H.] Emory Univ, Vaccine Ctr, Atlanta, GA 30322 USA; [Choi, H. S.; Renne, R.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Hufford, M. M.; Kaplan, M. H.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Hufford, M. M.; Kaplan, M. H.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Goel, G.; Xavier, R. J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Goel, G.; Xavier, R. J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Murray, P. J.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Murray, P. J.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	Washington University (WUSTL); Emory University; State University System of Florida; University of Florida; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	virgin@wustl.edu	Speck, Samuel/L-5893-2019; Huang, Stanley Ching-Cheng/AAE-7866-2019; Murray, Peter J/K-4725-2018	Huang, Stanley Ching-Cheng/0000-0002-6557-3737; Murray, Peter J/0000-0001-6329-9802; Virgin, Herbert/0000-0001-8580-7628; Reese, Tiffany/0000-0003-2325-6546; Jezewski, Andrew/0000-0002-2004-1278; Buck, Michael/0000-0002-9611-1199	Damon Runyon Postdoctoral Fellowship; Crohn's and Colitis Foundation [274415, AI032573, CA164062, CA119917, CA52004];  [U54 AI057160];  [AI084887]; NATIONAL CANCER INSTITUTE [R01CA096511, R01CA164062, R01CA119917, R01CA052004, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032573, R01AI095282, R01AI084887, R56AI032573, U54AI057160] Funding Source: NIH RePORTER	Damon Runyon Postdoctoral Fellowship; Crohn's and Colitis Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	T. A. R. was supported by a Damon Runyon Postdoctoral Fellowship. This work was supported by grants U54 AI057160 and AI084887 and Crohn's and Colitis Foundation grant 274415 to H. W. V., grants AI032573 and CA164062 to E.J.P., grant CA119917 to R. R., and grant CA52004 to S. H. S. We thank R. Schreiber and K. Sheehan for supplying anti-IFNg and PIP, G. Randolph and E. Gautier for PPAR gamma f/f x LyzMcre mice and helpful discussion, J. Urban for help setting up the H. polygyrus system, D. Kreamalmeyer for animal care and breeding, members of the Virgin lab for manuscript review and discussion, the Genome Technology Access Center at Washington University for sequencing, and the Flow Cytometry Core at Washington University for assistance with sorting. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. The GEO accession numbers for RNAseq data on virus-infected cells and for the BMDMs are GSE58116 and GSE21895, respectively. T. A. R. designed the project, performed experiments, and wrote the paper. H. W. V. assisted with project design and paper writing. B. S. W. and S. H. S. defined promoters and performed promoter assays. X.Z. created and characterized MHV68-cre virus and performed limiting dilution PCR and Western blots. H. S. C. and R. R. performed KSHV experiments. M. M. H. and M. H. K. performed ChIP experiments. S. C. H. and E. J. P. helped design helminth experiments and supplied reagents. M. D. B. did RT-PCR for gene 50 and host genes. A. J. did flow cytometry with IL-4 in RAW264.7 cells. A. K. did Western blots. C.Y.L. did plaque assays. G. G. and R. J. X. did initial bioinformatic analysis of gene expression by array, later replaced with RNASeq. P. J. M. provided arginase mice. M.N.A. analyzed sequencing data.	Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; Goodwin MM, 2010, J VIROL, V84, P12039, DOI 10.1128/JVI.00396-10; Goodwin MM, 2010, J VIROL, V84, P3711, DOI 10.1128/JVI.02099-09; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gray KS, 2009, J VIROL, V83, P314, DOI 10.1128/JVI.01444-08; HARTY JT, 1992, P NATL ACAD SCI USA, V89, P11612, DOI 10.1073/pnas.89.23.11612; Hwang S, 2008, J VIROL, V82, P12498, DOI 10.1128/JVI.01152-08; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kis LL, 2011, BLOOD, V117, P165, DOI 10.1182/blood-2010-01-265272; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; McSorley HJ, 2013, INT J PARASITOL, V43, P301, DOI 10.1016/j.ijpara.2012.11.011; Moser JM, 2005, J VIROL, V79, P9480, DOI 10.1128/JVI.79.15.9480-9491.2005; Nakamura H, 2003, J VIROL, V77, P4205, DOI 10.1128/JVI.77.7.4205-4220.2003; Nguyen YN, 2008, VIROLOGY, V380, P182, DOI 10.1016/j.virol.2008.07.031; Ohmori Y, 2000, J BIOL CHEM, V275, P38095, DOI 10.1074/jbc.M006227200; Peacock JW, 2003, EUR J IMMUNOL, V33, P1849, DOI 10.1002/eji.200323148; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Saito F, 2013, INFLAMMATION, V36, P1295, DOI 10.1007/s10753-013-9668-1; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Steed A, 2007, J VIROL, V81, P6134, DOI 10.1128/JVI.00108-07; Tibbetts SA, 2002, J VIROL, V76, P7125, DOI 10.1128/JVI.76.14.7125-7132.2002; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wakeham K, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-15; Wakeman BS, 2014, J VIROL, V88, P5474, DOI 10.1128/JVI.03110-13; Weck KE, 1996, J VIROL, V70, P6775, DOI 10.1128/JVI.70.10.6775-6780.1996; Weck KE, 1999, J VIROL, V73, P3273, DOI 10.1128/JVI.73.4.3273-3283.1999	30	140	143	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					573	577		10.1126/science.1254517	http://dx.doi.org/10.1126/science.1254517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	24968940	Green Submitted, Green Published, Green Accepted			2022-12-01	WOS:000339651300048
J	Sandler, NG; Bosinger, SE; Estes, JD; Zhu, RTR; Tharp, GK; Boritz, E; Levin, D; Wijeyesinghe, S; Makamdop, KN; del Prete, GQ; Hill, BJ; Timmer, JK; Reiss, E; Yarden, G; Darko, S; Contijoch, E; Todd, JP; Silvestri, G; Nason, M; Norgren, RB; Keele, BF; Rao, S; Langer, JA; Lifson, JD; Schreiber, G; Douek, DC				Sandler, Netanya G.; Bosinger, Steven E.; Estes, Jacob D.; Zhu, Richard T. R.; Tharp, Gregory K.; Boritz, Eli; Levin, Doron; Wijeyesinghe, Sathi; Makamdop, Krystelle Nganou; del Prete, Gregory Q.; Hill, Brenna J.; Timmer, J. Katherina; Reiss, Emma; Yarden, Ganit; Darko, Samuel; Contijoch, Eduardo; Todd, John Paul; Silvestri, Guido; Nason, Martha; Norgren, Robert B., Jr.; Keele, Brandon F.; Rao, Srinivas; Langer, Jerome A.; Lifson, Jeffrey D.; Schreiber, Gideon; Douek, Daniel C.			Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression	NATURE			English	Article							PERSISTENT LCMV INFECTION; CD4(+) T-CELLS; HIV-1 INFECTION; ALPHA; REPLICATION; ACQUISITION; ACTIVATION; BLOCKADE; THERAPY; GENES	Inflammation in HIV infection is predictive of non-AIDS morbidity and death(1), higher set point plasma virus load(2) and virus acquisition3; thus, therapeutic agents are in development to reduce its causes and consequences. However, inflammation may simultaneously confer both detrimental and beneficial effects. This dichotomy is particularly applicable to type I interferons (IFN-I) which, while contributing to innate control of infection(4-10), also provide target cells for the virus during acute infection, impair CD4 T-cell recovery, and are associated with disease progression(6,11-19). Here we manipulated IFN-I signalling in rhesus macaques (Macaca mulatta) during simian immunodeficiency virus (Sly) transmission and acute infection with two complementary in vivo interventions. We show that blockade of the IFN-I receptor caused reduced antiviral gene expression, increased SIV reservoir size and accelerated CD4 T-cell depletion with progression to AIDS despite decreased T-cell activation. In contrast, IFN-a2a administration initially upreg-ulated expression of antiviral genes and prevented systemic infection. However, continued IFN-a2a treatment induced IFN-I desensitization and decreased antiviral gene expression, enabling infection with increased SIV reservoir size and accelerated CD4 T-cell loss. Thus, the timing of IFN-induced innate responses in acute SIV infection profoundly affects overall disease course and outweighs the detrimental consequences of increased immune activation. Yet, the clinical consequences of manipulation of IFN signalling are difficult to predict in vivo and therapeutic interventions in human studies should be approached with caution.	[Sandler, Netanya G.; Zhu, Richard T. R.; Boritz, Eli; Wijeyesinghe, Sathi; Makamdop, Krystelle Nganou; Hill, Brenna J.; Timmer, J. Katherina; Reiss, Emma; Darko, Samuel; Contijoch, Eduardo; Douek, Daniel C.] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Bosinger, Steven E.; Tharp, Gregory K.; Silvestri, Guido] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Div Microbiol & Immunol, Atlanta, GA 30322 USA; [Bosinger, Steven E.; Tharp, Gregory K.] Emory Univ, Robert W Woodruff Hlth Sci Ctr, Yerkes Natl Primate Res Ctr, Nonhuman Primate Genom Core, Atlanta, GA 30322 USA; [Estes, Jacob D.; del Prete, Gregory Q.; Keele, Brandon F.; Lifson, Jeffrey D.] Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick Natl Lab, Frederick, MD 21702 USA; [Levin, Doron; Yarden, Ganit; Schreiber, Gideon] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Todd, John Paul; Rao, Srinivas] NIAID, Lab Anim Med, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Nason, Martha] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20892 USA; [Norgren, Robert B., Jr.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Langer, Jerome A.] Rutgers Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University; Emory University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Weizmann Institute of Science; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Nebraska System; University of Nebraska Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Douek, DC (corresponding author), NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ddouek@mail.nih.gov		Utay, Netanya/0000-0002-6407-8670; Langer, Jerome/0000-0002-4617-3260; Contijoch, Eduardo/0000-0002-2873-6808; Wijeyesinghe, Sathi/0000-0002-8819-2654; Norgren, Robert/0000-0002-0021-5875	NIH Intramural Funding; NCI/NIH [HHSN261200800001E]; NIH [R24 RR017444, AI-076174]; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation grant [1775/12]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI076174] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	NIH Intramural Funding; NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation grant(Israel Science Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to acknowledge A. Zimin for his work in creating the MuSuRCA rhesus assembly, C. Miller for the gift of 6 rhesus macaques and Y. Peleg and S. Albeck at the Israel Structure Proteomic Center and G. Jona from Weizmann Institute Biological services for helping with protein production and purification; A. Roque and N. Haining for initial work on the pilot study; N. Modi, D. Ambrozak, R. Koup, M. Ghosh, I. Srivastava, R. Schwartz, F. Villinger, K. Zoon, J. Bekisz, K. Ghneim, A. Filali, R. Sekaly, L. Mach and L. Shen for their assistance on the current project; and A. Somasunderam for additional support This project was supported by NIH Intramural Funding, federal funds from NCI/NIH Contract HHSN261200800001E, NIH R24 RR017444, NIH AI-076174, I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation grant No. 1775/12.	Abel K, 2002, J VIROL, V76, P8433, DOI 10.1128/JVI.76.16.8433-8445.2002; Asmuth DM, 2008, J MED PRIMATOL, V37, P26, DOI 10.1111/j.1600-0684.2007.00221.x; Azzoni L, 2013, J INFECT DIS, V207, P213, DOI 10.1093/infdis/jis663; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Brenchley JM, 2012, BLOOD, V120, P4172, DOI 10.1182/blood-2012-06-437608; Carrington M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007070; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Fenton-May AE, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-146; Fernandez S, 2011, J INFECT DIS, V204, P1927, DOI 10.1093/infdis/jir659; Fraietta JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003658; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Haas DW, 2000, AIDS RES HUM RETROV, V16, P183, DOI 10.1089/088922200309278; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hunt PW, 2014, J INFECT DIS; LANE HC, 1988, LANCET, V2, P1218; Levin D, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004998; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Litvak V, 2012, NATURE, V490, P421, DOI 10.1038/nature11428; Manion M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030306; McElrath MJ, 2013, JAIDS-J ACQ IMM DEF, V63, P263, DOI 10.1097/QAI.0b013e3182898392; Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Roberts L, 2012, J INFECT DIS, V205, P194, DOI 10.1093/infdis/jir715; Schellekens H, 1996, ANTIVIR RES, V32, P1, DOI 10.1016/0166-3542(95)00955-8; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Vanderford TH, 2012, BLOOD, V119, P5750, DOI 10.1182/blood-2012-02-411496; Waggoner SN, 2014, J VIROL, V88, P1953, DOI 10.1128/JVI.03002-13; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208	34	331	336	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					601	+		10.1038/nature13554	http://dx.doi.org/10.1038/nature13554			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043006	Green Published, Green Accepted			2022-12-01	WOS:000339566300037
J	Zhang, LR; Wang, SX; Yin, S; Hong, S; Kim, KP; Kleckner, N				Zhang, Liangran; Wang, Shunxin; Yin, Shen; Hong, Soogil; Kim, Keun P.; Kleckner, Nancy			Topoisomerase II mediates meiotic crossover interference	NATURE			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; CROSSING-OVER; CHROMOSOME SYNAPSIS; MITOTIC CHROMOSOMES; CHIASMA FORMATION; YEAST MEIOSIS; RECOMBINATION; PROTEIN	Spatial patterning is a ubiquitous feature of biological systems. Meiotic crossovers provide an interesting example, defined by the classic phenomenon of crossover interference. Here we identify a molecular pathway for interference by analysing crossover patterns in budding yeast. Topoisomerase II plays a central role, thus identifying a new function for this critical molecule. SUMOylation (of topoisomerase II and axis component Red1) and ubiquitin-mediated removal of SUMOylated proteins are also required. The findings support the hypothesis that crossover interference involves accumulation, relief and redistribution of mechanical stress along the protein/ DNA meshwork of meiotic chromosome axes, with topoisomerase II required to adjust spatial relationships among DNA segments.	[Zhang, Liangran; Wang, Shunxin; Yin, Shen; Kleckner, Nancy] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Hong, Soogil; Kim, Keun P.] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea	Harvard University; Chung Ang University	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kleckner@fas.harvard.edu		zhang, liangran/0000-0002-8550-6742; Kim, Keun/0000-0002-5973-8259	National Institutes of Health [RO1 GM044794]; National Research Foundation of Korea - Ministry of Science, ICT and Future Planning [2012-M3A9C6050367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea - Ministry of Science, ICT and Future Planning; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Hochstrasser, J. Bachant, S. Jentsch, L. Pillus and M. Weinreich for plasmids, J. Fung for Zip2 focus data, D. Zickler for the image in Fig. 6a, and members of the Kleckner laboratory and D. Zickler for advice and discussions. This research, L.Z., S. W., S.Y. and N.K. were supported by a grant to N.K. from the National Institutes of Health (RO1 GM044794); S. H. and K. P. K. were supported by the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning (2012-M3A9C6050367).	Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Agostinho M, 2008, CANCER RES, V68, P2409, DOI 10.1158/0008-5472.CAN-07-2092; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Baldwin M, 2009, METHODS MOL BIOL, V582, P209, DOI 10.1007/978-1-60761-340-4_16; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Charles DR, 1938, J GENET, V36, P103, DOI 10.1007/BF02982376; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; Darst RP, 2008, MOL CELL BIOL, V28, P1361, DOI 10.1128/MCB.01291-07; de los Santos T, 2003, GENETICS, V164, P81; Deryshire MK, 1996, YEAST, V12, P631; Dhillon N, 2000, MOL CELL, V6, P769, DOI 10.1016/S1097-2765(00)00076-9; Drouaud J, 2007, PLOS GENET, V3, P1096, DOI 10.1371/journal.pgen.0030106; Eichinger CS, 2010, P NATL ACAD SCI USA, V107, P11370, DOI 10.1073/pnas.1004248107; Fung JC, 2004, CELL, V116, P795, DOI 10.1016/S0092-8674(04)00249-1; Henderson KA, 2005, BIOESSAYS, V27, P995, DOI 10.1002/bies.20310; Henderson KA, 2004, P NATL ACAD SCI USA, V101, P4519, DOI 10.1073/pnas.0400843101; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hong S, 2013, MOL CELL, V51, P440, DOI 10.1016/j.molcel.2013.08.008; Hooker GW, 2006, CURR BIOL, V16, P1238, DOI 10.1016/j.cub.2006.04.045; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Hunter N, 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Jones GH, 2006, CELL, V126, P246, DOI 10.1016/j.cell.2006.07.010; Kauppi L, 2013, GENE DEV, V27, P873, DOI 10.1101/gad.213652.113; Kawamura R, 2010, J CELL BIOL, V188, P653, DOI 10.1083/jcb.200910085; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; KING JS, 1990, GENETICS, V126, P1127; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kleckner N., 2011, GENOME ORG FUNCTION, P487; Kleckner N, 2013, SCIENCE, V342, P940, DOI 10.1126/science.1247514; KLEIN F, 1992, J CELL BIOL, V117, P935, DOI 10.1083/jcb.117.5.935; Koszul R, 2009, TRENDS CELL BIOL, V19, P716, DOI 10.1016/j.tcb.2009.09.007; Lee MT, 2009, DNA REPAIR, V8, P557, DOI 10.1016/j.dnarep.2009.01.004; Libuda DE, 2013, NATURE, V502, P703, DOI 10.1038/nature12577; Loidl J, 1998, METHOD CELL BIOL, V53, P257; Malkova A, 2004, GENETICS, V168, P49, DOI 10.1534/genetics.104.027961; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; MOENS PB, 1989, CHROMOSOMA, V98, P317, DOI 10.1007/BF00292383; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Nagai S, 2011, CELL RES, V21, P474, DOI 10.1038/cr.2011.31; Nishant KT, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001109; Novak I, 2008, J CELL BIOL, V180, P83, DOI 10.1083/jcb.200706136; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Petkolv PM, 2007, TRENDS GENET, V23, P539, DOI 10.1016/j.tig.2007.08.015; Pope LH, 2006, MOL BIOL CELL, V17, P104, DOI 10.1091/mbc.e05-04-0321; ROSE D, 1993, MOL CELL BIOL, V13, P3445, DOI 10.1128/MCB.13.6.3445; Serrentino ME, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003416; Shinohara M, 2008, NAT GENET, V40, P299, DOI 10.1038/ng.83; Storlazzi A, 2010, CELL, V141, P94, DOI 10.1016/j.cell.2010.02.041; Sturtevant A. H., 1915, Zs indukt Abstamm Berlin, V13, DOI 10.1007/BF01792906; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; Vecchiarelli AG, 2013, P NATL ACAD SCI USA, V110, pE1390, DOI 10.1073/pnas.1302745110; Warsi T. H., 2009, THESIS U CALIF; Wu CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002000; Zhang LR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004042; Zhang LR, 2011, P NATL ACAD SCI USA, V108, P20036, DOI 10.1073/pnas.1117937108; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	67	108	108	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					551	+		10.1038/nature13442	http://dx.doi.org/10.1038/nature13442			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043020	Green Accepted			2022-12-01	WOS:000339566300026
J	Qin, H; Diaz, A; Blouin, L; Lebbink, RJ; Patena, W; Tanbun, P; LeProust, EM; McManus, MT; Song, JS; Ramalho-Santos, M				Qin, Han; Diaz, Aaron; Blouin, Laure; Lebbink, Robert Jan; Patena, Weronika; Tanbun, Priscilia; LeProust, Emily M.; McManus, Michael T.; Song, Jun S.; Ramalho-Santos, Miguel			Systematic Identification of Barriers to Human iPSC Generation	CELL			English	Article							PLURIPOTENT STEM-CELLS; SOMATIC-CELLS; REVEALS; PATHWAY; DISTINCT	Reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) holds enormous promise for regenerative medicine. To elucidate endogenous barriers limiting this process, we systematically dissected human cellular reprogramming by combining a genome-wide RNAi screen, innovative computational methods, extensive single-hit validation, and mechanistic investigation of relevant pathways and networks. We identify reprogramming barriers, including genes involved in transcription, chromatin regulation, ubiquitination, dephosphorylation, vesicular transport, and cell adhesion. Specific a disintegrin and metalloproteinase (ADAM) proteins inhibit reprogramming, and the disintegrin domain of ADAM29 is necessary and sufficient for this function. Clathrin-mediated endocytosis can be targeted with small molecules and opposes reprogramming by positively regulating TGF-beta signaling. Genetic interaction studies of endocytosis or ubiquitination reveal that barrier pathways can act in linear, parallel, or feedforward loop architectures to antagonize reprogramming. These results provide a global view of barriers to human cellular reprogramming.	[Qin, Han; Diaz, Aaron; Blouin, Laure; Lebbink, Robert Jan; Patena, Weronika; Tanbun, Priscilia; McManus, Michael T.; Song, Jun S.; Ramalho-Santos, Miguel] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Qin, Han; Blouin, Laure; Tanbun, Priscilia; Ramalho-Santos, Miguel] Univ Calif San Francisco, Ctr Reprod Sci, Dept Ob Gyn, San Francisco, CA 94143 USA; [Qin, Han; Blouin, Laure; Tanbun, Priscilia; Ramalho-Santos, Miguel] Univ Calif San Francisco, Ctr Reprod Sci, Dept Pathol, San Francisco, CA 94143 USA; [Qin, Han; Blouin, Laure; Tanbun, Priscilia; Ramalho-Santos, Miguel] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Diaz, Aaron; Song, Jun S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Lebbink, Robert Jan; Patena, Weronika; McManus, Michael T.] Univ Calif San Francisco, Ctr Diabet, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Lebbink, Robert Jan; Patena, Weronika; McManus, Michael T.] Univ Calif San Francisco, WM Keck Ctr Noncoding RNAs, San Francisco, CA 94143 USA; [Song, Jun S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Song, Jun S.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [LeProust, Emily M.] Agilent Technol, Genom Solut Unit, Santa Clara, CA 95051 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Agilent Technologies	Song, JS (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	songj@illinois.edu; miguel.ramalho-santos@ucsf.edu	Ramalho-Santos, Miguel/L-9092-2018; Song, Jun S/E-2526-2016; Lebbink, Robert Jan/GNH-5209-2022; Patena, Weronika/AAZ-3275-2020; mcmanus, michael/AAB-1239-2020	Ramalho-Santos, Miguel/0000-0003-0177-5556; Song, Jun S/0000-0002-0422-2175; Patena, Weronika/0000-0002-8388-1303; mcmanus, michael/0000-0003-3013-6569; Lebbink, Robert Jan/0000-0002-1981-0420	NWO Rubicon [825.06.030]; NWO Veni [916.10.138]; UCSF Program for Breakthrough Biomedical Research; NIH [1U01CA168370, R01 GM80783, R01CA163336, DP2OD4698]; Sontag Foundation Distinguished Scientist Award; CIRM [RB4-06028]; NATIONAL CANCER INSTITUTE [R01CA163336, U01CA168370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080783] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004698] Funding Source: NIH RePORTER	NWO Rubicon(Netherlands Organization for Scientific Research (NWO)); NWO Veni(Netherlands Organization for Scientific Research (NWO)); UCSF Program for Breakthrough Biomedical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sontag Foundation Distinguished Scientist Award; CIRM(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Robert Blelloch, Keith Mostov, and Zena Werb for critical reading of the manuscript, Jonathan Weissman, Martin Kampann, and Michael Bassick for discussions and help with library generation, Nikki Shariat for input on the experiment design, Xiaoyin Wang for virus production, Fong Ming Koh for providing the pGAMA vector, Charles Nicolet and Henriette O'Geen for support on NGS, and Tara Rambaldo and Michael Kissner for support with FACS. This work was supported by NWO Rubicon grant 825.06.030 and Veni grant 916.10.138 to R.J.L.; the UCSF Program for Breakthrough Biomedical Research and NIH grants 1U01CA168370 and R01 GM80783 to M.T.M.; NIH R01CA163336 and Sontag Foundation Distinguished Scientist Award to J.S.S.; and CIRM grant RB4-06028 and NIH Director's New Innovator Award DP2OD4698 to M.R.-S.E.M.L. is an employee of Agilent Technologies.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bassik MC, 2009, NAT METHODS, V6, P443, DOI [10.1038/NMETH.1330, 10.1038/nmeth.1330]; Buckley SM, 2012, CELL STEM CELL, V11, P783, DOI 10.1016/j.stem.2012.09.011; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Calvete JJ, 2005, TOXICON, V45, P1063, DOI 10.1016/j.toxicon.2005.02.024; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Daley GQ, 2008, COLD SH Q B, V73, P171, DOI 10.1101/sqb.2008.73.041; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Handl J, 2007, IEEE ACM T COMPUT BI, V4, P279, DOI 10.1109/TCBB.2007.070203; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Igarashi T, 2007, FEBS LETT, V581, P2416, DOI 10.1016/j.febslet.2007.04.057; Karpiuk O, 2012, MOL CELL, V46, P705, DOI 10.1016/j.molcel.2012.05.022; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Persaud A, 2011, EMBO J, V30, P3259, DOI 10.1038/emboj.2011.234; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Qin H, 2012, HUM MOL GENET, V21, P2054, DOI 10.1093/hmg/dds023; Ramalho-Santos M, 2009, CELL, V138, P616, DOI 10.1016/j.cell.2009.08.012; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan TZ, 2013, EMBO MOL MED, V5, P1051, DOI 10.1002/emmm.201201823; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wei XM, 2011, HUM MUTAT, V32, pE2148, DOI 10.1002/humu.21477; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	38	62	62	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					449	461		10.1016/j.cell.2014.05.040	http://dx.doi.org/10.1016/j.cell.2014.05.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036638	Bronze, Green Accepted			2022-12-01	WOS:000340943600022
J	Wolfe, BE; Button, JE; Santarelli, M; Dutton, RJ				Wolfe, Benjamin E.; Button, Julie E.; Santarelli, Marcela; Dutton, Rachel J.			Cheese Rind Communities Provide Tractable Systems for In Situ and In Vitro Studies of Microbial Diversity	CELL			English	Article							FUNCTIONAL-ANALYSIS; BACTERIAL; IDENTIFICATION; SURFACE; PATTERNS; GENOME; COLD	Tractable microbial communities are needed to bridge the gap between observations of patterns of microbial diversity and mechanisms that can explain these patterns. We developed cheese rinds as model microbial communities by characterizing in situ patterns of diversity and by developing an in vitro system for community reconstruction. Sequencing of 137 different rind communities across 10 countries revealed 24 widely distributed and culturable genera of bacteria and fungi as dominant community members. Reproducible community types formed independent of geographic location of production. Intensive temporal sampling demonstrated that assembly of these communities is highly reproducible. Patterns of community composition and succession observed in situ can be recapitulated in a simple in vitro system. Widespread positive and negative interactions were identified between bacterial and fungal community members. Cheese rind microbial communities represent an experimentally tractable system for defining mechanisms that influence microbial community assembly and function.	[Wolfe, Benjamin E.; Button, Julie E.; Santarelli, Marcela; Dutton, Rachel J.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University	Dutton, RJ (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	rdutton@cgr.harvard.edu			National Institutes of Health [P50 GM068763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Andrew Murray, Bodo Stern, Peter Turnbaugh, the Turnbaugh lab, Lawrence David, Miriam Shiffman, Jon Calarco, Lauren O'Connell, Mike Laub, and Kevin Verstrepen for helpful comments and discussions; Noah Fierer for fungal ITS primers; Christian Daly, Michele Clamp, Claire Reardon, and Noelani Kamelamela for technical support; Mateo and Andy Kehler, Vince Razionale, Jasper Hill Farm, the Cellars at Jasper Hill, Bronwen Percival, Sister Noella Marcellino, Catherine Donnelly, Eric Meredith, Brian Ralph, Ihsan Gurdal, and the many members of the artisan cheese community who made collection of samples possible. This work was supported by the National Institutes of Health (P50 GM068763).	Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Amarita F, 2004, APPL ENVIRON MICROB, V70, P7348, DOI 10.1128/AEM.70.12.7348-7354.2004; Beresford TP, 2001, INT DAIRY J, V11, P259, DOI 10.1016/S0958-6946(01)00056-5; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Bokulich NA, 2013, APPL ENVIRON MICROB, V79, P5214, DOI 10.1128/AEM.00934-13; Brennan NM, 2002, APPL ENVIRON MICROB, V68, P820, DOI 10.1128/AEM.68.2.820-830.2002; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cheeseman K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3876; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; de Pascale D, 2010, POLAR SCI, V4, P285, DOI 10.1016/j.polar.2010.03.009; de Pascale D, 2008, EXTREMOPHILES, V12, P311, DOI 10.1007/s00792-008-0163-9; Engel AS, 2010, GEOMICROBIOLOGY: MOLECULAR AND ENVIRONMENTAL PERSPECTIVE, P219, DOI 10.1007/978-90-481-9204-5_10; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Feligini M, 2012, J FOOD SCI, V77, pM609, DOI 10.1111/j.1750-3841.2012.02932.x; Fierer N, 2012, ANNU REV ECOL EVOL S, V43, P137, DOI 10.1146/annurev-ecolsys-110411-160307; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Fox P.F., 2004, CHEESE CHEM PHYS MIC, VVolume 1, P1, DOI DOI 10.1016/S1874-558X(04)80060-5; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Holmstrom C, 1999, FEMS MICROBIOL ECOL, V30, P285, DOI 10.1016/S0168-6496(99)00063-X; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kuck U, 2010, APPL MICROBIOL BIOT, V86, P51, DOI 10.1007/s00253-009-2416-7; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; MARCELLINO N, 1992, APPL ENVIRON MICROB, V58, P3448, DOI 10.1128/AEM.58.11.3448-3454.1992; Marsh AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069371; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; Medigue C, 2005, GENOME RES, V15, P1325, DOI 10.1101/gr.4126905; Meersman E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081559; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Minhas A, 2009, FEMS YEAST RES, V9, P95, DOI 10.1111/j.1567-1364.2008.00457.x; Monnet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015489; Mounier J, 2009, INT J FOOD MICROBIOL, V133, P31, DOI 10.1016/j.ijfoodmicro.2009.04.020; Mounier J, 2008, APPL ENVIRON MICROB, V74, P172, DOI 10.1128/AEM.01338-07; Na Jong-Min, 2011, Korean Journal of Microbiology and Biotechnology, V39, P133; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; Passerini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015306; Prax M, 2013, MICROBIOL-SGM, V159, P421, DOI 10.1099/mic.0.061705-0; Quigley L, 2013, FEMS MICROBIOL REV, V37, P664, DOI 10.1111/1574-6976.12030; Quigley L, 2012, APPL ENVIRON MICROB, V78, P5717, DOI 10.1128/AEM.00918-12; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Reen FJ, 2006, NAT REV MICROBIOL, V4, P697, DOI 10.1038/nrmicro1476; Schroder J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-545; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shade A, 2013, ISME J, V7, P1493, DOI 10.1038/ismej.2013.54; Sieuwerts S, 2008, APPL ENVIRON MICROB, V74, P4997, DOI 10.1128/AEM.00113-08; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Verdier-Metz I, 2012, APPL ENVIRON MICROB, V78, P326, DOI 10.1128/AEM.06229-11; White TJ., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	50	325	353	26	233	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					422	433		10.1016/j.cell.2014.05.041	http://dx.doi.org/10.1016/j.cell.2014.05.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036636	Bronze, Green Accepted			2022-12-01	WOS:000340943600020
J	Lansdorp-Vogelaar, I; Gulati, R; Mariotto, AB; Schechter, CB; de Carvalho, TM; Knudsen, AB; van Ravesteyn, NT; Heijnsdijk, EAM; Pabiniak, C; van Ballegooijen, M; Rutter, CM; Kuntz, KM; Feuer, EJ; Etzioni, R; de Koning, HJ; Zauber, AG; Mandelblatt, JS				Lansdorp-Vogelaar, Iris; Gulati, Roman; Mariotto, Angela B.; Schechter, Clyde B.; de Carvalho, Tiago M.; Knudsen, Amy B.; van Ravesteyn, Nicolien T.; Heijnsdijk, Eveline A. M.; Pabiniak, Chester; van Ballegooijen, Marjolein; Rutter, Carolyn M.; Kuntz, Karen M.; Feuer, Eric J.; Etzioni, Ruth; de Koning, Harry J.; Zauber, Ann G.; Mandelblatt, Jeanne S.			Personalizing Age of Cancer Screening Cessation Based on Comorbid Conditions: Model Estimates of Harms and Benefits	ANNALS OF INTERNAL MEDICINE			English	Article							SERVICES TASK-FORCE; COLORECTAL-CANCER; PROSTATE-CANCER; LIFE-STYLE; RECOMMENDATION STATEMENT; POTENTIAL BENEFITS; COST-EFFECTIVENESS; DECISION-ANALYSIS; ELDERLY-PATIENTS; BREAST	Background: Harms and benefits of cancer screening depend on age and comorbid conditions, but reliable estimates are lacking. Objective: To estimate the harms and benefits of cancer screening by age and comorbid conditions to inform decisions about screening cessation. Design: Collaborative modeling with 7 cancer simulation models and common data on average and comorbid condition level-specific life expectancy. Setting: U. S. population. Patients: U. S. cohorts aged 66 to 90 years in 2010 with average health or 1 of 4 comorbid condition levels: none, mild, moderate, or severe. Intervention: Mammography, prostate-specific antigen testing, or fecal immunochemical testing. Measurements: Lifetime cancer deaths prevented and life-years gained (benefits); false-positive test results and overdiagnosed cancer cases (harms). For each comorbid condition level, the age at which harms and benefits of screening were similar to that for persons with average health having screening at age 74 years. Results: Screening 1000 women with average life expectancy at age 74 years for breast cancer resulted in 79 to 96 (range across models) false-positive results, 0.5 to 0.8 overdiagnosed cancer cases, and 0.7 to 0.9 prevented cancer deaths. Although absolute numbers of harms and benefits differed across cancer sites, the ages at which to cease screening were consistent across models and cancer sites. For persons with no, mild, moderate, and severe comorbid conditions, screening until ages 76, 74, 72, and 66 years, respectively, resulted in harms and benefits similar to average-health persons. Limitation: Comorbid conditions influenced only life expectancy. Conclusion: Comorbid conditions are an important determinant of harms and benefits of screening. Estimates of screening benefits and harms by comorbid condition can inform discussions between providers and patients about personalizing screening cessation decisions.	Erasmus Univ, Med Ctr, NL-3000 CA Rotterdam, Netherlands; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Grp Hlth Res Inst, Seattle, WA 98101 USA; NCI, Bethesda, MD 20892 USA; Yeshiva Univ, Albert Einstein Coll Med, Bronx, NY USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Univ Minnesota, Minneapolis, MN 55455 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; Georgetown Univ, Washington, DC 20007 USA	Erasmus University Rotterdam; Erasmus MC; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine; Harvard University; Massachusetts General Hospital; University of Minnesota System; University of Minnesota Twin Cities; Memorial Sloan Kettering Cancer Center; Georgetown University	Lansdorp-Vogelaar, I (corresponding author), Erasmus Univ, Med Ctr, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	i.vogelaar@erasmusmc.nl	Rutter, Carolyn/AAZ-3677-2021; Gulati, Roman/AAE-4298-2019; de+Koning, Harry/AAF-9062-2019	Gulati, Roman/0000-0002-7592-6567; de+Koning, Harry/0000-0003-4682-3646	National Cancer Institute at the National Institutes of Health; Centers for Disease Control and Prevention [U01CA097426, U01CA115953, U01CA152959, U01CA157224, U01CA088283, U01CA152958]; National Cancer Institute at the National Institutes of Health [KO5CA96940, P01CA154292, U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040, HHSN261201100031C]; Dutch Cancer Society [94-869, 98-1657, 2002-277, 2006-3518]; Netherlands Organisation for Health Research and Development [002822820, 22000106, 50-50110-98-311]; NATIONAL CANCER INSTITUTE [U01CA063731, P01CA154292, U01CA097426, U01CA086082, U01CA115953, U01CA086076, U01CA063740, U01CA152958, UM1CA182883, P30CA008748, U01CA070040, U01CA157224, U01CA069976, U01CA152959, U01CA063736, U01CA088283, K05CA096940, U01CA070013] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute at the National Institutes of Health and the Centers for Disease Control and Prevention (grants U01CA097426, U01CA115953, U01CA152959, U01CA157224, U01CA088283, and U01CA152958) and in part by the National Cancer Institute at the National Institutes of Health (grants KO5CA96940 to Dr. Mandelblatt and P01CA154292 to Drs. Mandelblatt, Schechter, van Ravesteyn, Heijnsdijk, and de Koning), the Dutch Cancer Society (grants 94-869, 98-1657, 2002-277, and 2006-3518 to Drs. Heijnsdijk and de Koning), and the Netherlands Organisation for Health Research and Development (grants 002822820, 22000106, and 50-50110-98-311 to Drs. Heijnsdijk and de Koning). Breast Cancer Surveillance Consortium data collection and sharing used in some variables for modeling breast cancer screening was supported by the National Cancer Institute at the National Institutes of Health (grants U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040, and HHSN261201100031C).	Begg CB, 2010, ANN INTERN MED, V152, P540, DOI 10.7326/0003-4819-152-8-201004200-00203; Braithwaite RS, 2010, ANN INTERN MED, V152, P539, DOI 10.7326/0003-4819-152-8-201004200-00201; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; Chang YJ, 2012, BREAST CANCER RES TR, V136, P823, DOI 10.1007/s10549-012-2274-3; Cho H, 2013, ANN INTERN MED, V159, P667, DOI 10.7326/0003-4819-159-10-201311190-00005; Col NF, 2010, ANN INTERN MED, V152, P542, DOI 10.7326/0003-4819-152-8-201004200-00206; Dinh TA, 2012, J GEN INTERN MED, V27, P730, DOI 10.1007/s11606-011-1972-6; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; Gong ZH, 2006, CANCER EPIDEM BIOMAR, V15, P1977, DOI 10.1158/1055-9965.EPI-06-0477; Greene KL, 2009, J UROLOGY, V182, P2232, DOI 10.1016/j.juro.2009.07.093; Gulati R, 2013, ANN INTERN MED, V158, P145, DOI 10.7326/0003-4819-158-3-201302050-00003; Gulati R, 2011, CANCER EPIDEM BIOMAR, V20, P740, DOI 10.1158/1055-9965.EPI-10-0718; Gulati R, 2010, BIOSTATISTICS, V11, P707, DOI 10.1093/biostatistics/kxq036; Harewood GC, 2006, J GASTROEN HEPATOL, V21, P1021, DOI 10.1111/j.1440-1746.2006.04218.x; Harris R, 2011, EPIDEMIOL REV, V33, P20, DOI 10.1093/epirev/mxr005; Heijnsdijk EAM, 2012, NEW ENGL J MED, V367, P595, DOI 10.1056/NEJMoa1201637; Ho A, 2010, ANN INTERN MED, V152, P542, DOI 10.7326/0003-4819-152-8-201004200-00207; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Kawachi Mark H, 2007, J Natl Compr Canc Netw, V5, P714; Klabunde CN, 2007, ANN EPIDEMIOL, V17, P584, DOI 10.1016/j.annepidem.2007.03.011; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Klijs B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-378; Ko CW, 2005, GASTROENTEROLOGY, V129, P1163, DOI 10.1053/j.gastro.2005.07.027; Lee SJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8441; Loeve F, 1999, COMPUT BIOMED RES, V32, P13, DOI 10.1006/cbmr.1998.1498; Maheshwari S, 2008, J AGING HEALTH, V20, P126, DOI 10.1177/0898264307309939; Mandelblatt Jeanne, 2006, J Natl Cancer Inst Monogr, P47, DOI 10.1093/jncimonographs/lgj008; Mandelblatt JS, 2013, JAMA INTERN MED, V173, P227, DOI 10.1001/jamainternmed.2013.2127; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Mandelblatt JS, 2005, J GEN INTERN MED, V20, P487, DOI 10.1111/j.1525-1497.2005.0116.x; MANDELBLATT JS, 1992, ANN INTERN MED, V116, P722, DOI 10.7326/0003-4819-116-9-722; Nelson NJ, 2012, J NATL CANCER I, V104, P574, DOI 10.1093/jnci/djs213; Qaseem A, 2013, ANN INTERN MED, V158, P761, DOI 10.7326/0003-4819-158-10-201305210-00633; Rich J S, 2000, Eff Clin Pract, V3, P78; Rutter CM, 2010, CANCER EPIDEM BIOMAR, V19, P1992, DOI 10.1158/1055-9965.EPI-09-0954; Schonberg MA, 2011, J AM GERIATR SOC, V59, P1444, DOI 10.1111/j.1532-5415.2011.03523.x; Schonberg MA, 2009, J GEN INTERN MED, V24, P1115, DOI 10.1007/s11606-009-1073-y; Smith RA, 2012, CA CANCER J CLIN; Stevens T, 2003, AM J GASTROENTEROL, V98, P1881, DOI 10.1016/S0002-9270(03)00425-8; Tan Sita Y G L, 2006, J Natl Cancer Inst Monogr, P56, DOI 10.1093/jncimonographs/lgj009; U.S. Census Bureau, 2013, 2012 NATIONAL POPULA; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; Wolk A, 2005, ACTA ONCOL, V44, P277, DOI 10.1080/02841860510029572; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	50	91	92	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2					104	+		10.7326/M13-2867	http://dx.doi.org/10.7326/M13-2867			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	25023249	Green Accepted			2022-12-01	WOS:000339764600019
J	Clayton, GM; Wang, Y; Crawford, F; Novikov, A; Wimberly, BT; Kieft, JS; Falta, MT; Bowerman, NA; Marrack, P; Fontenot, AP; Dai, SD; Kappler, JW				Clayton, Gina M.; Wang, Yang; Crawford, Frances; Novikov, Andrey; Wimberly, Brian T.; Kieft, Jeffrey S.; Falta, Michael T.; Bowerman, Natalie A.; Marrack, Philippa; Fontenot, Andrew P.; Dai, Shaodong; Kappler, John W.			Structural Basis of Chronic Beryllium Disease: Linking Allergic Hypersensitivity and Autoimmunity	CELL			English	Article							CD4(+) T-CELLS; MHC-CLASS-II; RECEPTOR TCR INTERACTION; RHEUMATOID-ARTHRITIS; LUNG-DISEASE; PEPTIDES; BINDING; RECOGNITION; PROTEINS; HLA-DP2	T-cell-mediated hypersensitivity to metal cations is common in humans. How the T cell antigen receptor (TCR) recognizes these cations bound to a major histocompatibility complex (MHC) protein and self-peptide is unknown. Individuals carrying the MHCII allele, HLA-DP2, are at risk for chronic beryllium disease (CBD), a debilitating inflammatory lung condition caused by the reaction of CD4 T cells to inhaled beryllium. Here, we show that the T cell ligand is created when a Be2+ cation becomes buried in an HLA-DP2/peptide complex, where it is coordinated by both MHC and peptide acidic amino acids. Surprisingly, the TCR does not interact with the Be2+ itself, but rather with surface changes induced by the firmly bound Be2+ and an accompanying Na+ cation. Thus, CBD, by creating a new antigen by indirectly modifying the structure of preexisting self MHC-peptide complex, lies on the border between allergic hypersensitivity and autoimmunity.	[Clayton, Gina M.; Crawford, Frances; Marrack, Philippa; Kappler, John W.] Natl Jewish Hlth, Howard Hughes Med Inst, Denver, CO 80206 USA; [Clayton, Gina M.; Wang, Yang; Crawford, Frances; Novikov, Andrey; Marrack, Philippa; Fontenot, Andrew P.; Dai, Shaodong; Kappler, John W.] Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA; [Clayton, Gina M.; Wang, Yang; Crawford, Frances; Novikov, Andrey; Marrack, Philippa; Fontenot, Andrew P.; Dai, Shaodong; Kappler, John W.] Univ Colorado, Denver Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA; [Wimberly, Brian T.; Kieft, Jeffrey S.] Univ Colorado, Denver Sch Med, Howard Hughes Med Inst, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Wimberly, Brian T.; Kieft, Jeffrey S.; Marrack, Philippa] Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Falta, Michael T.; Bowerman, Natalie A.; Fontenot, Andrew P.] Univ Colorado, Dept Med, Aurora, CO 80045 USA; [Wimberly, Brian T.; Kieft, Jeffrey S.; Kappler, John W.] Univ Colorado, Denver Sch Med, Program Struct Biol & Biochem, Aurora, CO 80045 USA	Howard Hughes Medical Institute; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Dai, SD (corresponding author), Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA.	dais@njhealth.org; kapplerj@njhealth.org	Wang, Yang/D-5344-2016; Marrack, Philippa/AHE-6316-2022	Wang, Yang/0000-0002-6510-6653; Marrack, Philippa/0000-0003-1883-3687; Falta, Michael/0000-0002-0835-6904	NIH [AI17785, HL62410, HL92997, ES011810, AI17134]; CCTSI [KL2TR000156, KL1TR000155]; Boettcher Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001080, UL1TR001082, KL2TR000156, TL1TR001081, TL1TR000155] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062410, R01HL092997, K24HL102245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI017134, R01AI018785, R56AI017134, R01AI017134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCTSI; Boettcher Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Igor Kurinov for data collection assistance at APS Argonne National Laboratory, Beamline 24 ID-C and Corie Ralston at ALS Lawrence Berkley National Laboratory, Beamline 822. Oliver Smart (Global Phasing) assisted us with beryllium definitions in AUTOBuster, and Mario Santiago made the BIORAD CFX96 RCT-PCR instrument available to us. We also thank Randy Anselment at the Molecular Resource Center, National Jewish Health, for oligonucleotide synthesis and DNA sequencing. This work was supported in part by NIH grant AI17785 (P. C. M.), by NIH grants HL62410, HL92997, and ES011810 (to A. P. F.), by CCTSI KL2TR000156 and KL1TR000155 and the Boettcher Foundation (to S. D.), and NIH grant AI17134 (to J. W. K).	Alerghi L., 1999, POLYHEDRON, V18, P3305; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bill JR, 2005, J IMMUNOL, V175, P7029, DOI 10.4049/jimmunol.175.10.7029; Bowerman NA, 2011, J IMMUNOL, V187, P3694, DOI 10.4049/jimmunol.1101872; Cordova KN, 2013, J IMMUNOL, V190, P1457, DOI 10.4049/jimmunol.1201517; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Crawford F, 2011, P NATL ACAD SCI USA, V108, P16729, DOI 10.1073/pnas.1113954108; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Dai SD, 2013, CURR OPIN IMMUNOL, V25, P775, DOI 10.1016/j.coi.2013.07.012; Dai SD, 2010, P NATL ACAD SCI USA, V107, P7425, DOI 10.1073/pnas.1001772107; Diaz G, 2005, IMMUNOGENETICS, V56, P754, DOI 10.1007/s00251-004-0735-5; Diyabalanage HVK, 2008, ANGEW CHEM INT EDIT, V47, P7332, DOI 10.1002/anie.200801965; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Evans PR, 2007, ACTA CRYSTALLOGR D, V63, P58, DOI 10.1107/S090744490604604X; Everest D.A., 1964, TOPICS INORGANIC GEN, V1; Falta MT, 2013, J EXP MED, V210, P1403, DOI 10.1084/jem.20122426; Fontenot AP, 2006, J IMMUNOL, V177, P3874, DOI 10.4049/jimmunol.177.6.3874; Fontenot AP, 2008, SEMIN RESP CRIT CARE, V29, P662, DOI 10.1055/s-0028-1101276; Fontenot AP, 1999, J IMMUNOL, V163, P1019; Fontenot JD, 2004, SEMIN IMMUNOL, V16, P73, DOI 10.1016/j.smim.2003.12.002; Gras S, 2008, CURR OPIN IMMUNOL, V20, P119, DOI 10.1016/j.coi.2007.12.001; Illing PT, 2013, CURR OPIN IMMUNOL, V25, P81, DOI 10.1016/j.coi.2012.10.002; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; KALISH RS, 1990, J INVEST DERMATOL, V94, pS108, DOI 10.1111/1523-1747.ep12876061; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Keizer TS, 2005, J INORG BIOCHEM, V99, P1174, DOI 10.1016/j.jinorgbio.2005.02.017; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8820, DOI 10.1073/pnas.132272099; Louis-Dit-Sully Christine, 2014, Exp Suppl, V104, P25, DOI 10.1007/978-3-0348-0726-5_3; Maier LA, 2003, J IMMUNOL, V171, P6910, DOI 10.4049/jimmunol.171.12.6910; Marrack P, 2008, CURR OPIN IMMUNOL, V20, P203, DOI 10.1016/j.coi.2008.03.008; MARTIN S, 1994, INT ARCH ALLERGY IMM, V104, P10, DOI 10.1159/000236703; Mohan JF, 2013, MOL IMMUNOL, V55, P166, DOI 10.1016/j.molimm.2012.10.024; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Pichler Werner J, 2006, Allergol Int, V55, P17, DOI 10.2332/allergolint.55.17; SALTINI C, 1989, NEW ENGL J MED, V320, P1103, DOI 10.1056/NEJM198904273201702; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Sollid LM, 2011, CURR OPIN IMMUNOL, V23, P732, DOI 10.1016/j.coi.2011.08.006; Sutton M, 2003, CHEM RES TOXICOL, V16, P1145, DOI 10.1021/tx0256477; Thierse HJ, 2005, TOXICOLOGY, V209, P101, DOI 10.1016/j.tox.2004.12.015; White J, 2000, METH MOL B, V134, P185; Wilson IA, 1997, CURR OPIN STRUC BIOL, V7, P839, DOI 10.1016/S0959-440X(97)80156-X; Yin L, 2012, P NATL ACAD SCI USA, V109, P18517, DOI 10.1073/pnas.1215928109	47	72	75	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					132	142		10.1016/j.cell.2014.04.048	http://dx.doi.org/10.1016/j.cell.2014.04.048			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995984	Green Accepted, Bronze			2022-12-01	WOS:000340943100013
J	Koroshetz, WJ				Koroshetz, Walter J.			PERSPECTIVE Time to tackle blood pressure	NATURE			English	Editorial Material							PREVALENCE; DEMENTIA		US Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Koroshetz, WJ (corresponding author), US Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20892 USA.	koroshetzw@ninds.nih.gov						Cholerton B, 2013, J ALZHEIMERS DIS, V36, P699, DOI 10.3233/JAD-130281; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Derdeyn CP, 2014, LANCET, V383, P333, DOI 10.1016/S0140-6736(13)62038-3; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Gillespie CD, 2013, MMWR-MORBID MORTAL W, V62, P157; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Lv JC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001293; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Wang J, 2014, AM J HYPERTENS	10	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S4	S4		10.1038/510S4a	http://dx.doi.org/10.1038/510S4a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24964024	Bronze			2022-12-01	WOS:000337806300003
J	Lee, K; Zhong, XF; Gu, SY; Kruel, AM; Dorner, MB; Perry, K; Rummel, A; Dong, M; Jin, RS				Lee, Kwangkook; Zhong, Xiaofen; Gu, Shenyan; Kruel, Anna Magdalena; Dorner, Martin B.; Perry, Kay; Rummel, Andreas; Dong, Min; Jin, Rongsheng			Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex	SCIENCE			English	Article							CLOSTRIDIUM-BOTULINUM; ADHERENS JUNCTIONS; CRYSTAL-STRUCTURE; ORAL TOXICITIES; BINDING; CELL; TOXINS; TRANSCYTOSIS; DOMAINS	How botulinum neurotoxins (BoNTs) cross the host intestinal epithelial barrier in foodborne botulism is poorly understood. Here, we present the crystal structure of a clostridial hemagglutinin (HA) complex of serotype BoNT/A bound to the cell adhesion protein E-cadherin at 2.4 angstroms. The HA complex recognizes E-cadherin with high specificity involving extensive intermolecular interactions and also binds to carbohydrates on the cell surface. Binding of the HA complex sequesters E-cadherin in the monomeric state, compromising the E-cadherin-mediated intercellular barrier and facilitating paracellular absorption of BoNT/A. We reconstituted the complete 14-subunit BoNT/A complex using recombinantly produced components and demonstrated that abolishing either E-cadherin- or carbohydrate-binding of the HA complex drastically reduces oral toxicity of BoNT/A complex in vivo. Together, these studies establish the molecular mechanism of how HAs contribute to the oral toxicity of BoNT/A.	[Lee, Kwangkook; Gu, Shenyan; Jin, Rongsheng] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Zhong, Xiaofen; Dong, Min] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Div Neurosci,New England Primate Res Ctr, Southborough, MA 01772 USA; [Kruel, Anna Magdalena; Rummel, Andreas] Hannover Med Sch, Inst Toxikol, D-30625 Hannover, Germany; [Dorner, Martin B.] Robert Koch Inst, Ctr Biol Threats & Special Pathogens Biol Toxins, D-13353 Berlin, Germany; [Perry, Kay] Cornell Univ, Northeastern Collaborat Access Team NE CAT, Argonne Natl Lab, Argonne, IL 60439 USA; [Perry, Kay] Cornell Univ, Dept Chem & Chem Biol, Argonne Natl Lab, Argonne, IL 60439 USA	University of California System; University of California Irvine; Harvard University; Hannover Medical School; Robert Koch Institute; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Jin, RS (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	r.jin@uci.edu	Jin, Rongsheng/M-7797-2013; Dorner, Martin B/C-5703-2013	Jin, Rongsheng/0000-0003-0348-7363; Dorner, Martin B/0000-0002-8176-797X; Lipton, Stuart/0000-0002-3490-1259; Rummel, Andreas/0000-0002-0645-1641	National Institute of Allergy and Infectious Diseases (NIAID) [R01AI091823]; NIH [8P51OD011103-51, 1R56AI097834-01, 1R01NS080833-01]; Swiss Federal Office for Civil Protection BABS [353003325]; National Institute of General Medical Sciences [P41 GM103403]; U.S. DOE [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091823, R56AI097834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080833, P30NS076411] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011103] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss Federal Office for Civil Protection BABS; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Bobkov for technical assistance. This work was partly supported by National Institute of Allergy and Infectious Diseases (NIAID) grant R01AI091823 to R.J.; by the NIH grant 8P51OD011103-51 (to the New England Primate Research Center), 1R56AI097834-01, and 1R01NS080833-01 to M. D.; and by the Swiss Federal Office for Civil Protection BABS #353003325 to A. R. NE-CAT at the Advanced Photon Source (APS) is supported by a grant from the National Institute of General Medical Sciences (P41 GM103403). Use of the APS, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under contract DE-AC02-06CH11357. The atomic coordinates and structure factors of the mini-HA-EC1-EC2 complex have been deposited in the Protein Data Bank under the accession code 4QD2. BoNT availability is subject to the restrictions that apply to Centers for Disease Control and Prevention select agents and NIAID Category A pathogens. R.J. is named as an inventor on a U.S. patent application applied for by University of California, Irvine related to oral drug delivery systems.	Amatsu S, 2013, J BIOL CHEM, V288, P35617, DOI 10.1074/jbc.M113.521179; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Cheng LW, 2008, TOXICOLOGY, V249, P123, DOI 10.1016/j.tox.2008.04.018; Collins MD, 1998, J APPL MICROBIOL, V84, P5, DOI 10.1046/j.1365-2672.1997.00313.x; Couesnon A, 2008, CELL MICROBIOL, V10, P375, DOI 10.1111/j.1462-5822.2007.01051.x; Fujinaga Y, 2013, CURR TOP MICROBIOL, V364, P45, DOI 10.1007/978-3-642-33570-9_3; Gu SY, 2012, SCIENCE, V335, P977, DOI 10.1126/science.1214270; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; Harrison OJ, 2010, NAT STRUCT MOL BIOL, V17, P348, DOI 10.1038/nsmb.1784; Hill KK, 2013, CURR TOP MICROBIOL, V364, P1, DOI 10.1007/978-3-642-33570-9_1; Ito H, 2011, FEMS IMMUNOL MED MIC, V61, P323, DOI 10.1111/j.1574-695X.2011.00779.x; Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624; Lee K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003690; Lin GY, 2010, APPL ENVIRON MICROB, V76, P40, DOI 10.1128/AEM.01882-09; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Maksymowych AB, 2004, J PHARMACOL EXP THER, V310, P633, DOI 10.1124/jpet.104.066845; Matsumura T, 2008, CELL MICROBIOL, V10, P355, DOI 10.1111/j.1462-5822.2007.01048.x; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; OHISHI I, 1984, INFECT IMMUN, V43, P487, DOI 10.1128/IAI.43.2.487-490.1984; OHISHI I, 1977, INFECT IMMUN, V16, P107, DOI 10.1128/IAI.16.1.107-109.1977; Parisini E, 2007, J MOL BIOL, V373, P401, DOI 10.1016/j.jmb.2007.08.011; SAKAGUCHI G, 1982, PHARMACOL THERAPEUT, V19, P165, DOI 10.1016/0163-7258(82)90061-4; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Sugawara Y, 2010, J CELL BIOL, V189, P691, DOI 10.1083/jcb.200910119; Vendome J, 2011, NAT STRUCT MOL BIOL, V18, P693, DOI 10.1038/nsmb.2051	28	76	81	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1405	1410		10.1126/science.1253823	http://dx.doi.org/10.1126/science.1253823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948737	Green Accepted			2022-12-01	WOS:000337531700042
J	Mahroo, OA; Graham, EM				Mahroo, Omar A.; Graham, Elizabeth M.			Roth Spots in Infective Endocarditis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mahroo, Omar A.; Graham, Elizabeth M.] St Thomas Hosp, London, England	Guy's & St Thomas' NHS Foundation Trust	Mahroo, OA (corresponding author), St Thomas Hosp, London, England.	oarm2@cam.ac.uk		Mahroo, Omar/0000-0003-1254-0832	National Institute for Health Research [CL-2011-17-501] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))			0	5	5	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2014	370	25					E38	E38		10.1056/NEJMicm1312093	http://dx.doi.org/10.1056/NEJMicm1312093			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0OA	24941198				2022-12-01	WOS:000337353000001
J	Estrada, K; Aukrust, I; Bjorkhaug, L; Burtt, NP; Mercader, JM; Garcia-Ortiz, H; Huerta-Chagoya, A; Moreno-Macias, H; Walford, G; Flannick, J; Williams, AL; Gomez-Vazquez, MJ; Fernandez-Lopez, JC; Martinez-Hernandez, A; Centeno-Cruz, F; Mendoza-Caamal, E; Revilla-Monsalve, C; Islas-Andrade, S; Cordova, EJ; Soberon, X; Gonzalez-Villalpando, ME; Henderson, E; Wilkens, LR; Le Marchand, L; Arellano-Campos, O; Ordonez-Sanchez, ML; Rodriguez-Torres, M; Rodriguez-Guillen, R; Riba, L; Najmi, LA; Jacobs, SBR; Fennell, T; Gabriel, S; Fontanillas, P; Hanis, CL; Lehman, DM; Jenkinson, CP; Abboud, HE; Bell, GI; Cortes, ML; Boehnke, M; Gonzalez-Villalpando, C; Orozco, L; Haiman, CA; Tusie-Luna, T; Aguilar-Salinas, CA; Altshuler, D; Njolstad, PR; Florez, JC; MacArthur, DG				Estrada, Karol; Aukrust, Ingvild; Bjorkhaug, Lise; Burtt, Noel P.; Mercader, Josep M.; Garcia-Ortiz, Humberto; Huerta-Chagoya, Alicia; Moreno-Macias, Hortensia; Walford, Geoffrey; Flannick, Jason; Williams, Amy L.; Gomez-Vazquez, Maria J.; Fernandez-Lopez, Juan C.; Martinez-Hernandez, Angelica; Centeno-Cruz, Federico; Mendoza-Caamal, Elvia; Revilla-Monsalve, Cristina; Islas-Andrade, Sergio; Cordova, Emilio J.; Soberon, Xavier; Gonzalez-Villalpando, Maria E.; Henderson, E.; Wilkens, Lynne R.; Le Marchand, Loic; Arellano-Campos, Olimpia; Ordonez-Sanchez, Maria L.; Rodriguez-Torres, Maribel; Rodriguez-Guillen, Rosario; Riba, Laura; Najmi, Laeya A.; Jacobs, Suzanne B. R.; Fennell, Timothy; Gabriel, Stacey; Fontanillas, Pierre; Hanis, Craig L.; Lehman, Donna M.; Jenkinson, Christopher P.; Abboud, Hanna E.; Bell, Graeme I.; Cortes, Maria L.; Boehnke, Michael; Gonzalez-Villalpando, Clicerio; Orozco, Lorena; Haiman, Christopher A.; Tusie-Luna, Teresa; Aguilar-Salinas, Carlos A.; Altshuler, David; Njolstad, Pal R.; Florez, Jose C.; MacArthur, Daniel G.		SIGMA Type 2 Diabet Consortium	Association of a Low-Frequency Variant in HNF1A With Type 2 Diabetes in a Latino Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; MEXICAN-AMERICANS; YOUNG MODY; RARE VARIANTS; ONSET; MUTATIONS; MELLITUS; PREVALENCE; COMMON; HNF-1-ALPHA	IMPORTANCE Latino populations have one of the highest prevalences of type 2 diabetes worldwide. OBJECTIVES To investigate the association between rare protein-coding genetic variants and prevalence of type 2 diabetes in a large Latino population and to explore potential molecular and physiological mechanisms for the observed relationships. DESIGN, SETTING, AND PARTICIPANTS Whole-exome sequencing was performed on DNA samples from 3756 Mexican and US Latino individuals (1794 with type 2 diabetes and 1962 without diabetes) recruited from 1993 to 2013. One variant was further tested for allele frequency and association with type 2 diabetes in large multiethnic data sets of 14 276 participants and characterized in experimental assays. MAIN OUTCOME AND MEASURES Prevalence of type 2 diabetes. Secondary outcomes included age of onset, body mass index, and effect on protein function. RESULTS A single rare missense variant (c.1522G>A [p.E508K]) was associated with type 2 diabetes prevalence (odds ratio [OR], 5.48; 95% Cl, 2.83-10.61; P = 4.4 x 10(-7)) in hepatocyte nuclear factor 1-a (HNF1A), the gene responsible for maturity onset diabetes of the young type 3 (MODY3). This variant was observed in 0.36% of participants without type 2 diabetes and 2.1% of participants with it. In multiethnic replication data sets, the p.E508K variant was seen only in Latino patients (n = 1443 with type 2 diabetes and 1673 without it) and was associated with type 2 diabetes (OR, 4.16; 95% Cl, 1.75-9.92; P = .0013). In experimental assays, HNF-1A protein encoding the p.E508K mutant demonstrated reduced transactivation activity of its target promoter compared with a wild-type protein. In our data, carriers and noncarriers of the p.E508K mutation with type 2 diabetes had no significant differences in compared clinical characteristics, including age at onset. The mean (SD) age for carriers was 45.3 years (11.2) vs 47.5 years (11.5) for noncarriers (P = .49) and the mean (SD) BMI for carriers was 28.2 (5.5) vs 29.3 (5.3) for noncarriers (P = .19). CONCLUSIONS AND RELEVANCE Using whole-exome sequencing, we identified a single low-frequency variant in the MODY3-causing gene HNF1A that is associated with type 2 diabetes in Latino populations and may affect protein function. This finding may have implications for screening and therapeutic modification in this population, but additional studies are required.	[Estrada, Karol; Burtt, Noel P.; Mercader, Josep M.; Flannick, Jason; Williams, Amy L.; Jacobs, Suzanne B. R.; Fontanillas, Pierre; Altshuler, David; Florez, Jose C.; MacArthur, Daniel G.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Estrada, Karol] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Estrada, Karol; Walford, Geoffrey; Altshuler, David; Florez, Jose C.; MacArthur, Daniel G.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Aukrust, Ingvild; Bjorkhaug, Lise; Najmi, Laeya A.; Njolstad, Pal R.] Univ Bergen, Dept Clin Sci, KG Jebsen Ctr Diabet Res, Bergen, Norway; [Bjorkhaug, Lise; Njolstad, Pal R.] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Aukrust, Ingvild] Univ Bergen, Dept Biomed, Bergen, Norway; [Mercader, Josep M.; Walford, Geoffrey; Altshuler, David; Florez, Jose C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Mercader, Josep M.; Walford, Geoffrey; Altshuler, David; Florez, Jose C.] Massachusetts Gen Hosp, Diabet Res Ctr, Diabet Unit, Boston, MA 02114 USA; [Mercader, Josep M.] Barcelona Supercomp Ctr, Joint BSC CRG IRB Res Program Computat Biol, Barcelona, Spain; [Garcia-Ortiz, Humberto; Fernandez-Lopez, Juan C.; Martinez-Hernandez, Angelica; Centeno-Cruz, Federico; Mendoza-Caamal, Elvia; Cordova, Emilio J.; Soberon, Xavier; Orozco, Lorena] Inst Nacl Med Genom, Mexico City, DF, Mexico; [Huerta-Chagoya, Alicia; Riba, Laura; Tusie-Luna, Teresa] UNAM INCMNSZ, UNAM Unidad Biol Mol & Med Genom, Inst Invest Biomed, Mexico City, DF, Mexico; [Moreno-Macias, Hortensia] Univ Autonoma Metropolitana, Mexico City, DF, Mexico; [Gonzalez-Villalpando, Maria E.; Gonzalez-Villalpando, Clicerio] Inst Nacl Salud Publ, Ctr Estudios Diabet, Unidad Invest Diabet & Riesgo Cardiovasc, Ctr Invest Salud Poblac, Mexico City, DF, Mexico; [Flannick, Jason; Altshuler, David] Harvard Univ, Sch Med, Dept Mol Biol, Boston, MA USA; [Williams, Amy L.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Boehnke, Michael] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Henderson, E.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Gomez-Vazquez, Maria J.; Arellano-Campos, Olimpia; Ordonez-Sanchez, Maria L.; Rodriguez-Torres, Maribel; Rodriguez-Guillen, Rosario; Tusie-Luna, Teresa; Aguilar-Salinas, Carlos A.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Secc 16, Mexico City, DF, Mexico; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Altshuler, David] MIT, Dept Biol, Cambridge, MA 02139 USA; [Revilla-Monsalve, Cristina; Islas-Andrade, Sergio] Inst Mexicano Seguro Social, CMN SXXI, Unidad Invest Med Enfermedades Metab, Mexico City, DF, Mexico; [Wilkens, Lynne R.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Najmi, Laeya A.] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Fennell, Timothy; Gabriel, Stacey; Cortes, Maria L.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Hanis, Craig L.] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Lehman, Donna M.; Jenkinson, Christopher P.; Abboud, Hanna E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Bell, Graeme I.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Bell, Graeme I.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); Instituto Nacional de Medicina Genomica; Universidad Autonoma Metropolitana - Mexico; Instituto Nacional de Salud Publica; Harvard University; Harvard Medical School; Columbia University; University of Michigan System; University of Michigan; University of Southern California; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Instituto Mexicano del Seguro Social; Cancer Research Center of Hawaii; University of Hawaii System; University of Bergen; Haukeland University Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health San Antonio; University of Chicago; University of Chicago	Florez, JC (corresponding author), Massachusetts Gen Hosp, Dept Med, Ctr Human Genet Res, Diabet Unit, Boston, MA 02114 USA.	jcflorez@partners.org	Aukrust, Ingvild/ABG-2219-2021; Altshuler, David M/A-4476-2009; Bjørkhaug, Lise/AAA-4356-2021; Najmi, Laeya Abdoli/AAC-9091-2019; Najmi, Laeya/AAB-5487-2022; Aukrust, Ingvild/ABB-4526-2021; /ABI-8453-2020; Salinas, Carlos A Aguilar/AAL-4491-2020; Revilla-Monsalve, Cristina/ABG-6663-2021; Aukrust, Ingvild/AAY-9434-2020; Fernandez, Juan Carlos/C-4976-2013; del Rosario, Rodriguez-Guillen Maria/ADO-2554-2022	Altshuler, David M/0000-0002-7250-4107; Bjørkhaug, Lise/0000-0002-9695-4559; /0000-0002-9402-4219; Fernandez, Juan Carlos/0000-0003-3680-4193; del Rosario, Rodriguez-Guillen Maria/0000-0002-6587-5786; Garcia-Ortiz, Humberto/0000-0002-0453-980X; Orozco, Lorena/0000-0002-5801-9180; Williams, Amy L./0000-0003-0737-0533; Revilla Monsalve, Maria Cristina/0000-0002-6202-1160; Centeno Cruz, Federico/0000-0002-3512-4519; MacArthur, Daniel/0000-0002-5771-2290; Jacobs, Suzanne/0000-0002-8103-1700; Huerta-Chagoya, Alicia/0000-0001-6218-3904; Mercader, Josep M/0000-0001-8494-3660	Carlos Slim Health Institute in Mexico; Consejo Nacional de Ciencia y Tecnologia [138826, 128877, CONACT-SALUD 2009-01-115250, 86867]; Direccion General de Asuntos del Personal Academic, UNAM [IT 214711]; Instituto Carlos Slim de la Salud, A.C.; National Institutes of Health (NIH) [R01HL24799]; Consejo Nacional de Ciencia y Tenologia [2092, M9303, F677-M9407, 251M, 2005-C01-14502, SALUD 2010-2-151165]; NIH [CA164973, CA054281, CA063464, R01 CA55069, R35 CA53890, R01 CA80205, R01 CA144034, U01DK085526, U01DK085501]; National Medical Research Council of Singapore; Veterans Administration Epidemiologic grant; University of Bergen; Research Council of Norway; KG Jebsen Foundation; Helse Vest; European Research Council; Instituto Carlos III, Spain; Netherlands Organization for Scientific Research [825.12.023];  [R01 DK042273];  [R01 DK047482];  [R01DK053889];  [R01 DK057295];  [P01 HL045522]	Carlos Slim Health Institute in Mexico; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academic, UNAM(Universidad Nacional Autonoma de Mexico); Instituto Carlos Slim de la Salud, A.C.; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Ciencia y Tenologia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Medical Research Council of Singapore(National Medical Research Council, Singapore); Veterans Administration Epidemiologic grant; University of Bergen; Research Council of Norway(Research Council of Norway); KG Jebsen Foundation; Helse Vest; European Research Council(European Research Council (ERC)European Commission); Instituto Carlos III, Spain(Instituto de Salud Carlos III); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); ; ; ; ; 	The work was conducted as part of the Slim Initiative for Genomic Medicine, a project funded by the Carlos Slim Health Institute in Mexico. The UNAM/INCMNSZ Diabetes Study was supported by Consejo Nacional de Ciencia y Tecnologia grants 138826, 128877, CONACT-SALUD 2009-01-115250, and a grant from Direccion General de Asuntos del Personal Academic, UNAM, IT 214711. The Diabetes in Mexico Study was supported by Consejo Nacional de Ciencia y Tecnologia grant 86867 and by Instituto Carlos Slim de la Salud, A.C. The Mexico City Diabetes Study was supported by National Institutes of Health (NIH) grant R01HL24799 and by the Consejo Nacional de Ciencia y Tenologia grants 2092, M9303, F677-M9407, 251M, and 2005-C01-14502, SALUD 2010-2-151165. The Multiethnic Cohort was supported by NIH grants CA164973, CA054281, and CA063464. The Singapore Chinese Health Study was funded by the National Medical Research Council of Singapore under its individual research grant scheme and by NIH grants R01 CA55069, R35 CA53890, R01 CA80205, and R01 CA144034. The Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples (T2D-GENES) project was supported by NIH grants U01DK085526 and U01DK085501. The San Antonio Mexican American Family Studies (SAMAFS) were supported by R01 DK042273, R01 DK047482, R01DK053889, R01 DK057295, P01 HL045522, and a Veterans Administration Epidemiologic grant (R.A.D). The University of Bergen, Research Council of Norway, KG Jebsen Foundation, Helse Vest, and European Research Council funded the Norwegian team. Dr Mercader was supported by Sara Borrell Fellowship from the Instituto Carlos III, Spain. Dr Estrada was supported by The Netherlands Organization for Scientific Research under the Rubicon fellowship 825.12.023.	Albrechtsen A, 2013, DIABETOLOGIA, V56, P298, DOI 10.1007/s00125-012-2756-1; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aukrust I, 2013, J BIOL CHEM, V288, P5951, DOI 10.1074/jbc.M112.393769; Barquera S, 2003, ARCH MED RES, V34, P407, DOI 10.1016/S0188-4409(03)00075-4; BAUMHUETER S, 1990, GENE DEV, V4, P372, DOI 10.1101/gad.4.3.372; Bellanne-Chantelot C, 2008, DIABETES, V57, P503, DOI 10.2337/db07-0859; Bjorkhaug L, 2003, J CLIN ENDOCR METAB, V88, P920, DOI 10.1210/jc.2002-020945; Bjorkhaug L, 2000, BIOCHEM BIOPH RES CO, V279, P792, DOI 10.1006/bbrc.2000.4024; CHOUARD T, 1990, NUCLEIC ACIDS RES, V18, P5853, DOI 10.1093/nar/18.19.5853; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Eide SA, 2008, DIABETIC MED, V25, P775, DOI 10.1111/j.1464-5491.2008.02459.x; Ellard S, 2000, HUM MUTAT, V16, P377, DOI 10.1002/1098-1004(200011)16:5<377::AID-HUMU1>3.0.CO;2-2; FALCONER DS, 1967, ANN HUM GENET, V31, P1; Fang Qi-chen, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P329; Flannick J, 2013, NAT GENET, V45, P1380, DOI 10.1038/ng.2794; Forlani G, 2010, DIABETES CARE, V33, P2336, DOI 10.2337/dc10-0561; HANIS CL, 1983, AM J EPIDEMIOL, V118, P659, DOI 10.1093/oxfordjournals.aje.a113677; Hara K, 2014, HUM MOL GENET, V23, P239, DOI 10.1093/hmg/ddt399; Hegele RA, 1999, J CLIN ENDOCR METAB, V84, P1077, DOI 10.1210/jc.84.3.1077; Hunt KJ, 2011, ANN EPIDEMIOL, V21, P899, DOI 10.1016/j.annepidem.2011.07.003; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Kristinsson SY, 2001, DIABETOLOGIA, V44, P2098, DOI 10.1007/s001250100016; Kropff J, 2011, DIABETOLOGIA, V54, P1261, DOI 10.1007/s00125-011-2090-z; LEDERMANN HM, 1995, DIABETOLOGIA, V38, P1482, DOI 10.1007/BF00400611; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lohmueller KE, 2013, AM J HUM GENET, V93, P1072, DOI 10.1016/j.ajhg.2013.11.005; Lorenzo C, 2005, DIABETES CARE, V28, P2480, DOI 10.2337/diacare.28.10.2480; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Molven A, 2011, EXPERT REV MOL DIAGN, V11, P313, DOI [10.1586/erm.10.123, 10.1586/ERM.10.123]; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nishigori H, 1998, J HUM GENET, V43, P107, DOI 10.1007/s100380050049; Pearson ER, 2003, LANCET, V362, P1275, DOI 10.1016/S0140-6736(03)14571-0; Shepherd M, 2009, DIABETIC MED, V26, P437, DOI 10.1111/j.1464-5491.2009.02690.x; Shields BM, 2010, DIABETOLOGIA, V53, P2504, DOI 10.1007/s00125-010-1799-4; Sovik O, 1998, DIABETOLOGIA, V41, P607, DOI 10.1007/s001250050956; Steinthorsdottir V, 2014, NAT GENET, V46, P294, DOI 10.1038/ng.2882; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tonooka N, 2002, DIABETOLOGIA, V45, P1709, DOI 10.1007/s00125-002-0978-3; TRONCHE F, 1992, BIOESSAYS, V14, P579, DOI 10.1002/bies.950140902; Villalpando S, 2010, SALUD PUBLICA MEXICO, V52, pS19, DOI 10.1590/S0036-36342010000700005; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Yorifuji T, 2012, PEDIATR DIABETES, V13, P26, DOI 10.1111/j.1399-5448.2011.00827.x; Zaitlen N, 2012, BIOINFORMATICS, V28, P1729, DOI 10.1093/bioinformatics/bts259; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	51	151	152	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2305	2314		10.1001/jama.2014.6511	http://dx.doi.org/10.1001/jama.2014.6511			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915262	Bronze, Green Accepted			2022-12-01	WOS:000336972600022
J	Mohn, F; Sienski, G; Handler, D; Brennecke, J				Mohn, Fabio; Sienski, Grzegorz; Handler, Dominik; Brennecke, Julius			The Rhino-Deadlock-Cutoff Complex Licenses Noncanonical Transcription of Dual-Strand piRNA Clusters in Drosophila	CELL			English	Article							QUALITY-CONTROL MECHANISM; SMALL RNAS; CHROMATIN STATE; MULTIPLE ROLES; GENOME DEFENSE; PIWI; HETEROCHROMATIN; GERMLINE; PROTEIN; TRANSPOSONS	Argonaute proteins of the PIWI clade are central to transposon silencing in animal gonads. Their target specificity is defined by 23-30 nt PIWI interacting RNAs (piRNAs), which mostly originate from discrete genomic loci termed piRNA clusters. Here, we show that a complex composed of Rhino, Deadlock, and Cutoff (RDC) defines dual-strand piRNA clusters genome-wide in Drosophila ovaries. The RDC is anchored to H3K9me3-marked chromatin in part via Rhino's chromodomain. Depletion of Piwi results in loss of the RDC and small RNAs at a subset of piRNA clusters, demonstrating a feedback loop between Piwi and piRNA source loci. Intriguingly, profiles of RNA polymerase II occupancy, nascent transcription, and steady-state RNA levels reveal that the RDC licenses noncanonical transcription of dual-strand piRNA clusters. Likely, this process involves 50 end protection of nascent RNAs and suppression of transcription termination. Our data provide key insight into the regulation and evolution of piRNA clusters.	[Mohn, Fabio; Sienski, Grzegorz; Handler, Dominik; Brennecke, Julius] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Mohn, F (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, Dr Bohrgasse 3, A-1030 Vienna, Austria.	fabio.mohn@imba.oeaw.ac.at; julius.brennecke@imba.oeaw.ac.at	Brennecke, Julius/T-5883-2019; Brennecke, Julius/C-1626-2015	Brennecke, Julius/0000-0002-5141-0814; Brennecke, Julius/0000-0002-5141-0814; Mohn, Fabio/0000-0001-9889-5225; Handler, Dominik/0000-0002-1059-4960	Austrian Academy of Sciences; European Community (ERC) [260711EU]; Austrian Science Fund (FWF) [510-B12]; SNF; HFSP; Boehringer Ingelheim Fonds; Austrian Science Fund (FWF) [Y 510] Funding Source: researchfish	Austrian Academy of Sciences; European Community (ERC)(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); SNF; HFSP(Human Frontier Science Program); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank F. Gruber, K. Meixner, K. Senti, J. Batki, and A. Wenger for experimental support, M. Madalinski for antibody purifications, S. Lopez for fly injections, the VDRC, the TrIP collection, the Bloomington stock center, and B. Theurkauf, T. Schupbach for flies, A. Schleiffer, D. Jurczak, and R. Sachidanandam for bioinformatics support, the CSF NGS unit for deep sequencing and P. Refsing Andersen for comments on the manuscript. This work was supported by the Austrian Academy of Sciences, the European Community's 7th Framework Programme (FP7/2007-2013; ERC grant # 260711EU) and the Austrian Science Fund (FWF; Y 510-B12). F. M. is supported by SNF and HFSP fellowships; G. S. is supported by the Boehringer Ingelheim Fonds.	Andersen PR, 2013, NAT STRUCT MOL BIOL, V20, P1367, DOI 10.1038/nsmb.2703; Beliveau BJ, 2012, P NATL ACAD SCI USA, V109, P21301, DOI 10.1073/pnas.1213818110; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; de Vanssay A, 2012, NATURE, V490, P112, DOI 10.1038/nature11416; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; Jiao XF, 2013, MOL CELL, V50, P104, DOI 10.1016/j.molcel.2013.02.017; Jiao XF, 2010, NATURE, V467, P608, DOI 10.1038/nature09338; Keller C, 2012, MOL CELL, V47, P215, DOI 10.1016/j.molcel.2012.05.009; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Le Thomas A, 2013, GENE DEV, V27, P390, DOI 10.1101/gad.209841.112; Li XZG, 2013, MOL CELL, V50, P67, DOI 10.1016/j.molcel.2013.02.016; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Muerdter F, 2012, RNA, V18, P42, DOI 10.1261/rna.029769.111; Pane A, 2011, EMBO J, V30, P4601, DOI 10.1038/emboj.2011.334; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rangan P, 2011, CURR BIOL, V21, P1373, DOI 10.1016/j.cub.2011.06.057; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Rozhkov NV, 2013, GENE DEV, V27, P400, DOI 10.1101/gad.209767.112; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Shpiz S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004138; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Vermaak D, 2005, PLOS GENET, V1, P96, DOI 10.1371/journal.pgen.0010009; Vermaak D, 2009, ANNU REV GENET, V43, P467, DOI 10.1146/annurev-genet-102108-134802; Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109; Wehr K, 2006, DEV BIOL, V294, P406, DOI 10.1016/j.ydbio.2006.03.002; Zhang F, 2012, CELL, V151, P871, DOI 10.1016/j.cell.2012.09.040	36	201	212	2	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1364	1379		10.1016/j.cell.2014.04.031	http://dx.doi.org/10.1016/j.cell.2014.04.031			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906153	Bronze			2022-12-01	WOS:000340881400013
J	Sedgwick, P				Sedgwick, Philip			Understanding statistical hypothesis testing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUESTION		Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Fagerstrom K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6549; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2130; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6282	3	12	12	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2014	348								g3557	10.1136/bmj.g3557	http://dx.doi.org/10.1136/bmj.g3557			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EO	24879817				2022-12-01	WOS:000336742800004
J	Pallotta, M; Schnurbusch, T; Hayes, J; Hay, A; Baumann, U; Paull, J; Langridge, P; Sutton, T				Pallotta, Margaret; Schnurbusch, Thorsten; Hayes, Julie; Hay, Alison; Baumann, Ute; Paull, Jeff; Langridge, Peter; Sutton, Tim			Molecular basis of adaptation to high soil boron in wheat landraces and elite cultivars	NATURE			English	Article							TRITICUM-AESTIVUM L.; TOXICITY TOLERANCE; AEGILOPS-TAUSCHII; DRAFT GENOME; BARLEY; GENES; IDENTIFICATION; EXPRESSION; EVOLUTION; SOFTWARE	Environmental constraints severely restrict crop yields inmost production environments, and expanding the use of variation will underpin future progress in breeding. In semi-arid environments boron toxicity constrains productivity, and genetic improvement is the only effective strategy for addressing the problem(1). Wheat breeders have sought and used available genetic diversity from landraces to maintain yield in these environments; however, the identity of the genes at the major tolerance loci was unknown. Here we describe the identification of near-identical, root-specific boron transporter genes underlying the two major-effect quantitative trait loci for boron tolerance in wheat, Bo1 and Bo4 (ref. 2). We show that tolerance to a high concentration of boron is associated with multiple genomic changes including tetraploid introgression, dispersed gene duplication, and variation in gene structure and transcript level. An allelic series was identified from a panel of bread and durum wheat cultivars and landraces originating from diverse agronomic zones. Our results demonstrate that, during selection, breeders have matched functionally different boron tolerance alleles to specific environments. The characterization of boron tolerance in wheat illustrates the power of the new wheat genomic resources to define key adaptive processes that have underpinned crop improvement.	[Pallotta, Margaret; Schnurbusch, Thorsten; Hayes, Julie; Hay, Alison; Baumann, Ute; Langridge, Peter; Sutton, Tim] Univ Adelaide, Sch Agr Food & Wine, Australian Ctr Plant Funct Genom, Urrbrae, SA 5064, Australia; [Schnurbusch, Thorsten] Leibniz Inst Plant Genet & Crop Plant Res IPK, Genebank Dept, D-06466 Gatersleben, Germany; [Paull, Jeff] Univ Adelaide, Sch Agr Food & Wine, Urrbrae, SA 5064, Australia	University of Adelaide; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of Adelaide	Sutton, T (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Australian Ctr Plant Funct Genom, Waite Campus, Urrbrae, SA 5064, Australia.	tim.sutton@acpfg.com.au	Langridge, Peter/G-5864-2010; Sutton, Tim/ABC-8454-2020; Schnurbusch, Thorsten/B-2249-2009	Langridge, Peter/0000-0001-9494-400X; Schnurbusch, Thorsten/0000-0002-5267-0677; Hayes, Julie/0000-0001-8716-5024; Pallotta, Margaret/0000-0002-1642-5623; Sutton, Timothy/0000-0002-9059-0774	Australian Research Council; Grains Research and Development Corporation; South Australian Government	Australian Research Council(Australian Research Council); Grains Research and Development Corporation(Grains R&D Corp); South Australian Government	We thank N. Collins, J. Dvorjak, H. Kuchel, D. Mares, S. Wu, the John Innes Centre, the Biotechnology and Biological Sciences Research Council, the Institut National de la Recherche Agronomique and the International Wheat Genome Sequencing Consortium for resources, and J. Tiong, T. Oz and A. Pohlen for assistance. The authors are supported by grants from the Australian Research Council, the Grains Research and Development Corporation and the South Australian Government.	Akhunov ED, 2007, MOL BIOL EVOL, V24, P539, DOI 10.1093/molbev/msl183; Allouis S, 2003, CEREAL RES COMMUN, V31, P331; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Burton RA, 2004, PLANT PHYSIOL, V134, P224, DOI 10.1104/pp.103.032904; Chantachume Y, 1995, PLANT SOIL, V177, P249, DOI 10.1007/BF00010131; Chantachume Y., 1995, THESIS U ADELAIDE; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Jamjod S., 1996, THESIS U ADELAIDE; Jefferies SP, 1999, THEOR APPL GENET, V98, P1293, DOI 10.1007/s001220051195; Jefferies SP, 2000, THEOR APPL GENET, V101, P767, DOI 10.1007/s001220051542; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Lai KT, 2012, PLANT CELL PHYSIOL, V53, DOI 10.1093/pcp/pcr141; Leaungthitikanchana S, 2013, PLANT CELL PHYSIOL, V54, P1056, DOI 10.1093/pcp/pct059; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Luo MC, 2013, P NATL ACAD SCI USA, V110, P7940, DOI 10.1073/pnas.1219082110; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Mares D, 2008, J CEREAL SCI, V47, P6, DOI 10.1016/j.jcs.2007.01.005; Mathews KL, 2011, CROP PASTURE SCI, V62, P313, DOI 10.1071/CP10318; McCouch S, 2013, NATURE, V499, P23, DOI 10.1038/499023a; McDonald GK, 2012, CROP PASTURE SCI, V63, P1043, DOI 10.1071/CP12244; McIntosh R., 2008, P 11 INT WHEAT GEN S; Miwa K, 2010, ANN BOT-LONDON, V105, P1103, DOI 10.1093/aob/mcq044; Nable RO, 1997, PLANT SOIL, V193, P181, DOI 10.1023/A:1004272227886; Pallotta MA, 2000, THEOR APPL GENET, V101, P1100, DOI 10.1007/s001220051585; Pallotta MA, 2003, PROC INT WHEAT GENET, V2, P789; PAULL JG, 1991, EUPHYTICA, V55, P217, DOI 10.1007/BF00021242; PAULL JG, 1992, PLANT SOIL, V146, P251, DOI 10.1007/BF00012019; Paull JG, 1993, P 8 INT WHEAT GEN S, V2, P1065; Preuss CP, 2010, PLANT PHYSIOL, V152, P1431, DOI 10.1104/pp.109.152009; Reid R, 2007, PLANT CELL PHYSIOL, V48, P1673, DOI 10.1093/pcp/pcm159; Rerkasem B, 1997, EUPHYTICA, V96, P257, DOI 10.1023/A:1003093532561; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Schnurbusch T, 2008, GENOME, V51, P963, DOI 10.1139/G08-084; Schnurbusch T, 2007, THEOR APPL GENET, V115, P451, DOI 10.1007/s00122-007-0579-0; Schnurbusch T, 2010, PLANT PHYSIOL, V153, P1706, DOI 10.1104/pp.110.158832; Schreiber AW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-285; Sutton T, 2007, SCIENCE, V318, P1446, DOI 10.1126/science.1146853; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Yau SK, 2008, CROP SCI, V48, P854, DOI 10.2135/cropsci2007.10.0539	40	69	69	1	126	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					88	+		10.1038/nature13538	http://dx.doi.org/10.1038/nature13538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25043042				2022-12-01	WOS:000342420800041
J	Li, B; Qiu, B; Lee, DSM; Walton, ZE; Ochocki, JD; Mathew, LK; Mancuso, A; Gade, TPF; Keith, B; Nissim, I; Simon, MC				Li, Bo; Qiu, Bo; Lee, David S. M.; Walton, Zandra E.; Ochocki, Joshua D.; Mathew, Lijoy K.; Mancuso, Anthony; Gade, Terence P. F.; Keith, Brian; Nissim, Itzhak; Simon, M. Celeste			Fructose-1,6-bisphosphatase opposes renal carcinoma progression	NATURE			English	Article							CELL CARCINOMA; IDENTIFICATION; METABOLISM; INACTIVATION; DISEASE	Clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer(1), is characterized by elevated glycogen levels and fat deposition(2). These consistent metabolic alterations are associated with normoxic stabilization of hypoxia-inducible factors (HIFs)3 secondary to von Hippel-Lindau (VHL) mutations that occur in over 90% of ccRCC tumours(4). However, kidney-specific VHL deletion in mice fails to elicit ccRCC-specific metabolic phenotypes and tumour formation(5), suggesting that additional mechanisms are essential. Recent large-scale sequencing analyses revealed the loss of several chromatin remodelling enzymes in a subset of ccRCC (these included polybromo-1, SET domain containing 2 and BRCA1 -associated protein-1, among others)(6-9), indicating that epigenetic perturbations are probably important contributors to the natural history of this disease. Here we used an integrative approach comprising pan-metabolomic profiling and metabolic gene set analysis and determined that the gluconeogenic enzyme fructose-1,6-bisphosphatase 1 (FBP1)(10) is uniformly depleted in over six hundred ccRCC tumours examined. Notably, the human FBP1 locus resides on chromosome 9q22, the loss of which is associated with poor prognosis for ccRCC patients". Our data further indicate that FBP1 inhibits ccRCC progression through two distinct mechanisms. First, FBP1 antagonizes glycolytic flux in renal tubular epithelial cells, the presumptive ccRCC cell of origin(12), thereby inhibiting a potential Warburg effect(13,14). Second, in pVHL (the protein encoded by the VHL gene)-deficient ccRCC cells, FBP1 restrains cell proliferation, glycolysis and the pentose phosphate pathway in a catalyticactivity-independent manner, by inhibiting nuclear HIF function via direct interaction with the HIF inhibitory domain. This unique dual function of the FBP1 protein explains its ubiquitous loss in ccRCC, distinguishing FBP1 from previously identified tumour suppressors that are not consistently mutated in all tumours(6,7,15).	[Li, Bo; Qiu, Bo; Lee, David S. M.; Walton, Zandra E.; Ochocki, Joshua D.; Mathew, Lijoy K.; Mancuso, Anthony; Keith, Brian; Simon, M. Celeste] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Lee, David S. M.; Mathew, Lijoy K.; Simon, M. Celeste] Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Walton, Zandra E.; Mancuso, Anthony; Keith, Brian] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Mancuso, Anthony; Gade, Terence P. F.] Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA; [Nissim, Itzhak] Univ Penn, Dept Pediat,Biochem & Biophys, Philadelphia, PA 19104 USA; [Nissim, Itzhak] Childrens Hosp Philadelphia, Div Child Dev & Metab Dis, Philadelphia, PA 19104 USA; [Simon, M. Celeste] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Simon, MC (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	celeste2@mail.med.upenn.edu	Li, Bo/Y-2835-2019; Lorkiewicz, Pawel/A-2126-2011; Li, Bo/O-7127-2019; Li, Bo/M-2192-2013; Simon, Celeste/AAG-3941-2021	Li, Bo/0000-0002-7979-8339; Lorkiewicz, Pawel/0000-0002-1755-9826; Li, Bo/0000-0002-7979-8339; Qiu, Bo/0000-0003-4199-1659; Lee, David/0000-0002-8821-9028; Walton, Zandra/0000-0002-0465-0153	Howard Hughes Medical Institute, NIH Grant [CA104838, DK053761]; NATIONAL CANCER INSTITUTE [P30CA016520, F32CA192758, F30CA177106, P01CA104838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK053761, R01DK053761] Funding Source: NIH RePORTER	Howard Hughes Medical Institute, NIH Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Y. Daikhin, O. Horyn and Ilana Nissim for assistance with the isotopomer enrichment analysis in the Metabolomic Core facility, Children's Hospital of Philadelphia. We also thank J. Tobias for help with processing the TCGA RNA-sequencing data. This work was supported by the Howard Hughes Medical Institute, NIH Grant CA104838 to M.C.S. and DK053761 to I.N. M.C.S. is an Investigator of the Howard Hughes Medical Institute.	Asberg C, 2010, J INHERIT METAB DIS, V33, pS113, DOI 10.1007/s10545-009-9034-5; Choe JY, 2000, BIOCHEMISTRY-US, V39, P8565, DOI 10.1021/bi000574g; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Dondeti VR, 2012, CANCER RES, V72, P112, DOI 10.1158/0008-5472.CAN-11-1698; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hakimi AA, 2013, CLIN CANCER RES, V19, P3259, DOI 10.1158/1078-0432.CCR-12-3886; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Lee WNP, 1998, AM J PHYSIOL-ENDOC M, V274, pE843, DOI 10.1152/ajpendo.1998.274.5.E843; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Moore LE, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.14; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Nissim I, 2012, BIOCHEM J, V444, P537, DOI 10.1042/BJ20120163; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Salway JG, 2004, METABOLISM GLANCE; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; TEJWANI GA, 1983, ADV ENZYMOL RAMB, V54, P121; Valera VA, 2011, NAT REV UROL, V8, P321, DOI 10.1038/nrurol.2011.64; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2	30	331	344	3	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					251	+		10.1038/nature13557	http://dx.doi.org/10.1038/nature13557			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25043030	Green Accepted			2022-12-01	WOS:000341362800054
J	Morris, SC; Caron, JB				Morris, Simon Conway; Caron, Jean-Bernard			A primitive fish from the Cambrian of North America	NATURE			English	Article							PIKAIA-GRACILENS WALCOTT; BURGESS SHALE; VERTEBRATE JAW; EVOLUTION; CHORDATE; LAMPREY; ANATOMY	Knowledge of the early evolution of fish largely depends on soft-bodied material from the Lower (Series 2) Cambrian period of South China(1,2). Owing to the rarity of some of these forms and a general lack of comparative material from other deposits, interpretations of various features remain controversial(3,4), as do their wider relationships amongst post-Cambrian early un-skeletonized jawless vertebrates. Here we redescribe Metaspriggina(5) on the basis of new material from the Burgess Shale and exceptionally preserved material collected near Marble Canyon, British Columbia(6), and three other Cambrian Burgess Shale-type deposits from Laurentia. This primitive fish displays unambiguous vertebrate features: a notochord, a pair of prominent camera-type eyes, paired nasal sacs, possible cranium and arcualia, W-shaped myomeres, and a post-anal tail. A striking feature is the branchial area with an array of bipartite bars. Apart from the anterior most bar, which appears to be slightly thicker, each is associated with externally located gills, possibly housed in pouches. Phylogenetic analysis places Metaspriggina as a basal vertebrate, apparently close to the Chengjiang taxa Haikouichthys(1-4) and Myllokunmingia(1), demonstrating also that this primitive group of fish was cosmopolitan during Lower-Middle Cambrian times (Series 2-3). However, the arrangement of the branchial region in Metaspriggina has wider implications for reconstructing the morphology of the primitive vertebrate. Each bipartite bar is identified as being respectively equivalent to an epibranchial and ceratobranchial. This configuration suggests that a bipartite arrangement is primitive and reinforces the view that the branchial basket of lampreys(7) is probably derived. Other features of Metaspriggina, including the external position of the gills and possible absence of a gill opposite the more robust anterior-most bar, are characteristic of gnathostomes(8) and so may be primitive within vertebrates.	[Morris, Simon Conway] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Caron, Jean-Bernard] Royal Ontario Museum, Dept Nat Hist Palaeobiol, Toronto, ON M5S 2C6, Canada; [Caron, Jean-Bernard] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada	University of Cambridge; Royal Ontario Museum; University of Toronto	Morris, SC (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.	sc113@cam.ac.uk; jcaron@rom.on.ca		Caron, Jean-Bernard/0000-0002-1670-5502	Department of Earth Sciences and St John's College, Cambridge; Natural Sciences and Engineering Research Council [341944]; Royal Ontario Museum [53]	Department of Earth Sciences and St John's College, Cambridge; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Royal Ontario Museum	We thank T. Lacalli for comments on an earlier draft of the manuscript,J. Mallatt for an extensive series of critiques, and J. Hoyal-Cuthill and C. Aria for assistance with phylogenetic analyses. We also thank M. Collins for technical drawings and reconstructions, and R. Thomas and M. Webster for information on the Kinzers and Parker formations, respectively. S.C.M. thanks V. Brown for manuscript preparation, and the Department of Earth Sciences and St John's College, Cambridge for support. We thank Parks Canada for granting a collection and research permit to J.-B.C. (YNP-2012-12054). Fieldwork support for the 2012 expedition comes from the Royal Ontario Museum (DMV Research and Acquisition Fund and DNH Fieldwork Fund), M. Streng (Uppsala University and the Swedish Research Council), R. Gaines (Pomona College), G. Mangano (University of Saskatchewan) and a Natural Sciences and Engineering Research Council Discovery Grant (to J.-B.C., #341944). This is Royal Ontario Museum Burgess Shale project number 53.	Caron JB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4210; Depew MJ, 2008, J EXP ZOOL PART B, V310B, P315, DOI 10.1002/jez.b.21205; Gai ZK, 2011, NATURE, V476, P324, DOI 10.1038/nature10276; Gess RW, 2006, NATURE, V443, P981, DOI 10.1038/nature05150; Gillis JA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2429; Hou XG, 2002, P ROY SOC B-BIOL SCI, V269, P1865, DOI 10.1098/rspb.2002.2104; Janvier P, 2006, NATURE, V440, P1183, DOI 10.1038/nature04471; Janvier P, 1996, OXFORD MONOGRAPHS GE, V33; Janvier P, 2007, GEODIVERSITAS, V29, P143; Johnston KJ, 2009, PALAEOGEOGR PALAEOCL, V277, P106, DOI 10.1016/j.palaeo.2009.02.015; Kuratani S, 2005, J ANAT, V207, P489, DOI 10.1111/j.1469-7580.2005.00483.x; Kuratani S, 2012, EVOL DEV, V14, P76, DOI 10.1111/j.1525-142X.2011.00523.x; Lacalli T, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-12; MALLATT J, 1984, J ZOOL, V204, P169; Mallatt J, 2013, J EXP ZOOL PART B, V320B, P247, DOI 10.1002/jez.b.22500; Martin WM, 2009, DEV DYNAM, V238, P3126, DOI 10.1002/dvdy.22164; Medeiros DM, 2012, DEV BIOL, V371, P121, DOI 10.1016/j.ydbio.2012.08.026; MORRIS SC, 1993, PALAEONTOLOGY, V36, P593; Morris SC, 2008, J PALEONTOL, V82, P424, DOI 10.1666/06-130.1; Morris SC, 2012, BIOL REV, V87, P480, DOI 10.1111/j.1469-185X.2012.00220.x; Nichols JT, 2013, DEVELOPMENT, V140, P2765, DOI 10.1242/dev.090639; Sansom RS, 2013, PALAEONTOLOGY, V56, P457, DOI 10.1111/pala.12037; Shu DG, 2003, NATURE, V421, P526, DOI 10.1038/nature01264; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Van Leeuwen JL, 1999, J EXP BIOL, V202, P3405; Webster M, 2009, MEM ASSOC AUSTRALAS, V37, P369; Zhang XG, 2004, J EVOLUTION BIOL, V17, P1162, DOI 10.1111/j.1420-9101.2004.00741.x	27	93	93	3	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					419	U413		10.1038/nature13414	http://dx.doi.org/10.1038/nature13414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	24919146				2022-12-01	WOS:000340840600031
J	Bingel, U				Bingel, Ulrike			Avoiding Nocebo Effects to Optimize Treatment Outcome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Duisburg Essen, Dept Neurol, Univ Hosp Essen, D-45147 Essen, Germany	University of Duisburg Essen	Bingel, U (corresponding author), Univ Duisburg Essen, Dept Neurol, Univ Hosp Essen, Hufelandstr 55, D-45147 Essen, Germany.	ulrike.bingel@uk-essen.de						Benedetti F, 2014, PAIN, V155, P921, DOI 10.1016/j.pain.2014.01.016; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Colloca L, 2012, JAMA-J AM MED ASSOC, V307, P567, DOI 10.1001/jama.2012.115; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; Faasse K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5613; Kam-Hansen S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006175; Kessner S, 2013, JAMA INTERN MED, V173, P1468, DOI 10.1001/jamainternmed.2013.6705; Rief W, 2006, ARCH INTERN MED, V166, P155, DOI 10.1001/archinte.166.2.155; Varelmann D, 2010, ANESTH ANALG, V110, P868, DOI 10.1213/ANE.0b013e3181cc5727	9	113	114	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2014	312	7					693	694		10.1001/jama.2014.8342	http://dx.doi.org/10.1001/jama.2014.8342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN2TR	25003609				2022-12-01	WOS:000340438700013
J	Desai, SA; Miller, LH				Desai, Sanjay A.; Miller, Louis H.			MALARIA Protein-export pathway illuminated	NATURE			English	Editorial Material							PLASMODIUM-FALCIPARUM; HOST ERYTHROCYTES; VIRULENCE; PARASITES; MEMBRANE; REVEALS; CHANNEL; PTEX		[Desai, Sanjay A.; Miller, Louis H.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Desai, SA (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.	sdesai@niaid.nih.gov; lmiller@niaid.nih.gov		Desai, Sanjay/0000-0003-2150-2483	Intramural NIH HHS [ZIA AI000882-13] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000882, ZIAAI000241] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Gehde N, 2009, MOL MICROBIOL, V71, P613, DOI 10.1111/j.1365-2958.2008.06552.x; Goldberg DE, 2010, NAT REV MICROBIOL, V8, P617, DOI 10.1038/nrmicro2420; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108; Kulzer S, 2012, CELL MICROBIOL, V14, P1784, DOI 10.1111/j.1462-5822.2012.01840.x; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Papakrivos J, 2005, MOL MICROBIOL, V55, P1272, DOI 10.1111/j.1365-2958.2004.04468.x; Pesce E.-R., 2014, PARASITOLOGY; Pillai AD, 2012, MOL PHARMACOL, V82, P1104, DOI 10.1124/mol.112.081224; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084	16	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					541	542		10.1038/nature13646	http://dx.doi.org/10.1038/nature13646			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043009	Green Accepted			2022-12-01	WOS:000339566300023
J	Marx, V				Marx, Vivien			STOP THE MICROBIAL CHATTER	NATURE			English	Editorial Material							IDENTIFICATION; BACTERIA											Bjarnsholt T, 2013, NAT REV DRUG DISCOV, V12, P791, DOI 10.1038/nrd4000; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; Hastings JW, 1999, J BACTERIOL, V181, P2667, DOI 10.1128/JB.181.9.2667-2668.1999; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100	8	13	14	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					493	497		10.1038/511493a	http://dx.doi.org/10.1038/511493a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25056065	Bronze			2022-12-01	WOS:000339335700052
J	Nabavi, S; Fox, R; Proulx, CD; Lin, JY; Tsien, RY; Malinow, R				Nabavi, Sadegh; Fox, Rocky; Proulx, Christophe D.; Lin, John Y.; Tsien, Roger Y.; Malinow, Roberto			Engineering a memory with LTD and LTP	NATURE			English	Article							LONG-TERM POTENTIATION; FEAR; AMYGDALA; EXPRESSION; NEURONS; ACQUISITION; RECEPTORS; INDUCTION; NETWORKS; CIRCUITS	It has been proposed that memories are encoded by modification of synaptic strengths through cellular mechanisms such as long-term potentiation (LTP) and long-term depression (LTD)(1). However, the causal link between these synaptic processes and memory has been difficult to demonstrate(2). Here we show that fear conditioning(3-8), a type of associative memory, can be inactivated and reactivated by LTD and LTP, respectively. We began by conditioning an animal to associate a foot shock with optogenetic stimulation of auditory inputs targeting the amygdala, a brain region known to be essential for fear conditioning(3-8). Subsequent optogenetic delivery of LTD conditioning to the auditory input inactivates memory of the shock. Then subsequent optogenetic delivery of LTP conditioning to the auditory input reactivates memory of the shock. Thus, we have engineered inactivation and reactivation of a memory using LTD and LTP, supporting a causal link between these synaptic processes and memory.	[Nabavi, Sadegh; Fox, Rocky; Proulx, Christophe D.; Malinow, Roberto] Univ Calif San Diego, Dept Neurosci, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Nabavi, Sadegh; Fox, Rocky; Proulx, Christophe D.; Malinow, Roberto] Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA; [Lin, John Y.; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Tsien, Roger Y.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Malinow, R (corresponding author), Univ Calif San Diego, Dept Neurosci, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA.	rmalinow@ucsd.edu		Proulx, Christophe/0000-0001-6484-9677; Lin, John/0000-0002-1723-4597; Nabavi, Sadegh/0000-0002-3940-1210	NIH [MH049159, NS27177]; Cure Alzheimer's Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091119, R29MH049159, R37MH049159, R01MH049159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027177, R37NS027177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032132] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Isaacson, L. Squire and members of the Malinow laboratory for suggestions. This study was supported by NIH MH049159 and Cure Alzheimer's Foundation grants to R. M. and NIH grant NS27177 to R. T.; R. T. is an Investigator of the HHMI.	Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Hoffman DA, 1998, J NEUROSCI, V18, P3521; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Kirby ED, 2012, JOVE-J VIS EXP, DOI 10.3791/4079; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Li XF, 1996, LEARN MEMORY, V3, P229, DOI 10.1101/lm.3.2-3.229; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; ROGAN MT, 1995, NEURON, V15, P127, DOI 10.1016/0896-6273(95)90070-5; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Squire L.R., 2009, MEMORY MIND MOL; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006	36	562	572	9	248	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					348	+		10.1038/nature13294	http://dx.doi.org/10.1038/nature13294			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	24896183	Green Accepted, Green Submitted			2022-12-01	WOS:000338992200036
J	Paszek, MJ; DuFort, CC; Rossier, O; Bainer, R; Mouw, JK; Godula, K; Hudak, JE; Lakins, JN; Wijekoon, AC; Cassereau, L; Rubashkin, MG; Magbanua, MJ; Thorn, KS; Davidson, MW; Rugo, HS; Park, JW; Hammer, DA; Giannone, G; Bertozzi, CR; Weaver, VM				Paszek, Matthew J.; DuFort, Christopher C.; Rossier, Olivier; Bainer, Russell; Mouw, Janna K.; Godula, Kamil; Hudak, Jason E.; Lakins, Jonathon N.; Wijekoon, Amanda C.; Cassereau, Luke; Rubashkin, Matthew G.; Magbanua, Mark J.; Thorn, Kurt S.; Davidson, Michael W.; Rugo, Hope S.; Park, John W.; Hammer, Daniel A.; Giannone, Gregory; Bertozzi, Carolyn R.; Weaver, Valerie M.			The cancer glycocalyx mechanically primes integrin-mediated growth and survival	NATURE			English	Article							CELL-ADHESION; X-RAY; MICROSCOPY; RECEPTOR; GLYCOPOLYMERS; HYALURONAN; SCATTERING; NANOSCALE; DYNAMICS; TENSION	Malignartcy is associated with altered expression of glycans and glycoprotems that contribute the cellular glycocalyx. We constructed a glycoprotein expression signature, which revealed that metastatic tumours upregulate expression of bulky glycoproteins. A computational model predicted that these glycoproteins would influence transmembrane receptor spatial organization and function. We tested this prediction by investigating whether bulky glycoproteins in the glycocalyx promote a tumour phenotype in human cells by increasing integrin adhesion and signalling. Our data revealed that a bulky glycocalyx facilitates integrin clustering by funnelling active integrins into adhesions and altering integrin state by applying tension to matrix-bound integrins, independent of actomyosin contractility. Expression of large tumour-associated glycoproteins in non-transformed mammary cells promoted focal adhesion assembly and facilitated integrin dependent growth factor signalling to support cell growth and survival. Clinical studies revealed that large glycoproteins are abundantly expressed on circulating tumour cells from patients with advanced disease. Thus, a bulky glycocalyx is a feature of tumour cells that could foster metastasis by mechanically enhancing cell-surface receptor function.	[Paszek, Matthew J.; DuFort, Christopher C.; Bainer, Russell; Mouw, Janna K.; Lakins, Jonathon N.; Wijekoon, Amanda C.; Cassereau, Luke; Rubashkin, Matthew G.; Weaver, Valerie M.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Paszek, Matthew J.; DuFort, Christopher C.; Bainer, Russell; Mouw, Janna K.; Lakins, Jonathon N.; Wijekoon, Amanda C.; Cassereau, Luke; Rubashkin, Matthew G.; Weaver, Valerie M.] Univ Calif San Francisco, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA; [Paszek, Matthew J.; DuFort, Christopher C.; Bainer, Russell; Wijekoon, Amanda C.; Cassereau, Luke; Rubashkin, Matthew G.; Weaver, Valerie M.] Univ Calif Berkeley, Bay Area Phys Sci Oncol Program, Berkeley, CA 94720 USA; [Paszek, Matthew J.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [Paszek, Matthew J.] Cornell Univ, Cornell Nanoscale Sci, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Paszek, Matthew J.] Cornell Univ, Cornell Nanoscale Sci, Kavli Inst, Ithaca, NY 14853 USA; [Rossier, Olivier; Giannone, Gregory] Univ Bordeaux, UMR 5297, Interdisciplinary Inst Neurosci, F-33000 Bordeaux, France; [Rossier, Olivier; Giannone, Gregory] Univ Bordeaux, CNRS, Interdisciplinary Inst Neurosci, UMR 5297, F-33000 Bordeaux, France; [Godula, Kamil; Hudak, Jason E.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Godula, Kamil] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [Magbanua, Mark J.; Rugo, Hope S.; Park, John W.; Weaver, Valerie M.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Magbanua, Mark J.; Rugo, Hope S.; Park, John W.] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94143 USA; [Thorn, Kurt S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32310 USA; [Hammer, Daniel A.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Hammer, Daniel A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Mol Biol, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Cornell University; Cornell University; Cornell University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of Pennsylvania; University of Pennsylvania; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weaver, VM (corresponding author), Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA.	Valerie.Weaver@ucsfmedctr.org	Rossier, Olivier M/I-6569-2013	Rossier, Olivier M/0000-0002-6932-931X; Thorn, Kurt/0000-0001-9310-288X; Mouw, Janna K/0000-0002-9846-8466; Weaver, Valerie marie/0000-0003-4786-6752; Giannone, Gregory/0000-0002-0932-1690	Kavli Institute; UCSF Program for Biomedical Breakthrough postdoctoral fellowships; DoD NDSEG Fellowship; NIH Pathway to Independence Award [K99 EB013446-02]; French Ministry of Research; CNRS; ANR grant Nanomotility; INSERM; Fondation ARC pour la Recherche sur le Cancer; Conseil Regional Aquitaine; NIH [AI082292-03A1, 2R01GM059907-13, GM59907]; Breast Cancer Research Foundation; BCRP DOD Era of Hope Scholar Expansion grant [BC122990]; NIH NCI [U54CA163155-01, U54CA143836-01, 1U01 E5019458-01, CA138818-01A1]; France BioImaging [ANR-10-INBS-04-01]; NATIONAL CANCER INSTITUTE [U01CA151925, R01CA138818, U54CA143836, U54CA163155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K99EB013446, R00EB013446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698, R01GM059907] Funding Source: NIH RePORTER	Kavli Institute; UCSF Program for Biomedical Breakthrough postdoctoral fellowships; DoD NDSEG Fellowship; NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Ministry of Research(Ministry of Research, FranceEuropean Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR grant Nanomotility(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Conseil Regional Aquitaine(Region Nouvelle-Aquitaine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; BCRP DOD Era of Hope Scholar Expansion grant; NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); France BioImaging(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Gendler, J. Goedhart and M. McMahon for cDNAs, as indicated in the Methods section. We thank A. Walker for bioinformatics support, L. Hauranieh for assistance in CTC analysis, H. Aaron for assistance with FLIM, J. B. Sibarita and M. Lagardere for support in sptPALM analysis, B. Hoffman in design of the FRET sensor, and T. Wittmann in assistance with pbFRET measurements. Image acquisition was partly performed at the Nikon Imaging Center and Biological Imaging Development Center at UCSF and the Berkeley Molecular Imaging Center. This work was supported by the Kavli Institute and UCSF Program for Biomedical Breakthrough postdoctoral fellowships to M.J.P.; DoD NDSEG Fellowship to M.G.R.; NIH GM59907 to C.R.B.; NIH Pathway to Independence Award K99 EB013446-02 to K.G.; French Ministry of Research, CNRS,ANR grant Nanomotility, INSERM, Fondation ARC pour la Recherche sur le Cancer, France BioImaging ANR-10-INBS-04-01, and Conseil Regional Aquitaine to O.R. and G.G.; NIH AI082292-03A1 to D.A.H.; The Breast Cancer Research Foundation to M.J.M., H.S.R. and J.W.P.; NIH 2R01GM059907-13 to C.R.B. and V.M.W.; and BCRP DOD Era of Hope Scholar Expansion grant BC122990, and NIH NCI grants U54CA163155-01, U54CA143836-01, 1U01 E5019458-01, and CA138818-01A1 to V.M.W.	Bono P, 2001, MOL BIOL CELL, V12, P891, DOI 10.1091/mbc.12.4.891; Bruns N, 2009, ANGEW CHEM INT EDIT, V48, P5666, DOI 10.1002/anie.200900554; Chen W, 2012, J CELL BIOL, V199, P497, DOI 10.1083/jcb.201201091; Comoletti D, 2007, STRUCTURE, V15, P693, DOI 10.1016/j.str.2007.04.010; Coombs D, 2004, BIOPHYS J, V86, P1408, DOI 10.1016/S0006-3495(04)74211-3; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dustin ML, 2012, J CLIN INVEST, V122, P1149, DOI 10.1172/JCI58705; Eng ET, 2011, J BIOL CHEM, V286, P35218, DOI 10.1074/jbc.M111.275107; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Friedrichs J, 2010, NAT PROTOC, V5, P1353, DOI 10.1038/nprot.2010.89; Godula K, 2009, J AM CHEM SOC, V131, P10263, DOI 10.1021/ja903114g; Godula K, 2009, ANGEW CHEM INT EDIT, V48, P4973, DOI 10.1002/anie.200805756; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Groves JT, 2007, ANNU REV PHYS CHEM, V58, P697, DOI 10.1146/annurev.physchem.56.092503.141216; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lakins Johnathon N, 2012, Methods Mol Biol, V916, P317, DOI 10.1007/978-1-61779-980-8_24; Lanctot PM, 2007, CURR OPIN CHEM BIOL, V11, P373, DOI 10.1016/j.cbpa.2007.05.032; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lundmark R, 2010, SEMIN CELL DEV BIOL, V21, P363, DOI 10.1016/j.semcdb.2009.11.014; Magbanua MJM, 2013, CANCER RES, V73, P30, DOI 10.1158/0008-5472.CAN-11-3017; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Pankov Roumen, 2009, V522, P261, DOI 10.1007/978-1-59745-413-1_18; Paszek MJ, 2012, NAT METHODS, V9, DOI [10.1038/NMETH.2077, 10.1038/nmeth.2077]; Paszek MJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000604; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Rossier O, 2012, NAT CELL BIOL, V14, P1057, DOI 10.1038/ncb2588; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Varki A, 2009, ESSENTIALS GLYCOBIOL; Walker JL, 2005, CYTOKINE GROWTH F R, V16, P395, DOI 10.1016/j.cytogfr.2005.03.003	35	421	424	13	265	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					319	+		10.1038/nature13535	http://dx.doi.org/10.1038/nature13535			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030168	Green Accepted			2022-12-01	WOS:000338992200029
J	Wang, LH; Yamaguchi, S; Burstein, MD; Terashima, K; Chang, K; Ng, HK; Nakamura, H; He, ZX; Doddapaneni, H; Lewis, L; Wang, M; Suzuki, T; Nishikawa, R; Natsume, A; Terasaka, S; Dauser, R; Whitehead, W; Adekunle, A; Sun, JY; Qiao, Y; Marth, G; Muzny, DM; Gibbs, RA; Leal, SM; Wheeler, DA; Lau, CC				Wang, Linghua; Yamaguchi, Shigeru; Burstein, Matthew D.; Terashima, Keita; Chang, Kyle; Ng, Ho-Keung; Nakamura, Hideo; He, Zongxiao; Doddapaneni, Harshavardhan; Lewis, Lora; Wang, Mark; Suzuki, Tomonari; Nishikawa, Ryo; Natsume, Atsushi; Terasaka, Shunsuke; Dauser, Robert; Whitehead, William; Adekunle, Adesina; Sun, Jiayi; Qiao, Yi; Marth, Gabor; Muzny, Donna M.; Gibbs, Richard A.; Leal, Suzanne M.; Wheeler, David A.; Lau, Ching C.			Novel somatic and germline mutations in intracranial germ cell tumours	NATURE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; SEQUENCING DATA; CANCER-CELLS; LUNG-CANCER; SNP ARRAYS; GENE; RESISTANCE; VARIANTS; COMMON; JMJD1C	Intracranial germ cell tumours (IGCTs) are a group of rare heterogeneous brain tumours that are clinically and histologically similar to the more common gonadal GCTs. IGCTs show great variation in their geographical and gender distribution, histological composition and treatment outcomes. The incidence of IGCTs is historically five- to eightfold greater in Japan and other East Asian countries than in Western countries(1), with peak incidence near the time of puberty(2). About half of the tumours are located in the pineal region. The male to-female incidence ratio is approximately 3-4:1 overall, but is even higher for tumours located in the pineal region(3). Owing to the scarcity of tumour specimens available for research, little is currently known about this rare disease. Here we report the analysis of 62 cases by next-generation sequencing, single nucleotide polymorphism array and expression array. We find the KIT/RAS signalling pathway frequently mutated in more than 50% of IGCTs, including novel recurrent somatic mutations in KIT, its downstream mediators KRAS and NRAS, and its negative regulator CBL. Novel somatic alterations in the AKT/mTOR pathway included copy number gains of the AKT1 locus at 14q32.33 in 19% of patients, with corresponding upregulation of AKT1 expression. We identified loss-of-function mutations in BCORL1, a transcriptional co-repressor and tumour suppressor. We report significant enrichment of novel and rare germline variants in JMJD1C, which codes for a histone demethylase and is a coactivator of the androgen receptor, among Japanese IGCT patients. This study establishes a molecular foundation for understanding the biology of IGCTs and suggests potentially promising therapeutic strategies focusing on the inhibition of KIT/RAS activation and the AKT1/mTOR pathway.	[Wang, Linghua; Chang, Kyle; Doddapaneni, Harshavardhan; Lewis, Lora; Wang, Mark; Muzny, Donna M.; Gibbs, Richard A.; Wheeler, David A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Yamaguchi, Shigeru; Terashima, Keita; Lau, Ching C.] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Yamaguchi, Shigeru; Terashima, Keita; Lau, Ching C.] Baylor Coll Med, Texas Childrens Hematol Ctr, Houston, TX 77030 USA; [Burstein, Matthew D.] Baylor Coll Med, Struct & Computat Biol & Mol Biophys Program, Houston, TX 77030 USA; [Burstein, Matthew D.; Sun, Jiayi; Lau, Ching C.] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Terashima, Keita] Natl Ctr Child Hlth & Dev, Tokyo 1578535, Japan; [Ng, Ho-Keung] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China; [Nakamura, Hideo] Kumamoto Univ, Dept Neurosurg, Kumamoto 8600862, Japan; [He, Zongxiao; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA; [Suzuki, Tomonari; Nishikawa, Ryo] Saitama Med Univ, Dept Neurosurg, Saitama 3500495, Japan; [Natsume, Atsushi] Nagoya Univ, Dept Neurosurg, Nagoya, Aichi 4668550, Japan; [Terasaka, Shunsuke] Hokkaido Univ, Dept Neurosurg, Sapporo, Hokkaido 0600808, Japan; [Dauser, Robert; Whitehead, William] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Adekunle, Adesina] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Qiao, Yi; Marth, Gabor] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA; [Lau, Ching C.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; National Center for Child Health & Development - Japan; Chinese University of Hong Kong; Prince of Wales Hospital; Kumamoto University; Baylor College of Medicine; Saitama Medical University; Nagoya University; Hokkaido University; Baylor College of Medicine; Baylor College of Medicine; Boston College; Baylor College of Medicine	Wheeler, DA (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	wheeler@bcm.edu; cclau@txch.org	Dauser, Thomas/AAU-1209-2020; Burstein, Matthew/GWZ-8436-2022; Ng, Ho Keung/I-3952-2015; Yamaguchi, Shigeru/G-5419-2012; Natsume, Atsushi/I-7364-2014; Wheeler, David A/M-9740-2018	Dauser, Thomas/0000-0003-4583-9048; Yamaguchi, Shigeru/0000-0003-3710-5888; Natsume, Atsushi/0000-0002-9113-0470; Wheeler, David A/0000-0002-9056-6299; doddapaneni, harshavardhan/0000-0002-2433-633X; Wang, Linghua/0000-0001-9380-0266; Chang, Kyle/0000-0001-5295-9676	National Human Genome Research Institute (NHGRI) [5U54HG003273]; Children Brain Tumor Foundation; Gillson Longenbaugh Foundation; Anderson Charitable Foundation; CCBTP Fellowship from the Cancer Prevention & Research Institute of Texas (CPRIT) [RP101489]; St Baldrick's Foundation; NLM predoctoral fellowships [5T15 LM07093-18, 5T15 LM07093-19]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Children Brain Tumor Foundation; Gillson Longenbaugh Foundation; Anderson Charitable Foundation; CCBTP Fellowship from the Cancer Prevention & Research Institute of Texas (CPRIT); St Baldrick's Foundation; NLM predoctoral fellowships; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by research funding from the National Human Genome Research Institute (NHGRI, grant number 5U54HG003273) to D. A. W., the Children Brain Tumor Foundation, the Gillson Longenbaugh Foundation and Anderson Charitable Foundation to C. C. L., the CCBTP Fellowship from the Cancer Prevention & Research Institute of Texas (CPRIT grant RP101489) to S.Y., the St Baldrick's Foundation to K. T. and the NLM predoctoral fellowships to M. D. B. (5T15 LM07093-18) and J.S. (5T15 LM07093-19). We thank H. H. Dinh and Y. Han for their technical support, J. G. Reid for Illumina sequence mapping.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gajiwala KS, 2009, P NATL ACAD SCI USA, V106, P1542, DOI 10.1073/pnas.0812413106; Hatzivassiliou G, 2012, MOL CANCER THER, V11, P1143, DOI 10.1158/1535-7163.MCT-11-1010; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; JENNINGS MT, 1985, J NEUROSURG, V63, P155, DOI 10.3171/jns.1985.63.2.0155; Jin GF, 2012, HUM MOL GENET, V21, P5222, DOI 10.1093/hmg/dds361; Kamakura Y, 2006, J NEUROSURG, V104, P173, DOI 10.3171/ped.2006.104.3.173; Katoh M, 2003, INT J MOL MED, V12, P817; Kemmer K, 2004, AM J PATHOL, V164, P305, DOI 10.1016/S0002-9440(10)63120-3; Kim SM, 2010, NUCLEIC ACIDS RES, V38, P6389, DOI 10.1093/nar/gkq491; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kuroki S, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108597; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2011, BLOOD, V118, P5914, DOI 10.1182/blood-2011-05-356204; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Makishima H, 2012, LEUKEMIA, V26, P1547, DOI 10.1038/leu.2012.7; Makishima H, 2009, J CLIN ONCOL, V27, P6109, DOI 10.1200/JCO.2009.23.7503; Matsutani M, 1997, J NEUROSURG, V86, P446, DOI 10.3171/jns.1997.86.3.0446; McCarthy BJ, 2012, NEURO-ONCOLOGY, V14, P1194, DOI 10.1093/neuonc/nos155; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Okada Y, 2002, J NEUROPATH EXP NEUR, V61, P531, DOI 10.1093/jnen/61.6.531; Packer R J, 2000, Oncologist, V5, P312; Pagan JK, 2007, J BIOL CHEM, V282, P15248, DOI 10.1074/jbc.M700246200; Popova T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r128; Rickert CH, 2000, J NEUROPATH EXP NEUR, V59, P815, DOI 10.1093/jnen/59.9.815; Sakuma Y, 2004, CANCER SCI, V95, P716, DOI 10.1111/j.1349-7006.2004.tb03251.x; Schneider DT, 2006, MODERN PATHOL, V19, P864, DOI 10.1038/modpathol.3800607; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Staaf J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r136; Terashima K, 2014, PEDIATR BLOOD CANCER, V61, P593, DOI 10.1002/pbc.24833; Thien CBF, 2001, MOL CELL, V7, P355, DOI 10.1016/S1097-2765(01)00183-6; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wolf SS, 2007, ARCH BIOCHEM BIOPHYS, V460, P56, DOI 10.1016/j.abb.2007.01.017; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	41	115	120	3	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					241	+		10.1038/nature13296	http://dx.doi.org/10.1038/nature13296			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	24896186	Green Accepted			2022-12-01	WOS:000338649800048
J	Sydeman, WJ; Garcia-Reyes, M; Schoeman, DS; Rykaczewski, RR; Thompson, SA; Black, BA; Bograd, SJ				Sydeman, W. J.; Garcia-Reyes, M.; Schoeman, D. S.; Rykaczewski, R. R.; Thompson, S. A.; Black, B. A.; Bograd, S. J.			Climate change and wind intensification in coastal upwelling ecosystems	SCIENCE			English	Article							CALIFORNIA CURRENT; TRENDS; FUTURE	In 1990, Andrew Bakun proposed that increasing greenhouse gas concentrations would force intensification of upwelling-favorable winds in eastern boundary current systems that contribute substantial services to society. Because there is considerable disagreement about whether contemporary wind trends support Bakun's hypothesis, we performed a meta-analysis of the literature on upwelling-favorable wind intensification. The preponderance of published analyses suggests that winds have intensified in the California, Benguela, and Humboldt upwelling systems and weakened in the Iberian system over time scales ranging up to 60 years; wind change is equivocal in the Canary system. Stronger intensification signals are observed at higher latitudes, consistent with the warming pattern associated with climate change. Overall, reported changes in coastal winds, although subtle and spatially variable, support Bakun's hypothesis of upwelling intensification in eastern boundary current systems.	[Sydeman, W. J.; Garcia-Reyes, M.; Thompson, S. A.] Farallon Inst Adv Ecosyst Res, Petaluma, CA 94952 USA; [Schoeman, D. S.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Maroochydore, Qld 4558, Australia; [Rykaczewski, R. R.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Rykaczewski, R. R.] Univ S Carolina, Marine Sci Program, Columbia, SC 29208 USA; [Thompson, S. A.] Univ Washington, Climate Impacts Grp, Seattle, WA 98195 USA; [Black, B. A.] Univ Texas Richardson, Inst Marine Sci, Port Aransas, TX 78373 USA; [Bograd, S. J.] NOAA, Environm Res Div, Southwest Fisheries Sci Ctr, Pacific Grove, CA 93950 USA	University of the Sunshine Coast; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Dallas; National Oceanic Atmospheric Admin (NOAA) - USA	Sydeman, WJ (corresponding author), Farallon Inst Adv Ecosyst Res, Suite Q,101 H St, Petaluma, CA 94952 USA.	wsydeman@comcast.net	Bograd, Steven/AAA-4824-2021; Rykaczewski, Ryan/A-8625-2016; Black, Bryan/A-7057-2009	Rykaczewski, Ryan/0000-0001-8893-872X; Black, Bryan/0000-0001-6851-257X; Schoeman, David/0000-0003-1258-0885	NSF [1130125]; NOAA's Environmental Research Division; Australian Research Council's Collaborative Research Network; Directorate For Geosciences [1026607] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NOAA's Environmental Research Division; Australian Research Council's Collaborative Research Network(Australian Research Council); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Support for this study was provided by NSF award no. 1130125, NOAA's Environmental Research Division, and donors to the Farallon Institute. D.S. was supported by the Australian Research Council's Collaborative Research Network. The data reported in this paper are tabulated in the supplementary materials; electronic files of the tabulated data are available upon request from the senior author and at www.faralloninstitute.org.	BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Bakun A, 2010, GLOBAL CHANGE BIOL, V16, P1213, DOI 10.1111/j.1365-2486.2009.02094.x; Barton ED, 2013, PROG OCEANOGR, V116, P167, DOI 10.1016/j.pocean.2013.07.007; Baumann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067596; Black BA, 2011, GLOBAL CHANGE BIOL, V17, P2536, DOI 10.1111/j.1365-2486.2011.02422.x; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Botsford LW, 2006, DEEP-SEA RES PT II, V53, P3116, DOI 10.1016/j.dsr2.2006.07.011; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Cropper TE, 2014, DEEP-SEA RES PT I, V86, P94, DOI 10.1016/j.dsr.2014.01.007; CURY P, 1989, CAN J FISH AQUAT SCI, V46, P670, DOI 10.1139/f89-086; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Gruber N, 2012, SCIENCE, V337, P220, DOI 10.1126/science.1216773; Hakkinen S, 2011, SCIENCE, V334, P655, DOI 10.1126/science.1205683; Hurrell J.W., 2003, GEOPHYS MONOGR SER, V134, P1, DOI [10.1029/134GM01, DOI 10.1029/134GM01]; Kahru M, 2012, DEEP-SEA RES PT II, V77-80, P89, DOI 10.1016/j.dsr2.2012.04.007; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; Narayan N, 2010, OCEAN SCI, V6, P815, DOI 10.5194/os-6-815-2010; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; Schroeder ID, 2009, MAR ECOL PROG SER, V393, P211, DOI 10.3354/meps08103; Snyder MA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017647; Solomon S., 2007, ADV CLIM CHANG RES; Thomas BR, 2008, INT J CLIMATOL, V28, P747, DOI 10.1002/joc.1570; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270	25	331	345	19	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					77	80		10.1126/science.1251635	http://dx.doi.org/10.1126/science.1251635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994651				2022-12-01	WOS:000338284400053
J	Kryazhimskiy, S; Rice, DP; Jerison, ER; Desai, MM				Kryazhimskiy, Sergey; Rice, Daniel P.; Jerison, Elizabeth R.; Desai, Michael M.			Global epistasis makes adaptation predictable despite sequence-level stochasticity	SCIENCE			English	Article							BENEFICIAL MUTATIONS; ESCHERICHIA-COLI; CLONAL INTERFERENCE; EVOLUTION; POPULATIONS; EVOLVABILITY; RATES	Epistatic interactions between mutations can make evolutionary trajectories contingent on the chance occurrence of initial mutations. We used experimental evolution in Saccharomyces cerevisiae to quantify this contingency, finding differences in adaptability among 64 closely related genotypes. Despite these differences, sequencing of 104 evolved clones showed that initial genotype did not constrain future mutational trajectories. Instead, reconstructed combinations of mutations revealed a pattern of diminishing-returns epistasis: Beneficial mutations have consistently smaller effects in fitter backgrounds. Taken together, these results show that beneficial mutations affecting a variety of biological processes are globally coupled; they interact strongly, but only through their combined effect on fitness. As a consequence, fitness evolution follows a predictable trajectory even though sequence-level adaptation is stochastic.	[Kryazhimskiy, Sergey; Rice, Daniel P.; Desai, Michael M.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Jerison, Elizabeth R.; Desai, Michael M.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Kryazhimskiy, Sergey; Rice, Daniel P.; Jerison, Elizabeth R.; Desai, Michael M.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Kryazhimskiy, S (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	skryazhi@oeb.harvard.edu; mdesai@oeb.harvard.edu	Kryazhimskiy, Sergey/AAV-1258-2020	Kryazhimskiy, Sergey/0000-0001-9128-8705; Jerison, Elizabeth/0000-0003-3793-8839; Desai, Michael/0000-0002-9581-1150	Burroughs Wellcome Foundation; NSF graduate research fellowships; James S. McDonnell Foundation; Alfred P. Sloan Foundation; Harvard Milton Fund; NSF [PHY 1313638]; NIH [GM104239]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104239] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1313638] Funding Source: National Science Foundation	Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NSF graduate research fellowships(National Science Foundation (NSF)); James S. McDonnell Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Harvard Milton Fund; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank A. Murray, Q. Justman, B. Good, D. van Dyken, M. McDonald for useful discussions; A. Subramaniam, G. Lang, M. Muller, and J. Koschwanez for experimental advice and strains; and P. Rogers and C. Daly for technical support. Supported by the Burroughs Wellcome Foundation (S.K.), NSF graduate research fellowships (D.P.R., E.R.J.), and the James S. McDonnell Foundation, the Alfred P. Sloan Foundation, the Harvard Milton Fund, NSF grant PHY 1313638, and NIH grant GM104239 (M.M.D.). Sequence data have been deposited to GenBank under BioProject identifier PRJNA242140.	Barrick JE, 2010, MOL BIOL EVOL, V27, P1338, DOI 10.1093/molbev/msq024; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Bollback JP, 2007, MOL BIOL EVOL, V24, P1397, DOI 10.1093/molbev/msm056; Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Chou HH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000652; Gould S.J., 1989, WONDERFUL LIFE; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kryazhimskiy S, 2009, P NATL ACAD SCI USA, V106, P18638, DOI 10.1073/pnas.0905497106; Lang GI, 2013, NATURE, V500, P571, DOI 10.1038/nature12344; Lang GI, 2011, GENETICS, V188, P647, DOI 10.1534/genetics.111.128942; Perfeito L, 2014, EVOLUTION, V68, P150, DOI 10.1111/evo.12234; Rokyta DR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002075; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914	20	222	224	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1519	1522		10.1126/science.1250939	http://dx.doi.org/10.1126/science.1250939			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970088	Green Accepted, Green Submitted			2022-12-01	WOS:000337889900051
J	Monk, J; Palsson, BO				Monk, Jonathan; Palsson, Bernhard O.			Predicting microbial growth	SCIENCE			English	Editorial Material									[Monk, Jonathan; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92093 USA	University of California System; University of California San Diego	Monk, J (corresponding author), Univ Calif San Diego, Dept Bioengn, San Diego, CA 92093 USA.	palsson@ucsd.edu		Palsson, Bernhard/0000-0003-2357-6785; Monk, Jonathan M./0000-0002-3895-8949				Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barua D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000970; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Deutschbauer A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002385; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Monk J, 2014, NAT BIOTECHNOL, V32, P447, DOI 10.1038/nbt.2870; Nakahigashi K, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.65; Orth JD, 2010, BIOTECHNOL BIOENG, V107, P403, DOI 10.1002/bit.22844; Rolfsson O, 2013, BIOCHEM J, V449, P427, DOI 10.1042/BJ20120980; Szappanos B, 2011, NAT GENET, V43, P656, DOI 10.1038/ng.846	12	31	31	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1448	1449		10.1126/science.1253388	http://dx.doi.org/10.1126/science.1253388			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970063				2022-12-01	WOS:000337889900019
J	Genovese, P; Schiroli, G; Escobar, G; Di Tomaso, T; Firrito, C; Calabria, A; Moi, D; Mazzieri, R; Bonini, C; Holmes, MC; Gregory, PD; van der Burg, M; Gentner, B; Montini, E; Lombardo, A; Naldini, L				Genovese, Pietro; Schiroli, Giulia; Escobar, Giulia; Di Tomaso, Tiziano; Firrito, Claudia; Calabria, Andrea; Moi, Davide; Mazzieri, Roberta; Bonini, Chiara; Holmes, Michael C.; Gregory, Philip D.; van der Burg, Mirjam; Gentner, Bernhard; Montini, Eugenio; Lombardo, Angelo; Naldini, Luigi			Targeted genome editing in human repopulating haematopoietic stem cells	NATURE			English	Article							ZINC-FINGER NUCLEASES; GENE-THERAPY; LENTIVIRAL VECTOR; T-CELLS; INTEGRATION; SAFE; CCR5	Targeted genome editing by artificial nucleases has brought the goal of site-specific transgene integration and gene correction within the reach of gene therapy. However, its application to long-term repopulating haematopoietic stem cells (HSCs) has remained elusive. Here we show that poor permissiveness to gene transfer and limited proficiency of the homology-directed DNA repair pathway constrain gene targeting in human HSCs. By tailoring delivery platforms and culture conditions we overcame these barriers and provide stringent evidence of targeted integration in human HSCs by long-term multilineage repopulation of transplanted mice. We demonstrate the therapeutic potential of our strategy by targeting a corrective complementary DNA into the IL2RG gene of HSCs from healthy donors and a subject with X-linked severe combined immunodeficiency (SCID-X1). Gene-edited HSCs sustained normal haematopoiesis and gave rise to functional lymphoid cells that possess a selective growth advantage over those carrying disruptive IL2RG mutations. These results open up new avenues for treating SCID-X1 and other diseases.	[Genovese, Pietro; Schiroli, Giulia; Escobar, Giulia; Di Tomaso, Tiziano; Firrito, Claudia; Calabria, Andrea; Moi, Davide; Mazzieri, Roberta; Gentner, Bernhard; Montini, Eugenio; Lombardo, Angelo; Naldini, Luigi] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy, TIGET, I-20132 Milan, Italy; [Schiroli, Giulia; Escobar, Giulia; Gentner, Bernhard; Lombardo, Angelo; Naldini, Luigi] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Bonini, Chiara] Ist Sci San Raffaele, Expt Hematol Unit, I-20132 Milan, Italy; [Holmes, Michael C.; Gregory, Philip D.] Sangamo BioSci Inc, Richmond, CA 94804 USA; [van der Burg, Mirjam] Univ Med Ctr, Erasmus MC, Dept Immunol, NL-3015 Rotterdam, Netherlands	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Sangamo Therapeutics, Inc.; Erasmus University Rotterdam; Erasmus MC	Naldini, L (corresponding author), Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy, TIGET, I-20132 Milan, Italy.	naldini.luigi@hsr.it	Mazzieri, Roberta/C-9773-2015; Escobar, Giulia/AFD-7497-2022; Genovese, Pietro/H-3710-2018; bonini, chiara/I-9202-2012; Montini, Eugenio/L-1152-2016; lombardo, angelo/J-6241-2016; Calabria, Andrea/AAA-3349-2019	Mazzieri, Roberta/0000-0002-5172-0927; Genovese, Pietro/0000-0001-9507-9003; Montini, Eugenio/0000-0003-1771-6067; lombardo, angelo/0000-0001-8262-042X; Calabria, Andrea/0000-0003-3515-3384; Schiroli, Giulia/0000-0002-9812-8728; Escobar, Giulia/0000-0001-9177-0251; Moi, Davide/0000-0002-1198-5146; Gentner, Bernhard/0000-0001-6024-4718; Gregory, Philip/0000-0001-9249-2468; BONINI, Maria Chiara/0000-0002-0772-1674; NALDINI, Luigi/0000-0002-7835-527X	Telethon (TIGET grant) [D2]; EU [249845]; Italian Ministry of Health	Telethon (TIGET grant)(Fondazione Telethon); EU(European Commission); Italian Ministry of Health(Ministry of Health, Italy)	We thank D. Weissman for advice on mRNA production and the whole Naldini laboratory for discussion, F. Benedicenti for help with MiSeq sequencing, L. Sergi Sergi, T. Plati, V. Valtolina, B. Camisa and A. Ranghetti for technical help. SR1 was provided by T. Boitano and M. Cooke under an MTA with the Genomics Institute of the Novartis Research Foundation. This work was supported by grants to L.N. from Telethon (TIGET grant D2) EU (FP7 222878 PERSIST, FP7 601958 SUPERSIST, ERC Advanced Grant 249845 TARGETINGGENETHERAPY) and the Italian Ministry of Health.	Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Akatsuka Y, 1999, TISSUE ANTIGENS, V53, P122, DOI 10.1034/j.1399-0039.1999.530202.x; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazza A, 2013, HUM GENE THER, V24, P119, DOI 10.1089/hum.2012.203; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cieri N, 2013, BLOOD, V121, P573, DOI 10.1182/blood-2012-05-431718; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Escobar G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006353; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gentner B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001522; Goessling W, 2011, CELL STEM CELL, V8, P445, DOI 10.1016/j.stem.2011.02.003; Harris DT, 2013, CLIN EXP IMMUNOL, V174, P402, DOI 10.1111/cei.12192; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Matrai J, 2011, HEPATOLOGY, V53, P1696, DOI 10.1002/hep.24230; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Mukherjee S, 2013, GENE, V525, P174, DOI 10.1016/j.gene.2013.03.098; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Woods NB, 2006, NATURE, V440, P1123, DOI 10.1038/4401123a; Wu CJ, 2000, BLOOD, V95, P352; Zou JZ, 2011, BLOOD, V117, P5561, DOI 10.1182/blood-2010-12-328161	42	395	422	0	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					235	+		10.1038/nature13420	http://dx.doi.org/10.1038/nature13420			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24870228	Green Accepted			2022-12-01	WOS:000337032400043
J	Shi, YK; Hu, FB				Shi, Yuankai; Hu, Frank B.			The global implications of diabetes and cancer	LANCET			English	Editorial Material							PROSTATE-CANCER; MELLITUS; RISK; MORTALITY; ADULTS; TYPE-2; WOMEN		[Shi, Yuankai] Chinese Acad Med Sci, Canc Inst Hosp, Peking Union Med Coll, Dept Med Oncol, Beijing 100730, Peoples R China; [Shi, Yuankai] Natl Ctr Anticanc Drugs Clin Study, Beijing, Peoples R China; [Shi, Yuankai] Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hu, Frank B.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Med, Boston, MA USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Shi, YK (corresponding author), Chinese Acad Med Sci, Canc Inst Hosp, Peking Union Med Coll, Dept Med Oncol, Beijing 100730, Peoples R China.	syuankai@cicams.ac.cn						Bensimon L, 2014, CANCER CAUSE CONTROL, V25, P329, DOI 10.1007/s10552-013-0334-6; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Gallagher EJ, 2013, DIABETES CARE, V36, pS233, DOI 10.2337/dcS13-2001; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Goodwin PJ, 2008, CLIN BREAST CANCER, V8, P501, DOI 10.3816/CBC.2008.n.060; Goss PE, 2014, LANCET ONCOL, V15, P489, DOI 10.1016/S1470-2045(14)70029-4; Home P, 2013, DIABETES CARE, V36, pS240, DOI 10.2337/dcS13-2002; Hu FB, 1999, JNCI-J NATL CANCER I, V91, P542, DOI 10.1093/jnci/91.6.542; Kasper JS, 2006, CANCER EPIDEM BIOMAR, V15, P2056, DOI 10.1158/1055-9965.EPI-06-0410; Le TN, 2012, TRENDS ENDOCRIN MET, V23, P32, DOI 10.1016/j.tem.2011.09.005; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Vangoitsenhoven R, 2012, ENDOCR-RELAT CANCER, V19, pF77, DOI 10.1530/ERC-12-0111; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118	13	270	290	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2014	383	9933					1947	1948		10.1016/S0140-6736(14)60886-2	http://dx.doi.org/10.1016/S0140-6736(14)60886-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PV	24910221				2022-12-01	WOS:000336848200004
J	Blackledge, NP; Farcas, AM; Kondo, T; King, HW; McGouran, JF; Hanssen, LLP; Ito, S; Cooper, S; Kondo, K; Koseki, Y; Ishikura, T; Long, HK; Sheahan, TW; Brockdorff, N; Kessler, BM; Koseki, H; Klose, RJ				Blackledge, Neil P.; Farcas, Anca M.; Kondo, Takashi; King, Hamish W.; McGouran, Joanna F.; Hanssen, Lars L. P.; Ito, Shinsuke; Cooper, Sarah; Kondo, Kaori; Koseki, Yoko; Ishikura, Tomoyuki; Long, Hannah K.; Sheahan, Thomas W. p; Brockdorff, Neil; Kessler, Benedikt M.; Koseki, Haruhiko; Klose, Robert J.			Variant PRC1 Complex-Dependent H2A Ubiquitylation Drives PRC2 Recruitment and Polycomb Domain Formation	CELL			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; EMBRYONIC STEM-CELLS; UBIQUITIN LIGASE COMPLEX; GROUP PROTEINS RING1A/B; REPRESSIVE COMPLEX; GENOME-WIDE; CPG ISLANDS; DROSOPHILA-MELANOGASTER; X-INACTIVATION; SAM DOMAIN	Chromatin modifying activities inherent to polycomb repressive complexes PRC1 and PRC2 play an essential role in gene regulation, cellular differentiation, and development. However, the mechanisms by which these complexes recognize their target sites and function together to form repressive chromatin domains remain poorly understood. Recruitment of PRC1 to target sites has been proposed to occur through a hierarchical process, dependent on prior nucleation of PRC2 and placement of H3K27me3. Here, using a de novo targeting assay in mouse embryonic stem cells we unexpectedly discover that PRC1-dependent H2AK119ub1 leads to recruitment of PRC2 and H3K27me3 to effectively initiate a polycomb domain. This activity is restricted to variant PRC1 complexes, and genetic ablation experiments reveal that targeting of the variant PCGF1/PRC1 complex by KDM2B to CpG islands is required for normal polycomb domain formation and mouse development. These observations provide a surprising PRC1-dependent logic for PRC2 occupancy at target sites in vivo.	[Blackledge, Neil P.; Farcas, Anca M.; King, Hamish W.; Hanssen, Lars L. P.; Long, Hannah K.; Sheahan, Thomas W. p; Klose, Robert J.] Univ Oxford, Dept Biochem, Lab Chromatin Biol & Transcript, Oxford OX1 3QU, England; [Kondo, Takashi; Ito, Shinsuke; Kondo, Kaori; Koseki, Yoko; Ishikura, Tomoyuki; Koseki, Haruhiko] RIKEN, Ctr Integrat Med Sci, Lab Dev Genet, Yokohama, Kanagawa 2300045, Japan; [McGouran, Joanna F.; Kessler, Benedikt M.] Univ Oxford, Target Discovery Inst, Nuffield Dept Med, Cent Prote Facil,Ubiquitin Proteolysis Grp, Oxford OX3 7BN, England; [Cooper, Sarah; Brockdorff, Neil] Univ Oxford, Dept Biochem, Lab Dev Epigenet, Oxford OX1 3QU, England	University of Oxford; RIKEN; University of Oxford; University of Oxford	Klose, RJ (corresponding author), Univ Oxford, Dept Biochem, Lab Chromatin Biol & Transcript, S Parks Rd, Oxford OX1 3QU, England.	rob.klose@bioch.ox.ac.uk	Kessler, Benedikt/AAY-8614-2021; Long, Hannah/A-6301-2013; McGouran, Joanna/A-1545-2019; Long, Hannah/X-9731-2019; King, Hamish/U-9808-2019; Koseki, Haruhiko/I-3825-2014	Kessler, Benedikt/0000-0002-8160-2446; Long, Hannah/0000-0002-5694-0398; McGouran, Joanna/0000-0002-9349-2141; Long, Hannah/0000-0002-5694-0398; King, Hamish/0000-0001-5972-8926; Koseki, Haruhiko/0000-0001-8424-5854; jin teng, long/0000-0002-1948-9331; Farcas, Anca Madalina/0000-0002-6467-494X; Hanssen, Lars/0000-0002-2551-2278; Sheahan, Thomas/0000-0002-9457-4691; Brockdorff, Neil/0000-0003-4838-2653	Wellcome Trust [WT0834922, WT081385]; CRUK [C28585/A10839]; NIHR; EMBO; Lister Institute of Preventative Medicine; RIKEN; MEXT; JST CREST; Medical Research Council [G0501068] Funding Source: researchfish; MRC [G0501068] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); CRUK(Cancer Research UK); NIHR(National Institute for Health Research (NIHR)); EMBO(European Molecular Biology Organization (EMBO)); Lister Institute of Preventative Medicine; RIKEN; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Dr. Tom Milne for comments and suggestions, Marie-Laetitia Thezenas and Dr. Rebecca Konietzny for mass spectrometry expertise. This study was funded by the Wellcome Trust (WT0834922 and WT081385), CRUK (C28585/A10839), NIHR, EMBO, Lister Institute of Preventative Medicine, RIKEN, MEXT, and JST CREST. The WTCHG Genomics Facility carried out massively parallel sequencing.	Akasaka T, 1996, DEVELOPMENT, V122, P1513; Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Cooper S, 2014, CELL REP, V7, P1456, DOI 10.1016/j.celrep.2014.04.012; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dietrich N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002494; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Fukuda T, 2011, MOL CELL NEUROSCI, V46, P614, DOI 10.1016/j.mcn.2011.01.001; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Grossmann V, 2011, BLOOD, V118, P6153, DOI 10.1182/blood-2011-07-365320; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; He J, 2013, NAT CELL BIOL, V15, P373, DOI 10.1038/ncb2702; Hosogane M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003698; Isono K, 2013, DEV CELL, V26, P565, DOI 10.1016/j.devcel.2013.08.016; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Ketel CS, 2005, MOL CELL BIOL, V25, P6857, DOI 10.1128/MCB.25.16.6857-6868.2005; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; Klose RJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003717; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Long HK, 2013, BIOCHEM SOC T, V41, P727, DOI 10.1042/BST20130028; Lorente MD, 2000, DEVELOPMENT, V127, P5093; Lynch MD, 2012, EMBO J, V31, P317, DOI 10.1038/emboj.2011.399; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Posfai E, 2012, GENE DEV, V26, P920, DOI 10.1101/gad.188094.112; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Suzuki M, 2002, DEVELOPMENT, V129, P4171; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; van der Stoop P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002235; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wang RJ, 2010, STRUCTURE, V18, P966, DOI 10.1016/j.str.2010.04.013; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Yuan W, 2012, SCIENCE, V337, P971, DOI 10.1126/science.1225237; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733	68	472	484	1	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1445	1459		10.1016/j.cell.2014.05.004	http://dx.doi.org/10.1016/j.cell.2014.05.004			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24856970	Green Published, hybrid			2022-12-01	WOS:000340881400019
J	Tsai, KL; Tomomori-Sato, C; Sato, S; Conaway, RC; Conaway, JW; Asturias, FJ				Tsai, Kuang-Lei; Tomomori-Sato, Chieri; Sato, Shigeo; Conaway, Ronald C.; Conaway, Joan W.; Asturias, Francisco J.			Subunit Architecture and Functional Modular Rearrangements of the Transcriptional Mediator Complex	CELL			English	Article							RNA-POLYMERASE-II; HEAD MODULE; YEAST MEDIATOR; MIDDLE MODULE; TAIL MODULE; IN-VIVO; ACTIVATOR; DOMAIN; BINDING; CRSP	The multisubunit Mediator, comprising similar to 30 distinct proteins, plays an essential role in gene expression regulation by acting as a bridge between DNA-binding transcription factors and the RNA polymerase II (RNAPII) transcription machinery. Efforts to uncover the Mediator mechanism have been hindered by a poor understanding of its structure, subunit organization, and conformational rearrangements. By overcoming biochemical and image analysis hurdles, we obtained accurate EM structures of yeast and human Mediators. Subunit localization experiments, docking of partial X-ray structures, and biochemical analyses resulted in comprehensive mapping of yeast Mediator subunits and a complete reinterpretation of our previous Mediator organization model. Large-scale Mediator rearrangements depend on changes at the interfaces between previously described Mediator modules, which appear to be facilitated by factors conducive to transcription initiation. Conservation across eukaryotes of Mediator structure, subunit organization, and RNA polymerase II interaction suggest conservation of fundamental aspects of the Mediator mechanism.	[Tsai, Kuang-Lei; Asturias, Francisco J.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Tomomori-Sato, Chieri; Sato, Shigeo; Conaway, Ronald C.; Conaway, Joan W.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Conaway, Ronald C.; Conaway, Joan W.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Scripps Research Institute; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Asturias, FJ (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	asturias@scripps.edu		Conaway, Joan/0000-0002-2786-0663; Tomomori-Sato, Chieri/0000-0002-2543-293X	US National Institutes of Health [R01 GM67167, R01 GM41628]; Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067167, R01GM041628] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health grants R01 GM67167 (F.J.A.) and R01 GM41628 (R. C. C. and J.W.C.) and by a grant to the Stowers Institute from the Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation. We thank Y. Takagi for providing the plasmid for MBP tagging in yeast, G. C. Lander for critical reading of manuscript, and Patrick Cramer for providing a Med19 Delta yeast strain. We thank T. Otomo for providing the plasmid for HA-tagging in yeast. EM data collection was carried out at the National Resource for Automated Macromolecular Microscopy (NRAMM).	Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Ansari SA, 2012, EMBO J, V31, P44, DOI 10.1038/emboj.2011.362; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baidoobonso SM, 2007, J BIOL CHEM, V282, P5551, DOI 10.1074/jbc.M609484200; Baumli S, 2005, J BIOL CHEM, V280, P18171, DOI 10.1074/jbc.M413466200; Bernecky C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000603; Beve J, 2005, J BIOL CHEM, V280, P41366, DOI 10.1074/jbc.M511181200; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Brzovic PS, 2011, MOL CELL, V44, P942, DOI 10.1016/j.molcel.2011.11.008; Cai G, 2012, STRUCTURE, V20, P899, DOI 10.1016/j.str.2012.02.023; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; Conaway RC, 2013, BBA-GENE REGUL MECH, V1829, P69, DOI 10.1016/j.bbagrm.2012.08.017; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Ebmeier CC, 2010, P NATL ACAD SCI USA, V107, P11283, DOI 10.1073/pnas.0914215107; Ge K, 2008, MOL CELL BIOL, V28, P1081, DOI 10.1128/MCB.00967-07; Hallberg M, 2006, MOL GENET GENOMICS, V276, P197, DOI 10.1007/s00438-006-0135-7; Hoeppner S, 2005, J MOL BIOL, V350, P833, DOI 10.1016/j.jmb.2005.05.041; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; Ito M, 2002, EMBO J, V21, P3464, DOI 10.1093/emboj/cdf348; Kim S, 2013, J BIOL CHEM, V288, P12197, DOI 10.1074/jbc.M112.449553; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Koschubs T, 2010, NUCLEIC ACIDS RES, V38, P3186, DOI 10.1093/nar/gkq029; Koschubs T, 2009, EMBO J, V28, P69, DOI 10.1038/emboj.2008.254; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Lariviere L, 2013, NUCLEIC ACIDS RES, V41, P9266, DOI 10.1093/nar/gkt704; Lariviere L, 2012, NATURE, V492, P448, DOI 10.1038/nature11670; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; Linder T, 2006, BIOCHEM BIOPH RES CO, V349, P948, DOI 10.1016/j.bbrc.2006.08.099; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Meyer KD, 2010, NAT STRUCT MOL BIOL, V17, P753, DOI 10.1038/nsmb.1816; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; Robinson PJJ, 2012, P NATL ACAD SCI USA, V109, P17931, DOI 10.1073/pnas.1215241109; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Sato S, 2003, J BIOL CHEM, V278, P49671, DOI 10.1074/jbc.C300444200; Sato S, 2003, J BIOL CHEM, V278, P15123, DOI 10.1074/jbc.C300054200; Soutourina J, 2011, SCIENCE, V331, P1451, DOI 10.1126/science.1200188; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Taatjes DJ, 2004, NAT STRUCT MOL BIOL, V11, P664, DOI 10.1038/nsmb789; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Thakur JK, 2009, J BIOL CHEM, V284, P4422, DOI 10.1074/jbc.M808263200; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; Vojnic E, 2011, NAT STRUCT MOL BIOL, V18, P404, DOI 10.1038/nsmb.1997; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004	56	142	146	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1430	1444		10.1016/j.cell.2014.05.015	http://dx.doi.org/10.1016/j.cell.2014.05.015			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24882805	Green Accepted, Bronze			2022-12-01	WOS:000340881400018
J	Tallis, R				Tallis, Ray			Assisted dying is not the same as euthanasia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												raymond@rtallis.wanadoo.co.uk						Hartropp P., 2014, BMJ; YouGov, 2013, YOU GOV DIGN DYING S	2	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2014	348								g3532	10.1136/bmj.g3532	http://dx.doi.org/10.1136/bmj.g3532			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EH	24871316				2022-12-01	WOS:000336742000009
J	Mingote, LR; Namutamba, D; Apina, F; Barnabas, N; Contreras, C; Elnour, T; Frick, MW; Lee, C; Seaworth, B; Shelly, D; Skipper, N; dos Santos, ET				Mingote, Laia Ruiz; Namutamba, Dorothy; Apina, Francis; Barnabas, Nomampondo; Contreras, Carmen; Elnour, Taharqa; Frick, Mike Watson; Lee, Cynthia; Seaworth, Barbara; Shelly, Debra; Skipper, Natalie; dos Santos Filho, Ezio Tavora			The use of bedaquiline in regimens to treat drug-resistant and drug-susceptible tuberculosis: a perspective from tuberculosis-affected communities	LANCET			English	Editorial Material							OUTCOMES		[Mingote, Laia Ruiz; Namutamba, Dorothy; Apina, Francis; Barnabas, Nomampondo; Contreras, Carmen; Elnour, Taharqa; Lee, Cynthia; Seaworth, Barbara; Shelly, Debra; Skipper, Natalie; dos Santos Filho, Ezio Tavora] Community Res Advisors Grp, New York, NY USA; [Frick, Mike Watson] Treatment Act Grp, New York, NY 10016 USA		Frick, MW (corresponding author), Treatment Act Grp, 261 5th Ave Suite 2110, New York, NY 10016 USA.	mike.frick@treatmentactiongroup.org						Diacon A, 2014, 2014 C RETR OPP INF; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Edney A., 2012, BLOOMBERG NEWS; FDA. Division of Anti-Infective Products. Office of Antimicrobial Products, 2012, FDA ANT DRUGS ADV CO; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Lessem E., 2013, ACTIVISTS GUIDE BEDA; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Pietersen E, 2014, LANCET, V383, P1230, DOI 10.1016/S0140-6736(13)62675-6; World Health Organization (WHO), 2013, WHONMHNHDEPG131	9	13	14	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2015	385	9966					477	479		10.1016/S0140-6736(14)60523-7	http://dx.doi.org/10.1016/S0140-6736(14)60523-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CT	25018118				2022-12-01	WOS:000348509900035
J	Radford, EJ; Ito, M; Shi, H; Corish, JA; Yamazawa, K; Isganaitis, E; Seisenberger, S; Hore, TA; Reik, W; Erkek, S; Peters, AHFM; Patti, ME; Ferguson-Smith, AC				Radford, Elizabeth J.; Ito, Mitsuteru; Shi, Hui; Corish, Jennifer A.; Yamazawa, Kazuki; Isganaitis, Elvira; Seisenberger, Stefanie; Hore, Timothy A.; Reik, Wolf; Erkek, Serap; Peters, Antoine H. F. M.; Patti, Mary-Elizabeth; Ferguson-Smith, Anne C.			In utero undernourishment perturbs the adult sperm methylome and intergenerational metabolism	SCIENCE			English	Article							LOW-BIRTH-WEIGHT; PROMOTER DNA METHYLATION; EMBRYONIC STEM-CELLS; TRANSGENERATIONAL INHERITANCE; ACTIVATING MUTATIONS; EPIGENETIC MEMORY; GENE-EXPRESSION; C. ELEGANS; MOUSE; GENOME	Adverse prenatal environments can promote metabolic disease in offspring and subsequent generations. Animal models and epidemiological data implicate epigenetic inheritance, but the mechanisms remain unknown. In an intergenerational developmental programming model affecting F-2 mouse metabolism, we demonstrate that the in utero nutritional environment of F-1 embryos alters the germline DNA methylome of F-1 adult males in a locus-specific manner. Differentially methylated regions are hypomethylated and enriched in nucleosome-retaining regions. A substantial fraction is resistant to early embryo methylation reprogramming, which may have an impact on F-2 development. Differential methylation is not maintained in F-2 tissues, yet locus-specific expression is perturbed. Thus, in utero nutritional exposures during critical windows of germ cell development can impact the male germline methylome, associated with metabolic disease in offspring.	[Radford, Elizabeth J.; Ito, Mitsuteru; Shi, Hui; Corish, Jennifer A.; Yamazawa, Kazuki; Ferguson-Smith, Anne C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Isganaitis, Elvira; Patti, Mary-Elizabeth] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Isganaitis, Elvira; Patti, Mary-Elizabeth] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Seisenberger, Stefanie; Hore, Timothy A.; Reik, Wolf] Babraham Inst, Cambridge, England; [Seisenberger, Stefanie; Hore, Timothy A.; Reik, Wolf] Wellcome Trust Sanger Inst, Cambridge, England; [Erkek, Serap; Peters, Antoine H. F. M.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Erkek, Serap; Peters, Antoine H. F. M.] Univ Basel, Fac Sci, Basel, Switzerland; [Erkek, Serap] Swiss Inst Bioinformat, Basel, Switzerland	University of Cambridge; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Wellcome Trust Sanger Institute; Friedrich Miescher Institute for Biomedical Research; University of Basel; Swiss Institute of Bioinformatics	Patti, ME (corresponding author), Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.	mary.elizabeth.patti@joslin.harvard.edu; afsmith@mole.bio.cam.ac.uk	Shi, Hui/Z-1004-2019; Peters, Antoine/ABA-6283-2020; Reik, Wolf/I-6794-2012; Erkek, Serap/AAV-5549-2020	Shi, Hui/0000-0001-9126-4607; Radford, Elizabeth/0000-0002-7829-5422; Peters, Antoine/0000-0002-0311-1887; Isganaitis, Elvira/0000-0003-3477-0305; Yamazawa, Kazuki/0000-0003-4895-2759; Reik, Wolf/0000-0003-0216-9881; Ferguson-Smith, Anne/0000-0002-7608-5894; Erkek, Serap/0000-0003-4439-5203; Hore, Timothy/0000-0002-6735-225X	U.K. Medical Research Council; Wellcome Trust; European Commission FP7, EpiGeneSys; European Commission FP7, EpiHealth; Pediatric Endocrine Society; Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH; American Diabetes Association; Graetz Foundation; NIH [P30DK036836]; Novartis Research Foundation; BBSRC [BBS/E/B/0000S266, BBS/E/B/000C0402] Funding Source: UKRI; MRC [MR/J001597/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0402, BBS/E/B/0000S266] Funding Source: researchfish; Medical Research Council [MR/J001597/1] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD064793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25713040] Funding Source: KAKEN	U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission FP7, EpiGeneSys; European Commission FP7, EpiHealth; Pediatric Endocrine Society; Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American Diabetes Association(American Diabetes Association); Graetz Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Research Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to members of the Ferguson-Smith and Patti labs for useful discussions of this work and to K. Tabbada and D. Oxley for expert technical assistance with Illumina sequencing and mass spectrometry. Work was supported by grants from the U.K. Medical Research Council; Wellcome Trust; and European Commission FP7, EpiGeneSys and EpiHealth (to A.C.F.-S.), from the Pediatric Endocrine Society and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH (to E.I.), and from the American Diabetes Association, the Graetz Foundation, and NIH P30DK036836 (to M.-E.P.). W.R. is a consultant for Cambridge Epigenetix. The MeDIP-Seq data sets have been deposited in GEO with accession number GSE58747. A.H.F.M.P. and S.E. are funded by the Novartis Research Foundation.	Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; BRUNO JF, 1994, ENDOCRINOLOGY, V135, P1787, DOI 10.1210/en.135.5.1787; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Drake AJ, 2004, J ENDOCRINOL, V180, P1, DOI 10.1677/joe.0.1800001; Erkek S, 2013, NAT STRUCT MOL BIOL, V20, P868, DOI 10.1038/nsmb.2599; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Isganaitis E, 2009, DIABETES, V58, P1192, DOI 10.2337/db08-1266; Iwanaga T, 2011, BIOMED RES-TOKYO, V32, P73, DOI 10.2220/biomedres.32.73; Jimenez-Chillaron JC, 2005, DIABETES, V54, P702, DOI 10.2337/diabetes.54.3.702; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Laukkanen O, 2004, J CLIN ENDOCR METAB, V89, P6286, DOI 10.1210/jc.2004-1204; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Taiwo O, 2012, NAT PROTOC, V7, P617, DOI 10.1038/nprot.2012.012; Takeuchi T, 2011, ANAL CELL PATHOL, V34, P113, DOI [10.1155/2011/578097, 10.3233/ACP-2011-009]; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wei YC, 2014, P NATL ACAD SCI USA, V111, P1873, DOI 10.1073/pnas.1321195111; Woo M, 2011, STEM CELLS DEV, V20, P1763, DOI 10.1089/scd.2010.0349; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	42	424	437	6	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					785	+	1255903	10.1126/science.1255903	http://dx.doi.org/10.1126/science.1255903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6ZT	25011554	Green Accepted			2022-12-01	WOS:000349776300001
J	Wagner, TA; McLaughlin, S; Garg, K; Cheung, CYK; Larsen, BB; Styrchak, S; Huang, HC; Edlefsen, PT; Mullins, JI; Frenkel, LM				Wagner, Thor A.; McLaughlin, Sherry; Garg, Kavita; Cheung, Charles Y. K.; Larsen, Brendan B.; Styrchak, Sheila; Huang, Hannah C.; Edlefsen, Paul T.; Mullins, James I.; Frenkel, Lisa M.			Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GENOME-WIDE ANALYSIS; ANTIRETROVIRAL THERAPY; LATENT RESERVOIR; T-CELLS; REPLICATION; EXPRESSION; MUTATIONS; LANDSCAPE; SELECTION	Antiretroviral treatment (ART) of HIV infection suppresses viral replication. Yet if ART is stopped, virus reemerges because of the persistence of infected cells. We evaluated the contribution of infected-cell proliferation and sites of proviral integration to HIV persistence. A total of 534 HIV integration sites (IS) and 63 adjacent HIV env sequences were derived from three study participants over 11.3 to 12.7 years of ART. Each participant had identical viral sequences integrated at the same position in multiple cells, demonstrating infected-cell proliferation. Integrations were overrepresented in genes associated with cancer and favored in 12 genes across multiple participants. Over time on ART, a greater proportion of persisting proviruses were in proliferating cells. HIV integration into specific genes may promote proliferation of HIV-infected cells, slowing viral decay during ART.	[Wagner, Thor A.; McLaughlin, Sherry; Styrchak, Sheila; Huang, Hannah C.; Frenkel, Lisa M.] Seattle Childrens Res Inst, Seattle, WA 98101 USA; [Wagner, Thor A.; McLaughlin, Sherry; Larsen, Brendan B.; Edlefsen, Paul T.; Mullins, James I.; Frenkel, Lisa M.] Univ Washington, Seattle, WA 98195 USA; [Garg, Kavita; Cheung, Charles Y. K.; Edlefsen, Paul T.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Frenkel, LM (corresponding author), Seattle Childrens Res Inst, 1900 9th Ave, Seattle, WA 98101 USA.	lfrenkel@uw.edu			Molecular Profiling and Computational Biology Core of the University of Washington's Center for AIDS Research [P30 AI027757]; Canadian Institutes of Health (HIV/AIDS Research Initiative award) [201311CVI-322424-244686];  [R01AI091550];  [K23AI077357];  [R01 AI111806]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, R01AI091550, P01AI057005, K23AI077357, R01AI111806] Funding Source: NIH RePORTER	Molecular Profiling and Computational Biology Core of the University of Washington's Center for AIDS Research; Canadian Institutes of Health (HIV/AIDS Research Initiative award); ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to express gratitude to the study participants who donated their time and provided specimens, and to N. H. Tobin, A. J. Melvin, and K. M. Mohan for their contributions to this study. Additionally, we thank Y. C. Ho, R. and J. Siliciano, H. Imamichi and C. Lane, and N. Malani and F. Bushman for providing their HIV integration site data. HIV env sequences generated from specific integration sites were deposited in GenBank under accession numbers (KM025062 to KM025124 and KM201287 to KM201295). Additional HIV env sequences were deposited in GenBank under accession numbers AY075701 to AY077450 (44), AY483287 to AY484389 (2), and KC314011 to KC315287 (8). Sequences of HIV-3'-LTR and adjacent chromosome integration sites are available in table S3. Other data are tabulated in the main paper and in the supplementary materials. Integration site sequences and HIV sequence alignments are available for download at http://mullinslab.microbiol.washington.edu/publications/supplemental.html. These studies were funded by R01AI091550 (L. M. F.), K23AI077357 (T. A. W.), R01 AI111806 (J. I. M.), the Molecular Profiling and Computational Biology Core of the University of Washington's Center for AIDS Research (P30 AI027757), and the Canadian Institutes of Health (HIV/AIDS Research Initiative award 201311CVI-322424-244686) (C. Y. K. C.). We wish to thank A. Embry and D. Lawrence at the National Institutes of Health for their support. The authors report no conflicts of interest related to this research.	Anderson JA, 2011, J VIROL, V85, P5220, DOI 10.1128/JVI.00284-11; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Eipers PG, 2011, VIROLOGY, V410, P151, DOI 10.1016/j.virol.2010.11.001; Fan H, 2011, VIRUSES-BASEL, V3, P398, DOI 10.3390/v3040398; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Frenkel LM, 2003, J VIROL, V77, P5721, DOI 10.1128/JVI.77.10.5721-5730.2003; Friedman J, 2011, J VIROL, V85, P9078, DOI 10.1128/JVI.00836-11; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; Han YF, 2004, J VIROL, V78, P6122, DOI 10.1128/JVI.78.12.6122-6133.2004; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Ikeda T, 2007, J INFECT DIS, V195, P716, DOI 10.1086/510915; Imai K, 2010, J BIOL CHEM, V285, P16538, DOI 10.1074/jbc.M110.103531; Imamichi H., 2014, AIDS, V1; Josefsson L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003432; Soto MJ, 2011, AIDS RES HUM RETROV, V27, P547, DOI 10.1089/aid.2010.0182; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kuwahara M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4555; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Lewinski MK, 2005, J VIROL, V79, P6610, DOI 10.1128/JVI.79.11.6610-6619.2005; Liu JH, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-2; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Mok HP, 2007, GENE THER, V14, P741, DOI 10.1038/sj.gt.3302923; Persaud D, 2004, J VIROL, V78, P968, DOI 10.1128/JVI.78.2.968-979.2004; Plaisier CL, 2012, GENOME RES, V22, P2302, DOI 10.1101/gr.133991.111; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Sherrill-Mix S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-90; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Swaminathan S, 2013, NAT MED, V19, P1014, DOI 10.1038/nm.3247; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; Tsukumo S, 2013, P NATL ACAD SCI USA, V110, P10735, DOI 10.1073/pnas.1306691110; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wagner TA, 2013, J VIROL, V87, P1770, DOI 10.1128/JVI.01985-12; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937	45	426	432	6	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					570	573		10.1126/science.1256304	http://dx.doi.org/10.1126/science.1256304			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25011556	Green Accepted			2022-12-01	WOS:000339651300047
J	Sabo, A; Kress, TR; Pelizzola, M; de Pretis, S; Gorski, MM; Tesi, A; Morelli, MJ; Bora, P; Doni, M; Verrecchia, A; Tonelli, C; Faga, G; Bianchi, V; Ronchi, A; Low, D; Muller, H; Guccione, E; Campaner, S; Amati, B				Sabo, Arianna; Kress, Theresia R.; Pelizzola, Mattia; de Pretis, Stefano; Gorski, Marcin M.; Tesi, Alessandra; Morelli, Marco J.; Bora, Pranami; Doni, Mirko; Verrecchia, Alessandro; Tonelli, Claudia; Faga, Giovanni; Bianchi, Valerio; Ronchi, Alberto; Low, Diana; Mueller, Heiko; Guccione, Ernesto; Campaner, Stefano; Amati, Bruno			Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis	NATURE			English	Article							C-MYC; IN-VIVO; EXPRESSION ANALYSIS; MAMMALIAN GENOMES; PROTEIN-SYNTHESIS; GLOBAL REGULATION; GENE-EXPRESSION; RNA-SEQ; CHROMATIN; CELLS	The c-myc proto-oncogene product, Myc, is a transcription factor that binds thousands of genomic loci(1). Recent work suggested that rather than up-and downregulating selected groups of genes(1-3), Myc targets all active promoters and enhancers in the genome (a phenomenon termed 'invasion') and acts as a general amplifier of transcription(4,5). However, the available data did not readily discriminate between direct and indirect effects of Myc on RNA biogenesis. We addressed this issue with genome-wide chromatin immunoprecipitation and RNA expression profiles during B-cell lymphomagenesis in mice, in cultured B cells and fibroblasts. Consistent with long-standing observations(6), we detected general increases in total RNA or messenger RNA copies per cell (hereby termed 'amplification')(4,5) when comparing actively proliferating cells with control quiescent cells: this was true whether cells were stimulated by mitogens (requiring endogenous Myc for a proliferative response)(7,8) or by deregulated, oncogenic Myc activity. RNA amplification and promoter/enhancer invasion by Myc were separable phenomena that could occur without one another. Moreover, whether or not associated with RNA amplification, Myc drove the differential expression of distinct subsets of target genes. Hence, although having the potential to interact with all active or poised regulatory elements in the genome(4,5,9-11), Myc does not directly act as a global transcriptional amplifier(4,5). Instead, our results indicate that Myc activates and represses transcription of discrete gene sets, leading to changes in cellular state that can in turn feed back on global RNA production and turnover.	[Sabo, Arianna; Kress, Theresia R.; Pelizzola, Mattia; de Pretis, Stefano; Tesi, Alessandra; Morelli, Marco J.; Bora, Pranami; Bianchi, Valerio; Ronchi, Alberto; Mueller, Heiko; Campaner, Stefano; Amati, Bruno] Fdn Ist Italiano Tecnol IIT, Ctr Genom Sci IIT SEMM, I-20139 Milan, Italy; [Sabo, Arianna; Kress, Theresia R.; Gorski, Marcin M.; Doni, Mirko; Verrecchia, Alessandro; Tonelli, Claudia; Faga, Giovanni; Amati, Bruno] European Inst Oncol IEO, Dept Expt Oncol, I-20139 Milan, Italy; [Low, Diana; Guccione, Ernesto] Inst Mol & Cell Biol, Singapore 138673, Singapore	Istituto Italiano di Tecnologia - IIT; IRCCS European Institute of Oncology (IEO); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Amati, B (corresponding author), Fdn Ist Italiano Tecnol IIT, Ctr Genom Sci IIT SEMM, Via Adamello 16, I-20139 Milan, Italy.	bruno.amati@iit.it	Morelli, Marco/AAN-1879-2020; Doni, Mirko/AAN-6027-2020; Doni, Mirko/ABA-9174-2021; de Pretis, Stefano/T-9728-2019; Sabò, Arianna/J-9531-2018; Faga, Giovanni/AAB-5540-2021; Verrecchia, Alessandro/AAQ-6454-2020; Amati, Bruno/AAM-3418-2020	Morelli, Marco/0000-0003-1862-667X; Doni, Mirko/0000-0001-7099-2701; Sabò, Arianna/0000-0002-9542-0045; Verrecchia, Alessandro/0000-0002-8596-6650; Low, Diana/0000-0002-6054-8524; Pelizzola, Mattia/0000-0001-6672-9636; Gorski, Marcin M./0000-0002-8276-3866; CAMPANER, Stefano/0000-0003-4547-6849; de Pretis, Stefano/0000-0003-1103-7688; Tonelli, Claudia/0000-0002-5626-3403; Bianchi, Valerio/0000-0001-9025-7923; Muller, Heiko/0000-0001-9873-3146; Amati, Bruno/0000-0002-2958-1799	European School of Molecular Medicine; European Community [305626, 200720, 259743]; European Research Council; Association for International Cancer Research (AICR); Italian Health Ministry; Fondazione Cariplo; Italian Association for Cancer Research (AIRC); Worldwide Cancer Research [10-0245] Funding Source: researchfish	European School of Molecular Medicine; European Community; European Research Council(European Research Council (ERC)European Commission); Association for International Cancer Research (AICR); Italian Health Ministry; Fondazione Cariplo(Fondazione Cariplo); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Worldwide Cancer Research	We thank A. Piontini, P. Nicoli, A. Gobbi and M. Capillo for their help with the management of mouse colonies; S. Bianchi, L. Rotta and T. Capra for assistance with the Illumina HiSeq and NanoString platforms; S. Barozzi, A. Oldani and D. Parazzoli for assistance with imaging technologies; S. Bonifacio and G. Diaferia for discussions about DNase I sequencing; and G. Natoli for comments on the manuscript. We are grateful to C.-L. Wei and collaborators (Genome Institute of Singapore) for the sequencing of ChIP-seq samples in a preliminary phase of this study. T.R.K. was supported by the Structured International Post Doc program of the European School of Molecular Medicine. This work was supported by funding from the European Community's Seventh Framework Programme (FP7/2007-2013), project RADIANT (grant agreement no. 305626) to M.P. and projects EuroSystem (grant agreement no. 200720) and MODHEP (grant agreement no. 259743) to B.A., as well as grants from the European Research Council, the Association for International Cancer Research (AICR), the Italian Health Ministry, Fondazione Cariplo and the Italian Association for Cancer Research (AIRC) to B.A.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Dang CV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014217; DARZYNKIEWICZ Z, 1980, CYTOMETRY, V1, P98, DOI 10.1002/cyto.990010203; das Neves RP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000560; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Ehrensberger AH, 2013, CELL, V154, P713, DOI 10.1016/j.cell.2013.07.032; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fan JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009691; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerondakis S, 2007, IMMUNOL CELL BIOL, V85, P471, DOI 10.1038/sj.icb.7100097; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Graves JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037699; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Guertin MJ, 2013, CURR OPIN GENET DEV, V23, P116, DOI 10.1016/j.gde.2012.11.008; He HSHS, 2012, GENOME RES, V22, P1015, DOI 10.1101/gr.133280.111; Herkert Barbara, 2010, Genes Cancer, V1, P580, DOI 10.1177/1947601910379012; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Kouzine F, 2013, CELL, V153, P988, DOI 10.1016/j.cell.2013.04.033; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Marguerat S, 2012, TRENDS GENET, V28, P560, DOI 10.1016/j.tig.2012.07.003; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murn J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-323; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Perna D, 2012, ONCOGENE, V31, P1695, DOI 10.1038/onc.2011.359; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rounbehler RJ, 2012, CELL, V150, P563, DOI 10.1016/j.cell.2012.06.033; Sabo A, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014191; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Yustein JT, 2010, P NATL ACAD SCI USA, V107, P3534, DOI 10.1073/pnas.0901230107; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	56	306	315	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					488	+		10.1038/nature13537	http://dx.doi.org/10.1038/nature13537			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25043028	Green Accepted			2022-12-01	WOS:000339335700051
J	Servick, K				Servick, Kelly			Top heart lab comes under fire	SCIENCE			English	Editorial Material																			0	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					254	254		10.1126/science.345.6194.254	http://dx.doi.org/10.1126/science.345.6194.254			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035470				2022-12-01	WOS:000339400700016
J	Conway, TM; John, SG				Conway, Tim M.; John, Seth G.			Quantification of dissolved iron sources to the North Atlantic Ocean	NATURE			English	Article							CONTINENTAL-SHELF; AEROSOL IRON; ISOTOPES; SEAWATER; DUST; FE; CONSTRAINTS; CYCLE; FLUX	Dissolved iron is an essential micronutrient for marine phytoplankton, and its availability controls patterns of primary productivity and carbon cycling throughout the oceans(1,2). The relative importance of different sources of iron to the oceans is not well known, however, and flux estimates from atmospheric dust, hydrothermal vents and oceanic sediments vary by orders of magnitude. Here we present a high-resolution transect of dissolved stable iron isotope ratios (delta Fe-56) and iron concentrations ([Fe]) along a section of the North Atlantic Ocean. The different iron sources can be identified by their unique delta Fe-56 signatures, which persist throughout the water column. This allows us to calculate the relative contribution from dust, hydrothermal venting and reductive and non-reductive sedimentary release to the dissolved phase. We find that Saharan dust aerosol is the dominant source of dissolved iron along the section, contributing 71-87 per cent of dissolved iron. Additional sources of iron are non-reductive release from oxygenated sediments on the North American margin (10-19 per cent), reductive sedimentary dissolution on the African margin (1-4 per cent) and hydrothermal venting at the Mid-Atlantic Ridge (2-6 per cent). Our data also indicate that hydrothermal vents in the North Atlantic are a source of isotopically light iron, which travels thousands of kilometres from vent sites, potentially influencing surface productivity. Changes in the relative importance of the different iron sources through time may affect interactions between the carbon cycle and climate.	[Conway, Tim M.; John, Seth G.] Univ S Carolina, Dept Earth & Ocean Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Conway, TM (corresponding author), ETH, Inst Geochem & Petrol, NWD81-4,Clausiusstr 25, CH-8092 Zurich, Switzerland.	conway.tm@gmail.com		John, Seth/0000-0002-8257-626X	National Science Foundation [OCE-1131387]	National Science Foundation(National Science Foundation (NSF))	We thank the Captain, crew and GEOTRACES sampling team on RV Knorr on both USGT10 and USGT11; A. Rosenberg for technical assistance; J. Wu, R. Middag, K. Bruland and P. Sedwick for supplying concentration data that informed double-spike calculations; and C. Hayes for calibrating transmissometry data. We thank W. Jenkins, W. Smethie, E. Boyle and G. Cutter for water mass observations. The Ocean Data Facility supplied temperature, PSS-78 salinity, fluorescence, transmissometry, dissolved oxygen and nutrient data from both cruises. Figures were created with Matlab and Adobe Illustrator. This study was funded by National Science Foundation grant OCE-1131387.	Beard BL, 2003, GEOLOGY, V31, P629, DOI 10.1130/0091-7613(2003)031<0629:IICOFC>2.0.CO;2; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/ngeo964, 10.1038/NGEO964]; Carazzo G, 2013, EARTH PLANET SC LETT, V382, P66, DOI 10.1016/j.epsl.2013.09.008; Conway TM, 2013, ANAL CHIM ACTA, V793, P44, DOI 10.1016/j.aca.2013.07.025; Elrod VA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020216; Fitzsimmons JN, 2013, MAR CHEM, V154, P87, DOI 10.1016/j.marchem.2013.05.009; Homoky WB, 2009, GEOLOGY, V37, P751, DOI 10.1130/G25731A.1; Homoky WB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3143; Ilina SM, 2013, GEOCHIM COSMOCHIM AC, V101, P96, DOI 10.1016/j.gca.2012.10.023; Jeandel C., 2011, EOS, V92, P217, DOI DOI 10.1029/2011E0260001; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; John SG, 2012, GEOCHIM COSMOCHIM AC, V93, P14, DOI 10.1016/j.gca.2012.06.003; John SG, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004043; John SG, 2010, MAR CHEM, V119, P65, DOI 10.1016/j.marchem.2010.01.001; Kohfeld KE, 2009, GEOPHYS MONOGR SER, V187, P251, DOI 10.1029/2008GM000845; Lacan F, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035841; Lacan F, 2010, ANAL CHEM, V82, P7103, DOI 10.1021/ac1002504; Mahowald NM, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002402; Mead C, 2013, GEOPHYS RES LETT, V40, P5722, DOI 10.1002/2013GL057713; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; Palter JB, 2005, NATURE, V437, P687, DOI 10.1038/nature03969; Radic A, 2011, EARTH PLANET SC LETT, V306, P1, DOI 10.1016/j.epsl.2011.03.015; Saito MA, 2013, NAT GEOSCI, V6, P775, DOI [10.1038/ngeo1893, 10.1038/NGEO1893]; Severmann S, 2004, EARTH PLANET SC LETT, V225, P63, DOI 10.1016/j.epsl.2004.06.001; Tagliabue A, 2010, NAT GEOSCI, V3, P252, DOI 10.1038/NGEO818; Toner BM, 2012, OCEANOGRAPHY, V25, P209, DOI 10.5670/oceanog.2012.19; Toner BM, 2009, NAT GEOSCI, V2, P197, DOI 10.1038/NGEO433; Waeles M, 2007, ENVIRON CHEM, V4, P233, DOI 10.1071/EN07013	28	238	254	18	295	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					212	+		10.1038/nature13482	http://dx.doi.org/10.1038/nature13482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008528				2022-12-01	WOS:000338649800041
J	Mayer-Barber, KD; Andrade, BB; Oland, SD; Amaral, EP; Barber, DL; Gonzales, J; Derrick, SC; Shi, RR; Kumar, NP; Wei, W; Yuan, X; Zhang, GL; Cai, Y; Babu, S; Catalfamo, M; Salazar, AM; Via, LE; Barry, CE; Sher, A				Mayer-Barber, Katrin D.; Andrade, Bruno B.; Oland, Sandra D.; Amaral, Eduardo P.; Barber, Daniel L.; Gonzales, Jacqueline; Derrick, Steven C.; Shi, Ruiru; Kumar, Nathella Pavan; Wei, Wang; Yuan, Xing; Zhang, Guolong; Cai, Ying; Babu, Subash; Catalfamo, Marta; Salazar, Andres M.; Via, Laura E.; Barry, Clifton E., III; Sher, Alan			Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk	NATURE			English	Article							NECROSIS-FACTOR-ALPHA; MYCOBACTERIUM-TUBERCULOSIS; INDUCTION; SUSCEPTIBILITY; INFLAMMATION; INFECTION; IMMUNITY; INNATE	Tuberculosis remains second only to HIV/AIDS as the leading cause of mortality worldwide due to a single infectious agent(1). Despite chemotherapy, the global tuberculosis epidemic has intensified because of HIV co-infection, the lack of an effective vaccine and the emergence of multi-drug-resistant bacteria(2-5). Alternative host-directed strategies could be exploited to improve treatment efficacy and outcome, contain drug-resistant strains and reduce disease severity and mortality(6). The innate inflammatory response elicited by Mycobacterium tuberculosis (Mtb) represents a logical host target(7). Here we demonstrate that interleukin-1 (IL-1) confers host resistance through the induction of eicosanoids that limit excessive type I interferon (IFN) production and foster bacterial containment. We further show that, in infected mice and patients, reduced IL-1 responses and/or excessive type I IFN induction are linked to an eicosanoid imbalance associated with disease exacerbation. Host-directed immunotherapy with clinically approved drugs that augment prostaglandin E2 levels in these settings prevented acute mortality of Mtb-infected mice. Thus, IL-1 and type I IFNs represent two major counter-regulatory classes of inflammatory cytokines that control the outcome of Mtb infection and are functionally linked via eicosanoids. Our findings establish proof of concept for host-directed treatment strategies that manipulate the host eicosanoid network and represent feasible alternatives to conventional chemotherapy.	[Mayer-Barber, Katrin D.; Andrade, Bruno B.; Oland, Sandra D.; Amaral, Eduardo P.; Sher, Alan] NIAID, Immunobiol Sect, LPD, NIH, Bethesda, MD 20892 USA; [Amaral, Eduardo P.] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, BR-05508900 Sao Paulo, Brazil; [Barber, Daniel L.] NIAID, Lymphocyte Biol Unit T, LPD, NIH, Bethesda, MD 20892 USA; [Gonzales, Jacqueline; Via, Laura E.; Barry, Clifton E., III] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Derrick, Steven C.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; [Shi, Ruiru; Wei, Wang; Yuan, Xing] Henan Chest Hosp, Zhengzhou 450003, Peoples R China; [Kumar, Nathella Pavan; Babu, Subash] Int Ctr Excellence Res, NIH, Madras 600031, Tamil Nadu, India; [Kumar, Nathella Pavan] NIRT, Madras 600031, Tamil Nadu, India; [Zhang, Guolong] SinoUS Int Res Ctr TB, Zhengzhou 450003, Peoples R China; [Zhang, Guolong] Henan Publ Hlth Ctr, Zhengzhou 450003, Peoples R China; [Babu, Subash] NIAID, Helminth Immunol Sect, LPD, NIH, Bethesda, MD 20892 USA; [Catalfamo, Marta] NIAID, Clin & Mol Retrovirol Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Salazar, Andres M.] Oncovir Inc, Washington, DC 20008 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade de Sao Paulo; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); US Food & Drug Administration (FDA); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mayer-Barber, KD (corresponding author), NIAID, Immunobiol Sect, LPD, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mayerk@niaid.nih.gov	Zhang, Guolong/HCI-5587-2022; Via, Laura/AAD-3917-2021; Barry, Clifton E/H-3839-2012; Babu, Subash/GXG-4746-2022; Andrade, Bruno/J-9111-2012; Amaral, Eduardo EP/M-2456-2014; Andrade, Bruno/AAI-2248-2020; Kumar, Nathella Pavan/AAU-2328-2021; Barry, Clifton E/ABE-7992-2020	Via, Laura/0000-0001-6074-9521; Barry, Clifton E/0000-0002-2927-270X; Andrade, Bruno/0000-0001-6833-3811; Amaral, Eduardo EP/0000-0001-5465-8113; Barry, Clifton E/0000-0002-2927-270X	NIAID Intramural Research program; Concept Acceleration Program-Award from DMID, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001171, ZIAAI001065, ZIAAI000783, ZIAAI001044, ZIAAI001081, ZIAAI000734] Funding Source: NIH RePORTER	NIAID Intramural Research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Concept Acceleration Program-Award from DMID, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIAID Intramural Research program and a Concept Acceleration Program-Award (K.D.M.-B., B.B.A. and A.S.) from DMID, NIAID. We are grateful to K. Elkins, S. Morris, M. Belcher as well as the NIAID ABSL3 support staff for facilitating our animal studies. We thank R. Chen, L. Goldfeder and Q. Gao for sharing their clinical trial expertise and research facilities, respectively. We also thank K. Kauffman, R. Thompson, S. Hieny, P. Dayal, D. Surman, L. Meng, Z. Li, L. Lifa, Q. Shen and Z. Huang for technical assistance, H. Boshoff for help with direct anti-mycobacterial activity assays and M. S. Jawahar, V. V. Banurekha and R. Sridhar for recruitment and clinical evaluation of patients in Chennai, India. We are grateful to F. Andrade Neto, H. Remold, K. Arora, J. Aliberti, M. Moayeri, P. Murphy, A. O'Garra, R. Germain and C. Serhan for discussion or critical reading of the manuscript. Finally, we thank the patients, volunteer participants, and clinical staff of the Tuberculosis department of Henan Chest Hospital in Zhengzhou, China and the Department of Clinical Research (NIRT) and Department of Thoracic Medicine (Government Stanley Medical Hospital) in Chennai, India for their participation in our clinical studies.	Andrade BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062618; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Bafica A, 2005, J CLIN INVEST, V115, P1601, DOI 10.1172/JCI23949; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bishai W, 2013, NAT MED, V19, P410, DOI 10.1038/nm.3153; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Humason G. L., 1979, ANIMAL TISSUE TECHNI, P355; Kaufmann SHE, 2013, CURR OPIN IMMUNOL, V25, P441, DOI 10.1016/j.coi.2013.05.005; Kirtikara K, 1998, J EXP MED, V187, P517, DOI 10.1084/jem.187.4.517; Kuo HP, 2000, AM J RESP CRIT CARE, V161, P192, DOI 10.1164/ajrccm.161.1.9902113; Law K, 1996, AM J RESP CRIT CARE, V153, P799, DOI 10.1164/ajrccm.153.2.8564135; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Nathan C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003081; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Ottenhoff THM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045839; Rayamajhi M, 2010, VIRULENCE, V1, P418, DOI 10.4161/viru.1.5.12787; Redford PS, 2014, J INFECT DIS, V209, P270, DOI 10.1093/infdis/jit424; Rousu J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003018; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Tsao T.C.Y., 1999, Tubercle and Lung Disease, V79, P279, DOI 10.1054/tuld.1999.0215; Wang C H, 2001, Respirology, V6, P79	32	480	495	1	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					99	U491		10.1038/nature13489	http://dx.doi.org/10.1038/nature13489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990750	Green Published, Green Accepted			2022-12-01	WOS:000338199400044
J	Boissan, M; Montagnac, G; Shen, QF; Griparic, L; Guitton, J; Romao, M; Sauvonnet, N; Lagache, T; Lascu, I; Raposo, G; Desbourdes, C; Schlattner, U; Lacombe, ML; Polo, S; van der Bliek, AM; Roux, A; Chavrier, P				Boissan, Mathieu; Montagnac, Guillaume; Shen, Qinfang; Griparic, Lorena; Guitton, Jerome; Romao, Maryse; Sauvonnet, Nathalie; Lagache, Thibault; Lascu, Ioan; Raposo, Graca; Desbourdes, Celine; Schlattner, Uwe; Lacombe, Marie-Lise; Polo, Simona; van der Bliek, Alexander M.; Roux, Aurelien; Chavrier, Philippe			Nucleoside diphosphate kinases fuel dynamin superfamily proteins with GTP for membrane remodeling	SCIENCE			English	Article							FISSION; CARDIOLIPIN; MECHANISM; HOMOLOG; RINGS; NM23; AWD	Dynamin superfamily molecular motors use guanosine triphosphate (GTP) as a source of energy for membrane-remodeling events. We found that knockdown of nucleoside diphosphate kinases (NDPKs) NM23-H1/H2, which produce GTP through adenosine triphosphate (ATP)-driven conversion of guanosine diphosphate (GDP), inhibited dynamin-mediated endocytosis. NM23-H1/H2 localized at clathrin-coated pits and interacted with the proline-rich domain of dynamin. In vitro, NM23-H1/H2 were recruited to dynamin-induced tubules, stimulated GTP-loading on dynamin, and triggered fission in the presence of ATP and GDP. NM23-H4, a mitochondria-specific NDPK, colocalized with mitochondrial dynamin-like OPA1 involved in mitochondria inner membrane fusion and increased GTP-loading on OPA1. Like OPA1 loss of function, silencing of NM23-H4 but not NM23-H1/H2 resulted in mitochondrial fragmentation, reflecting fusion defects. Thus, NDPKs interact with and provide GTP to dynamins, allowing these motor proteins to work with high thermodynamic efficiency.	[Boissan, Mathieu; Montagnac, Guillaume; Romao, Maryse; Raposo, Graca; Chavrier, Philippe] Inst Curie, Res Ctr, Paris, France; [Boissan, Mathieu; Montagnac, Guillaume; Chavrier, Philippe] CNRS, UMR 144, Paris, France; [Boissan, Mathieu; Lacombe, Marie-Lise] Univ Paris 06, Paris, France; [Boissan, Mathieu; Lacombe, Marie-Lise] INSERM, UMR S 938, St Antoine Res Ctr, Paris, France; [Shen, Qinfang; Griparic, Lorena; van der Bliek, Alexander M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Guitton, Jerome] Hosp Civils Lyon, Pierre Benite, France; [Guitton, Jerome] Univ Lyon, Lyon, France; [Romao, Maryse; Raposo, Graca] CNRS, UMR 144, Paris, France; [Sauvonnet, Nathalie] Inst Pasteur, Unite Biol Interact Cellulaires, Paris, France; [Lagache, Thibault] Inst Pasteur, Quantitat Image Anal Unit, Paris, France; [Lascu, Ioan] Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, F-33076 Bordeaux, France; [Desbourdes, Celine; Schlattner, Uwe] Univ Grenoble Alpes, Lab Fundamental & Appl Bioenerget, Grenoble, France; [Desbourdes, Celine; Schlattner, Uwe] INSERM, U1055, Grenoble, France; [Polo, Simona] Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy; [Polo, Simona] Univ Milan, Dipartimento Sci Salute, Milan, Italy; [Roux, Aurelien] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Roux, Aurelien] Swiss Natl Ctr Competence Res Program Chem Biol, Geneva, Switzerland	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); IFOM - FIRC Institute of Molecular Oncology; University of Milan; University of Geneva	Boissan, M (corresponding author), Inst Curie, Res Ctr, Paris, France.	mathieu.boissan@inserm.fr; philippe.chavrier@curie.fr	Schlattner, Uwe/D-1267-2009; CHAVRIER, Philippe/B-4707-2010; Polo, Simona/P-3509-2014; Lagache, Thibaut/AAC-1067-2020; Roux, Aurelien R/G-9541-2013; CHAVRIER, Philippe/AAG-2645-2020; Roux, Aurelien/AAU-1262-2021	Schlattner, Uwe/0000-0003-1159-5911; CHAVRIER, Philippe/0000-0002-7351-733X; Lagache, Thibaut/0000-0002-7033-4677; Roux, Aurelien R/0000-0002-6088-0711; CHAVRIER, Philippe/0000-0002-7351-733X; Roux, Aurelien/0000-0002-6088-0711; sauvonnet, nathalie/0000-0003-0306-3376; Guitton, Jerome/0000-0001-6180-5708; Raposo, graca/0000-0001-9590-1298; Polo, Simona/0000-0001-5536-9399	Institut Curie; CNRS; Fondation ARC pour la Recherche sur le Cancer; Groupement des Entreprises Francaises contre le Cancer; Fondation pour la Recherche Medicale; Human Frontier Science Program; Swiss National Fund for Research Grant; European Research Council	Institut Curie; CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Groupement des Entreprises Francaises contre le Cancer; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Human Frontier Science Program(Human Frontier Science Program); Swiss National Fund for Research Grant; European Research Council(European Research Council (ERC)European Commission)	We thank P. De Camilli, E. Smythe, and J. Bertoglio for reagents; S. L. Schmid and M. Mettlen for discussion; the Nikon Imaging Center@Institut Curie & Centre National de la Recherche Scientifique (CNRS) for image acquisition; and I. Hurbain for EM quantification. This work was supported by Institut Curie, CNRS, Fondation ARC pour la Recherche sur le Cancer, Groupement des Entreprises Francaises contre le Cancer, Fondation pour la Recherche Medicale, the Human Frontier Science Program, the Swiss National Fund for Research Grant, and the European Research Council.	Binns DD, 2000, BIOCHEMISTRY-US, V39, P7188, DOI 10.1021/bi000033r; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Dammai V, 2003, GENE DEV, V17, P2812, DOI 10.1101/gad.1096903; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Krishnan KS, 2001, NEURON, V30, P197, DOI 10.1016/S0896-6273(01)00273-2; Lascu I, 1997, J BIOL CHEM, V272, P15599, DOI 10.1074/jbc.272.25.15599; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Milon L, 2000, J BIOL CHEM, V275, P14264, DOI 10.1074/jbc.275.19.14264; Morlot S, 2012, CELL, V151, P619, DOI 10.1016/j.cell.2012.09.017; Nallamothu G, 2008, MOL CELL BIOL, V28, P1964, DOI 10.1128/MCB.01743-07; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Schlattner U, 2013, J BIOL CHEM, V288, P111, DOI 10.1074/jbc.M112.408633; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Tokarska-Schlattner M, 2008, J BIOL CHEM, V283, P26198, DOI 10.1074/jbc.M803132200; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072	21	92	93	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1510	1515		10.1126/science.1253768	http://dx.doi.org/10.1126/science.1253768			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970086	Green Accepted			2022-12-01	WOS:000337889900049
J	Stolper, DA; Lawson, M; Davis, CL; Ferreira, AA; Neto, EVS; Ellis, GS; Lewan, MD; Martini, AM; Tang, Y; Schoell, M; Sessions, AL; Eiler, JM				Stolper, D. A.; Lawson, M.; Davis, C. L.; Ferreira, A. A.; Santos Neto, E. V.; Ellis, G. S.; Lewan, M. D.; Martini, A. M.; Tang, Y.; Schoell, M.; Sessions, A. L.; Eiler, J. M.			Formation temperatures of thermogenic and biogenic methane	SCIENCE			English	Article							NATURAL-GAS GENERATION; ISOTOPE FRACTIONATION; PETROLEUM; CARBON; CONSTRAINTS; SHALE; OIL; OXIDATION; EXPULSION; KINETICS	Methane is an important greenhouse gas and energy resource generated dominantly by methanogens at low temperatures and through the breakdown of organic molecules at high temperatures. However, methane-formation temperatures in nature are often poorly constrained. We measured formation temperatures of thermogenic and biogenic methane using a "clumped isotope" technique. Thermogenic gases yield formation temperatures between 157 degrees and 221 degrees C, within the nominal gas window, and biogenic gases yield formation temperatures consistent with their comparatively lower-temperature formational environments (<50 degrees C). In systems where gases have migrated and other proxies for gas-generation temperature yield ambiguous results, methane clumped-isotope temperatures distinguish among and allow for independent tests of possible gas-formation models.	[Stolper, D. A.; Sessions, A. L.; Eiler, J. M.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Lawson, M.; Davis, C. L.] ExxonMobil Upstream Res Co, Houston, TX USA; [Ferreira, A. A.; Santos Neto, E. V.] Petrobras Res & Dev Ctr CENPES, Div Geochem, Rio De Janeiro, RJ, Brazil; [Ellis, G. S.; Lewan, M. D.] US Geol Survey, Denver Fed Ctr, Denver, CO 80225 USA; [Martini, A. M.] Amherst Coll, Dept Geol, Amherst, MA 01002 USA; [Tang, Y.] Power Environm & Energy Res Inst, Covina, CA USA; [Schoell, M.] GasConsult Int Inc, Berkeley, CA USA	California Institute of Technology; Exxon Mobil Corporation; Petrobras; United States Department of the Interior; United States Geological Survey; Amherst College	Stolper, DA (corresponding author), CALTECH, Div Geol & Planetary Sci, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	dstolper@caltech.edu	Sessions, Alex/ABC-9207-2020; Ellis, Geoffrey S/G-8970-2011	Sessions, Alex/0000-0001-6120-2763; Ellis, Geoffrey/0000-0003-4519-3320; Lawson, Michael/0000-0003-2743-3773	NSF; Petrobras; ExxonMobil; Caltech	NSF(National Science Foundation (NSF)); Petrobras(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP)Petrobras); ExxonMobil(Exxon Mobil Corporation); Caltech	This work was supported by the NSF, Petrobras, ExxonMobil, and Caltech. We thank Petrobras and ExxonMobil for providing samples and permission to publish, C. Araujo and B. Peterson for helpful discussions, and R. Burruss and three anonymous reviewers for helpful comments on the manuscript. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. All data used to support the conclusions in this manuscript are provided in the supplementary materials.	[Anonymous], 21665 UCID LAWR LIV; CLAYTON C, 1991, MAR PETROL GEOL, V8, P232, DOI 10.1016/0264-8172(91)90010-X; Curtis JB, 2002, AAPG BULL, V86, P1921, DOI 10.1306/61eeddbe-173e-11d7-8645000102c1865d; Eiler JM, 2007, EARTH PLANET SC LETT, V262, P309, DOI 10.1016/j.epsl.2007.08.020; ENGLAND WA, 1987, J GEOL SOC LONDON, V144, P327, DOI 10.1144/gsjgs.144.2.0327; ESPITALIE J, 1988, ORG GEOCHEM, V13, P893, DOI 10.1016/0146-6380(88)90243-4; Hammes U, 2011, AAPG BULL, V95, P1643, DOI 10.1306/02141110128; Hoering T., 1984, ORG GEOCHEM, V5, P267, DOI DOI 10.1016/0146-6380(84)90014-7; Hunt J.M., 1996, PETROLEUM GEOLOGY GE; Lash GG, 2011, AAPG BULL, V95, P61, DOI 10.1306/06301009150; Lewan MD, 2002, ORG GEOCHEM, V33, P1457, DOI 10.1016/S0146-6380(02)00182-1; Lewan MD, 1997, GEOCHIM COSMOCHIM AC, V61, P3691, DOI 10.1016/S0016-7037(97)00176-2; Lorant F, 1998, CHEM GEOL, V147, P249, DOI 10.1016/S0009-2541(98)00017-5; Mahlstedt N, 2012, MAR PETROL GEOL, V31, P27, DOI 10.1016/j.marpetgeo.2011.06.011; Mango FD, 1997, GEOCHIM COSMOCHIM AC, V61, P5347, DOI 10.1016/S0016-7037(97)00310-4; MANGO FD, 1994, NATURE, V368, P536, DOI 10.1038/368536a0; Martini AM, 1996, NATURE, V383, P155, DOI 10.1038/383155a0; Ni YY, 2011, GEOCHIM COSMOCHIM AC, V75, P2696, DOI 10.1016/j.gca.2011.02.016; PRICE LC, 1995, NATURE, V378, P368, DOI 10.1038/378368a0; Prinzhofer AA, 1995, CHEM GEOL, V126, P281, DOI 10.1016/0009-2541(95)00123-9; Prinzhofer A, 2010, MAR PETROL GEOL, V27, P1273, DOI 10.1016/j.marpetgeo.2010.03.004; QUIGLEY TM, 1988, NATURE, V333, P549, DOI 10.1038/333549a0; Scheller S, 2010, NATURE, V465, P606, DOI 10.1038/nature09015; SCHOELL M, 1983, AAPG BULL, V67, P2225; Seewald JS, 2003, NATURE, V426, P327, DOI 10.1038/nature02132; Seewald JS, 1998, GEOCHIM COSMOCHIM AC, V62, P1599, DOI 10.1016/S0016-7037(98)00000-3; Stolper DA, 2014, GEOCHIM COSMOCHIM AC, V126, P169, DOI 10.1016/j.gca.2013.10.045; Stolper D. A., 2014, MINERAL MAG, V78, P2393; Tang Y, 2000, GEOCHIM COSMOCHIM AC, V64, P2673, DOI 10.1016/S0016-7037(00)00377-X; Tissot BP, 1984, PETROLEUM FORMATION; TRINDADE LAF, 1992, AAPG BULL, V76, P1903; UNGERER P, 1990, ORG GEOCHEM, V16, P1, DOI 10.1016/0146-6380(90)90022-R; Valentine DL, 2011, ANNU REV MAR SCI, V3, P147, DOI 10.1146/annurev-marine-120709-142734; Valentine DL, 2004, GEOCHIM COSMOCHIM AC, V68, P1571, DOI 10.1016/j.gca.2003.10.012; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; WHITICAR MJ, 1986, GEOCHIM COSMOCHIM AC, V50, P693, DOI 10.1016/0016-7037(86)90346-7; Wilhelms A, 2001, NATURE, V411, P1034, DOI 10.1038/35082535; Xiao Y, 2001, REV MINERAL GEOCHEM, V42, P383, DOI 10.2138/rmg.2001.42.11	38	169	185	8	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1500	1503		10.1126/science.1254509	http://dx.doi.org/10.1126/science.1254509			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970083	Green Accepted			2022-12-01	WOS:000337889900046
J	Scott, DC; Sviderskiy, VO; Monda, JK; Lydeard, JR; Cho, SE; Harper, JW; Schulman, BA				Scott, Daniel C.; Sviderskiy, Vladislav O.; Monda, Julie K.; Lydeard, John R.; Cho, Shein Ei; Harper, J. Wade; Schulman, Brenda A.			Structure of a RING E3 Trapped in Action Reveals Ligation Mechanism for the Ubiquitin-like Protein NEDD8	CELL			English	Article							COMPLEX REVEALS; LIGASE COMPLEX; ACTIVATION; SCF; CONJUGATION; SUBSTRATE; ENZYME; INSIGHTS; BINDING; E2	Most E3 ligases use a RING domain to activate a thioester-linked E2 similar to ubiquitin-like protein (UBL) intermediate and promote UBL transfer to a remotely bound target protein. Nonetheless, RING E3 mechanisms matching a specific UBL and acceptor lysine remain elusive, including for RBX1, which mediates NEDD8 ligation to cullins and >10% of all ubiquitination. We report the structure of a trapped RING E3-E2 similar to UBL-target intermediate representing RBX1-UBC12 similar to NEDD8-CUL1-DCN1, which reveals the mechanism of NEDD8 ligation and how a particular UBL and acceptor lysine are matched by a multifunctional RING E3. Numerous mechanisms specify cullin neddylation while preventing noncognate ubiquitin ligation. Notably, E2-E3-target and RING-E2 similar to UBL modules are not optimized to function independently, but instead require integration by the UBL and target for maximal reactivity. The UBL and target regulate the catalytic machinery by positioning the RING-E2 similar to UBL catalytic center, licensing the acceptor lysine, and influencing E2 reactivity, thereby driving their specific coupling by a multifunctional RING E3.	[Scott, Daniel C.; Sviderskiy, Vladislav O.; Monda, Julie K.; Cho, Shein Ei; Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Scott, Daniel C.; Sviderskiy, Vladislav O.; Monda, Julie K.; Cho, Shein Ei; Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; [Scott, Daniel C.; Schulman, Brenda A.] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; [Lydeard, John R.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Howard Hughes Medical Institute; St Jude Children's Research Hospital; Harvard University; Harvard Medical School	Schulman, BA (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale, Memphis, TN 38105 USA.	brenda.schulman@stjude.org		Schulman, Brenda/0000-0002-3083-1126; Harper, Jeffrey/0000-0002-6944-7236; Sviderskiy, Vladislav/0000-0002-9692-5328	Howard Hughes Medical Institute (HHMI); American Lebanese Syrian Associated Charities (ALSAC); NIH [5P30CA021765, R01GM069530, R01AG011085]; Damon Runyon [DRG 2061-10]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Bozeman, D. W. Miller, J. Bollinger, D. J. Miller, and I. Kurinov for support. Funding was provided by the Howard Hughes Medical Institute (HHMI), the American Lebanese Syrian Associated Charities (ALSAC), NIH (5P30CA021765, R01GM069530 to B.A.S. and R01AG011085 to J.W.H.), and Damon Runyon (DRG 2061-10 to J.R.L.). B.A.S. is an Investigator of Howard Hughes Medical Institute.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Berndsen CE, 2013, NAT CHEM BIOL, V9, P154, DOI [10.1038/NCHEMBIO.1159, 10.1038/nchembio.1159]; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Calabrese MF, 2011, NAT STRUCT MOL BIOL, V18, P947, DOI 10.1038/nsmb.2086; Choi YS, 2010, J BIOL CHEM, V285, P17754, DOI 10.1074/jbc.M109.090621; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dou H, 2013, NAT STRUCT MOL BIOL, V20, P982, DOI 10.1038/nsmb.2621; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P184, DOI 10.1038/nsmb.2231; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2012, MOL CELL, V47, P371, DOI 10.1016/j.molcel.2012.05.044; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Dueber EC, 2011, SCIENCE, V334, P376, DOI 10.1126/science.1207862; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Huang H, 2014, NAT CHEM BIOL, V10, P156, DOI [10.1038/NCHEMBIO.1412, 10.1038/nchembio.1412]; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Kleiger G, 2009, J BIOL CHEM, V284, P36012, DOI 10.1074/jbc.M109.058529; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Kobashigawa Y, 2011, P NATL ACAD SCI USA, V108, P20579, DOI 10.1073/pnas.1110712108; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Mattiroli F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4291; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Monda JK, 2013, STRUCTURE, V21, P42, DOI 10.1016/j.str.2012.10.013; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rojas-Fernandez A, 2014, MOL CELL, V53, P880, DOI 10.1016/j.molcel.2014.02.031; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Spratt DE, 2012, J BIOL CHEM, V287, P17374, DOI 10.1074/jbc.M112.353748; Spratt DE, 2011, J MOL BIOL, V407, P425, DOI 10.1016/j.jmb.2011.01.047; Stanley DJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003085; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	52	128	133	1	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1671	1684		10.1016/j.cell.2014.04.037	http://dx.doi.org/10.1016/j.cell.2014.04.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949976	Bronze, Green Accepted			2022-12-01	WOS:000340941900020
J	[Anonymous]				[Anonymous]			Screening an Asymptomatic Person for Genetic Risk	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Dimmock, David/I-7913-2015	Dimmock, David/0000-0001-6690-2523					0	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2014	370	25					2442	2443						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ0OA	24941182				2022-12-01	WOS:000337353000014
J	Roumie, CL; Greevy, RA; Grijalva, CG; Hung, AM; Liu, XL; Murff, HJ; Elasy, TA; Griffin, MR				Roumie, Christianne L.; Greevy, Robert A.; Grijalva, Carlos G.; Hung, Adriana M.; Liu, Xulei; Murff, Harvey J.; Elasy, Tom A.; Griffin, Marie R.			Association Between Intensification of Metformin Treatment With Insulin vs Sulfonylureas and Cardiovascular Events and All-Cause Mortality Among Patients With Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MARGINAL STRUCTURAL MODELS; AFFAIRS HEALTH-CARE; BETA-CELL FUNCTION; SEVERE HYPOGLYCEMIA; GLUCOSE CONTROL; FOLLOW-UP; TYPE-2; RISK; THERAPIES; OUTCOMES	IMPORTANCE Preferred second-line medication for diabetes treatment after metformin failure remains uncertain. OBJECTIVE To compare time to acute myocardial infarction (AMI), stroke, or death in a cohort of metformin initiators who added insulin or a sulfonylurea. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort constructed with national Veterans Health Administration, Medicare, and National Death Index databases. The study population comprised veterans initially treated with metformin from 2001 through 2008 who subsequently added either insulin or sulfonylurea. Propensity score matching on characteristics was performed, matching each participant who added insulin to 5 who added a sulfonylurea. Patients were followed through September 2011 for primary analyses or September 2009 for cause-of-death analyses. MAIN OUTCOMES AND MEASURES Risk of a composite outcome of AMI, stroke hospitalization, or all-cause death was compared between therapies with marginal structural Cox proportional hazard models adjusting for baseline and time-varying demographics, medications, cholesterol level, hemoglobin A(1c) level, creatinine level, blood pressure, body mass index, and comorbidities. RESULTS Among 178 341 metformin monotherapy patients, 2948 added insulin and 39 990 added a sulfonylurea. Propensity score matching yielded 2436 metformin + insulin and 12 180 metformin + sulfonylurea patients. At intensification, patients had received metformin for a median of 14 months (IQR, 5-30), and hemoglobin A(1c) level was 8.1% (IQR, 7.2%-9.9%). Median follow-up after intensification was 14 months (IQR, 6-29 months). There were 172 vs 634 events for the primary outcome among patients who added insulin vs sulfonylureas, respectively (42.7 vs 32.8 events per 1000 person-years; adjusted hazard ratio [aHR],1.30; 95% Cl, 1.07-1.58; P = .009). Acute myocardial infarction and stroke rates were statistically similar, 41 vs 229 events (10.2 and 11.9 events per 1000 person-years; aHR, 0.88; 95% Cl, 0.59-1.30; P =.52), whereas all-cause death rates were 137 vs 444 events, respectively (33.7 and 22.7 events per 1000 person-years; aHR, 1.44; 95% Cl, 1.15-1.79; P = .001). There were 54 vs 258 secondary outcomes: AMI, stroke hospitalizations, or cardiovascular deaths (22.8 vs 22.5 events per 1000 person-years; aHR, 0.98; 95% Cl, 0.71-1.34; P = .87). CONCLUSIONS AND RELEVANCE Among patients with diabetes who were receiving metformin, the addition of insulin vs a sulfonylurea was associated with an increased risk of a composite of nonfatal cardiovascular outcomes and all-cause mortality. These findings require further investigation to understand risks associated with insulin use in these patients.	[Roumie, Christianne L.; Greevy, Robert A.; Grijalva, Carlos G.; Hung, Adriana M.; Liu, Xulei; Murff, Harvey J.; Elasy, Tom A.; Griffin, Marie R.] Geriatr Res Educ Clin Ctr, Vet Hlth Adm Valley Healthcare Syst, HSR&D Ctr, Nashville, TN USA; [Roumie, Christianne L.; Hung, Adriana M.; Murff, Harvey J.; Elasy, Tom A.; Griffin, Marie R.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Greevy, Robert A.; Liu, Xulei] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA; [Grijalva, Carlos G.; Griffin, Marie R.] Vanderbilt Univ, Dept Hlth Policy, Nashville, TN 37235 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vanderbilt University; Vanderbilt University; Vanderbilt University	Roumie, CL (corresponding author), Geriatr Res Educ Clin Ctr, Nashville VA Med Ctr, 1310 24th Ave S, Nashville, TN 37212 USA.	christianne.roumie@vanderbilt.edu		Grijalva, Carlos/0000-0002-2329-7797	Agency for Healthcare Research and Quality, US Department of Health and Human Services [HHSA2902010000161]; VA Clinical Science Research and Development investigator-initiated grant [I01CX000570-01]; Center for Diabetes Translation Research [P30DK092986]; VA Career Development Award [2-031-09S]; Department of Veterans Affairs, Veterans Affairs Health Services Research and Development Service, Veterans Affairs Information Resource Center [SDR 02-237, 98-004]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092986] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000570] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality, US Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); VA Clinical Science Research and Development investigator-initiated grant; Center for Diabetes Translation Research; VA Career Development Award; Department of Veterans Affairs, Veterans Affairs Health Services Research and Development Service, Veterans Affairs Information Resource Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This project was funded by the Agency for Healthcare Research and Quality, US Department of Health and Human Services, contract HHSA2902010000161, as part of the Developing Evidence to Inform Decisions About Effectiveness (DEcIDE 2) program. This work was supported in part by VA Clinical Science Research and Development investigator-initiated grant I01CX000570-01 (Dr Roumie) and the Center for Diabetes Translation Research P30DK092986 (Drs Roumie and Elasy). Dr Hung (2-031-09S) was supported by a VA Career Development Award. Support for Veterans Affairs/Centers for Medicare & Medicaid Services data was provided by the Department of Veterans Affairs, Veterans Affairs Health Services Research and Development Service, Veterans Affairs Information Resource Center (project numbers SDR 02-237 and 98-004).	Alvarsson M, 2008, DIABETES OBES METAB, V10, P421, DOI 10.1111/j.1463-1326.2007.00719.x; [Anonymous], 2010, OPTMACH FUNCTIONS FO; [Anonymous], 2010, RITOOLS RANDOMIZATIO; Arnold N, 2006, COMPARISON OF VA OUT; Bonds DE, 2012, BMC ENDOCR DISORD, V12, DOI 10.1186/1472-6823-12-5; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Centers for Disease Control and Prevention, ADULTS WITH DIABETES; Cohen FJ, 2003, DIABETES CARE, V26, P1847, DOI 10.2337/diacare.26.6.1847; Currie CJ, 2013, J CLIN ENDOCR METAB, V98, P668, DOI 10.1210/jc.2012-3042; D'Agostino RB, 2000, J AM STAT ASSOC, V95, P749, DOI 10.2307/2669455; Gamble JM, 2010, DIABETES OBES METAB, V12, P47, DOI 10.1111/j.1463-1326.2009.01125.x; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Greevy RA, 2011, CLIN PHARMACOL THER, V90, P813, DOI 10.1038/clpt.2011.228; Harrison LB, 2012, DIABETES CARE, V35, P1406, DOI 10.2337/dc11-2170; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Holden SE, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000258; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Humensky J, 2012, MEDICARE MEDICAID RE, V2; Hung AM, 2012, KIDNEY INT, V81, P698, DOI 10.1038/ki.2011.444; Hynes DM, 2007, MED CARE, V45, P214, DOI 10.1097/01.mlr.0000244657.90074.b7; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Kerr EA, 2004, ANN INTERN MED, V141, P272, DOI 10.7326/0003-4819-141-4-200408170-00007; McCarthy JF, 2009, AM J EPIDEMIOL, V169, P1033, DOI 10.1093/aje/kwp010; National Center for Health Statistics, 1988, INTERNATIONAL CLASSI; Niesner K, 2013, EPIDEMIOLOGY, V24, P334, DOI 10.1097/EDE.0b013e3182821e75; Office of Minority Health Department of Health and Human Services, HEART DISEASE AND AF; Parsons L., REDUCING BIAS IN A P; Peyrot Mark, 2010, Prim Care Diabetes, V4 Suppl 1, pS11, DOI 10.1016/S1751-9918(10)60004-6; Ray WA, 2001, ARCH GEN PSYCHIAT, V58, P1161, DOI 10.1001/archpsyc.58.12.1161; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Roumie CL, 2012, ANN INTERN MED, V157, P601, DOI 10.7326/0003-4819-157-9-201211060-00003; Roumie CL, 2012, PHARMACOEPIDEM DR S, V21, P515, DOI 10.1002/pds.3249; Roumie CL, 2011, PHARMACOEPIDEM DR S, V20, P36, DOI 10.1002/pds.2029; Schneeweiss S, 2005, EPIDEMIOLOGY, V16, P17, DOI 10.1097/01.ede.0000147164.11879.b5; Selbly JV, 2009, MED CARE, V47, P395, DOI 10.1097/MLR.0b013e31818d775c; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Yuan Y. C., 2011, MULTIPLE IMPUTATION	40	134	138	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2288	2296		10.1001/jama.2014.4312	http://dx.doi.org/10.1001/jama.2014.4312			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915260	Green Accepted, Bronze			2022-12-01	WOS:000336972600020
J	McClure, C; Chandler, C; Bissell, S				McClure, Craig; Chandler, Caitlin; Bissell, Susan			Responses to HIV in sexually exploited children or adolescents who sell sex	LANCET			English	Editorial Material							INFECTION; WORKERS; INDIA; AGE		[McClure, Craig] UNICEF, New York, NY 10017 USA; HIV Young Leaders Fund, New York, NY USA	UNICEF	McClure, C (corresponding author), UNICEF, New York, NY 10017 USA.	cmcclure@unicef.org						[Anonymous], 2014, UN IATT TEC IN PRESS; Conner B, 2014, SEXUAL REPR IN PRESS; Goldenberg SM, 2012, AIDS BEHAV, V16, P969, DOI 10.1007/s10461-011-0063-3; Gupta J, 2009, INT J GYNECOL OBSTET, V107, P30, DOI 10.1016/j.ijgo.2009.06.009; Moscicki AB, 2001, J INFECT DIS, V183, P865, DOI 10.1086/319261; Sarkar K, 2008, J HEALTH POPUL NUTR, V26, P223; Sarkar K, 2006, J INFECTION, V53, P255, DOI 10.1016/j.jinf.2005.11.009; Silverman JG, 2011, ARCH DIS CHILD, V96, P478, DOI 10.1136/adc.2009.178715; Strode A, 2009, S AFR J HIV MED, P8; UNAIDS, 2013, REP GLOB AIDS EP; UNICEF, 2010, BLAM BAN UND HIV EP; WHO, 2014, POL BRIEF Y IN PRESS	12	18	18	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2015	385	9963					97	99		10.1016/S0140-6736(14)60979-X	http://dx.doi.org/10.1016/S0140-6736(14)60979-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY7BI	25059951				2022-12-01	WOS:000347715900007
J	Bertazzo, S; Steele, JAM; Chester, AH; Yacoub, MH; Stevens, MM				Bertazzo, Sergio; Steele, Joseph A. M.; Chester, Adrian H.; Yacoub, Magdi H.; Stevens, Molly M.			Cardiovascular calcification violet pearl	LANCET			English	Editorial Material									[Bertazzo, Sergio; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, Dept Bioengn, London SW7 2AZ, England; [Chester, Adrian H.; Yacoub, Magdi H.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Harefield Heart Sci Ctr, London SW7 2AZ, England; [Steele, Joseph A. M.; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London SW7 2AZ, England	Imperial College London; Imperial College London; Imperial College London	Bertazzo, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.	s.bertazzo@imperial.ac.uk; m.stevens@imperial.ac.uk	Bertazzo, Sergio/J-7357-2016	Bertazzo, Sergio/0000-0003-4889-8190; Steele, Joseph/0000-0002-7913-0531					0	4	4	1	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2014	384	9950					1294	1294		10.1016/S0140-6736(13)62369-7	http://dx.doi.org/10.1016/S0140-6736(13)62369-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NB	24857203				2022-12-01	WOS:000343003400032
J	Santos, MA; Faryabi, RB; Ergen, AV; Day, AM; Malhowski, A; Canela, A; Onozawa, M; Lee, JE; Callen, E; Gutierrez-Martinez, P; Chen, HT; Wong, N; Finkel, N; Deshpande, A; Sharrow, S; Rossi, DJ; Ito, K; Ge, K; Aplan, PD; Armstrong, SA; Nussenzweig, A				Santos, Margarida A.; Faryabi, Robert B.; Ergen, Aysegul V.; Day, Amanda M.; Malhowski, Amy; Canela, Andres; Onozawa, Masahiro; Lee, Ji-Eun; Callen, Elsa; Gutierrez-Martinez, Paula; Chen, Hua-Tang; Wong, Nancy; Finkel, Nadia; Deshpande, Aniruddha; Sharrow, Susan; Rossi, Derrick J.; Ito, Keisuke; Ge, Kai; Aplan, Peter D.; Armstrong, Scott A.; Nussenzweig, Andre			DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; OXIDATIVE STRESS; RNA-SEQ; MLL; PROGENITORS; BREAKS; RESISTANCE; DISCOVERY; LYMPHOMA; RENEWAL	Self-renewal is the hallmark feature both of normal stem cells and cancer stem cells(1). Since the regenerative capacity of normal haematopoietic stem cells is limited by the accumulation of reactive oxygen species and DNA double-strand breaks(2-4), we speculated that DNA damage might also constrain leukaemic self-renewal and malignant haematopoiesis. Here we show that the histone methyl-transferase MLL4, a suppressor of B-cell lymphoma(5,6), is required for stem-cell activity and an aggressive form of acutemyeloid leukaemia harbouring the MLL-AF9 oncogene. Deletion of MLL4 enhances myelopoiesis and myeloid differentiation of leukaemic blasts, which protects mice from death related to acute myeloid leukaemia. MLL4 exerts its function by regulating transcriptional programs associated with the antioxidant response. Addition of reactive oxygen species scavengers or ectopic expression of FOXO3 protects MLL-/- MLL-AF9 cells from DNA damage and inhibits myeloid maturation. Similar to MLL4 deficiency, loss of ATM or BRCA1 sensitizes transformed cells to differentiation, suggesting that myeloid differentiation is promoted by loss of genome integrity. Indeed, we show that restriction-enzyme-induced double-strand breaks are sufficient to induce differentiation of MLL-AF9 blasts, which requires cyclin-dependent kinase inhibitor p21(Cip1) (Cdkn1a) activity. In summary, we have uncovered an unexpected tumour-promoting role of genome guardians in enforcing the oncogene-induced differentiation blockade in acute myeloid leukaemia.	[Santos, Margarida A.; Faryabi, Robert B.; Ergen, Aysegul V.; Day, Amanda M.; Malhowski, Amy; Canela, Andres; Callen, Elsa; Chen, Hua-Tang; Wong, Nancy; Finkel, Nadia; Nussenzweig, Andre] NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA; [Onozawa, Masahiro; Aplan, Peter D.] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; [Lee, Ji-Eun; Ge, Kai] NIDDKD, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Gutierrez-Martinez, Paula; Rossi, Derrick J.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Gutierrez-Martinez, Paula; Rossi, Derrick J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Deshpande, Aniruddha; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Deshpande, Aniruddha; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA; [Sharrow, Susan] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Ito, Keisuke] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Dept Cell Biol, Bronx, NY 10461 USA; [Ito, Keisuke] Albert Einstein Coll Med, Dept Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Nussenzweig, A (corresponding author), NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	Ge, Kai/H-2810-2019; Aplan, Peter D/K-9064-2016; Santos, Margarida/GWR-2285-2022; Faryabi, Robert/AAN-5512-2020; Lee, Ji-Eun/F-7891-2011; Faryabi, Robert B/H-3544-2015	Ge, Kai/0000-0002-7442-5138; Faryabi, Robert/0000-0002-7931-2175; Lee, Ji-Eun/0000-0002-3768-7016; Faryabi, Robert B/0000-0002-7931-2175	Leukemia and Lymphoma Society; National Cancer Institute [CA66996, CA140575]; National Institutes of Health; National Cancer Institute; Center for Cancer Research; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [ZIABC010983, R00CA139009, P30CA008748, ZICBC009255, R01CA140575, P01CA066996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075003, R01DK098263, R01DK100689] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all members of the A. Nussenzweig laboratory, J. Daniel and P. Love for discussions; L. Granger for flow cytometry; M. J. Kruhlak for microscopy; K. Zhao for RNA sequencing; R. Anderson and K. Smith for animal care; K. Naka for the FOXO3 retrovirus; G. Legube for the pBABE-AsiSI-ER plasmid; J. Zuber for pLEPG and pRT3GEPIR plasmids; O. Fernandez-Capetillo for ATRi; and S. John for suggestions. S. A. A. was supported by the Leukemia and Lymphoma Society and National Cancer Institute grants CA66996 and CA140575. This work was supported by the Intramural Research Program of the National Institutes of Health, the National Cancer Institute and the Center for Cancer Research, and an Ellison Medical Foundation Senior Scholar in Aging Award to A.N.	Argast GM, 1998, J MOL BIOL, V280, P345, DOI 10.1006/jmbi.1998.1886; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gorrini C, 2013, J EXP MED, V210, P1529, DOI 10.1084/jem.20121337; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Schoppy DW, 2012, J CLIN INVEST, V122, P241, DOI 10.1172/JCI58928; Smyth G.K., 2004, STAT APPL GENET MOL, V3, pArticl, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Somervaille TCP, 2010, INT J HEMATOL, V91, P735, DOI 10.1007/s12185-010-0579-8; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007	40	135	137	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					107	+		10.1038/nature13483	http://dx.doi.org/10.1038/nature13483			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25079327	Green Accepted			2022-12-01	WOS:000342420800045
J	Cong, PY; Ma, XY; Hou, XG; Edgecombe, GD; Strausfeld, NJ				Cong, Peiyun; Ma, Xiaoya; Hou, Xianguang; Edgecombe, Gregory D.; Strausfeld, Nicholas J.			Brain structure resolves the segmental affinity of anomalocaridid appendages	NATURE			English	Article							BURGESS SHALE; ARTHROPOD; EVOLUTION; ONYCHOPHORA; ORIGIN; PERIPATOPSIDAE; ORGANIZATION; MORPHOLOGY; SUGGESTS; LABRUM	Despite being among the most celebrated taxa from Cambrian biotas, anomalocaridids (order Radiodonta) have provoked intense debate about their affinities within the moulting-animal clade that includes Arthropoda. Current alternatives identify anomalocaridids as either stem-group euarthropods(1-3), crown-group euarthropods near the ancestry of chelicerates(4), or a segmented ecdysozoan lineage with convergent similarity to arthropods in appendage construction(5). Determining unambiguous affinities has been impeded by uncertainties about the segmental affiliation of anomalocaridid frontal appendages. These structures are variably homologized with jointed appendages of the second (deutocerebral) head segment, including antennae and 'great appendages' of Cambrian arthropods, or with the paired antenniform frontal appendages of living Onychophora and some Cambrian lobopodians. Here we describe Lyrarapax unguis-pinus, a new anomalocaridid from the early Cambrian Chengjiang biota, southwest China, nearly complete specimens of which preserve traces of muscles, digestive tract and brain. The traces of brain provide the first direct evidence for the segmental composition of the anomalocaridid head and its appendicular organization. Carbon-rich areas in the head resolve paired pre-protocerebral ganglia at the origin of paired frontal appendages. The ganglia connect to areas indicative of a bilateral pre-oral brain that receives projections from the eyestalk neuropils and compound retina. The dorsal, segmented brain of L. unguispinus reinforces an alliance between anomalocaridids and arthropods rather than cycloneuralians. Correspondences in brain organization between anomalocaridids and Onychophora resolve pre-protocerebral ganglia, associated with pre-ocular frontal appendages, as characters of the last common ancestor of euarthropods and onychophorans. A position of Radiodonta on the euarthropod stem-lineage implies the transformation of frontal appendages to another structure in crown-group euarthropods, with gene expression and neuroanatomy providing strong evidence that the paired, pre-oral labrum is the remnant of paired frontal appendages(1).	[Cong, Peiyun; Ma, Xiaoya; Hou, Xianguang] Yunnan Univ, Yunnan Key Lab Palaeobiol, Kunming 650091, Peoples R China; [Ma, Xiaoya; Edgecombe, Gregory D.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Strausfeld, Nicholas J.] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA; [Strausfeld, Nicholas J.] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA	Yunnan University; Natural History Museum London; University of Arizona; University of Arizona	Hou, XG (corresponding author), Yunnan Univ, Yunnan Key Lab Palaeobiol, Kunming 650091, Peoples R China.	xghou@ynu.edu.cn; flybrain@neurobio.arizona.edu	Strausfeld, Nicholas James/AAF-4566-2021; Cong, Pei-yun/D-2537-2009	Strausfeld, Nicholas James/0000-0002-1115-1774; Cong, Pei-yun/0000-0001-9910-6478; Edgecombe, Gregory/0000-0002-9591-8011	National Natural Science Foundation of China [U1302232, 41372031, 40962001]; Leverhulme Trust [F/00 696/T]; Center for Insect Science, University of Arizona; Air Force Research Laboratory [FA86511010001]; NERC [NE/L011751/1] Funding Source: UKRI; Natural Environment Research Council [NE/L011751/1] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Leverhulme Trust(Leverhulme Trust); Center for Insect Science, University of Arizona; Air Force Research Laboratory; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the National Natural Science Foundation of China (U1302232, 41372031 and 40962001), a Leverhulme Trust Research Project Grant (F/00 696/T), by the Center for Insect Science, University of Arizona, and by a grant from the Air Force Research Laboratory (FA86511010001) to N.J.S. We thank T. Goral for assistance with energy dispersive X-ray spectroscopy. We acknowledge A. Daley's advice about anomalocaridid anatomy.	Boxshall GA, 2004, BIOL REV, V79, P253, DOI 10.1017/S1464793103006274; Boyan GS, 2002, ARTHROPOD STRUCT DEV, V31, P65, DOI 10.1016/S1467-8039(02)00016-6; Browne WE, 2005, GENESIS, V42, P124, DOI 10.1002/gene.20145; Budd GE, 1998, LETHAIA, V31, P197, DOI 10.1111/j.1502-3931.1998.tb00508.x; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; Daley AC, 2014, J PALEONTOL, V88, P68, DOI 10.1666/13-067; Daley AC, 2012, NATURWISSENSCHAFTEN, V99, P501, DOI 10.1007/s00114-012-0910-8; Daley AC, 2009, SCIENCE, V323, P1597, DOI 10.1126/science.1169514; Eriksson BJ, 2009, DEV GENES EVOL, V219, P249, DOI 10.1007/s00427-009-0287-7; Haas MS, 2001, DEV GENES EVOL, V211, P96, DOI 10.1007/s004270000129; Haug JT, 2012, PALAEONTOLOGY, V55, P369, DOI 10.1111/j.1475-4983.2011.01124.x; Hou Xiang, 2006, P139; Legg DA, 2013, LETHAIA, V46, P540, DOI 10.1111/let.12032; Legg DA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3485; Ma XY, 2012, NATURE, V490, P258, DOI 10.1038/nature11495; Mayer G, 2008, J COMP NEUROL, V507, P1196, DOI 10.1002/cne.21603; Mayer G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-255; Mayer G, 2009, DEV BIOL, V335, P263, DOI 10.1016/j.ydbio.2009.08.011; Paterson JR, 2011, NATURE, V480, P237, DOI 10.1038/nature10689; Scholtz G, 2006, DEV GENES EVOL, V216, P395, DOI 10.1007/s00427-006-0085-4; Schurmann F.-W., 1987, P159; Stein M, 2010, ZOOL J LINN SOC-LOND, V158, P477, DOI 10.1111/j.1096-3642.2009.00562.x; Strausfeld N. J., 2012, ARTHROPOD BRAINS EVO, P427; Strausfeld NJ, 2006, ARTHROPOD STRUCT DEV, V35, P169, DOI 10.1016/j.asd.2006.06.002; Strausfeld NJ, 2006, P ROY SOC B-BIOL SCI, V273, P1857, DOI 10.1098/rspb.2006.3536; Tanaka G, 2013, NATURE, V502, P364, DOI 10.1038/nature12520; Vinther J, 2014, NATURE, V507, P496, DOI 10.1038/nature13010; WIGGLESWORTH VB, 1957, PROC R SOC SER B-BIO, V147, P185, DOI 10.1098/rspb.1957.0043	28	115	118	4	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					538	+		10.1038/nature13486	http://dx.doi.org/10.1038/nature13486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25043032				2022-12-01	WOS:000342075800038
J	Wright, JD; Tergas, AI; Burke, WM; Cui, RR; Ananth, CV; Chen, L; Hershman, DL				Wright, Jason D.; Tergas, Ana I.; Burke, William M.; Cui, Rosa R.; Ananth, Cande V.; Chen, Ling; Hershman, Dawn L.			Uterine Pathology in Women Undergoing Minimally Invasive Hysterectomy Using Morcellation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Wright, Jason D.; Tergas, Ana I.; Burke, William M.; Cui, Rosa R.; Ananth, Cande V.; Chen, Ling] Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA; [Hershman, Dawn L.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University	Wright, JD (corresponding author), Columbia Univ Coll Phys & Surg, Div Gynecol Oncol, Dept Obstet & Gynecol, 161 Ft Washington Ave,Eighth Floor, New York, NY 10032 USA.	jw2459@columbia.edu	Hershman, Dawn/AAG-2114-2020		NATIONAL CANCER INSTITUTE [R01CA169121, R25CA094061, R01CA134964] Funding Source: NIH RePORTER; NCI NIH HHS [R25 CA094061, R25 CA094061-11, R01 CA169121, R01CA169121-01A1, R01CA134964, R01 CA134964] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2014, LANCET ONCOL, V15, P123; Hagemann IS, 2011, INT J GYNECOL PATHOL, V30, P476, DOI 10.1097/PGP.0b013e3182107ecf; Kho KA, 2014, JAMA-J AM MED ASSOC, V311, P905, DOI 10.1001/jama.2014.1093; Oduyebo T, 2014, GYNECOL ONCOL, V132, P360, DOI 10.1016/j.ygyno.2013.11.024; Seidman MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050058; Wright JD, 2013, JAMA-J AM MED ASSOC, V309, P689, DOI 10.1001/jama.2013.186	6	111	113	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2014	312	12					1253	1255		10.1001/jama.2014.9005	http://dx.doi.org/10.1001/jama.2014.9005			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP3QA	25051495	Bronze, Green Accepted			2022-12-01	WOS:000341990600027
J	Hwang, WL; Deindl, S; Harada, BT; Zhuang, XW				Hwang, William L.; Deindl, Sebastian; Harada, Bryan T.; Zhuang, Xiaowei			Histone H4 tail mediates allosteric regulation of nucleosome remodelling by linker DNA	NATURE			English	Article							SINGLE-MOLECULE; CORE PARTICLE; CHROMATIN; ISWI; ACF; COMPLEXES; RESOLUTION; CONTAINS; DYNAMICS; SUBUNITS	Imitation switch (ISWI)-family remodelling enzymes regulate access to genomic DNA by mobilizing nucleosomes(1). These ATP-dependent chromatin remodellers promote heterochromatin formation and transcriptional silencing(1) by generating regularly spaced nucleosome arrays(2-5). The nucleosome-spacing activity arises from the dependence of nucleosome translocation on the length of extranucleosomal linker DNA(6-10), but the underlying mechanism remains unclear. Here we study nucleosome remodelling by human ATP-dependent chromatin assembly and remodelling factor (ACF), an ISWI enzyme comprising a catalytic subunit, Snf2h, and an accessory subunit, Acf1 (refs 2, 11-13). We find that ACF senses linker DNA length through an interplay between its accessory and catalytic subunits mediated by the histone H4 tail of the nucleosome. Mutation of AutoN, an auto-inhibitory domain within Snf2h that bears sequence homology to the H4 tail(14), abolishes the linker-length sensitivity in remodelling. Addition of exogenous H4-tail peptide or deletion of the nucleosomal H4 tail also diminishes the linker-length sensitivity. Moreover, Acf1 binds both the H4-tail peptide and DNA in an amino (N)-terminal domain dependent manner, and in the ACF-bound nucleosome, lengthening the linker DNA reduces the Acf1-H4 tail proximity. Deletion of the N-terminal portion of Acf1 (or itshomologue in yeast) abolishes linker-length sensitivity in remodelling and leads to severe growth defects in vivo. Taken together, our results suggest a mechanism for nucleosome spacing where linker DNA sensing by Acf1 is allosterically transmitted to Snf2h through the H4 tail of the nucleosome. For nucleosomes with short linker DNA, Acf1 preferentially binds to the H4 tail, allowing AutoN to inhibit the ATPase activity of Snf2h. As the linker DNA lengthens, Acf1 shifts its binding preference to the linker DNA, freeing the H4 tail to compete Auto N off the ATPase and thereby activating ACF.	[Hwang, William L.; Deindl, Sebastian; Harada, Bryan T.; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Hwang, William L.; Harada, Bryan T.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Hwang, William L.] Harvard Univ, Sch Med, Harvard MIT MD PhD Program, Boston, MA 02115 USA; [Deindl, Sebastian; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu	Harada, Bryan T/AAW-3169-2020	Harada, Bryan T/0000-0002-9683-782X; Deindl, Sebastian/0000-0001-6807-8654	National Institutes of Health [GM105637, T32G007753]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105637, T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Narlikar, T. Tsukiyama, J. Vaughan, J. Moffitt and E. Sun for discussions, S. Mukherji for assistance in designing the yeast experiments, S. Trauger, K. L. Hwang, R. Magnusson, G. Hilinski and J. McGee for assistance with protein characterization and biochemistry, and G. Narlikar for providing Snf2h and Acf1 expression vectors and purification protocols. This work was supported in part by the National Institutes of Health (GM105637 to X.Z.). W.L.H. acknowledges support from the National Institutes of Health T32G007753 Training Grant. S.D. was a Merck Fellow of the Jane Coffin Childs Foundation. X.Z. is a Howard Hughes Medical Investigator.	Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Blosser TR, 2009, NATURE, V462, P1022, DOI 10.1038/nature08627; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Dang WW, 2006, MOL CELL BIOL, V26, P7388, DOI 10.1128/MCB.01159-06; Deindl S, 2013, CELL, V152, P442, DOI 10.1016/j.cell.2012.12.040; Eberharter A, 2004, EMBO J, V23, P4029, DOI 10.1038/sj.emboj.7600382; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Fyodorov DV, 2002, MOL CELL BIOL, V22, P6344, DOI 10.1128/MCB.22.18.6344-6353.2002; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; He X, 2008, BIOCHEMISTRY-US, V47, P7025, DOI 10.1021/bi702304p; He X, 2006, J BIOL CHEM, V281, P28636, DOI 10.1074/jbc.M603008200; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Kagalwala MN, 2004, EMBO J, V23, P2092, DOI 10.1038/sj.emboj.7600220; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Killian JL, 2012, CURR OPIN STRUC BIOL, V22, P80, DOI 10.1016/j.sbi.2011.11.003; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; LeRoy G, 2000, J BIOL CHEM, V275, P14787, DOI 10.1074/jbc.C000093200; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mueller-Planitz F, 2013, NAT STRUCT MOL BIOL, V20, P82, DOI 10.1038/nsmb.2457; Narlikar GJ, 2010, CURR OPIN CHEM BIOL, V14, P660, DOI 10.1016/j.cbpa.2010.08.001; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170	36	60	60	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					213	+		10.1038/nature13380	http://dx.doi.org/10.1038/nature13380			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043036	Green Submitted, Green Accepted			2022-12-01	WOS:000340200700036
J	Chokshi, DA				Chokshi, Dave A.			Improving Health Care for Veterans - A Watershed Moment for the VA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSFORMATION; SYSTEM		[Chokshi, Dave A.] NYU, Dept Populat Hlth, Langone Med Ctr, New York, NY 10012 USA; [Chokshi, Dave A.] NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Chokshi, DA (corresponding author), NYU, Dept Populat Hlth, Langone Med Ctr, New York, NY 10012 USA.			Chokshi, Dave/0000-0001-7467-4591				Department of Veterans Affairs Office of Public and Intergovernmental Affairs, 2014, IND 2013 SURV SHOWS; Government Accountability Office, 2012, GAO13130; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Kizer KW, 2012, J GEN INTERN MED, V27, P395, DOI 10.1007/s11606-011-1981-5; Kizer KW, 2009, ANNU REV PUBL HEALTH, V30, P313, DOI 10.1146/annurev.publhealth.29.020907.090940; Trivedi AN, 2011, MED CARE, V49, P76, DOI 10.1097/MLR.0b013e3181f53575	6	28	28	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					297	299		10.1056/NEJMp1406868	http://dx.doi.org/10.1056/NEJMp1406868			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL7TY	24896820	Bronze			2022-12-01	WOS:000339339800005
J	Forcada, J; Hoffman, JI				Forcada, Jaume; Hoffman, Joseph Ivan			Climate change selects for heterozygosity in a declining fur seal population	NATURE			English	Article							INBREEDING DEPRESSION; ARCTOCEPHALUS-GAZELLA; ADAPTATION; RESPONSES; GENETICS; SUCCESS; STRESS; MODEL; SIZE; LONG	Global environmental change is expected to alter selection pressures in many biological systems(1-3), but the long-term molecular and life history data required to quantify changes in selection are rare(4). An unusual opportunity is afforded by three decades of individual-based data collected from a declining population of Antarctic fur seals in the South Atlantic. Here, climate change has reduced prey availability and caused a significant decline in seal birth weight. However, the mean age and size of females recruiting into the breeding population are increasing. We show that such females have significantly higher heterozygosity (a measure of within-individual genetic variation) than their non-recruiting siblings and their own mothers. Thus, breeding female heterozygosity has increased by 8.5% per generation over the last two decades. Nonetheless, as heterozygosity is not inherited from mothers to daughters, substantial heterozygote advantage is not transmitted from one generation to the next and the decreasing viability of homozygous individuals causes the population to decline. Our results provide compelling evidence that selection due to climate change is intensifying, with far-reaching consequences for demography as well as phenotypic and genetic variation.	[Forcada, Jaume] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Hoffman, Joseph Ivan] Univ Bielefeld, Dept Anim Behav, D-33501 Bielefeld, Germany	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Bielefeld	Forcada, J (corresponding author), British Antarctic Survey, Nat Environm Res Council, Madingley Rd, Cambridge CB3 0ET, England.	jfor@bas.ac.uk	Forcada, Jaume/GYU-0677-2022; Hoffman, Joseph i/K-7725-2012	Hoffman, Joseph i/0000-0001-5895-8949	Marie Curie FP7-Reintegration-Grant within the 7th European Community Framework Programme [PCIG-GA-2011-303618]; Deutsche Forschungsgemeinschaft standard grant [HO 5122/3-1]	Marie Curie FP7-Reintegration-Grant within the 7th European Community Framework Programme; Deutsche Forschungsgemeinschaft standard grant	The authors thank the many fieldworkers who have contributed to data collection over the years. We are also grateful to W. Amos, J. Bascompte, M. Boerner, K. Dasmahapatra, O. Kruger and I. Staniland for advice and feedback on the manuscript, together with T. Coulson for helpful referee comments. This work contributes to the Long Term Monitoring and Survey project and Ecosystems project of the British Antarctic Survey, Natural Environment Research Council, part of the Polar Science for Planet Earth programme. The genetic work was supported by a Marie Curie FP7-Reintegration-Grant within the 7th European Community Framework Programme (PCIG-GA-2011-303618) and a Deutsche Forschungsgemeinschaft standard grant (HO 5122/3-1) awarded to J.I.H.	Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Caswell H., 2001, MATRIX POPULATION MO, V2nd; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Coulson T, 2010, J ANIM ECOL, V79, P1226, DOI 10.1111/j.1365-2656.2010.01734.x; Di Fonzo MMI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019667; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.2307/177370; Eberhardt LL, 2002, ECOLOGY, V83, P2841, DOI 10.1890/0012-9658(2002)083[2841:APFPAO]2.0.CO;2; Forcada J, 2005, ECOLOGY, V86, P2408, DOI 10.1890/04-1153; Forcada J, 2008, GLOBAL CHANGE BIOL, V14, P2473, DOI 10.1111/j.1365-2486.2008.01678.x; Franks SJ, 2012, ANNU REV GENET, V46, P185, DOI 10.1146/annurev-genet-110711-155511; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Hoffman JI, 2007, NATURE, V445, P912, DOI 10.1038/nature05558; Hoffman JI, 2012, MOL ECOL RESOUR, V12, P861, DOI 10.1111/j.1755-0998.2012.03158.x; Hoffman JI, 2004, EVOLUTION, V58, P2087; Hoffman JI, 2014, P NATL ACAD SCI USA, V111, P3775, DOI 10.1073/pnas.1318945111; Hoffman JI, 2010, J HERED, V101, P527, DOI 10.1093/jhered/esq045; Hoffmann AA, 2000, BIOSCIENCE, V50, P217, DOI 10.1641/0006-3568(2000)050[0217:ESAAEF]2.3.CO;2; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; JIMENEZ JA, 1994, SCIENCE, V266, P271, DOI 10.1126/science.7939661; Meredith MP, 2008, DEEP-SEA RES PT II, V55, P2007, DOI 10.1016/j.dsr2.2008.05.020; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; MITTON JB, 1993, HEREDITY, V71, P59, DOI 10.1038/hdy.1993.107; Murphy EJ, 2007, P ROY SOC B-BIOL SCI, V274, P3057, DOI 10.1098/rspb.2007.1180; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; SAMOLLOW PB, 1983, EVOLUTION, V37, P646, DOI 10.1111/j.1558-5646.1983.tb05584.x; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x	26	99	104	1	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					462	+		10.1038/nature13542	http://dx.doi.org/10.1038/nature13542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25056064				2022-12-01	WOS:000339335700045
J	Chi, BH; Thirumurthy, H; Stringer, JSA				Chi, Benjamin H.; Thirumurthy, Harsha; Stringer, Jeffrey S. A.			Maximizing Benefits of New Strategies to Prevent Mother-to-Child HIV Transmission Without Harming Existing Services	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AFRICA		[Chi, Benjamin H.; Thirumurthy, Harsha; Stringer, Jeffrey S. A.] Univ N Carolina, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill	Chi, BH (corresponding author), POB 34681,5032 Great North Rd, Lusaka, Zambia.	bchi@med.unc.edu	Stringer, Jeffrey S. A./AAU-2342-2021	Thirumurthy, Harsha/0000-0002-3308-7603; Stringer, Jeffrey/0000-0002-9590-7216	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD075131, K01HD061605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI050410] Funding Source: Medline; NICHD NIH HHS [P2C HD050924, K01 HD061605, R01 HD075131] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Duber HC, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-21; Goodson JL, 2013, JAIDS-J ACQ IMM DEF, V63, pE9, DOI 10.1097/QAI.0b013e31828a3e3f; Grepin KA, 2012, HEALTH AFFAIR, V31, P1406, DOI 10.1377/hlthaff.2012.0279; Nelson LJ, 2014, AIDS, V28, pS217, DOI 10.1097/QAD.0000000000000239; Rasschaert Freya, 2011, J Int AIDS Soc, V14 Suppl 1, pS3, DOI 10.1186/1758-2652-14-S1-S3; Shiffman J, 2008, HEALTH POLICY PLANN, V23, P95, DOI 10.1093/heapol/czm045; Topp SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011522	8	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					341	342		10.1001/jama.2014.6929	http://dx.doi.org/10.1001/jama.2014.6929			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038348	Green Accepted			2022-12-01	WOS:000339257800016
J	Sandler, VM; Lis, R; Liu, Y; Kedem, A; James, D; Elemento, O; Butler, JM; Scandura, JM; Rafii, S				Sandler, Vladislav M.; Lis, Raphael; Liu, Ying; Kedem, Alon; James, Daylon; Elemento, Olivier; Butler, Jason M.; Scandura, Joseph M.; Rafii, Shahin			Reprogramming human endothelial cells to haematopoietic cells requires vascular induction	NATURE			English	Article							STEM-CELLS; HAEMOGENIC ENDOTHELIUM; ANGIOCRINE SIGNALS; PROGENITOR CELLS; SELF-RENEWAL; CORD BLOOD; B-CELLS; DIFFERENTIATION; REGENERATION; NICHE	Generating engraftable human haematopoietic cells from autologous tissues is a potential route to new therapies for blood diseases. However, directed differentiation of pluripotent stem cells yields haematopoietic cells that engraft poorly. Here, we have devised a method to phenocopy the vascular-niche microenvironment of haemogenic cells, thereby enabling reprogramming of human endothelial cells into engraftable haematopoietic cells without transition through a pluripotent intermediate. Highly purifiednon-haemogenic human umbilical vein endothelial cells or adult dermalmicrovascular endothelial cells were transduced with the transcription factors FOSB, GFI1, RUNX1 and SPI1 (hereafter referred to as FGRS), and then propagated on serum-free instructive vascular niche monolayers to induce outgrowth of haematopoietic colonies containing cells with functional and immunophenotypic features of multipotent progenitor cells (MPPs). These endothelial cells that have been reprogrammed into human MPPs (rEC-hMPPs) acquire colony-forming-cell potential and durably engraft into immune-deficient mice after primary and secondary transplantation, producing long-term rEC-hMPP-derived myeloid (granulocytic/monocytic, erythroid, megakaryocytic) and lymphoid (natural killer and B cell) progenies. Conditional expression of FGRS transgenes, combined with vascular induction, activates endogenous FGRS genes, endowing rEC-hMPPs with a transcriptional and functional profile similar to that of self-renewing MPPs. Our approach underscores the role of inductive cues from the vascular niche in coordinating and sustaining haematopoietic specification and may prove useful for engineering autologous haematopoietic grafts to treat inherited and acquired blood disorders.	[Sandler, Vladislav M.; Lis, Raphael; Liu, Ying; Kedem, Alon; James, Daylon; Butler, Jason M.; Rafii, Shahin] Weill Cornell Med Coll, Ansary Stem Cell Inst, Dept Med Genet, New York, NY 10065 USA; [Sandler, Vladislav M.; Lis, Raphael; Liu, Ying; Kedem, Alon; James, Daylon; Butler, Jason M.; Rafii, Shahin] Weill Cornell Med Coll, Howard Hughes Med Inst, New York, NY 10065 USA; [Lis, Raphael; Kedem, Alon; James, Daylon] Weill Cornell Med Coll, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA; [Elemento, Olivier] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10065 USA; [Scandura, Joseph M.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Scandura, Joseph M.] New York Presbyterian Hosp, New York, NY 10065 USA	Cornell University; Cornell University; Howard Hughes Medical Institute; Cornell University; Cornell University; Cornell University; NewYork-Presbyterian Hospital	Rafii, S (corresponding author), Weill Cornell Med Coll, Ansary Stem Cell Inst, Dept Med Genet, New York, NY 10065 USA.	srafii@med.cornell.edu		Scandura, Joseph/0000-0002-9525-143X; Rafii, Shahin/0000-0001-5605-1067	Empire State Stem Cell Board (ESSCB); New York State Department of Health [NYSDH C026878]; Ansary Stem Cell Institute (ASCI); HHMI; ESSCB/NYSDH [C024180, C026438, C026878, C028117]; NHLBI [R01HL097797, R01HL119872, U01 HL099997, HL119872, HL055748, U01-HL099997]; NIDDK [R01DK095039]; NCI [U54CA163167, CA159175, CA163167]; Qatar National Priorities Research Foundation [NPRP08-663-3-140]; Qatar Foundation BioMedical Research Program; Starr Foundation and a Leukemia & Lymphoma Society Scholar award; American Society of Hematology Scholar Award; Angiocrine Bioscience; ASCI; NATIONAL CANCER INSTITUTE [U54CA163167, R21CA159175] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097797, R01HL119872, U01HL099997, R01HL115128, R01HL055748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095039] Funding Source: NIH RePORTER	Empire State Stem Cell Board (ESSCB); New York State Department of Health; Ansary Stem Cell Institute (ASCI); HHMI(Howard Hughes Medical Institute); ESSCB/NYSDH; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Qatar National Priorities Research Foundation; Qatar Foundation BioMedical Research Program(Qatar National Research Fund (QNRF)); Starr Foundation and a Leukemia & Lymphoma Society Scholar award; American Society of Hematology Scholar Award; Angiocrine Bioscience; ASCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	V.M.S. is supported by Empire State Stem Cell Board (ESSCB) and New York State Department of Health (NYSDH C026878). S. R. is supported by Ansary Stem Cell Institute (ASCI), HHMI, ESSCB/NYSDH (C024180, C026438, C026878, C028117), NHLBI (R01HL097797, R01HL119872, U01 HL099997), NIDDK (R01DK095039), NCI (U54CA163167), Qatar National Priorities Research Foundation grant NPRP08-663-3-140 and the Qatar Foundation BioMedical Research Program. J.M.S. is supported by grants from NCI (CA159175 and CA163167), NHLBI (HL119872 and HL055748), Starr Foundation and a Leukemia & Lymphoma Society Scholar award. J.M.B. is supported by an American Society of Hematology Scholar Award, NHLBI U01-HL099997 and Angiocrine Bioscience and ASCI. We acknowledge the contribution of J. Z. Xiang and Agnes J. Viale for enabling and executing molecular profiling, and E. Gars for technical support. We appreciate W. Schachterle for recommendations and edits of the manuscript.	Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Butler JM, 2012, BLOOD, V120, P1344, DOI 10.1182/blood-2011-12-398115; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Chao MP, 2008, COLD SH Q B, V73, P439, DOI 10.1101/sqb.2008.73.031; Chen MJ, 2011, CELL STEM CELL, V9, P541, DOI 10.1016/j.stem.2011.10.003; Choi KD, 2012, CELL REP, V2, P553, DOI 10.1016/j.celrep.2012.08.002; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Doan PL, 2013, STEM CELLS, V31, P327, DOI 10.1002/stem.1275; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Ginsberg M, 2012, CELL, V151, P559, DOI 10.1016/j.cell.2012.09.032; Gordon-Keylock S, 2013, BLOOD, V122, P2338, DOI 10.1182/blood-2012-12-470971; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Lancrin C, 2012, BLOOD, V120, P314, DOI 10.1182/blood-2011-10-386094; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Marcelo KL, 2013, DEV CELL, V27, P504, DOI 10.1016/j.devcel.2013.11.004; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Poulos MG, 2013, CELL REP, V4, P1022, DOI 10.1016/j.celrep.2013.07.048; RAFII S, 1994, BLOOD, V84, P10; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Rafii S, 2013, BLOOD, V121, P770, DOI 10.1182/blood-2012-07-444208; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Sandler VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018265; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; Sturgeon CM, 2013, NAT BIOTECHNOL, V31, P416, DOI 10.1038/nbt.2571; Swiers G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3924; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Wu X, 2007, STEM CELLS, V25, P2770, DOI 10.1634/stemcells.2006-0783; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yoshimoto M, 2008, CELL STEM CELL, V3, P583, DOI 10.1016/j.stem.2008.11.002; Zou GM, 2005, P NATL ACAD SCI USA, V102, P13236, DOI 10.1073/pnas.0506218102; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	43	154	164	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					312	+		10.1038/nature13547	http://dx.doi.org/10.1038/nature13547			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030167	Green Accepted			2022-12-01	WOS:000338992200028
J	Eisenstein, M				Eisenstein, Michael			NEUROBIOLOGY Unrestrained excitement	NATURE			English	Editorial Material																		Christian CA, 2013, P NATL ACAD SCI USA, V110, P20278, DOI 10.1073/pnas.1318031110; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Schevon CA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2056; Wykes RC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004190	4	5	5	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					S4	S6		10.1038/511S4a	http://dx.doi.org/10.1038/511S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25019125	Bronze			2022-12-01	WOS:000338649800002
J	Kapoor, A				Kapoor, Akhil			PERSONAL VIEW A train offers hope to Punjab's patients with cancer but it isn't enough	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Sardar Patel Med Coll & Hosp, Acharya Tulsi Reg Canc Treatment & Res Ctr, Dept Radiat Oncol, Bikaner 334003, Rajasthan, India	Sardar Patel Medical College, Bikaner	Kapoor, A (corresponding author), Sardar Patel Med Coll & Hosp, Acharya Tulsi Reg Canc Treatment & Res Ctr, Dept Radiat Oncol, Bikaner 334003, Rajasthan, India.	kapoorakhil1987@gmail.com	Kapoor, Akhil/H-4224-2019	Kapoor, Akhil/0000-0001-6006-2631				Government of Punjab, 2013, STAT WID DOOR DOOR C; Indian Railways, CONC RUL; Kaur J., 2012, GOVERNANCE NOW  0420; Kaur Raminderjeet, 2011, Indian J Hum Genet, V17, P179, DOI 10.4103/0971-6866.92100; Mallath MK, 2014, LANCET ONCOL, V15, pE205, DOI 10.1016/S1470-2045(14)70115-9; Nayak R., 2013, HLTH SITE       0130; Sandhu K., 2009, TRIBUNE INDIA   1001; US Environmental Protection Agency, BANN SEV RESTR PEST; US Library of Congress, COUNTR STUD	9	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2014	349								g4484	10.1136/bmj.g4484	http://dx.doi.org/10.1136/bmj.g4484			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZB	25005259				2022-12-01	WOS:000338993300010
J	Liu, E; Lee, HS; Aronsson, CA; Hagopian, WA; Koletzko, S; Rewers, MJ; Eisenbarth, GS; Bingley, PJ; Bonifacio, E; Simell, V; Agardh, D				Liu, Edwin; Lee, Hye-Seung; Aronsson, Carin A.; Hagopian, William A.; Koletzko, Sibylle; Rewers, Marian J.; Eisenbarth, George S.; Bingley, Polly J.; Bonifacio, Ezio; Simell, Ville; Agardh, Daniel		TEDDY Study Grp	Risk of Pediatric Celiac Disease According to HLA Haplotype and Country	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE DOSAGE; AUTOIMMUNITY; ANTIBODIES; CHILDHOOD; CHILDREN; GLUTEN	Background The presence of HLA haplotype DR3-DQ2 or DR4-DQ8 is associated with an increased risk of celiac disease. In addition, nearly all children with celiac disease have serum antibodies against tissue transglutaminase (tTG). Methods We studied 6403 children with HLA haplotype DR3-DQ2 or DR4-DQ8 prospectively from birth in the United States, Finland, Germany, and Sweden. The primary end point was the development of celiac disease autoimmunity, which was defined as the presence of tTG antibodies on two consecutive tests at least 3 months apart. The secondary end point was the development of celiac disease, which was defined for the purpose of this study as either a diagnosis on biopsy or persistently high levels of tTG antibodies. Results The median follow-up was 60 months (interquartile range, 46 to 77). Celiac disease autoimmunity developed in 786 children (12%). Of the 350 children who underwent biopsy, 291 had confirmed celiac disease; an additional 21 children who did not undergo biopsy had persistently high levels of tTG antibodies. The risks of celiac disease autoimmunity and celiac disease by the age of 5 years were 11% and 3%, respectively, among children with a single DR3-DQ2 haplotype, and 26% and 11%, respectively, among those with two copies (DR3-DQ2 homozygosity). In the adjusted model, the hazard ratios for celiac disease autoimmunity were 2.09 (95% confidence interval [CI], 1.70 to 2.56) among heterozygotes and 5.70 (95% CI, 4.66 to 6.97) among homozygotes, as compared with children who had the lowest-risk genotypes (DR4-DQ8 heterozygotes or homozygotes). Residence in Sweden was also independently associated with an increased risk of celiac disease autoimmunity (hazard ratio, 1.90; 95% CI, 1.61 to 2.25). Conclusions Children with the HLA haplotype DR3-DQ2, especially homozygotes, were found to be at high risk for celiac disease autoimmunity and celiac disease early in childhood. The higher risk in Sweden than in other countries highlights the importance of studying environmental factors associated with celiac disease. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others.)	[Liu, Edwin] Univ Colorado Denver, Digest Hlth Inst, Childrens Hosp Colorado, Aurora, CO USA; [Liu, Edwin; Rewers, Marian J.; Eisenbarth, George S.] Univ Colorado Denver, Barbara Davis Ctr, Aurora, CO USA; [Lee, Hye-Seung] Univ S Florida, Pediat Epidemiol Ctr, Tampa, FL USA; [Aronsson, Carin A.; Agardh, Daniel] Lund Univ, Diabet & Celiac Dis Unit, Dept Clin Sci, Malmo, Sweden; [Hagopian, William A.] Pacific Northwest Diabet Res Inst, Seattle, WA USA; [Koletzko, Sibylle] Univ Munich, Dr Von Haunerschen Kinderspital, D-80337 Munich, Germany; [Bonifacio, Ezio] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany; [Bonifacio, Ezio] Helmholz Zentrum Munchen, Forschergrp Diabet, Neuherberg, Germany; [Bingley, Polly J.] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Simell, Ville] Univ Turku, Dept Pediat, Turku Univ Hosp, Turku, Finland	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; State University System of Florida; University of South Florida; Lund University; Pacific Northwest Diabetes Research Institute (PNDRI); University of Munich; Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bristol; University of Turku	Agardh, D (corresponding author), Skane Univ Hosp SUS, Dept Pediat, Diabet & Celiac Dis Unit, Entrance 72 60 10, SE-20502 Malmo, Sweden.	daniel.agardh@med.lu.se	Ziegler, Anette-Gabriele/M-4614-2014; Bonifacio, Ezio/E-7700-2010	Ziegler, Anette-Gabriele/0000-0002-6290-5548; Bonifacio, Ezio/0000-0002-8704-4713; Virtanen, Suvi/0000-0001-8928-0878; Kurppa, Kalle/0000-0003-4757-2164; Hyoty, Heikki/0000-0003-0370-4145; Elding Larsson, Helena/0000-0003-3306-1742; Carreno, Gabriela/0000-0003-4725-6225; Ilonen, Jorma/0000-0002-9973-2062; Knip, Mikael/0000-0003-0474-0033; Ridewood, Sophie/0000-0002-1845-361X	National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064, UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK063865, UC4DK063861, UC4DK063863, U01DK063861, U01DK063821, UC4DK063829, U01DK063829, UC4DK063836, UC4DK095300, U01DK063865, U01DK063836, U01DK063863, U01DK063790, UC4DK063821] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others.	Andren Aronsson C, 2013, MATERN CHILD NUTR; Bazzigaluppi E, 1999, J AUTOIMMUN, V12, P51, DOI 10.1006/jaut.1998.0253; Hagopian WA, 2011, PEDIATR DIABETES, V12, P733, DOI 10.1111/j.1399-5448.2011.00774.x; Hoffenberg EJ, 2000, J PEDIATR-US, V137, P356, DOI 10.1067/mpd.2000.107582; Hoffenberg EJ, 2003, J PEDIATR-US, V143, P308, DOI 10.1067/S0022-3476(03)00282-8; Hummel M, 2000, DIABETOLOGIA, V43, P1005, DOI 10.1007/s001250051483; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Ivarsson A, 2000, ACTA PAEDIATR, V89, P165, DOI 10.1080/080352500750028771; Krischer J, 2007, PEDIATR DIABETES, V8, P286; Lernmark B, 2011, CONTEMP CLIN TRIALS, V32, P517, DOI 10.1016/j.cct.2011.03.009; Li M, 2009, AM J GASTROENTEROL, V104, P154, DOI 10.1038/ajg.2008.8; Margaritte-Jeannin P, 2004, TISSUE ANTIGENS, V63, P562, DOI 10.1111/j.0001-2815.2004.00237.x; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Murray JA, 2007, CLIN GASTROENTEROL H, V5, P1406, DOI 10.1016/j.cgh.2007.08.013; Norris JM, 2005, JAMA-J AM MED ASSOC, V293, P2343, DOI 10.1001/jama.293.19.2343; PLOSKI R, 1993, TISSUE ANTIGENS, V41, P173, DOI 10.1111/j.1399-0039.1993.tb01998.x; Simell S, 2005, SCAND J GASTROENTERO, V40, P1182, DOI 10.1080/00365520510024034; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Stene LC, 2006, AM J GASTROENTEROL, V101, P2333, DOI 10.1111/j.1572-0241.2006.00741.x; Vehik K, 2013, DIABETES-METAB RES, V29, P557, DOI 10.1002/dmrr.2427; Zubillaga P, 2002, J PEDIATR GASTR NUTR, V34, P548, DOI 10.1097/00005176-200205000-00014	21	196	202	0	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2014	371	1					42	49		10.1056/NEJMoa1313977	http://dx.doi.org/10.1056/NEJMoa1313977			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK2RA	24988556	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000338265700008
J	Lopez-Rios, J; Duchesne, A; Speziale, D; Andrey, G; Peterson, KA; Germann, P; Unal, E; Liu, J; Floriot, S; Barbey, S; Gallard, Y; Muller-Gerbl, M; Courtney, AD; Klopp, C; Rodriguez, S; Ivanek, R; Beisel, C; Wicking, C; Iber, D; Robert, B; McMahon, AP; Duboule, D; Zeller, R				Lopez-Rios, Javier; Duchesne, Amandine; Speziale, Dario; Andrey, Guillaume; Peterson, Kevin A.; Germann, Philipp; Uenal, Erkan; Liu, Jing; Floriot, Sandrine; Barbey, Sarah; Gallard, Yves; Mueller-Gerbl, Magdalena; Courtney, Andrew D.; Klopp, Christophe; Rodriguez, Sabrina; Ivanek, Robert; Beisel, Christian; Wicking, Carol; Iber, Dagmar; Robert, Benoit; McMahon, Andrew P.; Duboule, Denis; Zeller, Rolf			Attenuated sensing of SHH by Ptch1 underlies evolution of bovine limbs	NATURE			English	Article							GENE REGULATORY NETWORKS; SONIC-HEDGEHOG; BAC LIBRARY; DEVELOPMENTAL BASIS; DIGIT NUMBER; EXPRESSION; CONSTRUCTION; RANGE; MORPHOGEN; REDUCTION	The large spectrum of limb morphologies reflects the wide evolutionary diversification of the basic pentadactyl pattern in tetrapods. In even-toed ungulates (artiodactyls, including cattle), limbs are adapted for running as a consequence of progressive reduction of their distal skeleton to symmetrical and elongated middle digits with hoofed phalanges. Here we analyse bovine embryos to establish that polarized gene expression is progressively lost during limb development in comparison to the mouse. Notably, the transcriptional upregulation of the Ptch1 gene, which encodes a Sonic hedgehog (SHH) receptor, is disrupted specifically in the bovine limb bud mesenchyme. This is due to evolutionary alteration of a Ptch1 cis-regulatory module, which no longer responds to graded SHH signalling during bovine handplate development. Our study provides a molecular explanation for the loss of digit asymmetry in bovine limb buds and suggests that modifications affecting the Ptch1 cis-regulatory landscape have contributed to evolutionary diversification of artiodactyl limbs.	[Lopez-Rios, Javier; Duchesne, Amandine; Speziale, Dario; Uenal, Erkan; Ivanek, Robert; Zeller, Rolf] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland; [Duchesne, Amandine; Floriot, Sandrine; Rodriguez, Sabrina] INRA, Genet Anim & Biol Integrat, F-78350 Jouy En Josas, France; [Andrey, Guillaume; Duboule, Denis] Fed Inst Technol Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Peterson, Kevin A.; Liu, Jing; McMahon, Andrew P.] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA 90089 USA; [Germann, Philipp; Uenal, Erkan; Beisel, Christian; Iber, Dagmar] Fed Inst Technol Zurich, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Germann, Philipp; Uenal, Erkan; Ivanek, Robert; Beisel, Christian; Iber, Dagmar] Swiss Inst Bioinformat, CH-4058 Basel, Switzerland; [Barbey, Sarah; Gallard, Yves] INRA, Domaine Expt Pin Haras, F-61310 Exmes, France; [Mueller-Gerbl, Magdalena] Univ Basel, Dept Biomed, Inst Anat, CH-4056 Basel, Switzerland; [Courtney, Andrew D.; Wicking, Carol] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Klopp, Christophe] INRA, Biometrie & Intelligence Artificielle, F-31326 Castanet Tolosan, France; [Robert, Benoit] Inst Pasteur, F-75015 Paris, France; [Robert, Benoit] CNRS, URA 2578, F-75015 Paris, France; [Duboule, Denis] Univ Geneva, Dept Genet & Evolut, CH-1211 Geneva, Switzerland	University of Basel; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Southern California; Swiss Institute of Bioinformatics; INRAE; University of Basel; University of Queensland; INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of Geneva	Zeller, R (corresponding author), Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland.	amandine.duchesne@jouy.inra.fr; rolf.zeller@unibas.ch	Andrey, Guillaume/AAL-4397-2020; McMahon, Andrew P/ABE-7520-2020; Iber, Dagmar/V-2846-2019; Zeller, Rolf/C-2610-2013; Germann, Philipp/M-6769-2015; Lopez-Rios, Javier/D-8094-2014; Klopp, Christophe/J-3164-2019; Wicking, Carol/J-1814-2014	Iber, Dagmar/0000-0001-8051-1035; Zeller, Rolf/0000-0002-3186-7403; Germann, Philipp/0000-0002-2057-4883; Lopez-Rios, Javier/0000-0001-6731-3798; Klopp, Christophe/0000-0001-7126-5477; Wicking, Carol/0000-0002-7225-3803; duboule, denis/0000-0001-9961-2960; Ivanek, Robert/0000-0002-8403-056X; Andrey, Guillaume/0000-0002-0911-4907; Beisel, Christian/0000-0001-5360-2193; Duchesne, Amandine/0000-0002-9713-2274	SNF [31003A_130803/146248]; University of Basel; EU [PERG-GA-2009-246576]; SystemsX.ch iPhD Grant [20101078]; INRA; ANR grant [06-MRAR-027-01]; EPFL; ERC grant SystemsHox.ch; NIH grant [NS 033642]; Australian National Health; Medical Research Council [569713]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033642, R01NS033642] Funding Source: NIH RePORTER	SNF; University of Basel; EU(European Commission); SystemsX.ch iPhD Grant; INRA; ANR grant(French National Research Agency (ANR)); EPFL; ERC grant SystemsHox.ch; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Cooper and C. Tabin for sharing their results before publication and providing camel genomic DNA. Dolphin samples were received from C. Frere and D. Duffield. Pigmy hippopotamus mouth swabs for DNA extraction were provided by S. Furrer and B. Zimmerman from the Zoo of Zurich, whereas all other artiodactyl blood samples were donated from available frozen stocks by S. and M. Hoby from the Zoo of Basel. B. Wainwright provided the Ptch1 conditional mouse line. We are grateful to E. Terszowska and A. Offinger for mouse care; V. Metis and M. Rondon for assistance in colony maintenance and collection of Prx1-Cre Ptch1<SUP>Delta c/Delta c</SUP> mouse embryos; and N. Dumesnil for assistance in collecting bovine embryos. All lentivector-mediated transgenic mouse embryos were produced by the EPFL transgenic platform, whereas conventional mouse transgenic embryos were produced commercially by Cyagen Biosciences Inc. We thank S. Beck-Cormier, A. Gritli-Linde, D. Haag-Wackernagel, Y. Lallemand, P. Zimmermann, G. Nusspaumer and A. Zuniga for technical advice and input and M. Bertaud, I. Ginez, D. Jardet and M. Moroldo for technical assistance. We are grateful to V. Taylor and members of our research groups for critical discussions and input on the manuscript. This research was supported by SNF grants 31003A_130803/146248 and the University of Basel (to R.Z.), EU reintegration grant PERG-GA-2009-246576 (to J.L.-R.), SystemsX.ch iPhD Grant 20101078 (to D.I. and R.Z.), INRA (to A.D.), ANR grant No. 06-MRAR-027-01 (to B.R.), the EPFL and ERC grant SystemsHox.ch (to D.D.), NIH grant no. NS 033642 (to A.P.M.) and Australian National Health and Medical Research Council grant no. 569713 (to C.W.).	Benazet JD, 2009, SCIENCE, V323, P1050, DOI 10.1126/science.1168755; Bouldin CM, 2010, P NATL ACAD SCI USA, V107, P5489, DOI 10.1073/pnas.0912818107; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Budras K-D, 2011, BOVINE ANATOMY, Vsecond; Butterfield NC, 2009, DEVELOPMENT, V136, P3515, DOI 10.1242/dev.037507; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Clifford AB, 2010, J VERTEBR PALEONTOL, V30, P1827, DOI 10.1080/02724634.2010.521216; Cooper K. L., NATURE IN PRESS; Cotney J, 2012, GENOME RES, V22, P1069, DOI 10.1101/gr.129817.111; Cretekos CJ, 2008, GENE DEV, V22, P141, DOI 10.1101/gad.1620408; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; de Bakker MAG, 2013, NATURE, V500, P445, DOI 10.1038/nature12336; Eggen A, 2001, GENET SEL EVOL, V33, P543, DOI 10.1051/gse:2001132; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Friedli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015741; Galli A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000901; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gritli-Linde A, 2001, DEV BIOL, V236, P364, DOI 10.1006/dbio.2001.0336; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Koyama E, 2001, DEV DYNAM, V222, P178, DOI 10.1002/dvdy.1186; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lopez-Rios J, 2012, DEV CELL, V22, P837, DOI 10.1016/j.devcel.2012.01.006; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Polly P. David, 2007, P245; Prothero D.R., 2007, EVOLUTION ARTIODACTY; Quintana Laura, 2011, Cold Spring Harb Protoc, V2011, P664, DOI 10.1101/pdb.prot5639; Rogel-Gaillard C, 1999, CYTOGENET CELL GENET, V85, P205, DOI 10.1159/000015294; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Ross DGF, 2009, SEX DEV, V3, P273, DOI 10.1159/000252791; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Sagai T, 2004, MAMM GENOME, V15, P23, DOI 10.1007/s00335-033-2317-5; Sanz-Ezquerro JJ, 2003, CURR BIOL, V13, P1830, DOI 10.1016/j.cub.2003.09.040; Schibler L, 1998, MAMM GENOME, V9, P119, DOI 10.1007/s003359900701; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sears KE, 2011, EVOL DEV, V13, P533, DOI 10.1111/j.1525-142X.2011.00509.x; Shapiro MD, 2003, J EXP ZOOL PART B, V297B, P48, DOI 10.1002/jez.b.00019; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Spaulding M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007062; Stern DL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0028; Stern DL, 2013, NAT REV GENET, V14, P751, DOI 10.1038/nrg3483; Vaiman D, 1999, MAMM GENOME, V10, P585, DOI 10.1007/s003359901049; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/nmeth.2173, 10.1038/NMETH.2173]; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; van den Brandt J, 2004, GENESIS, V39, P94, DOI 10.1002/gene.20037; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Welscher PT, 2002, GENE DEV, V16, P421, DOI 10.1101/gad.219202; Woltering JM, 2010, DEV CELL, V18, P526, DOI 10.1016/j.devcel.2010.04.002; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	62	75	76	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					46	+		10.1038/nature13289	http://dx.doi.org/10.1038/nature13289			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990743				2022-12-01	WOS:000338199400032
J	Taylor, RW; Pyle, A; Griffin, H; Blakely, EL; Duff, J; He, LP; Smertenko, T; Alston, CL; Neeve, VC; Best, A; Yarham, JW; Kirschner, J; Schara, U; Talim, B; Topaloglu, H; Baric, I; Holinski-Feder, E; Abicht, A; Czermin, B; Kleinle, S; Morris, AAM; Vassallo, G; Gorman, GS; Ramesh, V; Turnbull, DM; Santibanez-Koref, M; McFarland, R; Horvath, R; Chinnery, PF				Taylor, Robert W.; Pyle, Angela; Griffin, Helen; Blakely, Emma L.; Duff, Jennifer; He, Langping; Smertenko, Tania; Alston, Charlotte L.; Neeve, Vivienne C.; Best, Andrew; Yarham, John W.; Kirschner, Janbernd; Schara, Ulrike; Talim, Beril; Topaloglu, Haluk; Baric, Ivo; Holinski-Feder, Elke; Abicht, Angela; Czermin, Birgit; Kleinle, Stephanie; Morris, Andrew A. M.; Vassallo, Grace; Gorman, Grainne S.; Ramesh, Venkateswaran; Turnbull, Douglass M.; Santibanez-Koref, Mauro; McFarland, Robert; Horvath, Rita; Chinnery, Patrick F.			Use of Whole-Exome Sequencing to Determine the Genetic Basis of Multiple Mitochondrial Respiratory Chain Complex Deficiencies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRANSFER-RNA SYNTHETASE; SIDEROBLASTIC ANEMIA-MLASA; HYPERTROPHIC CARDIOMYOPATHY; LACTIC-ACIDOSIS; I DEFICIENCY; TRANSLATION DEFECT; HIGH-THROUGHPUT; RMND1 MUTATION; DISORDERS; DISEASE	IMPORTANCE Mitochondrial disorders have emerged as a common cause of inherited disease, but their diagnosis remains challenging. Multiple respiratory chain complex defects are particularly difficult to diagnose at the molecular level because of the massive number of nuclear genes potentially involved in intramitochondrial protein synthesis, with many not yet linked to human disease. OBJECTIVE To determine the molecular basis of multiple respiratory chain complex deficiencies. DESIGN, SETTING, AND PARTICIPANTS We studied 53 patients referred to 2 national centers in the United Kingdom and Germany between 2005 and 2012. All had biochemical evidence of multiple respiratory chain complex defects but no primary pathogenic mitochondrial DNA mutation. Whole-exome sequencing was performed using 62-Mb exome enrichment, followed by variant prioritization using bioinformatic prediction tools, variant validation by Sanger sequencing, and segregation of the variant with the disease phenotype in the family. RESULTS Presumptive causal variants were identified in 28 patients (53%; 95% CI, 39%-67%) and possible causal variants were identified in 4 (8%; 95% CI, 2%-18%). Together these accounted for 32 patients (60% 95% CI, 46%-74%) and involved 18 different genes. These included recurrent mutations in RMND1, AARS2, and MTO1, each on a haplotype background consistent with a shared founder allele, and potential novel mutations in 4 possible mitochondrial disease genes (VARS2, GARS, FLAD1, and PTCD1). Distinguishing clinical features included deafness and renal involvement associated with RMND1 and cardiomyopathy with AARS2 and MTO1. However, atypical clinical features were present in some patients, including normal liver function and Leigh syndrome (subacute necrotizing encephalomyelopathy) seen in association with TRMU mutations and no cardiomyopathy with founder SCO2 mutations. It was not possible to confidently identify the underlying genetic basis in 21 patients (40%; 95% CI, 26%-54%). CONCLUSIONS AND RELEVANCE Exome sequencing enhances the ability to identify potential nuclear gene mutations in patients with biochemically defined defects affecting multiple mitochondrial respiratory chain complexes. Additional study is required in independent patient populations to determine the utility of this approach in comparison with traditional diagnostic methods.	[Taylor, Robert W.; Blakely, Emma L.; He, Langping; Alston, Charlotte L.; Yarham, John W.; Gorman, Grainne S.; Turnbull, Douglass M.; McFarland, Robert] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Pyle, Angela; Griffin, Helen; Duff, Jennifer; Smertenko, Tania; Neeve, Vivienne C.; Best, Andrew; Santibanez-Koref, Mauro; Horvath, Rita; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Kirschner, Janbernd] Univ Med Ctr Freiburg, Div Neuropediat & Muscle Disorders, Freiburg, Germany; [Schara, Ulrike] Univ Essen Gesamthsch, Dept Neuropediat, Essen, Germany; [Talim, Beril; Topaloglu, Haluk] Hacettepe Univ, Dept Pediat, Ankara, Turkey; [Baric, Ivo] Univ Zagreb, Sch Med, Univ Hosp Ctr Zagreb, Dept Paediat, Zagreb 41001, Croatia; [Holinski-Feder, Elke; Abicht, Angela; Czermin, Birgit; Kleinle, Stephanie] Ctr Med Genet, Munich, Germany; [Morris, Andrew A. M.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, Willink Biochem Genet Unit, Manchester, Lancs, England; [Vassallo, Grace] Cent Manchester Univ Hosp NHS Fdn Trust, Dept Paediat Neurol, Manchester, Lancs, England; [Ramesh, Venkateswaran; McFarland, Robert] Newcastle Upon Tyne Hosp NHS Trust, Dept Paediat Neurol, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; University of Freiburg; University of Duisburg Essen; Hacettepe University; University of Zagreb; University of Zagreb, School of Dental Medicine; University of Manchester; University of Manchester; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Chinnery, PF (corresponding author), Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Cent Pkwy, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	patrick.chinnery@ncl.ac.uk	Kirschner, Janbernd/Q-1493-2019; Horvath, Rita/AAY-7042-2020; Alston, Charlotte/ABG-9602-2020; Kirschner, Janbernd/H-7418-2016; TOPALOGLU, HALUK AYDIN/I-9318-2013	Kirschner, Janbernd/0000-0003-1618-7386; Alston, Charlotte/0000-0003-2095-5464; Kirschner, Janbernd/0000-0003-1618-7386; McFarland, Robert/0000-0002-8833-2688; Griffin, Helen R/0000-0002-5288-3322; Turnbull, Doug/0000-0002-8878-9901; Gorman, Grainne/0000-0002-7585-3409; Horvath, Rita/0000-0002-9841-170X; Chinnery, Patrick/0000-0002-7065-6617	Wellcome Trust Centre for Mitochondrial Research [096919Z/11/Z]; UK Medical Research Council Centre for Translational Muscle Diseases [G0601943]; Mitochondrial Disease Patient Cohort [G0800674]; UK Medical Research Council [G1000848]; European Research Council [309548]; Wellcome Trust Senior Fellow in Clinical Science [101876/Z/13/Z]; EU FP7 TIRCON; NIHR Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust; Newcastle University; MRC [MR/K000608/1, G0800674, MR/K006312/1, G1000848, G0601943] Funding Source: UKRI; Medical Research Council [G0800674, G1000848, MR/K006312/1, G0601943, MR/K000608/1] Funding Source: researchfish; National Institute for Health Research [NIHR-HCS-D12-03-04] Funding Source: researchfish; NIHR Newcastle Biomedical Research Centre [BH111030] Funding Source: researchfish	Wellcome Trust Centre for Mitochondrial Research(Wellcome Trust); UK Medical Research Council Centre for Translational Muscle Diseases(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Mitochondrial Disease Patient Cohort; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust Senior Fellow in Clinical Science(Wellcome Trust); EU FP7 TIRCON; NIHR Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust; Newcastle University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR Newcastle Biomedical Research Centre	Drs Taylor, Turnbull, and Chinnery receive support from the Wellcome Trust Centre for Mitochondrial Research (grant 096919Z/11/Z). Drs Taylor, Gorman, Turnbull, McFarland, Horvath, and Chinnery receive support from the UK Medical Research Council Centre for Translational Muscle Diseases (grant G0601943) and Mitochondrial Disease Patient Cohort (grant G0800674). Dr Horvath was supported by the UK Medical Research Council (grant G1000848) and the European Research Council (grant 309548). Dr Chinnery is a Wellcome Trust Senior Fellow in Clinical Science (grant 101876/Z/13/Z), is a UK National Institute for Health Research (NIHR) senior investigator, and receives additional support from EU FP7 TIRCON and the NIHR Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004; Baruffini E, 2013, HUM MUTAT, V34, P1501, DOI 10.1002/humu.22393; Brizio C, 2006, BIOCHEM BIOPH RES CO, V344, P1008, DOI 10.1016/j.bbrc.2006.04.003; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Garcia-Diaz B, 2012, AM J HUM GENET, V91, P729, DOI 10.1016/j.ajhg.2012.08.019; Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011; Gotz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006; Haack TB, 2013, AM J HUM GENET, V93, P211, DOI 10.1016/j.ajhg.2013.06.006; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; Haack TB, 2012, J MED GENET, V49, P83, DOI 10.1136/jmedgenet-2011-100577; Janer A, 2012, AM J HUM GENET, V91, P737, DOI 10.1016/j.ajhg.2012.08.020; Kemp JP, 2011, BRAIN, V134, P183, DOI 10.1093/brain/awq320; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40; McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2; McMillan HJ, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-36; Papadopoulou LC, 1999, NAT GENET, V23, P333; Rackham O, 2009, NUCLEIC ACIDS RES, V37, P5859, DOI 10.1093/nar/gkp627; Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001; Rotig A, 2010, DIABETES METAB, V36, P97, DOI 10.1016/j.diabet.2009.11.002; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Skladal D, 2000, J INHERIT METAB DIS, V23, P513, DOI 10.1023/A:1005620515996; Steenweg ME, 2012, ARCH NEUROL-CHICAGO, V69, P718, DOI 10.1001/archneurol.2011.1048; Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070; Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547; Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004	38	229	233	4	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					68	77		10.1001/jama.2014.7184	http://dx.doi.org/10.1001/jama.2014.7184			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK0UK	25058219	Green Accepted			2022-12-01	WOS:000338131100022
J	Gallant, JR; Traeger, LL; Volkening, JD; Moffett, H; Chen, PH; Novina, CD; Phillips, GN; Anand, R; Wells, GB; Pinch, M; Guth, R; Unguez, GA; Albert, JS; Zakon, HH; Samanta, MP; Sussman, MR				Gallant, Jason R.; Traeger, Lindsay L.; Volkening, Jeremy D.; Moffett, Howell; Chen, Po-Hao; Novina, Carl D.; Phillips, George N., Jr.; Anand, Rene; Wells, Gregg B.; Pinch, Matthew; Gueth, Robert; Unguez, Graciela A.; Albert, James S.; Zakon, Harold H.; Samanta, Manoj P.; Sussman, Michael R.			NONHUMAN GENETICS Genomic basis for the convergent evolution of electric organs	SCIENCE			English	Article							GROWTH; PROTEINS; SUBUNIT; MUSCLE; SIZE; EXPRESSION; MEMBRANES; DOGS	Little is known about the genetic basis of convergent traits that originate repeatedly over broad taxonomic scales. The myogenic electric organ has evolved six times in fishes to produce electric fields used in communication, navigation, predation, or defense. We have examined the genomic basis of the convergent anatomical and physiological origins of these organs by assembling the genome of the electric eel (Electrophorus electricus) and sequencing electric organ and skeletal muscle transcriptomes from three lineages that have independently evolved electric organs. Our results indicate that, despite millions of years of evolution and large differences in the morphology of electric organ cells, independent lineages have leveraged similar transcription factors and developmental and cellular pathways in the evolution of electric organs.	[Gallant, Jason R.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Gallant, Jason R.; Zakon, Harold H.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Traeger, Lindsay L.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Traeger, Lindsay L.; Volkening, Jeremy D.; Sussman, Michael R.] Univ Wisconsin, Biotechnol Ctr, Madison, WI 53706 USA; [Volkening, Jeremy D.; Sussman, Michael R.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Moffett, Howell; Chen, Po-Hao; Novina, Carl D.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Moffett, Howell; Chen, Po-Hao; Novina, Carl D.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Chen, Po-Hao; Novina, Carl D.] Broad Inst Harvard & MIT, Cambridge, MA 02141 USA; [Phillips, George N., Jr.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Phillips, George N., Jr.] Rice Univ, Dept Chem, Houston, TX 77005 USA; [Anand, Rene] Ohio State Univ, Coll Med, Dept Pharmacol, Wexner Med Ctr, Columbus, OH 43210 USA; [Anand, Rene] Ohio State Univ, Coll Med, Dept Neurosci, Wexner Med Ctr, Columbus, OH 43210 USA; [Wells, Gregg B.] Texas A&M Univ, Dept Mol & Cellular Med, College Stn, TX 77483 USA; [Pinch, Matthew; Gueth, Robert; Unguez, Graciela A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Albert, James S.] Univ Louisiana, Dept Biol, Lafayette, LA 70503 USA; [Zakon, Harold H.] Univ Texas Austin, Austin, TX 78712 USA; [Zakon, Harold H.] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Samanta, Manoj P.] Systemix Inst, Redmond, WA 98053 USA	Michigan State University; Michigan State University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rice University; Rice University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Texas A&M University System; Texas A&M University College Station; New Mexico State University; University of Louisiana Lafayette; University of Texas System; University of Texas Austin; Marine Biological Laboratory - Woods Hole	Zakon, HH (corresponding author), Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA.	h.zakon@austin.utexas.edu; manoj.samanta@systemix.org; msussman@wisc.edu	Wells, Gregg/AAU-7798-2021; Volkening, Jeremy/AAC-2454-2020; Gallant, Jason/A-9629-2015	Volkening, Jeremy/0000-0002-8892-7155; Gallant, Jason/0000-0002-6528-090X	NSF grant MCB [1144012]; NSF grant CNS [1248109]; NSF grant DEB [0741450]; W.M. Keck Foundation; NIH [R01 GM084879, R01 GM088670, 1SC1GM092297-01A1]; Texas A&M University Health Science Center College of Medicine; Cornell University Center for Vertebrate Genomics; University of Wisconsin Genetics NIH Graduate Training Grant; Morgridge Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM092297, R01GM084879, T32GM007133, R01GM088670] Funding Source: NIH RePORTER	NSF grant MCB; NSF grant CNS; NSF grant DEB; W.M. Keck Foundation(W.M. Keck Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas A&M University Health Science Center College of Medicine; Cornell University Center for Vertebrate Genomics; University of Wisconsin Genetics NIH Graduate Training Grant; Morgridge Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project has been funded in part by NSF grants MCB no. 1144012 (M.R.S.), CNS no. 1248109 (G.A.U.), and DEB no. 0741450 (J.S.A.); the W.M. Keck Foundation Distinguished Young Scholars in Medical Research (C.D.N.); NIH grants R01 GM084879 (H.H.Z.), R01 GM088670 (R.A.), and 1SC1GM092297-01A1 (G.A.U.); the Texas A&M University Health Science Center College of Medicine (G.B.W.); the Cornell University Center for Vertebrate Genomics (J.R.G.); the University of Wisconsin Genetics NIH Graduate Training Grant (L.L.T.); and the Morgridge Graduate Fellowship (J.D.V.). E. V. Armbrust provided computing assistance, and S. B. McKay assisted with data analysis. M. P. S. acknowledges useful discussions with R. Chikhi, R. Luo, and J. Simpson. We thank J. Bayliss for dissection of E. electricus and R. Amasino for help in preparing this manuscript. M. R. S. and L. L. T. acknowledge the guidance of J. Hyman, M. Adams, and J. Speers from the University of Wisconsin Biotechnology Center for their excellent assistance in E. electricus sequencing. The raw sequencing reads have been deposited in the National Center for Biotechnology Information short-read archive for the E. electricus genome (BioProject ID: PRJNA249073) and transcriptome sequences of E. electricus, S. macrurus, E. virescens, M. electricus, and B. brachyistius (BioProject ID: PRJNA248545). The whole-genome assemblies and annotation, together with the transcriptome assemblies, are available at http://efishgenomics.zoology.msu.edu, along with BLAST and genome-browsing services.	Albert J. S., 2005, PHYSL FISHES, P431; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Berry RG, 2007, CARDIOVASC RES, V73, P92, DOI 10.1016/j.cardiores.2006.11.006; BLOCK BA, 1991, AM ZOOL, V31, P726; Buas MF, 2010, J BIOL CHEM, V285, P1249, DOI 10.1074/jbc.M109.046441; Chen IHB, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-38; Darwin C., 1859, ORIGIN SPECIES MEANS, V1, pix, DOI [10.5962/bhl.title.82303, DOI 10.5962/BHL.TITLE.82303]; Datta K, 2009, J BIOL CHEM, V284, P29666, DOI 10.1074/jbc.M109.034041; Duan CM, 2010, GEN COMP ENDOCR, V167, P344, DOI 10.1016/j.ygcen.2010.04.009; Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286; Ghanbari H, 2001, MECH DEVELOP, V101, P271, DOI 10.1016/S0925-4773(00)00572-4; Hoopes BC, 2012, MAMM GENOME, V23, P780, DOI 10.1007/s00335-012-9417-z; KAWAKAMI K, 1985, NATURE, V316, P733, DOI 10.1038/316733a0; Kluver N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029063; Kokubo H, 2007, DEVELOPMENT, V134, P747, DOI 10.1242/dev.02777; Lowe J, 2004, BBA-BIOMEMBRANES, V1661, P40, DOI 10.1016/j.bbamem.2003.11.020; Mate SE, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-20; Mothe I, 1997, MOL ENDOCRINOL, V11, P1911, DOI 10.1210/me.11.13.1911; Nowak KJ, 2004, EMBO REP, V5, P872, DOI 10.1038/sj.embor.7400221; Otto A, 2010, EXP CELL RES, V316, P3059, DOI 10.1016/j.yexcr.2010.04.009; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Unguez GA, 1998, J NEUROSCI, V18, P9924; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064	24	126	128	11	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1522	1525		10.1126/science.1254432	http://dx.doi.org/10.1126/science.1254432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970089	Green Accepted			2022-12-01	WOS:000337889900052
J	Penny, AM; Wood, R; Curtis, A; Bowyer, F; Tostevin, R; Hoffman, KH				Penny, A. M.; Wood, R.; Curtis, A.; Bowyer, F.; Tostevin, R.; Hoffman, K-H			Ediacaran metazoan reefs from the Nama Group, Namibia	SCIENCE			English	Article							LIFE-STYLES; CLOUDINA; SECTION; BORINGS; FOSSILS; GROWTH	Reef-building in metazoans represents an important ecological innovation whereby individuals collectively enhance feeding efficiency and gain protection from competitors and predation. The appearance of metazoan reefs in the fossil record therefore indicates an adaptive response to complex ecological pressures. In the Nama Group, Namibia, we found evidence of reef-building by the earliest known skeletal metazoan, the globally distributed Cloudina, similar to 548 million years ago. These Cloudina reefs formed open frameworks without a microbial component but with mutual attachment and cementation between individuals. Orientated growth implies a passive suspension-feeding habit into nutrient-rich currents. The characteristics of Cloudina support the view that metazoan reef-building was promoted by the rise of substrate competitors and predators.	[Penny, A. M.; Wood, R.; Curtis, A.; Bowyer, F.] Univ Edinburgh, Sch GeoSci, Edinburgh EH9 3JW, Midlothian, Scotland; [Tostevin, R.] UCL, Dept Earth Sci, London WC1E 6BT, England; [Hoffman, K-H] Geol Survey Namibia, Windhoek, Namibia	University of Edinburgh; University of London; University College London	Penny, AM (corresponding author), Univ Edinburgh, Sch GeoSci, W Mains Rd, Edinburgh EH9 3JW, Midlothian, Scotland.	a.m.penny@ed.ac.uk		Tostevin, Rosalie/0000-0003-2843-7741	University of Edinburgh, School of Geosciences Scholarship; International Centre for Carbonate Reservoirs; Natural Environment Research Council (NERC) project "Re-inventing the planet: the Neoproterozoic revolution in oxygenation, biogeochemistry and biological complexity" [NE/I005978/1]; NERC [NE/I005978/1, NE/I005935/1] Funding Source: UKRI; Natural Environment Research Council [1511982, 1220713, NE/I005978/1, NE/I005935/1] Funding Source: researchfish	University of Edinburgh, School of Geosciences Scholarship; International Centre for Carbonate Reservoirs; Natural Environment Research Council (NERC) project "Re-inventing the planet: the Neoproterozoic revolution in oxygenation, biogeochemistry and biological complexity"(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	A.M.P. acknowledges funding from a University of Edinburgh, School of Geosciences Scholarship and the International Centre for Carbonate Reservoirs. R. W., R. T., and A. M. P. acknowledge support from Natural Environment Research Council (NERC) project "Re-inventing the planet: the Neoproterozoic revolution in oxygenation, biogeochemistry and biological complexity" (NE/I005978/1). F. B. thanks the Laidlaw Trust for fieldwork support. We thank the Geological Survey of Namibia; C. Husselmann for access to Driedoornvlagte; M. Hall for technical support; and A. Yu. Zhuravlev, B. MacGabhann, and S. Brusatte for comments and discussion. All data are available online in the supplementary materials on Science Online.	BENGTSON S, 1992, SCIENCE, V257, P367, DOI 10.1126/science.257.5068.367; Bengtson S., 2004, PALEONTOLOGICAL SOC, V10, P67, DOI DOI 10.1017/S1089332600002345; Bengtson S., 1992, TOP GEOBIOL, V20, P447; Brasier M.D., 1989, Oxford Monographs on Geology and Geophysics, V12, P117; Cai YP, 2014, GONDWANA RES, V25, P1008, DOI 10.1016/j.gr.2012.12.027; Cortijo I, 2010, PRECAMBRIAN RES, V176, P1, DOI 10.1016/j.precamres.2009.10.010; Droser ML, 2008, SCIENCE, V319, P1660, DOI 10.1126/science.1152595; Gehling JG, 1996, J PALEONTOL, V70, P185, DOI 10.1017/S0022336000023283; GERMS GJB, 1972, AM J SCI, V272, P752, DOI 10.2475/ajs.272.8.752; GRANT SWF, 1990, AM J SCI, V290A, P261; Grotzinger J. P., 2002, COMMUN GEOL SURV NAM, V11, P77; Grotzinger JP, 2000, PALEOBIOLOGY, V26, P334, DOI 10.1666/0094-8373(2000)026<0334:CMITSR>2.0.CO;2; Hua H, 2005, GEOLOGY, V33, P277, DOI 10.1130/G21198.1; Hua H, 2003, PALAIOS, V18, P454, DOI 10.1669/0883-1351(2003)018<0454:BICSCP>2.0.CO;2; Jackson J. B. C., 1983, BIOTIC INTERACTIONS, V39; Knoll AH, 2003, REV MINERAL GEOCHEM, V54, P329, DOI 10.2113/0540329; Kontorovich AE, 2008, RUSS GEOL GEOPHYS+, V49, P932, DOI 10.1016/j.rgg.2008.06.012; KRUSE PD, 1995, PALAIOS, V10, P291, DOI 10.2307/3515157; Narbonne GM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P413, DOI 10.1016/B978-0-444-59425-9.00018-4; Narbonne GM, 1997, J PALEONTOL, V71, P953, DOI 10.1017/S0022336000035940; Saylor BZ, 1998, J SEDIMENT RES, V68, P1223, DOI 10.2110/jsr.68.1223; Seilacher A, 1999, PALAIOS, V14, P86, DOI 10.2307/3515363; Vermeij G.J., 1993, NATURAL HIST SHELLS; Warren LV, 2011, TERRA NOVA, V23, P382, DOI 10.1111/j.1365-3121.2011.01023.x; Wood R., 1999, REEF EVOLUTION; Wood RA, 2002, SCIENCE, V296, P2383, DOI 10.1126/science.1071599; Wood RA, 2011, EARTH-SCI REV, V106, P184, DOI 10.1016/j.earscirev.2011.01.011	27	97	99	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1504	1506		10.1126/science.1253393	http://dx.doi.org/10.1126/science.1253393			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970084	Green Accepted			2022-12-01	WOS:000337889900047
J	Dutta, S; Whicher, JR; Hansen, DA; Hale, WA; Chemler, JA; Congdon, GR; Narayan, ARH; Hakansson, K; Sherman, DH; Smith, JL; Skiniotis, G				Dutta, Somnath; Whicher, Jonathan R.; Hansen, Douglas A.; Hale, Wendi A.; Chemler, Joseph A.; Congdon, Grady R.; Narayan, Alison R. H.; Hakansson, Kristina; Sherman, David H.; Smith, Janet L.; Skiniotis, Georgios			Structure of a modular polyketide synthase	NATURE			English	Article							PARTICLE ELECTRON CRYOMICROSCOPY; ACYL CARRIER PROTEIN; 6-DEOXYERYTHRONOLIDE B SYNTHASE; ITERATIVE CHAIN ELONGATION; NEAR-ATOMIC-RESOLUTION; FATTY-ACID SYNTHASE; CRYO-EM STRUCTURE; CRYSTAL-STRUCTURE; DOCKING DOMAINS; SUBSTRATE-SPECIFICITY	Polyketide natural products constitute a broad class of compounds with diverse structural features and biological activities. Their biosynthetic machinery, represented by type I polyketide synthases (PKSs), has an architecture in which successive modules catalyse two-carbon linear extensions and keto-group processing reactions on intermediates covalently tethered to carrier domains. Here we used electron cryo-microscopy to determine sub-nanometre-resolution three-dimensional reconstructions of a full-length PKS module from the bacterium Streptomyces venezuelae that revealed an unexpectedly different architecture compared to the homologous dimeric mammalian fatty acid synthase. A single reaction chamber provides access to all catalytic sites for the intramodule carrier domain. In contrast, the carrier from the preceding module uses a separate entrance outside the reaction chamber to deliver the upstream polyketide intermediate for subsequent extension and modification. This study reveals for the first time, to our knowledge, the structural basis for both intramodule and intermodule substrate transfer in polyketide synthases, and establishes a new model for molecular dissection of these multifunctional enzyme systems.	[Dutta, Somnath; Whicher, Jonathan R.; Hansen, Douglas A.; Chemler, Joseph A.; Congdon, Grady R.; Narayan, Alison R. H.; Sherman, David H.; Smith, Janet L.; Skiniotis, Georgios] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Whicher, Jonathan R.] Univ Michigan, Chem Biol Grad Program, Ann Arbor, MI 48109 USA; [Hansen, Douglas A.; Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Hale, Wendi A.; Sherman, David H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Smith, Janet L.; Skiniotis, Georgios] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Skiniotis, G (corresponding author), Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA.	skinioti@umich.edu	Dutta, Somnath/AAI-2977-2020; Hakansson, Kristina/G-9428-2016	Hakansson, Kristina/0000-0003-1926-0542; Skiniotis, Georgios/0000-0003-0238-7846; Hansen, Douglas/0000-0003-4681-650X	Pew Scholar Program in Biomedical Sciences; University of Michigan Biological Sciences Scholars Program; Rackham Merit fellowship; American Foundation for Pharmaceutical Education predoctoral fellowship; National Research Service Award postdoctoral fellowship; Life Sciences Research Foundation; National Institutes of Health [1R21CA138331-01A1, GM076477, DK042303, DK090165]; Hans W. Vahlteich Professorship; NATIONAL CANCER INSTITUTE [R21CA138331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042303, R01DK042303, R01DK090165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076477, T32GM008597] Funding Source: NIH RePORTER	Pew Scholar Program in Biomedical Sciences; University of Michigan Biological Sciences Scholars Program(University of Michigan System); Rackham Merit fellowship; American Foundation for Pharmaceutical Education predoctoral fellowship; National Research Service Award postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Sciences Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hans W. Vahlteich Professorship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Henderson for sharing the phase-randomization program and for valuable advice on the implementation of the tilt-pair validation, and Y. Cheng and X. Li for sharing the image sub-frame alignment program. This work was supported by the Pew Scholar Program in Biomedical Sciences (G.S.), the University of Michigan Biological Sciences Scholars Program (G.S.), Rackham Merit and American Foundation for Pharmaceutical Education predoctoral fellowships (D.A.H.), a National Research Service Award postdoctoral fellowship (J.A.C.), the Life Sciences Research Foundation (A.R.H.N.), National Institutes of Health grants 1R21CA138331-01A1 (K.H.),GM076477 (D.H.S. and J.L.S.), DK042303 (J.L.S.) and DK090165 (G.S.), and the Hans W. Vahlteich Professorship (to D.H.S.).	Akey DL, 2010, STRUCTURE, V18, P94, DOI 10.1016/j.str.2009.10.018; Aldrich CC, 2005, J AM CHEM SOC, V127, P8910, DOI 10.1021/ja0504340; Aldrich CC, 2005, J AM CHEM SOC, V127, P8441, DOI 10.1021/ja042592h; Alekseyev VY, 2007, PROTEIN SCI, V16, P2093, DOI 10.1110/ps.073011407; Baker ML, 2010, NAT PROTOC, V5, P1697, DOI 10.1038/nprot.2010.126; Beck BJ, 2003, J AM CHEM SOC, V125, P4682, DOI 10.1021/ja029974c; Beck BJ, 2002, CHEM BIOL, V9, P575, DOI 10.1016/S1074-5521(02)00146-1; Bonnett SA, 2013, CHEM BIOL, V20, P772, DOI 10.1016/j.chembiol.2013.04.014; Bonnett SA, 2011, CHEM BIOL, V18, P1075, DOI 10.1016/j.chembiol.2011.07.016; Broadhurst RW, 2003, CHEM BIOL, V10, P723, DOI 10.1016/S1074-5521(03)00156-X; Buchholz TJ, 2009, ACS CHEM BIOL, V4, P41, DOI 10.1021/cb8002607; Bunkoczi G, 2007, CHEM BIOL, V14, P1243, DOI 10.1016/j.chembiol.2007.10.013; Chemler JA, 2012, J AM CHEM SOC, V134, P7359, DOI 10.1021/ja2112228; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; Fernandez JJ, 2008, J STRUCT BIOL, V164, P170, DOI 10.1016/j.jsb.2008.05.010; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Gehret JJ, 2011, J BIOL CHEM, V286, P14445, DOI 10.1074/jbc.M110.214635; Gokhale RS, 1998, BIOCHEMISTRY-US, V37, P2524, DOI 10.1021/bi971887n; Hansen DA, 2013, J AM CHEM SOC, V135, P11232, DOI 10.1021/ja404134f; Henderson R, 2011, J MOL BIOL, V413, P1028, DOI 10.1016/j.jmb.2011.09.008; Huang WJ, 1998, EMBO J, V17, P1183, DOI 10.1093/emboj/17.5.1183; Kao CM, 1996, BIOCHEMISTRY-US, V35, P12363, DOI 10.1021/bi9616312; Kapur S, 2012, P NATL ACAD SCI USA, V109, P4110, DOI 10.1073/pnas.1118734109; Kapur S, 2010, P NATL ACAD SCI USA, V107, P22066, DOI 10.1073/pnas.1014081107; Keatinge-Clay A, 2004, NAT STRUCT MOL BIOL, V11, P888, DOI 10.1038/nsmb808; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; Kittendorf JD, 2007, CHEM BIOL, V14, P944, DOI 10.1016/j.chembiol.2007.07.013; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lyon AM, 2013, NAT STRUCT MOL BIOL, V20, P355, DOI 10.1038/nsmb.2497; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Masoudi A, 2014, NATURE, V505, P422, DOI 10.1038/nature12679; Murray SC, 2013, STRUCTURE, V21, P900, DOI 10.1016/j.str.2013.04.016; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rowe CJ, 2001, CHEM BIOL, V8, P475, DOI 10.1016/S1074-5521(01)00024-2; Sanchez C, 2001, CHEM BIOL, V8, P725, DOI 10.1016/S1074-5521(01)00047-3; Scaglione JB, 2010, ANGEW CHEM INT EDIT, V49, P5726, DOI 10.1002/anie.201000032; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Smith S, 2007, NAT PROD REP, V24, P1041, DOI 10.1039/b603600g; Staunton J, 1996, NAT STRUCT BIOL, V3, P188, DOI 10.1038/nsb0296-188; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Tang YY, 2007, CHEM BIOL, V14, P931, DOI 10.1016/j.chembiol.2007.07.012; Tsai SC, 2001, P NATL ACAD SCI USA, V98, P14808, DOI 10.1073/pnas.011399198; Tsai SC, 2002, BIOCHEMISTRY-US, V41, P12598, DOI 10.1021/bi0260177; Whicher JR, 2013, CHEM BIOL, V20, P1340, DOI 10.1016/j.chembiol.2013.09.015; Wu N, 2001, J AM CHEM SOC, V123, P6465, DOI 10.1021/ja010219t; Xue YQ, 1998, P NATL ACAD SCI USA, V95, P12111, DOI 10.1073/pnas.95.21.12111; Yin YF, 2003, J AM CHEM SOC, V125, P5671, DOI 10.1021/ja034574q; Yuzawa S, 2012, BIOCHEMISTRY-US, V51, P3708, DOI 10.1021/bi300399u; Zheng JT, 2013, ACS CHEM BIOL, V8, P1263, DOI 10.1021/cb400047s; Zheng JT, 2012, NAT CHEM BIOL, V8, P615, DOI [10.1038/NCHEMBIO.964, 10.1038/nchembio.964]; Zheng JT, 2011, J MOL BIOL, V410, P105, DOI 10.1016/j.jmb.2011.04.065; Zheng JT, 2010, STRUCTURE, V18, P913, DOI 10.1016/j.str.2010.04.015	64	183	189	2	202	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					512	+		10.1038/nature13423	http://dx.doi.org/10.1038/nature13423			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24965652	Green Accepted			2022-12-01	WOS:000337806300041
J	Whicher, JR; Dutta, S; Hansen, DA; Hale, WA; Chemler, JA; Dosey, AM; Narayan, ARH; Hakansson, K; Sherman, DH; Smith, JL; Skiniotis, G				Whicher, Jonathan R.; Dutta, Somnath; Hansen, Douglas A.; Hale, Wendi A.; Chemler, Joseph A.; Dosey, Annie M.; Narayan, Alison R. H.; Hakansson, Kristina; Sherman, David H.; Smith, Janet L.; Skiniotis, Georgios			Structural rearrangements of a polyketide synthase module during its catalytic cycle	NATURE			English	Article							CHAIN ELONGATION; BIOSYNTHESIS; PIKROMYCIN; RESOLUTION; RECOGNITION; REVEALS; DESIGN; DOMAIN	The polyketide synthase (PKS) mega-enzyme assembly line uses a modular architecture to synthesize diverse and bioactive natural products that often constitute the core structures or complete chemical entities for many clinically approved therapeutic agents(1). The architecture of a full-length PKS module from the pikromycin pathway of Streptomyces venezuelae creates a reaction chamber for the intra-module acyl carrier protein (ACP) domain that carries building blocks and intermediates between acyltransferase, ketosynthase and ketoreductase active sites (see accompanying paper(2)). Here we determine electron cryo-microscopy structures of a full-length pikromycin PKS module in three key biochemical states of its catalytic cycle. Each biochemical state was confirmed by bottom-up liquid chromatography/Fourier transform ion cyclotron resonance mass spectrometry. The ACP domain is differentially and precisely positioned after polyketide chain substrate loading on the active site of the ketosynthase, after extension to the beta-keto intermediate, and after beta-hydroxy product generation. The structures reveal the ACP dynamics for sequential interactions with catalytic domains within the reaction chamber, and for transferring the elongated and processed polyketide substrate to the next module in the PKS pathway. During the enzymatic cycle the ketoreductase domain undergoes dramatic conformational rearrangements that enable optimal positioning for reductive processing of the ACP-bound polyketide chain elongation intermediate. These findings have crucial implications for the design of functional PKS modules, and for the engineering of pathways to generate pharmacologically relevant molecules.	[Whicher, Jonathan R.; Dutta, Somnath; Hansen, Douglas A.; Chemler, Joseph A.; Dosey, Annie M.; Narayan, Alison R. H.; Sherman, David H.; Smith, Janet L.; Skiniotis, Georgios] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Whicher, Jonathan R.] Univ Michigan, Chem Biol Grad Program, Ann Arbor, MI 48109 USA; [Hansen, Douglas A.; Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Hale, Wendi A.; Hakansson, Kristina; Sherman, David H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Smith, Janet L.; Skiniotis, Georgios] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Skiniotis, G (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	kicki@umich.edu; davidhs@umich.edu; JanetSmith@umich.edu; skinioti@umich.edu	Hakansson, Kristina/G-9428-2016; Dutta, Somnath/AAI-2977-2020	Hakansson, Kristina/0000-0003-1926-0542; Skiniotis, Georgios/0000-0003-0238-7846; Hansen, Douglas/0000-0003-4681-650X	Pew Scholar Program in Biomedical Sciences; University of Michigan Biological Sciences Scholars Program; Rackham Merit fellowship; American Foundation for Pharmaceutical Education predoctoral fellowship; National Research Service Award postdoctoral fellowship; Life Sciences Research Foundation; National Institutes of Health [1 R21CA138331-01A1, GM076477, DK042303, DK090165]; Hans W. Vahlteich Professorship; NATIONAL CANCER INSTITUTE [R21CA138331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090165, R01DK042303, R37DK042303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008597, R01GM076477] Funding Source: NIH RePORTER	Pew Scholar Program in Biomedical Sciences; University of Michigan Biological Sciences Scholars Program(University of Michigan System); Rackham Merit fellowship; American Foundation for Pharmaceutical Education predoctoral fellowship; National Research Service Award postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Sciences Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hans W. Vahlteich Professorship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Pew Scholar Program in Biomedical Sciences (G.S.), the University of Michigan Biological Sciences Scholars Program (G.S.), Rackham Merit and American Foundation for Pharmaceutical Education predoctoral fellowships (D.A.H.), a National Research Service Award postdoctoral fellowship (J.A.C.), the Life Sciences Research Foundation (A.R.H.N.), National Institutes of Health grant 1 R21CA138331-01A1 (K.H.), GM076477 (D.H.S. and J.L.S.), DK042303 (J.L.S.), and DK090165 (G.S.), and the Hans W. Vahlteich Professorship (to D.H.S.).	Aldrich CC, 2005, J AM CHEM SOC, V127, P8910, DOI 10.1021/ja0504340; Aldrich CC, 2005, J AM CHEM SOC, V127, P8441, DOI 10.1021/ja042592h; Alekseyev VY, 2007, PROTEIN SCI, V16, P2093, DOI 10.1110/ps.073011407; Beck BJ, 2003, J AM CHEM SOC, V125, P4682, DOI 10.1021/ja029974c; Bonnett SA, 2013, CHEM BIOL, V20, P772, DOI 10.1016/j.chembiol.2013.04.014; Bonnett SA, 2011, CHEM BIOL, V18, P1075, DOI 10.1016/j.chembiol.2011.07.016; Bunkoczi G, 2007, CHEM BIOL, V14, P1243, DOI 10.1016/j.chembiol.2007.10.013; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; Fernandez JJ, 2008, J STRUCT BIOL, V164, P170, DOI 10.1016/j.jsb.2008.05.010; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Hansen DA, 2013, J AM CHEM SOC, V135, P11232, DOI 10.1021/ja404134f; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; Kittendorf JD, 2006, CURR OPIN BIOTECH, V17, P597, DOI 10.1016/j.copbio.2006.09.005; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lyon AM, 2013, NAT STRUCT MOL BIOL, V20, P355, DOI 10.1038/nsmb.2497; Masoudi A, 2014, NATURE, V505, P422, DOI 10.1038/nature12679; Menzella HG, 2005, NAT BIOTECHNOL, V23, P1171, DOI 10.1038/nbt1128; Menzella HG, 2007, CURR OPIN MICROBIOL, V10, P238, DOI 10.1016/j.mib.2007.05.005; Menzella HG, 2007, CHEM BIOL, V14, P143, DOI 10.1016/j.chembiol.2006.12.002; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Sherman DH, 2005, NAT BIOTECHNOL, V23, P1083, DOI 10.1038/nbt0905-1083; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Walsh CT, 2002, CHEMBIOCHEM, V3, P125; Wong FT, 2010, BIOCHEMISTRY-US, V49, P95, DOI 10.1021/bi901826g; Xue YQ, 1998, P NATL ACAD SCI USA, V95, P12111, DOI 10.1073/pnas.95.21.12111; Yin YF, 2003, J AM CHEM SOC, V125, P5671, DOI 10.1021/ja034574q; Zheng JT, 2010, STRUCTURE, V18, P913, DOI 10.1016/j.str.2010.04.015	37	125	127	1	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					560	+		10.1038/nature13409	http://dx.doi.org/10.1038/nature13409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24965656	Green Accepted			2022-12-01	WOS:000337806300052
J	Eswarappa, SM; Potdar, AA; Koch, WJ; Fan, Y; Vasu, K; Lindner, D; Wiiiard, B; Graham, LM; DiCorieto, PE; Fox, PL				Eswarappa, Sandeepa M.; Potdar, Alka A.; Koch, William J.; Fan, Yi; Vasu, Kommireddy; Lindner, Daniel; Wiiiard, Belinda; Graham, Linda M.; DiCorieto, Paul E.; Fox, Paul L.			Programmed Translational Readthrough Generates Antiangiogenic VEGF-Ax	CELL			English	Article							ENDOTHELIAL GROWTH-FACTOR; STOP CODON READTHROUGH; INHIBITORY SPLICE VARIANT; SUPPRESSOR TRANSFER-RNAS; MESSENGER-RNA; IN-VIVO; TERMINATION CODONS; ESCHERICHIA-COLI; FACTOR ISOFORM; TUMOR-GROWTH	Translational readthrough, observed primarily in less complex organisms from viruses to Drosophila, expands the proteome by translating select transcripts beyond the canonical stop codon. Here, we show that vascular endothelial growth factor A (VEGFA) mRNA in mammalian endothelial cells undergoes programmed translational readthrough (PTR) generating VEGF-Ax, an isoform containing a unique 22-amino-acid C terminus extension. A cis-acting element in the VEGFA 30 UTR serves a dual function, not only encoding the appended peptide but also directing the PTR by decoding the UGA stop codon as serine. Heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1 binds this element and promotes readthrough. Remarkably, VEGF-Ax exhibits antiangiogenic activity in contrast to the proangiogenic activity of VEGF-A. Pathophysiological significance of VEGF-Ax is indicated by robust expression in multiple human tissues but depletion in colon adenocarcinoma. Furthermore, genome-wide analysis revealed AGO1 and MTCH2 as authentic readthrough targets. Overall, our studies reveal a novel protein-regulated PTR event in a vertebrate system.	[Eswarappa, Sandeepa M.; Potdar, Alka A.; Koch, William J.; Fan, Yi; Vasu, Kommireddy; DiCorieto, Paul E.; Fox, Paul L.] Lerner Res Inst, Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Potdar, Alka A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Lindner, Daniel] Taussig Canc Ctr, Cleveland Clin, Cleveland, OH 44195 USA; [Wiiiard, Belinda] Lerner Res Inst, Cleveland Clin, Mass Spectrometry Lab Prot Sequencing, Cleveland, OH 44195 USA; [Graham, Linda M.] Lerner Res Inst, Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Fox, PL (corresponding author), Lerner Res Inst, Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA.	foxp@ccf.org	Eswarappa, Sandeep/AFG-1997-2022; Lindner, Daniel/ABB-5440-2020; Kommireddy, Vasu/C-3928-2018	Kommireddy, Vasu/0000-0002-7608-7566; Koch, William/0000-0002-4820-3451	NIH [P01 HL029582, P01 HL076491, R01 GM086430, R01 DK083359, R21 HL094841, S10 RR031537]; American Heart Association, Great Rivers Affiliate; Athymic Animal and Xenograft Core, NCI of the Case Comprehensive Cancer Center [P30 CA043703-23]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582, R21HL094841, P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086430] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, Great Rivers Affiliate(American Heart Association); Athymic Animal and Xenograft Core, NCI of the Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grants P01 HL029582, P01 HL076491, R01 GM086430, R01 DK083359, and R21 HL094841 (to P.L. F.). S.M.E. was supported by a fellowship from the American Heart Association, Great Rivers Affiliate. A shared instrument grant (S10 RR031537) from the NIH (to B.W.) was used to purchase the Orbitrap mass spectrometer. Mouse studies were supported by the Athymic Animal and Xenograft Core, NCI P30 CA043703-23, of the Case Comprehensive Cancer Center (to D. L.). We are grateful to Donna Driscoll and Jodi Bubenik for helpful discussions. S.M.E. and P.L.F. are inventors on a patent that has been filed related to this work.	AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; Bates DO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068399; Bates DO, 2002, CANCER RES, V62, P4123; Beier H, 2001, NUCLEIC ACIDS RES, V29, P4767, DOI 10.1093/nar/29.23.4767; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Cebe-Suarez S, 2008, FASEB J, V22, P3078, DOI 10.1096/fj.08-107219; Chittum HS, 1998, BIOCHEMISTRY-US, V37, P10866, DOI 10.1021/bi981042r; Cromer W, 2010, MICROCIRCULATION, V17, P536, DOI 10.1111/j.1549-8719.2010.00047.x; DIAMOND A, 1981, CELL, V25, P497, DOI 10.1016/0092-8674(81)90068-4; Dunn JG, 2013, ELIFE, V2, DOI 10.7554/eLife.01179; FENG YX, 1990, P NATL ACAD SCI USA, V87, P8860, DOI 10.1073/pnas.87.22.8860; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Firth AE, 2011, NUCLEIC ACIDS RES, V39, P6679, DOI 10.1093/nar/gkr224; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Harris S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035231; HATFIELD DL, 1990, CRIT REV BIOCHEM MOL, V25, P71, DOI 10.3109/10409239009090606; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Houck-Loomis B, 2011, NATURE, V480, P561, DOI 10.1038/nature10657; Howard MT, 2004, ANN NEUROL, V55, P422, DOI 10.1002/ana.20052; Huez I, 2001, MOL ENDOCRINOL, V15, P2197, DOI 10.1210/me.15.12.2197; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; JALAJAKUMARI MB, 1989, MOL MICROBIOL, V3, P1685, DOI 10.1111/j.1365-2958.1989.tb00154.x; Jungreis I, 2011, GENOME RES, V21, P2096, DOI 10.1101/gr.119974.110; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; Kondo Jiro, 2005, Nucleic Acids Symp Ser (Oxf), P253; Konopatskaya O, 2006, MOL VIS, V12, P626; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; LI GP, 1989, J VIROL, V63, P1326, DOI 10.1128/JVI.63.3.1326-1337.1989; Low SC, 1996, TRENDS BIOCHEM SCI, V21, P203, DOI 10.1016/0968-0004(96)10025-6; Manetti M, 2011, CIRC RES, V109, pE14, DOI 10.1161/CIRCRESAHA.111.242057; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Munro TP, 1999, J BIOL CHEM, V274, P34389, DOI 10.1074/jbc.274.48.34389; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; Namy O, 2003, NUCLEIC ACIDS RES, V31, P2289, DOI 10.1093/nar/gkg330; PELHAM HRB, 1978, NATURE, V272, P469, DOI 10.1038/272469a0; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; Qiu Y, 2008, FASEB J, V22, P1104, DOI 10.1096/fj.07-9718com; Rajon E, 2011, P NATL ACAD SCI USA, V108, P1082, DOI 10.1073/pnas.1012918108; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Rennel ES, 2009, BRIT J CANCER, V101, P1183, DOI 10.1038/sj.bjc.6605249; Rennel ES, 2008, EUR J CANCER, V44, P1883, DOI 10.1016/j.ejca.2008.05.027; Robinson DN, 1997, DEVELOPMENT, V124, P1405; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; SCHWARTZ SM, 1978, LAB INVEST, V38, P568; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Shan JG, 2003, J NEUROSCI, V23, P8859; Shih SC, 1999, J BIOL CHEM, V274, P1359, DOI 10.1074/jbc.274.3.1359; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Steneberg P, 2001, EMBO REP, V2, P593, DOI 10.1093/embo-reports/kve128; Suarez SC, 2006, CELL MOL LIFE SCI, V63, P2067, DOI 10.1007/s00018-006-6254-9; Tate WP, 1999, BIOCHEMISTRY-MOSCOW+, V64, P1342; Turanov AA, 2011, ADV NUTR, V2, P122, DOI 10.3945/an.110.000265; Varey AHR, 2008, BRIT J CANCER, V98, P1366, DOI 10.1038/sj.bjc.6604308; von der Haar T, 2007, TRENDS MICROBIOL, V15, P78, DOI 10.1016/j.tim.2006.12.002; Woolard J, 2004, CANCER RES, V64, P7822, DOI 10.1158/0008-5472.CAN-04-0934; Yamaguchi Y, 2012, J BIOL CHEM, V287, P17765, DOI 10.1074/jbc.M111.314468; Yao P, 2012, CELL, V149, P88, DOI 10.1016/j.cell.2012.02.018; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057	66	128	129	1	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1605	1618		10.1016/j.cell.2014.04.033	http://dx.doi.org/10.1016/j.cell.2014.04.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949972	Bronze, Green Accepted			2022-12-01	WOS:000340941900015
J	Procko, E; Berguig, GY; Shen, BW; Song, YF; Frayo, S; Convertine, AJ; Margineantu, D; Booth, G; Correia, BE; Cheng, YH; Schief, WR; Hockenbery, DM; Press, OW; Stoddard, BL; Stayton, PS; Baker, D				Procko, Erik; Berguig, Geoffrey Y.; Shen, Betty W.; Song, Yifan; Frayo, Shani; Convertine, Anthony J.; Margineantu, Daciana; Booth, Garrett; Correia, Bruno E.; Cheng, Yuanhua; Schief, William R.; Hockenbery, David M.; Press, Oliver W.; Stoddard, Barry L.; Stayton, Patrick S.; Baker, David			A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells	CELL			English	Article							INTRACELLULAR DELIVERY; EPITOPE-SCAFFOLDS; B-CELLS; VIRUS; HOMOLOG; BHRF1; ANTIBODIES; DYNAMICS; LIGANDS; PEPTIDE	Because apoptosis of infected cells can limit virus production and spread, some viruses have co-opted prosurvival genes from the host. This includes the Epstein-Barr virus (EBV) gene BHRF1, a homolog of human Bcl-2 proteins that block apoptosis and are associated with cancer. Computational design and experimental optimization were used to generate a novel protein called BINDI that binds BHRF1 with picomolar affinity. BINDI recognizes the hydrophobic cleft of BHRF1 in a manner similar to other Bcl-2 protein interactions but makes many additional contacts to achieve exceptional affinity and specificity. BINDI induces apoptosis in EBV-infected cancer lines, and when delivered with an antibody-targeted intracellular delivery carrier, BINDI suppressed tumor growth and extended survival in a xenograft disease model of EBV-positive human lymphoma. High-specificity-designed proteins that selectively kill target cells may provide an advantage over the toxic compounds used in current generation antibody-drug conjugates.	[Procko, Erik; Song, Yifan; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Berguig, Geoffrey Y.; Convertine, Anthony J.; Cheng, Yuanhua; Stayton, Patrick S.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Shen, Betty W.; Stoddard, Barry L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Frayo, Shani; Margineantu, Daciana; Booth, Garrett; Hockenbery, David M.; Press, Oliver W.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Correia, Bruno E.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Schief, William R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Scripps Research Institute; Scripps Research Institute; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012; Stayton, Patrick/C-1975-2018; Schief, William/ABF-3645-2020	Baker, David/0000-0001-7896-6217; Stayton, Patrick/0000-0001-6939-6371; Schief, William/0000-0002-1120-0150; Press, Oliver/0000-0002-3147-8037; Procko, Erik/0000-0002-0028-490X	National Institute of General Medical Studies of the National Institutes of Health (NIH) [P41GM103533, R01GM49857]; NIH [R21EB014572, R01CA076287, R01CA154897]; Washington State Life Sciences Discovery Fund [2496490]; Defence Threat Reduction Agency; David and Patricia Giuliani Family Foundation; National Science Foundation [SCI-0221529, SCI-0438443, SCI-0506411, PHY/0555655, OCI-0721124]; NATIONAL CANCER INSTITUTE [R01CA076287, R01CA154897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB014572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533, R01GM049857] Funding Source: NIH RePORTER	National Institute of General Medical Studies of the National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington State Life Sciences Discovery Fund; Defence Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); David and Patricia Giuliani Family Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Studies of the National Institutes of Health (NIH) under award numbers P41GM103533 and R01GM49857; NIH grants R21EB014572, R01CA076287, and R01CA154897; the Washington State Life Sciences Discovery Fund grant 2496490 to the Center for Intracellular Delivery of Biologics; the Defence Threat Reduction Agency; and a grant by the David and Patricia Giuliani Family Foundation. Computational resources were provided by BOINC and supported by the National Science Foundation through awards SCI-0221529, SCI-0438443, SCI-0506411, PHY/0555655, and OCI-0721124. P.S.S. and O.W.P. are cofounders of PhaseRx Pharmaceuticals, which has licensed drug delivery technology from University of Washington that encompasses aspects of the polymeric carriers used in this study.	Altmann M, 2005, PLOS BIOL, V3, P2148, DOI 10.1371/journal.pbio.0030404; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Azzarito V, 2013, NAT CHEM, V5, P161, DOI [10.1038/NCHEM.1568, 10.1038/nchem.1568]; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berguig GY, 2012, MOL PHARMACEUT, V9, P3506, DOI 10.1021/mp300338s; Caria S, 2012, ACTA CRYSTALLOGR F, V68, P1521, DOI 10.1107/S1744309112043333; Chin JW, 2001, ANGEW CHEM INT EDIT, V40, P3806, DOI 10.1002/1521-3773(20011015)40:20<3806::AID-ANIE3806>3.0.CO;2-B; Convertine AJ, 2010, BIOMACROMOLECULES, V11, P2904, DOI 10.1021/bm100652w; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; Desbien AL, 2009, P NATL ACAD SCI USA, V106, P5663, DOI 10.1073/pnas.0901036106; Dutta S, 2013, ACS CHEM BIOL, V8, P778, DOI 10.1021/cb300679a; Dutta S, 2010, J MOL BIOL, V398, P747, DOI 10.1016/j.jmb.2010.03.058; Duvall CL, 2010, MOL PHARMACEUT, V7, P468, DOI 10.1021/mp9002267; Fire E, 2010, PROTEIN SCI, V19, P507, DOI 10.1002/pro.329; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Gemperli AC, 2005, J AM CHEM SOC, V127, P1596, DOI 10.1021/ja0441211; Goulet A, 2009, P NATL ACAD SCI USA, V106, P21155, DOI 10.1073/pnas.0909893106; HENDERSON S, 1993, P NATL ACAD SCI USA, V90, P8479, DOI 10.1073/pnas.90.18.8479; Hogbom M, 2003, P NATL ACAD SCI USA, V100, P3191, DOI 10.1073/pnas.0436100100; ISHII HH, 1995, IMMUNOL CELL BIOL, V73, P463, DOI 10.1038/icb.1995.72; Kelly GL, 2013, J VIROL, V87, P2882, DOI 10.1128/JVI.03003-12; Kelly GL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000341; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kvansakul M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001236; Lanci CJ, 2012, P NATL ACAD SCI USA, V109, P7304, DOI [10.1073/pnas.1112595109, 10.1073/pnas.111259510]; Leao M, 2007, J VIROL, V81, P248, DOI 10.1128/JVI.01096-06; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lee EF, 2009, J BIOL CHEM, V284, P30508, DOI 10.1074/jbc.M109.040725; Lessene G, 2013, NAT CHEM BIOL, V9, P390, DOI [10.1038/NCHEMBIO.1246, 10.1038/nchembio.1246]; Manganiello MJ, 2012, BIOMATERIALS, V33, P2301, DOI 10.1016/j.biomaterials.2011.11.019; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; O'Connor OA, 2006, CLIN CANCER RES, V12, P2902, DOI 10.1158/1078-0432.CCR-05-0308; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Procko E, 2013, J MOL BIOL, V425, P3563, DOI 10.1016/j.jmb.2013.06.035; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Watanabe A, 2010, J VIROL, V84, P2893, DOI 10.1128/JVI.01616-09	38	92	106	1	76	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1644	1656		10.1016/j.cell.2014.04.034	http://dx.doi.org/10.1016/j.cell.2014.04.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949974	Green Accepted, Bronze			2022-12-01	WOS:000340941900018
J	Harris, MF; Knechtli, C				Harris, Michael Frank; Knechtli, Christopher			A PATIENT'S JOURNEY Lymphoma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Harris, Michael Frank] Gore Cottage, Old Gore Lane, Emborough BA3 4SJ, Radstock, England; [Knechtli, Christopher] Royal United Hosp Bath NHS Trust, Bath BA1 3NG, Avon, England		Harris, MF (corresponding author), Gore Cottage, Old Gore Lane, Emborough BA3 4SJ, Radstock, England.	michaelharris681@btinternet.com						Ardeshna KM, 2014, LANCET ONCOL, V15, P424, DOI 10.1016/S1470-2045(14)70027-0	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2014	348								g3736	10.1136/bmj.g3736	http://dx.doi.org/10.1136/bmj.g3736			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KX	24934281	Green Published, Bronze			2022-12-01	WOS:000337804300010
J	King, NP; Bale, JB; Sheffler, W; McNamara, DE; Gonen, S; Gonen, T; Yeates, TO; Baker, D				King, Neil P.; Bale, Jacob B.; Sheffler, William; McNamara, Dan E.; Gonen, Shane; Gonen, Tamir; Yeates, Todd O.; Baker, David			Accurate design of co-assembling multi-component protein nanomaterials	NATURE			English	Article							COMPUTATIONAL DESIGN; DIRECTED EVOLUTION; DNA; SYMMETRY; NANOSTRUCTURES; INTERFACES; HOMODIMER; CONTAINER; ARRAYS; CAGES	The self-assembly of proteins into highly ordered nanoscale architectures is a hallmark of biological systems. The sophisticated functions of these molecular machines have inspired the development of methods to engineer self-assembling protein nanostructures; however, the design of multi-component protein nanomaterials with high accuracy remains an outstanding challenge. Here we report a computational method for designing protein nanomaterials in which multiple copies of two distinct subunits co-assemble into a specific architecture. We use the method to design five 24-subunit cage-like protein nanomaterials in two distinct symmetric architectures and experimentally demonstrate that their structures are in close agreement with the computational design models. The accuracy of the method and the number and variety of two-component materials that it makes accessible suggest a route to the construction of functional protein nanomaterials tailored to specific applications.	[King, Neil P.; Bale, Jacob B.; Sheffler, William; Gonen, Shane; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [King, Neil P.; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Bale, Jacob B.] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [McNamara, Dan E.; Yeates, Todd O.] UCLA Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Gonen, Shane; Gonen, Tamir] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Yeates, Todd O.] UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA; [Yeates, Todd O.] UCLA Mol Biol Inst, Los Angeles, CA 90095 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Bale, Jacob/0000-0003-2444-5875; Gonen, Shane/0000-0002-4829-3151; Yeates, Todd/0000-0001-5709-9839; McNamara, Dan/0000-0003-0600-7847	Howard Hughes Medical Institute; JFRC; National Science Foundation [CHE-1332907]; International AIDS Vaccine Initiative, DTRA [N00024-10-D-6318/0024]; AFOSR [FA950-12-10112]; DOE [DE-SC0005155]; NIH [T32GM067555]; NSF [DGE-0718124]; BER programme of the DOE Office of Science; Division Of Chemistry [1332907] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067555] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); JFRC; National Science Foundation(National Science Foundation (NSF)); International AIDS Vaccine Initiative, DTRA; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); DOE(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); BER programme of the DOE Office of Science(United States Department of Energy (DOE)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Shi and B. Nannenga (JFRC) for help with electron microscopy, F. DiMaio and R. Moretti for assistance with software development, P. Greisen for scripts used to compare side-chain conformations, J. Gallaher for technical assistance, M. Collazo for help with preliminary crystallization screening, D. Cascio and M. Sawaya for help with crystallographic experiments, and M. Capel, J. Schuermann and I. Kourinov at NE-CAT beamline 24-ID-C for help with data collection. This work was supported by the Howard Hughes Medical Institute (T. G. and D. B.) and the JFRC visitor program (S. G.), the National Science Foundation under CHE-1332907 (D. B. and T.O.Y.), grants from the International AIDS Vaccine Initiative, DTRA (N00024-10-D-6318/0024), AFOSR (FA950-12-10112) and DOE (DE-SC0005155) to D. B., an NIH Biotechnology Training Program award to D. E. M. (T32GM067555) and an NSF graduate research fellowship to J. B. B. (DGE-0718124). T.O.Y. and D.E.M. also acknowledge support from the BER programme of the DOE Office of Science. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding bodies.	Arnold FH, 1999, CURR OPIN CHEM BIOL, V3, P54, DOI 10.1016/S1367-5931(99)80010-6; Boyle AL, 2012, J AM CHEM SOC, V134, P15457, DOI 10.1021/ja3053943; Bradley P, 2006, PROTEINS, V65, P922, DOI 10.1002/prot.21133; Brodin JD, 2012, NAT CHEM, V4, P375, DOI [10.1038/NCHEM.1290, 10.1038/nchem.1290]; Der BS, 2012, J AM CHEM SOC, V134, P375, DOI 10.1021/ja208015j; DiMaio F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020450; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fletcher JM, 2013, SCIENCE, V340, P595, DOI 10.1126/science.1233936; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Grigoryan G, 2011, SCIENCE, V332, P1071, DOI 10.1126/science.1198841; Han DR, 2013, SCIENCE, V339, P1412, DOI 10.1126/science.1232252; Howorka S, 2011, CURR OPIN BIOTECH, V22, P485, DOI 10.1016/j.copbio.2011.05.003; Huang PS, 2007, PROTEIN SCI, V16, P2770, DOI 10.1110/ps.073125207; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jha RK, 2010, J MOL BIOL, V400, P257, DOI 10.1016/j.jmb.2010.05.006; Karanicolas J, 2011, MOL CELL, V42, P250, DOI 10.1016/j.molcel.2011.03.010; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Khare SD, 2013, FEBS LETT, V587, P1147, DOI 10.1016/j.febslet.2012.12.009; King NP, 2013, CURR OPIN STRUC BIOL, V23, P632, DOI 10.1016/j.sbi.2013.06.002; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Lai YT, 2012, TRENDS CELL BIOL, V22, P653, DOI 10.1016/j.tcb.2012.08.004; Lai YT, 2012, SCIENCE, V336, P1129, DOI 10.1126/science.1219351; Lanci CJ, 2012, P NATL ACAD SCI USA, V109, P7304, DOI [10.1073/pnas.1112595109, 10.1073/pnas.111259510]; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Salgado EN, 2010, ACCOUNTS CHEM RES, V43, P661, DOI 10.1021/ar900273t; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Sinclair JC, 2013, CURR OPIN CHEM BIOL, V17, P946, DOI 10.1016/j.cbpa.2013.10.004; Sinclair JC, 2011, NAT NANOTECHNOL, V6, P558, DOI [10.1038/nnano.2011.122, 10.1038/NNANO.2011.122]; Stranges PB, 2011, P NATL ACAD SCI USA, V108, P20562, DOI 10.1073/pnas.1115124108; Usui K, 2009, PROTEIN SCI, V18, P960, DOI 10.1002/pro.106; Worsdorfer B, 2012, J AM CHEM SOC, V134, P909, DOI 10.1021/ja211011k; Worsdorfer B, 2011, SCIENCE, V331, P589, DOI 10.1126/science.1199081	38	381	391	13	401	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					103	+		10.1038/nature13404	http://dx.doi.org/10.1038/nature13404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24870237	Green Accepted			2022-12-01	WOS:000336768900037
J	Walch, M; Dotiwala, F; Mulik, S; Thiery, J; Kirchhausen, T; Clayberger, C; Krensky, AM; Martinvalet, D; Lieberman, J				Walch, Michael; Dotiwala, Farokh; Mulik, Sachin; Thiery, Jerome; Kirchhausen, Tomas; Clayberger, Carol; Krensky, Alan M.; Martinvalet, Denis; Lieberman, Judy			Cytotoxic Cells Kill Intracellular Bacteria through Granulysin-Mediated Delivery of Granzymes	CELL			English	Article							ESCHERICHIA-COLI; COMPLEX-I; HYDROGEN-PEROXIDE; T-CELLS; SUPEROXIDE; DEATH; ANTIBIOTICS; SCAVENGER; APOPTOSIS; OXIDOREDUCTASE	When killer lymphocytes recognize infected cells, perforin delivers cytotoxic proteases (granzymes) into the target cell to trigger apoptosis. What happens to intracellular bacteria during this process is unclear. Human, but not rodent, cytotoxic granules also contain granulysin, an antimicrobial peptide. Here, we show that granulysin delivers granzymes into bacteria to kill diverse bacterial strains. In Escherichia coli, granzymes cleave electron transport chain complex I and oxidative stress defense proteins, generating reactive oxygen species (ROS) that rapidly kill bacteria. ROS scavengers and bacterial antioxidant protein overexpression inhibit bacterial death. Bacteria overexpressing a GzmB-uncleavable mutant of the complex I subunit nuoF or strains that lack complex I still die, but more slowly, suggesting that granzymes disrupt multiple vital bacterial pathways. Mice expressing transgenic granulysin are better able to clear Listeria monocytogenes. Thus killer cells play an unexpected role in bacterial defense.	[Walch, Michael; Dotiwala, Farokh; Mulik, Sachin; Thiery, Jerome; Kirchhausen, Tomas; Martinvalet, Denis; Lieberman, Judy] Harvard Univ, Sch Med, Boston Childrens Hosp, Cellular & Mol Med Program, Boston, MA 02115 USA; [Clayberger, Carol; Krensky, Alan M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Northwestern University; Feinberg School of Medicine	Walch, M (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Cellular & Mol Med Program, 200 Longwood Ave, Boston, MA 02115 USA.	michael.walch@unifr.ch; judy.lieberman@childrens.harvard.edu	THIERY, Jerome/N-2469-2018; Dotiwala, Farokh/S-5367-2019; Lieberman, Judy/A-2717-2015	THIERY, Jerome/0000-0002-0998-3627; Dotiwala, Farokh/0000-0002-7387-2219; Walch, Michael/0000-0001-7284-3291; MULIK, SACHIN/0000-0003-2568-3402	NIH [AI-045587, GM-075252]; Stiefel-Zangger Foundation; Kurt and Senta Herrmann Foundation; PCMM-Glaxo Smith Kline Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045587, R56AI045587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stiefel-Zangger Foundation; Kurt and Senta Herrmann Foundation; PCMM-Glaxo Smith Kline Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH AI-045587 (to J.L.), the Stiefel-Zangger and the Kurt and Senta Herrmann Foundations (to M. W.), and PCMM-Glaxo Smith Kline Alliance (to F. D.), and by NIH grant GM-075252 (to T. K.). We thank Zhan Xu and Solange Kharoubi Hess for technical support, Luis Filgueira for helpful discussions, Marshall Thomas for HeLa-BCL2 cells, James Imlay (University of Illinois) for valuable suggestions and for the L106 E. coli strain, Susan Lovett (Brandeis) for the recA strain, Thorsten Friedrich (Albert-Ludwigs-University, Freiburg, Germany) for E. coli strain ANN0221/pBADnuo/His-nuoF, and Darren Higgins (Harvard Medical School) for the Lm expression plasmid pLIV1 and Eric Marino for maintaining the Imaging Resource used in this study.	Chiang SM, 2012, ARCH BIOCHEM BIOPHYS, V525, P161, DOI 10.1016/j.abb.2012.02.007; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Ernst WA, 2000, J IMMUNOL, V165, P7102, DOI 10.4049/jimmunol.165.12.7102; Friedrich T, 1997, J THEOR BIOL, V187, P529, DOI 10.1006/jtbi.1996.0387; Gallo RL, 2003, CURR ALLERGY ASTHM R, V3, P402, DOI 10.1007/s11882-003-0074-x; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hirche TO, 2008, J IMMUNOL, V181, P4945, DOI 10.4049/jimmunol.181.7.4945; Huang LP, 2007, J IMMUNOL, V178, P77, DOI 10.4049/jimmunol.178.1.77; KAGI D, 1994, EUR J IMMUNOL, V24, P3068, DOI 10.1002/eji.1830241223; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Konola JT, 2000, MUTAT RES-DNA REPAIR, V459, P187, DOI 10.1016/S0921-8777(99)00073-7; Krensky AM, 2009, TISSUE ANTIGENS, V73, P193, DOI 10.1111/j.1399-0039.2008.01218.x; LEDENEV AN, 1986, BIOCHEM INT, V13, P391; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Martinvalet D, 2008, CELL, V133, P681, DOI 10.1016/j.cell.2008.03.032; Pitabut N, 2011, MICROBIOL IMMUNOL, V55, P565, DOI 10.1111/j.1348-0421.2011.00348.x; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Spaeny-Dekking EHA, 1998, J IMMUNOL, V160, P3610; Spehr V, 1999, BIOCHEMISTRY-US, V38, P16261, DOI 10.1021/bi9919605; Steinwede K, 2012, J IMMUNOL, V188, P4476, DOI 10.4049/jimmunol.1103346; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Taiwo FA, 2008, SPECTROSC-INT J, V22, P491, DOI 10.1155/2008/953692; Thiery J., 2010, CURR PROTOC CELL BIO; Thoma-Uszynski S, 2000, J IMMUNOL, V165, P5773, DOI 10.4049/jimmunol.165.10.5773; Walch M, 2009, J IMMUNOL, V182, P7569, DOI 10.4049/jimmunol.0800296; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	32	114	118	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1309	1323		10.1016/j.cell.2014.03.062	http://dx.doi.org/10.1016/j.cell.2014.03.062			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906149	Green Accepted, Bronze			2022-12-01	WOS:000340881400009
J	Peacock, S				Peacock, Sharon			Bring microbial sequencing to hospitals	NATURE			English	Editorial Material									[Peacock, Sharon] Univ Cambridge, Cambridge CB2 1TN, England; [Peacock, Sharon] Publ Hlth England, London, England; [Peacock, Sharon] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England	University of Cambridge; Public Health England; University of Cambridge	Peacock, S (corresponding author), Univ Cambridge, Cambridge CB2 1TN, England.	sjp97@medschl.cam.ac.uk	Peacock, Sharon J/ABE-6331-2020					Bernard EJ, 2007, HIV MED, V8, P382, DOI 10.1111/j.1468-1293.2007.00486.x; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Reuter S, 2013, JAMA INTERN MED, V173, P1397, DOI 10.1001/jamainternmed.2013.7734; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1	5	13	13	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					557	559		10.1038/509557a	http://dx.doi.org/10.1038/509557a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24877182	Bronze			2022-12-01	WOS:000336457100024
J	Wright, J				Wright, Jessica			NANOTECHNOLOGY Deliver on a promise	NATURE			English	Editorial Material																		Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Hrkach J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003651; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124	3	27	27	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S58	S59		10.1038/509S58a	http://dx.doi.org/10.1038/509S58a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870822				2022-12-01	WOS:000336457100005
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION What is an open label trial?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ALLOCATION		Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Bawaskar HS, 2010, BMJ-BRIT MED J, V341, pc7136; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5518; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2409; Sedgwick P, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f3345; Sedgwick P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6068	5	6	6	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2014	348								g3434	10.1136/bmj.g3434	http://dx.doi.org/10.1136/bmj.g3434			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH9AC	24859904				2022-12-01	WOS:000336429700012
J	Spiegel, I; Mardinly, AR; Gabel, HW; Bazinet, JE; Couch, CH; Tzeng, CP; Harmin, DA; Greenberg, ME				Spiegel, Ivo; Mardinly, Alan R.; Gabel, Harrison W.; Bazinet, Jeremy E.; Couch, Cameron H.; Tzeng, Christopher P.; Harmin, David A.; Greenberg, Michael E.			Npas4 Regulates Excitatory-Inhibitory Balance within Neural Circuits through Cell-Type-Specific Gene Programs	CELL			English	Article							NEURONAL-ACTIVITY; CRITICAL PERIOD; VISUAL-CORTEX; INTERNEURONS; PLASTICITY; TRANSCRIPTION; EXPRESSION; MECHANISMS; MATURATION; EXPERIENCE	The nervous system adapts to experience by inducing a transcriptional program that controls important aspects of synaptic plasticity. Although the molecular mechanisms of experience-dependent plasticity are well characterized in excitatory neurons, the mechanisms that regulate this process in inhibitory neurons are only poorly understood. Here, we describe a transcriptional program that is induced by neuronal activity in inhibitory neurons. We find that, while neuronal activity induces expression of early-response transcription factors such as Npas4 in both excitatory and inhibitory neurons, Npas4 activates distinct programs of late-response genes in inhibitory and excitatory neurons. These late-response genes differentially regulate synaptic input to these two types of neurons, promoting inhibition onto excitatory neurons while inducing excitation onto inhibitory neurons. These findings suggest that the functional outcomes of activity-induced transcriptional responses are adapted in a cell-type-specific manner to achieve a circuit-wide homeostatic response.	[Spiegel, Ivo; Mardinly, Alan R.; Gabel, Harrison W.; Bazinet, Jeremy E.; Couch, Cameron H.; Tzeng, Christopher P.; Harmin, David A.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Mardinly, Alan R.; Tzeng, Christopher P.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	meg@hms.harvard.edu	Spiegel, Ivo/O-4025-2014	Tzeng, Christopher/0000-0003-4734-6298; Spiegel, Ivo/0000-0003-0979-1358; Mardinly, Alan/0000-0001-9891-6719	Human Frontiers Science Program; Swiss National Science Foundation; National Institutes of Health [NS048276]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048276, R37NS028829] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank F. Polleux and J. De Marchena for help with establishing the MGE cultures, C. Mandel-Brehm and C. Chen for help with electrophysiology experiments, J. M. Gray and A. M. Costa for help with preparing RNA-seq libraries, B. L. Bloodgood for preliminary recordings from MGE cultures, N. Sharma for the lentiviral expression construct of Npas4, E. Griffith and T. Cherry for critical reading of the manuscript, and P. Zhang for managing the mouse colony. This work was funded by fellowships by the Human Frontiers Science Program and the Swiss National Science Foundation (I. S.) and the National Institutes of Health grant NS048276 (M.E.G.).	Batista-Brito R, 2008, CEREB CORTEX, V18, P2306, DOI 10.1093/cercor/bhm258; Bloodgood BL, 2013, NATURE, V503, P121, DOI 10.1038/nature12743; Chang MC, 2010, NAT NEUROSCI, V13, P1090, DOI 10.1038/nn.2621; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chen JL, 2011, NAT NEUROSCI, V14, P587, DOI 10.1038/nn.2799; Coutellier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046604; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lee HW, 2008, J NEUROSCI, V28, P14546, DOI 10.1523/JNEUROSCI.3112-08.2008; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Maya-Vetencourt JF, 2012, J PHYSIOL-LONDON, V590, P4777, DOI 10.1113/jphysiol.2012.234237; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Ploski JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023760; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954	31	211	215	3	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1216	1229		10.1016/j.cell.2014.03.058	http://dx.doi.org/10.1016/j.cell.2014.03.058			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855953	Green Accepted, Bronze			2022-12-01	WOS:000336437200021
J	Sakala, C; Newburn, M				Sakala, Carol; Newburn, Mary			Meeting needs of childbearing women and newborn infants through strengthened midwifery	LANCET			English	Editorial Material							HEALTH		[Sakala, Carol] Natl Partnership Women & Families, Childbirth Connect Programs, Washington, DC 20009 USA; [Newburn, Mary] NCT, London W3 6NH, England		Sakala, C (corresponding author), Natl Partnership Women & Families, Childbirth Connect Programs, Washington, DC 20009 USA.	csakala@nationalpartnership.org						Bell AF, 2014, J MIDWIFERY WOM HEAL, V59, P35, DOI 10.1111/jmwh.12101; Buckley S., 2014, HORMONAL PHYSL CHILD; Care Quality Commission, NAT FIND 2013 SURV W; Collado MC, 2012, GUT MICROBES, V3, P352, DOI 10.4161/gmic.21215; Csaba G, 2011, CLIN EPIGENETICS, V2, P187, DOI 10.1007/s13148-011-0024-8; Dahlen HG, 2013, MED HYPOTHESES, V80, P656, DOI 10.1016/j.mehy.2013.01.017; Declercq ER, 2013, LISTENING MOTHERS IL; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Halfon N, 2014, MATERN CHILD HLTH J, V18, P344, DOI 10.1007/s10995-013-1346-2; International Confederation of Midwives, 2010, ESS COMP BAS MIDW PR; Kriebel D, 2001, AM J PUBLIC HEALTH, V91, P1351, DOI 10.2105/AJPH.91.9.1351; Olza-Fernandez I, 2014, FRONT NEUROENDOCRIN, V35, P459, DOI 10.1016/j.yfrne.2014.03.007; Renfrew MJ, 2014, LANCET; UNFPA, 2014, STAT WORLDS MIDW 201	14	26	26	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					E39	E40		10.1016/S0140-6736(14)60856-4	http://dx.doi.org/10.1016/S0140-6736(14)60856-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ2PU	24965817				2022-12-01	WOS:000342630600001
J	Miller, PS; Aricescu, AR				Miller, Paul S.; Aricescu, A. Radu			Crystal structure of a human GABA(A) receptor	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; SIZE-EXCLUSION CHROMATOGRAPHY; LIGAND-BINDING DOMAIN; X-RAY-STRUCTURE; EXTRACELLULAR DOMAIN; ALPHA-BUNGAROTOXIN; ION SELECTIVITY; CHANNEL; MUTATION; EXPRESSION	Type-A gamma-aminobutyric acid receptors (GABA(A)Rs) are the principal mediators of rapid inhibitory synaptic transmission in the human brain. A decline in GABA(A)R signalling triggers hyperactive neurological disorders such as insomnia, anxiety and epilepsy. Here we present the first three-dimensional structure of a GABA(A)R, the human beta 3homopentamer, at 3 angstrom resolution. This structure reveals architectural elements unique to eukaryotic Cys-loop receptors, explains the mechanistic consequences of multiple human disease mutations and shows an unexpected structural role for a conserved N-linked glycan. The receptor was crystallized bound to a previously unknown agonist, benzamidine, opening a new avenue for the rational design of GABA(A)R modulators. The channel region forms a closed gate at the base of the pore, representative of a desensitized state. These results offer new insights into the signalling mechanisms of pentameric ligand-gated ion channels and enhance current understanding of GABAergic neurotransmission.	[Miller, Paul S.; Aricescu, A. Radu] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Aricescu, AR (corresponding author), Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	paul@strubi.ox.ac.uk; radu@strubi.ox.ac.uk		Miller, Paul/0000-0002-6512-9441; Aricescu, Alexandru ARadu/0000-0003-3783-1388	Wellcome Trust (OXION: Ion channels and Disease Initiative) [084655]; UK Medical Research Council ((MRC)) [G0700232]; Royal Society [RG090810]; Wellcome Trust [090532/Z/09/Z]; Medical Research Council [MR/L009609/1, G0700232] Funding Source: researchfish; MRC [G0700232, MR/L009609/1] Funding Source: UKRI	Wellcome Trust (OXION: Ion channels and Disease Initiative); UK Medical Research Council ((MRC))(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank T. Malinauskas, Y. Kong and staff at Diamond Light Source beamlines I03 and I24 for synchrotron assistance; K. Harlos and T. Walter for technical support with crystallization; G. Schertler and J. Standfuss for advice concerning the Rho-1D4 affinity purification method; T. Nakagawa for electron microscopy sample examination; F. Ashcroft, S. Tucker, M. Clausen and P. Proks for access to electrophysiology equipment and assistance with electrophysiological recordings; J. McIlhinney, M. Sansom, L. Carpenter, S. Newstead, I. de Moraes and members of the Aricescu laboratory for discussions; E. Y. Jones, D. I. Stuart and C. Siebold for reading the manuscript. This work was supported by grants from the Wellcome Trust (OXION: Ion channels and Disease Initiative, 084655), the UK Medical Research Council ((MRC) G0700232) and the Royal Society (RG090810). Further support from the Wellcome Trust Core Award Grant Number 090532/Z/09/Z is acknowledged. P. S. M. was a Wellcome Trust OXION Training Fellow. A. R. A. is an MRC Senior Research Fellow.	Akabas MH, 2013, P NATL ACAD SCI USA, V110, P16700, DOI 10.1073/pnas.1316157110; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Aricescu AR, 2013, CURR OPIN STRUC BIOL, V23, P345, DOI 10.1016/j.sbi.2013.04.003; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/ng0501-46; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Bergmann R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052323; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Bricogne G., 2011, BUSTER VERSION 2 11; Buhr A, 2002, HUM GENET, V111, P154, DOI 10.1007/s00439-002-0766-7; Butts CA, 2009, P NATL ACAD SCI USA, V106, P6501, DOI 10.1073/pnas.0810590106; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Chaudhary S, 2012, NAT PROTOC, V7, P453, DOI 10.1038/nprot.2011.453; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; daCosta CJB, 2011, J NEUROSCI, V31, P13870, DOI 10.1523/JNEUROSCI.2652-11.2011; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Deprez C, 2005, J MOL BIOL, V346, P1047, DOI 10.1016/j.jmb.2004.12.028; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farre C, 2009, COMB CHEM HIGH T SCR, V12, P24, DOI 10.2174/138620709787047966; GRENNINGLOH G, 1987, NATURE, V330, P25, DOI 10.1038/330025b0; Gurba KN, 2012, J BIOL CHEM, V287, P12083, DOI 10.1074/jbc.M111.332528; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Horenstein J, 1998, MOL PHARMACOL, V53, P870; Huang S, 2013, BIOCHEM J, V454, P303, DOI 10.1042/BJ20130636; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Jensen ML, 2002, J BIOL CHEM, V277, P41438, DOI 10.1074/jbc.M205645200; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lape R, 2012, J NEUROSCI, V32, P1336, DOI 10.1523/JNEUROSCI.4346-11.2012; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Lo WY, 2010, J BIOL CHEM, V285, P31348, DOI 10.1074/jbc.M110.151449; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Miller PS, 2005, J BIOL CHEM, V280, P37877, DOI 10.1074/jbc.M508303200; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Newell JG, 2004, J NEUROSCI, V24, P11226, DOI 10.1523/JNEUROSCI.3746-04.2004; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Parker JL, 2012, PROTEIN SCI, V21, P1358, DOI 10.1002/pro.2122; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; RAJENDRA S, 1995, NEURON, V14, P169, DOI 10.1016/0896-6273(95)90251-1; Rees DC, 2004, NAT REV DRUG DISCOV, V3, P660, DOI 10.1038/nrd1467; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; Sancar F, 2004, J BIOL CHEM, V279, P47034, DOI 10.1074/jbc.M403388200; Saras A, 2008, J BIOL CHEM, V283, P10470, DOI 10.1074/jbc.M709993200; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Simon J, 2004, J BIOL CHEM, V279, P41422, DOI 10.1074/jbc.M401354200; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Tasneem A, 2005, GENOME BIOL, V6; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Wagner DA, 2004, J NEUROSCI, V24, P2733, DOI 10.1523/JNEUROSCI.4316-03.2004; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195; Yip GMS, 2013, NAT CHEM BIOL, V9, P715, DOI [10.1038/NCHEMBIO.1340, 10.1038/nchembio.1340]; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	80	498	512	4	194	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					270	+		10.1038/nature13293	http://dx.doi.org/10.1038/nature13293			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	24909990	Green Accepted			2022-12-01	WOS:000340508200026
J	Ongen, H; Andersen, CL; Bramsen, JB; Oster, B; Rasmussen, MH; Ferreira, PG; Sandoval, J; Vidal, E; Whiffin, N; Planchon, A; Padioleau, I; Bielser, D; Romano, L; Tomlinson, I; Houlston, RS; Esteller, M; Orntoft, TF; Dermitzakis, ET				Ongen, Halit; Andersen, Claus L.; Bramsen, Jesper B.; Oster, Bodil; Rasmussen, Mads H.; Ferreira, Pedro G.; Sandoval, Juan; Vidal, Enrique; Whiffin, Nicola; Planchon, Alexandra; Padioleau, Ismael; Bielser, Deborah; Romano, Luciana; Tomlinson, Ian; Houlston, Richard S.; Esteller, Manel; Orntoft, Torben F.; Dermitzakis, Emmanouil T.			Putative cis-regulatory drivers in colorectal cancer	NATURE			English	Article							MUTATIONS; HETEROZYGOSITY; IDENTIFICATION; MICRORNA; GENE	The cis-regulatory effects responsible for cancer development have not been as extensively studied as the perturbations of the protein coding genome in tumorigenesis(1,2). To better characterize colorectal cancer (CRC) development we conducted an RNA-sequencing experiment of 103 matched tumour and normal colon mucosa samples from Danish CRC patients, 90 of which were germline-genotyped. By investigating allele-specific expression (ASE) we show that the germline genotypes remain important determinants of allelic gene expression in tumours. Using the changes in ASE in matched pairs of samples we discover 71 genes with excess of somaticc is-regulatory effects in CRC, suggesting a cancer driver role. We correlate genotypes and gene expression to identify expression quantitative trait loci (eQTLs) and find 1,693 and 948 eQTLs in normal samples and tumours, respectively. We estimate that 36% of the tumour eQTLs are exclusive to CRC and show that this specificity is partially driven by increased expression of specific transcription factors and changes in methylation patterns. We show that tumour-specific eQTLs are more enriched for low CRC genome-wide association study (GWAS) P values than shared eQTLs, which suggests that some of the GWAS variants are tumour specific regulatory variants. Importantly, tumour-specific eQTL genes also accumulate more somatic mutations when compared to the shared eQTL genes, raising the possibility that they constitute germline-derived cancer regulatory drivers. Collectively the integration of genome and the transcriptome reveals a substantial number of putative somatic and germline cis-regulatory cancer changes that may have a role in tumorigenesis.	[Ongen, Halit; Ferreira, Pedro G.; Planchon, Alexandra; Padioleau, Ismael; Bielser, Deborah; Romano, Luciana; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Ongen, Halit; Ferreira, Pedro G.; Planchon, Alexandra; Padioleau, Ismael; Bielser, Deborah; Romano, Luciana; Dermitzakis, Emmanouil T.] Univ Geneva, Inst Genet & Genom Geneva IGE3, CH-1211 Geneva, Switzerland; [Ongen, Halit; Ferreira, Pedro G.; Planchon, Alexandra; Padioleau, Ismael; Bielser, Deborah; Romano, Luciana; Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Andersen, Claus L.; Bramsen, Jesper B.; Oster, Bodil; Rasmussen, Mads H.; Orntoft, Torben F.] Aarhus Univ Hosp, Dept Mol Med, DK-8000 Aarhus, Denmark; [Sandoval, Juan; Vidal, Enrique] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona 08908, Catalonia, Spain; [Whiffin, Nicola; Houlston, Richard S.] Inst Canc Res, Div Genet & Epidemiol, Sutton SM2 5NG, Surrey, England; [Tomlinson, Ian] Wellcome Trust Ctr Human Genet, Nuffield Dept Clin Med, Oxford OX3 7BN, England; [Tomlinson, Ian] Wellcome Trust Ctr Human Genet, Oxford NIHR Comprehens Biomed Res Ctr, Oxford OX3 7BN, England; [Esteller, Manel] Univ Barcelona, Sch Med, Dept Physiol Sci 2, E-08007 Barcelona, Spain; [Esteller, Manel] ICREA, Barcelona 08010, Spain	University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; Aarhus University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of London; Institute of Cancer Research - UK; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; University of Barcelona; ICREA	Ongen, H (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	halit.ongen@unige.ch; emmanouil.dermitzakis@unige.ch	W, Nicola/AAG-3227-2020; Andersen, Claus L/C-1477-2017; Esteller, Manel/L-5956-2014; Ferreira, Pedro G/J-6379-2013; sandoval, juan/M-4593-2015; Vidal, Enrique/J-7118-2015; Padioleau, Ismaël/AAE-8927-2019; Vidal, Enrique/A-9455-2014; Ferreira, Pedro/HDO-1346-2022; Vidal, Enrique/R-5593-2019; Andersen, Claus Lindbjerg/A-9217-2012	W, Nicola/0000-0003-1554-6594; Esteller, Manel/0000-0003-4490-6093; Ferreira, Pedro G/0000-0003-3838-8664; sandoval, juan/0000-0002-5100-973X; Vidal, Enrique/0000-0002-4217-1807; Padioleau, Ismaël/0000-0003-4935-3248; Vidal, Enrique/0000-0002-4217-1807; Vidal, Enrique/0000-0002-4217-1807; Houlston, Richard/0000-0002-5268-0242; Ongen, Halit/0000-0002-4197-5790; Andersen, Claus Lindbjerg/0000-0002-7406-2103; Rasmussen, Mads Heilskov/0000-0001-5723-6303	European Commission SYSCOL FP7 [UE7-SYSCOL-258236]; European Research Council [ERC 260927]; Louis Jeantet Foundation; Swiss National Science Foundation [130326, 130342]; NIH-NIMH [MH090941]; Danish National Advanced Technology Foundation; John and Birthe Meyer Foundation; Danish Council for Independent Research (Medical Sciences); Danish Council for Strategic Research; Danish Cancer Society; Cellex Foundation; Botin Foundation; Fundacion Olga Torres; Health Department of the Catalan Government (Generalitat de Catalunya); Science Department of the Catalan Government (Generalitat de Catalunya); Cancer Research UK [C1298/A8362]; Oxford Comprehensive Biomedical Research Centre;  [090532/Z/09/Z]; Cancer Research UK [15116] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090941] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	European Commission SYSCOL FP7; European Research Council(European Research Council (ERC)European Commission); Louis Jeantet Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH-NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Danish National Advanced Technology Foundation; John and Birthe Meyer Foundation; Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Cancer Society(Danish Cancer Society); Cellex Foundation(Foundation CELLEX); Botin Foundation; Fundacion Olga Torres; Health Department of the Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya); Science Department of the Catalan Government (Generalitat de Catalunya); Cancer Research UK(Cancer Research UK); Oxford Comprehensive Biomedical Research Centre; ; Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ICREA(ICREA)	This study was designed under the SYSCOL project and samples were collected with informed consent in accordance with local law. This research is supported by grants from European Commission SYSCOL FP7 (UE7-SYSCOL-258236), European Research Council (ERC 260927), Louis Jeantet Foundation, Swiss National Science Foundation (130326, 130342), the NIH-NIMH (MH090941), the Danish National Advanced Technology Foundation, the John and Birthe Meyer Foundation, the Danish Council for Independent Research (Medical Sciences), the Danish Council for Strategic Research, the Danish Cancer Society, The Cellex Foundation, the Botin Foundation, the Fundacion Olga Torres, and the Health and Science Departments of the Catalan Government (Generalitat de Catalunya). The Danish Cancer Biobank is acknowledged for biological material. We thank S. Moran, D. Garcia and C. Arribas for their technical support. This study was also funded by Cancer Research UK and The Oxford Comprehensive Biomedical Research Centre (I.P.T.). Core infrastructure support to the Wellcome Trust Centre for Human Genetics, Oxford, was provided by grant (090532/Z/09/Z). Cancer Research UK provided funding individually to R.S.H. (C1298/A8362-Bobby Moore Fund for Cancer Research UK). This study made use of genotyping data from the 1958 Birth Cohort and NBS samples, kindly made available by the Wellcome Trust Case Control Consortium 2. The computations were performed at the Vital-IT (http://www.vital-it.ch) Center for high-performance computing of the SIB Swiss Institute of Bioinformatics.	Aerts S, 2013, NATURE, V499, P35, DOI 10.1038/499035a; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Dalla-Torre CA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-237; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; EMI M, 1992, CANCER RES, V52, P5368; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lappalainen T, 2011, AM J HUM GENET, V89, P459, DOI 10.1016/j.ajhg.2011.08.004; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1078-0432.CCR-05-0859; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; SCHWEINFEST CW, 1993, P NATL ACAD SCI USA, V90, P4166, DOI 10.1073/pnas.90.9.4166; Sun DF, 2013, J BIOL CHEM, V288, P9508, DOI 10.1074/jbc.M112.367763; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Thorsen K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002998; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034	20	105	106	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					87	90		10.1038/nature13602	http://dx.doi.org/10.1038/nature13602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25079323				2022-12-01	WOS:000339908000037
J	Cantrell, KA; Sutton, S; Gaur, AH				Cantrell, Kathryn A.; Sutton, Sylvia; Gaur, Aditya H.			Pause, Listen, Share	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NARRATIVE MEDICINE; ILLNESS NARRATIVES		[Cantrell, Kathryn A.] Univ Massachusetts, Dept Counseling, Boston, MA 02125 USA; [Cantrell, Kathryn A.] Univ Massachusetts, Sch Psychol, Boston, MA 02125 USA; [Sutton, Sylvia; Gaur, Aditya H.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston; St Jude Children's Research Hospital	Gaur, AH (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	aditya.gaur@stjude.org	Gaur, Aditya H/N-8057-2018	Gaur, Aditya H/0000-0002-6639-5231; Cantrell, Kathryn/0000-0001-7198-3807	NCI NIH HHS [CA 21765] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Charon R, 2001, JAMA-J AM MED ASSOC, V286, P1897, DOI 10.1001/jama.286.15.1897; DasGupta S, 2007, PEDIATRICS, V119, pE1384, DOI 10.1542/peds.2006-2619; Ezzy D, 2000, SOC SCI MED, V50, P605, DOI 10.1016/S0277-9536(99)00306-8; Frank A., 2010, WOUNDED STORYTELLER; Frank A, 1998, FAM SYST HEALTH, V16, P197, DOI [DOI 10.1037/H0089849, 10.1037/h0089849]; Kleinman A., 1988, ILLNESS NARRATIVES S; Nowaczyk MJM, 2013, AM J MED GENET A, V161, P2117, DOI 10.1002/ajmg.a.36114	7	2	2	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					345	346		10.1001/jama.2014.6201	http://dx.doi.org/10.1001/jama.2014.6201			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038350				2022-12-01	WOS:000339257800018
J	Chamberlain, PI				Chamberlain, Paul Ivor			An assisted dying law might save me from a lingering and unpleasant death Paul Ivor Chamberlain has motor neurone disease and explains why he backs Lord Falconer's bill	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												paul.chamberlain@sky.com						Dyer C, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4739	1	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2014	349								g4784	10.1136/bmj.g4784	http://dx.doi.org/10.1136/bmj.g4784			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VN	25052048				2022-12-01	WOS:000339565700015
J	Yuen, TJ; Silbereis, JC; Griveau, A; Chang, SM; Daneman, R; Fancy, SPJ; Zahed, H; Maltepe, E; Rowitch, DH				Yuen, Tracy J.; Silbereis, John C.; Griveau, Amelie; Chang, Sandra M.; Daneman, Richard; Fancy, Stephen P. J.; Zahed, Hengameh; Maltepe, Emin; Rowitch, David H.			Oligodendrocyte-Encoded HIF Function Couples Postnatal Myelination and White Matter Angiogenesis	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; NUCLEAR TRANSLOCATOR ARNT; HYPOXIA-INDUCIBLE FACTORS; BETA-CATENIN; MULTIPLE-SCLEROSIS; ENDOTHELIAL-CELLS; AXONAL INTEGRITY; PROGENITOR CELLS; CEREBRAL-PALSY	Myelin sheaths provide critical functional and trophic support for axons in white matter tracts of the brain. Oligodendrocyte precursor cells (OPCs) have extraordinary metabolic requirements during development as they differentiate to produce multiple myelin segments, implying that they must first secure adequate access to blood supply. However, mechanisms that coordinate myelination and angiogenesis are unclear. Here, we show that oxygen tension, mediated by OPC-encoded hypoxia-inducible factor (HIF) function, is an essential regulator of postnatal myelination. Constitutive HIF1/2 alpha stabilization resulted in OPC maturation arrest through autocrine activation of canonical Wnt7 alpha/7 beta. Surprisingly, such OPCs also show paracrine activity that induces excessive postnatal white matter angiogenesis in vivo and directly stimulates endothelial cell proliferation in vitro. Conversely, OPC-specific HIF1/2 alpha loss of function leads to insufficient angiogenesis in corpus callosum and catastrophic axon loss. These findings indicate that OPC-intrinsic HIF signaling couples postnatal white matter angiogenesis, axon integrity, and the onset of myelination in mammalian forebrain.	[Yuen, Tracy J.; Silbereis, John C.; Griveau, Amelie; Chang, Sandra M.; Fancy, Stephen P. J.; Zahed, Hengameh; Rowitch, David H.] Univ Calif San Francisco, Eli & Edythe Broad Inst Stem Cell Res & Regenerat, Dept Pediat, San Francisco, CA 94143 USA; [Yuen, Tracy J.; Silbereis, John C.; Griveau, Amelie; Chang, Sandra M.; Fancy, Stephen P. J.; Zahed, Hengameh; Rowitch, David H.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Silbereis, John C.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; [Daneman, Richard] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Zahed, Hengameh] Univ Calif San Francisco, Med Sci Training Program, San Francisco, CA 94143 USA; [Maltepe, Emin; Rowitch, David H.] Univ Calif San Francisco, Div Neonatol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rowitch, DH (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Inst Stem Cell Res & Regenerat, Dept Pediat, 513 Parnassus Ave, San Francisco, CA 94143 USA.	rowitchd@peds.ucsf.edu		Yuen, Tracy/0000-0002-3451-9279; Rowitch, David/0000-0002-0079-0060	National Multiple Sclerosis Society (NMSS); NIGMS [T32 GM007449-36]; Ruth Kirschstein NRSA fellowship from NINDS [F31 NS076254-03]; NICHD [HD072544]; NINDS [NS040511, P01NS083513]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS076254, P01NS083513, R01NS040511] Funding Source: NIH RePORTER	National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ruth Kirschstein NRSA fellowship from NINDS; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Emily Harrington and April Tenney for expert technical help and Matt Rasband, Nenad Sestan, and Klaus Nave for discussions. We thank Andrew McMahon (USC) for genomic sequence information for Wnt7a and 7b loci, William Kaelin (Dana-Farber Cancer Institute) for floxed VHL transgenic mice, and William Richardson (UCL) for Sox10-cre transgenic mice. We also thank Nina Bauer, who drew all illustrations. T.J.Y. acknowledges a postdoctoral fellowship from the National Multiple Sclerosis Society (NMSS). J.C.S. acknowledges support from training grant T32 GM007449-36 from NIGMS and the Ruth Kirschstein NRSA fellowship F31 NS076254-03 from NINDS. This work was made possible by grants from NICHD (HD072544 to E.M.), NMSS (to D.H.R.) and NINDS (NS040511 and P01NS083513 to D.H.R.). D.H.R. is a HHMI Investigator.	Aboul-Enein F, 2003, J NEUROPATH EXP NEUR, V62, P25, DOI 10.1093/jnen/62.1.25; Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Baron W, 2010, FEBS LETT, V584, P1760, DOI 10.1016/j.febslet.2009.10.085; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CAMMERMEYER J, 1960, AM J ANAT, V106, P197, DOI 10.1002/aja.1001060303; Cayre M, 2013, DEVELOPMENT, V140, P3107, DOI 10.1242/dev.092999; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; Chrast R, 2011, J LIPID RES, V52, P419, DOI 10.1194/jlr.R009761; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Davies AL, 2013, ANN NEUROL, V74, P815, DOI 10.1002/ana.24006; del Rio-Hortega P, 2012, CLIN NEUROPATHOL, V31, P460, DOI 10.5414/NP301000; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; Dugas-Ford J, 2012, P NATL ACAD SCI USA, V109, P16974, DOI 10.1073/pnas.1204773109; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Emery Ben, 2013, Cold Spring Harb Protoc, V2013, P854, DOI 10.1101/pdb.prot073973; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Franceschini MA, 2007, PEDIATR RES, V61, P546, DOI 10.1203/pdr.0b013e318045be99; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Harb R, 2013, J CEREBR BLOOD F MET, V33, P146, DOI 10.1038/jcbfm.2012.152; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012; Hirose K, 1996, MOL CELL BIOL, V16, P1706; Hu FH, 2004, SEMIN PERINATOL, V28, P371, DOI 10.1053/j.semperi.2004.10.001; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Jiang LD, 2011, TRANSL STROKE RES, V2, P366, DOI 10.1007/s12975-011-0078-0; Joza N, 2009, ANN NY ACAD SCI, V1171, P2, DOI 10.1111/j.1749-6632.2009.04681.x; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Lee H, 2006, MOL CELLS, V21, P1; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Ment LR, 1998, DEV BRAIN RES, V111, P197, DOI 10.1016/S0165-3806(98)00139-4; Miller DJ, 2012, P NATL ACAD SCI USA, V109, P16480, DOI 10.1073/pnas.1117943109; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Pham LDD, 2012, GLIA, V60, P875, DOI 10.1002/glia.22320; Porfiri E, 1997, ONCOGENE, V15, P2833, DOI 10.1038/sj.onc.1201462; Rankin EB, 2005, MOL CELL BIOL, V25, P3163, DOI 10.1128/MCB.25.8.3163-3172.2005; Rinholm JE, 2011, J NEUROSCI, V31, P538, DOI 10.1523/JNEUROSCI.3516-10.2011; Rosenstein JM, 2010, ORGANOGENESIS, V6, P107, DOI 10.4161/org.6.2.11687; Ryan HE, 2000, CANCER RES, V60, P4010; Sapieha P, 2012, BLOOD, V120, P2182, DOI 10.1182/blood-2012-04-396846; Sawamiphak S, 2010, NAT PROTOC, V5, P1659, DOI 10.1038/nprot.2010.130; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Silbereis JC, 2010, DIS MODEL MECH, V3, P678, DOI 10.1242/dmm.002915; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Tan S, 2005, J CHILD NEUROL, V20, P972, DOI 10.1177/08830738050200120801; Tanaka K, 2001, NEUROREPORT, V12, P2169, DOI 10.1097/00001756-200107200-00025; TESSITORE C, 1988, DEV BRAIN RES, V43, P139, DOI 10.1016/0165-3806(88)90159-9; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Weiss J, 2004, EXP NEUROL, V189, P141, DOI 10.1016/j.expneurol.2004.05.018; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Yuen TJ, 2013, BRAIN, V136, P1035, DOI 10.1093/brain/awt024	76	235	243	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					383	396		10.1016/j.cell.2014.04.052	http://dx.doi.org/10.1016/j.cell.2014.04.052			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25018103	Green Accepted, Bronze			2022-12-01	WOS:000340943600017
J	Narain, C				Narain, Charvy			GENETICS Complex expressions	NATURE			English	Editorial Material																		Glasscock E, 2007, NAT NEUROSCI, V10, P1554, DOI 10.1038/nn1999; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Lerche H, 2013, J PHYSIOL-LONDON, V591, P753, DOI 10.1113/jphysiol.2012.240606; Thomas EA, 2010, EPILEPSIA, V51, P136, DOI 10.1111/j.1528-1167.2009.02202.x	4	5	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					S8	S9		10.1038/511S8a	http://dx.doi.org/10.1038/511S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25019127				2022-12-01	WOS:000338649800004
J	Chinthapalli, K				Chinthapalli, Krishna			ALZHEIMER'S DISEASE Alzheimer's disease: still a perplexing problem	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TASK-FORCE; FOLLOW-UP; DEMENTIA; THERAPY; BETA; ASSOCIATION; DIAGNOSIS; MUTATION; TRIALS; TAU		Royal Surrey Cty Hosp, Guildford, Surrey, England	Royal Surrey County Hospital	Chinthapalli, K (corresponding author), Royal Surrey Cty Hosp, Guildford, Surrey, England.	kchinthapalli@bmj.com	Chinthapalli, Krishna/P-8428-2019	Chinthapalli, Krishna/0000-0003-4136-4882				Aisen PS, 2011, ARCH MED SCI, V7, P102, DOI 10.5114/aoms.2011.20612; Anand R, 2014, NEUROPHARMACOLOGY, V76, P27, DOI 10.1016/j.neuropharm.2013.07.004; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Birks J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005593; Booth P, 2008, STANDPOINT       NOV; Brayne C, 2007, NAT REV NEUROSCI, V8, P233, DOI 10.1038/nrn2091; Cameron D., 2014, GIRL SUMMIT SPEECH; Castellani RJ, 2011, J PATHOL, V224, P147, DOI 10.1002/path.2885; Coric V, 2012, ARCH NEUROL-CHICAGO, V69, P1430, DOI 10.1001/archneurol.2012.2194; Danysz W, 2012, BRIT J PHARMACOL, V167, P324, DOI 10.1111/j.1476-5381.2012.02057.x; DEAKIN JFW, 1983, BRIT MED J, V287, P1323, DOI 10.1136/bmj.287.6402.1323; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Ferrer I, 2012, PROG NEUROBIOL, V97, P38, DOI 10.1016/j.pneurobio.2012.03.005; Fineberg NA, 2013, J PSYCHOPHARMACOL, V27, P761, DOI 10.1177/0269881113495118; Frisoni GB, 2013, NEUROLOGY, V81, P487, DOI 10.1212/WNL.0b013e31829d86e8; Giacobini E, 2013, NAT REV NEUROL, V9, P677, DOI 10.1038/nrneurol.2013.223; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; HARRISON PJ, 1986, J ROY SOC MED, V79, P347, DOI 10.1177/014107688607900612; Hawkes N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7529; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Huang YD, 2010, TRENDS MOL MED, V16, P287, DOI 10.1016/j.molmed.2010.04.004; Johnson KA, 2013, ALZHEIMERS DEMENT, V9, pE1, DOI [10.1016/j.jalz.2013.06.001, 10.1016/j.jalz.2013.01.002, 10.1016/j.jalz.2012.10.007]; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Rodriguez JJ, 2012, PROG NEUROBIOL, V99, P15, DOI 10.1016/j.pneurobio.2012.06.010; Karran E, 2014, NEW ENGL J MED, V370, P377, DOI 10.1056/NEJMe1313943; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; McShane R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003154.pub5; Middleton LE, 2009, ARCH NEUROL-CHICAGO, V66, P1210, DOI 10.1001/archneurol.2009.201; Mrak RE, 2004, J NEUROPATH EXP NEUR, V63, P679, DOI 10.1093/jnen/63.7.679; Muller U, 2013, LANCET NEUROL, V12, P129, DOI 10.1016/S1474-4422(12)70307-1; Nygaard HB, 2013, CLIN THER, V35, P1480, DOI 10.1016/j.clinthera.2013.09.009; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Richards M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4670; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Strassnig Martin, 2005, Psychiatry (Edgmont), V2, P30; SUMMERS WK, 1986, NEW ENGL J MED, V315, P1241, DOI 10.1056/NEJM198611133152001; Welge V, 2009, J NEURAL TRANSM, V116, P203, DOI 10.1007/s00702-008-0177-6; Winblad B, 2012, LANCET NEUROL, V11, P597, DOI 10.1016/S1474-4422(12)70140-0; Wischik CM, 2014, BIOCHEM PHARMACOL, V88, P529, DOI 10.1016/j.bcp.2013.12.008; Zetterberg H, 2014, EXPERT REV NEUROTHER, V14, P621, DOI 10.1586/14737175.2014.915740	48	2	4	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2014	349								g4433	10.1136/bmj.g4433	http://dx.doi.org/10.1136/bmj.g4433			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZB	25005430				2022-12-01	WOS:000338993300008
J	Azzolin, L; Panciera, T; Soligo, S; Enzo, E; Bicciato, S; Dupont, S; Bresolin, S; Frasson, C; Basso, G; Guzzardo, V; Fassina, A; Cordenonsi, M; Piccolo, S				Azzolin, Luca; Panciera, Tito; Soligo, Sandra; Enzo, Elena; Bicciato, Silvio; Dupont, Sirio; Bresolin, Silvia; Frasson, Chiara; Basso, Giuseppe; Guzzardo, Vincenza; Fassina, Ambrogio; Cordenonsi, Michelangelo; Piccolo, Stefano			YAP/TAZ Incorporation in the beta-Catenin Destruction Complex Orchestrates the Wnt Response	CELL			English	Article							CELL SELF-RENEWAL; HIPPO SIGNALING PATHWAY; INTESTINAL REGENERATION; DIFFERENTIATION; INHIBITION; TAZ; TUMORIGENESIS; DISEASE; KINASE; GROWTH	The Hippo transducers YAP/TAZ have been shown to play positive, as well as negative, roles in Wnt signaling, but the underlying mechanisms remain unclear. Here, we provide biochemical, functional, and genetic evidence that YAP and TAZ are integral components of the beta-catenin destruction complex that serves as cytoplasmic sink for YAP/TAZ. In Wnt-ON cells, YAP/TAZ are physically dislodged from the destruction complex, allowing their nuclear accumulation and activation of Wnt/YAP/TAZ-dependent biological effects. YAP/TAZ are required for intestinal crypt overgrowth induced by APC deficiency and for crypt regeneration ex vivo. In Wnt-OFF cells, YAP/TAZ are essential for beta-TrCP recruitment to the complex and b-catenin inactivation. In Wnt-ON cells, release of YAP/TAZ from the complex is instrumental for Wnt/beta-catenin signaling. In line, the beta-catenin-dependent maintenance of ES cells in an undifferentiated state is sustained by loss of YAP/TAZ. This work reveals an unprecedented signaling framework relevant for organ size control, regeneration, and tumor suppression.	[Azzolin, Luca; Panciera, Tito; Soligo, Sandra; Enzo, Elena; Dupont, Sirio; Cordenonsi, Michelangelo; Piccolo, Stefano] Univ Padua, Sch Med, Dept Mol Med, I-35126 Padua, Italy; [Bicciato, Silvio] Univ Modena & Reggio Emilia, Ctr Genome Res, Dept Biomed Sci, I-41100 Modena, Italy; [Bresolin, Silvia; Frasson, Chiara; Basso, Giuseppe] Univ Padua, Dept Paediat, I-35128 Padua, Italy; [Guzzardo, Vincenza; Fassina, Ambrogio] Univ Padua, Sch Med, Dept Med, I-35126 Padua, Italy	University of Padua; Universita di Modena e Reggio Emilia; University of Padua; University of Padua	Cordenonsi, M (corresponding author), Univ Padua, Sch Med, Dept Mol Med, Viale Colombo 3, I-35126 Padua, Italy.	michelangelo.cordenonsi@unipd.it; piccolo@bio.unipd.it	BICCIATO, Silvio/J-4466-2019; Bresolin, Silvia/K-6576-2016; Azzolin, Luca/K-8012-2016; Bicciato, Silvio/C-9825-2009; Dupont, Sirio/AAP-8133-2021; Cordenonsi, Michelangelo/K-7692-2016	BICCIATO, Silvio/0000-0002-1944-7078; Bresolin, Silvia/0000-0001-7677-7084; Azzolin, Luca/0000-0002-2425-6153; Bicciato, Silvio/0000-0002-1944-7078; Cordenonsi, Michelangelo/0000-0002-8253-5724; Dupont, Sirio/0000-0002-6869-1966; PICCOLO, STEFANO/0000-0002-2037-0004; Panciera, Tito/0000-0002-9272-5716; Enzo, Elena/0000-0001-9768-6368; BASSO, GIUSEPPE/0000-0002-2634-9302	"Young Italian Researchers'' grant from the Italian Welfare Ministry; AIRC-MFAG; Fondazione Citta della Speranza Grant; AIRC Special Program Molecular Clinical Oncology "5 per mille''; Epigenetics Flagship project CNR-Miur; HSFP; Excellence-IIT	"Young Italian Researchers'' grant from the Italian Welfare Ministry; AIRC-MFAG(Fondazione AIRC per la ricerca sul cancro); Fondazione Citta della Speranza Grant; AIRC Special Program Molecular Clinical Oncology "5 per mille''(Fondazione AIRC per la ricerca sul cancro); Epigenetics Flagship project CNR-Miur; HSFP; Excellence-IIT	We thank O. Wessely and Francesca Zanconato for comments; E. Batlle for training with crypt cultures; G. Martello and A. Smith for reagents and suggestions with ES experiments. We are indebted to the following colleagues for generously sharing transgenic mice: A. Clarke (APC fl/fl), D. J. Pan (YAP fl/fl), J. Miyazaki (CAG-Cre), and Sylvie Robine (Villin-CreERT2). We thank Lorenza Ronzani and the transgenic core facility (CFCM-San Raffaele) for TAZ conditional knockout. Axin plasmid was deposited by F. Costantini in Addgene. This work is supported by a "Young Italian Researchers'' grant from the Italian Welfare Ministry and AIRC-MFAG to M. C.; from Fondazione Citta della Speranza Grant to G. B.; from AIRC Special Program Molecular Clinical Oncology "5 per mille'' to S. P. and S. B.; from a donation in memoriam of Liana Simonutti; and from HSFP, Excellence-IIT, and Epigenetics Flagship project CNR-Miur grants to S. P.	Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Buske P, 2012, FEBS J, V279, P3475, DOI 10.1111/j.1742-4658.2012.08646.x; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Cordero JB, 2012, ACTA PHYSIOL, V204, P137, DOI 10.1111/j.1748-1716.2011.02288.x; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Gonzalez-Sancho JM, 2013, J BIOL CHEM, V288, P9428, DOI 10.1074/jbc.M112.448480; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Piccolo S, 2013, CLIN CANCER RES, V19, P4925, DOI 10.1158/1078-0432.CCR-12-3172; Roman AKS, 2014, STEM CELL REP, V2, P127, DOI 10.1016/j.stemcr.2013.12.012; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	30	684	707	2	123	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					157	170		10.1016/j.cell.2014.06.013	http://dx.doi.org/10.1016/j.cell.2014.06.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24976009	Bronze			2022-12-01	WOS:000340943100015
J	Ben-Johny, M; Yang, PS; Niu, J; Yang, WJ; Joshi-Mukherjee, R; Yue, DT				Ben-Johny, Manu; Yang, Philemon S.; Niu, Jacqueline; Yang, Wanjun; Joshi-Mukherjee, Rosy; Yue, David T.			Conservation of Ca2+/Calmodulin Regulation across Na and Ca2+ Channels	CELL			English	Article							CA2+-DEPENDENT INACTIVATION; CA2+-SENSITIVE INACTIVATION; EF-HAND; CALMODULIN-BINDING; CALCIUM REGULATION; CA(V)1.3 CHANNELS; SKELETAL-MUSCLE; C-TERMINUS; MOTIF; DETERMINANTS	Voltage-gated Na and Ca2+ channels comprise distinct ion channel superfamilies, yet the carboxy tails of these channels exhibit high homology, hinting at a long-shared and purposeful module. For different Ca2+ channels, carboxyl-tail interactions with calmodulin do elaborate robust and similar forms of Ca2+ regulation. However, Na channels have only shown subtler Ca2+ modulation that differs among reports, challenging attempts at unified understanding. Here, by rapid Ca2+ photorelease onto Na channels, we reset this view of Na channel regulation. For cardiac-muscle channels (Na(V)1.5), reported effects from which most mechanistic proposals derive, we observe no Ca2+ modulation. Conversely, for skeletal-muscle channels (Na(V)1.4), we uncover fast Ca2+ regulation eerily similar to that of Ca2+ channels. Channelopathic myotonia mutations halve Na(V)1.4 Ca2+ regulation, and transplanting the Na(V)1.4 carboxy tail onto Ca2+ channels recapitulates Ca2+ regulation. Thus, we argue for the persistence and physiological relevance of an ancient Ca2+ regulatory module across Na and Ca2+ channels.	[Yue, David T.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Calcium Signals Lab, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Calcium Signals Lab, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Cell Dynam, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Calcium Signals Lab, Ross Bldg,Room 713,720 Rutland Ave, Baltimore, MD 21205 USA.	dyue@jhmi.edu		Ben-Johny, Manu/0000-0002-5645-0815; Joshi-Mukherjee, Rosy/0000-0003-0162-1004	NINDS; NIMH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073874] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Gordon Tomaselli, King-Wai Yau, Paul Adams, and members of the Ca<SUP>2+</SUP> signals lab for comments. Michael Tadross helped construct and advised on the use of the flash photolysis setup. We thank Dr. Yi Chen-Izu for the generous loan of a flash photolysis system and Drs. Manfred Grabner and Bernhard Flucher for GLT cells. This work was supported by grants from the NINDS (to D.T.Y.) and NIMH (M.B.J.).	Adams P. J., 2007, V45, P215; BABITCH J, 1990, NATURE, V346, P321, DOI 10.1038/346321b0; Bazzazi H, 2013, CELL REP, V5, P367, DOI 10.1016/j.celrep.2013.09.006; BENJOHNY M, 2012, BIOPHYS J, V102, pA125; Berridge MJ, 2012, BIOCHEM SOC T, V40, P297, DOI 10.1042/BST20110766; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Biswas S, 2008, J GEN PHYSIOL, V131, P197, DOI 10.1085/jgp.200709863; Biswas S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081063; Biswas S, 2009, CIRC RES, V104, P870, DOI 10.1161/CIRCRESAHA.108.193565; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; Cannon SC, 1997, NEUROMUSCULAR DISORD, V7, P241, DOI 10.1016/S0960-8966(97)00430-6; Chagot B, 2009, J BIOL CHEM, V284, P6436, DOI 10.1074/jbc.M807747200; CHAO SH, 1984, MOL PHARMACOL, V26, P75; Clausen T, 2011, EXP PHYSIOL, V96, P356, DOI 10.1113/expphysiol.2010.054999; Crotti L, 2013, CIRCULATION, V127, P1009, DOI 10.1161/CIRCULATIONAHA.112.001216; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Deschenes I, 2002, CIRC RES, V90, pE49, DOI 10.1161/01.RES.0000012502.92751.E6; Dunlap K, 2007, J GEN PHYSIOL, V129, P379, DOI 10.1085/jgp.200709786; ECKERT R, 1984, PROG BIOPHYS MOL BIO, V44, P215, DOI 10.1016/0079-6107(84)90009-9; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Feldkamp MD, 2011, STRUCTURE, V19, P733, DOI 10.1016/j.str.2011.02.009; Herzog RI, 2003, J NEUROSCI, V23, P8261; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Huang H, 2012, NEURON, V73, P304, DOI 10.1016/j.neuron.2011.11.022; IMREDY JP, 1994, NEURON, V12, P1301, DOI 10.1016/0896-6273(94)90446-4; JAN LY, 1989, CELL, V56, P13, DOI 10.1016/0092-8674(89)90979-3; Johny MB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2727; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Kubota T, 2009, MUSCLE NERVE, V39, P666, DOI 10.1002/mus.21155; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Limpitikul WB, 2014, J MOL CELL CARDIOL, V74, P115, DOI 10.1016/j.yjmcc.2014.04.022; LINSE S, 1995, ADV SEC MESS PHOSPH, V30, P89; Mahajan A, 2008, BIOPHYS J, V94, P411, DOI 10.1529/biophysj.106.98590; Miloushev VZ, 2009, J BIOL CHEM, V284, P6446, DOI 10.1074/jbc.M807401200; Mori M, 2000, BIOCHEMISTRY-US, V39, P1316, DOI 10.1021/bi9912600; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Potet F, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M806871200; PRESTON RR, 1991, ANNU REV PHYSIOL, V53, P309, DOI 10.1146/annurev.ph.53.030191.001521; PRODHOM B, 1987, NATURE, V329, P243, DOI 10.1038/329243a0; Sarhan MF, 2012, P NATL ACAD SCI USA, V109, P3558, DOI 10.1073/pnas.1114748109; Shah VN, 2006, P NATL ACAD SCI USA, V103, P3592, DOI 10.1073/pnas.0507397103; STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Tadross MR, 2013, P NATL ACAD SCI USA, V110, P15794, DOI 10.1073/pnas.1313898110; Tan HL, 2002, NATURE, V415, P442, DOI 10.1038/415442a; TRIMMER JS, 1990, DEV BIOL, V142, P360, DOI 10.1016/0012-1606(90)90356-N; Van Petegem F, 2012, BIOPHYS J, V103, P2243, DOI 10.1016/j.bpj.2012.10.020; Wagner Stefan, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS26, DOI 10.1111/j.1540-8167.2006.00382.x; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; Wingo TL, 2004, NAT STRUCT MOL BIOL, V11, P219, DOI 10.1038/nsmb737; Wu FF, 2005, J PHYSIOL-LONDON, V565, P371, DOI 10.1113/jphysiol.2005.082909; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; Zhou JM, 1997, P NATL ACAD SCI USA, V94, P2301, DOI 10.1073/pnas.94.6.2301; Zimmer T, 2008, PROG BIOPHYS MOL BIO, V98, P120, DOI 10.1016/j.pbiomolbio.2008.10.005; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	64	71	73	2	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1657	1670		10.1016/j.cell.2014.04.035	http://dx.doi.org/10.1016/j.cell.2014.04.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949975	Bronze, Green Accepted			2022-12-01	WOS:000340941900019
J	Andersen, NN; Pasternak, B; Basit, S; Andersson, M; Svanstrom, H; Caspersen, S; Munkholm, P; Hviid, A; Jess, T				Andersen, Nynne Nyboe; Pasternak, Bjorn; Basit, Saima; Andersson, Mikael; Svanstrom, Henrik; Caspersen, Sarah; Munkholm, Pia; Hviid, Anders; Jess, Tine			Association Between Tumor Necrosis Factor-alpha Antagonists and Risk of Cancer in Patients With Inflammatory Bowel Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONMELANOMA SKIN CANCERS; CROHNS-DISEASE; RHEUMATOID-ARTHRITIS; ULCERATIVE-COLITIS; INFLIXIMAB; THERAPY; MALIGNANCIES; METAANALYSIS; MAINTENANCE; COHORT	IMPORTANCE A Cochrane review and network meta-analysis concluded that there is need for more research on adverse effects, including cancer, after treatment with tumor necrosis factor a (TNF-alpha) antagonists and that national registries and large databases would provide relevant sources of data to evaluate these effects. OBJECTIVE To investigate whether patients with inflammatory bowel disease (IBD) exposed to TNF-alpha antagonists were at increased risk of developing cancer. DESIGN, SETTING, AND PARTICIPANTS Nationwide register-based cohort study in Denmark, 1999-2012. Participants were 56 146 patients 15 years or older with IBD identified in the National Patient Registry, of whom 4553 (8.1%) were exposed to TNF-alpha antagonists. Cancer cases were identified in the Danish Cancer Registry. MAIN OUTCOMES AND MEASURES Rate ratios (RRs) for incident cancer (overall and site-specific) comparing TNF-alpha antagonist users and nonusers, estimated using Poisson regression adjusted for age, calendar year, disease duration, propensity scores, and use of other IBD medications. RESULTS During 489 433 person-years of follow-up (median, 9.3 years [interquartile range, 4.2-14.0]), 81 of 4553 patients exposed to TNF-alpha antagonists (1.8%) (median follow-up, 3.7 years [interquartile range, 1.8-6.0]) and 3465 of 51 593 unexposed patients (6.7%) developed cancer, yielding a fully adjusted RR of 1.07 (95% CI, 0.85-1.36). There was no significantly increased risk of cancer by TNF-alpha antagonist exposure. No site-specific cancers were in significant excess in fully adjusted models. [GRAPHICS] CONCLUSIONS AND RELEVANCE In this Danish nationwide study, exposure to TNF-alpha antagonists among patients with IBD was not associated with an increased risk of cancer over a median follow-up of 3.7 years among those exposed. An increased risk associated with longer-term accumulated doses and follow-up cannot be excluded.	[Andersen, Nynne Nyboe; Pasternak, Bjorn; Basit, Saima; Andersson, Mikael; Svanstrom, Henrik; Hviid, Anders; Jess, Tine] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark; [Caspersen, Sarah; Munkholm, Pia] Herlev Univ Hosp, Gastroenterol Unit, Copenhagen, Denmark	Statens Serum Institut; University of Copenhagen; Herlev & Gentofte Hospital	Andersen, NN (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	nyna@ssi.dk	Pasternak, Bjorn/H-5739-2012; Munkholm, Pia/ABD-2432-2021; Andersen, Nynne Nyboe/I-1043-2019; Hviid, Anders/AAH-4319-2020	Pasternak, Bjorn/0000-0002-2097-8466; Andersen, Nynne Nyboe/0000-0003-0874-0356; Hviid, Anders/0000-0002-7509-9127	Lundbeck Foundation [R83-A7812]; Danish Cancer Society [R40-A1737-11-S2]; Crohn's & Colitis Association of Denmark; Danish Council of Independent Research [09-066323]	Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); Crohn's & Colitis Association of Denmark; Danish Council of Independent Research(Det Frie Forskningsrad (DFF))	This study was supported by grants from the Lundbeck Foundation (R83-A7812), the Danish Cancer Society (R40-A1737-11-S2), and the Crohn's & Colitis Association of Denmark. Dr Jess holds a Female Research Leader grant (09-066323) from the Danish Council of Independent Research.	Andersen TF, 1999, DAN MED BULL, V46, P263; Askling J, 2009, ARTHRITIS RHEUM-US, V60, P3180, DOI 10.1002/art.24941; Beaugerie L, 2009, LANCET, V374, P1617, DOI 10.1016/S0140-6736(09)61302-7; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Caspersen S, 2008, CLIN GASTROENTEROL H, V6, P1212, DOI 10.1016/j.cgh.2008.05.010; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; Fidder H, 2009, GUT, V58, P501, DOI 10.1136/gut.2008.163642; Fonager K, 1996, SCAND J GASTROENTERO, V31, P154, DOI 10.3109/00365529609031980; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Haynes K, 2013, ARTHRITIS RHEUM-US, V65, P48, DOI 10.1002/art.37740; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Lichtenstein GR, 2012, AM J GASTROENTEROL, V107, P1051, DOI 10.1038/ajg.2012.89; Long MD, 2012, GASTROENTEROLOGY, V143, P390, DOI 10.1053/j.gastro.2012.05.004; Lopez-Olivo MA, 2012, JAMA-J AM MED ASSOC, V308, P898, DOI 10.1001/2012.jama.10857; Moulis G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048991; Osterman MT, 2014, GASTROENTEROLOGY, V146, P941, DOI 10.1053/j.gastro.2013.12.025; Pasternak B, 2013, AM J EPIDEMIOL, V177, P1296, DOI 10.1093/aje/kws375; Pedersen CB, 2006, DAN MED BULL, V53, P441; Peyrin-Biroulet L, 2011, GASTROENTEROLOGY, V141, P1621, DOI 10.1053/j.gastro.2011.06.050; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sandborn WJ, 2007, NEW ENGL J MED, V357, P228, DOI 10.1056/NEJMoa067594; Sandborn WJ, 2012, GASTROENTEROLOGY, V142, P257, DOI 10.1053/j.gastro.2011.10.032; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Setshedi M, 2012, J GASTROEN HEPATOL, V27, P385, DOI 10.1111/j.1440-1746.2011.06865.x; Singh H, 2011, GASTROENTEROLOGY, V141, P1612, DOI 10.1053/j.gastro.2011.07.039; Singh JA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008794.pub2; Storm HH, 1997, DAN MED BULL, V44, P535; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; van Schaik FDM, 2011, CLIN GASTROENTEROL H, V9, P449, DOI 10.1016/j.cgh.2011.01.021; Williams CJM, 2014, ALIMENT PHARM THER, V39, P447, DOI 10.1111/apt.12624	31	159	161	2	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2014	311	23					2406	2413		10.1001/jama.2014.5613	http://dx.doi.org/10.1001/jama.2014.5613			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9XV	24938563	Bronze			2022-12-01	WOS:000337301500021
J	Friend, SH; Schadt, EE				Friend, Stephen H.; Schadt, Eric E.			Clues from the resilient	SCIENCE			English	Editorial Material							GENETIC-VARIATION; CYSTIC-FIBROSIS; DISEASE		[Friend, Stephen H.] Sage Bionetworks, Seattle, WA 98109 USA; [Friend, Stephen H.; Schadt, Eric E.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Friend, Stephen H.; Schadt, Eric E.] Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Friend, SH (corresponding author), Sage Bionetworks, Seattle, WA 98109 USA.	friend@sagebase.org; eric.schadt@exchange.mssm.edu						Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Galarneau G, 2010, NAT GENET, V42, P1049, DOI 10.1038/ng.707; Gorry PR, 2002, LANCET, V359, P1832, DOI 10.1016/S0140-6736(02)08681-6; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hartman JL, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r49; Hartman JL, 2007, P NATL ACAD SCI USA, V104, P11700, DOI 10.1073/pnas.0705212104; Hood L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008665; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kaiser J, 2014, SCIENCE, V344, P687, DOI 10.1126/science.344.6185.687; Louie RJ, 2012, GENOME MED, V4, DOI 10.1186/gm404; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Stenson Peter D, 2012, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0113s39; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229	16	32	32	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					970	972		10.1126/science.1255648	http://dx.doi.org/10.1126/science.1255648			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876479				2022-12-01	WOS:000336495800020
J	Luquero, FJ; Grout, L; Ciglenecki, I; Sakoba, K; Traore, B; Heile, M; Diallo, AA; Itama, C; Page, AL; Quilici, ML; Mengel, MA; Eiros, JM; Serafini, M; Legros, D; Grais, RF				Luquero, Francisco J.; Grout, Lise; Ciglenecki, Iza; Sakoba, Keita; Traore, Bala; Heile, Melat; Diallo, Alpha Amadou; Itama, Christian; Page, Anne-Laure; Quilici, Marie-Laure; Mengel, Martin A.; Maria Eiros, Jose; Serafini, Micaela; Legros, Dominique; Grais, Rebecca F.			Use of Vibrio cholerae Vaccine in an Outbreak in Guinea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MASS VACCINATION; CONTROLLED-TRIAL; BANGLADESH; CAMPAIGN; EPIDEMIC; EFFICACY; KOLKATA; BURDEN; INDIA	BACKGROUND The use of vaccines to prevent and control cholera is currently under debate. Shanchol is one of the two oral cholera vaccines prequalified by the World Health Organization; however, its effectiveness under field conditions and the protection it confers in the first months after administration remain unknown. The main objective of this study was to estimate the short-term effectiveness of two doses of Shanchol used as a part of the integrated response to a cholera outbreak in Africa. METHODS We conducted a matched case-control study in Guinea between May 20 and October 19, 2012. Suspected cholera cases were confirmed by means of a rapid test, and controls were selected among neighbors of the same age and sex as the case patients. The odds of vaccination were compared between case patients and controls in bivariate and adjusted conditional logistic-regression models. Vaccine effectiveness was calculated as (1-odds ratio) x 100. RESULTS Between June 8 and October 19, 2012, we enrolled 40 case patients and 160 controls in the study for the primary analysis. After adjustment for potentially confounding variables, vaccination with two complete doses was associated with significant protection against cholera (effectiveness, 86.6%; 95% confidence interval, 56.7 to 95.8; P=0.001). CONCLUSIONS In this study, Shanchol was effective when used in response to a cholera outbreak in Guinea. This study provides evidence supporting the addition of vaccination as part of the response to an outbreak. It also supports the ongoing efforts to establish a cholera vaccine stockpile for emergency use, which would enhance outbreak prevention and control strategies. (Funded by Medecins sans Frontieres.)	[Luquero, Francisco J.; Grout, Lise; Page, Anne-Laure; Grais, Rebecca F.] Epictr, F-75011 Paris, France; [Sakoba, Keita; Mengel, Martin A.] Agence Med Prevent, African Cholera Surveillance Network, Paris, France; [Quilici, Marie-Laure] Inst Pasteur, Natl Reference Ctr Vibrios & Cholera, Enter Bacterial Pathogens Res & Expertise Unit, Paris, France; [Grout, Lise; Ciglenecki, Iza; Serafini, Micaela; Legros, Dominique] Med Sans Frontieres, Geneva, Switzerland; [Sakoba, Keita] Minist Hlth, Conakry, Guinea; [Traore, Bala] Minist Hlth, Direct Prefectorale Sante, Conakry, Guinea; [Diallo, Alpha Amadou] Minist Hlth, Res & Documentat Serv, Conakry, Guinea; [Heile, Melat] Med Sans Frontieres, Conakry, Guinea; [Itama, Christian] WHO, Conakry, Guinea; [Maria Eiros, Jose] Univ Valladolid, Dept Microbiol, Valladolid, Spain	Agence de Medecine Preventive; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Doctors Without Borders; World Health Organization; Universidad de Valladolid	Luquero, FJ (corresponding author), Epictr, 8 Rue St Sabin, F-75011 Paris, France.	francisco.luquero@epicentre.msf.org		Eiros, Jose M/0000-0002-5357-6340; Freeman Grais, Rebecca/0000-0002-5037-8218	Medecins sans Frontieres; Division of Disease Prevention and Control of the Ministry of Health of Guinea, Africhol; Institut Pasteur; French Institute for Public Health Surveillance	Medecins sans Frontieres; Division of Disease Prevention and Control of the Ministry of Health of Guinea, Africhol; Institut Pasteur(European Commission); French Institute for Public Health Surveillance	Supported by Medecins sans Frontieres.; We thank the people of Guinea for their support and participation in the conduct of this survey; the Division of Disease Prevention and Control of the Ministry of Health of Guinea, Africhol, and all the district health and medical officers involved in the study for their support; Jean Rauzier for the work performed at the French National Reference Center for Vibrios and Cholera, which is funded by the Institut Pasteur and the French Institute for Public Health Surveillance; Charles Gaudry, head of mission for Medecins sans Frontieres in Guinea, and the emergency coordinators, logisticians, and administrative staff of the Medecins sans Frontieres Geneva operational center for their patience and enthusiastic support; the study teams and the Medecins sans Frontieres teams in Boffa and Forecariah, especially the research assistants Drs. Soumah Abubacar and Oumar Toure; and Dr. Pedro Pablo Palma, medical director of the Medecins sans Frontieres Barcelona-Athens operational center, for his comments and insight into this project and his continuing support.	AHMED ZU, 1994, MICROBIOL IMMUNOL, V38, P837, DOI 10.1111/j.1348-0421.1994.tb02135.x; Ali M, 2005, LANCET, V366, P44, DOI 10.1016/S0140-6736(05)66550-6; Ali M, 2013, CLIN INFECT DIS, V56, P1123, DOI 10.1093/cid/cit009; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Bhattacharya SK, 2013, LANCET INFECT DIS, V13, P1011, DOI 10.1016/S1473-3099(13)70347-5; Bhattacharya S, 2013, LANCET INFECT DIS, V13, P1050, DOI 10.1016/S1473-3099(13)70273-1; Ciglenecki I, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001512; CLEMENS JD, 1986, LANCET, V2, P124; Dorlencourt F, 1999, B WORLD HEALTH ORGAN, V77, P949; Fournier J. M., 1992, LAB METHODS DIAGNOSI, P59; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Holmgren J, 2012, CURR OPIN IMMUNOL, V24, P343, DOI 10.1016/j.coi.2012.03.014; Hoshino K, 1998, FEMS IMMUNOL MED MIC, V20, P201, DOI 10.1111/j.1574-695X.1998.tb01128.x; Khatib AM, 2012, LANCET INFECT DIS, V12, P837, DOI 10.1016/S1473-3099(12)70196-2; Lucas MES, 2005, NEW ENGL J MED, V352, P757, DOI 10.1056/NEJMoa043323; Luquero FJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002465; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Martin S, 2012, B WORLD HEALTH ORGAN, V90, P714, DOI 10.2471/BLT.12.112433; Martinez-Pino I, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002366; Medecins Sans Frontieres, 2004, CHOL GUID, V2nd; Page AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037360; Pastor M, 2013, VACCINE, V31, P4069, DOI 10.1016/j.vaccine.2013.06.096; Shin S, 2011, CLIN INFECT DIS, V52, P1343, DOI 10.1093/cid/cir141; Sur D, 2010, LANCET, V376, P1392; Sur D, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001289; World Health Organisation, 2010, CHOL OUTBR ASS OUTBR, pWorld health organisation; World Health Organization, 2010, 1 STEPS MAN OUTBR AC; Zuckerman JN, 2007, LANCET INFECT DIS, V7, P521, DOI 10.1016/S1473-3099(07)70138-X	30	104	105	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					2111	2120		10.1056/NEJMoa1312680	http://dx.doi.org/10.1056/NEJMoa1312680			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH9BM	24869721	Green Submitted, Green Published			2022-12-01	WOS:000336434000009
J	Alushin, GM; Lander, GC; Kellogg, EH; Zhang, R; Baker, D; Nogales, E				Alushin, Gregory M.; Lander, Gabriel C.; Kellogg, Elizabeth H.; Zhang, Rui; Baker, David; Nogales, Eva			High-Resolution Microtubule Structures Reveal the Structural Transitions in alpha beta-Tubulin upon GTP Hydrolysis	CELL			English	Article							SLOWLY HYDROLYZABLE ANALOG; NDC80 KINETOCHORE COMPLEX; STATHMIN-LIKE DOMAIN; ELECTRON CRYSTALLOGRAPHY; CRYOELECTRON MICROSCOPY; DYNAMIC INSTABILITY; GAMMA-TUBULIN; DENSITY MAPS; UCSF CHIMERA; BINDING	Dynamic instability, the stochastic switching between growth and shrinkage, is essential for microtubule function. This behavior is driven by GTP hydrolysis in the microtubule lattice and is inhibited by anticancer agents like Taxol. We provide insight into the mechanism of dynamic instability, based on high-resolution cryo-EM structures (4.7-5.6 angstrom) of dynamic microtubules and microtubules stabilized by GMPCPP or Taxol. We infer that hydrolysis leads to a compaction around the E-site nucleotide at longitudinal interfaces, as well as movement of the alpha-tubulin intermediate domain and H7 helix. Displacement of the C-terminal helices in both alpha- and beta-tubulin subunits suggests an effect on interactions with binding partners that contact this region. Taxol inhibits most of these conformational changes, allosterically inducing a GMPCPP-like state. Lateral interactions are similar in all conditions we examined, suggesting that microtubule lattice stability is primarily modulated at longitudinal interfaces.	[Alushin, Gregory M.] Univ Calif Berkeley, Biophys Grad Program, Berkeley, CA 94720 USA; [Lander, Gabriel C.; Zhang, Rui; Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Kellogg, Elizabeth H.; Baker, David] Univ Washington, Dept Biochem, Howard Hughes Med Inst, Seattle, WA 98105 USA; [Nogales, Eva] Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Nogales, E (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	enogales@lbl.gov	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Alushin, Gregory/0000-0001-7250-4484; Lander, Gabriel C./0000-0003-4921-1135	National Institute of General Medical Sciences [GM051487]; Damon Runyon Cancer Research Foundation [DRG 2055-10]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM051487] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Patricia Grob and Tom Houweling for electron microscopy and computer support, respectively, Tom Goddard for help with UCSF Chimera, Yifan Song and Frank DiMaio for making code available for use prior to publication, and Stuart Howes for assistance with kinesin purification. We are grateful to Robert Glaeser for assistance with data collection and many discussions. The kinesin expression construct was the gift of Erik Jonsson and Ron Vale. This work was funded by the National Institute of General Medical Sciences (GM051487) (to E.N.) and a Damon Runyon Cancer Research Foundation fellowship (DRG 2055-10) (to G. C. L.). E.N. and D. B. are Howard Hughes Medical Institute Investigators.	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Alushin GM, 2012, NAT STRUCT MOL BIOL, V19, P1161, DOI 10.1038/nsmb.2411; Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Amos LA, 1999, CHEM BIOL, V6, pR65, DOI 10.1016/S1074-5521(99)89002-4; ARNAL I, 1995, CURR BIOL, V5, P900, DOI 10.1016/S0960-9822(95)00180-1; Ayaz P, 2012, SCIENCE, V337, P857, DOI 10.1126/science.1221698; Aylett CHS, 2011, INT REV CEL MOL BIO, V292, P1, DOI 10.1016/B978-0-12-386033-0.00001-3; Barbier P, 2010, J BIOL CHEM, V285, P31672, DOI 10.1074/jbc.M110.141929; CAPLOW M, 1994, J CELL BIOL, V127, P779, DOI 10.1083/jcb.127.3.779; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; DiMaio F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020450; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Egelman EH, 2007, J STRUCT BIOL, V157, P83, DOI 10.1016/j.jsb.2006.05.015; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Grafmuller A, 2013, J MOL BIOL, V425, P2232, DOI 10.1016/j.jmb.2013.03.029; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Hyams J. S, 1993, MICROTUBULES; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Maurer SP, 2011, P NATL ACAD SCI USA, V108, P3988, DOI 10.1073/pnas.1014758108; McIntosh JR, 2010, J CELL SCI, V123, P3425, DOI 10.1242/jcs.067611; Menendez M, 1998, J BIOL CHEM, V273, P167, DOI 10.1074/jbc.273.1.167; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MITCHISON TJ, 1993, SCIENCE, V261, P1044, DOI 10.1126/science.8102497; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; Nakata T, 2011, J CELL BIOL, V194, P245, DOI 10.1083/jcb.201104034; Nawrotek A, 2011, J MOL BIOL, V412, P35, DOI 10.1016/j.jmb.2011.07.029; Nettles JH, 2004, SCIENCE, V305, P866, DOI 10.1126/science.1099190; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 2006, CURR OPIN STRUC BIOL, V16, P221, DOI 10.1016/j.sbi.2006.03.005; NOGALES E, 1995, J STRUCT BIOL, V115, P199, DOI 10.1006/jsbi.1995.1044; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prota AE, 2013, SCIENCE, V339, P587, DOI 10.1126/science.1230582; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; SIMON JR, 1990, J CELL SCI, V96, P571; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Sui HX, 2010, STRUCTURE, V18, P1022, DOI 10.1016/j.str.2010.05.010; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; VALE RD, 1994, J BIOL CHEM, V269, P23769; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Yajima H, 2012, J CELL BIOL, V198, P315, DOI 10.1083/jcb.201201161	56	390	395	2	142	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1117	1129		10.1016/j.cell.2014.03.053	http://dx.doi.org/10.1016/j.cell.2014.03.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855948	Green Accepted, Bronze			2022-12-01	WOS:000336437200014
J	Rusakova, M; Rakhmetova, A; Strathdee, SA				Rusakova, Maia; Rakhmetova, Aliya; Strathdee, Steffanie A.			Why are sex workers who use substances at risk for HIV?	LANCET			English	Editorial Material							BORDER CITIES; MALE PARTNERS; INJECT DRUGS; FEMALE; BEHAVIORS; RUSSIA		[Rusakova, Maia] NGO Stellit, St Petersburg, Russia; [Rakhmetova, Aliya] Sex Workers Rights Advocacy Network, Budapest, Hungary; [Strathdee, Steffanie A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Strathdee, SA (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	sstrathdee@ucsd.edu	Strathdee, Steffanie A/B-9042-2009	Strathdee, Steffanie/0000-0002-7724-691X; Rusakova, Mayya/0000-0003-1381-353X				Cottler LB, 2014, AM J PUBLIC HEALTH, V104, P338, DOI 10.2105/AJPH.2013.301513; Decker MR, 2014, AIDS BEHAV, V18, P562, DOI 10.1007/s10461-013-0577-y; Des Jarlais DC, 2012, DRUG ALCOHOL DEPEN, V124, P95, DOI 10.1016/j.drugalcdep.2011.12.020; Goldenberg SM, 2012, AIDS BEHAV, V16, P969, DOI 10.1007/s10461-011-0063-3; Rolon ML, 2013, J TROP PEDIATRICS, V59, P214, DOI 10.1093/tropej/fmt009; Odinokova V, 2014, INT J DRUG POLICY, V25, P96, DOI 10.1016/j.drugpo.2013.06.008; Open Society Institute, 2008, NOTH US US GREAT MEA; Patterson TL, 2012, JAIDS-J ACQ IMM DEF, V60, P414, DOI 10.1097/QAI.0b013e31825693f2; Platt L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002836; Robertson AM, 2013, SEX TRANSM DIS, V40, P801, DOI 10.1097/OLQ.0000000000000016; Shannon K., 2014, LANCET; Strathdee SA, 2008, DRUG ALCOHOL DEPEN, V92, P132, DOI 10.1016/j.drugalcdep.2007.07.001; Strathdee SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065812; UNAIDS, 2013, RUSS FED HIV AIDS ES; United Nations & AIDS (UNAIDS), 2012, WORLD AIDS DAY REP; Urada LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033282; World Health Organization, 2013, IMPL COMPR HIV STI P	17	16	17	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2015	385	9964					211	212		10.1016/S0140-6736(14)61042-4	http://dx.doi.org/10.1016/S0140-6736(14)61042-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ2DL	25059944				2022-12-01	WOS:000348044800009
J	Suh, JM; Jonker, JW; Ahmadian, M; Goetz, R; Lackey, D; Osborn, O; Huang, ZF; Liu, WL; Yoshihara, E; van Dijk, TH; Havinga, R; Fan, WW; Yin, YQ; Yu, RT; Liddle, C; Atkins, AR; Olefsky, JM; Mohammadi, M; Downes, M; Evans, RM				Suh, Jae Myoung; Jonker, Johan W.; Ahmadian, Maryam; Goetz, Regina; Lackey, Denise; Osborn, Olivia; Huang, Zhifeng; Liu, Weilin; Yoshihara, Eiji; van Dijk, Theo H.; Havinga, Rick; Fan, Weiwei; Yin, Yun-Qiang; Yu, Ruth T.; Liddle, Christopher; Atkins, Annette R.; Olefsky, Jerrold M.; Mohammadi, Moosa; Downes, Michael; Evans, Ronald M.			Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer	NATURE			English	Article							GROWTH-FACTOR-I; PPAR-GAMMA-FGF1 AXIS; PPAR-GAMMA; FIBROBLAST; HOMEOSTASIS; MICE; SUPPRESSION; METABOLISM; RATS	Fibroblast growth factor 1 (FGF1) is an autocrine/paracrine regulator whose binding to heparan sulphate proteoglycans effectively precludes its circulation(1,2). Although FGF1 is known as a mitogenic factor, FGF1 knockout mice develop insulin resistance when stressed by a high-fat diet, suggesting a potential role in nutrient homeostasis(3,4). Here we show that parenteral delivery of a single dose of recombinant FGF1(rFGF1) results in potent, insulin-dependent lowering of glucose levels in diabetic mice that is dose-dependent but does not lead to hypoglycaemia. Chronic pharmacological treatment with rFGF1 increases insulin-dependent glucose uptake in skeletal muscle and suppresses the hepatic production of glucose to achieve whole-body insulin sensitization. The sustained glucose lowering and insulin sensitization attributed to rFGF1 are not accompanied by the side effects of weight gain, liver steatosis and bone loss associated with current insulin-sensitizing therapies. We also show that the glucose-lowering activity of FGF1 can be dissociated from its mitogenic activity and is mediated predominantly via FGF receptor 1 signalling. Thus we have uncovered an unexpected, neomorphic insulin-sensitizing action for exogenous non-mitogenic human FGF1 with therapeutic potential for the treatment of insulin resistance and type 2 diabetes.	[Suh, Jae Myoung; Ahmadian, Maryam; Yoshihara, Eiji; Fan, Weiwei; Yin, Yun-Qiang; Yu, Ruth T.; Atkins, Annette R.; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Jonker, Johan W.; Liu, Weilin; van Dijk, Theo H.; Havinga, Rick] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, NL-9713 GZ Groningen, Netherlands; [Jonker, Johan W.; Liu, Weilin; van Dijk, Theo H.; Havinga, Rick] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Lab Med, NL-9713 GZ Groningen, Netherlands; [Goetz, Regina; Huang, Zhifeng; Mohammadi, Moosa] New York Univ Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Lackey, Denise; Osborn, Olivia; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Liddle, Christopher] Westmead Millennium Inst, Storr Liver Unit, Westmead, NSW 2145, Australia; [Liddle, Christopher] Univ Sydney, Westmead Hosp, Westmead, NSW 2145, Australia; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; University of Groningen; University of Groningen; New York University; University of California System; University of California San Diego; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Howard Hughes Medical Institute; Salk Institute	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	downes@salk.edu; evans@salk.edu	Goetz, Regina/M-2411-2019; osborn, olivia/R-1460-2018; Frank, Viki/GXZ-9902-2022; Suh, Jae Myoung/B-3268-2015; Mohammadi, Moosa/ABA-6745-2020; kasaei, fahime/T-7197-2018; Jonker, Johan W./ABE-6853-2020; Evans, Ronald/AAF-4001-2019	Goetz, Regina/0000-0003-3681-4703; osborn, olivia/0000-0003-0516-7937; Suh, Jae Myoung/0000-0001-8097-4662; Mohammadi, Moosa/0000-0003-2434-9437; Jonker, Johan W./0000-0002-3919-5437; Evans, Ronald/0000-0002-9986-5965; Yoshihara, Eiji/0000-0001-6324-6495; Yu, Ruth/0000-0002-9527-9627; Atkins, Annette/0000-0003-2558-7058	National Institutes of Health (NIH) [DK057978, DK090962, HL088093, HL105278, ES010337]; Glenn Foundation for Medical Research; Leona M. and Harry B. Helmsley Charitable Trust; Ipsen/Biomeasure; California Institute for Regenerative Medicine; The Ellison Medical Foundation; National Health and Medical Research Council [512354, 632886, 1043199]; European Research Council [IRG-277169]; Human Frontier Science Program [CDA00013/2011-C]; Netherlands Organisation for Scientific Research (VIDI grant) [016.126.338]; Dutch Digestive Foundation [WO 11-67]; Dutch Diabetes Foundation [2012.00.1537]; NIH [DK-033651, DK-074868, T32-DK-007494, DK-063491, P01-DK054441-14A1]; Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH [U54-HD-012303-25]; National Institute of Dental and Craniofacial Research [DE13686]; F32 Ruth L. Kirschstein National Research Service Award (National Institute of Diabetes and Digestive and Kidney Diseases); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303, P50HD012303] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088093, R01HL105278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868, R24DK090962, R01DK033651, P01DK054441, R37DK033651, R37DK057978, T32DK007494, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; Leona M. and Harry B. Helmsley Charitable Trust; Ipsen/Biomeasure(Ipsen); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); The Ellison Medical Foundation(Lawrence Ellison Foundation); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); European Research Council(European Research Council (ERC)European Commission); Human Frontier Science Program(Human Frontier Science Program); Netherlands Organisation for Scientific Research (VIDI grant); Dutch Digestive Foundation; Dutch Diabetes Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); F32 Ruth L. Kirschstein National Research Service Award (National Institute of Diabetes and Digestive and Kidney Diseases); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank L. Chong, J. Alvarez, S. Kaufman, B. Collins, X. Zhao, S. Liu, A. Jurdzinski, A. Bleeker, K. Bijsterveld, D. Oh and G. Bandyopadhyay for technical assistance, and L. Ong and C. Brondos for administrative assistance. Computed tomography was performed at the Veterans Medical Research Foundation. R. M. E. is a Howard Hughes Medical Institute Investigator at the Salk Institute and March of Dimes Chair, and is supported by National Institutes of Health (NIH) grants (DK057978, DK090962, HL088093, HL105278 and ES010337), the Glenn Foundation for Medical Research, the Leona M. and Harry B. Helmsley Charitable Trust, Ipsen/Biomeasure, the California Institute for Regenerative Medicine and The Ellison Medical Foundation. C. L. and M. D. are funded by the National Health and Medical Research Council (grants 512354, 632886 and 1043199); J. W. J. by the European Research Council (grant IRG-277169), the Human Frontier Science Program (CDA00013/2011-C), the Netherlands Organisation for Scientific Research (VIDI grant 016.126.338), the Dutch Digestive Foundation (grant WO 11-67) and the Dutch Diabetes Foundation (grant 2012.00.1537); J.M.O. by NIH grants (DK-033651, DK-074868, T32-DK-007494, DK-063491 and P01-DK054441-14A1) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH through cooperative agreement of U54-HD-012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research; M. M. by the National Institute of Dental and Craniofacial Research grant (DE13686); and M.A. by an F32 Ruth L. Kirschstein National Research Service Award (National Institute of Diabetes and Digestive and Kidney Diseases).	Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Jonker JW, 2012, NATURE, V485, P391, DOI 10.1038/nature10998; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Lee J, 2009, J MOL BIOL, V393, P113, DOI 10.1016/j.jmb.2009.08.026; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li AJ, 1998, NEUROSCI LETT, V255, P41, DOI 10.1016/S0304-3940(98)00701-0; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; SASAKI K, 1994, PHYSIOL BEHAV, V56, P211, DOI 10.1016/0031-9384(94)90186-4; Sun K, 2012, CELL RES, V22, P1416, DOI 10.1038/cr.2012.94; Suzuki S, 2001, EUR J NEUROSCI, V13, P2299, DOI 10.1046/j.0953-816x.2001.01606.x; van Dijk TH, 2003, ANAL BIOCHEM, V322, P1, DOI 10.1016/j.ab.2003.07.008; Wei W, 2012, P NATL ACAD SCI USA, V109, P3143, DOI 10.1073/pnas.1200797109; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Zinn KR, 2000, NUCL MED BIOL, V27, P407, DOI 10.1016/S0969-8051(00)00090-1	18	157	188	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					436	+		10.1038/nature13540	http://dx.doi.org/10.1038/nature13540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043058	Green Accepted			2022-12-01	WOS:000341814900064
J	Pollux, BJA; Meredith, RW; Springer, MS; Garland, T; Reznick, DN				Pollux, B. J. A.; Meredith, R. W.; Springer, M. S.; Garland, T.; Reznick, D. N.			The evolution of the placenta drives a shift in sexual selection in livebearing fish	NATURE			English	Article							MOLECULAR PHYLOGENETIC-RELATIONSHIPS; PARENT-OFFSPRING CONFLICT; REPRODUCTIVE ISOLATION; SIZE DIMORPHISM; VIVIPARITY; POECILIA; CYPRINODONTIFORMES; COEVOLUTION; POLYTOMIES; PATTERNS	The evolution of the placenta from a non-placental ancestor causes a shift of maternal investment from pre- to post-fertilization, creating a venue for parent-offspring conflicts during pregnancy(1-4). Theory predicts that the rise of these conflicts should drive a shift from a reliance on pre-copulatory female mate choice to polyandry in conjunction with post-zygotic mechanisms of sexual selection(2). This hypothesis has not yet been empirically tested. Here we apply comparative methods to test a key prediction of this hypothesis, which is that the evolution of placentation is associated with reduced pre-copulatory female mate choice. We exploit a unique quality of the livebearing fish family Poeciliidae: placentas have repeatedly evolved or been lost, creating diversity among closely related lineages in the presence or absence of placentation(5,6). We show that post-zygotic maternal provisioning by means of a placenta is associated with the absence of bright coloration, courtship behaviour and exaggerated ornamental display traits in males. Furthermore, we found that males of placental species have smaller bodies and longer genitalia, which facilitate sneak or coercive mating and, hence, circumvents female choice. Moreover, we demonstrate that post-zygotic maternal provisioning correlates with superfetation, a female reproductive adaptation that may result in polyandry through the formation of temporally overlapping, mixed-paternity litters. Our results suggest that the emergence of prenatal conflict during the evolution of the placenta correlates with a suite of phenotypic and behavioural male traits that is associated with a reduced reliance on pre-copulatory female mate choice.	[Pollux, B. J. A.; Meredith, R. W.; Springer, M. S.; Garland, T.; Reznick, D. N.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Pollux, B. J. A.] Wageningen Univ, Expt Zool Grp, NL-6708 WD Wageningen, Netherlands; [Meredith, R. W.] Montclair State Univ, Dept Biol & Mol Biol, Montclair, NJ 07043 USA	University of California System; University of California Riverside; Wageningen University & Research; Montclair State University	Pollux, BJA (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	b.pollux@gmail.com; david.reznick@ucr.edu		reznick, david/0000-0002-1144-0568; Garland, Theodore/0000-0002-7916-3552	Netherlands Organisation for Scientific Research [825.07.017]; European Union [299048]; US National Science Foundation [DEB0416085]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); US National Science Foundation(National Science Foundation (NSF))	We thank all individuals and institutions who provided samples for this study (Rehoboth Aquatics, H. Bart Jr, R. Davis, D. Fromm, J. de Greef, H. Hieronimus, B. Hobbs, T. Hrbek, J. Johnson, B. Kohler, J. Langenhammer, C. Li, J. Lundberg, M. Mateos, A. Meyer, D. Nelson, L. Page, L. Parenti, M. Sabaj Perez, R. Robins, R. de Ruiter, S. Schaefer, M. Schartl, J. Sparks, M. Stiassny, J. Travis, J. Trexler and J. Williams); L. Rowe and A. Furness for discussions and reading the manuscript; and C. Oufiero and M. Banet for help in collecting part of the data. This study was supported by Rubicon grant 825.07.017 of the Netherlands Organisation for Scientific Research and Marie Curie - IIF grant 299048 of the European Union to B.J.A.P. and grant DEB0416085 of the US National Science Foundation to D.N.R. and M.S.S.	Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Banet AI, 2010, EVOLUTION, V64, P3172, DOI 10.1111/j.1558-5646.2010.01059.x; BISAZZA A, 1995, ETHOL ECOL EVOL, V7, P169, DOI 10.1080/08927014.1995.9522963; BISAZZA A, 1993, MAR BEHAV PHYSIOL, V23, P257, DOI 10.1080/10236249309378869; Bonduriansky R, 2009, TRENDS ECOL EVOL, V24, P280, DOI 10.1016/j.tree.2008.12.005; Breden F, 1999, MOL PHYLOGENET EVOL, V12, P95, DOI 10.1006/mpev.1998.0600; Bruggeman J, 2009, NUCLEIC ACIDS RES, V37, pW179, DOI 10.1093/nar/gkp370; Burnham KP., 2002, MODEL SELECTION MULT, V2, P70; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Coleman SW, 2009, AM NAT, V173, P291, DOI 10.1086/596542; Crespi B, 2004, AM NAT, V163, P635, DOI 10.1086/382734; Dugdale HL, 2007, MOL ECOL, V16, P5294, DOI 10.1111/j.1365-294X.2007.03571.x; Evans J., 2011, ECOLOGY EVOLUTION PO; Evans JP, 2011, P ROY SOC B-BIOL SCI, V278, P2611, DOI 10.1098/rspb.2010.2453; Fairbairn D.J., 2007, SEX SIZE GENDER ROLE; Felsenstein J., 2004, INFERRING PHYLOGENIE; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; Garland T, 1999, SYST BIOL, V48, P547, DOI 10.1080/106351599260139; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAIG D, 1990, AM NAT, V136, P550, DOI 10.1086/285113; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Hrbek T, 2007, MOL PHYLOGENET EVOL, V43, P986, DOI 10.1016/j.ympev.2006.06.009; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kocher TD, 1995, MOL PHYLOGENET EVOL, V4, P420, DOI 10.1006/mpev.1995.1039; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Maddison WP, MESQUITE MODULAR SYS; Meffe GK, 1989, ECOLOGY EVOLUTION LI; Meredith RW, 2011, MOL PHYLOGENET EVOL, V59, P148, DOI 10.1016/j.ympev.2011.01.014; Meredith RW, 2010, MOL PHYLOGENET EVOL, V55, P631, DOI 10.1016/j.ympev.2009.11.006; MEYER A, 1993, P ROY SOC B-BIOL SCI, V254, P153, DOI 10.1098/rspb.1993.0140; O'Neill MJ, 2007, P NATL ACAD SCI USA, V104, P12404, DOI 10.1073/pnas.0705048104; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M., 2013, USERS MANUAL BAYES T; Pilastro A, 1997, P ROY SOC B-BIOL SCI, V264, P1125, DOI 10.1098/rspb.1997.0155; Pollux BJA, 2009, ANNU REV ECOL EVOL S, V40, P271, DOI 10.1146/annurev.ecolsys.110308.120209; Pollux BJA, 2011, FUNCT ECOL, V25, P747, DOI 10.1111/j.1365-2435.2011.01831.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ptacek MB, 1998, J FISH BIOL, V53, P64, DOI 10.1006/jfbi.1998.0807; PURVIS A, 1993, SYST BIOL, V42, P569, DOI 10.2307/2992489; Rambaut A., SE AL SEQUENCE ALIGN; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Reznick DN, 2002, SCIENCE, V298, P1018, DOI 10.1126/science.1076018; SAS Institute, 2012, SAS ETS 12 1 US GUID, P1121; Schmidt TR, 1998, COPEIA, P14, DOI 10.2307/1447697; Schrader M, 2012, EVOLUTION, V66, P272, DOI 10.1111/j.1558-5646.2011.01422.x; Schrader M, 2008, AM NAT, V172, P806, DOI 10.1086/592999; SHACKELFORD RM, 1952, AM NAT, V86, P311, DOI 10.1086/281738; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Yamaguchi N, 2006, Q REV BIOL, V81, P33, DOI 10.1086/503923; Yang Z., 2006, COMPUTATIONAL MOL EV; Zeh DW, 2000, BIOESSAYS, V22, P938, DOI 10.1002/1521-1878(200010)22:10<938::AID-BIES9>3.0.CO;2-9; Zeh JA, 2003, ETHOLOGY, V109, P929, DOI 10.1046/j.1439-0310.2003.00945.x	59	110	110	1	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					233	+		10.1038/nature13451	http://dx.doi.org/10.1038/nature13451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25043015				2022-12-01	WOS:000341362800050
J	Heidari, S; Mofenson, LM; Bekker, LG				Heidari, Shirin; Mofenson, Lynne M.; Bekker, Linda-Gail			Realization of an AIDS-Free Generation Ensuring Sustainable Treatment for Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ANTIRETROVIRAL THERAPY		[Heidari, Shirin] Inforia, CH-1202 Geneva, Switzerland; [Mofenson, Lynne M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Cape Town	Heidari, S (corresponding author), Inforia, Rue Henri Veyrassat 3, CH-1202 Geneva, Switzerland.	shirin.heidari@inforia.org	Mofenson, Lynne/P-9631-2019; Bekker, Linda-Gail/AAZ-8929-2020	Mofenson, Lynne/0000-0002-2818-9808; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Heidari, Shirin/0000-0002-6837-491X				Penazzato M, 2014, LANCET INFECT DIS, P20; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; UNAIDS, GLOB REP UNAIDS REP; United Nations Joint Programme on HIV/AIDS (UNAIDS), GLOB PLAN EL NEW HIV; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WHO, GLOB UPD HIV TREATM; World Health Organization, CONS GUID US ANT DRU; World Health Organization, MARCH 2014 SUPPL 201	8	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					339	340		10.1001/jama.2014.5806	http://dx.doi.org/10.1001/jama.2014.5806			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038347				2022-12-01	WOS:000339257800015
J	Ohno, H; Kato, S; Naito, Y; Kunitomo, H; Tomioka, M; Iino, Y				Ohno, Hayao; Kato, Shinya; Naito, Yasuki; Kunitomo, Hirofumi; Tomioka, Masahiro; Iino, Yuichi			Role of synaptic phosphatidylinositol 3-kinase in a behavioral learning response in C. elegans	SCIENCE			English	Article							INSULIN-RECEPTOR; PROTEIN; CHEMOTAXIS; PLASTICITY; COMPONENTS; KINESIN-1; CASY-1	The phosphatidylinositol 3-kinase (PI3K) pathway regulates many cellular functions, but its roles in the nervous system are still poorly understood. We found that a newly discovered insulin receptor isoform, DAF-2c, is translocated from the cell body to the synaptic region of the chemosensory neuron in Caenorhabditis elegans by a conditioning stimulus that induces taste avoidance learning. This translocation is essential for learning and is dependent on the mitogen-activated protein kinase-regulated interaction of CASY-1 (the calsyntenin ortholog) and kinesin-1. The PI3K pathway is required downstream of the receptor. Light-regulated activation of PI3K in the synaptic region, but not in other parts of the cell, switched taste-attractive behavior to taste avoidance, mimicking the effect of conditioning. Thus, synaptic PI3K is crucial for the behavioral switch caused by learning.	[Ohno, Hayao; Kato, Shinya; Naito, Yasuki; Kunitomo, Hirofumi; Iino, Yuichi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; [Ohno, Hayao; Iino, Yuichi] JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Naito, Yasuki; Tomioka, Masahiro; Iino, Yuichi] Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Tokyo 1130033, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Tomioka, M (corresponding author), Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Tokyo 1130033, Japan.	seidai@gen.s.u-tokyo.ac.jp; iino@bs.s.u-tokyo.ac.jp	IINO, YUICHI/G-4962-2014; KUNITOMO, HIROFUMI/G-4963-2014; TOMIOKA, MASAHIRO/G-4890-2014	KUNITOMO, HIROFUMI/0000-0001-7312-7051; TOMIOKA, MASAHIRO/0000-0002-7537-714X; Ohno, Hayao/0000-0003-2635-6964	Ministry of Education, Culture, Sports, Science and Technology of Japan [20115002, 25115010, 21370002, 23112704]; Grants-in-Aid for Scientific Research [25115010] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the Caenorhabditis Genetics Center (CGC), the National Bioresource Project, R. Iwata, O. Hobert, K. Matsumoto, M. Han, G. Ruvkun, M. Doi, and S. Oda for strains; N. Chronis for the design of the olfactory chip; K. D. Kimura and G. Ruvkun for daf-2a cDNA; and K. Shen, C. Bargmann, K. Takeo, and members of the Iino lab for thoughtful comments and discussions. The primary data of this study are archived in the Iino laboratory in the Department of Biological Sciences, University of Tokyo, and are available upon request. Y.I. was supported by a Grant-in-Aid for Innovative Areas "Systems molecular ethology" (20115002) and "Memory dynamism" (25115010) and for Scientific Research (B) (21370002), and M. T. was supported by a Grant-in-Aid for Innovative Areas "RNA regulation" (23112704), from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abbott MA, 1999, J NEUROSCI, V19, P7300, DOI 10.1523/JNEUROSCI.19-17-07300.1999; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Chiu SL, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-7; Cornils A, 2011, DEVELOPMENT, V138, P1183, DOI 10.1242/dev.060905; Frokjaer-Jensen C, 2012, NAT METHODS, V9, P117, DOI 10.1038/nmeth.1865; Hoerndli FJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004880; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Ikeda DD, 2008, P NATL ACAD SCI USA, V105, P5260, DOI 10.1073/pnas.0711894105; Kunitomo H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3210; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Oda S, 2011, J NEUROPHYSIOL, V106, P301, DOI 10.1152/jn.01029.2010; Patel DS, 2008, GENETICS, V178, P931, DOI 10.1534/genetics.107.070813; Preuschhof C, 2010, NEUROPSYCHOLOGIA, V48, P402, DOI 10.1016/j.neuropsychologia.2009.09.031; Sakamoto R, 2005, MOL BIOL CELL, V16, P483, DOI 10.1091/mbc.E04-07-0553; Samuel ADT, 2003, J NEUROSCI, V23, P373, DOI 10.1523/JNEUROSCI.23-02-00373.2003; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Schioth HB, 2012, MOL NEUROBIOL, V46, P4, DOI 10.1007/s12035-011-8229-6; Tomida T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002983; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Vagnoni A, 2012, HUM MOL GENET, V21, P2845, DOI 10.1093/hmg/dds109; Vagnoni A, 2011, J CELL SCI, V124, P1032, DOI 10.1242/jcs.075168; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	24	54	57	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					313	317		10.1126/science.1250709	http://dx.doi.org/10.1126/science.1250709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035490				2022-12-01	WOS:000339400700048
J	Rabar, S; Harker, M; O'Flynn, N; Wierzbicki, AS				Rabar, Silvia; Harker, Martin; O'Flynn, Norma; Wierzbicki, Anthony S.		Guideline Dev Grp	GUIDELINES Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHOLESTEROL; METAANALYSIS; THERAPY		[Rabar, Silvia; Harker, Martin; O'Flynn, Norma] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Wierzbicki, Anthony S.] Guys & St Thomas Hosp, London SE1 9RT, England	Royal College of Physicians; Guy's & St Thomas' NHS Foundation Trust	Rabar, S (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	silvia.rabar@rcplondon.ac.uk	Wierzbicki, Anthony/AAP-1735-2020	Wierzbicki, Anthony/0000-0003-2756-372X; Harker, Martin/0000-0001-6154-3517; Khan, Michael/0000-0002-8591-384X	Merck-Sharp-Dohme; Amgen; Pfizer; NICE	Merck-Sharp-Dohme(Merck & Company); Amgen(Amgen); Pfizer(Pfizer); NICE	We have read and understood BMJ policy on declaration of interests and declare the following interests: ASW declares contracts held by his institution and a role as principal site investigator for phase II and phase III studies on lipid lowering agents sponsored by Merck-Sharp-Dohme, Amgen, and Pfizer; these include phase III outcome studies that were sponsored by these companies but whose design and analysis are independent. These agents are not mentioned in the article because they are not licensed and are not likely to be licensed before the guideline is reviewed (2017). NICE did not consider these declared interests to be competing interests for this guideline. SR, MH, and NO'F are employed by the National Clinical Guideline Centre, which was funded by NICE to develop this guideline. The authors' statements can be viewed at www.bmj.com/content/bmj/349/bmj.g4356/related#datasupp.	[Anonymous], 2014, JBS3 RISK CALC; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Department of Health, 2013, NHS HLTH CHECK VASC; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; National Institue for Health and Care Excellence, 2013, DEV NICE CLIN GUID; National Institute for Health and Care Excellence, 2014, CLIN GUIDELINE; National Institute for Health and Clinical Excellence, 2006, CLIN GUIDELINE; National Institute for Health and Clinical Excellence, 2011, CLIN GUIDELINE; National Institute for Health and Clinical Excellence, 2008, CLIN GUIDELINE; National Institute for Health and Clinical Excellence, 2008, CLIN GUIDELINE	14	140	148	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 17	2014	349								g4356	10.1136/bmj.g4356	http://dx.doi.org/10.1136/bmj.g4356			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7PI	25035388				2022-12-01	WOS:000339326400003
J	Stroebel, D; Paoletti, P				Stroebel, David; Paoletti, Pierre			NEUROSCIENCE A structure to remember	NATURE			English	Editorial Material							VOLTAGE-DEPENDENT BLOCK; SUBUNIT ARRANGEMENT; GLUTAMATE-RECEPTOR; NMDA RECEPTORS; DYNAMICS; BINDING; NEURONS; CHANNEL		[Stroebel, David; Paoletti, Pierre] Ecole Normale Super, Inst Biol, CNRS, INSERM,U1024,UMR8197, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite	Stroebel, D (corresponding author), Ecole Normale Super, Inst Biol, CNRS, INSERM,U1024,UMR8197, F-75005 Paris, France.	david.stroebel@ens.fr; pierre.paoletti@ens.fr	Paoletti, Pierre/L-7358-2013	Paoletti, Pierre/0000-0002-3681-4845				Burger PB, 2012, MOL PHARMACOL, V82, P344, DOI 10.1124/mol.112.078568; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Dutta A, 2012, STRUCTURE, V20, P1838, DOI 10.1016/j.str.2012.08.012; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Watkins JC, 2006, BRIT J PHARMACOL, V147, pS100, DOI 10.1038/sj.bjp.0706444; Wollmuth LP, 1998, J PHYSIOL-LONDON, V506, P13, DOI 10.1111/j.1469-7793.1998.013bx.x; Zhu SJ, 2013, NAT STRUCT MOL BIOL, V20, P477, DOI 10.1038/nsmb.2522	14	1	2	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					162	163		10.1038/511162a	http://dx.doi.org/10.1038/511162a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008517				2022-12-01	WOS:000338649800031
J	Zahreddine, HA; Culjkovic-Kraljacic, B; Assouline, S; Gendron, P; Romeo, AA; Morris, SJ; Cormack, G; Jaquith, JB; Cerchietti, L; Cocolakis, E; Amri, A; Bergeron, J; Leber, B; Becker, MW; Pei, SS; Jordan, CT; Miller, WH; Borden, KLB				Zahreddine, Hiba Ahmad; Culjkovic-Kraljacic, Biljana; Assouline, Sarit; Gendron, Patrick; Romeo, Andrea A.; Morris, Stephen J.; Cormack, Gregory; Jaquith, James B.; Cerchietti, Leandro; Cocolakis, Eftihia; Amri, Abdellatif; Bergeron, Julie; Leber, Brian; Becker, Michael W.; Pei, Shanshan; Jordan, Craig T.; Miller, Wilson H., Jr.; Borden, Katherine L. B.			The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; LIVER-MICROSOMES; ONCOGENE EIF4E; INHIBITION; EXPRESSION; TRIALS; AZT	Drug resistance is a major hurdle in oncology. Responses of acute myeloid leukaemia (AML) patients to cytarabine (Ara-C)-based therapies are often short lived with a median overall survival of months(1-4). Therapies are under development to improve outcomes and include targeting the eukaryotic translation initiation factor (eIF4E) with its inhibitor ribavirin(5-7). In a Phase II clinical trial in poor prognosis AML(5), ribavirin monotherapy yielded promising responses including remissions; however, all patients relapsed. Here we identify a novel form of drug resistance to ribavirin and Ara-C. We observe that the sonic hedgehog transcription factor glioma-associated protein 1 (GLI1) and the UDP glucuronosyltransferase (UGT1A) family of enzymes are elevated in resistant cells. UGT1As add glucuronic acid to many drugs, modifying their activity in diverse tissues(8). GLI1 alone is sufficient to drive UGT1A-dependent glucuronidation of ribavirin and Ara-C, and thus drug resistance. Resistance is overcome by genetic or pharmacological inhibition of GLI1, revealing a potential strategy to overcome drug resistance in some patients.	[Zahreddine, Hiba Ahmad; Culjkovic-Kraljacic, Biljana; Gendron, Patrick; Cormack, Gregory; Amri, Abdellatif; Borden, Katherine L. B.] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Zahreddine, Hiba Ahmad; Culjkovic-Kraljacic, Biljana; Gendron, Patrick; Cormack, Gregory; Amri, Abdellatif; Borden, Katherine L. B.] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada; [Assouline, Sarit; Cocolakis, Eftihia; Miller, Wilson H., Jr.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Romeo, Andrea A.; Morris, Stephen J.; Jaquith, James B.] Pharmascience Inc, Montreal, PQ H4P 2T4, Canada; [Cerchietti, Leandro] Cornell Univ, Div Hematol & Oncol, Dept Med, Weill Cornell Med Coll, New York, NY 10021 USA; [Bergeron, Julie] Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada; [Leber, Brian] McMaster Univ, Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada; [Becker, Michael W.] Univ Rochester, Dept Med, Div Hematol Oncol, Rochester, NY 14627 USA; [Pei, Shanshan; Jordan, Craig T.] Univ Colorado Denver, Dept Med,Univ, Div Hematol, Aurora, CO 80045 USA	Universite de Montreal; Universite de Montreal; Lady Davis Institute; McGill University; Cornell University; Universite de Montreal; McMaster University; University of Rochester; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Borden, KLB (corresponding author), Univ Montreal, Inst Res Immunol & Canc, POB 6128, Montreal, PQ H3C 3J7, Canada.	katherine.borden@umontreal.ca	PEI, SHANSHAN/D-8200-2016; Romeo, Andrea Antonino/AAY-2175-2021; jordan, craig/D-7666-2014	PEI, SHANSHAN/0000-0001-9619-2614; Becker, Michael/0000-0001-9890-8815; Gendron, Patrick/0000-0001-9829-2600; jordan, craig/0000-0003-0869-3465; Cerchietti, Leandro/0000-0003-0608-1350; Romeo, Andrea Antonino/0000-0002-1579-2480; Leber, Brian/0000-0001-5502-1480	National Institutes of Health [RO1 80728, 98571]; IRICoR; Leukemia and Lymphoma Society USA; Cole Foundation Fellowship; CNRS Lebanon Fellowship; NATIONAL CANCER INSTITUTE [R01CA098571, R01CA080728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IRICoR; Leukemia and Lymphoma Society USA(Leukemia and Lymphoma Society); Cole Foundation Fellowship; CNRS Lebanon Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful for reading of the manuscript by A. Kentsis, M. Osborne, F. Pettersson, S. del Rincon and C. Perreault. We are grateful for the use of Pharmascience facilities thanks to M. Goodman and D. Goodman, for specimens from the Banques de Cellules Leucemiques Du Quebec (BCLQ), and for technical discussions with M. Ouellet. We thank nursing and support staff at all the clinical sites, and A. Ramteke for technical support. K.L.B.B. is supported by funds from the National Institutes of Health (RO1 80728 and 98571), IRICoR and Translational Research Program grants from the Leukemia and Lymphoma Society USA. K.L.B.B. holds a Canada Research Chair and H.A.Z. holds a Cole Foundation Fellowship and a CNRS Lebanon Fellowship.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Assouline S, 2009, BLOOD, V114, P257, DOI 10.1182/blood-2009-02-205153; Barbier O, 2000, DRUG METAB DISPOS, V28, P497; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Culjkovic-Kraljacic B, 2012, CELL REP, V2, P207, DOI 10.1016/j.celrep.2012.07.007; Deschler B, 2006, HAEMATOLOGICA, V91, P1513; Deschler B, 2006, CANCER-AM CANCER SOC, V107, P2099, DOI 10.1002/cncr.22233; Dutton G., 1980, GLUCURONIDATION DRUG; Engtrakul JJ, 2005, DRUG METAB DISPOS, V33, P1621, DOI 10.1124/dmd.105.005058; Fisher MB, 2000, DRUG METAB DISPOS, V28, P560; Hiddemann W, 1999, J CLIN ONCOL, V17, P3569, DOI 10.1200/JCO.1999.17.11.3569; HORNY HP, 1994, HUM PATHOL, V25, P810, DOI 10.1016/0046-8177(94)90251-8; Jarvis SM, 1998, BRIT J PHARMACOL, V123, P1587, DOI 10.1038/sj.bjp.0701775; Kentsis A, 2004, P NATL ACAD SCI USA, V101, P18105, DOI 10.1073/pnas.0406927102; Kraljacic BC, 2011, LEUKEMIA, V25, P1197, DOI 10.1038/leu.2011.57; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; LoRusso PM, 2011, CLIN CANCER RES, V17, P5774, DOI 10.1158/1078-0432.CCR-11-0972; Mas C, 2010, BIOCHEM PHARMACOL, V80, P712, DOI 10.1016/j.bcp.2010.04.016; Olah E, 1996, ANTICANCER RES, V16, P2469; Pulsoni A, 2004, HAEMATOLOGICA, V89, P296; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; WILLIS RC, 1978, P NATL ACAD SCI USA, V75, P3042, DOI 10.1073/pnas.75.7.3042	23	136	142	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					90	U459		10.1038/nature13283	http://dx.doi.org/10.1038/nature13283			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24870236	Green Accepted			2022-12-01	WOS:000338199400042
J	Hollowed, AB; Sundby, S				Hollowed, Anne B.; Sundby, Svein			ECOLOGY Change is coming to the northern oceans	SCIENCE			English	Editorial Material							POLLOCK THERAGRA-CHALCOGRAMMA; EASTERN BERING-SEA; CLIMATE-CHANGE; RECRUITMENT; ATLANTIC		[Hollowed, Anne B.] NOAA, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA; [Sundby, Svein] Inst Marine Res, N-5005 Bergen, Norway; [Sundby, Svein] Hjort Ctr Marine Ecosyst Dynam, N-5005 Bergen, Norway	National Oceanic Atmospheric Admin (NOAA) - USA; Institute of Marine Research - Norway	Hollowed, AB (corresponding author), NOAA, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	anne.hollowed@noaa.gov; svein.sundby@imr.no		Sundby, Svein/0000-0002-0815-9740				Drinkwater KF, 2006, PROG OCEANOGR, V68, P134, DOI 10.1016/j.pocean.2006.02.011; ELLERTSEN B, 1989, RAP PROCES, V191, P209; Gaichas S, 2009, PROG OCEANOGR, V81, P47, DOI 10.1016/j.pocean.2009.04.005; Heintz RA, 2013, DEEP-SEA RES PT II, V94, P150, DOI 10.1016/j.dsr2.2013.04.006; International Council for the Exploration of the Sea, 2013, 2013ACOM05 ICES CM, P05; Kjesbu OS, 2014, P NATL ACAD SCI USA, V111, P3478, DOI 10.1073/pnas.1316342111; Kotwicki S, 2013, DEEP-SEA RES PT II, V94, P231, DOI 10.1016/j.dsr2.2013.03.017; Mueter FJ, 2011, ICES J MAR SCI, V68, P1284, DOI 10.1093/icesjms/fsr022; NAKKEN O, 1994, ICES MAR SC, V198, P212; North Pacific Fishery Management Council (NPFMC), 2013, BER SEA AL ISL GROUN; Overland JE, 2012, DEEP-SEA RES PT II, V65-70, P6, DOI 10.1016/j.dsr2.2012.02.013; Saetersdal B., 1987, FISH RES, V5, P253; Sigler MF, 2011, OCEANOGRAPHY, V24, P250, DOI 10.5670/oceanog.2011.77; Sundby S, 2008, ICES J MAR SCI, V65, P953, DOI 10.1093/icesjms/fsn085	14	33	35	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1084	1085		10.1126/science.1251166	http://dx.doi.org/10.1126/science.1251166			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904138				2022-12-01	WOS:000336791200019
J	Zhang, Z; Wang, J; Schultz, N; Zhang, F; Parhad, SS; Tu, S; Vreven, T; Zamore, PD; Weng, ZP; Theurkauf, WE				Zhang, Zhao; Wang, Jie; Schultz, Nadine; Zhang, Fan; Parhad, Swapnil S.; Tu, Shikui; Vreven, Thom; Zamore, Phillip D.; Weng, Zhiping; Theurkauf, William E.			The HP1 Homolog Rhino Anchors a Nuclear Complex that Suppresses piRNA Precursor Splicing	CELL			English	Article							WIDE RNAI SCREEN; I-TASSER; PROTEIN; HETEROCHROMATIN; REQUIRES; PATHWAY; GENE; CAP; MECHANISM; CUTOFF	piRNAs guide an adaptive genome defense system that silences transposons during germline development. The Drosophila HP1 homolog Rhino is required for germline piRNA production. We show that Rhino binds specifically to the heterochromatic clusters that produce piRNA precursors, and that binding directly correlates with piRNA production. Rhino colocalizes to germline nuclear foci with Rai1/DXO-related protein Cuff and the DEAD box protein UAP56, which are also required for germline piRNA production. RNA sequencing indicates that most cluster transcripts are not spliced and that rhino, cuff, and uap56 mutations increase expression of spliced cluster transcripts over 100-fold. LacI::Rhino fusion protein binding suppresses splicing of a reporter transgene and is sufficient to trigger piRNA production from a trans combination of sense and antisense reporters. We therefore propose that Rhino anchors a nuclear complex that suppresses cluster transcript splicing and speculate that stalled splicing differentiates piRNA precursors from mRNAs.	[Zhang, Zhao; Schultz, Nadine; Zhang, Fan; Theurkauf, William E.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Wang, Jie; Tu, Shikui; Vreven, Thom; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Zhang, Zhao; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Zhang, Zhao; Zamore, Phillip D.] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA; [Zamore, Phillip D.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Weng, ZP (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, 368 Plantation St, Worcester, MA 01605 USA.	zhiping.weng@umassmed.edu; william.theurkauf@umassmed.edu	Parhad, Swapnil S./J-7174-2019	Parhad, Swapnil S./0000-0002-5723-9384; Zamore, Phillip/0000-0002-4505-9618; Theurkauf, William/0000-0001-7342-1912	National Institute of Child Health and Human Development, NIH [R01HD049116]; National Institutes of Health [GM62862]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062862, R37GM062862] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Theurkauf and Weng labs and the UMass RNA biology community for critical feedback and encouragement. This work was supported by a grant R01HD049116 from the National Institute of Child Health and Human Development, NIH, to W. E. T., Z.W. and P.D.Z., and in part by National Institutes of Health grant GM62862 to P.D.Z.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; Dumesic PA, 2013, CELL, V152, P957, DOI 10.1016/j.cell.2013.01.046; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gornemann J, 2005, MOL CELL, V19, P53, DOI 10.1016/j.molcel.2005.05.007; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Guzzardo PM, 2013, CURR OPIN GENET DEV, V23, P44, DOI 10.1016/j.gde.2012.12.003; Handler D, 2013, MOL CELL, V50, P762, DOI 10.1016/j.molcel.2013.04.031; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; Jiao XF, 2013, MOL CELL, V50, P104, DOI 10.1016/j.molcel.2013.02.017; Keller C, 2012, MOL CELL, V47, P215, DOI 10.1016/j.molcel.2012.05.009; Khurana JS, 2011, CELL, V147, P1551, DOI 10.1016/j.cell.2011.11.042; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; Muerdter F, 2013, MOL CELL, V50, P736, DOI 10.1016/j.molcel.2013.04.006; Muerdter F, 2012, RNA, V18, P42, DOI 10.1261/rna.029769.111; Pane A, 2011, EMBO J, V30, P4601, DOI 10.1038/emboj.2011.334; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Tabach Y, 2013, NATURE, V493, P694, DOI 10.1038/nature11779; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Zhang F, 2012, CELL, V151, P871, DOI 10.1016/j.cell.2012.09.040; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Zhao, 2012, Silence, V3, P9, DOI 10.1186/1758-907X-3-9; Zhang Z, 2011, MOL CELL, V44, P572, DOI 10.1016/j.molcel.2011.10.011	46	133	139	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1353	1363		10.1016/j.cell.2014.04.030	http://dx.doi.org/10.1016/j.cell.2014.04.030			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906152	Green Accepted, Bronze			2022-12-01	WOS:000340881400012
J	Fakhri, N; Wessel, AD; Willms, C; Pasquali, M; Klopfenstein, DR; MacKintosh, FC; Schmidt, CF				Fakhri, Nikta; Wessel, Alok D.; Willms, Charlotte; Pasquali, Matteo; Klopfenstein, Dieter R.; MacKintosh, Frederick C.; Schmidt, Christoph F.			High-resolution mapping of intracellular fluctuations using carbon nanotubes	SCIENCE			English	Article							MULTIPLE-PARTICLE-TRACKING; BLEBBISTATIN INHIBITION; CELL MECHANICS; LIVING CELLS; LIVE CELLS; MYOSIN-II; SINGLE; TRANSPORT; MOVEMENT; MOTORS	Cells are active systems with molecular force generation that drives complex dynamics at the supramolecular scale. We present a quantitative study of molecular motions in cells over times from milliseconds to hours. Noninvasive tracking was accomplished by imaging highly stable near-infrared luminescence of single-walled carbon nanotubes targeted to kinesin-1 motor proteins in COS-7 cells. We observed a regime of active random "stirring" that constitutes an intermediate mode of transport, different from both thermal diffusion and directed motor activity. High-frequency motion was found to be thermally driven. At times greater than 100 milliseconds, nonequilibrium dynamics dominated. In addition to directed transport along microtubules, we observed strong random dynamics driven by myosins that result in enhanced nonspecific transport. We present a quantitative model connecting molecular mechanisms to mesoscopic fluctuations.	[Fakhri, Nikta; Wessel, Alok D.; Willms, Charlotte; Klopfenstein, Dieter R.; Schmidt, Christoph F.] Univ Gottingen, Drittes Phys Inst Biophys, D-37077 Gottingen, Germany; [Pasquali, Matteo] Rice Univ, Smalley Inst Nanoscale Sci & Technol, Dept Chem & Biomol Engn, Dept Chem, Houston, TX 77005 USA; [MacKintosh, Frederick C.] Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands	University of Gottingen; Rice University; Vrije Universiteit Amsterdam	MacKintosh, FC (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands.	fcmack@gmail.com; christoph.schmidt@phys.uni-goettingen.de	MacKintosh, Frederick/AAB-9332-2021; MacKintosh, Fred C/A-9450-2008; Fakhri, Nikta/B-4657-2008; Schmidt, Christoph/G-3787-2011; Pasquali, Matteo/A-2489-2008	MacKintosh, Frederick/0000-0002-2607-9541; MacKintosh, Fred C/0000-0002-2607-9541; Fakhri, Nikta/0000-0003-1261-7465; Schmidt, Christoph/0000-0003-2864-6973; Pasquali, Matteo/0000-0001-5951-395X	Center for Nanoscale Microscopy and Molecular Physiology of the Brain - Deutsche Forschungsgemeinschaft; Collaborative Research Center - Deutsche Forschungsgemeinschaft [SFB 937]; Foundation for Fundamental Research on Matter of the Netherlands Organization for Scientific Research, Welch Foundation [C-1668]; NSF [NSF PHY11-25915]; Human Frontier Science Program Fellowship	Center for Nanoscale Microscopy and Molecular Physiology of the Brain - Deutsche Forschungsgemeinschaft; Collaborative Research Center - Deutsche Forschungsgemeinschaft; Foundation for Fundamental Research on Matter of the Netherlands Organization for Scientific Research, Welch Foundation; NSF(National Science Foundation (NSF)); Human Frontier Science Program Fellowship(Human Frontier Science Program)	We thank L. Cognet, J. Enderlein, M. Guo, J. Lippincott-Schwartz, and D. A. Weitz for helpful discussions; I. Schaap and M. Platen for atomic force microscopy measurements; and the Kavli Institute for Theoretical Physics (University of California, Santa Barbara) for hospitality and useful discussions. Supported by the Center for Nanoscale Microscopy and Molecular Physiology of the Brain and the Collaborative Research Center SFB 937 (Project A2), both funded by the Deutsche Forschungsgemeinschaft, as well as by the Foundation for Fundamental Research on Matter of the Netherlands Organization for Scientific Research, Welch Foundation grant C-1668, and NSF grant NSF PHY11-25915. N.F. was supported by a Human Frontier Science Program Fellowship. N. F. and C. F. S. are inventors on a provisional U. S. patent application on the method used in the paper, filed by Georg-August-Universitat. The single-walled carbon nanotubes are available from M. P. under a material transfer agreement with Rice University.	Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Balint S, 2013, P NATL ACAD SCI USA, V110, P3375, DOI 10.1073/pnas.1219206110; Basu A, 2008, EUR PHYS J E, V27, P149, DOI 10.1140/epje/i2008-10364-9; Berciaud S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.077402; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Brangwynne CP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118104; Brangwynne CP, 2008, J CELL BIOL, V183, P583, DOI 10.1083/jcb.200806149; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Courty S, 2006, NANO LETT, V6, P1491, DOI 10.1021/nl060921t; Crocker JC, 2007, METHOD CELL BIOL, V83, P141, DOI 10.1016/S0091-679X(07)83007-X; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Fakhri N, 2010, SCIENCE, V330, P1804, DOI 10.1126/science.1197321; Fakhri N, 2009, P NATL ACAD SCI USA, V106, P14219, DOI 10.1073/pnas.0904148106; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Howard J., 2001, MECH MOTOR PROTEINS; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Huber F, 2013, ADV PHYS, V62, P1, DOI 10.1080/00018732.2013.771509; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Kim H, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/1/016601; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Kulic IM, 2008, P NATL ACAD SCI USA, V105, P10011, DOI 10.1073/pnas.0800031105; Lau AWC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.198101; Leduc C, 2007, P NATL ACAD SCI USA, V104, P10847, DOI 10.1073/pnas.0701B64104; Levine AJ, 2009, J PHYS CHEM B, V113, P3820, DOI 10.1021/jp808192w; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; MacKintosh FC, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018104; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; Ramamurthy B, 2004, BIOCHEMISTRY-US, V43, P14832, DOI 10.1021/bi0490284; Rubinstein M., 2003, POLYM PHYS CHEM; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Stricker J, 2010, J BIOMECH, V43, P9, DOI 10.1016/j.jbiomech.2009.09.003; Tseng Y, 2002, BIOPHYS J, V83, P3162, DOI 10.1016/S0006-3495(02)75319-8; Tsyboulski DA, 2005, NANO LETT, V5, P975, DOI 10.1021/nl050366f; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Weisman RB, 2010, ANAL BIOANAL CHEM, V396, P1015, DOI 10.1007/s00216-009-3062-8	39	142	144	2	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1031	1035		10.1126/science.1250170	http://dx.doi.org/10.1126/science.1250170			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876498				2022-12-01	WOS:000336495800046
J	Gumbinger, C; Reuter, B; Stock, C; Sauer, T; Wietholter, H; Bruder, I; Rode, S; Kern, R; Ringleb, P; Hennerici, MG; Hacke, W				Gumbinger, Christoph; Reuter, Bjoern; Stock, Christian; Sauer, Tamara; Wiethoelter, Horst; Bruder, Ingo; Rode, Susanne; Kern, Rolf; Ringleb, Peter; Hennerici, Michael G.; Hacke, Werner		AG Schlaganfall	Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE ISCHEMIC-STROKE; INTRAVENOUS THROMBOLYSIS; SAFE IMPLEMENTATION; POOLED ANALYSIS; SITS-ISTR; ALTEPLASE; ATLANTIS; GERMANY; NINDS; ECASS	Objective To study the time dependent effectiveness of thrombolytic therapy for acute ischaemic stroke in daily clinical practice. Design A retrospective cohort study using data from a large scale, comprehensive population based state-wide stroke registry in Germany. Setting All 148 hospitals involved in acute stroke care in a large state in southwest Germany with 10.4 million inhabitants. Participants Data from 84 439 patients with acute ischaemic stroke were analysed, 10 263 (12%) were treated with thrombolytic therapy and 74 176 (88%) were not treated. Main outcome measures Primary endpoint was the dichotomised score on a modified Rankin scale at discharge ("favourable outcome" score 0 or 1 or "unfavourable outcome" score 2-6) analysed by binary logistic regression. Patients treated with recombinant tissue plasminogen activator (rtPA) were categorised according to time from onset of stroke to treatment. Analogous analyses were conducted for the association between rtPA treatment of stroke and in-hospital mortality. As a co-primary endpoint the chance of a lower modified Rankin scale score at discharge was analysed by ordinal logistic regression analysis (shift analysis). Results After adjustment for characteristics of patients, hospitals, and treatment, rtPA was associated with better outcome in a time dependent pattern. The number needed to treat ranged from 4.5 (within first 1.5 hours after onset; odds ratio 2.49) to 18.0 (up to 4.5 hours; odds ratio 1.26), while mortality did not vary up to 4.5 hours. Patients treated with rtPA beyond 4.5 hours (including mismatch based approaches) showed a significantly better outcome only in dichotomised analysis (odds ratio 1.25, 95% confidence interval 1.01 to 1.55) but the mortality risk was higher (1.45, 1.08 to 1.92). Conclusion The effectiveness of thrombolytic therapy in daily clinical practice might be comparable with the effectiveness shown in randomised clinical trials and pooled analysis. Early treatment was associated with favourable outcome in daily clinical practice, which underlines the importance of speeding up the process for thrombolytic therapy in hospital and before admission to achieve shorter time from door to needle and from onset to treatment for thrombolytic therapy.	[Gumbinger, Christoph; Ringleb, Peter; Hacke, Werner] Heidelberg Univ, Dept Neurol Heidelberg, D-69120 Heidelberg, Germany; [Reuter, Bjoern; Sauer, Tamara; Kern, Rolf; Hennerici, Michael G.] Heidelberg Univ, Dept Neurol Mannheim, D-68167 Mannheim, Germany; [Stock, Christian] Heidelberg Univ, Inst Med Biometry & Informat, D-69120 Heidelberg, Germany; [Bruder, Ingo; Rode, Susanne] Baden Wuerttemberg Hosp Federat, Off Qual Assurance Hosp GeQiK Stuttgart, D-70191 Stuttgart, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Hacke, W (corresponding author), Heidelberg Univ, Dept Neurol Heidelberg, D-69120 Heidelberg, Germany.	werner.hacke@med.uni-heidelberg.de	Hacke, Werner/ABE-8661-2020; Stock, Christian/F-6180-2015	Stock, Christian/0000-0002-3493-3234; Gumbinger, Christoph/0000-0002-6137-1169	department of neurology, University of Heidelberg, Heidelberg; department of neurology, Mannheim Campus; German network "Health Services Research Baden-Wuerttemberg" of the Ministry of Science, Research and Arts; Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wuerttemberg; Institute for Applied Quality Improvement and Research in Health Care GmbH (AQUA Institute)	department of neurology, University of Heidelberg, Heidelberg; department of neurology, Mannheim Campus; German network "Health Services Research Baden-Wuerttemberg" of the Ministry of Science, Research and Arts; Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wuerttemberg; Institute for Applied Quality Improvement and Research in Health Care GmbH (AQUA Institute)	This study was funded by internal research funds from the departments of neurology, University of Heidelberg, Heidelberg, and Mannheim Campus. The study was supported by the young scientists programme of the German network "Health Services Research Baden-Wuerttemberg" of the Ministry of Science, Research and Arts in collaboration with the Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wuerttemberg, in collaboration with the Institute for Applied Quality Improvement and Research in Health Care GmbH (AQUA Institute) (scholarship holder CG). The sources of funding had no role in study design, data collection, analyses, interpretation, and decision to submit the article for publication.	Ahmed N, 2013, JAMA NEUROL, V70, P837, DOI 10.1001/jamaneurol.2013.406; Ahmed N, 2010, LANCET NEUROL, V9, P866, DOI 10.1016/S1474-4422(10)70165-4; Bath PMW, 2012, STROKE, V43, P1171, DOI 10.1161/STROKEAHA.111.641456; Bender R, 2002, J CLIN EPIDEMIOL, V55, P525, DOI 10.1016/S0895-4356(01)00510-8; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Dirks M, 2013, LANCET NEUROL, V12, P120, DOI 10.1016/S1474-4422(12)70304-6; Emberson JR, 2014, ISC 2014 SAN DIEG CA; Gumbinger C, 2013, NEUROEPIDEMIOLOGY, V41, P161, DOI 10.1159/000354356; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Meretoja A, 2012, NEUROLOGY, V79, P306, DOI 10.1212/WNL.0b013e31825d6011; Ovbiagele B, 2010, CEREBROVASC DIS, V29, P50, DOI 10.1159/000255974; Palm F, 2010, STROKE, V41, P1865, DOI 10.1161/STROKEAHA.110.592642; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Saposnik G, 2005, NEUROLOGY, V65, P1169, DOI 10.1212/01.wnl.0000180687.75907.4b; Saver JL, 2007, STROKE, V38, P3055, DOI 10.1161/STROKEAHA.107.488536; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Scott PA, 2013, LANCET NEUROL, V12, P139, DOI 10.1016/S1474-4422(12)70311-3; Sobesky J, 2007, CEREBROVASC DIS, V24, P56, DOI 10.1159/000103117; Strbian D, 2010, STROKE, V41, P712, DOI 10.1161/STROKEAHA.109.571976; Wahlgren N, 2008, LANCET, V372, P1303, DOI 10.1016/S0140-6736(08)61339-2; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4	25	57	63	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2014	348								g3429	10.1136/bmj.g3429	http://dx.doi.org/10.1136/bmj.g3429			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EO	24879819	Green Published, hybrid			2022-12-01	WOS:000336742800002
J	Reed, C				Reed, Christina			Winter is coming	SCIENCE			English	Editorial Material													Abreu, Carlos A F de/AGB-1792-2022	Abreu, Carlos A F de/0000-0001-5440-9563					0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1054	1054		10.1126/science.344.6187.1054	http://dx.doi.org/10.1126/science.344.6187.1054			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876500				2022-12-01	WOS:000336495800050
J	Block, JP; Roberto, CA				Block, Jason P.; Roberto, Christina A.			Potential Benefits of Calorie Labeling in Restaurants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHAIN RESTAURANTS		[Block, Jason P.] Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Obes Prevent Program,Dept Populat Med, Boston, MA 02215 USA; [Roberto, Christina A.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Dept Social & Behav Sci, Boston, MA 02215 USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Block, JP (corresponding author), Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Dept Populat Med, 133 Brookline Ave,Sixth Floor, Boston, MA 02215 USA.	jblock1@partners.org			NHLBI NIH HHS [1K23HL111211-01A1, K23 HL111211] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL111211] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Auchincloss AH, 2013, AM J PREV MED, V45, P710, DOI 10.1016/j.amepre.2013.07.014; Bollinger B, 2011, AM ECON J-ECON POLIC, V3, P91, DOI 10.1257/pol.3.1.91; Bruemmer B, 2012, J ACAD NUTR DIET, V112, P1169, DOI 10.1016/j.jand.2012.04.019; Bruni, 2013, NEW YORK TIMES; Clifford Gay, 1977, NEW YORK TIMES; Dumanovsky Tamara, 2011, BMJ, V343, pd4464, DOI 10.1136/bmj.d4464; Elbel B, 2009, HEALTH AFFAIR, V28, pW1110, DOI 10.1377/hlthaff.28.6.w1110; Morain S, 2013, HEALTH AFFAIR, V32, P486, DOI 10.1377/hlthaff.2012.0609	8	30	30	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2014	312	9					887	888		10.1001/jama.2014.9239	http://dx.doi.org/10.1001/jama.2014.9239			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9IE	25077460	Green Accepted			2022-12-01	WOS:000341668600012
J	Chen, J; Petrov, A; Johansson, M; Tsai, A; O'Leary, SE; Puglisi, JD				Chen, Jin; Petrov, Alexey; Johansson, Magnus; Tsai, Albert; O'Leary, Sean E.; Puglisi, Joseph D.			Dynamic pathways of-1 translational frameshifting	NATURE			English	Article							SINGLE-MOLECULE FLUORESCENCE; TRANSFER-RNA SELECTION; MESSENGER-RNA; HYBRID STATE; REAL-TIME; COMPOSITIONAL DYNAMICS; P-SITE; RIBOSOME; TRANSLOCATION; CODON	Spontaneous changes in the reading frame of translation are rare (frequency of 10(-3) to 10(-4) per codon)(1), but can be induced by specific features in the messenger RNA (mRNA). In the presence of mRNA secondary structures, a heptanucleotide 'slippery sequence' usually defined by the motif X XXY YYZ, and (in some prokaryotic cases) mRNA sequences that base pair with the 39 end of the 16S ribosomal rRNA (internal Shine-Dalgarno sequences), there is an increased probability that a specific programmed change of frame occurs, wherein the ribosome shifts one nucleotide backwards into an overlapping reading frame(-1 frame) and continues by translating a new sequence of amino acids(2,3). Despite extensive biochemical and genetic studies, there is no clear mechanistic description for frameshifting. Here we apply single-molecule fluorescence to track the compositional and conformational dynamics of individual ribosomes at each codon during translation of a frameshift-inducing mRNA from the dnaX gene in Escherichia coli. Ribosomes that frameshift into the -1 frame are characterized by a tenfold longer pause in elongation compared to non-frameshifted ribosomes, which translate through unperturbed. During the pause, interactions of the ribosome with the mRNA stimulatory elements uncouple EF-Gcatalysed translocation from normal ribosomal subunit reverse-rotation, leaving the ribosome in a non-canonical intersubunit rotated state with an exposed codon in the aminoacyl-tRNA site (A site). tRNA(Lys) sampling and accommodation to the empty A site and EF-G action either leads to the slippage of the tRNAs into the-1 frame or maintains the ribosome into the 0 frame. Our results provide a general mechanistic and conformational framework for -1 frameshifting, highlighting multiple kinetic branchpoints during elongation.	[Chen, Jin; Tsai, Albert] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Chen, Jin; Petrov, Alexey; Johansson, Magnus; Tsai, Albert; O'Leary, Sean E.; Puglisi, Joseph D.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Stanford University	Puglisi, JD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	puglisi@stanford.edu	Johansson, Magnus/J-8841-2014	Johansson, Magnus/0000-0001-8811-2629; Tsai, Albert/0000-0002-1643-0780	US National Institutes of Health (NIH) [GM51266]; NIH [GM099687]; Wenner-Gren Foundations (Stockholm); Stanford Interdisciplinary Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099687, R01GM051266] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenner-Gren Foundations (Stockholm); Stanford Interdisciplinary Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health (NIH) grant GM51266 to J.C., A. T. and J.D.P.; by NIH grant GM099687 to A. P., S.E.O'L. and J.D.P.; Wenner-Gren Foundations (Stockholm) to M.J.; and by a Stanford Interdisciplinary Graduate Fellowship to J.C. The authors thank D. Hsu and R. Dalal (Pacific Biosciences Inc.) for their assistance on the ZMW instrumentation; and S. Yan, H. K. Kim and I. Tinoco Jr (University of California at Berkeley) for helpful discussions. J.C. would like to thank I Lin for support.	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Aitken CE, 2010, NAT STRUCT MOL BIOL, V17, P793, DOI 10.1038/nsmb.1828; Baranov PV, 2004, RNA, V10, P221, DOI 10.1261/rna.5122604; Bertrand C, 2002, RNA, V8, P16, DOI 10.1017/S1355838202012086; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Chen J, 2014, P NATL ACAD SCI USA, V111, P664, DOI 10.1073/pnas.1315735111; Chen J, 2013, NAT STRUCT MOL BIOL, V20, P718, DOI 10.1038/nsmb.2567; Chen J, 2012, J AM CHEM SOC, V134, P5734, DOI 10.1021/ja2119964; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Dorywalska M, 2005, NUCLEIC ACIDS RES, V33, P182, DOI 10.1093/nar/gki151; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; HORSFIELD JA, 1995, NUCLEIC ACIDS RES, V23, P1487, DOI 10.1093/nar/23.9.1487; HUGHES D, 1987, EMBO J, V6, P4235, DOI 10.1002/j.1460-2075.1987.tb02772.x; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Johansson M, 2012, P NATL ACAD SCI USA, V109, P131, DOI 10.1073/pnas.1116480109; Kim HK, 2014, P NATL ACAD SCI USA, V111, P5538, DOI 10.1073/pnas.1403457111; Larsen B, 1997, J MOL BIOL, V271, P47, DOI 10.1006/jmbi.1997.1162; LARSEN B, 1994, J BACTERIOL, V176, P6842, DOI 10.1128/JB.176.22.6842-6851.1994; Leger M, 2007, NUCLEIC ACIDS RES, V35, P5581, DOI 10.1093/nar/gkm578; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Liao PY, 2011, NUCLEIC ACIDS RES, V39, P300, DOI 10.1093/nar/gkq761; Liu CY, 2011, BIOPHYS J, V100, P2201, DOI 10.1016/j.bpj.2011.03.023; Lopinski JD, 2000, MOL CELL BIOL, V20, P1095, DOI 10.1128/MCB.20.4.1095-1103.2000; Marshall RA, 2008, P NATL ACAD SCI USA, V105, P15364, DOI 10.1073/pnas.0805299105; Marshall RA, 2009, MOL CELL, V35, P37, DOI 10.1016/j.molcel.2009.06.008; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Plant EP, 2003, RNA, V9, P168, DOI 10.1261/rna.2132503; Qin PW, 2014, EMBO REP, V15, P185, DOI 10.1002/embr.201337762; Qu XH, 2011, NATURE, V475, P118, DOI 10.1038/nature10126; Tinoco I, 2013, BIOPOLYMERS, V99, P1147, DOI 10.1002/bip.22293; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; TSUCHIHASHI Z, 1990, P NATL ACAD SCI USA, V87, P2516, DOI 10.1073/pnas.87.7.2516; TSUCHIHASHI Z, 1992, GENE DEV, V6, P511, DOI 10.1101/gad.6.3.511; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; WEISS R B, 1989, New Biologist, V1, P159; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716	43	112	112	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					328	+		10.1038/nature13428	http://dx.doi.org/10.1038/nature13428			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	24919156	Green Accepted			2022-12-01	WOS:000340508200039
J	Flach, J; Bakker, ST; Mohrin, M; Conroy, PC; Pietras, EM; Reynaud, D; Alvarez, S; Diolaiti, ME; Ugarte, F; Forsberg, EC; Le Beau, MM; Stohr, BA; Mendez, J; Morrison, CG; Passegue, E				Flach, Johanna; Bakker, Sietske T.; Mohrin, Mary; Conroy, Pauline C.; Pietras, Eric M.; Reynaud, Damien; Alvarez, Silvia; Diolaiti, Morgan E.; Ugarte, Fernando; Forsberg, E. Camilla; Le Beau, Michelle M.; Stohr, Bradley A.; Mendez, Juan; Morrison, Ciaran G.; Passegue, Emmanuelle			Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells	NATURE			English	Article							DNA-DAMAGE-RESPONSE; ORIGIN; MAINTENANCE; DEFICIENCY; EXPRESSION; MUTATIONS; PROTEINS; COMPLEX; REPAIR; CYCLE	Haematopoietic stem cells (HSCs) self-renew for life, thereby making them one of the few blood cells that truly age(1,2). Paradoxically, although HSCs numerically expand with age, their functional activity declines over time, resulting in degraded blood production and impaired engraftment following transplantation(2). While many drivers of HSC ageing have been proposed(2-5), the reason why HSC function degrades with age remains unknown. Here we show that cycling old HSCs in mice have heightened levels of replication stress associated with cell cycle defects and chromosome gaps or breaks, which are due to decreased expression of mini-chromosome maintenance (MCM) helicase components and altered dynamics of DNA replication forks. Nonetheless, old HSCs survive replication unless confronted with a strong replication challenge, such as transplantation. Moreover, once old HSCs re-establish quiescence, residual replication stress on ribosomal DNA (rDNA) genes leads to the formation of nucleolar-associated gamma H2AX signals, which persist owing to ineffective H2AX dephosphorylation by mislocalized PP4c phosphatase rather than ongoing DNA damage. Persistent nucleolar gamma H2AX also acts as a histone modification marking the transcriptional silencing of rDNA genes and decreased ribosome biogenesis in quiescent old HSCs. Our results identify replication stress as a potent driver of functional decline in old HSCs, and highlight the MCM DNA helicase as a potential molecular target for rejuvenation therapies.	[Flach, Johanna; Bakker, Sietske T.; Mohrin, Mary; Pietras, Eric M.; Reynaud, Damien; Passegue, Emmanuelle] Univ Calif San Francisco, Dept Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Hem Onc Div, San Francisco, CA 94143 USA; [Flach, Johanna] Ctr Comprehens Canc, Inst Expt Canc Res, D-89081 Ulm, Germany; [Conroy, Pauline C.; Morrison, Ciaran G.] Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland; [Alvarez, Silvia; Mendez, Juan] Spanish Natl Canc Res Ctr CNIO, E-28049 Madrid, Spain; [Diolaiti, Morgan E.; Stohr, Bradley A.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Ugarte, Fernando; Forsberg, E. Camilla] Univ Calif Santa Cruz, Inst Biol Stem Cells, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Le Beau, Michelle M.] Univ Chicago, Sect Hematol Oncol, Chicago, IL 60637 USA; [Le Beau, Michelle M.] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA	University of California System; University of California San Francisco; Ulm University; Ollscoil na Gaillimhe-University of Galway; Centro Nacional de Investigaciones Oncologicas (CNIO); University of California System; University of California San Francisco; University of California System; University of California Santa Cruz; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago	Passegue, E (corresponding author), Univ Calif San Francisco, Dept Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Hem Onc Div, San Francisco, CA 94143 USA.	PassegueE@stemcell.ucsf.edu	Morrison, Ciaran/B-6568-2008; Morrison, Ciaran/AAH-2034-2019; Mendez, Juan/K-8001-2014	Morrison, Ciaran/0000-0003-2401-7029; Morrison, Ciaran/0000-0003-2401-7029; Mendez, Juan/0000-0002-3235-2559; Passegue, Emmanuelle/0000-0002-3516-297X; Reynaud, Damien/0000-0001-8765-8419; Alvarez Nanez, Silvia/0000-0003-0664-650X; Bakker, Sietske/0000-0003-4962-3594	National Institutes of Health (NIH) [F32 HL106989]; Science Foundation Ireland PI award [10/IN.1/B2972]; CIRM New Faculty Award [RN2-00934, NIH R01 HL092471]; California Institute for Regenerative Medicine (CIRM); NATIONAL CANCER INSTITUTE [R01CA184014] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092471, R01HL115158, F32HL106989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation Ireland PI award(Science Foundation Ireland); CIRM New Faculty Award; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Brunet and S. Villeda for providing some old C57BL/6 mice, B. McStay for advice on nucleolar analyses, C. Klijn for assistance with microarray analyses, S. Katzman for the SNP analyses, E. Davis for help with cytogenetic studies, I. Grummt for the rDNA plasmid, M. Kissner and M. Lee for management of our Flow Cytometry Core Facility, and all members of the Passegue laboratory for critical insights and suggestions. S. T. B. and M. M. were supported by a California Institute for Regenerative Medicine (CIRM) training grant and E. M. P. by National Institutes of Health (NIH) F32 HL106989. This work was supported by Science Foundation Ireland PI award 10/IN.1/B2972 to C. G. M. and a CIRM New Faculty Award RN2-00934 and NIH R01 HL092471 to E.P.	Aparicio T, 2009, NUCLEIC ACIDS RES, V37, P2087, DOI 10.1093/nar/gkp065; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Bersenev A, 2012, AGING CELL, V11, P949, DOI 10.1111/j.1474-9726.2012.00862.x; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Burhans WC, 2007, NUCLEIC ACIDS RES, V35, P7545, DOI 10.1093/nar/gkm1059; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cooley C, 2009, MOL BIOL CELL, V20, P2563, DOI 10.1091/mbc.E08-10-1019; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Narla A, 2011, INT J HEMATOL, V93, P144, DOI 10.1007/s12185-011-0776-0; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Pruitt SC, 2007, STEM CELLS, V25, P3121, DOI 10.1634/stemcells.2007-0483; Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Smyth G.K., 2004, STAT APPL GENET MOL, V3, pArticl, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Will B, 2013, NAT IMMUNOL, V14, P437, DOI 10.1038/ni.2572; Zhong Y, 2013, J CELL BIOL, V201, P373, DOI 10.1083/jcb.201208060	36	380	389	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					198	+		10.1038/nature13619	http://dx.doi.org/10.1038/nature13619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25079315	Green Accepted, Green Published			2022-12-01	WOS:000340200700033
J	Vande Walle, L; Van Opdenbosch, N; Jacques, P; Fossoul, A; Verheugen, E; Vogel, P; Beyaert, R; Elewaut, D; Kanneganti, TD; van Loo, G; Lamkanfi, M				Vande Walle, Lieselotte; Van Opdenbosch, Nina; Jacques, Peggy; Fossoul, Amelie; Verheugen, Eveline; Vogel, Peter; Beyaert, Rudi; Elewaut, Dirk; Kanneganti, Thirumala-Devi; van Loo, Geert; Lamkanfi, Mohamed			Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis	NATURE			English	Article							NF-KAPPA-B; RHEUMATOID-ARTHRITIS; ACTIVATION; INHIBITOR; SUSCEPTIBILITY; ASSOCIATION; CASPASE-1; VARIANTS; RECEPTOR; TNFAIP3	Rheumatoid arthritis is a chronic autoinflammatory disease that affects 1-2% of the world's population and is characterized by widespread joint inflammation. Interleukin-1 is an important mediator of cartilage destruction in rheumatic diseases(1), but our understanding of the upstream mechanisms leading to production of interleukin-1 beta in rheumatoid arthritis is limited by the absence of suitable mouse models of the disease in which inflammasomes contribute to pathology. Myeloid-cell-specific deletion of the rheumatoid arthritis susceptibility gene A20/Tnfaip3 in mice (A20(myel-KO) mice) triggers a spontaneous erosive polyarthritis that resembles rheumatoid arthritis in patients(2). Rheumatoid arthritis in A20(myel-KO) mice is not rescued by deletion of tumour necrosis factor receptor 1 (ref. 2). Here we show, however, that it crucially relies on the Nlrp3 inflammasome and interleukin-1 receptor signalling. Macrophages lacking A 20 have increased basal and lipopolysaccharide-induced expression levels of the inflammasome adaptor Nlrp3 and proIL-beta b. As a result, A 20-deficiency in macrophages significantly enhances Nlrp3 inflammasome- mediated caspase-1 activation, pyroptosis and interleukin-1 beta secretion by soluble and crystalline Nlrp3 stimuli. In contrast, activation of the Nlrc4 and AIM2 inflammasomes is not altered. Importantly, increased Nlrp3 inflammasome activation contributes to the pathology of rheumatoid arthritis in vivo, because deletion of Nlrp3, caspase-1 and the interleukin-1 receptor markedly protects against rheumatoid-arthritis-associated inflammation and cartilage destruction in A20(myel-KO) mice. These results reveal A20 as a novel negative regulator of Nlrp3 inflammasome activation, and describe A(20myel-KO) mice as the first experimental model to study the role of inflammasomes in the pathology of rheumatoid arthritis.	[Vande Walle, Lieselotte; Van Opdenbosch, Nina; Fossoul, Amelie; Lamkanfi, Mohamed] Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Vande Walle, Lieselotte; Van Opdenbosch, Nina; Fossoul, Amelie; Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Jacques, Peggy; Verheugen, Eveline; Elewaut, Dirk] Univ Ghent, Dept Rheumatol, B-9000 Ghent, Belgium; [Vogel, Peter; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Beyaert, Rudi; van Loo, Geert] Univ Ghent VIB, Inflammat Res Ctr, B-9052 Ghent, Belgium; [Beyaert, Rudi; van Loo, Geert] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University; St Jude Children's Research Hospital; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Lamkanfi, M (corresponding author), Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium.	mohamed.lamkanfi@vib-ugent.be	Kanneganti, Thirumala-Devi/Y-2503-2019; Beyaert, Rudi/B-2589-2009; Kanneganti, Thirumala-Devi/M-9435-2018; , van Loo Geert/AAD-1220-2019; van Loo, Geert/C-1505-2009; Elewaut, Dirk/K-6831-2014; Vogel, Peter/N-2490-2018	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; , van Loo Geert/0000-0002-8427-4775; Vogel, Peter/0000-0002-7535-0545; Beyaert, Rudi/0000-0002-5704-582X; Jacques, Peggy/0000-0001-9227-257X; Elewaut, Dirk/0000-0002-7468-974X	Ghent University [BOF14/GOA/013]; European Research Council [281600]; FWO [G030212N, 1.2.201.10.N.00, 1.5.122.11.N.00, Odysseus-G091908, G061910N, G016812N]; Queen Elisabeth Medical Foundation; Ghent University Group-ID MRP; National Institutes of Health [AR056296, CA163507, AI101935]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA163507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101935, R37AI101935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	Ghent University(Ghent University); European Research Council(European Research Council (ERC)European Commission); FWO(FWO); Queen Elisabeth Medical Foundation; Ghent University Group-ID MRP(Ghent University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank R. Flavell and V. Dixit for supplying mutant mice. L.V.W. is a postdoctoral fellow with the Fund for Scientific Research-Flanders (FWO). This work was supported by the Ghent University Concerted Research Actions (grant BOF14/GOA/013) and grants from the European Research Council (Grant 281600) and the FWO (grants G030212N, 1.2.201.10.N.00 and 1.5.122.11.N.00) to M.L., and by FWO research grants (Odysseus-G091908, G061910N and G016812N) and a Queen Elisabeth Medical Foundation grant to G.V.L., and by the Ghent University Group-ID MRP to G.V.L., R.B. and D.E.T.-D.K. is supported by grants from the National Institutes of Health (AR056296, CA163507 and AI101935) and the American Lebanese Syrian Associated Charities.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Ben Hamad M, 2012, INT J IMMUNOGENET, V39, P131, DOI 10.1111/j.1744-313X.2011.01070.x; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Burger D, 2006, BEST PRACT RES CL RH, V20, P879, DOI 10.1016/j.berh.2006.06.004; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Dieguez-Gonzalez R, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2650; Fernandes-Alnemri T, 2013, J IMMUNOL, V191, P3995, DOI 10.4049/jimmunol.1301681; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Ippagunta SK, 2010, J BIOL CHEM, V285, P12454, DOI 10.1074/jbc.M109.093252; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kastbom A, 2008, RHEUMATOLOGY, V47, P415, DOI 10.1093/rheumatology/kem372; Kolly L, 2009, J IMMUNOL, V183, P4003, DOI 10.4049/jimmunol.0802173; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lin KM, 2014, P NATL ACAD SCI USA, V111, P775, DOI 10.1073/pnas.1320294111; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mathews RJ, 2014, ANN RHEUM DIS, V73, P1202, DOI 10.1136/annrheumdis-2013-203276; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Schott WH, 2004, DIABETES, V53, P99, DOI 10.2337/diabetes.53.1.99; Schroder K, 2012, IMMUNOBIOLOGY, V217, P1325, DOI 10.1016/j.imbio.2012.07.020; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794	26	316	324	10	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					69	+		10.1038/nature13322	http://dx.doi.org/10.1038/nature13322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043000	Green Accepted			2022-12-01	WOS:000339908000033
J	Kwiatkowski, N; Zhang, TH; Rahl, PB; Abraham, BJ; Reddy, J; Ficarro, SB; Dastur, A; Amzallag, A; Ramaswamy, S; Tesar, B; Jenkins, CE; Hannett, NM; McMillin, D; Sanda, T; Sim, T; Kim, ND; Look, T; Mitsiades, CS; Weng, AP; Brown, JR; Benes, CH; Marto, JA; Young, RA; Gray, NS				Kwiatkowski, Nicholas; Zhang, Tinghu; Rahl, Peter B.; Abraham, Brian J.; Reddy, Jessica; Ficarro, Scott B.; Dastur, Anahita; Amzallag, Arnaud; Ramaswamy, Sridhar; Tesar, Bethany; Jenkins, Catherine E.; Hannett, Nancy M.; McMillin, Douglas; Sanda, Takaomi; Sim, Taebo; Kim, Nam Doo; Look, Thomas; Mitsiades, Constantine S.; Weng, Andrew P.; Brown, Jennifer R.; Benes, Cyril H.; Marto, Jarrod A.; Young, Richard A.; Gray, Nathanael S.			Targeting transcription regulation in cancer with a covalent CDK7 inhibitor	NATURE			English	Article							RNA-POLYMERASE-II; ACTIVATING KINASE; SUPER-ENHANCERS; FACTOR TFIIH; CTD KINASE; PHOSPHORYLATION; ELONGATION; COMPLEX; IDENTIFICATION; DISCOVERY	Tumour oncogenes include transcription factors that co-opt the general transcriptional machinery to sustain the oncogenic state', but direct pharmacological inhibition of transcription factors has so far proven difficult(2). However, the transcriptional machinery contains various enzymatic cofactors that can be targeted for the development of new therapeutic candidates', including cyclin-dependent kinases (CDKs)(4). Here we present the discovery and characterization of a covalent CDK7 inhibitor, THZ1, which has the unprecedented ability to target a remote cysteine residue located outside of the canonical kinase domain, providing an unanticipated means of achieving selectivity for CDK7. Cancer cell-line profiling indicates that a subset of cancer cell lines, including human T-cell acute lymphoblastic leukaemia (T-ALL), have exceptional sensitivity to THZ1. Genome-wide analysis in Jurkat T-ALL cells shows that THZ1 disproportionally affects transcription of RUNXI and suggests that sensitivity to THZ I may be due to vulnerability conferred by the RUNX1 super-enhancer and the key role of RUNXI in the core transcriptional regulatory circuitry of these tumour cells. Pharmacological modulation of CDK7 Ifinase activity may thus provide an approach to identify and treat tumour types that are dependent on transcription for maintenance of the oncogenic state.	[Kwiatkowski, Nicholas; Zhang, Tinghu; Ficarro, Scott B.; Marto, Jarrod A.; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Kwiatkowski, Nicholas; Zhang, Tinghu; Ficarro, Scott B.; Marto, Jarrod A.; Gray, Nathanael S.] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA; [Kwiatkowski, Nicholas; Rahl, Peter B.; Abraham, Brian J.; Reddy, Jessica; Hannett, Nancy M.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Reddy, Jessica; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Ficarro, Scott B.; Marto, Jarrod A.] Dana Farber Canc Inst, Blais Prote Ctr, Boston, MA 02115 USA; [Dastur, Anahita; Amzallag, Arnaud; Ramaswamy, Sridhar; Benes, Cyril H.] Massachusetts Gen Hosp, Ctr Canc, Dept Med, Charlestown, MA 02129 USA; [Dastur, Anahita; Amzallag, Arnaud; Ramaswamy, Sridhar; Benes, Cyril H.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Amzallag, Arnaud; Ramaswamy, Sridhar] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Tesar, Bethany; McMillin, Douglas; Mitsiades, Constantine S.; Brown, Jennifer R.] Harvard Univ, Dana Farber Canc Inst, Dept Med Oncol, Sch Med, Boston, MA 02115 USA; [Tesar, Bethany; McMillin, Douglas; Mitsiades, Constantine S.; Brown, Jennifer R.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med, Boston, MA 02115 USA; [Jenkins, Catherine E.; Weng, Andrew P.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Sanda, Takaomi; Look, Thomas] Harvard Univ, Dana Farber Canc Inst, Dept Pediat Oncol, Sch Med, Boston, MA 02215 USA; [Sanda, Takaomi] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Sim, Taebo] Korea Inst Sci & Technol, Chem Kinom Res Ctr, Seoul 136791, South Korea; [Sim, Taebo] KU KIST Grad Sch Converging Sci & Technol, Seoul 136713, South Korea; [Kim, Nam Doo] Daegu Gyeongbuk Med Innovat Fdn, Taegu 706010, South Korea; [Look, Thomas] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; British Columbia Cancer Agency; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; National University of Singapore; Korea Institute of Science & Technology (KIST); Korea University; Harvard University; Boston Children's Hospital	Gray, NS (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	young@wi.mit.edu; nathanael_gray@dfci.harvard.edu	Young, Richard A/F-6495-2012; Amzallag, Arnaud/Y-5802-2019; Abraham, Brian/C-2230-2019	Young, Richard A/0000-0001-8855-8647; Amzallag, Arnaud/0000-0001-7467-1227; Abraham, Brian/0000-0001-8085-3027	National Institutes of Health [R01 CA130876-04, U54 HG006097-02, CA178860-01, P01 N5047572-10, HG002668, CA109901]; American Cancer Society Postdoctoral Fellowship [120272-PF-11-042-01-DMC]; Translational Research Program of the Leukemia Lymphoma Society; American Cancer Society; NATIONAL CANCER INSTITUTE [R21CA178860, R01CA179483, P01CA109901, P30CA014051, R01CA130876] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668, U54HG006097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Postdoctoral Fellowship(American Cancer Society); Translational Research Program of the Leukemia Lymphoma Society; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Gray and Young laboratories for helpful discussions; D. Orlando, L. Lawton and L. Anders for advice; and C. Thoreen and D. Sabatini, as well as S. Cheng and G. Morin, for reagents. We thank K. Jones and N. Kohl for performing mouse studies and K. Jones and C. Christensen for prepping mouse tissues. We thank S. Riddle for performing LanthaScreen Eu Kinase Assays. This work was supported by the National Institutes of Health (R01 CA130876-04 and U54 HG006097-02 to N.S.G.; CA178860-01 and P01 N5047572-10 to J.A.M.; HG002668 and CA109901 to R.A.Y.), and the American Cancer Society Postdoctoral Fellowship 120272-PF-11-042-01-DMC (P.B.R.). J.R.B. is a Scholar in Clinical Research of the Leukemia Lymphoma Society and is supported by the Translational Research Program of the Leukemia Lymphoma Society and by the American Cancer Society.	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Berg T, 2008, CURR OPIN CHEM BIOL, V12, P464, DOI 10.1016/j.cbpa.2008.07.023; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Lu Q, 2012, J BIOMOL SCREEN, V17, P555, DOI 10.1177/1087057112437763; MAKELA TP, 1994, NATURE, V371, P254, DOI 10.1038/371254a0; Nottingham WT, 2007, BLOOD, V110, P4188, DOI 10.1182/blood-2007-07-100883; O'Neil J, 2007, ONCOGENE, V26, P6838, DOI 10.1038/sj.onc.1210766; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Sanso M, 2013, TRANSCR-AUSTIN, V4, P146, DOI 10.4161/trns.25146; Schachter MM, 2013, MOL CELL, V50, P250, DOI 10.1016/j.molcel.2013.04.003; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; Watanabe Y, 2000, GENES CELLS, V5, P407, DOI 10.1046/j.1365-2443.2000.00336.x; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024	30	515	546	12	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					616	+		10.1038/nature13393	http://dx.doi.org/10.1038/nature13393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043025	Green Accepted, Green Submitted			2022-12-01	WOS:000339566300040
J	Afonso, O; Matos, I; Pereira, AJ; Aguiar, P; Lampson, MA; Maiato, H				Afonso, Olga; Matos, Irina; Pereira, Antonio J.; Aguiar, Paulo; Lampson, Michael A.; Maiato, Helder			Feedback control of chromosome separation by a midzone Aurora B gradient	SCIENCE			English	Article							MITOTIC CHROMOSOMES; CENTRAL SPINDLE; CONDENSIN-I; REPO-MAN; MITOSIS; CYTOKINESIS; KINASE; EXIT; PHOSPHORYLATION; ASSOCIATION	Accurate chromosome segregation during mitosis requires the physical separation of sister chromatids before nuclear envelope reassembly (NER). However, how these two processes are coordinated remains unknown. Here, we identified a conserved feedback control mechanism that delays chromosome decondensation and NER in response to incomplete chromosome separation during anaphase. A midzone-associated Aurora B gradient was found to monitor chromosome position along the division axis and to prevent premature chromosome decondensation by retaining Condensin I. PP1/PP2A phosphatases counteracted this gradient and promoted chromosome decondensation and NER. Thus, an Aurora B gradient appears to mediate a surveillance mechanism that prevents chromosome decondensation and NER until effective separation of sister chromatids is achieved. This allows the correction and reintegration of lagging chromosomes in the main nuclei before completion of NER.	[Afonso, Olga; Matos, Irina; Pereira, Antonio J.; Aguiar, Paulo; Maiato, Helder] Univ Porto, Inst Biol Mol & Celular, Chromosome Instabil & Dynam Lab, P-4150180 Oporto, Portugal; [Aguiar, Paulo] Univ Porto, Ctr Math, P-4169007 Oporto, Portugal; [Lampson, Michael A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Maiato, Helder] Univ Porto, Fac Med, Dept Expt Biol, Cell Div Unit, P-4200319 Oporto, Portugal	Universidade do Porto; Universidade do Porto; University of Pennsylvania; Universidade do Porto	Maiato, H (corresponding author), Univ Porto, Inst Biol Mol & Celular, Chromosome Instabil & Dynam Lab, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	maiato@ibmc.up.pt	Afonso, Olga/N-4802-2017; Aguiar, Paulo/AAD-2462-2020; Maiato, Helder/J-9466-2013	Afonso, Olga/0000-0002-5054-2460; Aguiar, Paulo/0000-0003-4164-5713; Maiato, Helder/0000-0002-6200-9997; Pereira, Antonio/0000-0002-1053-8715	COMPETE [FCOMP-01-0124-FEDER-015941 (PTDC/SAU-ONC/112917/2009)]; Fundacao para a Ciencia e a Tecnologia of Portugal; Human Frontier Science Program; European Research Council; Fundação para a Ciência e a Tecnologia [PTDC/SAU-ONC/112917/2009] Funding Source: FCT; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083988] Funding Source: NIH RePORTER	COMPETE; Fundacao para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology); Human Frontier Science Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); Fundação para a Ciência e a Tecnologia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all colleagues who provided reagents and P. Sampaio for technical help with FRET. H. M. is funded by FCOMP-01-0124-FEDER-015941 (PTDC/SAU-ONC/112917/2009) through COMPETE and Fundacao para a Ciencia e a Tecnologia of Portugal, the Human Frontier Science Program, and PRECISE grant from the European Research Council. Data described can be found in the main figures and supplementary materials. The authors declare no conflict of interests.	Cesario JM, 2006, J CELL SCI, V119, P4770, DOI 10.1242/jcs.03235; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hummer S, 2009, CURR BIOL, V19, P607, DOI 10.1016/j.cub.2009.02.046; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Lipp JJ, 2007, J CELL SCI, V120, P1245, DOI 10.1242/jcs.03425; Mendoza M, 2009, NAT CELL BIOL, V11, P477, DOI 10.1038/ncb1855; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; Nakazawa N, 2011, J CELL SCI, V124, P1795, DOI 10.1242/jcs.078733; Neurohr G, 2011, SCIENCE, V332, P465, DOI 10.1126/science.1201578; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; Qian JB, 2013, CURR BIOL, V23, P1136, DOI 10.1016/j.cub.2013.05.017; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; Smurnyy Yegor, 2010, ACS Chem Biol, V5, P1015, DOI 10.1021/cb1001685; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Tada K, 2011, NATURE, V474, P477, DOI 10.1038/nature10179; Takemoto A, 2007, NUCLEIC ACIDS RES, V35, P2403, DOI 10.1093/nar/gkm157; Vagnarelli P, 2011, DEV CELL, V21, P328, DOI 10.1016/j.devcel.2011.06.020; Wheatley SP, 1997, J CELL BIOL, V138, P385, DOI 10.1083/jcb.138.2.385	26	79	81	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					332	336		10.1126/science.1251121	http://dx.doi.org/10.1126/science.1251121			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	24925910	Green Accepted, Green Submitted			2022-12-01	WOS:000339400700053
J	Zhang, ZG; Wang, W; Qiu, B				Zhang, Zhengguang; Wang, Wei; Qiu, Bo			Oceanic mass transport by mesoscale eddies	SCIENCE			English	Article							HEAT; VARIABILITY; CIRCULATION	Oceanic transports of heat, salt, fresh water, dissolved CO2, and other tracers regulate global climate change and the distribution of natural marine resources. The time-mean ocean circulation transports fluid as a conveyor belt, but fluid parcels can also be trapped and transported discretely by migrating mesoscale eddies. By combining available satellite altimetry and Argo profiling float data, we showed that the eddy-induced zonal mass transport can reach a total meridionally integrated value of up to 30 to 40 sverdrups (Sv) (1 Sv = 10(6) cubic meters per second), and it occurs mainly in subtropical regions, where the background flows are weak. This transport is comparable in magnitude to that of the large-scale wind-and thermohaline-driven circulation.	[Zhang, Zhengguang; Wang, Wei] Ocean Univ China, Qingdao Collaborat Innovat Ctr Marine Sci & Techn, Phys Oceanog Lab, Qingdao, Peoples R China; [Qiu, Bo] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA	Ocean University of China; University of Hawaii System; University of Hawaii Manoa	Wang, W (corresponding author), Ocean Univ China, Qingdao Collaborat Innovat Ctr Marine Sci & Techn, Phys Oceanog Lab, Qingdao, Peoples R China.	wei@ouc.edu.cn	Qiu, Bo/D-9569-2017		National Basic Research Priorities Program of China [2013CB430303]; National Natural Science Foundation of China [41276014]; National Global Change Major Research Project of China [2013CB956201]	National Basic Research Priorities Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Global Change Major Research Project of China	We thank the reviewers for their constructive and detailed comments. This research was supported by the National Basic Research Priorities Program of China through grant 2013CB430303, the National Natural Science Foundation of China under grant 41276014, and the National Global Change Major Research Project of China through grant 2013CB956201. The sources of the data used in this paper are contained in the supplementary materials.	Beron-Vera FJ, 2013, J PHYS OCEANOGR, V43, P1426, DOI 10.1175/JPO-D-12-0171.1; BRYDEN HL, 1989, J MAR RES, V47, P55, DOI 10.1357/002224089785076389; Chang YL, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047062; Chelton DB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030812; Chelton DB, 2011, SCIENCE, V334, P328, DOI 10.1126/science.1208897; Chelton DB, 2011, PROG OCEANOGR, V91, P167, DOI 10.1016/j.pocean.2011.01.002; DANABASOGLU G, 1994, SCIENCE, V264, P1123, DOI 10.1126/science.264.5162.1123; de Jong MF, 2014, J PHYS OCEANOGR, V44, P427, DOI 10.1175/JPO-D-13-070.1; Dong CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4294; Early JJ, 2011, J PHYS OCEANOGR, V41, P1535, DOI 10.1175/2011JPO4601.1; FLIERL GR, 1981, GEOPHYS ASTRO FLUID, V18, P39, DOI 10.1080/03091928108208773; Lee MM, 1997, J MAR RES, V55, P483, DOI 10.1357/0022240973224346; LUYTEN JR, 1983, J PHYS OCEANOGR, V13, P292, DOI 10.1175/1520-0485(1983)013<0292:TVT>2.0.CO;2; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; Minobe S, 2008, NATURE, V452, P206, DOI 10.1038/nature06690; Peacock S, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002211; Qiu B, 2000, J PHYS OCEANOGR, V30, P1486, DOI 10.1175/1520-0485(2000)030<1486:IVOTKE>2.0.CO;2; Qiu B, 2003, J PHYS OCEANOGR, V33, P2465, DOI 10.1175/2459.1; Qiu B, 2013, J PHYS OCEANOGR, V43, P344, DOI 10.1175/JPO-D-12-0133.1; RHINES PB, 1982, J FLUID MECH, V122, P347, DOI 10.1017/S0022112082002250; Schmitz Jr W.J., 1996, WHOI9603, V1; Schmitz W.J.J., 1996, WHOI9608, VII; Taylor GI, 1917, P R SOC LOND A-CONTA, V93, P99, DOI 10.1098/rspa.1917.0007; Zhang ZG, 2013, GEOPHYS RES LETT, V40, P3677, DOI 10.1002/grl.50736	24	313	356	23	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					322	324		10.1126/science.1252418	http://dx.doi.org/10.1126/science.1252418			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035491				2022-12-01	WOS:000339400700050
J	Cimermancic, P; Medema, MH; Claesen, J; Kurita, K; Brown, LCW; Mavrommatis, K; Pati, A; Godfrey, PA; Koehrsen, M; Clardy, J; Birren, BW; Takano, E; Sali, A; Linington, RG; Fischbach, MA				Cimermancic, Peter; Medema, Marnix H.; Claesen, Jan; Kurita, Kenji; Brown, Laura C. Wieland; Mavrommatis, Konstantinos; Pati, Amrita; Godfrey, Paul A.; Koehrsen, Michael; Clardy, Jon; Birren, Bruce W.; Takano, Eriko; Sali, Andrej; Linington, Roger G.; Fischbach, Michael A.			Insights into Secondary Metabolism from a Global Analysis of Prokaryotic Biosynthetic Gene Clusters	CELL			English	Article							POLYMERASE EXTENSION CLONING; GENOMICS-DRIVEN DISCOVERY; IN-VITRO RECONSTITUTION; NATURAL-PRODUCT; STAPHYLOCOCCUS-AUREUS; POLYKETIDE; SEQUENCE; IDENTIFICATION; XANTHOMONADIN; BACTERIAL	Although biosynthetic gene clusters (BGCs) have been discovered for hundreds of bacterial metabolites, our knowledge of their diversity remains limited. Here, we used a novel algorithm to systematically identify BGCs in the extensive extant microbial sequencing data. Network analysis of the predicted BGCs revealed large gene cluster families, the vast majority uncharacterized. We experimentally characterized the most prominent family, consisting of two subfamilies of hundreds of BGCs distributed throughout the Proteobacteria; their products are aryl polyenes, lipids with an aryl head group conjugated to a polyene tail. We identified a distant relationship to a third subfamily of aryl polyene BGCs, and together the three subfamilies represent the largest known family of biosynthetic gene clusters, with more than 1,000 members. Although these clusters are widely divergent in sequence, their small molecule products are remarkably conserved, indicating for the first time the important roles these compounds play in Gram-negative cell biology.	[Cimermancic, Peter; Claesen, Jan; Sali, Andrej; Fischbach, Michael A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Cimermancic, Peter; Claesen, Jan; Sali, Andrej; Fischbach, Michael A.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Medema, Marnix H.; Takano, Eriko] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Microbial Physiol, NL-9747 AG Groningen, Netherlands; [Medema, Marnix H.] Univ Groningen, Groningen Bioinformat Ctr, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Kurita, Kenji; Linington, Roger G.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Brown, Laura C. Wieland] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Mavrommatis, Konstantinos; Pati, Amrita] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Godfrey, Paul A.; Koehrsen, Michael; Birren, Bruce W.] Broad Inst, Cambridge, MA 02142 USA; [Sali, Andrej] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Groningen; University of Groningen; University of California System; University of California Santa Cruz; Indiana University System; Indiana University Bloomington; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Fischbach, MA (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.	fischbach@fischbachgroup.org	Linington, Roger/ABD-5582-2021; Medema, Marnix H./AAR-3138-2021	Linington, Roger/0000-0003-1818-4971; Medema, Marnix H./0000-0002-2191-2821; Claesen, Jan/0000-0002-0755-7974; Fischbach, Michael/0000-0003-3079-8247; Takano, Eriko/0000-0002-6791-3256; Mavrommatis, Konstantinos/0000-0003-4549-385X	HHMI Predoctoral Fellowship; Boehringer Ingelheim Fonds; GenBiotics programme of the Dutch Technology Foundation STW [10463]; NIH [TW006634, OD007290, AI101018, AI101722, GM081879]; James and Eleanor Delfino Charitable Trust; Medical Research Program Grant from the W.M. Keck Foundation; David and Lucile Packard Foundation; DARPA [HR0011-12-C-0067]; National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services [HHSN272200900018C]; FOGARTY INTERNATIONAL CENTER [U01TW006634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101722, U19AI110818, R01AI101018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067547, P50GM081879] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007290] Funding Source: NIH RePORTER	HHMI Predoctoral Fellowship(Howard Hughes Medical Institute); Boehringer Ingelheim Fonds(Boehringer Ingelheim); GenBiotics programme of the Dutch Technology Foundation STW; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James and Eleanor Delfino Charitable Trust; Medical Research Program Grant from the W.M. Keck Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Fischbach lab for helpful discussions and Rainer Breitling and an anonymous reviewer for constructive feedback on the manuscript. We thank Edward Ruby (University of Wisconsin) for providing us with V. fischeri ES114, Didier Mazel (Institut Pasteur) for plasmid pSW8197, and Mervyn Bibb (John Innes Centre) for plasmids pIJ773, pIJ790 and pIJ10257. This work was supported by an HHMI Predoctoral Fellowship (P.C.), a Boehringer Ingelheim Fonds travel grant (M.H.M.), Grant 10463 from the GenBiotics programme of the Dutch Technology Foundation STW to ET (M.H.M.), NIH grant TW006634 (R.G.L.), the James and Eleanor Delfino Charitable Trust (K.K.), a Medical Research Program Grant from the W.M. Keck Foundation (M.A.F.), a Fellowship for Science and Engineering from the David and Lucile Packard Foundation (M.A.F.), DARPA award HR0011-12-C-0067 (M.A.F.), and NIH grants OD007290, AI101018, AI101722, and GM081879 (M.A.F.). This project has been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services, under Contract No.: HHSN272200900018C. M.A.F. is on the scientific advisory board of Warp Drive Bio.	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Barbe V, 2004, NUCLEIC ACIDS RES, V32, P5766, DOI 10.1093/nar/gkh910; Bergmann S, 2007, NAT CHEM BIOL, V3, P213, DOI 10.1038/nchembio869; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Challis GL, 2008, J MED CHEM, V51, P2618, DOI 10.1021/jm700948z; Clauditz A, 2006, INFECT IMMUN, V74, P4950, DOI 10.1128/IAI.00204-06; Dong T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-349; FAUTZ E, 1979, PHYTOCHEMISTRY, V18, P957, DOI 10.1016/S0031-9422(00)91457-2; Fischbach MA, 2008, P NATL ACAD SCI USA, V105, P4601, DOI 10.1073/pnas.0709132105; Flatt PM, 2007, NAT PROD REP, V24, P358, DOI 10.1039/b603816f; Franke J, 2012, ANGEW CHEM INT EDIT, V51, P11611, DOI 10.1002/anie.201205566; Frasch HJ, 2013, CURR OPIN BIOTECH, V24, P1144, DOI 10.1016/j.copbio.2013.03.006; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; Fuchs SW, 2013, ANGEW CHEM INT EDIT, V52, P4108, DOI 10.1002/anie.201210116; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goel AK, 2002, J BACTERIOL, V184, P3539, DOI 10.1128/JB.184.13.3539-3548.2002; Gust B, 2004, ADV APPL MICROBIOL, V54, P107, DOI 10.1016/S0065-2164(04)54004-2; Hassan KA, 2010, ENVIRON MICROBIOL, V12, P899, DOI 10.1111/j.1462-2920.2009.02134.x; JENKINS CL, 1982, CURR MICROBIOL, V7, P195, DOI 10.1007/BF01568797; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kahne D, 2005, CHEM REV, V105, P425, DOI 10.1021/cr030103a; Kersten RD, 2013, P NATL ACAD SCI USA, V110, pE4407, DOI 10.1073/pnas.1315492110; Kersten RD, 2011, NAT CHEM BIOL, V7, P794, DOI 10.1038/nchembio.684; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Laureti L, 2011, P NATL ACAD SCI USA, V108, P6258, DOI 10.1073/pnas.1019077108; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; Letzel AC, 2013, NAT PROD REP, V30, P392, DOI 10.1039/c2np20103h; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li MHT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-185; Lin K, 2006, BIOINFORMATICS, V22, P2081, DOI 10.1093/bioinformatics/btl366; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Lowry B, 2013, J AM CHEM SOC, V135, P16809, DOI 10.1021/ja409048k; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McBride MJ, 2009, APPL ENVIRON MICROB, V75, P6864, DOI 10.1128/AEM.01495-09; Medema MH, 2013, MOL BIOL EVOL, V30, P1218, DOI 10.1093/molbev/mst025; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Nguyen T, 2008, NAT BIOTECHNOL, V26, P225, DOI 10.1038/nbt1379; Oliynyk M, 2007, NAT BIOTECHNOL, V25, P447, DOI 10.1038/nbt1297; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pelzer S, 1999, ANTIMICROB AGENTS CH, V43, P1565, DOI 10.1128/AAC.43.7.1565; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Poplawsky AR, 2000, APPL ENVIRON MICROB, V66, P5123, DOI 10.1128/AEM.66.12.5123-5127.2000; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Rajagopal L, 1997, FEBS LETT, V415, P125, DOI 10.1016/S0014-5793(97)01109-5; Rehm BHA, 2010, NAT REV MICROBIOL, V8, P578, DOI 10.1038/nrmicro2354; REICHENBACH H, 1980, ARCH MICROBIOL, V126, P291, DOI 10.1007/BF00409934; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Sattely ES, 2008, NAT PROD REP, V25, P757, DOI 10.1039/b801747f; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; Segata N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3304; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Starcevic A, 2008, NUCLEIC ACIDS RES, V36, P6882, DOI 10.1093/nar/gkn685; STARR MP, 1977, ARCH MICROBIOL, V113, P1, DOI 10.1007/BF00428572; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Walsh CT, 2010, J AM CHEM SOC, V132, P2469, DOI 10.1021/ja909118a; Walter MH, 2011, NAT PROD REP, V28, P663, DOI 10.1039/c0np00036a; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066633; Weber T, 2009, J BIOTECHNOL, V140, P13, DOI 10.1016/j.jbiotec.2009.01.007; Weitnauer G, 2001, CHEM BIOL, V8, P569, DOI 10.1016/S1074-5521(01)00040-0; Winter JM, 2011, CURR OPIN CHEM BIOL, V15, P22, DOI 10.1016/j.cbpa.2010.10.020	68	543	560	12	188	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					412	421		10.1016/j.cell.2014.06.034	http://dx.doi.org/10.1016/j.cell.2014.06.034			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036635	Bronze, Green Accepted			2022-12-01	WOS:000340943600019
J	Hill, A; Cooke, G				Hill, Andrew; Cooke, Graham			Hepatitis C can be cured globally, but at what cost?	SCIENCE			English	Editorial Material							VIRAL-HEPATITIS; ACCESS; BURDEN		[Hill, Andrew] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England; [Cooke, Graham] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	University of Liverpool; Imperial College London	Hill, A (corresponding author), Univ Liverpool, Dept Pharmacol & Therapeut, POB 147, Liverpool L69 3BX, Merseyside, England.	microhaart@aol.com		Cooke, Graham/0000-0001-6475-5056	Medical Research Council [MR/K01532X/1] Funding Source: Medline; MRC [MR/K01532X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2013, FAIR PRICING COALITI; Cooke GS, 2013, J VIRAL HEPATITIS, V20, P600, DOI 10.1111/jvh.12123; Ford N, 2012, CLIN INFECT DIS, V54, P1465, DOI 10.1093/cid/cis227; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Medivir, 2012, MED 2012 ANN REP, P26; MSF Drug Access Team, 2012, UNT WEB ANT VIR PROC; Schwartlander B, 2006, LANCET, V368, P541, DOI 10.1016/S0140-6736(06)69164-2; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218	11	55	55	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					141	142		10.1126/science.1257737	http://dx.doi.org/10.1126/science.1257737			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8SS	25013048				2022-12-01	WOS:000339409900023
J	Sedgwick, P				Sedgwick, Philip			Understanding P values	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							STATISTICAL QUESTION; TRIAL		Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P., 2010, BMJ, V340, pc2673, DOI [10.1136/bmj.c2673, DOI 10.1136/BMJ.C2673]; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4287; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3557; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2130; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6282; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1041; Sedgwick P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4285; Walsh JM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5605	8	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 11	2014	349								g4550	10.1136/bmj.g4550	http://dx.doi.org/10.1136/bmj.g4550			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZH	25015369				2022-12-01	WOS:000338993900006
J	Brazil, R				Brazil, Rachel			FOOD SCIENCE Fat chance	NATURE			English	Editorial Material							KETOGENIC DIET; EPILEPSY; EFFICACY											Chang PS, 2013, NEUROPHARMACOLOGY, V69, P105, DOI 10.1016/j.neuropharm.2012.11.004; Gimenez-Cassina A, 2012, NEURON, V74, P719, DOI 10.1016/j.neuron.2012.03.032; Hallbook T, 2012, EPILEPSY RES, V100, P304, DOI 10.1016/j.eplepsyres.2011.04.017; Hughes SD, 2014, J NEUROCHEM, V129, P426, DOI 10.1111/jnc.12646; Kobow K, 2013, ACTA NEUROPATHOL, V126, P741, DOI 10.1007/s00401-013-1168-8; Kossoff EH, 2003, NEUROLOGY, V61, P1789, DOI 10.1212/01.WNL.0000098889.35155.72; Kossoff EH, 2009, EPILEPSIA, V50, P304, DOI 10.1111/j.1528-1167.2008.01765.x; Levy RG, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001903.pub2, 10.1002/14651858.CD001903.pub3]; McNally MA, 2012, J NEUROCHEM, V121, P28, DOI 10.1111/j.1471-4159.2012.07670.x; Muzykewicz DA, 2009, EPILEPSIA, V50, P1118, DOI 10.1111/j.1528-1167.2008.01959.x	10	1	1	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					S14	S15		10.1038/511S14a	http://dx.doi.org/10.1038/511S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8AP	25019130				2022-12-01	WOS:000338649800007
J	Dubash, NK; Fleurbaey, M; Kartha, S				Dubash, Navroz K.; Fleurbaey, Marc; Kartha, Sivan			Political implications of data presentation	SCIENCE			English	Editorial Material														Kartha, Sivan/0000-0002-6014-2161					0	16	16	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					36	37		10.1126/science.1255734	http://dx.doi.org/10.1126/science.1255734			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2XU	24994639				2022-12-01	WOS:000338284400038
J	Morell, V				Morell, Virginia			When the bat sings	SCIENCE			English	Editorial Material																			0	6	6	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1334	1337		10.1126/science.344.6190.1334	http://dx.doi.org/10.1126/science.344.6190.1334			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948718				2022-12-01	WOS:000337531700015
J	Rotimi, C				Rotimi, Charles		H3Africa Consortium	Enabling the genomic revolution in Africa	SCIENCE			English	Editorial Material							CHRONIC KIDNEY-DISEASE; APOL1 RISK VARIANTS; HIV-ASSOCIATED NEPHROPATHY; POPULATION		[Rotimi, Charles] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Rotimi, C (corresponding author), NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA.	rotimic@mail.nih.gov	Ramesar, Raj S/I-6941-2015; Martin, Darren/ABE-3614-2021; Engel, Mark/AAP-6570-2020; Adebamowo, Clement/C-8778-2011; Makani, Julie/E-8525-2017; Hide, Winston/R-3815-2019; Nicol, Mark/W-4149-2019; Tiffin, Nicki/ABA-9391-2020; Owen, Andrew/M-7509-2017; Mayige, Mary/GLU-6412-2022; McCurdy, Sheryl A/F-9107-2016; Hide, Winston Hide/C-7217-2009; Bishop, Ozlem Tastan/J-3084-2016; Stein, Dan/A-1752-2008; Ameni, Gobena/AAR-4201-2020; Pare, Guillaume/T-9631-2018; De Vries, Jantina/I-2752-2014; Hide, Winston A/V-2727-2017; Anabwani, Gabriel/I-2371-2016; Hazelhurst, Scott/A-5591-2009; Mbanya, Jean Claude N/T-5147-2018; Norris, Shane/C-4664-2014; Mpoloka, Sununguko/GQP-6235-2022; Kamal Kassim, Samar/G-4701-2015; McCarthy, Mark/M-3763-2015; christoffels, alan/C-3269-2014; Smeeth, Liam/X-5862-2018	Ramesar, Raj S/0000-0001-5688-1634; Engel, Mark/0000-0002-1334-8829; Adebamowo, Clement/0000-0002-6571-2880; Makani, Julie/0000-0002-4801-6250; Hide, Winston/0000-0002-8621-3271; Nicol, Mark/0000-0002-1366-4805; Tiffin, Nicki/0000-0001-5083-2735; Owen, Andrew/0000-0002-9819-7651; Mayige, Mary/0000-0003-4861-7870; McCurdy, Sheryl A/0000-0003-0526-1608; Hide, Winston Hide/0000-0002-8621-3271; Bishop, Ozlem Tastan/0000-0001-6861-7849; Stein, Dan/0000-0001-7218-7810; Ameni, Gobena/0000-0003-3987-0671; Pare, Guillaume/0000-0002-6795-4760; De Vries, Jantina/0000-0001-7192-2633; Hide, Winston A/0000-0002-8621-3271; Gomez-Olive, Francesc Xavier/0000-0002-4876-0848; ODURO, ABRAHAM/0000-0002-4191-7419; King, Mary-Claire/0000-0001-9426-1743; Carstens, Nadia/0000-0003-4754-7030; Moxey-Mims, Marva/0000-0001-8542-9313; Lesosky, Maia/0000-0002-2026-958X; Adebamowo, Sally/0000-0003-4713-2433; Zar, Heather/0000-0002-9046-759X; Anabwani, Gabriel/0000-0002-8555-4373; Mocumbi, Ana/0000-0002-9564-2860; McIlleron, Helen/0000-0002-0982-6226; Cordell, Heather/0000-0002-1879-5572; Nguyen, Anh/0000-0001-6280-0490; Matovu, Enock/0000-0003-0714-7032; Levitt, Naomi/0000-0001-6480-8066; Adeyemo, Adebowale/0000-0002-3105-3231; Fakunle, Eyitayo/0000-0001-7123-008X; Kumuthini, Judit/0000-0002-8008-1917; Hazelhurst, Scott/0000-0002-0581-149X; Joloba, Moses/0000-0002-0334-9983; Kapiga, Saidi/0000-0003-1753-4060; Crowther, Nigel/0000-0002-5766-1745; Happi, Christian/0000-0002-3056-6705; Owolabi, Mayowa/0000-0003-1146-3070; Mulder, Nicola J/0000-0003-4905-0941; Mbanya, Jean Claude N/0000-0001-9651-8653; ElSayed, Ahmed/0000-0001-7422-7169; lawlor, Rita/0000-0003-3160-0634; Dareng, Eileen/0000-0003-0802-419X; Keavney, Bernard/0000-0001-9573-0812; Tangwa, Godfrey B./0000-0003-0062-8108; Nyarko, Alexander/0000-0002-9923-360X; Norris, Shane/0000-0001-7124-3788; Mpoloka, Sununguko/0000-0003-0147-1819; Kamal Kassim, Samar/0000-0002-4359-6620; TOBIN, EKAETE/0000-0001-5059-807X; Kyobutungi, Catherine/0000-0002-5344-5631; Akpalu, Albert/0000-0002-4802-9852; Kahn, Kathleen/0000-0003-3339-3931; Ramsay, Michele/0000-0002-4156-4801; Kasvosve, Ishmael/0000-0002-2046-545X; Jongeneel, Cornelis Victor/0000-0002-3922-1906; Rasooly, Rebekah/0000-0002-6357-5528; Lombard, Zane/0000-0002-7997-2616; Amodu, Olukemi/0000-0003-1477-4229; Merle, Corinne/0000-0003-4229-365X; Msefula, Chisomo/0000-0003-2304-886X; Nkomazana, Oathokwa/0000-0002-2040-4059; McCarthy, Mark/0000-0002-4393-0510; Swanepoel, Carmen/0000-0002-3344-5546; Motala, Ayesha/0000-0003-0517-1784; Boima, Vincent/0000-0002-0562-6307; christoffels, alan/0000-0002-0420-2916; Benkahla, Alia/0000-0001-9988-3250; Tollman, Stephen/0000-0003-0744-7588; Garry, Robert/0000-0002-5683-3250; Akinyemi, Rufus/0000-0001-5286-428X; Everett, Dean/0000-0002-8458-6779; Wade, Alisha/0000-0002-1158-2523; Tinto, Halidou/0000-0002-0472-3586; Tukei, Vincent Joseph/0000-0002-9525-2600; Masiga, Daniel/0000-0001-7513-0887; Arulogun, Oyedunni/0000-0002-2173-4682; Parekh, Rulan/0000-0001-6313-5752; Wachinou, Ablo Prudence/0000-0002-1024-9665; Patterton, Hugh-George/0000-0003-2550-0493; Mahomva, Chengetai/0000-0001-7933-5441; Smeeth, Liam/0000-0002-9168-6022; Bethke, Lara/0000-0002-1316-4704; Ofori-Acquah, Solomon/0000-0001-5000-3048	MRC [MC_U123292700, G0800247] Funding Source: UKRI; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish; Wellcome Trust [099310/Z/12/Z] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [D43TW009140] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010022] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UH2HG007051, U41HG006941, U01HG007459, UH3HG007008, U01HG007044, U54HG006947, U54HG006938, U54HG006939, ZIAHG200362, U54HG007479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089696, R01AI104621, U54AI110398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002974] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/012/25941] Funding Source: Medline; FIC NIH HHS [D43 TW009140, U2R TW010679] Funding Source: Medline; Medical Research Council [MC_U123292700, G0800247] Funding Source: Medline; NHGRI NIH HHS [U54 HG006939, UH3 HG007008, U54 HG006947, U01 HG009716, U54 HG006938, U41 HG006941, U01 HG007044, U01 HG007459, U54 HG007479, UH2 HG007051, U24 HG007008] Funding Source: Medline; NHLBI NIH HHS [U24 HL135600] Funding Source: Medline; NIAID NIH HHS [U19 AI089696, U54 AI110398, R01 AI104621] Funding Source: Medline; NIMHD NIH HHS [P20 MD006899] Funding Source: Medline; NINDS NIH HHS [R01 NS107900] Funding Source: Medline; Wellcome Trust [085349, 095201, 099313, 095009, 098610, 098504, 093727, 104111] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); British Heart Foundation(British Heart Foundation); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust)		[Anonymous], 2010, NATURE, V465, P990; Ayele FT, 2012, NEW ENGL J MED, V366, P1200, DOI 10.1056/NEJMoa1108448; Behar DM, 2011, AM J NEPHROL, V34, P452, DOI 10.1159/000332378; Bentley AR, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/748984; De Vre R., 2010, MCKINSEY Q REPORT; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Parsa A, 2013, NEW ENGL J MED, V369, P2183, DOI 10.1056/NEJMoa1310345; Rotimi CN, 2010, GENOME MED, V2, DOI 10.1186/gm141; Tayo BO, 2013, INT UROL NEPHROL, V45, P485, DOI 10.1007/s11255-012-0263-4; Ulasi II, 2013, NEPHRON CLIN PRACT, V123, P123, DOI 10.1159/000353223	11	243	243	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1346	1348		10.1126/science.1251546	http://dx.doi.org/10.1126/science.1251546			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948725	Green Accepted			2022-12-01	WOS:000337531700022
J	Gornall, J				Gornall, Jonathan			ALCOHOL World Cup 2014: festival of football or alcohol?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						All Party Parliamentary Beer Group, REG ALL PART GROUPS; [Anonymous], 2010, DUTCH NEWS      0717; [Anonymous], 2009, REUTERS; Brown L, 2013, MORNING ADVERTI 1220; Charles G., 2011, MARKETING; Clarke Miles, 2010, COMMUNICATION; Conn D., 2013, GUARDIAN; Costa B., 2014, WALL STREET J; Crumley B., 1997, ADVERTISING AGE; Fifa, 2004, SAF GUID; Foottit L., 2009, MORNING ADVERTI 1208; Gornall J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7646; Hogan T., 2013, IRISH INDEPENDE 0327; Home Office, 2014, WORLD CUP LIC HOURS; Joint Committee on Transport and Communications, 2013, REP SPONS SPORTS ALC; Joseph S., 2014, MARKETING WEEK; Kelso Paul, 2009, TELEGRAPH; Quigg Z, 2012, EUR J PUBLIC HLTH; Rigaud A, 2004, GLOBE, V1, P33; Simoes C, 2014, BLOOMBERG; South African Sport and Recreation Department, 2013, 2010 FIF WORLD CUP C	21	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2014	348								g3772	10.1136/bmj.g3772	http://dx.doi.org/10.1136/bmj.g3772			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1GY	24916959				2022-12-01	WOS:000337405200009
J	May, M				May, Mike			ATTACKING AN EPIDEMIC	NATURE			English	Editorial Material																			0	26	28	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S50	S51		10.1038/509S50a	http://dx.doi.org/10.1038/509S50a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870819	Bronze			2022-12-01	WOS:000336457100002
J	Schmalen, I; Reischl, S; Wallach, T; Klemz, R; Grudziecki, A; Prabu, JR; Benda, C; Kramer, A; Wolf, E				Schmalen, Ira; Reischl, Silke; Wallach, Thomas; Klemz, Roman; Grudziecki, Astrid; Prabu, J. Rajan; Benda, Christian; Kramer, Achim; Wolf, Eva			Interaction of Circadian Clock Proteins CRY1 and PER2 Is Modulated by Zinc Binding and Disulfide Bond Formation	CELL			English	Article							CRYPTOCHROME1 TRANSGENIC MICE; CRYSTAL-STRUCTURE; MAMMALIAN CRY1; C-TERMINUS; RHYTHMS; IDENTIFICATION; DEGRADATION; NUCLEUS; CELLS	Period (PER) proteins are essential components of the mammalian circadian clock. They form complexes with cryptochromes (CRY), which negatively regulate CLOCK/BMAL1-dependent transactivation of clock and clock-controlled genes. To define the roles of mammalian CRY/PER complexes in the circadian clock, we have determined the crystal structure of a complex comprising the photolyase homology region of mouse CRY1 (mCRY1) and a C-terminal mouse PER2 (mPER2) fragment. mPER2 winds around the helical mCRY1 domain covering the binding sites of FBXL3 and CLOCK/BMAL1, but not the FAD binding pocket. Our structure revealed an unexpected zinc ion in one interface, which stabilizes mCRY1-mPER2 interactions in vivo. We provide evidence that mCRY1/mPER2 complex formation is modulated by an interplay of zinc binding and mCRY1 disulfide bond formation, which may be influenced by the redox state of the cell. Our studies may allow for the development of circadian and metabolic modulators.	[Schmalen, Ira; Prabu, J. Rajan; Benda, Christian; Wolf, Eva] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany; [Wolf, Eva] Univ Munich, Butenandt Inst, Dept Physiol Chem, D-81377 Munich, Germany; [Reischl, Silke; Wallach, Thomas; Klemz, Roman; Grudziecki, Astrid; Kramer, Achim] Charite, Lab Chronobiol, D-10115 Berlin, Germany	Max Planck Society; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kramer, A (corresponding author), Charite, Lab Chronobiol, Hessische Str 3-4, D-10115 Berlin, Germany.	achim.kramer@charite.de; evawolf1@uni-mainz.de		Kramer, Achim/0000-0001-9671-6078; Benda, Christian/0000-0001-5551-1332	DFG grants [Wo695-3 (FOR526), Wo695-4, Wo695-6, SFB740/D2]; Studienstiftung des deutschen Volkes	DFG grants(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes	We thank the beamline staff at Swiss Light Source (SLS, Villingen) for excellent assistance and the Max Planck Institute (MPI) of Biochemistry Crystallization Facility and Biochemistry Core Facility, especially Elisabeth Wehyer-Stingl, for technical assistance and support. Further, we thank Helmut Hartl and Jaroslava Obel (Department of Chemistry and Pharmacy, LMU Munich) for ICP-OES analysis. We thank our colleagues of the Department of Structural Cell Biology at the MPI of Biochemistry for help with data collection, fruitful discussions, and critical comments. We are indebted to Claire Basquin for assistance with ITC, thermofluor, and other biophysical methods and to Michaela Rode for assistance with insect cell culture. Anna Czarna, Sebastian Falk, Kai Hell, Debora Makino, Michael Taschner, and Justine Witosch are thanked for valuable suggestions and discussions. This study was supported by DFG grants Wo695-3 (FOR526), Wo695-4, and Wo695-6 to E.W., DFG grant SFB740/D2 to A.K., and a fellowship of the Studienstiftung des deutschen Volkes to I.S.	Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Barclay JL, 2013, AM J PHYSIOL-ENDOC M, V304, pE1053, DOI 10.1152/ajpendo.00512.2012; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Czarna A, 2013, CELL, V153, P1394, DOI 10.1016/j.cell.2013.05.011; Czarna A, 2011, J BIOL CHEM, V286, P22414, DOI 10.1074/jbc.M111.244749; Eckel-Mahan K, 2009, NAT STRUCT MOL BIOL, V16, P462, DOI 10.1038/nsmb.1595; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Evans JC, 2002, STRUCTURE, V10, P1159, DOI 10.1016/S0969-2126(02)00796-7; Gatfield D, 2007, SCIENCE, V316, P1135, DOI 10.1126/science.1144165; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Ilbert M, 2006, ANTIOXID REDOX SIGN, V8, P835, DOI 10.1089/ars.2006.8.835; King DP, 1997, GENETICS, V146, P1049; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kucera N, 2012, P NATL ACAD SCI USA, V109, P3311, DOI 10.1073/pnas.1113280109; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; Miyazaki K, 2001, MOL CELL BIOL, V21, P6651, DOI 10.1128/MCB.21.19.6651-6659.2001; Muller M, 2009, CURR OPIN STRUC BIOL, V19, P277, DOI 10.1016/j.sbi.2009.05.003; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Okano S, 2013, J DIABETES INVEST, V4, P428, DOI 10.1111/jdi.12080; Okano S, 2010, EUR J CLIN INVEST, V40, P1011, DOI 10.1111/j.1365-2362.2010.02359.x; Okano S, 2009, NEUROSCI LETT, V451, P246, DOI 10.1016/j.neulet.2009.01.014; Oteiza PI, 2012, FREE RADICAL BIO MED, V53, P1748, DOI 10.1016/j.freeradbiomed.2012.08.568; Ozber N, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-69; Templeton DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015012; Tomita T, 2010, BBA-MOL CELL RES, V1803, P492, DOI 10.1016/j.bbamcr.2010.01.012; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Wang TA, 2012, SCIENCE, V337, P839, DOI 10.1126/science.1222826; Weir JR, 2010, P NATL ACAD SCI USA, V107, P12139, DOI 10.1073/pnas.1004953107; Wu HH, 2000, BIOCHEM J, V351, P87, DOI 10.1042/0264-6021:3510087; Xing WM, 2013, NATURE, V496, P64, DOI 10.1038/nature11964; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Ye R, 2011, J BIOL CHEM, V286, P25891, DOI 10.1074/jbc.M111.254680; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214	44	120	122	1	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1203	1215		10.1016/j.cell.2014.03.057	http://dx.doi.org/10.1016/j.cell.2014.03.057			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855952	Bronze, Green Published			2022-12-01	WOS:000336437200020
J	Fonseca-Pereira, D; Arroz-Madeira, S; Rodrigues-Campos, M; Barbosa, IAM; Domingues, RG; Bento, T; Almeida, ARM; Ribeiro, H; Potocnik, AJ; Enomoto, H; Veiga-Fernandes, H				Fonseca-Pereira, Diogo; Arroz-Madeira, Silvia; Rodrigues-Campos, mariana; Barbosa, Ines A. M.; Domingues, Rita G.; Bento, Teresa; Almeida, Afonso R. M.; Ribeiro, Helder; Potocnik, Alexandre J.; Enomoto, Hideki; Veiga-Fernandes, Henrique			The neurotrophic factor receptor RET drives haematopoietic stem cell survival and function	NATURE			English	Article							NERVOUS-SYSTEM; MICE LACKING; FETAL; EXPRESSION; MIGRATION; COMPONENT; KIDNEY; DEATH	Haematopoiesis is a developmental cascade that generates all blood cell lineages in health and disease. This process relies on quiescent haematopoietic stem cells capable of differentiating, self renewing and expanding upon physiological demand(1,2). However, the mechanisms that regulate haematopoietic stem cell homeostasis and function remain largely unknown. Here we show that the neurotrophic factor receptor RET (rearranged during transfection) drives haematopoietic stem cell survival, expansion and function. We find that haematopoietic stem cells express RET and that its neurotrophic factor partners are produced in the haematopoietic stem cell environment. Ablation of Ret leads to impaired survival and reduced numbers of haematopoietic stem cells with normal differentiation potential, but loss of cell-autonomous stress response and reconstitution potential. Strikingly, RET signals provide haematopoietic stem cells with critical Bcl2 and Bcl2l1 surviving cues, downstream of p38 mitogen-activated protein (MAP) kinase and cyclic-AMP-response element binding protein (CREB) activation. Accordingly, enforced expression of RET downstream targets, Bcl2 or Bcl2l1, is sufficient to restore the activity of Ret null progenitors in vivo. Activation of RET results in improved haematopoietic stem cell survival, expansion and in vivo transplantation efficiency. Remarkably, human cord-blood progenitor expansion and transplantation is also improved by neurotrophic factors, opening the way for exploration of RET agonists in human haematopoietic stem cell transplantation. Ourwork shows that neurotrophic factors are novel components of the haematopoietic stem cell microenvironment, revealing that	[Fonseca-Pereira, Diogo; Arroz-Madeira, Silvia; Rodrigues-Campos, mariana; Barbosa, Ines A. M.; Domingues, Rita G.; Bento, Teresa; Almeida, Afonso R. M.; Ribeiro, Helder; Veiga-Fernandes, Henrique] Fac Med Lisbon, Inst Mol Med, P-1649028 Lisbon, Portugal; [Potocnik, Alexandre J.] MRC Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England; [Potocnik, Alexandre J.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland; [Enomoto, Hideki] RIKEN Ctr Dev Biol, Lab Neuronal Differentiat & Regenerat, Kobe, Hyogo 6500047, Japan; [Enomoto, Hideki] Kobe Univ, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan	Universidade de Lisboa; MRC National Institute for Medical Research; University of Edinburgh; RIKEN; Kobe University	Veiga-Fernandes, H (corresponding author), Fac Med Lisbon, Inst Mol Med, Ave Prof Egas Moniz,Edif Egas Moniz, P-1649028 Lisbon, Portugal.	jhfernandes@medicina.ulisboa.pt	da Fonseca Pereira, Diogo/O-9894-2019; Fonseca-Pereira, Diogo/U-1275-2018	Fonseca-Pereira, Diogo/0000-0002-7400-9804; Potocnik, Alexandre/0000-0002-4730-8593; Barbosa, Ines/0000-0001-8977-0930; Veiga-Fernandes, Henrique/0000-0001-6216-1836; Rodrigues-Campos, Mariana/0000-0002-6116-5613; Almeida, Afonso/0000-0002-4292-8558; Ribeiro, Helder/0000-0002-7090-9274	Fundacao para a Ciencia e Tecnologia, Portugal; Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/SAU-MII/104931/2008]; European Molecular Biology Organisation [1648]; European Research Council [207057]; National Blood Foundation, USA; MRC [MC_U117565359] Funding Source: UKRI; Medical Research Council [MC_U117565359] Funding Source: researchfish	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); European Molecular Biology Organisation; European Research Council(European Research Council (ERC)European Commission); National Blood Foundation, USA; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank I. Monteiro Grillo and the radiotherapy service at Hospital de Santa Maria; H. Ferreira and the service of obstetrics, gynaecology and reproductive medicine at the Hospital of Santa Maria; the Instituto de Medicina Molecular animal facility, flow cytometry unit, bioimaging unit and histology unit for technical assistance. We also thank all members of H.V.-F. laboratory for discussion. D. F.-P., S. A.-M., R. G. D. and A. R. M. A. were supported by scholarships from Fundacao para a Ciencia e Tecnologia, Portugal. H.V.-F. was supported by Fundacao para a Ciencia e Tecnologia (PTDC/SAU-MII/104931/2008), Portugal, the European Molecular Biology Organisation (Project 1648), European Research Council (Project 207057) and National Blood Foundation, USA.	Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Almeida ARM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052949; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Mulligan LM, 2014, NAT REV CANCER, V14, P173, DOI 10.1038/nrc3680; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; Nishino J, 1999, NEURON, V23, P725, DOI 10.1016/S0896-6273(01)80031-3; Patel A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002734; Peixoto A, 2007, J EXP MED, V204, P1193, DOI 10.1084/jem.20062349; Perianayagam MC, 2006, EUR J CLIN INVEST, V36, P353, DOI 10.1111/j.1365-2362.2006.01637.x; Rossi J, 1999, NEURON, V22, P243, DOI 10.1016/S0896-6273(00)81086-7; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Shukla A, 2009, AM J PATHOL, V175, P2197, DOI 10.2353/ajpath.2009.090400; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Terskikh AV, 2003, BLOOD, V102, P94, DOI 10.1182/blood-2002-08-2509; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Uesaka T, 2010, J NEUROSCI, V30, P5211, DOI 10.1523/JNEUROSCI.6244-09.2010; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Winkler IG, 2010, BLOOD, V116, P375, DOI 10.1182/blood-2009-07-233437; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053	34	69	71	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					98	+		10.1038/nature13498	http://dx.doi.org/10.1038/nature13498			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25079320				2022-12-01	WOS:000342420800043
J	Colegio, OR; Chu, NQ; Szabo, AL; Chu, T; Rhebergen, AM; Jairam, V; Cyrus, N; Brokowski, CE; Eisenbarth, SC; Phillips, GM; Cline, GW; Phillips, AJ; Medzhitov, R				Colegio, Oscar R.; Ngoc-Quynh Chu; Szabo, Alison L.; Chu, Thach; Rhebergen, Anne Marie; Jairam, Vikram; Cyrus, Nika; Brokowski, Carolyn E.; Eisenbarth, Stephanie C.; Phillips, Gillian M.; Cline, Gary W.; Phillips, Andrew J.; Medzhitov, Ruslan			Functional polarization of tumour-associated macrophages by tumour-derived lactic acid	NATURE			English	Article							ANGIOGENESIS; ACTIVATION; CELLS; INFLAMMATION; HYPOXIA; GROWTH	Macrophages have an important role in the maintenance of tissue homeostasis(1). To perform this function, macrophages must have the capacity to monitor the functional states of their 'client cells': namely, the parenchymal cells in the various tissues in which macrophages reside. Tumours exhibit many features of abnormally developed organs, including tissue architecture and cellular composition(2). Similarly to macrophages in normal tissues and organs, macrophages in tumours (tumour-associated macrophages) perform some key homeostatic functions that allow tumour maintenance and growth(3-5). However, the signals involved in communication between tumours and macrophages are poorly defined. Here we show that lactic acid produced by tumour cells, as a by-product of aerobic or anaerobic glycolysis, has a critical function in signalling, through inducing the expression of vascular endothelial growth factor and the M2-like polarization of tumour-associated macrophages. Furthermore, we demonstrate that this effect of lactic acid is mediated by hypoxia-inducible factor 1 alpha (HIF1 alpha). Finally, we show that the lactate-induced expression of arginase 1 by macrophages has an important role in tumour growth. Collectively, these findings identify a mechanism of communication between macrophages and their client cells, including tumour cells. This communication most probably evolved to promote homeostasis in normal tissues but can also be engaged in tumours to promote their growth.	[Colegio, Oscar R.; Ngoc-Quynh Chu; Szabo, Alison L.; Chu, Thach; Rhebergen, Anne Marie; Jairam, Vikram; Cyrus, Nika; Brokowski, Carolyn E.; Eisenbarth, Stephanie C.; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA; [Colegio, Oscar R.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA; [Colegio, Oscar R.] Yale Univ, Sch Med, Yale New Haven Transplantat Ctr, New Haven, CT 06519 USA; [Colegio, Oscar R.; Medzhitov, Ruslan] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA; [Eisenbarth, Stephanie C.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Phillips, Gillian M.; Phillips, Andrew J.] Yale Univ, Sch Med, Dept Chem, New Haven, CT 06520 USA; [Cline, Gary W.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Medzhitov, Ruslan] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA.	ruslan.medzhitov@yale.edu		Colegio, Oscar/0000-0002-6519-3718; Cyrus, Nika/0000-0002-7511-8631; Colegio, Oscar/0000-0002-9524-6235; Eisenbarth, Stephanie/0000-0002-1244-208X	National Cancer Institute [1K08CA172580-01]; Yale Center for Clinical Investigation [5KL2RR024138]; Yale SPORE in Skin Cancer [1 P50 CA121974]; Damon Runyon Cancer Research Foundation [DRG 108-09]; Dermatology Foundation; Blavatnik Family Foundation; National Institutes of Health [AI046688, AI089771, CA157461]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA016359, K08CA172580, P50CA121974, R01CA157461] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046688, R01AI089771, R01AI046688] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Yale Center for Clinical Investigation; Yale SPORE in Skin Cancer; Damon Runyon Cancer Research Foundation; Dermatology Foundation; Blavatnik Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Medzhitov laboratory for discussions, L. Xu, C. Annicelli, S. Cronin and G. Tokmoulina for animal care and technical help, and N. Palm for critical feedback on the manuscript. O.R.C. is supported by the National Cancer Institute (1K08CA172580-01), the Yale Center for Clinical Investigation (5KL2RR024138), the Yale SPORE in Skin Cancer (1 P50 CA121974), the Damon Runyon Cancer Research Foundation (DRG 108-09) and the Dermatology Foundation. R.M.'s laboratory is supported by The Blavatnik Family Foundation, grants from the National Institutes of Health (AI046688, AI089771 and CA157461) and the Howard Hughes Medical Institute.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Chang CI, 2001, CANCER RES, V61, P1100; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; De Ponti C, 2007, J LEUKOCYTE BIOL, V82, P392, DOI 10.1189/jlb.0107060; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mekhail K, 2004, NAT CELL BIOL, V6, P642, DOI 10.1038/ncb1144; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354	23	1407	1456	33	400	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					559	+		10.1038/nature13490	http://dx.doi.org/10.1038/nature13490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25043024	Green Accepted			2022-12-01	WOS:000342075800043
J	Kir, S; White, JP; Kleiner, S; Kazak, L; Cohen, P; Baracos, VE; Spiegelman, BM				Kir, Serkan; White, James P.; Kleiner, Sandra; Kazak, Lawrence; Cohen, Paul; Baracos, Vickie E.; Spiegelman, Bruce M.			Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia	NATURE			English	Article							HORMONE-RELATED PROTEIN; SKELETAL-MUSCLE; MONOCLONAL-ANTIBODY; NUDE-MICE; MECHANISMS; CELL; THERMOGENESIS; ACTIVATION; SURVIVAL	Cachexia is a wasting disorder of adipose and skeletal muscle tissues that leads to profound weight loss and frailty. About half of all cancer patients suffer from cachexia, which impairs quality of life, limits cancer therapy and decreases survival. One key characteristic of cachexia is higher resting energy expenditure levels than in healthy individuals, which has been linked to greater thermogenesis by brown fat(1-6). How tumours induce brown fat activity is unknown. Here, using a Lewis lung carcinoma model of cancer cachexia, we show that tumour-derived parathyroid-hormone-related protein (PTHrP) has an important role in wasting, through driving the expression of genes involved in thermogenesis in adipose tissues. Neutralization of PTHrP in tumour-bearing mice blocked adipose tissue browning and the loss of muscle mass and strength. Our results demonstrate that PTHrP mediates energy wasting in fat tissues and contributes to the broader aspects of cancer cachexia. Thus, neutralization of PTHrP might hold promise for ameliorating cancer cachexia and improving patient survival.	[Kir, Serkan; White, James P.; Kleiner, Sandra; Kazak, Lawrence; Cohen, Paul; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Baracos, Vickie E.] Univ Alberta, Div Palliat Care Med, Dept Oncol, Edmonton, AB T6G 1Z2, Canada	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Alberta	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.	bruce_spiegelman@dfci.harvard.edu		Baracos, Vickie/0000-0002-9609-1001	American Cancer Society [PF-13-385-01-TBE]; National Institutes of Health [DK31405]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031405, R01DK031405] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Mourtzakis and C. Prado for their help with the human study. S. Kir is a Robert Black Fellow of the Damon Runyon Cancer Research Foundation (DRG-2153-13), and J.P.W. is supported by a postdoctoral fellowship from the American Cancer Society (PF-13-385-01-TBE). This work was supported by National Institutes of Health grant DK31405 to B.M.S.	BIANCHI A, 1989, HORM METAB RES, V21, P640, DOI 10.1055/s-2007-1009308; Bing C, 2000, CANCER RES, V60, P2405; BROOKS SL, 1981, BIOSCIENCE REP, V1, P509, DOI 10.1007/BF01121584; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Iguchi H, 2006, J BONE MINER METAB, V24, P16, DOI 10.1007/s00774-005-0640-5; Iguchi H, 2001, INT J CANCER, V94, P24, DOI 10.1002/ijc.1425; Lieffers JR, 2009, AM J CLIN NUTR, V89, P1173, DOI 10.3945/ajcn.2008.27273; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; Mundy GR, 2008, J AM SOC NEPHROL, V19, P672, DOI 10.1681/ASN.2007090981; OVESEN L, 1993, J CLIN ONCOL, V11, P2043, DOI 10.1200/JCO.1993.11.10.2043; Penna F, 2010, EXPERT OPIN BIOL TH, V10, P1241, DOI 10.1517/14712598.2010.503773; Prado Carla M M, 2012, Can J Diet Pract Res, V73, pe298, DOI 10.3148/73.4.2012.e298; Roe S, 1996, METABOLISM, V45, P645, DOI 10.1016/S0026-0495(96)90037-2; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; SATO K, 1993, J BONE MINER RES, V8, P849; SHELLOCK FG, 1986, J CANCER RES CLIN, V111, P82, DOI 10.1007/BF00402783; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tsoli M, 2012, CANCER RES, V72, P4372, DOI 10.1158/0008-5472.CAN-11-3536; Vilardaga JP, 2011, CELL MOL LIFE SCI, V68, P1, DOI 10.1007/s00018-010-0465-9; White JP, 2013, MOL CELL ENDOCRINOL, V365, P174, DOI 10.1016/j.mce.2012.10.019; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	24	376	390	4	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					100	+		10.1038/nature13528	http://dx.doi.org/10.1038/nature13528			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25043053	Green Accepted			2022-12-01	WOS:000341174800038
J	Annas, GJ; Ruger, TW; Ruger, JP				Annas, George J.; Ruger, Theodore W.; Ruger, Jennifer Prah			Money, Sex, and Religion - The Supreme Court's ACA Sequel	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARE		[Annas, George J.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA; [Ruger, Theodore W.] Univ Penn, Sch Law, Philadelphia, PA 19104 USA; [Ruger, Jennifer Prah] Perelman Sch Med, Philadelphia, PA USA; [Ruger, Jennifer Prah] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	Boston University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.							Annas GJ, 2009, NEW ENGL J MED, V361, P2589, DOI 10.1056/NEJMp0911513; [Anonymous], 2014, NEW YORK TIMES, pA16; [Anonymous], 2011, COMMITTEE ON PREVENT, P102; [Anonymous], BIRTH CONTROL MEDICI; [Anonymous], 2014, WALL STREET JOURNAL, pA12; Cohen IG, 2014, NEW ENGL J MED, V371, P596, DOI 10.1056/NEJMp1407965; Long H., 2014, HOBBY LOBBY DOES INV; Mariner WK, 2012, NEW ENGL J MED, V367, P1154, DOI 10.1056/NEJMhle1208437; Mariner WK, 2014, HOBBY LOBBY PART 2 D; Ruger JP, 2012, NEW ENGL J MED, V366, P681, DOI 10.1056/NEJMp1200751; Ruger JP, 2009, HEALTH AND SOCIAL JU	11	8	8	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 28	2014	371	9					862	866		10.1056/NEJMhle1408081	http://dx.doi.org/10.1056/NEJMhle1408081			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7ZN	25029337	Green Published, Green Submitted			2022-12-01	WOS:000340819800014
J	Behnia, R; Clark, DA; Carter, AG; Clandinin, TR; Desplan, C				Behnia, Rudy; Clark, Damon A.; Carter, Adam G.; Clandinin, Thomas R.; Desplan, Claude			Processing properties of ON and OFF pathways for Drosophila motion detection	NATURE			English	Article							VISUAL INTERNEURONS; OPTIC LOBE; WILD-TYPE; MELANOGASTER; PATTERNS; MEDULLA; CIRCUIT; LAMINA	The algorithms and neural circuits that process spatio-temporal changes in luminance to extract visual motion cues have been the focus of intense research. An influential model, the Hassenstein-Reichardt correlator(1), relies on differential temporal filtering of two spatially separated input channels, delaying one input signal with respect to the other. Motion in a particular direction causes these delayed and non-delayed luminance signals to arrive simultaneously at a subsequent processing step in the brain; these signals are then nonlinearly amplified to produce a direction-selective response. Recent work in Drosophila has identified two parallel pathways that selectively respond to either moving light or dark edges(2,3). Each of these pathways requires two critical processing steps to be applied to incoming signals: differential delay between the spatial input channels, and distinct processing of brightness increment and decrement signals. Here we demonstrate, using in vivo patch-clamp recordings, that four medulla neurons implement these two processing steps. The neurons Mi1 and Tm3 respond selectively to brightness increments, with the response of Mi1 delayed relative to Tm3. Conversely, Tm1 and Tm2 respond selectively to brightness decrements, with the response of Tm1 delayed compared with Tm2. Remarkably, constraining Hassenstein-Reichardt correlator models using these measurements produces outputs consistent with previously measured properties of motion detectors, including temporal frequency tuning and specificity for light versus dark edges. We propose that Mi1 and Tm3 perform critical processing of the delayed and non-delayed input channels of the correlator responsible for the detection of light edges, while Tm1 and Tm2 play analogous roles in the detection of moving dark edges. Our data show that specific medulla neurons possess response properties that allow them to implement the algorithmic steps that precede the correlative operation in the Hassenstein-Reichardt correlator, revealing elements of the long-sought neural substrates of motion detection in the fly.	[Behnia, Rudy; Desplan, Claude] NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA; [Clark, Damon A.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Clark, Damon A.; Clandinin, Thomas R.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Carter, Adam G.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Desplan, Claude] New York Univ Abu Dhabi Inst, Ctr Genom & Syst Biol, Abu Dhabi, U Arab Emirates	New York University; Yale University; Stanford University; New York University	Behnia, R (corresponding author), NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA.	rb141@nyu.edu; damon.clark@yale.edu		Clark, Damon/0000-0001-8487-700X; Desplan, Claude/0000-0002-6914-1413; Behnia, Rudy/0000-0001-7258-1885	National Institutes of Health (NIH) [R01EY017916]; New York University Abu Dhabi Institute [G1205C]; EMBO; Human Frontier Science Program; NIH [R01EY022638, DP1 OD003530]; NIH; Jane Coffin Childs postdoctoral fellowship; McKnight Foundation; NATIONAL EYE INSTITUTE [R01EY022638, R01EY017916] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003530] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Abu Dhabi Institute; EMBO(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs postdoctoral fellowship; McKnight Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Turner for his initial help on whole-cell recordings; X. Li for providing the confocal image of the 686-Gal4 flip-out clone, and N. Vogt, J. Rister and members of the Clandin in laboratory, as well as H. S. Seung and S.A. Baccus, for reading of the manuscript. We also thank D. B. Chklovskii for suggesting recording from Tm3 and T. Erclick for identifying the Tm3 Gal4 line. This work was supported by a grant from the National Institutes of Health (NIH) (R01EY017916) and a grant from New York University Abu Dhabi Institute (G1205C) to C.D.; R.B. was supported by fellowships from EMBO and the Human Frontier Science Program. This work was also supported by grants from the NIH to T.R.C. (R01EY022638 and DP1 OD003530). D.A.C. was partly supported by an NIH T32 Vision Training Grant and a Jane Coffin Childs postdoctoral fellowship. A.G.C. was supported by a Scholar Award from The McKnight Foundation.	Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BAUSENWEIN B, 1992, CELL TISSUE RES, V270, P25, DOI 10.1007/BF00381876; BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; BORST A, 1989, TRENDS NEUROSCI, V12, P297, DOI 10.1016/0166-2236(89)90010-6; BORST A, 1986, BIOL CYBERN, V55, P59, DOI 10.1007/BF00363978; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BUCHNER E, 1976, BIOL CYBERN, V24, P85, DOI 10.1007/BF00360648; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; Eichner H, 2011, NEURON, V70, P1155, DOI 10.1016/j.neuron.2011.03.028; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Franceschini N., 1989, FACETS VISION, P360; Freifeld L, 2013, NEURON, V78, P1075, DOI 10.1016/j.neuron.2013.04.024; Harris RA, 2000, NEURON, V28, P595, DOI 10.1016/S0896-6273(00)00136-7; Hasegawa E, 2011, DEVELOPMENT, V138, P983, DOI 10.1242/dev.058370; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; Katsov AY, 2008, NEURON, V59, P322, DOI 10.1016/j.neuron.2008.05.022; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; MARMARELIS PZ, 1973, KYBERNETIK, V12, P74, DOI 10.1007/BF00272463; Meier M., 2014, CURRENT BIOL; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Morante J, 2008, CURR BIOL, V18, P553, DOI 10.1016/j.cub.2008.02.075; Morante Javier, 2011, Cold Spring Harb Protoc, V2011, P652, DOI 10.1101/pdb.prot5629; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Schnell B, 2012, J COMP PHYSIOL A, V198, P389, DOI 10.1007/s00359-012-0716-3; Shinomiya K, 2014, CURR BIOL, V24, P1062, DOI 10.1016/j.cub.2014.03.051; Silies M, 2013, NEURON, V79, P111, DOI 10.1016/j.neuron.2013.04.029; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P189, DOI 10.1007/s00359-003-0390-6; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Tuthill JC, 2013, NEURON, V79, P128, DOI 10.1016/j.neuron.2013.05.024; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782	38	134	134	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					427	U443		10.1038/nature13427	http://dx.doi.org/10.1038/nature13427			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25043016	Green Accepted			2022-12-01	WOS:000340840600033
J	Gao, F; Bonsignori, M; Liao, HX; Kumar, A; Xia, SM; Lu, XZ; Cai, FP; Hwang, KK; Song, HS; Zhou, TQ; Lynch, RM; Alam, SM; Moody, MA; Ferrari, G; Berrong, M; Kelsoe, G; Shaw, GM; Hahn, BH; Montefiori, DC; Kamanga, G; Cohen, MS; Hraber, P; Kwong, PD; Korber, BT; Mascola, JR; Kepler, TB; Haynes, BF				Gao, Feng; Bonsignori, Mattia; Liao, Hua-Xin; Kumar, Amit; Xia, Shi-Mao; Lu, Xiaozhi; Cai, Fangping; Hwang, Kwan-Ki; Song, Hongshuo; Zhou, Tongqing; Lynch, Rebecca M.; Alam, S. Munir; Moody, M. Anthony; Ferrari, Guido; Berrong, Mark; Kelsoe, Garnett; Shaw, George M.; Hahn, Beatrice H.; Montefiori, David C.; Kamanga, Gift; Cohen, Myron S.; Hraber, Peter; Kwong, Peter D.; Korber, Bette T.; Mascola, John R.; Kepler, Thomas B.; Haynes, Barton F.			Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies	CELL			English	Article							CD4 BINDING-SITE; HIV-1-INFECTED INDIVIDUALS; CONFORMATIONAL EPITOPE; MONOCLONAL-ANTIBODIES; BROAD NEUTRALIZATION; IMMUNE-RESPONSES; GERMINAL-CENTERS; HIV-1 INFECTION; AFFINITY; MUTATIONS	Development of strategies for induction of HIV-1 broadly neutralizing antibodies (bnAbs) by vaccines is a priority. Determining the steps of bnAb induction in HIV-1-infected individuals who make bnAbs is a key strategy for immunogen design. Here, we study the B cell response in a bnAb-producing individual and report cooperation between two B cell lineages to drive bnAb development. We isolated a virus-neutralizing antibody lineage that targeted an envelope region (loop D) and selected virus escape mutants that resulted in both enhanced bnAb lineage envelope binding and escape mutant neutralization-traits associated with increased B cell antigen drive. Thus, in this individual, two B cell lineages cooperated to induce the development of bnAbs. Design of vaccine immunogens that simultaneously drive both helper and broadly neutralizing B cell lineages may be important for vaccine-induced recapitulation of events that transpire during the maturation of neutralizing antibodies in HIV-1-infected individuals.	[Gao, Feng; Bonsignori, Mattia; Liao, Hua-Xin; Kumar, Amit; Xia, Shi-Mao; Lu, Xiaozhi; Cai, Fangping; Hwang, Kwan-Ki; Song, Hongshuo; Alam, S. Munir; Moody, M. Anthony; Ferrari, Guido; Berrong, Mark; Kelsoe, Garnett; Montefiori, David C.; Haynes, Barton F.] Duke Univ, Sch Med, Human Vaccine Inst, Dept Med, Durham, NC 27710 USA; [Gao, Feng; Bonsignori, Mattia; Liao, Hua-Xin; Kumar, Amit; Xia, Shi-Mao; Lu, Xiaozhi; Cai, Fangping; Hwang, Kwan-Ki; Song, Hongshuo; Alam, S. Munir; Moody, M. Anthony; Ferrari, Guido; Berrong, Mark; Kelsoe, Garnett; Montefiori, David C.; Haynes, Barton F.] Duke Univ, Sch Med, Human Vaccine Inst, Dept Surg, Durham, NC 27710 USA; [Gao, Feng; Bonsignori, Mattia; Liao, Hua-Xin; Kumar, Amit; Xia, Shi-Mao; Lu, Xiaozhi; Cai, Fangping; Hwang, Kwan-Ki; Song, Hongshuo; Alam, S. Munir; Moody, M. Anthony; Ferrari, Guido; Berrong, Mark; Kelsoe, Garnett; Montefiori, David C.; Haynes, Barton F.] Duke Univ, Sch Med, Human Vaccine Inst, Dept Pediat & Immunol, Durham, NC 27710 USA; [Gao, Feng; Bonsignori, Mattia; Liao, Hua-Xin; Kumar, Amit; Xia, Shi-Mao; Lu, Xiaozhi; Cai, Fangping; Hwang, Kwan-Ki; Song, Hongshuo; Alam, S. Munir; Moody, M. Anthony; Ferrari, Guido; Berrong, Mark; Kelsoe, Garnett; Montefiori, David C.; Haynes, Barton F.] Duke Univ, Ctr HIV AIDS Vaccine Immunol Immunogen Discovery, Durham, NC 27710 USA; [Zhou, Tongqing; Lynch, Rebecca M.; Kwong, Peter D.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Shaw, George M.; Hahn, Beatrice H.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Shaw, George M.; Hahn, Beatrice H.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Kamanga, Gift] UNC Project, Lilongwe, Malawi; [Kamanga, Gift] Univ N Carolina, Dept Hlth Policy, Chapel Hill, NC 27599 USA; [Kamanga, Gift] Univ N Carolina, Dept Management, Chapel Hill, NC 27599 USA; [Cohen, Myron S.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Cohen, Myron S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Cohen, Myron S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Hraber, Peter; Korber, Bette T.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87544 USA; [Kepler, Thomas B.] Boston Univ, Dept Microbiol, Boston, MA 02215 USA	Duke University; Duke University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Energy (DOE); Los Alamos National Laboratory; Boston University	Gao, F (corresponding author), Duke Univ, Sch Med, Human Vaccine Inst, Dept Med, Durham, NC 27710 USA.	fgao@duke.edu; barton.haynes@duke.edu	Bonsignori, Mattia/AAE-7678-2019; Zhou, Tongqing/A-6880-2010; Ferrari, Guido/A-6088-2015; Mascola, John/AAI-7193-2021; Alam, S. Munir/AAC-6711-2019; Ferrari, Guido/Z-2137-2019; Moody, M/AAB-6947-2020	Bonsignori, Mattia/0000-0003-2973-2101; Zhou, Tongqing/0000-0002-3935-4637; Ferrari, Guido/0000-0001-7747-3349; Moody, M/0000-0002-3890-5855; Hahn, Beatrice/0000-0002-9400-9887; Kelsoe, Garnett/0000-0002-8770-040X; Korber, Bette/0000-0002-2026-5757; Hraber, Peter/0000-0002-2920-4897	Center For HIV/AIDS Vaccine Immunology-Immunogen Discovery grant (CHAVI-ID) [UM1 AI100645]; Duke University Center for AIDS Research (CFAR) [P30-AI-64518]; intramural research program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645, P30AI045008, ZIAAI005024, P30AI050410, P30AI064518] Funding Source: NIH RePORTER	Center For HIV/AIDS Vaccine Immunology-Immunogen Discovery grant (CHAVI-ID); Duke University Center for AIDS Research (CFAR); intramural research program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Center For HIV/AIDS Vaccine Immunology-Immunogen Discovery grant (CHAVI-ID; UM1 AI100645), the Duke University Center for AIDS Research (CFAR; P30-AI-64518), and the intramural research program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH. We thank Mark Hallen and Jiang Zhu for assistance and discussion on calculation of binding affinity and Daniel M Kozink, Abby Cooper, and Florence Perrin for technical assistance. Provisional patents have been filed by B. F. H., H.-X. L., R. M. L., T.Z., F. G., G. M. S., B. H. H., T. B. K., B. T. K., P. D. K., J.R.M., and P. H. M. S. C. served at Advisory Board of Roche Molecular Systems, Expert Advisory Panel of Gates Foundation, and Pipeline Advisory Board of Janssen Global Services.	Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Bonsignori M, 2014, J CLIN INVEST, V124, P1835, DOI 10.1172/JCI73441; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Cai FP, 2007, NAT METHODS, V4, P123, DOI 10.1038/nmeth995; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Cox JH, 2006, METHODS, V38, P274, DOI 10.1016/j.ymeth.2005.11.006; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; Dehouck Y, 2013, NUCLEIC ACIDS RES, V41, pW333, DOI 10.1093/nar/gkt450; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Fera D, 2014, P NATL ACAD SCI USA, V111, P10275, DOI 10.1073/pnas.1409954111; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Kepler Thomas B, 2013, F1000Res, V2, P103, DOI 10.12688/f1000research.2-103.v1; Kirchherr JL, 2007, J VIROL METHODS, V143, P104, DOI 10.1016/j.jviromet.2007.02.015; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liao HX, 2013, J VIROL, V87, P4185, DOI 10.1128/JVI.02297-12; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Montefiori D.C., 2004, CURRENT PROTOCOLS IM; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Moore PL, 2009, CURR OPIN HIV AIDS, V4, P358, DOI 10.1097/COH.0b013e32832ea7e8; Moretti R, 2013, PROTEINS, V81, P1980, DOI 10.1002/prot.24356; Mouquet H, 2012, CELL MOL LIFE SCI, V69, P1435, DOI 10.1007/s00018-011-0872-6; Sattentau Quentin J, 2010, F1000 Biol Rep, V2, P60, DOI 10.3410/B2-60; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Song HS, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-89; Stamatatos L, 2012, CURR OPIN IMMUNOL, V24, P316, DOI 10.1016/j.coi.2012.04.006; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Volpe JM, 2006, BIOINFORMATICS, V22, P438, DOI 10.1093/bioinformatics/btk004; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wibmer CK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003738; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	51	195	208	0	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					481	491		10.1016/j.cell.2014.06.022	http://dx.doi.org/10.1016/j.cell.2014.06.022			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25065977	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000340944300004
J	Beck, JR; Muralidharan, V; Oksman, A; Goldberg, DE				Beck, Josh R.; Muralidharan, Vasant; Oksman, Anna; Goldberg, Daniel E.			PTEX component HSP101 mediates export of diverse malaria effectors into host erythrocytes	NATURE			English	Article							PLASMODIUM-FALCIPARUM PROTEIN; PLASMEPSIN V; FOOD VACUOLE; VIRULENCE; BIOSYNTHESIS; LOCALIZATION; TRANSLOCON; PARASITES; MEMBRANE; CELLS	To mediate its survival and virulence, the malaria parasite Plasmodium falciparum exports hundreds of proteins into the host erythrocyte(1). To enter the host cell, exported proteins must cross the parasitophorous vacuolar membrane (PVM) within which the parasite resides, but the mechanism remains unclear. A putative Plasmodium translocon of exported proteins (PTEX) has been suggested to be involved for at least one class of exported proteins; however, direct functional evidence for this has been elusive(2-4). Here we show that export across the PVM requires heat shock protein 101 (HSP101), a ClpB-likeAAA+ ATPase component of PTEX. Using a chaperone auto-inhibition strategy, we achieved rapid, reversible ablation of HSP101 function, resulting in a nearly complete block in export with substrates accumulating in the vacuole in both asexual and sexual parasites. Surprisingly, this block extended to all classes of exported proteins, revealing HSP101-dependent translocation across the PVM as a convergent step in the multi-pathway export process. Under export-blocked conditions, association between HSP101 and other components of the PTEX complex was lost, indicating that the integrity of the complex is required for efficient protein export. Our results demonstrate an essential and universal role for HSP101 in protein export and provide strong evidence for PTEX function in protein translocation into the host cell.	[Beck, Josh R.; Oksman, Anna; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Muralidharan, Vasant; Oksman, Anna; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Muralidharan, Vasant; Oksman, Anna; Goldberg, Daniel E.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Goldberg, DE (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	dgoldberg@wustl.edu		Muralidharan, Vasant/0000-0001-6367-6284	National Institutes of Health [AI047798, T32-AI007172, AI099156]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K99AI099156, T32AI007172, R01AI047798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI047798 to D.E.G., T32-AI007172 to J.R.B. and AI099156 to V.M. We thank J. McBride, D. Cavanagh and EMRR for anti-EXP2 antibody, J. Adams and ATCC (MR4) for anti-BiP antibody, D. Taylor for anti-HRP2 antibody, R. Anders for anti-RESA antibody, C. Braun-Breton for anti-SBP1 antibody, K. Williamson for anti-PfGECO and anti-Pfs16 antibodies, T. Spielmann for anti-REX2, anti-REX3 and anti-MSRP6 antibodies, L. Tilley for anti-REX1 and anti-PfEMP1 antibodies, S. Desai for anti-CLAG3 antibody, A. Cowman for anti-KAHRP antibody, J. Przyborski and K. Lingelbach for anti-SERP antibody, W. Beatty for assistance with electron microscopy, B. Vaupel and T. Butler for technical assistance and P. Sigala and N. Spillman for suggestions.	Babbitt SE, 2012, P NATL ACAD SCI USA, V109, pE3278, DOI 10.1073/pnas.1209823109; Balu B, 2005, P NATL ACAD SCI USA, V102, P16391, DOI 10.1073/pnas.0504679102; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Boddey JA, 2013, ANNU REV MICROBIOL, V67, P243, DOI 10.1146/annurev-micro-092412-155730; Boddey JA, 2013, TRAFFIC, V14, P532, DOI 10.1111/tra.12053; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Bullen HE, 2012, J BIOL CHEM, V287, P7871, DOI 10.1074/jbc.M111.328591; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; CULVENOR JG, 1991, INFECT IMMUN, V59, P1183, DOI 10.1128/IAI.59.3.1183-1187.1991; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Eksi S, 2005, MOL BIOCHEM PARASIT, V143, P90, DOI 10.1016/j.molbiopara.2005.05.010; Francis SE, 1997, J BIOL CHEM, V272, P14961, DOI 10.1074/jbc.272.23.14961; Frankland S, 2007, EUKARYOT CELL, V6, P1584, DOI 10.1128/EC.00063-07; GINSBURG H, 1985, MOL BIOCHEM PARASIT, V14, P313, DOI 10.1016/0166-6851(85)90059-3; Gruring C, 2012, CELL HOST MICROBE, V12, P717, DOI 10.1016/j.chom.2012.09.010; Hawthorne PL, 2004, MOL BIOCHEM PARASIT, V136, P181, DOI 10.1016/j.molbiopara.2004.03.013; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725; KIRK K, 1994, J BIOL CHEM, V269, P3339; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; Kulzer S, 2010, CELL MICROBIOL, V12, P1398, DOI 10.1111/j.1462-5822.2010.01477.x; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Matthews K, 2013, MOL MICROBIOL, V89, P1167, DOI 10.1111/mmi.12334; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Morahan BJ, 2011, EUKARYOT CELL, V10, P1492, DOI 10.1128/EC.05155-11; Mundwiler-Pachlatko E, 2013, P NATL ACAD SCI USA, V110, P19987, DOI 10.1073/pnas.1309247110; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Riglar DT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2449; ROCK EP, 1987, PARASITOLOGY, V95, P209, DOI 10.1017/S0031182000057681; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; Silvestrini F, 2010, MOL CELL PROTEOMICS, V9, P1437, DOI 10.1074/mcp.M900479-MCP200; Spielmann T, 2006, MOL BIOL CELL, V17, P3613, DOI 10.1091/mbc.E06-04-0291; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	40	157	157	0	31	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					592	+		10.1038/nature13574	http://dx.doi.org/10.1038/nature13574			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043010	Green Accepted			2022-12-01	WOS:000339566300035
J	Cohen, IG; Feigenbaum, J; Adashi, EY				Cohen, I. Glenn; Feigenbaum, Jeremy; Adashi, Eli Y.			Reconsideration of the Lifetime Ban on Blood Donation by Men Who Have Sex With Men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cohen, I. Glenn; Feigenbaum, Jeremy] Harvard Univ, Sch Law, Cambridge, MA 02138 USA; [Cohen, I. Glenn] Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA USA; [Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA	Harvard University; Brown University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA.	eli_adashi@brown.edu						American Medical Association, 2013, AMA OPPOSES LIFETIME; [Anonymous], 2013, COMMUNICATION, P2; [Anonymous], 2013, BLOOD DONATIONS FROM; Suligoil B, 2013, BLOOD TRANSFUS-ITALY, V11, P441, DOI 10.2450/2013.0162-12; US Department of Health and Human Services, 2013, FORTY FOURTH MEETING; US Department of Health and Human Services, 1992, REVISED RECOMMENDATI; US Department of Health and Human Services, 2010, ADVISORY COMMITTEE O	7	15	15	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					337	338		10.1001/jama.2014.8037	http://dx.doi.org/10.1001/jama.2014.8037			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038346				2022-12-01	WOS:000339257800014
J	Anderson, SJ; Cherutich, P; Kilonzo, N; Cremin, I; Fecht, D; Kimanga, D; Harper, M; Masha, RL; Ngongo, PB; Maina, W; Dybul, M; Hallett, TB				Anderson, Sarah-Jane; Cherutich, Peter; Kilonzo, Nduku; Cremin, Ide; Fecht, Daniela; Kimanga, Davies; Harper, Malayah; Masha, Ruth Laibon; Ngongo, Prince Bahati; Maina, William; Dybul, Mark; Hallett, Timothy B.			Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study	LANCET			English	Article							MALE CIRCUMCISION; EFFECTIVE RESPONSE; SPATIAL-ANALYSIS; HIGH-RISK; HIV/AIDS; INTERVENTIONS; INFECTION; IMPACT; STRATEGIES; MALARIA	Background Epidemiological data show substantial variation in the risk of HIV infection between communities within African countries. We hypothesised that focusing appropriate interventions on geographies and key populations at high risk of HIV infection could improve the effect of investments in the HIV response. Methods With use of Kenya as a case study, we developed a mathematical model that described the spatiotemporal evolution of the HIV epidemic and that incorporated the demographic, behavioural, and programmatic differences across subnational units. Modelled interventions (male circumcision, behaviour change communication, early antiretoviral therapy, and pre-exposure prophylaxis) could be provided to different population groups according to their risk behaviours or their location. For a given national budget, we compared the effect of a uniform intervention strategy, in which the same complement of interventions is provided across the country, with a focused strategy that tailors the set of interventions and amount of resources allocated to the local epidemiological conditions. Findings A uniformly distributed combination of HIV prevention interventions could reduce the total number of new HIV infections by 40% during a 15-year period. With no additional spending, this effect could be increased by 14% during the 15 years-almost 100 000 extra infections, and result in 33% fewer new HIV infections occurring every year by the end of the period if the focused approach is used to tailor resource allocation to reflect patterns in local epidemiology. The cumulative difference in new infections during the 15-year projection period depends on total budget and costs of interventions, and could be as great as 150 000 (a cumulative difference as great as 22%) under different assumptions about the unit costs of intervention. Interpretation The focused approach achieves greater effect than the uniform approach despite exactly the same investment. Through prioritisation of the people and locations at greatest risk of infection, and adaption of the interventions to reflect the local epidemiological context, the focused approach could substantially increase the efficiency and effectiveness of investments in HIV prevention.	[Anderson, Sarah-Jane; Cremin, Ide; Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England; [Fecht, Daniela] Univ London Imperial Coll Sci Technol & Med, MRC PHE Ctr Environm & Hlth, SAHSU, London W2 1PG, England; [Cherutich, Peter; Kimanga, Davies; Maina, William] Natl AIDS & STI Control Programme NASCOP, Nairobi, Kenya; [Kilonzo, Nduku] Liverpool VCT Care & Treatment, Nairobi, Kenya; [Harper, Malayah; Masha, Ruth Laibon] UNAIDS, Nairobi, Kenya; [Ngongo, Prince Bahati] IAVI, Nairobi, Kenya; [Dybul, Mark] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland	Imperial College London; Imperial College London; International AIDS Vaccine Initiative	Anderson, SJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England.	sarah-jane.anderson@imperial.ac.uk	Maina, William/L-6650-2017	Maina, William/0000-0002-3184-9854; Cremin, Ide/0000-0003-2560-6247; Hallett, Timothy/0000-0002-9681-0424; Fecht, Daniela/0000-0002-0738-0013	Bill & Melinda Gates Foundation; UNAIDS; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1, MR/K010174/1B] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); UNAIDS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding for this study was provided by the Bill & Melinda Gates Foundation and UNAIDS.	[Anonymous], 2005, METHODS EC EVALUATIO; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Beyrer C, 2012, LANCET; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Chandrasekaran P, 2008, AIDS, V22, pS1, DOI 10.1097/01.aids.0000343760.70078.89; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cooke GS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-585; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109; Government of India Ministry of Health and Family Welfare, 1999, NAT OP GUID ART SER; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hallett TB, 2009, EPIDEMICS-NETH, V1, P108, DOI 10.1016/j.epidem.2009.03.001; Halli SS, 2009, SEX TRANSM DIS, V36, P556, DOI 10.1097/OLQ.0b013e3181a8cdcf; Health Protection Agency, 2012, HIV UK 2012 REP; http://www.who.int/hiv/pub/surveillance/en/cds_edc_2000_5.pdf, 2000, GUID 2 GEN HIV SURV; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, S AFRICA; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, LOC LOC CONN PEOPL F; Jones A, 2014, LANCET; Kabatereine NB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-232; Kandala NB, 2012, HIV AIDS-RES PALLIAT, V4, P95, DOI 10.2147/HIV.S30537; Kenya National AIDS and STI Control Program (NASCOP), 2013, COUNT HIV SERV DEL P; Kenya National AIDS and STI Control Programme (NASCOP), 2011, SENT SURV HIV SYPH I; Kenya National AIDS and STI Control Programme (NASCOP) National AIDS Control Council (NACC), 2012, GEOGR MAPP MOST RISK; Kenya National Bureau of Statistics (KNBS) and ICF Macro, 2010, KEN DEM HLTH SURV 20; Lafort Y, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-144; Larmarange J, 2014, CYBERGEO EUROPEAN J; Law DCG, 2004, SEX TRANSM INFECT, V80, P294, DOI 10.1136/sti.2003.006700; Leydon NG, S AFR MED J, V100, P420; LowBeer D, 1997, NAT MED, V3, P553, DOI 10.1038/nm0597-553; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Magalhaes RJS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001200; Meyer-Rath G, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001247; Mishra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032324; Moran D, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-22; Musenge E, 2013, GLOBAL HEALTH ACTION, V6, P38, DOI 10.3402/gha.v6i0.19266; Ortblad KF, 2013, AIDS, V27, P2003, DOI 10.1097/QAD.0b013e328362ba67; Piot P, 2013, NEW ENGL J MED, V368, P2210, DOI 10.1056/NEJMra1201533; Qian HZ, 2006, AIDS CARE, V18, pS6, DOI 10.1080/09540120600839074; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Sgaier SK, 2012, SEX TRANSM INFECT, V88, P240, DOI 10.1136/sextrans-2011-050382; Shepard D, 1968, P 1968 ACM NAT C NEW; Shisana O, 2013, 6 SA AIDS C DURB S A; Sumartojo E, 1997, AIDS, V11, P1201, DOI 10.1097/00002030-199710000-00002; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; Tanzania Commission for HIV and AIDS, UNGASS REP 2010 TANZ; The Global Fund, 2013, NEW FUND MOD 2013; The United States President's Emergency Plan for AIDS Relief (PEPFAR), 2012, PEPFAR BLUEPR CREAT; US Centers for Disease Control and Prevention, 2013, HIV AIDS US GEOGR DI; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Verguet Stephane, 2013, Cost Eff Resour Alloc, V11, P1, DOI 10.1186/1478-7547-11-1; Weir SS, 2002, MEASURE EVALUATION B, V2002, P1; Williams BG, 2000, S AFR J SCI, V96, P297; Wilson DP, 2005, PLOS MED, V2, P132, DOI 10.1371/journal.pmed.0020050; World Health Organization, 2013, GUID 2 GEN HIV SURV; Yao J, 2013, SOC SCI MED, V96, P60, DOI [10.1016/j.socscimed.2013.07.025, 10.1016/j.socscimed.2012.11.005]	58	170	171	0	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					249	256		10.1016/S0140-6736(14)61053-9	http://dx.doi.org/10.1016/S0140-6736(14)61053-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL8JI	25042235	Green Submitted			2022-12-01	WOS:000339384100026
J	Smith, CJ; Ryom, L; Weber, R; Morlat, P; Pradier, C; Reiss, P; Kowalska, JD; de Wit, S; Law, M; el Sadr, W; Kirk, O; Friis-Moller, N; Monforte, AD; Phillips, AN; Sabin, CA; Lundgren, JD				Smith, Colette J.; Ryom, Lene; Weber, Rainer; Morlat, Philippe; Pradier, Christian; Reiss, Peter; Kowalska, Justyna D.; de Wit, Stephane; Law, Matthew; el Sadr, Wafaa; Kirk, Ole; Friis-Moller, Nina; Monforte, Antonella d'Arminio; Phillips, Andrew N.; Sabin, Caroline A.; Lundgren, Jens D.		D A D Study Grp	Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AIDS-DEFINING CANCERS; ANTIRETROVIRAL THERAPY; MYOCARDIAL-INFARCTION; DATA-COLLECTION; ADVERSE EVENTS; RISK-FACTORS; HEPATITIS-C; MORTALITY; INFECTION	Background With the advent of effective antiretroviral treatment, the life expectancy for people with HIV is now approaching that seen in the general population. Consequently, the relative importance of other traditionally non-AIDS-related morbidities has increased. We investigated trends over time in all-cause mortality and for specific causes of death in people with HIV from 1999 to 2011. Methods Individuals from the Data collection on Adverse events of anti-HIV Drugs (D: A: D) study were followed up from March, 1999, until death, loss to follow-up, or Feb 1, 2011, whichever occurred first. The D: A: D study is a collaboration of 11 cohort studies following HIV-1-positive individuals receiving care at 212 clinics in Europe, USA, and Australia. All fatal events were centrally validated at the D: A: D coordinating centre using coding causes of death in HIV (CoDe) methodology. We calculated relative rates using Poisson regression. Findings 3909 of the 49 731 D: A: D study participants died during the 308 719 person-years of follow-up (crude incidence mortality rate, 12 7 per 1000 person-years [95% CI 12.3-13.1]). Leading underlying causes were: AIDS-related (1123 [29%] deaths), non-AIDS-defining cancers (590 [15%] deaths), liver disease (515 [13%] deaths), and cardiovascular disease (436 [11%] deaths). Rates of all-cause death per 1000 person-years decreased from 17 5 in 1999-2000 to 9 1 in 2009-11; we saw similar decreases in death rates per 1000 person-years over the same period for AIDS-related deaths (5 9 to 2 0), deaths from liver disease (2 7 to 0 9), and cardiovascular disease deaths (1 8 to 0 9). However, non-AIDS cancers increased slightly from 1 6 per 1000 person-years in 1999-2000 to 2 1 in 2009-11 (p=0.58). After adjustment for factors that changed over time, including CD4 cell count, we detected no decreases in AIDS-related death rates (relative rate for 2009-11 vs 1999-2000: 0 92 [0.70-1.22]). However, all-cause (0 72 [0.61-0.83]), liver disease (0 48 [0.32-0.74]), and cardiovascular disease (0 33 [0.20-0.53) death rates still decreased over time. The percentage of all deaths that were AIDS-related (87/256 [34%] in 1999-2000 and 141/627 [22%] in 2009-11) and liver-related (40/256 [16%] in 1999-2000 and 64/627 [10%] in 2009-11) decreased over time, whereas non-AIDS cancers increased (24/256 [9%] in 1999-2000 to 142/627 [23%] in 2009-11). Interpretation Recent reductions in rates of AIDS-related deaths are linked with continued improvement in CD4 cell count. We hypothesise that the substantially reduced rates of liver disease and cardiovascular disease deaths over time could be explained by improved use of non-HIV-specific preventive interventions. Non-AIDS cancer is now the leading non-AIDS cause and without any evidence of improvement.	[Smith, Colette J.; Phillips, Andrew N.; Sabin, Caroline A.] UCL, Res Dept Infect & Populat Hlth, London NW3 2PF, England; [Ryom, Lene; Kirk, Ole; Lundgren, Jens D.] Univ Copenhagen, Rigshosp, CHIP, Dept Infect Dis 2100, DK-1168 Copenhagen, Denmark; [Weber, Rainer] Univ Zurich, Univ Zurich Hosp, Div Infect Dis, Zurich, Switzerland; [Morlat, Philippe] Univ Bordeaux Segalen, CHU Bordeaux, Serv Med Intern & Malad Infect, Bordeaux, France; [Pradier, Christian] Nice Univ Hosp, Dept Publ Hlth, Nice, France; [Reiss, Peter] Univ Amsterdam, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands; [Reiss, Peter] Stichting HIV Monitoring, Amsterdam, Netherlands; [Kowalska, Justyna D.] Med Univ Warsaw, Dept Adults Infect Dis, Warsaw, Poland; [de Wit, Stephane] Hop Univ St Pierre, Dept Infect Dis, B-1000 Brussels, Belgium; [Law, Matthew] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [el Sadr, Wafaa] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Friis-Moller, Nina] Odense Univ Hosp, Dept Infect Dis, Odense, Denmark; [Monforte, Antonella d'Arminio] San Paolo Univ Hosp, Dept Hlth Sci, Milan, Italy	University of London; University College London; Rigshospitalet; University of Copenhagen; University of Zurich; University Zurich Hospital; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Nice; University of Amsterdam; Academic Medical Center Amsterdam; Medical University of Warsaw; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of New South Wales Sydney; Kirby Institute; Columbia University; University of Southern Denmark; Odense University Hospital	Smith, CJ (corresponding author), UCL, Res Dept Infect & Populat Hlth, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	c.smith@ucl.ac.uk	Soriano, Vicente/O-5730-2018; Vandekerckhove, Linos/J-6420-2013; Phillips, Andrew N/B-4427-2008; Ippolito, Giuseppe/J-7207-2017; Pradier, Christian/AFE-8255-2022; Weber, Rainer/D-5175-2012; Sabin, Caroline/C-2464-2008; Ostergaard, Lars/AAA-3020-2020; Koopmans, Peter/O-9276-2015; Pradier, Christian/AAE-9669-2022; Torres, Ferran/D-1296-2011; perno, carlo federico/O-1544-2016; kirk, ole/ABB-4746-2021; Lundgren, Jens/AAE-6876-2019; van der Ven, A.J.A.M./H-8102-2014; Pantaleo, Giuseppe/K-6163-2016; Buonfrate, Dora/N-2965-2016; VELLA, STEFANO/V-8440-2019; Harding, Richard/G-9729-2012	Soriano, Vicente/0000-0002-4624-5199; Vandekerckhove, Linos/0000-0002-8600-1631; Phillips, Andrew N/0000-0003-2384-4807; Sabin, Caroline/0000-0001-5173-2760; Ostergaard, Lars/0000-0003-2459-0511; Torres, Ferran/0000-0002-7355-7913; van der Ven, A.J.A.M./0000-0003-1833-3391; Buonfrate, Dora/0000-0003-0108-6822; VELLA, STEFANO/0000-0003-2347-5984; Ippolito, Giuseppe/0000-0002-1076-2979; Katzenstein, Terese L/0000-0002-2233-500X; Colebunders, Robert/0000-0002-1919-1340; Ristola, Matti/0000-0001-5115-2811; Lundgren, Jens/0000-0001-8901-7850; Smith, Colette/0000-0003-2847-3355; Ostergaard, Lars/0000-0002-7619-605X; PERNO, CARLO FEDERICO/0000-0002-0825-5388; LIBOIS, Agnes/0000-0002-6078-878X; d'Arminio Monforte, Antonella/0000-0003-0073-1789; McManus, Hamish/0000-0002-7264-8848; Leen, Clifford/0000-0001-8439-7719; Lo Caputo, Sergio/0000-0002-4729-7548; CAMANNI, GUIDO/0000-0003-0881-5426; Rijnders, Bart/0000-0003-3343-9610; Law, Matthew/0000-0002-3540-8837; CAUDA, Roberto/0000-0002-1498-4229; COSTANTINI, ANDREA/0000-0003-1588-7030	Oversight Committee for the Evaluation of Metabolic Complications of HAART; MRC [G0701639] Funding Source: UKRI; Medical Research Council [G0701639] Funding Source: researchfish	Oversight Committee for the Evaluation of Metabolic Complications of HAART; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Oversight Committee for the Evaluation of Metabolic Complications of HAART, with representatives from academia, patient community, US Food and Drug Administration, European Medicines Agency and consortium of AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, ViiV Healthcare, Merck, Pfizer, F Hoffmann-La Roche, and Janssen Pharmaceuticals.	[Anonymous], 2012, INT J EPIDEMIOL, V41, P433; Antiretroviral Therapy Cohort Collaboration, 1996, CLIN INFECT DIS, V50, P1387; Berenguer J, 2012, AIDS, V26, P2241, DOI 10.1097/QAD.0b013e3283574e94; Blanco F, 2011, J VIRAL HEPATITIS, V18, P11, DOI 10.1111/j.1365-2893.2009.01261.x; Bruyand M, 2013, 20 C RETR OPP INF CR; Buchacz K, 2013, ANTIVIR THER, V18, P65, DOI 10.3851/IMP2450; Conigliaro J, 2003, JAIDS-J ACQ IMM DEF, V33, P521, DOI 10.1097/00126334-200308010-00014; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Helleberg M, 2012, INFECTION, V40, P627, DOI 10.1007/s15010-012-0293-y; Hernando V, 2012, AIDS, V26, P1829, DOI 10.1097/QAD.0b013e328352ada4; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Horvath KJ, 2012, AM J PREV MED, V43, pS214, DOI 10.1016/j.amepre.2012.07.032; Kovari H, 2013, CLIN INFECT DIS, V56, P870, DOI 10.1093/cid/cis919; Kowalska JD, 2011, EPIDEMIOLOGY, V22, P516, DOI 10.1097/EDE.0b013e31821b5332; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Lundgren JD, 2012, 19 INT AIDS C WASH D; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Pinzone MR, 2012, EUR REV MED PHARMACO, V16, P1377; Sabin C, 2013, 20 C RETR OPP INF CR; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Scarborough P, 2010, CORONARY HEART DIS S; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simard EP, 2012, AIDS, V26, P1311, DOI 10.1097/QAD.0b013e328353f38e; Soriano V, 2012, INFECT DIS CLIN N AM, V26, P931, DOI 10.1016/j.idc.2012.08.004; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Weber R, 2013, HIV MED, V14, P195, DOI 10.1111/j.1468-1293.2012.01051.x; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918; Worm SW, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-471; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Worm SW, 2012, 19 C RETR OPP INF CR	33	619	655	1	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					241	248		10.1016/S0140-6736(14)60604-8	http://dx.doi.org/10.1016/S0140-6736(14)60604-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL8JI	25042234	Green Submitted			2022-12-01	WOS:000339384100025
J	Bhatia, V; Barroso, SI; Garcia-Rubio, ML; Tumini, E; Herrera-Moyano, E; Aguilera, A				Bhatia, Vaibhav; Barroso, Sonia I.; Garcia-Rubio, Maria L.; Tumini, Emanuela; Herrera-Moyano, Emilia; Aguilera, Andres			BRCA2 prevents R-loop accumulation and associates with TREX-2 mRNA export factor PCID2	NATURE			English	Article							REPLICATION FORK PROGRESSION; FANCONI-ANEMIA; TRANSCRIPTION ELONGATION; GENOMIC INSTABILITY; IN-VITRO; COMPLEX; IMPAIRMENT; STABILITY; GENES; RECOMBINATION	Genome instability is central to ageing, cancer and other diseases. It is not only proteins involved in DNA replication or the DNA damage response (DDR) that are important for maintaining genome integrity: from yeast to higher eukaryotes, mutations in genes involved in pre-mRNA splicing and in the biogenesis and export of messenger ribonudeoprotein (mRNP) also induce DNA damage and genome instability. This instability is frequently mediated by R-loops formed by DNA-RNA hybrids and a displaced single-stranded DNA(1). Here we show that the human TREX-2 complex, which is involved in mRNP biogenesis and export, prevents genome instability as determined by the accumulation of gamma-H2AX (Ser-139 phosphorylated histone H2AX) and 53BP1 foci and single-cell electrophoresis in cells depleted of the TREX-2 subunits PCID2, GANP and DSSI. We show that the BRCA2 repair factor, which binds to DSS1, also associates with PCID2 in the cell. The use of an enhanced green fluorescent protein-tagged hybrid-binding domain of RNase HI and the S9.6 antibody did not detect R-loops in TREX-2-depleted cells, but did detect the accumulation of R-loops in BRCA2-depleted cells. The results indicate that R-loops are frequently formed in cells and that BRCA2 is required for their processing. This link between BRCA2 and RNA-mediated genome instability indicates that R-loops may be a chief source of replication stress and cancer-associated instability.	[Bhatia, Vaibhav; Barroso, Sonia I.; Garcia-Rubio, Maria L.; Tumini, Emanuela; Herrera-Moyano, Emilia; Aguilera, Andres] Univ Seville, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville 41092, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Aguilera, A (corresponding author), Univ Seville, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Ave Amer Vespucio S-N, Seville 41092, Spain.	aguilo@us.es	Garcia-Rubio, Maria/C-2061-2017; Tumini, Emanuela/C-2163-2017; Herrera-Moyano, Emilia/F-3314-2016; Barroso, Sonia/F-2288-2016; Herrera-Moyano, Emilia/AAV-4989-2020; Aguilera, Andres/L-1825-2014	Garcia-Rubio, Maria/0000-0003-0981-0555; Tumini, Emanuela/0000-0001-9412-9355; Barroso, Sonia/0000-0002-0062-2016; Herrera-Moyano, Emilia/0000-0003-3948-3874; Aguilera, Andres/0000-0003-4782-1714; bhatia, vaibhav/0000-0003-4553-7824	Spanish Ministry of Economy and Competitiveness [C5D2007-00015, BFU2010-16372]; Junta de Andalucia [CVI4567]; European Union (FEDER)	Spanish Ministry of Economy and Competitiveness(Spanish Government); Junta de Andalucia(Junta de Andalucia); European Union (FEDER)(European Commission)	We thank J.C. Reyes and A. G. Rondon for comments on the manuscript,and D. Haun for style supervision. Research was funded by grants from the Spanish Ministry of Economy and Competitiveness (Consolider C5D2007-00015 and BFU2010-16372), the Junta de Andalucia (CVI4567) and the European Union (FEDER).	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Bayani J., 2005, CURR PROTOC CELL BIO, V25; Bermejo R, 2011, CELL, V146, P233, DOI 10.1016/j.cell.2011.06.033; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Castellano-Pozo M, 2012, EMBO REP, V13, P923, DOI 10.1038/embor.2012.119; Dominguez-Sanchez MS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002386; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Ellisdon AM, 2012, NAT STRUCT MOL BIOL, V19, P328, DOI 10.1038/nsmb.2235; Gallardo M, 2003, J BIOL CHEM, V278, P24225, DOI 10.1074/jbc.M302900200; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Gomez-Gonzalez B, 2011, EMBO J, V30, P3106, DOI 10.1038/emboj.2011.206; Gravells P, 2013, ONCOGENE, V32, P5338, DOI 10.1038/onc.2012.627; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Jani D, 2012, NUCLEIC ACIDS RES, V40, P4562, DOI 10.1093/nar/gks059; Kaneko S, 2007, P NATL ACAD SCI USA, V104, P17620, DOI 10.1073/pnas.0708866104; Li J, 2006, ONCOGENE, V25, P1186, DOI 10.1038/sj.onc.1209153; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Smith AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016206; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; ten Asbroek ALMA, 2002, EUR J BIOCHEM, V269, P583, DOI 10.1046/j.0014-2956.2001.02686.x; Tous C, 2007, BIOCHEM BIOPH RES CO, V360, P428, DOI 10.1016/j.bbrc.2007.06.098; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; Umlauf D, 2013, J CELL SCI, V126, P2656, DOI 10.1242/jcs.118000; Urtishak KA, 2009, J BIOL CHEM, V284, P8768, DOI 10.1074/jbc.M806103200; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837	33	312	320	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					362	+		10.1038/nature13374	http://dx.doi.org/10.1038/nature13374			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	24896180				2022-12-01	WOS:000338992200039
J	Lucas, JS; Zhang, YJ; Dudko, OK; Murre, C				Lucas, Joseph S.; Zhang, Yaojun; Dudko, Olga K.; Murre, Cornelis			3D Trajectories Adopted by Coding and Regulatory DNA Elements: First-Passage Times for Genomic Interactions	CELL			English	Article							IMMUNOGLOBULIN-HEAVY-CHAIN; V(D)J RECOMBINATION; B-CELLS; LYMPHOCYTE DEVELOPMENT; ANOMALOUS DIFFUSION; SEQUENCING REVEALS; ALLELIC EXCLUSION; VARIABLE REGION; MONTE-CARLO; IGH LOCUS	During B lymphocyte development, immunoglobulin heavy-chain variable (V-H), diversity (D-H), and joining (J(H)) segments assemble to generate a diverse antigen receptor repertoire. Here, we have marked the distal V-H and D-H-J(H)-E-mu regions with Tet-operator binding sites and traced their 3D trajectories in proB cells transduced with a retrovirus encoding Tetrepressor-EGFP. We found that these elements displayed fractional Langevin motion (fLm) due to the viscoelastic hindrance from the surrounding network of proteins and chromatin fibers. Using fractional Langevin dynamics modeling, we found that, with high probability, D(H)J(H) elements reach a V-H elementwithin minutes. Spatial confinement emerged as the dominant parameter that determined the frequency of such encounters. We propose that the viscoelastic nature of the nuclear environment causes coding elements and regulatory elements to bounce back and forth in a spring-like fashion until specific genomic interactions are established and that spatial confinement of topological domains largely controls first-passage times for genomic interactions.	[Lucas, Joseph S.; Murre, Cornelis] Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, San Diego, CA 92093 USA; [Zhang, Yaojun; Dudko, Olga K.] Univ Calif San Diego, Dept Phys, San Diego, CA 92093 USA; [Zhang, Yaojun; Dudko, Olga K.] Univ Calif San Diego, Ctr Theoret Biol Phys, San Diego, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dudko, OK (corresponding author), Univ Calif San Diego, Dept Phys, San Diego, CA 92093 USA.	dudko@physics.ucsd.edu; murre@biomail.ucsd.edu			National Institutes of Health [AI00880, AI082850]; National Science Foundation Faculty Early Career Development Award [MCB-0845099]; National Science Foundation Center for Theoretical Biological Physics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100880, R01AI082850, Z01AI000880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Faculty Early Career Development Award(National Science Foundation (NSF)); National Science Foundation Center for Theoretical Biological Physics(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Peter Geiduschek, Alex Bortnick, and Roy Riblet for editing the manuscript. We thank John Sedat, Richard Flavell, Cornelia Zorca, and Lena Koslover for stimulating discussions. We thank Claudia Bossen, Joe Pogliano, and Ralf Metzler for advice. We thank James Fitzpatrick and Jamie Kasuboski (Waitt Advanced Biophotonics Center Core Facility) for help with imaging and image analysis. J.S.L. was supported by a training grant from the National Institutes of Health (Cellular and Molecular Genetics). The studies were supported by the National Science Foundation Faculty Early Career Development Award (MCB-0845099) to O.K.D., by the grant from the National Institutes of Health (AI00880 and AI082850) to C.M., and by the National Science Foundation Center for Theoretical Biological Physics.	Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Boveri T., 1909, ARCH ZELLFORSCH, V3, P181; Bronstein I, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.018102; Bunting SF, 2013, NAT REV CANCER, V13, P443, DOI 10.1038/nrc3537; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Cedar H, 2011, NAT REV IMMUNOL, V11, P478, DOI 10.1038/nri2991; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Condamin S, 2007, NATURE, V450, P77, DOI 10.1038/nature06201; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Dietrich CR, 1997, SIAM J SCI COMPUT, V18, P1088, DOI 10.1137/S1064827592240555; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Gostissa M, 2014, P NATL ACAD SCI USA, V111, P2644, DOI 10.1073/pnas.1324176111; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Guo CY, 2011, CELL, V147, P332, DOI 10.1016/j.cell.2011.08.049; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Hawley RG, 1996, ANN NY ACAD SCI, V795, P341, DOI 10.1111/j.1749-6632.1996.tb52687.x; Hewitt SL, 2010, IMMUNOL REV, V237, P43, DOI 10.1111/j.1600-065X.2010.00931.x; Jeon JH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021103; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Luby TM, 2001, J EXP MED, V193, P159, DOI 10.1084/jem.193.2.159; Lucas JS, 2011, CURR OPIN CELL BIOL, V23, P318, DOI 10.1016/j.ceb.2010.11.007; Lutz E, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051106; MANZ J, 1988, J EXP MED, V168, P1363, DOI 10.1084/jem.168.4.1363; Medvedovic J, 2013, IMMUNITY, V39, P229, DOI 10.1016/j.immuni.2013.08.011; MONTROLL EW, 1965, J MATH PHYS, V6, P167, DOI 10.1063/1.1704269; Munkel C, 1998, PHYS REV E, V57, P5888, DOI 10.1103/PhysRevE.57.5888; NUSSENZWEIG MC, 1988, J EXP MED, V167, P1969, DOI 10.1084/jem.167.6.1969; Onozawa M, 2012, GENE CHROMOSOME CANC, V51, P525, DOI 10.1002/gcc.21942; Rabl C., 1885, MORPHOL JB, V10, P214; Retter I, 2007, J IMMUNOL, V179, P2419, DOI 10.4049/jimmunol.179.4.2419; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Saxton MJ, 1996, BIOPHYS J, V70, P1250, DOI 10.1016/S0006-3495(96)79682-0; SAXTON MJ, 1994, BIOPHYS J, V66, P394, DOI 10.1016/S0006-3495(94)80789-1; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Sedat J., 1978, S QUANT BIOL, V42, P331; SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Weber SC, 2012, BIOPHYS J, V102, P2443, DOI 10.1016/j.bpj.2012.03.062; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	54	143	144	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					339	352		10.1016/j.cell.2014.05.036	http://dx.doi.org/10.1016/j.cell.2014.05.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	24998931	Green Accepted, Bronze			2022-12-01	WOS:000340943600014
J	Orritt, R				Orritt, Rachel			PERSONAL VIEW Dog ownership has unknown risks but known health benefits: we need evidence based policy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BITES; ATTACKS		Lincoln Univ, Sch Psychol, Lincoln LN6 7TS, England	University of Lincoln	Orritt, R (corresponding author), Lincoln Univ, Sch Psychol, Lincoln LN6 7TS, England.	rorritt@lincoln.ac.uk		Orritt, Rachel/0000-0001-8396-7679				Besser R, 2007, BRIT MED J, V334, P425, DOI 10.1136/bmj.39129.471505.94; Christian HE, 2013, J PHYS ACT HEALTH, V10, P750, DOI 10.1123/jpah.10.5.750; Douglas K.S., 1999, LEGAL CRIMINOL PSYCH, V4, P149, DOI [https://doi.org/10.1348/135532599167824, DOI 10.1348/135532599167824]; Headey B, 1999, SOC INDIC RES, V47, P233, DOI 10.1023/A:1006892908532; HSCIC, 2012, HOSP STAT ADM PAT CA; Klaassen B, 1996, INJURY, V27, P89, DOI 10.1016/0020-1383(96)83411-5; McConnell AR, 2011, J PERS SOC PSYCHOL, V101, P1239, DOI 10.1037/a0024506; Morgan M, 2007, BMJ-BRIT MED J, V334, P413, DOI 10.1136/bmj.39105.659919.BE; THOMAS HF, 1990, J ROY SOC HEALTH, V110, P173, DOI 10.1177/146642409011000508; Wells DL, 2007, BRIT J HEALTH PSYCH, V12, P145, DOI 10.1348/135910706X103284	10	6	6	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 17	2014	349								g4081	10.1136/bmj.g4081	http://dx.doi.org/10.1136/bmj.g4081			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL7PI	25034209	Green Submitted			2022-12-01	WOS:000339326400002
J	Preitner, N; Quan, J; Nowakowski, DW; Hancock, ML; Shi, JH; Tcherkezian, J; Young-Pearse, TL; Flanagan, JG				Preitner, Nicolas; Quan, Jie; Nowakowski, Dan W.; Hancock, Melissa L.; Shi, Jianhua; Tcherkezian, Joseph; Young-Pearse, Tracy L.; Flanagan, John G.			APC Is an RNA-Binding Protein, and Its Interactome Provides a Link to Neural Development and Microtubule Assembly	CELL			English	Article							TUMOR-SUPPRESSOR PROTEIN; POLYPOSIS-COLI PROTEIN; CANONICAL WNT PATHWAY; BETA-TUBULIN; CELL-MIGRATION; MESSENGER-RNAS; GENE; CYTOSKELETON; TRANSLATION; GROWTH	Adenomatous polyposis coli (APC) is a microtubule plus-end scaffolding protein important in biology and disease. APC is implicated in RNA localization, although the mechanisms and functional significance remain unclear. We show APC is an RNA-binding protein and identify an RNA interactome by HITS-CLIP. Targets were highly enriched for APC-related functions, including microtubule organization, cell motility, cancer, and neurologic disease. Among the targets is beta 2B-tubulin, known to be required in human neuron and axon migration. We show beta 2B-tubulin is synthesized in axons and localizes preferentially to dynamic microtubules in the growth cone periphery. APC binds the beta 2B-tubulin 3' UTR; experiments interfering with this interaction reduced beta 2B-tubulin mRNA axonal localization and expression, depleted dynamic microtubules and the growth cone periphery, and impaired neuron migration. These results identify APC as a platform binding functionally related protein and RNA networks, and suggest a self-organizing model for the microtubule to localize synthesis of its own subunits.	[Preitner, Nicolas; Quan, Jie; Nowakowski, Dan W.; Hancock, Melissa L.; Shi, Jianhua; Flanagan, John G.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Preitner, Nicolas; Quan, Jie; Nowakowski, Dan W.; Hancock, Melissa L.; Shi, Jianhua; Flanagan, John G.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Tcherkezian, Joseph] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Lab Therapeut Dev, Montreal, PQ H3G 1Y6, Canada; [Young-Pearse, Tracy L.] Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; McGill University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Flanagan, JG (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	flanagan@hms.harvard.edu	Flanagan, John/AAM-2995-2020; Shi, Jianhua/L-8463-2016	Shi, Jianhua/0000-0002-5351-406X; Young-Pearse, Tracy/0000-0001-7846-1542	NIH; Charles A. King Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD029417] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069913] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles A. King Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Kyoko Okada, Philippe Roux, David Van Vactor, Peter Park, Xinmin Li, Rebecca Meyer, Inke Nathke, Olivier Pertz, Antonina Andreeva, and Alexey Murzin for help, reagents, advice, and/or comments on the manuscript. We thank Jiangwen Zhang, Christian Daly, and the Bauer Center for Genomic Research for support with deep sequencing and Jennifer Waters, Josh Rosenberg, Lauren Piedmont, Lara Petrak, Gaudenz Danuser, Hunter Elliott, Yichao Xu, the Nikon Imaging Center, and the Image and Data Analysis Core at Harvard Medical School for imaging equipment and expertise. This work was supported by grants from the NIH and a fellowship from the Charles A. King Trust (to N.P.).	Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Askham JM, 2000, ONCOGENE, V19, P1950, DOI 10.1038/sj.onc.1203498; Bahi-Buisson N, 2014, BRAIN, V137, P1676, DOI 10.1093/brain/awu082; Barth AIM, 2008, SEMIN CELL DEV BIOL, V19, P245, DOI 10.1016/j.semcdb.2008.02.003; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Burgess AW, 2011, EXP CELL RES, V317, P2748, DOI 10.1016/j.yexcr.2011.08.010; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cederquist GY, 2012, HUM MOL GENET, V21, P5484, DOI 10.1093/hmg/dds393; Chang L, 2006, J CELL BIOL, V172, P747, DOI 10.1083/jcb.200511033; Chen YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024335; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Condeelis J, 2005, BIOL CELL, V97, P97; Cui DH, 2005, MOL PSYCHIATR, V10, P669, DOI 10.1038/sj.mp.4001653; Darnell RB, 2013, ANNU REV NEUROSCI, V36, P243, DOI 10.1146/annurev-neuro-062912-114322; Deka J, 1999, ONCOGENE, V18, P5654, DOI 10.1038/sj.onc.1202944; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Dyson HJ, 2012, MOL BIOSYST, V8, P97, DOI 10.1039/c1mb05258f; Eng H, 1999, J NEUROSCI, V19, P1; Gerdes JM, 2005, CELL MOL LIFE SCI, V62, P1556, DOI 10.1007/s00018-005-5007-5; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Hall KB, 2002, CURR OPIN STRUC BIOL, V12, P283, DOI 10.1016/S0959-440X(02)00323-8; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Jones KJ, 2008, GLIA, V56, P1401, DOI 10.1002/glia.20707; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Kalkman HO, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-10; Karkare S, 2006, APPL MICROBIOL BIOT, V71, P575, DOI 10.1007/s00253-006-0434-2; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006; Marin O, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001834; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Minde DP, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-101; Myers KA, 2006, NEUROSCIENTIST, V12, P107, DOI 10.1177/1073858405283428; Nathke I, 2006, NAT REV CANCER, V6, P967, DOI 10.1038/nrc2010; Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016; Pellegrini F, 2005, CANCER INVEST, V23, P264, DOI 10.1081/CNV-200055970; Qian J, 2008, GASTROENTEROLOGY, V135, P152, DOI 10.1053/j.gastro.2008.03.074; Romaniello R, 2012, DEV MED CHILD NEUROL, V54, P765, DOI 10.1111/j.1469-8749.2012.04316.x; Salinas PC, 2007, TRENDS CELL BIOL, V17, P333, DOI 10.1016/j.tcb.2007.07.003; Stiess M, 2011, DEV NEUROBIOL, V71, P430, DOI 10.1002/dneu.20849; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; Tischfield MA, 2010, BIOSCIENCE REP, V30, P319, DOI 10.1042/BSR20100025; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Vuzman D, 2012, MOL BIOSYST, V8, P47, DOI 10.1039/c1mb05273j; Xing L, 2013, TRAFFIC, V14, P2, DOI 10.1111/tra.12004; Yasuda K, 2013, J CELL BIOL, V203, P737, DOI 10.1083/jcb.201306058; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010	52	110	112	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					368	382		10.1016/j.cell.2014.05.042	http://dx.doi.org/10.1016/j.cell.2014.05.042			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036633	Bronze, Green Accepted			2022-12-01	WOS:000340943600016
J	Beaglehole, R; Bonita, R; Ezzati, M; Alleyne, G; Dain, K; Kishore, SP; Horton, R				Beaglehole, Robert; Bonita, Ruth; Ezzati, Majid; Alleyne, George; Dain, Katie; Kishore, Sandeep P.; Horton, Richard			NCD Countdown 2025: accountability for the 25 x 25 NCD mortality reduction target	LANCET			English	Editorial Material							NONCOMMUNICABLE DISEASES		[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC,PHE Ctr Environm & Hlth, London, England; [Alleyne, George] Pan Amer Hlth Org, Washington, DC USA; [Dain, Katie] NCD Alliance, London, England; [Kishore, Sandeep P.] Young Profess Chron Dis Network, New Haven, CT USA; [Horton, Richard] The Lancet, London NW1 7BY, England	University of Auckland; Imperial College London; Pan American Health Organization	Beaglehole, R (corresponding author), 42 Albert Rd, Auckland 0624, New Zealand.	r.beaglehole@auckland.ac.nz			MRC [G0801056] Funding Source: UKRI; Medical Research Council [G0801056] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2014, LANCET; Beaglehole R, 2013, LANCET, V381, P602, DOI 10.1016/S0140-6736(13)60101-4; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Healthy Caribbean Coalition, 2014, RESP NCDS CAR COMM; Requejo JH, 2014, LANCET; Smith R, 2014, LANCET, V383, P1446, DOI 10.1016/S0140-6736(13)61808-5; The NCD Alliance, 2013, NONC DIS JOINT FIGHT; UN Secretary General, 2014, POST 2015 ACC SYST M; UNICEF, 2014, TRANSMONEE 2014 GUID; WHO, 2010, GLOB STAT REP NONC D; World Health Organization, 2017, UPD APP 3 WHO GLOB N	11	42	45	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					105	107		10.1016/S0140-6736(14)61091-6	http://dx.doi.org/10.1016/S0140-6736(14)61091-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1YC	25012115				2022-12-01	WOS:000338921500008
J	Potenski, CJ; Niu, HY; Sung, P; Klein, HL				Potenski, Catherine J.; Niu, Hengyao; Sung, Patrick; Klein, Hannah L.			Avoidance of ribonucleotide-induced mutations by RNase H2 and Srs2-Exo1 mechanisms	NATURE			English	Article							RAD51 PRESYNAPTIC FILAMENT; SACCHAROMYCES-CEREVISIAE; MISMATCH REPAIR; SRS2 HELICASE; ANTI-RECOMBINASE; TOPOISOMERASE-I; DNA; YEAST; PROTEIN; SIGNALS	Srs2 helicase is known to dismantle nucleofilaments of Rad51 recombinase to prevent spurious recombination events(1-6) and unwind trinucleotide sequences that are prone to hairpin formation(7). Here we document a new, unexpected genome maintenance role of Srs2 in the suppression of mutations arising from mis-insertion of ribonucleoside monophosphates during DNA replication. In cells lacking RNase H2, Srs2 unwinds DNA from the 5' side of a nick generated by DNA topoisomerase I-8 at a ribonucleoside monophosphate residue. In addition, Srs2 interacts with and enhances the activity of the nuclease Exo1, to generate a DNA gap in preparation for repair. Srs2-Exo1 thus functions in a new pathway of nick processing-gap filling that mediates tolerance of ribonucleoside monophosphates in the genome. Our results have implications for understanding the basis of Aicardi-Goutieres syndrome, which stems from inactivation of the human RNase H2 complex(9).	[Potenski, Catherine J.; Klein, Hannah L.] NYU, Dept Biochem & Mol Pharmacol, Sch Med, New York, NY 10016 USA; [Niu, Hengyao; Sung, Patrick] Yale Univ, Sch Med, New Haven, CT 06520 USA	New York University; Yale University	Sung, P (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.	patrick.sung@yale.edu; Hannah.Klein@nyumc.org	Niu, Hengyao/AAE-9269-2020	Klein, Hannah/0000-0003-4228-8535; Potenski, Catherine/0000-0002-4843-7071	National Institutes of Health [RO1GM053738, RO1ES007061, K99ES021441]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061, K99ES021441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Jinks-Robertson and T. Kunkel for plasmids used in strain construction, R. Bermejo and M. Foiani for the genome sequencing of the original hpr4 strain, and G.-M. Li and S. Lee for providing hEXO1. This work was supported by National Institutes of Health grants RO1GM053738 (to H. L. K.), RO1ES007061 (to P. S.) and K99ES021441 (to H.N.).	ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Adkins NL, 2013, NAT STRUCT MOL BIOL, V20, P836, DOI 10.1038/nsmb.2585; AGUILERA A, 1988, GENETICS, V119, P779; Bhattacharyya S, 2004, MOL CELL BIOL, V24, P7324, DOI 10.1128/MCB.24.17.7324-7330.2004; Chanet R, 1996, MOL CELL BIOL, V16, P4782; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Cho JE, 2013, DNA REPAIR, V12, P205, DOI 10.1016/j.dnarep.2012.12.004; Colavito S, 2009, NUCLEIC ACIDS RES, V37, P6754, DOI 10.1093/nar/gkp748; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Fiorani S, 2008, CELL CYCLE, V7, P493, DOI 10.4161/cc.7.4.5323; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Ghodgaonkar MM, 2013, MOL CELL, V50, P323, DOI 10.1016/j.molcel.2013.03.019; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2004, J BIOL CHEM, V279, P23193, DOI 10.1074/jbc.M402586200; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Lujan SA, 2013, MOL CELL, V50, P437, DOI 10.1016/j.molcel.2013.03.017; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/nchembio.424, 10.1038/NCHEMBIO.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Scheller J, 2000, GENETICS, V155, P1069; Sekiguchi J, 1997, MOL CELL, V1, P89, DOI 10.1016/S1097-2765(00)80010-6; Seong C, 2009, J BIOL CHEM, V284, P24363, DOI 10.1074/jbc.M109.032953; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; Spell Rachelle Miller, 2004, Methods Mol Biol, V262, P3; Van Komen S, 2003, J BIOL CHEM, V278, P44331, DOI 10.1074/jbc.M307256200; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585	26	69	69	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					251	+		10.1038/nature13292	http://dx.doi.org/10.1038/nature13292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	24896181	Green Accepted			2022-12-01	WOS:000338649800050
J	McCartney, M				McCartney, Margaret			Jeremy Hunt's bizarre ideas show that he doesn't understand general practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Adams Stephen, 2014, DAILY MAIL; Jones R, 2007, BMJ-BRIT MED J, V334, P1040, DOI 10.1136/bmj.39171.637106.AE; NHS Choices, GUID NHS WAIT TIM	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2014	349								g4368	10.1136/bmj.g4368	http://dx.doi.org/10.1136/bmj.g4368			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YY	24986834	Green Published, hybrid			2022-12-01	WOS:000338645400021
J	Frank, M; Knechtli, C				Frank, Michael; Knechtli, Christopher			Lymphoma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												michaelharris681@btinternet.com						Ardeshna KM, 2014, LANCET ONCOL, V15, P424, DOI 10.1016/S1470-2045(14)70027-0	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2014	348								g3736	10.1136/bmj.g3736	http://dx.doi.org/10.1136/bmj.g3736			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6LH	24934281	Bronze, Green Published			2022-12-01	WOS:000337805800010
J	Moreno-Estrada, A; Gignoux, CR; Fernandez-Lopez, JC; Zakharia, F; Sikora, M; Contreras, AV; Acuna-Alonzo, V; Sandoval, K; Eng, C; Romero-Hidalgo, S; Ortiz-Tello, P; Robles, V; Kenny, EE; Nuno-Arana, I; Barquera-Lozano, R; Macin-Perez, G; Granados-Arriola, J; Huntsman, S; Galanter, JM; Via, M; Ford, JG; Chapela, R; Rodriguez-Cintron, W; Rodriguez-Santana, JR; Romieu, I; Sienra-Monge, JJ; Navarro, BD; London, SJ; Ruiz-Linares, A; Garcia-Herrera, R; Estrada, K; Hidalgo-Miranda, A; Jimenez-Sanchez, G; Carnevale, A; Soberon, X; Canizales-Quinteros, S; Rangel-Villalobos, H; Silva-Zolezzi, I; Burchard, EG; Bustamante, CD				Moreno-Estrada, Andres; Gignoux, Christopher R.; Carlos Fernandez-Lopez, Juan; Zakharia, Fouad; Sikora, Martin; Contreras, Alejandra V.; Acuna-Alonzo, Victor; Sandoval, Karla; Eng, Celeste; Romero-Hidalgo, Sandra; Ortiz-Tello, Patricia; Robles, Victoria; Kenny, Eimear E.; Nuno-Arana, Ismael; Barquera-Lozano, Rodrigo; Macin-Perez, Gaston; Granados-Arriola, Julio; Huntsman, Scott; Galanter, Joshua M.; Via, Marc; Ford, Jean G.; Chapela, Rocio; Rodriguez-Cintron, William; Rodriguez-Santana, Jose R.; Romieu, Isabelle; Jose Sienra-Monge, Juan; del Rio Navarro, Blanca; London, Stephanie J.; Ruiz-Linares, Andres; Garcia-Herrera, Rodrigo; Estrada, Karol; Hidalgo-Miranda, Alfredo; Jimenez-Sanchez, Gerardo; Carnevale, Alessandra; Soberon, Xavier; Canizales-Quinteros, Samuel; Rangel-Villalobos, Hector; Silva-Zolezzi, Irma; Burchard, Esteban Gonzalez; Bustamante, Carlos D.			HUMAN GENETICS The genetics of Mexico recapitulates Native American substructure and affects biomedical traits	SCIENCE			English	Article							ANCESTRY; ADMIXTURE; POPULATIONS; CHROMOSOME; DIVERSITY; SAMPLE; RISK	Mexico harbors great cultural and ethnic diversity, yet fine-scale patterns of human genome-wide variation from this region remain largely uncharacterized. We studied genomic variation within Mexico from over 1000 individuals representing 20 indigenous and 11 mestizo populations. We found striking genetic stratification among indigenous populations within Mexico at varying degrees of geographic isolation. Some groups were as differentiated as Europeans are from East Asians. Pre-Columbian genetic substructure is recapitulated in the indigenous ancestry of admixed mestizo individuals across the country. Furthermore, two independently phenotyped cohorts of Mexicans and Mexican Americans showed a significant association between subcontinental ancestry and lung function. Thus, accounting for fine-scale ancestry patterns is critical for medical and population genetic studies within Mexico, in Mexican-descent populations, and likely in many other populations worldwide.	[Moreno-Estrada, Andres; Zakharia, Fouad; Sikora, Martin; Sandoval, Karla; Ortiz-Tello, Patricia; Robles, Victoria; Kenny, Eimear E.; Rodriguez-Santana, Jose R.; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Gignoux, Christopher R.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Carlos Fernandez-Lopez, Juan; Contreras, Alejandra V.; Romero-Hidalgo, Sandra; Rodriguez-Santana, Jose R.; Garcia-Herrera, Rodrigo; Estrada, Karol; Hidalgo-Miranda, Alfredo; Jimenez-Sanchez, Gerardo; Carnevale, Alessandra; Soberon, Xavier; Canizales-Quinteros, Samuel; Silva-Zolezzi, Irma] Inst Nacl Med Genom INMEGEN, Mexico City, DF, Mexico; [Acuna-Alonzo, Victor; Barquera-Lozano, Rodrigo; Macin-Perez, Gaston] ENAH, Mexico City, DF, Mexico; [Acuna-Alonzo, Victor; Ruiz-Linares, Andres] UCL, Dept Genet Evolut & Environm, London, England; [Eng, Celeste; Huntsman, Scott; Galanter, Joshua M.; Via, Marc; Burchard, Esteban Gonzalez] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Nuno-Arana, Ismael; Rangel-Villalobos, Hector] Univ Guadalajara, Inst Invest Genet Mol, Ocotlan, Mexico; [Granados-Arriola, Julio] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Galanter, Joshua M.; Burchard, Esteban Gonzalez] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Ford, Jean G.] Brooklyn Hosp Ctr, Brooklyn, NY USA; [Chapela, Rocio; Romieu, Isabelle] INER, Mexico City, DF, Mexico; [Rodriguez-Cintron, William] Vet Caribbean Hlth Care Syst, San Juan, PR USA; Ctr Neumol Pediat, San Juan, PR USA; Int Agcy Res Canc, F-69372 Lyon, France; [Jose Sienra-Monge, Juan; del Rio Navarro, Blanca] Hosp Infantil Mexico Dr Federico Gomez, Mexico City, DF, Mexico; [London, Stephanie J.] NIEHS, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Canizales-Quinteros, Samuel] Univ Nacl Autonoma Mexico, Fac Quim, Mexico City 04510, DF, Mexico	Stanford University; University of California System; University of California San Francisco; Instituto Nacional de Medicina Genomica; University of London; University College London; University of California System; University of California San Francisco; Universidad de Guadalajara; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; University of California System; University of California San Francisco; Brooklyn Hospital Center; World Health Organization; International Agency for Research on Cancer (IARC); Hospital Infantil de Mexico Federico Gomez; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Universidad Nacional Autonoma de Mexico	Moreno-Estrada, A (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	morenoe@stanford.edu; esteban.burchard@ucsf.edu; cdbustam@stanford.edu	Sikora, Martin/C-8609-2015; Via, Marc/L-6511-2014; Fernandez, Juan Carlos/C-4976-2013; Contreras, Alejandra/E-7815-2013; London, Stephanie/C-3734-2019; Ruiz-Linares, Andres/AAR-1104-2021; Moreno-Estrada, Andres/R-3950-2017; Hidalgo-Miranda, Alfredo/B-2123-2010; Moreno-Estrada, Andres/AAP-4657-2021; RANGEL-VILLALOBOS, HECTOR/C-5081-2018	Sikora, Martin/0000-0003-2818-8319; Via, Marc/0000-0002-9966-9921; Fernandez, Juan Carlos/0000-0003-3680-4193; Contreras, Alejandra/0000-0003-3653-5958; London, Stephanie/0000-0003-4911-5290; Ruiz-Linares, Andres/0000-0001-8372-1011; Moreno-Estrada, Andres/0000-0001-8329-8292; Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Moreno-Estrada, Andres/0000-0001-8329-8292; Bustamante, Carlos D./0000-0002-4187-7920; Romero-Hidalgo, Sandra/0000-0003-3077-7825; RANGEL-VILLALOBOS, HECTOR/0000-0003-2641-8782; Barquera, Rodrigo/0000-0003-0518-4518; Garcia-Herrera, Rodrigo/0000-0002-7972-5746; Sandoval, Karla/0000-0002-6175-2463; Garcia Herrera, Ricardo/0000-0003-2456-4727; Galanter, Joshua/0000-0002-2561-6384	Stanford University; Department of Genetics; Federal Government of Mexico; Ministry of Health; Mexican Health Foundation (FUNSALUD); Gonzalo Rio Arronte Foundation; George Rosenkranz Prize for Health Care Research in Developing Countries; University of California San Francisco (UCSF) Chancellor's Research Fellowship; Dissertation Year Fellowship; NIH Training Grants [T32GM007175, T32HG000044]; Robert Wood Johnson Foundation Amos Medical Faculty Development Award; Sandler Foundation; American Asthma Foundation; CONACYT [129693]; BBSRC grant [BB/I021213/1]; National Institutes of Health (NIH) [R01GM090087, R01HG003229, ES015794, GM007546, GM061390, HL004464, HL078885, HL088133, HL111636, RR000083, P60MD006902, ZIA ES49019]; National Science Foundation [DMS-1201234]; Intramural Research Program of NIH, National Institute of Environmental Health Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000083] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078885, K23HL111636, K23HL004464, R01HL088133] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229, T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES043012, ZIAES049019, R01ES015794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM061390, R01GM090087, T32GM007546, R01GM083606, T32GM007175, U01GM061390] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R13MD008154, P60MD006902] Funding Source: NIH RePORTER; BBSRC [BB/I021213/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I021213/1] Funding Source: researchfish	Stanford University(Stanford University); Department of Genetics; Federal Government of Mexico; Ministry of Health; Mexican Health Foundation (FUNSALUD); Gonzalo Rio Arronte Foundation; George Rosenkranz Prize for Health Care Research in Developing Countries; University of California San Francisco (UCSF) Chancellor's Research Fellowship; Dissertation Year Fellowship; NIH Training Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation Amos Medical Faculty Development Award(Robert Wood Johnson Foundation (RWJF)); Sandler Foundation; American Asthma Foundation; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); BBSRC grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Intramural Research Program of NIH, National Institute of Environmental Health Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank all volunteers for generously donating DNA samples and participating in the study. This project was possible with the joint support from multiple Institutions in Mexico and the United States. Stanford University supported C.D.B. with funding from the Department of Genetics. INMEGEN received support from the Federal Government of Mexico, particularly the Ministry of Health, the Mexican Health Foundation (FUNSALUD), and the Gonzalo Rio Arronte Foundation. State governments and universities of Durango, Campeche, Guanajuato, Guerrero, Oaxaca, Sonora, Tamaulipas, Veracruz, Yucatan, and Zacatecas contributed significantly to this work. This research was also supported by the George Rosenkranz Prize for Health Care Research in Developing Countries awarded to A.M.-E.; University of California San Francisco (UCSF) Chancellor's Research Fellowship, Dissertation Year Fellowship, and NIH Training Grants T32GM007175 and T32HG000044 (to C. R. G.); the Robert Wood Johnson Foundation Amos Medical Faculty Development Award; the Sandler Foundation; the American Asthma Foundation (to E. G. B.); CONACYT grant 129693 (to H. R.-V.); BBSRC grant BB/I021213/1 (to A. R.-L.); the National Institutes of Health (NIH) (grants R01GM090087, R01HG003229, ES015794, GM007546, GM061390, HL004464, HL078885, HL088133, HL111636, RR000083, P60MD006902, and ZIA ES49019); and National Science Foundation award DMS-1201234. This work was supported in part by the Intramural Research Program of NIH, National Institute of Environmental Health Sciences (to S.J.L.). Some computations were performed using the UCSF Biostatistics High Performance Computing System. We also thank B. Henn, S. Gravel, and J. Byrnes for helpful discussions; C. Gunter and M. Carpenter for editing the manuscript; and M. Morales for informatics and programming support. C. D. B. is on the advisory board of a project at 23andMe; and on the scientific advisory boards of Personalis, Inc.; InVitae; Etalon, Inc.; and Ancestry.com. The collections and methods for the Population Reference Sample (POPRES) are described by Nelson et al. (2008). The POPRES data sets used for the analyses described here were obtained from dbGaP through accession number phs000145.v1.p1. Access to the MCCAS data set may be obtained under the terms of a data transfer agreement with the National Institute of Environmental Health Sciences; the contact is S.J.L.. Individual-level genotypes for new data presented in this study are available, through a data access agreement to respect the privacy of the participants for the transfer of genetic data, by contacting C.D.B., A.M.-E., and INMEGEN (http://www.inmegen.gob.mx/).	Acuna-Alonzo V, 2010, HUM MOL GENET, V19, P2877, DOI 10.1093/hmg/ddq173; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Botigue LR, 2013, P NATL ACAD SCI USA, V110, P11791, DOI 10.1073/pnas.1306223110; Brisbin A, 2012, HUM BIOL, V84, P343, DOI 10.3378/027.084.0401; CAMPBELL L, 1985, ANNU REV ANTHROPOL, V14, P187; Fejerman L, 2008, CANCER RES, V68, P9723, DOI 10.1158/0008-5472.CAN-08-2039; Gorostiza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044666; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Hancock DB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000623; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Henn BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034267; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Johnson NA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002410; Kumar R, 2010, NEW ENGL J MED, V363, P321, DOI 10.1056/NEJMoa0907897; Lisker R, 1996, HUM BIOL, V68, P395; Moreno-Estrada A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003925; Nalls MA, 2008, AM J HUM GENET, V82, P81, DOI 10.1016/j.ajhg.2007.09.003; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Pascual Soto Arturo, 2006, TAJIN BUSCA ORIGENES; Peralta CA, 2010, AM J NEPHROL, V31, P202, DOI 10.1159/000268955; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Salari K, 2005, GENET EPIDEMIOL, V29, P76, DOI 10.1002/gepi.20079; Sandoval K, 2012, AM J PHYS ANTHROPOL, V148, P395, DOI 10.1002/ajpa.22062; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; Torgerson DG, 2012, J ALLERGY CLIN IMMUN, V130, P76, DOI 10.1016/j.jaci.2012.02.040; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828	31	305	311	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1280	1285		10.1126/science.1251688	http://dx.doi.org/10.1126/science.1251688			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926019	Green Accepted			2022-12-01	WOS:000337077500040
J	Cai, WJ; Santoso, A; Wang, GJ; Weller, E; Wu, LX; Ashok, K; Masumoto, Y; Yamagata, T				Cai, Wenju; Santoso, Agus; Wang, Guojian; Weller, Evan; Wu, Lixin; Ashok, Karumuri; Masumoto, Yukio; Yamagata, Toshio			Increased frequency of extreme Indian Ocean Dipole events due to greenhouse warming	NATURE			English	Article							EL-NINO; FOREST-FIRES; SHORT RAINS; VARIABILITY; CIRCULATION; INDONESIA; RAINFALL; PROJECT; MODELS; IMPACT	The Indian Ocean dipole is a prominent mode of coupled ocean-atmosphere variability(1-4), affecting the lives of millions of people in Indian Ocean rim countries(5-15). In its positive phase, sea surface temperatures are lower than normal off the Sumatra-Java coast, but higher in the western tropical Indian Ocean. During the extreme positive-IOD (pIOD) events of 1961, 1994 and 1997, the eastern cooling strengthened and extended westward along the equatorial Indian Ocean through strong reversal of both the mean westerly winds and the associated eastward-flowing upper ocean currents(1,2). This created anomalously dry conditions from the eastern to the central Indian Ocean along the Equator and atmospheric convergence farther west, leading to catastrophic floods in eastern tropical African countries(13,14) but devastating droughts in eastern Indian Ocean rim countries(8-10,16,17). Despite these serious consequences, the response of pIOD events to greenhouse warming is unknown. Here, using an ensemble of climate models forced by a scenario of high greenhouse gas emissions (Representative Concentration Pathway 8.5), we project that the frequency of extreme pIOD events will increase by almost a factor of three, from one event every 17.3 years over the twentieth century to one event every 6.3 years over the twenty-first century. We find that a mean state change-with weakening of both equatorial westerly winds and eastward oceanic currents in association with a faster warming in the western than the eastern equatorial Indian Ocean-facilitates more frequent occurrences of wind and oceanic current reversal. This leads to more frequent extreme pIOD events, suggesting an increasing frequency of extreme climate and weather events in regions affected by the pIOD.	[Cai, Wenju; Wang, Guojian; Weller, Evan] CSIRO Marine & Atmospher Res, Aspendale, Vic 3195, Australia; [Cai, Wenju; Wang, Guojian; Wu, Lixin] Ocean Univ China, Qingdao Collaborat Innovat Ctr Marine Sci & Techn, Phys Oceanog Lab, Qingdao 266003, Peoples R China; [Santoso, Agus] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Santoso, Agus] Univ New S Wales, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW 2052, Australia; [Ashok, Karumuri] Indian Inst Trop Meteorol, Ctr Climate Change Res, Pune 411008, Maharashtra, India; [Masumoto, Yukio] Univ Tokyo, Dept Earth & Planetary Sci, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Masumoto, Yukio] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Climate Variat Predictabil & Applicatabil Res Pro, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Yamagata, Toshio] JAMSTEC, Applicat Lab, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Ocean University of China; University of New South Wales Sydney; ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney; Ministry of Earth Sciences (MoES) - India; Indian Institute of Tropical Meteorology (IITM); Centre for Climate Change Research - India; University of Tokyo; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Cai, WJ (corresponding author), CSIRO Marine & Atmospher Res, Aspendale, Vic 3195, Australia.	wenju.cai@csiro.au	MASUMOTO, YUKIO/G-5021-2014; Santoso, Agus/P-1918-2019; Wang, Guojian/AAF-9297-2020; Cai, Wenju/C-2864-2012; Yamagata, Toshio/A-1807-2009; Santoso, Agus/J-7350-2012	Santoso, Agus/0000-0001-7749-8124; Wang, Guojian/0000-0002-8881-7394; Cai, Wenju/0000-0001-6520-0829; Santoso, Agus/0000-0001-7749-8124; Ashok, Karumuri/0000-0002-5937-8089; Weller, Evan/0000-0002-7454-9827	Australian Climate Change Science Program; Goyder Institute; CSIRO Office of Chief Executive Science Leader award; Australian Research Council	Australian Climate Change Science Program; Goyder Institute; CSIRO Office of Chief Executive Science Leader award; Australian Research Council(Australian Research Council)	W.C. and E. W. are supported by the Australian Climate Change Science Program, and the Goyder Institute. W. C. is also supported by a CSIRO Office of Chief Executive Science Leader award. A. S. is supported by the Australian Research Council.	Abram NJ, 2003, SCIENCE, V301, P952, DOI 10.1126/science.1083841; Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Ashok K, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017926; Ashok K, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003798; Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; Balmaseda MA, 2008, MON WEATHER REV, V136, P3018, DOI 10.1175/2008MWR2433.1; Behera SK, 2005, J CLIMATE, V18, P4514, DOI 10.1175/JCLI3541.1; Black E, 2003, MON WEATHER REV, V131, P74, DOI 10.1175/1520-0493(2003)131<0074:AOSOTR>2.0.CO;2; Cai W, 2009, GEOPHYS RES LETT, V36, DOI [10.1029/2009GL039902, 10.1029/2009GL037604]; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Cai WJ, 2013, NAT GEOSCI, V6, P999, DOI [10.1038/NGEO2009, 10.1038/ngeo2009]; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Emmanuel S C, 2000, Respirology, V5, P175, DOI 10.1046/j.1440-1843.2000.00247.x; Feng M, 2003, DEEP-SEA RES PT II, V50, P2263, DOI 10.1016/S0967-0645(03)00056-0; Fischer AS, 2005, J CLIMATE, V18, P3428, DOI 10.1175/JCLI3478.1; Frankenberg E, 2005, DEMOGRAPHY, V42, P109, DOI 10.1353/dem.2005.0004; Guilyardi E, 2009, B AM METEOROL SOC, V90, P325, DOI 10.1175/2008BAMS2387.1; Hashizume M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00269; Hong CC, 2008, J CLIMATE, V21, P4834, DOI 10.1175/2008JCLI2222.1; Izumo T, 2010, NAT GEOSCI, V3, P168, DOI 10.1038/NGEO760; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Lorenz EN, 1956, 1 MIT DEP MET; Luo JJ, 2010, J CLIMATE, V23, P726, DOI 10.1175/2009JCLI3104.1; Meyers G, 2007, J CLIMATE, V20, P2872, DOI 10.1175/JCLI4152.1; Murtugudde R, 2000, J GEOPHYS RES-OCEANS, V105, P3295, DOI 10.1029/1999JC900294; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43855; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Udea H., 2000, J METEOR SOC JAPAN, V78, P803; Ummenhofer CC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036801; Vecchi GA, 2007, J CLIMATE, V20, P4316, DOI 10.1175/JCLI4258.1; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; Wijffels S, 2004, J PHYS OCEANOGR, V34, P1232, DOI 10.1175/1520-0485(2004)034<1232:AIOOWV>2.0.CO;2; WYRTKI K, 1973, SCIENCE, V181, P264; Yu LS, 1999, GEOPHYS RES LETT, V26, P735, DOI 10.1029/1999GL900072; Zheng XT, 2013, J CLIMATE, V26, P6067, DOI 10.1175/JCLI-D-12-00638.1; Zubair L, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015639	39	208	217	11	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					254	+		10.1038/nature13327	http://dx.doi.org/10.1038/nature13327			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24919920				2022-12-01	WOS:000337032400047
J	Jiang, Y; Xie, M; Chen, WB; Talbot, R; Maddox, JF; Faraut, T; Wu, CH; Muzny, DM; Li, YX; Zhang, WG; Stanton, JA; Brauning, R; Barris, WC; Hourlier, T; Aken, BL; Searle, SMJ; Adelson, DL; Bian, C; Cam, GR; Chen, YL; Cheng, SF; DeSilva, U; Dixen, K; Dong, Y; Fan, GY; Franklin, IR; Fu, SY; Fuentes-Utrilla, P; Guan, R; Highland, MA; Holder, ME; Huang, GD; Ingham, AB; Jhangiani, SN; Kalra, D; Kovar, CL; Lee, SL; Liu, WQ; Liu, X; Lu, CX; Lv, T; Mathew, T; McWilliam, S; Menzies, M; Pan, SK; Robelin, D; Servin, B; Townley, D; Wang, WL; Wei, B; White, SN; Yang, XH; Ye, C; Yue, YJ; Zeng, P; Zhou, Q; Hansen, JB; Kristiansen, K; Gibbs, RA; Flicek, P; Warkup, CC; Jones, HE; Oddy, VH; Nicholas, FW; McEwan, JC; Kijas, JW; Wang, J; Worley, KC; Archibald, AL; Cockett, N; Xu, X; Wang, W; Dalrymple, BP				Jiang, Yu; Xie, Min; Chen, Wenbin; Talbot, Richard; Maddox, Jillian F.; Faraut, Thomas; Wu, Chunhua; Muzny, Donna M.; Li, Yuxiang; Zhang, Wenguang; Stanton, Jo-Ann; Brauning, Rudiger; Barris, Wesley C.; Hourlier, Thibaut; Aken, Bronwen L.; Searle, Stephen M. J.; Adelson, David L.; Bian, Chao; Cam, Graham R.; Chen, Yulin; Cheng, Shifeng; DeSilva, Udaya; Dixen, Karen; Dong, Yang; Fan, Guangyi; Franklin, Ian R.; Fu, Shaoyin; Fuentes-Utrilla, Pablo; Guan, Rui; Highland, Margaret A.; Holder, Michael E.; Huang, Guodong; Ingham, Aaron B.; Jhangiani, Shalini N.; Kalra, Divya; Kovar, Christie L.; Lee, Sandra L.; Liu, Weiqing; Liu, Xin; Lu, Changxin; Lv, Tian; Mathew, Tittu; McWilliam, Sean; Menzies, Moira; Pan, Shengkai; Robelin, David; Servin, Bertrand; Townley, David; Wang, Wenliang; Wei, Bin; White, Stephen N.; Yang, Xinhua; Ye, Chen; Yue, Yaojing; Zeng, Peng; Zhou, Qing; Hansen, Jacob B.; Kristiansen, Karsten; Gibbs, Richard A.; Flicek, Paul; Warkup, Christopher C.; Jones, Huw E.; Oddy, V. Hutton; Nicholas, Frank W.; McEwan, John C.; Kijas, James W.; Wang, Jun; Worley, Kim C.; Archibald, Alan L.; Cockett, Noelle; Xu, Xun; Wang, Wen; Dalrymple, Brian P.			The sheep genome illuminates biology of the rumen and lipid metabolism	SCIENCE			English	Article							PROLINE-RICH PROTEINS; IDENTIFICATION; EVOLUTIONARY; EXPRESSION; ENVELOPES; RUMINANT; GENES; SITE; FAT	Sheep (Ovis aries) are a major source of meat, milk, and fiber in the form of wool and represent a distinct class of animals that have a specialized digestive organ, the rumen, that carries out the initial digestion of plant material. We have developed and analyzed a high-quality reference sheep genome and transcriptomes from 40 different tissues. We identified highly expressed genes encoding keratin cross-linking proteins associated with rumen evolution. We also identified genes involved in lipid metabolism that had been amplified and/or had altered tissue expression patterns. This may be in response to changes in the barrier lipids of the skin, an interaction between lipid metabolism and wool synthesis, and an increased role of volatile fatty acids in ruminants compared with nonruminant animals.	[Jiang, Yu; Zhang, Wenguang; Dong, Yang; Wang, Wen] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Jiang, Yu; Barris, Wesley C.; Adelson, David L.; Cam, Graham R.; DeSilva, Udaya; Franklin, Ian R.; Ingham, Aaron B.; McWilliam, Sean; Menzies, Moira; Townley, David; Kijas, James W.; Dalrymple, Brian P.] Commonwealth Sci & Ind Res Org Anim Food & Hlth S, St Lucia, Qld 4067, Australia; [Jiang, Yu; Chen, Yulin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Peoples R China; [Xie, Min; Chen, Wenbin; Li, Yuxiang; Bian, Chao; Cheng, Shifeng; Fan, Guangyi; Guan, Rui; Huang, Guodong; Liu, Weiqing; Liu, Xin; Lu, Changxin; Lv, Tian; Pan, Shengkai; Wang, Wenliang; Wei, Bin; Yang, Xinhua; Ye, Chen; Zeng, Peng; Zhou, Qing; Wang, Jun; Xu, Xun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Talbot, Richard; Fuentes-Utrilla, Pablo] Univ Edinburgh, Ediburgh Genom, Easter Bush EH25 9RG, Midlothian, Scotland; [Maddox, Jillian F.; Wu, Chunhua; Cockett, Noelle] Utah State Univ, Logan, UT 84322 USA; [Faraut, Thomas; Robelin, David; Servin, Bertrand] INRA, Lab Genet Cellulaire, UMR 444, F-31326 Castanet Tolosan, France; [Muzny, Donna M.; Holder, Michael E.; Jhangiani, Shalini N.; Kalra, Divya; Kovar, Christie L.; Lee, Sandra L.; Mathew, Tittu; Gibbs, Richard A.; Worley, Kim C.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Zhang, Wenguang; Fu, Shaoyin] Inner Mongolia Agr Univ, Hohhot 010018, Peoples R China; [Zhang, Wenguang] Nei Mongol Bioinformat, Inst ATCG, Hohhot, Peoples R China; [Stanton, Jo-Ann] Univ Otago, Dept Anat, Dunedin 9054, New Zealand; [Brauning, Rudiger; McEwan, John C.] AgResearch, Invermay Agr Ctr, Mosgiel 9053, New Zealand; [Hourlier, Thibaut; Aken, Bronwen L.; Searle, Stephen M. J.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Dixen, Karen; Hansen, Jacob B.] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen O, Denmark; [Highland, Margaret A.; White, Stephen N.] Washington State Univ, USDA ARS, Anim Dis Res Unit, Pullman, WA 99164 USA; [Highland, Margaret A.; White, Stephen N.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Wei, Bin] Sichuan Agr Univ, Maize Res Inst, Chengdu 611130, Peoples R China; [Yue, Yaojing] Lanzhou Inst Husb & Pharmaceut Sci, Lanzhou 730050, Peoples R China; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark; [Hourlier, Thibaut; Aken, Bronwen L.; Flicek, Paul] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SA, England; [Warkup, Christopher C.; Jones, Huw E.] Roslin Inst, Biosci Knowledge Transfer Network, Easter Bush EH25 9RG, Midlothian, Scotland; [Oddy, V. Hutton] Univ New England, Sch Environm & Rural Sci, Armidale, NSW 2351, Australia; [Nicholas, Frank W.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Ctr Excellence Res Hereditary, Jeddah 21589, Saudi Arabia; [Wang, Jun] Macau Univ Sci & Technol, Macau 999078, Peoples R China; [Archibald, Alan L.] Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; [Archibald, Alan L.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush EH25 9RG, Midlothian, Scotland	Chinese Academy of Sciences; Kunming Institute of Zoology; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Northwest A&F University - China; Beijing Genomics Institute (BGI); University of Edinburgh; Utah System of Higher Education; Utah State University; INRAE; Baylor College of Medicine; Inner Mongolia Agricultural University; University of Otago; AgResearch - New Zealand; Wellcome Trust Sanger Institute; University of Copenhagen; United States Department of Agriculture (USDA); Washington State University; Washington State University; Sichuan Agricultural University; Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS; University of Copenhagen; European Molecular Biology Laboratory (EMBL); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of New England; University of Sydney; King Abdulaziz University; Macau University of Science & Technology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Dalrymple, BP (corresponding author), Commonwealth Sci & Ind Res Org Anim Food & Hlth S, St Lucia, Qld 4067, Australia.	kworley@bcm.edu; alan.archibald@roslin.ed.ac.uk; noelle.cockett@usu.edu; xuxun@genomics.cn; wwang@mail.kiz.ac.cn; brian.dalrymple@csiro.au	Ingham, Aaron/C-1166-2008; Nicholas, Frank/AGY-8318-2022; XIE, MIN/P-8062-2019; Jiang, Yu/O-5114-2015; McWilliam, Sean M/H-8978-2013; Menzies, Moira/AAY-2850-2020; Hansen, Jacob B/F-3775-2010; Xu, Xun/AAI-6763-2020; Wang, Wen/AAP-9873-2020; Kristiansen, Karsten/J-5148-2014; Kijas, James W/A-4656-2011; Stanton, Jo-Ann L/C-6621-2009; Nicholas, Frank William/AAE-5566-2022; Kalra, Divya/N-5453-2014; Dalrymple, Brian P/F-8721-2010; Kalra, D/H-6661-2019; Adelson, David L/E-5506-2011; Servin, Bertrand/B-2206-2008; Highland, Margaret/ABF-3396-2021; McEwan, John/A-1143-2008; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Ingham, Aaron/0000-0001-8006-9443; Nicholas, Frank/0000-0002-9178-3965; XIE, MIN/0000-0002-5652-5039; Jiang, Yu/0000-0003-4821-3585; McWilliam, Sean M/0000-0002-3148-0428; Menzies, Moira/0000-0002-5752-0846; Hansen, Jacob B/0000-0001-5249-2586; Xu, Xun/0000-0002-5338-5173; Kristiansen, Karsten/0000-0002-6024-0917; Kijas, James W/0000-0002-1417-8278; Stanton, Jo-Ann L/0000-0001-8139-4694; Nicholas, Frank William/0000-0002-9178-3965; Dalrymple, Brian P/0000-0003-3891-5233; Kalra, D/0000-0001-5254-4067; Adelson, David L/0000-0003-2404-5636; Servin, Bertrand/0000-0001-5141-0913; McEwan, John/0000-0003-4801-6207; Flicek, Paul/0000-0002-3897-7955; DeSilva, Udaya/0000-0003-2517-6566; White, Stephen N./0000-0001-9255-6054; Wang, Wen/0000-0002-7801-2066; Liu, Xin/0000-0003-3256-2940; Wang, Jun/0000-0002-8540-8931; Archibald, Alan/0000-0001-9213-1830; Aken, Bronwen/0000-0002-3032-4095; Bian, Chao/0000-0001-9904-721X; Wang, Jun/0000-0002-2113-5874; Oddy, Hutton/0000-0003-1783-1049; Guan, Rui/0000-0003-0862-2368; Hourlier, Thibaut/0000-0003-4894-7773; Worley, Kim/0000-0002-0282-1000; Brauning, Rudiger/0000-0001-5068-9166	one 973 Program [2013CB835200]; one CAS Program [XDB13000000]; BGI-Shenzhen [ZYC200903240077A, ZYC200903240078A]; Inner Mongolia Agricultural University [30960246, 31260538]; Roslin Institute; University of Edinburgh and Biotechnology; Biological Sciences Research Council, UK (BBSRC) [BB/1025360/1, BB/I025328/1]; Institute Strategic Programme; National Capability Grants; Roslin Foundation; Scottish Government, UK; Department for Environment, Food and Rural Affairs/Higher Education Funding Council/Scottish Higher Education Funding Council Veterinary Training and Research Initiative, UK; USDA-ARS, USA; USDA-National Research Initiative Competitive Grants Program, USA [2008-03923, 2009-03305]; Wellcome Trust [WT095908, WT098051]; BBSRC [BB/I025506/1, BB/I025360/1]; European Molecular Biology Laboratory; USDA-NRSP-8, USA; USDA-ARS [5348-32000-031-00D]; Meat and Livestock Australia; Australian Wool Innovation Limited through SheepGENOMICS, Australia; Australian Government International Science Linkages Grant, Australia [CG090143]; University of Sydney, Australia; CSIRO, Australia; AgResearch, NZ, Beef + Lamb NZ through Ovita, New Zealand; INRA, France; Agence Nationale de la Recherche project SheepSNPQTL, France; European Union through the Seventh Framework Programme Quantomics project [KBBE222664]; 3SR project [KBBE245140]; Ole Romer grant from Danish Natural Science Research Council, BGI-Shenzhen, China; Earmarked Fund for Modern China Wool & Cashmere Technology Research System [nycytx-40-3]; Australian Department of Agriculture Food and Fisheries, Filling the Research Gap project, "Host control of methane emissions"; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/I025328/1, BB/I025360/2, BB/I025506/1, BBS/E/D/20310000, BBS/E/D/05191130, BB/I025360/1, BBS/E/D/20211550, BBS/E/D/20211552] Funding Source: researchfish; BBSRC [BBS/E/D/05191130, BB/I025360/2, BBS/E/D/20211552, BBS/E/D/20310000, BBS/E/D/20211550, BB/I025328/1] Funding Source: UKRI	one 973 Program; one CAS Program; BGI-Shenzhen; Inner Mongolia Agricultural University; Roslin Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Edinburgh and Biotechnology; Biological Sciences Research Council, UK (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute Strategic Programme; National Capability Grants; Roslin Foundation; Scottish Government, UK; Department for Environment, Food and Rural Affairs/Higher Education Funding Council/Scottish Higher Education Funding Council Veterinary Training and Research Initiative, UK; USDA-ARS, USA(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA-National Research Initiative Competitive Grants Program, USA(United States Department of Agriculture (USDA)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Laboratory; USDA-NRSP-8, USA; USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Meat and Livestock Australia(Meat and Livestock Australia); Australian Wool Innovation Limited through SheepGENOMICS, Australia(Australian Wool Innovation); Australian Government International Science Linkages Grant, Australia(Australian GovernmentDepartment of Industry, Innovation and Science); University of Sydney, Australia(University of Sydney); CSIRO, Australia(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); AgResearch, NZ, Beef + Lamb NZ through Ovita, New Zealand; INRA, France; Agence Nationale de la Recherche project SheepSNPQTL, France(French National Research Agency (ANR)); European Union through the Seventh Framework Programme Quantomics project; 3SR project; Ole Romer grant from Danish Natural Science Research Council, BGI-Shenzhen, China; Earmarked Fund for Modern China Wool & Cashmere Technology Research System; Australian Department of Agriculture Food and Fisheries, Filling the Research Gap project, "Host control of methane emissions"(Australian GovernmentDepartment of Agriculture and Water Resources); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The International Sheep Genomics Sequencing Consortium is grateful to the following for funding support for the sheep genome sequencing project: one 973 Program (no. 2013CB835200) and one CAS Program (XDB13000000) to Kunming Institute of Zoology, China; BGI-Shenzhen (ZYC200903240077A and ZYC200903240078A); China National GeneBank-Shenzhen for support for the storage of samples and data; Inner Mongolia Agricultural University (30960246 and 31260538); The Roslin Institute, University of Edinburgh and Biotechnology and Biological Sciences Research Council, UK (BBSRC): BB/1025360/1, BB/I025328/1, Institute Strategic Programme, and National Capability Grants; The Roslin Foundation; The Scottish Government, UK; Department for Environment, Food and Rural Affairs/Higher Education Funding Council/Scottish Higher Education Funding Council Veterinary Training and Research Initiative, UK; USDA-ARS, USA, USDA-National Research Initiative Competitive Grants Program, USA (grant nos. 2008-03923 and 2009-03305); Wellcome Trust (grant nos. WT095908 and WT098051), BBSRC (grant nos. BB/I025506/1 and BB/I025360/1) and European Molecular Biology Laboratory; USDA-NRSP-8, USA; USDA-ARS grant 5348-32000-031-00D; Meat and Livestock Australia and Australian Wool Innovation Limited through SheepGENOMICS, Australia; Australian Government International Science Linkages Grant (CG090143), Australia; University of Sydney, Australia; CSIRO, Australia; AgResearch, NZ, Beef + Lamb NZ through Ovita, New Zealand; INRA and Agence Nationale de la Recherche project SheepSNPQTL, France; European Union through the Seventh Framework Programme Quantomics (KBBE222664) and 3SR (KBBE245140) projects; the Ole Romer grant from Danish Natural Science Research Council, BGI-Shenzhen, China; the Earmarked Fund for Modern China Wool & Cashmere Technology Research System (no. nycytx-40-3); and the Australian Department of Agriculture Food and Fisheries, Filling the Research Gap project, "Host control of methane emissions." We thank B. Freking (USDA-ARS-U.S. Meat Animal Research Center) for provision of Texel ram tissue samples for DNA extraction and sequencing. We thank the sequencing teams and other contributors; full details are in the acknowledgements section of the supplementary materials. We thank SheepGENOMICS and Utah State University for access to the genotyping data for the SheepGENOMICS and Louisiana State University flocks, respectively. We thank L. Goodman for help with condensing the text. The genome assemblies have been deposited in GenBank, Oar v1.0 (GCA_000005525.1), and Oar v3.1 (GCA_000298735.1) and in GigaDB, Oar v2.0 (http://dx.doi.org/10.5524/100023). The Ensembl annotation of the Oar v3.1 assembly is available at http://e74.ensembl.org, and the gene builds are available from ftp://ftp.ensembl.org/pub/release-74/bam/ovis_aries/genebuild/. The RNA-Seq data sets have been deposited in public databases: 83 samples from The Roslin Institute (European Nucleotide Archive (ENA) study accession PRJEB6169), seven tissues from the genome-sequenced Texel ewe and Gansu alpine fine wool sheep skin (GenBank accession GSE56643), and three blood samples (GenBank BioProject accession PRJNA245615). The methylated DNA immunoprecipitation sequencing (MeDIP-seq) raw reads from the Texel ewe liver have been deposited in GenBank (GSE56644). The bacterial artificial chromosome sequence assembly has been deposited in GenBank (KJ735098).; The raw reads of the genome sequencing projects have been deposited in public nucleotide databases: Texel ewe (GenBank accession SRA059406), Texel ram (ENA study accession PRJEB6251, GenBank accession SRP015759), and 0.5-fold coverage 454 sequencing of six animals (GenBank accessions SRP000982, SRP003883, and SRP006794). The authors declare no competing financial interests.	BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bobe G, 2004, J DAIRY SCI, V87, P3105, DOI 10.3168/jds.S0022-0302(04)73446-3; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Deng J, 2000, J BIOL CHEM, V275, P5739, DOI 10.1074/jbc.275.8.5739; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Feingold KR, 2007, J LIPID RES, V48, P2531, DOI 10.1194/jlr.R700013-JLR200; Hackmann TJ, 2010, J DAIRY SCI, V93, P1320, DOI 10.3168/jds.2009-2071; Hall AM, 2012, J LIPID RES, V53, P990, DOI 10.1194/jlr.P025536; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; INGLE DL, 1972, J NUTR, V102, P617, DOI 10.1093/jn/102.5.617; Inoue A, 2011, EMBO J, V30, P4248, DOI 10.1038/emboj.2011.296; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Kypriotou M, 2012, EXP DERMATOL, V21, P643, DOI 10.1111/j.1600-0625.2012.01472.x; Marshall D, 2001, P NATL ACAD SCI USA, V98, P13031, DOI 10.1073/pnas.231489198; Radner FPW, 2011, DERM-ENDOCRINOL, V3, P77, DOI 10.4161/derm.3.2.15472; SCHLOSSMAN ML, 1978, J AM OIL CHEM SOC, V55, P447, DOI 10.1007/BF02911911; Song HJ, 1999, GENOMICS, V55, P28, DOI 10.1006/geno.1998.5607; Steinert PM, 1998, J STRUCT BIOL, V122, P76, DOI 10.1006/jsbi.1998.3957; Stewart M. E., 1986, BIOL INTEGUMENT, V2, P824; Stromberg CAE, 2011, ANNU REV EARTH PL SC, V39, P517, DOI 10.1146/annurev-earth-040809-152402; Wang LQ, 1996, BIOCHEM J, V317, P225, DOI 10.1042/bj3170225; WOLIN MJ, 1981, SCIENCE, V213, P1463, DOI 10.1126/science.7280665	24	281	308	11	322	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1168	1173		10.1126/science.1252806	http://dx.doi.org/10.1126/science.1252806			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904168	Green Accepted			2022-12-01	WOS:000336791200050
J	Handel, MA; Eppig, JJ; Schimenti, JC				Handel, Mary Ann; Eppig, John J.; Schimenti, John C.			Applying "Gold Standards" to In-Vitro-Derived Germ Cells	CELL			English	Article							EMBRYONIC STEM-CELLS; METABOLIC COOPERATIVITY; MOUSE; MEIOSIS; OOCYTES; FATE; OOGENESIS; GENETICS; OVARIES; MICE	Germ cells are the ultimate stem cells, and reports of their in vitro derivation generate excitement due to potential applications in reproductive medicine. To date, there is no firm evidence that meiosis, the hallmark of gametogenesis, can be faithfully replicated outside of the gonad. We propose benchmarks for evaluating in vitro derivation of germ cells, facilitating realization of their potential.	[Handel, Mary Ann; Eppig, John J.] Jackson Lab, Bar Harbor, ME 04609 USA; [Schimenti, John C.] Cornell Univ, Ithaca, NY 14853 USA	Jackson Laboratory; Cornell University	Handel, MA (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	maryann.handel@jax.org; jcs92@cornell.edu			NCI NIH HHS [P30 CA034196] Funding Source: Medline; NIGMS NIH HHS [R01 GM045415] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045415] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bolcun-Filas E, 2012, INT REV CEL MOL BIO, V298, P179, DOI 10.1016/B978-0-12-394309-5.00005-5; Dokshin GA, 2013, NAT GENET, V45, P877, DOI 10.1038/ng.2672; Duncan FE, 2009, BIOL REPROD, V81, P768, DOI 10.1095/biolreprod.109.077909; Eguizabal C, 2011, STEM CELLS, V29, P1186, DOI 10.1002/stem.672; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Lei L, 2013, P NATL ACAD SCI USA, V110, P8585, DOI 10.1073/pnas.1306189110; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Morgan CT, 2013, P NATL ACAD SCI USA, V110, P3411, DOI 10.1073/pnas.1300928110; Nakaki F, 2013, NATURE, V501, P222, DOI 10.1038/nature12417; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Oatley J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.100297; Okae H, 2014, HUM MOL GENET, V23, P992, DOI 10.1093/hmg/ddt495; Ramathal C, 2014, CELL REP, V7, P1284, DOI 10.1016/j.celrep.2014.03.067; Su YQ, 2008, DEVELOPMENT, V135, P111, DOI 10.1242/dev.009068; Sugiura K, 2005, DEV BIOL, V279, P20, DOI 10.1016/j.ydbio.2004.11.027; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; White YAR, 2012, NAT MED, V18, P413, DOI 10.1038/nm.2669; Woods DC, 2013, REPROD SCI, V20, P7, DOI 10.1177/1933719112462632; Wu GM, 2005, GENETICS, V170, P327, DOI 10.1534/genetics.104.039479; Yuan JH, 2013, STEM CELLS, V31, P2538, DOI 10.1002/stem.1480; Zhang H, 2012, P NATL ACAD SCI USA, V109, P12580, DOI 10.1073/pnas.1206600109	22	60	63	3	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1257	1261		10.1016/j.cell.2014.05.019	http://dx.doi.org/10.1016/j.cell.2014.05.019			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906145	Green Accepted, Bronze			2022-12-01	WOS:000340881400005
J	Song, R; Walentek, P; Sponer, N; Klimke, A; Lee, JS; Dixon, G; Harland, R; Wan, Y; Lishko, P; Lize, M; Kessel, M; He, L				Song, Rui; Walentek, Peter; Sponer, Nicole; Klimke, Alexander; Lee, Joon Sub; Dixon, Gary; Harland, Richard; Wan, Ying; Lishko, Polina; Lize, Muriel; Kessel, Michael; He, Lin			miR-34/449 miRNAs are required for motile ciliogenesis by repressing cp110	NATURE			English	Article							PRIMARY CILIARY DYSKINESIA; EPITHELIAL-CELLS; BASAL BODIES; SMALL RNAS; C-ELEGANS; MICRORNA; XENOPUS; BIOGENESIS; EXPRESSION; MUTATIONS	The mir-34/449 family consists of six homologous miRNAs at three genomic loci. Redundancy of miR-34/449 miRNAs and their dominant expression in multiciliated epithelia suggest a functional significance in ciliogenesis. Here we report that mice deficient for all miR-34/449 miRNAs exhibited postnatal mortality, infertility and strong respiratory dysfunction caused by defective mucociliary clearance. In both mouse and Xenopus, miR-34/449-deficient multiciliated cells (MCCs) exhibited a significant decrease in cilia length and number, due to defective basal body maturation and apical docking. The effect of miR-34/449 on ciliogenesis was mediated, at least in part, by post-transcriptional repression of Cp110, a centriolar protein suppressing cilia assembly. Consistent with this, cp110 knockdown in miR-34/449-deficient MCCs restored ciliogenesis by rescuing basal body maturation and docking. Altogether, our findings elucidate conserved cellular and molecular mechanisms through which miR-34/449 regulate motile ciliogenesis.	[Song, Rui; Sponer, Nicole; Lee, Joon Sub; Dixon, Gary; Lishko, Polina; He, Lin] Univ Calif Berkeley, Div Cellular & Dev Biol, MCB Dept, Berkeley, CA 94705 USA; [Walentek, Peter; Harland, Richard] Univ Calif Berkeley, Div Genet Genom & Dev, MCB Dept, Ctr Integrat Genom, Berkeley, CA 94705 USA; [Klimke, Alexander; Kessel, Michael] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany; [Wan, Ying] Third Mil Med Univ, Chongqing 400038, Peoples R China; [Lize, Muriel] Univ Gottingen, Dept Mol Oncol, D-37073 Gottingen, Germany	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Max Planck Society; Army Medical University; University of Gottingen	He, L (corresponding author), Univ Calif Berkeley, Div Cellular & Dev Biol, MCB Dept, Berkeley, CA 94705 USA.	rui.song@berkeley.edu; lhe@berkeley.edu	Lishko, Polina/GQH-9569-2022; Lishko, Polina/L-1191-2017	Lee, Joon Sub/0000-0003-1151-1343; Lize, Muriel/0000-0002-4954-3503; Walentek, Peter/0000-0002-2332-6068	NCI [R01 CA139067, 1R21CA175560-01]; CIRM new faculty award [RN2-00923-1]; TRDRP research grant [21RT-0133]; American Cancer Society (ACS) [123339-RSG-12-265-01-RMC]; Siebel postdoctoral fellowship; CIRM postdoctoral fellowship; Deutsche Forschungsgemeinschaft (DFG) [Wa 3365/1-1]; NIH [GM42341]; Dorothea Schloezer Fellowship; NATIONAL CANCER INSTITUTE [R01CA139067, R21CA175560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042341] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CIRM new faculty award; TRDRP research grant; American Cancer Society (ACS)(American Cancer Society); Siebel postdoctoral fellowship; CIRM postdoctoral fellowship; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dorothea Schloezer Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. J. Bennett, M. Butler, B. Dynlacht, W. Finkbeiner, P. Kysar, B. Lee, T. Machen, B. Mitchell and J. Wallingford for constructs, technical assistance, stimulating discussions and helpful input. We also thank P. Margolis for careful reading of our manuscript. L. H. acknowledges an R01 and an R21 grant from NCI (R01 CA139067, 1R21CA175560-01), a CIRM new faculty award (RN2-00923-1), a TRDRP research grant (21RT-0133), and a research scholar award from American Cancer Society (ACS, 123339-RSG-12-265-01-RMC). R. S. acknowledges the support of Siebel postdoctoral fellowship and CIRM postdoctoral fellowship. P. W. was funded by the Deutsche Forschungsgemeinschaft (DFG, Wa 3365/1-1), and frog work in the Harland laboratory was funded by NIH grant GM42341. M. L. would like to thank M. Dobbelstein for support and discussions, and was financed by a Dorothea Schloezer Fellowship.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Avasthi P, 2012, DIFFERENTIATION, V83, pS30, DOI 10.1016/j.diff.2011.11.015; Cao JL, 2012, NAT CELL BIOL, V14, P697, DOI 10.1038/ncb2512; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Deblandre GA, 1999, DEVELOPMENT, V126, P4715; Dehring DAK, 2013, DEV CELL, V27, P103, DOI 10.1016/j.devcel.2013.08.021; Delaval B, 2011, CELL CYCLE, V10, P3964, DOI 10.4161/cc.10.22.18150; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gomperts BN, 2004, J CELL SCI, V117, P1329, DOI 10.1242/jcs.00978; Hagenlocher Cathrin, 2013, Cilia, V2, P12, DOI 10.1186/2046-2530-2-12; HE L, 2004, NAT REV GENET, V5, P522; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hoh RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052166; Kim VN, 2005, MOL CELLS, V19, P1; Kott E, 2013, AM J HUM GENET, V93, P561, DOI 10.1016/j.ajhg.2013.07.013; Kunimoto K, 2012, CELL, V148, P189, DOI 10.1016/j.cell.2011.10.052; Lai YY, 2011, J ALLERGY CLIN IMMUN, V128, P1207, DOI 10.1016/j.jaci.2011.09.001; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li J, 2013, NATURE, V495, P255, DOI 10.1038/nature11941; Lize M, 2011, CELL CYCLE, V10, P2874, DOI 10.4161/cc.10.17.17181; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Marshall WF, 2008, CURR TOP DEV BIOL, V85, P1, DOI 10.1016/S0070-2153(08)00801-6; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martinez-Anton A, 2013, AM J RESP CELL MOL, V49, P384, DOI 10.1165/rcmb.2012-0368OC; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Okada N., 2014, GENES DEV; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Sive H. L., 2000, EARLY DEV XENOPUS LA; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Tanos BE, 2013, GENE DEV, V27, P163, DOI 10.1101/gad.207043.112; Tsang William Y, 2013, Cilia, V2, P9, DOI 10.1186/2046-2530-2-9; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Vladar EK, 2013, METHOD ENZYMOL, V525, P285, DOI 10.1016/B978-0-12-397944-5.00014-6; Walentek P, 2014, DEVELOPMENT, V141, P1526, DOI 10.1242/dev.102343; Walentek P, 2012, CELL REP, V1, P516, DOI 10.1016/j.celrep.2012.03.005; Werner ME, 2012, GENESIS, V50, P176, DOI 10.1002/dvg.20824; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	50	144	149	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					115	+		10.1038/nature13413	http://dx.doi.org/10.1038/nature13413			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24899310	Green Accepted, Green Submitted			2022-12-01	WOS:000336768900039
J	Wilhelm, M; Schlegl, J; Hahne, H; Gholami, AM; Lieberenz, M; Savitski, MM; Ziegler, E; Butzmann, L; Gessulat, S; Marx, H; Mathieson, T; Lemeer, S; Schnatbaum, K; Reimer, U; Wenschuh, H; Mollenhauer, M; Slotta-Huspenina, J; Boese, JH; Bantscheff, M; Gerstmair, A; Faerber, F; Kuster, B				Wilhelm, Mathias; Schlegl, Judith; Hahne, Hannes; Gholami, Amin Moghaddas; Lieberenz, Marcus; Savitski, Mikhail M.; Ziegler, Emanuel; Butzmann, Lars; Gessulat, Siegfried; Marx, Harald; Mathieson, Toby; Lemeer, Simone; Schnatbaum, Karsten; Reimer, Ulf; Wenschuh, Holger; Mollenhauer, Martin; Slotta-Huspenina, Julia; Boese, Joos-Hendrik; Bantscheff, Marcus; Gerstmair, Anja; Faerber, Franz; Kuster, Bernhard			Mass-spectrometry-based draft of the human proteome	NATURE			English	Article							GROWTH-FACTOR RECEPTOR; NONCODING RNAS; IDENTIFICATION; EXPRESSION; QUANTIFICATION; PROTEINS; DATABASE; REVEALS; PEPTIDE; PROJECT	Proteomes are characterized by large protein-abundance differences, cell-type- and time-dependent expression patterns and post-translational modifications, all of which carry biological information that is not accessible by genomics or transcriptomics. Here we present a mass-spectrometry-based draft of the human proteome and a public, high-performance, in-memory database for real-time analysis of terabytes of big data, called ProteomicsDB. The information assembled from human tissues, cell lines and body fluids enabled estimation of the size of the protein-coding genome, and identified organ-specific proteins and a large number of translated lincRNAs (long intergenic non-coding RNAs). Analysis of messenger RNA and protein-expression profiles of human tissues revealed conserved control of protein abundance, and integration of drug-sensitivity data enabled the identification of proteins predicting resistance or sensitivity. The proteome profiles also hold considerable promise for analysing the composition and stoichiometry of protein complexes. ProteomicsDB thus enables navigation of proteomes, provides biological insight and fosters the development of proteomic technology.	[Wilhelm, Mathias; Hahne, Hannes; Gholami, Amin Moghaddas; Marx, Harald; Lemeer, Simone; Kuster, Bernhard] Tech Univ Munich, Chair Prote & Bioanalyt, D-85354 Freising Weihenstephan, Germany; [Wilhelm, Mathias; Schlegl, Judith; Lieberenz, Marcus; Ziegler, Emanuel; Butzmann, Lars; Gessulat, Siegfried; Boese, Joos-Hendrik; Gerstmair, Anja; Faerber, Franz] SAP AG, D-69190 Walldorf, Germany; [Savitski, Mikhail M.; Mathieson, Toby; Bantscheff, Marcus] Cellzome GmbH, D-69117 Heidelberg, Germany; [Schnatbaum, Karsten; Reimer, Ulf; Wenschuh, Holger] JPT Peptide Technol GmbH, D-12489 Berlin, Germany; [Mollenhauer, Martin; Slotta-Huspenina, Julia] Tech Univ Munich, Inst Pathol, D-81675 Munich, Germany; [Kuster, Bernhard] Ctr Integrated Prot Sci Munich, Munich, Germany	Technical University of Munich; SAP; GlaxoSmithKline; Cellzome GmbH; Technical University of Munich; University of Munich	Kuster, B (corresponding author), Tech Univ Munich, Chair Prote & Bioanalyt, Emil Erlenmeyer Forum 5, D-85354 Freising Weihenstephan, Germany.	kuster@tum.de	Ziegler, Emanuel CM/V-4496-2018; Bantscheff, Marcus/AAQ-2903-2021; Lemeer, Simone/I-4363-2016; Kuster, Bernhard/Q-6031-2016	Ziegler, Emanuel CM/0000-0001-8330-7144; Bantscheff, Marcus/0000-0002-8343-8977; Kuster, Bernhard/0000-0002-9094-1677; Gessulat, Siegfried/0000-0001-5530-0674; Wilhelm, Mathias/0000-0002-9224-3258; Reimer, Ulf/0000-0002-3375-6889; Mathieson, Toby/0000-0002-6153-3113				Ahrne E, 2013, PROTEOMICS, V13, P2567, DOI 10.1002/pmic.201300135; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Argenzio E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.118; Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Domon B, 2012, PROTEOM CLIN APPL, V6, P609, DOI 10.1002/prca.201200111; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Farrah T, 2014, J PROTEOME RES, V13, P60, DOI 10.1021/pr4010037; Flintoft L, 2013, NAT REV GENET, V14, P3534, DOI 10.1038/nrg3534; Gallien S, 2012, MOL CELL PROTEOMICS, V11, P1709, DOI 10.1074/mcp.O112.019802; Geiger T, 2013, MOL CELL PROTEOMICS, V12, P1709, DOI 10.1074/mcp.M112.024919; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Gupta N, 2011, J AM SOC MASS SPECTR, V22, P1111, DOI 10.1007/s13361-011-0139-3; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Higdon R, 2011, J PROTEOMICS, V75, P116, DOI 10.1016/j.jprot.2011.06.003; Hisamatsu H, 1996, J EXP MED, V183, P1807, DOI 10.1084/jem.183.4.1807; Hughes GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084714; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Johansson HJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3175; Klingelhofer J, 2009, FEBS J, V276, P5936, DOI 10.1111/j.1742-4658.2009.07274.x; Koumangoye RB, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-167; Lane L, 2014, J PROTEOME RES, V13, P15, DOI 10.1021/pr401144x; Low TY, 2013, CELL REP, V5, P1469, DOI 10.1016/j.celrep.2013.10.041; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Marx H, 2013, NAT BIOTECHNOL, V31, P557, DOI 10.1038/nbt.2585; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nandi D, 1996, J IMMUNOL, V156, P2361; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Paik YK, 2012, NAT BIOTECHNOL, V30, P221, DOI 10.1038/nbt.2152; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200; Schirle M, 2003, MOL CELL PROTEOMICS, V2, P1297, DOI 10.1074/mcp.M300087-MCP200; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shiromizu T, 2013, J PROTEOME RES, V12, P2414, DOI 10.1021/pr300825v; Tran JC, 2011, NATURE, V480, P254, DOI 10.1038/nature10575; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704	46	1254	1284	7	593	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					582	+		10.1038/nature13319	http://dx.doi.org/10.1038/nature13319			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870543				2022-12-01	WOS:000336457100041
J	Majeed, A				Majeed, Azeem			PRIMARY CARE Statins for primary prevention of cardiovascular disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Majeed, Azeem] Univ London Imperial Coll Sci Technol & Med, London, England; [Majeed, Azeem] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England	Imperial College London; Imperial College London	Majeed, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, London, England.	a.majeed@imperial.ac.uk		Majeed, Azeem/0000-0002-2357-9858	Department of Health Funding Source: Medline	Department of Health		Artac M, 2013, FAM PRACT, V30, P426, DOI 10.1093/fampra/cmt002; Artac M, 2013, PREV MED, V57, P129, DOI 10.1016/j.ypmed.2013.05.002; Iacobucci G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1748; Majeed A, 2014, BMJ; NICE, LIP MOD UPD GUID CON; OECD, 2013, HLTH GLANC 2013 OECD	6	6	6	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2014	348								g3491	10.1136/bmj.g3491	http://dx.doi.org/10.1136/bmj.g3491			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EB	24868092				2022-12-01	WOS:000336741400013
J	Kaukua, N; Shahidi, MK; Konstantinidou, C; Dyachuk, V; Kaucka, M; Furlan, A; An, ZW; Wang, LL; Hultman, I; Ahrlund-Richter, L; Blom, H; Brismar, H; Lopes, NA; Pachnis, V; Suter, U; Clevers, H; Thesleff, I; Sharpe, P; Ernfors, P; Fried, K; Adameyko, I				Kaukua, Nina; Shahidi, Maryam Khatibi; Konstantinidou, Chrysoula; Dyachuk, Vyacheslav; Kaucka, Marketa; Furlan, Alessandro; An, Zhengwen; Wang, Longlong; Hultman, Isabell; Ahrlund-Richter, Larsa; Blom, Hans; Brismar, Hjalmar; Lopes, Natalia Assaife; Pachnis, Vassilis; Suter, Ueli; Clevers, Hans; Thesleff, Irma; Sharpe, Paul; Ernfors, Patrik; Fried, Kaj; Adameyko, Igor			Glial origin of mesenchymal stem cells in a tooth model system	NATURE			English	Article							CRANIAL NEURAL CREST; REGENERATION; HOMEOSTASIS; GENERATION; MICE	Mesenchymal stem cells occupy niches in stromal tissues where they provide sources of cells for specialized mesenchymal derivatives during growth and repair(1). The origins of mesenchymal stem cells have been the subject of considerable discussion, and current consensus holds that perivascular cells form mesenchymal stem cells in most tissues. The continuously growing mouse incisor tooth offers an excellent model to address the origin of mesenchymal stem cells. These stem cells dwell in a niche at the tooth apex where they produce a variety of differentiated derivatives. Cells constituting the tooth are mostly derived from two embryonic sources: neural crest ectomesenchyme and ectodermal epithelium(2). It has been thought for decades that the dental mesenchymal stem cells(3) giving rise to pulp cells and odontoblasts derive from neural crest cells after their migration in the early head and formation of ectomesenchymal tissue(4,5). Here we show that a significant population of mesenchymal stem cells during development, self-renewal and repair of a tooth are derived from peripheral nerve-associated glia. Glial cells generate multipotent mesenchymal stem cells that produce pulp cells and odontoblasts. By combining a clonal colour-coding technique(6) with tracing of peripheral glia, we provide new insights into the dynamics of tooth organogenesis and growth.	[Kaukua, Nina; Fried, Kaj] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Konstantinidou, Chrysoula; Pachnis, Vassilis] Natl Inst Med Res, MRC, Div Mol Neurobiol, London NW7 1AA, England; [Dyachuk, Vyacheslav; Kaucka, Marketa; Adameyko, Igor] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Dyachuk, Vyacheslav] Russian Acad Sci, Far Eastern Branch, AV Zhirmunsky Inst Marine Biol, Vladivostok 690041, Russia; [Furlan, Alessandro; Lopes, Natalia Assaife; Ernfors, Patrik] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Unit, S-17177 Stockholm, Sweden; [An, Zhengwen; Wang, Longlong; Sharpe, Paul] Guys Hosp, Inst Dent, Kings Coll London, Dept Craniofacial Dev & Stem Cell Biol, London SE1 3QD, England; [Hultman, Isabell; Ahrlund-Richter, Larsa] Karolinska Inst, Dept Womens & Childrens Hlth, S-17177 Stockholm, Sweden; [Blom, Hans; Brismar, Hjalmar] Royal Inst Technol, Sci Life Lab, S-17177 Stockholm, Sweden; [Suter, Ueli] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, CH-8093 Zurich, Switzerland; [Clevers, Hans] Koninklijke Nederlandse Akad Wetenschappen KNAW, Hubrecht Inst, NL-3508 AD Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, Dept Mol Genet, NL-3508 GA Utrecht, Netherlands; [Clevers, Hans] Univ Helsinki, Dev Biol Program, Inst Biotechnol, FI-00014 Helsinki, Finland	Karolinska Institutet; MRC National Institute for Medical Research; Karolinska Institutet; Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; Karolinska Institutet; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Karolinska Institutet; Royal Institute of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Helsinki	Adameyko, I (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.	Kaj.Fried@ki.se; Igor.Adameyko@ki.se	Furlan, Alessandro/AAM-4680-2021; Brismar, Hjalmar/E-8524-2011; Kaucka, Marketa/AAG-2000-2021; Suter, Ueli/A-1624-2010; Dyachuk, Vyacheslav/U-9115-2019	Furlan, Alessandro/0000-0001-5149-6331; Brismar, Hjalmar/0000-0003-0578-4003; Kaucka, Marketa/0000-0002-8781-9769; Dyachuk, Vyacheslav/0000-0001-8100-7367; Pachnis, Vassilis/0000-0001-9733-7686; Sharpe, Paul/0000-0003-2116-9561; An, Zhengwen/0000-0003-0360-7388	Swedish Research Council; Bertil Hallsten Research Foundation; StratRegen; Wallenberg Foundation; Swiss National Science Foundation; Medical Research Council [G0901599]; Wallenberg Scholar and European Research Council; National Graduate School in Odontological Science; Swedish Dental Association; EMBO Long-Term Fellowship; Stockholm County Council; Developmental Studies Hybridoma Bank; Medical Research Council [MC_U117537087, MR/K018035/1] Funding Source: researchfish; MRC [MR/K018035/1, MC_U117537087, G0901599] Funding Source: UKRI	Swedish Research Council(Swedish Research CouncilEuropean Commission); Bertil Hallsten Research Foundation; StratRegen; Wallenberg Foundation(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wallenberg Scholar and European Research Council; National Graduate School in Odontological Science; Swedish Dental Association; EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Stockholm County Council(Stockholm County Council); Developmental Studies Hybridoma Bank; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	P. Kovaleva and O. Rogachevskaya helped with illustrations. This study was supported by the Swedish Research Council (I. A., K. F., P. E.), The Bertil Hallsten Research Foundation (I. A.), StratRegen and the Wallenberg Foundation (CLICK, I. A.), the Swiss National Science Foundation (U.S.), Medical Research Council (G0901599; P. S.), a Wallenberg Scholar and European Research Council advanced grant (P. E.), National Graduate School in Odontological Science (M. K. S.), the Swedish Dental Association(N.K., M. K. S.), an EMBO Long-Term Fellowship(M. K.) and Stockholm County Council (N.K.) and Developmental Studies Hybridoma Bank.	Adameyko I, 2012, DEVELOPMENT, V139, P397, DOI 10.1242/dev.065581; Adameyko I, 2010, CELL MOL LIFE SCI, V67, P3037, DOI 10.1007/s00018-010-0390-y; Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Caton J, 2009, J ANAT, V214, P502, DOI 10.1111/j.1469-7580.2008.01014.x; Chung IH, 2009, STEM CELLS, V27, P866, DOI 10.1002/stem.2; Crisan M, 2012, J CELL MOL MED, V16, P2851, DOI 10.1111/j.1582-4934.2012.01617.x; Dewachter I, 2002, J NEUROSCI, V22, P3445; Feng JF, 2011, P NATL ACAD SCI USA, V108, P6503, DOI 10.1073/pnas.1015449108; Hari L, 2012, DEVELOPMENT, V139, P2107, DOI 10.1242/dev.073064; Jinno H, 2010, STEM CELLS, V28, P2027, DOI 10.1002/stem.525; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Koussoulakou DS, 2009, INT J BIOL SCI, V5, P226; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; Luukko K, 2008, ANN ANAT, V190, P178, DOI 10.1016/j.aanat.2007.10.003; Miletich Isabelle, 2004, Birth Defects Res C Embryo Today, V72, P200, DOI 10.1002/bdrc.20012; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Zhao H, 2014, CELL STEM CELL, V14, P160, DOI 10.1016/j.stem.2013.12.013	18	262	270	4	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					551	+		10.1038/nature13536	http://dx.doi.org/10.1038/nature13536			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25079316				2022-12-01	WOS:000342075800041
J	Shipony, Z; Mukamel, Z; Cohen, NM; Landan, G; Chomsky, E; Zeliger, SR; Fried, YC; Ainbinder, E; Friedman, N; Tanay, A				Shipony, Zohar; Mukamel, Zohar; Cohen, Netta Mendelson; Landan, Gilad; Chomsky, Elad; Zeliger, Shlomit Reich; Fried, Yael Chagit; Ainbinder, Elena; Friedman, Nir; Tanay, Amos			Dynamic and static maintenance of epigenetic memory in pluripotent and somatic cells	NATURE			English	Article							DNA METHYLATION PATTERNS; STEM-CELLS; GENOME; PLASTICITY; CHROMATIN; ELEMENTS; DOMAINS; REGIONS	Stable maintenance of gene regulatory programs is essential for normal function in multicellular organisms. Epigenetic mechanisms, and DNA methylation in particular, are hypothesized to facilitate such maintenance by creating cellular memory(1-4) that can be written during embryonic development(5,6) and then guide cell-type-specific gene expression(7). Here we develop new methods for quantitative inference of DNA methylation turnover rates, and show that human embryonic stem cells preserve their epigenetic state by balancing antagonistic processes that add and remove methylation marks rather than by copying epigenetic information from mother to daughter cells. In contrast, somatic cells transmit considerable epigenetic information to progenies. Paradoxically, the persistence of the somatic epigenome makes it more vulnerable to noise, since random epimutations can accumulate to massively perturb the epigenomic ground state. The rate of epigenetic perturbation depends on the genomic context, and, in particular, DNA methylation loss is coupled to late DNA replication dynamics. Epigenetic perturbation is not observed in the pluripotent state, because the rapid turnover-based equilibrium continuously reinforces the canonical state. This dynamic epigenetic equilibrium also explains how the epigenome can be reprogrammed quickly(8) and to near perfection(9) after induced pluripotency.	[Shipony, Zohar; Mukamel, Zohar; Cohen, Netta Mendelson; Landan, Gilad; Chomsky, Elad; Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Shipony, Zohar; Mukamel, Zohar; Cohen, Netta Mendelson; Landan, Gilad; Chomsky, Elad; Tanay, Amos] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Chomsky, Elad] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Zeliger, Shlomit Reich; Friedman, Nir] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Fried, Yael Chagit; Ainbinder, Elena] Weizmann Inst Sci, Dept Biol Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Tanay, A (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	amos.tanay@weizmann.ac.il			European Research Council (EVOEPIC); EU BLUEPRINT project; Israel Science Foundation [1050/12]; Israel Ministry of Science; Helen and Martin Kimmel Award	European Research Council (EVOEPIC); EU BLUEPRINT project; Israel Science Foundation(Israel Science Foundation); Israel Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Helen and Martin Kimmel Award	We thank E. Kenigsberg, E. Yaffe and the Tanay group for discussions. Research in the Tanay group was supported by the European Research Council (EVOEPIC), the EU BLUEPRINT project, the Israel Science Foundation (1050/12 and I-Core) the Israel Ministry of Science and the Helen and Martin Kimmel Award.	Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Cohen NM, 2011, CELL, V145, P773, DOI 10.1016/j.cell.2011.04.024; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Halligan DL, 2009, ANNU REV ECOL EVOL S, V40, P151, DOI 10.1146/annurev.ecolsys.39.110707.173437; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/NMETH.1778, 10.1038/nmeth.1778]; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Landan G, 2012, NAT GENET, V44, P1207, DOI 10.1038/ng.2442; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Milyavsky M, 2003, CANCER RES, V63, P7147; Mohn F, 2009, TRENDS GENET, V25, P129, DOI 10.1016/j.tig.2008.12.005; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; STEIN R, 1982, P NATL ACAD SCI-BIOL, V79, P61, DOI 10.1073/pnas.79.1.61; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	36	92	99	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					115	+		10.1038/nature13458	http://dx.doi.org/10.1038/nature13458			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25043040				2022-12-01	WOS:000341174800041
J	Lu, PL; Bai, XC; Ma, D; Xie, T; Yan, CY; Sun, LF; Yang, GH; Zhao, YY; Zhou, R; Scheres, SHW; Shi, YG				Lu, Peilong; Bai, Xiao-chen; Ma, Dan; Xie, Tian; Yan, Chuangye; Sun, Linfeng; Yang, Guanghui; Zhao, Yanyu; Zhou, Rui; Scheres, Sjors H. W.; Shi, Yigong			Three-dimensional structure of human gamma-secretase	NATURE			English	Article							INTRAMEMBRANE PROTEOLYSIS; TRANSMEMBRANE DOMAIN-4; PRESENILIN; NICASTRIN; COMPLEX; BINDING; PROTEIN; RESOLUTION; APH-1; MODEL	The gamma-secretase complex, comprising presenilin 1 (PS1), PEN-2, APH-1 and nicastrin, is a membrane-embedded protease that controls a number of important cellular functions through substrate cleavage. Aberrant cleavage of the amyloid precursor protein (APP) results in aggregation of amyloid-beta, which accumulates in the brain and consequently causes Alzheimer's disease. Here we report the three-dimensional structure of an intact human gamma-secretase complex at 4.5 angstrom resolution, determined by cryo-electron-microscopy single-particle analysis. The gamma-secretase complex comprises a horseshoe-shaped transmembrane domain, which contains 19 transmembrane segments (TMs), and a large extracellular domain (ECD) from nicastrin, which sits immediately above the hollow space formed by the TM horseshoe. Intriguingly, nicastrin ECD is structurally similar to a large family of peptidases exemplified by the glutamate carboxypeptidase PSMA. This structure serves as an important basis for understanding the functional mechanisms of the gamma-secretase complex.	[Lu, Peilong; Ma, Dan; Xie, Tian; Sun, Linfeng; Zhao, Yanyu; Zhou, Rui; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China; [Lu, Peilong; Ma, Dan; Xie, Tian; Yan, Chuangye; Sun, Linfeng; Yang, Guanghui; Zhao, Yanyu; Zhou, Rui; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Lu, Peilong; Ma, Dan; Xie, Tian; Yan, Chuangye; Sun, Linfeng; Yang, Guanghui; Zhao, Yanyu; Zhou, Rui; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Struct Biol Ctr, Beijing 100084, Peoples R China; [Bai, Xiao-chen; Scheres, Sjors H. W.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Yan, Chuangye; Yang, Guanghui] Tsinghua Univ, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; MRC Laboratory Molecular Biology; Tsinghua University	Scheres, SHW (corresponding author), MRC Lab Mol Biol, Cambridge Biomed Campus, Cambridge CB2 0QH, England.	scheres@mrc-lmb.cam.ac.uk; shi-lab@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021; Scheres, Sjors H.W./AAY-2265-2021	Scheres, Sjors H.W./0000-0002-0462-6540; Xie, Tian/0000-0002-5445-664X; Bai, Xiao-chen/0000-0002-4234-5686; Shi, Yigong/0000-0003-2030-168X; Lu, Peilong/0000-0001-5894-9268; Yan, Chuangye/0000-0001-9338-8048	Ministry of Science and Technology of China [2009CB918801]; National Natural Science Foundation of China [30888001, 31021002, 31130002]; European Union Marie Curie Fellowship; UK Medical Research Council [MC_UP_A025_1013]; MRC [MC_UP_A025_1013] Funding Source: UKRI; Medical Research Council [MC_UP_A025_1013] Funding Source: researchfish	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); European Union Marie Curie Fellowship(European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Wolfeand D. Selkoe for support and encouragement, and S. Chen, C. Savva, J. Grimmett and T. Darling for technical support. This work was funded by the Ministry of Science and Technology of China (2009CB918801 to Y.S.), National Natural Science Foundation of China (projects 30888001, 31021002 and 31130002 to Y.S.), a European Union Marie Curie Fellowship (to X. C. B.), and the UK Medical Research Council (MC_UP_A025_1013, to S.H.W.S.).	Alexandrov A, 2004, MOL CELL PROTEOMICS, V3, P934, DOI 10.1074/mcp.T400008-MCP200; Allegretti M, 2014, ELIFE, V3, DOI 10.7554/eLife.01963; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Bammens L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216978; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Dries DR, 2009, J BIOL CHEM, V284, P29714, DOI 10.1074/jbc.M109.038737; Elmlund H, 2013, STRUCTURE, V21, P1299, DOI 10.1016/j.str.2013.07.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fagan R, 2001, TRENDS BIOCHEM SCI, V26, P213, DOI 10.1016/S0968-0004(01)01789-3; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Li Y, 2014, STRUCTURE, V22, P125, DOI 10.1016/j.str.2013.09.018; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Ogura T, 2006, BIOCHEM BIOPH RES CO, V345, P543, DOI 10.1016/j.bbrc.2006.04.025; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Renzi F, 2011, J BIOL CHEM, V286, P21440, DOI 10.1074/jbc.M110.193326; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Schedin-Weiss S, 2014, FEBS J, V281, P46, DOI 10.1111/febs.12590; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Sobhanifar S, 2010, P NATL ACAD SCI USA, V107, P9644, DOI 10.1073/pnas.1000778107; Steiner H, 2008, J BIOL CHEM, V283, P34677, DOI 10.1074/jbc.M709067200; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tang Ya-Ping, 2003, Dialogues Clin Neurosci, V5, P17; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Wolfe MS, 2013, BBA-BIOMEMBRANES, V1828, P2886, DOI 10.1016/j.bbamem.2013.04.015; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Zhang AX, 2010, J AM CHEM SOC, V132, P12711, DOI 10.1021/ja104591m	60	253	268	7	295	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					166	+		10.1038/nature13567	http://dx.doi.org/10.1038/nature13567			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043039	Green Accepted			2022-12-01	WOS:000340200700025
J	Wang, Y; Waters, J; Leung, ML; Unruh, A; Roh, W; Shi, XQ; Chen, K; Scheet, P; Vattathil, S; Liang, H; Multani, A; Zhang, H; Zhao, R; Michor, F; Meric-Bernstam, F; Navin, NE				Wang, Yong; Waters, Jill; Leung, Marco L.; Unruh, Anna; Roh, Whijae; Shi, Xiuqing; Chen, Ken; Scheet, Paul; Vattathil, Selina; Liang, Han; Multani, Asha; Zhang, Hong; Zhao, Rui; Michor, Franziska; Meric-Bernstam, Funda; Navin, Nicholas E.			Clonal evolution in breast cancer revealed by single nucleus genome sequencing	NATURE			English	Article							GROWTH-RATE; CARCINOMAS; MUTATIONS; HETEROGENEITY; REARRANGEMENT; HYBRIDIZATION; NUCLEOTIDE; PATTERNS; EXPRESS	Sequencing studies of breast tumour cohorts have identified many prevalent mutations, but provide limited insight into the genomic diversity within tumours. Here we developed a whole-genome and exome single cell sequencing approach called nuc-seq that uses G2/M nuclei to achieve 91% mean coverage breadth. We applied this method to sequence single normal and tumour nuclei from an oestrogen-receptor-positive(ER+) breast cancer and a triple-negative ductal carcinoma. In parallel, we performed single nuclei copy number profiling. Our data show that aneuploid rearrangements occurred early in tumour evolution and remained highly stable as the tumour masses clonally expanded. In contrast, point mutations evolved gradually, generating extensive clonal diversity. Using targeted single-molecule sequencing, many of the diverse mutations were shown to occur at low frequencies (<10%) in the tumour mass. Using mathematical modelling we found that the triple-negative tumour cells had an increased mutation rate (13.3x), whereas the ER+ tumour cells did not. These findings have important implications for the diagnosis, therapeutic treatment and evolution of chemoresistance in breast cancer.	[Wang, Yong; Waters, Jill; Leung, Marco L.; Unruh, Anna; Roh, Whijae; Shi, Xiuqing; Multani, Asha; Navin, Nicholas E.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Leung, Marco L.; Scheet, Paul; Vattathil, Selina; Navin, Nicholas E.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Chen, Ken; Liang, Han; Navin, Nicholas E.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Scheet, Paul] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Zhang, Hong] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Zhao, Rui; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Zhao, Rui; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Meric-Bernstam, Funda] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; UTMD Anderson Cancer Center	Navin, NE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.	nnavin@mdanderson.org	Chen, Ken/AAU-1432-2021; Leung, Marco/AAH-3178-2021	Chen, Ken/0000-0003-4013-5279; Wang, Yong/0000-0001-7183-3737; Roh, Whijae/0000-0002-7395-9939; Casasent, Anna/0000-0002-7857-179X	NIH [R21CA174397-01, TR000371, U24CA143883]; NCI [1RO1CA169244-01, RO1CA172652, CA016672]; T.C. Hsu and the Alice-Reynolds Kleberg Foundation; Center for Genetics Genomics; Susan Komen [SAC10006]; PS-OC [U54CA143798]; Dell Foundation; ALA; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA169244, R21CA174397, P50CA098258, U54CA143798, U24CA143883, R01CA172652] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); T.C. Hsu and the Alice-Reynolds Kleberg Foundation; Center for Genetics Genomics; Susan Komen(Susan G. Komen Breast Cancer Foundation); PS-OC; Dell Foundation; ALA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank L. Ramagli, H. Tang, E. Thompson, K. Khanna, W. Schober and J. Tyler. We are grateful to S. Kennedy and L. Loeb for help with the duplex protocols. We thank M. Edgerton, J. Hicks, M. Wigler and J. Kendall for discussions. We thank R. Krahe and M. Rui for reviewing the manuscript. N.E.N. is a Nadia's Gift Foundation Damon Runyon-Rachleff Innovator (DRR-25-13). This research was supported by grants to N.E.N. from NIH (R21CA174397-01) and NCI (1RO1CA169244-01). N.E.N. was supported by T. C. Hsu and the Alice-Reynolds Kleberg Foundation. N.E.N. and P. S. were supported by the Center for Genetics & Genomics. F.M.-B was supported by an NIH UL1 (TR000371) and Susan Komen (SAC10006). K. C. was supported by the NCI (RO1CA172652). H. L. was supported by the NIH (U24CA143883). F. M. was supported by PS-OC (U54CA143798). K. C. and H. L. were supported by the Dell Foundation. M. L. L. is a CPRIT scholar and is supported by ALA. This work was also supported by an NCI center grant (CA016672). A.U. is a Rosalie B. Hite Fellow.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dichosa AEK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037387; Drake JW, 1998, GENETICS, V148, P1667; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grubor V, 2009, BLOOD, V113, P1294, DOI 10.1182/blood-2008-05-158865; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; KUROISHI T, 1990, JPN J CANCER RES, V81, P454, DOI 10.1111/j.1349-7006.1990.tb02591.x; Kytola S, 2000, GENE CHROMOSOME CANC, V28, P308, DOI 10.1002/1098-2264(200007)28:3<308::AID-GCC9>3.0.CO;2-B; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loeb LA, 2011, NAT REV CANCER, V11, P450, DOI 10.1038/nrc3063; Lorenz MO, 1905, J AM STAT ASSOC, V9, P209; Luria SE, 1943, GENETICS, V28, P491; McClintock B, 1941, GENETICS, V26, P234; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Michaelson J., 2003, J WOMENS IMAGING, V5, P11; Nachman MW, 2000, GENETICS, V156, P297; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; PEER PGM, 1993, CANCER, V71, P3547, DOI 10.1002/1097-0142(19930601)71:11<3547::AID-CNCR2820711114>3.0.CO;2-C; Pellman D, 2007, NATURE, V446, P38, DOI 10.1038/446038a; Preston BD, 2010, SEMIN CANCER BIOL, V20, P281, DOI 10.1016/j.semcancer.2010.10.009; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Torres L, 2007, BREAST CANCER RES TR, V102, P143, DOI 10.1007/s10549-006-9317-6; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/NMETH.1628, 10.1038/nmeth.1628]; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Woyke T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010314; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	51	670	702	3	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					155	+		10.1038/nature13600	http://dx.doi.org/10.1038/nature13600			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25079324	Green Submitted, Green Accepted			2022-12-01	WOS:000340200700023
J	Hotchkiss, RS; Moldawer, LL				Hotchkiss, Richard S.; Moldawer, Lyle L.			Parallels between Cancer and Infectious Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IMMUNOTHERAPY		[Hotchkiss, Richard S.] Washington Univ, Dept Anesthesiol, Sch Med, St Louis, MO 63130 USA; [Hotchkiss, Richard S.] Washington Univ, Dept Med, Sch Med, St Louis, MO 63130 USA; [Hotchkiss, Richard S.] Washington Univ, Dept Surg, Sch Med, St Louis, MO 63130 USA; [Moldawer, Lyle L.] Univ Florida, Coll Med, Dept Surg, Gainesville, FL USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); State University System of Florida; University of Florida	Hotchkiss, RS (corresponding author), Washington Univ, Dept Anesthesiol, Sch Med, St Louis, MO 63130 USA.			Moldawer, Lyle/0000-0002-9041-9838				Cheever MAM, 2008, IMMUNOL REV, V222, P357, DOI 10.1111/j.1600-065X.2008.00604.x; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Deloitte CIO Journal Editor, 2014, WALL STREET J; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Patel A, 2010, J ANTIMICROB CHEMOTH, V65, P2697, DOI 10.1093/jac/dkq359	7	128	132	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					380	383		10.1056/NEJMcibr1404664	http://dx.doi.org/10.1056/NEJMcibr1404664			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7TY	25054723	Green Published			2022-12-01	WOS:000339339800017
J	Walz, S; Lorenzin, F; Morton, J; Wiese, KE; von Eyss, B; Herold, S; Rycak, L; Dumay-Odelot, H; Karim, S; Bartkuhn, M; Roels, F; Wustefeld, T; Fischer, M; Teichmann, M; Zender, L; Wei, CL; Sansom, O; Wolf, E; Eilers, M				Walz, Susanne; Lorenzin, Francesca; Morton, Jennifer; Wiese, Katrin E.; von Eyss, Bjoern; Herold, Steffi; Rycak, Lukas; Dumay-Odelot, Helene; Karim, Saadia; Bartkuhn, Marek; Roels, Frederik; Wuestefeld, Torsten; Fischer, Matthias; Teichmann, Martin; Zender, Lars; Wei, Chia-Lin; Sansom, Owen; Wolf, Elmar; Eilers, Martin			Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles	NATURE			English	Article							C-MYC; TRANSCRIPTION; PROMOTER; BINDING; GENOME; DNA; ASSOCIATION; INTEGRATION; INDUCTION; CELLS	In mammalian cells, the MYC oncoprotein binds to thousands of promoters(1-4). During mitogenic stimulation of primary lymphocytes, MYC promotes an increase in the expression of virtually all genes(1). In contrast, MYC-driven tumour cells differ from normal cells in the expression of specific sets of up-and downregulated genes that have considerable prognostic value(5-7). To understand this discrepancy, we studied the consequences of inducible expression and depletion of MYC in human cells and murine tumour models. Changes in MYC levels activate and repress specific sets of direct target genes that are characteristic of MYC-transformed tumour cells. Three factors account for this specificity. First, the magnitude of response parallels the change in occupancy by MYC at each promoter. Functionally distinct classes of target genes differ in the E-box sequence bound by MYC, suggesting that different cellular responses to physiological and oncogenic MYC levels are controlled by promoter affinity. Second, MYC both positively and negatively affects transcription initiation independent of its effect on transcriptional elongation(8). Third, complex formation with MIZ1 (also known as ZBTB17)(9) mediates repression of multiple target genes by MYC and the ratio of MYC and MIZ1 bound to each promoter correlates with the direction of response.	[Walz, Susanne; Lorenzin, Francesca; Wiese, Katrin E.; von Eyss, Bjoern; Herold, Steffi; Wolf, Elmar; Eilers, Martin] Univ Wurzburg, Bioctr, Theodor Boveri Inst, D-97074 Wurzburg, Germany; [Morton, Jennifer; Karim, Saadia; Sansom, Owen] CRUK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland; [Rycak, Lukas] Inst Mol Biol & Tumor Res IMT, D-35033 Marburg, Germany; [Dumay-Odelot, Helene; Teichmann, Martin] Univ Bordeaux, IECB, ARNA Lab, Equipe Labellisee Canc, F-33600 Pessac, France; [Bartkuhn, Marek] Univ Giessen, Inst Genet, D-35390 Giessen, Germany; [Roels, Frederik; Fischer, Matthias] Univ Cologne, Univ Childrens Hosp Cologne, D-50924 Cologne, Germany; [Roels, Frederik; Fischer, Matthias] Univ Cologne, Cologne Ctr Mol Med CMMC, D-50924 Cologne, Germany; [Wuestefeld, Torsten; Zender, Lars] Univ Tubingen Hosp, Div Translat Gastrointestinal Oncol, Dept Internal Med 1, D-72076 Tubingen, Germany; [Zender, Lars] German Canc Res Ctr, German Ctr Translat Canc Res DKTK, Translat Gastrointestinal Oncol Grp, D-69121 Heidelberg, Germany; [Wei, Chia-Lin] DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; [Wolf, Elmar] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Eilers, Martin] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, D-97080 Wurzburg, Germany	University of Wurzburg; Beatson Institute; UDICE-French Research Universities; Universite de Bordeaux; Justus Liebig University Giessen; University of Cologne; University of Cologne; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); United States Department of Energy (DOE); German Research Foundation (DFG); University of Wurzburg; University of Wurzburg	Eilers, M (corresponding author), Univ Wurzburg, Bioctr, Theodor Boveri Inst, Hubland, D-97074 Wurzburg, Germany.	elmar.wolf@biozentrum.uni-wuerzburg.de; martin.eilers@biozentrum.uni-wuerzburg.de	Morton, Jennifer/AAJ-5113-2021; von Eyss, Bjoern/P-1077-2019; Morton, Jennifer P/E-1633-2011; Wolf, Elmar/AAY-8493-2021; DUMAY-ODELOT, Hélène/M-7751-2014; Teichmann, Martin/M-7407-2014	Morton, Jennifer/0000-0001-5766-9141; von Eyss, Bjoern/0000-0002-4731-6841; Morton, Jennifer P/0000-0001-5766-9141; Wolf, Elmar/0000-0002-5299-6335; Sansom, Owen J./0000-0001-9540-3010; DUMAY-ODELOT, Helene/0000-0002-7245-084X; Teichmann, Martin/0000-0002-5257-0510; Eilers, Martin/0000-0002-0376-6533; Wiese, Katrin Evelyn/0000-0002-1603-2846; Bartkuhn, Marek/0000-0001-6872-9082	Deutsche Forschungsgemeinschaft (DFG) [222/5-3, 222/12-1]; graduate college 1048 ("Molecular basis of organ development in vertebrates''); DFG Research Center for Experimental Biomedicine; Institut National Du Cancer (INCa); Ligue National Contre le Cancer (Equipe Labellisee); Cancer Research UK core grant; European Research Council investigator grant, "Coloncan''; Cancer Research UK [12481] Funding Source: researchfish	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); graduate college 1048 ("Molecular basis of organ development in vertebrates''); DFG Research Center for Experimental Biomedicine(German Research Foundation (DFG)); Institut National Du Cancer (INCa)(Institut National du Cancer (INCA) France); Ligue National Contre le Cancer (Equipe Labellisee); Cancer Research UK core grant; European Research Council investigator grant, "Coloncan''; Cancer Research UK(Cancer Research UK)	This work was funded by the Deutsche Forschungsgemeinschaft (DFG) through grants 222/5-3 and 222/12-1 (to M.E.), by a stipend of the graduate college 1048 ("Molecular basis of organ development in vertebrates'' to S.W.) and through the DFG Research Center for Experimental Biomedicine (to E.W.). M. T. was supported by grants from the Institut National Du Cancer (INCa) and by the Ligue National Contre le Cancer (Equipe Labellisee). O.S. and J.M. are funded by a Cancer Research UK core grant and a European Research Council investigator grant, "Coloncan''. We thank Y. L. Lee and T. Poh for help with ChIP-sequencing, F. Finkernagel for help with the bioinformatic analysis, A. Au for help with mouse experiments, B. Luscher for critical reading of the manuscript and D. Levens for providing data before publication.	Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Boyd KE, 1997, MOL CELL BIOL, V17, P2529, DOI 10.1128/MCB.17.5.2529; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Horiuchi D, 2012, J EXP MED, V209, P679, DOI 10.1084/jem.20111512; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iraci N, 2011, CANCER RES, V71, P404, DOI 10.1158/0008-5472.CAN-10-2627; Kosan C, 2010, IMMUNITY, V33, P917, DOI 10.1016/j.immuni.2010.11.028; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; van Riggelen J, 2010, GENE DEV, V24, P1281, DOI 10.1101/gad.585710; Wiese KE, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014290; Wolf E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3535; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Yustein JT, 2010, P NATL ACAD SCI USA, V107, P3534, DOI 10.1073/pnas.0901230107; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	38	302	309	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					483	+		10.1038/nature13473	http://dx.doi.org/10.1038/nature13473			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25043018	Green Accepted			2022-12-01	WOS:000339335700050
J	Jorgensen, ME; Torp-Pedersen, C; Gislason, GH; Jensen, PF; Berger, SM; Christiansen, CB; Overgaard, C; Schmiegelow, MD; Andersson, C				Jorgensen, Mads E.; Torp-Pedersen, Christian; Gislason, Gunnar H.; Jensen, Per Foge; Berger, Siv Mari; Christiansen, Christine Benn; Overgaard, Charlotte; Schmiegelow, Michelle D.; Andersson, Charlotte			Time Elapsed After Ischemic Stroke and Risk of Adverse Cardiovascular Events and Mortality Following Elective Noncardiac Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERIOPERATIVE STROKE; CARDIAC RISK; MYOCARDIAL-INFARCTION; OUTCOMES; ASSOCIATION; VALIDATION; PREDICTORS; GUIDELINES; MANAGEMENT; VALIDITY	IMPORTANCE The timing of surgery in patients with recent ischemic stroke is an important and inadequately addressed issue. OBJECTIVE To assess the safety and importance of time elapsed between stroke and surgery in the risk of perioperative cardiovascular events and mortality. DESIGN, SETTING, AND PARTICIPANTS Danish nationwide cohort study (2005-2011) including all patients aged 20 years or older undergoing elective noncardiac surgeries (n = 481 183 surgeries). EXPOSURES Time elapsed between stroke and surgery in categories and as a continuous measure. MAIN OUTCOMES AND MEASURES Risk of major adverse cardiovascular events (MACE; including ischemic stroke, acutemyocardial infarction, and cardiovascular mortality) and all-cause mortality up to 30 days after surgery. Odds ratios (ORs) were calculated by multivariable logistic regression models. RESULTS Crude incidence rates ofMACE among patients with (n = 7137) and without (n = 474 046) prior stroke were 54.4 (95% CI, 49.1-59.9) vs 4.1 (95% CI, 3.9-4.2) per 1000 patients. Compared with patients without stroke, ORs forMACE were 14.23 (95% CI, 11.61-17.45) for stroke less than 3 months prior to surgery, 4.85 (95% CI, 3.32-7.08) for stroke 3 to less than 6 months prior, 3.04 (95% CI, 2.13-4.34) for stroke 6 to less than 12 months prior, and 2.47 (95% CI, 2.07-2.95) for stroke 12 months or more prior. MACE risks were at least as high for low-risk (OR, 9.96; 95% CI, 5.49-18.07 for stroke < 3 months) and intermediate-risk (OR, 17.12; 95% CI, 13.68-21.42 for stroke < 3 months) surgery compared with high-risk surgery (OR, 2.97; 95% CI, 0.98-9.01 for stroke < 3 months) (P =.003 for interaction). Similar patterns were found for 30-day mortality: ORs were 3.07 (95% CI, 2.30-4.09) for stroke less than 3 months prior, 1.97 (95% CI, 1.22-3.19) for stroke 3 to less than 6 months prior, 1.45 (95% CI, 0.95-2.20) for stroke 6 to less than 12 months prior, and 1.46 (95% CI, 1.21-1.77) for stroke 12 months or more prior to surgery compared with patients without stroke. Cubic regression splines performed on the stroke subgroup supported that risk leveled off after 9 months. CONCLUSIONS AND RELEVANCE A history of stroke was associated with adverse outcomes following surgery, in particular if time between stroke and surgery was less than 9 months. After 9 months, the associated risk appeared stable yet still increased compared with patients with no stroke. The time dependency of risk may warrant attention in future guidelines. Copyright 2014 American Medical Association. All rights reserved.	[Jorgensen, Mads E.; Gislason, Gunnar H.; Berger, Siv Mari; Christiansen, Christine Benn; Schmiegelow, Michelle D.; Andersson, Charlotte] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Copenhagen, Denmark; [Torp-Pedersen, Christian; Overgaard, Charlotte] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Gislason, Gunnar H.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Gislason, Gunnar H.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Jensen, Per Foge] Univ Copenhagen, Rigshosp, Dept Cardiothorac Anesthesia, DK-2100 Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Aalborg University; University of Copenhagen; University of Southern Denmark; Rigshospitalet; University of Copenhagen	Jorgensen, ME (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Hjertemedicinsk Forskning 1, DK-2900 Hellerup, Denmark.	mads.emil.joergensen@regionh.dk	Gislason, Gunnar/B-7561-2009; Overgaard, Charlotte/D-8083-2011; Overgaard, Charlotte/Q-2032-2019; Andersson, Charlotte/P-4849-2014	Gislason, Gunnar/0000-0002-0548-402X; Overgaard, Charlotte/0000-0002-3370-2338; Overgaard, Charlotte/0000-0002-3370-2338; 	Danish Agency for Science, Technology and Innovation [FSS-11-120873]; Novo Nordisk Foundation; University of Copenhagen	Danish Agency for Science, Technology and Innovation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); University of Copenhagen	Dr Andersson was funded by an independent research grant from the Danish Agency for Science, Technology and Innovation (grant FSS-11-120873). Dr Gislason is supported by an independent research scholarship from the Novo Nordisk Foundation. Dr Schmiegelow was funded by an independent research grant from the University of Copenhagen.	Andersson C, 2014, JAMA INTERN MED, V174, P336, DOI 10.1001/jamainternmed.2013.11349; Andersson C, 2012, JAMA-J AM MED ASSOC, V308, P882, DOI 10.1001/2012.jama.10779; Andersson C, 2010, ESSENTIAL DURER, P12; Aries MJH, 2010, STROKE, V41, P2697, DOI 10.1161/STROKEAHA.110.594168; Bateman BT, 2009, ANESTHESIOLOGY, V110, P231, DOI 10.1097/ALN.0b013e318194b5ff; Boersma E, 2005, AM J MED, V118, P1134, DOI 10.1016/j.amjmed.2005.01.064; Bottle A, 2013, ANESTHESIOLOGY, V118, P885, DOI 10.1097/ALN.0b013e3182815912; Brilakis ES, 2007, J AM COLL CARDIOL, V49, P2145, DOI 10.1016/j.jacc.2007.02.046; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Fleisher LA, 2007, CIRCULATION, V116, pE418, DOI 10.1161/CIRCULATIONAHA.107.185699; Gaist D, 1997, DAN MED BULL, V44, P445; Hawn MT, 2013, JAMA-J AM MED ASSOC, V310, P1462, DOI 10.1001/jama.2013.278787; Hogue CW, 1999, CIRCULATION, V100, P642, DOI 10.1161/01.CIR.100.6.642; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Livhits M, 2011, ANN SURG, V253, P857, DOI 10.1097/SLA.0b013e3182125196; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Mashour GA, 2013, ANESTHESIOLOGY, V119, P1340, DOI 10.1097/ALN.0b013e318295a25f; Mashour GA, 2011, ANESTHESIOLOGY, V114, P1289, DOI 10.1097/ALN.0b013e318216e7f4; Ng JLW, 2011, ANESTHESIOLOGY, V115, P879, DOI 10.1097/ALN.0b013e31822e9499; NOMESCO N., 2009, NOMESCO CLASSIFICATI; Noordzij PG, 2010, ANESTHESIOLOGY, V112, P1105, DOI 10.1097/ALN.0b013e3181d5f95c; Poldermans D, 2009, EUR HEART J, V30, P2769, DOI 10.1093/eurheartj/ehp337; Sanders RD, 2012, ANN SURG, V255, P901, DOI 10.1097/SLA.0b013e31824c438d; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Sharifpour M, 2013, ANESTH ANALG, V116, P424, DOI 10.1213/ANE.0b013e31826a1a32; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; van Kuijk JP, 2009, AM J CARDIOL, V104, P1229, DOI 10.1016/j.amjcard.2009.06.038; Vicenzi MN, 2006, BRIT J ANAESTH, V96, P686, DOI 10.1093/bja/ael083	30	90	97	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2014	312	3					269	277		10.1001/jama.2014.8165	http://dx.doi.org/10.1001/jama.2014.8165			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2FC	25027142	Bronze			2022-12-01	WOS:000338940300024
J	Costandi, M				Costandi, Moheb			REHABILITATION Machine recovery	NATURE			English	Editorial Material							ROBOT-ASSISTED THERAPY; UPPER-LIMB IMPAIRMENT; STROKE											Burgar CG, 2011, J REHABIL RES DEV, V48, P445, DOI 10.1682/JRRD.2010.04.0062; Jarrasse N., 2013, IEEE INT C REH ROB; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Lambercy O, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-63; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; Maciejasz P, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-3; Taheri H, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-10; Volpe BT, 2000, NEUROLOGY, V54, P1938, DOI 10.1212/WNL.54.10.1938; Wagner TH, 2011, STROKE, V42, P2630, DOI 10.1161/STROKEAHA.110.606442	9	8	8	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S8	S9		10.1038/510S8a	http://dx.doi.org/10.1038/510S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ6LK	24964027				2022-12-01	WOS:000337806300006
J	Friedewald, SM; Rafferty, EA; Rose, SL; Durand, MA; Plecha, DM; Greenberg, JS; Hayes, MK; Copit, DS; Carlson, KL; Cink, TM; Barke, LD; Greer, LN; Miller, DP; Conant, EF				Friedewald, Sarah M.; Rafferty, Elizabeth A.; Rose, Stephen L.; Durand, Melissa A.; Plecha, Donna M.; Greenberg, Julianne S.; Hayes, Mary K.; Copit, Debra S.; Carlson, Kara L.; Cink, Thomas M.; Barke, Lora D.; Greer, Linda N.; Miller, Dave P.; Conant, Emily F.			Breast Cancer Screening Using Tomosynthesis in Combination With Digital Mammography	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERFORMANCE; POPULATION; TRIAL	IMPORTANCE Mammography plays a key role in early breast cancer detection. Single-institution studies have shown that adding tomosynthesis to mammography increases cancer detection and reduces false-positive results. OBJECTIVE To determine if mammography combined with tomosynthesis is associated with better performance of breast screening programs in the United States. DESIGN, SETTING, AND PARTICIPANTS Retrospective analysis of screening performance metrics from 13 academic and nonacademic breast centers using mixed models adjusting for site as a random effect. EXPOSURES Period 1: digital mammography screening examinations 1 year before tomosynthesis implementation (start dates ranged from March 2010 to October 2011 through the date of tomosynthesis implementation); period 2: digital mammography plus tomosynthesis examinations from initiation of tomosynthesis screening (March 2011 to October 2012) through December 31, 2012. MAIN OUTCOMES AND MEASURES Recall rate for additional imaging, cancer detection rate, and positive predictive values for recall and for biopsy. RESULTS A total of 454 850 examinations (n = 281 187 digital mammography; n = 173 663 digital mammography + tomosynthesis) were evaluated. With digital mammography, 29 726 patients were recalled and 5056 biopsies resulted in cancer diagnosis in 1207 patients (n = 815 invasive; n = 392 in situ). With digital mammography + tomosynthesis, 15 541 patients were recalled and 3285 biopsies resulted in cancer diagnosis in 950 patients (n = 707 invasive; n = 243 in situ). Model-adjusted rates per 1000 screens were as follows: for recall rate, 107 (95% CI, 89-124) with digital mammography vs 91 (95% CI, 73-108) with digital mammography + tomosynthesis; difference, -16 (95% CI, -18 to -14; P < .001); for biopsies, 18.1 (95% CI, 15.4-20.8) with digital mammography vs 19.3 (95% CI, 16.6-22.1) with digital mammography + tomosynthesis; difference, 1.3 (95% CI, 0.4-2.1; P = .004); for cancer detection, 4.2 (95% CI, 3.8-4.7) with digital mammography vs 5.4 (95% CI, 4.9-6.0) with digital mammography + tomosynthesis; difference, 1.2 (95% CI, 0.8-1.6; P < .001); and for invasive cancer detection, 2.9 (95% CI, 2.5-3.2) with digital mammography vs 4.1 (95% CI, 3.7-4.5) with digital mammography + tomosynthesis; difference, 1.2 (95% CI, 0.8-1.6; P < .001). The in situ cancer detection rate was 1.4 (95% CI, 1.2-1.6) per 1000 screens with both methods. Adding tomosynthesis was associated with an increase in the positive predictive value for recall from 4.3% to 6.4%(difference, 2.1%; 95% CI, 1.7%-2.5%; P < .001) and for biopsy from 24.2% to 29.2%(difference, 5.0%; 95% CI, 3.0%-7.0%; P < .001). CONCLUSIONS AND RELEVANCE Addition of tomosynthesis to digital mammography was associated with a decrease in recall rate and an increase in cancer detection rate. Further studies are needed to assess the relationship to clinical outcomes.	[Friedewald, Sarah M.] Advocate Lutheran Gen Hosp, Ctr Adv Care, Caldwell Breast Ctr, Park Ridge, IL 60068 USA; [Rafferty, Elizabeth A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Rose, Stephen L.] TOPS Comprehens Breast Ctr, Houston, TX USA; [Rose, Stephen L.] Solis Womens Hlth, Dallas, TX USA; [Durand, Melissa A.] Yale Univ, Sch Med, Dept Diagnost Radiol, Breast Imaging Sect, New Haven, CT 06510 USA; [Plecha, Donna M.] Univ Hosp Case Med Ctr, Dept Radiol, Cleveland, OH USA; [Greenberg, Julianne S.] Washington Radiol Associates, Fairfax, VA USA; [Hayes, Mary K.] Radiol Associates Hollywood, Hollywood, FL USA; [Hayes, Mary K.] Mem Healthcare Syst, Hollywood, FL USA; [Copit, Debra S.] Albert Einstein Healthcare Network, Dept Diagnost Radiol, Philadelphia, PA USA; [Carlson, Kara L.] Evergreen Hlth Breast Ctr, Kirkland, WA USA; [Carlson, Kara L.] Radia Inc, Kirkland, WA USA; [Cink, Thomas M.] Edith Sanford Breast Hlth Inst, Sioux Falls, SD USA; [Barke, Lora D.] Invis Sally Jobe Breast Ctr, Denver, CO USA; [Barke, Lora D.] Radiol Imaging Associates, Denver, CO USA; [Greer, Linda N.] John C Lincoln Breast Hlth & Res Ctr, Phoenix, AZ USA; [Miller, Dave P.] ICON Clin Res, San Francisco, CA USA; [Conant, Emily F.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA	Harvard University; Massachusetts General Hospital; Yale University; Case Western Reserve University; Case Western Reserve University Hospital; Yeshiva University; ICON plc; University of Pennsylvania; Pennsylvania Medicine	Friedewald, SM (corresponding author), Advocate Lutheran Gen Hosp, Ctr Adv Care, Caldwell Breast Ctr, Third Floor,1700 Luther Ln, Park Ridge, IL 60068 USA.	sarah.friedewald@advocatehealth.com		Plecha, Donna/0000-0003-1714-4337; Miller, Dave/0000-0003-2947-152X	Hologic; National Cancer Institute [5U54CA163316-03]	Hologic; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Drs Friedewald, Rafferty, Rose, Durand, Plecha, Greenberg, Hayes, Copit, Carlson, Cink, Barke, and Greer received a research grant from Hologic. Dr Conant received research grant 5U54CA163316-03 from the National Cancer Institute.	Andersson I, 2008, EUR RADIOL, V18, P2817, DOI 10.1007/s00330-008-1076-9; Berg WA, 2008, JAMA-J AM MED ASSOC, V299, P2151, DOI 10.1001/jama.299.18.2151; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Carney PA, 2010, RADIOLOGY, V255, P354, DOI 10.1148/radiol.10091636; Ciatto S, 2013, LANCET ONCOL, V14, P583, DOI 10.1016/S1470-2045(13)70134-7; Gur D, 2009, AM J ROENTGENOL, V193, P586, DOI 10.2214/AJR.08.2031; Haas BM, 2013, RADIOLOGY, V269, P694, DOI 10.1148/radiol.13130307; Park JM, 2007, RADIOGRAPHICS, V27, pS231, DOI 10.1148/rg.27si075511; Pisano ED, 2005, RADIOLOGY, V234, P353, DOI 10.1148/radiol.2342030897; Rafferty EA, 2013, RADIOLOGY, V266, P104, DOI 10.1148/radiol.12120674; Rose SL, 2013, AM J ROENTGENOL, V200, P1401, DOI 10.2214/AJR.12.9672; Rosenberg RD, 2006, RADIOLOGY, V241, P55, DOI 10.1148/radiol.2411051504; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Skaane P, 2013, RADIOLOGY, V267, P47, DOI 10.1148/radiol.12121373; Tabar L, 2011, RADIOLOGY, V260, P658, DOI 10.1148/radiol.11110469; US Food and Drug Administration, SEL DIM 3D SYST P080; US Food and Drug Administration, SEL DIM 3D SYST P008; Welch HG, 2014, JAMA INTERN MED, V174, P448, DOI 10.1001/jamainternmed.2013.13635	18	554	561	4	58	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2014	311	24					2499	2507		10.1001/jama.2014.6095	http://dx.doi.org/10.1001/jama.2014.6095			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ5VE	25058084	Bronze			2022-12-01	WOS:000337757000023
J	Fukushima, FB; Bezerra, DM; Boas, PJFV; Valle, AP; Vidal, EIO				Fukushima, Fernanda B.; Bezerra, Dailson M.; Villas Boas, Paulo J. F.; Valle, Adriana P.; Vidal, Edison I. O.			Complex regional pain syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Fukushima, Fernanda B.; Bezerra, Dailson M.] Univ Estadual Paulista UNESP, Dept Anesthesiol, BR-18618970 Botucatu, SP, Brazil; [Villas Boas, Paulo J. F.; Valle, Adriana P.; Vidal, Edison I. O.] Univ Estadual Paulista UNESP, Dept Internal Med, BR-18618970 Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Fukushima, FB (corresponding author), Univ Estadual Paulista UNESP, Dept Anesthesiol, BR-18618970 Botucatu, SP, Brazil.	ffukushima@fmb.unesp.br	de Oliveira Vidal, Edison Iglesias/G-1882-2012; Valle, Adriana P/F-9897-2014; Valle, Adriana/ABI-5894-2020; Fukushima, Fernanda Bono/AAR-2740-2021; Fukushima, Fernanda Bono/E-3196-2012; Boas, Paulo J F Villas/I-4656-2014	de Oliveira Vidal, Edison Iglesias/0000-0002-1573-4678; Valle, Adriana P/0000-0002-0090-8524; Fukushima, Fernanda Bono/0000-0001-8055-5425; Boas, Paulo J F Villas/0000-0001-9876-3222				Albazaz R, 2008, ANN VASC SURG, V22, P297, DOI 10.1016/j.avsg.2007.10.006; Allen G, 1999, PAIN, V80, P539, DOI 10.1016/S0304-3959(98)00246-2; Beerthuizen A, 2012, PAIN, V153, P1187, DOI 10.1016/j.pain.2012.01.026; Centre for Clinical Practice at NICE (UK), 2010, NEUR PAIN PHARM MAN; de Mos M, 2007, PAIN, V129, P12, DOI 10.1016/j.pain.2006.09.008; de Mos M, 2009, CLIN J PAIN, V25, P590, DOI 10.1097/AJP.0b013e3181a11623; Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Goebel A, 2012, COMPLEX REGIONAL PAI; Harden RN, 2013, PAIN MED, V14, P180, DOI 10.1111/pme.12033; Harden RN, 2010, PAIN, V150, P268, DOI 10.1016/j.pain.2010.04.030; International Association for the Study of Pain, CLASSIFICATION CHRON; Marinus Johan, 2011, Lancet Neurol, V10, P637, DOI 10.1016/S1474-4422(11)70106-5; Moseley GL, 2014, J PAIN, V15, P16, DOI 10.1016/j.jpain.2013.08.009; O'Connell NE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009416.pub2; Sandroni P, 2003, PAIN, V103, P199, DOI 10.1016/S0304-3959(03)00065-4	15	8	9	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2014	348								g3683	10.1136/bmj.g3683	http://dx.doi.org/10.1136/bmj.g3683			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK1UK	24965221	Green Published			2022-12-01	WOS:000338202200001
J	Palmer, JC; Martelli, F; Liu, Y; Car, R; Panagiotopoulos, AZ; Debenedetti, PG				Palmer, Jeremy C.; Martelli, Fausto; Liu, Yang; Car, Roberto; Panagiotopoulos, Athanassios Z.; Debenedetti, Pablo G.			Metastable liquid-liquid transition in a molecular model of water	NATURE			English	Article							SUPERCOOLED WATER; HEAT-CAPACITY; CUBIC ICE; ST2 WATER; ENERGY; SIMULATION; DYNAMICS; BEHAVIOR; SINGULARITY; STABILITY	Liquid water's isothermal compressibility(1) and isobaric heat capacity(2), and the magnitude of its thermal expansion coefficient(3), increase sharply on cooling below the equilibrium freezing point. Many experimental(4-8), theoretical(9-11) and computational(12,13) studies have sought to understand the molecular origin and implications of this anomalous behaviour. Of the different theoretical scenarios(9,14,15) put forward, one posits the existence of a first-order phase transition that involves two forms of liquid water and terminates at a critical point located at deeply supercooled conditions(9,12). Some experimental evidence is consistent with this hypothesis(4,16), but no definitive proof of a liquid-liquid transition in water has been obtained to date: rapid ice crystallization has so far prevented decisive measurements on deeply supercooled water, although this challenge has been overcome recently(16). Computer simulations are therefore crucial for exploring water's structure and behaviour in this regime, and have shown(13,17-21) that some water models exhibit liquid-liquid transitions and others do not. However, recent work(22,23) has argued that the liquid-liquid transition has been mistakenly interpreted, and is in fact a liquid-crystal transition in all atomistic models of water. Here we show, by studying the liquid-liquid transition in the ST2 model of water(24) with the use of six advanced sampling methods to compute the free-energy surface, that two metastable liquid phases and a stable crystal phase exist at the same deeply supercooled thermodynamic condition, and that the transition between the two liquids satisfies the thermodynamic criteria of a first-order transition(25). We follow the rearrangement of water's coordination shell and topological ring structure along a thermodynamically reversible path from the low-density liquid to cubic ice(26). We also show that the system fluctuates freely between the two liquid phases rather than crystallizing. These findings provide unambiguous evidence for a liquid-liquid transition in the ST2 model of water, and point to the separation of time scales between crystallization and relaxation as being crucial for enabling it.	[Palmer, Jeremy C.; Liu, Yang; Panagiotopoulos, Athanassios Z.; Debenedetti, Pablo G.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Martelli, Fausto; Car, Roberto] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Princeton University	Debenedetti, PG (corresponding author), Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA.	pdebene@princeton.edu	Panagiotopoulos, Athanassios Z/K-2955-2014; Debenedetti, Pablo/ABD-1497-2021; Martelli, Fausto/A-6148-2017	Panagiotopoulos, Athanassios Z/0000-0002-8152-6615; Debenedetti, Pablo/0000-0003-1881-1728; Martelli, Fausto/0000-0002-5350-8225	National Science Foundation [CHE 1213343]; US Department of Energy [DE-SC0002128, DE-SC0008626]; Direct For Mathematical & Physical Scien [1213343] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Computations were performed at the Terascale Infrastructure for Groundbreaking Research in Engineering and Science (TIGRESS) facility at Princeton University. P.G.D. acknowledges support from the National Science Foundation (CHE 1213343), A.Z.P. acknowledges support from the US Department of Energy (DE-SC0002128), and R.C. acknowledges support from the US Department of Energy (DE-SC0008626).	Amann-Winkel K, 2013, P NATL ACAD SCI USA, V110, P17720, DOI 10.1073/pnas.1311718110; ANGELL CA, 1982, J PHYS CHEM-US, V86, P998, DOI 10.1021/j100395a032; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Bonomi M, 2009, J COMPUT CHEM, V30, P1615, DOI 10.1002/jcc.21305; Choukroun M, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3487520; Choukroun M, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2768957; Clark GNI, 2010, P NATL ACAD SCI USA, V107, P14003, DOI 10.1073/pnas.1006599107; DUANE S, 1987, PHYS LETT B, V195, P216, DOI 10.1016/0370-2693(87)91197-X; Frenkel D, 1996, UNDERSTANDING MOL SI, V50, P66; Gee J, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3551576; HANDA YP, 1986, J CHEM PHYS, V84, P7009, DOI 10.1063/1.450622; Handel R, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.036104; HARE DE, 1986, J CHEM PHYS, V84, P5085, DOI 10.1063/1.450660; Holten V, 2012, SCI REP-UK, V2, DOI 10.1038/srep00713; Huang C, 2009, P NATL ACAD SCI USA, V106, P15214, DOI 10.1073/pnas.0904743106; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; HUNTER JE, 1995, J CHEM PHYS, V103, P8627, DOI 10.1063/1.470121; Kesselring TA, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4808355; KING SV, 1967, NATURE, V213, P1112, DOI 10.1038/2131112a0; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LEE JY, 1990, PHYS REV LETT, V65, P137, DOI 10.1103/PhysRevLett.65.137; Li YP, 2013, P NATL ACAD SCI USA, V110, P12209, DOI 10.1073/pnas.1309042110; Limmer DT, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4807479; Limmer DT, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3643333; Liu Y, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4769126; Liu Y, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3229892; Matsumoto M, 2002, NATURE, V416, P409, DOI 10.1038/416409a; MAYER E, 1987, NATURE, V325, P601, DOI 10.1038/325601a0; MCMILLAN JA, 1965, NATURE, V206, P806, DOI 10.1038/206806a0; Miller TF, 2002, J CHEM PHYS, V116, P8649, DOI 10.1063/1.1473654; Mishima O, 1998, NATURE, V392, P164, DOI 10.1038/32386; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Moore EB, 2011, NATURE, V479, P506, DOI 10.1038/nature10586; Moore EB, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3451112; Overduin SD, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4803868; Palmer J. C., 2013, FARADAY DISCUSS, V167, P118; Palmer JC, 2013, FARADAY DISCUSS, V167, P77, DOI 10.1039/c3fd00074e; Poole PH, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4775738; POOLE PH, 1994, PHYS REV LETT, V73, P1632, DOI 10.1103/PhysRevLett.73.1632; POOLE PH, 1992, NATURE, V360, P324, DOI 10.1038/360324a0; Reinhardt A, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4766362; ROSSKY PJ, 1978, J CHEM PHYS, V69, P4628, DOI 10.1063/1.436415; Sastry S, 1996, PHYS REV E, V53, P6144, DOI 10.1103/PhysRevE.53.6144; Shilling JE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026671; Shiratani E, 1998, J CHEM PHYS, V108, P3264, DOI 10.1063/1.475723; Soper AK, 2000, PHYS REV LETT, V84, P2881, DOI 10.1103/PhysRevLett.84.2881; SPEEDY RJ, 1976, J CHEM PHYS, V65, P851, DOI 10.1063/1.433153; SPEEDY RJ, 1982, J PHYS CHEM-US, V86, P982, DOI 10.1021/j100395a030; STEINHARDT PJ, 1983, PHYS REV B, V28, P784, DOI 10.1103/PhysRevB.28.784; STILLINGER FH, 1974, J CHEM PHYS, V60, P1545, DOI 10.1063/1.1681229; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Tanaka H, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.064202; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Vega C, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2715577; WEBER TA, 1984, J CHEM PHYS, V80, P438, DOI 10.1063/1.446468; Winkel K, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2830029; YAMAMURO O, 1987, J PHYS CHEM SOLIDS, V48, P935, DOI 10.1016/0022-3697(87)90130-2	57	359	362	15	424	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					385	+		10.1038/nature13405	http://dx.doi.org/10.1038/nature13405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24943954				2022-12-01	WOS:000337350200032
J	Regot, S; Hughey, JJ; Bajar, BT; Carrasco, S; Covert, MW				Regot, Sergi; Hughey, Jacob J.; Bajar, Bryce T.; Carrasco, Silvia; Covert, Markus W.			High-Sensitivity Measurements of Multiple Kinase Activities in Live Single Cells	CELL			English	Article							PROTEIN-PHOSPHORYLATION; FRET BIOSENSORS; GROWTH-FACTOR; DYNAMICS; ACTIVATION; REPORTERS; DECISION; PATHWAY; SIGNALS; BRIGHT	Increasing evidence has shown that population dynamics are qualitatively different from single-cell behaviors. Reporters to probe dynamic, single-cell behaviors are desirable yet relatively scarce. Here, we describe an easy-to-implement and generalizable technology to generate reporters of kinase activity for individual cells. Our technology converts phosphorylation into a nucleocytoplasmic shuttling event that can be measured by epifluorescence microscopy. Our reporters reproduce kinase activity for multiple types of kinases and allow for calculation of active kinase concentrations via a mathematical model. Using this technology, we made several experimental observations that had previously been technically-unfeasible, including stimulus-dependent patterns of c-Jun N-terminal kinase (JNK) and nuclear factor kappa B (NF-kappa B) activation. We also measured JNK, p38, and ERK activities simultaneously, finding that p38 regulates the peak number, but not the intensity, of ERK fluctuations. Our approach opens the possibility of analyzing a wide range of kinase-mediated processes in individual cells.	[Regot, Sergi; Hughey, Jacob J.; Bajar, Bryce T.; Carrasco, Silvia; Covert, Markus W.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University	Regot, S (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	sregot@stanford.edu; mcovert@stanford.edu		Bajar, Bryce/0000-0002-0169-0870; Hughey, Jacob/0000-0002-1558-6089; Regot, Sergi/0000-0001-9786-3897; Covert, Markus/0000-0002-5993-8912	Human Frontier Science Program (HFSP) postdoctoral fellowship [LT000529/2012-L]; NIH [5R21AI104305-02, 5DP1LM01150-05]; Stanford Center for Systems Biology [NIH P50GM107615]; Allen Distinguished Investigator Award; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [R18DP001150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI104305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [DP1LM011510] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006413] Funding Source: NIH RePORTER	Human Frontier Science Program (HFSP) postdoctoral fellowship(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Center for Systems Biology; Allen Distinguished Investigator Award; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Collins and members of the Covert lab, in particular D. Macklin, for helpful discussions and comments on the manuscript. We thank Dr. K. Aoki for providing the FRET-based JNKAR plasmid. We also gratefully acknowledge a Human Frontier Science Program (HFSP) postdoctoral fellowship (LT000529/2012-L) to S.R., as well as an NIH R21 (5R21AI104305-02), an NIH Pioneer Award (5DP1LM01150-05), the Stanford Center for Systems Biology (NIH P50GM107615), and an Allen Distinguished Investigator Award to M.W.C. S.R., J.J.H., and M.W.C. are listed as inventors in a patent application for KTR technology.	Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Bagowski CP, 2001, CURR BIOL, V11, P1176, DOI 10.1016/S0960-9822(01)00330-X; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Fosbrink M, 2010, P NATL ACAD SCI USA, V107, P5459, DOI 10.1073/pnas.0909671107; Fritz RD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004135; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gu JM, 2004, MOL BIOL CELL, V15, P3320, DOI 10.1091/mbc.E04-03-0227; Hahn AT, 2009, CELL CYCLE, V8, P1044, DOI 10.4161/cc.8.7.8042; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Jensen KJ, 2013, CELL HOST MICROBE, V13, P67, DOI 10.1016/j.chom.2012.11.009; Joaquin M, 2012, EMBO J, V31, P2952, DOI 10.1038/emboj.2012.122; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Westermarck J, 2001, MOL CELL BIOL, V21, P2373, DOI 10.1128/MCB.21.7.2373-2383.2001; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	36	281	283	1	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1724	1734		10.1016/j.cell.2014.04.039	http://dx.doi.org/10.1016/j.cell.2014.04.039			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949979	Green Accepted, Bronze			2022-12-01	WOS:000340941900024
J	Farvid, MS; Cho, E; Chen, WY; Eliassen, AH; Willett, WC				Farvid, Maryam S.; Cho, Eunyoung; Chen, Wendy Y.; Eliassen, A. Heather; Willett, Walter C.			Dietary protein sources in early adulthood and breast cancer incidence: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHASEOLUS-VULGARIS L.; TOTAL-ENERGY-INTAKE; FOOD-CONSUMPTION; FATTY-ACIDS; MEAT INTAKE; RISK; WOMEN; METAANALYSIS; NUTRITION; HEALTH	Objective To investigate the association between dietary protein sources in early adulthood and risk of breast cancer. Design Prospective cohort study. Setting Health professionals in the United States. Participants 88 803 premenopausal women from the Nurses' Health Study II who completed a questionnaire on diet in 1991. Main outcome measure Incident cases of invasive breast carcinoma, identified through self report and confirmed by pathology report. Results We documented 2830 cases of breast cancer during 20 years of follow-up. Higher intake of total red meat was associated with an increased risk of breast cancer overall (relative risk 1.22, 95% confidence interval 1.06 to 1.40; P-trend=0.01, for highest fifth v lowest fifth of intake). However, higher intakes of poultry, fish, eggs, legumes, and nuts were not related to breast cancer overall. When the association was evaluated by menopausal status, higher intake of poultry was associated with a lower risk of breast cancer in postmenopausal women (0.73, 0.58 to 0.91; P-trend=0.02, for highest fifth v lowest fifth of intake) but not in premenopausal women (0.93, 0.78 to 1.11; P-trend=0.60, for highest fifth v lowest fifth of intake). In estimating the effects of exchanging different protein sources, substituting one serving/day of legumes for one serving/day of red meat was associated with a 15% lower risk of breast cancer among all women (0.85, 0.73 to 0.98) and a 19% lower risk among premenopausal women (0.81, 0.66 to 0.99). Also, substituting one serving/day of poultry for one serving/day of red meat was associated with a 17% lower risk of breast cancer overall (0.83, 0.72 to 0.96) and a 24% lower risk of postmenopausal breast cancer (0.76, 0.59 to 0.99). Furthermore, substituting one serving/day of combined legumes, nuts, poultry, and fish for one serving/day of red meat was associated with a 14% lower risk of breast cancer overall (0.86, 0.78 to 0.94) and premenopausal breast cancer (0.86, 0.76 to 0.98). Conclusion Higher red meat intake in early adulthood may be a risk factor for breast cancer, and replacing red meat with a combination of legumes, poultry, nuts and fish may reduce the risk of breast cancer.	[Farvid, Maryam S.; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Farvid, Maryam S.] Shahid Beheshti Univ Med Sci, Fac Nutr Sci & Food Technol, Dept Community Nutr, Tehran, Iran; [Cho, Eunyoung] Brown Univ, Warren Alpert Med Sch, Dept Dermatol, Providence, RI 02912 USA; [Cho, Eunyoung; Chen, Wendy Y.; Eliassen, A. Heather; Willett, Walter C.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Cho, Eunyoung; Chen, Wendy Y.; Eliassen, A. Heather; Willett, Walter C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chen, Wendy Y.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Eliassen, A. Heather; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Shahid Beheshti University Medical Sciences; Brown University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Farvid, MS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	mfarvid@hsph.harvard.edu	Cho, Eunyoung/AAV-4469-2020; f, m/AAM-2063-2021	Cho, Eunyoung/0000-0001-6594-2582; Farvid, Maryam/0000-0003-1783-4186; Eliassen, A Heather/0000-0002-3961-6609	National Institutes of Health [R01CA050385]; NATIONAL CANCER INSTITUTE [R01CA050385, UM1CA176726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health grant (R01CA050385). The study sponsors were not involved in the study design and collection, analysis, and interpretation of data, or the writing of the article or the decision to submit it for publication. The authors were independent from study sponsors.	Alexander DD, 2010, NUTR RES REV, V23, P349, DOI 10.1017/S0954422410000235; Andersson AM, 1999, EUR J ENDOCRINOL, V140, P477, DOI 10.1530/eje.0.1400477; Aune D, 2012, ANN ONCOL, V23, P1394, DOI 10.1093/annonc/mdr589; Buck K, 2010, AM J CLIN NUTR, V92, P141, DOI 10.3945/ajcn.2009.28573; Carruba G, 2006, NUTR CANCER, V56, P253, DOI 10.1207/s15327914nc5602_18; Cho EY, 2006, ARCH INTERN MED, V166, P2253, DOI 10.1001/archinte.166.20.2253; COLDITZ GA, 1987, AM J EPIDEMIOL, V126, P319, DOI 10.1093/aje/126.2.319; DeStefani E, 1997, CANCER EPIDEM BIOMAR, V6, P573; Dial S, 1995, TOCOPHEROLS TOCOTRIE, P327; Engeset D, 2006, INT J CANCER, V119, P175, DOI 10.1002/ijc.21819; Farvid MS, 2014, BREAST CANCER RES TR, V145, P255, DOI 10.1007/s10549-014-2895-9; Ferrucci LM, 2009, BRIT J CANCER, V101, P178, DOI 10.1038/sj.bjc.6605118; Gago-Dominguez M, 2003, BRIT J CANCER, V89, P1686, DOI 10.1038/sj.bjc.6601340; Genkinger JM, 2013, CANCER CAUSE CONTROL, V24, P675, DOI 10.1007/s10552-013-0146-8; Halton TL, 2006, AM J CLIN NUTR, V83, P284; Holland GWA, 1991, COMPOSITION FOODS; Holmes MD, 2003, INT J CANCER, V104, P221, DOI 10.1002/ijc.10910; Kallianpur AR, 2008, BREAST CANCER RES TR, V107, P123, DOI 10.1007/s10549-007-9538-3; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Land CE, 2003, RADIAT RES, V160, P707, DOI 10.1667/RR3082; Lauber SN, 2004, CARCINOGENESIS, V25, P2509, DOI 10.1093/carcin/bgh268; Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006; Missmer SA, 2002, INT J EPIDEMIOL, V31, P78, DOI 10.1093/ije/31.1.78; Nutrient Database for Standard Reference Release 14, 2001, NUTR DAT STAND REF R; Pala V, 2009, AM J CLIN NUTR, V90, P602, DOI 10.3945/ajcn.2008.27173; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Steck SE, 2007, EPIDEMIOLOGY, V18, P373, DOI 10.1097/01.ede.0000259968.11151.06; Swerdlow AJ, 2000, J CLIN ONCOL, V18, P498, DOI 10.1200/JCO.2000.18.3.498; Thompson MD, 2012, CELL CYCLE, V11, P835, DOI 10.4161/cc.11.5.19676; Thompson MD, 2012, CARCINOGENESIS, V33, P226, DOI 10.1093/carcin/bgr247; Wahner-Roedler DL, 2003, MAYO CLIN PROC, V78, P708, DOI 10.4065/78.6.708; Weroha SJ, 2012, ENDOCRIN METAB CLIN, V41, P335, DOI 10.1016/j.ecl.2012.04.014; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Willett WC, 1997, AM J CLIN NUTR, P1229; Zheng JS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3706	36	71	72	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2014	348								g3437	10.1136/bmj.g3437	http://dx.doi.org/10.1136/bmj.g3437			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1FH	24916719	Green Published, hybrid			2022-12-01	WOS:000337400800001
J	Weekes, MP; Tomasec, P; Huttlin, EL; Fielding, CA; Nusinow, D; Stanton, RJ; Wang, ECY; Aicheler, R; Murrell, I; Wilkinson, GWG; Lehner, PJ; Gygi, SP				Weekes, Michael P.; Tomasec, Peter; Huttlin, Edward L.; Fielding, Ceri A.; Nusinow, David; Stanton, Richard J.; Wang, Eddie C. Y.; Aicheler, Rebecca; Murrell, Isa; Wilkinson, Gavin W. G.; Lehner, Paul J.; Gygi, Steven P.			Quantitative Temporal Viromics: An Approach to Investigate Host-Pathogen Interaction	CELL			English	Article							DOWN-REGULATION; FAMILY-MEMBERS; GENE-PRODUCTS; CYTOMEGALOVIRUS; PROTEIN; DEGRADATION; EXPRESSION; PHOSPHORYLATION; TRANSCRIPTION; RECOGNITION	A systematic quantitative analysis of temporal changes in host and viral proteins throughout the course of a productive infection could provide dynamic insights into virus-host interaction. We developed a proteomic technique called "quantitative temporal viromics" (QTV), which employs multiplexed tandem-mass-tag-based mass spectrometry. Human cytomegalovirus (HCMV) is not only an important pathogen but a paradigm of viral immune evasion. QTV detailed how HCMV orchestrates the expression of >8,000 cellular proteins, including 1,200 cell-surface proteins to manipulate signaling pathways and counterintrinsic, innate, and adaptive immune defenses. QTV predicted natural killer and T cell ligands, as well as 29 viral proteins present at the cell surface, potential therapeutic targets. Temporal profiles of >80% of HCMV canonical genes and 14 noncanonical HCMV open reading frames were defined. QTV is a powerful method that can yield important insights into viral infection and is applicable to any virus with a robust in vitro model.	[Weekes, Michael P.; Huttlin, Edward L.; Nusinow, David; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Tomasec, Peter; Fielding, Ceri A.; Stanton, Richard J.; Wang, Eddie C. Y.; Aicheler, Rebecca; Murrell, Isa; Wilkinson, Gavin W. G.] Cardiff Univ, Sch Med, Cardiff CF14 4XX, S Glam, Wales; [Weekes, Michael P.; Lehner, Paul J.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England	Harvard University; Harvard Medical School; Cardiff University; University of Cambridge	Weekes, MP (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	mpw1001@cam.ac.uk; steven_gygi@hms.harvard.edu	Fielding, Ceri A/F-5638-2014; Nusinow, David/AAJ-4284-2020; Wilkinson, Gavin WG/J-6388-2015; Stanton, Richard James/B-4695-2008	Fielding, Ceri A/0000-0002-5817-3153; Nusinow, David/0000-0002-7819-5261; Wilkinson, Gavin WG/0000-0002-5623-0126; Stanton, Richard James/0000-0002-6799-1182; Weekes, Michael/0000-0003-3196-5545; Lehner, Paul Joseph/0000-0001-9383-1054; Wang, Eddie/0000-0002-2243-4964; Huttlin, Edward/0000-0002-1822-1173	Wellcome Trust [093966/Z/10/Z, G1000236, WT090323MA, 084957/Z/08/Z]; MRC; National Institute of Health [GM067945]; Cambridge Biomedical Research Centre, UK; MRC [MR/L008734/1, G1000236, G0901119] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER; Medical Research Council [G0901119, MR/L008734/1, G1000236, MR/L018373/1] Funding Source: researchfish; Wellcome Trust [090323/Z/09/Z] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cambridge Biomedical Research Centre, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We are grateful to Dr. Andrew Davison for assistance with the assembly of HCMV FASTA files; to Joao Paulo, Ryan Kunz, and Martin Wuehr for mass spectrometry and to Alexander Devaux for technical assistance. This work was supported by a Wellcome Trust Fellowship (093966/Z/10/Z) to M. P. W.; an MRC Project Grant and a Wellcome Trust Programme Grant (G1000236, WT090323MA) to G. W. G. W., P. T., and E.C.Y.W.; a Wellcome Trust Senior Fellowship (084957/Z/08/Z) to P.J.L. and National Institute of Health grant (GM067945) to S. P. G. This study was additionally supported by the Cambridge Biomedical Research Centre, UK. We have filed a provisional patent based on our findings.	Alexander BT, 2010, PHARMACOTHERAPY, V30, P554, DOI 10.1592/phco.30.6.554; Alwine JC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002878; Amsler L, 2013, J MOL BIOL, V425, P4857, DOI 10.1016/j.jmb.2013.08.023; Angelova M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002959; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Ceeraz S, 2013, TRENDS IMMUNOL, V34, P556, DOI 10.1016/j.it.2013.07.003; Chambers J, 1999, J VIROL, V73, P5757, DOI 10.1128/JVI.73.7.5757-5766.1999; Duggal NK, 2012, NAT REV IMMUNOL, V12, P687, DOI 10.1038/nri3295; Dunn C, 2003, J EXP MED, V197, P1427, DOI 10.1084/jem.20022059; Feng XY, 2006, J VIROL, V80, P8371, DOI 10.1128/JVI.00399-06; Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubo M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00082; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Khan Z, 2014, CARCINOGENESIS, V35, P145, DOI 10.1093/carcin/bgt292; Kim YE, 2011, J VIROL, V85, P11928, DOI 10.1128/JVI.00758-11; Koyuncu E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003333; Le VTK, 2008, J GEN VIROL, V89, P2416, DOI 10.1099/vir.0.2008/001669-0; Ma YP, 2012, FUTURE MICROBIOL, V7, P577, DOI [10.2217/FMB.12.32, 10.2217/fmb.12.32]; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; Mocarski E. S., 2013, CYTOMEGALOVIRUSES; Nichols WG, 2002, J INFECT DIS, V185, P273, DOI 10.1086/338624; Nikolov DB, 2013, BBA-PROTEINS PROTEOM, V1834, P2160, DOI 10.1016/j.bbapap.2013.04.020; Omoto S, 2014, J VIROL, V88, P120, DOI 10.1128/JVI.02983-13; Paludan SR, 2011, NAT REV IMMUNOL, V11, P143, DOI 10.1038/nri2937; Pease BN, 2013, J PROTEOME RES, V12, P4028, DOI 10.1021/pr400394g; Powers C, 2008, CURR TOP MICROBIOL, V325, P333; Prod'homme V, 2010, J GEN VIROL, V91, P2034, DOI 10.1099/vir.0.021931-0; Rahm N, 2012, CURR OPIN HIV AIDS, V7, P180, DOI 10.1097/COH.0b013e32835048e1; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Scott I, 2009, MICROBES INFECT, V11, P973, DOI 10.1016/j.micinf.2009.07.001; Stanton RJ, 2007, J VIROL, V81, P7860, DOI 10.1128/JVI.02247-06; STENBERG RM, 1989, J VIROL, V63, P2699, DOI 10.1128/JVI.63.6.2699-2708.1989; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SULLIVAN R, 1971, APPL MICROBIOL, V22, P61, DOI 10.1128/AEM.22.1.61-65.1971; Takamatsu H, 2012, TRENDS IMMUNOL, V33, P127, DOI 10.1016/j.it.2012.01.008; Terhune SS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000965; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Tomasec P, 2005, NAT IMMUNOL, V6, P181, DOI 10.1038/ni1156; van der Wal FJ, 2002, CURR TOP MICROBIOL, V269, P37; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Vavassori S, 2013, NAT IMMUNOL, V14, P908, DOI 10.1038/ni.2665; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Weekes MP, 2013, SCIENCE, V340, P199, DOI 10.1126/science.1235047; Weekes MP, 2012, J PROTEOME RES, V11, P1475, DOI 10.1021/pr201135e; Wilkinson GWG, 2008, J CLIN VIROL, V41, P206, DOI 10.1016/j.jcv.2007.10.027; Witherden DA, 2012, IMMUNITY, V37, P314, DOI 10.1016/j.immuni.2012.05.026	50	280	289	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1460	1472		10.1016/j.cell.2014.04.028	http://dx.doi.org/10.1016/j.cell.2014.04.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906157	hybrid, Green Published, Green Accepted			2022-12-01	WOS:000340881400020
J	Karakas, E; Furukawa, H				Karakas, Erkan; Furukawa, Hiro			Crystal structure of a heterotetrameric NMDA receptor ion channel	SCIENCE			English	Article							AMINO-TERMINAL DOMAIN; K+ CHANNEL; SUBUNIT ARRANGEMENT; BINDING DOMAIN; MECHANISM; SENSITIVITY; INSIGHTS; COMPLEX; RESIDUE	N-Methyl-D-aspartate (NMDA) receptors belong to the family of ionotropic glutamate receptors, which mediate most excitatory synaptic transmission in mammalian brains. Calcium permeation triggered by activation of NMDA receptors is the pivotal event for initiation of neuronal plasticity. Here, we show the crystal structure of the intact heterotetrameric GluN1-GluN2B NMDA receptor ion channel at 4 angstroms. The NMDA receptors are arranged as a dimer of GluN1-GluN2B heterodimers with the twofold symmetry axis running through the entire molecule composed of an amino terminal domain (ATD), a ligand-binding domain (LBD), and a transmembrane domain (TMD). The ATD and LBD are much more highly packed in the NMDA receptors than non-NMDA receptors, which may explain why ATD regulates ion channel activity in NMDA receptors but not in non-NMDA receptors.	[Karakas, Erkan; Furukawa, Hiro] Cold Spring Harbor Lab, WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Furukawa, H (corresponding author), Cold Spring Harbor Lab, WM Keck Struct Biol Lab, One Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	furukawa@cshl.edu			NIH [MH085926]; Mirus Research Award; Robertson Research Fund of Cold Spring Harbor Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085926] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mirus Research Award; Robertson Research Fund of Cold Spring Harbor Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank staffs at the 23-ID-B and D beamlines at the Advanced Photon System in the Argonne National Laboratory and the BL41XU beamline at the Spring 8 for their excellent beamline supports. We thank N. Simorowski for her technical support, H. Yuan and S. Traynelis for sharing unpublished data with us and for critical comments on this manuscript, and S. Harrison for making important comments on this work. This work was supported by NIH (MH085926 to H. F.), Mirus Research Award (to H. F.), and a Robertson Research Fund of Cold Spring Harbor Laboratory (to H. F.). Coordinates and structure factors have been deposited in the Protein Data Bank under accession code 4PE5. DNA constructs, recombinant virus, and proteins used in this study are available from H. F. under a material transfer agreement with Cold Spring Harbor Laboratory.	Das U, 2010, P NATL ACAD SCI USA, V107, P8463, DOI 10.1073/pnas.1000838107; Farina AN, 2011, J NEUROSCI, V31, P3565, DOI 10.1523/JNEUROSCI.6041-10.2011; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Hayashi T, 1954, KEIO J MED, V3; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jespersen A, 2014, NEURON, V81, P366, DOI 10.1016/j.neuron.2013.11.033; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Kashiwagi K, 1996, MOL PHARMACOL, V49, P1131; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Lau AY, 2013, NEURON, V79, P492, DOI 10.1016/j.neuron.2013.06.003; Li WY, 2009, P NATL ACAD SCI USA, V106, P1075, DOI 10.1073/pnas.0812008106; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Mony L, 2011, EMBO J, V30, P3134, DOI 10.1038/emboj.2011.203; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Regalado MP, 2001, NEURON, V32, P1085, DOI 10.1016/S0896-6273(01)00539-6; Retchless BS, 2012, NAT NEUROSCI, V15, P406, DOI 10.1038/nn.3025; Riou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035134; Salussolia CL, 2011, J NEUROSCI, V31, P11295, DOI 10.1523/JNEUROSCI.5612-10.2011; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; TRAYNELIS SF, 1995, SCIENCE, V268, P873, DOI 10.1126/science.7754371; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vance KM, 2012, J PHYSIOL-LONDON, V590, P3857, DOI 10.1113/jphysiol.2012.234062; Vance KM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1295; Watanabe J, 2002, J NEUROSCI, V22, P10209; Yao Y, 2008, EMBO J, V27, P2158, DOI 10.1038/emboj.2008.140; Ye S, 2010, NAT STRUCT MOL BIOL, V17, P1019, DOI 10.1038/nsmb.1865; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Zheng F, 2001, NAT NEUROSCI, V4, P894, DOI 10.1038/nn0901-894; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	38	399	408	3	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					992	997		10.1126/science.1251915	http://dx.doi.org/10.1126/science.1251915			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876489	Green Accepted			2022-12-01	WOS:000336495800036
J	Fridman, O; Goldberg, A; Ronin, I; Shoresh, N; Balaban, NQ				Fridman, Ofer; Goldberg, Amir; Ronin, Irine; Shoresh, Noam; Balaban, Nathalie Q.			Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations	NATURE			English	Article							ESCHERICHIA-COLI; PERSISTENCE; AMPICILLIN; RESISTANCE; EVOLUTION	The great therapeutic achievements of antibiotics have been dramatically undercut by the evolution of bacterial strategies that overcome antibiotic stress(1),(2). These strategies fall into two classes. 'Resistance' makes it possible for a microorganism to grow in the constant presence of the antibiotic, provided that the concentration of the antibiotic is not too high. 'Tolerance' allows a microorganism to survive antibiotic treatment, even at high antibiotic concentrations, as long as the duration of the treatment is limited. Although both resistance and tolerance are important reasons for the failure of antibiotic treatments(3-6), the evolution of resistance(7-9) is much better understood than that of tolerance. Here we followed the evolution of bacterial populations under intermittent exposure to the high concentrations of antibiotics used in the clinic and characterized the evolved strains in terms of both resistance and tolerance. We found that all strains adapted by specific genetic mutations, which became fixed in the evolved populations. By monitoring the phenotypic changes at the population and single-cell levels, we found that the first adaptive change to antibiotic stress was the development of tolerance through a major adjustment in the single-cell lag-time distribution, without a change in resistance. Strikingly, we found that the lag time of bacteria before regrowth was optimized to match the duration of the antibiotic-exposure interval. Whole genome sequencing of the evolved strains and restoration of the wild-type alleles allowed us to identify target genes involved in this antibiotic-driven phenotype: 'tolerance by lag' (tbl). Better understanding of lag-time evolution as a key determinant of the survival of bacterial populations under high antibiotic concentrations could lead to new approaches to impeding the evolution of antibiotic resistance.	[Fridman, Ofer; Goldberg, Amir; Ronin, Irine; Balaban, Nathalie Q.] Hebrew Univ Jerusalem, Sudarsky Ctr Computat Biol, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Fridman, Ofer; Goldberg, Amir; Ronin, Irine; Balaban, Nathalie Q.] Hebrew Univ Jerusalem, Ctr NanoSci, IL-91904 Jerusalem, Israel; [Shoresh, Noam] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Balaban, NQ (corresponding author), Hebrew Univ Jerusalem, Sudarsky Ctr Computat Biol, Racah Inst Phys, Edmond J Safra Campus, IL-91904 Jerusalem, Israel.	nathalieqb@phys.huji.ac.il	Balaban, Nathalie/AGI-1487-2022; Balaban, Nathalie/AAH-1004-2019	Balaban, Nathalie/0000-0001-8018-0766; Balaban, Nathalie/0000-0001-8018-0766	European Research Council [260871]; Israel Science Foundation [592/10]; Levtzion Fellowship	European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Levtzion Fellowship	We thank I. Levin-Riesman for discussions and technical help with the ScanLag system, S. Belkin for strains, and the National BioResource Project and National Institute of Genetics, Japan, for the Keio collection deletion mutants. The work was supported by the European Research Council (Starting Grant no. 260871) and the Israel Science Foundation (no. 592/10). O.F. acknowledges support from the Levtzion Fellowship.	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Baranyi J, 2002, INT J FOOD MICROBIOL, V73, P203, DOI 10.1016/S0168-1605(01)00650-X; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; BLACK DS, 1991, J BACTERIOL, V173, P5732, DOI 10.1128/jb.173.18.5732-5739.1991; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Cohen NR, 2013, CELL HOST MICROBE, V13, P632, DOI 10.1016/j.chom.2013.05.009; Collignon PJ, 2002, MED J AUSTRALIA, V177, P325, DOI 10.5694/j.1326-5377.2002.tb04794.x; Fauvart M, 2011, J MED MICROBIOL, V60, P699, DOI 10.1099/jmm.0.030932-0; Gefen O, 2009, FEMS MICROBIOL REV, V33, P704, DOI 10.1111/j.1574-6976.2008.00156.x; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Germain E, 2013, MOL CELL, V52, P248, DOI 10.1016/j.molcel.2013.08.045; GILBERT P, 1990, ANTIMICROB AGENTS CH, V34, P1865, DOI 10.1128/AAC.34.10.1865; Girgis HS, 2012, P NATL ACAD SCI USA, V109, P12740, DOI 10.1073/pnas.1205124109; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Kaspy I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4001; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Levin-Reisman I, 2010, NAT METHODS, V7, P737, DOI 10.1038/nmeth.1485; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Nahata MC, 1999, ANTIMICROB AGENTS CH, V43, P1225, DOI 10.1128/AAC.43.5.1225; OLSSON O, 1983, P NATL ACAD SCI-BIOL, V80, P7556, DOI 10.1073/pnas.80.24.7556; Oxman E, 2008, EVOLUTION, V62, P1547, DOI 10.1111/j.1558-5646.2008.00397.x; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Toprak E, 2012, NAT GENET, V44, P101, DOI 10.1038/ng.1034; TUOMANEN E, 1986, J GEN MICROBIOL, V132, P1297; WOLFSON JS, 1990, ANTIMICROB AGENTS CH, V34, P1938, DOI 10.1128/AAC.34.10.1938	30	312	322	18	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					418	+		10.1038/nature13469	http://dx.doi.org/10.1038/nature13469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043002				2022-12-01	WOS:000341814900060
J	Harms, MJ; Thornton, JW				Harms, Michael J.; Thornton, Joseph W.			Historical contingency and its biophysical basis in glucocorticoid receptor evolution	NATURE			English	Article							MOLECULAR-DYNAMICS METHOD; LIGAND-BINDING DOMAIN; DIRECTED EVOLUTION; KEY INNOVATION; FORCE-FIELD; PROTEIN; MUTATIONS; SIMULATIONS; RESISTANCE; EPISTASIS	Understanding how chance historical events shape evolutionary processes is a central goal of evolutionary biology(1-7). Direct insights into the extent and causes of evolutionary contingency have been limited to experimental systems(7-9), because it is difficult to know what happened in the deep past and to characterize other paths that evolution could have followed. Here we combine ancestral protein reconstruction, directed evolution and biophysical analysis to explore alternative 'might-have-been' trajectories during the ancient evolution of a novel protein function. We previously found that the evolution of cortisol specificity in the ancestral glucocorticoid receptor (GR) was contingent on permissive substitutions, which had no apparent effect on receptor function but were necessary for GR to tolerate the large-effect mutations that caused the shift in specificity(6). Here we show that alternative mutations that could have permitted the historical function-switching substitutions are extremely rare in the ensemble of genotypes accessible to the ancestral GR. In a library of thousands of variants of the ancestral protein, we recovered historical permissive substitutions but no alternative permissive genotypes. Using biophysical analysis, we found that permissive mutations must satisfy at least three physical requirements-they must stabilize specific local elements of the protein structure, maintain the correct energetic balance between functional conformations, and be compatible with the ancestral and derived structures-thus revealing why permissive mutations are rare. These findings demonstrate that GR evolution depended strongly on improbable, non-deterministic events, and this contingency arose from intrinsic biophysical properties of the protein.	[Harms, Michael J.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Harms, Michael J.] Univ Oregon, Dept Chem & Biochem, Eugene, OR 97403 USA; [Harms, Michael J.; Thornton, Joseph W.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Harms, Michael J.; Thornton, Joseph W.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Thornton, Joseph W.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA	University of Oregon; University of Oregon; University of Chicago; University of Chicago; University of Oregon	Thornton, JW (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	joet1@uchicago.edu	Thornton, Joseph/GSN-4190-2022	Harms, Michael/0000-0002-0241-4122	National Institutes of Health (NIH) [F32-GM090650, NIH R01-GM081592, R01-GM104397]; NSF [IOB-0546906]; Howard Hughes Medical Institute Early Career Scientist award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081592, R01GM104397] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute Early Career Scientist award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Bridgham, members of the Thornton laboratory, and B. Buckley McAllister for technical assistance and fruitful discussions. We thank M. Stallcup for sharing plasmids and the University of Oregon ACISS cluster for computing resources (National Science Foundation (NSF) OCI-0960354). This work was supported by National Institutes of Health (NIH) F32-GM090650 (M.J.H.), NIH R01-GM081592 (J.W.T.) and R01-GM104397 (J.W.T.), NSF IOB-0546906 (J.W.T.) and a Howard Hughes Medical Institute Early Career Scientist award (J.W.T.).	[Anonymous], 2011, R LANG ENV STAT COMP; Beatty J, 2006, J PHILOS, V103, P336, DOI 10.5840/jphil2006103716; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Bledsoe RK, 2004, VITAM HORM, V68, P49; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100119; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Carroll SM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002117; Chen ZL, 2004, J BIOL CHEM, V279, P33855, DOI 10.1074/jbc.M402118200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; Drummond DA, 2005, J MOL BIOL, V350, P806, DOI 10.1016/j.jmb.2005.05.023; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Field SF, 2010, MOL BIOL EVOL, V27, P225, DOI 10.1093/molbev/msp230; Fisher R., 2005, TEACHING CHILDREN TH; Gong LI, 2013, ELIFE, V2, DOI 10.7554/eLife.00631; Gould S.J., 1990, WONDERFUL LIFE BURGE; Granovsky A. A., FIREFLY VERSION 7 1; Harju S, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-8; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Lynch VJ, 2011, NATURE, V480, P383, DOI 10.1038/nature10595; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449; Monod, 1972, CHANCE NECESSITY ESS; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Morris S. C., 2000, CRUCIBLE CREATION BU; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peisajovich SG, 2007, NAT METHODS, V4, P991, DOI 10.1038/nmeth1207-991; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	48	100	101	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					203	+		10.1038/nature13410	http://dx.doi.org/10.1038/nature13410			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	24930765	Green Accepted			2022-12-01	WOS:000340200700034
J	Huerta-Sanchez, E; Jin, X; Asan; Bianba, Z; Peter, BM; Vinckenbosch, N; Liang, Y; Yi, X; He, MZ; Somel, M; Ni, PX; Wang, B; Ou, XH; Huasang; Luosang, JB; Cuo, ZXP; Li, K; Gao, GY; Yin, Y; Wang, W; Zhang, XQ; Xu, X; Yang, HM; Li, YR; Wang, J; Wang, J; Nielsen, R				Huerta-Sanchez, Emilia; Jin, Xin; Asan; Bianba, Zhuoma; Peter, Benjamin M.; Vinckenbosch, Nicolas; Liang, Yu; Yi, Xin; He, Mingze; Somel, Mehmet; Ni, Peixiang; Wang, Bo; Ou, Xiaohua; Huasang; Luosang, Jiangbai; Cuo, Zha Xi Ping; Li, Kui; Gao, Guoyi; Yin, Ye; Wang, Wei; Zhang, Xiuqing; Xu, Xun; Yang, Huanming; Li, Yingrui; Wang, Jian; Wang, Jun; Nielsen, Rasmus			Altitude adaptation in Tibetans caused by introgression of Denisovan-like DNA	NATURE			English	Article							HEMOGLOBIN CONCENTRATION; POSITIVE SELECTION; GENOME SEQUENCE; RECOMBINATION; SAMPLES; PIGMENTATION; PREGNANCY; ANCESTRY; SIGNALS	As modern humans migrated out of Africa, they encountered many new environmental conditions, including greater temperature extremes, different pathogens and higher altitudes. These diverse environments are likely to have acted as agents of natural selection and to have led to local adaptations. One of the most celebrated examples in humans is the adaptation of Tibetans to the hypoxic environment of the high-altitude Tibetan plateau(1-3). A hypoxia pathway gene, EPAS1, was previously identified as having the most extreme signature of positive selection in Tibetans(4-10), and was shown to be associated with differences in haemoglobin concentration at high altitude. Re-sequencing the region around EPAS1 in 40 Tibetan and 40 Han individuals, we find that this gene has a highly unusual haplotype structure that can only be convincingly explained by introgression of DNA from Denisovan or Denisovan-related individuals into humans. Scanning a larger set of worldwide populations, we find that the selected haplotype is only found in Denisovans and in Tibetans, and at very low frequency among Han Chinese. Furthermore, the length of the haplotype, and the fact that it is not found in any other populations, makes it unlikely that the haplotype sharing between Tibetans and Denisovans was caused by incomplete ancestral lineage sorting rather than introgression. Our findings illustrate that admixture with other hominin species has provided genetic variation that helped humans to adapt to new environments.	[Huerta-Sanchez, Emilia; Jin, Xin; Asan; Liang, Yu; Yi, Xin; He, Mingze; Somel, Mehmet; Ni, Peixiang; Wang, Bo; Ou, Xiaohua; Huasang; Luosang, Jiangbai; Yin, Ye; Wang, Wei; Zhang, Xiuqing; Xu, Xun; Yang, Huanming; Li, Yingrui; Wang, Jian; Wang, Jun; Nielsen, Rasmus] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Huerta-Sanchez, Emilia; Peter, Benjamin M.; Vinckenbosch, Nicolas; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Huerta-Sanchez, Emilia] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA; [Jin, Xin] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China; [Asan; Liang, Yu; Yi, Xin] BGI Tianjin, Binhai Genom Inst, Tianjin 300308, Peoples R China; [Asan; Liang, Yu; Yi, Xin] BGI Tianjin, Tianjin Translat Genom Ctr, Tianjin 300308, Peoples R China; [Bianba, Zhuoma] Peoples Hosp Lhasa, Lhasa 850000, Peoples R China; [He, Mingze] Iowa State Univ, Bioinformat & Computat Biol Program, Ames, IA 50011 USA; [Somel, Mehmet] Middle E Tech Univ, Dept Biol Sci, TR-06800 Ankara, Turkey; [Cuo, Zha Xi Ping] Second Peoples Hosp Tibet Autonomous Reg, Lhasa 850000, Peoples R China; [Li, Kui] Peoples Hosp Tibet Autonomous Reg, Lhasa 850000, Peoples R China; [Gao, Guoyi] Hosp XiShuangBanNa Dai Nationalities, Autonomous Jinghong 666100, Yunnan, Peoples R China; [Zhang, Xiuqing] BGI Shenzhen, Guangdong Enterprise Key Lab Human Dis Genom, Shenzhen 518083, Peoples R China; [Zhang, Xiuqing] BGI Shenzhen, Shenzhen Key Lab Trans Biotechnol, Shenzhen 518083, Peoples R China; [Yang, Huanming; Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Ctr Excellence Res Hereditary, Jeddah 21589, Saudi Arabia; [Yang, Huanming; Wang, Jian] James D Watson Inst Genome Sci, Hangzhou 310008, Zhejiang, Peoples R China; [Wang, Jun; Nielsen, Rasmus] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Wang, Jun] Macau Univ Sci & Technol, Taipa 999078, Macau, Peoples R China; [Wang, Jun] Univ Hong Kong, Dept Med, Hong Kong 999077, Hong Kong, Peoples R China; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	Beijing Genomics Institute (BGI); University of California System; University of California Berkeley; University of California System; University of California Merced; South China University of Technology; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Iowa State University; Middle East Technical University; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); King Abdulaziz University; University of Copenhagen; Macau University of Science & Technology; University of Hong Kong; University of California System; University of California Berkeley	Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	wangjian@genomics.cn; wangj@genomics.cn; rasmus_nielsen@berkeley.edu	Li, Yingrui/K-1064-2015; Somel, Mehmet/B-1471-2016; Xu, Xun/AAI-6763-2020; Jin, Xin/ABF-1329-2020; Nielsen, Rasmus/D-4405-2009; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Xu, Xun/0000-0002-5338-5173; Jin, Xin/0000-0001-7554-4975; Nielsen, Rasmus/0000-0003-0513-6591; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; Somel, Mehmet/0000-0002-3138-1307; He, Mingze/0000-0002-8164-2480	973 Program [2011CB809203, 2012CB518201, 2011CB809201, 2011CB809202]; State Key Development Program for Basic Research of China; China National GeneBank-Shenzhen; Shenzhen Key Laboratory of Transomics Biotechnologies [CXB201108250096A]; US NIH [R01HG003229, R01HG003229-08S2]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER	973 Program(National Basic Research Program of China); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); China National GeneBank-Shenzhen; Shenzhen Key Laboratory of Transomics Biotechnologies; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was funded by the State Key Development Program for Basic Research of China, 973 Program (2011CB809203, 2012CB518201, 2011CB809201, 2011CB809202), China National GeneBank-Shenzhen and Shenzhen Key Laboratory of Transomics Biotechnologies (no. CXB201108250096A). This work was also supported by research grants from the US NIH; R01HG003229 to R.N. and R01HG003229-08S2 to E.H.S. We thank F. Jay, M. Liang and F. Casey for useful discussions.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 2011, R LANG ENV STAT COMP; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Ewing G, 2010, BIOINFORMATICS, V26, P2064, DOI 10.1093/bioinformatics/btq322; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Mendez FL, 2012, AM J HUM GENET, V91, P265, DOI 10.1016/j.ajhg.2012.06.015; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Moore LG, 2004, PLACENTA, V25, pS60, DOI 10.1016/j.placenta.2004.01.008; Moore LG, 2001, AM J HUM BIOL, V13, P635, DOI 10.1002/ajhb.1102; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Niermeyer S, 2009, ARCH DIS CHILD, V94, P806, DOI 10.1136/adc.2008.141838; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; REYNOLDS J, 1983, GENETICS, V105, P767; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Sankararaman S, 2014, NATURE; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Skoglund P, 2011, P NATL ACAD SCI USA, V108, P18301, DOI 10.1073/pnas.1108181108; Soejima M, 2007, INT J LEGAL MED, V121, P36, DOI 10.1007/s00414-006-0112-z; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Teshima KM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-166; Vargas EE, 2006, HIGH ALT MED BIOL, V7, P138, DOI 10.1089/ham.2006.7.138; Vernot B., 2014, SCIENCE; Wang BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017002; Wu TY, 2005, J APPL PHYSIOL, V98, P598, DOI 10.1152/japplphysiol.01034.2002; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yip R, 2000, AM J CLIN NUTR, V72, p272S, DOI 10.1093/ajcn/72.1.272S	43	547	573	33	487	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					194	+		10.1038/nature13408	http://dx.doi.org/10.1038/nature13408			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043035	Green Accepted, Green Submitted			2022-12-01	WOS:000340200700032
J	Whitney, JB; Hill, AL; Sanisetty, S; Penaloza-MacMaster, P; Liu, JY; Shetty, M; Parenteau, L; Cabral, C; Shields, J; Blackmore, S; Smith, JY; Brinkman, AL; Peter, LE; Mathew, SI; Smith, KM; Borducchi, EN; Rosenbloom, DIS; Lewis, MG; Hattersley, J; Li, B; Hesselgesser, J; Geleziunas, R; Robb, ML; Kim, JH; Michael, NL; Barouch, DH				Whitney, James B.; Hill, Alison L.; Sanisetty, Srisowmya; Penaloza-MacMaster, Pablo; Liu, Jinyan; Shetty, Mayuri; Parenteau, Lily; Cabral, Crystal; Shields, Jennifer; Blackmore, Stephen; Smith, Jeffrey Y.; Brinkman, Amanda L.; Peter, Lauren E.; Mathew, Sheeba I.; Smith, Kaitlin M.; Borducchi, Erica N.; Rosenbloom, Daniel I. S.; Lewis, Mark G.; Hattersley, Jillian; Li, Bei; Hesselgesser, Joseph; Geleziunas, Romas; Robb, Merlin L.; Kim, Jerome H.; Michael, Nelson L.; Barouch, Dan H.			Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys	NATURE			English	Article							ANTIRETROVIRAL THERAPY; LATENT RESERVOIR; HIV-1 INFECTION; REPLICATION; VACCINE; PREVENTION; INITIATION; DYNAMICS; DEPENDS; ASSAY	The viral reservoir represents a critical challenge for human immunodeficiency virus type 1 (HIV-1) eradication strategies(1-5). However, it remains unclear when and where the viral reservoir is seeded during acute infection and the extent to which it is susceptible to early anti-retroviral therapy (ART). Here we show that the viral reservoir is seeded rapidly after mucosal simian immunodeficiency virus (SIV) infection of rhesus monkeys and before systemic viraemia. We initiated suppressive ART in groups of monkeys on days 3, 7, 10 and 14 after intrarectal SIVMAC251 infection. Treatment with ART on day 3 blocked the emergence of viral RNA and proviral DNA in peripheral blood and also substantially reduced levels of proviral DNA in lymph nodes and gastrointestinal mucosa as compared with treatment at later time points. In addition, treatment on day 3 abrogated the induction of SIV-specific humoral and cellular immune responses. Nevertheless, after discontinuation of ART following 24 weeks of fully suppressive therapy, virus rebounded in all animals, although the monkeys that were treated on day 3 exhibited a delayed viral rebound as compared with those treated on days 7, 10 and 14. The time to viral rebound correlated with total viraemia during acute infection and with proviral DNA at the time of ART discontinuation. These data demonstrate that the viral reservoir is seeded rapidly after intrarectal SIV infection of rhesus monkeys, during the 'eclipse' phase, and before detectable viraemia. This strikingly early seeding of the refractory viral reservoir raises important new challenges for HIV-1 eradication strategies.	[Whitney, James B.; Sanisetty, Srisowmya; Penaloza-MacMaster, Pablo; Liu, Jinyan; Shetty, Mayuri; Parenteau, Lily; Cabral, Crystal; Shields, Jennifer; Blackmore, Stephen; Smith, Jeffrey Y.; Brinkman, Amanda L.; Peter, Lauren E.; Mathew, Sheeba I.; Smith, Kaitlin M.; Borducchi, Erica N.; Barouch, Dan H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Whitney, James B.; Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Hill, Alison L.; Rosenbloom, Daniel I. S.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Lewis, Mark G.] Bioqual, Rockville, MD 20852 USA; [Hattersley, Jillian; Li, Bei; Hesselgesser, Joseph; Geleziunas, Romas] Gilead Sci Inc, Foster City, CA 94404 USA; [Robb, Merlin L.; Kim, Jerome H.; Michael, Nelson L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; BIOQUAL Inc.; Gilead Sciences; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Barouch, DH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Hill, Alison Lynn/W-7839-2019; Barouch, Dan/Y-3918-2019	Hill, Alison Lynn/0000-0002-6583-3623; Brinkman, Amanda/0000-0002-2845-6494; Peter, Lauren/0000-0002-2105-7503	US Army Medical Research and Material Command; US Military HIV Research Program; Henry M. Jackson Foundation for the Advancement of Military Medicine [W81XWH-07-2-0067, W81XWH-11-2-0174]; NIH [AI060354, AI078526, AI084794, AI095985, AI096040, AI100645]; Ragon Institute of MGH, MIT and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095985, R56AI091514, R01AI084794, U19AI078526, UM1AI100645, T32AI007245, U19AI096040, P30AI060354, UM1AI100663] Funding Source: NIH RePORTER	US Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); US Military HIV Research Program; Henry M. Jackson Foundation for the Advancement of Military Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of MGH, MIT and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Pensiero, M. Marovich, C. Dieffenbach, W. Wagner, C. Gittens, J. Yalley-Ogunro, M. Nowak, R. Siliciano, D. Persaud, S. Deeks, N. Chomont, J. Ananworanich, L. Picker, F. Stephens, R. Hamel, K. Kelly and L. Dunne for advice, assistance and reagents. The SIV<INF>MAC239</INF> peptides were obtained from the National Institutes of Health (NIH) AIDS Research and Reference Reagent Program. We acknowledge support from the US Army Medical Research and Material Command and the US Military HIV Research Program through its cooperative agreement with the Henry M. Jackson Foundation for the Advancement of Military Medicine (W81XWH-07-2-0067, W81XWH-11-2-0174); the NIH (AI060354, AI078526, AI084794, AI095985, AI096040, AI100645); and the Ragon Institute of MGH, MIT and Harvard. The views expressed in this manuscript are those of the authors and do not represent the official views of the Department of the Army or the Department of Defense.	Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Archin NM, 2012, P NATL ACAD SCI USA, V109, P9523, DOI 10.1073/pnas.1120248109; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Cline AN, 2005, J MED PRIMATOL, V34, P303; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hocqueloux L, 2013, J ANTIMICROB CHEMOTH, V68, P1169, DOI 10.1093/jac/dks533; Liu JY, 2012, J VIROL, V86, P7829, DOI 10.1128/JVI.00512-12; Liu JY, 2010, J VIROL, V84, P10406, DOI 10.1128/JVI.01155-10; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Nowak MA, 1997, J VIROL, V71, P7518, DOI 10.1128/JVI.71.10.7518-7525.1997; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Persaud D, 2003, J VIROL, V77, P1659, DOI 10.1128/JVI.77.3.1659-1665.2003; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Rosenberg ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010555; Rosenbloom DIS, 2012, NAT MED, V18, P1378, DOI 10.1038/nm.2892; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Steingrover R, 2008, AIDS, V22, P1583, DOI 10.1097/QAD.0b013e328305bd77; Stohr W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078287; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; von Wyl V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027463; Whitney JB, 2009, J VIROL, V83, P10840, DOI 10.1128/JVI.01202-09; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101	28	393	406	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					74	+		10.1038/nature13594	http://dx.doi.org/10.1038/nature13594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25042999	Green Submitted, Green Accepted			2022-12-01	WOS:000339908000034
J	Fontana, L; Kennedy, BK; Longo, VD				Fontana, Luigi; Kennedy, Brian K.; Longo, Valter D.			Prepare for human testing	NATURE			English	Editorial Material									[Fontana, Luigi] Washington Univ, St Louis, MO 63130 USA; [Fontana, Luigi] Univ Brescia, I-25121 Brescia, Italy; [Kennedy, Brian K.] Buck Inst Res Aging, Novato, CA USA; [Longo, Valter D.] Univ So Calif, Longev Inst, Los Angeles, CA USA	Washington University (WUSTL); University of Brescia; Buck Institute for Research on Aging; University of Southern California	Fontana, L (corresponding author), Washington Univ, St Louis, MO 63130 USA.	fontana.luigi@gmail.com		Kennedy, Brian/0000-0002-5754-1874; Fontana, Luigi/0000-0001-8500-5537					0	157	167	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					405	406		10.1038/511405a	http://dx.doi.org/10.1038/511405a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL7SO	25056047	Bronze			2022-12-01	WOS:000339335700021
J	Northcott, PA; Lee, C; Zichner, T; Stutz, AM; Erkek, S; Kawauchi, D; Shih, DJH; Hovestadt, V; Zapatka, M; Sturm, D; Jones, DTW; Kool, M; Remke, M; Cavalli, FMG; Zuyderduyn, S; Bader, GD; VandenBerg, S; Esparza, LA; Ryzhova, M; Wang, W; Wittmann, A; Stark, S; Sieber, L; Seker-Cin, H; Linke, L; Kratochwil, F; Jager, N; Buchhalter, I; Imbusch, CD; Zipprich, G; Raeder, B; Schmidt, S; Diessl, N; Wolf, S; Wiemann, S; Brors, B; Lawerenz, C; Eils, J; Warnatz, HJ; Risch, T; Yaspo, ML; Weber, UD; Bartholomae, CC; von Kalle, C; Turanyi, E; Hauser, P; Sanden, E; Darabi, A; Siesjo, P; Sterba, J; Zitterbart, K; Sumerauer, D; van Sluis, P; Versteeg, R; Volckmann, R; Koster, J; Schuhmann, MU; Ebinger, M; Grimes, HL; Robinson, GW; Gajjar, A; Mynarek, M; von Hoff, K; Rutkowski, S; Pietsch, T; Scheurlen, W; Felsberg, J; Reifenberger, G; Kulozik, AE; von Deimling, A; Witt, O; Eils, R; Gilbertson, RJ; Korshunov, A; Taylor, MD; Lichter, P; Korbel, JO; Wechsler-Reya, RJ; Pfister, SM				Northcott, Paul A.; Lee, Catherine; Zichner, Thomas; Stuetz, Adrian M.; Erkek, Serap; Kawauchi, Daisuke; Shih, David J. H.; Hovestadt, Volker; Zapatka, Marc; Sturm, Dominik; Jones, David T. W.; Kool, Marcel; Remke, Marc; Cavalli, Florence M. G.; Zuyderduyn, Scott; Bader, Gary D.; VandenBerg, Scott; Esparza, Lourdes Adriana; Ryzhova, Marina; Wang, Wei; Wittmann, Andrea; Stark, Sebastian; Sieber, Laura; Seker-Cin, Huriye; Linke, Linda; Kratochwil, Fabian; Jaeger, Natalie; Buchhalter, Ivo; Imbusch, Charles D.; Zipprich, Gideon; Raeder, Benjamin; Schmidt, Sabine; Diessl, Nicolle; Wolf, Stephan; Wiemann, Stefan; Brors, Benedikt; Lawerenz, Chris; Eils, Juergen; Warnatz, Hans-Joerg; Risch, Thomas; Yaspo, Marie-Laure; Weber, Ursula D.; Bartholomae, Cynthia C.; von Kalle, Christof; Turanyi, Eszter; Hauser, Peter; Sanden, Emma; Darabi, Anna; Siesjoe, Peter; Sterba, Jaroslav; Zitterbart, Karel; Sumerauer, David; van Sluis, Peter; Versteeg, Rogier; Volckmann, Richard; Koster, Jan; Schuhmann, Martin U.; Ebinger, Martin; Grimes, H. Leighton; Robinson, Giles W.; Gajjar, Amar; Mynarek, Martin; von Hoff, Katja; Rutkowski, Stefan; Pietsch, Torsten; Scheurlen, Wolfram; Felsberg, Joerg; Reifenberger, Guido; Kulozik, Andreas E.; von Deimling, Andreas; Witt, Olaf; Eils, Roland; Gilbertson, Richard J.; Korshunov, Andrey; Taylor, Michael D.; Lichter, Peter; Korbel, Jan O.; Wechsler-Reya, Robert J.; Pfister, Stefan M.			Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma	NATURE			English	Article							FINGER PROTEIN GFI-1; SUPER-ENHANCERS; CELL IDENTITY; GENOME; GENE; MYC; MUTATIONS; SUBGROUP; MODEL; PIM-1	Medulloblastoma is a highly malignant paediatric brain tumour currently treated with a combination of surgery, radiation and chemotherapy, posing a considerable burden of toxicity to the developing child. Genomics has illuminated the extensive intertumoral heterogeneity of medulloblastoma, identifying four distinct molecular subgroups. Group 3 and group 4 subgroup medulloblastomas account for most paediatric cases; yet, oncogenic drivers for these subtypes remain largely unidentified. Here we describe a series of prevalent, highly disparate genomic structural variants, restricted to groups 3 and 4, resulting in specific and mutually exclusive activation of the growth factor independent 1 family proto-oncogenes, GFI1 and GFI1B. Somatic structural variants juxtapose GFI1 or GFI1B coding sequences proximal to active enhancer elements, including super-enhancers, instigating oncogenic activity. Our results, supported by evidence from mouse models, identify GFI1 and GFI1B as prominent medulloblastoma oncogenes and implicate 'enhancer hijacking' as an efficient mechanism driving oncogene activation in a childhood cancer.	[Northcott, Paul A.; Erkek, Serap; Kawauchi, Daisuke; Sturm, Dominik; Jones, David T. W.; Kool, Marcel; Wittmann, Andrea; Stark, Sebastian; Sieber, Laura; Seker-Cin, Huriye; Linke, Linda; Kratochwil, Fabian; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Lee, Catherine] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Lee, Catherine; Esparza, Lourdes Adriana; Wechsler-Reya, Robert J.] Sanford Burnham Med Res Inst, Tumor Initiat & Maintenance Program, La Jolla, CA 92037 USA; [Zichner, Thomas; Stuetz, Adrian M.; Erkek, Serap; Raeder, Benjamin; Korbel, Jan O.] European Mol Biol Lab EMBL, Genome Biol Unit, D-69117 Heidelberg, Germany; [Shih, David J. H.; Remke, Marc; Cavalli, Florence M. G.; Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON M5G 1X8, Canada; [Hovestadt, Volker; Zapatka, Marc; Wang, Wei; Weber, Ursula D.; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Zuyderduyn, Scott; Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [VandenBerg, Scott] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Ryzhova, Marina] NN Burdenko Inst Neurosurg, Dept Neuropathol, Moscow 125047, Russia; [Jaeger, Natalie; Buchhalter, Ivo; Brors, Benedikt; Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Imbusch, Charles D.; Zipprich, Gideon; Lawerenz, Chris; Eils, Juergen] German Canc Res Ctr, Data Management Facil, D-69120 Heidelberg, Germany; [Schmidt, Sabine; Diessl, Nicolle; Wolf, Stephan; Wiemann, Stefan] German Canc Res Ctr, Genom & Prote Core Facil, D-69120 Heidelberg, Germany; [Warnatz, Hans-Joerg; Risch, Thomas; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Bartholomae, Cynthia C.; von Kalle, Christof] German Canc Res Ctr, Div Translat Oncol, D-69120 Heidelberg, Germany; [Bartholomae, Cynthia C.; von Kalle, Christof] Natl Ctr Tumor Dis NCT, D-69120 Heidelberg, Germany; [von Kalle, Christof; Eils, Roland; Lichter, Peter] Heidelberg Ctr Personalised Oncol DKFZ HIPO, D-69120 Heidelberg, Germany; [Turanyi, Eszter] Semmelweis Univ SE, Dept Pathol & Expt Canc Res 1, H-1094 Budapest, Hungary; [Hauser, Peter] Semmelweis Univ, Dept Pediat 2, H-1094 Budapest, Hungary; [Sanden, Emma; Darabi, Anna; Siesjoe, Peter] Lund Univ, Div Neurosurg, Glioma Immunotherapy Grp, S-22100 Lund, Sweden; [Sanden, Emma; Darabi, Anna; Siesjoe, Peter] Lund Univ, Dept Clin Sci, S-22100 Lund, Sweden; [Sterba, Jaroslav; Zitterbart, Karel] Masaryk Univ, Dept Pediat Oncol, Brno 61300, Czech Republic; [Sterba, Jaroslav; Zitterbart, Karel] Univ Hosp, Brno 61300, Czech Republic; [Sumerauer, David] Charles Univ Prague, Dept Pediat Hematol & Oncol, Fac Med 2, Prague 15006, Czech Republic; [Sumerauer, David] Univ Hosp Motol, Prague 15006, Czech Republic; [van Sluis, Peter; Versteeg, Rogier; Volckmann, Richard; Koster, Jan] Univ Amsterdam, AMC, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands; [Schuhmann, Martin U.; Ebinger, Martin] Tubingen Univ Hosp, Dept Neurosurg, D-72076 Tubingen, Germany; [Grimes, H. Leighton] Cincinnati Childrens Hosp Med Ctr, Program Hematol Malignancies, Program Canc Pathol, Div Immunobiol,Div Expt Hematol & Pathol,Canc & B, Cincinnati, OH 45229 USA; [Robinson, Giles W.; Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Robinson, Giles W.; Gajjar, Amar; Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; Univ Med Ctr Hamburg Eppendorf, Dept Paediat Haematol & Oncol, D-20246 Hamburg, Germany; [Pietsch, Torsten] Univ Bonn, Dept Neuropathol, D-53105 Bonn, Germany; [Scheurlen, Wolfram] Nurnberg Childrens Hosp, Cnopfsche Kinderklin, D-90419 Nurnberg, Germany; [Felsberg, Joerg; Reifenberger, Guido] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Kulozik, Andreas E.; Witt, Olaf; Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [von Deimling, Andreas; Korshunov, Andrey] Heidelberg Univ, Dept Neuropathol, D-69120 Heidelberg, Germany; [Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Korbel, Jan O.] European Bioinformat Inst EMBL EBI, EMBL, Saffron Walden CB10 1SD, Essex, England	Helmholtz Association; German Cancer Research Center (DKFZ); University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; European Molecular Biology Laboratory (EMBL); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; University of California System; University of California San Diego; Russian Academy of Medical Sciences; N.N.Burdenko National Medical Research Center of Neurosurgery; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Semmelweis University; Semmelweis University; Lund University; Lund University; Masaryk University Brno; University Hospital Brno; Charles University Prague; Motol University Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn; Heinrich Heine University Dusseldorf; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); European Molecular Biology Laboratory (EMBL)	Northcott, PA (corresponding author), German Canc Res Ctr, Div Pediat Neurooncol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	m.macleod@dkfz-heidelberg.de; korbel@embl.de; rwreya@sanfordburnham.org; s.pfister@dkfz-heidelberg.de	Sturm, Dominik/AAL-3689-2020; Jones, David T. W./Z-1963-2019; Kool, Marcel/H-2541-2013; Northcott, Paul A/N-4022-2018; Gilbertson, Richard James/ABE-1346-2021; Gajjar, Amar/N-8059-2018; Koster, Jan/C-5934-2008; Kulozik, Andreas/AAO-2432-2020; Eils, Roland/B-6121-2009; Pfister, Stefan M/F-6860-2013; von Deimling, Andreas/F-7774-2013; Ryzhova, Marina/G-4178-2014; Shih, David J H/H-3186-2011; Mynarek, Martin/AAY-6129-2020; Reifenberger, Guido/AAE-3599-2019; Brors, Benedikt/E-5620-2013; Erkek, Serap/AAV-5549-2020; Robinson, Giles W/N-8095-2018; Ebinger, Martin/O-4936-2016; Sterba, Jaroslav/N-6156-2016; Bader, Gary/C-1176-2009; Versteeg, Rogier/AAQ-1765-2020; Jones, David TW/G-9588-2013; Korbel, Jan O/G-6470-2012; Zapatka, Marc/G-9896-2013; Kawauchi, Daisuke/ABE-9133-2021; Shih, David J. H./AAE-8726-2019; Wiemann, Stefan/E-4424-2013	Sturm, Dominik/0000-0003-0250-1696; Northcott, Paul A/0000-0002-1220-5252; Gilbertson, Richard James/0000-0001-7539-9472; Koster, Jan/0000-0002-0890-7585; Eils, Roland/0000-0002-0034-4036; Pfister, Stefan M/0000-0002-5447-5322; von Deimling, Andreas/0000-0002-5863-540X; Ryzhova, Marina/0000-0001-7206-6365; Shih, David J H/0000-0002-9802-4937; Brors, Benedikt/0000-0001-5940-3101; Robinson, Giles W/0000-0001-7441-9486; Ebinger, Martin/0000-0002-4229-8058; Bader, Gary/0000-0003-0185-8861; Jones, David TW/0000-0002-2036-5141; Korbel, Jan O/0000-0002-2798-3794; Zapatka, Marc/0000-0001-8287-5967; Shih, David J. H./0000-0002-9802-4937; Wiemann, Stefan/0000-0003-4683-3174; Taylor, Michael/0000-0001-7009-3466; Zichner, Thomas/0000-0001-9848-7598; Erkek, Serap/0000-0003-4439-5203; Sterba, Jaroslav/0000-0002-8482-8352; Stuetz, Adrian/0000-0001-7650-3470; Lee, Catherine/0000-0002-3105-3557; Mynarek, Martin/0000-0003-3302-2719; Remke, Marc/0000-0002-9404-9993; Versteeg, Rogier/0000-0001-7172-0388; Grimes, H. Leighton/0000-0001-8162-6758; Buchhalter, Ivo/0000-0003-0764-5832; Warnatz, Hans-Jorg/0000-0002-0327-9209; Korshunov, Andrey/0000-0002-5257-3623; Cavalli, Florence M. G./0000-0002-4409-9642; Jaeger, Natalie/0000-0002-9589-7580; Hovestadt, Volker/0000-0002-3480-6649; Raeder, Benjamin/0000-0002-9494-8884; von Hoff, Katja/0000-0002-5669-8546	PedBrain Tumor Project - German Cancer Aid [109252]; German Federal Ministry of Education and Research (BMBF) [01KU1201A, MedSys 0315416C, NGFNplus 01GS0883]; German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); EMBL International PhD Programme; Dutch Cancer Foundation KWF [2010-4713]; Dutch Cancer Foundation KIKA; US National Institutes of Health, National Center for Research Resources [P41 GM103504]; CancerSys grant MYC-NET (German Federal Ministry of Education and Research, BMBF) [0316076A]; European Commission [Health-F2-2010-260791]; Helmholtz Alliance PCCC [HA-305]; Hertie Foundation; DKFZ; California Institute for Regenerative Medicine [CIRM LA1-01747]; National Cancer Institute [5P30CA030199, R01 CA159859]; CureSearch for Children's Cancer Foundation; NATIONAL CANCER INSTITUTE [P30CA030199, P01CA096832, R01CA129541, R01CA159859] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER	PedBrain Tumor Project - German Cancer Aid; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); EMBL International PhD Programme; Dutch Cancer Foundation KWF(KWF Kankerbestrijding); Dutch Cancer Foundation KIKA; US National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); CancerSys grant MYC-NET (German Federal Ministry of Education and Research, BMBF)(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Helmholtz Alliance PCCC; Hertie Foundation; DKFZ(Helmholtz Association); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CureSearch for Children's Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	For technical support and expertise we thank: the DKFZ Genomics and Proteomics Core Facility; B. Haase, D. Pavlinic and B. Baying (EMBL Genomics Core Facility); M. Knopf (NCT Heidelberg); the Sanford-Burnham Animal Facility and Cell Imaging, Tissue & Histopathology Shared Resource; and the UCSD Flow Cytometry Core Facility. We also thank Active Motif for the preparation of histone ChIP libraries. This work was principally supported by the PedBrain Tumor Project contributing to the International Cancer Genome Consortium, funded by the German Cancer Aid (109252) and by the German Federal Ministry of Education and Research (BMBF, grants 01KU1201A, MedSys 0315416C and NGFNplus 01GS0883). Additional support came from the German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO), the EMBL International PhD Programme (T.Z.), Dutch Cancer Foundations KWF (2010-4713) and KIKA (M.Ko.), the US National Institutes of Health, National Center for Research Resources (P41 GM103504; G.D.B.), the CancerSys grant MYC-NET (German Federal Ministry of Education and Research, BMBF, 0316076A), the European Commission (Health-F2-2010-260791), and the Helmholtz Alliance PCCC (grant number HA-305). PAN is a Roman Herzog Postdoctoral Fellow funded by the Hertie Foundation and the DKFZ. R.J.W.-R. is the recipient of a Research Leadership Award from the California Institute for Regenerative Medicine (CIRM LA1-01747) and obtained additional support from the National Cancer Institute (5P30CA030199 and R01 CA159859), and the CureSearch for Children's Cancer Foundation.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bhatia B, 2009, CANCER RES, V69, P7224, DOI 10.1158/0008-5472.CAN-09-1299; Boutros PC, 2010, CANCER INFORM, V9, P197; Cairns J, 2011, BIOINFORMATICS, V27, P713, DOI 10.1093/bioinformatics/btq685; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Hovestadt V, 2013, ACTA NEUROPATHOL, V125, P913, DOI 10.1007/s00401-013-1126-5; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kawauchi D, 2012, CANCER CELL, V21, P168, DOI 10.1016/j.ccr.2011.12.023; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kim TM, 2013, GENOME RES, V23, P217, DOI 10.1101/gr.140301.112; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Nambiar M, 2008, BBA-REV CANCER, V1786, P139, DOI 10.1016/j.bbcan.2008.07.005; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Northcott PA, 2012, ACTA NEUROPATHOL, V123, P615, DOI 10.1007/s00401-011-0899-7; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Pei YX, 2012, CANCER CELL, V21, P155, DOI 10.1016/j.ccr.2011.12.021; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Scheijen B, 1997, J VIROL, V71, P9, DOI 10.1128/JVI.71.1.9-16.1997; Schmidt T, 1998, ONCOGENE, V17, P2661, DOI 10.1038/sj.onc.1202191; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977; Zhukova N, 2013, J CLIN ONCOL, V31, P2927, DOI 10.1200/JCO.2012.48.5052; Zornig M, 1996, ONCOGENE, V12, P1789	46	376	385	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					428	+		10.1038/nature13379	http://dx.doi.org/10.1038/nature13379			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25043047	Green Published, Green Accepted			2022-12-01	WOS:000339335700038
J	Neuman, MD; Rosenbaum, PR; Ludwig, JM; Zubizarreta, JR; Silber, JH				Neuman, Mark D.; Rosenbaum, Paul R.; Ludwig, Justin M.; Zubizarreta, Jose R.; Silber, Jeffrey H.			Anesthesia Technique, Mortality, and Length of Stay After Hip Fracture Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENERAL-ANESTHESIA; ELDERLY-PATIENTS; POSTOPERATIVE DELIRIUM; CONFIDENCE-INTERVALS; SENSITIVITY-ANALYSIS; BIAS REDUCTION; OUTCOMES; CARE; ASSOCIATION; INSTRUMENT	IMPORTANCE More than 300 000 hip fractures occur each year in the United States. Recent practice guidelines have advocated greater use of regional anesthesia for hip fracture surgery. OBJECTIVE To test the association of regional (ie, spinal or epidural) anesthesia vs general anesthesia with 30-day mortality and hospital length of stay after hip fracture. DESIGN, SETTING, AND PATIENTS We conducted a matched retrospective cohort study involving patients 50 years or older who were undergoing surgery for hip fracture at general acute care hospitals in New York State between July 1, 2004, and December 31, 2011. Our main analysis was a near-far instrumental variable match that paired patients who lived at different distances from hospitals that specialized in regional or general anesthesia. Supplementary analyses included a within-hospital match that paired patients within the same hospital and an across-hospital match that paired patients at different hospitals. EXPOSURES Spinal or epidural anesthesia; general anesthesia. MAIN OUTCOMES AND MEASURES Thirty-day mortality and hospital length of stay. Because the distribution of length of stay had long tails, we characterized this outcome using the Huber M estimate with Huber weights, a robust estimator similar to a trimmed mean. RESULTS Of 56 729 patients, 15 904 (28%) received regional anesthesia and 40 825 (72%) received general anesthesia. Overall, 3032 patients (5.3%) died. The M estimate of the length of stay was 6.2 days (95% CI, 6.2 to 6.2). The near-far matched analysis showed no significant difference in 30-day mortality by anesthesia type among the 21 514 patients included in this match: 583 of 10 757 matched patients (5.4%) who lived near a regional anesthesia-specialized hospital died vs 629 of 10 757 matched patients (5.8%) who lived near a general anesthesia-specialized hospital (instrumental variable estimate of risk difference, -1.1%; 95% CI, -2.8 to 0.5; P = .20). Supplementary analyses of within and across hospital patient matches yielded mortality findings to be similar to the main analysis. In the near-far match, regional anesthesia was associated with a 0.6-day shorter length of stay than general anesthesia (95% CI, -0.8 to -0.4, P < .001). Supplementary analyses also showed regional anesthesia to be associated with shorter length of stay, although the observed association was smaller in magnitude than in the main analysis. CONCLUSIONS AND RELEVANCE Among adults in acute care hospitals in New York State undergoing hip repair, the use of regional anesthesia compared with general anesthesia was not associated with lower 30-day mortality but was associated with a modestly shorter length of stay. These findings do not support a mortality benefit for regional anesthesia in this setting.	[Neuman, Mark D.; Silber, Jeffrey H.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Neuman, Mark D.; Rosenbaum, Paul R.; Silber, Jeffrey H.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Rosenbaum, Paul R.] Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA; [Ludwig, Justin M.; Silber, Jeffrey H.] Childrens Hosp Philadelphia, Ctr Outcomes Res, Philadelphia, PA USA; [Zubizarreta, Jose R.] Columbia Business Sch, Div Decis Risk & Operat, New York, NY USA; [Zubizarreta, Jose R.] Columbia Univ, Dept Stat, New York, NY USA; [Silber, Jeffrey H.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Silber, Jeffrey H.] Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Columbia University; Columbia University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Neuman, MD (corresponding author), Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, 1119 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	neumanm@mail.med.upenn.edu	Rosenbaum, Paul R/H-8687-2012		Foundation for Anesthesia Education and Research; National Institute on Aging [1K08AG043548]; National Science Foundation [1260782]; NATIONAL INSTITUTE ON AGING [K08AG043548] Funding Source: NIH RePORTER	Foundation for Anesthesia Education and Research; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants to MDN from the Foundation for Anesthesia Education and Research and 1K08AG043548 from the National Institute on Aging (Dr Neuman) and by grant 1260782 the from the National Science Foundation, (Dr Rosenbaum).	Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Baiocchi M, 2012, HEALTH SERV OUTCOME, V12, P237, DOI 10.1007/s10742-012-0091-0; Baiocchi M, 2010, J AM STAT ASSOC, V105, P1285, DOI 10.1198/jasa.2010.ap09490; BERGGREN D, 1987, ANESTH ANALG, V66, P497; Blackman D K, 1999, MMWR CDC Surveill Summ, V48, P1; Boulton C, 2014, NATL HIP FRACTURE DA; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; COCHRAN WG, 1973, SANKHYA SER A, V35, P417; DAVIS FM, 1987, BRIT J ANAESTH, V59, P561, DOI 10.1093/bja/59.5.561; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Foss NB, 2005, ANESTHESIOLOGY, V102, P1197, DOI 10.1097/00000542-200506000-00020; Griffiths R, 2012, ANAESTHESIA, V67, P85, DOI 10.1111/j.1365-2044.2011.06957.x; Horlocker TT, 2010, REGION ANESTH PAIN M, V35, P64, DOI 10.1097/AAP.0b013e3181c15c70; Huber P.J., 1981, ROBUST STAT; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Imbens GW, 2005, J ROY STAT SOC A STA, V168, P109, DOI 10.1111/j.1467-985X.2004.00339.x; Lee HB, 2011, J AM GERIATR SOC, V59, P2306, DOI 10.1111/j.1532-5415.2011.03725.x; Lorch SA, 2012, PEDIATRICS, V130, P270, DOI 10.1542/peds.2011-2820; Magaziner J, 2000, J GERONTOL A-BIOL, V55, pM498, DOI 10.1093/gerona/55.9.M498; Mahalanobis P.C., 1936, P NATL I SCI INDIA, P49, DOI DOI 10.1145/1390156.1390302; Maritz J. S., 1995, DISTRIBUTION FREE ST, V2nd; Neuman MD, 2012, ANESTHESIOLOGY, V117, P72, DOI 10.1097/ALN.0b013e3182545e7c; Neuman MD, 2010, MED CARE, V48, P314, DOI 10.1097/MLR.0b013e3181ca4126; O'Hara DA, 2000, ANESTHESIOLOGY, V92, P947, DOI 10.1097/00000542-200004000-00011; Parker MJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000521.PUB2; Polsky D, 2008, HEALTH SERV RES, V43, P1388, DOI 10.1111/j.1475-6773.2008.00837.x; Radcliff TA, 2008, J BONE JOINT SURG AM, V90A, P34, DOI 10.2106/JBJS.G.00065; Regan EA, 2013, COPD, V10, P11, DOI 10.3109/15412555.2012.723072; Rosenbaum PR, 2007, BIOMETRICS, V63, P456, DOI 10.1111/j.1541-0420.2006.00717.x; Rosenbaum PR, 2007, J AM STAT ASSOC, V102, P75, DOI 10.1198/016214506000001059; Rosenbaum PR, 2012, J COMPUT GRAPH STAT, V21, P57, DOI 10.1198/jcgs.2011.09219; Rosenbaum PR, 2009, J AM STAT ASSOC, V104, P1398, DOI 10.1198/jasa.2009.tm08470; Rosenbaum PR, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-1213-8; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; RUBIN DB, 1980, BIOMETRICS, V36, P293, DOI 10.2307/2529981; Rubin DB, 2007, STAT MED, V26, P20, DOI 10.1002/sim.2739; Scheinin H, 2000, ACTA ANAESTH SCAND, V44, P1061, DOI 10.1034/j.1399-6576.2000.440905.x; Scottish Intercollegiate Guidelines Network, 2009, MAN HIP FRACT OLD PE; Sheffield KM, 2013, JAMA-J AM MED ASSOC, V310, P812, DOI 10.1001/jama.2013.276205; Sieber FE, 2010, J CLIN ANESTH, V22, P179, DOI 10.1016/j.jclinane.2009.06.005; Sieber FE, 2010, MAYO CLIN PROC, V85, P18, DOI 10.4065/mcp.2009.0469; Silber JH, 2007, MED CARE, V45, P918, DOI 10.1097/MLR.0b013e31812e01cc; Silber JH, 2001, MED CARE, V39, P1048, DOI 10.1097/00005650-200110000-00003; Small DS, 2008, J AM STAT ASSOC, V103, P924, DOI 10.1198/016214507000001247; UK National Clinical Guideline Centre, 2011, MAN HIP FRACT AD; VALENTIN N, 1986, BRIT J ANAESTH, V58, P284, DOI 10.1093/bja/58.3.284; White SM, 2014, ANAESTHESIA, V69, P224, DOI 10.1111/anae.12542; White SM, 2010, ANAESTHESIA, V65, P243, DOI 10.1111/j.1365-2044.2009.06208.x; Zubizarreta JR, 2012, J AM STAT ASSOC, V107, P1360, DOI 10.1080/01621459.2012.703874	49	178	191	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2014	311	24					2508	2517		10.1001/jama.2014.6499	http://dx.doi.org/10.1001/jama.2014.6499			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ5VE	25058085	Green Accepted, Green Published			2022-12-01	WOS:000337757000024
J	Macaraig, M; Burzynski, J; Varma, JK				Macaraig, Michelle; Burzynski, Joseph; Varma, Jay K.			Tuberculosis Control in New York City - A Changing Landscape	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Macaraig, Michelle; Burzynski, Joseph; Varma, Jay K.] New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA	New York City Department of Health & Mental Hygiene	Macaraig, M (corresponding author), New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA.							[Anonymous], 2013, CONTR ANN TUB SUMM; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Krueger K, 2010, INT J TUBERC LUNG D, V14, P779; REICHMAN LB, 1991, AM REV RESPIR DIS, V144, P741, DOI 10.1164/ajrccm/144.4.741; Warkentin J, 2013, MMWR-MORBID MORTAL W, V62, P398	5	11	11	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2014	370	25					2362	2365		10.1056/NEJMp1402147	http://dx.doi.org/10.1056/NEJMp1402147			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ0OA	24941176				2022-12-01	WOS:000337353000004
J	Voorhees, RM; Fernandez, IS; Scheres, SHW; Hegde, RS				Voorhees, Rebecca M.; Fernandez, Israel S.; Scheres, Sjors H. W.; Hegde, Ramanujan S.			Structure of the Mammalian Ribosome-Sec61 Complex to 3.4 angstrom Resolution	CELL			English	Article							EM STRUCTURE DETERMINATION; ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL SEQUENCE RECOGNITION; PROTEIN-CONDUCTING CHANNEL; NASCENT SECRETORY PROTEINS; TRANSFER-RNA; CRYO-EM; ELECTRON CRYOMICROSCOPY; TRANSLOCATION CHANNEL; ELONGATION CYCLE	Cotranslational protein translocation is a universally conserved process for secretory and membrane protein biosynthesis. Nascent polypeptides emerging from a translating ribosome are either transported across or inserted into the membrane via the ribosome-bound Sec61 channel. Here, we report structures of a mammalian ribosome-Sec61 complex in both idle and translating states, determined to 3.4 and 3.9 angstrom resolution. The data sets permit building of a near-complete atomic model of the mammalian ribosome, visualization of A/P and P/E hybrid-state tRNAs, and analysis of a nascent polypeptide in the exit tunnel. Unprecedented chemical detail is observed for both the ribosome-Sec61 interaction and the conformational state of Sec61 upon ribosome binding. Comparison of the maps from idle and translating complexes suggests how conformational changes to the Sec61 channel could facilitate translocation of a secreted polypeptide. The high-resolution structure of the mammalian ribosome-Sec61 complex provides a valuable reference for future functional and structural studies.	[Voorhees, Rebecca M.; Fernandez, Israel S.; Scheres, Sjors H. W.; Hegde, Ramanujan S.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Voorhees, RM (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	voorhees@mrc-lmb.cam.ac.uk; rhegde@mrc-lmb.cam.ac.uk	Scheres, Sjors H.W./AAY-2265-2021	Scheres, Sjors H.W./0000-0002-0462-6540; Fernandez, Israel/0000-0001-7218-1603; VOORHEES, REBECCA/0000-0003-1640-2293; Hegde, Ramanujan/0000-0001-8338-852X	UK Medical Research Council [MC_UP_A022_1007, MC_UP_A025_1013, MC_U105184332]; Wellcome Trust [WT096570]; Agouron Institute; Jeantet Foundation; MRC [MC_UP_A022_1007, MC_U105184332, MC_UP_A025_1013] Funding Source: UKRI; Medical Research Council [MC_UP_A025_1013, MC_UP_A022_1007, MC_U105184332] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Jeantet Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Kasim Sader and Vinothkumar Ragunath for help with data collection; Alice Clark for reagents; Tim Stevens for bioinformatic analysis; Christos Savva for help with sample preparation and data collection; Shaoxia Chen, Greg McMullan, Jake Grimmett, and Toby Darling for technical support; and Alan Brown, Garib Murshudov, and Paul Emsley for help with model building and refinement. We are especially grateful to V. Ramakrishnan for advice, support, and critical reading of the manuscript. This work was supported by the UK Medical Research Council (MC_UP_A022_1007 to R.S.H., MC_UP_A025_1013 to S.H.W.S.) and a Wellcome Trust postdoctoral fellowship (R.M.V.). I.S.F. is supported by grants to V. Ramakrishnan including the UK Medical Research Council (MC_U105184332), a Wellcome Trust Senior Investigator award (WT096570), the Agouron Institute, and the Jeantet Foundation.	ADELMAN MR, 1973, J CELL BIOL, V56, P206, DOI 10.1083/jcb.56.1.206; Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Allegretti M, 2014, ELIFE, V3, DOI 10.7554/eLife.01963; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Berndt U, 2009, P NATL ACAD SCI USA, V106, P1398, DOI 10.1073/pnas.0808584106; Chen E, 2014, MOL CELL, V54, P407, DOI 10.1016/j.molcel.2014.03.023; Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188; CONNOLLY T, 1989, J CELL BIOL, V108, P299, DOI 10.1083/jcb.108.2.299; du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez IS, 2013, SCIENCE, V342, P824, DOI 10.1126/science.1240585; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Hegde RS, 1996, CELL, V85, P217, DOI 10.1016/S0092-8674(00)81098-3; HIRSH, 1971, J MOL BIOL, V58, P439, DOI 10.1016/0022-2836(71)90362-7; HIRSH D, 1971, J MOL BIOL, V58, P459, DOI 10.1016/0022-2836(71)90363-9; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; MacKinnon AL, 2014, ELIFE, V3, DOI 10.7554/eLife.01483; MATLACK KES, 1995, J BIOL CHEM, V270, P6170, DOI 10.1074/jbc.270.11.6170; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Nyathi Y, 2013, BBA-MOL CELL RES, V1833, P2392, DOI 10.1016/j.bbamcr.2013.02.021; PALADE GE, 1955, J BIOPHYS BIOCHEM CY, V1, P59, DOI 10.1083/jcb.1.1.59; Park E, 2014, NATURE, V506, P102, DOI 10.1038/nature12720; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-402312, 10.1146/annurev-biophys-050511-102312]; Park E, 2011, NATURE, V473, P239, DOI 10.1038/nature10014; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Pool MR, 2009, J CELL BIOL, V185, P889, DOI 10.1083/jcb.200807066; Raden D, 2000, J CELL BIOL, V150, P53, DOI 10.1083/jcb.150.1.53; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Scheres SHW, 2010, METHOD ENZYMOL, V482, P295, DOI 10.1016/S0076-6879(10)82012-9; Schmeing TM, 2011, NAT STRUCT MOL BIOL, V18, P432, DOI 10.1038/nsmb.2003; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Trueman SF, 2012, J CELL BIOL, V199, P907, DOI 10.1083/jcb.201207163; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Zhou MY, 1998, J BIOL CHEM, V273, P24649, DOI 10.1074/jbc.273.38.24649; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	65	228	237	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1632	1643		10.1016/j.cell.2014.05.024	http://dx.doi.org/10.1016/j.cell.2014.05.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24930395	Green Accepted, hybrid, Green Published			2022-12-01	WOS:000340941900017
J	Khan, SS; Butler, J; Gheorghiade, M				Khan, Sadiya S.; Butler, Javed; Gheorghiade, Mihai			Management of Comorbid Diabetes Mellitus and Worsening Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSTDISCHARGE OUTCOMES; ASSOCIATION		[Khan, Sadiya S.; Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA; [Butler, Javed] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA	Northwestern University; Feinberg School of Medicine; Emory University	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, 201 E Huron St,Galter 3-150, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu		Khan, Sadiya/0000-0003-0643-1859				Bertoni AG, 2004, DIABETES CARE, V27, P699, DOI 10.2337/diacare.27.3.699; Das SR, 2004, AM HEART J, V148, P883, DOI 10.1016/j.ahj.2004.04.019; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Greenberg BH, 2007, AM HEART J, V154, P646, DOI 10.1016/j.ahj.2007.05.001; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Maggioni AP, 2013, EUR HEART J, V34, P3117, DOI 10.1093/eurheartj/eht342; Sarma S, 2013, EUR J HEART FAIL, V15, P194, DOI 10.1093/eurjhf/hfs153; Shah SJ, 2013, CIRC-HEART FAIL, V6, P184, DOI 10.1161/CIRCHEARTFAILURE.112.972794; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049	10	39	41	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2014	311	23					2379	2380		10.1001/jama.2014.4115	http://dx.doi.org/10.1001/jama.2014.4115			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9XV	24938559				2022-12-01	WOS:000337301500015
J	Szyk, A; Deaconescu, AM; Spector, J; Goodman, B; Valenstein, ML; Ziolkowska, NE; Kormendi, V; Grigorieff, N; Roll-Mecak, A				Szyk, Agnieszka; Deaconescu, Alexandra M.; Spector, Jeffrey; Goodman, Benjamin; Valenstein, Max L.; Ziolkowska, Natasza E.; Kormendi, Vasilisa; Grigorieff, Nikolaus; Roll-Mecak, Antonina			Molecular Basis for Age-Dependent Microtubule Acetylation by Tubulin Acetyltransferase	CELL			English	Article							CHLAMYDOMONAS ALPHA-TUBULIN; STRUCTURAL BASIS; POSTTRANSLATIONAL MODIFICATION; CRYOELECTRON TOMOGRAPHY; CELLULAR MICROTUBULES; BINDING; MEC-17; RESOLUTION; LATTICE; NEURONS	Acetylation of alpha-tubulin Lys40 by tubulin acetyltransferase (TAT) is the only known posttranslational modification in the microtubule lumen. It marks stable microtubules and is required for polarity establishment and directional migration. Here, we elucidate the mechanistic underpinnings for TAT activity and its preference for microtubules with slow turnover. 1.35 angstrom TAT cocrystal structures with bisubstrate analogs constrain TAT action to the microtubule lumen and reveal Lys40 engaged in a suboptimal active site. Assays with diverse tubulin polymers show that TAT is stimulated by microtubule interprotofilament contacts. Unexpectedly, despite the confined intraluminal location of Lys40, TAT efficiently scans the microtubule bidirectionally and acetylates stochastically without preference for ends. First-principles modeling and single-molecule measurements demonstrate that TAT catalytic activity, not constrained luminal diffusion, is rate limiting for acetylation. Thus, because of its preference for microtubules over free tubulin and its modest catalytic rate, TAT can function as a slow clock for microtubule lifetimes.	[Szyk, Agnieszka; Spector, Jeffrey; Goodman, Benjamin; Valenstein, Max L.; Ziolkowska, Natasza E.; Kormendi, Vasilisa; Roll-Mecak, Antonina] Porter Neurosci Res Ctr, Natl Inst Neurol Disorders & Stroke, Cell Biol & Biophys Unit, Bethesda, MD 20892 USA; [Deaconescu, Alexandra M.; Grigorieff, Nikolaus] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Roll-Mecak, Antonina] NHLBI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Roll-Mecak, A (corresponding author), Porter Neurosci Res Ctr, Natl Inst Neurol Disorders & Stroke, Cell Biol & Biophys Unit, Bethesda, MD 20892 USA.	antonina@mail.nih.gov	Deaconescu, Alexandra/AAW-8139-2021	Deaconescu, Alexandra/0000-0002-2742-5493; Valenstein, Max/0000-0001-7616-0148; Roll-Mecak, Antonina/0000-0003-2621-7307; Grigorieff, Nikolaus/0000-0002-1506-909X	NIH [P01 GM62580]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003122] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Piszczek (National Heart, Lung and Blood Institute Biophysics core) for AUC help, B. Castle and D. Odde (University of Minnesota) for modifying the TipTracker program, and G. Brouhard (McGill University) for the doublecortin expression plasmid. A.R.-M. thanks A. Szabo for discussions on diffusion and A. Ferre-D'Amare, E. Giniger, S. Gottesman, K. Swartz, and R. Vale for critical reading of the manuscript. We are grateful to Chen Xu for training at the Brandeis University EM facility where the EM data was collected (supported by NIH grant P01 GM62580 awarded to N.G.). A.R.-M. is a Searle Scholar and supported by the intramural program of the NIH.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Bechstedt S, 2012, DEV CELL, V23, P181, DOI 10.1016/j.devcel.2012.05.006; BLACK MM, 1989, J NEUROSCI, V9, P358; Bungay P.M., 1973, INT J MULTIPHAS FLOW, V1, P25, DOI [DOI 10.1016/0301-9322(73)90003-7, 10.1016/0301-9322(73)90003-7]; BURTON PR, 1984, J CELL BIOL, V99, P520, DOI 10.1083/jcb.99.2.520; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; CHRETIEN D, 1992, J CELL BIOL, V117, P1031, DOI 10.1083/jcb.117.5.1031; Cooper JR, 2009, CURR OPIN CELL BIOL, V21, P68, DOI 10.1016/j.ceb.2009.01.005; CUEVA JG, 2012, CURR BIOL, V22, P1066, DOI [DOI 10.1016/j.cub.2012.05.012, DOI 10.1016/J.CUB.2012.05.012]; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Fourniol FJ, 2010, J CELL BIOL, V191, P463, DOI 10.1083/jcb.201007081; Friedmann DR, 2012, P NATL ACAD SCI USA, V109, P19655, DOI 10.1073/pnas.1209357109; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; Garvalov BK, 2006, J CELL BIOL, V174, P759, DOI 10.1083/jcb.200606074; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; GREER K, 1985, J CELL BIOL, V101, P2081, DOI 10.1083/jcb.101.6.2081; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hinrichs MH, 2012, J BIOL CHEM, V287, P38559, DOI 10.1074/jbc.M112.369785; Howes SC, 2014, MOL BIOL CELL, V25, P257, DOI 10.1091/mbc.E13-07-0387; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kalebic N, 2013, MOL CELL BIOL, V33, P1114, DOI 10.1128/MCB.01044-12; Kim GW, 2013, J BIOL CHEM, V288, P20334, DOI 10.1074/jbc.M113.464792; Kormendi V, 2012, J BIOL CHEM, V287, P41569, DOI 10.1074/jbc.C112.421222; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Li L, 2012, J NEUROSCI, V32, P12673, DOI 10.1523/JNEUROSCI.0016-12.2012; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mulder AM, 2009, J CELL BIOL, V185, P51, DOI 10.1083/jcb.200812052; Neumann B, 2014, CELL REP, V6, P93, DOI 10.1016/j.celrep.2013.12.004; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Odde D, 1998, EUR BIOPHYS J BIOPHY, V27, P514, DOI 10.1007/s002490050161; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Poux AN, 2002, P NATL ACAD SCI USA, V99, P14065, DOI 10.1073/pnas.222373899; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; SCHULZE E, 1987, J CELL BIOL, V104, P277, DOI 10.1083/jcb.104.2.277; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Soppina V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048204; Subramanian R, 2013, CELL, V154, P377, DOI 10.1016/j.cell.2013.06.021; Sui HX, 2006, NATURE, V442, P475, DOI 10.1038/nature04816; TAKEMURA R, 1992, J CELL SCI, V103, P953; Taschner M, 2012, P NATL ACAD SCI USA, V109, P19649, DOI 10.1073/pnas.1209343109; Topalidou I, 2012, CURR BIOL, V22, P1057, DOI 10.1016/j.cub.2012.03.066; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WEBSTER DR, 1989, J CELL SCI, V92, P57; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; Yajima H, 2012, J CELL BIOL, V198, P315, DOI 10.1083/jcb.201201161; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891; Ziolkowska NE, 2013, METHODS MOL BIOL, V1046, P323, DOI 10.1007/978-1-62703-538-5_19	59	130	137	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1405	1415		10.1016/j.cell.2014.03.061	http://dx.doi.org/10.1016/j.cell.2014.03.061			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906155	Bronze, Green Accepted			2022-12-01	WOS:000340881400016
J	Hwang, TJ; Carpenter, D; Kesselheim, AS				Hwang, Thomas J.; Carpenter, Daniel; Kesselheim, Aaron S.			Target small firms for antibiotic innovation	SCIENCE			English	Editorial Material							DRUGS		[Hwang, Thomas J.; Carpenter, Daniel] Harvard Univ, Fac Arts & Sci, Cambridge, MA 02138 USA; [Carpenter, Daniel] Harvard Univ, Radclif Inst Adv Study, Cambridge, MA 02138 USA; [Hwang, Thomas J.; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, PORTAL, Boston, MA 02115 USA; [Hwang, Thomas J.; Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hwang, TJ (corresponding author), Blackstone Grp, London W1J5AL, England.	tjhwang@post.harvard.edu; akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Hwang, Thomas/0000-0003-0717-1497				Blume-Kohout ME, 2012, J POLICY ANAL MANAG, V31, P641, DOI 10.1002/pam.21640; Boucher HW, 2013, CLIN INFECT DIS, V56, P1685, DOI 10.1093/cid/cit152; Coates A, 2002, NAT REV DRUG DISCOV, V1, P895, DOI 10.1038/nrd940; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; Holmes D, 2014, NAT MED, V20, P320, DOI 10.1038/nm0414-320; Hwang TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071966; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; Rex JH, 2013, LANCET INFECT DIS, V13, P269, DOI 10.1016/S1473-3099(12)70293-1	9	11	11	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					967	969		10.1126/science.1251419	http://dx.doi.org/10.1126/science.1251419			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876477				2022-12-01	WOS:000336495800018
J	Hewitt, PE; Ijaz, S; Brailsford, SR; Brett, R; Dicks, S; Haywood, B; Kennedy, ITR; Kitchen, A; Patel, P; Poh, J; Russell, K; Tettmar, KI; Tossell, J; Ushiro-Lumb, I; Tedder, RS				Hewitt, Patricia E.; Ijaz, Samreen; Brailsford, Su R.; Brett, Rachel; Dicks, Steven; Haywood, Becky; Kennedy, Iain T. R.; Kitchen, Alan; Patel, Poorvi; Poh, John; Russell, Katherine; Tettmar, Kate I.; Tossell, Joanne; Ushiro-Lumb, Ines; Tedder, Richard S.			Hepatitis E virus in blood components: a prevalence and transmission study in southeast England	LANCET			English	Article							NON-B HEPATITIS; NON-A; INFECTION; DONORS; WALES; RNA; RECIPIENTS; THERAPY; HIV	Background The prevalence of hepatitis E virus (HEV) genotype 3 infections in the English population (including blood donors) is unknown, but is probably widespread, and the virus has been detected in pooled plasma products. HEV-infected donors have been retrospectively identified through investigation of reported cases of possible transfusion-transmitted hepatitis E. The frequency of HEV transmission by transfusion and its outcome remains unknown. We report the prevalence of HEV RNA in blood donations, the transmission of the virus through a range of blood components, and describe the resulting morbidity in the recipients. Methods From Oct 8, 2012, to Sept 30, 2013, 225 000 blood donations that were collected in southeast England were screened retrospectively for HEV RNA. Donations containing HEV were characterised by use of serology and genomic phylogeny. Recipients, who received any blood components from these donations, were identified and the outcome of exposure was ascertained. Findings 79 donors were viraemic with genotype 3 HEV, giving an RNA prevalence of one in 2848. Most viraemic donors were seronegative at the time of donation. The 79 donations had been used to prepare 129 blood components, 62 of which had been transfused before identification of the infected donation. Follow-up of 43 recipients showed 18 (42%) had evidence of infection. Absence of detectable antibody and high viral load in the donation rendered infection more likely. Recipient immunosuppression delayed or prevented seroconversion and extended the duration of viraemia. Three recipients cleared longstanding infection after intervention with ribavirin or alteration in immunosuppressive therapy. Ten recipients developed prolonged or persistent infection. Transaminitis was common, but short-term morbidity was rare; only one recipient developed apparent but clinically mild post-transfusion hepatitis. Interpretation Our findings suggest that HEV genotype 3 infections are widespread in the English population and in blood donors. Transfusion-transmitted infections rarely caused acute morbidity, but in some immunosuppressed patients became persistent. Although at present blood donations are not screened, an agreed policy is needed for the identification of patients with persistent HEV infection, irrespective of origin, so that they can be offered antiviral therapy.	[Hewitt, Patricia E.; Brailsford, Su R.; Brett, Rachel; Dicks, Steven; Kitchen, Alan; Patel, Poorvi; Tettmar, Kate I.; Tossell, Joanne; Ushiro-Lumb, Ines; Tedder, Richard S.] Natl Hlth Serv Blood & Transplant, London, England; [Ijaz, Samreen; Dicks, Steven; Haywood, Becky; Patel, Poorvi; Tettmar, Kate I.; Ushiro-Lumb, Ines; Tedder, Richard S.] Publ Hlth England, Virus Reference Dept, Microbiol Serv, Blood Borne Virus Unit, London NW9 5EQ, England; [Brailsford, Su R.; Kennedy, Iain T. R.; Russell, Katherine] Publ Hlth England, Infect Dis Surveillance Ctr, London NW9 5EQ, England; [Tedder, Richard S.] UCL, London, England	NHS Blood & Transplant (NHSBT); Public Health England; Public Health England; University of London; University College London	Tedder, RS (corresponding author), Publ Hlth England, Virus Reference Dept, Microbiol Serv, Blood Borne Virus Unit, London NW9 5EQ, England.	richard.tedder@phe.gov.uk	Ushiro-Lumb, Ines/GXM-3502-2022	Ushiro-Lumb, Ines/0000-0003-0989-8091; Haywood, Becky/0000-0002-1461-9619; Tedder, Richard/0000-0002-9672-5721; Kennedy, Iain/0000-0003-0395-1269; Ijaz, Samreen/0000-0001-6658-3542	Public Health England; National Health Service Blood and Transplant	Public Health England; National Health Service Blood and Transplant	Public Health England and National Health Service Blood and Transplant.	Andersson MI, 2013, AIDS, V27, P487, DOI 10.1097/QAD.0b013e32835b1074; BALAYAN MS, 1983, INTERVIROLOGY, V20, P23, DOI 10.1159/000149370; BALAYAN MS, 1990, J MED VIROL, V32, P58, DOI 10.1002/jmv.1890320110; Baylis SA, 2012, VOX SANG, V103, P89, DOI 10.1111/j.1423-0410.2011.01583.x; Beale MA, 2011, VOX SANG, V100, P340, DOI 10.1111/j.1423-0410.2010.01412.x; Boxall E, 2006, TRANSFUSION MED, V16, P79, DOI 10.1111/j.1365-3148.2006.00652.x; Casas M, 2009, VET MICROBIOL, V138, P78, DOI 10.1016/j.vetmic.2009.03.008; Cleland A, 2013, VOX SANG, V105, P283, DOI 10.1111/vox.12056; Coilly A, 2013, TRANSPLANTATION, V96, pE4, DOI 10.1097/TP.0b013e318296c9f7; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; Corman VM, 2013, VOX SANG, V104, P179, DOI 10.1111/j.1423-0410.2012.01638.x; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; Feray C, 2014, LANCET, V383, P218, DOI 10.1016/S0140-6736(14)60072-6; Garson JA, 2012, J VIROL METHODS, V186, P157, DOI 10.1016/j.jviromet.2012.07.027; Gottstein B, 2009, CLIN MICROBIOL REV, V22, P127, DOI 10.1128/CMR.00026-08; Ijaz S, 2005, J INFECT DIS, V192, P1166, DOI 10.1086/444396; Ijaz S, 2012, VOX SANG, V102, P272, DOI 10.1111/j.1423-0410.2011.01554.x; Ijaz S, 2014, J INFECT DIS, V209, P1212, DOI 10.1093/infdis/jit652; Ijaz S, 2009, J CLIN VIROL, V44, P272, DOI 10.1016/j.jcv.2009.01.005; Juhl D, 2014, TRANSFUSION, V54, P49, DOI 10.1111/trf.12121; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2013, SEMIN LIVER DIS, V33, P62, DOI 10.1055/s-0033-1338115; KHUROO MS, 1980, AM J MED, V68, P818, DOI 10.1016/0002-9343(80)90200-4; Lewis HC, 2008, EMERG INFECT DIS, V14, P165, DOI 10.3201/eid1401.070307; Masuda JI, 2005, HEPATOL RES, V31, P178, DOI 10.1016/j.hepres.2005.01.008; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; Said B, 2014, EPIDEMIOL INFECT, V142, P1467, DOI 10.1017/S0950268813002318; Singh GKJ, 2013, J INFECTION, V66, P103, DOI 10.1016/j.jinf.2011.11.027; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; Versluis J, 2013, BLOOD, V122, P1079, DOI 10.1182/blood-2013-03-492363	30	351	359	0	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2014	384	9956					1766	1773		10.1016/S0140-6736(14)61034-5	http://dx.doi.org/10.1016/S0140-6736(14)61034-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7KX	25078306	Green Submitted			2022-12-01	WOS:000345116400027
J	Anders, C; Niewoehner, O; Duerst, A; Jinek, M				Anders, Carolin; Niewoehner, Ole; Duerst, Alessia; Jinek, Martin			Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease	NATURE			English	Article							RNA; CRISPR; SPECIFICITY; SYSTEM; REFINEMENT; DROSOPHILA	The CRISPR-associated protein Cas9 is anRNA-guided endonuclease that cleaves double-stranded DNA bearing sequences complementary to a 20-nucleotide segment in the guideRNA(1,2). Cas9 hase merged as a versatile molecular tool for genome editing and gene expression control(3). RNA-guided DNA recognition and cleavage strictly require the presence of a protospacer adjacent motif (PAM) in the target DNA(1,4-6). Here we report a crystal structure of Streptococcus pyogenes Cas9 in complex with a single-molecule guide RNA and a target DNA containing a canonical 5'-NGG-3' PAM. The structure reveals that the PAM motif resides in a base-paired DNA duplex. The non-complementary strand GG dinucleotide is read out via major-groove interactions with conserved arginine residues from the carboxyterminal domain of Cas9. Interactions with the minor groove of the PAM duplex and the phosphodiester group at the +1 position in the target DNA strand contribute to local strand separation immediately upstream of the PAM. These observations suggest a mechanism for PAM-dependent target DNA melting and RNA-DNA hybrid formation. Furthermore, this study establishes a framework for the rational engineering of Cas9 enzymes with novel PAM specificities.	[Anders, Carolin; Niewoehner, Ole; Duerst, Alessia; Jinek, Martin] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Jinek, M (corresponding author), Univ Zurich, Inst Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jinek@bioc.uzh.ch	Jinek, Martin/E-6621-2011	Jinek, Martin/0000-0002-7601-210X	European Research Council [337284 ANTIVIRNA]; University of Zurich	European Research Council(European Research Council (ERC)European Commission); University of Zurich	We are grateful to J. Doudna for agreement on research directions, helpful discussions and encouragement throughout the project. We thank B. Blattmann and C. Stutz-Ducommun for crystallization screening, N. Ban and M. Leibundgut for the gift of iridium hexamine, and R. Dutzler for sharing synchrotron beam time and crystallographic advice. We thank E. Charpentier, I. Fonfara, S. Sternberg, P. Sledz, A. May and S. Kassube for critical reading of the manuscript. Part of this work was performed at the Swiss Light Source at the Paul Scherrer Institute, Villigen, Switzerland. We thank T. Tomizaki, V. Olieric and M. Wang for assistance with X-ray data collection. This work was supported by the European Research Council Starting Grant no. 337284 ANTIVIRNA and by start-up funds from the University of Zurich.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ashworth J, 2010, NUCLEIC ACIDS RES, V38, P5601, DOI 10.1093/nar/gkq283; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Briner AE, 2014, APPL ENVIRON MICROB, V80, P994, DOI 10.1128/AEM.03015-13; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025	36	728	825	18	359	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					569	+		10.1038/nature13579	http://dx.doi.org/10.1038/nature13579			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25079318	Green Accepted			2022-12-01	WOS:000342075800045
J	Horton, DK; Mehta, P; Antao, VC				Horton, D. Kevin; Mehta, Paul; Antao, Vinicius C.			Quantifying a Nonnotifiable Disease in the United States The National Amyotrophic Lateral Sclerosis Registry Model	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Horton, D. Kevin; Mehta, Paul; Antao, Vinicius C.] Agcy Tox Subst & Dis Registry, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Horton, DK (corresponding author), Agcy Tox Subst & Dis Registry, 4770 Buford Hwy,Mailstop F-58, Atlanta, GA 30341 USA.	dhorton@cdc.gov	Mehta, Paul/ABH-6582-2020	Mehta, Paul/0000-0002-0796-8861; Horton, D. Kevin/0000-0001-6214-6687	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Buehler James W, 2012, MMWR Suppl, V61, P1; Kaye WE, 2014, AMYOTROPH LAT SCL FR, V15, P433, DOI 10.3109/21678421.2014.887119; Logroscino G, 2010, J NEUROL NEUROSUR PS, V81, P385, DOI 10.1136/jnnp.2009.183525; Mehta P, 2014, MMWR SURVEILL SUMM, V63, P1; Mitsumoto H., 1998, AMYOTROPHIC LATERAL	5	20	20	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2014	312	11					1097	1098		10.1001/jama.2014.9799	http://dx.doi.org/10.1001/jama.2014.9799			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO8SN	25057819	Green Accepted			2022-12-01	WOS:000341624700016
J	Cohen, IG; Lynch, HF; Curfman, GD				Cohen, I. Glenn; Lynch, Holly Fernandez; Curfman, Gregory D.			When Religious Freedom Clashes with Access to Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cohen, I. Glenn; Lynch, Holly Fernandez] Harvard Univ, Sch Law, Cambridge, MA 02138 USA	Harvard University	Cohen, IG (corresponding author), Harvard Univ, Sch Law, Cambridge, MA 02138 USA.								0	14	14	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2014	371	7					596	599		10.1056/NEJMp1407965	http://dx.doi.org/10.1056/NEJMp1407965			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7ZL	24988298				2022-12-01	WOS:000340819600005
J	Lu, KF; Psakhye, I; Jentsch, S				Lu, Kefeng; Psakhye, Ivan; Jentsch, Stefan			Autophagic Clearance of PolyQ Proteins Mediated by Ubiquitin-Atg8 Adaptors of the Conserved CUET Protein Family	CELL			English	Article							SELECTIVE AUTOPHAGY; MISFOLDED PROTEINS; PROTEASOME SYSTEM; DEGRADATION; BINDING; DOMAIN; TOLLIP; RECOGNITION; DISEASE; AGGREGATION	Selective ubiquitin-dependent autophagy plays a pivotal role in the elimination of protein aggregates, assemblies, or organelles and counteracts the cytotoxicity of proteins linked to neurodegenerative diseases. Following substrate ubiquitylation, the cargo is delivered to autophagosomes involving adaptors like human p62 that bind ubiquitin and the autophagosomal ubiquitin-like protein Atg8/LC3; however, whether similar pathways exist in lower eukaryotes remained unclear. Here, we identify by a screen in yeast a new class of ubiquitin-Atg8 adaptors termed CUET proteins, comprising the ubiquitin-binding CUE-domain protein Cue5 from yeast and its human homolog Tollip. Cue5 collaborates with Rsp5 ubiquitin ligase, and the corresponding yeast mutants accumulate aggregation-prone proteins and are vulnerable to polyQ protein expression. Similarly, Tollip depletion causes cytotoxicity toward polyQ proteins, whereas Tollip overexpression clears human cells from Huntington's disease-linked polyQ proteins by autophagy. We thus propose that CUET proteins play a critical and ancient role in autophagic clearance of cytotoxic protein aggregates.	[Lu, Kefeng; Psakhye, Ivan; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	jentsch@biochem.mpg.de		Psakhye, Ivan/0000-0003-3877-133X; Lu, Kefeng/0000-0001-8200-9380	Max Planck Society; Deutsche Forschungsgemeinschaft; Center for Integrated Protein Science Munich; ERC Advanced Grant; Louis-Jeantet Foundation	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; ERC Advanced Grant; Louis-Jeantet Foundation	We thank F. den Brave, F. Paasch, and F. Wilfling for comments on the manuscript; U. Hartl and E. Lemichez for materials; C. Boulegue for mass spectrometry analysis; B. Habermann for help with bioinformatic analysis; T. Ammon for help with mammalian cell culture techniques; and A. Strasser for technical assistance. S.J. is supported by Max Planck Society, Deutsche Forschungsgemeinschaft, Center for Integrated Protein Science Munich, ERC Advanced Grant, and the Louis-Jeantet Foundation.	Ankem G, 2011, BIOCHEM J, V435, P597, DOI 10.1042/BJ20102160; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bagola K, 2013, MOL CELL, V50, P528, DOI 10.1016/j.molcel.2013.04.005; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Capelluto DGS, 2012, MICROBES INFECT, V14, P140, DOI 10.1016/j.micinf.2011.08.018; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Katoh Y, 2006, BIOCHEM BIOPH RES CO, V341, P143, DOI 10.1016/j.bbrc.2005.12.156; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Mitra S, 2013, J BIOL CHEM, V288, P25780, DOI 10.1074/jbc.M113.484170; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Moreno-Borchart AC, 2001, EMBO J, V20, P6946, DOI 10.1093/emboj/20.24.6946; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Oguro A, 2011, NEUROSCI LETT, V503, P234, DOI 10.1016/j.neulet.2011.08.043; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Pohl C, 2009, NAT CELL BIOL, V11, P65, DOI 10.1038/ncb1813; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Visvikis O, 2011, TRAFFIC, V12, P579, DOI 10.1111/j.1600-0854.2011.01174.x	47	223	229	1	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					549	563		10.1016/j.cell.2014.05.048	http://dx.doi.org/10.1016/j.cell.2014.05.048			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25042851	Bronze			2022-12-01	WOS:000340944300009
J	Colussi, TM; Costantino, DA; Hammond, JA; Ruehle, GM; Nix, JC; Kieft, JS				Colussi, Timothy M.; Costantino, David A.; Hammond, John A.; Ruehle, Grant M.; Nix, Jay C.; Kieft, Jeffrey S.			The structural basis of transfer RNA mimicry and conformational plasticity by a viral RNA	NATURE			English	Article							MOSAIC-VIRUS RNA; MINUS-STRAND SYNTHESIS; STRUCTURE VALIDATION; CRYSTAL-STRUCTURE; 3' END; INITIATION; RIBOSOME; BINDING; VALINE; TRANSLATION	RNA is arguably the most functionally diverse biological macromolecule. In some cases a single discrete RNA sequence performs multiple roles, and this can be conferred by a complex three-dimensional structure. Such multifunctionality can also be driven or enhanced by the ability of a given RNA to assume different conformational (and therefore functional) states'. Despite its biological importance, a detailed structural understanding of the paradigm of RNA structure-driven multifunctionality is lacking. To address this gap it is useful to study examples from single-stranded positive-sense RNA viruses, a prototype being the tRNA-like structure (TLS) found at the 3' end of the turnip yellow mosaic virus (TYMV). This TLS not only acts like a tRNA to drive aminoacylation of the viral genomic (g)RNA(2-4), but also interacts with other structures in the 3' untranslated region of the gRNA(5), contains the promoter for negative-strand synthesis, and influences several infection-critical processes'. TLS RNA can provide a glimpse into the structural basis of RNA multifunctionality and plasticity, but for decades its high-resolution structure has remained elusive. Here we present the crystal structure of the complete TYMV TLS to 2.0 angstrom resolution. Globally, the RNA adopts a shape that mimics tRNA, but it uses a very different set of intramolecular interactions to achieve this shape. These interactions also allow the TLS to readily switch conformations. In addition, the TLS structure is 'two faced': one face closely mimics tRNA and drives aminoacylation, the other face diverges from tRNA and enables additional functionality. The TLS is thus structured to perform several functions and interact with diverse binding partners, and we demonstrate its ability to specifically bind to ribosomes.	[Colussi, Timothy M.; Costantino, David A.; Hammond, John A.; Ruehle, Grant M.; Kieft, Jeffrey S.] Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Colussi, Timothy M.; Costantino, David A.; Kieft, Jeffrey S.] Univ Colorado, Denver Sch Med, Howard Hughes Med Inst, Aurora, CO 80045 USA; [Nix, Jay C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biol Consortium, Adv Light Source, Berkeley, CA 94720 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kieft, JS (corresponding author), Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	jeffrey.kieft@ucdenver.edu		Hammond, John/0000-0002-1170-3532	UC Cancer Center [P30CA046934]; Office of Science, Office of Basic Energy Sciences of the US Department of Energy [DE-ACO2-05CH11231]; National Institutes of Health [GM081346, GM097333]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081346, R01GM097333] Funding Source: NIH RePORTER	UC Cancer Center; Office of Science, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Noller for the gift of 70S ribosomes. We thank I. Tinoco Jr, C. Musselman and T. Dreher for critical reading of this manuscript. The University of Colorado (UC) Denver X-ray Facility is supported by UC Cancer Center Support Grant P30CA046934. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences of the US Department of Energy under contract #DE-ACO2-05CH11231. J.S.K. is supported by grants GM081346 and GM097333 from the National Institutes of Health and is an Early Career Scientist of the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barends S, 2003, CELL, V112, P123, DOI 10.1016/S0092-8674(02)01256-4; BERTHELOT F, 1973, MOL CELL BIOCHEM, V1, P63, DOI 10.1007/BF01659939; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cliffe AR, 2009, J VIROL, V83, P2321, DOI 10.1128/JVI.02303-08; Costantino D, 2005, RNA, V11, P332, DOI 10.1261/rna.7184705; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Deiman BALM, 1998, J VIROL, V72, P3965, DOI 10.1128/JVI.72.5.3965-3972.1998; Dethoff EA, 2012, NATURE, V482, P322, DOI 10.1038/nature10885; Dreher TW, 2010, WIRES RNA, V1, P402, DOI 10.1002/wrna.42; Dreher TW, 2009, VIRUS RES, V139, P217, DOI 10.1016/j.virusres.2008.06.010; Dreher TW, 1998, NUCLEIC ACIDS RES, V26, P4356, DOI 10.1093/nar/26.19.4356; DREHER TW, 1992, BIOCHEMISTRY-US, V31, P9183, DOI 10.1021/bi00153a010; DUMAS P, 1987, J BIOMOL STRUCT DYN, V4, P707, DOI 10.1080/07391102.1987.10507674; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FLORENTZ C, 1982, EMBO J, V1, P269, DOI 10.1002/j.1460-2075.1982.tb01158.x; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Giege R, 1998, CURR OPIN STRUC BIOL, V8, P286, DOI 10.1016/S0959-440X(98)80060-2; GIEGE R, 1993, BIOCHIMIE, V75, P569, DOI 10.1016/0300-9084(93)90063-X; Hammond JA, 2010, J MOL BIOL, V399, P450, DOI 10.1016/j.jmb.2010.04.016; Hammond JA, 2009, RNA, V15, P294, DOI 10.1261/rna.1360709; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.1218231, 10.1126/science.121823]; Keel AY, 2007, STRUCTURE, V15, P761, DOI 10.1016/j.str.2007.06.003; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Kolk MH, 1998, SCIENCE, V280, P434, DOI 10.1126/science.280.5362.434; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Litvak S, 1970, FEBS Lett, V11, P316, DOI 10.1016/0014-5793(70)80557-9; Matsuda D, 2004, VIROLOGY, V321, P36, DOI 10.1016/j.virol.2003.10.023; Matsuda D, 2004, VIROLOGY, V321, P47, DOI 10.1016/j.virol.2003.10.028; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; PINCK M, 1970, NATURE, V226, P954, DOI 10.1038/226954a0; RIETVELD K, 1983, EMBO J, V2, P1079, DOI 10.1002/j.1460-2075.1983.tb01549.x; RIETVELD K, 1982, NUCLEIC ACIDS RES, V10, P1929, DOI 10.1093/nar/10.6.1929; RIETVELD K, 1984, EMBO J, V3, P2613, DOI 10.1002/j.1460-2075.1984.tb02182.x; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Singh RN, 1997, VIROLOGY, V233, P430, DOI 10.1006/viro.1997.8621; Singh RN, 1998, RNA, V4, P1083, DOI 10.1017/S1355838298980694; Skuzeski JM, 1996, J VIROL, V70, P2107, DOI 10.1128/JVI.70.4.2107-2115.1996; Wientges J, 2000, BIOCHEMISTRY-US, V39, P6207, DOI 10.1021/bi992852l; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; YOT P, 1970, P NATL ACAD SCI USA, V67, P1345, DOI 10.1073/pnas.67.3.1345; Zhu JY, 2011, P NATL ACAD SCI USA, V108, P1839, DOI 10.1073/pnas.1018582108	45	56	58	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					366	+		10.1038/nature13378	http://dx.doi.org/10.1038/nature13378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	24909993	Green Accepted			2022-12-01	WOS:000338992200040
J	Kessler, DA				Kessler, David A.			Toward More Comprehensive Food Labeling	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kessler, David A.] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Kessler, David A.] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kessler, DA (corresponding author), Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA.							Food and Drug Administration Silver Spring, PROP CHANG NUTR FACT; Food Marketing Institute, SUP FACTS IND OV 201; Kessler D.A, 2003, HARVARD HLTH POLICY, V4, P13; Nestle M, 2011, IOM RELEASES TOUGH R; Todd J. E, 2008, DECLINE CONSUMER USE	5	19	19	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2014	371	3					193	195		10.1056/NEJMp1402971	http://dx.doi.org/10.1056/NEJMp1402971			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL3BK	25014683				2022-12-01	WOS:000338999800001
J	Sylvetsky, AC; Dietz, WH				Sylvetsky, Allison C.; Dietz, William H.			Nutrient-Content Claims - Guidance or Cause for Confusion?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FOODS		[Sylvetsky, Allison C.] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Exercise & Nutr Sci, Washington, DC 20052 USA; [Dietz, William H.] George Washington Univ, Milken Inst Sch Publ Hlth, Sumner M Redstone Global Ctr Prevent & Wellness, Washington, DC USA	George Washington University; George Washington University	Sylvetsky, AC (corresponding author), George Washington Univ, Milken Inst Sch Publ Hlth, Dept Exercise & Nutr Sci, Washington, DC 20052 USA.							[Anonymous], 2011, GUID FOOD LAB ADV; Colby SE, 2010, J NUTR EDUC BEHAV, V42, P92, DOI 10.1016/j.jneb.2008.11.002; LeGault L, 2004, J AM DIET ASSOC, V104, P952, DOI 10.1016/j.jada.2004.03.024; Sylvetsky AC, 2013, FASEB J, V27; Williams P, 2005, NUTR REV, V63, P256, DOI 10.1111/j.1753-4887.2005.tb00382.x	5	39	40	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2014	371	3					195	198		10.1056/NEJMp1404899	http://dx.doi.org/10.1056/NEJMp1404899			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL3BK	25014684				2022-12-01	WOS:000338999800002
J	McMahon, TA; Sears, BF; Venesky, MD; Bessler, SM; Brown, JM; Deutsch, K; Halstead, NT; Lentz, G; Tenouri, N; Young, S; Civitello, DJ; Ortega, N; Fites, JS; Reinert, LK; Rollins-Smith, LA; Raffel, TR; Rohr, JR				McMahon, Taegan A.; Sears, Brittany F.; Venesky, Matthew D.; Bessler, Scott M.; Brown, Jenise M.; Deutsch, Kaitlin; Halstead, Neal T.; Lentz, Garrett; Tenouri, Nadia; Young, Suzanne; Civitello, David J.; Ortega, Nicole; Fites, J. Scott; Reinert, Laura K.; Rollins-Smith, Louise A.; Raffel, Thomas R.; Rohr, Jason R.			Amphibians acquire resistance to live and dead fungus overcoming fungal immunosuppression	NATURE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; CHYTRID FUNGUS; IMMUNE DEFENSES; INFECTION; CHYTRIDIOMYCOSIS; FROG; PATHOGEN; DECLINES; HOSTS; PLANT	Emerging fungal pathogens pose a greater threat to biodiversity than any other parasitic group(1), causing declines of many taxa, including bats, corals, bees, snakes and amphibians(1-4). Currently, there is little evidence that wild animals can acquire resistance to these pathogens(5). Batrachochytrium dendrobatidis is a pathogenic fungus implicated in the recent global decline of amphibians(6). Here we demonstrate that three species of amphibians can acquire behavioural or immunological resistance to B. dendrobatidis. Frogs learned to avoid the fungus after just one B. dendrobatidis exposure and temperature-induced clearance. In subsequent experiments in which B. dendrobatidis avoidance was prevented, the number of previous exposures was a negative predictor of B. dendrobatidis burden on frogs and B. dendrobatidis-induced mortality, and was a positive predictor of lymphocyte abundance and proliferation. These results suggest that amphibians can acquire immunity to B. dendrobatidis that overcomes pathogen-induced immunosuppression(7-9) and increases their survival. Importantly, exposure to dead fungus induced a similar magnitude of acquired resistance as exposure to live fungus. Exposure of frogs to B. dendrobatidis antigens might offer a practical way to protect pathogen-naive amphibians and facilitate the reintroduction of amphibians to locations in the wild where B. dendrobatidis persists. Moreover, given the conserved nature of vertebrate immune responses to fungi(5) and the fact that many animals are capable of learning to avoid natural enemies(10), these results offer hope that other wild animal taxa threatened by invasive fungi might be rescued by management approaches based on herd immunity.	[McMahon, Taegan A.; Sears, Brittany F.; Bessler, Scott M.; Brown, Jenise M.; Deutsch, Kaitlin; Halstead, Neal T.; Lentz, Garrett; Tenouri, Nadia; Young, Suzanne; Civitello, David J.; Ortega, Nicole; Rohr, Jason R.] Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA; [McMahon, Taegan A.] Univ Tampa, Dept Biol, Tampa, FL 33606 USA; [Venesky, Matthew D.] Allegheny Coll, Dept Biol, Meadville, PA 16335 USA; [Fites, J. Scott; Rollins-Smith, Louise A.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Reinert, Laura K.; Rollins-Smith, Louise A.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA; [Reinert, Laura K.; Rollins-Smith, Louise A.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Reinert, Laura K.; Rollins-Smith, Louise A.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; [Raffel, Thomas R.] Oakland Univ, Dept Biol, Rochester, MI 48309 USA	State University System of Florida; University of South Florida; University of Tampa; Allegheny College; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Oakland University	McMahon, TA (corresponding author), Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA.	taeganmcmahon@gmail.com; jasonrohr@gmail.com	Rohr, Jason R./AAJ-5856-2021; Bessler, Scott/ABG-5280-2021	Lentz, Garrett/0000-0003-1588-8148; Deutsch, Kaitlin/0000-0002-6492-366X; Sears, Brittany/0000-0002-8515-8573	National Science Foundation [DEB 0516227, EF-1241889, IOS-1121758]; National Institutes of Health [R01GM109499]; US Department of Agriculture [NRI 2006-01370, 2009-35102-0543]; US Environmental Protection Agency [STAR R83-3835, CAREER 83518801]; NSF RCN "Refining and Diversifying Ecoimmunology"; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109499] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Agriculture(United States Department of Agriculture (USDA)); US Environmental Protection Agency(United States Environmental Protection Agency); NSF RCN "Refining and Diversifying Ecoimmunology"(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Holden and J. Pask for their assistance with the immunological assays, J. Cohen for comments on the manuscript, and our undergraduate assistants H. Folse, S. Lopez, L. Soto, S. Hekkanen and E. Creasey. We also thank V. Vasquez and J. Longcore for providing the Bd isolates used in these experiments. Funds were provided by grants from the National Science Foundation (DEB 0516227 and EF-1241889 to J. R. R. and IOS-1121758 to L.A.R.-S.), the National Institutes of Health (R01GM109499 to J. R. R.), the US Department of Agriculture (NRI 2006-01370 and 2009-35102-0543 to J. R. R.), the US Environmental Protection Agency grant (STAR R83-3835 and CAREER 83518801 to J. R. R.), and the NSF RCN "Refining and Diversifying Ecoimmunology". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender MC, 2011, EMERG INFECT DIS, V17, P2383, DOI 10.3201/eid1712.110240; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cashins SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056747; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fites JS, 2013, SCIENCE, V342, P366, DOI 10.1126/science.1243316; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Kiesecker JM, 1999, P NATL ACAD SCI USA, V96, P9165, DOI 10.1073/pnas.96.16.9165; McMahon TA, 2013, P NATL ACAD SCI USA, V110, P210, DOI 10.1073/pnas.1200592110; Murphy PJ, 2011, DIS AQUAT ORGAN, V95, P31, DOI 10.3354/dao02336; PAWELEC G, 1991, INT J IMMUNOPHARMACO, V13, P299, DOI 10.1016/0192-0561(91)90111-J; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Richmond JQ, 2009, BIOSCIENCE, V59, P311, DOI 10.1525/bio.2009.59.4.9; Rohr JR, 2009, OECOLOGIA, V159, P447, DOI 10.1007/s00442-008-1208-6; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Rollins-Smith Louise A, 2009, Front Biosci (Schol Ed), V1, P68; ROLLINSSMITH LA, 1984, IMMUNOLOGY, V52, P491; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Sexton AC, 2006, EUKARYOT CELL, V5, P1941, DOI 10.1128/EC.00277-06; Shaw SD, 2010, DIS AQUAT ORGAN, V92, P159, DOI 10.3354/dao02227; Stice MJ, 2010, J WILDLIFE DIS, V46, P70, DOI 10.7589/0090-3558-46.1.70; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Venesky MD, 2014, BIOL REV, V89, P477, DOI 10.1111/brv.12064; Venesky MD, 2012, CONSERV BIOL, V26, P586, DOI 10.1111/j.1523-1739.2012.01854.x; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8	30	150	153	2	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					224	+		10.1038/nature13491	http://dx.doi.org/10.1038/nature13491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008531	Green Accepted			2022-12-01	WOS:000338649800044
J	Budkevich, TV; Giesebrecht, J; Behrmann, E; Loerke, J; Ramrath, DJF; Mielke, T; Ismer, J; Hildebrand, PW; Tung, CS; Nierhaus, KH; Sanbonmatsu, KY; Spahn, CMT				Budkevich, Tatyana V.; Giesebrecht, Jan; Behrmann, Elmar; Loerke, Justus; Ramrath, David J. F.; Mielke, Thorsten; Ismer, Jochen; Hildebrand, Peter W.; Tung, Chang-Shung; Nierhaus, Knud H.; Sanbonmatsu, Karissa Y.; Spahn, Christian M. T.			Regulation of the Mammalian Elongation Cycle by Subunit Rolling: A Eukaryotic-Specific Ribosome Rearrangement	CELL			English	Article							AMINOACYL-TRANSFER-RNA; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; EF-TU; GTP HYDROLYSIS; CRYO-EM; COMPLEX; TRANSLOCATION; MECHANISM; SELECTION	The extent to which bacterial ribosomes and the significantly larger eukaryotic ribosomes share the same mechanisms of ribosomal elongation is unknown. Here, we present subnanometer resolution cryoelectron microscopy maps of the mammalian 80S ribosome in the posttranslocational state and in complex with the eukaryotic eEF1A, Val-tRNA, GMPPNP ternary complex, revealing significant differences in the elongation mechanism between bacteria and mammals. Surprisingly, and in contrast to bacterial ribosomes, a rotation of the small subunit around its long axis and orthogonal to the well-known intersubunit rotation distinguishes the posttranslocational state from the classical pre-translocational state ribosome. We term this motion "subunit rolling.'' Correspondingly, a mammalian decoding complex visualized in substates before and after codon recognition reveals structural distinctions from the bacterial system. These findings suggest how codon recognition leads to GTPase activation in the mammalian system and demonstrate that in mammalia subunit rolling occurs during tRNA selection.	[Budkevich, Tatyana V.; Giesebrecht, Jan; Behrmann, Elmar; Loerke, Justus; Ramrath, David J. F.; Mielke, Thorsten; Ismer, Jochen; Hildebrand, Peter W.; Nierhaus, Knud H.; Spahn, Christian M. T.] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Budkevich, Tatyana V.; Nierhaus, Knud H.] Max Planck Inst Mol Genet, Abt Vingron, D-14195 Berlin, Germany; [Budkevich, Tatyana V.] Inst Mol Biol & Genet, Grp Prot Biosynthesis, UA-03143 Kiev, Ukraine; [Mielke, Thorsten] Max Planck Inst Mol Genet, UltraStrukturNetzwerk, D-14195 Berlin, Germany; [Tung, Chang-Shung; Sanbonmatsu, Karissa Y.] Los Alamos Natl Lab, Div Theoret, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA; [Sanbonmatsu, Karissa Y.] New Mexico Consortium, Los Alamos, NM 87544 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; Max Planck Society; United States Department of Energy (DOE); Los Alamos National Laboratory	Spahn, CMT (corresponding author), Charite, Inst Med Phys & Biophys, CharitePl 1, D-10117 Berlin, Germany.	christian.spahn@charite.de	Behrmann, Elmar/I-5808-2015	Behrmann, Elmar/0000-0001-6794-3669; Loerke, Justus/0000-0002-3424-8536	Deutsche Forschungsgemeinschaft DFG [SFB 740, 436 UKR 113/64/1-1, HI 1502]; HSFP and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum); HFSP, NIH [R01-GM072686]; Los Alamos Institutional Computing; North-German Supercomputing Alliance (HLRN) [beb00001, bec00085]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072686] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); HSFP and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum); HFSP, NIH; Los Alamos Institutional Computing; North-German Supercomputing Alliance (HLRN); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Scott Blanchard for helpful discussion. The present work was supported by grants from the Deutsche Forschungsgemeinschaft DFG (SFB 740 to C. M. T. S., P. W. H., and T. M.; 436 UKR 113/64/1-1 to T. B. and HI 1502 to P. W. H.), HSFP and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum). K.Y.S. was supported by HFSP, NIH Grant R01-GM072686 and Los Alamos Institutional Computing. We acknowledge the use of computational resources supplied by the North-German Supercomputing Alliance (HLRN; project beb00001 to C. M. T. S and bec00085 to P. W. H.).	Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bommer U, 1997, SUBCELLULAR FRACTION, P271; Budkevich T, 2011, MOL CELL, V44, P214, DOI 10.1016/j.molcel.2011.07.040; Budkevich TV, 2008, NUCLEIC ACIDS RES, V36, P4736, DOI 10.1093/nar/gkn424; Connell SR, 2008, NAT STRUCT MOL BIOL, V15, P910, DOI 10.1038/nsmb.1469; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Fagan CE, 2013, P NATL ACAD SCI USA, V110, P9716, DOI 10.1073/pnas.1301585110; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frank J, 2006, REP PROG PHYS, V69, P1383, DOI 10.1088/0034-4885/69/5/R03; Geggier P, 2010, J MOL BIOL, V399, P576, DOI 10.1016/j.jmb.2010.04.038; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kobayashi K, 2012, NUCLEIC ACIDS RES, V40, P9319, DOI 10.1093/nar/gks660; Loerke J, 2010, METHOD ENZYMOL, V483, P161, DOI 10.1016/S0076-6879(10)83008-3; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; Munro JB, 2009, TRENDS BIOCHEM SCI, V34, P390, DOI 10.1016/j.tibs.2009.04.004; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Penczek PA, 2006, J STRUCT BIOL, V154, P168, DOI 10.1016/j.jsb.2006.01.003; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Sanbonmatsu KY, 2005, P NATL ACAD SCI USA, V102, P15854, DOI 10.1073/pnas.0503456102; SCHILLINGBARTETZKO S, 1992, J BIOL CHEM, V267, P4703; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; STEITZ JA, 1969, COLD SPRING HARB SYM, V34, P621, DOI 10.1101/SQB.1969.034.01.072; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Wilson DN, 2009, CRIT REV BIOCHEM MOL, V44, P393, DOI 10.3109/10409230903307311	38	82	83	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					121	131		10.1016/j.cell.2014.04.044	http://dx.doi.org/10.1016/j.cell.2014.04.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995983	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000340943100012
J	Fang, Y				Fang, Yu			PERSONAL VIEW China should curb non-prescription use of antibiotics in the community	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ATTITUDES; KNOWLEDGE		Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharm Adm, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Fang, Y (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharm Adm, Xian, Shaanxi, Peoples R China.	yufang@mail.xjtu.edu.cn						China Food and Drug Administration, PROV SUP DRUG DISTR; China Food and Drug Administration, 2013, 2013 ANN REP NAT ADV; Hvistendahl M, 2012, SCIENCE, V336, P795, DOI 10.1126/science.336.6083.795; Jiang MH, 2013, CHINESE J HLTH POLIC, V1, P40; Li YF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-995; Liu ZJ, 2011, EVALUATION ANAL DRUG, V11, P853; Lv B, 2014, TROP MED INT HEALTH, V19, P769, DOI 10.1111/tmi.12322; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Reynolds L, 2009, HEALTH POLICY, V90, P32, DOI 10.1016/j.healthpol.2008.09.002; The State Council, 12 5 YEAR PLAN DRUG; Xiao Y., 2010, CHINESE HLTH EC, V29, P94, DOI [10.3969/j.issn.1003-0743.2010.05.034, DOI 10.3969/J.ISSN.1003-0743.2010.05.034]; Xiao YH, 2011, DRUG RESIST UPDATE, V14, P236, DOI 10.1016/j.drup.2011.07.001; Xiao YH, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001556; Xiao YH, 2013, LANCET INFECT DIS, V13, P189, DOI 10.1016/S1473-3099(13)70011-2; Yip WCM, 2010, LANCET, V375, P1120, DOI 10.1016/S0140-6736(10)60063-3; Yu M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-112; SHANGHAI DAILY	17	30	30	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2014	348								g4233	10.1136/bmj.g4233	http://dx.doi.org/10.1136/bmj.g4233			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YU	24982508				2022-12-01	WOS:000338644600003
J	Donoso, M; Collins, AGE; Koechlin, E				Donoso, Mael; Collins, Anne G. E.; Koechlin, Etienne			Foundations of human reasoning in the prefrontal cortex	SCIENCE			English	Article							COGNITIVE CONTROL; FRONTAL-CORTEX; INFORMATION	The prefrontal cortex (PFC) subserves reasoning in the service of adaptive behavior. Little is known, however, about the architecture of reasoning processes in the PFC. Using computational modeling and neuroimaging, we show here that the human PFC has two concurrent inferential tracks: (i) one from ventromedial to dorsomedial PFC regions that makes probabilistic inferences about the reliability of the ongoing behavioral strategy and arbitrates between adjusting this strategy versus exploring new ones from long-term memory, and (ii) another from polar to lateral PFC regions that makes probabilistic inferences about the reliability of two or three alternative strategies and arbitrates between exploring new strategies versus exploiting these alternative ones. The two tracks interact and, along with the striatum, realize hypothesis testing for accepting versus rejecting newly created strategies.	[Donoso, Mael; Koechlin, Etienne] INSERM, U960, Cognit Neurosci Lab, F-75005 Paris, France; [Donoso, Mael; Collins, Anne G. E.; Koechlin, Etienne] Ecole Normale Super, DEC, F-75005 Paris, France; [Donoso, Mael; Koechlin, Etienne] Univ Paris 06, Ctr Neuroimagerie Rech CENIR, F-75005 Paris, France; [Collins, Anne G. E.] Brown Univ, Providence, RI 02912 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Sorbonne Universite; Brown University	Koechlin, E (corresponding author), INSERM, U960, Cognit Neurosci Lab, 29 Rue Ulm, F-75005 Paris, France.	etienne.koechlin@upmc.fr	Koechlin, Etienne/AAF-5717-2021; Koechlin, Etienne/E-5061-2016	Koechlin, Etienne/0000-0002-6514-9311; Koechlin, Etienne/0000-0002-6514-9311	European Research Council Grant (ERC-AdG) [250106]	European Research Council Grant (ERC-AdG)	We thank C. Summerfield and S. Palminteri for their helpful comments. Funded by a European Research Council Grant (ERC-2009-AdG#250106) to E. K. MRI data are available at http://central.xnat.org, project ID: PROBE.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Badre D, 2010, NEURON, V66, P315, DOI 10.1016/j.neuron.2010.03.025; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Boorman ED, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001093; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Charron S, 2010, SCIENCE, V328, P360, DOI 10.1126/science.1183614; Collins A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001293; Cowan N, 2005, HUMAN LEARING AND MEMORY: ADVANCES IN THEORY AND APPLICATION, P155; Daw N, 2007, ADV NEURAL INFORM PR, V20, P369; De Martino B, 2013, NAT NEUROSCI, V16, P105, DOI 10.1038/nn.3279; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Doshi-Velez F., 2009, ADV NEURAL INFORM PR, V22, P477; Doya K, 2007, HFSP J, V1, P30, DOI [10.2976/1.2732246/10.2976/1, 10.2976/1.2732246]; Esterman M, 2010, NEUROIMAGE, V50, P572, DOI 10.1016/j.neuroimage.2009.10.092; Gershman SJ, 2010, PSYCHOL REV, V117, P197, DOI 10.1037/a0017808; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Neubert FX, 2014, NEURON, V81, P700, DOI 10.1016/j.neuron.2013.11.012; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Oaksford M, 2009, BEHAV BRAIN SCI, V32, P69, DOI 10.1017/S0140525X09000284; Ribas-Fernandes JJF, 2011, NEURON, V71, P370, DOI 10.1016/j.neuron.2011.05.042; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Teffer K, 2012, PROG BRAIN RES, V195, P191, DOI 10.1016/B978-0-444-53860-4.00009-X; Teh YW, 2006, J AM STAT ASSOC, V101, P1566, DOI 10.1198/016214506000000302	31	222	223	0	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1481	1486		10.1126/science.1252254	http://dx.doi.org/10.1126/science.1252254			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24876345				2022-12-01	WOS:000337889900041
J	Kelly, RP; Port, JA; Yamahara, KM; Martone, RG; Lowell, N; Thomsen, PF; Mach, ME; Bennett, M; Prahler, E; Caldwell, MR; Crowder, LB				Kelly, Ryan P.; Port, Jesse A.; Yamahara, Kevan M.; Martone, Rebecca G.; Lowell, Natalie; Thomsen, Philip Francis; Mach, Megan E.; Bennett, Meredith; Prahler, Erin; Caldwell, Margaret R.; Crowder, Larry B.			Harnessing DNA to improve environmental management	SCIENCE			English	Editorial Material							FUTURE		[Kelly, Ryan P.; Lowell, Natalie] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98103 USA; [Kelly, Ryan P.; Port, Jesse A.; Yamahara, Kevan M.; Martone, Rebecca G.; Mach, Megan E.; Bennett, Meredith; Prahler, Erin; Caldwell, Margaret R.; Crowder, Larry B.] Stanford Univ, Ctr Ocean Solut, Stanford, CA 94305 USA; [Thomsen, Philip Francis] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark	University of Washington; University of Washington Seattle; Stanford University; University of Copenhagen	Kelly, RP (corresponding author), Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98103 USA.	rpkelly@uw.edu	Thomsen, Philip Francis/AAE-9354-2019	Thomsen, Philip Francis/0000-0002-9867-4366; Mach, Megan/0000-0003-2697-1254; Kelly, Ryan/0000-0001-5037-2441				BAKER CS, 1994, SCIENCE, V265, P1538, DOI 10.1126/science.265.5178.1538; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Gooding JJ, 2006, ANAL CHIM ACTA, V559, P137, DOI 10.1016/j.aca.2005.12.020; Griffith J.F., 2013, CALIFORNIA MICROBIAL; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wood SA, 2013, NEW ZEAL J MAR FRESH, V47, P90, DOI 10.1080/00288330.2012.745885	14	132	141	8	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1455	1456		10.1126/science.1251156	http://dx.doi.org/10.1126/science.1251156			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970068				2022-12-01	WOS:000337889900024
J	Caliskan, N; Katunin, VI; Belardinelli, R; Peske, F; Rodnina, MV				Caliskan, Neva; Katunin, Vladimir I.; Belardinelli, Riccardo; Peske, Frank; Rodnina, Marina V.			Programmed-1 Frameshifting by Kinetic Partitioning during Impeded Translocation	CELL			English	Article							MESSENGER-RNA TRANSLOCATION; E-SITE; HYBRID STATE; P-SITE; RIBOSOMAL FRAMESHIFT; ESCHERICHIA-COLI; SINGLE RIBOSOMES; A-SITE; TRANSLATION; SIGNAL	Programmed -1 ribosomal frameshifting (-1PRF) is an mRNA recoding event utilized by cells to enhance the information content of the genome and to regulate gene expression. The mechanism of -1PRF and its timing during translation elongation are unclear. Here, we identified the steps that govern -1PRF by following the stepwise movement of the ribosome through the frameshifting site of a model mRNA derived from the IBV 1a/1b gene in a reconstituted in vitro translation system from Escherichia coli. Frameshifting occurs at a late stage of translocation when the two tRNAs are bound to adjacent slippery sequence codons of the mRNA. The downstream pseudoknot in the mRNA impairs the closing movement of the 30S subunit head, the dissociation of EF-G, and the release of tRNA from the ribosome. The slippage of the ribosome into the -1 frame accelerates the completion of translocation, thereby further favoring translation in the new reading frame.	[Caliskan, Neva; Belardinelli, Riccardo; Peske, Frank; Rodnina, Marina V.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany; [Katunin, Vladimir I.] BP Konstantinov Petersburg Nucl Phys Inst, Dept Mol & Radiat Biophys, Gatchina 188300, Russia	Max Planck Society; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute	Rodnina, MV (corresponding author), Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany.	rodnina@mpibpc.mpg.de	Rodnina, Marina V./AAD-4667-2019; Belardinelli, Riccardo/I-4363-2013; Caliskan, Neva/N-5537-2017	Rodnina, Marina V./0000-0003-0105-3879; Belardinelli, Riccardo/0000-0002-3333-0466; Caliskan, Neva/0000-0003-0435-4757	Deutsche Forschungsgemeinschaft [RO 2004/9-1, SFB860]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This paper is dedicated to the memory of Vladimir Katunin, who sadly passed away before submission of the manuscript. We thank Anja Lehwess-Litzmann and Carlos da Cunha for sharing their L12-EF-G FRET reporter system prior to publication. We thank Anna Bursy, Olaf Geintzer, Sandra Kappler, Christina Kothe, Theresia Uhlendorf, Tanja Wiles, and Michael Zimmermann for expert technical assistance. This work was supported by grants from the Deutsche Forschungsgemeinschaft (RO 2004/9-1 and SFB860 to M.V.R.).	Bekaert M, 2005, MOL CELL, V17, P61, DOI 10.1016/j.molcel.2004.12.009; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; Brierley I, 1997, J MOL BIOL, V270, P360, DOI 10.1006/jmbi.1997.1134; Brierley I, 2010, NUCLEIC ACIDS MOL BI, V24, P149, DOI 10.1007/978-0-387-89382-2_7; Chen CL, 2013, NAT STRUCT MOL BIOL, V20, P582, DOI 10.1038/nsmb.2544; Devaraj A, 2009, RNA, V15, P255, DOI 10.1261/rna.1320109; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Dorner S, 2006, NAT STRUCT MOL BIOL, V13, P234, DOI 10.1038/nsmb1060; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; Fayet O, 2010, NUCLEIC ACIDS MOL BI, V24, P259, DOI 10.1007/978-0-387-89382-2_12; Fredrick K, 2002, MOL CELL, V9, P1125, DOI 10.1016/S1097-2765(02)00523-3; Gesteland RF, 1996, ANNU REV BIOCHEM, V65, P741, DOI 10.1146/annurev.bi.65.070196.003521; Guo ZJ, 2012, P NATL ACAD SCI USA, V109, P20391, DOI 10.1073/pnas.1218999109; Harger JW, 2002, TRENDS BIOCHEM SCI, V27, P448, DOI 10.1016/S0968-0004(02)02149-7; Holtkamp W, 2014, EMBO J, V33, P1073, DOI 10.1002/embj.201387465; HORSFIELD JA, 1995, NUCLEIC ACIDS RES, V23, P1487, DOI 10.1093/nar/23.9.1487; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; LARSEN B, 1994, J BACTERIOL, V176, P6842, DOI 10.1128/JB.176.22.6842-6851.1994; Leger M, 2004, RNA, V10, P1225, DOI 10.1261/rna.7670704; Leger M, 2007, NUCLEIC ACIDS RES, V35, P5581, DOI 10.1093/nar/gkm578; Liao PY, 2011, NUCLEIC ACIDS RES, V39, P300, DOI 10.1093/nar/gkq761; LILL R, 1987, J MOL BIOL, V196, P137, DOI 10.1016/0022-2836(87)90516-X; Lin ZR, 2012, NUCLEIC ACIDS RES, V40, P8674, DOI 10.1093/nar/gks629; McGarry KG, 2005, MOL CELL, V20, P613, DOI 10.1016/j.molcel.2005.10.007; Mittelstaet J, 2013, J AM CHEM SOC, V135, P17031, DOI 10.1021/ja407511q; Mouzakis KD, 2013, NUCLEIC ACIDS RES, V41, P1901, DOI 10.1093/nar/gks1254; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Napthine S, 2003, EMBO J, V22, P3941, DOI 10.1093/emboj/cdg365; Plant EP, 2003, RNA, V9, P168, DOI 10.1261/rna.2132503; Qin PW, 2014, EMBO REP, V15, P185, DOI 10.1002/embr.201337762; Qu XH, 2011, NATURE, V475, P118, DOI 10.1038/nature10126; Ramrath DJF, 2013, P NATL ACAD SCI USA, V110, P20964, DOI 10.1073/pnas.1320387110; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; SEMENKOV Y, 1992, FEBS LETT, V296, P207, DOI 10.1016/0014-5793(92)80380-Y; Sergiev PV, 2005, NUCLEIC ACIDS RES, V33, P6048, DOI 10.1093/nar/gki910; Sharma D, 2004, RNA, V10, P102, DOI 10.1261/rna.5148704; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Uemura S, 2007, NATURE, V446, P454, DOI 10.1038/nature05625; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; WEISS R B, 1989, New Biologist, V1, P159; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; YELVERTON E, 1994, MOL MICROBIOL, V11, P303, DOI 10.1111/j.1365-2958.1994.tb00310.x	42	108	109	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1619	1631		10.1016/j.cell.2014.04.041	http://dx.doi.org/10.1016/j.cell.2014.04.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949973	Green Published, Bronze			2022-12-01	WOS:000340941900016
J	Soleimanpour, SA; Gupta, A; Bakay, M; Ferrari, AM; Groff, DN; Fadista, J; Spruce, LA; Kushner, JA; Groop, L; Seeholzer, SH; Kaufman, BA; Hakonarson, H; Stoffers, DA				Soleimanpour, Scott A.; Gupta, Aditi; Bakay, Marina; Ferrari, Alana M.; Groff, David N.; Fadista, Joao; Spruce, Lynn A.; Kushner, Jake A.; Groop, Leif; Seeholzer, Steven H.; Kaufman, Brett A.; Hakonarson, Hakon; Stoffers, Doris A.			The Diabetes Susceptibility Gene Clec16a Regulates Mitophagy	CELL			English	Article							PANCREATIC BETA-CELL; MITOFUSIN 2; ENDOPLASMIC-RETICULUM; MITOCHONDRIAL DYNAMICS; PARKIN OVEREXPRESSION; STRESS; MORPHOLOGY; INSULITIS; PROTEINS; PRECEDES	Clec16a has been identified as a disease susceptibility gene for type 1 diabetes, multiple sclerosis, and adrenal dysfunction, but its function is unknown. Here we report that Clec16a is a membrane-associated endosomal protein that interacts with E3 ubiquitin ligase Nrdp1. Loss of Clec16a leads to an increase in the Nrdp1 target Parkin, a master regulator of mitophagy. Islets from mice with pancreas-specific deletion of Clec16a have abnormal mitochondria with reduced oxygen consumption and ATP concentration, both of which are required for normal beta cell function. Indeed, pancreatic Clec16a is required for normal glucose-stimulated insulin release. Moreover, patients harboring a diabetogenic SNP in the Clec16a gene have reduced islet Clec16a expression and reduced insulin secretion. Thus, Clec16a controls beta cell function and prevents diabetes by controlling mitophagy. This pathway could be targeted for prevention and control of diabetes and may extend to the pathogenesis of other Clec16a- and Parkin-associated diseases.	[Soleimanpour, Scott A.; Gupta, Aditi; Ferrari, Alana M.; Groff, David N.; Stoffers, Doris A.] Univ Penn Perelman, Sch Med, Inst Diabet Obes & Metab, Dept Med,Div Endrocrinol Diabet & Metab, Philadelphia, PA 19104 USA; [Soleimanpour, Scott A.] Univ Michigan, Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab, Ann Arbor, MI 48105 USA; [Bakay, Marina; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Fadista, Joao; Groop, Leif] Lund Univ, Skane Univ Hosp, Ctr Diabet, Dept Clin Sci Diabet & Endocrinol, S-20502 Malmo, Sweden; [Spruce, Lynn A.; Seeholzer, Steven H.] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Kushner, Jake A.] Baylor Coll Med, McNair Med Inst, Houston, TX 77030 USA; [Kaufman, Brett A.] Univ Penn, Sch Vet Med, Dept Biol Anim, Philadelphia, PA 19104 USA; [Hakonarson, Hakon] Univ Penn Perelman, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Lund University; Skane University Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Baylor College of Medicine; University of Pennsylvania; University of Pennsylvania	Stoffers, DA (corresponding author), Univ Penn Perelman, Sch Med, Inst Diabet Obes & Metab, Dept Med,Div Endrocrinol Diabet & Metab, Philadelphia, PA 19104 USA.	stoffers@mail.med.upenn.edu	Kushner, Jake A/AAF-5049-2022; Ferrari, Alana/S-4566-2019; Fadista, Joao/AAM-4870-2020; Kushner, Jake A/AFJ-8198-2022	Kushner, Jake A/0000-0002-3646-1744; Ferrari, Alana/0000-0002-9058-8041; Fadista, Joao/0000-0003-2539-634X; Kushner, Jake A/0000-0002-3646-1744; fadista, joao/0000-0001-7558-7043; Soleimanpour, Scott/0000-0001-6777-4498	Margaret Q. Landenberger Foundation; Charles H. Humpton, Jr. Endowment; JDRF; NIH [K08-DK089117, 5-P01-DK049210-15, 1DP3DK085708-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, DP3DK085708, K08DK089117, P30DK020572, P01DK049210] Funding Source: NIH RePORTER	Margaret Q. Landenberger Foundation; Charles H. Humpton, Jr. Endowment; JDRF(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge Dr. N. Doliba and Q. Wei of the Penn Islet Cell Biology Core of the University of Pennsylvania DRC (P30DK19525) for assistance with islet oxygen consumption studies, Dr. D. Williams of the Penn EM Resource Laboratory for imaging assistance, Dr. J. Florez for access to and assistance with MAGIC data, Drs. B. Keith and S. Reiner for immune cell samples, and Dr. P. Herrera for Pdx1-Cre mice. We thank Drs. M. Lazar, M. Birnbaum, M. Marks, J. Raum, and J. Baur for helpful advice. We acknowledge funding support from the Margaret Q. Landenberger Foundation, the Charles H. Humpton, Jr. Endowment, the JDRF, and the NIH (K08-DK089117, 5-P01-DK049210-15, and 1DP3DK085708-01).	Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Booth DR, 2009, GENES IMMUN, V10, P11, DOI 10.1038/gene.2008.83; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Herrera PL, 2000, DEVELOPMENT, V127, P2317; In't Veld P, 2007, DIABETES, V56, P2400, DOI 10.2337/db07-0416; Ize-Ludlow D, 2011, DIABETES, V60, P2086, DOI 10.2337/db11-0373; Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849; Kartner N, 2010, J BIOL CHEM, V285, P37476, DOI 10.1074/jbc.M110.123281; Kim S, 2012, P NATL ACAD SCI USA, V109, pE1072, DOI 10.1073/pnas.1120320109; Kim S, 2010, J CELL BIOL, V188, P717, DOI 10.1083/jcb.200911126; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Ngoh GA, 2012, J BIOL CHEM, V287, P20321, DOI 10.1074/jbc.M112.359174; Pociot F, 2010, DIABETES, V59, P1561, DOI 10.2337/db10-0076; Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Skinningsrud B, 2008, J CLIN ENDOCR METAB, V93, P3310, DOI 10.1210/jc.2008-0821; Soleimanpour SA, 2013, TRENDS ENDOCRIN MET, V24, P324, DOI 10.1016/j.tem.2013.03.005; Stiles L, 2012, BEST PRACT RES CL EN, V26, P725, DOI 10.1016/j.beem.2012.05.004; Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Supale S, 2012, TRENDS ENDOCRIN MET, V23, P477, DOI 10.1016/j.tem.2012.06.002; 't Hart LM, 2013, DIABETES, V62, P3275, DOI 10.2337/db13-0227; Tackett AJ, 2005, J PROTEOME RES, V4, P1752, DOI 10.1021/pr050225e; Taneera J, 2012, CELL METAB, V16, P122, DOI 10.1016/j.cmet.2012.06.006; Teplova VV, 2007, J BIOENERG BIOMEMBR, V39, P321, DOI 10.1007/s10863-007-9095-9; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhao T, 2012, J BIOL CHEM, V287, P23615, DOI 10.1074/jbc.M112.379164; Zhong L, 2005, J BIOL CHEM, V280, P9425, DOI 10.1074/jbc.M408955200; Zorzano A, 2010, SEMIN CELL DEV BIOL, V21, P566, DOI 10.1016/j.semcdb.2010.01.002; Zouk H, 2014, CLIN EXP IMMUNOL, V175, P485, DOI 10.1111/cei.12240	49	122	132	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1577	1590		10.1016/j.cell.2014.05.016	http://dx.doi.org/10.1016/j.cell.2014.05.016			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949970	Green Accepted, Bronze			2022-12-01	WOS:000340941900013
J	Wahl, AS; Omlor, W; Rubio, JC; Chen, JL; Zheng, H; Schroter, A; Gullo, M; Weinmann, O; Kobayashi, K; Helmchen, F; Ommer, B; Schwab, ME				Wahl, A. S.; Omlor, W.; Rubio, J. C.; Chen, J. L.; Zheng, H.; Schroeter, A.; Gullo, M.; Weinmann, O.; Kobayashi, K.; Helmchen, F.; Ommer, B.; Schwab, M. E.			NEURONAL REPAIR Asynchronous therapy restores motor control by rewiring of the rat corticospinal tract after stroke	SCIENCE			English	Article							ADULT RATS; REHABILITATION; PLASTICITY; RECOVERY; PATHWAYS; CIRCUIT	The brain exhibits limited capacity for spontaneous restoration of lost motor functions after stroke. Rehabilitation is the prevailing clinical approach to augment functional recovery, but the scientific basis is poorly understood. Here, we show nearly full recovery of skilled forelimb functions in rats with large strokes when a growth-promoting immunotherapy against a neurite growth-inhibitory protein was applied to boost the sprouting of new fibers, before stabilizing the newly formed circuits by intensive training. In contrast, early high-intensity training during the growth phase destroyed the effect and led to aberrant fiber patterns. Pharmacogenetic experiments identified a subset of corticospinal fibers originating in the intact half of the forebrain, side-switching in the spinal cord to newly innervate the impaired limb and restore skilled motor function.	[Wahl, A. S.; Gullo, M.; Weinmann, O.; Schwab, M. E.] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland; [Wahl, A. S.; Omlor, W.; Chen, J. L.; Gullo, M.; Weinmann, O.; Helmchen, F.; Schwab, M. E.] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Rubio, J. C.; Zheng, H.; Ommer, B.] Heidelberg Univ, Comp Vis Grp, Heidelberg Collaboratory Image Proc, Heidelberg, Germany; [Rubio, J. C.; Zheng, H.; Ommer, B.] Heidelberg Univ, Interdisciplinary Ctr Sci Comp IWR, Heidelberg, Germany; [Schroeter, A.] Swiss Fed Inst Technol, Inst Biomed Engn, Zurich, Switzerland; [Kobayashi, K.] Natl Inst Nat Sci Myodaiji, Natl Inst Physiol Sci, Okazaki, Aichi, Japan	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; ETH Zurich; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Wahl, AS (corresponding author), Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland.	wahl@hifo.uzh.ch; schwab@hifo.uzh.ch	Omlor, Wolfgang/AAS-3163-2020; Schwab, Martin E/B-6818-2016; Omlor, Wolfgang/AAJ-8288-2021; Helmchen, Fritjof/A-6255-2008	Chen, Jerry/0000-0002-7409-7859; Omlor, Wolfgang/0000-0003-1979-7147; Helmchen, Fritjof/0000-0002-8867-9569; Wahl, Anna-Sophia/0000-0001-9498-4263	European Union [201024, 223524]; advanced European Research Council grant NOGORISE; Swiss National Science Foundation [31-138676, 3100A0_12252711, 31003A_149858]; Christopher and Dana Reeve Foundation; Dr. Wilhelm Hurka Foundation; German Excellence Initiative, Deutsche Forschungsgemeinschaft project [49/2]	European Union(European Commission); advanced European Research Council grant NOGORISE; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Christopher and Dana Reeve Foundation; Dr. Wilhelm Hurka Foundation; German Excellence Initiative, Deutsche Forschungsgemeinschaft project	We thank T. Isa from the National Institute for Physiological Sciences, Okazaki, Japan, as well as K. Kobayashi, Fukushima Medical University, and D. Watanabe, Kyoto University, for kindly providing plasmids for viral vector production. We thank H. Kasper, C. Bleul, and N. Lindau for technical advice and fruitful discussions, as well as B. Seifert for statistical assistance. This work is supported by the European Union grants FP7 Collaborative Projects ARISE (201024) and PLASTICISE (223524), the advanced European Research Council grant NOGORISE (to M. E. S.), the Swiss National Science Foundation grants Nr. 31-138676 and 3100A0_12252711 (to M. E. S.) and Nr. 31003A_149858 (to F. H.), the Christopher and Dana Reeve Foundation (to M. E. S.), and the Dr. Wilhelm Hurka Foundation (F.H. and W.O.). The work by J.C.R and B.O. was supported by the German Excellence Initiative, Deutsche Forschungsgemeinschaft project number 49/2. A. S. W. and M. E. S. designed the study; A. S. W. and M. G. carried out experiments; A.S.W., W.O., B.O., and F.H. performed data analysis; J.C.R., H.Z., and B.O. developed computer and machine learning algorithm tools for data analysis; J. L. C. and K. K. provided virus vectors; A. S. performed magnetic resonance imaging; O.W. carried out histological analysis; and A.S.W, B.O., F.H., and M.E.S. prepared figures and wrote the manuscript. The University of Zurich holds joint patents with Novartis Pharma for antibodies against Nogo-A and their use in neurological diseases. Otherwise, we have no patents pending or financial conflicts to disclose. Materials and methods are available as supplementary materials on Science Online. Plasmids for lentiviral and AAV vectors for the TeNT experiment were obtained under material transfer agreements (MTAs) with Kyoto University, Japan (pLenti-TRE-EGFP-eTeNT-PEST-WPRE, pLenti-TRE-EGFP-WPRE, pRSV-Rev, pMDLg/pRRE, pAAV2-RC, pAAV2-CMV-rtTAV16), and Fukushima Medical University, Japan (pCAGGS-FuG-B2), respectively. Viral vectors for the DREADD experiment were obtained under a MTA with the University of Pennsylvania, Philadelphia, PA (AAV2.9-CamKII alpha.-Cre vector). The anti-Nogo-A antibody (11C7) was a gift from Novartis Pharma. The supplementary materials contain additional data.	Adkins DL, 2005, NEUROSCI LETT, V380, P214, DOI 10.1016/j.neulet.2005.01.036; Alaverdashvili M, 2008, BEHAV BRAIN RES, V188, P281, DOI 10.1016/j.bbr.2007.11.007; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Asante CO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074454; Azim E, 2014, NATURE, V508, P357, DOI 10.1038/nature13021; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Dimyan MA, 2011, NAT REV NEUROL, V7, P76, DOI 10.1038/nrneurol.2010.200; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Kinoshita M, 2012, NATURE, V487, P235, DOI 10.1038/nature11206; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lindau NT, 2014, BRAIN, V137, P739, DOI 10.1093/brain/awt336; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Oertle T, 2003, J NEUROSCI, V23, P5393; Ommer B, 2009, INT J COMPUT VISION, V83, P57, DOI 10.1007/s11263-009-0211-7; Petruska JC, 2007, J NEUROSCI, V27, P4460, DOI 10.1523/JNEUROSCI.2302-06.2007; Starkey ML, 2011, EXP NEUROL, V232, P81, DOI 10.1016/j.expneurol.2011.08.006; Tsai SY, 2007, EXP BRAIN RES, V182, P261, DOI 10.1007/s00221-007-1067-0; Wiessner C, 2003, J CEREBR BLOOD F MET, V23, P154, DOI 10.1097/01.WCB.0000040400.30600.AF; Zeiler SR, 2013, CURR OPIN NEUROL, V26, P609, DOI 10.1097/WCO.0000000000000025	23	223	234	5	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1250	1255		10.1126/science.1253050	http://dx.doi.org/10.1126/science.1253050			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926013				2022-12-01	WOS:000337077500032
J	Sacks, DB; John, WG				Sacks, David B.; John, W. Garry			Interpretation of Hemoglobin A(1c) Values	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SYSTEM; CHAOS		[Sacks, David B.] NIH, Dept Lab Med, Bethesda, MD 20892 USA; [John, W. Garry] Norfolk & Norwich Univ Hosp, Dept Clin Biochem, Norwich, Norfolk, England; [John, W. Garry] Norwich Med Sch, Norwich, Norfolk, England	National Institutes of Health (NIH) - USA; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; University of East Anglia	Sacks, DB (corresponding author), NIH, Bldg 10,Room 2C306,10 Ctr Dr, Bethesda, MD 20892 USA.	sacksdb@mail.nih.gov		Sacks, David/0000-0003-3100-0735				Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Berg AH, 2008, J CLIN PATHOL, V61, P983, DOI 10.1136/jcp.2007.049205; Bry L, 2001, CLIN CHEM, V47, P153; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Little RR, 2011, CLIN CHEM, V57, P205, DOI 10.1373/clinchem.2010.148841; National Glycohemoglobin Standardization Program, HARMONIZING HEMOGLOB; Sacks DB, 2011, CLIN CHEM, V57, pE1, DOI 10.1373/clinchem.2010.161596; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Weykamp C, 2008, CLIN CHEM, V54, P240, DOI 10.1373/clinchem.2007.097402	9	35	36	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2271	2272		10.1001/jama.2014.6342	http://dx.doi.org/10.1001/jama.2014.6342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915255				2022-12-01	WOS:000336972600015
J	Maund, E; Tendal, B; Hrobjartsson, A; Lundh, A; Gotzsche, PC				Maund, Emma; Tendal, Britta; Hrobjartsson, Asbjorn; Lundh, Andreas; Gotzsche, Peter C.			Coding of adverse events of suicidality in clinical study reports of duloxetine for the treatment of major depressive disorder: descriptive study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To assess the effects of coding and coding conventions on summaries and tabulations of adverse events data on suicidality within clinical study reports. Design Systematic electronic search for adverse events of suicidality in tables, narratives, and listings of adverse events in individual patients within clinical study reports. Where possible, for each event we extracted the original term reported by the investigator, the term as coded by the medical coding dictionary, medical coding dictionary used, and the patient's trial identification number. Using the patient's trial identification number, we attempted to reconcile data on the same event between the different formats for presenting data on adverse events within the clinical study report. Setting 9 randomised placebo controlled trials of duloxetine for major depressive disorder submitted to the European Medicines Agency for marketing approval. Data sources Clinical study reports obtained from the EMA in 2011. Results Six trials used the medical coding dictionary COSTART (Coding Symbols for a Thesaurus of Adverse Reaction Terms) and three used MedDRA (Medical Dictionary for Regulatory Activities). Suicides were clearly identifiable in all formats of adverse event data in clinical study reports. Suicide attempts presented in tables included both definitive and provisional diagnoses. Suicidal ideation and preparatory behaviour were obscured in some tables owing to the lack of specificity of the medical coding dictionary, especially COSTART. Furthermore, we found one event of suicidal ideation described in narrative text that was absent from tables and adverse event listings of individual patients. The reason for this is unclear, but may be due to the coding conventions used. Conclusion Data on adverse events in tables in clinical study reports may not accurately represent the underlying patient data because of the medical dictionaries and coding conventions used. In clinical study reports, the listings of adverse events for individual patients and narratives of adverse events can provide additional information, including original investigator reported adverse event terms, which can enable a more accurate estimate of harms.	[Maund, Emma; Tendal, Britta; Hrobjartsson, Asbjorn; Lundh, Andreas; Gotzsche, Peter C.] Rigshosp, Dept 7811, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark; [Lundh, Andreas] Hvidovre Univ Hosp, Dept Infect Dis, DK-2650 Hvidovre, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Maund, E (corresponding author), Rigshosp, Dept 7811, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark.	em@cochrane.dk		Lundh, Andreas/0000-0002-4982-8680	Rigshospitalets Forskningsudvalg	Rigshospitalets Forskningsudvalg	This study is part of a PhD (EM) funded by Rigshospitalets Forskningsudvalg. The funding source had no role in the design and conduct of the study; data collection, management, analysis, and interpretation; preparation, review, and approval of the manuscript; or the decision to submit the paper for publication.	ABBYY, 2013, ABBYY FINEREADER 11; [Anonymous], 2014, SELECTIVE SEROTONIN; [Anonymous], 2013, SCI DISCUSSION EMA 2; [Anonymous], 1995, STRUCT CONT CLIN STU; [Anonymous], 2014, CHALLENGES WRITING 1; [Anonymous], 2013, GUID GOOD CLIN PRACT; [Anonymous], 1998, STAT PRINC CLIN TRIA; Brown DR, 1997, INT J PHARM MED, V11, P85; Brown EG, 2004, STEPHENS DETECTION N, P533; Central authorisation of medicines, 2014, CENTRAL AUTHORISATIO; Chow S.-C., 2004, DESIGN ANAL CLIN TRI; Committee for medicinal products for human use (CHMP), 2004, CHMPEWP299803; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Fizames C., 1997, THER INNOV REGUL SCI, V31, P85, DOI [10.1177/009286159703100112, DOI 10.1177/009286159703100112]; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Healy D., 2004, LET THEM EAT PROZAC; Hrobjartsson A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1119; ICH Secretariat, 2014, MEDDRA TERM SEL POIN; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub3, 10.1002/14651858.CD008965.pub4]; Kornai A, 2004, STUD FUZZ SOFT COMP, V140, P413; Lundh A, 2011, LANCET, V378, P1995, DOI 10.1016/S0140-6736(11)61871-0; Matsumoto C, 1991, DRUG INF J, V25, P201; MedDRA, 2013, HISTORY; Peters PH, 2001, J AM GERIATR SOC, V49, P1025, DOI 10.1046/j.1532-5415.2001.49204.x; Posner K, 2007, AM J PSYCHIAT, V164, P1035, DOI 10.1176/appi.ajp.164.7.1035; US FDA, 2010, ADV COMM M NDA 21071; White CA, 1998, DRUG INF J, V32, P347, DOI 10.1177/009286159803200204	27	6	6	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2014	348								g3555	10.1136/bmj.g3555	http://dx.doi.org/10.1136/bmj.g3555			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7CC	24899651	Green Published, hybrid			2022-12-01	WOS:000337037700002
J	Bass, AJ; Thorsson, V; Shmulevich, I; Reynolds, SM; Miller, M; Bernard, B; Hinoue, T; Laird, PW; Curtis, C; Shen, H; Weisenberger, DJ; Schultz, N; Shen, RL; Weinhold, N; Keiser, DP; Bowlby, R; Sipahimalani, P; Cherniack, AD; Getz, G; Liu, YC; Noble, MS; Pedamallu, C; Sougnez, C; Taylor-Weiner, A; Akbani, R; Lee, JS; Liu, WB; Mills, GB; Yang, D; Zhang, W; Pantazi, A; Parfenov, M; Gulley, M; Piazuelo, MB; Schneider, BG; Kim, J; Boussioutas, A; Sheth, M; Demchok, JA; Rabkin, CS; Willis, JE; Ng, S; Garman, K; Beer, DG; Pennathur, A; Raphael, BJ; Wu, HT; Odze, R; Kim, HK; Bowen, J; Leraas, KM; Lichtenberg, TM; Weaver, L; McLellan, M; Wiznerowicz, M; Sakai, R; Getz, G; Sougnez, C; Lawrence, MS; Cibulskis, K; Lichtenstein, L; Fisher, S; Gabriel, SB; Lander, ES; Ding, L; Niu, BF; Ally, A; Balasundaram, M; Birol, I; Bowlby, R; Brooks, D; Butterfield, YSN; Carlsen, R; Chu, A; Chu, J; Chuah, E; Chun, HJE; Clarke, A; Dhalla, N; Guin, R; Holt, RA; Jones, SJM; Kasaian, K; Lee, D; Li, HYA; Lim, E; Ma, Y; Marra, MA; Mayo, M; Moore, RA; Mungall, AJ; Mungall, KL; Nip, KM; Robertson, AG; Schein, JE; Sipahimalani, P; Tam, A; Thiessen, N; Beroukhim, R; Carter, SL; Cherniack, AD; Cho, J; Cibulskis, K; DiCara, D; Frazer, S; Fisher, S; Gabriel, SB; Gehlenborg, N; Heiman, DI; Jung, J; Kim, J; Lander, ES; Lawrence, MS; Lichtenstein, L; Lin, P; Meyerson, M; Ojesina, AI; Pedamallu, CS; Saksena, G; Schumacher, SE; Sougnez, C; Stojanov, P; Tabak, B; Taylor-Weiner, A; Voet, D; Rosenberg, M; Zack, TI; Zhang, HL; Zou, LH; Protopopov, A; Santoso, N; Parfenov, M; Lee, S; Zhang, J; Mahadeshwar, HS; Tang, JB; Ren, XJ; Seth, S; Yang, LX; Xu, AW; Song, XZ; Pantazi, A; Xi, RB; Bristow, CA; Hadjipanayis, A; Seidman, J; Chin, L; Park, PJ; Kucherlapati, R; Akbani, R; Ling, SY; Liu, WB; Rao, A; Weinstein, JN; Kim, SB; Lee, JS; Lu, YL; Mills, G; Hinoue, T; Weisenberger, DJ; Bootwalla, MS; Lai, PH; Shen, H; Triche, T; Van Den Berg, DJ; Baylin, SB; Herman, JG; Getz, G; Chin, L; Liu, YC; Murray, BA; Noble, MS; Askoy, BA; Ciriello, G; Dresdner, G; Gao, JJ; Gross, B; Jacobsen, A; Lee, W; Ramirez, R; Sander, C; Schultz, N; Senbabaoglu, Y; Sinha, R; Sumer, SO; Sun, YC; Weinhold, N; Thorsson, V; Bernard, B; Iype, L; Kramer, RW; Kreisberg, R; Miller, M; Reynolds, SM; Rovira, H; Tasman, N; Shmulevich, I; Ng, S; Haussler, D; Stuart, JM; Akbani, R; Ling, SY; Liu, WB; Rao, A; Weinstein, JN; Verhaak, RGW; Mills, GB; Leiserson, MDM; Raphael, BJ; Wu, HT; Taylor, BS; Black, AD; Bowen, J; Carney, JA; Gastier-Foster, JM; Helsel, C; Leraas, KM; Lichtenberg, TM; McAllister, C; Ramirez, NC; Tabler, TR; Wise, L; Zmuda, E; Penny, R; Crain, D; Gardner, J; Lau, K; Curely, E; Mallery, D; Morris, S; Paulauskis, J; Shelton, T; Shelton, C; Sherman, M; Benz, C; Lee, JH; Fedosenko, K; Manikhas, G; Voronina, O; Belyaev, D; Dolzhansky, O; Rathmell, WK; Brzezinski, J; Ibbs, M; Korski, K; Kycler, W; Lazniak, R; Leporowska, E; Mackiewicz, A; Murawa, D; Murawa, P; Spychala, A; Suchorska, WM; Tatka, H; Teresiak, M; Wiznerowicz, M; Abdel-Misih, R; Bennett, J; Brown, J; Iacocca, M; Rabeno, B; Kwon, SY; Penny, R; Gardner, J; Kemkes, A; Mallery, D; Morris, S; Shelton, T; Shelton, C; Curley, E; Alexopoulou, I; Engel, J; Bartlett, J; Albert, M; Park, DY; Dhir, R; Luketich, J; Landreneau, R; Janjigian, YY; Kelsen, DP; Cho, E; Ladanyi, M; Tang, L; McCall, SJ; Park, YS; Cheong, JH; Ajani, J; Camargo, MC; Alonso, S; Ayala, B; Jensen, MA; Pihl, T; Raman, R; Walton, J; Wan, YH; Demchok, JA; Eley, G; Shaw, KRM; Sheth, M; Tarnuzzer, R; Wang, ZN; Yang, LM; Zenklusen, JC; Davidsen, T; Hutter, CM; Sofia, HJ; Burton, R; Chudamani, S; Liu, J				Bass, Adam J.; Thorsson, Vesteinn; Shmulevich, Ilya; Reynolds, Sheila M.; Miller, Michael; Bernard, Brady; Hinoue, Toshinori; Laird, Peter W.; Curtis, Christina; Shen, Hui; Weisenberger, Daniel J.; Schultz, Nikolaus; Shen, Ronglai; Weinhold, Nils; Keiser, David P.; Bowlby, Reanne; Sipahimalani, Payal; Cherniack, Andrew D.; Getz, Gad; Liu, Yingchun; Noble, Michael S.; Pedamallu, Chandra; Sougnez, Carrie; Taylor-Weiner, Amaro; Akbani, Rehan; Lee, Ju-Seog; Liu, Wenbin; Mills, Gordon B.; Yang, Da; Zhang, Wei; Pantazi, Angeliki; Parfenov, Michael; Gulley, Margaret; Piazuelo, M. Blanca; Schneider, Barbara G.; Kim, Jihun; Boussioutas, Alex; Sheth, Margi; Demchok, John A.; Rabkin, Charles S.; Willis, Joseph E.; Ng, Sam; Garman, Katherine; Beer, David G.; Pennathur, Arjun; Raphael, Benjamin J.; Wu, Hsin-Ta; Odze, Robert; Kim, Hark K.; Bowen, Jay; Leraas, Kristen M.; Lichtenberg, Tara M.; Weaver, Lichtenberg; McLellan, Michael; Wiznerowicz, Maciej; Sakai, Ryo; Getz, Gad; Sougnez, Carrie; Lawrence, Michael S.; Cibulskis, Kristian; Lichtenstein, Lee; Fisher, Sheila; Gabriel, Stacey B.; Lander, Eric S.; Ding, Li; Niu, Beifang; Ally, Adrian; Balasundaram, Miruna; Birol, Inanc; Bowlby, Reanne; Brooks, Denise; Butterfield, Yaron S. N.; Carlsen, Rebecca; Chu, Andy; Chu, Justin; Chuah, Eric; Chun, Hye-Jung E.; Clarke, Amanda; Dhalla, Noreen; Guin, Ranabir; Holt, Robert A.; Jones, Steven J. M.; Kasaian, Katayoon; Lee, Darlene; Li, Haiyan A.; Lim, Emilia; Ma, Yussanne; Marra, Marco A.; Mayo, Michael; Moore, Richard A.; Mungall, Andrew J.; Mungall, Karen L.; Nip, Ka Ming; Robertson, A. Gordon; Schein, Jacqueline E.; Sipahimalani, Payal; Tam, Angela; Thiessen, Nina; Beroukhim, Rameen; Carter, Scott L.; Cherniack, Andrew D.; Cho, Juok; Cibulskis, Kristian; DiCara, Daniel; Frazer, Scott; Fisher, Sheila; Gabriel, Stacey B.; Gehlenborg, Nils; Heiman, David I.; Jung, Joonil; Kim, Jaegil; Lander, Eric S.; Lawrence, Michael S.; Lichtenstein, Lee; Lin, Pei; Meyerson, Matthew; Ojesina, Akinyemi I.; Pedamallu, Chandra Sekhar; Saksena, Gordon; Schumacher, Steven E.; Sougnez, Carrie; Stojanov, Petar; Tabak, Barbara; Taylor-Weiner, Amaro; Voet, Doug; Rosenberg, Mara; Zack, Travis I.; Zhang, Hailei; Zou, Lihua; Protopopov, Alexei; Santoso, Netty; Parfenov, Michael; Lee, Semin; Zhang, Jianhua; Mahadeshwar, Harshad S.; Tang, Jiabin; Ren, Xiaojia; Seth, Sahil; Yang, Lixing; Xu, Andrew W.; Song, Xingzhi; Pantazi, Angeliki; Xi, Ruibin; Bristow, Christopher A.; Hadjipanayis, Angela; Seidman, Jonathan; Chin, Lynda; Park, Peter J.; Kucherlapati, Raju; Akbani, Rehan; Ling, Shiyun; Liu, Wenbin; Rao, Arvind; Weinstein, John N.; Kim, Sang-Bae; Lee, Ju-Seog; Lu, Yiling; Mills, Gordon; Hinoue, Toshinori; Weisenberger, Daniel J.; Bootwalla, Moiz S.; Lai, Phillip H.; Shen, Hui; Triche, Timothy, Jr.; Van Den Berg, David J.; Baylin, Stephen B.; Herman, James G.; Getz, Gad; Chin, Lynda; Liu, Yingchun; Murray, Bradley A.; Noble, Michael S.; Askoy, B. Arman; Ciriello, Giovanni; Dresdner, Gideon; Gao, Jianjiong; Gross, Benjamin; Jacobsen, Anders; Lee, William; Ramirez, Ricardo; Sander, Chris; Schultz, Nikolaus; Senbabaoglu, Yasin; Sinha, Rileen; Sumer, S. Onur; Sun, Yichao; Weinhold, Nils; Thorsson, Vesteinn; Bernard, Brady; Iype, Lisa; Kramer, Roger W.; Kreisberg, Richard; Miller, Michael; Reynolds, Sheila M.; Rovira, Hector; Tasman, Natalie; Shmulevich, Ilya; Ng, Sam; Haussler, David; Stuart, Josh M.; Akbani, Rehan; Ling, Shiyun; Liu, Wenbin; Rao, Arvind; Weinstein, John N.; Verhaak, Roeland G. W.; Mills, Gordon B.; Leiserson, Mark D. M.; Raphael, Benjamin J.; Wu, Hsin-Ta; Taylor, Barry S.; Black, Aaron D.; Bowen, Jay; Carney, Julie Ann; Gastier-Foster, Julie M.; Helsel, Carmen; Leraas, Kristen M.; Lichtenberg, Tara M.; McAllister, Cynthia; Ramirez, Nilsa C.; Tabler, Teresa R.; Wise, Lisa; Zmuda, Erik; Penny, Robert; Crain, Daniel; Gardner, Johanna; Lau, Kevin; Curely, Erin; Mallery, David; Morris, Scott; Paulauskis, Joseph; Shelton, Troy; Shelton, Candace; Sherman, Mark; Benz, Christopher; Lee, Jae-Hyuk; Fedosenko, Konstantin; Manikhas, Georgy; Voronina, Olga; Belyaev, Dmitry; Dolzhansky, Oleg; Rathmell, W. Kimryn; Brzezinski, Jakub; Ibbs, Matthew; Korski, Konstanty; Kycler, Witold; Lazniak, Radoslaw; Leporowska, Ewa; Mackiewicz, Andrzej; Murawa, Dawid; Murawa, Pawel; Spychala, Arkadiusz; Suchorska, Wiktoria M.; Tatka, Honorata; Teresiak, Marek; Wiznerowicz, Maciej; Abdel-Misih, Raafat; Bennett, Joseph; Brown, Jennifer; Iacocca, Mary; Rabeno, Brenda; Kwon, Sun-Young; Penny, Robert; Gardner, Johanna; Kemkes, Ariane; Mallery, David; Morris, Scott; Shelton, Troy; Shelton, Candace; Curley, Erin; Alexopoulou, Iakovina; Engel, Jay; Bartlett, John; Albert, Monique; Park, Do-Youn; Dhir, Rajiv; Luketich, James; Landreneau, Rodney; Janjigian, Yelena Y.; Kelsen, David P.; Cho, Eunjung; Ladanyi, Marc; Tang, Laura; McCall, Shannon J.; Park, Young S.; Cheong, Jae-Ho; Ajani, Jaffer; Camargo, M. Constanza; Alonso, Shelley; Ayala, Brenda; Jensen, Mark A.; Pihl, Todd; Raman, Rohini; Walton, Jessica; Wan, Yunhu; Demchok, John A.; Eley, Greg; Shaw, Kenna R. Mills; Sheth, Margi; Tarnuzzer, Roy; Wang, Zhining; Yang, Liming; Zenklusen, Jean Claude; Davidsen, Tanja; Hutter, Carolyn M.; Sofia, Heidi J.; Burton, Robert; Chudamani, Sudha; Liu, Jia		Canc Genome Atlas Res Network	Comprehensive molecular characterization of gastric adenocarcinoma	NATURE			English	Article							SOMATIC MUTATIONS; GENE-EXPRESSION; CELL LYMPHOMAS; EBV-INFECTION; CANCER; EXOME; METHYLATION; SUBTYPES; KINASE; CLASSIFICATION	Gastric cancer is a leading cause of cancer deaths, but analysis of molecular and clinical characteristics has been complicated by histological and aetiological heterogeneity. Here we describe a comprehensive molecular evaluation of 295 primary gastric adenocarcinomas as part of The Cancer Genome Atlas (TCGA) project. We propose a molecular classification dividing gastric cancer into four subtypes: tumours positive for Epstein-Barr virus, which display recurrent PIK3CA mutations, extreme DNA hypermethylation, and amplification of JAK2, CD274 (also known as PD-L1) and PDCD1LG2 (also known as PD-L2); microsatellite unstable tumours, which show elevated mutation rates, including mutations of genes encoding targetable oncogenic signalling proteins; genomically stable tumours, which are enriched for the diffuse histological variant and mutations of RHOA or fusions involving RHO-family GTPase-activating proteins; and tumours with chromosomal instability, which show marked aneuploidy and focal amplification of receptor tyrosine kinases. Identification of these subtypes provides a roalmap for patient stratification and trials of targeted therapies.	[Bass, Adam J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Bass, Adam J.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02215 USA; [Thorsson, Vesteinn; Shmulevich, Ilya; Reynolds, Sheila M.; Miller, Michael; Bernard, Brady; Iype, Lisa; Kramer, Roger W.; Kreisberg, Richard; Rovira, Hector; Tasman, Natalie] Inst Syst Biol, Seattle, WA 98109 USA; [Hinoue, Toshinori; Laird, Peter W.; Shen, Hui; Weisenberger, Daniel J.; Bootwalla, Moiz S.; Lai, Phillip H.; Triche, Timothy, Jr.; Van Den Berg, David J.] Univ So Calif, USC Epigenome Ctr, Los Angeles, CA 90033 USA; [Curtis, Christina] Univ So Calif, Dept Prevent Med, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Schultz, Nikolaus; Weinhold, Nils; Askoy, B. Arman; Ciriello, Giovanni; Dresdner, Gideon; Gao, Jianjiong; Gross, Benjamin; Jacobsen, Anders; Lee, William; Ramirez, Ricardo; Sander, Chris; Senbabaoglu, Yasin; Sinha, Rileen; Sumer, S. Onur; Sun, Yichao] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Shen, Ronglai] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Keiser, David P.; Janjigian, Yelena Y.; Kelsen, David P.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Bowlby, Reanne; Sipahimalani, Payal; Ally, Adrian; Balasundaram, Miruna; Birol, Inanc; Brooks, Denise; Butterfield, Yaron S. N.; Carlsen, Rebecca; Chu, Andy; Chu, Justin; Chuah, Eric; Chun, Hye-Jung E.; Clarke, Amanda; Dhalla, Noreen; Guin, Ranabir; Holt, Robert A.; Jones, Steven J. M.; Kasaian, Katayoon; Lee, Darlene; Li, Haiyan A.; Lim, Emilia; Ma, Yussanne; Marra, Marco A.; Mayo, Michael; Moore, Richard A.; Mungall, Andrew J.; Mungall, Karen L.; Nip, Ka Ming; Robertson, A. Gordon; Schein, Jacqueline E.; Tam, Angela; Thiessen, Nina] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Cherniack, Andrew D.; Getz, Gad; Liu, Yingchun; Noble, Michael S.; Pedamallu, Chandra; Sougnez, Carrie; Taylor-Weiner, Amaro; Lawrence, Michael S.; Cibulskis, Kristian; Lichtenstein, Lee; Fisher, Sheila; Gabriel, Stacey B.; Lander, Eric S.; Beroukhim, Rameen; Carter, Scott L.; Cho, Juok; DiCara, Daniel; Frazer, Scott; Gehlenborg, Nils; Heiman, David I.; Jung, Joonil; Kim, Jaegil; Lin, Pei; Meyerson, Matthew; Ojesina, Akinyemi I.; Pedamallu, Chandra Sekhar; Saksena, Gordon; Schumacher, Steven E.; Stojanov, Petar; Tabak, Barbara; Voet, Doug; Rosenberg, Mara; Zack, Travis I.; Zhang, Hailei; Zou, Lihua; Murray, Bradley A.] Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA; [Akbani, Rehan; Lee, Ju-Seog; Liu, Wenbin; Ling, Shiyun; Rao, Arvind; Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Mills, Gordon B.; Kim, Sang-Bae; Lee, Ju-Seog; Lu, Yiling; Mills, Gordon] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Yang, Da; Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Pantazi, Angeliki; Parfenov, Michael; Santoso, Netty; Ren, Xiaojia; Hadjipanayis, Angela; Seidman, Jonathan; Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Gulley, Margaret] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Piazuelo, M. Blanca; Schneider, Barbara G.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Kim, Jihun; Park, Young S.] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul 138736, South Korea; [Boussioutas, Alex] Univ Melbourne, Sir Peter MacCallum Canc Dept Oncol, East Melbourne 3002, Australia; [Sheth, Margi; Demchok, John A.; Eley, Greg; Shaw, Kenna R. Mills; Tarnuzzer, Roy; Wang, Zhining; Yang, Liming; Zenklusen, Jean Claude] NCI, Bethesda, MD 20892 USA; [Rabkin, Charles S.; Camargo, M. Constanza] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Willis, Joseph E.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Ng, Sam; Haussler, David; Stuart, Josh M.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Haussler, David; Stuart, Josh M.] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Garman, Katherine] Duke Univ, Dept Med, Div Gastroenterol, Durham, NC 27710 USA; [Beer, David G.] Univ Michigan, Ctr Canc, Dept Thorac Surg, Ann Arbor, MI 48109 USA; [Pennathur, Arjun; Dhir, Rajiv; Luketich, James; Landreneau, Rodney] Univ Pittsburgh, Pittsburgh, PA 15213 USA; [Raphael, Benjamin J.; Wu, Hsin-Ta; Leiserson, Mark D. M.] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Wu, Hsin-Ta; Leiserson, Mark D. M.] Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA; [Odze, Robert] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Kim, Hark K.] Natl Canc Ctr, Goyang 410769, South Korea; [Bowen, Jay; Leraas, Kristen M.; Lichtenberg, Tara M.; Weaver, Lichtenberg; Black, Aaron D.; Carney, Julie Ann; Gastier-Foster, Julie M.; Helsel, Carmen; McAllister, Cynthia; Ramirez, Nilsa C.; Tabler, Teresa R.; Wise, Lisa; Zmuda, Erik] Nationwide Childrens Hosp, Res Inst, Columbus, OH 43205 USA; [McLellan, Michael; Ding, Li; Niu, Beifang] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Wiznerowicz, Maciej; Brzezinski, Jakub; Ibbs, Matthew; Korski, Konstanty; Kycler, Witold; Lazniak, Radoslaw; Leporowska, Ewa; Mackiewicz, Andrzej; Murawa, Dawid; Murawa, Pawel; Spychala, Arkadiusz; Suchorska, Wiktoria M.; Tatka, Honorata; Teresiak, Marek] Greater Poland Canc Ctr, PL-61866 Poznan, Poland; [Sakai, Ryo] Katholieke Univ Leuven, Dept Elect Engn ESAT STADIUS, Leuven, Belgium; [Protopopov, Alexei; Zhang, Jianhua; Mahadeshwar, Harshad S.; Tang, Jiabin; Seth, Sahil; Song, Xingzhi; Bristow, Christopher A.; Chin, Lynda; Verhaak, Roeland G. W.] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Dept Genom Med, Houston, TX 77054 USA; [Lee, Semin; Yang, Lixing; Xu, Andrew W.; Xi, Ruibin; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Baylin, Stephen B.; Herman, James G.] Johns Hopkins Univ, Canc Biol Div, Baltimore, MD 21231 USA; [Taylor, Barry S.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Penny, Robert; Crain, Daniel; Gardner, Johanna; Lau, Kevin; Curely, Erin; Mallery, David; Morris, Scott; Paulauskis, Joseph; Shelton, Troy; Shelton, Candace; Sherman, Mark; Kemkes, Ariane] Int Genom Consortium, Phoenix, AZ 85004 USA; [Benz, Christopher] Buck Inst Res Aging, Novato, CA 94945 USA; [Lee, Jae-Hyuk] Chonnam Natl Univ, Sch Med, Kwangju 501746, South Korea; [Fedosenko, Konstantin; Manikhas, Georgy] City Clin Oncol Dispensary, St Petersburg 198255, Russia; [Voronina, Olga; Belyaev, Dmitry; Dolzhansky, Oleg] Cureline Inc, San Francisco, CA 94080 USA; [Rathmell, W. Kimryn] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Rathmell, W. Kimryn] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Abdel-Misih, Raafat; Bennett, Joseph; Brown, Jennifer; Iacocca, Mary; Rabeno, Brenda] Christiana Care Hlth Syst, Helen Graham Canc Ctr & Res Inst, Newark, DE 19713 USA; [Kwon, Sun-Young] Keimyung Univ, Sch Med, Taegu 700712, South Korea; [Alexopoulou, Iakovina] St Josephs Healthcare Hamilton, Ontario Tumour Bank, Hamilton, ON L8N 3Z5, Canada; [Engel, Jay] Kingston Gen Hosp, Ontario Tumour Bank, Kingston, ON K7L 5H6, Canada; [Bartlett, John; Albert, Monique] Ontario Inst Canc Res, Ontario Tumour Bank, Toronto, ON M5G 0A3, Canada; [Park, Do-Youn] Pusan Natl Univ Hosp, Pusan 602739, South Korea; [Cho, Eunjung; Ladanyi, Marc; Tang, Laura] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [McCall, Shannon J.] Duke Univ, Dept Pathol, Durham, NC 27710 USA; [Cheong, Jae-Ho] Yonsei Univ, Coll Med, Dept Surg, Seoul 120752, South Korea; [Ajani, Jaffer] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Alonso, Shelley; Ayala, Brenda; Jensen, Mark A.; Pihl, Todd; Raman, Rohini; Walton, Jessica; Wan, Yunhu] SRA Int, Fairfax, VA 22033 USA; [Davidsen, Tanja] NCI, Ctr Biomed Informat & Informat Technol, Rockville, MD 20850 USA; [Hutter, Carolyn M.; Sofia, Heidi J.] NHGRI, Bethesda, MD 20892 USA; [Burton, Robert; Chudamani, Sudha; Liu, Jia] SAIC Frederick Inc, Frederick, MD 21702 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Institute for Systems Biology (ISB); University of Southern California; University of Southern California; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; British Columbia Cancer Agency; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University; University of Ulsan; Asan Medical Center; Peter Maccallum Cancer Center; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Case Western Reserve University; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Duke University; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Brown University; Brown University; Harvard University; Brigham & Women's Hospital; National Cancer Center - Korea (NCC); University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Washington University (WUSTL); Wielkopolskie Centrum Onkologii; KU Leuven; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; Johns Hopkins University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; International Genomics Consortium; Buck Institute for Research on Aging; Chonnam National University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; Keimyung University; McMaster University; Queens University - Canada; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Pusan National University; Pusan National University Hospital; Memorial Sloan Kettering Cancer Center; Duke University; Yonsei University; Yonsei University Health System; University of Texas System; UTMD Anderson Cancer Center; SRA International; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Science Applications International Corporation (SAIC); SAIC-Frederick	Bass, AJ (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	adam_bass@dfci.harvard.edu	Holt, Robert A/C-3303-2009; Pedamallu, Chandra Sekhar/AAV-6723-2020; Van Den Berg, David J/G-8598-2017; Pedamallu, Chandra Sekhar/AAV-6745-2020; Schein, Jacquie E/G-3674-2015; Schultz, Nikolaus/ABE-6347-2020; Shen, Hui/AAO-4387-2020; Cherniack, Andrew D./AAY-8132-2020; Ladanyi, Marc/AAG-8585-2019; Birol, Inanc/G-5440-2011; Cherniack, Andrew/AAC-5310-2019; luketich, james/AAY-6230-2020; Weisenberger, Daniel/AAA-8314-2020; Lee, Ju-Seog/X-1786-2018; Laird, Peter W/G-8683-2012; liu, ying/GXF-4294-2022; Mungall, Andrew J./U-7067-2018; Suchorska, Wiktoria/CAG-0479-2022; Skanderup, Anders Jacobsen/K-1081-2013; Camargo, M. Constanza/R-9891-2016; Kucherlapati, Raju/ABC-8807-2021; Ibbs, Matthew/AAU-1511-2021; Akbani, Rehan/AAG-1490-2019; Verhaak, Roel/ABE-7058-2020; Seth, Sahil/I-5809-2019; Lawrence, Michael/AAC-8202-2020; Cibulskis, Kristian/AAC-7380-2019; Ling, Shiyun/P-2242-2014; Lee, Semin/S-2629-2016; Stojanov, Petar/GQI-4462-2022; Marra, Marco A/B-5987-2008; Jones, Steven J/C-3621-2009; Gao, JianJiong/B-5673-2016; LIU, YING/GZL-7252-2022; Senbabaoglu, Yasin/I-4922-2013	Holt, Robert A/0000-0002-7259-1247; Van Den Berg, David J/0000-0002-5404-5218; Cherniack, Andrew D./0000-0003-0470-0111; Birol, Inanc/0000-0003-0950-7839; Weisenberger, Daniel/0000-0001-8303-2603; Lee, Ju-Seog/0000-0002-5666-9753; Laird, Peter W/0000-0001-9117-3641; Mungall, Andrew J./0000-0002-0905-2742; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Camargo, M. Constanza/0000-0002-1065-2198; Ibbs, Matthew/0000-0003-2510-3447; Seth, Sahil/0000-0003-4579-3959; Lee, Semin/0000-0002-9015-6046; Stojanov, Petar/0000-0001-7815-776X; Marra, Marco A/0000-0001-7146-7175; Jones, Steven J/0000-0003-3394-2208; Gao, JianJiong/0000-0002-5739-1781; Ajani, Jaffer A/0000-0001-9946-0629; Boussioutas, Alex/0000-0002-8109-6897; Cibulskis, Kristian/0000-0003-1343-1582; Meyerson, Matthew/0000-0002-9133-8108; Heiman, David/0000-0001-7895-4259; Senbabaoglu, Yasin/0000-0003-0958-958X; MCLELLAN, MICHAEL/0000-0002-2703-8784; Tarnuzzer, Roy/0000-0002-3725-4173; Gehlenborg, Nils/0000-0003-0327-8297; Sinha, Rileen/0000-0001-5497-5055; McCall, Shannon/0000-0003-3957-061X; Xi, Ruibin/0000-0001-7545-7361; Ciriello, Giovanni/0000-0003-2021-8683; Schneider, Barbara/0000-0003-4421-1355; Suchorska, Wiktoria/0000-0003-4742-2465; Schultz, Nikolaus/0000-0002-0131-4904; Jensen, Mark/0000-0001-5215-101X; Triche, Tim/0000-0001-5665-946X; Bowen, Jay/0000-0001-6861-9043; Shen, Hui/0000-0001-9767-4084; Cheong, Jae-Ho/0000-0002-1703-1781; Weinstein, John/0000-0001-9401-6908; Yang, Da/0000-0002-8336-9457; Stuart, Joshua/0000-0002-2171-565X; Bootwalla, Moiz/0000-0001-6158-7114; Curtis, Christina/0000-0003-0166-3802; Rosenberg, Mara/0000-0001-6400-3161; Park, Peter/0000-0001-9378-960X; Ojesina, Akinyemi/0000-0003-0755-3639	Intramural Research Program; United States National Institutes of Health [5U24CA143799, 5U24CA143835, 5U24CA143840, 5U24CA143843, 5U24CA143845, 5U24CA143848, 5U24CA143858, 5U24CA143866, 5U24CA143867, 5U24CA143882, 5U24CA143883, 5U24CA144025, U54HG003067, U54HG003079, U54HG003273, P30CA16672]; Div Of Information & Intelligent Systems [1016648] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [U24CA144025, U24CA143882, U24CA143835, K99CA166729, P30CA006973, U24CA143867, U24CA126543, U24CA143883, U24CA143840, U24CA143799, U24CA143858, U24CA143843, U24CA143848, R01CA180006, U24CA143866, U24CA143845, K08CA134931, U24CA180951, P50CA098258, P30CA016672, P01CA028842] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, U54HG003067, U54HG003273, R01HG005690] Funding Source: NIH RePORTER	Intramural Research Program; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to all the patients and families who contributed to this study and to C. Gunter and J. Weinstein for scientific editing, to M. Sheth for administrative support and to L. Omberg for support with the Sage Bionetworks Synapse platform. This work was supported by the Intramural Research Program and the following grants from the United States National Institutes of Health: 5U24CA143799, 5U24CA143835, 5U24CA143840, 5U24CA143843, 5U24CA143845, 5U24CA143848, 5U24CA143858, 5U24CA143866, 5U24CA143867, 5U24CA143882, 5U24CA143883, 5U24CA144025, U54HG003067, U54HG003079, U54HG003273 and P30CA16672.	Aznar S, 2001, MOL BIOL CELL, V12, P3282, DOI 10.1091/mbc.12.10.3282; Bernal M, 2012, CANCER IMMUNOL IMMUN, V61, P1359, DOI 10.1007/s00262-012-1321-6; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Boussioutas A, 2003, CANCER RES, V63, P2569; Chen BJ, 2013, CLIN CANCER RES, V19, P3462, DOI 10.1158/1078-0432.CCR-13-0855; Doherty GJ, 2011, MOL BIOL CELL, V22, P4380, DOI 10.1091/mbc.E10-12-0936; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Ferlay J, 2013, IARC CANC BASE; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Geddert H, 2010, ANAL CELL PATHOL, V33, P143, DOI [10.1155/2010/453764, 10.3233/ACP-CLO-2010-0540]; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Green MR, 2012, CLIN CANCER RES, V18, P1611, DOI 10.1158/1078-0432.CCR-11-1942; Greulich H, 2012, P NATL ACAD SCI USA, V109, P14476, DOI 10.1073/pnas.1203201109; Grossmann V, 2011, BLOOD, V118, P6153, DOI 10.1182/blood-2011-07-365320; International Agency for Research on Cancer, 2010, WHO CLASSIFICATION T; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; Keller G, 1996, INT J CANCER, V68, P571; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038892; Lei ZD, 2013, GASTROENTEROLOGY, V145, P554, DOI 10.1053/j.gastro.2013.05.010; Matsusaka K, 2011, CANCER RES, V71, P7187, DOI 10.1158/0008-5472.CAN-11-1349; Murphy G, 2009, GASTROENTEROLOGY, V137, P824, DOI 10.1053/j.gastro.2009.05.001; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Richards FM, 1999, HUM MOL GENET, V8, P607, DOI 10.1093/hmg/8.4.607; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Strong MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003341; Sukawa Y, 2012, WORLD J GASTROENTERO, V18, P6577, DOI 10.3748/wjg.v18.i45.6577; Tan IB, 2011, GASTROENTEROLOGY, V141, P476, DOI 10.1053/j.gastro.2011.04.042; Thumkeo D, 2013, EUR J CELL BIOL, V92, P303, DOI 10.1016/j.ejcb.2013.09.002; Toyota M, 1999, CANCER RES, V59, P5438; Tureci O, 2011, GENE, V481, P83, DOI 10.1016/j.gene.2011.04.007; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	40	3503	3655	31	411	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					202	209		10.1038/nature13480	http://dx.doi.org/10.1038/nature13480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25079317	Green Published, hybrid, Green Accepted			2022-12-01	WOS:000341362800044
J	Elsworth, B; Matthews, K; Nie, CQ; Kalanon, M; Charnaud, SC; Sanders, PR; Chisholm, SA; Counihan, NA; Shaw, PJ; Pino, P; Chan, JA; Azevedo, MF; Rogerson, SJ; Beeson, JG; Crabb, BS; Gilson, PR; de Koning-Ward, TF				Elsworth, Brendan; Matthews, Kathryn; Nie, Catherine Q.; Kalanon, Ming; Charnaud, Sarah C.; Sanders, Paul R.; Chisholm, Scott A.; Counihan, Natalie A.; Shaw, Philip J.; Pino, Paco; Chan, Jo-Anne; Azevedo, Mauro F.; Rogerson, Stephen J.; Beeson, James G.; Crabb, Brendan S.; Gilson, Paul R.; de Koning-Ward, Tania F.			PTEX is an essential nexus for protein export in malaria parasites	NATURE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; PLASMODIUM-FALCIPARUM; PARASITOPHOROUS VACUOLE; CHONDROITIN SULFATE; PLACENTAL MALARIA; SURFACE; VIRULENCE; INVASION; ANTIBODIES; ANTIGEN	During the blood stages of malaria, several hundred parasite-encoded proteins are exported beyond the double-membrane barrier that separates the parasite from the host cell cytosol(1-6). These proteins have a variety of roles that are essential to virulence or parasite growth(7). There is keen interest in understanding how proteins are exported and whether common machineries are involved in trafficking the different classes of exported proteins(8,9). One potential trafficking machine is a protein complex known as the Plasmodium translocon of exported proteins (PTEX)(10). Although PTEX has been linked to the export of one class of exported proteins(10,11), there has been no direct evidence for its role and scope in protein translocation. Here we show, through the generation of two parasite lines defective for essential PTEX components (HSP101 or PTEX150), and analysis of a line lacking the non-essential component TRX2 (ref. 12), greatly reduced trafficking of all classes of exported proteins beyond the double membrane barrier enveloping the parasite. This includes proteins containing the PEXEL motif (RxLxE/Q/D)(1,2) and PEXEL-negative exported proteins (PNEPs)(6). Moreover, the export of proteins destined for expression on the infected erythrocyte surface, including the major virulence factor PfEMP1 in Plasmodium falciparum, was significantly reduced in PTEX knockdown parasites. PTEX function was also essential for blood-stage growth, because even a modest knockdown of PTEX components had a strong effect on the parasite's capacity to complete the erythrocytic cycle both in vitro and in vivo. Hence, as the only known nexus for protein export in Plasmodium parasites, and an essential enzymic machine, PTEX is a prime drug target.	[Elsworth, Brendan; Nie, Catherine Q.; Charnaud, Sarah C.; Sanders, Paul R.; Chan, Jo-Anne; Azevedo, Mauro F.; Beeson, James G.; Crabb, Brendan S.; Gilson, Paul R.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3004, Australia; [Elsworth, Brendan; Charnaud, Sarah C.; Beeson, James G.; Crabb, Brendan S.; Gilson, Paul R.] Monash Univ, Clayton, Vic 3800, Australia; [Matthews, Kathryn; Kalanon, Ming; Chisholm, Scott A.; Counihan, Natalie A.; de Koning-Ward, Tania F.] Deakin Univ, Waurn Ponds, Vic 3216, Australia; [Shaw, Philip J.] Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani 12120, Thailand; [Pino, Paco] Univ Geneva, CH-1211 Geneva 4, Switzerland; [Rogerson, Stephen J.; Beeson, James G.; Crabb, Brendan S.] Univ Melbourne, Parkville, Vic 3010, Australia	Burnet Institute; Monash University; Deakin University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); University of Geneva; University of Melbourne	de Koning-Ward, TF (corresponding author), Deakin Univ, Waurn Ponds, Vic 3216, Australia.	crabb@burnet.edu.au; gilson@burnet.edu.au; taniad@deakin.edu.au	de Koning-Ward, Tania F/N-3572-2017; Chisholm, Scott/K-2661-2019; Azevedo, Mauro/H-6180-2012	de Koning-Ward, Tania F/0000-0001-5810-8063; Chisholm, Scott/0000-0002-3833-8854; Azevedo, Mauro/0000-0002-5233-2037; Rogerson, Stephen/0000-0003-4287-1982; Charnaud, Sarah/0000-0002-9029-9696	National Health and Medical Research Council (NHMRC) of Australia [1021560, 1025665, 637406]; Victorian State Government; Australian Postgraduate Awards	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government; Australian Postgraduate Awards(Australian Government)	We thank T. Templeton, B. Franke-Fayard, C. Janse, A. Cowman, J. Boddey, B. Cooke, M. Duffy, L. Tilley, R. Anders, F. Fowkes, A. McLean and D. Bursac for reagents and/or other assistance with aspects of this study; D. Stanisic, F. Baiwog and I. Mueller for contributions to clinical studies of pregnant women; and P. Siba. We also thank the Australian Red Cross Blood Bank for the provision of human blood and serum. This work was supported by grants from the National Health and Medical Research Council (NHMRC) of Australia (1021560, 1025665 and 637406) and the Victorian State Government Operational Infrastructure Support Scheme. T.F.d.K.-W. is an NHMRC Career Development Fellow, and J.G.B. is a NHMRC Senior Research Fellow. B.E. and K.M. are the recipients of Australian Postgraduate Awards.	Avril M, 2010, INFECT IMMUN, V78, P2248, DOI 10.1128/IAI.00410-09; Beeson JG, 2006, J INFECT DIS, V193, P721, DOI 10.1086/500145; Beeson JG, 2004, J INFECT DIS, V189, P540, DOI 10.1086/381186; Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Boddey JA, 2013, ANNU REV MICROBIOL, V67, P243, DOI 10.1146/annurev-micro-092412-155730; Boddey JA, 2013, TRAFFIC, V14, P532, DOI 10.1111/tra.12053; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Boyle MJ, 2010, BLOOD, V115, P4559, DOI 10.1182/blood-2009-09-243725; Bullen HE, 2012, J BIOL CHEM, V287, P7871, DOI 10.1074/jbc.M111.328591; Chan JA, 2012, J CLIN INVEST, V122, P3227, DOI 10.1172/JCI62182; Cooke BM, 1996, BLOOD, V88, P4040, DOI 10.1182/blood.V88.10.4040.bloodjournal88104040; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; CULVENOR JG, 1991, INFECT IMMUN, V59, P1183, DOI 10.1128/IAI.59.3.1183-1187.1991; de Koning-Ward TF, 2008, MOL BIOCHEM PARASIT, V159, P69, DOI 10.1016/j.molbiopara.2008.01.005; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; de Koning-Ward TF, 2003, J EXP MED, V198, P869, DOI 10.1084/jem.20030085; Drew DR, 2005, INFECT IMMUN, V73, P3912, DOI 10.1128/IAI.73.7.3912-3922.2005; Elsworth B, 2014, CELL MICROBIOL, V16, P355, DOI 10.1111/cmi.12261; Haase S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061482; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Matthews K, 2013, MOL MICROBIOL, V89, P1167, DOI 10.1111/mmi.12334; Matz JM, 2013, MOL BIOCHEM PARASIT, V191, P44, DOI 10.1016/j.molbiopara.2013.09.003; Pasini EM, 2013, MOL CELL PROTEOMICS, V12, P426, DOI 10.1074/mcp.M112.021238; Pino P, 2012, CELL HOST MICROBE, V12, P824, DOI 10.1016/j.chom.2012.10.016; POLOGE LG, 1986, NATURE, V322, P474, DOI 10.1038/322474a0; Prommana P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073783; Riglar DT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2449; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Sleebs BE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001897; Umbers AJ, 2011, J INFECT DIS, V203, P561, DOI 10.1093/infdis/jiq080; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084	42	166	169	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					587	+		10.1038/nature13555	http://dx.doi.org/10.1038/nature13555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043043				2022-12-01	WOS:000339566300034
J	Mehrabadi, A; Liu, SL; Bartholomew, S; Hutcheon, JA; Magee, LA; Kramer, MS; Liston, RM; Joseph, KS				Mehrabadi, Azar; Liu, Shiliang; Bartholomew, Sharon; Hutcheon, Jennifer A.; Magee, Laura A.; Kramer, Michael S.; Liston, Robert M.; Joseph, K. S.		Canadian Perinatal Surveillance	Hypertensive disorders of pregnancy and the recent increase in obstetric acute renal failure in Canada: population based retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEVERE MATERNAL MORBIDITY; ACUTE KIDNEY INJURY; ATONIC POSTPARTUM HEMORRHAGE; TEMPORAL TRENDS; RISK; PREECLAMPSIA; ADMISSION; OUTCOMES; RATES	Objective To examine whether changes in postpartum haemorrhage, hypertensive disorders of pregnancy, or other risk factors explain the increase in obstetric acute renal failure in Canada. Design Retrospective cohort study. Setting Canada (excluding the province of Quebec). Participants All hospital deliveries from 2003 to 2010 (n=2 193 425). Main outcome measures Obstetric acute renal failure identified by ICD-10 diagnostic codes. Methods Information on all hospital deliveries in Canada (excluding Quebec) between 2003 and 2010 (n=2 193 425) was obtained from the Canadian Institute for Health Information. Temporal trends in obstetric acute renal failure were assessed among women with and without postpartum haemorrhage, hypertensive disorders of pregnancy, or other risk factors. Logistic regression was used to determine if changes in risk factors explained the temporal increase in obstetric acute renal failure. Results Rates of obstetric acute renal failure rose from 1.66 to 2.68 per 10 000 deliveries between 2003-04 and 2009-10 (61% increase, 95% confidence interval 24% to 110%). Adjustment for postpartum haemorrhage, hypertensive disorders, and other factors did not attenuate the increase. The temporal increase in acute renal failure was restricted to deliveries with hypertensive disorders (adjusted increase 95%, 95% confidence interval 38% to 176%), and was especially pronounced among women with gestational hypertension with significant proteinuria (adjusted increase 171%, 71% to 329%). No significant increase occurred among women without hypertensive disorders (adjusted increase 12%, -28 to 72%). Conclusions The increase in obstetric acute renal failure in Canada between 2003 and 2010 was restricted to women with hypertensive disorders and was especially pronounced among women with pre-eclampsia. Further study is required to determine the cause of the increase among women with pre-eclampsia.	[Mehrabadi, Azar; Hutcheon, Jennifer A.; Magee, Laura A.; Liston, Robert M.; Joseph, K. S.] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada; [Mehrabadi, Azar; Hutcheon, Jennifer A.; Magee, Laura A.; Liston, Robert M.; Joseph, K. S.] Childrens & Womens Hlth Ctr British Columbia, Vancouver, BC, Canada; [Mehrabadi, Azar; Hutcheon, Jennifer A.; Magee, Laura A.; Joseph, K. S.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Liu, Shiliang; Bartholomew, Sharon] Publ Hlth Agcy Canada, Maternal & Infant Hlth Sect, Ottawa, ON, Canada; [Magee, Laura A.] Univ British Columbia, Fac Med, Div Gen Internal Med, Vancouver, BC, Canada; [Kramer, Michael S.] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Kramer, Michael S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	University of British Columbia; BC Women's Hospital & Health Centre; University of British Columbia; Public Health Agency of Canada; University of British Columbia; McGill University; McGill University	Mehrabadi, A (corresponding author), Womens Hosp British Columbia, Vancouver, BC V6H 3N1, Canada.	azar@alumni.ubc.ca		Hutcheon, Jennifer/0000-0002-6618-6018; Joseph, K.S./0000-0003-2317-5607	Canadian Institutes of Health Research (CIHR) [MAH-115445]; CIHR; Michael Smith Foundation for Health Research; British Columbia's Women's Hospital and Health Centre; Child and Family Research Institute; CIHR chair in maternal, fetal, and infant health services research [APR-126338]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); British Columbia's Women's Hospital and Health Centre; Child and Family Research Institute; CIHR chair in maternal, fetal, and infant health services research(Canadian Institutes of Health Research (CIHR))	This work is supported by a Canadian Institutes of Health Research (CIHR) team grant in severe maternal morbidity (MAH-115445). JAH is the recipient of a CIHR new investigator award and a scholar award from the Michael Smith Foundation for Health Research. LAM receives salary support from British Columbia's Women's Hospital and Health Centre. KSJ is supported by an investigator award from the Child and Family Research Institute and a CIHR chair in maternal, fetal, and infant health services research (APR-126338). The funding sources had no role in the design, analysis, interpretation of the results, or the writing of the manuscript.	Abuelo JG, 2007, NEW ENGL J MED, V357, P797, DOI 10.1056/NEJMra064398; Acharya A, 2013, ADV CHRONIC KIDNEY D, V20, P215, DOI 10.1053/j.ackd.2013.02.002; Bateman BT, 2010, ANESTH ANALG, V110, P1368, DOI 10.1213/ANE.0b013e3181d74898; Blomberg M, 2011, OBSTET GYNECOL, V118, P561, DOI 10.1097/AOG.0b013e31822a6c59; Callaghan WM, 2012, OBSTET GYNECOL, V120, P1029, DOI [10.1097/AOG.0b013e31826d60c5, http://10.1097/AOG.0b013e31826d60c5]; Callaghan WM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.011; Choudhury D, 2006, NAT CLIN PRACT NEPHR, V2, P80, DOI 10.1038/ncpneph0076; Dormuth CR, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f880; Drakeley AJ, 2002, AM J OBSTET GYNECOL, V186, P253, DOI 10.1067/mob.2002.120279; Ford JB, 2007, INT J GYNECOL OBSTET, V98, P237, DOI 10.1016/j.ijgo.2007.03.011; Gammill Hilary S, 2005, Crit Care Med, V33, pS372, DOI 10.1097/01.CCM.0000183155.46886.C6; Gandhi S, 2013, JAMA-J AM MED ASSOC, V310, P2544, DOI 10.1001/jama.2013.282426; Gurrieri C, 2012, ARCH GYNECOL OBSTET, V286, P567, DOI 10.1007/s00404-012-2323-5; Harrell Jr FE, 2001, REGRESSION MODELING, DOI DOI 10.1007/978-3-319-19425-7; Howe CJ, 2011, EPIDEMIOLOGY, V22, P874, DOI 10.1097/EDE.0b013e31823029dd; Hwang YJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001821; Joseph KS, 2007, BJOG-INT J OBSTET GY, V114, P751, DOI 10.1111/j.1471-0528.2007.01316.x; Joseph KS, 2010, J OBSTET GYNAECOL CA, V32, P837, DOI 10.1016/S1701-2163(16)34655-2; Joseph KS, 2009, CHRONIC DIS CAN, V29, P96; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Koren G, 2006, LANCET, V368, P704, DOI 10.1016/S0140-6736(06)69255-6; KRANE NK, 1988, ARCH INTERN MED, V148, P2347, DOI 10.1001/archinte.148.11.2347; Lapi F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8525; Lewis G, 2004, 6 REPORT CONFIDENTIA; Liu SL, 2010, J OBSTET GYNAECOL CA, V32, P847, DOI 10.1016/S1701-2163(16)34656-4; Lutomski JE, 2012, BJOG-INT J OBSTET GY, V119, P306, DOI 10.1111/j.1471-0528.2011.03198.x; Magee LA, 2008, J OBSTET GYNAECOL CA, V30, pS1, DOI 10.1016/S1701-2163(16)32776-1; Mehrabadi A, 2013, BJOG-INT J OBSTET GY, V120, P853, DOI 10.1111/1471-0528.12149; Mehrabadi A, 2014, J OBSTET GYNAECOL CA, V36, P21, DOI 10.1016/S1701-2163(15)30680-0; Nzerue CM, 1998, J NATL MED ASSOC, V90, P486; Roberts CL, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000101; Rossen J, 2011, OBSTET GYNECOL SURV, V66, P18; Royal College of Obstetricians and Gynaelcologists, 2006, GUIDELINE; SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P777, DOI 10.1016/0002-9378(90)91009-2; So L, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-161; STEWART GK, 1971, OBSTET GYNECOL, V37, P510; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Thornton CE, 2011, HYPERTENS PREGNANCY, V30, P169, DOI 10.3109/10641950902972140; Tuffnell DJ, 2005, BJOG-INT J OBSTET GY, V112, P875, DOI 10.1111/j.1471-0528.2005.00565.x; TURNEY JH, 1989, BRIT J OBSTET GYNAEC, V96, P679, DOI 10.1111/j.1471-0528.1989.tb03282.x; Vikse BE, 2013, LANCET, V382, P104, DOI 10.1016/S0140-6736(13)60741-2; von Dadelszen P, 2010, OBSTET GYNECOL, V116, P659, DOI 10.1097/AOG.0b013e3181eb669d; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073	43	63	68	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2014	349								g4731	10.1136/bmj.g4731	http://dx.doi.org/10.1136/bmj.g4731			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NP	25077825	Green Published, hybrid			2022-12-01	WOS:000339907000002
J	Ball, SJ; Pereira, G; Jacoby, P; de Klerk, N; Stanley, FJ				Ball, Stephen J.; Pereira, Gavin; Jacoby, Peter; de Klerk, Nicholas; Stanley, Fiona J.			Re-evaluation of link between interpregnancy interval and adverse birth outcomes: retrospective cohort study matching two intervals per mother	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRETERM BIRTH; PREGNANCY INTERVAL; PERINATAL OUTCOMES; HEALTH; CHILD; RISK; ASSOCIATION; WEIGHT; INFANT	Objective To re-evaluate the causal effect of interpregnancy interval on adverse birth outcomes, on the basis that previous studies relying on between mother comparisons may have inadequately adjusted for confounding by maternal risk factors. Design Retrospective cohort study using conditional logistic regression (matching two intervals per mother so each mother acts as her own control) to model the incidence of adverse birth outcomes as a function of interpregnancy interval; additional unconditional logistic regression with adjustment for confounders enabled comparison with the unmatched design of previous studies. Setting Perth, Western Australia, 1980-2010. Participants 40 441 mothers who each delivered three liveborn singleton neonates. Main outcome measures Preterm birth (< 37 weeks), small for gestational age birth (< 10th centile of birth weight by sex and gestational age), and low birth weight (< 2500 g). Results Within mother analysis of interpregnancy intervals indicated a much weaker effect of short intervals on the odds of preterm birth and low birth weight compared with estimates generated using a traditional between mother analysis. The traditional unmatched design estimated an adjusted odds ratio for an interpregnancy interval of 0-5 months (relative to the reference category of 18-23 months) of 1.41 (95% confidence interval 1.31 to 1.51) for preterm birth, 1.26 (1.15 to 1.37) for low birth weight, and 0.98 (0.92 to 1.06) for small for gestational age birth. In comparison, the matched design showed a much weaker effect of short interpregnancy interval on preterm birth (odds ratio 1.07, 0.86 to 1.34) and low birth weight (1.03, 0.79 to 1.34), and the effect for small for gestational age birth remained small (1.08, 0.87 to 1.34). Both the unmatched and matched models estimated a high odds of small for gestational age birth and low birth weight for long interpregnancy intervals (longer than 59 months), but the estimated effect of long interpregnancy intervals on the odds of preterm birth was much weaker in the matched model than in the unmatched model. Conclusion This study questions the causal effect of short interpregnancy intervals on adverse birth outcomes and points to the possibility of unmeasured or inadequately specified maternal factors in previous studies.	[Ball, Stephen J.; Pereira, Gavin; Jacoby, Peter; de Klerk, Nicholas; Stanley, Fiona J.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6872, Australia; [Pereira, Gavin] Yale Univ, Yale Ctr Perinatal Pediat & Environm Epidemiol, New Haven, CT 06510 USA	Telethon Kids Institute; University of Western Australia; Yale University	Ball, SJ (corresponding author), Univ Western Australia, Telethon Kids Inst, POB 855, Perth, WA 6872, Australia.	stephen.ball@telethonkids.org.au	de Klerk, Nicholas H/D-8388-2016; Pereira, Gavin/D-7136-2014	de Klerk, Nicholas H/0000-0001-9223-0767; Pereira, Gavin/0000-0003-3740-8117	Australian National Health and Medical Research Council [572742, 1052236]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this research was received from the Australian National Health and Medical Research Council as a program grant (572742) and early career fellowship (1052236 to GP). The authors maintained full control over the design and conduct of the study; the collection, management, analysis, and interpretation of the data; and the preparation, review, and approval of the manuscript.	Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Breslow NE, 1980, STAT METHODS CANC RE; Cheslack-Postava K, 2011, PEDIATRICS, V127, P246; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; Conde-Agudelo A, 2005, OBSTET GYNECOL, V106, P359, DOI 10.1097/01.AOG.0000171118.79529.a3; Conde-Agudelo A, 2012, STUD FAMILY PLANN, V43, P93, DOI 10.1111/j.1728-4465.2012.00308.x; Dobbins TA, 2012, MED J AUSTRALIA, V197, P291, DOI 10.5694/mja11.11331; ERICKSON JD, 1978, J EPIDEMIOL COMMUN H, V32, P124, DOI 10.1136/jech.32.2.124; Gee V, 1994, VALIDATION STUDY WES; Grisaru-Granovsky S, 2009, CONTRACEPTION, V80, P512, DOI 10.1016/j.contraception.2009.06.006; Gunawardana L, 2011, BRIT J PSYCHIAT, V199, P338, DOI 10.1192/bjp.bp.111.092916; Howard EJ, 2013, MATERN CHILD HLTH J, V17, P933, DOI 10.1007/s10995-012-1073-0; Huynh M, 2006, PAEDIATR PERINAT EP, V20, P454, DOI 10.1111/j.1365-3016.2006.00759.x; Klebanoff MA, 1999, NEW ENGL J MED, V340, P643, DOI 10.1056/NEJM199902253400809; Kwon S, 2012, J PERINATOL, V32, P45, DOI 10.1038/jp.2011.49; Lindblad F, 2010, NICOTINE TOB RES, V12, P408, DOI 10.1093/ntr/ntq017; Lindstrom K, 2011, PEDIATRICS, V127, P858, DOI 10.1542/peds.2010-1279; Marston C., 2005, REPORT WHO TECHNICAL; McClennan W., 1996, 20390 AUSTR BUR STAT; MILLER JE, 1991, FAM PLANN PERSPECT, V23, P62, DOI 10.2307/2135451; Read A W, 1993, Paediatr Perinat Epidemiol, V7, P177, DOI 10.1111/j.1365-3016.1993.tb00392.x; Ritsmitchai S, 1997, J OCCUP HEALTH, V39, P217, DOI 10.1539/joh.39.217; Rousso D, 2002, EUR J OBSTET GYN R B, V105, P4, DOI 10.1016/S0301-2115(02)00077-5; Shachar BZ, 2012, OBSTET GYNECOL SURV, V67, P584, DOI 10.1097/OGX.0b013e31826b2c3e; Wendt A, 2012, PAEDIATR PERINAT EP, V26, P239, DOI 10.1111/j.1365-3016.2012.01285.x; WINIKOFF B, 1983, STUD FAMILY PLANN, V14, P231, DOI 10.2307/1965748; Zhu Bao-Ping, 2003, Matern Child Health J, V7, P169, DOI 10.1023/A:1025184304391; Zhu BP, 2005, INT J GYNECOL OBSTET, V89, pS25, DOI 10.1016/j.ijgo.2004.08.002; Zhu BP, 1999, NEW ENGL J MED, V340, P589, DOI 10.1056/NEJM199902253400801	29	113	118	2	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2014	349								g4333	10.1136/bmj.g4333	http://dx.doi.org/10.1136/bmj.g4333			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM0VP	25056260	Green Published, hybrid			2022-12-01	WOS:000339565900001
J	McKenney, RJ; Huynh, W; Tanenbaum, ME; Bhabha, G; Vale, RD				McKenney, Richard J.; Huynh, Walter; Tanenbaum, Marvin E.; Bhabha, Gira; Vale, Ronald D.			Activation of cytoplasmic dynein motility by dynactin-cargo adapter complexes	SCIENCE			English	Article							MICROTUBULE-BINDING; PROCESSIVITY; TRANSPORT; MOTOR; PROTEIN; LIS1; INCREASES; DOMAIN	Cytoplasmic dynein is a molecular motor that transports a large variety of cargoes (e. g., organelles, messenger RNAs, and viruses) along microtubules over long intracellular distances. The dynactin protein complex is important for dynein activity in vivo, but its precise role has been unclear. Here, we found that purified mammalian dynein did not move processively on microtubules in vitro. However, when dynein formed a complex with dynactin and one of four different cargo-specific adapter proteins, the motor became ultraprocessive, moving for distances similar to those of native cargoes in living cells. Thus, we propose that dynein is largely inactive in the cytoplasm and that a variety of adapter proteins activate processive motility by linking dynactin to dynein only when the motor is bound to its proper cargo.	[Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	vale@ucsf.edu			NIH [F32GM096484, R01GM097312]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096484, R01GM097312] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Ori-McKenney for helpful discussions and analysis. This work was supported by NIH F32 postdoctoral grant F32GM096484 (to R.J.M.) and R01GM097312 (to R.D.V.). G. B. is the Merck Fellow of the Damon Runyon Cancer Research Foundation (DRG-2136-12).	Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; Bielska E, 2014, J CELL BIOL, V204, P989, DOI 10.1083/jcb.201309022; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; Culver-Hanlon TL, 2006, NAT CELL BIOL, V8, P264, DOI 10.1038/ncb1370; Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Horgan CP, 2010, J CELL SCI, V123, P181, DOI 10.1242/jcs.052670; Huang J, 2012, CELL, V150, P975, DOI 10.1016/j.cell.2012.07.022; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; Kim H, 2007, J CELL BIOL, V176, P641, DOI 10.1083/jcb.200608128; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Lazarus JE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001611; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Miura M, 2010, FEBS LETT, V584, P2351, DOI 10.1016/j.febslet.2010.04.016; Moughamian AJ, 2012, NEURON, V74, P331, DOI 10.1016/j.neuron.2012.02.025; Ori-McKenney KM, 2010, NAT CELL BIOL, V12, P1228, DOI 10.1038/ncb2127; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Soundararajan HC, 2014, ELIFE, V3, DOI 10.7554/eLife.01596; Splinter D, 2012, MOL BIOL CELL, V23, P4226, DOI 10.1091/mbc.E12-03-0210; Stuurman N, 1999, EUR J CELL BIOL, V78, P278, DOI 10.1016/S0171-9335(99)80061-2; Tanenbaum ME, 2013, ELIFE, V2, DOI 10.7554/eLife.00943; Tokito MK, 1996, MOL BIOL CELL, V7, P1167, DOI 10.1091/mbc.7.8.1167; Trokter M, 2012, P NATL ACAD SCI USA, V109, P20895, DOI 10.1073/pnas.1210573110; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; Wang ZH, 1995, BIOPHYS J, V69, P2011, DOI 10.1016/S0006-3495(95)80071-8; Zhang J, 2014, J CELL BIOL, V204, P1009, DOI 10.1083/jcb.201308009	30	302	306	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					337	341		10.1126/science.1254198	http://dx.doi.org/10.1126/science.1254198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035494	Green Accepted			2022-12-01	WOS:000339400700054
J	McKinley, KL; Cheeseman, IM				McKinley, Kara L.; Cheeseman, Iain M.			Polo-like Kinase 1 Licenses CENP-A Deposition at Centromeres	CELL			English	Article							CYTOKINESIS; RECRUITMENT; REVEALS; PLK1; MAINTENANCE; INHIBITOR; BI-2536; M18BP1; HJURP	To ensure the stable transmission of the genome during vertebrate cell division, the mitotic spindle must attach to a single locus on each chromosome, termed the centromere. The fundamental requirement for faithful centromere inheritance is the controlled deposition of the centromere-specifying histone, CENP-A. However, the regulatory mechanisms that ensure the precise control of CENP-A deposition have proven elusive. Here, we identify polo-like kinase 1 (Plk1) as a centromere-localized regulator required to initiate CENP-A deposition in human cells. We demonstrate that faithful CENP-A deposition requires integrated signals from Plk1 and cyclin-dependent kinase (CDK), with Plk1 promoting the localization of the key CENP-A deposition factor, the Mis18 complex, and CDK inhibiting Mis18 complex assembly. By bypassing these regulated steps, we uncoupled CENP-A deposition from cell-cycle progression, resulting in mitotic defects. Thus, CENP-A deposition is controlled by a two-step regulatory paradigm comprised of Plk1 and CDK that is crucial for genomic integrity.	[McKinley, Kara L.; Cheeseman, Iain M.] MIT, Cambridge Ctr 9, Whitehead Inst, Cambridge, MA 02142 USA; [McKinley, Kara L.; Cheeseman, Iain M.] MIT, Cambridge Ctr 9, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Cheeseman, IM (corresponding author), MIT, Cambridge Ctr 9, Whitehead Inst, Cambridge, MA 02142 USA.	icheese@wi.mit.edu		McKinley, Kara/0000-0001-6283-9168; Cheeseman, Iain/0000-0002-3829-5612	Scholar Award from the Leukemia & Lymphoma Society; NIH/National Institute of General Medical Sciences [GM088313]; American Cancer Society [121776]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287, R01GM088313] Funding Source: NIH RePORTER	Scholar Award from the Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the I.M.C. laboratory, Defne Yarar, David Sabatini, Peter Reddien, Steve Bell, Frank Solomon, Terry Orr-Weaver, and Rick Young for discussions and critical reading of the manuscript. We are grateful to Daniel Lim and Michael Yaffe (MIT) for providing the GST-Plk1-PBD and advice on working with Plk1. We thank Aaron Straight (Stanford University) for the CENP-A-SNAP cell line, Prasad Jallepalli (Sloan Kettering) for the Rpe1-Plk1<SUP>as</SUP> cell line, and Lars Jansen (Gulbenkian Institute) for the M18BP1 cDNA and CENP-A-SNAP plasmids. We thank Paul Fields and Laurie Boyer (MIT) and Chikdu Shivalila and Rudolf Jaenisch (Whitehead Institute and MIT) for advice and reagents for CRISPR/Cas9-mediated genome editing. This work was supported by a Scholar Award from the Leukemia & Lymphoma Society, a grant from the NIH/National Institute of General Medical Sciences (GM088313), and a Research Scholar Grant (121776) from the American Cancer Society to I.M. C.I.M.C. is a Thomas D. and Virginia W. Cabot Career Development Professor of Biology.	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Arnaud L, 1998, CHROMOSOMA, V107, P424, DOI 10.1007/s004120050326; Barnhart MC, 2011, J CELL BIOL, V194, P229, DOI 10.1083/jcb.201012017; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Black BE, 2010, COLD SH Q B, V75, P403, DOI 10.1101/sqb.2010.75.038; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Cheeseman I. M., 2005, SCI STKE, V266, P1; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dambacher S, 2012, NUCLEUS-PHILA, V3, P101, DOI 10.4161/nucl.18955; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fachinetti D, 2013, NAT CELL BIOL, V15, P1056, DOI 10.1038/ncb2805; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Gascoigne KE, 2013, CHROMOSOME RES, V21, P407, DOI 10.1007/s10577-013-9368-6; Gisselsson D, 2000, P NATL ACAD SCI USA, V97, P5357, DOI 10.1073/pnas.090013497; Gomez-Rodriguez M, 2013, CURR OPIN GENET DEV, V23, P219, DOI 10.1016/j.gde.2012.11.002; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kishi K, 2009, MOL CELL BIOL, V29, P3134, DOI 10.1128/MCB.01663-08; Lagana A, 2010, NAT CELL BIOL, V12, P1186, DOI 10.1038/ncb2129; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; Moree B, 2011, J CELL BIOL, V194, P855, DOI 10.1083/jcb.201106079; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Shiromizu T, 2013, J PROTEOME RES, V12, P2414, DOI 10.1021/pr300825v; Silva MCC, 2012, DEV CELL, V22, P52, DOI 10.1016/j.devcel.2011.10.014; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Wang H, 2013, CELL, V153; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110	37	97	97	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					397	411		10.1016/j.cell.2014.06.016	http://dx.doi.org/10.1016/j.cell.2014.06.016			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036634	Bronze, Green Accepted, Green Submitted			2022-12-01	WOS:000340943600018
J	Rechavi, O; Houri-Ze'evi, L; Anava, S; Goh, WSS; Kerk, SY; Hannon, GJ; Hobert, O				Rechavi, Oded; Houri-Ze'evi, Leah; Anava, Sarit; Goh, Wee Siong Sho; Kerk, Sze Yen; Hannon, Gregory J.; Hobert, Oliver			Starvation-Induced Transgenerational Inheritance of Small RNAs in C. elegans	CELL			English	Article							GERMLINE GENE-EXPRESSION; CAENORHABDITIS-ELEGANS; EPIGENETIC INHERITANCE; NUTRITIONAL CONTROL; PRENATAL EXPOSURE; MEMORY; PIRNAS; AMPLIFICATION; INTERFERENCE; LONGEVITY	Evidence from animal studies and human famines suggests that starvation may affect the health of the progeny of famished individuals. However, it is not clear whether starvation affects only immediate offspring or has lasting effects; it is also unclear how such epigenetic information is inherited. Small RNA-induced gene silencing can persist over several generations via transgenerationally inherited small RNA molecules in C. elegans, but all known transgenerational silencing responses are directed against foreign DNA introduced into the organism. We found that starvation-induced developmental arrest, a natural and drastic environmental change, leads to the generation of small RNAs that are inherited through at least three consecutive generations. These small, endogenous, transgenerationally transmitted RNAs target genes with roles in nutrition. We defined genes that are essential for this multigenerational effect. Moreover, we show that the F3 offspring of starved animals show an increased lifespan, corroborating the notion of a transgenerational memory of past conditions.	[Rechavi, Oded; Houri-Ze'evi, Leah; Anava, Sarit] Tel Aviv Univ, Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Rechavi, Oded; Houri-Ze'evi, Leah; Anava, Sarit] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Rechavi, Oded; Kerk, Sze Yen; Hobert, Oliver] Columbia Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Goh, Wee Siong Sho; Hannon, Gregory J.] Watson Sch Biol Sci, Howard Hughes Med Inst, Cold Spring Harbor Lab, New York, NY 11724 USA	Tel Aviv University; Tel Aviv University; Columbia University; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Rechavi, O (corresponding author), Tel Aviv Univ, Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	odedrechavi@gmail.com	Houri-Zeevi, Leah/AAR-2327-2021; Hannon, Gregory/AAB-3568-2019; Goh, Sho/AAG-6762-2021	Goh, Sho/0000-0003-4355-3927; Kerk, Sze Yen/0000-0003-2358-9674; Hobert, Oliver/0000-0002-7634-2854	Alon fellowship; Bikura fellowship; Yad Hanadiv fellowship; CBRC grant; Teva NNE grant; ISF grant; ERC grant; Howard Hughes Medical Institute; Cancer Research UK [21143] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062534] Funding Source: NIH RePORTER	Alon fellowship; Bikura fellowship; Yad Hanadiv fellowship; CBRC grant; Teva NNE grant(Teva Pharmaceutical Industries); ISF grant; ERC grant; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Yoav Benjamini for help with the statistical methods. We thank Scott Kennedy for providing the hrde-1 strain. We also thank Assaf Gordon, Michal lineal, Shelly Mahlab, and all members of the Rechavi and Hobert lab for their helpful comments. Oded Rechavi, Leah Houri-Ze'evi, and Sarit Anava were supported by funds from the Alon, Bikura, and Yad Hanadiv fellowships, and by the CBRC, Teva NNE, ISF, and ERC grants. This work was supported by the Howard Hughes Medical Institute.	Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Baugh LR, 2013, GENETICS, V194, P539, DOI 10.1534/genetics.113.150847; Billi AC, 2012, PLOS GENET, V8, P84, DOI 10.1371/journal.pgen.1002617; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Burton NO, 2011, P NATL ACAD SCI USA, V108, P19683, DOI 10.1073/pnas.1113310108; Bygren LO, 2001, ACTA BIOTHEOR, V49, P53, DOI 10.1023/A:1010241825519; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Conine CC, 2013, CELL, V155, P1532, DOI 10.1016/j.cell.2013.11.032; DePina Ana S., 2011, BMC Physiology, V11, P11, DOI 10.1186/1472-6793-11-11; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fischer S. E. J., 2014, C ELEGANS RES COMMUN; Fischer SEJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002369; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Grishok A, 2013, ADV GENET, V83, P1, DOI 10.1016/B978-0-12-407675-4.00001-8; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Hall SE, 2013, RNA, V19, P306, DOI 10.1261/rna.036418.112; Han T, 2009, P NATL ACAD SCI USA, V106, P18674, DOI 10.1073/pnas.0906378106; Harvey SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025840; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Hellwig S, 2008, P NATL ACAD SCI USA, V105, P12897, DOI 10.1073/pnas.0805118105; Jablonka E, 2008, GENET MOL BIOL, V31, P389, DOI 10.1590/S1415-47572008000300001; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Kamminga LM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002702; Koonin EV, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-42; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Mansisidor AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002299; Maxwell CS, 2012, GENOME RES, V22, P1920, DOI 10.1101/gr.133587.111; Meloche S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003163; Montgomery TA, 2012, PLOS GENET, V8, P72, DOI 10.1371/journal.pgen.1002616; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Rechavi O, 2014, TRENDS CELL BIOL, V24, P212, DOI 10.1016/j.tcb.2013.10.003; Rechavi O, 2011, CELL, V147, P1248, DOI 10.1016/j.cell.2011.10.042; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Remy JJ, 2010, CURR BIOL, V20, pR877, DOI 10.1016/j.cub.2010.08.013; Remy JJ, 2005, SCIENCE, V309, P787, DOI 10.1126/science.1114209; Seth M, 2013, DEV CELL, V27, P656, DOI 10.1016/j.devcel.2013.11.014; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; SIMPSON VJ, 1986, NUCLEIC ACIDS RES, V14, P6711, DOI 10.1093/nar/14.16.6711; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Song SG, 2009, SOC SCI MED, V68, P1315, DOI 10.1016/j.socscimed.2009.01.027; Stanner SA, 1997, BMJ-BRIT MED J, V315, P1342, DOI 10.1136/bmj.315.7119.1342; Sterken MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089760; Vasale JJ, 2010, P NATL ACAD SCI USA, V107, P3582, DOI 10.1073/pnas.0911908107; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Wedeles CJ, 2013, DEV CELL, V27, P664, DOI 10.1016/j.devcel.2013.11.016; Zhang XC, 2011, P NATL ACAD SCI USA, V108, P17997, DOI 10.1073/pnas.1105982108	53	286	296	3	89	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					277	287		10.1016/j.cell.2014.06.020	http://dx.doi.org/10.1016/j.cell.2014.06.020			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25018105	Green Accepted, Bronze			2022-12-01	WOS:000340943600009
J	Chandel, NS; Tuveson, DA				Chandel, Navdeep S.; Tuveson, David A.			The Promise and Perils of Antioxidants for Cancer Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chandel, Navdeep S.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Tuveson, David A.] Cold Spring Harbor Lab, Lustgarten Fdn Lab, Cold Spring Harbor, NY 11724 USA	Northwestern University; Feinberg School of Medicine; Cold Spring Harbor Laboratory	Chandel, NS (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.							Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107	5	135	141	1	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2014	371	2					177	178		10.1056/NEJMcibr1405701	http://dx.doi.org/10.1056/NEJMcibr1405701			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YZ	25006725				2022-12-01	WOS:000338645500015
J	Lee, CH; Lu, W; Michel, JC; Goehring, A; Du, J; Song, XQ; Gouaux, E				Lee, Chia-Hsueh; Lu, Wei; Michel, Jennifer Carlisle; Goehring, April; Du, Juan; Song, Xianqiang; Gouaux, Eric			NMDA receptor structures reveal subunit arrangement and pore architecture	NATURE			English	Article							AMINO-TERMINAL DOMAIN; SIZE-EXCLUSION CHROMATOGRAPHY; LIGAND-BINDING DOMAIN; HIGH-LEVEL EXPRESSION; D-ASPARTATE RECEPTORS; GLUTAMATE-RECEPTOR; CRYSTAL-STRUCTURE; ALLOSTERIC INHIBITION; MOLECULAR-BASIS; CENTRAL NEURONS	N-methyl-D-aspartate (NMDA) receptors are Hebbian-like coincidence detectors, requiring binding of glycine and glutamate in combination with the relief of voltage-dependent magnesium block to open an ion conductive pore across the membrane bilayer. Despite the importance of the NMDA receptor in the development and function of the brain, a molecular structure of an intact receptor has remained elusive. Here we present X-ray crystal structures of the Xenopus laevis GluN1-GluN2B NMDA receptor with the allosteric inhibitor, Ro25-6981, partial agonists and the ion channel blocker, MK-801. Receptor subunits are arranged in a 1-2-1-2 fashion, demonstrating extensive interactions between the amino-terminal and ligand-binding domains. The transmembrane domains harbour a closed-blocked ion channel, a pyramidal central vestibule lined by residues implicated in binding ion channel blockers and magnesium, and a twofold symmetric arrangement of ion channel pore loops. These structures provide new insights into the architecture, allosteric coupling and ion channel function of NMDA receptors.	[Lee, Chia-Hsueh; Lu, Wei; Michel, Jennifer Carlisle; Goehring, April; Du, Juan; Song, Xianqiang; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Michel, Jennifer Carlisle; Goehring, April; Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Song, Xianqiang/B-9768-2017	Gouaux, Eric/0000-0002-8549-2360; Song, Xianqiang/0000-0002-5637-3119	Oregon Brain Institute Graduate Student Fellowship; NIH; Vollum Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS038631] Funding Source: NIH RePORTER	Oregon Brain Institute Graduate Student Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vollum Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	All members of the Gouaux laboratory are gratefully acknowledged for their support and assistance, especially L. Chen, K. Duerr and K. Wang. We thank L. Vaskalis for assistance with the figures, G. Westbrook and C. Jahr for comments on the manuscript, H. Owen for proofreading and I. Baconguis for making the animation. E. G. acknowledges the generous support of R. LaCroute, B. LaCroute and J. LaCroute. This work was also supported by an Oregon Brain Institute Graduate Student Fellowship (C. H. L.), the NIH (E. G.) and the Vollum Institute (E. G.). E. G. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALLAN RD, 1990, J MED CHEM, V33, P2905, DOI 10.1021/jm00172a036; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2002, PYMOL MOL GRAPHIC SY; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Erreger K, 2007, MOL PHARMACOL, V72, P907, DOI 10.1124/mol.107.037333; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gielen M, 2008, NEURON, V57, P80, DOI 10.1016/j.neuron.2007.11.021; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Gourdon P, 2011, CRYST GROWTH DES, V11, P2098, DOI 10.1021/cg101360d; Hansen KB, 2012, J NEUROSCI, V32, P6197, DOI 10.1523/JNEUROSCI.5757-11.2012; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Hansen MC, 2013, SCIENCE, V342, P850, DOI [10.1126/science.1215904, 10.1126/science.1244693]; HART HE, 1979, MOL IMMUNOL, V16, P265, DOI 10.1016/0161-5890(79)90065-8; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Kashiwagi K, 2002, MOL PHARMACOL, V61, P533, DOI 10.1124/mol.61.3.533; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Kuner T, 2003, TRENDS NEUROSCI, V26, P27, DOI 10.1016/S0166-2236(02)00010-3; Lee CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019180; Mayer ML, 2011, STRUCTURE, V19, P1370, DOI 10.1016/j.str.2011.08.009; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mony L, 2011, EMBO J, V30, P3134, DOI 10.1038/emboj.2011.203; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Peery HE, 2012, AUTOIMMUN REV, V11, P863, DOI 10.1016/j.autrev.2012.03.001; Pohlsgaard J, 2011, NEUROPHARMACOLOGY, V60, P135, DOI 10.1016/j.neuropharm.2010.08.004; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; REICHLING DB, 1991, J PHYSIOL-LONDON, V441, P199, DOI 10.1113/jphysiol.1991.sp018746; Riou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035134; Salussolia CL, 2011, J NEUROSCI, V31, P11295, DOI 10.1523/JNEUROSCI.5612-10.2011; SHERRY AD, 1975, BIOCHEMISTRY-US, V14, P2191, DOI 10.1021/bi00681a023; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Soto David, 2014, Commun Integr Biol, V7, pe27887, DOI 10.4161/cib.27887; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; SUGIHARA H, 1992, BIOCHEM BIOPH RES CO, V185, P826, DOI 10.1016/0006-291X(92)91701-Q; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tovar KR, 2013, J NEUROSCI, V33, P9150, DOI 10.1523/JNEUROSCI.0829-13.2013; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; WATSON GB, 1990, NEUROPHARMACOLOGY, V29, P727, DOI 10.1016/0028-3908(90)90125-B; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; Weston MC, 2006, NAT STRUCT MOL BIOL, V13, P1120, DOI 10.1038/nsmb1178; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004; Zhu SJ, 2013, NAT STRUCT MOL BIOL, V20, P477, DOI 10.1038/nsmb.2522	68	340	349	3	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					191	+		10.1038/nature13548	http://dx.doi.org/10.1038/nature13548			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008524	Green Accepted			2022-12-01	WOS:000338649800037
J	Wiebe, S				Wiebe, Samuel			PERSPECTIVE The surgical solution	NATURE			English	Editorial Material							TEMPORAL-LOBE EPILEPSY; SURGERY; TRIAL		Univ Calgary, Calgary, AB T2N 1N4, Canada	University of Calgary	Wiebe, S (corresponding author), Univ Calgary, Calgary, AB T2N 1N4, Canada.							Engel J, 2003, NEUROLOGY, V60, P538, DOI 10.1212/01.WNL.0000055086.35806.2D; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; Fiest KM, 2014, EPILEPSIA; Jette N, 2012, NEUROLOGY, V79, P1084, DOI 10.1212/WNL.0b013e3182698c4c; Schmidt D, 2009, EPILEPSIA, V50, P1301, DOI 10.1111/j.1528-1167.2008.01997.x; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wiebe S, 2012, NAT REV NEUROL, V8, P669, DOI 10.1038/nrneurol.2012.181	7	4	4	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					S7	S7		10.1038/511S7a	http://dx.doi.org/10.1038/511S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25019126	Bronze			2022-12-01	WOS:000338649800003
J	Dvir, D; Webb, JG; Bleiziffer, S; Pasic, M; Waksman, R; Kodali, S; Barbanti, M; Latib, A; Schaefer, U; Rodes-Cabau, J; Treede, H; Piazza, N; Hildick-Smith, D; Himbert, D; Walther, T; Hengstenberg, C; Nissen, H; Bekeredjian, R; Presbitero, P; Ferrari, E; Segev, A; de Weger, A; Windecker, S; Moat, NE; Napodano, M; Wilbring, M; Cerillo, AG; Brecker, S; Tchetche, D; Lefevre, T; De Marco, F; Fiorina, C; Petronio, AS; Teles, RC; Testa, L; Laborde, JC; Leon, MB; Kornowski, R				Dvir, Danny; Webb, John G.; Bleiziffer, Sabine; Pasic, Miralem; Waksman, Ron; Kodali, Susheel; Barbanti, Marco; Latib, Azeem; Schaefer, Ulrich; Rodes-Cabau, Josep; Treede, Hendrik; Piazza, Nicolo; Hildick-Smith, David; Himbert, Dominique; Walther, Thomas; Hengstenberg, Christian; Nissen, Henrik; Bekeredjian, Raffi; Presbitero, Patrizia; Ferrari, Enrico; Segev, Amit; de Weger, Arend; Windecker, Stephan; Moat, Neil E.; Napodano, Massimo; Wilbring, Manuel; Cerillo, Alfredo G.; Brecker, Stephen; Tchetche, Didier; Lefevre, Thierry; De Marco, Federico; Fiorina, Claudia; Petronio, Anna Sonia; Teles, Rui C.; Testa, Luca; Laborde, Jean-Claude; Leon, Martin B.; Kornowski, Ran		Valve In Valve Int Data Registry	Transcatheter Aortic Valve Implantation in Failed Bioprosthetic Surgical Valves	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROSTHESIS-PATIENT MISMATCH; HIGH-RISK PATIENTS; HEART-VALVES; NATIONAL DATABASE; ELDERLY-PATIENTS; REPLACEMENT; STENOSIS; IMPACT; ENLARGEMENT; SURVIVAL	IMPORTANCE Owing to a considerable shift toward bioprosthesis implantation rather than mechanical valves, it is expected that patients will increasingly present with degenerated bioprostheses in the next few years. Transcatheter aortic valve-in-valve implantation is a less invasive approach for patients with structural valve deterioration; however, a comprehensive evaluation of survival after the procedure has not yet been performed. OBJECTIVE To determine the survival of patients after transcatheter valve-in-valve implantation inside failed surgical bioprosthetic valves. DESIGN, SETTING, AND PARTICIPANTS Correlates for survivalwere evaluated using a multinational valve-in-valve registry that included 459 patients with degenerated bioprosthetic valves undergoing valve-in-valve implantation between 2007 and May 2013 in 55 centers (mean age, 77.6 [SD, 9.8] years; 56% men; median Society of Thoracic Surgeons mortality prediction score, 9.8%[interquartile range, 7.7%-16%]). Surgical valves were classified as small (<= 21 mm; 29.7%), intermediate (> 21 and < 25 mm; 39.3%), and large (<= 25 mm; 31%). Implanted devices included both balloon-and self-expandable valves. MAIN OUTCOMES AND MEASURES Survival, stroke, and New York Heart Association functional class. RESULTS Modes of bioprosthesis failure were stenosis (n = 181 [39.4%]), regurgitation (n = 139 [30.3%]), and combined (n = 139 [30.3%]). The stenosis group had a higher percentage of small valves (37% vs 20.9% and 26.6% in the regurgitation and combined groups, respectively; P =.005). Within 1 month following valve-in-valve implantation, 35 (7.6%) patients died, 8 (1.7%) had major stroke, and 313 (92.6%) of surviving patients had good functional status (New York Heart Association class I/II). The overall 1-year Kaplan-Meier survival rate was 83.2%(95% CI, 80.8%-84.7%; 62 death events; 228 survivors). Patients in the stenosis group had worse 1-year survival (76.6%; 95% CI, 68.9%-83.1%; 34 deaths; 86 survivors) in comparison with the regurgitation group (91.2%; 95% CI, 85.7%-96.7%; 10 deaths; 76 survivors) and the combined group (83.9%; 95% CI, 76.8%-91%; 18 deaths; 66 survivors) (P =.01). Similarly, patients with small valves had worse 1-year survival (74.8%[95% CI, 66.2%-83.4%]; 27 deaths; 57 survivors) vs with intermediate-sized valves (81.8%; 95% CI, 75.3%-88.3%; 26 deaths; 92 survivors) and with large valves (93.3%; 95% CI, 85.7%-96.7%; 7 deaths; 73 survivors) (P =.001). Factors associated with mortality within 1 year included having small surgical bioprosthesis (<= 21 mm; hazard ratio, 2.04; 95% CI, 1.14-3.67; P =.02) and baseline stenosis (vs regurgitation; hazard ratio, 3.07; 95% CI, 1.33-7.08; P =.008). CONCLUSIONS AND RELEVANCE In this registry of patients who underwent transcatheter valve-in-valve implantation for degenerated bioprosthetic aortic valves, overall 1-year survival was 83.2%. Survival was lower among patients with small bioprostheses and those with predominant surgical valve stenosis.	[Dvir, Danny; Webb, John G.; Barbanti, Marco] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Bleiziffer, Sabine] German Heart Ctr, Munich, Germany; [Pasic, Miralem] Deutsch Herzzentrum Berlin, Berlin, Germany; [Waksman, Ron] Washington Hosp Ctr, Washington, DC 20010 USA; [Kodali, Susheel; Leon, Martin B.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA; [Kodali, Susheel; Leon, Martin B.] Cardiovasc Res Fdn, New York, NY USA; [Latib, Azeem] Ist Sci San Raffaele, I-20132 Milan, Italy; [Schaefer, Ulrich] Asklepios Clin St Georg, Hamburg, Germany; [Rodes-Cabau, Josep] Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Treede, Hendrik] Univ Heart Ctr Hamburg, Hamburg, Germany; [Piazza, Nicolo] McGill Univ, Ctr Hlth, Dept Intervent Cardiol, Montreal, PQ, Canada; [Hildick-Smith, David] Sussex Cardiac Ctr, Brighton, E Sussex, England; [Himbert, Dominique] Hosp Bichat, Paris, France; [Walther, Thomas] Kerckhoff Heart Ctr, Bad Nauheim, Germany; [Hengstenberg, Christian] Univ Klinikum Regensburg, Regensburg, Germany; [Nissen, Henrik] Odense Univ Hosp, DK-5000 Odense, Denmark; [Bekeredjian, Raffi] Heidelberg Univ, Heidelberg, Germany; [Presbitero, Patrizia] IRCCS Ist Clin Humanitas, Hemodynam & Invas Cardiol Unit, Milan, Italy; [Ferrari, Enrico] Univ Lausanne Hosp, Lausanne, Switzerland; [Segev, Amit] Sheba Med Ctr, Ramat Gan, Israel; [de Weger, Arend] Leids Univ Med Ctr, Leiden, Netherlands; [Windecker, Stephan] Univ Hosp Bern, CH-3010 Bern, Switzerland; [Moat, Neil E.] Royal Brompton Hosp, London SW3 6LY, England; [Napodano, Massimo] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy; [Wilbring, Manuel] Univ Heart Ctr Dresden, Dresden, Germany; [Cerillo, Alfredo G.] G Pasquinucci Hosp, Massa, Italy; [Brecker, Stephen; Laborde, Jean-Claude] Univ London St Georges Hosp, London, England; [Tchetche, Didier] Clin Pasteur, Toulouse, France; [Lefevre, Thierry] Hop Jacques Cartier, Massy, France; [De Marco, Federico] Osped Niguarda Ca Granda, Milan, Italy; [Fiorina, Claudia] Azienda Osped Spedali Civili Brescia, Brescia, Italy; [Petronio, Anna Sonia] Azienda Osped Univ Pisana, Pisa, Italy; [Teles, Rui C.] Hosp Santa Cruz, Lisbon, Portugal; [Testa, Luca] Clin Inst S Ambrogio, Milan, Italy; [Kornowski, Ran] Rabin Med Ctr, Tel Aviv, Israel; [Kornowski, Ran] Tel Aviv Univ, IL-69978 Tel Aviv, Israel	St. Paul's Hospital; University of Saskatchewan; German Heart Centre Munich; German Heart Center Berlin; MedStar Washington Hospital Center; Columbia University; NewYork-Presbyterian Hospital; Cardiovascular Research Foundation (CRF); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Asklepios Klinik St. Georg; Quebec Heart & Lung Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; McGill University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Kerckhoff Clinic; University of Regensburg; University of Southern Denmark; Odense University Hospital; Ruprecht Karls University Heidelberg; Humanitas University; IRCCS Humanitas Research Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Chaim Sheba Medical Center; University of Bern; University Hospital of Bern; Royal Brompton Hospital; University of Padua; Technische Universitat Dresden; St Georges University London; Jacques Cartier Private Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Hospital Spedali Civili Brescia; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Universidade de Lisboa; Rabin Medical Center; Tel Aviv University	Dvir, D (corresponding author), St Pauls Hosp, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	ddvir@providencehealth.bc.ca	Testa, Luca/J-8226-2018; De Marco, Federico/AAB-4605-2021; Barbanti, Marco/AAP-4373-2020; Hengstenberg, Christian/U-5485-2019; Bleiziffer, Sabine/AAU-2081-2020; Doğan, Ali/AAN-5331-2020; Latib, Azeem/B-4165-2008; Treede, Hendrik/I-3630-2017; Ferrari, Enrico/AAD-2897-2020	De Marco, Federico/0000-0003-3554-6938; Barbanti, Marco/0000-0002-4903-5437; Latib, Azeem/0000-0001-9035-343X; Ferrari, Enrico/0000-0002-2837-3242; SEgev, Amit/0000-0002-2290-0400; Cerillo, Alfredo Giuseppe/0000-0003-3430-2333; testa, luca/0000-0003-4687-3686	Edwards Lifesciences; Medtronic; Boston Scientific; St Jude; Biotronik; Abbott; Cordis	Edwards Lifesciences; Medtronic(Medtronic); Boston Scientific(Boston Scientific); St Jude(St. Jude Medical); Biotronik; Abbott(Abbott Laboratories); Cordis	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Webb reports grants and personal fees from Edwards Lifesciences. Dr Bleiziffer reports serving as proctor for Medtronic and JenaValve. Dr Kodali reports consultancy for Edwards Lifesciences, Claret Medical, and Merril Lifesciences and serving on the scientific advisory board for Thubrikar. Dr Latib reports serving on the scientific advisory board for Medtronic and as a consultant and proctor for Direct Flow Medical Inc. Dr Rodes-Cabau reports consultancy for Edwards Lifesciences and St Jude Medical. Dr Piazza reports receipt of grants and serving as a proctor for Medtronic. Dr Hildick-Smith reports personal fees from Medtronic, Edwards Lifesciences, and Boston Scientific. Dr Himbert reports serving as a consultant and proctor for Edwards Lifesciences and Medtronic. Dr Hengstenberg reports lecture/speakers bureau fees and travel reimbursement from Edwards Lifesciences. Dr Segev reports personal fees from Medtronic and Edwards Lifesciences. Dr Windecker reports receipt of grants from St Jude and Biotronik. Dr Moat reports personal fees from Medtronic. Dr Brecker reports serving as a proctor for Medtronic. Dr Lefevre reports serving as a proctor and receipt of fees for Edwards Lifesciences and travel reimbursement from Directflow and Symetis. Dr Petronio reports serving as a proctor for Medtronic. Dr Teles reports personal fees from Medtronic, Abbott, and Cordis. No other disclosures were reported.	Bedogni F, 2011, JACC-CARDIOVASC INTE, V4, P1228, DOI 10.1016/j.jcin.2011.10.002; Bonow Robert O, 2008, Circulation, V118, pe523, DOI 10.1161/CIRCULATIONAHA.108.190748; Brennan JM, 2013, CIRCULATION, V127, P1647, DOI 10.1161/CIRCULATIONAHA.113.002003; Brown JM, 2009, J THORAC CARDIOV SUR, V137, P82, DOI 10.1016/j.jtcvs.2008.08.015; Castro LJ, 2002, ANN THORAC SURG, V74, P31, DOI 10.1016/S0003-4975(02)03680-9; Connolly HM, 2000, CIRCULATION, V101, P1940, DOI 10.1161/01.CIR.101.16.1940; David TE, 2001, J THORAC CARDIOV SUR, V121, P268, DOI 10.1067/mtc.2001.112208; Dvir D, 2012, CIRCULATION, V126, P2335, DOI 10.1161/CIRCULATIONAHA.112.104505; Eggebrecht H, 2011, JACC-CARDIOVASC INTE, V4, P1218, DOI 10.1016/j.jcin.2011.07.015; Flameng W, 2010, CIRCULATION, V121, P2123, DOI 10.1161/CIRCULATIONAHA.109.901272; Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705; Glower DD, 1998, ANN THORAC SURG, V66, pS44, DOI 10.1016/S0003-4975(98)01114-X; Gurvitch R, 2011, J AM COLL CARDIOL, V58, P2196, DOI 10.1016/j.jacc.2011.09.009; HE GW, 1995, ANN THORAC SURG, V59, P1056, DOI 10.1016/0003-4975(95)00075-V; Head SJ, 2012, EUR HEART J, V33, P1518, DOI 10.1093/eurheartj/ehs003; Khawaja MZ, 2010, J AM COLL CARDIOL, V55, P97, DOI 10.1016/j.jacc.2009.06.060; Kirsch M, 2004, J HEART VALVE DIS, V13, P991; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Leon MB, 2011, J AM COLL CARDIOL, V57, P253, DOI 10.1016/j.jacc.2010.12.005; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Maganti M, 2009, ANN THORAC SURG, V87, P521, DOI 10.1016/j.athoracsur.2008.09.030; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Nishida T, 2013, GEN THORAC CARDIOVAS, V61, P182, DOI 10.1007/s11748-013-0202-z; Peterson MD, 2007, ANN THORAC SURG, V83, P2044, DOI 10.1016/j.athoracsur.2007.01.059; Piazza N, 2011, JACC-CARDIOVASC INTE, V4, P733, DOI 10.1016/j.jcin.2011.05.007; Pibarot P, 2006, HEART, V92, P1022, DOI 10.1136/hrt.2005.067363; Pibarot P, 2009, CIRCULATION, V119, P1034, DOI 10.1161/CIRCULATIONAHA.108.778886; Rosenhek R, 2003, J AM SOC ECHOCARDIOG, V16, P1116, DOI 10.1067/S0894-7317(03)00638-2; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Sommers KE, 1997, ANN THORAC SURG, V63, P1608, DOI 10.1016/S0003-4975(97)00127-6; Tasca G, 2006, CIRCULATION, V113, P570, DOI 10.1161/CIRCULATIONAHA.105.587022; Urso S, 2009, J HEART VALVE DIS, V18, P248; Webb JG, 2013, CIRCULATION, V127, P2542, DOI 10.1161/CIRCULATIONAHA.113.000631; Webb JG, 2010, CIRCULATION, V121, P1848, DOI 10.1161/CIRCULATIONAHA.109.924613; WHEATLEY DJ, 1987, J THORAC CARDIOV SUR, V94, P367	35	615	633	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2014	312	2					162	170		10.1001/jama.2014.7246	http://dx.doi.org/10.1001/jama.2014.7246			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK6BB	25005653	Green Published, Bronze			2022-12-01	WOS:000338511200022
J	Crosby, J; Peloso, GM; Auer, PL; Crosslin, DR; Stitziel, NO; Lange, LA; Lu, YC; Tang, ZZ; Zhang, H; Hindy, G; Masca, N; Stirrups, K; Kanoni, S; Do, R; Jun, G; Hu, YN; Kang, HM; Xue, CY; Goel, A; Farrall, M; Duga, S; Merlini, PA; Asselta, R; Girelli, D; Olivieri, O; Martinelli, N; Yin, W; Reilly, D; Speliotes, E; Fox, CS; Hveem, K; Holmen, OL; Nikpay, M; Farlow, DN; Assimes, TL; Franceschini, N; Robinson, J; North, KE; Martin, LW; DePristo, M; Gupta, N; Escher, SA; Jansson, JH; Van Zuydam, N; Palmer, CNA; Wareham, N; Koch, W; Meitinger, T; Peters, A; Lieb, W; Erbel, R; Konig, IR; Kruppa, J; Degenhardt, F; Gottesman, O; Bottinger, EP; O'Donnell, CJ; Psaty, BM; Ballantyne, CM; Abecasis, G; Ordovas, JM; Melander, O; Watkins, H; Orho-Melander, M; Ardissino, D; Loos, RJF; McPherson, R; Willer, CJ; Erdmann, J; Hall, AS; Samani, NJ; Deloukas, P; Schunkert, H; Wilson, JG; Kooperberg, C; Rich, SS; Tracy, RP; Lin, DY; Altshuler, D; Gabriel, S; Nickerson, DA; Jarvik, GP; Cupples, LA; Reiner, AP; Boerwinkle, E; Kathiresan, S				Crosby, Jacy; Peloso, Gina M.; Auer, Paul L.; Crosslin, David R.; Stitziel, Nathan O.; Lange, Leslie A.; Lu, Yingchang; Tang, Zheng-zheng; Zhang, He; Hindy, George; Masca, Nicholas; Stirrups, Kathleen; Kanoni, Stavroula; Do, Ron; Jun, Goo; Hu, Youna; Kang, Hyun Min; Xue, Chenyi; Goel, Anuj; Farrall, Martin; Duga, Stefano; Merlini, Pier Angelica; Asselta, Rosanna; Girelli, Domenico; Olivieri, Oliviero; Martinelli, Nicola; Yin, Wu; Reilly, Dermot; Speliotes, Elizabeth; Fox, Caroline S.; Hveem, Kristian; Holmen, Oddgeir L.; Nikpay, Majid; Farlow, Deborah N.; Assimes, Themistocles L.; Franceschini, Nora; Robinson, Jennifer; North, Kari E.; Martin, Lisa W.; DePristo, Mark; Gupta, Namrata; Escher, Stefan A.; Jansson, Jan-Hakan; Van Zuydam, Natalie; Palmer, Colin N. A.; Wareham, Nicholas; Koch, Werner; Meitinger, Thomas; Peters, Annette; Lieb, Wolfgang; Erbel, Raimund; Konig, Inke R.; Kruppa, Jochen; Degenhardt, Franziska; Gottesman, Omri; Bottinger, Erwin P.; O'Donnell, Christopher J.; Psaty, Bruce M.; Ballantyne, Christie M.; Abecasis, Goncalo; Ordovas, Jose M.; Melander, Olle; Watkins, Hugh; Orho-Melander, Marju; Ardissino, Diego; Loos, Ruth J. F.; McPherson, Ruth; Willer, Cristen J.; Erdmann, Jeanette; Hall, Alistair S.; Samani, Nilesh J.; Deloukas, Panos; Schunkert, Heribert; Wilson, James G.; Kooperberg, Charles; Rich, Stephen S.; Tracy, Russell P.; Lin, Dan-Yu; Altshuler, David; Gabriel, Stacey; Nickerson, Deborah A.; Jarvik, Gail P.; Cupples, L. Adrienne; Reiner, Alex P.; Boerwinkle, Eric; Kathiresan, Sekar		Exome Sequencing Project; Natl Heart Lung Blood Inst	Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							APOLIPOPROTEIN C-III; CARDIOVASCULAR-DISEASE; PLASMA TRIGLYCERIDES; RICH LIPOPROTEINS; RARE VARIANTS; PCSK9; ASSOCIATIONS; INHIBITION; CAPTURE; DESIGN	Background Plasma triglyceride levels are heritable and are correlated with the risk of coronary heart disease. Sequencing of the protein-coding regions of the human genome (the exome) has the potential to identify rare mutations that have a large effect on phenotype. Methods We sequenced the protein-coding regions of 18,666 genes in each of 3734 participants of European or African ancestry in the Exome Sequencing Project. We conducted tests to determine whether rare mutations in coding sequence, individually or in aggregate within a gene, were associated with plasma triglyceride levels. For mutations associated with triglyceride levels, we subsequently evaluated their association with the risk of coronary heart disease in 110,970 persons. Results An aggregate of rare mutations in the gene encoding apolipoprotein C3 (APOC3) was associated with lower plasma triglyceride levels. Among the four mutations that drove this result, three were loss-of-function mutations: a nonsense mutation (R19X) and two splice-site mutations (IVS2+1G -> A and IVS3+1G -> T). The fourth was a missense mutation (A43T). Approximately 1 in 150 persons in the study was a heterozygous carrier of at least one of these four mutations. Triglyceride levels in the carriers were 39% lower than levels in noncarriers (P<1x10(-20)), and circulating levels of APOC3 in carriers were 46% lower than levels in noncarriers (P = 8x10(-10)). The risk of coronary heart disease among 498 carriers of any rare APOC3 mutation was 40% lower than the risk among 110,472 noncarriers (odds ratio, 0.60; 95% confidence interval, 0.47 to 0.75; P = 4x10(-6)). Conclusions Rare mutations that disrupt APOC3 function were associated with lower levels of plasma triglycerides and APOC3. Carriers of these mutations were found to have a reduced risk of coronary heart disease. (Funded by the National Heart, Lung, and Blood Institute and others.)	[Crosby, Jacy] Univ Texas Houston, Dept Biostat Bioinformat & Syst Biol, Grad Sch Biomed Sci, Houston, TX USA; [Crosby, Jacy; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Ballantyne, Christie M.; Boerwinkle, Eric] Baylor Coll Med, Houston, TX 77030 USA; [Ballantyne, Christie M.] Methodist DeBakey Heart & Vasc Ctr, Houston, TX USA; [Peloso, Gina M.; Do, Ron; Altshuler, David; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Peloso, Gina M.; Do, Ron; Altshuler, David; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Peloso, Gina M.; Do, Ron; Altshuler, David; Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Yin, Wu; Reilly, Dermot] Merck Sharp & Dohme Ltd, Boston, MA USA; [Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Peloso, Gina M.; Do, Ron; Farlow, Deborah N.; DePristo, Mark; Gupta, Namrata; Altshuler, David; Gabriel, Stacey; Kathiresan, Sekar] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Auer, Paul L.] Univ Wisconsin, Sch Publ Hlth, Milwaukee, WI 53201 USA; [Crosslin, David R.; Nickerson, Deborah A.; Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Crosslin, David R.; Jarvik, Gail P.] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Reiner, Alex P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol & Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Kooperberg, Charles; Reiner, Alex P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Dept Med, Cardiovasc Div, St Louis, MO 63130 USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Div Stat Genom, St Louis, MO 63130 USA; [Lange, Leslie A.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Tang, Zheng-zheng; Lin, Dan-Yu] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Franceschini, Nora; North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [North, Kari E.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Lu, Yingchang; Gottesman, Omri; Bottinger, Erwin P.; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY USA; [Zhang, He; Speliotes, Elizabeth; Willer, Cristen J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Zhang, He; Xue, Chenyi; Speliotes, Elizabeth; Willer, Cristen J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Zhang, He; Willer, Cristen J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Jun, Goo; Hu, Youna; Kang, Hyun Min; Abecasis, Goncalo] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Speliotes, Elizabeth] Univ Michigan, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Abecasis, Goncalo] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Hindy, George; Orho-Melander, Marju] Lund Univ, Dept Clin Sci, Clin Res Ctr, Malmo, Sweden; [Escher, Stefan A.] Lund Univ, Dept Clin Sci, Genet & Mol Epidemiol Unit, Malmo, Sweden; [Melander, Olle] Lund Univ, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden; Malmo Univ Hosp, Malmo, Sweden; [Jansson, Jan-Hakan] Skelleftea Hosp, Dept Med, Skelleftea, Sweden; [Jansson, Jan-Hakan] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Masca, Nicholas; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Masca, Nicholas; Samani, Nilesh J.] Natl Inst Hlth Res Leicester, Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Stirrups, Kathleen; Kanoni, Stavroula; Deloukas, Panos] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Goel, Anuj; Farrall, Martin; Watkins, Hugh] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Wellcome Trust Ctr Human Genet, Oxford, England; [Van Zuydam, Natalie; Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland; [Wareham, Nicholas; Cupples, L. Adrienne] Addenbrookes Hosp, Med Res Council Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge, England; [Hall, Alistair S.] Univ Leeds, Sch Med, Div Epidemiol, Leeds LS2 9JT, W Yorkshire, England; [Duga, Stefano; Asselta, Rosanna] Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, Milan, Italy; [Merlini, Pier Angelica] Osped Niguarda Ca Granda, Div Cardiol, Milan, Italy; [Girelli, Domenico; Olivieri, Oliviero; Martinelli, Nicola] Univ Verona, Dept Med, Sch Med, I-37100 Verona, Italy; [Ardissino, Diego] Azienda Osped Univ Parma, Div Cardiol, Parma, Italy; [Fox, Caroline S.; O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Fox, Caroline S.] Ctr Populat Studies, Framingham, MA USA; [Hveem, Kristian; Holmen, Oddgeir L.] Norwegian Univ Sci & Technol, Nord Trondelag Hlth Study HUNT Res Ctr, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Hveem, Kristian] Levanger Hosp, Levanger, Norway; [Holmen, Oddgeir L.] Univ Trondheim Hosp, St Olav Hosp, Trondheim, Norway; [Nikpay, Majid; McPherson, Ruth] Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON, Canada; [Assimes, Themistocles L.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Robinson, Jennifer] Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Ames, IA USA; [Robinson, Jennifer] Univ Iowa, Dept Med, Coll Publ Hlth, Ames, IA USA; [Martin, Lisa W.] Washington Univ, Sch Med & Hlth Sci, Div Cardiol, Washington, DC USA; [Koch, Werner; Schunkert, Heribert] Deutsch Herzzentrum Munich, Munich, Germany; [Koch, Werner] Tech Univ Munich, Klinikum Rechts Isar, Med Klin, D-80290 Munich, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Koch, Werner; Peters, Annette] German Ctr Cardiovasc Res, Munich, Germany; [Peters, Annette] Helmholtz Zentrum Munchen, Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Lieb, Wolfgang] Univ Kiel, Inst Epidemiol & Biobank popgen, Kiel, Germany; [Erbel, Raimund] West German Heart Ctr, Dept Cardiol, Essen, Germany; [Konig, Inke R.; Kruppa, Jochen] Univ Lubeck, Univ Klinikum Schleswig Holstein, Inst Med Biometrie & Stat, Lubeck, Germany; [Erdmann, Jeanette] Univ Lubeck, Univ Klinikum Schleswig Holstein, Inst Integrat & Expt Genom, Lubeck, Germany; [Konig, Inke R.; Kruppa, Jochen] Univ Lubeck, Univ Klinikum Schleswig Holstein, Lubeck, Germany; [Erdmann, Jeanette] DZHK German Res Ctr Cardiovasc Res, Lubeck, Germany; [Degenhardt, Franziska] Univ Bonn, Inst Human Genet, Bonn, Germany; [Ordovas, Jose M.] Natl Ctr Cardiovasc Invest, Dept Cardiovasc Epidemiol & Populat Genet, Madrid, Spain; [Ordovas, Jose M.] Inst Madrileno Estudios Avanzados Alimentac, Madrid, Spain; [Deloukas, Panos] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Gen, Charlottesville, VA USA; [Tracy, Russell P.] Univ Vermont, Dept Pathol, Coll Med, Burlington, VT 05405 USA; [Tracy, Russell P.] Univ Vermont, Dept Biochem, Coll Med, Burlington, VT 05405 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Merck & Company; Tufts University; United States Department of Agriculture (USDA); Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Wisconsin System; University of Wisconsin Milwaukee; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Fred Hutchinson Cancer Center; Washington University (WUSTL); Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Lund University; Lund University; Lund University; Lund University; Skane University Hospital; Umea University; University of Leicester; University of London; Queen Mary University London; University of Oxford; Wellcome Centre for Human Genetics; University of Dundee; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Wellcome Trust Sanger Institute; University of Leeds; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Verona; University of Parma; University Hospital of Parma; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Ottawa; University of Ottawa Heart Institute; Stanford University; University of Iowa; University of Iowa; German Heart Centre Munich; Technical University of Munich; Technical University of Munich; German Centre for Cardiovascular Research; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; German Centre for Cardiovascular Research; University of Bonn; Centro Nacional de Investigaciones Cardiovasculares (CNIC); King Abdulaziz University; University of Mississippi; University of Mississippi Medical Center; University of Virginia; University of Vermont; University of Vermont	Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, 185 Cambridge St,CPZN 5-252, Boston, MA 02114 USA.	skathiresan@partners.org	Assimes, Themistocles Leonard/D-9696-2015; Meitinger, Thomas/O-1318-2015; Jun, Goo/F-1941-2017; Olivieri, Oliviero/A-9126-2008; Stitziel, Nathan/AAL-8413-2021; Lieb, Wolfgang/AAC-7650-2022; Altshuler, David M/A-4476-2009; Auer, Paul/AAC-5060-2019; Erdmann, Jeanette/A-4417-2009; König, Inke R/A-4544-2009; Loos, Ruth J F/Q-2862-2016; Ardissino, Diego/AAC-4041-2022; Peters, Annette/A-6117-2011; Asselta, Rosanna/AAC-2367-2019; Duga, Stefano/F-8173-2014; Girelli, Domenico/B-1183-2008; Hall, Alistair/K-1953-2019; Ballantyne, Christie/A-6599-2008; Hveem, Kristian/AFV-4683-2022; Degenhardt, Franziska/H-4169-2017; Deloukas, Panos/B-2922-2013; Erdmann, Jeanette/P-7513-2014; Kanoni, Stavroula/AAN-7161-2021; , Jennifer/AAD-8336-2019; Martinelli, Nicola/J-5622-2016; Palmer, Colin NA/C-7053-2008; Jarvik, Gail P/N-6476-2014; Loos, Ruth/GON-5877-2022; Study, GoDARTS/K-9448-2016; Ordovas, Jose/B-8727-2013	Assimes, Themistocles Leonard/0000-0003-2349-0009; Jun, Goo/0000-0003-0891-0204; Olivieri, Oliviero/0000-0001-8209-9056; Stitziel, Nathan/0000-0002-4963-8211; Altshuler, David M/0000-0002-7250-4107; König, Inke R/0000-0003-0504-6465; Loos, Ruth J F/0000-0002-8532-5087; Peters, Annette/0000-0001-6645-0985; Asselta, Rosanna/0000-0001-5351-0619; Duga, Stefano/0000-0003-3457-1410; Girelli, Domenico/0000-0001-9684-1899; Deloukas, Panos/0000-0001-9251-070X; Erdmann, Jeanette/0000-0002-4486-6231; Kanoni, Stavroula/0000-0002-1691-9615; Martinelli, Nicola/0000-0001-6465-5119; Palmer, Colin NA/0000-0002-6415-6560; Jarvik, Gail P/0000-0002-6710-8708; Zhang, He/0000-0001-9198-6503; Kruppa, Jochen/0000-0001-8376-8864; Melander, Olle/0000-0002-2581-484X; Goel, Anuj/0000-0003-2307-4021; Ballantyne, Christie/0000-0002-6432-1730; Rich, Stephen/0000-0003-3872-7793; Watkins, Hugh/0000-0002-5287-9016; Meitinger, Thomas/0000-0002-8838-8403; Ordovas, Jose/0000-0002-7581-5680; solinas, emilia/0000-0003-3532-1317; Hall, Alistair/0000-0003-0306-7887; Martin, Lisa Warsinger/0000-0003-4352-0914; Cupples, L. Adrienne/0000-0003-0273-7965; Hindy, George/0000-0002-7257-9299	National Heart, Lung, and Blood Institute; NATIONAL CANCER INSTITUTE [R01CA082659] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006173, ZIAHL006175, R01HL107816, T32HL007208, RC2HL102923, R01HL109946, RC2HL102924, RC2HL102925, ZIAHL006002, RC2HL102926, RC2HL103010, K08HL114642, ZIAHL006094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG049505] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0611-10170] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0009819, NNF14OC0011049, NNF13OC0005339] Funding Source: researchfish	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation)	Funded by the National Heart, Lung, and Blood Institute and others.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; ACCORD Stud Group, 2010, NEW ENGL J MED, V1362, P1748; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bochem AE, 2014, CLIN GENET, V85, P433, DOI 10.1111/cge.12201; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Graham MJ, 2013, CIRC RES, V112, P1479, DOI 10.1161/CIRCRESAHA.111.300367; Huff MW, 2013, CIRC RES, V112, P1405, DOI 10.1161/CIRCRESAHA.113.301464; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kozlitina J, 2011, HEPATOLOGY, V53, P467, DOI 10.1002/hep.24072; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015, 10.1016/j.ajhg.2011.07.015.]; Liu HQ, 2000, J LIPID RES, V41, P1760; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; NAMBOODIRI K K, 1985, Genetic Epidemiology, V2, P227, DOI 10.1002/gepi.1370020302; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Sundaram M, 2010, J LIPID RES, V51, P1524, DOI 10.1194/jlr.M005108; Taylor HA, 2005, ETHNIC DIS, V15, pS4; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; WINDLER E, 1985, J LIPID RES, V26, P556; Zheng CY, 2010, CIRCULATION, V121, P1722, DOI 10.1161/CIRCULATIONAHA.109.875807	40	685	727	1	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2014	371	1					22	31		10.1056/NEJMoa1307095	http://dx.doi.org/10.1056/NEJMoa1307095			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK2RA	24941081	Green Published, Green Accepted			2022-12-01	WOS:000338265700006
J	Ali, M				Ali, Mohsin			Treating tuberculosis as a social disease	LANCET			English	Editorial Material									Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England	University of Cambridge	Ali, M (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England.	ma611@cam.ac.uk						Barnes DS, 2000, MICROBES INFECT, V2, P431, DOI 10.1016/S1286-4579(00)00323-3; Craig GM, 2007, J ADV NURS, V58, P418, DOI 10.1111/j.1365-2648.2007.04257.x; Craig GA, 2008, J ADV NURS, V61, P413, DOI 10.1111/j.1365-2648.2007.04498.x; De Vries G, 2014, EURO SURVEILL, V19; Dubos R, 1952, WHITE PLAGUE TUBERCU; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2014, TUB SURV MON EUR 201; Public Health England, 2014, TB STRAT CONS; van Hest NA, 2014, EURO SURVEILL, V19	8	14	16	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2014	383	9936					2195	2195		10.1016/S0140-6736(14)61063-1	http://dx.doi.org/10.1016/S0140-6736(14)61063-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK8DO	24976317				2022-12-01	WOS:000338657600008
J	Riffell, JA; Shlizerman, E; Sanders, E; Abrell, L; Medina, B; Hinterwirth, AJ; Kutz, JN				Riffell, Jeffrey A.; Shlizerman, Eli; Sanders, Elischa; Abrell, Leif; Medina, Billie; Hinterwirth, Armin J.; Kutz, J. Nathan			Flower discrimination by pollinators in a dynamic chemical environment	SCIENCE			English	Article							PROJECTION NEURONS; MANDUCA-SEXTA; ODOR; RESPONSES; INSECTS	Pollinators use their sense of smell to locate flowers from long distances, but little is known about how they are able to discriminate their target odor from a m lange of other natural and anthropogenic odors. Here, we measured the plume from Datura wrightii flowers, a nectar resource for Manduca sexta moths, and show that the scent was dynamic and rapidly embedded among background odors. The moth's ability to track the odor was dependent on the background and odor frequency. By influencing the balance of excitation and inhibition in the antennal lobe, background odors altered the neuronal representation of the target odor and the ability of the moth to track the plume. These results show that the mix of odors present in the environment influences the pollinator's olfactory ability.	[Riffell, Jeffrey A.; Sanders, Elischa; Medina, Billie; Hinterwirth, Armin J.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Shlizerman, Eli; Kutz, J. Nathan] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Abrell, Leif] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA; [Abrell, Leif] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85721 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Arizona; University of Arizona	Riffell, JA (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	jriffell@u.washington.edu	Lei, Hong/ABH-1356-2020	Abrell, Leif/0000-0003-2490-1180; Shlizerman, Eli/0000-0002-3136-4531	University of Washington	University of Washington(University of Washington)	The authors thank B. Nguyen, W. Chan, K. Jardine, and J. Thornton for their assistance. This work was supported by funds from the University of Washington (J. A. R.). The electrophysiology data reported in this paper are tabulated in the supplementary materials (database S1).	Christensen TA, 1998, J NEUROSCI, V18, P5999; Dorsey Alfred, 2000, TOXICOLOGICAL PROFIL; FIELD RA, 1992, ATMOS ENVIRON A-GEN, V26, P2983, DOI 10.1016/0960-1686(92)90290-2; Girling RD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02779; Heinbockel T, 1999, J COMP NEUROL, V409, P1; HELMIG D, 1992, SCI TOTAL ENVIRON, V112, P233, DOI 10.1016/0048-9697(92)90190-4; Herrmann A., 2010, CHEM BIOL VOLATILES, DOI 10.1002/9780470669532; Jardine K, 2010, ATMOS CHEM PHYS, V10, P12191, DOI 10.5194/acp-10-12191-2010; Leonard AS, 2011, J EXP BIOL, V214, P113, DOI 10.1242/jeb.047407; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Raguso RA, 2003, INT J PLANT SCI, V164, P877, DOI 10.1086/378539; Riffell JA, 2008, J CHEM ECOL, V34, P837, DOI 10.1007/s10886-008-9490-7; Riffell JA, 2008, P NATL ACAD SCI USA, V105, P3404, DOI 10.1073/pnas.0709811105; Riffell JA, 2013, SCIENCE, V339, P200, DOI 10.1126/science.1225483; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Schroeder R, 2008, BIOSCIENCE, V58, P308, DOI 10.1641/B580406; Shlizerman E., FRONT COMPU IN PRESS; STOCKHOUSE RE, 1976, AM MIDL NAT, V96, P241; THIERY D, 1986, ENTOMOL EXP APPL, V41, P165, DOI 10.1007/BF00195573; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Zimmer RK, 2008, J CHEM ECOL, V34, P822, DOI 10.1007/s10886-008-9486-3	22	128	134	6	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1515	1518		10.1126/science.1251041	http://dx.doi.org/10.1126/science.1251041			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970087				2022-12-01	WOS:000337889900050
J	Hoag, H				Hoag, Hannah			DRUG DELIVERY Brain food	NATURE			English	Editorial Material							NEUROGENESIS; GENERATION											Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Caicco MJ, 2013, J CONTROL RELEASE, V166, P197, DOI 10.1016/j.jconrel.2013.01.002; Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402; Nakaguchi K, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/915160; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Wang Y, 2013, CURR TOP NUTRACEUT R, V11, P1	8	3	3	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S6	S7		10.1038/510S6a	http://dx.doi.org/10.1038/510S6a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24964026	Bronze			2022-12-01	WOS:000337806300005
J	Shah, M				Shah, Maitri			Elephantiasis Nostras Verrucosa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Conemaugh Hlth Syst, Johnstown, PA 15905 USA		Shah, M (corresponding author), Conemaugh Hlth Syst, Johnstown, PA 15905 USA.	maitri86@gmail.com							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					2520	2520		10.1056/NEJMicm1310890	http://dx.doi.org/10.1056/NEJMicm1310890			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KY	24963571				2022-12-01	WOS:000337804400010
J	Rees, J; Bultitude, M; Challacombe, B				Rees, Jonathan; Bultitude, Matthew; Challacombe, Ben			The management of lower urinary tract symptoms in men	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BENIGN PROSTATIC HYPERPLASIA; SEXUAL DYSFUNCTION; METAANALYSIS; COMBINATION; FINASTERIDE; NOCTURIA; DISEASE; PATHOPHYSIOLOGY; EPIDEMIOLOGY; MONOTHERAPY		[Rees, Jonathan] Backwell & Nailsea Med Grp, North Somerset BS48 1BZ, England; [Bultitude, Matthew; Challacombe, Ben] Guys & St Thomas NHS Fdn Trust, Urol Ctr, London, England	Guy's & St Thomas' NHS Foundation Trust	Rees, J (corresponding author), Backwell & Nailsea Med Grp, North Somerset BS48 1BZ, England.	drjonrees@gmail.com	challacombe, Benjamin James/AAM-9505-2020	Challacombe, Benjamin/0000-0001-8631-0314	GSK; Lilly; Pfizer; Astellas	GSK(GlaxoSmithKline); Lilly(Eli Lilly); Pfizer(Pfizer); Astellas(Astellas Pharmaceuticals)	We have read and understood the BMJ Group policy on declaration of interests and declare the following interests: JR has received fees for advisory boards and speaker fees from GSK, Lilly, Pfizer, and Astellas. MB has no interests to declare. BC has received speaker fees from GSK and Astellas.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Ahyai SA, 2010, EUR UROL, V58, P384, DOI 10.1016/j.eururo.2010.06.005; [Anonymous], 2013, NICE TECHN APPR 290; Athanasopoulos A, 2011, EUR UROL, V60, P94, DOI 10.1016/j.eururo.2011.03.054; Blake-James BT, 2007, BJU INT, V99, P85, DOI 10.1111/j.1464-410X.2006.06574.x; Bosch JLHR, 2010, J UROLOGY, V184, P440, DOI 10.1016/j.juro.2010.04.011; Boyle P, 1996, UROLOGY, V48, P398, DOI 10.1016/S0090-4295(96)00353-6; Cornu JN, 2012, EUR UROL, V62, P877, DOI 10.1016/j.eururo.2012.07.004; Emberton M, 2003, UROLOGY, V61, P267, DOI 10.1016/S0090-4295(02)02371-3; Fullhase C, 2013, EUR UROL, V64, P228, DOI 10.1016/j.eururo.2013.01.018; Gacci M, 2012, EUR UROL, V61, P994, DOI 10.1016/j.eururo.2012.02.033; Gulur DM, 2011, BJU INT, V107, P702, DOI 10.1111/j.1464-410X.2010.09763.x; Hall SA, 2012, BJU INT, V109, P1676, DOI 10.1111/j.1464-410X.2011.10593.x; Hammarsten J, 2011, NAT REV UROL, V8, P483, DOI 10.1038/nrurol.2011.112; Hutchison A, 2006, EUR UROL, V50, P555, DOI 10.1016/j.eururo.2006.05.001; Irwin DE, 2009, EUR UROL, V56, P14, DOI 10.1016/j.eururo.2009.02.026; Kaplan SA, 2011, INT J CLIN PRACT, V65, P487, DOI 10.1111/j.1742-1241.2010.02611.x; Kashyap M, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-57; Lourenco Tania, 2008, BMJ, V337, pa449, DOI 10.1136/bmj.39575.517674.BE; MacDonald R, 2012, BJU INT, V109, P1756, DOI 10.1111/j.1464-410X.2012.11172.x; Matsumoto S, 2013, BJU INT, V111, P647, DOI 10.1111/j.1464-410X.2012.11591.x; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; McVary K, 2006, BJU INT, V97, P23, DOI 10.1111/j.1464-410X.2006.06102.x; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; National Institute for Health and Clinical Excellence, MAN LOW UR TRACT SYM; Nickel JC, 2011, BJU INT, V108, P388, DOI 10.1111/j.1464-410X.2011.10195.x; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Oelke M, 2012, EUR UROL, V61, P917, DOI 10.1016/j.eururo.2012.01.013; Omar MI, 2014, BJU INT, V113, P24, DOI 10.1111/bju.12281; Parsons JK, 2009, BJU INT, V104, P63, DOI 10.1111/j.1464-410X.2008.08317.x; Paterson J, 1997, BRIT J UROL, V79, P892, DOI 10.1046/j.1464-410X.1997.00180.x; Roehrborn CG, 2010, EUR UROL, V57, P123, DOI 10.1016/j.eururo.2009.09.035; Rosen R, 2003, EUR UROL, V44, P637, DOI 10.1016/j.eururo.2003.08.015; Speakman MJ, 2004, BJU INT, V93, P985, DOI 10.1111/j.1464-410X.2004.04765.x; T Brown C, 2007, BRIT MED J, V334, P25, DOI 10.1136/bmj.39010.551319.AE; Tacklind J, 2010, COCHRANE DB SYST REV, V10; Treagust J, 2001, J PUBLIC HEALTH MED, V23, P141, DOI 10.1093/pubmed/23.2.141; Weiss JP, 2011, BJU INT, V108, P6, DOI 10.1111/j.1464-410X.2011.10175.x; Wilt TJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f325	39	11	11	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2014	348								g3861	10.1136/bmj.g3861	http://dx.doi.org/10.1136/bmj.g3861			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK1UG	24963071				2022-12-01	WOS:000338201800004
J	Patel, AP; Tirosh, I; Trombetta, JJ; Shalek, AK; Gillespie, SM; Wakimoto, H; Cahill, DP; Nahed, BV; Curry, WT; Martuza, RL; Louis, DN; Rozenblatt-Rosen, O; Suva, ML; Regev, A; Bernstein, BE				Patel, Anoop P.; Tirosh, Itay; Trombetta, John J.; Shalek, Alex K.; Gillespie, Shawn M.; Wakimoto, Hiroaki; Cahill, Daniel P.; Nahed, Brian V.; Curry, William T.; Martuza, Robert L.; Louis, David N.; Rozenblatt-Rosen, Orit; Suva, Mario L.; Regev, Aviv; Bernstein, Bradley E.			Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma	SCIENCE			English	Article							STEM-LIKE CELLS; INTEGRATED GENOMIC ANALYSIS; TUMOR HETEROGENEITY; GROWTH; EXPRESSION; EVOLUTION; RECEPTOR; GENOTYPE; REVEALS; CANCER	Human cancers are complex ecosystems composed of cells with distinct phenotypes, genotypes, and epigenetic states, but current models do not adequately reflect tumor composition in patients. We used single-cell RNA sequencing (RNA-seq) to profile 430 cells from five primary glioblastomas, which we found to be inherently variable in their expression of diverse transcriptional programs related to oncogenic signaling, proliferation, complement/immune response, and hypoxia. We also observed a continuum of stemness-related expression states that enabled us to identify putative regulators of stemness in vivo. Finally, we show that established glioblastoma subtype classifiers are variably expressed across individual cells within a tumor and demonstrate the potential prognostic implications of such intratumoral heterogeneity. Thus, we reveal previously unappreciated heterogeneity in diverse regulatory programs central to glioblastoma biology, prognosis, and therapy.	[Patel, Anoop P.; Wakimoto, Hiroaki; Cahill, Daniel P.; Nahed, Brian V.; Curry, William T.; Martuza, Robert L.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Patel, Anoop P.; Gillespie, Shawn M.; Wakimoto, Hiroaki; Cahill, Daniel P.; Nahed, Brian V.; Curry, William T.; Martuza, Robert L.; Louis, David N.; Suva, Mario L.; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Patel, Anoop P.; Gillespie, Shawn M.; Louis, David N.; Suva, Mario L.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Patel, Anoop P.; Tirosh, Itay; Trombetta, John J.; Shalek, Alex K.; Gillespie, Shawn M.; Rozenblatt-Rosen, Orit; Suva, Mario L.; Regev, Aviv; Bernstein, Bradley E.] Broad Inst Harvard & Massachusetts Inst Techonol, Cambridge, MA 02142 USA; [Patel, Anoop P.; Gillespie, Shawn M.; Regev, Aviv; Bernstein, Bradley E.] Howard Hughes Med Inst Chevy Chase, Chevy Chase, MD 20815 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Suva, ML (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.	suva.mario@mgh.harvard.edu; aregev@broadinstitute.org; bernstein.bradley@mgh.harvard.edu	Wakimoto, Hiroaki/H-4533-2019; wang, edwin/G-5372-2010; Rozenblatt-Rosen, Orit/HDN-4182-2022; Shalek, Alex/Y-2434-2019; Suva, Mario/AAY-7798-2020; Nahed, Brian/E-4239-2014	Wakimoto, Hiroaki/0000-0001-8225-241X; Shalek, Alex/0000-0001-5670-8778; Suva, Mario/0000-0001-9898-5351; Cahill, Daniel/0000-0003-2552-6546; Gillespie, Shawn/0000-0003-1913-0860; Nahed, Brian/0000-0001-8537-106X	NIH- National Institute of Neurological Disorders and Stroke [R25NS065743]; Human Frontier Science Program fellowship; Rothschild fellowship; Medic Foundation; Howard Hughes Medical Institute; Burroughs Wellcome Fund; Harvard Stem Cell Institute; NIH [R01 NS032677, U24 CA180922]; National Brain Tumor Society; Klarman Family Foundation; NATIONAL CANCER INSTITUTE [U24CA180922, P50CA165962] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R25NS065743, R01NS032677] Funding Source: NIH RePORTER	NIH- National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Human Frontier Science Program fellowship(Human Frontier Science Program); Rothschild fellowship; Medic Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Brain Tumor Society; Klarman Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Shefler for project management, E. Rheinbay for graphical contributions, J. Kim and P. Santos for histology, and P. Bautista and Y. Yagi for slide scanning. A. P. P was supported by NIH- National Institute of Neurological Disorders and Stroke R25NS065743. I. T. was supported by a Human Frontier Science Program fellowship and a Rothschild fellowship. M. L. S was supported by a grant from Medic Foundation. This research was supported by funds from Howard Hughes Medical Institute, Burroughs Wellcome Fund, Harvard Stem Cell Institute, NIH (R01 NS032677 to R. L. M. and U24 CA180922 to A. R.), National Brain Tumor Society, and Klarman Family Foundation. A. R. is a scientific advisory board member for Syros Pharmaceuticals and a consultant for Cancer Therapeutics Innovation Group. B. E. B. is a scientific advisory board member for Syros Pharmaceuticals and a founder and scientific advisor for HiFiBio SAS. RNA-seq data are deposited in Gene Expression Omnibus with accession no. GSE57872.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cho MS, 2014, CELL REP, V6, P1085, DOI 10.1016/j.celrep.2014.02.014; Choi BD, 2013, P NATL ACAD SCI USA, V110, P270, DOI 10.1073/pnas.1219817110; Cloughesy TF, 2014, ANNU REV PATHOL-MECH, V9, P1, DOI 10.1146/annurev-pathol-011110-130324; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Martynoga B, 2013, GENE DEV, V27, P1769, DOI 10.1101/gad.216804.113; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Nathanson DA, 2014, SCIENCE, V343, P72, DOI 10.1126/science.1241328; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shostak KO, 2003, J SURG ONCOL, V82, P57, DOI 10.1002/jso.10180; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wakimoto H, 2012, NEURO-ONCOLOGY, V14, P132, DOI 10.1093/neuonc/nor195; Wang H, 2011, NEOPLASIA, V13, P461, DOI 10.1593/neo.101744; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Xu J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04223; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	42	2325	2410	31	486	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1396	1401		10.1126/science.1254257	http://dx.doi.org/10.1126/science.1254257			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24925914	Green Accepted, Green Submitted			2022-12-01	WOS:000337531700040
J	Marion, E; Song, OR; Christophe, T; Babonneau, J; Fenistein, D; Eyer, J; Letournel, F; Henrion, D; Clere, N; Paille, V; Guerineau, NC; Saint Andre, JP; Gersbach, P; Altmann, KH; Stinear, TP; Comoglio, Y; Sandoz, G; Preisser, L; Delneste, Y; Yeramian, E; Marsollier, L; Brodin, P				Marion, Estelle; Song, Ok-Ryul; Christophe, Thierry; Babonneau, Jeremie; Fenistein, Denis; Eyer, Joel; Letournel, Frank; Henrion, Daniel; Clere, Nicolas; Paille, Vincent; Guerineau, Nathalie C.; Saint Andre, Jean-Paul; Gersbach, Philipp; Altmann, Karl-Heinz; Stinear, Timothy Paul; Comoglio, Yannick; Sandoz, Guillaume; Preisser, Laurence; Delneste, Yves; Yeramian, Edouard; Marsollier, Laurent; Brodin, Priscille			Mycobacterial Toxin Induces Analgesia in Buruli Ulcer by Targeting the Angiotensin Pathways	CELL			English	Article							MYCOLACTONE; MODULATION; INFECTION; PAINLESSNESS; INHIBITION; ANTAGONIST; ACTIVATION; DIAGNOSIS; EFFICACY; CANCER	Mycobacterium ulcerans, the etiological agent of Buruli ulcer, causes extensive skin lesions, which despite their severity are not accompanied by pain. It was previously thought that this remarkable analgesia is ensured by direct nerve cell destruction. We demonstrate here that M. ulcerans-induced hypoesthesia is instead achieved through a specific neurological pathway triggered by the secreted mycobacterial polyketide mycolactone. We decipher this pathway at the molecular level, showing that mycolactone elicits signaling through type 2 angiotensin II receptors (AT(2)Rs), leading to potassium-dependent hyperpolarization of neurons. We further validate the physiological relevance of this mechanism with in vivo studies of pain sensitivity in mice infected with M. ulcerans, following the disruption of the identified pathway. Our findings shed new light on molecular mechanisms evolved by natural systems for the induction of very effective analgesia, opening up the prospect of new families of analgesics derived from such systems.	[Marion, Estelle; Song, Ok-Ryul; Marsollier, Laurent] Inserm Avenir, F-49933 Angers, France; [Marion, Estelle; Song, Ok-Ryul; Christophe, Thierry; Babonneau, Jeremie; Fenistein, Denis; Marsollier, Laurent; Brodin, Priscille] Inserm Avenir, Inst Pasteur Korea, Songnam 463400, Gyeonggi Do, South Korea; [Song, Ok-Ryul; Brodin, Priscille] Univ Lille Nord France, Inst Pasteur Lille, Ctr Infect & Immun, Inserm U1019,CNRS UMR8204, F-59000 Lille, France; [Eyer, Joel; Letournel, Frank] UPRES, EA 3143, Lab Neurobiol & Transgenese, F-49933 Angers, France; [Fenistein, Denis; Paille, Vincent; Guerineau, Nathalie C.] Inserm 1083, CNRS, UMR 6214, Lab Biol Neurovasc & Mitochondriale Integree, F-49933 Angers, France; [Clere, Nicolas] Inserm U1063, F-49933 Angers, France; [Saint Andre, Jean-Paul] Lab Anatomie Pathol, F-49933 Angers, France; [Gersbach, Philipp; Altmann, Karl-Heinz] ETH, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland; [Stinear, Timothy Paul] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Comoglio, Yannick; Sandoz, Guillaume] Univ Nice Sophia Antipolis, Inst Biol Valrose,Inserm Avenir, Labs Excellence Lon Channel Sci & Therapeut Nice, Inserm U1091,CNRS UMR 7277, F-06108 Nice, France; [Preisser, Laurence; Delneste, Yves; Marsollier, Laurent] Univ & CHU, CRCNA, CNRS U6299, Equipe 7,Inserm U892, F-49933 Angers, France; [Yeramian, Edouard] CNRS, Inst Pasteur, UMR 3528, Unite Bioinformat Struct, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Pasteur Korea; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Melbourne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Marsollier, L (corresponding author), Inserm Avenir, 4 Rue Larrey, F-49933 Angers, France.	laurent.marsollier@inserm.fr; priscille.brodin@inserm.fr	Letournel, Franck/K-4263-2015; Eyer, Joel/V-8679-2019; Henrion, Daniel/N-7023-2015; DELNESTE, Yves/K-7367-2015; preisser, laurence/K-7583-2015; Marsollier, Laurent/P-6178-2015; Brodin, Priscille/E-5802-2014; Eyer, Joel/K-4265-2015; Brodin, Priscille/N-6979-2019; Henrion, Daniel/AAK-1995-2021; Marion, Estelle/G-3437-2016; Henrion, Daniel/J-8141-2015; Clere, Nicolas/K-4414-2015; Delneste, Yves/O-3956-2016; sandoz, guillaume/AAI-9236-2020	Eyer, Joel/0000-0001-6301-7465; Henrion, Daniel/0000-0003-1094-0285; DELNESTE, Yves/0000-0002-2142-596X; Brodin, Priscille/0000-0003-0991-7344; Eyer, Joel/0000-0001-6301-7465; Brodin, Priscille/0000-0003-0991-7344; Henrion, Daniel/0000-0003-1094-0285; Marion, Estelle/0000-0003-4917-9665; Henrion, Daniel/0000-0003-1094-0285; sandoz, guillaume/0000-0003-1251-0852; Guerineau, Nathalie/0000-0003-2517-4210; deboosere, Nathalie/0000-0002-2873-5485; Stinear, Timothy/0000-0003-0150-123X; letournel, franck/0000-0003-2925-4453; Clere, Nicolas/0000-0002-6008-597X; Laurent, Marsollier/0000-0001-5497-5995; Paille, Vincent/0000-0003-0424-0821	Korea Research Foundation [K20802001409-09B1300-03700]; INSERM-Avenir; ANRS; Projet Tranversal de Recherche de l'Institut Pasteur [PTR212]; STAR Project; Raoul Follereau Foundation; European Community (ERC-STG) [260901]; European Community (MM4TB) [260872]; Agence Nationale de Recherche; Feder (Equipex Imaginex BioMed) [12001407 (D-AL)]; Region Nord Pas de Calais [1200080]; Region Pays de la Loire (ARMINA project)	Korea Research Foundation(National Research Foundation of Korea); INSERM-Avenir(Institut National de la Sante et de la Recherche Medicale (Inserm)); ANRS(ANRSFrench National Research Agency (ANR)); Projet Tranversal de Recherche de l'Institut Pasteur; STAR Project; Raoul Follereau Foundation; European Community (ERC-STG); European Community (MM4TB); Agence Nationale de Recherche(French National Research Agency (ANR)); Feder (Equipex Imaginex BioMed); Region Nord Pas de Calais(Region Hauts-de-France); Region Pays de la Loire (ARMINA project)(Region Pays de la Loire)	We gratefully acknowledge Natacha Denisenko, Viviane Cassisa, Camille Dantec, Rimi Oh, Jean-Philippe Carralot, Antoine Caillon, and Pierre Legras for their technical assistance; Gerd Pluschke and Nicole Scherr for generous gift of the synthetic mycolactone; Gaspard Deloison, Elizabeth Werkmeister, Antonino Bongiovanni, and Frank Lafont from the Biolmaging Center of Lille for technical assistance; Guillaume Mabilleau from the SCIAM platform for electron microscopy; Francois Trottein for advices on prostaglandins; and Olivier Neyrolles for his critical reading of the manuscript. Lutz Hein generated and generously offered the AT<INF>2</INF>R KO mice for the experiments. Financial support for this work was provided by the Korea Research Foundation (Grant K20802001409-09B1300-03700), INSERM-Avenir, ANRS, Projet Tranversal de Recherche de l'Institut Pasteur (PTR212), the STAR Project, the Raoul Follereau Foundation, the European Community (ERC-STG Grant n degrees 260901, MM4TB Grant n degrees 260872), the Agence Nationale de Recherche, the Feder (12001407 (D-AL) Equipex Imaginex BioMed), the Region Nord Pas de Calais (1200080), and the Region Pays de la Loire (ARMINA project).	Anand U, 2013, EUR J PAIN, V17, P1012, DOI 10.1002/j.1532-2149.2012.00269.x; Asiedu K, 2000, BURULI ULCER MYCOBAC; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bedecs K, 1997, BIOCHEM J, V325, P449, DOI 10.1042/bj3250449; Besson JM, 1999, LANCET, V353, P1610, DOI 10.1016/S0140-6736(99)01313-6; Carralot JP, 2009, J BIOMOL SCREEN, V14, P151, DOI 10.1177/1087057108328762; Clere N, 2010, INT J CANCER, V127, P2279, DOI 10.1002/ijc.25234; Coutanceau E, 2005, CELL MICROBIOL, V7, P1187, DOI 10.1111/j.1462-5822.2005.00546.x; DallAsta V, 1997, EXP CELL RES, V231, P260, DOI 10.1006/excr.1996.3469; En J, 2008, INFECT IMMUN, V76, P2002, DOI 10.1128/IAI.01588-07; Fenistein D, 2008, CYTOM PART A, V73A, P958, DOI 10.1002/cyto.a.20627; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; Gersbach P, 2011, CHEM-EUR J, V17, P13017, DOI 10.1002/chem.201101799; Goto M, 2006, AM J PATHOL, V168, P805, DOI 10.2353/ajpath.2006.050375; Griffin JW, 2008, GLIA, V56, P1518, DOI 10.1002/glia.20778; Guenin-Mace L, 2013, J CLIN INVEST, V123, P1501, DOI 10.1172/JCI66576; Guenin-Mace L, 2011, P NATL ACAD SCI USA, V108, P12833, DOI 10.1073/pnas.1016496108; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; Hoeijmakers JG, 2012, NAT REV NEUROL, V8, P369, DOI 10.1038/nrneurol.2012.97; Johnson PDR, 2005, PLOS MED, V2, P282, DOI 10.1371/journal.pmed.0020108; KANG J, 1994, AM J PHYSIOL-CELL PH, V267, pC1389, DOI 10.1152/ajpcell.1994.267.5.C1389; Lauritzen I, 2000, EMBO J, V19, P1784, DOI 10.1093/emboj/19.8.1784; Marsollier L, 2005, CELL MICROBIOL, V7, P935, DOI 10.1111/j.1462-5822.2005.00521.x; Marsollier L, 2007, PLOS PATHOG, V3, P582, DOI 10.1371/journal.ppat.0030062; Muralidharan A, 2014, PAIN MED, V15, P93, DOI 10.1111/pme.12258; Noel J, 2011, CHANNELS, V5, P400, DOI 10.4161/chan.5.5.16469; Nouet S, 2000, TRENDS ENDOCRIN MET, V11, P1, DOI 10.1016/S1043-2760(99)00205-2; Pelegrini-Da-Silva A, 2005, NEUROSCIENCE, V132, P453, DOI 10.1016/j.neuroscience.2004.12.046; Rice ASC, 2014, LANCET, V383, P1637, DOI 10.1016/S0140-6736(13)62337-5; Sandoz G, 2012, NEURON, V74, P1005, DOI 10.1016/j.neuron.2012.04.026; Sarfo FS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002101; Scherr N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002143; Simmonds RE, 2009, J IMMUNOL, V182, P2194, DOI 10.4049/jimmunol.0802294; Sizaire V, 2006, LANCET INFECT DIS, V6, P288, DOI 10.1016/S1473-3099(06)70464-9; Smith MT, 2013, PAIN MED, V14, P692, DOI 10.1111/pme.12063; Sumners C, 1998, CELL SIGNAL, V10, P303, DOI 10.1016/S0898-6568(97)00133-2; Szelenyi I, 2013, INFLAMM RES, V62, P251, DOI 10.1007/s00011-013-0592-5; Tobias NJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000553; Torrado E, 2010, J IMMUNOL, V184, P947, DOI 10.4049/jimmunol.0902717; Wansbrough-Jones M, 2006, LANCET, V367, P1849, DOI 10.1016/S0140-6736(06)68807-7; Williams FMK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003095	42	116	119	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1565	1576		10.1016/j.cell.2014.04.040	http://dx.doi.org/10.1016/j.cell.2014.04.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949969	Bronze			2022-12-01	WOS:000340941900012
J	Marquardt, S; Escalante-Chong, R; Pho, N; Wang, J; Churchman, LS; Springer, M; Buratowski, S				Marquardt, Sebastian; Escalante-Chong, Renan; Pho, Nam; Wang, Jue; Churchman, L. Stirling; Springer, Michael; Buratowski, Stephen			A Chromatin-Based Mechanism for Limiting Divergent Noncoding Transcription	CELL			English	Article							HISTONE H3; BIDIRECTIONAL PROMOTERS; SET2 METHYLATION; RNA; ACETYLATION; LYSINE-56; TERMINATION; CHAPERONE; UPSTREAM; EXCHANGE	In addition to their annotated transcript, many eukaryotic mRNA promoters produce divergent noncoding transcripts. To define determinants of divergent promoter directionality, we used genomic replacement experiments. Sequences within noncoding transcripts specified their degradation pathways, and functional protein-coding transcripts could be produced in the divergent direction. To screen for mutants affecting the ratio of transcription in each direction, a bidirectional fluorescent protein reporter construct was introduced into the yeast nonessential gene deletion collection. We identified chromatin assembly as an important regulator of divergent transcription. Mutations in the CAF-I complex caused genome-wide derepression of nascent divergent noncoding transcription. In opposition to the CAF-I chromatin assembly pathway, H3K56 hyperacetylation, together with the nucleosome remodeler SWI/SNF, facilitated divergent transcription by promoting rapid nucleosome turnover. We propose that these chromatin-mediated effects control divergent transcription initiation, complementing downstream pathways linked to early termination and degradation of the noncoding RNAs.	[Marquardt, Sebastian; Buratowski, Stephen] Harvard Med Sch, Dept Biol Chem & Mol Physiol, Boston, MA 02115 USA; [Escalante-Chong, Renan; Wang, Jue; Springer, Michael] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Pho, Nam] Harvard Med Sch, Res Comp Grp, Boston, MA 02115 USA; [Churchman, L. Stirling] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Buratowski, S (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Physiol, 240 Longwood Ave, Boston, MA 02115 USA.	steveb@hms.harvard.edu	Marquardt, Sebastian/C-2902-2015; Marquardt, Sebastian/AAU-8009-2021	Marquardt, Sebastian/0000-0003-1709-2717; Marquardt, Sebastian/0000-0003-1709-2717; /0000-0001-6913-4910	Feodor-Lynen Fellowship of the Alexander von Humboldt Foundation; Burroughs Wellcome Fund; Damon Runyon Cancer Research Foundation; NIH [HG007173NIH, GM46498, GM56663]; Harvard Medical School [NCRR 1S10RR028832-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028832] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056663, R01GM046498, R29GM046498] Funding Source: NIH RePORTER	Feodor-Lynen Fellowship of the Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Medical School; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Ollie Rando for strains, Magdelana Murawska for help with NET-seq, Jody Moore for help with flow cytometry, Hannah Mischo for reagents, and members of S.B. and M.S. labs for discussion. This work was supported by a Feodor-Lynen Fellowship of the Alexander von Humboldt Foundation to S.M., grants from the Burroughs Wellcome Fund, the Damon Runyon Cancer Research Foundation, and NIH HG007173NIH to S.C., and NIH grants GM46498 and GM56663 to S.B. Support for the high-performance computer cluster at Harvard Medical School provided through grant NCRR 1S10RR028832-01.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Bregman A, 2011, CELL, V147, P1473, DOI 10.1016/j.cell.2011.12.005; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Churchman L Stirling, 2012, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0414s98; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Fillingham J, 2009, MOL CELL, V35, P340, DOI 10.1016/j.molcel.2009.06.023; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; Imbeault D, 2008, J BIOL CHEM, V283, P27350, DOI 10.1074/jbc.C800147200; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Marquardt S, 2011, TRANSCR-AUSTIN, V2, P145, DOI 10.4161/trns.2.3.16298; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Mischo HE, 2013, BBA-GENE REGUL MECH, V1829, P174, DOI 10.1016/j.bbagrm.2012.10.003; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Preker P, 2009, CELL CYCLE, V8, P1106; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Schulz D, 2013, CELL, V155, P1075, DOI 10.1016/j.cell.2013.10.024; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Smolle M, 2012, NAT STRUCT MOL BIOL, V19, P884, DOI 10.1038/nsmb.2312; Steinmetz EJ, 2003, MOL CELL BIOL, V23, P6339, DOI 10.1128/MCB.23.18.6339-6349.2003; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Watanabe S, 2013, SCIENCE, V340, P195, DOI 10.1126/science.1229758; Wei W, 2011, TRENDS GENET, V27, P267, DOI 10.1016/j.tig.2011.04.002; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	48	76	78	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1712	1723		10.1016/j.cell.2014.04.036	http://dx.doi.org/10.1016/j.cell.2014.04.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949978	Bronze, Green Accepted			2022-12-01	WOS:000340941900023
J	Wolfe, SM				Wolfe, Sidney M.			A morphine-oxycodone combo pill: toward the "holy grail" for opioids or a justifiably rejected drug?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Publ Citizen, Hlth Res Grp, Washington, DC 20009 USA		Wolfe, SM (corresponding author), Publ Citizen, Hlth Res Grp, Washington, DC 20009 USA.	Swolfe@citizen.org						Corbett AD, 2006, BRIT J PHARMACOL, V147, pS153, DOI 10.1038/sj.bjp.0706435; FDA, 4 22 14 ADV COMM M, P122; FDA, 4 22 14 ADV COMM M, P5; Food and Drug Administration, 2014, AN AN DRUG PROD ADV; QRx Pharma, 2012, NONC OV DUAL OP TECH	5	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2014	348								g3620	10.1136/bmj.g3620	http://dx.doi.org/10.1136/bmj.g3620			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1DS	24912942	Bronze, Green Published			2022-12-01	WOS:000337396600005
J	Falaschetti, E; Mindell, J; Knott, C; Poulter, N				Falaschetti, Emanuela; Mindell, Jennifer; Knott, Craig; Poulter, Neil			Hypertension management in England: a serial cross-sectional study from 1994 to 2011	LANCET			English	Article							HEALTH SURVEY; BLOOD-PRESSURE; UNITED-KINGDOM; GLOBAL BURDEN; CANADA; IMPROVEMENT; GUIDELINES; OUTCOMES; SOCIETY; DISEASE	Background Hypertension is the leading risk factor contributing to the global burden of disease. We aimed to assess the change in blood pressure management between 1994 and 2011 in England with a series of annual surveys. Methods We did a serial cross-sectional study of five Health Survey for England surveys based on nationally representative samples of non-institutionalised adults (aged >= 16 years). Mean blood pressure levels and rates of awareness, treatment, and control of hypertension were assessed. Hypertension was defined as systolic blood pressure 140 mm Hg or higher, diastolic blood pressure 90 mm Hg or higher, or receiving treatment for high blood pressure. Findings The mean blood pressure levels of men and women in the general population and among patients with treated hypertension progressively improved between 1994 and 2011. In patients with treated hypertension, blood pressure improved from 150.0 (SE 0.59)/80.2 (0.27) mm Hg to 135.4 (0.58)/73.5 (0.41) mm Hg. Awareness, treatment, and control rates among men and women combined also improved significantly across each stage of this 17-year period, with the prevalence of control among treated patients almost doubling from 33% (SE 1.4) in 1994 to 63% (1.7) in 2011. Nevertheless, of all adults with survey-defined hypertension in 2011, hypertension was controlled in only 37%. Interpretation If the same systematic improvement in all aspects of hypertension management continues until 2022, 80% of patients with treated hypertension will have controlled blood pressure levels with a potential annual saving of about 50 000 major cardiovascular events.	[Falaschetti, Emanuela] Univ London Imperial Coll Sci Technol & Med, Imperial Clin Trials Unit, Sch Publ Hlth, London W2 1PG, England; [Poulter, Neil] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, Natl Heart & Lung Inst, London W2 1PG, England; [Mindell, Jennifer; Knott, Craig] UCL, Dept Epidemiol & Publ Hlth, London, England	Imperial College London; Imperial College London; University of London; University College London	Falaschetti, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Imperial Clin Trials Unit, Sch Publ Hlth, London W2 1PG, England.	e.falaschetti@imperial.ac.uk	Mindell, Jennifer S/G-2241-2011	Mindell, Jennifer S/0000-0002-7604-6131; Falaschetti, Emanuela/0000-0001-6964-2042	HSCIC; National Institute for Health Research [NF-SI-0510-10055] Funding Source: researchfish	HSCIC; National Institute for Health Research(National Institute for Health Research (NIHR))	JM is and EF and CK were funded by the HSCIC to work on the HSE, but the study reported in this paper was not funded.	Campbell NRC, 2013, CAN J CARDIOL, V29, P564, DOI 10.1016/j.cjca.2012.05.006; Colhoun HM, 1998, J HYPERTENS, V16, P747, DOI 10.1097/00004872-199816060-00005; Craig R, 2012, HLTH SURVY ENGLAND 2, V2; Department of Health, 2003, DEL INV GEN PRACT IM; Elliott William J, 2003, J Clin Hypertens (Greenwich), V5, P3, DOI 10.1111/j.1524-6175.2003.02463.x; Falaschetti E, 2009, HYPERTENSION, V53, P480, DOI 10.1161/HYPERTENSIONAHA.108.125617; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Joffres M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003423; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; McAlister FA, 2011, CAN MED ASSOC J, V183, P1007, DOI 10.1503/cmaj.101767; Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199; National Collaborating Centre for Chronic Conditions, 2006, HYP MAN HYP AD PRIM; ONS, 20 CENT MORT FIL 199; Primatesta P, 2001, HYPERTENSION, V38, P827, DOI 10.1161/hyp.38.4.827; Primatesta P, 2006, J HYPERTENS, V24, P1187, DOI 10.1097/01.hjh.0000226210.95936.bc; Ryan AM, 2012, MED CARE, V50, P191, DOI 10.1097/MLR.0b013e318244e6b5; Sadler K, 2013, NAT DIET NUTR SURV A; Serumaga Brian, 2011, BMJ, V342, pd108, DOI 10.1136/bmj.d108; SMITH WCS, 1990, BRIT MED J, V300, P981, DOI 10.1136/bmj.300.6730.981; Turnbull F, 2003, LANCET, V362, P1527; Volpe M, 2007, J HYPERTENS, V25, P1491, DOI 10.1097/HJH.0b013e3280fa83a6; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10	28	171	177	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1912	1919		10.1016/S0140-6736(14)60688-7	http://dx.doi.org/10.1016/S0140-6736(14)60688-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PR	24881995				2022-12-01	WOS:000336847800031
J	van Roosmalen, J; Meguid, T				van Roosmalen, Jos; Meguid, Tarek			The dilemma of vaginal breech delivery worldwide	LANCET			English	Editorial Material							CESAREAN-SECTION; TERM; DISAGREEMENT; TRIAL; ROOM		[van Roosmalen, Jos] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [van Roosmalen, Jos] Leiden Univ, Med Ctr, NL-2300 RC Leiden, Netherlands; [Meguid, Tarek] Mnazi Mmoja Hosp, Zanzibar, Tanzania; [Meguid, Tarek] State Univ Zanzibar, Sch Hlth & Med Sci, Zanzibar, Tanzania; [Meguid, Tarek] Haukeland Hosp, Helse Bergen, N-5021 Bergen, Norway	Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Bergen; Haukeland University Hospital	van Roosmalen, J (corresponding author), Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands.	j.j.m.van_roosmalen@lumc.nl						Grivell RM, 2011, EXPERT REV OBSTET GY, V6, P205, DOI [10.1586/eog.11.5, DOI 10.1586/eog.11.5]; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; Hendriks J, 2013, VOX SANG, V104, P234, DOI 10.1111/j.1423-0410.2012.01654.x; Kotaska AR, 2004, BRIT MED J, V329, P1039, DOI 10.1136/bmj.329.7473.1039; Lawson GW, 2012, BIRTH-ISS PERINAT C, V39, P3, DOI 10.1111/j.1523-536X.2011.00507.x; Lumley J, 2000, LANCET, V356, P1368, DOI 10.1016/S0140-6736(00)02833-6; Maaloe N, 2012, BJOG-INT J OBSTET GY, V119, P605, DOI 10.1111/j.1471-0528.2012.03284.x; Naicker Saraladevi, 2009, Ethn Dis, V19, pS1; Onah HE, 2002, INT J GYNECOL OBSTET, V76, P321, DOI 10.1016/S0020-7292(01)00578-1; Rietberg CCT, 2005, BJOG-INT J OBSTET GY, V112, P205, DOI 10.1111/j.1471-0528.2004.00317.x; Schutte JM, 2007, ACTA OBSTET GYN SCAN, V86, P240, DOI 10.1080/00016340601104054; van Roosmalen J, 2002, BJOG-INT J OBSTET GY, V109, P967, DOI 10.1016/S1470-0328(02)01705-6; Vlemmix F, 2013, AM J OBSTET GYNECOL, V208, pS321, DOI 10.1016/j.ajog.2012.10.102	13	32	32	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1863	1864		10.1016/S0140-6736(14)60618-8	http://dx.doi.org/10.1016/S0140-6736(14)60618-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PR	24881976				2022-12-01	WOS:000336847800007
J	Lampert, A; Hastings, A; Grosholz, ED; Jardine, SL; Sanchirico, JN				Lampert, Adam; Hastings, Alan; Grosholz, Edwin D.; Jardine, Sunny L.; Sanchirico, James N.			Optimal approaches for balancing invasive species eradication and endangered species management	SCIENCE			English	Article							BIRDS; CONSERVATION; FISHERIES; IMPACTS	Resolving conflicting ecosystem management goals-such as maintaining fisheries while conserving marine species or harvesting timber while preserving habitat-is a widely recognized challenge. Even more challenging may be conflicts between two conservation goals that are typically considered complementary. Here, we model a case where eradication of an invasive plant, hybrid Spartina, threatens the recovery of an endangered bird that uses Spartina for nesting. Achieving both goals requires restoration of native Spartina. We show that the optimal management entails less intensive treatment over longer time scales to fit with the time scale of natural processes. In contrast, both eradication and restoration, when considered separately, would optimally proceed as fast as possible. Thus, managers should simultaneously consider multiple, potentially conflicting goals, which may require flexibility in the timing of expenditures.	[Lampert, Adam; Hastings, Alan; Grosholz, Edwin D.; Sanchirico, James N.] Univ Calif Davis, Davis, CA 95616 USA; [Jardine, Sunny L.] Univ Delaware, Newark, DE 19716 USA; [Sanchirico, James N.] Resources Future Inc, Washington, DC 20036 USA	University of California System; University of California Davis; University of Delaware; Resources for the Future	Lampert, A (corresponding author), Univ Calif Davis, One Shield Ave, Davis, CA 95616 USA.	alampert@ucdavis.edu	Hastings, Alan/O-6864-2019	Hastings, Alan/0000-0002-0717-8026	NSF [DEB 1009957]; Division Of Environmental Biology [1009957] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the personnel of the Invasive Spartina Project, including P. Olofson, E. Grijalva, D. Kerr, I. Hogle, W. Thornton, M. Latta, and others, who provided data on Spartina distributions, clapper rail populations, and costs of eradication and restoration efforts. We thank D. Kling for research assistance and P. Reynolds for comments on the manuscript. We thank the California State Coastal Conservancy and the California State Wildlife Conservation Board for use of their data. The data used for this paper are summarized in table S1 (24) and are given in more detail in (24). This research was supported by NSF grant no. DEB 1009957 to A. H., E. D. G., J.N.S., A. L., and S.L.J.	Alverson D.L., 1994, GLOBAL ASSESSMENT FI, V339; Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; Ayres DR, 2004, BIOL INVASIONS, V6, P221, DOI 10.1023/B:BINV.0000022140.07404.b7; Buckley YM, 2008, J APPL ECOL, V45, P397, DOI 10.1111/j.1365-2664.2008.01471.x; Clark C., 1976, MATH BIOECONOMICS OP; Crowder LB, 1998, FISHERIES, V23, P8, DOI 10.1577/1548-8446(1998)023&lt;0008:FBIFM&gt;2.0.CO;2; Faber P, 2000, COAST OCEAN, V16, P14; Folke C, 2005, ANNU REV ENV RESOUR, V30, P441, DOI 10.1146/annurev.energy.30.050504.144511; Groom M.J., 2006, PRINCIPLES CONSERVAT; Grosholz E.D., 2009, HUMAN IMPACTS SALT M, P23; Hambright KD, 2000, AQUAT CONSERV, V10, P393, DOI 10.1002/1099-0755(200011/12)10:6<393::AID-AQC419>3.0.CO;2-O; Hastings A, 2003, ECOL APPL, V13, pS65; Hastings A, 2006, THEOR POPUL BIOL, V70, P431, DOI 10.1016/j.tpb.2006.05.003; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Holge I., 2012, SAN FRANCISCO ESTUAR; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Leslie HM, 2007, FRONT ECOL ENVIRON, V5, P540, DOI 10.1890/060093; Levin LA, 2006, ECOLOGY, V87, P419, DOI 10.1890/04-1752; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Martin TG, 2006, BIOL CONSERV, V127, P201, DOI 10.1016/j.biocon.2005.08.014; McBroom J., 2011, 2010 CALIFORNIA CLAP; Nalle D. J., 2004, Journal of Environmental Economics and Management, V48, P997, DOI 10.1016/j.jeem.2004.01.001; Neilan W, 2006, BIOL CONSERV, V129, P393, DOI 10.1016/j.biocon.2005.11.007; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Sogge MK, 2008, RESTOR ECOL, V16, P146, DOI 10.1111/j.1526-100X.2008.00357.x; Soulu M.E., 1980, CONSERVATION BIOL EV; Strong DR, 2013, ANNU REV ECOL EVOL S, V44, P389, DOI 10.1146/annurev-ecolsys-110512-135803; SWANSON FJ, 1992, ECOL APPL, V2, P262, DOI 10.2307/1941860; Taylor CM, 2004, J APPL ECOL, V41, P1049, DOI 10.1111/j.0021-8901.2004.00979.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yokomizo H, 2012, BIOL INVASIONS, V14, P839, DOI 10.1007/s10530-011-0120-x	31	80	83	6	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1028	1031		10.1126/science.1250763	http://dx.doi.org/10.1126/science.1250763			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876497				2022-12-01	WOS:000336495800045
J	Ravi, B; Jenkinson, R; Austin, PC; Croxford, R; Wasserstein, D; Escott, B; Paterson, JM; Kreder, H; Hawker, GA				Ravi, Bheeshma; Jenkinson, Richard; Austin, Peter C.; Croxford, Ruth; Wasserstein, David; Escott, Benjamin; Paterson, J. Michael; Kreder, Hans; Hawker, Gillian A.			Relation between surgeon volume and risk of complications after total hip arthroplasty: propensity score matched cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TOTAL KNEE REPLACEMENT; BODY-MASS INDEX; UNITED-STATES; PANCREATIC RESECTION; JOINT ARTHROPLASTY; SMOKING-CESSATION; DIABETES-MELLITUS; HOSPITAL VOLUME; SURGICAL VOLUME; OUTCOMES	Objectives To identify a cut point in annual surgeon volume associated with increased risk of complications after primary elective total hip arthroplasty and to quantify any risk identified. Design Propensity score matched cohort study. Setting Ontario, Canada Participants 37 881 people who received their first primary total hip arthroplasty during 2002-09 and were followed for at least two years after their surgery. Main outcome measure The rates of various surgical complications within 90 days (venous thromboembolism, death) and within two years (infection, dislocation, periprosthetic fracture, revision) of surgery. Results Multivariate splines were developed to visualize the relation between surgeon volume and the risk for various complications. A threshold of 35 cases a year was identified, under which there was an increased risk of dislocation and revision. 6716 patients whose total hip arthroplasty was carried out by surgeons who had done <= 35 such procedure in the previous year were successfully matched to patients whose surgeon had carried out more than 35 procedures. Patients in the former group had higher rates of dislocation (1.9% v 1.3%, P=0.006; NNH 172) and revision (1.5% v 1.0%, P=0.03; NNH 204). Conclusions In a cohort of first time recipients of total hip arthroplasty, patients whose operation was carried by surgeons who had performed 35 or fewer such procedures in the year before the index procedure were at increased risk for dislocation and early revision. Surgeons should consider performing 35 cases or more a year to minimize the risk for complications. Furthermore, the methods used to visualize the relationship between surgeon volume and the occurrence of complications can be easily applied in any jurisdiction, to help inform and optimize local healthcare delivery.	[Ravi, Bheeshma; Jenkinson, Richard; Wasserstein, David; Escott, Benjamin; Kreder, Hans] Univ Toronto, Dept Surg, Div Orthopaed Surg, Toronto, ON, Canada; [Austin, Peter C.; Croxford, Ruth; Paterson, J. Michael; Kreder, Hans; Hawker, Gillian A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Austin, Peter C.; Paterson, J. Michael; Kreder, Hans; Hawker, Gillian A.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Hawker, Gillian A.] Womens Coll Hosp, Dept Med, Div Rheumatol, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital	Ravi, B (corresponding author), Univ Toronto, Dept Surg, Div Orthopaed Surg, Toronto, ON, Canada.	bheeshma.ravi@mail.utoronto.ca		Austin, Peter/0000-0003-3337-233X	Canadian Institutes of Health Research; Institute for Clinical Evaluative Sciences - Ontario Ministry of Health and Long-Term Care; FM Hill Chair in Academic Women's Medicine; Ministry of Health and Long-Term Care; CIHR [MOP-15468]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute for Clinical Evaluative Sciences - Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); FM Hill Chair in Academic Women's Medicine; Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); CIHR(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Canadian Institutes of Health Research and by the Institute for Clinical Evaluative Sciences, a non-profit research institute funded by the Ontario Ministry of Health and Long-Term Care. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by the Institute for Clinical Evaluative Sciences or the Ontario Ministry of Health and Long-Term Care is intended or should be inferred. GAH is supported in part by the FM Hill Chair in Academic Women's Medicine. ICES received support from the Ministry of Health and Long-Term Care. CIHR Grant number: MOP-15468.	Agabiti N, 2007, INT J QUAL HEALTH C, V19, P37, DOI 10.1093/intqhc/mzl065; Alberton GM, 2002, J BONE JOINT SURG AM, V84A, P1788, DOI 10.2106/00004623-200210000-00008; Austin PC, 2011, STAT MED, V30, P1292, DOI 10.1002/sim.4200; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Baker P, 2011, SURG-J R COLL SURG E, V9, P13, DOI 10.1016/j.surge.2010.08.011; Bakhshi E, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/639124; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Bini S, 2013, J BONE JOINT SURG AM, V95A, P2195, DOI 10.2106/JBJS.L.01006; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Block EFJ, 2010, J TRAUMA, V69, P640, DOI 10.1097/TA.0b013e3181efbed9; Bourne RB, 2010, CLIN ORTHOP RELAT R, V468, P57, DOI 10.1007/s11999-009-1119-9; Burns AWR, 2006, CLIN ORTHOP RELAT R, P29, DOI 10.1097/01.blo.0000214420.14088.76; Clyburn TA, 2013, J AM ACAD ORTHOP SUR; Collier R, 2010, CAN MED ASSOC J, V182, P331, DOI 10.1503/cmaj.109-3167; Colosia AD, 2013, DIABETES METAB SYNDR, V6, P327, DOI 10.2147/DMSO.S51325; Cook RE, 2008, CLIN ORTHOP RELAT R, V466, P1652, DOI 10.1007/s11999-008-0289-1; Courcoulas A, 2003, SURGERY, V134, P613, DOI 10.1016/S0039-6060(03)00306-4; Cowan JA, 2003, J VASC SURG, V37, P1169, DOI 10.1016/S0741-5214(03)00085-5; Dawson NV, 2012, MED DECIS MAKING, V32, P225, DOI 10.1177/0272989X12437605; de Palma L, 2012, HIP INT, V22, P62, DOI 10.5301/HIP.2012.9059; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dobzyniak M, 2006, CLIN ORTHOP RELAT R, P76, DOI 10.1097/01.blo.0000203484.90711.52; FitzGerald JD, 2012, ARTHRIT CARE RES, V64, P890, DOI 10.1002/acr.21611; Franklin J, 2007, INJURY, V38, P655, DOI 10.1016/j.injury.2007.02.049; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Glazier RH, 2000, CAN J PUBLIC HEALTH, V91, P268, DOI 10.1007/BF03404286; Grossman E, 2008, ADV CARDIOL, V45, P82, DOI 10.1159/000115189; Gustafson P, 2002, BIOMETRICS, V58, P878, DOI 10.1111/j.0006-341X.2002.00878.x; Halimi JM, 2000, KIDNEY INT, V58, P1285, DOI 10.1046/j.1523-1755.2000.00284.x; HASTINGS DE, 1975, CLIN ORTHOP RELAT R, P76; Haverkamp D, 2011, ACTA ORTHOP, V82, P417, DOI 10.3109/17453674.2011.588859; Hu FB, 2003, LIPIDS, V38, P103, DOI 10.1007/s11745-003-1038-4; Hu JC, 2003, J CLIN ONCOL, V21, P401, DOI 10.1200/JCO.2003.05.169; Hubbard RE, 2009, J NUTR HEALTH AGING, V13, P468, DOI 10.1007/s12603-009-0085-y; Hubbard RE, 2010, J GERONTOL A-BIOL, V65, P377, DOI 10.1093/gerona/glp186; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Information CIfH, 2008, RED GAPS HLTH FOC SO; Information CIfH, 2006, ASS THEIR HLTH STAT; Kapadia BH, 2014, J ARTHROPLASTY, V29, P777, DOI 10.1016/j.arth.2013.08.023; Katz JN, 2007, ARTHRITIS RHEUM, V56, P568, DOI 10.1002/art.22333; Katz JN, 2001, J BONE JOINT SURG AM, V83A, P1622, DOI 10.2106/00004623-200111000-00002; Katz JN, 2003, ARTHRITIS RHEUM, V48, P560, DOI 10.1002/art.10754; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; KIRK PG, 1993, CAN J SURG, V36, P229; Kluess D, 2007, MED ENG PHYS, V29, P465, DOI 10.1016/j.medengphy.2006.07.001; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Kralj B, 2000, ONTARIO MED REV, P37; Kralj B., 2005, MEASURING RURALITY P; Lau RL, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-250; LAVERNIA CJ, 1995, J ARTHROPLASTY, V10, P133, DOI 10.1016/S0883-5403(05)80119-6; Lewis Steven, 2004, Healthc Pap, V5, P12; LIEBERMAN MD, 1995, ANN SURG, V222, P638, DOI 10.1097/00000658-199511000-00006; Lingard EA, 2004, J BONE JOINT SURG AM, V86A, P2179, DOI 10.2106/00004623-200410000-00008; Losina E, 2004, ARTHRITIS RHEUM-US, V50, P1338, DOI 10.1002/art.20148; Losina E, 2007, ARCH INTERN MED, V167, P182, DOI 10.1001/archinte.167.2.182; Marrie RA, 2009, J CLIN EPIDEMIOL, V62, P511, DOI 10.1016/j.jclinepi.2008.05.015; Masonis JL, 2002, CLIN ORTHOP RELAT R, P46, DOI 10.1097/01.blo.0000038476.05771.6c; Matheson F., 2011, ONTARIO MARGINALIZAT; Matheson FI, 2008, SOC SCI MED, V66, P675, DOI 10.1016/j.socscimed.2007.10.008; Matheson FI, 2006, SOC SCI MED, V63, P2604, DOI 10.1016/j.socscimed.2006.07.001; Matheson FI, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.112441; McMinn D, 2006, P I MECH ENG H, V220, P239, DOI 10.1243/095441105X68944; Morrey B F, 1992, J Arthroplasty, V7, P71, DOI 10.1016/0883-5403(92)90035-O; Morris AH, 2001, J BONE JOINT SURG AM, V83A, P1754, DOI 10.2106/00004623-200111000-00022; Moser BK, 2004, STAT MED, V23, P1843, DOI 10.1002/sim.1776; Nilsdotter AK, 2003, ANN RHEUM DIS, V62, P923, DOI 10.1136/ard.62.10.923; O'Donnell DE, 2012, PULM MED, V2012, DOI 10.1155/2012/818925; Papakostidou I, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-116; Paterson JM, 2010, CAN J SURG, V53, P175; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; RAGLAND DR, 1992, EPIDEMIOLOGY, V3, P434, DOI 10.1097/00001648-199209000-00009; Ravi B, 2014, ARTHRITIS RHEUMATOL, V66, P254, DOI 10.1002/art.38231; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Rutkowski P, 2006, J RENAL NUTR, V16, P216, DOI 10.1053/j.jrn.2006.04.017; Saleh K, 2002, J ORTHOP RES, V20, P506, DOI 10.1016/S0736-0266(01)00153-X; Santaguida PL, 2008, CAN J SURG, V51, P428; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; SHAH PK, 1988, CHEST, V94, P449, DOI 10.1378/chest.94.3.449; Simunovic M, 1999, CAN MED ASSOC J, V160, P643; Stavrakis AI, 2007, SURGERY, V142, P887, DOI 10.1016/j.surg.2007.09.003; Tashkin DP, 2009, RESP MED, V103, P963, DOI 10.1016/j.rmed.2009.02.013; Tu Karen, 2007, Open Med, V1, pe18; Urquhart DM, 2010, J ARTHROPLASTY, V25, P1216, DOI 10.1016/j.arth.2009.08.011; Weiner J., 2011, J HOPKINS ACG SYSTEM; White HL, 2011, HEALTH PLACE, V17, P361, DOI 10.1016/j.healthplace.2010.11.016; Will JC, 2001, INT J EPIDEMIOL, V30, P540, DOI 10.1093/ije/30.3.540	88	149	150	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2014	348								g3284	10.1136/bmj.g3284	http://dx.doi.org/10.1136/bmj.g3284			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH9AC	24859902	Green Published, hybrid			2022-12-01	WOS:000336429700004
J	Deng, L; Ignacio-Espinoza, JC; Gregory, AC; Poulos, BT; Weitz, JS; Hugenholtz, P; Sullivan, MB				Deng, Li; Ignacio-Espinoza, J. Cesar; Gregory, Ann C.; Poulos, Bonnie T.; Weitz, Joshua S.; Hugenholtz, Philip; Sullivan, Matthew B.			Viral tagging reveals discrete populations in Synechococcus viral genome sequence space	NATURE			English	Article							MARINE VIRUSES; GENE-TRANSFER; CYANOPHAGES; EVOLUTION; DIVERSITY; BACTERIOPHAGE; COMMUNITIES; PROPHAGES; ABUNDANCE; BACTERIAL	Microbes and their viruses drive myriad processes across ecosystems ranging from oceans and soils to bioreactors and humans(1-4). Despite this importance, microbial diversity is only now being mapped at scales relevant to nature(5), while the viral diversity associated with any particular host remains little researched. Here we quantify host-associated viral diversity using viral-tagged metagenomics, which links viruses to specific host cells for high-throughput screening and sequencing. In a single experiment, we screened 10(7) Pacific Ocean viruses against a single strain of Synechococcus and found that naturally occurring cyanophage genome sequence space is statistically clustered into discrete populations. These population-based, host-linked viral ecological data suggest that, for this single host and seawater sample alone, there are at least 26 double-stranded DNA viral populations with estimated relative abundances ranging from 0.06 to 18.2%. These populations include previously cultivated cyanophage and new viral types missed by decades of isolate-based studies. Nucleotide identities of homologous genes mostly varied by less than 1% within populations, even in hypervariable genome regions, and by 42-71% between populations, which provides benchmarks for viral metagenomics and genome-based viral species definitions. Together these findings showcase a new approach to viral ecology that quantitatively links objectively defined environmental viral populations, and their genomes, to their hosts.	[Deng, Li; Gregory, Ann C.; Poulos, Bonnie T.; Sullivan, Matthew B.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85719 USA; [Ignacio-Espinoza, J. Cesar; Sullivan, Matthew B.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85719 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Hugenholtz, Philip] Univ Queensland, Australian Ctr Ecogen, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Hugenholtz, Philip] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Arizona; University of Arizona; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University of Queensland; University of Queensland	Sullivan, MB (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85719 USA.	mbsulli@email.arizona.edu	Hugenholtz, Philip/G-9608-2011; Deng, Li/A-7233-2015; Sullivan, Matthew B/H-3256-2011; Hugenholtz, Philip/AAD-9138-2019	Hugenholtz, Philip/0000-0001-5386-7925; Deng, Li/0000-0003-0225-0663; Sullivan, Matthew B/0000-0003-4040-9831; Hugenholtz, Philip/0000-0001-5386-7925; Ignacio Espinoza, J. Cesar/0000-0001-9303-7504	US Department of Energy (DOE) Joint Genome Institute (JGI) Community Sequencing Program; Biosphere 2; BIO5; US National Science Foundation (NSF) [OCE0940390]; Gordon and Betty Moore Foundation grants; NSF [OCE1233760]; Burroughs Wellcome Fund grants; University Information Technology Services Research Computing Group; ARL Biotechnology Computing for high-performance computing clusters (HPCC); DOE JGI Community Sequencing Program under the Office of Science of the US DOE [DE-AC02-05CH11231]; Division Of Physics [1205878] Funding Source: National Science Foundation	US Department of Energy (DOE) Joint Genome Institute (JGI) Community Sequencing Program(United States Department of Energy (DOE)); Biosphere 2; BIO5; US National Science Foundation (NSF)(National Science Foundation (NSF)); Gordon and Betty Moore Foundation grants(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); Burroughs Wellcome Fund grants(Burroughs Wellcome Fund); University Information Technology Services Research Computing Group; ARL Biotechnology Computing for high-performance computing clusters (HPCC); DOE JGI Community Sequencing Program under the Office of Science of the US DOE(United States Department of Energy (DOE)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Funding was provided by the US Department of Energy (DOE) Joint Genome Institute (JGI) Community Sequencing Program, Biosphere 2, BIO5, US National Science Foundation (NSF) OCE0940390, and Gordon and Betty Moore Foundation grants to M.B.S., as well as NSF OCE1233760 and Burroughs Wellcome Fund grants to J.S.W. We thank J. Fuhrman for suggesting stable-isotope-labelled host DNA; A. Z. Warden and the CANON Initiative for the cruise opportunity; Warden laboratory members; the captain and crew of the R/V Western Flyer for operational/sampling support; J. B. Waterbury, S. W. Chisholm and A. Wichels for strains; the Tucson Marine Phage laboratory; Institute of Groundwater Ecology of Helmholtz Munich; and N. Pace, M. Young, S. W. Chisholm and S. Yilmaz for technical/analytical support and manuscript comments. We acknowledge the University of Arizona Genetics Core for viral-tagging metagenomic sequencing; iCyt and the Arizona Cancer Center and Arizona Research Laboratories (ARL) Division of Biotechnology Cytometry Core Facility for cytometry support; the University Information Technology Services Research Computing Group and the ARL Biotechnology Computing for high-performance computing clusters (HPCC) access and support. Community metagenomic sequencing was provided by the DOE JGI Community Sequencing Program under the Office of Science of the US DOE contract no. DE-AC02-05CH11231.	Akhter S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks406; Angly F, 2009, ENVIRON MICROBIOL, V11, P2863, DOI 10.1111/j.1462-2920.2009.02021.x; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Breitbart M, 2012, ANNU REV MAR SCI, V4, P425, DOI 10.1146/annurev-marine-120709-142805; Ceyssens PJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-134; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chen F, 2002, APPL ENVIRON MICROB, V68, P2589, DOI 10.1128/AEM.68.5.2589-2594.2002; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Deng L, 2008, FRESHWATER BIOL, V53, P1240, DOI 10.1111/j.1365-2427.2007.01947.x; Deng L, 2012, MBIO, V3, DOI 10.1128/mBio.00373-12; Duhaime MB, 2012, ENVIRON MICROBIOL, V14, P2526, DOI 10.1111/j.1462-2920.2012.02791.x; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Fuller NJ, 1998, APPL ENVIRON MICROB, V64, P2051; Hatfull GF, 2012, ADV VIRUS RES, V82, P179, DOI 10.1016/B978-0-12-394621-8.00015-7; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Hendrix RW, 2000, TRENDS MICROBIOL, V8, P504, DOI 10.1016/S0966-842X(00)01863-1; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Holmfeldt K, 2013, P NATL ACAD SCI USA, V110, P12798, DOI 10.1073/pnas.1305956110; Holmfeldt K, 2012, APPL ENVIRON MICROB, V78, P892, DOI 10.1128/AEM.06580-11; Hurwitz BL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r123; Hurwitz BL, 2013, ENVIRON MICROBIOL, V15, P1428, DOI 10.1111/j.1462-2920.2012.02836.x; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ignacio-Espinoza JC, 2012, ENVIRON MICROBIOL, V14, P2113, DOI 10.1111/j.1462-2920.2012.02704.x; John SG, 2011, ENV MICROBIOL REP, V3, P195, DOI 10.1111/j.1758-2229.2010.00208.x; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kuznetsov YG, 2012, MICRON, V43, P1336, DOI 10.1016/j.micron.2012.02.013; Labonte JM, 2013, ISME J, V7, P2169, DOI 10.1038/ismej.2013.110; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; Lawrence JG, 2002, J BACTERIOL, V184, P4891, DOI 10.1128/JB.184.17.4891-4905.2002; Lu J, 2001, APPL ENVIRON MICROB, V67, P3285, DOI 10.1128/AEM.67.7.3285-3290.2001; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marston MF, 2009, ENVIRON MICROBIOL, V11, P2893, DOI 10.1111/j.1462-2920.2009.02037.x; Marston MF, 2003, APPL ENVIRON MICROB, V69, P4639, DOI 10.1128/AEM.69.8.4639-4647.2003; Millard AD, 2009, ENVIRON MICROBIOL, V11, P2370, DOI 10.1111/j.1462-2920.2009.01966.x; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198; Sharon I, 2011, ISME J, V5, P1178, DOI 10.1038/ismej.2011.2; Sharon I, 2009, NATURE, V461, P258, DOI 10.1038/nature08284; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Solonenko SA, 2013, METHOD ENZYMOL, V531, P143, DOI 10.1016/B978-0-12-407863-5.00008-3; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; SUTTLE CA, 1993, MAR ECOL PROG SER, V92, P99, DOI 10.3354/meps092099; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Wang K, 2008, ENVIRON MICROBIOL, V10, P300, DOI 10.1111/j.1462-2920.2007.01452.x; Waterbury J.B., 1986, PHOTOSYNTHETIC PICOP, P71; WATERBURY JB, 1993, APPL ENVIRON MICROB, V59, P3393, DOI 10.1128/AEM.59.10.3393-3399.1993; Weitz JS, 2013, TRENDS MICROBIOL, V21, P82, DOI 10.1016/j.tim.2012.11.003; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; WILSON WH, 1993, APPL ENVIRON MICROB, V59, P3736, DOI 10.1128/AEM.59.11.3736-3743.1993; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	58	125	125	3	108	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					242	+		10.1038/nature13459	http://dx.doi.org/10.1038/nature13459			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25043051				2022-12-01	WOS:000341362800052
J	Kupitz, C; Basu, S; Grotjohann, I; Fromme, R; Zatsepin, NA; Rendek, KN; Hunter, MS; Shoeman, RL; White, TA; Wang, DJ; James, D; Yang, JH; Cobb, DE; Reeder, B; Sierra, RG; Liu, HG; Barty, A; Aquila, AL; Deponte, D; Kirian, RA; Bari, S; Bergkamp, JJ; Beyerlein, KR; Bogan, MJ; Caleman, C; Chao, TC; Conrad, CE; Davis, KM; Fleckenstein, H; Galli, L; Hau-Riege, SP; Kassemeyer, S; Laksmono, H; Liang, MN; Lomb, L; Marchesini, S; Martin, AV; Messerschmidt, M; Milathianaki, D; Nass, K; Ros, A; Roy-Chowdhury, S; Schmidt, K; Seibert, M; Steinbrener, J; Stellato, F; Yan, LF; Yoon, C; Moore, TA; Moore, AL; Pushkar, Y; Williams, GJ; Boutet, S; Doak, RB; Weierstall, U; Frank, M; Chapman, HN; Spence, JCH; Fromme, P				Kupitz, Christopher; Basu, Shibom; Grotjohann, Ingo; Fromme, Raimund; Zatsepin, Nadia A.; Rendek, Kimberly N.; Hunter, Mark S.; Shoeman, Robert L.; White, Thomas A.; Wang, Dingjie; James, Daniel; Yang, Jay-How; Cobb, Danielle E.; Reeder, Brenda; Sierra, Raymond G.; Liu, Haiguang; Barty, Anton; Aquila, Andrew L.; Deponte, Daniel; Kirian, Richard A.; Bari, Sadia; Bergkamp, Jesse J.; Beyerlein, Kenneth R.; Bogan, Michael J.; Caleman, Carl; Chao, Tzu-Chiao; Conrad, Chelsie E.; Davis, Katherine M.; Fleckenstein, Holger; Galli, Lorenzo; Hau-Riege, Stefan P.; Kassemeyer, Stephan; Laksmono, Hartawan; Liang, Mengning; Lomb, Lukas; Marchesini, Stefano; Martin, Andrew V.; Messerschmidt, Marc; Milathianaki, Despina; Nass, Karol; Ros, Alexandra; Roy-Chowdhury, Shatabdi; Schmidt, Kevin; Seibert, Marvin; Steinbrener, Jan; Stellato, Francesco; Yan, Lifen; Yoon, Chunhong; Moore, Thomas A.; Moore, Ana L.; Pushkar, Yulia; Williams, Garth J.; Boutet, Sebastien; Doak, R. Bruce; Weierstall, Uwe; Frank, Matthias; Chapman, Henry N.; Spence, John C. H.; Fromme, Petra			Serial time-resolved crystallography of photosystem II using a femtosecond X-ray laser	NATURE			English	Article							OXYGEN-EVOLVING COMPLEX; FREE-ELECTRON LASER; WATER OXIDATION; PROTEIN NANOCRYSTALLOGRAPHY; MN4CA CLUSTER; STRUCTURAL MODELS; CRYSTAL-STRUCTURE; D1 POLYPEPTIDE; S-3 STATES; OMIT MAPS	Photosynthesis, a process catalysed by plants, algae and cyanobacteria converts sunlight to energy thus sustaining all higher life on Earth. Two large membrane protein complexes, photosystem I and II (PSI and PSII), act in series to catalyse the light-driven reactions in photosynthesis. PSII catalyses the light-driven water splitting process, which maintains the Earth's oxygenic atmosphere(1). In this process, the oxygen-evolving complex (OEC) of PSII cycles through five states, S-0 to S-4, in which four electrons are sequentially extracted from the OEC in four light-driven charge-separation events. Here we describe time resolved experiments on PSII nano/microcrystals from Thermosynechococcus elongatus performed with the recently developed(2) technique of serial femtosecond crystallography. Structures have been determined from PSII in the dark S-1 state and after double laser excitation (putative S-3 state) at 5 and 5.5 angstrom resolution, respectively. The results provide evidence that PSII undergoes significant conformational changes at the electron acceptor side and at the Mn4CaO5 core of the OEC. These include an elongation of the metal cluster, accompanied by changes in the protein environment, which could allow for binding of the second substrate water molecule between the more distant protruding Mn (referred to as the 'dangler' Mn) and the Mn3CaOx cubane in the S-2 to S-3 transition, as predicted by spectroscopic and computational studies(3,4). This work shows the great potential for time-resolved serial femtosecond crystallography for investigation of catalytic processes in biomolecules.	[Kupitz, Christopher; Basu, Shibom; Grotjohann, Ingo; Fromme, Raimund; Rendek, Kimberly N.; Hunter, Mark S.; Yang, Jay-How; Cobb, Danielle E.; Reeder, Brenda; Bergkamp, Jesse J.; Chao, Tzu-Chiao; Conrad, Chelsie E.; Ros, Alexandra; Roy-Chowdhury, Shatabdi; Moore, Thomas A.; Moore, Ana L.; Fromme, Petra] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Zatsepin, Nadia A.; Wang, Dingjie; James, Daniel; Liu, Haiguang; Kirian, Richard A.; Schmidt, Kevin; Doak, R. Bruce; Weierstall, Uwe; Spence, John C. H.] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Hunter, Mark S.; Hau-Riege, Stefan P.; Frank, Matthias] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Shoeman, Robert L.; Kassemeyer, Stephan; Lomb, Lukas; Nass, Karol; Steinbrener, Jan] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [White, Thomas A.; Barty, Anton; Aquila, Andrew L.; Deponte, Daniel; Kirian, Richard A.; Beyerlein, Kenneth R.; Caleman, Carl; Fleckenstein, Holger; Galli, Lorenzo; Liang, Mengning; Martin, Andrew V.; Nass, Karol; Stellato, Francesco; Yoon, Chunhong; Chapman, Henry N.] Ctr Free Elect Laser Sci, DESY, D-22607 Hamburg, Germany; [Sierra, Raymond G.; Bogan, Michael J.; Laksmono, Hartawan] SLAC Natl Accelerator Lab, Stanford PULSE Inst, Menlo Pk, CA 94025 USA; [Aquila, Andrew L.; Yoon, Chunhong] European XFEL GmbH, D-22607 Hamburg, Germany; [Deponte, Daniel; Messerschmidt, Marc; Milathianaki, Despina; Seibert, Marvin; Williams, Garth J.; Boutet, Sebastien] Natl Accelerator Lab, Stanford Linear Accelerator Ctr SLAC, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Bari, Sadia; Kassemeyer, Stephan] Ctr Free Elect Laser Sci CFEL, Max Planck Adv Study Grp, D-22607 Hamburg, Germany; [Bari, Sadia] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Caleman, Carl] Uppsala Univ, Dept Phys & Astron, SE-75237 Uppsala, Sweden; [Chao, Tzu-Chiao] Univ Regina, Regina, SK S4S 0A2, Canada; [Davis, Katherine M.; Yan, Lifen; Pushkar, Yulia] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Galli, Lorenzo; Nass, Karol; Chapman, Henry N.] Univ Hamburg, D-22761 Hamburg, Germany; [Marchesini, Stefano] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Martin, Andrew V.] Univ Melbourne, Dept Phys, Ctr Excellence Coherent Xray Sci, Dept ARC, Melbourne, Vic 3010, Australia; [Seibert, Marvin] Uppsala Univ, S-75312 Uppsala, Sweden; [Chapman, Henry N.] Ctr Ultrafast Imaging, D-22761 Hamburg, Germany	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Max Planck Society; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; European XFEL; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Max Planck Society; Max Planck Society; Uppsala University; University of Regina; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Hamburg; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Melbourne; Uppsala University	Fromme, P (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.	pfromme@asu.edu	Stellato, Francesco/AAZ-4379-2020; Basu, Shibom/GLU-3308-2022; Messerschmidt, Marc/F-3796-2010; Fromme, Raimund/AAG-6578-2019; FRS, Henry N Chapman/G-2153-2010; Messerschmidt, Marc/Y-8929-2019; Chao, Tzu-Chiao/A-6400-2013; Bari, Sadia/E-6216-2015; Frank, Matthias/O-9055-2014; Nass, Karol/K-1970-2012; Barty, Anton/K-5137-2014; Marchesini, Stefano/GYR-1409-2022; Fromme, Raimund/W-5838-2019; Yan, Lifen/P-3920-2018; Milathianaki, Despina/AAG-5381-2021; Fromme, Raimund/C-8885-2012; Beyerlein, Kenneth/ABB-9823-2020; Marchesini, Stefano/A-6795-2009; Zatsepin, Nadia/AAF-2451-2019	Basu, Shibom/0000-0001-6484-8236; Messerschmidt, Marc/0000-0002-8641-3302; FRS, Henry N Chapman/0000-0002-4655-1743; Messerschmidt, Marc/0000-0002-8641-3302; Bari, Sadia/0000-0003-3985-2051; Nass, Karol/0000-0001-8843-1566; Barty, Anton/0000-0003-4751-2727; Fromme, Raimund/0000-0003-4835-1080; Fromme, Raimund/0000-0003-4835-1080; Beyerlein, Kenneth/0000-0002-7701-4369; Marchesini, Stefano/0000-0002-6798-2913; Zatsepin, Nadia/0000-0003-1757-0205; Aquila, Andrew/0000-0003-0358-2774; Fromme, Petra/0000-0003-0953-4909; Davis, Katherine/0000-0002-0258-8907; Schmidt, Kevin/0000-0002-1597-9835; Seibert, Mark Marvin/0000-0003-0251-0744; liu, haiguang/0000-0001-7324-6632; Bergkamp, Jesse/0000-0003-3443-0255; Frank, Matthias/0000-0002-5244-0791; White, Thomas/0000-0002-8407-0270; MARTIN, ANDREW/0000-0003-3704-1829	Center for Bio-Inspired Solar Fuel Production, an Energy Frontier Research Center - DOE, Office of Basic Energy Sciences [DE-SC0001016]; National Institutes of Health [1R01GM095583]; US National Science Foundation [MCB-1021557, MCB-1120997]; DFG Clusters of Excellence 'Inflammation at Interfaces' [EXC 306]; DFG Clusters of Excellence 'Center for Ultrafast Imaging'; Max Planck Society, the Atomic, Molecular and Optical Sciences Program; Deutsche Forschungsgemeinschaft (DFG); Chemical Sciences Geosciences and Biosciences Division, DOE OBES; SLAC LDRD program; US DOE through Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; UCOP Lab Fee Program [118036]; LLNL LDRD program [12-ERD-031]; Hamburg Ministry of Science and Research; Joachim Herz Stiftung as part of the Hamburg Initiative for Excellence in Research; U.S. Department of Energy (DOE), Office of Basic Energy Sciences [DE-FG02-12ER16340]; National Science Foundation Graduate Research Fellowship [0833366]; National Science Foundation through the BioFEL Science Technology Center [1231306]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095583] Funding Source: NIH RePORTER	Center for Bio-Inspired Solar Fuel Production, an Energy Frontier Research Center - DOE, Office of Basic Energy Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); DFG Clusters of Excellence 'Inflammation at Interfaces'; DFG Clusters of Excellence 'Center for Ultrafast Imaging'; Max Planck Society, the Atomic, Molecular and Optical Sciences Program; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Chemical Sciences Geosciences and Biosciences Division, DOE OBES; SLAC LDRD program; US DOE through Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); UCOP Lab Fee Program; LLNL LDRD program; Hamburg Ministry of Science and Research; Joachim Herz Stiftung as part of the Hamburg Initiative for Excellence in Research; U.S. Department of Energy (DOE), Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation through the BioFEL Science Technology Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Experiments were carried out at the Linac Coherent Light Source (LCLS), a national user facility operated by Stanford University on behalf of the US Department of Energy (DOE), Office of Basic Energy Sciences (OBES). This work was supported by the following agencies: the Center for Bio-Inspired Solar Fuel Production, an Energy Frontier Research Center funded by the DOE, Office of Basic Energy Sciences (award DE-SC0001016), the National Institutes of Health (award 1R01GM095583), the US National Science Foundation (award MCB-1021557 and MCB-1120997), the DFG Clusters of Excellence 'Inflammation at Interfaces' (EXC 306) and the 'Center for Ultrafast Imaging'; the Deutsche Forschungsgemeinschaft (DFG); the Max Planck Society, the Atomic, Molecular and Optical Sciences Program; Chemical Sciences Geosciences and Biosciences Division, DOE OBES (M.J.B.) and the SLAC LDRD program (M.J.B., H.L.); the US DOE through Lawrence Livermore National Laboratory under the contract DE-AC52-07NA27344 and supported by the UCOP Lab Fee Program (award no. 118036) and the LLNL LDRD program (12-ERD-031); the Hamburg Ministry of Science and Research and Joachim Herz Stiftung as part of the Hamburg Initiative for Excellence in Research. The research at Purdue University was supported by the U.S. Department of Energy (DOE), Office of Basic Energy Sciences DE-FG02-12ER16340 (Y.P.) and the National Science Foundation Graduate Research Fellowship under Grant 0833366 (K.M.D.). We also want to thank the National Science Foundation for providing funding for the publication of this work through the BioFEL Science Technology Center (award 1231306). We thank H. Isobe, M. Shoji, S. Yamanaka, Y. Umena, K. Kawakami, N. Kamiya, J. R. Shen and K. Yamaguchi for permission to show a section of Fig. 6 of their publication ref. 4 in Fig. 3d of this publication. We thank R. Neutze and his team for support and discussions during joint beamtime for the PSII project and his projects on time-resolved wide-angle scattering studies. We thank A. T. Brunger for discussions concerning data analysis. We thank T. Terwilliger for support with parameter setting of phenix.autobuild program for the SA-omit maps. We also wish to thank R. Burnap for discussions concerning interpretation of results of ligand mutagenesis. We thank J. D. Zook for his contributions concerning plastoquinone quantification. We thank M. Zhu for helping to create high resolution figures for this publication. We thank Raytheon for support of our studies by providing night-vision devices.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ames W, 2011, J AM CHEM SOC, V133, P19743, DOI 10.1021/ja2041805; Aquila A, 2012, OPT EXPRESS, V20, P2706, DOI 10.1364/OE.20.002706; Barty A, 2014, J APPL CRYSTALLOGR, V47, P1118, DOI 10.1107/S1600576714007626; Barty A, 2012, NAT PHOTONICS, V6, P35, DOI [10.1038/nphoton.2011.297, 10.1038/NPHOTON.2011.297]; BHAT TN, 1988, J APPL CRYSTALLOGR, V21, P279, DOI 10.1107/S0021889887012755; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Boutet S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035024; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; CHU HA, 1995, BIOCHEMISTRY-US, V34, P5839, DOI 10.1021/bi00017a016; Cox N, 2013, ACCOUNTS CHEM RES, V46, P1588, DOI 10.1021/ar3003249; Dau H, 2012, CURR OPIN CHEM BIOL, V16, P3, DOI 10.1016/j.cbpa.2012.02.011; Davis KM, 2013, J PHYS CHEM B, V117, P9161, DOI 10.1021/jp403654n; de Wijn R, 2001, BIOCHEMISTRY-US, V40, P11912, DOI 10.1021/bi010852r; Debus RJ, 2005, BIOCHEMISTRY-US, V44, P1367, DOI 10.1021/bi047558u; DEKKER JP, 1984, BIOCHIM BIOPHYS ACTA, V767, P176, DOI 10.1016/0005-2728(84)90093-8; DePonte DP, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/195505; Dilbeck PL, 2012, BIOCHEMISTRY-US, V51, P1079, DOI 10.1021/bi201659f; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/nphoton.2010.176, 10.1038/NPHOTON.2010.176]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grundmeier A, 2012, BBA-BIOENERGETICS, V1817, P88, DOI 10.1016/j.bbabio.2011.07.004; Han GY, 2008, BBA-BIOENERGETICS, V1777, P496, DOI 10.1016/j.bbabio.2008.03.007; Han GY, 2012, J BIOL CHEM, V287, P13422, DOI 10.1074/jbc.M112.342543; Herrmann S, 2013, NUCL INSTRUM METH A, V718, P550, DOI 10.1016/j.nima.2013.01.057; HODEL A, 1992, ACTA CRYSTALLOGR A, V48, P851, DOI 10.1107/S0108767392006044; Hundelt M, 1998, BIOCHEMISTRY-US, V37, P14450, DOI 10.1021/bi981164j; Isobe H, 2012, DALTON T, V41, P13727, DOI 10.1039/c2dt31420g; Kanady JS, 2011, SCIENCE, V333, P733, DOI 10.1126/science.1206036; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.1218231, 10.1126/science.121823]; Kern J, 2013, SCIENCE, V340, P491, DOI 10.1126/science.1234273; Kirian RA, 2010, OPT EXPRESS, V18, P5713, DOI 10.1364/OE.18.005713; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Lomb L, 2012, J APPL CRYSTALLOGR, V45, P674, DOI 10.1107/S0021889812024557; Luber S, 2011, BIOCHEMISTRY-US, V50, P6308, DOI 10.1021/bi200681q; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Navarro MP, 2013, P NATL ACAD SCI USA, V110, P15561, DOI 10.1073/pnas.1304334110; Neutze R, 2012, CURR OPIN STRUC BIOL, V22, P651, DOI 10.1016/j.sbi.2012.08.006; Philipp HT, 2011, NUCL INSTRUM METH A, V649, P67, DOI 10.1016/j.nima.2010.11.189; Pushkar YL, 2008, P NATL ACAD SCI USA, V105, P1879, DOI 10.1073/pnas.0707092105; Read RJ, 2003, ACTA CRYSTALLOGR D, V59, P1891, DOI 10.1107/S0907444903017918; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Renger G, 2012, BBA-BIOENERGETICS, V1817, P1164, DOI 10.1016/j.bbabio.2012.02.005; Rivalta I, 2012, CURR OPIN CHEM BIOL, V16, P11, DOI 10.1016/j.cbpa.2012.03.003; Sauter NK, 2013, ACTA CRYSTALLOGR D, V69, P1274, DOI 10.1107/S0907444913000863; Siegbahn PEM, 2013, BBA-BIOENERGETICS, V1827, P1003, DOI 10.1016/j.bbabio.2012.10.006; Siegbahn PEM, 2013, J AM CHEM SOC, V135, P9442, DOI 10.1021/ja401517e; Spence JCH, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/10/102601; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vellieux FMD, 1997, J APPL CRYSTALLOGR, V30, P396, DOI 10.1107/S0021889896012551; Wampler RD, 2008, J AM CHEM SOC, V130, P14076, DOI 10.1021/ja805983b; Weierstall U, 2008, EXP FLUIDS, V44, P675, DOI 10.1007/s00348-007-0426-8; Weierstall U, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3693040; White TA, 2012, J APPL CRYSTALLOGR, V45, P335, DOI 10.1107/S0021889812002312; Yamaguchi K, 2013, INT J QUANTUM CHEM, V113, P453, DOI 10.1002/qua.24280; Yano J, 2008, INORG CHEM, V47, P1711, DOI 10.1021/ic7016837; Yano J, 2007, PHOTOSYNTH RES, V92, P289, DOI 10.1007/s11120-007-9153-5; Zouni A, 2000, BBA-BIOENERGETICS, V1457, P103, DOI 10.1016/S0005-2728(00)00100-6; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	59	330	356	8	412	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					261	+		10.1038/nature13453	http://dx.doi.org/10.1038/nature13453			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25043005	Green Accepted			2022-12-01	WOS:000341362800056
J	Saha, SK; Parachoniak, CA; Ghanta, KS; Fitamant, J; Ross, KN; Najem, MS; Gurumurthy, S; Akbay, EA; Sia, D; Cornella, H; Miltiadous, O; Walesky, C; Deshpande, V; Zhu, AX; Hezel, AF; Yen, KE; Straley, KS; Travins, J; Popovici-Muller, J; Gliser, C; Ferrone, CR; Apte, U; Llovet, JM; Wong, KK; Ramaswamy, S; Bardeesy, N				Saha, Supriya K.; Parachoniak, Christine A.; Ghanta, Krishna S.; Fitamant, Julien; Ross, Kenneth N.; Najem, Mortada S.; Gurumurthy, Sushma; Akbay, Esra A.; Sia, Daniela; Cornella, Helena; Miltiadous, Oriana; Walesky, Chad; Deshpande, Vikram; Zhu, Andrew X.; Hezel, Aram F.; Yen, Katharine E.; Straley, Kimberly S.; Travins, Jeremy; Popovici-Muller, Janeta; Gliser, Camelia; Ferrone, Cristina R.; Apte, Udayan; Llovet, Josep M.; Wong, Kwok-Kin; Ramaswamy, Sridhar; Bardeesy, Nabeel			Mutant IDH inhibits HNF-4 alpha to block hepatocyte differentiation and promote biliary cancer	NATURE			English	Article							INTRAHEPATIC CHOLANGIOCARCINOMA; LIVER-REGENERATION; MUTATION; GROWTH; MICE; PROLIFERATION; PROGENITORS; HOMEOSTASIS; EXPRESSION	Mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 are among the most common genetic alterations in intrahepatic cholangiocarcinoma (IHCC), a deadly liver cancer(1-5). Mutant IDH proteins in IHCC and other malignancies acquire an abnormal enzymatic activity allowing themto convert alpha-ketoglutarate (alpha KG) to 2-hydroxyglutarate (2HG), which inhibits the activity of multiple alpha KG-dependent dioxygenases, and results in alterations in cell differentiation, survival, and extracellular matrix maturation(6-10). However, the molecular pathways by which IDH mutations lead to tumour formation remain unclear. Here we show that mutant IDH blocks liver progenitor cells from undergoing hepatocyte differentiation through the production of 2HG and suppression of HNF-4 alpha, a master regulator of hepatocyte identity and quiescence. Correspondingly, genetically engineered mouse models expressing mutant IDH in the adult liver show an aberrant response to hepatic injury, characterized by HNF-4 alpha silencing, impaired hepatocyte differentiation, and markedly elevated levels of cell proliferation. Moreover, IDH and Kras mutations, genetic alterations that co-exist in a subset of human IHCCs4,5, cooperate to drive the expansion of liver progenitor cells, development of premalignant biliary lesions, and progression to metastatic IHCC. These studies provide a functional link between IDH mutations, hepatic cell fate, and IHCC pathogenesis, and present a novel genetically engineered mouse model of IDH-driven malignancy.	[Saha, Supriya K.; Parachoniak, Christine A.; Ghanta, Krishna S.; Fitamant, Julien; Ross, Kenneth N.; Najem, Mortada S.; Gurumurthy, Sushma; Deshpande, Vikram; Zhu, Andrew X.; Ferrone, Cristina R.; Ramaswamy, Sridhar; Bardeesy, Nabeel] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA; [Akbay, Esra A.; Wong, Kwok-Kin] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Dept Med, Boston, MA 02115 USA; [Sia, Daniela; Cornella, Helena; Llovet, Josep M.] Univ Barcelona, Hosp Clin, Barcelona Clin Liver Canc Grp, HCC Translat Res Lab,IDIBAPS,Liver Unit, Catalonia 08036, Spain; [Sia, Daniela; Miltiadous, Oriana; Llovet, Josep M.] Icahn Sch Med Mt Sinai, Dept Med, Div Liver Dis, Mt Sinai Liver Canc Program, New York, NY 10029 USA; [Sia, Daniela] Natl Canc Inst, Gastrointestinal Surg & Liver Transplantat Unit, I-20133 Milan, Italy; [Sia, Daniela] Dept Expt Oncol, I-20133 Milan, Italy; [Walesky, Chad; Apte, Udayan] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Hezel, Aram F.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Yen, Katharine E.; Straley, Kimberly S.; Travins, Jeremy; Popovici-Muller, Janeta; Gliser, Camelia] Agios Pharmaceut, Cambridge, MA 02139 USA; [Llovet, Josep M.] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Catalonia, Spain; [Llovet, Josep M.] Univ Barcelona, Catalonia 08036, Spain; [Ramaswamy, Sridhar] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Icahn School of Medicine at Mount Sinai; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Kansas; University of Kansas Medical Center; University of Rochester; Agios Pharmaceuticals; ICREA; University of Barcelona; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bardeesy, N (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA.	Bardeesy.Nabeel@mgh.harvard.edu	Ghanta, Krishna S./M-1307-2019; Llovet, Josep M/ABB-6264-2021; Saha, Supriya/AAC-5365-2019; Llovet, Josep M/D-4340-2014	Ghanta, Krishna S./0000-0001-7502-3141; Llovet, Josep M/0000-0003-0547-2667; Llovet, Josep M/0000-0003-0547-2667; Sia, Daniela/0000-0002-9000-611X; Akbay, Esra/0000-0002-4149-2529; Miltiadous, Oriana/0000-0002-1571-3893; wong, kwok kin/0000-0001-6323-235X	TargetCancer Foundation; National Institutes of Health [R01CA136567-02, P50CA1270003]; Cholangiocarcinoma Foundation/Conquer Cancer Foundation of ASCO Young Investigator Award; American Cancer Society Postdoctoral Fellowship [PF-13-294-01-TBG]; Canadian Institutes of Health Research postdoctoral fellowship; Asociacion Espanola para el Estudio del Cancer; NATIONAL CANCER INSTITUTE [R01CA136567, P50CA127003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007792, R01DK098414] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	TargetCancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cholangiocarcinoma Foundation/Conquer Cancer Foundation of ASCO Young Investigator Award; American Cancer Society Postdoctoral Fellowship(American Cancer Society); Canadian Institutes of Health Research postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); Asociacion Espanola para el Estudio del Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ICREA(ICREA)	We thank R. Mostoslavsky, L. Ellisen, A. Kimmelman, and members of the Bardeesy laboratory for valuable input. We also thank S. Thorgeirsson and J. Andersen for sharing unpublished data sets. This work was supported by grants from TargetCancer Foundation and the National Institutes of Health (R01CA136567-02 and P50CA1270003) to N.B. N.B. holds the Gallagher Endowed Chair in Gastrointestinal Cancer Research at Massachusetts General Hospital. S. K. S. is the recipient of a Cholangiocarcinoma Foundation/Conquer Cancer Foundation of ASCO Young Investigator Award, and an American Cancer Society Postdoctoral Fellowship (PF-13-294-01-TBG). C. A. P. is the recipient of a Canadian Institutes of Health Research postdoctoral fellowship. N.B., J. M. L. and D. S are members of the Samuel Waxman Cancer Research Foundation Institute Without Walls. J. M. L. and D. S. are supported by the Asociacion Espanola para el Estudio del Cancer.	Avruch J, 2011, BRIT J CANCER, V104, P24, DOI 10.1038/sj.bjc.6606011; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Bluteau O, 2002, NAT GENET, V32, P312, DOI 10.1038/ng1001; Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Davis MI, 2014, J BIOL CHEM, V289, P13717, DOI 10.1074/jbc.M113.511030; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Hezel AF, 2010, J CLIN ONCOL, V28, P3531, DOI 10.1200/JCO.2009.27.4787; Kang JS, 2007, CANCER RES, V67, P11141, DOI 10.1158/0008-5472.CAN-07-1369; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Michalopoulos GK, 2013, COMPR PHYSIOL, V3, P485, DOI 10.1002/cphy.c120014; O'Dell MR, 2012, CANCER RES, V72, P1557, DOI 10.1158/0008-5472.CAN-11-3596; Oishi N, 2012, HEPATOLOGY, V56, P1792, DOI 10.1002/hep.25890; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Preisegger KH, 1999, LAB INVEST, V79, P103; Razumilava N, 2014, LANCET, V383, P2168, DOI 10.1016/S0140-6736(13)61903-0; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Sia D, 2013, GASTROENTEROLOGY, V144, P829, DOI 10.1053/j.gastro.2013.01.001; Strick-Marchand H, 2002, HEPATOLOGY, V36, P794, DOI 10.1053/jhep.2002.36123; Tefferi A, 2010, LEUKEMIA, V24, P1302, DOI 10.1038/leu.2010.113; Torres-Padilla ME, 2001, MECH DEVELOP, V109, P183, DOI 10.1016/S0925-4773(01)00521-4; Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9; Voss JS, 2013, HUM PATHOL, V44, P1216, DOI 10.1016/j.humpath.2012.11.006; Walesky C, 2013, HEPATOLOGY, V57, P2480, DOI 10.1002/hep.26251; Wang P, 2013, ONCOGENE, V32, P3091, DOI 10.1038/onc.2012.315; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112	38	290	302	3	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					110	+		10.1038/nature13441	http://dx.doi.org/10.1038/nature13441			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25043045	Green Accepted			2022-12-01	WOS:000341174800040
J	Ishimura, R; Nagy, G; Dotu, I; Zhou, HH; Yang, XL; Schimmel, P; Senju, S; Nishimura, Y; Chuang, JH; Ackerman, SL				Ishimura, Ryuta; Nagy, Gabor; Dotu, Ivan; Zhou, Huihao; Yang, Xiang-Lei; Schimmel, Paul; Senju, Satoru; Nishimura, Yasuharu; Chuang, Jeffrey H.; Ackerman, Susan L.			Ribosome stalling induced by mutation of a CNS-specific tRNA causes neurodegeneration	SCIENCE			English	Article							MESSENGER-RNA; IN-VIVO; TRANSLATION; MOUSE; DISSOCIATION; REVEALS; FAMILY; GTPBP2	In higher eukaryotes, transfer RNAs (tRNAs) with the same anticodon are encoded by multiple nuclear genes, and little is known about how mutations in these genes affect translation and cellular homeostasis. Similarly, the surveillance systems that respond to such defects in higher eukaryotes are not clear. Here, we discover that loss of GTPBP2, a novel binding partner of the ribosome recycling protein Pelota, in mice with a mutation in a tRNA gene that is specifically expressed in the central nervous system causes ribosome stalling and widespread neurodegeneration. Our results not only define GTPBP2 as a ribosome rescue factor but also unmask the disease potential of mutations in nuclear-encoded tRNA genes.	[Ishimura, Ryuta; Nagy, Gabor; Ackerman, Susan L.] Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; [Ishimura, Ryuta; Nagy, Gabor; Ackerman, Susan L.] Jackson Lab, Bar Harbor, ME 04609 USA; [Dotu, Ivan; Chuang, Jeffrey H.] Jackson Lab Genom Med, Farmington, CT 06030 USA; [Zhou, Huihao; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Senju, Satoru; Nishimura, Yasuharu] Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Chuo Ku, Kumamoto 8608556, Japan	Howard Hughes Medical Institute; Jackson Laboratory; Jackson Laboratory; Scripps Research Institute; Kumamoto University	Ackerman, SL (corresponding author), Howard Hughes Med Inst, 600 Main St, Bar Harbor, ME 04609 USA.	susan.ackerman@jax.org	Yang, Xiang-Lei/AAR-7107-2020; ZHOU, HUIHAO/L-6133-2016	ZHOU, HUIHAO/0000-0002-9675-5007; Nagy, Gabor/0000-0001-7452-5174; Yang, Xiang-Lei/0000-0003-2554-084X; Chuang, Jeffrey/0000-0002-3298-2358; Dotu, Ivan/0000-0002-0438-9557	CORE grant [CA34196]; National Science Foundation [0850155]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS096600, R01NS085092] Funding Source: NIH RePORTER	CORE grant; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Data were deposited in GenBank (GSE56127). We thank The Jackson Laboratory sequencing, histology, microinjection, and multimedia services for their assistance. We also thank K. Brown for mouse husbandry assistance and W. Frankel for comments on the manuscript. This work was supported in part by an institutional CORE grant CA34196 (JAX) and a National Science Foundation Award 0850155 to J.H.C. as part of the American Recovery and Reinvestment Act. S. L. A. is an investigator of the Howard Hughes Medical Institute.	Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Goldowitz D, 2004, MOL BRAIN RES, V132, P105, DOI 10.1016/j.molbrainres.2004.09.016; Goodenbour JM, 2006, NUCLEIC ACIDS RES, V34, P6137, DOI 10.1093/nar/gkl725; Guydosh NR, 2014, CELL, V156, P950, DOI 10.1016/j.cell.2014.02.006; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kudo H, 2000, BIOCHEM BIOPH RES CO, V272, P456, DOI 10.1006/bbrc.2000.2763; LEVINGER L, 1995, J BIOL CHEM, V270, P18903, DOI 10.1074/jbc.270.32.18903; Levinger L, 2012, RNA BIOL, V9, P283, DOI 10.4161/rna.19025; Moore SD, 2005, MOL MICROBIOL, V58, P456, DOI 10.1111/j.1365-2958.2005.04832.x; Pisareva VP, 2011, EMBO J, V30, P1804, DOI 10.1038/emboj.2011.93; Rooijers K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3886; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; Watanabe M, 2000, GENE, V256, P51, DOI 10.1016/S0378-1119(00)00346-2; Yanagitani K, 2011, SCIENCE, V331, P586, DOI 10.1126/science.1197142	17	247	250	4	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					455	459		10.1126/science.1249749	http://dx.doi.org/10.1126/science.1249749			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061210	Green Accepted			2022-12-01	WOS:000339655100044
J	Moore, TJ; Cohen, MR; Mattison, DR				Moore, Thomas J.; Cohen, Michael R.; Mattison, Donald R.			Dabigatran, bleeding, and the regulators	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MECHANICAL HEART-VALVES; ATRIAL-FIBRILLATION; WARFARIN; ETEXILATE; SAFETY		[Moore, Thomas J.; Cohen, Michael R.] Inst Safe Medicat Practices, Horsham, PA 19044 USA; [Mattison, Donald R.] Risk Sci Int, Ottawa, ON, Canada; [Mattison, Donald R.] Univ Ottawa, Ottawa, ON, Canada	University of Ottawa	Moore, TJ (corresponding author), Inst Safe Medicat Practices, 200 Lakeside Dr,Suite 200, Horsham, PA 19044 USA.	tmoore@ismp.org	Mattison, Donald/L-4661-2013	Mattison, Donald/0000-0001-5623-0874; Moore, Thomas/0000-0003-0994-836X				Advisory Committee Briefing Document, 2010, DRUG SUBST DAB ET; [Anonymous], 2012, MIN ANSW CHMP HOC AD; [Anonymous], 2011, CHMP ASSESSMENT REPO; [Anonymous], 2014, PRESCR INF XARELTO R; [Anonymous], 2014, FDA STUDY MEDICARE P; [Anonymous], 2014, PRESCR INF PRADAXA D; [Anonymous], 2012, CHMP ASSESSMENT REPO; [Anonymous], 2008, CHMP ASSESSMENT REPO; [Anonymous], 2012, U12107201; [Anonymous], 2012, BIPIPRA0028572360KLI; [Anonymous], 2014, PRESCR INF ELIZUIS A; [Anonymous], 2012, CV SCIENT ADV GROUP; Avorn J, 2013, CIRCULATION, V128, P745, DOI 10.1161/CIRCULATIONAHA.113.003419; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Cardiovascular and Renal Drugs Advisory Committee, 2010, M MOND SEP 20 2010 F; Connolly SJ, 2010, NEW ENGL J MED, V363, P1875, DOI 10.1056/NEJMc1007378; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Eikelboom JW, 2013, NEW ENGL J MED, V369, P1206, DOI 10.1056/NEJMoa1300615; Eikelboom JW, 2013, J AM COLL CARDIOL, V62, P900, DOI 10.1016/j.jacc.2013.05.042; FDA Drug Safety Communication, 2012, UPD RISK SER BLEED E; FDA Drug Safety Communication, SAF REV POST MARK RE; Larsen TB, 2013, J AM COLL CARDIOL, V61, P2264, DOI 10.1016/j.jacc.2013.03.020; Luik S, 2010, BIPIPRA006011738; Moore T. J., 2012, QUARTERWATCH; Moore TJ, 2011, QUARTERWATCH; Reilly PA, 2014, J AM COLL CARDIOL, V63, P321, DOI 10.1016/j.jacc.2013.07.104; Schulman S, 2010, J THROMB HAEMOST, V8, P202, DOI 10.1111/j.1538-7836.2009.03678.x; Southworth MR, 2013, NEW ENGL J MED, V368, P1272, DOI 10.1056/NEJMp1302834; Stangier J, 2012, BLOOD COAGUL FIBRIN, V23, P138, DOI 10.1097/MBC.0b013e32834f1b0c; ten Cate H, 2013, THROMB J, V11, DOI 10.1186/1477-9560-11-8; Unger EF, 2010, SUMMARY REVIEW DEPUT; Van de Werf F, 2012, AM HEART J, V163, P931, DOI 10.1016/j.ahj.2012.03.011	32	59	59	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2014	349								g4517	10.1136/bmj.g4517	http://dx.doi.org/10.1136/bmj.g4517			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VP	25056265				2022-12-01	WOS:000339565900002
J	Arnegard, ME; McGee, MD; Matthews, B; Marchinko, KB; Conte, GL; Kabir, S; Bedford, N; Bergek, S; Chan, YF; Jones, FC; Kingsley, DM; Peichel, CL; Schluter, D				Arnegard, Matthew E.; McGee, Matthew D.; Matthews, Blake; Marchinko, Kerry B.; Conte, Gina L.; Kabir, Sahriar; Bedford, Nicole; Bergek, Sara; Chan, Yingguang Frank; Jones, Felicity C.; Kingsley, David M.; Peichel, Catherine L.; Schluter, Dolph			Genetics of ecological divergence during speciation	NATURE			English	Article							DEPENDENT POSTMATING ISOLATION; ADAPTIVE RADIATION; NATURAL-SELECTION; 3-SPINED STICKLEBACKS; TROPHIC POSITION; SPECIES-PAIR; HABITAT USE; EVOLUTION; ADAPTATION; SIZE	Ecological differences often evolve early in speciation as divergent natural selection drives adaptation to distinct ecological niches, leading ultimately to reproductive isolation. Although this process is a major generator of biodiversity, its genetic basis is still poorly understood. Here we investigate the genetic architecture of niche differentiation in a sympatric species pair of threespine stickleback fish by mapping the environment-dependent effects of phenotypic traits on hybrid feeding and performance under semi-natural conditions. We show that multiple, unlinked loci act largely additively to determine position along the major niche axis separating these recently diverged species. We also find that functional mismatch between phenotypic traits reduces the growth of some stickleback hybrids beyond that expected from an intermediate phenotype, suggesting a role for epistasis between the underlying genes. This functional mismatch might lead to hybrid incompatibilities that are analogous to those underlying intrinsic reproductive isolation but depend on the ecological context.	[Arnegard, Matthew E.; Peichel, Catherine L.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA; [Arnegard, Matthew E.; Peichel, Catherine L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Arnegard, Matthew E.; Marchinko, Kerry B.; Conte, Gina L.; Kabir, Sahriar; Bedford, Nicole; Schluter, Dolph] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Arnegard, Matthew E.; Marchinko, Kerry B.; Conte, Gina L.; Kabir, Sahriar; Bedford, Nicole; Schluter, Dolph] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [McGee, Matthew D.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Matthews, Blake] EAWAG, Ctr Ecol Evolut & Biogeochem, Dept Aquat Ecol, CH-6047 Kastanienbaum, Switzerland; [Bergek, Sara] Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden; [Chan, Yingguang Frank; Jones, Felicity C.; Kingsley, David M.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Chan, Yingguang Frank; Jones, Felicity C.; Kingsley, David M.] Howard Hughes Med Inst, Stanford, CA 94305 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of British Columbia; University of British Columbia; University of California System; University of California Davis; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Uppsala University; Stanford University; Howard Hughes Medical Institute	Arnegard, ME (corresponding author), Fred Hutchinson Canc Res Ctr, Human Biol Div, 1100 Fairview Ave North, Seattle, WA 98109 USA.	marnegar@fhcrc.org	Jones, Felicity C/AAY-3523-2021; Chan, Yingguang Frank/ABG-9852-2020; Matthews, Blake/B-5608-2009	Jones, Felicity C/0000-0002-5027-1031; Chan, Yingguang Frank/0000-0001-6292-9681; Matthews, Blake/0000-0001-9089-704X; Bedford, Nicole/0000-0001-5700-1774; Schluter, Dolph/0000-0003-1683-7836; Peichel, Catherine/0000-0002-7731-8944	US National Institutes of Health [F32GM086125, R01 GM089733, P50 HG002568]; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089733, F32GM086125] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Perez for counting gill rakers; C. Sather for performing lab work for SNP genotyping; and K. Broman, G. Coop, I. Goodliffe, A. Greenwood, P. Wainwright, M. White and M. Wund for constructive comments. Stable isotopes were analysed at the University of California, Davis, Stable Isotope Facility. Funding was provided by grants from the US National Institutes of Health (F32GM086125 to M. E. A., R01 GM089733 to C. L. P. and D. S., and P50 HG002568 to C. L. P. and D. M. K.), the Natural Sciences and Engineering Research Council of Canada (to D. S.) and the Canada Foundation for Innovation (to D.S.).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albert AYK, 2008, EVOLUTION, V62, P76, DOI 10.1111/j.1558-5646.2007.00259.x; [Anonymous], 2011, R LANG ENV STAT COMP; Arnegard ME, 2010, AM NAT, V176, P335, DOI 10.1086/655221; Barrett RDH, 2011, NAT REV GENET, V12, P767, DOI 10.1038/nrg3015; Behm JE, 2010, AM NAT, V175, P11, DOI 10.1086/648559; Bolnick D. I., 2011, INT J ECOL, V2011, DOI [10.1155/2011/942847, DOI 10.1155/2011/942847)]; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Burnham KP., 2002, MODEL SELECTION MULT, V2; Candolin U, 2001, OIKOS, V95, P225, DOI 10.1034/j.1600-0706.2001.950204.x; Carlson SM, 2010, ECOLOGY, V91, P1016, DOI 10.1890/09-0252.1; Chase J.M., 2003, ECOLOGICAL NICHES LI; Coyne J.A., 2004, SPECIATION; Darwin C., 1859, ORIGIN SPECIES MEANS; Dryden I. L., 2009, PACKAGE SHAPES STAT; Egan SP, 2009, P NATL ACAD SCI USA, V106, P19426, DOI 10.1073/pnas.0909424106; ENGLE RF, 1986, APPL MATH COMPUT, V20, P313, DOI 10.1016/0096-3003(86)90009-3; Erickson DL, 2004, MOL ECOL, V13, P2505, DOI 10.1111/j.1365-294X.2004.02254.x; Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009; Fisher R.A., 1930, GENETICAL THEORY NAT; FRY B., 2006, STABLE ISOTOPE ECOLO; GAVRILETS S, 2004, MONOGRAPHS POPULATIO, V41; Gow JL, 2007, J EVOLUTION BIOL, V20, P2173, DOI 10.1111/j.1420-9101.2007.01427.x; Gow JL, 2006, MOL ECOL, V15, P739, DOI 10.1111/j.1365-294X.2006.02825.x; Hadfield J., 2012, PACKAGE MASTERBAYES; Hadfield JD, 2006, MOL ECOL, V15, P3715, DOI 10.1111/j.1365-294X.2006.03050.x; Harmon LJ, 2009, NATURE, V458, P1167, DOI 10.1038/nature07974; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hothorn T, 2012, PACKAGE IMTEST TESTI; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Jones FC, 2012, CURR BIOL, V22, P83, DOI 10.1016/j.cub.2011.11.045; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Lumley T, 2009, PACKAGE LEAPS REGRES; MacColl ADC, 2009, BIOL J LINN SOC, V96, P425, DOI 10.1111/j.1095-8312.2008.01123.x; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Maechler M., 2011, PACKAGE DIPTEST HART; MALLOWS CL, 1973, TECHNOMETRICS, V15, P661, DOI 10.2307/1267380; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; Marchinko KB, 2009, EVOLUTION, V63, P127, DOI 10.1111/j.1558-5646.2008.00529.x; Matthews B, 2010, ECOLOGY, V91, P1025, DOI 10.1890/09-0235.1; McBride CS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000529; McGee MD, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-277; McGee MD, 2013, EVOLUTION, V67, P1204, DOI 10.1111/j.1558-5646.2012.01839.x; McIntyre PB, 2006, OECOLOGIA, V148, P12, DOI 10.1007/s00442-005-0354-3; MCPHAIL JD, 1992, CAN J ZOOL, V70, P361, DOI 10.1139/z92-054; Miller A., 2002, MG STAT PRO, V95; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Rogers SM, 2012, EVOLUTION, V66, P2439, DOI 10.1111/j.1558-5646.2012.01622.x; Rohlf F.J., 2006, TPSDIG2; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Rundle HD, 2002, EVOLUTION, V56, P322, DOI 10.1111/j.0014-3820.2002.tb01342.x; Sambrook JF., 2001, MOL CLONING LAB MANU; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI [10.2307/2408904, 10.1111/j.1558-5646.1988.tb02507.x]; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; SCHLUTER D, 1993, ECOLOGY, V74, P699, DOI 10.2307/1940797; SCHLUTER D, 1995, ECOLOGY, V76, P82, DOI 10.2307/1940633; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schluter D, 2009, P NATL ACAD SCI USA, V106, P9955, DOI 10.1073/pnas.0901264106; Seehausen O, 2014, NAT REV GENET, V15, P176, DOI 10.1038/nrg3644; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Strasburg JL, 2012, PHILOS T R SOC B, V367, P364, DOI 10.1098/rstb.2011.0199; Taylor EB, 2000, P ROY SOC B-BIOL SCI, V267, P2375, DOI 10.1098/rspb.2000.1294; Theil H, 1961, EC FORECASTS POLICY; Van Ooijen JW, 2001, JOINMAP 3 0 SOFTWARE; Vander Zanden MJ, 2002, ECOLOGY, V83, P2152, DOI 10.1890/0012-9658(2002)083[2152:FAIOBA]2.0.CO;2; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; Wootton R.J., 1984, FUNCTIONAL BIOL STIC; Yeaman S, 2011, EVOLUTION, V65, P1897, DOI 10.1111/j.1558-5646.2011.01269.x	82	186	187	12	449	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					307	+		10.1038/nature13301	http://dx.doi.org/10.1038/nature13301			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	24909991	Green Accepted			2022-12-01	WOS:000338992200027
J	Chong, SS; Chen, CY; Ge, H; Xie, XS				Chong, Shasha; Chen, Chongyi; Ge, Hao; Xie, X. Sunney			Mechanism of Transcriptional Bursting in Bacteria	CELL			English	Article							STOCHASTIC GENE-EXPRESSION; RNA-POLYMERASE MOLECULES; REAL-TIME OBSERVATION; SINGLE-MOLECULE; ESCHERICHIA-COLI; DNA GYRASE; FLUCTUATING ENVIRONMENTS; TOPOISOMERASE-I; OXOLINIC ACID; CENTRAL DOGMA	Transcription of highly expressed genes has been shown to occur in stochastic bursts. But the origin of such ubiquitous phenomenon has not been understood. Here, we present the mechanism in bacteria. We developed a high-throughput, in vitro, single-molecule assay to follow transcription on individual DNA templates in real time. We showed that positive supercoiling buildup on a DNA segment by transcription slows down transcription elongation and eventually stops transcription initiation. Transcription can be resumed upon gyrase binding to the DNA segment. Furthermore, using single-cell mRNA counting fluorescence in situ hybridization (FISH), we found that duty cycles of transcriptional bursting depend on the intracellular gyrase concentration. Together, these findings prove that transcriptional bursting of highly expressed genes in bacteria is primarily caused by reversible gyrase dissociation from and rebinding to a DNA segment, changing the supercoiling level of the segment.	[Chong, Shasha; Chen, Chongyi; Xie, X. Sunney] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Chen, Chongyi] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Ge, Hao; Xie, X. Sunney] Peking Univ, Biodynam Opt Imaging Ctr BIOPIC, Beijing 100871, Peoples R China; [Ge, Hao] Peking Univ, BICMR, Beijing 100871, Peoples R China	Harvard University; Harvard University; Peking University; Peking University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	Chen, Chongyi/D-4178-2015	Chen, Chongyi/0000-0002-0504-5369; Chong, Shasha/0000-0002-5372-311X	NIH [1DP1OD000277, 5R01GM096450-02]; National Science Foundation of China [21373021]; Foundation for the Author of National Excellent Doctoral Dissertation of China [201119]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096450] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Xiaowei Zhuang for the collaboration on bacterial chromosomal structure study, which prompted us to conduct the current study; N. Patrick Higgins for providing the plasmid containing strong gyrase site sequence; Gene-Wei Li for development of FISH protocol; Minbiao Ji for help with microscope construction; Rahul Roy for advice on data analysis; and James Wang, Long Cai, Gene-Wei Li, and Paul Choi for critical reading of the manuscript. This work was supported by NIH Pioneer Award (1DP1OD000277; to X.S.X.), NIH grant TR01 (5R01GM096450-02; to X.S.X.), National Science Foundation of China (21373021; to H.G.), and the Foundation for the Author of National Excellent Doctoral Dissertation of China (201119; to H.G.).	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Bai L, 2006, ANNU REV BIOPH BIOM, V35, P343, DOI 10.1146/annurev.biophys.35.010406.150153; BAKER TA, 1987, J BIOL CHEM, V262, P6877; Billingsley DJ, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/2/021001; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bustamante C, 2011, CELL, V144, P480, DOI 10.1016/j.cell.2011.01.033; Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; Deng S, 2004, P NATL ACAD SCI USA, V101, P3398, DOI 10.1073/pnas.0307550101; Deng S, 2005, MOL MICROBIOL, V57, P1511, DOI 10.1111/j.1365-2958.2005.04796.x; Drolet M, 2006, MOL MICROBIOL, V59, P723, DOI 10.1111/j.1365-2958.2005.05006.x; Efron B., 1993, MONOGRAPHS STAT APPL, DOI 10.1007/978-1-4899-4541-9; El Hanafi D, 2000, MOL MICROBIOL, V37, P583; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; FRANCO RJ, 1988, J MOL BIOL, V201, P229, DOI 10.1016/0022-2836(88)90449-4; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Gore J, 2006, NATURE, V439, P100, DOI 10.1038/nature04319; Guptasarma P, 1996, BIOESSAYS, V18, P325, DOI 10.1002/bies.950180411; Hardy CD, 2005, MOL MICROBIOL, V57, P1636, DOI 10.1111/j.1365-2958.2005.04799.x; Hebenstreit D, 2013, TRENDS GENET, V29, P333, DOI 10.1016/j.tig.2013.04.001; Herbert KM, 2008, ANNU REV BIOCHEM, V77, P149, DOI 10.1146/annurev.biochem.77.073106.100741; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; HIGGINS NP, 1982, NUCLEIC ACIDS RES, V10, P6833, DOI 10.1093/nar/10.21.6833; Hocine S, 2013, NAT METHODS, V10, P119, DOI 10.1038/nmeth.2305; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Leng FF, 2011, P NATL ACAD SCI USA, V108, P19973, DOI 10.1073/pnas.1109854108; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Lim HM, 2003, BIOCHEMISTRY-US, V42, P10718, DOI 10.1021/bi030110t; Lionberger TA, 2010, BIOPHYS J, V99, P1139, DOI 10.1016/j.bpj.2010.04.074; Lionnet T, 2011, NAT METHODS, V8, P165, DOI 10.1038/NMETH.1551; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; LYNCH AS, 1993, J BACTERIOL, V175, P1645, DOI 10.1128/JB.175.6.1645-1655.1993; Ma J, 2013, SCIENCE, V340, P1580, DOI 10.1126/science.1235441; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; MAXWELL A, 1984, J BIOL CHEM, V259, P4472; Mitarai N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000109; MORRISON A, 1981, P NATL ACAD SCI-BIOL, V78, P1416, DOI 10.1073/pnas.78.3.1416; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Muramoto T, 2012, P NATL ACAD SCI USA, V109, P7350, DOI 10.1073/pnas.1117603109; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Peter BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r87; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; RAU DC, 1987, J MOL BIOL, V193, P555, DOI 10.1016/0022-2836(87)90266-X; REECE RJ, 1991, CRIT REV BIOCHEM MOL, V26, P335, DOI 10.3109/10409239109114072; Revyakin A, 2004, P NATL ACAD SCI USA, V101, P4776, DOI 10.1073/pnas.0307241101; Revyakin A, 2012, GENE DEV, V26, P1691, DOI 10.1101/gad.194936.112; Rovinskiy N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002845; Samul R, 2007, J MOL BIOL, V374, P925, DOI 10.1016/j.jmb.2007.10.011; Shundrovsky A, 2004, BIOPHYS J, V87, P3945, DOI 10.1529/biophysj.104.044081; Singh A, 2010, BIOPHYS J, V98, pL32, DOI 10.1016/j.bpj.2010.03.001; Skinner GM, 2004, J BIOL CHEM, V279, P3239, DOI 10.1074/jbc.M310471200; SNYDER M, 1979, J MOL BIOL, V131, P287, DOI 10.1016/0022-2836(79)90077-9; So LH, 2011, NAT GENET, V43, P554, DOI 10.1038/ng.821; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Tang GQ, 2009, P NATL ACAD SCI USA, V106, P22175, DOI 10.1073/pnas.0906979106; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; TENHEGGELERBORDIER B, 1992, EMBO J, V11, P667, DOI 10.1002/j.1460-2075.1992.tb05098.x; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; TSAO YP, 1989, CELL, V56, P111, DOI 10.1016/0092-8674(89)90989-6; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Weixlbaumer A, 2013, CELL, V152, P431, DOI 10.1016/j.cell.2012.12.020; WILLMOTT CJR, 1994, J MOL BIOL, V242, P351, DOI 10.1006/jmbi.1994.1586; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8; Zhang ZJ, 2014, ELIFE, V3, DOI 10.7554/eLife.01775; Zong CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.96	81	219	222	2	112	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					314	326		10.1016/j.cell.2014.05.038	http://dx.doi.org/10.1016/j.cell.2014.05.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036631	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000340943600012
J	Koton, S; Schneider, ALC; Rosamond, WD; Shahar, E; Sang, YY; Gottesman, RF; Coresh, J				Koton, Silvia; Schneider, Andrea L. C.; Rosamond, Wayne D.; Shahar, Eyal; Sang, Yingying; Gottesman, Rebecca F.; Coresh, Josef			Stroke Incidence and Mortality Trends in US Communities, 1987 to 2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; ISCHEMIC-STROKE; CARDIOVASCULAR-DISEASE; IMPROVED SURVIVAL; TEMPORAL TRENDS; INCIDENCE RATES; POPULATION; ATHEROSCLEROSIS; SEVERITY; AUCKLAND	IMPORTANCE Prior studies have shown decreases in stroke mortality over time, but data on validated stroke incidence and long-term trends by race are limited. OBJECTIVE To study trends in stroke incidence and subsequent mortality among black and white adults in the Atherosclerosis Risk in Communities (ARIC) cohort from 1987 to 2011. DESIGN, SETTING, AND PARTICIPANTS Prospective cohort study of 14 357 participants (282 097 person-years) free of stroke at baseline was facilitated in 4 different US communities. Participants were recruited for the purpose of studying all stroke hospitalizations and deaths and for collection of baseline information on cardiovascular risk factors (via interviews and physical examinations) in 1987-1989. Participants were followed up (via examinations, annual phone interviews, active surveillance of discharges from local hospitals, and linkage with the National Death Index) through December 31, 2011. The study physician reviewers adjudicated all possible strokes and classified them as definite or probable ischemic or hemorrhagic events. MAIN OUTCOMES AND MEASURES Trends in rates of first-ever stroke per 10 years of calendar time were estimated using Poisson regression incidence rate ratios (IRRs), with subsequent mortality analyzed using Cox proportional hazards regression models and hazard ratios (HRs) overall and by race, sex, and age divided at 65 years. RESULTS Among 1051 (7%) participants with incident stroke, there were 929 with incident ischemic stroke and 140 with incident hemorrhagic stroke (18 participants had both during the study period). Crude incidence rates were 3.73 (95% CI, 3.51-3.96) per 1000 person-years for total stroke, 3.29 (95% CI, 3.08-3.50) per 1000 person-years for ischemic stroke, and 0.49 (95% CI, 0.41-0.57) per 1000 person-years for hemorrhagic stroke. Stroke incidence decreased over time in white and black participants (age-adjusted IRRs per 10-year period, 0.76 [95% CI, 0.66-0.87]; absolute decrease of 0.93 per 1000 person-years overall). The decrease in age-adjusted incidence was evident in participants age 65 years and older (age-adjusted IRR per 10-year period, 0.69 [95% CI, 0.59-0.81]; absolute decrease of 1.35 per 1000 person-years) but not evident in participants younger than 65 years (age-adjusted IRR per 10-year period, 0.97 [95% CI, 0.76-1.25]; absolute decrease of 0.09 per 1000 person-years) (P =.02 for interaction). The decrease in incidence was similar by sex. Of participants with incident stroke, 614 (58%) died through 2011. The mortality rate was higher for hemorrhagic stroke (68%) than for ischemic stroke (57%). Overall, mortality after stroke decreased over time (hazard ratio [HR], 0.80 [95% CI, 0.66-0.98]; absolute decrease of 8.09 per 100 strokes after 10 years [per 10-year period]). The decrease in mortality was mostly accounted for by the decrease at younger than age 65 years (HR, 0.65 [95% CI, 0.46-0.93]; absolute decrease of 14.19 per 100 strokes after 10 years [per 10-year period]), but was similar across race and sex. CONCLUSIONS AND RELEVANCE In a multicenter cohort of black and white adults in US communities, stroke incidence and mortality rates decreased from 1987 to 2011. The decreases varied across age groups, but were similar across sex and race, showing that improvements in stroke incidence and outcome continued to 2011. Copyright 2014 American Medical Association. All rights reserved.	[Koton, Silvia] Tel Aviv Univ, Sackler Fac Med, Stanley Steyer Sch Hlth Profess, IL-69978 Tel Aviv, Israel; [Koton, Silvia; Schneider, Andrea L. C.; Sang, Yingying; Gottesman, Rebecca F.; Coresh, Josef] Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21287 USA; [Rosamond, Wayne D.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Shahar, Eyal] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Div Epidemiol & Biostat, Tucson, AZ USA; [Gottesman, Rebecca F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA	Tel Aviv University; Sackler Faculty of Medicine; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of Arizona; Johns Hopkins University	Coresh, J (corresponding author), Johns Hopkins Univ, Dept Epidemiol, 2024 E Monument,Ste 2-630, Baltimore, MD 21287 USA.	coresh@jhu.edu	Gottesman, Rebecca/ABA-8468-2020	Christman Schneider, Andrea Lauren/0000-0003-0026-5052; KOTON, SILVIA/0000-0002-9327-7505	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; National Institutes of Health (NIH)/NHLBI [T32 HL007024]; NIH/NHLBI [R01 AG040282];  [U01 HL096812];  [HL096814];  [HL096899];  [HL096902];  [HL096917];  [R01-HL70825]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL096812, U01HL096899, U01HL096917, U01HL096814, U01HL096902, T32HL007024, R01HL070825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040282] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (NIH)/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Atherosclerosis Risk in Communities (ARIC) study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute (NHLBI) contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C) with neurocognitive studies supported by U01 HL096812, HL096814, HL096899, HL096902, HL096917, and with previous brain magnetic resonance imaging examinations funded by R01-HL70825. Dr Schneider reports receipt of grant support from the National Institutes of Health (NIH)/NHLBI T32 HL007024. Dr Gottesman reports receit of grant support from NIH/NHLBI R01 AG040282.	Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; Anderson CS, 2005, STROKE, V36, P2087, DOI 10.1161/01.STR.0000181079.42690.bf; BRODERICK JP, 1989, STROKE, V20, P577, DOI 10.1161/01.STR.20.5.577; Carandang R, 2006, JAMA-J AM MED ASSOC, V296, P2939, DOI 10.1001/jama.296.24.2939; Carter KN, 2007, CEREBROVASC DIS, V23, P162, DOI 10.1159/000097054; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; Centers for Disease Control and Prevention National Center for Health Statistics, 2012, COMPL COMPR MORT FIL, V20; Chroinin DN, 2013, STROKE, V44, P448, DOI 10.1161/STROKEAHA.112.668277; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hata J, 2013, CIRCULATION, V128, P1198, DOI 10.1161/CIRCULATIONAHA.113.002424; Heuschmann PU, 2008, STROKE, V39, P2204, DOI 10.1161/STROKEAHA.107.507285; Islam SM, 2008, STROKE, V39, P776, DOI 10.1161/STROKEAHA.107.493643; Kelly AG, 2012, NEUROLOGY, V79, P941, DOI 10.1212/WNL.0b013e318266fc40; Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d; Kleindorfer DO, 2010, STROKE, V41, P1326, DOI 10.1161/STROKEAHA.109.575043; Koton S, 2010, NEUROEPIDEMIOLOGY, V34, P90, DOI 10.1159/000264826; Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf; MAY DS, 1994, STROKE, V25, P2343, DOI 10.1161/01.STR.25.12.2343; Medin J, 2004, STROKE, V35, P1047, DOI 10.1161/01.STR.0000125866.78674.96; Numminen H, 1996, STROKE, V27, P1487, DOI 10.1161/01.STR.27.9.1487; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Rosengren A, 2013, STROKE, V44, P2388, DOI 10.1161/STROKEAHA.113.001170; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Schmidt M, 2014, NEUROLOGY, V82, P340, DOI 10.1212/WNL.0000000000000062; SHAHAR E, 1995, STROKE, V26, P1; Shahar E, 1997, STROKE, V28, P275, DOI 10.1161/01.STR.28.2.275; Sivenius J, 2004, STROKE, V35, P420, DOI 10.1161/01.STR.0000110220.63212.59; Thorvaldsen P, 1999, STROKE, V30, P2529, DOI 10.1161/01.STR.30.12.2529; Wieberdink RG, 2012, EUR J EPIDEMIOL, V27, P287, DOI 10.1007/s10654-012-9673-y; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	31	330	334	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2014	312	3					259	268		10.1001/jama.2014.7692	http://dx.doi.org/10.1001/jama.2014.7692			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2FC	25027141	Bronze			2022-12-01	WOS:000338940300023
J	Casadei, CM; Gumiero, A; Metcalfe, CL; Murphy, EJ; Basran, J; Concilio, MG; Teixeira, SCM; Schrader, TE; Fielding, AJ; Ostermann, A; Blakeley, MP; Raven, EL; Moody, PCE				Casadei, Cecilia M.; Gumiero, Andrea; Metcalfe, Clive L.; Murphy, Emma J.; Basran, Jaswir; Concilio, Maria Grazia; Teixeira, Susana C. M.; Schrader, Tobias E.; Fielding, Alistair J.; Ostermann, Andreas; Blakeley, Matthew P.; Raven, Emma L.; Moody, Peter C. E.			Neutron cryo-crystallography captures the protonation state of ferryl heme in a peroxidase	SCIENCE			English	Article							CYTOCHROME-C PEROXIDASE; COMPOUND-I FORMATION; H BOND ACTIVATION; HORSERADISH-PEROXIDASE; CATALYTIC PATHWAY; CRYSTAL-STRUCTURE; ES; INTERMEDIATE; MECHANISM; RESONANCE	Heme enzymes activate oxygen through formation of transient iron-oxo (ferryl) intermediates of the heme iron. A long-standing question has been the nature of the iron-oxygen bond and, in particular, the protonation state. We present neutron structures of the ferric derivative of cytochrome c peroxidase and its ferryl intermediate; these allow direct visualization of protonation states. We demonstrate that the ferryl heme is an Fe(IV)=O species and is not protonated. Comparison of the structures shows that the distal histidine becomes protonated on formation of the ferryl intermediate, which has implications for the understanding of O-O bond cleavage in heme enzymes. The structures highlight the advantages of neutron cryo-crystallography in probing reaction mechanisms and visualizing protonation states in enzyme intermediates.	[Casadei, Cecilia M.; Basran, Jaswir; Moody, Peter C. E.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Casadei, Cecilia M.; Basran, Jaswir; Moody, Peter C. E.] Univ Leicester, Henry Wellcome Labs Struct Biol, Leicester LE1 9HN, Leics, England; [Casadei, Cecilia M.; Teixeira, Susana C. M.; Blakeley, Matthew P.] Inst Max Von Laue Paul Langevin, F-38000 Grenoble, France; [Gumiero, Andrea; Metcalfe, Clive L.; Murphy, Emma J.; Raven, Emma L.] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England; [Concilio, Maria Grazia; Fielding, Alistair J.] Univ Manchester, Photon Sci Inst, Manchester M13 9PL, Lancs, England; [Teixeira, Susana C. M.] Keele Univ, EPSAM, Keele ST5 5BG, Staffs, England; [Schrader, Tobias E.] Forschungszentrum Julich, JCNS, Outstn MLZ, D-85747 Garching, Germany; [Ostermann, Andreas] Tech Univ Munich, Heinz Maier Leibnitz Zentrum MLZ, D-85748 Garching, Germany	University of Leicester; University of Leicester; Institut Laue-Langevin (ILL); University of Leicester; University of Manchester; Keele University; Helmholtz Association; Research Center Julich; Technical University of Munich	Raven, EL (corresponding author), Univ Leicester, Dept Chem, Univ Rd, Leicester LE1 7RH, Leics, England.	emma.raven@le.ac.uk; peter.moody@le.ac.uk	Teixeira, Susana/H-2824-2013; Fielding, Alistair J./AAR-3101-2021; Blakeley, Matthew Paul/G-7984-2015; Concilio, Maria Grazia/GRX-4452-2022; Teixeira, Susana C. M./H-2205-2016; Moody, Peter/A-6832-2008	Teixeira, Susana/0000-0002-1967-0026; Fielding, Alistair J./0000-0002-4437-9791; Blakeley, Matthew Paul/0000-0002-6412-4358; Concilio, Maria Grazia/0000-0002-6534-4838; Teixeira, Susana C. M./0000-0002-6603-7936; Moody, Peter/0000-0003-1762-9238; Murphy, Emma/0000-0003-4551-8068; Schrader, Tobias Erich/0000-0001-5159-0846; Raven, Emma/0000-0002-1643-8694; Metcalfe, Clive/0000-0002-7856-8574	Leverhulme Trust [F/00 212/Q]; Biotechnology and Biological Sciences Research Council [BB/C001184/1]; Wellcome Trust, an Institut Laue-Langevin studentship [WT094104MA]; EU [283883]; Bruker UK; BBSRC [BB/K015656/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K015656/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust, an Institut Laue-Langevin studentship; EU(European Commission); Bruker UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank D. Collison for assistance with EPR, P. Ortiz de Montellano for discussions on the mechanisms, S. Fisher for assistance with the joint x-ray/neutron refinement, and the University of Leicester BioMedical Workshop for custom building of microspectrophotometry equipment, and J. Devos and the D-lab for experimental support. Atomic coordinates have been deposited in the Protein Data Bank under accession codes 4CVI for ferric CcP and 4CVJ for compound I. This work was supported by The Leverhulme Trust (grant F/00 212/Q to E.L.R./P.C.E.M.), Biotechnology and Biological Sciences Research Council (grant BB/C001184/1 to E.L.R./P.C.E.M., and a studentship to E. J. M.), The Wellcome Trust (grant WT094104MA to P.C.E.M./E.L.R.), an Institut Laue-Langevin studentship (to C. M. C.) and beam time at LADI-III and BIODIFF (EU FP7 NMI3-II grant 283883), Bruker UK (Sponsorship of A.J.F. and M. G. C.), and beam time at LADI-III and BIODIFF. P. C. E. M., M. P. B., and E. L. R. designed the research; C. M. C., A. G., M. P. B., A.O., S. C. M. T, T. E. S., C. L. M., E.J.M., and P. C. E. M. performed crystallographic experiments; C. M. C., A. G., M. P. B., S. C. M. T., A.O., T. E. S., E. L. R., and P. C. E. M. analyzed crystallographic data; C. M. C., A.J.F., M. G. C., J.B., and P. C. E. M. performed spectroscopic experiments; C. M. C., A. G., A.J.F., M. G. C., E. L. R., and P. C. E. M. analyzed spectra; and E. L. R., M. P. B., and P. C. E. M. wrote the paper, with contributions from all authors.	[Anonymous], 1999, HEME PEROXIDASES; Behan RK, 2006, J INORG BIOCHEM, V100, P448, DOI 10.1016/j.jinorgbio.2005.12.019; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Blakeley MP, 2009, CRYSTALLOGR REV, V15, P157, DOI 10.1080/08893110902965003; Blakeley MP, 2004, P NATL ACAD SCI USA, V101, P16405, DOI 10.1073/pnas.0405109101; Davidson VL, 2011, NAT CHEM, V3, P662, DOI 10.1038/nchem.1122; Derat E, 2006, J PHYS CHEM B, V110, P10526, DOI 10.1021/jp055412e; Dunford H. B., 2010, PEROXIDASES CATALASE; EDWARDS SL, 1987, BIOCHEMISTRY-US, V26, P1503, DOI 10.1021/bi00380a002; Efimov I, 2011, J AM CHEM SOC, V133, P15376, DOI 10.1021/ja2007017; ERMAN JE, 1992, J AM CHEM SOC, V114, P6592, DOI 10.1021/ja00042a068; ERMAN JE, 1975, BIOCHIM BIOPHYS ACTA, V393, P350, DOI 10.1016/0005-2795(75)90061-6; Groves JT, 2014, NAT CHEM, V6, P89, DOI 10.1038/nchem.1855; Gumiero A, 2011, J BIOL CHEM, V286, P1260, DOI 10.1074/jbc.M110.183483; HORI H, 1985, J BIOL CHEM, V260, P349; HUYETT JE, 1995, J AM CHEM SOC, V117, P9033, DOI 10.1021/ja00140a021; Karlin KD, 2010, NATURE, V463, P168, DOI 10.1038/463168a; Kellner DG, 2002, J BIOL CHEM, V277, P9641, DOI 10.1074/jbc.C100745200; McDonald AR, 2011, NAT CHEM, V3, P761, DOI 10.1038/nchem.1153; Meharenna YT, 2010, BIOCHEMISTRY-US, V49, P2984, DOI 10.1021/bi100238r; Ortiz de Montellano PR, 2005, CYTOCHROME P450 STRU, V3rd; Pond AE, 1998, INORG CHIM ACTA, V276, P250; POULOS TL, 1980, J BIOL CHEM, V255, P8199; POULOS TL, 1980, J BIOL CHEM, V255, P575; Que L, 2008, NATURE, V455, P333, DOI 10.1038/nature07371; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Shaik S, 2005, CHEM REV, V105, P2279, DOI 10.1021/cr030722j; SITTER AJ, 1985, J BIOL CHEM, V260, P7515; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; Sligar SG, 2010, SCIENCE, V330, P924, DOI 10.1126/science.1197881; Terner J, 2006, J INORG BIOCHEM, V100, P480, DOI 10.1016/j.jinorgbio.2006.01.008; Vidossich P, 2010, J PHYS CHEM B, V114, P5161, DOI 10.1021/jp911170b; Yosca TH, 2013, SCIENCE, V342, P825, DOI 10.1126/science.1244373	34	117	117	1	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					193	197		10.1126/science.1254398	http://dx.doi.org/10.1126/science.1254398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013070	Green Submitted, Green Accepted			2022-12-01	WOS:000339409900048
J	Zolla-Pazner, S				Zolla-Pazner, Susan			A critical question for HIV vaccine development: Which antibodies to induce?	SCIENCE			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; POTENT NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; HIV-1-INFECTED INDIVIDUALS; V3 LOOP; CONFORMATIONAL EPITOPE; EFFICACY TRIAL; CD4 BINDING; BROAD; SUPERINFECTION	A vaccine against HIV-1 must prevent infection against genetically diverse virus strains. Two approaches are currently being pursued to elicit antibody-mediated protection: vaccines that induce potent and broadly reactive neutralizing antibodies (bnAbs) or vaccines that induce "conventional antibodies," which are less potent and broadly neutralizing in comparison. Although bnAbs may provide the greatest level of protection, their structural and genetic characteristics make their elicitation through vaccination a major challenge. In contrast, conventional HIV-1 antibodies have been induced by vaccination and correlated with reduced HIV-1 infection in a phase III vaccine trial. Here, I present evidence that both approaches should be pursued with equal vigor.	[Zolla-Pazner, Susan] New York Vet Affairs Harbor Healthcare Syst, New York, NY 10010 USA; [Zolla-Pazner, Susan] NYU, Sch Med, New York, NY 10016 USA	New York University	Zolla-Pazner, S (corresponding author), New York Vet Affairs Harbor Healthcare Syst, New York, NY 10010 USA.	zollas01@med.nyu.edu	Zolla-Pazner, Susan/S-1864-2019	Zolla-Pazner, Susan/0000-0002-0750-2666	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100151] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL059725, R01 HL59725] Funding Source: Medline; NIAID NIH HHS [P01 AI100151, P01 AI 100151] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrus L, 1998, J INFECT DIS, V177, P889, DOI 10.1086/515251; Bar KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002721; Basu D, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-76; Bhattacharyya S, 2013, J BIOL CHEM, V288, P9815, DOI 10.1074/jbc.M112.425959; Blish CA, 2008, J VIROL, V82, P12094, DOI 10.1128/JVI.01730-08; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Delany I, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012476; EMINI EA, 1990, J VIROL, V64, P3674, DOI 10.1128/JVI.64.8.3674-3678.1990; Forthal DN, 2013, JAIDS-J ACQ IMM DEF, V63, P31, DOI 10.1097/QAI.0b013e3182874d41; Georgiev IS, 2014, J IMMUNOL, V192, P1100, DOI 10.4049/jimmunol.1302515; Gorny MK, 2012, VIROLOGY, V427, P198, DOI 10.1016/j.virol.2012.02.003; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; Haynes BF, 2014, SCIENCE, V344, P588, DOI 10.1126/science.1254990; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Israel ZR, 1997, AIDS, V11, P128; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lambert JS, 1997, J INFECT DIS, V175, P283, DOI 10.1093/infdis/175.2.283; Li LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039534; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Moody MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025797; Moore PL, 2013, J VIROL, V87, P4882, DOI 10.1128/JVI.03424-12; Mouquet H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024078; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Pollara J, 2014, J VIROL, V88, P7715, DOI 10.1128/JVI.00156-14; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; ROBBINS JB, 1995, J INFECT DIS, V171, P1387, DOI 10.1093/infdis/171.6.1387; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Ronen K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003593; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Smith DM, 2006, VIROLOGY, V355, P1, DOI 10.1016/j.virol.2006.08.009; Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Totrov M, 2010, VIROLOGY, V405, P513, DOI 10.1016/j.virol.2010.06.027; Vaine M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013916; Verrier F, 2001, J VIROL, V75, P9177, DOI 10.1128/JVI.75.19.9177-9186.2001; VijhWarrier S, 1996, J VIROL, V70, P4466, DOI 10.1128/JVI.70.7.4466-4473.1996; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Watkins JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018207; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner Susan, 2005, Human Antibodies, V14, P69; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572; Zolla-Pazner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053629; Zolla-Pazner S, 2011, J VIROL, V85, P9887, DOI 10.1128/JVI.05086-11	67	27	35	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					167	168		10.1126/science.1256526	http://dx.doi.org/10.1126/science.1256526			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013066	Green Accepted			2022-12-01	WOS:000339409900040
J	Gravitz, L				Gravitz, Lauren			SOCIOLOGY Shedding the shame	NATURE			English	Editorial Material							EPILEPSY											Ekenze OS, 2013, EPILEPSY BEHAV, V26, P87, DOI 10.1016/j.yebeh.2012.10.016; Kale R, 1997, BRIT MED J, V315, P2, DOI 10.1136/bmj.315.7099.2; Meador KJ, 2011, NEUROLOGY, V77, P1305, DOI 10.1212/WNL.0b013e318230a18f	3	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					S10	S11		10.1038/511S10a	http://dx.doi.org/10.1038/511S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8AP	25019128	Bronze			2022-12-01	WOS:000338649800005
J	Brenguier, F; Campillo, M; Takeda, T; Aoki, Y; Shapiro, NM; Briand, X; Emoto, K; Miyake, H				Brenguier, F.; Campillo, M.; Takeda, T.; Aoki, Y.; Shapiro, N. M.; Briand, X.; Emoto, K.; Miyake, H.			Mapping pressurized volcanic fluids from induced crustal seismic velocity drops	SCIENCE			English	Article							TOHOKU EARTHQUAKE; FAULT; AFTERSHOCKS; SUBSIDENCE; ROCKS	Volcanic eruptions are caused by the release of pressure that has accumulated due to hot volcanic fluids at depth. Here, we show that the extent of the regions affected by pressurized fluids can be imaged through the measurement of their response to transient stress perturbations. We used records of seismic noise from the Japanese Hi-net seismic network to measure the crustal seismic velocity changes below volcanic regions caused by the 2011 moment magnitude (M-w) 9.0 Tohoku-Oki earthquake. We interpret coseismic crustal seismic velocity reductions as related to the mechanical weakening of the pressurized crust by the dynamic stress associated with the seismic waves. We suggest, therefore, that mapping seismic velocity susceptibility to dynamic stress perturbations can be used for the imaging and characterization of volcanic systems.	[Brenguier, F.; Campillo, M.; Briand, X.] Univ Grenoble 1, CNRS, Inst Sci Terre, F-38041 Grenoble, France; [Takeda, T.; Emoto, K.] Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki, Japan; [Aoki, Y.; Miyake, H.] Univ Tokyo, Earthquake Res Inst, Tokyo 113, Japan; [Shapiro, N. M.] CNRS UMR7154, Sorbonne Paris Cite, Inst Phys Globe Paris, F-75238 Paris 5, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie; National Research Institute for Earth Science & Disaster Resilience; University of Tokyo; UDICE-French Research Universities; Universite Paris Cite	Brenguier, F (corresponding author), Univ Grenoble 1, CNRS, Inst Sci Terre, F-38041 Grenoble, France.	florent.brenguier@ujf-grenoble.fr	Aoki, Yosuke/I-8801-2019; Campillo, Michel/AAC-5666-2019; Shapiro, Nikolai M/G-1049-2010; Brenguier, Florent/E-4843-2017; Campillo, Michel/K-6231-2012	Aoki, Yosuke/0000-0002-2539-4144; Campillo, Michel/0000-0001-6971-4499; Shapiro, Nikolai M/0000-0002-0144-723X; Brenguier, Florent/0000-0001-8684-7613; Campillo, Michel/0000-0001-6971-4499	Rhone-Alpes region [CPER07_13 CIRA]; France Grilles; CNRS MASTODONS program; French National Research Agency [2011-JAPN-006-NAMAZU]; Japan Science and Technology Agency [2011-JAPN-006-NAMAZU]; European Union through the projects European Research Council [227507, FP7 RI283542]; Grants-in-Aid for Scientific Research [25800244] Funding Source: KAKEN	Rhone-Alpes region(Region Auvergne-Rhone-Alpes); France Grilles; CNRS MASTODONS program; French National Research Agency(French National Research Agency (ANR)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); European Union through the projects European Research Council; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	All of the seismological data used in this study are archived at the Japanese National Research Institute for Earth Science and Disaster Prevention (NIED) (www.hinet.bosai.go.jp/?LANG=en and www.kyoshin.bosai.go.jp/). The seismological data used in this study are available upon request at the NIED data center. We thank Geospatial Information Authority of Japan for access to Global Navigation Satellite System data. All of the computations in this study were performed using the High-Performance Computing (CIMENT) infrastructure (https://ciment.ujf-grenoble.fr), which is supported by the Rhone-Alpes region (GRANT CPER07_13 CIRA: www.ci-ra.org), France Grilles (www.france-grilles.fr), and the CNRS MASTODONS program. We acknowledge the French National Research Agency and the Japan Science and Technology Agency for funding support (project 2011-JAPN-006-NAMAZU). We received support from the European Union through the projects European Research Council advanced grant 227507 "Whisper" and FP7 RI283542 "VERCE." We thank T. Nishimura, P. Johnson, G. Olivier, G. Hillers, C. Jaupart, and T. Lecocq for useful discussions.	Adams LH, 1923, J FRANKL INST, V195, P475, DOI 10.1016/S0016-0032(23)90314-5; Brenguier F, 2008, SCIENCE, V321, P1478, DOI 10.1126/science.1160943; Gomberg J, 1996, B SEISMOL SOC AM, V86, P212; Hirose F, 2011, EARTH PLANETS SPACE, V63, P513, DOI 10.5047/eps.2011.05.019; Husen S, 2004, GEOLOGY, V32, P537, DOI 10.1130/G20381.1; Husen S, 2004, J VOLCANOL GEOTH RES, V131, P397, DOI 10.1016/S0377-0273(03)00416-5; Lees JM, 2007, J VOLCANOL GEOTH RES, V167, P37, DOI 10.1016/j.jvolgeores.2007.06.008; LOCKNER DA, 1977, J GEOPHYS RES, V82, P5374, DOI 10.1029/JB082i033p05374; Pollitz FF, 2012, NATURE, V490, P250, DOI 10.1038/nature11504; Pritchard ME, 2013, NAT GEOSCI, V6, P632, DOI [10.1038/ngeo1855, 10.1038/NGEO1855]; Rubinstein JL, 2007, NATURE, V448, P579, DOI 10.1038/nature06017; Shapiro SA, 2003, GEOPHYSICS, V68, P482, DOI 10.1190/1.1567215; Takada Y, 2013, NAT GEOSCI, V6, P637, DOI [10.1038/NGEO1857, 10.1038/ngeo1857]; Wegler U, 2007, GEOPHYS J INT, V168, P1029, DOI 10.1111/j.1365-246X.2006.03284.x; Yukutake Y, 2011, EARTH PLANETS SPACE, V63, P737, DOI 10.5047/eps.2011.05.004; Zhao DP, 2002, PHYS EARTH PLANET IN, V132, P249, DOI 10.1016/S0031-9201(02)00082-1; Zigone D, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009160; Zinszner B, 1997, J GEOPHYS RES-SOL EA, V102, P8105, DOI 10.1029/96JB03225	18	165	170	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					80	82		10.1126/science.1254073	http://dx.doi.org/10.1126/science.1254073			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994652				2022-12-01	WOS:000338284400054
J	Li, Y; Calvo, SE; Gutman, R; Liu, JS; Mootha, VK				Li, Yang; Calvo, Sarah E.; Gutman, Roee; Liu, Jun S.; Mootha, Vamsi K.			Expansion of Biological Pathways Based on Evolutionary Inference	CELL			English	Article							MITOCHONDRIAL CALCIUM UNIPORTER; PROTEOMIC ANALYSIS; COMPLEX; PROTEIN; GENES; GENOMICS; DISEASE; IDENTIFICATION; PREDICTION; TRANSPORT	The availability of diverse genomes makes it possible to predict gene function based on shared evolutionary history. This approach can be challenging, however, for pathways whose components do not exhibit a shared history but rather consist of distinct "evolutionary modules." We introduce a computational algorithm, clustering by inferred models of evolution (CLIME), which inputs a eukaryotic species tree, homology matrix, and pathway (gene set) of interest. CLIME partitions the gene set into disjoint evolutionary modules, simultaneously learning the number of modules and a tree-based evolutionary history that defines each module. CLIME then expands each module by scanning the genome for new components that likely arose under the inferred evolutionary model. Application of CLIME to similar to 1,000 annotated human pathways and to the proteomes of yeast, red algae, and malaria reveals unanticipated evolutionary modularity and coevolving components. CLIME is freely available and should become increasingly powerful with the growing wealth of eukaryotic genomes.	[Li, Yang; Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Li, Yang; Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Li, Yang; Liu, Jun S.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Calvo, Sarah E.; Mootha, Vamsi K.] Broad Inst, Cambridge, MA 02141 USA; [Gutman, Roee] Brown Univ, Dept Biostat, Providence, RI 02912 USA; [Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Brown University; Harvard University; Harvard Medical School	Liu, JS (corresponding author), Harvard Univ, Dept Stat, Cambridge, MA 02138 USA.	jliu@stat.harvard.edu; vamsi@hms.harvard.edu	/AAD-1516-2020; Gutman, Roee/J-2355-2014	Gutman, Roee/0000-0001-7095-3016	NIH [GM0077465]; National Science Foundations [DMS-1007762, IIS-1017967]; Shenzhen Special Fund for Strategic Emerging Industry grant [ZD201111080127A]; Investigator of the Howard Hughes Medical Institute; Division Of Mathematical Sciences [1007762] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077465] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundations(National Science Foundation (NSF)); Shenzhen Special Fund for Strategic Emerging Industry grant; Investigator of the Howard Hughes Medical Institute(Howard Hughes Medical Institute); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jagesh Shah for curation of cilia-related genes and Eran Mick and Daniel Arlow for manuscript feedback. This work was supported in part by grants from the NIH (GM0077465 to V.K.M.), National Science Foundations (DMS-1007762 and IIS-1017967 to J.S.L.), and the Shenzhen Special Fund for Strategic Emerging Industry grant (ZD201111080127A to J.S.L.). V.K.M. is an Investigator of the Howard Hughes Medical Institute.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Barker D, 2005, PLOS COMPUT BIOL, V1, P24, DOI 10.1371/journal.pcbi.0010003; Barker D, 2007, BIOINFORMATICS, V23, P14, DOI 10.1093/bioinformatics/btl558; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bick AG, 2012, SCIENCE, V336, P886, DOI 10.1126/science.1214977; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; Blacque OE, 2008, FRONT BIOSCI-LANDMRK, V13, P2633, DOI 10.2741/2871; DORFMAN BZ, 1969, GENETICS, V61, P377; DOVEY HF, 1984, MOL BIOCHEM PARASIT, V11, P157, DOI 10.1016/0166-6851(84)90062-8; Duleh SN, 2010, CYTOSKELETON, V67, P193, DOI 10.1002/cm.20437; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Gabaldon T, 2005, EVOL BIOINFORM, V1, P51; Glazko GV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r32; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Harbour ME, 2012, BIOCHEM J, V442, P209, DOI 10.1042/BJ20111761; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jamerson M, 2012, MICROBIOL-SGM, V158, P791, DOI 10.1099/mic.0.055020-0; Jim K, 2004, GENOME RES, V14, P109; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kensche PR, 2008, J R SOC INTERFACE, V5, P151, DOI 10.1098/rsif.2007.1047; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lim L, 2010, PHILOS T R SOC B, V365, P749, DOI 10.1098/rstb.2009.0273; Liu Jun S., 2008, MONTE CARLO STRATEGI; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Smith JC, 2005, J PROTEOME RES, V4, P909, DOI 10.1021/pr050013h; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Tabach Y, 2013, NATURE, V493, P694, DOI 10.1038/nature11779; Trachana K, 2011, BIOESSAYS, V33, P769, DOI 10.1002/bies.201100062; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Vert Jean-Philippe, 2002, Bioinformatics, V18 Suppl 1, pS276; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wapinski I, 2007, BIOINFORMATICS, V23, pI549, DOI 10.1093/bioinformatics/btm193; Zhou Y, 2006, J MOL BIOL, V359, P1150, DOI 10.1016/j.jmb.2006.04.011	45	70	72	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					213	225		10.1016/j.cell.2014.05.034	http://dx.doi.org/10.1016/j.cell.2014.05.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995987	Green Accepted, Bronze			2022-12-01	WOS:000340943100019
J	Qiao, S; Luo, QS; Zhao, Y; Zhang, XJC; Huang, YH				Qiao, Shuai; Luo, Qingshan; Zhao, Yan; Zhang, Xuejun Cai; Huang, Yihua			Structural basis for lipopolysaccharide insertion in the bacterial outer membrane	NATURE			English	Article							FUNCTIONAL-ANALYSIS; PROTEIN COMPLEX; CELL-ENVELOPE; TRANSPORT; IDENTIFICATION; MUTAGENESIS; BIOGENESIS; EXPORT; PLUG; LPTD	One of the fundamental properties of biological membranes is the asymmetric distribution of membrane lipids. In Gram-negative bacteria, the outer leaflet of the outer membrane is composed predominantly of lipopolysaccharides (LPS)(1). The export of LPS requires seven essential lipopolysaccharide transport (Lpt) proteins to move LPS from the inner membrane, through the periplasm to the surfac(2)e. Of the seven Lpt proteins, the LptD-LptE complex is responsible for inserting LPS into the external leaflet of the outer membrane(3,4). Here we report the crystal structure of the similar to 110-kilodalton membrane protein complex LptD-LptE from Shigella flexneri at 2.4 angstrom resolution. The structure reveals an unprecedented two-protein plug-and-barrel architecture with LptE embedded into a 26-stranded beta-barrel formed by LptD. Importantly, the secondary structures of the first two beta-strands are distorted by two proline residues, weakening their interactions with neighbouring beta-strands and creating a potential portal on the barrel wall that could allow lateral diffusion of LPS into the outer membrane. The crystal structure of the LptD-LptE complex opens the door to new antibiotic strategies targeting the bacterial outer membrane.	[Qiao, Shuai; Luo, Qingshan; Zhao, Yan; Zhang, Xuejun Cai; Huang, Yihua] Chinese Acad Sci, Inst Biophys, Natl Ctr Prot Sci Beijing, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Qiao, Shuai; Luo, Qingshan] Univ Chinese Acad Sci, Beijing 100101, Peoples R China; [Zhao, Yan] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Huang, YH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Ctr Prot Sci Beijing, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	yihuahuang@sun5.ibp.ac.cn		Qiao, Shuai/0000-0002-9573-8774	Ministry of Science and Technology [2012CB917302, 2013CB910603]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB080203]; National Natural Science Foundation of China [31170698]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Y. Shan for discussions, H. Wu, J. Deisenhofer, Y. Jiang, N. Huang, Z. Zhou, G. Li, Z. Liu and members of the Huang group for critically reading the manuscript. The diffraction data were collected at the Shanghai Synchrotron Radiation Facility (SSRF, China) and Beijing Synchrotron Radiation Facility of China (BSRF, China). This work was supported by grants from the Ministry of Science and Technology (2012CB917302 and 2013CB910603 to Y.H.), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB080203 to Y.H. and X.C.Z.) and the National Natural Science Foundation of China (31170698 to Y.H.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chng SS, 2012, SCIENCE, V337, P1665, DOI 10.1126/science.1227215; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; DeLano W. L., 2009, 238 ACS NAT M, V238; Denoncin K, 2010, J BIOL CHEM, V285, P29425, DOI 10.1074/jbc.M110.119321; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Grabowicz M, 2013, J BACTERIOL, V195, P1327, DOI 10.1128/JB.02142-12; Khan MA, 2009, BIOCHEMISTRY-US, V48, P9745, DOI 10.1021/bi9013566; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; MUHLRADT PF, 1975, EUR J BIOCHEM, V51, P343, DOI 10.1111/j.1432-1033.1975.tb03934.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Okuda S, 2012, SCIENCE, V338, P1214, DOI 10.1126/science.1228984; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1016/S0378-1097(98)00151-7; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Suits MDL, 2008, J MOL BIOL, V380, P476, DOI 10.1016/j.jmb.2008.04.045; Tran AX, 2010, J BIOL CHEM, V285, P33529, DOI 10.1074/jbc.M110.144709; van den Berg B, 2010, CHEMBIOCHEM, V11, P1339, DOI 10.1002/cbic.201000105; Villa R, 2013, J BACTERIOL, V195, P1100, DOI 10.1128/JB.02057-12; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103	30	169	176	1	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					108	U523		10.1038/nature13484	http://dx.doi.org/10.1038/nature13484			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990751				2022-12-01	WOS:000338199400046
J	Hakim, AM				Hakim, Antoine M.			PERSPECTIVE Silent, but preventable, perils	NATURE			English	Editorial Material							VASCULAR DEMENTIA; STROKE		[Hakim, Antoine M.] Ottawa Hosp, Res Inst, Canadian Stroke Network, Ottawa, ON, Canada; [Hakim, Antoine M.] Ottawa Hosp, Res Inst, Neurosci Res Program, Ottawa, ON, Canada; [Hakim, Antoine M.] Univ Ottawa Canada, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Hakim, AM (corresponding author), Ottawa Hosp, Res Inst, Canadian Stroke Network, Ottawa, ON, Canada.	ahakim@ohri.ca						Aguero-Torres H, 2006, DEMENT GERIATR COGN, V22, P244, DOI 10.1159/000094973; [Anonymous], 2010, POP PROJ CAN PROV TE; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Leary MC, 2003, CEREBROVASC DIS, V16, P280, DOI 10.1159/000071128; Neltner JH, 2014, BRAIN, V137, P255, DOI 10.1093/brain/awt318; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pergola P. E., 2014, AM J HYPERTENS; Shih AY, 2013, NAT NEUROSCI, V16, P55, DOI 10.1038/nn.3278	9	3	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S12	S12		10.1038/510S12a	http://dx.doi.org/10.1038/510S12a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ6LK	24964022	Bronze			2022-12-01	WOS:000337806300008
J	Wang, T; Sha, HY; Ji, DM; Zhang, HL; Chen, DW; Cao, YX; Zhu, JH				Wang, Tian; Sha, Hongying; Ji, Dongmei; Zhang, Helen L.; Chen, Dawei; Cao, Yunxia; Zhu, Jianhong			Polar Body Genome Transfer for Preventing the Transmission of Inherited Mitochondrial Diseases	CELL			English	Article							MOUSE EMBRYOS; PREIMPLANTATION EMBRYOS; POINT MUTATIONS; MTDNA MUTATIONS; HUMAN OOCYTES; DIGITAL PCR; DNA; METHYLATION; SEGREGATION; BODIES	Inherited mtDNA diseases transmit maternally and cause severe phenotypes. Currently, there is no effective therapy or genetic screens for these diseases; however, nuclear genome transfer between patients' and healthy eggs to replace mutant mtDNAs holds promises. Considering that a polar body contains few mitochondria and shares the same genomic material as an oocyte, we perform polar body transfer to prevent the transmission of mtDNA variants. We compare the effects of different types of germline genome transfer, including spindle-chromosome transfer, pronuclear transfer, and first and second polar body transfer, in mice. Reconstructed embryos support normal fertilization and produce live offspring. Importantly, genetic analysis confirms that the F1 generation from polar body transfer possesses minimal donor mtDNA carryover compared to the F1 generation from other procedures. Moreover, the mtDNA genotype remains stable in F2 progeny after polar body transfer. Our preclinical model demonstrates polar body transfer has great potential to prevent inherited mtDNA diseases.	[Wang, Tian; Sha, Hongying; Zhu, Jianhong] Fudan Univ, Inst Brain Sci, Sch Basic Med Sci, Dept Neurobiol, Shanghai 200032, Peoples R China; [Wang, Tian; Sha, Hongying; Zhu, Jianhong] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Neurosurg, Shanghai 200032, Peoples R China; [Ji, Dongmei; Chen, Dawei; Cao, Yunxia] Anhui Med Univ, Affiliated Hosp 1, Ctr Reprod Med, Dept Obstet & Gynecol, Hefei 230022, Peoples R China; [Zhang, Helen L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Fudan University; Fudan University; Anhui Medical University; Harvard University; Harvard Medical School	Sha, HY (corresponding author), Fudan Univ, Inst Brain Sci, Sch Basic Med Sci, Dept Neurobiol, Shanghai 200032, Peoples R China.	shahongying@fudan.edu.cn; jzhu@fudan.edu.cn	Chen, Dawei/V-4296-2019; Wang, Tian/AAX-8754-2021	Chen, Dawei/0000-0002-8201-0549; 	National Basic Research Program of China [2010CB945500, 2012CB966304, 2012CB944704]; Shanghai Municipality Project [11JC1401000]; National NSF [81271003]; Shanghai Medical College Accelerated Eight-Year Program (Zhengyi Scholarship) [2011S06]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipality Project; National NSF(National Natural Science Foundation of China (NSFC)); Shanghai Medical College Accelerated Eight-Year Program (Zhengyi Scholarship)	We are grateful to Dr. Bin Lai (Fudan) for assisting confocal analysis, Yimin Tian (Shanghai Geneland Biotech) for help with pyrosequencing, and Drs. Hongkui Deng (Peking University), Dangsheng Li (SIBCB), and Alastair Murchie (Fudan) for critical reading of the manuscript. This study was supported by grants from National Basic Research Program of China (2010CB945500 to J.Z., 2012CB966304 to H.S., 2012CB944704 to Y.C.), Shanghai Municipality Project (11JC1401000 to H.S.), National NSF grant (81271003 to J.Z.) and Shanghai Medical College Accelerated Eight-Year Program (Zhengyi Scholarship 2011S06 to T.W.).	Ballana E, 2008, HUM MUTAT, V29, P248, DOI 10.1002/humu.20639; BIEBER FR, 1981, SCIENCE, V213, P775, DOI 10.1126/science.7196086; Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358; Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232; Christopikou D, 2013, HUM REPROD, V28, P1426, DOI 10.1093/humrep/det053; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Dalton CM, 2013, J CELL SCI, V126, P2955, DOI 10.1242/jcs.128744; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; FDA: Cellular Tissue and Gene Therapies Advisory Committee, 2014, BRIEF DOC OOC MOD AS; Geraedts J, 2011, HUM REPROD, V26, P3173, DOI 10.1093/humrep/der294; Gigarel N, 2011, AM J HUM GENET, V88, P494, DOI 10.1016/j.ajhg.2011.03.010; Gu L, 2010, CELL CYCLE, V9, P1942, DOI 10.4161/cc.9.10.11599; HFEA, 2012, MIT PUBL CONS 2012 M; Hino T, 2013, J ASSIST REPROD GEN, V30, P91, DOI 10.1007/s10815-012-9899-3; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; HOULISTON E, 1988, DEVELOPMENT, V102, P271; HUTCHISO.CA, 1974, NATURE, V251, P536, DOI 10.1038/251536a0; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Kota SK, 2010, DEV CELL, V19, P675, DOI 10.1016/j.devcel.2010.10.009; Link J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003261; Liu HL, 2004, DEVELOPMENT, V131, P2269, DOI 10.1242/dev.01116; Lorthongpanich C, 2013, SCIENCE, V341, P1110, DOI 10.1126/science.1240617; MARO B, 1986, J EMBRYOL EXP MORPH, V92, P11; Meirelles FV, 1997, GENETICS, V145, P445; Nuffield Council on Bioethics, 2012, NOV TECHN PREV MIT D; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; Reinhardt K, 2013, SCIENCE, V341, P1345, DOI 10.1126/science.1237146; Sanders R, 2011, ANAL CHEM, V83, P6474, DOI 10.1021/ac103230c; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017; Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275; Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146; van der Heijden GW, 2005, MECH DEVELOP, V122, P1008, DOI 10.1016/j.mod.2005.04.009; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wakayama S, 2007, STEM CELLS, V25, P986, DOI 10.1634/stemcells.2006-0615; Wakayama T, 1997, J REPROD FERTIL, V110, P263, DOI 10.1530/jrf.0.1100263; Wakayama T, 1998, BIOL REPROD, V59, P100, DOI 10.1095/biolreprod59.1.100; White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190	48	104	119	8	101	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1591	1604		10.1016/j.cell.2014.04.042	http://dx.doi.org/10.1016/j.cell.2014.04.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949971	Bronze			2022-12-01	WOS:000340941900014
J	Cunningham, JT; Moreno, MV; Lodi, A; Ronen, SM; Ruggero, D				Cunningham, John T.; Moreno, Melissa V.; Lodi, Alessia; Ronen, Sabrina M.; Ruggero, Davide			Protein and Nucleotide Biosynthesis Are Coupled by a Single Rate-Limiting Enzyme, PRPS2, to Drive Cancer	CELL			English	Article							INITIATION-FACTOR 4E; C-MYC; METABOLISM; MTOR; TRANSLATION; ACTIVATION; MOUSE; SUPPRESSION; INHIBITION; EXPRESSION	Cancer cells must integrate multiple biosynthetic demands to drive indefinite proliferation. How these key cellular processes, such as metabolism and protein synthesis, crosstalk to fuel cancer cell growth is unknown. Here, we uncover the mechanism by which the Myc oncogene coordinates the production of the two most abundant classes of cellular macromolecules, proteins, and nucleic acids in cancer cells. We find that a single rate-limiting enzyme, phosphoribosyl- pyrophosphate synthetase 2 (PRPS2), promotes increased nucleotide biosynthesis in Myc-transformed cells. Remarkably, Prps2 couples protein and nucleotide biosynthesis through a specialized cis-regulatory element within the Prps2 50 UTR, which is controlled by the oncogene and translation initiation factor eIF4E downstream Myc activation. We demonstrate with a Prps2 knockout mouse that the nexus between protein and nucleotide biosynthesis controlled by PRPS2 is crucial for Myc-driven tumorigenesis. Together, these studies identify a translationally anchored anabolic circuit critical for cancer cell survival and an unexpected vulnerability for ``undruggable'' oncogenes, such as Myc.	[Cunningham, John T.; Moreno, Melissa V.; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Sch Med, San Francisco, CA 94158 USA; [Cunningham, John T.; Moreno, Melissa V.; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Urol, San Francisco, CA 94158 USA; [Lodi, Alessia; Ronen, Sabrina M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Ruggero, D (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Sch Med, San Francisco, CA 94158 USA.	davide.ruggero@ucsf.edu	Cunningham, John T./AAS-5008-2021	Cunningham, John T./0000-0001-6490-4533	NIH [R01 CA130812, R01 CA154915, R01CA140456, R01CA154916, U01HG004085]; American Cancer Society [121364-PF-11-184-01-TBG]; Children's Hospital Oakland Research Institute (CHORI)/Sanger/UC Davis Consortium [U01HG004080]; KOMP Repository at UC Davis and CHORI [U42RR024244]; NATIONAL CANCER INSTITUTE [R01CA140456, R01CA154915, R01CA154916] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR024244] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004085, U01HG004080] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Children's Hospital Oakland Research Institute (CHORI)/Sanger/UC Davis Consortium; KOMP Repository at UC Davis and CHORI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Maria Barna and Kevan Shokat for helpful discussions and their critical reading of the manuscript. D. R. is a Leukemia and Lymphoma Society Scholar. This work was supported by NIH (R01 CA130812 and R01 CA154915 to S. M. R. and R01CA140456 and R01CA154916 to D. R.) and the American Cancer Society (121364-PF-11-184-01-TBG to J.T.C.). NIH grants to Velocigene at Regeneron (U01HG004085) and the Children's Hospital Oakland Research Institute (CHORI)/Sanger/UC Davis Consortium (U01HG004080) funded the generation of gene-targeted ES cells for 8,500 genes in the KOMP Program and archived and distributed by the KOMP Repository at UC Davis and CHORI (U42RR024244). J.T.C. and D.R. are joint inventors on a UC Regents-owned patent application covering these molecules that has been licensed to eFFECTOR Therapeutics. D.R. is a shareholder of eFFECTOR Therapeutics and a member of its scientific advisory board.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Aird KM, 2013, CELL REP, V3, P1252, DOI 10.1016/j.celrep.2013.03.004; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; BECKER MA, 1990, GENOMICS, V8, P555, DOI 10.1016/0888-7543(90)90043-T; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; BOSS GR, 1982, J BIOL CHEM, V257, P4242; Bywater MJ, 2013, NAT REV CANCER, V13, P299, DOI 10.1038/nrc3496; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Dang Chi V, 2010, Genes Cancer, V1, P526; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Doherty JR, 2014, CANCER RES, V74, P908, DOI 10.1158/0008-5472.CAN-13-2034; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; GEYER PK, 1982, MOL CELL BIOL, V2, P685, DOI 10.1128/MCB.2.6.685; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; Graves JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013717; Gunther UL, 2000, J MAGN RESON, V145, P201, DOI 10.1006/jmre.2000.2071; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsieh AC, 2010, CLIN CANCER RES, V16, P4914, DOI 10.1158/1078-0432.CCR-10-0433; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Jones RM, 1996, MOL CELL BIOL, V16, P4754; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Ludwig C, 2012, METABOLOMICS, V8, P8, DOI 10.1007/s11306-011-0347-7; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; Morrish F, 2008, CELL CYCLE, V7, P1054, DOI 10.4161/cc.7.8.5739; NOSAL JM, 1993, J BIOL CHEM, V268, P10168; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Pourdehnada M, 2013, P NATL ACAD SCI USA, V110, P11988, DOI 10.1073/pnas.1310230110; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Ronen SM, 2001, BRIT J CANCER, V84, P691, DOI 10.1054/bjoc.2000.1663; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Shim H, 1998, P NATL ACAD SCI USA, V95, P1511, DOI 10.1073/pnas.95.4.1511; SMOLENSKI RT, 1990, J CHROMATOGR-BIOMED, V527, P414, DOI 10.1016/S0378-4347(00)82125-8	47	147	156	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1088	1103		10.1016/j.cell.2014.03.052	http://dx.doi.org/10.1016/j.cell.2014.03.052			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855946	Bronze, Green Accepted			2022-12-01	WOS:000336437200012
J	Bekker, LG; Johnson, L; Cowan, F; Overs, C; Besada, D; Hillier, S; Cates, W				Bekker, Linda-Gail; Johnson, Leigh; Cowan, Frances; Overs, Cheryl; Besada, Donela; Hillier, Sharon; Cates, Willard, Jr.			Combination HIV prevention for female sex workers: what is the evidence?	LANCET			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; PREEXPOSURE PROPHYLAXIS; ANTIRETROVIRAL THERAPY; HIGH-RISK; POPULATION-LEVEL; CONDOM USE; HETEROSEXUAL MEN; HIV/STI RISK; DOUBLE-BLIND; VIRAL LOAD	Sex work occurs in many forms and sex workers of all genders have been affected by HIV epidemics worldwide. The determinants of HIV risk associated with sex work occur at several levels, including individual biological and behavioural, dyadic and network, and community and social environmental levels. Evidence indicates that effective HIV prevention packages for sex workers should include combinations of biomedical, behavioural, and structural interventions tailored to local contexts, and be led and implemented by sex worker communities. A model simulation based on the South African heterosexual epidemic suggests that condom promotion and distribution programmes in South Africa have already reduced HIV incidence in sex workers and their clients by more than 70%. Under optimistic model assumptions, oral pre-exposure prophylaxis together with test and treat programmes could further reduce HIV incidence in South African sex workers and their clients by up to 40% over a 10-year period. Combining these biomedical approaches with a prevention package, including behavioural and structural components as part of a community-driven approach, will help to reduce HIV infection in sex workers in different settings worldwide.	[Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7705 Observatory, South Africa; [Johnson, Leigh] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7705 Observatory, South Africa; [Cowan, Frances] UCL, Res Dept Infect & Populat Hlth, London, England; [Cowan, Frances] Ctr Sexual Hlth & HIV AIDS Res CeSHHAR Zimbabwe, Harare, Zimbabwe; [Overs, Cheryl] Michael Kirby Ctr Publ Hlth & Human Rights, Melbourne, Vic, Australia; [Besada, Donela] Desmond Tutu HIV Fdn, Cape Town, South Africa; [Hillier, Sharon] Unvers Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Cates, Willard, Jr.] FHI 360, Durham, NC USA	University of Cape Town; University of Cape Town; University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; FHI 360	Bekker, LG (corresponding author), Univ Cape Town, Fac Hlth Sci, Desmond Tutu HIV Ctr, Anzio Rd, ZA-7705 Observatory, South Africa.	Linda-Gail.Bekker@hiv-research.org.za	Bekker, Linda-Gail/AAZ-8929-2020	Besada, Donela/0000-0002-2020-5244; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Cowan, Frances/0000-0003-3087-4422	National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); UCT CTU grant [2UM1AI069519-08]; NIH [1R01AI094586-01]; Hasso Plattner Foundation; NIAID; Microbicide Trials Network [1UM1AI068633]; USAID Preventive Technologies [GHO-A-00-09-00016-00]; NIH HIV Prevention Trials Network [1U01A1068619-01]; Center for Public Health and Human Rights at Johns Hopkins Bloomberg School of Public Health; Bill & Melinda Gates Foundation; United Nations Family Planning Association (UNFPA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069519, R01AI094586, UM1AI068633] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCT CTU grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hasso Plattner Foundation; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Microbicide Trials Network; USAID Preventive Technologies(United States Agency for International Development (USAID)); NIH HIV Prevention Trials Network; Center for Public Health and Human Rights at Johns Hopkins Bloomberg School of Public Health; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); United Nations Family Planning Association (UNFPA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	L-GB is supported in part by National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), UCT CTU grant 2UM1AI069519-08. LJ received support from NIH (1R01AI094586-01) and Hasso Plattner Foundation. SH received support from NIAID, Microbicide Trials Network (1UM1AI068633). WC received support from USAID Preventive Technologies Agreement (GHO-A-00-09-00016-00) and NIAID, NIH HIV Prevention Trials Network (1U01A1068619-01). This article and The Lancet Series on HIV and sex workers was supported by grants to the Center for Public Health and Human Rights at Johns Hopkins Bloomberg School of Public Health from The Bill & Melinda Gates Foundation and from The United Nations Family Planning Association (UNFPA).	Abdool Karim Quarraisha, 2010, Science, V329, P1168, DOI 10.1126/science.1193748; Ainsworth M, 2003, HEALTH POLICY, V64, P13, DOI 10.1016/S0168-8510(02)00079-9; Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; [Anonymous], 2008, OPEN DEMOGRAPHY J, DOI [DOI 10.2174/1874918600801010001, 10.2174/1874918600801010001]; [Anonymous], 2013, 20 C RETR OPP INF AT, DOI DOI 10.1056/NEJM0A1402269; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2013, JAIDS-J ACQ IMM DEF, V63, pS122, DOI 10.1097/QAI.0b013e3182986f69; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Baral SD, 2015, LANCET, V385, P260, DOI 10.1016/S0140-6736(14)60801-1; Baral SD, 2013, LANCET INFECT DIS, V13, P13, DOI 10.1016/S1473-3099(12)70319-5; Basu I, 2004, JAIDS-J ACQ IMM DEF, V36, P845, DOI 10.1097/00126334-200407010-00012; Beyrer C, 2015, LANCET, V385, P287, DOI 10.1016/S0140-6736(14)60933-8; Birungi J, 2012, J INT AIDS SOC, V15, P144; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Boily MC, 2013, AIDS, V27, P1449, DOI 10.1097/QAD.0b013e32835fba81; Boily MC, 2002, SEX TRANSM INFECT, V78, pI78, DOI 10.1136/sti.78.suppl_1.i78; Braunstein SL, 2011, JAIDS-J ACQ IMM DEF, V57, pE70, DOI 10.1097/QAI.0b013e3182170fd3; Brown B, 2012, SEX WORKERS INTRO MA; Buzdugan R, 2009, TROP MED INT HEALTH, V14, P673, DOI 10.1111/j.1365-3156.2009.02278.x; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Centers for Disease Control and Prevention, 2021, PREEXP PROPH PREV HI; Chersich MF, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17980; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cornman H, 2012, 1 USAID AIDSTARONE; Cowan FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077080; de Walque D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000747; Delva W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028363; Diabate S, 2011, WORLD J AIDS, V1, P94, DOI [10.4236/wja.2011.13014, DOI 10.4236/WJA.2011.13014]; Dickinson C, 2009, B WORLD HEALTH ORGAN, V87, P846, DOI 10.2471/BLT.08.059279; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dunkle KL, 2005, INT J STD AIDS, V16, P256, DOI 10.1258/0956462053420220; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; FACTS Consortium, FACTS 001 STUD DES; Folch C, 2009, MED CLIN-BARCELONA, V132, P385, DOI 10.1016/j.medcli.2008.05.019; Foss AM, 2003, AIDS, V17, P1227, DOI 10.1097/00002030-200305230-00015; French PP, 2003, SEX TRANSM DIS, V30, P433, DOI 10.1097/00007435-200305000-00010; Galarraga O, EUR J HLTH EC, V15, P41; Ghose T, 2011, QUAL HEALTH RES, V21, P587, DOI 10.1177/1049732310395328; Gomez GB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001401; GOSTIN LO, 1994, JAMA-J AM MED ASSOC, V271, P1436, DOI 10.1001/jama.271.18.1436; Gouws E, 2012, SEX TRANSM INFECT, V88, pI76, DOI 10.1136/sextrans-2012-050719; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; GROSSKURTH H, 1995, AIDS, V9, P927, DOI 10.1097/00002030-199508000-00015; Grosskurth H, 2000, LANCET, V355, P1981, DOI 10.1016/S0140-6736(00)02336-9; Guest PP BJ, 2007, SURVEY SEXUAL REPROD; Hallett TB, 2008, INT J EPIDEMIOL, V37, P77, DOI 10.1093/ije/dym232; HANENBERG RS, 1994, LANCET, V344, P243, DOI 10.1016/S0140-6736(94)93004-X; Harcourt C, 2005, SEX TRANSM INFECT, V81, P201, DOI 10.1136/sti.2004.012468; Harcourt C, 2010, AUST NZ J PUBL HEAL, V34, P482, DOI 10.1111/j.1753-6405.2010.00594.x; Hargreaves J, 2013, 17 ICASA C CAP TOWN; Heffron R, 2012, JAIDS-J ACQ IMM DEF, V61, P116, DOI 10.1097/QAI.0b013e31825da73f; Heise L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18615; Holmes K, 2007, LANCET INFECT DIS, V7, P516; Hong Y, 2008, SEX TRANSM DIS, V35, P662, DOI 10.1097/OLQ.0b013e31816b322c; Hong Y, 2012, AIDS BEHAV, V16, P44, DOI 10.1007/s10461-011-9960-8; Huet Charlotte, 2011, BMC Public Health, V11, P700, DOI 10.1186/1471-2458-11-700; Human Rights Watch, 2003, FANN FLAM HUM RIGHTS; Illife J., 2006, AFRICAN AIDS EPIDEMI; Izulla P, 2013, JAIDS-J ACQ IMM DEF, V62, P220, DOI 10.1097/QAI.0b013e318278ba1b; Jana S, 2006, LANCET, V367, P814, DOI 10.1016/S0140-6736(06)68331-1; Jana S, 2004, AIDS EDUC PREV, V16, P405, DOI 10.1521/aeap.16.5.405.48734; Jia ZW, 2013, LANCET, V382, P1195, DOI 10.1016/S0140-6736(12)61898-4; Johnson LFD, 2021, THEMBISA VERSION 4 4; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, GLOB REP UNAIDS REP; Jones A, 2014, LANCET, V384, P272, DOI 10.1016/S0140-6736(13)62230-8; Kahle EM, 2013, JAIDS-J ACQ IMM DEF, V62, P339, DOI 10.1097/QAI.0b013e31827e622d; KARIM QA, 1995, AM J PUBLIC HEALTH, V85, P1521, DOI 10.2105/AJPH.85.11.1521; Karim QA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-67; Karmon E, 2003, JAIDS-J ACQ IMM DEF, V34, P71, DOI 10.1097/00126334-200309010-00011; Kaul R, 2004, JAMA-J AM MED ASSOC, V291, P2555, DOI 10.1001/jama.291.21.2555; Kayigamba FR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036792; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; Kerrigan D, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9774-9; Kerrigan D., 2001, Culture, Health & Sexuality, V3, P221, DOI 10.1080/136910501750153049; Kerrigan D, 2014, LANCET; Kerrigan DL, 2013, AIDS BEHAV, V17, P1926, DOI 10.1007/s10461-013-0458-4; Kriitmaa K, 2010, AIDS, V24, pS61, DOI 10.1097/01.aids.0000386735.87177.2a; Kulkarni Prasad S., 2003, AIDS Reviews, V5, P87; Labbe AC, 2003, 15 BIENN C INT SOC S, P27; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; Lingappa JR, 2010, LANCET, V375, P824, DOI 10.1016/S0140-6736(09)62038-9; Lippman SA, 2010, AM J PUBLIC HEALTH, V100, pS216, DOI 10.2105/AJPH.2008.147462; Lowndes CM, 2003, SEX TRANSM DIS, V30, P46, DOI 10.1097/00007435-200301000-00010; Luchters S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-143; Mamaev T., 2007, MIKROBIOL EPIDEMIOL, V3, P72; Manhart LE, 2005, J INFECT DIS, V191, pS7, DOI 10.1086/425275; Marum E, 2012, JAIDS-J ACQ IMM DEF, V60, pS63, DOI 10.1097/QAI.0b013e31825f313b; McClelland RS, 2010, AIDS, V24, P891, DOI 10.1097/QAD.0b013e32833616c7; Michael M, 2013, HEALTH TECHNOL SOC, P1, DOI 10.1057/9781137316677; MILLS E.J., 2005, BMC INT HEALTH HUM R, V5, P1; Morar NS, 1998, S AFR MED J, V88, P470; Mugwanya KK, 2013, LANCET INFECT DIS, V13, P1021, DOI 10.1016/S1473-3099(13)70226-3; Munoz J, 2010, SAHARA J-J SOC ASP H, V7, P52, DOI 10.1080/17290376.2010.9724957; Murnane PM, 2013, AIDS, V27, P2155, DOI 10.1097/QAD.0b013e3283629037; Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465; Nel AM, 2011, J WOMENS HEALTH, V20, P1207, DOI 10.1089/jwh.2010.2476; Ng M, 2011, LANCET, V378, P1643, DOI 10.1016/S0140-6736(11)61390-1; Ngo AD, 2007, AIDS CARE, V19, P878, DOI 10.1080/09540120601163078; Ngugi EN BE, 1999, PREVENTING HIV DEV C, P205; Nnorom J, 2008, W AFRICA HIV AIDS EP; Overs C, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18459; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; Parker RG, 2000, AIDS, V14, pS22, DOI 10.1097/00002030-200006001-00004; Pathfinder International, 2004, COMB PREV HIV TECHN; Pickles M, 2013, LANCET GLOB HEALTH, V1, pE289, DOI 10.1016/S2214-109X(13)70083-4; Pleaner M, 2009, RHRU SUPPORT SEX WOR; Population Council, COMM APPR GOV POL RE; Poteat T, 2015, LANCET, V385, P274, DOI 10.1016/S0140-6736(14)60833-3; Pretorius C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013646; Pruss-Ustun A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063476; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ramjee G, 1998, SEX TRANSM DIS, V25, P346, DOI 10.1097/00007435-199808000-00004; Roberts L, 2011, 18 C RETR OPP INF FE; Rojanapithayakorn W, 1996, AIDS, V10, P1, DOI 10.1097/00002030-199601000-00001; Rou KM, 2010, INT J EPIDEMIOL, V39, pII38, DOI 10.1093/ije/dyq211; Rustomjee R, 1999, AIDS, V13, P1511, DOI 10.1097/00002030-199908200-00011; Scambler G, 2008, SOC SCI MED, V66, P1848, DOI 10.1016/j.socscimed.2008.01.002; Scheibe A, 2012, SAHARA J-J SOC ASP H, V9, P167, DOI 10.1080/17290376.2012.743809; Scorgie F, 2011, I EXPECT ABUSED I HA; Sex Workers Education and Advocacy Taskforce, SEX WORK S AFR RAP P; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Shannon K, 2005, J URBAN HEALTH, V82, P488, DOI 10.1093/jurban/jti076; Shannon K, 2008, SOC SCI MED, V66, P911, DOI 10.1016/j.socscimed.2007.11.008; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Shannon K, 2010, JAMA-J AM MED ASSOC, V304, P573, DOI 10.1001/jama.2010.1090; Sibongile Mtetwa FMC, SISTERS VOICE; Simoni JM, 2011, AIDS BEHAV, V15, P376, DOI 10.1007/s10461-010-9836-3; Singh JA, 2005, PLOS MED, V2, P824, DOI 10.1371/journal.pmed.0020234; Steen R, 2012, AIDS, V26, P437, DOI 10.1097/QAD.0b013e32834ed991; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Strathdee SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065812; SWEAT, 2004, WORK WIS SEX WORK HD; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tucker JD, 2013, CURR OPIN INFECT DIS, V26, P73, DOI 10.1097/QCO.0b013e32835c21b0; Ulibarri MD, 2010, PSYCHOL TRAUMA-US, V2, P318, DOI 10.1037/a0017500; UNAIDS, 2006, RISK NEGL 4 KEY POP; UNAIDS, 2012, GLOB REP GLOB AIDS E; UNAIDS, 2011, GLOB HIV AIDS RESP E; UNAIDS, 2013, GLOB HIV AIDS REP; UNAIDS A, 2007, GOOD PART PRACT GUID; UNAIDS World Bank, 2009, GLOB EC CRIS PREV TR; Underhill K, 2010, JAIDS-J ACQ IMM DEF, V55, P8, DOI 10.1097/QAI.0b013e3181e8efe4; UNFPA, 2010, HIV SEX WORK PREV HI; USAID, 2013, DHS COMP REPORTS, V30; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2012, AIDS BEHAV, V16, P1775, DOI 10.1007/s10461-012-0215-0; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Varga C A, 1997, Afr J Reprod Health, V1, P74, DOI 10.2307/3583277; Verma R, 2010, SEX TRANSM INFECT, V86, pI76, DOI 10.1136/sti.2009.039115; Vickerman P, 2006, SEX TRANSM DIS, V33, P397, DOI 10.1097/01.olq.0000218974.77208.cc; Vissers DCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002077; Wang Y, 2009, AIDS BEHAV, V13, P866, DOI 10.1007/s10461-008-9446-5; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Watts C, 2010, SEX TRANSM INFECT, V86, P85, DOI 10.1136/sti.2010.044602; Weeks MR, 2004, SEX TRANSM DIS, V31, P682, DOI 10.1097/01.olq.0000143113.04524.a5; WELLER SC, 1993, SOC SCI MED, V36, P1635, DOI 10.1016/0277-9536(93)90352-5; WHO (World Health Organization), 2005, VIOL WOM HIV AIDS CR; Wirtz AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088047; Witte SS, 1999, INT J STD AIDS, V10, P162, DOI 10.1258/0956462991913826; World Health Organization, 2012, GU OR PRE PROPHYL PR; World Health Organization, 2012, PREV TREATM HIV OTH; World Health Organization, 2011, PREV HIV SEX WORK SU; World Health Organization, 2013, PREP DEM PROJ FRAM C; Yam EA, 2013, SEX TRANSM DIS, V40, P406, DOI 10.1097/OLQ.0b013e318283c16d; Yao XD, 2014, MUCOSAL IMMUNOL, V7, P268, DOI 10.1038/mi.2013.44	173	148	153	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2015	385	9962					72	87		10.1016/S0140-6736(14)60974-0	http://dx.doi.org/10.1016/S0140-6736(14)60974-0			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX8IW	25059942				2022-12-01	WOS:000347154200029
J	Behjati, S; Huch, M; van Boxtel, R; Karthaus, W; Wedge, DC; Tamuri, AU; Martincorena, I; Petljak, M; Alexandrov, LB; Gundem, G; Tarpey, PS; Roerink, S; Blokker, J; Maddison, M; Mudie, L; Robinson, B; Nik-Zainal, S; Campbell, P; Goldman, N; van de Wetering, M; Cuppen, E; Clevers, H; Stratton, MR				Behjati, Sam; Huch, Meritxell; van Boxtel, Ruben; Karthaus, Wouter; Wedge, David C.; Tamuri, Asif U.; Martincorena, Inigo; Petljak, Mia; Alexandrov, Ludmil B.; Gundem, Gunes; Tarpey, Patrick S.; Roerink, Sophie; Blokker, Joyce; Maddison, Mark; Mudie, Laura; Robinson, Ben; Nik-Zainal, Serena; Campbell, Peter; Goldman, Nick; van de Wetering, Marc; Cuppen, Edwin; Clevers, Hans; Stratton, Michael R.			Genome sequencing of normal cells reveals developmental lineages and mutational processes	NATURE			English	Article							LGR5(+VE) STEM-CELLS; 21 BREAST CANCERS; SOMATIC MUTATIONS; SMALL-INTESTINE; SELF-RENEWAL; IN-VITRO; LGR5; COLON; FATE; HOMEOSTASIS	The somatic mutations present in the genome of a cell accumulate over the lifetime of a multicellular organism. These mutations can provide insights into the developmental lineage tree(1), the number of divisions that each cell has undergone and the mutational processes that have been operative(2). Here we describe whole genomes of clonal lines(3) derived from multiple tissues of healthy mice. Using somatic base substitutions, we reconstructed the early cell divisions of each animal, demonstrating the contributions of embryonic cells to adult tissues. Differences were observed between tissues in the numbers and types of mutations accumulated by each cell, which likely reflect differences in the number of cell divisions they have undergone and varying contributions of different mutational processes. If somatic mutation rates are similar to those in mice, the results indicate that precise insights into development and mutagenesis of normal human cells will be possible.	[Behjati, Sam; Wedge, David C.; Martincorena, Inigo; Petljak, Mia; Alexandrov, Ludmil B.; Gundem, Gunes; Tarpey, Patrick S.; Roerink, Sophie; Maddison, Mark; Mudie, Laura; Robinson, Ben; Nik-Zainal, Serena; Campbell, Peter; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, Cambs, England; [Behjati, Sam] Univ Cambridge, Dept Paediat, Cambridge CB2 2XY, England; [Huch, Meritxell; van Boxtel, Ruben; Karthaus, Wouter; Blokker, Joyce; van de Wetering, Marc; Cuppen, Edwin; Clevers, Hans] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, CancerGenom Nl, NL-3584 CT Utrecht, Netherlands; [Huch, Meritxell; van Boxtel, Ruben; Karthaus, Wouter; Blokker, Joyce; van de Wetering, Marc; Cuppen, Edwin; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Goldman, Nick] European Bioinformat Inst, European Mol Biol Lab, Hinxton CB10 1SA, Cambs, England; [Nik-Zainal, Serena] Cambridge Univ Hosp NHS Fdn Trust, East Anglian Med Genet Serv, Cambridge CB2 0QQ, England	Wellcome Trust Sanger Institute; University of Cambridge; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; European Molecular Biology Laboratory (EMBL); University of Cambridge	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	mrs@sanger.ac.uk	Alexandrov, Ludmil/AAS-1454-2021; Nik-Zainal, Serena/ABD-4437-2020; Cuppen, Edwin/F-5696-2011; Cuppen, Edwin/H-2389-2016; Wedge, David/AAC-4977-2021	Alexandrov, Ludmil/0000-0003-3596-4515; Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Martincorena, Inigo/0000-0003-1122-4416; Karthaus, Wouter R./0000-0002-9234-9044; Goldman, Nick/0000-0001-8486-2211; Wedge, David/0000-0002-7572-3196; Nik-Zainal, Serena/0000-0001-5054-1727; van Boxtel, Ruben/0000-0003-1285-2836; Tamuri, Asif/0000-0001-6633-3789; Behjati, Sam/0000-0002-6600-7665	Wellcome Trust [077012/Z/05/Z]; Kadoorie Charitable Foundation; Louis-Jeantet Foundation; Marie Curie IEF fellowship [EU/236954]; ERC [232814]; Netherlands Genomics Initiative [935.12.003]; Centre for Biomedical Genetics, Utrecht; EMBO Long Term Fellowship [ALTF-1287-2012]; Wellcome Trust Intermediate Clinical Fellowship [WT100183MA]; Wellcome-Beit Prize Fellowship; Wellcome Trust Research Training Fellowship for Clinicians; Wellcome Trust Senior Research Fellowship in Clinical Science	Wellcome Trust(Wellcome TrustEuropean Commission); Kadoorie Charitable Foundation; Louis-Jeantet Foundation; Marie Curie IEF fellowship(European Commission); ERC(European Research Council (ERC)European Commission); Netherlands Genomics Initiative; Centre for Biomedical Genetics, Utrecht; EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Wellcome Trust Intermediate Clinical Fellowship(Wellcome Trust); Wellcome-Beit Prize Fellowship; Wellcome Trust Research Training Fellowship for Clinicians; Wellcome Trust Senior Research Fellowship in Clinical Science(Wellcome Trust)	We thank M. Zernicka-Goetz and the Goldman group for discussion of our findings. This work was supported by funding from the Wellcome Trust (grant reference 077012/Z/05/Z), the Kadoorie Charitable Foundation and the Louis-Jeantet Foundation. Individual authors were supported as follows: M. H., Marie Curie IEF fellowship (EU/236954) and ERC grant (232814); R. B. and E. C., Zenith grant of the Netherlands Genomics Initiative (935.12.003); W. K., Centre for Biomedical Genetics, Utrecht; I. M., EMBO Long Term Fellowship (ALTF-1287-2012); S.N.Z., Wellcome Trust Intermediate Clinical Fellowship (WT100183MA) and Wellcome-Beit Prize Fellowship 2013; S. B., Wellcome Trust Research Training Fellowship for Clinicians; and P. C., Wellcome Trust Senior Research Fellowship in Clinical Science.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Barker N, 2008, COLD SH Q B, V73, P351, DOI 10.1101/sqb.2008.72.003; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bruce AW, 2010, CURR OPIN GENET DEV, V20, P485, DOI 10.1016/j.gde.2010.05.006; Carlson CA, 2012, NAT METHODS, V9, P78, DOI [10.1038/NMETH.1781, 10.1038/nmeth.1781]; De S, 2011, TRENDS GENET, V27, P217, DOI 10.1016/j.tig.2011.03.002; Feisenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Kennedy SR, 2012, MECH AGEING DEV, V133, P118, DOI 10.1016/j.mad.2011.10.009; Lasken RS, 2013, NAT BIOTECHNOL, V31, P211, DOI 10.1038/nbt.2523; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leushacke M, 2013, CELL REP, V5, P349, DOI 10.1016/j.celrep.2013.09.025; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Plusa B, 2005, NATURE, V434, P391, DOI 10.1038/nature03388; Salipante SJ, 2006, P NATL ACAD SCI USA, V103, P5448, DOI 10.1073/pnas.0601265103; Salipante SJ, 2007, CURR TOP DEV BIOL, V79, P157, DOI 10.1016/S0070-2153(06)79006-8; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Shibata D, 2006, CELL CYCLE, V5, P610, DOI 10.4161/cc.5.6.2570; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; van Loon B, 2010, DNA REPAIR, V9, P604, DOI 10.1016/j.dnarep.2010.03.004; Wasserstrom A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001939; Yang ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/nrg3186; Zhou WY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-39	30	221	225	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					422	+		10.1038/nature13448	http://dx.doi.org/10.1038/nature13448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043003	Green Accepted			2022-12-01	WOS:000341814900061
J	Kvon, EZ; Kazmar, T; Stampfel, G; Yanez-Cuna, JO; Pagani, M; Schernhuber, K; Dickson, BJ; Stark, A				Kvon, Evgeny Z.; Kazmar, Tomas; Stampfel, Gerald; Yanez-Cuna, J. Omar; Pagani, Michaela; Schernhuber, Katharina; Dickson, Barry J.; Stark, Alexander			Genome-scale functional characterization of Drosophila developmental enhancers in vivo	NATURE			English	Article							GENE-EXPRESSION PATTERNS; SITU HYBRIDIZATION; TISSUE; ELEMENTS; SPECIFICITY; RESOURCE; DATABASE; PROTEIN; TOOLS	Transcriptional enhancers are crucial regulators of gene expression and animal development(1) and the characterization of their genomic organization, spatiotemporal activities and sequence properties is a key goal in modern biology(2-8). Here we characterize the in vivo activity of 7,705 Drosophila melanogaster enhancer candidates covering 13.5% of the non-coding non-repetitive genome throughout embryogenesis. 3,557 (46%) candidates are active, suggesting a high density with 50,000 to 100,000 developmental enhancers genome-wide. The vast majority of enhancers display specific spatial patterns that are highly dynamic during development. Most appear to regulate their neighbouring genes, suggesting that the cis-regulatory genome is organized locally into domains, which are supported by chromosomal domains, insulator binding and genome evolution. However, 12 to 21 per cent of enhancers appear to skip non-expressed neighbours and regulate a more distal gene. Finally, we computationally identify cis-regulatory motifs that are predictive and required for enhancer activity, as we validate experimentally. This work provides global insights into the organization of an animal regulatory genome and the make-up of enhancer sequences and confirms and generalizes principles from previous studies(1,9). All enhancer patterns are annotated manually with a controlled vocabulary and all results are available through a web interface (http://enhancers.starklab.org), including the raw images of all microscopy slides for manual inspection at arbitrary zoom levels.	[Kvon, Evgeny Z.; Kazmar, Tomas; Stampfel, Gerald; Yanez-Cuna, J. Omar; Pagani, Michaela; Schernhuber, Katharina; Dickson, Barry J.; Stark, Alexander] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Stark, A (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	stark@starklab.org	Dickson, Barry/AAE-7632-2019; Stark, Alexander/D-1473-2012	Dickson, Barry/0000-0003-0715-892X; Stark, Alexander/0000-0003-2611-0841; Kvon, Evgeny/0000-0002-1562-0945	European Research Council (ERC) from the European Community [242922]; Austrian Science Fund (FWF) [F4303-B09]; ERC; Boehringer Ingelheim GmbH	European Research Council (ERC) from the European Community(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); ERC(European Research Council (ERC)European Commission); Boehringer Ingelheim GmbH(Boehringer Ingelheim)	We thank members of the Dickson laboratory VT project for cloning the candidate regions and generating transgenic flies and the VDRC (http://stockcenter.vdrc.at) for their maintenance and distribution. We are grateful to the IMP/IMBA Scientific Services, in particular BioOptics, Genomics, and IT for help and to C. H. Lampert (IST Austria) for advice. We thank M. Levine (UC Berkeley) and V. Hartenstein (UCLA) for their permission to reproduce figures. The Stark group is supported by a European Research Council (ERC) Starting Grant from the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 242922 awarded to A.S. and by the Austrian Science Fund (FWF, F4303-B09). Generation of transgenic lines was supported in part by an ERC Advanced Investigator Grant to B.J.D. Basic research at the IMP is supported by Boehringer Ingelheim GmbH.	Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Calhoun VC, 2002, P NATL ACAD SCI USA, V99, P9243, DOI 10.1073/pnas.142291299; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Erives A, 2004, P NATL ACAD SCI USA, V101, P3851, DOI 10.1073/pnas.0400611101; Fisher WW, 2012, P NATL ACAD SCI USA, V109, P21330, DOI 10.1073/pnas.1209589110; Frise E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.102; Gajewski K, 2001, DEV BIOL, V233, P425, DOI 10.1006/dbio.2001.0220; Gallo SM, 2011, NUCLEIC ACIDS RES, V39, pD118, DOI 10.1093/nar/gkq999; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; Hartenstein V., 1993, ATLAS DROSOPHILA DEV; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; JACK J, 1991, DEVELOPMENT, V113, P735; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Jory A, 2012, CELL REP, V2, P1014, DOI 10.1016/j.celrep.2012.09.010; Kvon EZ, 2012, GENE DEV, V26, P908, DOI 10.1101/gad.188052.112; Lecuyer Eric, 2008, V420, P289, DOI 10.1007/978-1-59745-583-1_18; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Maeda RK, 2011, CURR OPIN GENET DEV, V21, P187, DOI 10.1016/j.gde.2011.01.021; Manning L, 2012, CELL REP, V2, P1002, DOI 10.1016/j.celrep.2012.09.009; Marinic M, 2013, DEV CELL, V24, P530, DOI 10.1016/j.devcel.2013.01.025; NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; NGUYEN HT, 1994, P NATL ACAD SCI USA, V91, P7520, DOI 10.1073/pnas.91.16.7520; Nien CY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002339; Ochoa-Espinosa A, 2005, P NATL ACAD SCI USA, V102, P4960, DOI 10.1073/pnas.0500373102; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Perry MW, 2011, P NATL ACAD SCI USA, V108, P13570, DOI 10.1073/pnas.1109873108; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rubin GM, 2000, SCIENCE, V287, P2216, DOI 10.1126/science.287.5461.2216; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; The modENCODE Consortium, 2010, SCIENCE, V489, P57; Thomas S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r43; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Weiszmann R, 2009, NAT PROTOC, V4, P605, DOI 10.1038/nprot.2009.55; Yanez-Cuna JO, 2013, TRENDS GENET, V29, P11, DOI 10.1016/j.tig.2012.09.007; Yanez-Cuna JO, 2012, GENOME RES, V22, P2018, DOI 10.1101/gr.132811.111; Zeitlinger J, 2010, DEV BIOL, V339, P230, DOI 10.1016/j.ydbio.2009.12.039; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	51	262	264	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					91	+		10.1038/nature13395	http://dx.doi.org/10.1038/nature13395			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	24896182				2022-12-01	WOS:000339908000038
J	Crider, KS; Devine, O; Hao, L; Dowling, NF; Li, S; Molloy, AM; Li, Z; Zhu, JH; Berry, RJ				Crider, Krista S.; Devine, Owen; Hao, Ling; Dowling, Nicole F.; Li, Song; Molloy, Anne M.; Li, Zhu; Zhu, Jianghui; Berry, Robert J.			Population red blood cell folate concentrations for prevention of neural tube defects: bayesian model	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOLIC-ACID FORTIFICATION; DOUBLE-BLIND TRIAL; UNITED-STATES; CHILDBEARING AGE; HOMOCYSTEINE CONCENTRATIONS; ERYTHROCYTE FOLATE; FOOD FORTIFICATION; SPINA-BIFIDA; WOMEN; SUPPLEMENTATION	Objective To determine an optimal population red blood cell (RBC) folate concentration for the prevention of neural tube birth defects. Design Bayesian model. Setting Data from two population based studies in China. Participants 247 831 participants in a prospective community intervention project in China (1993-95) to prevent neural tube defects with 400 mu g/day folic acid supplementation and 1194 participants in a population based randomized trial (2003-05) to evaluate the effect of folic acid supplementation on blood folate concentration among Chinese women of reproductive age. Intervention Folic acid supplementation (400 mu g/day). Main outcome measures Estimated RBC folate concentration at time of neural tube closure (day 28 of gestation) and risk of neural tube defects. Results Risk of neural tube defects was high at the lowest estimated RBC folate concentrations (for example, 25.4 (95% uncertainty interval 20.8 to 31.2) neural tube defects per 10 000 births at 500 nmol/L) and decreased as estimated RBC folate concentration increased. Risk of neural tube defects was substantially attenuated at estimated RBC folate concentrations above about 1000 nmol/L (for example, 6 neural tube defects per 10 000 births at 1180 (1050 to 1340) nmol/L). The modeled dose-response relation was consistent with the existing literature. In addition, neural tube defect risk estimates developed using the proposed model and population level RBC information were consistent with the prevalence of neural tube defects in the US population before and after food fortification with folic acid. Conclusions A threshold for "optimal" population RBC folate concentration for the prevention of neural tube defects could be defined (for example, approximately 1000 nmol/L). Population based RBC folate concentrations, as a biomarker for risk of neural tube defects, can be used to facilitate evaluation of prevention programs as well as to identify subpopulations at elevated risk for a neural tube defect affected pregnancy due to folate insufficiency.	[Crider, Krista S.; Devine, Owen; Dowling, Nicole F.; Berry, Robert J.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA; [Hao, Ling; Li, Zhu; Zhu, Jianghui] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Hao, Ling] US Ctr Dis Control & Prevent, US Embassy, Beijing, Peoples R China; [Li, Song] Peking Univ, Hosp 3, Beijing 100871, Peoples R China; [Molloy, Anne M.] Univ Dublin Trinity Coll, Sch Med, Dublin 2, Ireland; [Zhu, Jianghui] China Natl Ctr Food Safety Risk Assessment, Div Risk Assessment, Beijing, Peoples R China	Centers for Disease Control & Prevention - USA; Peking University; Peking University; Trinity College Dublin	Crider, KS (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.	kcrider@cdc.gov		Berry, Robert/0000-0002-7162-5046; Crider, Krista/0000-0001-6997-5955; Molloy, Anne/0000-0002-1688-9049	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for salaries of CDC employees was provided by the Centers for Disease Control and Prevention. No specific funding was provided for this project. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.	Adank C, 2003, ANN NUTR METAB, V47, P55, DOI 10.1159/000069278; Agopian AJ, 2013, BIRTH DEFECTS RES A, V97, P42, DOI 10.1002/bdra.23100; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Bestwick JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089354; Bradbury KE, 2012, J NUTR, V142, P1633, DOI 10.3945/jn.112.161562; Branum AM, 2013, J NUTR, V143, P486, DOI 10.3945/jn.112.169987; Calonge N, 2009, ANN INTERN MED, V150, P626, DOI 10.7326/0003-4819-150-9-200905050-00009; Chen LT, 2004, NUTR REV, V62, pS40, DOI 10.1301/nr.2004.jun.S40-S43; Cordero A., 2010, Morbidity and Mortality Weekly Report, V59, P980; Cortes F, 2012, AM J MED GENET A, V158A, P1885, DOI 10.1002/ajmg.a.35430; Crider KS, 2011, AM J CLIN NUTR, V93, P1365, DOI 10.3945/ajcn.110.004671; Cuskelly GJ, 1999, AM J CLIN NUTR, V70, P234; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; DALY LE, 1995, JAMA-J AM MED ASSOC, V274, P1698, DOI 10.1001/jama.274.21.1698; Daly S, 1997, LANCET, V350, P1666, DOI 10.1016/S0140-6736(97)07247-4; De Wals P, 2008, BIRTH DEFECTS RES A, V82, P622, DOI 10.1002/bdra.20485; De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103; Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013; Green TJ, 2005, ASIA PAC J CLIN NUTR, V14, P173; Hao L, 2003, J NUTR, V133, P3630, DOI 10.1093/jn/133.11.3630; Hao L, 2008, AM J CLIN NUTR, V88, P448, DOI 10.1093/ajcn/88.2.448; Holmes MV, 2011, LANCET, V378, P584, DOI 10.1016/S0140-6736(11)60872-6; Horn F, 2014, BRATISL MED J, V115, P91, DOI 10.4149/BLL_2014_020; Hursthouse NA, 2011, NUTRIENTS, V3, P49, DOI 10.3390/nu3010049; Lamers Y, 2006, AM J CLIN NUTR, V84, P156, DOI 10.1093/ajcn/84.1.156; Mao RF, 2008, CELL BIOCHEM FUNCT, V26, P352, DOI 10.1002/cbf.1450; McDonnell R, 2014, J PUBLIC HLTH OXF; McMahon DM, 2013, BIRTH DEFECTS RES A, V97, P115, DOI 10.1002/bdra.23113; Milman N, 2006, EUR J HAEMATOL, V76, P200, DOI 10.1111/j.1600-0609.2005.00606.x; Nelson CRM, 2014, CAN J PUBLIC HEALTH, V105, pE40, DOI 10.17269/cjph.105.4155; Norsworthy B, 2004, EUR J CLIN NUTR, V58, P548, DOI 10.1038/sj.ejcn.1601843; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Pfeiffer CM, 2012, J NUTR, V142, P886, DOI 10.3945/jn.111.156919; Pfeiffer CM, 2011, J NUTR, V141, P1402, DOI 10.3945/jn.111.141515; Sayed AR, 2008, BIRTH DEFECTS RES A, V82, P211, DOI 10.1002/bdra.20442; SCHORAH CJ, 1983, BRIT J NUTR, V49, P203, DOI 10.1079/BJN19830026; Selhub J, 2008, FOOD NUTR BULL, V29, pS67, DOI 10.1177/15648265080292S110; Shibuya KMC, 1998, HLTH DIMENSIONS SEX, P455; Tinker SC, 2010, AM J PREV MED, V38, P534, DOI 10.1016/j.amepre.2010.01.025; Ubeda N, 2011, NUTRITION, V27, P925, DOI 10.1016/j.nut.2010.10.017; WALD N, 1991, LANCET, V338, P131; Wallingford JB, 2013, SCIENCE, V339, P1011, DOI 10.1126/science.1222002; Wilcken B, 2003, J MED GENET, V40, P619, DOI 10.1136/jmg.40.8.619; Williams LJ, 2002, TERATOLOGY, V66, P33, DOI 10.1002/tera.10060; Yan LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041689; Yang QH, 2010, AM J CLIN NUTR, V91, P64, DOI 10.3945/ajcn.2009.28401; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059570	48	125	128	0	115	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2014	349								g4554	10.1136/bmj.g4554	http://dx.doi.org/10.1136/bmj.g4554			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NG	25073783	Green Published, hybrid			2022-12-01	WOS:000339906000002
J	Godefroit, P; Sinitsa, SM; Dhouailly, D; Bolotsky, YL; Sizov, AV; McNamara, ME; Benton, MJ; Spagna, P				Godefroit, Pascal; Sinitsa, Sofia M.; Dhouailly, Danielle; Bolotsky, Yuri L.; Sizov, Alexander V.; McNamara, Maria E.; Benton, Michael J.; Spagna, Paul			A Jurassic ornithischian dinosaur from Siberia with both feathers and scales	SCIENCE			English	Article							INTEGUMENTARY STRUCTURES; CHINA; THEROPOD; ORIGIN; EVOLUTION; PLUMAGE; FOSSILS; COLOR; BIRDS	Middle Jurassic to Early Cretaceous deposits from northeastern China have yielded varied theropod dinosaurs bearing feathers. Filamentous integumentary structures have also been described in ornithischian dinosaurs, but whether these filaments can be regarded as part of the evolutionary lineage toward feathers remains controversial. Here we describe a new basal neornithischian dinosaur from the Jurassic of Siberia with small scales around the distal hindlimb, larger imbricated scales around the tail, monofilaments around the head and the thorax, and more complex featherlike structures around the humerus, the femur, and the tibia. The discovery of these branched integumentary structures outside theropods suggests that featherlike structures coexisted with scales and were potentially widespread among the entire dinosaur clade; feathers may thus have been present in the earliest dinosaurs.	[Godefroit, Pascal; Spagna, Paul] Royal Belgian Inst Nat Sci, Directorate Earth & Hist Life, B-1000 Brussels, Belgium; [Sinitsa, Sofia M.] Inst Nat Resources Ecol & Cryol, Chita 672014, Russia; [Dhouailly, Danielle] Univ Grenoble 1, AGIM, UJF CNRS FRE 3405, F-38706 La Tronche, France; [Bolotsky, Yuri L.] FEB RAS, Inst Geol & Nat Management, Blagoveshchensk, Russia; [Sizov, Alexander V.] SB RAS, Inst Earth Crust, Irkutsk, Russia; [McNamara, Maria E.] Natl Univ Ireland Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland; [McNamara, Maria E.; Benton, Michael J.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England	Royal Belgian Institute of Natural Sciences; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institute of Geology & Nature Management FEB RAS; Irkutsk Science Centre of the Russian Academy of Sciences; Institute of Earth's Crust of Siberian Branch of the Russian Academy of Sciences; Russian Academy of Sciences; University College Cork; University of Bristol	Godefroit, P (corresponding author), Royal Belgian Inst Nat Sci, Directorate Earth & Hist Life, Rue Vautier 29, B-1000 Brussels, Belgium.	pascal.godefroit@naturalsciences.be	Sinitsa, Sofia/J-3201-2018; Sizov, Alexander/ABH-9485-2020; Benton, Michael J/A-5639-2008; McNamara, Maria E/C-8431-2014	Sinitsa, Sofia/0000-0002-5074-787X; Sizov, Alexander/0000-0002-3029-9686; Benton, Michael J/0000-0002-4323-1824; McNamara, Maria E/0000-0003-0968-4624	Belgian Science Policy [BL/36/62]; Natural Environment Research Council [NE/I027630/1]; NERC [NE/I027630/1] Funding Source: UKRI	Belgian Science Policy(Belgian Federal Science Policy Office); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank A. B. Ptitsyn for making fossils available for study; Ph. Claeys, J.-M. Baele, and I. Y. Bolosky for help and comments on the manuscript; and P. Golinvaux, J. Dos Remedios Esteves, C. Desmedt, and A. Vandersypen for the drawings and reconstructions. This study was supported by Belgian Science Policy grant BL/36/62 to P. G. and by Natural Environment Research Council Standard Grant NE/I027630/1 awarded to M.J.B.	Bell PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031295; Brusatte SL, 2010, EARTH-SCI REV, V101, P68, DOI 10.1016/j.earscirev.2010.04.001; Buchwitz M, 2012, PALAEONTOL Z, V86, P313, DOI 10.1007/s12542-012-0135-3; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Currie PJ, 2001, CAN J EARTH SCI, V38, P1705, DOI 10.1139/e01-050; Dhouailly D, 2009, J ANAT, V214, P587, DOI 10.1111/j.1469-7580.2008.01041.x; Godefroit P, 2013, NATURE, V498, P359, DOI 10.1038/nature12168; Godefroit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2389; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Lingham-Soliar T, 2008, P ROY SOC B-BIOL SCI, V275, P775, DOI 10.1098/rspb.2007.1342; Lingham-Soliar T, 2007, P ROY SOC B-BIOL SCI, V274, P1823, DOI 10.1098/rspb.2007.0352; Lucas A.M., 1972, AVIAN ANATOMY INTEGU; Mayr G, 2002, NATURWISSENSCHAFTEN, V89, P361, DOI 10.1007/s00114-002-0339-6; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Prin F, 2004, INT J DEV BIOL, V48, P137, DOI 10.1387/ijdb.15272378; Rauhut OWM, 2012, P NATL ACAD SCI USA, V109, P11746, DOI 10.1073/pnas.1203238109; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Vickaryous MK, 2004, DINOSAURIA, 2ND EDITION, P363; Wang XL, 2002, CHINESE SCI BULL, V47, P226, DOI 10.1360/02tb9054; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Xu X, 2010, NATURE, V464, P1338, DOI 10.1038/nature08965; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zhang FC, 2006, GEOL J, V41, P395, DOI 10.1002/gj.1057; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740; Zheng XT, 2009, NATURE, V458, P333, DOI 10.1038/nature07856; Zheng XT, 2013, SCIENCE, V339, P1309, DOI 10.1126/science.1228753	27	75	77	1	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					451	455		10.1126/science.1253351	http://dx.doi.org/10.1126/science.1253351			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061209	Green Submitted			2022-12-01	WOS:000339655100043
J	Lewin, SR; Deeks, SG; Barre-Sinoussi, F				Lewin, Sharon R.; Deeks, Steven G.; Barre-Sinoussi, Francoise			Towards a cure for HIV-are we making progress?	LANCET			English	Editorial Material							LATENCY		[Lewin, Sharon R.] Alfred Hlth, Dept Infect Dis, Melbourne, Vic 3004, Australia; [Lewin, Sharon R.] Monash Univ, Melbourne, Vic 3004, Australia; [Lewin, Sharon R.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Deeks, Steven G.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA; [Barre-Sinoussi, Francoise] INSERM, Paris, France; [Barre-Sinoussi, Francoise] Inst Pasteur, Dept Virol, Unit Regulat Retroviral Infect, Paris, France	Monash University; Burnet Institute; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lewin, SR (corresponding author), Alfred Hlth, Dept Infect Dis, Melbourne, Vic 3004, Australia.	sharon.lewin@monash.edu	Lewin, Sharon/Z-3297-2019	Lewin, Sharon Ruth/0000-0002-0330-8241				Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Henrich TJ, 2013, J INFECT DIS, V207, P1694, DOI 10.1093/infdis/jit086; Henrich TJ, 2014, C RETR OPP INF CROI; Maartens G, 2014, LANCET; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Sogaard OS, 2014, 20 INT AIDS C MELB A; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662	14	23	23	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					209	211		10.1016/S0140-6736(14)61181-8	http://dx.doi.org/10.1016/S0140-6736(14)61181-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL8JI	25042220				2022-12-01	WOS:000339384100004
J	Bernier, R; Golzio, C; Xiong, B; Stessman, HA; Coe, BP; Penn, O; Witherspoon, K; Gerdts, J; Baker, C; Vulto-van Silfhout, AT; Schuurs-Hoeijmakers, JH; Fichera, M; Bosco, P; Buono, S; Alberti, A; Failla, P; Peeters, H; Steyaert, J; Vissers, LELM; Francescatto, L; Mefford, HC; Rosenfeld, JA; Bakken, T; O'Roak, BJ; Pawlus, M; Moon, R; Shendure, J; Amaral, DG; Lein, E; Rankin, J; Romano, C; de Vries, BBA; Katsanis, N; Eichler, EE				Bernier, Raphael; Golzio, Christelle; Xiong, Bo; Stessman, Holly A.; Coe, Bradley P.; Penn, Osnat; Witherspoon, Kali; Gerdts, Jennifer; Baker, Carl; Vulto-van Silfhout, Anneke T.; Schuurs-Hoeijmakers, Janneke H.; Fichera, Marco; Bosco, Paolo; Buono, Serafino; Alberti, Antonino; Failla, Pinella; Peeters, Hilde; Steyaert, Jean; Vissers, Lisenka E. L. M.; Francescatto, Ludmila; Mefford, Heather C.; Rosenfeld, Jill A.; Bakken, Trygve; O'Roak, Brian J.; Pawlus, Matthew; Moon, Randall; Shendure, Jay; Amaral, David G.; Lein, Ed; Rankin, Julia; Romano, Corrado; de Vries, Bert B. A.; Katsanis, Nicholas; Eichler, Evan E.			Disruptive CHD8 Mutations Define a Subtype of Autism Early in Development	CELL			English	Article							DE-NOVO MUTATIONS; HEART-DISEASE; GENE; ABNORMALITIES; EXPRESSION; CHILDREN; 16P11.2; PROTEIN; RISK	Autism spectrum disorder (ASD) is a heterogeneous disease in which efforts to define subtypes behaviorally have met with limited success. Hypothesizing that genetically based subtype identification may prove more productive, we resequenced the ASD-associated gene CHD8 in 3,730 children with developmental delay or ASD. We identified a total of 15 independent mutations; no truncating events were identified in 8,792 controls, including 2,289 unaffected siblings. In addition to a high likelihood of an ASD diagnosis among patients bearing CHD8 mutations, characteristics enriched in this group included macrocephaly, distinct faces, and gastrointestinal complaints. chd8 disruption in zebrafish recapitulates features of the human phenotype, including increased head size as a result of expansion of the forebrain/midbrain and impairment of gastrointestinal motility due to a reduction in postmitotic enteric neurons. Our findings indicate that CHD8 disruptions define a distinct ASD subtype and reveal unexpected comorbidities between brain development and enteric innervation.	[Bernier, Raphael; Gerdts, Jennifer] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [Golzio, Christelle; Francescatto, Ludmila; Katsanis, Nicholas] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Xiong, Bo; Coe, Bradley P.; Penn, Osnat; Witherspoon, Kali; Baker, Carl; Shendure, Jay; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Vulto-van Silfhout, Anneke T.; Schuurs-Hoeijmakers, Janneke H.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Fichera, Marco; Bosco, Paolo; Buono, Serafino; Alberti, Antonino; Failla, Pinella; Romano, Corrado] IRCCS Associaz Oasi Maria Santissima, I-94018 Troina, Italy; [Fichera, Marco] Univ Catania, I-95123 Catania, Italy; [Peeters, Hilde] Katholieke Univ Leuven, Univ Hosp Leuven, Ctr Human Genet, B-3000 Leuven, Belgium; [Peeters, Hilde; Steyaert, Jean] Leuven Autism Res LAuRes, B-3000 Leuven, Belgium; [Steyaert, Jean] Katholieke Univ Leuven, Dept Child & Adolescent Psychiat, B-3000 Leuven, Belgium; [Steyaert, Jean] Maastricht Univ, Acad Hosp Maastricht, Dept Clin Genet, NL-6200 MD Maastricht, Netherlands; [Steyaert, Jean] Maastricht Univ, Res Inst Growth & Dev GROW, NL-6200 MD Maastricht, Netherlands; [Mefford, Heather C.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rosenfeld, Jill A.] PerkinElmer Inc, Signature Genom Labs, Spokane, WA 99207 USA; [Bakken, Trygve] Allen Inst Brain Sci, Seattle, WA 98103 USA; [O'Roak, Brian J.] OHSU, Portland, OR 97208 USA; [Pawlus, Matthew; Moon, Randall] Univ Washington, Dept Pharmacol, Seattle, WA 98109 USA; [Amaral, David G.] Univ Calif Davis, MIND Inst, Autism Phenome Project, Sacramento, CA 95817 USA; [Rankin, Julia] Peninsula Clin Genet Serv, Exeter EX1 2ED, Devon, England; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Duke University; University of Washington; University of Washington Seattle; Radboud University Nijmegen; University of Catania; KU Leuven; University Hospital Leuven; KU Leuven; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; University of Washington; University of Washington Seattle; Allen Institute for Brain Science; Oregon Health & Science University; University of Washington; University of Washington Seattle; University of California System; University of California Davis; Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	AT, Vulto-van Silfhout/H-4199-2015; Failla, Pinella/AAE-9963-2019; Moon, Randall/M-5605-2019; Coe, Bradley/A-2878-2009; Alberti, Antonino/D-5653-2017; Bakken, Trygve E./R-4622-2017; Vissers, Lisenka ELM/A-2598-2015; Peeters, Hilde/AAA-7338-2020; Fichera, Marco/K-9220-2016; Xiong, Bo/M-3605-2014; Romano, Corrado/B-9695-2008; Shendure, Jay/AAU-3684-2021; Buono, Serafino/D-8568-2017; Steyaert, Jean/B-5326-2015	Failla, Pinella/0000-0003-3969-7266; Moon, Randall/0000-0002-9352-1408; Alberti, Antonino/0000-0001-6742-7429; Bakken, Trygve E./0000-0003-3373-7386; Vissers, Lisenka ELM/0000-0001-6470-5497; Fichera, Marco/0000-0002-8225-6880; Romano, Corrado/0000-0003-1049-0683; Buono, Serafino/0000-0002-3786-3323; Golzio, Christelle/0000-0002-4420-3921; Pawlus, Matthew/0000-0001-6007-7198; Peeters, Hilde/0000-0002-7295-3375; O'Roak, Brian/0000-0002-4141-0095; Xiong, Bo/0000-0002-2695-9100; Stessman, Holly/0000-0002-0764-3493; Shendure, Jay/0000-0002-1516-1865; Katsanis, Nicholas/0000-0002-2480-0171; Coe, Bradley/0000-0001-8471-4016; Steyaert, Jean/0000-0003-2512-4694	Simons Foundation Autism Research Initiative (SFARI) [303241]; NIH/NIMH [R01MH101221]; SFARI [239983]; NIH [P50MH094268]; NARSAD Young Investigator Grant from BBRF; European Commission; GENCODYS [241995]; Dutch Organisation for Health Research and Development (ZON-MW) [917-86-319, 912-12-109]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101221, P50MH094268] Funding Source: NIH RePORTER	Simons Foundation Autism Research Initiative (SFARI); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); SFARI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Young Investigator Grant from BBRF(NARSAD); European Commission(European CommissionEuropean Commission Joint Research Centre); GENCODYS; Dutch Organisation for Health Research and Development (ZON-MW)(Netherlands Organization for Health Research and Development); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Simons Foundation Autism Research Initiative (SFARI) 303241 and NIH/NIMH R01MH101221 to E.E.E.; by SFARI 239983 and NIH P50MH094268 to N.K.; by a NARSAD Young Investigator Grant from BBRF to C.G.; and by the European Commission: GENCODYS grant 241995 under FP7 and the Dutch Organisation for Health Research and Development (ZON-MW grants 917-86-319 and 912-12-109) to B.B.A.d.V. E.E.E. is an Investigator of the Howard Hughes Medical Institute and is on the scientific advisory board for DNAnexus, Inc. N.K. is a Distinguished Brumley Professor. We thank all of the families at the participating Simons Simplex Collection (SSC) sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, E. Hanson, D. Grice, A. Klin, R. Kochel, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren, and E. Wijsman). We are grateful to D. Raible and H. S. Zimmermann for providing zebrafish resources and for helpful discussions, to T. Brown for help with manuscript preparation, and to J. Huddleston and M. Malig for sequencing support.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, DOI [DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Batsukh T, 2010, HUM MOL GENET, V19, P2858, DOI 10.1093/hmg/ddq189; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Chaste P, 2013, BIOL PSYCHIAT, V74, P576, DOI 10.1016/j.biopsych.2013.04.018; CIMENT G, 1983, NATURE, V305, P424, DOI 10.1038/305424a0; Cocchiaro JL, 2013, JOVE-J VIS EXP, DOI 10.3791/4434; D'Autreaux F, 2007, DEVELOPMENT, V134, P2237, DOI 10.1242/dev.003814; Field HA, 2009, NEUROGASTROENT MOTIL, V21, P304, DOI 10.1111/j.1365-2982.2008.01234.x; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Gotham K, 2009, J AUTISM DEV DISORD, V39, P693, DOI 10.1007/s10803-008-0674-3; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Hennekam RCM, 2012, HUM MUTAT, V33, P884, DOI 10.1002/humu.22048; HITTNER HM, 1979, J PEDIAT OPHTH STRAB, V16, P122; Houdayer C, 2011, METHODS MOL BIOL, V760, P269, DOI 10.1007/978-1-61779-176-5_17; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Kim MS, 2011, HISTOPATHOLOGY, V58, P660, DOI 10.1111/j.1365-2559.2011.03819.x; Lord C, 2012, ARCH GEN PSYCHIAT, V69, P306, DOI 10.1001/archgenpsychiatry.2011.148; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nishiyama M, 2012, MOL CELL BIOL, V32, P501, DOI 10.1128/MCB.06409-11; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; PAGON RA, 1981, J PEDIATR-US, V99, P223, DOI 10.1016/S0022-3476(81)80454-4; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sawada G, 2013, ONCOL REP, V30, P1137, DOI 10.3892/or.2013.2597; Schulze TG, 2004, HUM HERED, V58, P131, DOI 10.1159/000083539; Shen EH, 2012, TRENDS NEUROSCI, V35, P711, DOI 10.1016/j.tins.2012.09.005; Simon JM, 2014, GENOME RES, V24, P241, DOI 10.1101/gr.158253.113; Simons VIP Consortium, 2012, NEURON, V73, P1063, DOI 10.1016/j.neuron.2012.02.014; Stessman HA, 2014, CELL, V156, P872, DOI 10.1016/j.cell.2014.02.002; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; THISSE C, 1993, DEVELOPMENT, V119, P1203; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Westerfield M., 1995, ZEBR BOOK GUID LAB U; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288	43	445	461	4	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					263	276		10.1016/j.cell.2014.06.017	http://dx.doi.org/10.1016/j.cell.2014.06.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	24998929	Bronze, Green Accepted			2022-12-01	WOS:000340943600008
J	Sham, LT; Butler, EK; Lebar, MD; Kahne, D; Bernhardt, TG; Ruiz, N				Sham, Lok-To; Butler, Emily K.; Lebar, Matthew D.; Kahne, Daniel; Bernhardt, Thomas G.; Ruiz, Natividad			MurJ is the flippase of lipid-linked precursors for peptidoglycan biogenesis	SCIENCE			English	Article							ESCHERICHIA-COLI; MUREIN SYNTHESIS; IDENTIFICATION; RODA; MVIN; GENE; FTSW	Peptidoglycan (PG) is a polysaccharide matrix that protects bacteria from osmotic lysis. Inhibition of its biogenesis is a proven strategy for killing bacteria with antibiotics. The assembly of PG requires disaccharide-pentapeptide building blocks attached to a polyisoprene lipid carrier called lipid II. Although the stages of lipid II synthesis are known, the identity of the essential flippase that translocates it across the cytoplasmic membrane for PG polymerization is unclear. We developed an assay for lipid II flippase activity and used a chemical genetic strategy to rapidly and specifically block flippase function. We combined these approaches to demonstrate that MurJ is the lipid II flippase in Escherichia coli.	[Sham, Lok-To; Bernhardt, Thomas G.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Butler, Emily K.; Ruiz, Natividad] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Lebar, Matthew D.; Kahne, Daniel] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Kahne, Daniel] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; University System of Ohio; Ohio State University; Harvard University; Harvard University; Harvard Medical School	Bernhardt, TG (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	thomas_bernhardt@hms.harvard.edu; ruiz.82@osu.edu	Sham, Lok To/L-8149-2016	Sham, Lok To/0000-0001-9047-0310; Lebar, Matthew/0000-0003-4910-1438; Butler, Emily K./0000-0003-2906-0595; Ruiz, Natividad/0000-0002-6369-2206	American Heart Association; National Institutes of Health (NIH) [F32GM103056, R01GM100951, R01AI099144, R01GM76710]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076710, F32GM103056, R01GM100951] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Mengin-Lecreulx for the generous gift of plasmids for ColM production and H. Joseph and R. M. Davis for their technical assistance. Research was supported by funds from the American Heart Association (L.S.) and the National Institutes of Health (NIH) under award numbers F32GM103056 (M.D.L.), R01GM100951 (N.R.), R01AI099144 (T.G.B.), and R01GM76710 (D.K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH. For additional data, see the supplementary materials.	Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Butler EK, 2013, J BACTERIOL, V195, P4639, DOI 10.1128/JB.00731-13; de Pedro MA, 2001, J BACTERIOL, V183, P4115, DOI 10.1128/JB.183.14.4115-4126.2001; El Ghachi M, 2006, J BIOL CHEM, V281, P22761, DOI 10.1074/jbc.M602834200; Henriques AO, 1998, MOL MICROBIOL, V28, P235, DOI 10.1046/j.1365-2958.1998.00766.x; HEPPEL LA, 1967, SCIENCE, V156, P1451, DOI 10.1126/science.156.3781.1451; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; Inoue A, 2008, J BACTERIOL, V190, P7298, DOI 10.1128/JB.00551-08; KHATTAR MM, 1994, J BACTERIOL, V176, P7140, DOI 10.1128/JB.176.23.7140-7147.1994; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P15553, DOI 10.1073/pnas.0808352105; Touze T, 2012, BIOCHEM SOC T, V40, P1522, DOI 10.1042/BST20120189; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677	13	187	192	1	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					220	222		10.1126/science.1254522	http://dx.doi.org/10.1126/science.1254522			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013077	Green Accepted			2022-12-01	WOS:000339409900055
J	Brooks-Pollock, E; Roberts, GO; Keeling, MJ				Brooks-Pollock, Ellen; Roberts, Gareth O.; Keeling, Matt J.			A dynamic model of bovine tuberculosis spread and control in Great Britain	NATURE			English	Article							MOUTH EPIDEMIC; CATTLE; TRANSMISSION; ENGLAND; FOOT	Bovine tuberculosis (TB) is one of the most complex, persistent and controversial problems facing the British cattle industry, costing the country an estimated 100 pound million per year(1). The low sensitivity of the standard diagnostic test leads to considerable ambiguity in determining the main transmission routes of infection, which exacerbates the continuing scientific debate(2-6). In turn this uncertainty fuels the fierce public and political disputes on the necessity of controlling badgers to limit the spread of infection. Here we present a dynamic stochastic spatial model for bovine TB in Great Britain that combines within-farm and between-farm transmission. At the farmscale the model incorporates stochastic transmission of infection, maintenance of infection in the environment and a testing protocol that mimics historical government policy. Between-farm transmission has a short-range environmental component and is explicitly driven by movements of individual cattle between farms, as recorded in the Cattle Tracing System(2). The resultant model replicates the observed annual increase of infection over time as well as the spread of infection into new areas. Given that our model is mechanistic, it can ascribe transmission pathways to each new case; the majority of newly detected cases involve several transmission routes with moving infected cattle, reinfection from an environmental reservoir and poor sensitivity of the diagnostic test all having substantive roles. This underpins our findings on the implications of control measures. Very few of the control options tested have the potential to reverse the observed annual increase, with only intensive strategies such as whole-herd culling or additional national testing proving highly effective, whereas controls focused on a single transmission route are unlikely to be highly effective.	[Brooks-Pollock, Ellen] Univ Cambridge, Dept Vet Med, Dis Dynam Unit, Cambridge CB3 0ES, England; [Brooks-Pollock, Ellen; Keeling, Matt J.] Univ Warwick, Math Inst, WIDER Ctr, Coventry CV4 7AL, W Midlands, England; [Brooks-Pollock, Ellen; Keeling, Matt J.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Roberts, Gareth O.] Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England	University of Cambridge; University of Warwick; University of Warwick; University of Warwick	Keeling, MJ (corresponding author), Univ Warwick, Math Inst, WIDER Ctr, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	M.J.Keeling@warwick.ac.uk	Keeling, Matt J/J-9280-2012	Keeling, Matt J/0000-0003-4639-4765; Brooks-Pollock, Ellen/0000-0002-5984-4932	BBSRC; Wellcome Trust; EPSRC; BBSRC [BB/H00811X/1, BB/I013482/1] Funding Source: UKRI; EPSRC [EP/H027270/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I013482/1, BB/H00811X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/D002060/1, EP/H027270/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by BBSRC, the Wellcome Trust and EPSRC. We would like to thank G. Medley, L. Green, O. Courtenay, A. Ramirez-Villaescusa, J. Wood and L. Danon for helpful discussions on bovine TB dynamics. Thanks to A. Conlan and T. J. McKinley for advice on implementing SMC-ABC and to A. Conlan to setting up the Marx Bros cluster. The breakdown and reactor data was supplied by the AHVLA team (particularly A. Mitchell and R. Blackwell), the RADAR team and DEFRA.	Barlow ND, 1997, PREV VET MED, V32, P57, DOI 10.1016/S0167-5877(97)00002-0; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Brooks-Pollock E, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-97; Conlan AJK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002730; Cox DR, 2005, P NATL ACAD SCI USA, V102, P17588, DOI 10.1073/pnas.0509003102; Department for Environment Food and Rural Affairs, 2013, BOV TUB EV PLAN; Department for Environment Food and Rural Affairs, 2011, BOV TB ER PROGR ENGL; Donnelly C. A., 2010, STAT COMMUN INFECT D, V2, P1; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Fischer EAJ, 2005, PREV VET MED, V67, P283, DOI 10.1016/j.prevetmed.2004.12.002; Godfray HCJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1634; Gopal R, 2006, VET REC, V159, P265, DOI 10.1136/vr.159.9.265; Green DM, 2008, P R SOC B, V275, P1001, DOI 10.1098/rspb.2007.1601; Green LE, 2005, PREV VET MED, V70, P293, DOI 10.1016/j.prevetmed.2005.05.005; Independent Scientific Group on Cattle TB, 2007, BOV TB SCI EV; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Krebs J., 1997, PB3423 HMSO; MONAGHAN ML, 1994, VET MICROBIOL, V40, P111, DOI 10.1016/0378-1135(94)90050-7; National Audit Office, 2003, ID TRACK LIV ENGL; O'Hare A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0248; Pollock JM, 2001, TUBERCULOSIS, V81, P103, DOI 10.1054/tube.2000.0258; Reynolds D, 2006, VET MICROBIOL, V112, P119, DOI 10.1016/j.vetmic.2005.11.042; Sisson SA, 2007, P NATL ACAD SCI USA, V104, P1760, DOI 10.1073/pnas.0607208104; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Waddington K, 2004, MED HIST, V48, P29, DOI 10.1017/S0025727300007043; Woolhouse MEJ, 2005, BIOL LETTERS, V1, P350, DOI 10.1098/rsbl.2005.0331	26	147	149	1	185	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					228	+		10.1038/nature13529	http://dx.doi.org/10.1038/nature13529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008532				2022-12-01	WOS:000338649800045
J	Cooper, KL; Sears, KE; Uygur, A; Maier, J; Baczkowski, KS; Brosnahan, M; Antczak, D; Skidmore, JA; Tabin, CJ				Cooper, Kimberly L.; Sears, Karen E.; Uygur, Aysu; Maier, Jennifer; Baczkowski, Karl-Stephan; Brosnahan, Margaret; Antczak, Doug; Skidmore, Julian A.; Tabin, Clifford J.			Patterning and post-patterning modes of evolutionary digit loss in mammals	NATURE			English	Article							APICAL ECTODERMAL RIDGE; PROGRAMMED CELL-DEATH; LIMB DEVELOPMENT; VERTEBRATE LIMB; DEVELOPMENTAL BASIS; REDUCTION; HEDGEHOG; BUD; HEMIERGIS; NUMBER	A reduction in the number of digits has evolved many times in tetrapods, particularly in cursorial mammals that travel over deserts and plains, yet the underlying developmental mechanisms have remained elusive. Here we show that digit loss can occur both during early limbpatterning and at later post-patterning stages of chondrogenesis. In the 'odd-toed' jerboa (Dipus sagitta) and horse and the 'even-toed' camel, extensive cell death sculpts the tissue around the remaining toes. In contrast, digit loss inthepig is orchestrated by earlier limb patterning mechanisms including downregulation of Ptch1 expression but no increase in cell death. Together these data demonstrate remarkable plasticity in the mechanisms of vertebrate limb evolution and shed light on the complexity of morphological convergence, particularly within the artiodactyl lineage.	[Cooper, Kimberly L.; Uygur, Aysu; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Sears, Karen E.; Maier, Jennifer] Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA; [Baczkowski, Karl-Stephan] Ecole Normale Super Lyon, F-69007 Lyon, France; [Brosnahan, Margaret; Antczak, Doug] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Skidmore, Julian A.] Camel Reprod Ctr, Dubai, U Arab Emirates	Harvard University; Harvard Medical School; University of Illinois System; University of Illinois Urbana-Champaign; Ecole Normale Superieure de Lyon (ENS de LYON); Cornell University	Cooper, KL (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	kcooper@ucsd.edu; ksears@life.illinois.edu		Antczak, Douglas/0000-0003-3336-5818; Sears, Karen/0000-0001-9744-9602	NIH [R37HD032443]; NSF IOS grant [1257873]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF IOS grant(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank J. Lopez-Rios and R. Zeller (University of Basel, Switzerland) for generously providing data and discussion before publication. We also thank J. Carlos Izpisua Belmonte and A. Aguirre for sharing space and materials to complete experiments subsequent to review. Jerboa embryos were harvested with the assistance of S. Wu and colleagues in Xinjiang, China. Pig embryos were harvested with the assistance of D. Urban. Additional horse embryos were provided by R. Turner and H. Galatino-Homer (University of Pennsylvania) and by R. Fritsche and S. Lyle (Louisiana State University). Mouse Gli1 probe plasmid, used in the pig in situ, was provided by A. Joyner. This work was supported by NIH grant R37HD032443 to C.J.T., and NSF IOS grant 1257873 to K.E.S.	ALBERCH P, 1983, J EMBRYOL EXP MORPH, V76, P177; Butterfield NC, 2009, DEVELOPMENT, V136, P3515, DOI 10.1242/dev.037507; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Clifford AB, 2010, J VERTEBR PALEONTOL, V30, P1827, DOI 10.1080/02724634.2010.521216; Cooper K. L, 2011, COLD SPRING HARB PRO; Cooper LN, 2007, ANAT REC, V290, P654, DOI 10.1002/ar.20532; Fernandez-Teran MA, 2006, DEV DYNAM, V235, P2521, DOI 10.1002/dvdy.20916; Ferrari D, 1998, DEV BIOL, V197, P12, DOI 10.1006/dbio.1998.8880; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; LANDE R, 1978, EVOLUTION, V32, P73, DOI 10.1111/j.1558-5646.1978.tb01099.x; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Li YN, 2006, P NATL ACAD SCI USA, V103, P6548, DOI 10.1073/pnas.0600124103; Marazzi G, 1997, DEV BIOL, V186, P127, DOI 10.1006/dbio.1997.8576; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Ovchinnikov Dmitry, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5170; Pizette S, 2001, DEVELOPMENT, V128, P4463; Prothero D.R., 2007, EVOLUTION ARTIODACTY; Rasweiler J. J., 2009, COLD SPRING HARB PRO; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Romer A, 1936, VERTEBRATE PALEONTOL; ROSE KD, 1982, SCIENCE, V216, P621, DOI 10.1126/science.216.4546.621; Rose KD, 1996, P NATL ACAD SCI USA, V93, P1705, DOI 10.1073/pnas.93.4.1705; Sanz-Ezquerro JJ, 2003, CURR BIOL, V13, P1830, DOI 10.1016/j.cub.2003.09.040; Sears KE, 2011, EVOL DEV, V13, P533, DOI 10.1111/j.1525-142X.2011.00509.x; Shapiro MD, 2003, J EXP ZOOL PART B, V297B, P48, DOI 10.1002/jez.b.00019; Shapiro MD, 2002, J MORPHOL, V254, P211, DOI 10.1002/jmor.10027; Shenbrot GI., 2008, JERBOAS MAMMALS RUSS; Skinner A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-310; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Theodor J., 2007, EVOLUTION ARTIODACTY; Towers M, 2008, NATURE, V452, P882, DOI 10.1038/nature06718; Walker E. P., 1964, MAMMALS WORLD; Whole-mount R. R., 2009, COLD SPRING HARB PRO; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008; Zuzarte-Luis V, 2005, SEMIN CELL DEV BIOL, V16, P261, DOI 10.1016/j.semcdb.2004.12.004	36	89	92	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					41	U537		10.1038/nature13496	http://dx.doi.org/10.1038/nature13496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990742	Green Accepted			2022-12-01	WOS:000338199400031
J	Dar, RD; Hosmane, NN; Arkin, MR; Siliciano, RF; Weinberger, LS				Dar, Roy D.; Hosmane, Nina N.; Arkin, Michelle R.; Siliciano, Robert F.; Weinberger, Leor S.			Screening for noise in gene expression identifies drug synergies	SCIENCE			English	Article							TRANSCRIPTIONAL REGULATION; LATENT INFECTION; HIV-1 LATENCY; STOCHASTICITY; CONSEQUENCES; FREQUENCY; PROMOTER; CELLS; CURE	Stochastic fluctuations are inherent to gene expression and can drive cell-fate specification. We used such fluctuations to modulate reactivation of HIV from latency-a quiescent state that is a major barrier to an HIV cure. By screening a diverse library of bioactive small molecules, we identified more than 80 compounds that modulated HIV gene-expression fluctuations (i.e., "noise"), without changing mean expression. These noise-modulating compounds would be neglected in conventional screens, and yet, they synergized with conventional transcriptional activators. Noise enhancers reactivated latent cells significantly better than existing best-in-class reactivation drug combinations (and with reduced off-target cytotoxicity), whereas noise suppressors stabilized latency. Noise-modulating chemicals may provide novel probes for the physiological consequences of noise and an unexplored axis for drug discovery, allowing enhanced control over diverse cell-fate decisions.	[Dar, Roy D.; Weinberger, Leor S.] Gladstone Inst, San Francisco, CA 94158 USA; [Hosmane, Nina N.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Arkin, Michelle R.] Univ Calif San Francisco, Small Mol Discovery Ctr, San Francisco, CA 94158 USA; [Arkin, Michelle R.] Univ Calif San Francisco, Dept Pharmaceut Chem, Sch Pharm, San Francisco, CA 94143 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Weinberger, Leor S.] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94158 USA; [Weinberger, Leor S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weinberger, LS (corresponding author), Gladstone Inst, 1650 Owens St, San Francisco, CA 94158 USA.	leor.weinberger@gladstone.ucsf.edu	arkin, michelle/AAN-4298-2021; Arkin, Michelle/AAO-2009-2021	arkin, michelle/0000-0002-9366-6770; Dar, Roy/0000-0002-6006-4888	NIH National Research Service Award fellowship [AI104380]; NIH Director's New Innovator Award [DP2-OD006677]; NIH Delaney Collaboratory of AIDS Researchers for a Cure [U19AI096113]; UCSF CTSI-SOS Award; UCSF-GIVI CFAR [P30AI027763]; UCSF-CSSB [P50GM081879]; Pew Scholars in the Biomedical Sciences; Alfred P. Sloan Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI104380, P30AI027763, U19AI096113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, T32GM008752] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006677] Funding Source: NIH RePORTER	NIH National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Delaney Collaboratory of AIDS Researchers for a Cure; UCSF CTSI-SOS Award; UCSF-GIVI CFAR; UCSF-CSSB; Pew Scholars in the Biomedical Sciences; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank I. Golding, J. Weissman, O. Weiner, E. Verdin, M. Simpson, C. Lee, A. Pai and the Weinberger lab for thoughtful discussions. We thank C. Wilson, M. Cavrois, M. Gesner, and M. Titus for technical expertise and assistance. R. D. D. was supported by an NIH National Research Service Award fellowship (AI104380). This work was supported by the NIH Director's New Innovator Award DP2-OD006677 (L. S. W.), the NIH Delaney Collaboratory of AIDS Researchers for a Cure (U19AI096113), a UCSF CTSI-SOS Award, UCSF-GIVI CFAR (P30AI027763), UCSF-CSSB (P50GM081879), the Pew Scholars in the Biomedical Sciences, and the Alfred P. Sloan Foundation.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Dar RD, 2012, P NATL ACAD SCI USA, V109, P17454, DOI 10.1073/pnas.1213530109; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Ruelas DS, 2013, CELL, V155, P519, DOI 10.1016/j.cell.2013.09.044; Simpson ML, 2004, J THEOR BIOL, V229, P383, DOI 10.1016/j.jtbi.2004.04.017; Singh A, 2010, BIOPHYS J, V98, pL32, DOI 10.1016/j.bpj.2010.03.001; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Vardi N, 2013, CURR BIOL, V23, P2051, DOI 10.1016/j.cub.2013.08.043; Weinberger AD, 2013, CELL, V155, P497, DOI 10.1016/j.cell.2013.09.039; Weinberger LS, 2008, NAT GENET, V40, P466, DOI 10.1038/ng.116; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199	27	137	140	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1392	1396		10.1126/science.1250220	http://dx.doi.org/10.1126/science.1250220			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24903562	Green Accepted			2022-12-01	WOS:000337531700039
J	Subramanian, S; Huq, S; Yatsunenko, T; Haque, R; Mahfuz, M; Alam, MA; Benezra, A; DeStefano, J; Meier, MF; Muegge, BD; Barratt, MJ; VanArendonk, LG; Zhang, QY; Province, MA; Petri, WA; Ahmed, T; Gordon, JI				Subramanian, Sathish; Huq, Sayeeda; Yatsunenko, Tanya; Haque, Rashidul; Mahfuz, Mustafa; Alam, Mohammed A.; Benezra, Amber; DeStefano, Joseph; Meier, Martin F.; Muegge, Brian D.; Barratt, Michael J.; VanArendonk, Laura G.; Zhang, Qunyuan; Province, Michael A.; Petri, William A., Jr.; Ahmed, Tahmeed; Gordon, Jeffrey I.			Persistent gut microbiota immaturity in malnourished Bangladeshi children	NATURE			English	Article							GROWTH; MALNUTRITION; AGE	Therapeutic food interventions have reduced mortality in children with severe acute malnutrition (SAM), but incomplete restoration of healthy growth remains a major problem(1,2). The relationships between the type of nutritional intervention, the gut microbiota, and therapeutic responses are unclear. In the current study, bacterial species whose proportional representation define a healthy gut microbiota as it assembles during the first two postnatal years were identified by applying amachine-learning-based approach to 16S ribosomal RNA data sets generated from monthly faecal samples obtained from birth onwards in a cohort of children living in an urban slum of Dhaka, Bangladesh, who exhibited consistently healthy growth. These age discriminatory bacterial species were incorporated into a model that computes a 'relative microbiota maturity index' and 'microbiotafor- age Z-score' that compare postnatal assembly (defined here as maturation) of a child's faecal microbiota relative to healthy children of similar chronologic age. The model was applied to twins and triplets (to test for associations of these indices with genetic and environmental factors, including diarrhoea), children with SAM enrolled in a randomized trial of two food interventions, and children with moderate acute malnutrition. Our results indicate that SAM is associated with significant relative microbiota immaturity that is only partially ameliorated following two widely used nutritional interventions. Immaturity is also evident in less severe forms of malnutrition and correlates with anthropometric measurements. Microbiota maturity indices provide a microbial measure of human postnatal development, a way of classifying malnourished states, and a parameter for judging therapeutic efficacy. More prolonged interventions with existing or new therapeutic foods and/or addition of gut microbes may be needed to achieve enduring repair of gut microbiota immaturity in childhood malnutrition and improve clinical outcomes.	[Subramanian, Sathish; Yatsunenko, Tanya; Benezra, Amber; DeStefano, Joseph; Meier, Martin F.; Muegge, Brian D.; Barratt, Michael J.; VanArendonk, Laura G.; Gordon, Jeffrey I.] Washington Univ, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Huq, Sayeeda; Haque, Rashidul; Mahfuz, Mustafa; Alam, Mohammed A.; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Ctr Nutr & Food Secur, Dhaka 1212, Bangladesh; [Benezra, Amber] New Sch Social Res, Dept Anthropol, New York, NY 10003 USA; [Zhang, Qunyuan; Province, Michael A.] Washington Univ, Div Stat Genom, St Louis, MO 63108 USA; [Petri, William A., Jr.] Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA; [Petri, William A., Jr.] Univ Virginia, Sch Med, Dept Microbiol & Pathol, Charlottesville, VA 22908 USA	Washington University (WUSTL); International Centre for Diarrhoeal Disease Research (ICDDR); The New School; Washington University (WUSTL); University of Virginia; University of Virginia	Gordon, JI (corresponding author), Washington Univ, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	jgordon@wustl.edu	Benezra, Amber/ABU-7951-2022; Petri, William A./D-3639-2019; alam, mohammed/GXH-3645-2022; Alam, Ashraful/AAA-3893-2020; Mahfuz, Mustafa/H-5923-2017; Petri, William/AAL-3642-2020	Benezra, Amber/0000-0002-7092-6808; Alam, Ashraful/0000-0003-1389-8510; Mahfuz, Mustafa/0000-0002-4090-785X; Petri, William/0000-0002-7268-1218; Muegge, Brian/0000-0002-0044-3704	Bill & Melinda Gates Foundation; International Atomic Energy Agency; NIH [AI043596]; SBE Doctoral Dissertation Research Improvement Grant (NSF) [SES-1027035]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); International Atomic Energy Agency(International Atomic Energy Agency); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SBE Doctoral Dissertation Research Improvement Grant (NSF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the parents and children from Dhaka, Bangladesh for their participation in this study, J. Hoisington-Lopez and S. Deng for technical assistance, and N. Griffin, A. Kau, N. Dey and J. Faith for suggestions during the course of this work. This work was supported by the Bill & Melinda Gates Foundation. The clinical component of the SAM study was funded by the International Atomic Energy Agency. The birth cohort study of singletons was supported in part by the NIH (AI043596). S. S. is a member of the Washington University Medical Scientist Training Program. A. B. is the recipient of an SBE Doctoral Dissertation Research Improvement Grant (NSF Award no. SES-1027035).	Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Ahmed T., 2004, J PEDIAT GASTROENTER, V39, pS277; Ahmed Tahmeed, 2001, Indian Journal of Pediatrics, V68, P45, DOI 10.1007/BF02728857; Ashraf H, 2012, J TROP PEDIATRICS, V58, P253, DOI 10.1093/tropej/fmr083; Bates D., 2011, LINEAR MIXED EFFECTS, V1; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dewey KG, 2005, MATERN CHILD NUTR, V1, P11, DOI 10.1111/j.1740-8709.2004.00004.x; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Kuznetsova A., 2013, CHRISTENSEN RHB LMER; Lazzerini M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009584.pub2; Lin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053838; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mondal D, 2012, CLIN INFECT DIS, V54, P185, DOI 10.1093/cid/cir807; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nahar B, 2012, EUR J CLIN NUTR, V66, P701, DOI 10.1038/ejcn.2012.13; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; Pathela P, 2006, ACTA PAEDIATR, V95, P430, DOI 10.1080/08035250500444875; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; World Health Organization Department of Nutrition for Health and Development, 2009, WHO CHILD GROWTH STA; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	27	703	722	11	192	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					417	+		10.1038/nature13421	http://dx.doi.org/10.1038/nature13421			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24896187	Green Accepted			2022-12-01	WOS:000337350200039
J	Vater, LB; Donohue, JM; Arnold, R; White, DB; Chu, E; Schenker, Y				Vater, Laura B.; Donohue, Julie M.; Arnold, Robert; White, Douglas B.; Chu, Edward; Schenker, Yael			What Are Cancer Centers Advertising to the Public? A Content Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							PALLIATIVE RADIOTHERAPY; PRESCRIPTION DRUGS; LUNG-CANCER; EXPECTATIONS; PATIENT; CARE; PERCEPTIONS; PROGNOSIS; THERAPY; COST	Background: Although critics have expressed concerns about cancer center advertising, analyses of the content of these advertisements are lacking. Objective: To characterize the information and emotional content of direct-to-consumer cancer center advertisements. Design: Content analysis. Setting: Top U. S. consumer magazines (n = 269) and television networks (n = 44) in 2012. Measurements: Types of clinical services promoted; information provided about clinical services, including risks, benefits, costs, and insurance availability; use of emotional advertising appeals; and use of patient testimonials were assessed. Two investigators independently coded advertisements using ATLAS.ti, and kappa values ranged from 0.77 to 1.00. Results: A total of 102 cancer centers placed 409 unique clinical advertisements in top media markets in 2012. Advertisements promoted treatments (88%) more often than screening (18%) or supportive services (13%). Benefits of advertised therapies were described more often than risks (27% vs. 2%) but were rarely quantified (2%). Few advertisements mentioned coverage or costs (5%), and none mentioned specific insurance plans. Emotional appeals were frequent (85%), evoking hope for survival (61%), describing cancer treatment as a fight or battle (41%), and inducing fear (30%). Nearly one half of advertisements included patient testimonials, which were usually focused on survival, rarely included disclaimers (15%), and never described the results that a typical patient may expect. Limitation: Internet advertisements were not included. Conclusion: Clinical advertisements by cancer centers frequently promote cancer therapy with emotional appeals that evoke hope and fear while rarely providing information about risks, benefits, costs, or insurance availability. Further work is needed to understand how these advertisements influence patient understanding and expectations of benefit from cancer treatments.	Univ Pittsburgh, Grad Sch Publ Hlth, Biobehav Oncol Program, Canc Inst,Palliat & Support Inst,Med Ctr, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness Ctr, Pittsburgh, PA 15213 USA; Indiana Univ, Sch Med, South Bend, IN 46615 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indiana University System; Indiana University South Bend	Schenker, Y (corresponding author), Univ Pittsburgh, Sect Palliat Care & Med Eth, Div Gen Med, 230 McKee Pl,Suite 600, Pittsburgh, PA 15213 USA.	schenkery@upmc.edu		Donohue, Julie/0000-0003-2418-6017; Vater, Laura/0000-0002-5920-9576	National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Primary Funding Source: National Institutes of Health.	Abel GA, 2007, J CLIN ONCOL, V25, P1267, DOI 10.1200/JCO.2006.09.5968; Abel GA, 2009, J CLIN ONCOL, V27, P4182, DOI 10.1200/JCO.2008.20.6599; Algie J, 2010, J PREV INTERV COMMUN, V38, P264, DOI 10.1080/10852352.2010.509019; Ambler T, 1999, J ADVERTISING RES, V39, P25; American College of Surgeons, SEARCH COC HOSP LOC; American College of Surgeons, ACCR; Armstrong JS., 2010, PERSUASIVE ADVERTISI, DOI 10.1057/9780230285804; Bell RA, 2000, J FAM PRACTICE, V49, P329; Burns CM, 2007, SUPPORT CARE CANCER, V15, P187, DOI 10.1007/s00520-006-0116-8; Char SJL, 2010, AM J RESP CRIT CARE, V182, P905, DOI 10.1164/rccm.201002-0262OC; Chen AB, 2013, J CLIN ONCOL, V31, P2730, DOI 10.1200/JCO.2012.48.5748; Chow E, 2001, CLIN ONCOL-UK, V13, P204, DOI 10.1007/s001740170077; Dillard JP, 2006, J COMMUN, V56, pS123, DOI 10.1111/j.1460-2466.2006.00286.x; Donohue JM, 2007, NEW ENGL J MED, V357, P673, DOI 10.1056/NEJMsa070502; Dunlop SM, 2014, J HEALTH COMMUN, V19, P41, DOI 10.1080/10810730.2013.798375; Dunlop SM, 2012, TOB CONTROL; EIDINGER RN, 1984, CANCER, V53, P2736, DOI 10.1002/1097-0142(19840615)53:12<2736::AID-CNCR2820531233>3.0.CO;2-W; Frosch DL, 2007, ANN FAM MED, V5, P6, DOI 10.1370/afm.611; Gattellari M, 2002, J CLIN ONCOL, V20, P503, DOI 10.1200/JCO.20.2.503; Gray SW, 2012, J ONCOL PRACT, V8, P124, DOI 10.1200/JOP.2011.000513; Illes J, 2004, ARCH INTERN MED, V164, P2415, DOI 10.1001/archinte.164.22.2415; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; Larson RJ, 2005, ARCH INTERN MED, V165, P645, DOI 10.1001/archinte.165.6.645; Lee SJ, 2001, JAMA-J AM MED ASSOC, V285, P1034, DOI 10.1001/jama.285.8.1034; Lovett KM, 2012, J CLIN ONCOL, V30, P1411, DOI 10.1200/JCO.2011.37.8984; MACKILLOP WJ, 1988, BRIT J CANCER, V58, P355, DOI 10.1038/bjc.1988.218; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Mehrotra A, 2006, HEALTH AFFAIR, V25, P759, DOI 10.1377/hlthaff.25.3.759; Mitera G, 2012, CLIN ONCOL-UK, V24, P134, DOI 10.1016/j.clon.2011.09.001; National Cancer Institute, NCI DES CANC CTR; National Research Council, 2013, DEL HIGH QUAL CANC C; Newman A. A., 2011, NY TIMES; Parrott Roxanne, 2008, Health Mark Q, V25, P8, DOI 10.1080/07359680802126061; PRONZATO P, 1994, SUPPORT CARE CANCER, V2, P242, DOI 10.1007/BF00365729; Ravdin PM, 1998, J CLIN ONCOL, V16, P515, DOI 10.1200/JCO.1998.16.2.515; Sapir R, 2000, SUPPORT CARE CANCER, V8, P458, DOI 10.1007/s005200000163; Schenker Y, 2014, AM J BIOETHICS, V14, P34, DOI 10.1080/15265161.2013.879943; SCHWARTZ IM, 1989, J ADOLESCENT HEALTH, V10, P473, DOI 10.1016/0197-0070(89)90009-0; Singer Natasha, 2009, NY TIMES        0805, pA1; STERN BB, 1994, J CONSUM RES, V20, P601, DOI 10.1086/209373; Tellis GJ, 2004, EFFECTIVE ADVERTISIN; Temel JS, 2011, J CLIN ONCOL, V29, P2319, DOI 10.1200/JCO.2010.32.4459; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; Volpp KG, 2012, JAMA-J AM MED ASSOC, V308, P1635, DOI 10.1001/jama.2012.13616; Warren JL, 2008, J NATL CANCER I, V100, P888, DOI 10.1093/jnci/djn175; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410; Weissman J. S., 2004, HLTH AFF MILLWOOD S	47	39	39	2	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12					813	U24		10.7326/M14-0500	http://dx.doi.org/10.7326/M14-0500			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ0VR	24863081	Green Accepted			2022-12-01	WOS:000337374900014
J	Kessler, R				Kessler, Rebecca			PREVENTION Air of danger	NATURE			English	Editorial Material							BREAST-CANCER; EXPOSURE; DDT; AGE											Cohn BA, 2007, ENVIRON HEALTH PERSP, V115, P1406, DOI 10.1289/ehp.10260; Cohn BA, 2012, BREAST CANCER RES TR, V136, P267, DOI 10.1007/s10549-012-2257-4; Cohn BA, 2010, ARCH ENVIRON OCCUP H, V65, P127, DOI 10.1080/19338241003730887; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005; National Toxicology Program, 2011, REP CARC; Prins GS, 2014, ENDOCRINOLOGY, V155, P805, DOI 10.1210/en.2013-1955; Straif K., 2013, AIR POLLUTION CANC; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; [No title captured]	10	15	16	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S62	S63		10.1038/509S62a	http://dx.doi.org/10.1038/509S62a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870824	Bronze			2022-12-01	WOS:000336457100007
J	Goodarzi, H; Zhang, S; Buss, CG; Fish, L; Tavazoie, S; Tavazoie, SF				Goodarzi, Hani; Zhang, Steven; Buss, Colin G.; Fish, Lisa; Tavazoie, Saeed; Tavazoie, Sohail F.			Metastasis-suppressor transcript destabilization through TARBP2 binding of mRNA hairpins	NATURE			English	Article							BREAST-CANCER METASTASIS; GENE-EXPRESSION; REGULATORY ELEMENTS; PROTEIN; SEQ; STABILITY; DISCOVERY; INVASION; DISEASE; COMPLEX	Aberrant regulation of RNA stability has an important role in many disease states(1,2). Deregulated post-transcriptional modulation, such as that governed by microRNAs targeting linear sequence elements in messenger RNAs, has been implicated in the progression of many cancer types(3-7). A defining feature of RNA is its ability to fold into structures. However, the roles of structural mRNA elements in cancer progression remain unexplored. Here we performed an unbiased search for post-transcriptional modulators of mRNA stability in breast cancer by conducting whole-genome transcript stability measurements in poorly and highly metastatic isogenic human breast cancer lines. Using a computational framework that searches RNA sequence and structure space(8), we discovered a family of GC-rich structural cis-regulatory RNA elements, termed sRSEs for structural RNA stability elements, which are significantly overrepresented in transcripts displaying reduced stability in highly metastatic cells. By integrating computational and biochemical approaches, we identified TARBP2, a double-stranded RNA-binding protein implicated in microRNA processing, as the trans factor that binds the sRSE family and similar structural elements collectively termed TARBP2-binding structural elements (TBSEs) in transcripts. TARBP2 is overexpressed in metastatic cells and metastatic human breast tumours and destabilizes transcripts containing TBSEs. Endogenous TARBP2 promotes metastatic cell invasion and colonization by destabilizing amyloid precursor protein (APP) and ZNF395 transcripts, two genes previously associated with Alzheimer's and Huntington's disease, respectively. We reveal these genes to be novel metastasis suppressor genes in breast cancer. The cleavage product of APP, extracellular alpha-myloida peptide, directly suppresses invasion while ZNF395 transcriptionally represses a pro-metastatic gene expression program. The expression levels of TARBP2, APP and ZNF395 in human breast carcinomas support their experimentally uncovered roles in metastasis. Our findings establish a non-canonical and direct role for TARBP2 in mammalian gene expression regulation and reveal that regulated RNA destabilization through protein-mediated binding of mRNA structural elements can govern cancer progression.	[Goodarzi, Hani; Zhang, Steven; Buss, Colin G.; Fish, Lisa; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA; [Tavazoie, Saeed] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Tavazoie, Saeed] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA	Rockefeller University; Columbia University; Columbia University	Tavazoie, S (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	st2744@columbia.edu; stavazoie@rockefeller.edu	Buss, Colin/I-5326-2014	Buss, Colin/0000-0001-7771-1685; Fish, Lisa/0000-0001-9184-0512; Goodarzi, Hani/0000-0002-9648-8949	Department of Defense Era of Hope Scholar; Department of Defense Breast Cancer Collaborative Scholars and Innovators Award; National Human Genome Research Institute [R01 HG003219]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003219] Funding Source: NIH RePORTER	Department of Defense Era of Hope Scholar(United States Department of Defense); Department of Defense Breast Cancer Collaborative Scholars and Innovators Award; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank C. Alarcon, N. Halberg, N. Pencheva, P. Furlow and A. Nguyen for technical assistance and comments on previous versions of this manuscript. We thank H. Lee for her help with orthotopic injections. We thank P. Oikonomou for providing the reporter constructs. We thank the Darnell laboratory for their input on the HITS-CLIP methodology. We are also grateful to M. McManus and Z. Mourelatos for providing Dicer-null cells. We thank C. Zhao, W. Zhang and S. Dewell of the Rockefeller Genomics Resource Center for assistance with next-generation RNA-sequencing and microarray profiling. H.G. is an Anderson Cancer Center Fellow at Rockefeller University. S.F.T. is a Department of Defense Era of Hope Scholar and a Department of Defense Breast Cancer Collaborative Scholars and Innovators Award recipient. S.T. was supported by the National Human Genome Research Institute (R01 HG003219). We also acknowledge the efforts of Expression Project for Oncology (ExpO) and International Genomics Consortium (IGC) in providing public access to breast cancer gene expression profiles and annotations.	Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cutroneo KR, 2006, CRIT REV EUKAR GENE, V16, P23; De Vito C, 2012, CANCER CELL, V21, P807, DOI 10.1016/j.ccr.2012.04.023; Eddy SR, 2002, CELL, V109, P137, DOI 10.1016/S0092-8674(02)00727-4; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Fan XX, 2010, ACTA BIOCH BIOPH SIN, V42, P318, DOI 10.1093/abbs/gmq026; Foat BC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.24; GATIGNOL A, 1993, MOL CELL BIOL, V13, P2193, DOI 10.1128/MCB.13.4.2193; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Goodarzi H, 2012, NATURE, V485, P264, DOI 10.1038/nature11013; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Manley James L, 2013, Cold Spring Harb Protoc, V2013, P156, DOI 10.1101/pdb.prot072934; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Oikonomou P, 2014, CELL REP, V7, P281, DOI 10.1016/j.celrep.2014.03.001; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Singh B, 2007, ONCOGENE, V26, P3789, DOI 10.1038/sj.onc.1210154; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Soria G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-130; STRIETER RM, 1992, AM J PATHOL, V141, P1279; Tanaka K, 2004, J BIOL CHEM, V279, P7275, DOI 10.1074/jbc.M310726200; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	47	59	62	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					256	+		10.1038/nature13466	http://dx.doi.org/10.1038/nature13466			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25043050	Green Accepted			2022-12-01	WOS:000341362800055
J	Pinan-Lucarre, B; Tu, HJ; Pierron, M; Cruceyra, PI; Zhan, H; Stigloher, C; Richmond, JE; Bessereau, JL				Pinan-Lucarre, Berangere; Tu, Haijun; Pierron, Marie; Cruceyra, Pablo Ibanez; Zhan, Hong; Stigloher, Christian; Richmond, Janet E.; Bessereau, Jean-Louis			C. elegans Punctin specifies cholinergic versus GABAergic identity of postsynaptic domains	NATURE			English	Article							RECEPTOR ALPHA-SUBUNIT; CAENORHABDITIS-ELEGANS; ACETYLCHOLINE-RECEPTOR; NEUROMUSCULAR-JUNCTION; EXTRACELLULAR-MATRIX; GABA RECEPTOR; GENE ENCODES; PROTEIN; COMPLEX	Because most neurons receive thousands of synaptic inputs, the neuronal membrane is a mosaic of specialized microdomains where neurotransmitter receptors cluster in register with the corresponding presynaptic neurotransmitter release sites. In many cases the coordinated differentiation of presynaptic and postsynaptic domains implicates trans-synaptic interactions between membrane-associated proteins such as neurexins and neuroligins(1-3). The Caenorhabditis elegans neuromuscular junction (NMJ) provides a genetically tractable system in which to analyse the segregation of neurotransmitter receptors, because muscle cells receive excitatory innervation from cholinergic neurons and inhibitory innervation from GABAergic neurons(4). Here we show that Ce-Punctin/madd-4 (ref.5), the C. elegans orthologue of mammalian punctin-1 and punctin-2, encodes neurally secreted isoforms that specify the excitatory or inhibitory identity of postsynaptic NMJ domains. These proteins belong to the ADAMTS (a disintegrin and metalloprotease with thrombospondin repeats)like family, a class of extracellular matrix proteins related to the ADAM proteases but devoid of proteolytic activity(6). Ce-Punctin deletion causes the redistribution of synaptic acetylcholine and GABA(A) (gamma-aminobutyric acid type A) receptors into extrasynaptic clusters, whereas neuronal presynaptic boutons remain unaltered. Alternative promoters generate different Ce-Punctin isoforms with distinct functions. A short isoform is expressed by cholinergic and GABAergic motoneurons and localizes to excitatory and inhibitory NMJs, whereas long isoforms are expressed exclusively by cholinergic motoneurons and are confined to cholinergic NMJs. The differential expression of these isoforms controls the congruence between presynaptic and postsynaptic domains: specific disruption of the short isoform relocalizes GABAA receptors from GABAergic to cholinergic synapses, whereas expression of a long isoform in GABAergic neurons recruits acetylcholine receptors to GABAergic NMJs. These results identify Ce-Punctin as a previously unknown synaptic organizer and show that presynaptic and postsynaptic domain identities can be genetically uncoupled in vivo. Because human punctin-2 was identified as a candidate gene for schizophrenia(7), ADAMTS-like proteins may also control synapse organization in the mammalian central nervous system.	[Pinan-Lucarre, Berangere; Tu, Haijun; Pierron, Marie; Cruceyra, Pablo Ibanez; Zhan, Hong; Stigloher, Christian; Bessereau, Jean-Louis] Ecole Normale Super, Inst Biol, F-75005 Paris, France; [Pinan-Lucarre, Berangere; Tu, Haijun; Pierron, Marie; Zhan, Hong; Bessereau, Jean-Louis] Univ Lyon 1, CGphiMC UMR CNRS 5534, F-69622 Villeurbanne, France; [Richmond, Janet E.] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bessereau, JL (corresponding author), Ecole Normale Super, Inst Biol, F-75005 Paris, France.	jean-louis.bessereau@univ-lyon1.fr	Zhan, Hong/AAS-8840-2020; Bessereau, Jean-Louis/M-2988-2017; Stigloher, Christian/E-4762-2015; Pinan-Lucarre, Berangere/H-4542-2017	Zhan, Hong/0000-0002-7625-3528; Bessereau, Jean-Louis/0000-0002-3088-7621; Stigloher, Christian/0000-0001-6941-2669; Pinan-Lucarre, Berangere/0000-0002-6866-4714	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; Association Francaise contre les Myopathies; Fondation pour la Recherche Medicale; Neuropole de Recherche Francilien; Fondation Pierre-Gilles de Gennes; Human Frontier Science Program Long-Term Fellowship; Agence Nationale de la Recherche [ANR-2010-BLAN-1618-01, ANR-11-BSV4-019]; Fondation pour la Recherche Medicale ('Equipe FRM' grant)	National Institutes of Health Office of Research Infrastructure Programs; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Neuropole de Recherche Francilien; Fondation Pierre-Gilles de Gennes; Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale ('Equipe FRM' grant)	We thank C. Lena for expert assistance with analysis of postsynaptic receptor distributions; A. Boyanov for whole genome sequencing; L. Briseno-Roa for technical advice; T. Boulin and M. Jospin for critical reading of the manuscript; M. J. Caron for suggestions on the figure display; A. Valfort, H. Gendrot, P. Muller and B. Mathieu for technical help; J. Rand for the anti-UNC-17 antibodies; M. Hammarlund and E. Jorgensen for plasmids; and P. Roy, the Caenorhabditis Genetic Center (which is funded by National Institutes of Health Office of Research Infrastructure Programs, P40 OD010440) and the International C. elegans Gene Knockout Consortium for strains. B. P.-L. was supported by the Association Francaise contre les Myopathies; H.T. by the Fondation pour la Recherche Medicale and by the Neuropole de Recherche Francilien; M.P. by the Neuropole de Recherche Francilien; H.Z. by the Fondation Pierre-Gilles de Gennes; and C.S. by a Human Frontier Science Program Long-Term Fellowship. This work was funded by the Agence Nationale de la Recherche (ANR-2010-BLAN-1618-01 and ANR-11-BSV4-019), the Fondation pour la Recherche Medicale ('Equipe FRM' grant to J.-L.B.) and the Association Francaise contre les Myopathies (J.-L.B.).	Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Bamber BA, 1999, J NEUROSCI, V19, P5348; Boulin T, 2008, P NATL ACAD SCI USA, V105, P18590, DOI 10.1073/pnas.0806933105; Boulin T, 2012, NAT NEUROSCI, V15, P1374, DOI 10.1038/nn.3197; BRENNER S, 1974, GENETICS, V77, P71; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; Culetto E, 2004, J BIOL CHEM, V279, P42476, DOI 10.1074/jbc.M404370200; Dixon SJ, 2005, DEVELOPMENT, V132, P3079, DOI 10.1242/dev.01883; Dow DJ, 2011, SCHIZOPHR RES, V127, P28, DOI 10.1016/j.schres.2010.12.009; Fleming JT, 1997, J NEUROSCI, V17, P5843; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Frokjaer-Jensen C, 2010, NAT METHODS, V7, P451, DOI [10.1038/NMETH.1454, 10.1038/nmeth.1454]; Gally C, 2004, NATURE, V431, P578, DOI 10.1038/nature02893; Gally C, 2003, J NEUROSCI, V23, P2591; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Gottschalk A, 2006, J NEUROSCI METH, V154, P68, DOI 10.1016/j.jneumeth.2005.11.016; Hall NG, 2003, MATRIX BIOL, V22, P501, DOI 10.1016/S0945-053X(03)00075-1; Hirohata S, 2002, J BIOL CHEM, V277, P12182, DOI 10.1074/jbc.M109665200; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Rapti G, 2011, EMBO J, V30, P706, DOI 10.1038/emboj.2010.355; Richard M, 2013, P NATL ACAD SCI USA, V110, pE1055, DOI 10.1073/pnas.1216154110; Richmond J. E, 2006, WORMBOOK; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Sancar F, 2011, J BIOL CHEM, V286, P33501, DOI 10.1074/jbc.M111.227678; Seetharaman A, 2011, DEV CELL, V21, P669, DOI 10.1016/j.devcel.2011.07.020; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Stigloher C, 2011, J NEUROSCI, V31, P4388, DOI 10.1523/JNEUROSCI.6164-10.2011; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Towers PR, 2005, J NEUROCHEM, V93, P1, DOI 10.1111/j.1471-4159.2004.02951.x; Tsutsui K, 2010, J BIOL CHEM, V285, P4870, DOI 10.1074/jbc.M109.076919; Tursun B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004625; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	41	41	43	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					466	+		10.1038/nature13313	http://dx.doi.org/10.1038/nature13313			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	24896188				2022-12-01	WOS:000339335700046
J	Lo, WS; Gardiner, E; Xu, ZW; Lau, CF; Wang, F; Zhou, JJ; Mendlein, JD; Nangle, LA; Chiang, KP; Yang, XL; Au, KF; Wong, WH; Guo, M; Zhang, MJ; Schimmel, P				Lo, Wing-Sze; Gardiner, Elisabeth; Xu, Zhiwen; Lau, Ching-Fun; Wang, Feng; Zhou, Jie J.; Mendlein, John D.; Nangle, Leslie A.; Chiang, Kyle P.; Yang, Xiang-Lei; Au, Kin-Fai; Wong, Wing Hung; Guo, Min; Zhang, Mingjie; Schimmel, Paul			Human tRNA synthetase catalytic nulls with diverse functions	SCIENCE			English	Article							PRETRANSFER; EXPRESSION; VARIANTS; PRESSURE; DOMAIN	Genetic efficiency in higher organisms depends on mechanisms to create multiple functions from single genes. To investigate this question for an enzyme family, we chose aminoacyl tRNA synthetases (AARSs). They are exceptional in their progressive and accretive proliferation of noncatalytic domains as the Tree of Life is ascended. Here we report discovery of a large number of natural catalytic nulls (CNs) for each human AARS. Splicing events retain noncatalytic domains while ablating the catalytic domain to create CNs with diverse functions. Each synthetase is converted into several new signaling proteins with biological activities "orthogonal" to that of the catalytic parent. We suggest that splice variants with nonenzymatic functions may be more general, as evidenced by recent findings of other catalytically inactive splice-variant enzymes.	[Lo, Wing-Sze; Xu, Zhiwen; Lau, Ching-Fun; Wang, Feng; Zhou, Jie J.; Yang, Xiang-Lei; Zhang, Mingjie; Schimmel, Paul] Hong Kong Univ Sci & Technol, Inst Adv Study, IAS HKUST Scripps R&D Lab, Kowloon, Hong Kong, Peoples R China; [Lo, Wing-Sze; Xu, Zhiwen; Lau, Ching-Fun; Wang, Feng; Zhou, Jie J.] Pangu Biopharma, Hong Kong, Hong Kong, Peoples R China; [Gardiner, Elisabeth; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Scripps Labs tRNA Synthetase Res, La Jolla, CA 92037 USA; [Gardiner, Elisabeth; Mendlein, John D.; Nangle, Leslie A.; Chiang, Kyle P.] aTyr Pharma, San Diego, CA 92121 USA; [Au, Kin-Fai] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Wong, Wing Hung] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Guo, Min; Schimmel, Paul] Scripps Florida, Scripps Labs tRNA Synthetase Res, Jupiter, FL 33458 USA; [Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Scripps Research Institute; University of Iowa; Stanford University; State University System of Florida; University of Florida; Hong Kong University of Science & Technology	Schimmel, P (corresponding author), Hong Kong Univ Sci & Technol, Inst Adv Study, IAS HKUST Scripps R&D Lab, Kowloon, Hong Kong, Peoples R China.	schimmel@scripps.edu	Lo, Cario Wing Sze/DGZ-8810-2022; Yang, Xiang-Lei/AAR-7107-2020	Zhang, Mingjie/0000-0001-9404-0190; Yang, Xiang-Lei/0000-0003-2554-084X	Innovation and Technology Fund from the Hong Kong Government [UIM181, UIM192, UIM199]; National Foundation for Cancer Research; NIH [R01CA92577, R01GM088278, R01NS085092, R01HG005717, R01GM100136]; NATIONAL CANCER INSTITUTE [R01CA092577] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100136, R01GM088278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085092] Funding Source: NIH RePORTER	Innovation and Technology Fund from the Hong Kong Government; National Foundation for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Innovation and Technology Fund from the Hong Kong Government (UIM181, UIM192, and UIM199); by a fellowship from the National Foundation for Cancer Research; and by NIH grants R01CA92577, R01GM088278, R01NS085092, R01HG005717, and R01GM100136. We thank K. Piehl and J. Li (aTyr Pharma) for help with splice variant cloning and protein expression. We also thank A. Cubitt (aTyr Pharma) for assistance on the transcriptional profiling, V. Trinh and J. Zhao (both formerly of aTyr Pharma) for assistance with cell profiling of recombinant tRNA synthetase fragments, and B. Cravatt (Scripps Research Institute) for help with interpretation of the PROTOMAP data. P. S. is a cofounder and member of the Board of Directors of aTyr Pharma, W. H. W. is a member of the aTyr Pharma Scientific Advisory Board, and X.-L.Y is a scientific cofounder and a member of the Scientific Advisory Board of aTyr Pharma. E. G. has no financial interest with aTyr Pharma. Clones of catalytic nulls are available for research purposes under a Material Transfer Agreement with aTyr Pharma. W.-S. L, L.A.N, and K. P. C. are inventors on patent applications filed by aTyr Pharma Inc. and Pangu Biopharma Ltd. that cover the splice variants described in this work.	Anamika K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-622; Arif A, 2011, P NATL ACAD SCI USA, V108, P1415, DOI 10.1073/pnas.1011275108; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Giege R, 2003, NAT STRUCT BIOL, V10, P414, DOI 10.1038/nsb0603-414; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/NCHEMBIO.1158, 10.1038/nchembio.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Ibba M, 2004, GENE DEV, V18, P731, DOI 10.1101/gad.1187404; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Kawahara A, 2009, TRENDS CARDIOVAS MED, V19, P179, DOI 10.1016/j.tcm.2009.11.001; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; LUDMERER SW, 1987, J BIOL CHEM, V262, P10807; Miyanokoshi M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03477; Nakanishi K, 2005, NAT STRUCT MOL BIOL, V12, P931, DOI 10.1038/nsmb988; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Rack JGM, 2014, J MOL BIOL, V426, P1677, DOI 10.1016/j.jmb.2013.10.027; Schwenzer H, 2014, BIOCHIMIE, V100, P18, DOI 10.1016/j.biochi.2013.09.027; Takeda J, 2006, NUCLEIC ACIDS RES, V34, P3917, DOI 10.1093/nar/gkl507; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Toung JM, 2011, GENOME RES, V21, P991, DOI 10.1101/gr.116335.110; Tzima E, 2005, J BIOL CHEM, V280, P2405, DOI 10.1074/jbc.C400431200; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wang F, 2013, J BIOL CHEM, V288, P29223, DOI 10.1074/jbc.C113.490599; Xu XL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1686; Xu ZW, 2012, STRUCTURE, V20, P1470, DOI 10.1016/j.str.2012.08.001; Yadavalli SS, 2008, P NATL ACAD SCI USA, V105, P19031, DOI 10.1073/pnas.0810781106; Zhou QS, 2010, NAT STRUCT MOL BIOL, V17, P57, DOI 10.1038/nsmb.1706	34	80	84	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					328	332		10.1126/science.1252943	http://dx.doi.org/10.1126/science.1252943			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035493	Green Accepted, Green Submitted			2022-12-01	WOS:000339400700052
J	Uyanik, M; Hayashi, H; Ishihara, K				Uyanik, Muhammet; Hayashi, Hiroki; Ishihara, Kazuaki			High-turnover hypoiodite catalysis for asymmetric synthesis of tocopherols	SCIENCE			English	Article							VITAMIN-E; ALCOHOLS	The diverse biological activities of tocopherols and their analogs have inspired considerable interest in the development of routes for their efficient asymmetric synthesis. Here, we report that chiral ammonium hypoiodite salts catalyze highly chemo-and enantioselective oxidative cyclization of gamma-(2-hydroxyphenyl) ketones to 2-acyl chromans bearing a quaternary stereocenter, which serve as productive synthetic intermediates for tocopherols. Raman spectroscopic analysis of a solution of tetrabutylammonium iodide and tert-butyl hydroperoxide revealed the in situ generation of the hypoiodite salt as an unstable catalytic active species and triiodide salt as a stable inert species. A high-performance catalytic oxidation system (turnover number of similar to 200) has been achieved through reversible equilibration between hypoiodite and triiodide in the presence of potassium carbonate base. We anticipate that these findings will open further prospects for the development of high-turnover redox organocatalysis.	[Uyanik, Muhammet; Hayashi, Hiroki; Ishihara, Kazuaki] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Ishihara, Kazuaki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Nagoya University; Japan Science & Technology Agency (JST)	Ishihara, K (corresponding author), Nagoya Univ, Grad Sch Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	ishihara@cc.nagoya-u.ac.jp	Uyanik, Muhammet/E-1533-2011	Uyanik, Muhammet/0000-0002-9751-1952; Hayashi, Hiroki/0000-0003-2081-6886	Japan Society for the Promotion of Science [24245020, 22750087, 25105722]; Program for Leading Graduate Schools "Integrative Graduate Education and Research in Green Natural Sciences," Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [25105722] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Leading Graduate Schools "Integrative Graduate Education and Research in Green Natural Sciences," Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support for this project was partially provided by the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (KAKENHI) (24245020, 22750087, and 25105722), and Program for Leading Graduate Schools "Integrative Graduate Education and Research in Green Natural Sciences," Ministry of Education, Culture, Sports, Science and Technology, Japan. Metrical parameters for the structure of compound 2h are available free of charge from the Cambridge Crystallographic Data Centre under reference number CCDC 996935. M. U. and K. I. developed the concept and conceived the experiments. H. H. performed the experiments. H. H. and M. U. analyzed the data. M. U. and K. I. prepared the manuscript, with assistance from H.H.	Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Blatt DH, 2004, J NUTR BIOCHEM, V15, P380, DOI 10.1016/j.jnutbio.2003.12.011; CADLE RD, 1950, J PHYS COLLOID CHEM, V54, P1191, DOI 10.1021/j150482a011; Chenevert R, 2006, BIOORGAN MED CHEM, V14, P5389, DOI 10.1016/j.bmc.2006.03.035; Chia Y., 1958, THESIS U CALIFORNIA; Chougnet A, 2010, CHIMIA, V64, P303, DOI 10.2533/chimia.2010.303; Evans DA, 2007, J AM CHEM SOC, V129, P10029, DOI 10.1021/ja072976i; Howard AC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1594; Huang PH, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003816; Ida A., 2011, U.S. Patent, Patent No. [8,080,676, 8080676]; Koyama H, 2004, J MED CHEM, V47, P3255, DOI 10.1021/jm030621d; List B., 2012, SCI SYNTHESIS ASYMME; Lopez GV, 2005, BIOORGAN MED CHEM, V13, P5787, DOI 10.1016/j.bmc.2005.05.060; Magdziak D, 2004, CHEM REV, V104, P1383, DOI 10.1021/cr0306900; Morimura Y., 2013, Japan patent, Patent No. 5212969; Netscher T, 2007, VITAM HORM, V76, P155, DOI 10.1016/S0083-6729(07)76007-7; Nozawa M, 2000, CHEM PHARM BULL, V48, P272; Ooi T, 2007, ANGEW CHEM INT EDIT, V46, P4222, DOI 10.1002/anie.200601737; PACKER JE, 1979, NATURE, V278, P737, DOI 10.1038/278737a0; Sekimoto M, 2010, BIOORG MED CHEM LETT, V20, P1063, DOI 10.1016/j.bmcl.2009.12.034; Shen HC, 2009, TETRAHEDRON, V65, P3931, DOI 10.1016/j.tet.2009.02.002; Tanaka S, 2009, ANGEW CHEM INT EDIT, V48, P8948, DOI 10.1002/anie.200904671; Tietze LF, 2005, ANGEW CHEM INT EDIT, V44, P257, DOI 10.1002/anie.200461629; Tokunou S, 2012, HETEROCYCLES, V84, P1045, DOI 10.3987/COM-11-S(P)82; Tomasetti M, 2007, VITAM HORM, V76, P463, DOI 10.1016/S0083-6729(07)76018-1; Trost BM, 2004, J AM CHEM SOC, V126, P11966, DOI 10.1021/ja048078t; Uyanik M, 2012, CHEMCATCHEM, V4, P177, DOI 10.1002/cctc.201100352; Uyanik M, 2010, SCIENCE, V328, P1376, DOI 10.1126/science.1188217; WALTHER W, 1992, J MICROCOLUMN SEP, V4, P45, DOI 10.1002/mcs.1220040109; WREN JC, 1986, CAN J CHEM, V64, P2284, DOI 10.1139/v86-375; YODA H, 1989, CHEM LETT, P465, DOI 10.1246/cl.1989.465	31	138	138	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					291	294		10.1126/science.1254976	http://dx.doi.org/10.1126/science.1254976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035486				2022-12-01	WOS:000339400700042
J	Ouyang, H; Xue, YC; Lin, Y; Zhang, XH; Xi, L; Patel, S; Cai, HM; Luo, J; Zhang, MX; Zhang, M; Yang, Y; Li, G; Li, HR; Jiang, W; Yeh, E; Lin, J; Pei, M; Zhu, J; Cao, GQ; Zhang, LF; Yu, B; Chen, SC; Fu, XD; Liu, YZ; Zhang, K				Ouyang, Hong; Xue, Yuanchao; Lin, Ying; Zhang, Xiaohui; Xi, Lei; Patel, Sherrina; Cai, Huimin; Luo, Jing; Zhang, Meixia; Zhang, Ming; Yang, Yang; Li, Gen; Li, Hairi; Jiang, Wei; Yeh, Emily; Lin, Jonathan; Pei, Michelle; Zhu, Jin; Cao, Guiqun; Zhang, Liangfang; Yu, Benjamin; Chen, Shaochen; Fu, Xiang-Dong; Liu, Yizhi; Zhang, Kang			WNT7A and PAX6 define corneal epithelium homeostasis and pathogenesis	NATURE			English	Article							STEM-CELLS; P63; MORPHOGENESIS; PATHWAY; DIFFERENTIATION; EXPRESSION; KERATINS; LIMB; SKIN	The surface of the cornea consists of a unique type of non-keratinized epithelial cells arranged in an orderly fashion, and this is essential for vision by maintaining transparency for light transmission. Cornea epithelial cells (CECs) undergo continuous renewal from limbal stem or progenitor cells (LSCs)(1,2), and deficiency in LSCs or corneal epithelium-which turns cornea into a non-transparent, keratinized skin-like epithelium-causes corneal surface disease that leads to blindness in millions of people worldwide(3). How LSCs are maintained and differentiated into corneal epithelium in healthy individuals and which key molecular events are defective in patients have been largely unknown. Here we report establishment of an in vitro feeder-cell-free LSC expansion and three-dimensional corneal differentiation protocol in which we found that the transcription factors p63 (tumour protein 63) and PAX6 (paired box protein PAX6) act together to specify LSCs, and WNT7A controls corneal epithelium differentiation through PAX6. Loss of WNT7A or PAX6 induces LSCs into skin-like epithelium, a critical defect tightly linked to common human corneal diseases. Notably, transduction of PAX6 in skin epithelial stem cells is sufficient to convert them to LSC-like cells, and upon transplantation onto eyes in a rabbit corneal injury model, these reprogrammed cells are able to replenish CECs and repair damaged corneal surface. These findings suggest a central role of the WNT7A-PAX6 axis in corneal epithelial cell fate determination, and point to a new strategy for treating corneal surface diseases.	[Ouyang, Hong; Lin, Ying; Xi, Lei; Liu, Yizhi; Zhang, Kang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China; [Ouyang, Hong; Lin, Ying; Zhang, Xiaohui; Xi, Lei; Patel, Sherrina; Luo, Jing; Yang, Yang; Yeh, Emily; Lin, Jonathan; Pei, Michelle; Zhu, Jin; Zhang, Liangfang; Chen, Shaochen; Fu, Xiang-Dong; Zhang, Kang] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA; [Ouyang, Hong; Lin, Ying; Zhang, Xiaohui; Xi, Lei; Patel, Sherrina; Luo, Jing; Yang, Yang; Yeh, Emily; Lin, Jonathan; Pei, Michelle; Zhu, Jin; Zhang, Liangfang; Chen, Shaochen; Fu, Xiang-Dong; Zhang, Kang] Univ Calif San Diego, Biomat & Tissue Engn Ctr, Inst Engn Med, La Jolla, CA 92093 USA; [Xue, Yuanchao; Li, Hairi; Fu, Xiang-Dong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Cai, Huimin; Zhang, Meixia; Zhang, Ming; Li, Gen; Jiang, Wei; Cao, Guiqun; Zhang, Kang] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Mol Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China; [Cai, Huimin] Guangzhou KangRui Biol Pharmaceut Technol Co Ltd, Guangzhou 510005, Guangdong, Peoples R China; [Zhang, Liangfang; Chen, Shaochen] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA; [Yu, Benjamin] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Yu, Benjamin; Fu, Xiang-Dong; Zhang, Kang] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Zhang, Kang] Vet Adm Healthcare Syst, San Diego, CA 92093 USA	Sun Yat Sen University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Sichuan University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhang, K (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China.	xdfu@ucsd.edu; yzliu62@yahoo.com; kangzhang@ucsd.edu	liu, yi/GXE-9662-2022; Zhang, Kang/Y-2740-2019	Zhang, Kang/0000-0002-4549-1697; Ouyang, Hong/0000-0002-7622-7733; Zhang, Ming/0000-0003-0151-7813; Yu, Benjamin/0000-0001-6663-6616; Lin, Jonathan/0000-0002-7438-6941; XUE, YUANCHAO/0000-0002-8113-2333; Luo, Jing/0000-0002-8905-9388	973 program [2013CB967504, 2014CB964900]; Project of Fundamental Research Funds [2012KF03]; State Key laboratory of Ophthalmology; NIH [GM049369]; KACST-UCSD Center of Excellence in Nanomedicine; NIH Director's Transformative R01 Program [R01 EY021374]; CIRM; NATIONAL EYE INSTITUTE [R01EY021374, R01EY020846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049369] Funding Source: NIH RePORTER	973 program(National Basic Research Program of China); Project of Fundamental Research Funds; State Key laboratory of Ophthalmology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KACST-UCSD Center of Excellence in Nanomedicine; NIH Director's Transformative R01 Program; CIRM(California Institute for Regenerative Medicine); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported in part by the 973 program (2013CB967504 and 2014CB964900), Project of Fundamental Research Funds (no.2012KF03), State Key laboratory of Ophthalmology, NIH (GM049369), KACST-UCSD Center of Excellence in Nanomedicine, NIH Director's Transformative R01 Program (R01 EY021374) and CIRM.	Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; EICHNER R, 1984, J CELL BIOL, V98, P1388, DOI 10.1083/jcb.98.4.1388; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fox-Walsh K, 2011, GENOMICS, V98, P266, DOI 10.1016/j.ygeno.2011.04.003; KOPAN R, 1989, GENE DEV, V3, P1, DOI 10.1101/gad.3.1.1; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; LAUWERYNS B, 1993, INVEST OPHTH VIS SCI, V34, P1991; Li W, 2008, J PATHOL, V214, P114, DOI 10.1002/path.2256; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037	22	157	170	3	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					358	+		10.1038/nature13465	http://dx.doi.org/10.1038/nature13465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030175	Green Accepted			2022-12-01	WOS:000338992200038
J	Ottesen, EA; Young, CR; Gifford, SM; Eppley, JM; Marin, R; Schuster, SC; Scholin, CA; DeLong, EF				Ottesen, Elizabeth A.; Young, Curtis R.; Gifford, Scott M.; Eppley, John M.; Marin, Roman, III; Schuster, Stephan C.; Scholin, Christopher A.; DeLong, Edward F.			Multispecies diel transcriptional oscillations in open ocean heterotrophic bacterial assemblages	SCIENCE			English	Article							BACTERIOPLANKTON; POPULATIONS; EXPRESSION; PATTERNS; SEA	Oscillating diurnal rhythms of gene transcription, metabolic activity, and behavior are found in all three domains of life. However, diel cycles in naturally occurring heterotrophic bacteria and archaea have rarely been observed. Here, we report time-resolved whole-genome transcriptome profiles of multiple, naturally occurring oceanic bacterial populations sampled in situ over 3 days. As anticipated, the cyanobacterial transcriptome exhibited pronounced diel periodicity. Unexpectedly, several different heterotrophic bacterioplankton groups also displayed diel cycling in many of their gene transcripts. Furthermore, diel oscillations in different heterotrophic bacterial groups suggested population-specific timing of peak transcript expression in a variety of metabolic gene suites. These staggered multispecies waves of diel gene transcription may influence both the tempo and the mode of matter and energy transformation in the sea.	[Ottesen, Elizabeth A.; Young, Curtis R.; Gifford, Scott M.; Eppley, John M.; DeLong, Edward F.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Ottesen, Elizabeth A.; Young, Curtis R.; Gifford, Scott M.; Eppley, John M.; DeLong, Edward F.] Univ Hawaii, C MORE, Honolulu, HI 96822 USA; [Ottesen, Elizabeth A.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Marin, Roman, III; Scholin, Christopher A.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Schuster, Stephan C.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore; [DeLong, Edward F.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); University of Hawaii System; University System of Georgia; University of Georgia; Monterey Bay Aquarium Research Institute; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Massachusetts Institute of Technology (MIT)	DeLong, EF (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	edelong@hawaii.edu			Gordon and Betty Moore Foundation GBMF [492.01, 3777]; NSF [EF0424599, OCE-0314222]; NASA [NNG06GB34G, NNX09AB78G]; Gordon and Betty Moore Foundation [731, 2728]; David and Lucile Packard Foundation	Gordon and Betty Moore Foundation GBMF(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	We thank the officers and crew of the Kilo Moana, J. Robidart, S. Wilson, and the ESP engineering and science team (J. Ryan, J. Birch, C. Preston, G. Massion, S. Jensen, and B. Roman) for all of the able assistance. This work was supported by grants from the Gordon and Betty Moore Foundation GBMF nos. 492.01 and 3777 (E.F.D.) and NSF grant EF0424599 (E.F.D.). Development of the ESP was supported by NSF grant OCE-0314222 (to C.A.S.), NASA Astrobiology grants NNG06GB34G and NNX09AB78G (to C.A.S.), the Gordon and Betty Moore Foundation nos. 731 and 2728 (C.A.S.), and the David and Lucile Packard Foundation. This work is a contribution of C-MORE. Sequences reported in this paper have been deposited in the GenBank database (accession no. SRP041215). The Monterey Bay Aquarium Research Institute holds rights to C. A. Scholin et al., U.S. Patent 6187530 (2001). C.A.S. is disqualified from receiving any royalties that might arise from licensing agreements. The ESP is available commercially from Spyglass Technologies and MacLane Research Laboratories; C.A.S. has no financial interest in either company and is not compensated in any way for giving advice on ESP technology transfer.	Axmann I. M., 2014, MAR GENOMICS; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Flint JF, 2005, J BACTERIOL, V187, P7460, DOI 10.1128/JB.187.21.7460-7470.2005; Gali M, 2013, GLOBAL BIOGEOCHEM CY, V27, P620, DOI 10.1002/gbc.20047; Gasol JM, 1998, MAR ECOL PROG SER, V164, P107, DOI 10.3354/meps164107; Gifford SM, 2013, ISME J, V7, P281, DOI 10.1038/ismej.2012.96; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Li N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009894; Liu ZQ, 2011, BIOINFORMATICS, V27, P3242, DOI 10.1093/bioinformatics/btr547; Okansen J., 2012, PACKAGE VEGAN COMMUN; Ottesen EA, 2013, P NATL ACAD SCI USA, V110, pE488, DOI 10.1073/pnas.1222099110; Ottesen EA, 2011, ISME J, V5, P1881, DOI 10.1038/ismej.2011.70; Preston CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022522; Steindler L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019725; Tomasch J, 2011, ISME J, V5, P1957, DOI 10.1038/ismej.2011.68; Whitehead K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005485; Wier AM, 2010, P NATL ACAD SCI USA, V107, P2259, DOI 10.1073/pnas.0909712107; Winter C, 2004, AQUAT MICROB ECOL, V35, P207, DOI 10.3354/ame035207; Zinser ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005135	19	151	152	3	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					207	212		10.1126/science.1252476	http://dx.doi.org/10.1126/science.1252476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013074	Green Submitted, Green Accepted			2022-12-01	WOS:000339409900052
J	Yu, M; Bardia, A; Aceto, N; Bersani, F; Madden, MW; Donaldson, MC; Desai, R; Zhu, HL; Comaills, V; Zheng, ZL; Wittner, BS; Stojanov, P; Brachtel, E; Sgroi, D; Kapur, R; Shioda, T; Ting, DT; Ramaswamy, S; Getz, G; Iafrate, AJ; Benes, C; Toner, M; Maheswaran, S; Haber, DA				Yu, Min; Bardia, Aditya; Aceto, Nicola; Bersani, Francesca; Madden, Marissa W.; Donaldson, Maria C.; Desai, Rushil; Zhu, Huili; Comaills, Valentine; Zheng, Zongli; Wittner, Ben S.; Stojanov, Petar; Brachtel, Elena; Sgroi, Dennis; Kapur, Ravi; Shioda, Toshihiro; Ting, David T.; Ramaswamy, Sridhar; Getz, Gad; Iafrate, A. John; Benes, Cyril; Toner, Mehmet; Maheswaran, Shyamala; Haber, Daniel A.			Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility	SCIENCE			English	Article							CANCER; INHIBITOR; IDENTIFICATION; MUTATIONS; DISCOVERY; FAMILY; POTENT; DOMAIN; ALPHA	Circulating tumor cells (CTCs) are present at low concentrations in the peripheral blood of patients with solid tumors. It has been proposed that the isolation, ex vivo culture, and characterization of CTCs may provide an opportunity to noninvasively monitor the changing patterns of drug susceptibility in individual patients as their tumors acquire new mutations. In a proof-of-concept study, we established CTC cultures from six patients with estrogen receptor-positive breast cancer. Three of five CTC lines tested were tumorigenic in mice. Genome sequencing of the CTC lines revealed preexisting mutations in the PIK3CA gene and newly acquired mutations in the estrogen receptor gene (ESR1), PIK3CA gene, and fibroblast growth factor receptor gene (FGFR2), among others. Drug sensitivity testing of CTC lines with multiple mutations revealed potential new therapeutic targets. With optimization of CTC culture conditions, this strategy may help identify the best therapies for individual cancer patients over the course of their disease.	[Yu, Min; Bardia, Aditya; Aceto, Nicola; Bersani, Francesca; Madden, Marissa W.; Donaldson, Maria C.; Desai, Rushil; Zhu, Huili; Comaills, Valentine; Zheng, Zongli; Wittner, Ben S.; Sgroi, Dennis; Shioda, Toshihiro; Ting, David T.; Ramaswamy, Sridhar; Getz, Gad; Iafrate, A. John; Benes, Cyril; Maheswaran, Shyamala; Haber, Daniel A.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Yu, Min; Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Bardia, Aditya; Shioda, Toshihiro; Ting, David T.; Ramaswamy, Sridhar; Benes, Cyril; Haber, Daniel A.] Harvard Univ, Sch Med, Dept Med, Charlestown, MA 02129 USA; [Zheng, Zongli; Brachtel, Elena; Sgroi, Dennis; Getz, Gad; Iafrate, A. John] Harvard Univ, Sch Med, Dept Pathol, Charlestown, MA 02129 USA; [Zheng, Zongli] Karolinska Insitutet, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Stojanov, Petar; Getz, Gad] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Kapur, Ravi; Toner, Mehmet] Harvard Univ, Sch Med, Ctr Bioengn Med, Charlestown, MA 02129 USA; [Toner, Mehmet; Maheswaran, Shyamala] Harvard Univ, Sch Med, Dept Surg, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard University; Karolinska Institutet; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University	Maheswaran, S (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	maheswaran@helix.mgh.harvard.edu; haber@helix.mgh.harvard.edu	COMAILLS, VALENTINE/AAX-1697-2021; Sgroi, Dennis/AAV-2487-2021; Stojanov, Petar/GQI-4462-2022; zheng, zongli/B-2917-2011; zheng, zongli/C-7309-2008; Ting, David/F-4389-2017; Aceto, Nicola/O-2484-2014	COMAILLS, VALENTINE/0000-0001-8857-6976; Stojanov, Petar/0000-0001-7815-776X; zheng, zongli/0000-0003-4849-4903; Ting, David/0000-0002-3261-2322; Aceto, Nicola/0000-0001-9579-6918; Donaldson Collier, Maria/0000-0001-6403-6713; Bersani, Francesca/0000-0002-0343-7078; Yu, Min/0000-0002-3969-8720	Breast Cancer Research Foundation; Stand Up to Cancer; Wellcome TrustNational Foundation for Cancer Research; NIH [CA129933]; NIBIB [EB008047]; Susan G. Komen for the Cure [KG09042]; National Cancer Institute-MGH Proton Federal Share Program; MGH-Johnson and Johnson Center for Excellence in CTCs; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA129933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503, U01EB012493, R01EB008047] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Stand Up to Cancer; Wellcome TrustNational Foundation for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Cancer Institute-MGH Proton Federal Share Program; MGH-Johnson and Johnson Center for Excellence in CTCs; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We are grateful to all the patients who participated in this study. We thank Dr. Lecia Sequist for coordinating the clinical studies, A. McGovern, C. Hart, and the Massachusetts General Hospital (MGH) clinical research coordinators P. Spuhler, A. Shah, J. Ciciliano, and V. Pai for bioengineering technical support; R. Milano, K. Lynch, H. Robinson, and M. Liebers for technical support; L. Collins (Beth Israel Deaconess Medical Center) for providing pathological specimens; and L. Libby for mouse studies. N. Aceto is a fellow of the Human Frontiers Science Program, the Swiss National Science Foundation, and the Swiss Foundation for Grants in Biology and Medicine. This work was supported by grants from the Breast Cancer Research Foundation (D. A. H), Stand Up to Cancer (D. A. H., M. T., S. M.), the Wellcome Trust (D. A. H., C. B.), National Foundation for Cancer Research (D. A. H.), NIH CA129933 (D. A. H.), NIBIB EB008047 (M. T., D. A. H.), Susan G. Komen for the Cure KG09042 (S. M.), National Cancer Institute-MGH Proton Federal Share Program (S. M.), the MGH-Johnson and Johnson Center for Excellence in CTCs (M. T., S. M.), and the Howard Hughes Medical Institute (M.Y., D. A. H.). A. J. I. holds equity in, and is a paid consultant for, Enzymatics, Inc. M. T., D. A. H., and the Massachusetts General Hospital have filed for patent protection for the CTC-iChip technology. RNA-Seq reads have been deposited into Gene Expression Omnibus: uncultured CTCs (accession no. GSE51827); the six cultured CTC lines (accession no. GSE55807).	Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Furet P, 2013, BIOORG MED CHEM LETT, V23, P3741, DOI 10.1016/j.bmcl.2013.05.007; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Haber DA, 2011, CELL, V145, P19, DOI 10.1016/j.cell.2011.03.026; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Merenbakh-Lamin K, 2013, CANCER RES, V73, P6856, DOI 10.1158/0008-5472.CAN-13-1197; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Wang YS, 2010, CURR OPIN INVEST DR, V11, P1466; Weis KE, 1996, MOL ENDOCRINOL, V10, P1388, DOI 10.1210/me.10.11.1388; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Zhang LX, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005109; Zhang QX, 1997, CANCER RES, V57, P1244	26	660	719	9	344	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					216	220		10.1126/science.1253533	http://dx.doi.org/10.1126/science.1253533			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013076	Green Submitted, Green Accepted			2022-12-01	WOS:000339409900054
J	Scheller, NM; Pasternak, B; Svanstrom, H; Hviid, A				Scheller, Nikolai Madrid; Pasternak, Bjorn; Svanstrom, Henrik; Hviid, Anders			Quadrivalent Human Papillomavirus Vaccine and the Risk of Venous Thromboembolism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CASE SERIES; SAFETY; IMMUNIZATION; AUTOIMMUNE; ADOLESCENT		[Scheller, Nikolai Madrid; Pasternak, Bjorn; Svanstrom, Henrik; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Scheller, NM (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	nmscheller@gmail.com	Hviid, Anders/AAH-4319-2020; Pasternak, Bjorn/H-5739-2012	Hviid, Anders/0000-0002-7509-9127; Pasternak, Bjorn/0000-0002-2097-8466				Arnheim-Dahlstom L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5906; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; Gee J, 2011, VACCINE, V29, P8279, DOI 10.1016/j.vaccine.2011.08.106; Siegrist CA, 2007, CAN MED ASSOC J, V177, P1352, DOI 10.1503/cmaj.071134; Slade BA, 2009, JAMA-J AM MED ASSOC, V302, P750, DOI 10.1001/jama.2009.1201; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302	6	25	26	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2014	312	2					187	188		10.1001/jama.2014.2198	http://dx.doi.org/10.1001/jama.2014.2198			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK6BB	25005658				2022-12-01	WOS:000338511200027
J	Dyachuk, V; Furlan, A; Shahidi, MK; Giovenco, M; Kaukua, N; Konstantinidou, C; Pachnis, V; Memic, F; Marklund, U; Muller, T; Birchmeier, C; Fried, K; Ernfors, P; Adameyko, I				Dyachuk, Vyacheslav; Furlan, Alessandro; Shahidi, Maryam Khatibi; Giovenco, Marcela; Kaukua, Nina; Konstantinidou, Chrysoula; Pachnis, Vassilis; Memic, Fatima; Marklund, Ulrika; Mueller, Thomas; Birchmeier, Carmen; Fried, Kaj; Ernfors, Patrik; Adameyko, Igor			Parasympathetic neurons originate from nerve-associated peripheral glial progenitors	SCIENCE			English	Article							NEURAL CREST; DIFFERENTIATION; SPECIFICATION; MELANOCYTES; CELLS; ERBB2	The peripheral autonomic nervous system reaches far throughout the body and includes neurons of diverse functions, such as sympathetic and parasympathetic. We show that the parasympathetic system in mice-including trunk ganglia and the cranial ciliary, pterygopalatine, lingual, submandibular, and otic ganglia-arise from glial cells in nerves, not neural crest cells. The parasympathetic fate is induced in nerve-associated Schwann cell precursors at distal peripheral sites. We used multicolor Cre-reporter lineage tracing to show that most of these neurons arise from bi-potent progenitors that generate both glia and neurons. This nerve origin places cellular elements for generating parasympathetic neurons in diverse tissues and organs, which may enable wiring of the developing parasympathetic nervous system.	[Dyachuk, Vyacheslav; Furlan, Alessandro; Giovenco, Marcela; Memic, Fatima; Marklund, Ulrika; Ernfors, Patrik] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Unit, Stockholm, Sweden; [Dyachuk, Vyacheslav] Russian Acad Sci, AV Zhirmunsky Inst Marine Biol, Far Eastern Branch, Vladivostok 690022, Russia; [Shahidi, Maryam Khatibi] Karolinska Inst, Dept Dent Med, Stockholm, Sweden; [Kaukua, Nina; Fried, Kaj] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Konstantinidou, Chrysoula; Pachnis, Vassilis] Med Res Council MRC Natl Inst Med Res, Div Mol Neurobiol, London, England; [Mueller, Thomas; Birchmeier, Carmen] Max Delbruck Ctr Mol Med, Dept Neurosci, Berlin, Germany; [Adameyko, Igor] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Karolinska Institutet; Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; Karolinska Institutet; Karolinska Institutet; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Karolinska Institutet	Ernfors, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Unit, Stockholm, Sweden.	patrik.ernfors@ki.se; igor.adameyko@ki.se	Dyachuk, Vyacheslav/U-9115-2019; Marklund, Ulrika/I-8814-2012; Furlan, Alessandro/AAM-4680-2021	Dyachuk, Vyacheslav/0000-0001-8100-7367; Marklund, Ulrika/0000-0003-1426-1271; Furlan, Alessandro/0000-0001-5149-6331; Muller, Thomas/0000-0001-8096-1853; Pachnis, Vassilis/0000-0001-9733-7686	Swedish Research Council for Medicine and Health; Swedish Cancer Society; Strategiska Forskningsomradena (SFO); Swedish Brain Foundation; Wallenberg Scholar; Soderberg Foundation; European Research Council (ERC) [232675]; Swedish Research Council; Bertil Hallsten Research Foundation; SFO on Stem Cells and Regenerative Medicine (StratRegen); Knut and Alice Wallenberg Foundation (CLICK); Swedish Dental Association; Stockholm County Council; Swedish National Graduate School in Odontological Science; German Science Foundation [SFB 665]; MRC [A2525RF00]; MRC National Institute of Medical Research; Knut and Alice Wallenberg Foundation [KAW2008.0123]; Swedish Research Council [521-2012-1676]; Swedish Doctoral Society [SLS330921, SLS331191]; Ruth and Richard Julin Foundation [36938]; Ake Wiberg Foundation [613512953]; Eva and Oscar Ahren Foundation; MRC [MC_U117537087] Funding Source: UKRI; Medical Research Council [MC_U117537087] Funding Source: researchfish	Swedish Research Council for Medicine and Health; Swedish Cancer Society(Swedish Cancer Society); Strategiska Forskningsomradena (SFO); Swedish Brain Foundation; Wallenberg Scholar; Soderberg Foundation; European Research Council (ERC)(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Bertil Hallsten Research Foundation; SFO on Stem Cells and Regenerative Medicine (StratRegen); Knut and Alice Wallenberg Foundation (CLICK)(Knut & Alice Wallenberg Foundation); Swedish Dental Association; Stockholm County Council(Stockholm County Council); Swedish National Graduate School in Odontological Science; German Science Foundation(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC National Institute of Medical Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Doctoral Society; Ruth and Richard Julin Foundation; Ake Wiberg Foundation; Eva and Oscar Ahren Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Lubke for breeding Ret mice; J.-F. Brunet, M. Wegner, and F. Lallemend for generously providing Phox2b, Sox10, and 2H3 antibodies; H. Clevers for Confetti; H. Enomoto (RIKEN) for Ret <SUP>CFP</SUP> mice; and the CLICK Imaging Facility supported by the Wallenberg Foundation. This work was supported by the Swedish Research Council for Medicine and Health, the Swedish Cancer Society and Strategiska Forskningsomradena (SFO) grants, the Swedish Brain Foundation, Wallenberg Scholar, Soderberg Foundation, and European Research Council (ERC) advanced grant (232675) to P. E. I. A. and K. F. were supported by grants from Swedish Research Council, The Bertil Hallsten Research Foundation, SFO on Stem Cells and Regenerative Medicine (StratRegen), and the Knut and Alice Wallenberg Foundation (CLICK). N.K. and M. K. S. received support from the Swedish Dental Association and Stockholm County Council. M. K. S. also received support from Swedish National Graduate School in Odontological Science. C. B. was supported by a grant from German Science Foundation (SFB 665). V. P. was supported by MRC (grant-in-aid A2525RF00). C. K. is a recipient of a Ph.D. studentship from the MRC National Institute of Medical Research. U. M. was supported by the Knut and Alice Wallenberg Foundation (KAW2008.0123), Swedish Research Council (521-2012-1676), Swedish Doctoral Society (SLS330921 and SLS331191), Ruth and Richard Julin Foundation (36938), Ake Wiberg Foundation (613512953), and Eva and Oscar Ahren Foundation. In-house-generated plasmids and antibodies are freely available from the authors. Mouse strains Plp<SUP>CreERT2</SUP>, Ascl1<SUP>CreERT2</SUP>, R26R<SUP>YFP</SUP>, R26R<SUP>TOMATO</SUP>, and R26R<SUP>Confetti</SUP> are freely available from The Jacksons Laboratory (United States). Other strains will require materials transfer agreements (MTAs) of future users: Sox10<SUP>CreERT2</SUP> and Ascl1<SUP>NGN2</SUP>(MTA from MRC), ErbB3 KO (MTA from the Max Delbruck Center for Molecular Medicine), and Ret <SUP>CFP</SUP> (MTA from RIKEN). MTA for Ret <SUP>CFP</SUP> mice is attached with submission. The supplementary materials contain additional data.	Adameyko I, 2012, DEVELOPMENT, V139, P397, DOI 10.1242/dev.065581; Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Aoki Y, 2003, DEV BIOL, V259, P19, DOI 10.1016/S0012-1606(03)00161-1; DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406; Enomoto H, 2000, DEVELOPMENT, V127, P4877; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Honore SM, 2003, DEV BIOL, V259, P502; Howard MJ, 2005, DEV BIOL, V277, P271, DOI 10.1016/j.ydbio.2004.09.034; Le Douarin N, 1999, NEURAL CREST, Vxxiii; Lee VM, 2003, DEV BIOL, V263, P176, DOI 10.1016/j.ydbio.2003.07.004; Muller F, 2002, DEVELOPMENT, V129, P5707, DOI 10.1242/dev.00165; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; White PM, 2001, NEURON, V29, P57, DOI 10.1016/S0896-6273(01)00180-5; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Young HM, 2011, AUTON NEUROSCI-BASIC, V165, P10, DOI 10.1016/j.autneu.2010.03.002	20	133	133	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					82	87		10.1126/science.1253281	http://dx.doi.org/10.1126/science.1253281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24925909				2022-12-01	WOS:000338284400055
J	Espinosa-Medina, I; Outin, E; Picard, CA; Chettouh, Z; Dymecki, S; Consalez, GG; Coppola, E; Brunet, JF				Espinosa-Medina, I.; Outin, E.; Picard, C. A.; Chettouh, Z.; Dymecki, S.; Consalez, G. G.; Coppola, E.; Brunet, J. -F.			Parasympathetic ganglia derive from Schwann cell precursors	SCIENCE			English	Article							STEM-CELLS; NEUROGENIN 2; MOUSE LINE; EXPRESSION; DIFFERENTIATION; PHOX2B; ORIGIN	Neural crest cells migrate extensively and give rise to most of the peripheral nervous system, including sympathetic, parasympathetic, enteric, and dorsal root ganglia. We studied how parasympathetic ganglia form close to visceral organs and what their precursors are. We find that many cranial nerve-associated crest cells coexpress the pan-autonomic determinant Paired-like homeodomain 2b (Phox2b) together with markers of Schwann cell precursors. Some give rise to Schwann cells after down-regulation of PHOX2b. Others form parasympathetic ganglia after being guided to the site of ganglion formation by the nerves that carry preganglionic fibers, a parsimonious way of wiring the pathway. Thus, cranial Schwann cell precursors are the source of parasympathetic neurons during normal development.	[Espinosa-Medina, I.; Outin, E.; Picard, C. A.; Chettouh, Z.; Coppola, E.; Brunet, J. -F.] Inserm U1024, Ecole Normale Super, Inst Biol, F-75005 Paris, France; [Espinosa-Medina, I.; Outin, E.; Picard, C. A.; Chettouh, Z.; Coppola, E.; Brunet, J. -F.] CNRS UMR 8197, F-75005 Paris, France; [Dymecki, S.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Consalez, G. G.] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Harvard University; Harvard Medical School; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Brunet, JF (corresponding author), Inserm U1024, Ecole Normale Super, Inst Biol, F-75005 Paris, France.	jfbrunet@biologie.ens.fr	Consalez, Giacomo/AAA-2146-2019	Consalez, Giacomo/0000-0003-4594-6273; Brunet, Jean-Francois/0000-0002-1985-6103	Agence Nationale de la Recherche [ANR-12-BSV4-0007-01]; Investissements d'Avenir [ANR-10-LABX-54 MEMO LIFE, ANR-11-IDEX-0001-02]; Federation pour la Recherche sur le Cerveau; NIH [R01 DK067826, R21 DA023643, P01 HD036379]; Fondazione CARIPLO, Milan, Italy; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD036379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023643] Funding Source: NIH RePORTER	Agence Nationale de la Recherche(French National Research Agency (ANR)); Investissements d'Avenir(French National Research Agency (ANR)); Federation pour la Recherche sur le Cerveau; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione CARIPLO, Milan, Italy(Fondazione Cariplo); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Lazdunski for the ASIC2a<SUP>G430F</SUP> clone; C. Birchmeier, T. Muller, and M. Wegner for antibodies; M.-C. Tiveron for the original discovery of the limb ganglion; V. Michel for preliminary experiments; the imaging facilities of IBENS and Institut de la Vision, B. Mathieu, and D. Godefroy for technical assistance; and C. Goridis for helpful discussions. This work was supported by the Agence Nationale de la Recherche (ANR-12-BSV4-0007-01) and Investissements d'Avenir (ANR-10-LABX-54 MEMO LIFE and ANR-11-IDEX-0001-02 PSL* Research University) (to J.-F.B.); Federation pour la Recherche sur le Cerveau (to Institut de la Vision); and NIH grants R01 DK067826, R21 DA023643, and P01 HD036379 (to S.D.). G.G.C. was funded by the Fondazione CARIPLO, Milan, Italy, and I.-E.M. received a Ph.D. studentship.	Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Al J, 2007, NEUROSCIENCE, V149, P845, DOI 10.1016/j.neuroscience.2007.07.062; Blessing WW, 1997, LOWER BRAINSTEM BODI; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; Coppola E, 2010, P NATL ACAD SCI USA, V107, P2066, DOI 10.1073/pnas.0910213107; D'Autreaux F, 2011, P NATL ACAD SCI USA, V108, P20018, DOI 10.1073/pnas.1110416108; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; Florio M, 2012, DEVELOPMENT, V139, P2308, DOI 10.1242/dev.075861; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; FURBER S, 1987, J NEUROSCI, V7, P1816; Harbinder S, 1997, P NATL ACAD SCI USA, V94, P13128, DOI 10.1073/pnas.94.24.13128; Hirsch MR, 2013, GENESIS, V51, P506, DOI 10.1002/dvg.22393; Hirsch MR, 1998, DEVELOPMENT, V125, P599; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kandel E.R., 2012, PRINCIPLES NEURAL SC, V5th; Le Douarin N.M., 1999, NEURAL CREST; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Takahashi Y, 2013, SCIENCE, V341, P860, DOI 10.1126/science.1230717; Tiveron MC, 1996, J NEUROSCI, V16, P7649; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; White PM, 2001, NEURON, V29, P57, DOI 10.1016/S0896-6273(01)00180-5	26	125	126	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					87	90		10.1126/science.1253286	http://dx.doi.org/10.1126/science.1253286			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24925912				2022-12-01	WOS:000338284400056
J	Fell, GL; Robinson, KC; Mao, J; Woolf, CJ; Fisher, DE				Fell, Gillian L.; Robinson, Kathleen C.; Mao, Jianren; Woolf, Clifford J.; Fisher, David E.			Skin beta-Endorphin Mediates Addiction to UV Light	CELL			English	Article							FREQUENT INDOOR TANNERS; ULTRAVIOLET-RADIATION; ENDOGENOUS OPIOIDS; NUCLEUS-ACCUMBENS; PLASMA-LEVELS; SUN EXPOSURE; MICE; WITHDRAWAL; INDUCTION; EXERCISE	UV light is an established carcinogen, yet evidence suggests that UV-seeking behavior has addictive features. Following UV exposure, epidermal keratinocytes synthesize proopiomelanocortin (POMC) that is processed to melanocyte-stimulating hormone, inducing tanning. We show that, in rodents, another POMC-derived peptide, beta-endorphin, is coordinately synthesized in skin, elevating plasma levels after low-dose UV. Increases in pain-related thresholds are observed and reversed by pharmacologic opioid antagonism. Opioid blockade also elicits withdrawal signs after chronic UV exposure. This effect was sufficient to guide operant behavioral choices to avoidance of opioid withdrawal (conditioned place aversion). These UV-induced nociceptive and behavioral effects were absent in beta-endorphin knockout mice and in mice lacking p53-mediated POMC induction in epidermal keratinocytes. Although primordial UV addiction, mediated by the hedonic action of beta-endorphin and anhedonic effects of withdrawal, may theoretically have enhanced evolutionary vitamin D biosynthesis, it now may contribute to the relentless rise in skin cancer incidence in humans.	[Fell, Gillian L.; Robinson, Kathleen C.; Fisher, David E.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr,Dept Dermatol, Boston, MA 02114 USA; [Fell, Gillian L.; Robinson, Kathleen C.; Fisher, David E.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MGH Canc Ctr, Boston, MA 02114 USA; [Mao, Jianren] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MGH Ctr Translat Pain Res,Dept Anesthesia Critica, Boston, MA 02114 USA; [Woolf, Clifford J.] Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA 02114 USA; [Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Fisher, DE (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr,Dept Dermatol, Boston, MA 02114 USA.	dfisher3@partners.org	Fisher, David/AAH-2878-2019; Woolf, Clifford/A-9784-2010		NIH [R01 AR043369-16, P01CA163222, R01 CA150226-03]; Melanoma Research Alliance; US-Israel Binational Science Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL CANCER INSTITUTE [P01CA163222, R01CA150226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS039518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors gratefully acknowledge Dr. Charles Berde, Dr. Jeff Mogil, Ms. Vivien Igras, Mr. John Dellorusso, Ms. Teri Herbert, Ms. Leeza Hargreaves, Dr. Roydon Price, and Dr. Grewo Lim for productive discussions during the early phases of this project and for technical assistance with the experiments and manuscript. The authors thank Dr. Mary Jeanne Kreek for useful discussions. The authors also acknowledge Douglas Hayden from the MGH Biostatistics Center for consultation regarding the statistical analysis. This work was supported by NIH under award numbers R01 AR043369-16, P01CA163222, and R01 CA150226-03 and by grants from the Melanoma Research Alliance, the US-Israel Binational Science Foundation, and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (D.E.F.).	ARAVICH PF, 1993, BRAIN RES, V622, P1, DOI 10.1016/0006-8993(93)90794-N; Bender T, 2007, EUR J APPL PHYSIOL, V100, P371, DOI 10.1007/s00421-007-0469-9; BILBEY DLJ, 1960, BRIT J PHARM CHEMOTH, V15, P540, DOI 10.1111/j.1476-5381.1960.tb00277.x; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Dassule HR, 2000, DEVELOPMENT, V127, P4775; de Gruijl FR, 1999, EUR J CANCER, V35, P2003, DOI 10.1016/S0959-8049(99)00283-X; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Fassoulaki A, 2007, ANESTH ANALG, V104, P312, DOI 10.1213/01.ane.0000250911.43942.4e; Feldman SR, 2004, J AM ACAD DERMATOL, V51, P45, DOI 10.1016/j.jaad.2004.01.053; Gambichler T, 2002, BRIT J DERMATOL, V147, P1207, DOI 10.1046/j.1365-2133.2002.04859.x; Gandini S, 2011, PROG BIOPHYS MOL BIO, V107, P362, DOI 10.1016/j.pbiomolbio.2011.09.011; Gianoulakis C, 1996, ALCOHOL, V13, P19, DOI 10.1016/0741-8329(95)02035-7; Gianoulakis C, 2009, CURR TOP MED CHEM, V9, P999, DOI 10.2174/156802609789630956; Glass MJ, 2008, EXP NEUROL, V213, P57, DOI 10.1016/j.expneurol.2008.04.045; Harrington CR, 2011, CLIN EXP DERMATOL, V36, P33, DOI 10.1111/j.1365-2230.2010.03882.x; Harrington CR, 2012, ADDICT BIOL, V17, P680, DOI 10.1111/j.1369-1600.2010.00312.x; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; KASTIN AJ, 1979, PHARMACOL BIOCHEM BE, V11, P713, DOI 10.1016/0091-3057(79)90268-5; Kaur M, 2006, J AM ACAD DERMATOL, V54, P919, DOI 10.1016/j.jaad.2006.01.062; Kaur M, 2006, J AM ACAD DERMATOL, V54, P709, DOI 10.1016/j.jaad.2005.11.1059; Kenny PJ, 2006, J NEUROSCI, V26, P5894, DOI 10.1523/JNEUROSCI.0740-06.2006; Kourosh AS, 2010, AM J DRUG ALCOHOL AB, V36, P284, DOI 10.3109/00952990.2010.491883; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lazovich D, 2010, CANCER EPIDEM BIOMAR, V19, P1557, DOI 10.1158/1055-9965.EPI-09-1249; Leppaluoto J, 2008, SCAND J CLIN LAB INV, V68, P145, DOI 10.1080/00365510701516350; LEVINS PC, 1983, LANCET, V2, P166; Mao J, 2000, NEUROSCI LETT, V280, P13, DOI 10.1016/S0304-3940(99)00998-2; Marino S, 2000, GENE DEV, V14, P994; MCMURRAY RG, 1990, CHRONOBIOL INT, V7, P135, DOI 10.3109/07420529009056965; Mogil JS, 1999, PAIN, V80, P83, DOI 10.1016/S0304-3959(98)00196-1; Mosher CE, 2010, ARCH DERMATOL, V146, P412, DOI 10.1001/archdermatol.2009.385; Nguyen AT, 2012, EUR J PHARMACOL, V686, P50, DOI 10.1016/j.ejphar.2012.04.040; Olive MF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0002.2001; Olson VG, 2006, SYNAPSE, V60, P553, DOI 10.1002/syn.20328; PETRAGLIA F, 1990, J ENDOCRINOL INVEST, V13, P19, DOI 10.1007/BF03348571; Racz I, 2008, BIOL PSYCHIAT, V64, P989, DOI 10.1016/j.biopsych.2008.05.008; Robinson JK, 1997, J AM ACAD DERMATOL, V37, P179, DOI 10.1016/S0190-9622(97)80122-3; Roma PG, 2005, PHARMACOL BIOCHEM BE, V82, P163, DOI 10.1016/j.pbb.2005.08.004; Roth-Deri I, 2003, J NEUROCHEM, V84, P930, DOI 10.1046/j.1471-4159.2003.01584.x; Rubinstein M, 1996, P NATL ACAD SCI USA, V93, P3995, DOI 10.1073/pnas.93.9.3995; SCHOFFELMEER ANM, 1991, J PHARMACOL EXP THER, V258, P237; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Technology Planning and Management Corporation, 2000, REP CARC BACKGR DOC; Trigo JM, 2009, NEUROPHARMACOLOGY, V56, P1147, DOI 10.1016/j.neuropharm.2009.03.013; TSENG LF, 1976, NATURE, V263, P239, DOI 10.1038/263239a0; US-EPA, 1994, FED EXP ULTR IND WHA; Warthan MM, 2005, ARCH DERMATOL, V141, P963, DOI 10.1001/archderm.141.8.963; Weitemier AZ, 2009, EUR J NEUROSCI, V29, P1015, DOI 10.1111/j.1460-9568.2009.06652.x; Welch CC, 1996, BRAIN RES, V721, P126, DOI 10.1016/0006-8993(96)00151-5; Wintzen M, 2001, PHOTODERMATOL PHOTO, V17, P256, DOI 10.1034/j.1600-0781.2001.170602.x; Zeller S, 2006, J AM ACAD DERMATOL, V54, P589, DOI 10.1016/j.jaad.2005.12.038	54	152	156	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1527	1534		10.1016/j.cell.2014.04.032	http://dx.doi.org/10.1016/j.cell.2014.04.032			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949966	Green Accepted, Bronze			2022-12-01	WOS:000340941900009
J	Jousimo, J; Tack, AJM; Ovaskainen, O; Mononen, T; Susi, H; Tollenaere, C; Laine, AL				Jousimo, Jussi; Tack, Ayco J. M.; Ovaskainen, Otso; Mononen, Tommi; Susi, Hanna; Tollenaere, Charlotte; Laine, Anna-Liisa			DISEASE ECOLOGY Ecological and evolutionary effects of fragmentation on infectious disease dynamics	SCIENCE			English	Article							PLANT-PATHOGEN METAPOPULATION; LOCAL ADAPTATION; HOST; POPULATION; COEVOLUTION; RESISTANCE; DISPERSAL; SCALE; SIZE	Ecological theory predicts that disease incidence increases with increasing density of host networks, yet evolutionary theory suggests that host resistance increases accordingly. To test the combined effects of ecological and evolutionary forces on host-pathogen systems, we analyzed the spatiotemporal dynamics of a plant (Plantago lanceolata)-fungal pathogen (Podosphaera plantaginis) relationship for 12 years in over 4000 host populations. Disease prevalence at the metapopulation level was low, with high annual pathogen extinction rates balanced by frequent (re-) colonizations. Highly connected host populations experienced less pathogen colonization and higher pathogen extinction rates than expected; a laboratory assay confirmed that this phenomenon was caused by higher levels of disease resistance in highly connected host populations.	[Jousimo, Jussi; Tack, Ayco J. M.; Ovaskainen, Otso; Mononen, Tommi; Susi, Hanna; Tollenaere, Charlotte; Laine, Anna-Liisa] Univ Helsinki, Metapopulat Res Grp, Dept Biosci, FI-00014 Helsinki, Finland; [Mononen, Tommi] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci, FI-00076 Aalto, Finland	University of Helsinki; Aalto University	Laine, AL (corresponding author), Univ Helsinki, Metapopulat Res Grp, Dept Biosci, Post Off Box 65,Viikinkaari 1, FI-00014 Helsinki, Finland.	anna-liisa.laine@helsinki.fi	Tack, Ayco/B-7120-2017; Ovaskainen, Otso/D-9119-2012; Tollenaere, Charlotte/ABB-6175-2020; Ovaskainen, Otso/AGN-4838-2022; Laine, Anna-Liisa/B-1398-2016	Tack, Ayco/0000-0002-3550-1070; Ovaskainen, Otso/0000-0001-9750-4421; Tollenaere, Charlotte/0000-0003-2045-2824; Ovaskainen, Otso/0000-0001-9750-4421; Laine, Anna-Liisa/0000-0002-0703-5850; Mononen, Tommi/0000-0002-3603-0813	Academy of Finland [250444, 136393, 133499]; European Research Council (Independent Starting grant PATHEVOL) [281517]	Academy of Finland(Academy of Finland); European Research Council (Independent Starting grant PATHEVOL)	We acknowledge I. Hanski, S. Ojanen, and M. Nieminen for organizing the large-scale field surveys in land and E. Meyke for managing the database. The numerous biology students who have participated in years 2001 and 2012 are gratefully acknowledged for their hard work in the field. H. Hohti and the Finnish Meteorological Institute kindly provided the rainfall radar images. I. Hanski, J.Antonovics, and R. Penczykowski provided valuable comments on the manuscript. This work was supported by funding from the Academy of Finland (grant nos. 250444, 136393, and 133499) and the European Research Council (Independent Starting grant PATHEVOL; 281517) to A.L.L. The data presented in this paper are deposited in Dryad (10.5061/dryad.vf210).	Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Antonovics J., 2004, ECOLOGY GENETICS EVO, P471, DOI DOI 10.1016/B978-012323448-3/50021-0; AYLOR DE, 1990, ANNU REV PHYTOPATHOL, V28, P73, DOI 10.1146/annurev.py.28.090190.000445; Borer ET, 2010, ECOL LETT, V13, P810, DOI 10.1111/j.1461-0248.2010.01475.x; Bradley DJ, 2008, ECOL LETT, V11, P461, DOI 10.1111/j.1461-0248.2008.01162.x; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Carlsson-Graner U, 2002, OIKOS, V97, P97, DOI 10.1034/j.1600-0706.2002.970110.x; Cressey D, 2013, NATURE, V493, P587, DOI 10.1038/493587a; Decaestecker E, 2013, ECOL LETT, V16, P1455, DOI 10.1111/ele.12186; Duffy MA, 2012, SCIENCE, V335, P1636, DOI 10.1126/science.1215429; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Gandon S, 2009, AM NAT, V173, P212, DOI 10.1086/593706; Grenfell B, 1997, TRENDS ECOL EVOL, V12, P395, DOI 10.1016/S0169-5347(97)01174-9; Hanski I. A., 1999, METAPOPULATION ECOLO; Hoeksema JD, 2008, AM NAT, V171, P275, DOI 10.1086/527496; Laine AL, 2006, P ROY SOC B-BIOL SCI, V273, P267, DOI 10.1098/rspb.2005.3303; Laine AL, 2006, J ECOL, V94, P217, DOI 10.1111/j.1365-2745.2005.01075.x; Laine AL, 2004, J ECOL, V92, P990, DOI 10.1111/j.0022-0477.2004.00925.x; Laine AL, 2007, J EVOLUTION BIOL, V20, P1665, DOI 10.1111/j.1420-9101.2007.01359.x; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Ovaskainen O, 2006, ECOLOGY, V87, P880, DOI 10.1890/0012-9658(2006)87[880:IESFED]2.0.CO;2; Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325; Smith DL, 2011, J ECOL, V99, P634, DOI 10.1111/j.1365-2745.2010.01788.x; Tack AJM, 2014, NEW PHYTOL, V202, P297, DOI 10.1111/nph.12646; Thompson J.N., 2005, INTERSPEC INTERACT; Thrall PH, 2012, ECOL LETT, V15, P425, DOI 10.1111/j.1461-0248.2012.01749.x; Thrall PH, 2002, PLANT PATHOL, V51, P169, DOI 10.1046/j.1365-3059.2002.00683.x; THRALL PH, 1995, CAN J BOT, V73, pS1249, DOI 10.1139/b95-385; Tollenaere C, 2013, J EVOLUTION BIOL, V26, P1716, DOI 10.1111/jeb.12169; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237	31	123	124	1	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1289	1293		10.1126/science.1253621	http://dx.doi.org/10.1126/science.1253621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926021				2022-12-01	WOS:000337077500042
J	Xu, K; Wu, ZH; Renier, N; Antipenko, A; Tzvetkova-Robev, D; Xu, Y; Minchenko, M; Nardi-Dei, V; Rajashankar, KR; Himanen, J; Tessier-Lavigne, M; Nikolov, DB				Xu, Kai; Wu, Zhuhao; Renier, Nicolas; Antipenko, Alexander; Tzvetkova-Robev, Dorothea; Xu, Yan; Minchenko, Maria; Nardi-Dei, Vincenzo; Rajashankar, Kanagalaghatta R.; Himanen, Juha; Tessier-Lavigne, Marc; Nikolov, Dimitar B.			NEURAL MIGRATION Structures of netrin-1 bound to two receptors provide insight into its axon guidance mechanism	SCIENCE			English	Article							HEPARAN-SULFATE; DCC; BINDING; EXPRESSION; FAMILY; MOLECULE; MIDLINE; UNC5; SLIT	Netrins are secreted proteins that regulate axon guidance and neuronal migration. Deleted in colorectal cancer (DCC) is a well-established netrin-1 receptor mediating attractive responses. We provide evidence that its close relative neogenin is also a functional netrin-1 receptor that acts with DCC to mediate guidance in vivo. We determined the structures of a functional netrin-1 region, alone and in complexes with neogenin or DCC. Netrin-1 has a rigid elongated structure containing two receptor-binding sites at opposite ends through which it brings together receptor molecules. The ligand/receptor complexes reveal two distinct architectures: a 2:2 heterotetramer and a continuous ligand/receptor assembly. The differences result from different lengths of the linker connecting receptor domains fibronectin type III domain 4 (FN4) and FN5, which differs among DCC and neogenin splice variants, providing a basis for diverse signaling outcomes.	[Xu, Kai; Antipenko, Alexander; Tzvetkova-Robev, Dorothea; Xu, Yan; Minchenko, Maria; Nardi-Dei, Vincenzo; Himanen, Juha; Nikolov, Dimitar B.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Wu, Zhuhao; Renier, Nicolas; Tessier-Lavigne, Marc] Rockefeller Univ, Lab Brain Dev & Repair, New York, NY 10065 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Dept Chem & Chem Biol, Argonne, IL 60439 USA; [Rajashankar, Kanagalaghatta R.] Argonne Natl Lab, Adv Photon Source, Northeastern Collaborat Access Team, Argonne, IL 60439 USA	Memorial Sloan Kettering Cancer Center; Rockefeller University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Tessier-Lavigne, M (corresponding author), Rockefeller Univ, Lab Brain Dev & Repair, New York, NY 10065 USA.	marctl@mail.rockefeller.edu; nikolovd@mskcc.org	Wu, Zhuhao/I-5852-2018; Renier, Nicolas/E-1855-2018	Renier, Nicolas/0000-0003-2642-4402; Wu, Zhuhao/0000-0002-2471-0555	National Institute of General Medical Sciences from NIH [P41 GM103403]; U.S. DOE [DE-AC02-06CH11357]; Bristol-Myers Squibb postdoctoral fellowship at the Rockefeller University; European Molecular Biology Organization long-term postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	National Institute of General Medical Sciences from NIH; U.S. DOE(United States Department of Energy (DOE)); Bristol-Myers Squibb postdoctoral fellowship at the Rockefeller University; European Molecular Biology Organization long-term postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Kolev for technical support, M. Himanen for illustrations, Y. Goldgur for help with data collection and processing, and O. Olsen for help and support. X-ray diffraction studies were conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by a grant from the National Institute of General Medical Sciences (P41 GM103403) from NIH. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under contract no. DE-AC02-06CH11357. Z.W. was supported in part by a Bristol-Myers Squibb postdoctoral fellowship at the Rockefeller University; N.R. was supported by a European Molecular Biology Organization long-term postdoctoral fellowship. The netrin-1, netrin-1/neogenin, and netrin-1/DCC structures have been deposited in the Protein Data Bank under codes 4PLM, 4PLN, and 4PLO, respectively.	Bell CH, 2013, SCIENCE, V341, P77, DOI 10.1126/science.1232322; Brasch J, 2011, J MOL BIOL, V414, P723, DOI 10.1016/j.jmb.2011.10.030; Carafoli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042473; Engle EC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001784; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Geisbrecht BV, 2003, J BIOL CHEM, V278, P32561, DOI 10.1074/jbc.M302943200; Hussain SA, 2011, EMBO REP, V12, P276, DOI 10.1038/embor.2011.3; Kappler J, 2000, BIOCHEM BIOPH RES CO, V271, P287, DOI 10.1006/bbrc.2000.2583; Kastenhuber E, 2009, J NEUROSCI, V29, P8914, DOI 10.1523/JNEUROSCI.0568-09.2009; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kruger RP, 2004, J NEUROSCI, V24, P10826, DOI 10.1523/JNEUROSCI.3715-04.2004; Manitt C, 2004, J NEUROSCI RES, V77, P690, DOI 10.1002/jnr.20199; Matsumoto Y, 2007, J NEUROSCI, V27, P4342, DOI 10.1523/JNEUROSCI.0700-07.2007; Mille F, 2009, CELL DEATH DIFFER, V16, P1344, DOI 10.1038/cdd.2009.75; Moore SW, 2007, ADV EXP MED BIOL, V621, P17, DOI 10.1007/978-0-387-76715-4_2; Palmesino E, 2012, J NEUROSCI, V32, P411, DOI 10.1523/JNEUROSCI.3563-11.2012; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Rajasekharan S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-239; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Seiradake E, 2011, EMBO J, V30, P4479, DOI 10.1038/emboj.2011.346; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shen H, 2002, MECH DEVELOP, V118, P219, DOI 10.1016/S0925-4773(02)00255-1; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Srour M, 2010, SCIENCE, V328, P592, DOI 10.1126/science.1186463; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Vulliemoz S, 2005, LANCET NEUROL, V4, P87, DOI 10.1016/S1474-4422(05)00990-7; Wang H, 1999, J NEUROSCI, V19, P4938; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018	30	115	116	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1275	1279		10.1126/science.1255149	http://dx.doi.org/10.1126/science.1255149			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24876346	Green Accepted			2022-12-01	WOS:000337077500039
J	Martin, WF; Sousa, FL; Lane, N				Martin, William F.; Sousa, Filipa L.; Lane, Nick			EVOLUTION Energy at life's origin	SCIENCE			English	Editorial Material							CARBON; FIXATION; DEEP; ACID		[Martin, William F.; Sousa, Filipa L.] Univ Dusseldorf, Inst Mol Evolut, D-40225 Dusseldorf, Germany; [Lane, Nick] UCL, Res Dept Genet Evolut & Environm, London WC1E 6BT, England	Heinrich Heine University Dusseldorf; University of London; University College London	Martin, WF (corresponding author), Univ Dusseldorf, Inst Mol Evolut, Univ Str 1, D-40225 Dusseldorf, Germany.	bill@hhu.de	Sousa, Filipa L./H-6192-2012; Martin, William F./O-5446-2015; Sousa, Filipa/ACC-2848-2022	Sousa, Filipa L./0000-0002-4075-1701; Martin, William F./0000-0003-1478-6449; Sousa, Filipa/0000-0002-4084-1942; Lane, Nick/0000-0002-5433-3973				Arndt NT, 2012, ANNU REV EARTH PL SC, V40, P521, DOI 10.1146/annurev-earth-042711-105316; BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; Chivian D, 2008, SCIENCE, V322, P275, DOI 10.1126/science.1155495; DECKER K, 1970, ANGEW CHEM INT EDIT, V9, P138, DOI 10.1002/anie.197001381; ECK RV, 1966, SCIENCE, V152, P363, DOI 10.1126/science.152.3720.363; Ferry JG, 2006, MOL BIOL EVOL, V23, P1286, DOI 10.1093/molbev/msk014; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; Huber C, 1997, SCIENCE, V276, P245, DOI 10.1126/science.276.5310.245; Lane N, 2012, CELL, V151, P1406, DOI 10.1016/j.cell.2012.11.050; Mayer F, 2014, FEMS MICROBIOL REV, V38, P449, DOI 10.1111/1574-6976.12043; McCollom TM, 2013, ELEMENTS, V9, P129, DOI 10.2113/gselements.9.2.129; Mulkidjanian AY, 2012, P NATL ACAD SCI USA, V109, pE821, DOI 10.1073/pnas.1117774109; Russell MJ, 1997, J GEOL SOC LONDON, V154, P377, DOI 10.1144/gsjgs.154.3.0377; Schrenk MO, 2013, REV MINERAL GEOCHEM, V75, P575, DOI 10.2138/rmg.2013.75.18	15	79	82	3	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1092	1093		10.1126/science.1251653	http://dx.doi.org/10.1126/science.1251653			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904143				2022-12-01	WOS:000336791200024
J	Finkelstein, Y; Macdonald, EM; Li, P; Hutson, JR; Juurlink, DN				Finkelstein, Yaron; Macdonald, Erin M.; Li, Ping; Hutson, Janine R.; Juurlink, David N.			Recurrence and Mortality Following Severe Cutaneous Adverse Reactions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS		[Finkelstein, Yaron; Hutson, Janine R.] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Macdonald, Erin M.; Li, Ping] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Juurlink, David N.] Sunnybrook Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Finkelstein, Y (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	yaron.finkelstein@sickkids.ca			Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Finkelstein Y, 2011, PEDIATRICS, V128, P723, DOI 10.1542/peds.2010-3322; Mockenhaupt M, 2011, EXPERT REV CLIN IMMU, V7, P803, DOI [10.1586/eci.11.66, 10.1586/ECI.11.66]; Papay J, 2012, PHARMACOEPIDEM DR S, V21, P289, DOI 10.1002/pds.2276; Park-Wyllie LY, 2011, JAMA-J AM MED ASSOC, V305, P783, DOI 10.1001/jama.2011.190; Phillips EJ, 2011, J ALLERGY CLIN IMMUN, V127, pS60, DOI 10.1016/j.jaci.2010.11.046	6	36	36	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2231	2232		10.1001/jama.2014.839	http://dx.doi.org/10.1001/jama.2014.839			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24893093				2022-12-01	WOS:000336668400027
J	Frisch, S				Frisch, Suzy			Going hungry in America	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												suzyfrisch@yahoo.com						Bartlett S, 2013, HEALTHY INCENTIVES P; Beatty T, 2013, SUPPLEMENTAL NUTRITI; Gregory C, 2013, ECONOMIC RESEARCH RE; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; US Department of Agriculture Food and Nutrition Service Office of Research and Analysis, 2012, BUILDING A HEALTHY A; USDA, 2013, SUPPLEMENTAL NUTRITI	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2014	348								g3548	10.1136/bmj.g3548	http://dx.doi.org/10.1136/bmj.g3548			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EO	24879820				2022-12-01	WOS:000336742800003
J	Fischer, ES; Bohm, K; Lydeard, JR; Yang, HD; Stadler, MB; Cavadini, S; Nagel, J; Serluca, F; Acker, V; Lingaraju, GM; Tichkule, RB; Schebesta, M; Forrester, WC; Schirle, M; Hassiepen, U; Ottl, J; Hild, M; Beckwith, REJ; Harper, JW; Jenkins, JL; Thoma, NH				Fischer, Eric S.; Boehm, Kerstin; Lydeard, John R.; Yang, Haidi; Stadler, Michael B.; Cavadini, Simone; Nagel, Jane; Serluca, Fabrizio; Acker, Vincent; Lingaraju, Gondichatnahalli M.; Tichkule, Ritesh B.; Schebesta, Michael; Forrester, William C.; Schirle, Markus; Hassiepen, Ulrich; Ottl, Johannes; Hild, Marc; Beckwith, Rohan E. J.; Harper, J. Wade; Jenkins, Jeremy L.; Thomae, Nicolas H.			Structure of the DDBI-CRBN E3 ubiquitin ligase in complex with thalidomide	NATURE			English	Article							MULTIPLE-MYELOMA; CONGENITAL ABNORMALITIES; MENTAL-RETARDATION; LENALIDOMIDE; POMALIDOMIDE; CEREBLON; PROTEIN; CELLS; RECOGNITION; CANCER	In the 1950s, the drug thalidomide, administered as a sedative to pregnant women, led to the birth of thousands of children with multiple defects. Despite the teratogenicity of thalidomide and its derivatives lenalidomide and pomalidomide, these immunomodulatory drugs (IMiDs) recently emerged as effective treatments for multiple myeloma and 5q-deletion-associated dysplasia. IMiDs target the E3 ubiquitin ligase CUL4-RBX1-DDB1-CRBN (known as CRL4(CRBN)) and promote the ubiquitination of the IKAROS family transcription factors IKZF1 and IKZF3 by CRL4(CRBN). Here we present crystal structures of the DDB1-CRBN complex bound to thalidomide, lenalidomide and pomalidomide. The structure establishes that CRBN is a substrate receptor within CRL4(CRBN) and enantioselectively binds IMiDs. Using an unbiased screen, we identified the homeobox transcription factor MEIS2 as an endogenous substrate of CRL4(CRBN). Our studies suggest that IMiDs block endogenous substrates (MEIS2) from binding to CRL4(CRBN) while the ligase complex is recruiting IKZF1 or IKZF3 for degradation. This dual activity implies that small molecules can modulate an E3 ubiquitin ligase and thereby upregulate or downregulate the ubiquitination of proteins.	[Fischer, Eric S.; Boehm, Kerstin; Stadler, Michael B.; Cavadini, Simone; Lingaraju, Gondichatnahalli M.; Thomae, Nicolas H.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Fischer, Eric S.; Boehm, Kerstin; Stadler, Michael B.; Cavadini, Simone; Lingaraju, Gondichatnahalli M.; Thomae, Nicolas H.] Univ Basel, CH-4003 Basel, Switzerland; [Lydeard, John R.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Yang, Haidi; Nagel, Jane; Serluca, Fabrizio; Tichkule, Ritesh B.; Schebesta, Michael; Forrester, William C.; Schirle, Markus; Hild, Marc; Beckwith, Rohan E. J.; Jenkins, Jeremy L.] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Stadler, Michael B.] Swiss Inst Bioinformat, CH-4058 Basel, Switzerland; [Acker, Vincent; Hassiepen, Ulrich; Ottl, Johannes] Novartis Pharma AG, Inst Biomed Res, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel; Harvard University; Harvard Medical School; Novartis; Swiss Institute of Bioinformatics; Novartis; Universita della Svizzera Italiana	Thoma, NH (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	nicolas.thoma@fmi.ch		Fischer, Eric S./0000-0001-7337-6306; Harper, Jeffrey/0000-0002-6944-7236; Thoma, Nicolas/0000-0003-2685-906X	Novartis Research Foundation; European Research Council [260481-MoBa-CS]; National Institutes of Health [AG011085]; Damon Runyon Postdoctoral Fellowship [DRG 2061-10]; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Novartis Research Foundation; European Research Council(European Research Council (ERC)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Postdoctoral Fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Novartis Research Foundation and grants to N.H.T. from the European Research Council (ERC-2010-StG 260481-MoBa-CS) and to J.W.H. from the National Institutes of Health (AG011085). J.R.L. was supported by a Damon Runyon Postdoctoral Fellowship (DRG 2061-10). We acknowledge J. Reilly for performing immobilized artificial membrane (IAM) experiments. We thank J. Tallarico, J. Porter, W. Sellers, S. Cottens and M. Renatus for help and comments. D. Hess, R. Sack and J. Seebacher for the mass spectrometry analysis and J. Keusch and H. Gut for support. We thank W. Kaelin for kindly providing the IKZF1 reporter plasmid (pCMV-IRES-Renilla luciferase-IRES-Gateway-firefly luciferase). Part of this work was performed at the Swiss Light Source, Paul Scherrer Institute, Villigen, Switzerland.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bartlett JB, 2004, NAT REV CANCER, V4, P314, DOI 10.1038/nrc1323; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Crowley MA, 2010, AM J MED GENET A, V152A, P1326, DOI 10.1002/ajmg.a.33375; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Hofmeister CC, 2011, J CLIN ONCOL, V29, P3427, DOI 10.1200/JCO.2010.32.4962; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huai Q, 2002, P NATL ACAD SCI USA, V99, P12037, DOI 10.1073/pnas.192206699; Hur S, 2006, J BIOL CHEM, V281, P38969, DOI 10.1074/jbc.R600034200; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LENZ W, 1962, LANCET, V1, P45; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; MCBRIDE WG, 1961, LANCET, V2, P1358; Melchert M, 2007, INT J BIOCHEM CELL B, V39, P1489, DOI 10.1016/j.biocel.2007.01.022; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Pan BQ, 2012, PHARMACOL THERAPEUT, V136, P56, DOI 10.1016/j.pharmthera.2012.07.004; Roche S, 2012, J CHROMATOGR B, V902, P16, DOI 10.1016/j.jchromb.2012.06.008; Ruchelman AL, 2013, BIOORG MED CHEM LETT, V23, P360, DOI 10.1016/j.bmcl.2012.10.071; Scrima A, 2011, FEBS LETT, V585, P2818, DOI 10.1016/j.febslet.2011.04.064; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; SHESKIN J, 1965, CLIN PHARMACOL THER, V6, P303; Shortt J, 2013, ONCOGENE, V32, P4191, DOI 10.1038/onc.2012.599; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Xu GQ, 2013, J BIOL CHEM, V288, P29573, DOI 10.1074/jbc.M113.472092; Zhang L, 2012, CELL CYCLE, V11, P4378, DOI 10.4161/cc.22688; Zhang X, 2012, NAT GENET, V44, P593, DOI 10.1038/ng.2228; Zhou SF, 2005, EUR J DRUG METAB PH, V30, P49, DOI 10.1007/BF03226408; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	42	524	579	16	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					49	+		10.1038/nature13527	http://dx.doi.org/10.1038/nature13527			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043012	Green Accepted, Green Submitted			2022-12-01	WOS:000339908000028
J	Deyo, RA; Jarvik, JG; Chou, R				Deyo, Richard A.; Jarvik, Jeffrey G.; Chou, Roger			RATIONAL IMAGING Low back pain in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; LUMBAR SPINE; RED FLAGS; METAANALYSIS; STRATEGIES; OUTCOMES; CANCER		[Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97239 USA; [Deyo, Richard A.; Chou, Roger] Oregon Hlth & Sci Univ, Dept Internal Med, Portland, OR 97239 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97239 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97239 USA; [Deyo, Richard A.; Jarvik, Jeffrey G.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Jarvik, Jeffrey G.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Jarvik, Jeffrey G.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Chou, Roger] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Oregon Health & Science University	Deyo, RA (corresponding author), Oregon Hlth & Sci Univ, Dept Family Med, Mail Code FM, Portland, OR 97239 USA.	deyor@ohsu.edu	Jarvik, Jeffrey/AAL-4292-2021	Chou, Roger/0000-0001-9889-8610				[Anonymous], 2009, PAIN MANAG; Ash LM, 2008, AM J NEURORADIOL, V29, P1098, DOI 10.3174/ajnr.A0999; Carragee Eugene, 2006, Spine J, V6, P624, DOI 10.1016/j.spinee.2006.03.005; Chou R, 2011, ANN INTERN MED, V154, P181, DOI 10.7326/0003-4819-154-3-201102010-00008; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Downie A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7095; Henschke N, 2009, ARTHRITIS RHEUM-US, V60, P3072, DOI 10.1002/art.24853; Jarvik JG, 2002, ANN INTERN MED, V137, P586, DOI 10.7326/0003-4819-137-7-200210010-00010; Jarvik JG, 2003, JAMA-J AM MED ASSOC, V289, P2810, DOI 10.1001/jama.289.21.2810; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Joines JD, 2001, J GEN INTERN MED, V16, P14, DOI 10.1111/j.1525-1497.2001.00249.x; Kendrick D, 2001, BRIT MED J, V322, P400, DOI 10.1136/bmj.322.7283.400; Knopp-Sihota JA, 2012, OSTEOPOROSIS INT, V23, P17, DOI 10.1007/s00198-011-1676-0; Lurie JD, 2003, SPINE, V28, P616, DOI 10.1097/00007632-200303150-00018; McCullough BJ, 2012, RADIOLOGY, V262, P941, DOI 10.1148/radiol.11110618; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; Underwood M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7432; Webster BS, 2010, J OCCUP ENVIRON MED, V52, P900, DOI 10.1097/JOM.0b013e3181ef7e53	19	18	21	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 16	2014	349								g4266	10.1136/bmj.g4266	http://dx.doi.org/10.1136/bmj.g4266			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7PE	25030632				2022-12-01	WOS:000339326000002
J	Fuentes, I; Stegemann, S; Golczyk, H; Karcher, D; Bock, R				Fuentes, Ignacia; Stegemann, Sandra; Golczyk, Hieronim; Karcher, Daniel; Bock, Ralph			Horizontal genome transfer as an asexual path to the formation of new species	NATURE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; INTERCELLULAR MOVEMENT; TISSUE; PLANTS; ORGANIZATION; POLYPLOIDY; PROTOPLASM; DIVERSITY; NUCLEAR; GLAUCA	Allopolyploidization, the combination of the genomes from two different species, has been a major source of evolutionary innovation and a driver of speciation and environmental adaptation(1-4). Inplants, it has also contributed greatly to crop domestication, as the superior properties of many modern crop plants were conferred by ancient allopolyploidization events(5,6). It is generally thought that allopolyploidization occurred through hybridization events between species, accompanied or followed by genome duplication(6,7). Although many allopolyploids arose from closely related species (congeners), there are also allopolyploid species that were formed from more distantly related progenitor species belonging to different genera or even different tribes(8). Here we have examined the possibility that allopolyploidization can also occur by asexual mechanisms. We show that upon grafting-a mechanism of plant-plant interaction that is widespread in nature-entire nuclear genomes can be transferred between plant cells. We provide direct evidence for this process resulting in speciation by creating a new allopolyploid plant species from a herbaceous species and a woody species in the nightshade family. The new species is fertile and produces fertile progeny. Our data highlight natural grafting as a potential asexual mechanism of speciation and also provide a method for the generation of novel allopolyploid crop species.	[Fuentes, Ignacia; Stegemann, Sandra; Karcher, Daniel; Bock, Ralph] Max Planck Inst Mol Pflanzenphysiol, D-14476 Potsdam, Germany; [Golczyk, Hieronim] John Paul II Catholic Univ Lublin, Inst Biotechnol, Dept Mol Biol, PL-20708 Lublin, Poland	Max Planck Society; Catholic University of Lublin	Bock, R (corresponding author), Max Planck Inst Mol Pflanzenphysiol, Muhlenberg 1, D-14476 Potsdam, Germany.	rbock@mpimp-golm.mpg.de	Bock, Ralph/B-4352-2009; Fuentes, Ignacia/G-4785-2016	Bock, Ralph/0000-0001-7502-6940; Karcher, Daniel/0000-0001-6393-7376	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank the MPI-MP Green Team for help with plant transformation, K. Kohl for providing the hpt vector and S. Ruf (MPI-MP) for discussions. We are grateful to J. Fuchs (IPK Gatersleben) for advice on flow cytometry measurements. This research was financed by the Max Planck Society.	Beddie A. D., 1942, T P R SOC NZ, V71, P199; Bock R, 2010, TRENDS PLANT SCI, V15, P11, DOI 10.1016/j.tplants.2009.10.001; Chester M, 2012, P NATL ACAD SCI USA, V109, P1176, DOI 10.1073/pnas.1112041109; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Doyle JJ., 1987, FOCUS, V19, P11, DOI DOI 10.2307/2419362; EVANS DA, 1980, PHYSIOL PLANTARUM, V48, P225, DOI 10.1111/j.1399-3054.1980.tb03246.x; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Greiner S, 2013, BIOESSAYS, V35, P354, DOI 10.1002/bies.201200137; Hegarty MJ, 2008, CURR BIOL, V18, pR435, DOI 10.1016/j.cub.2008.03.043; Joly S, 2009, MOL PHYLOGENET EVOL, V51, P365, DOI 10.1016/j.ympev.2009.02.015; KUSTER E, 1899, JB WISS BOT, V0033, P00487; Larson P.R., 1994, SPRINGER SERIES, P1; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Madlung A, 2005, PLANT J, V41, P221, DOI 10.1111/j.1365-313X.2004.02297.x; Madlung A, 2013, HEREDITY, V110, P99, DOI 10.1038/hdy.2012.79; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Moon HS, 2008, GENOME, V51, P547, DOI 10.1139/G08-039; Mudge K., 2009, Horticultural Reviews, V35, P437; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mursalimov SR, 2013, PLANTA, V238, P415, DOI 10.1007/s00425-013-1914-0; Paterson AH, 2005, GENETICA, V123, P191, DOI 10.1007/s10709-003-2742-0; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; Seidel C. F., 1879, NATURWISS GES ISIS D, P161; SHEPARD JF, 1983, SCIENCE, V219, P683, DOI 10.1126/science.219.4585.683; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Sobel JM, 2010, EVOLUTION, V64, P295, DOI 10.1111/j.1558-5646.2009.00877.x; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Stegemann S, 2012, P NATL ACAD SCI USA, V109, P2434, DOI 10.1073/pnas.1114076109; Stegemann S, 2009, SCIENCE, V324, P649, DOI 10.1126/science.1170397; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Thyssen G, 2012, P NATL ACAD SCI USA, V109, P2439, DOI 10.1073/pnas.1114297109; Trojak-Goluch A, 2003, J APPL GENET, V44, P45; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108; YU HS, 1994, PLANT CELL, V6, P1477, DOI 10.1105/tpc.6.10.1477; ZHANG WC, 1990, PROTOPLASMA, V153, P193, DOI 10.1007/BF01354004; Zhang WC, 2002, ACTA BOT SIN, V44, P1068	37	123	140	6	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					232	+		10.1038/nature13291	http://dx.doi.org/10.1038/nature13291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	24909992				2022-12-01	WOS:000338649800046
J	Zhao, L; Lee, X; Smith, RB; Oleson, K				Zhao, Lei; Lee, Xuhui; Smith, Ronald B.; Oleson, Keith			Strong contributions of local background climate to urban heat islands	NATURE			English	Article							CITIES; URBANIZATION; IMPACT; EXCHANGES; HEATWAVES; FORESTS; SYSTEM; MODEL	The urban heat island(UHI), a common phenomenon in which surface temperatures are higher in urban areas than in surrounding rural areas, represents one of the most significant human-induced changes to Earth's surface climate(1,2). Even though they are localized hotspots in the landscape, UHIs have a profound impact on the lives of urban residents, who comprise more than half of the world's population(3). A barrier to UHI mitigation is the lack of quantitative attribution of the various contributions to UHI intensity(4) (expressed as the temperature difference between urban and rural areas, Delta T). A common perception is that reduction in evaporative cooling in urban land is the dominant driver of DT (ref. 5). Here we use a climate model to show that, for cities across North America, geographic variations in daytime Delta T are largely explained by variations in the efficiency with which urban and rural areas convect heat to the lower atmosphere. If urban areas are aerodynamically smoother than surrounding rural areas, urban heat dissipation is relatively less efficient and urban warming occurs (and vice versa). This convection effect depends on the local background climate, increasing daytime Delta T by 3.06 +/- 0.3 kelvin (mean and standard error) in humid climates but decreasing Delta T by 1.5 +/- 0.2 kelvin in dry climates. In the humid eastern United States, there is evidence of higher Delta T in drier years. These relationship simply that UHIs will exacerbate heat wave stress on human health in wet climates where high temperature effects are already compounded by high air humidity(6,7) and in drier years when positive temperature anomalies may be reinforced by a precipitation temperature feedback(8). Our results support albedo management as a viable means of reducing Delta T on large scales(9,10).	[Zhao, Lei; Lee, Xuhui] Nanjing Univ Informat Sci & Technol, Yale NUIST Ctr Atmospher Environm, Nanjing 210044, Jiangsu, Peoples R China; [Zhao, Lei; Lee, Xuhui] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Smith, Ronald B.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA; [Oleson, Keith] Natl Ctr Atmospher Res, Boulder, CO 80305 USA	Nanjing University of Information Science & Technology; Yale University; Yale University; National Center Atmospheric Research (NCAR) - USA	Lee, X (corresponding author), Nanjing Univ Informat Sci & Technol, Yale NUIST Ctr Atmospher Environm, Nanjing 210044, Jiangsu, Peoples R China.	xuhui.lee@yale.edu	Oleson, Keith/A-9328-2008; Zhao, Lei/S-1855-2019	Oleson, Keith/0000-0002-0057-9900; Zhao, Lei/0000-0002-6481-3786	Ministry of Education of China (grant PCSIRT); Yale Climate and Energy Institute; Yale Institute of Biospheric Studies; Yale University Graduate Fellowship; NASA [NNX10AK79G]; NCARWCIASP; US National Science Foundation	Ministry of Education of China (grant PCSIRT); Yale Climate and Energy Institute; Yale Institute of Biospheric Studies; Yale University Graduate Fellowship; NASA(National Aeronautics & Space Administration (NASA)); NCARWCIASP; US National Science Foundation(National Science Foundation (NSF))	This research was supported by the Ministry of Education of China (grant PCSIRT), the Yale Climate and Energy Institute, the Yale Institute of Biospheric Studies, and a Yale University Graduate Fellowship. K.O. acknowledges support from NASA grant NNX10AK79G (the SIMMER project) and the NCARWCIASP. NCAR is sponsored by the US National Science Foundation. The model simulations were supported by the Yale University Faculty of Arts and Sciences High Performance Computing Center.	Akbari H, 2009, CLIMATIC CHANGE, V94, P275, DOI 10.1007/s10584-008-9515-9; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Clinton N, 2013, REMOTE SENS ENVIRON, V134, P294, DOI 10.1016/j.rse.2013.03.008; Fischer EM, 2010, NAT GEOSCI, V3, P398, DOI 10.1038/NGEO866; Gallo KP, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002588; Garratt JR, 1994, ATMOSPHERIC BOUNDARY; Georgescu M, 2013, NAT CLIM CHANGE, V3, P37, DOI 10.1038/nclimate1656; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Grimmond S, 2007, GEOGR J, V173, P83, DOI 10.1111/j.1475-4959.2007.232_3.x; Gu LH, 1999, J GEOPHYS RES-ATMOS, V104, P31421, DOI 10.1029/1999JD901068; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Hung T, 2006, INT J APPL EARTH OBS, V8, P34, DOI 10.1016/j.jag.2005.05.003; Hurrell JW, 2013, B AM METEOROL SOC, V94, P1339, DOI 10.1175/BAMS-D-12-00121.1; Imhoff ML, 2010, REMOTE SENS ENVIRON, V114, P504, DOI 10.1016/j.rse.2009.10.008; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Lee X, 2011, NATURE, V479, P384, DOI 10.1038/nature10588; Li D, 2013, J APPL METEOROL CLIM, V52, P2051, DOI 10.1175/JAMC-D-13-02.1; Mackey CW, 2012, BUILD ENVIRON, V49, P348, DOI 10.1016/j.buildenv.2011.08.004; Nichol JE, 2009, ATMOS RES, V94, P276, DOI 10.1016/j.atmosres.2009.06.011; OKE TR, 1982, Q J ROY METEOR SOC, V108, P1, DOI 10.1002/qj.49710845502; Oleson KW, 2008, J APPL METEOROL CLIM, V47, P1061, DOI 10.1175/2007JAMC1598.1; Oleson KW, 2011, INT J CLIMATOL, V31, P1848, DOI 10.1002/joc.2201; Oleson K. W., 2013, NCARTN478STR, DOI [10.5065/D6RR1W7M, DOI 10.5065/D6RR1W7M, DOI 10.5065/D6FB50WZ]; Oleson K, 2012, J CLIMATE, V25, P1390, DOI 10.1175/JCLI-D-11-00098.1; Peng SS, 2012, ENVIRON SCI TECHNOL, V46, P696, DOI 10.1021/es2030438; Qian TT, 2006, J HYDROMETEOROL, V7, P953, DOI 10.1175/JHM540.1; Rosenzweig C, 2009, B AM METEOROL SOC, V90, P1297, DOI 10.1175/2009BAMS2308.1; Rotenberg E, 2010, SCIENCE, V327, P451, DOI 10.1126/science.1179998; ROTH M, 1989, INT J REMOTE SENS, V10, P1699, DOI 10.1080/01431168908904002; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Smith TT, 2013, CLIMATIC CHANGE, V118, P811, DOI 10.1007/s10584-012-0659-2; Taha H, 1997, ENERG BUILDINGS, V25, P99, DOI 10.1016/S0378-7788(96)00999-1; Voogt JA, 2000, J APPL METEOROL, V39, P1679, DOI 10.1175/1520-0450-39.10.1679; Voogt JA, 2003, REMOTE SENS ENVIRON, V86, P370, DOI 10.1016/S0034-4257(03)00079-8; Zhou LM, 2004, P NATL ACAD SCI USA, V101, P9540, DOI 10.1073/pnas.0400357101	36	607	658	68	764	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					216	219		10.1038/nature13462	http://dx.doi.org/10.1038/nature13462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008529				2022-12-01	WOS:000338649800042
J	Rauskolb, C; Sun, SG; Sun, GP; Pan, YW; Irvine, KD				Rauskolb, Cordelia; Sun, Shuguo; Sun, Gongping; Pan, Yuanwang; Irvine, Kenneth D.			Cytoskeletal Tension Inhibits Hippo Signaling through an Ajuba-Warts Complex	CELL			English	Article							WING IMAGINAL DISC; F-ACTIN; CELL-PROLIFERATION; ALPHA-CATENIN; SIZE-CONTROL; DROSOPHILA; PATHWAY; GROWTH; MECHANISM; PROTEIN	Mechanical forces have been proposed to modulate organ growth, but a molecular mechanism that links them to growth regulation in vivo has been lacking. We report that increasing tension within the cytoskeleton increases Drosophila wing growth, whereas decreasing cytoskeletal tension decreases wing growth. These changes in growth can be accounted for by changes in the activity of Yorkie, a transcription factor regulated by the Hippo pathway. The influence of myosin activity on Yorkie depends genetically on the Ajuba LIM protein Jub, a negative regulator of Warts within the Hippo pathway. We further show that Jub associates with a-catenin and that its localization to adherens junctions and association with alpha-catenin are promoted by cytoskeletal tension. Jub recruits Warts to junctions in a tension-dependent manner. Our observations delineate a mechanism that links cytoskeletal tension to regulation of Hippo pathway activity, providing a molecular understanding of how mechanical forces can modulate organ growth.	[Rauskolb, Cordelia; Sun, Shuguo; Sun, Gongping; Pan, Yuanwang; Irvine, Kenneth D.] Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; [Rauskolb, Cordelia; Sun, Shuguo; Sun, Gongping; Pan, Yuanwang; Irvine, Kenneth D.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Irvine, KD (corresponding author), Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA.	irvine@waksman.rutgers.edu		Sun, Gongping/0000-0002-0411-2697	Howard Hughes Medical Institute; National Institutes of Health [R01 GM078620]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078620] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Yongqiang Feng for Wts:V5-expressing flies, Spencer Irvine for initial characterization of rok RNAi phenotypes, and Martha Soto for helpful discussion in suggesting alpha-catenin experiments. We thank R. Basto, C. Bokel, R. Fehon, B. Hay, J. Jiang, D. Kiehart, L. Luo, G. Longmore, T. Lecuit, D. Pan, U. Tepass, J. Zallen, the Developmental Studies Hybridoma Bank, the Gene Disruption Project, the Bloomington Stock Center for antibodies and Drosophila stocks, and the Drosophila Genomics Resource Center for plasmids. This research was supported by the Howard Hughes Medical Institute and the National Institutes of Health (R01 GM078620).	Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Aegerter-Wilmsen T, 2012, DEVELOPMENT, V139, P3221, DOI 10.1242/dev.082800; Aliee M, 2012, CURR BIOL, V22, P967, DOI 10.1016/j.cub.2012.03.070; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Bertet C, 2009, DEVELOPMENT, V136, P4199, DOI 10.1242/dev.040402; BRYANT PJ, 1985, DEV BIOL, V107, P355, DOI 10.1016/0012-1606(85)90317-3; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; Degoutin JL, 2013, NAT CELL BIOL, V15, P1176, DOI 10.1038/ncb2829; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Enderle L, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004208; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Grusche FA, 2011, DEV BIOL, V350, P255, DOI 10.1016/j.ydbio.2010.11.020; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Herranz H, 2008, EMBO J, V27, P1633, DOI 10.1038/emboj.2008.84; Hirata Hiroaki, 2008, Commun Integr Biol, V1, P192; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Huveneers S, 2013, J CELL SCI, V126, P403, DOI 10.1242/jcs.109447; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; LeGoff L, 2013, DEVELOPMENT, V140, P4051, DOI 10.1242/dev.090878; Major RJ, 2005, DEVELOPMENT, V132, P3823, DOI 10.1242/dev.01957; Major RJ, 2006, DEV DYNAM, V235, P3051, DOI 10.1002/dvdy.20966; Mao YL, 2013, EMBO J, V32, P2790, DOI 10.1038/emboj.2013.197; Marie H, 2003, J BIOL CHEM, V278, P1220, DOI 10.1074/jbc.M205391200; Martin FA, 2009, DEVELOPMENT, V136, P3747, DOI 10.1242/dev.038406; Nienhaus U, 2009, MECH DEVELOP, V126, P942, DOI 10.1016/j.mod.2009.09.002; OBROCHTA DA, 1987, DEV BIOL, V119, P137, DOI 10.1016/0012-1606(87)90215-6; Oh H, 2010, TRENDS CELL BIOL, V20, P410, DOI 10.1016/j.tcb.2010.04.005; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Rauskolb C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000624; Reddy BVVG, 2013, DEV CELL, V24, P459, DOI 10.1016/j.devcel.2013.01.020; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Sarpal R, 2012, J CELL SCI, V125, P233, DOI 10.1242/jcs.096644; Schluck T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076171; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Sun GP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004324; Sun GP, 2011, DEV BIOL, V350, P139, DOI 10.1016/j.ydbio.2010.11.036; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Warner SJ, 2010, CURR BIOL, V20, P677, DOI 10.1016/j.cub.2010.03.025; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111	57	217	222	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					143	156		10.1016/j.cell.2014.05.035	http://dx.doi.org/10.1016/j.cell.2014.05.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995985	Bronze, Green Accepted			2022-12-01	WOS:000340943100014
J	Sutendra, G; Kinnaird, A; Dromparis, P; Paulin, R; Stenson, TH; Haromy, A; Hashimoto, K; Zhang, N; Flaim, E; Michelakis, ED				Sutendra, Gopinath; Kinnaird, Adam; Dromparis, Peter; Paulin, Roxane; Stenson, Trevor H.; Haromy, Alois; Hashimoto, Kyoko; Zhang, Nancy; Flaim, Eric; Michelakis, Evangelos D.			A Nuclear Pyruvate Dehydrogenase Complex Is Important for the Generation of Acetyl-CoA and Histone Acetylation	CELL			English	Article							HEAT-SHOCK-PROTEIN; GENE-TRANSCRIPTION; KINASE M2; EXPRESSION; TRANSPORT; HYPOXIA; CANCER; HSP70; PROLIFERATION; REQUIRES	DNA transcription, replication, and repair are regulated by histone acetylation, a process that requires the generation of acetyl-coenzyme A (CoA). Here, we show that all the subunits of the mitochondrial pyruvate dehydrogenase complex (PDC) are also present and functional in the nucleus of mammalian cells. We found that knockdown of nuclear PDC in isolated functional nuclei decreased the de novo synthesis of acetyl-CoA and acetylation of core histones. Nuclear PDC levels increased in a cell-cycle-dependent manner and in response to serum, epidermal growth factor, or mitochondrial stress; this was accompanied by a corresponding decrease in mitochondrial PDC levels, suggesting a translocation from the mitochondria to the nucleus. Inhibition of nuclear PDC decreased acetylation of specific lysine residues on histones important for G1-S phase progression and expression of S phase markers. Dynamic translocation of mitochondrial PDC to the nucleus provides a pathway for nuclear acetyl-CoA synthesis required for histone acetylation and epigenetic regulation.	[Sutendra, Gopinath; Kinnaird, Adam; Dromparis, Peter; Paulin, Roxane; Stenson, Trevor H.; Haromy, Alois; Hashimoto, Kyoko; Michelakis, Evangelos D.] Univ Alberta, Dept Med, Edmonton, AB T6G 2B7, Canada; [Zhang, Nancy; Flaim, Eric] Univ Alberta, NanoFAB Fabricat & Characterizat Facil, Edmonton, AB T6G 2B7, Canada	University of Alberta; University of Alberta	Sutendra, G (corresponding author), Univ Alberta, Dept Med, Edmonton, AB T6G 2B7, Canada.	gopinath.sutendra@ludwig.ox.ac.uk	Kinnaird, Adam/O-3969-2017	Kinnaird, Adam/0000-0002-4115-4327; Stenson, Trevor/0000-0001-7164-1137	Canadian Institutes for Health Research; Alberta Innovation for Health Solutions; Hecht Foundation (Vancouver, Canada)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovation for Health Solutions; Hecht Foundation (Vancouver, Canada)	We would like to thank Dr. Ryan McKay of the Canadian National High Field NMR Centre (NANUC) and Chenomx for the NMR acquisition and data analysis, Dr. Nasser Tahbaz (University of Alberta) for the immunogold labeling and electron microscopy, and Dr. Gregg Semenza (Johns Hopkins University) for the adenoviruses encoding LacZ and CA5. This study was funded by the Canadian Institutes for Health Research, the Alberta Innovation for Health Solutions, and the Hecht Foundation (Vancouver, Canada) to E. D. M.	Alarcon-Vargas D, 2002, ONCOGENE, V21, P4384, DOI 10.1038/sj.onc.1205543; BEHAL RH, 1993, ANNU REV NUTR, V13, P497, DOI 10.1146/annurev.nu.13.070193.002433; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dhar S, 2009, P NATL ACAD SCI USA, V106, P22199, DOI 10.1073/pnas.0912276106; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Horner DS, 1999, MOL BIOL EVOL, V16, P1280, DOI 10.1093/oxfordjournals.molbev.a026218; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kiang JG, 2006, AM J PHYSIOL-GASTR L, V291, pG117, DOI 10.1152/ajpgi.00397.2005; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Koishi M, 2001, CLIN CANCER RES, V7, P215; Lodish H, 2000, MOL CELL BIOL, V4; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; MILARSKI KL, 1986, P NATL ACAD SCI USA, V83, P9517, DOI 10.1073/pnas.83.24.9517; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Rodriguez MA, 1998, MICROB PATHOGENESIS, V25, P1, DOI 10.1006/mpat.1998.0202; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; SHI YG, 1992, MOL CELL BIOL, V12, P2186, DOI 10.1128/MCB.12.5.2186; SIEBERT GUNTHER, 1965, ADVANCE ENZYMOL, V27, P239; SUMEGI B, 1987, EUR J BIOCHEM, V169, P223, DOI 10.1111/j.1432-1033.1987.tb13601.x; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yi CH, 2011, CELL, V146, P607, DOI 10.1016/j.cell.2011.06.050; Yogev O, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000328; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445; Zhou ZH, 2001, P NATL ACAD SCI USA, V98, P14802, DOI 10.1073/pnas.011597698; Zhou ZH, 2001, J BIOL CHEM, V276, P21704, DOI 10.1074/jbc.M101765200	39	342	347	1	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					84	97		10.1016/j.cell.2014.04.046	http://dx.doi.org/10.1016/j.cell.2014.04.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995980	Bronze			2022-12-01	WOS:000340943100009
J	Yelagandula, R; Stroud, H; Holec, S; Zhou, K; Feng, SH; Zhong, XH; Muthurajan, UM; Nie, X; Kawashima, T; Groth, M; Luger, K; Jacobsen, SE; Berger, F				Yelagandula, Ramesh; Stroud, Hume; Holec, Sarah; Zhou, Keda; Feng, Suhua; Zhong, Xuehua; Muthurajan, Uma M.; Nie, Xin; Kawashima, Tomokazu; Groth, Martin; Luger, Karolin; Jacobsen, Steven E.; Berger, Frederic			The Histone Variant H2A. W Defines Heterochromatin and Promotes Chromatin Condensation in Arabidopsis	CELL			English	Article							DNA METHYLATION; NUCLEOSOME; GENOME; MAINTENANCE; LINKER; GENES; SPKK; LOCALIZATION; EUCHROMATIN; ASSOCIATION	Histone variants play crucial roles in gene expression, genome integrity, and chromosome segregation. We report that the four H2A variants in Arabidopsis define different genomic features, contributing to overall genomic organization. The histone variant H2A. W marks heterochromatin specifically and acts in synergy with heterochromatic marks H3K9me2 and DNA methylation to maintain transposon silencing. In vitro, H2A. W enhances chromatin condensation by promoting fiber-to-fiber interactions via its conserved C-terminal motif. In vivo, H2A. W is required for heterochromatin condensation, demonstrating that H2A. W plays critical roles in heterochromatin organization. Similarities in conserved motifs between H2A. W and another H2A variant in metazoans suggest that plants and animals share common mechanisms for heterochromatin condensation.	[Yelagandula, Ramesh; Holec, Sarah; Nie, Xin; Kawashima, Tomokazu; Berger, Frederic] Natl Univ Singapore, Temasek Lifesci Lab, Singapore 117604, Singapore; [Yelagandula, Ramesh; Nie, Xin; Berger, Frederic] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Stroud, Hume; Feng, Suhua; Zhong, Xuehua; Groth, Martin; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Feng, Suhua; Groth, Martin; Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Zhou, Keda; Muthurajan, Uma M.; Luger, Karolin] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Luger, Karolin] Colorado State Univ, Howard Hughes Med Inst, Ft Collins, CO 80523 USA	National University of Singapore; National University of Singapore; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Colorado State University; Colorado State University; Howard Hughes Medical Institute	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu; fred@tll.org.sg	Kawashima, Tomokazu/I-9333-2014; Stroud, Hume/ABF-1325-2021; Kawashima, Tomo/AAM-9411-2021; zhou, keda/AAH-9343-2021	Kawashima, Tomokazu/0000-0003-3803-3070; Kawashima, Tomo/0000-0003-3803-3070; SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331; Berger, Frederic/0000-0002-3609-8260; Yelagandula, Ramesh/0000-0001-7418-4322; Groth, Martin/0000-0003-0547-5032	UCLA; NSF [1121245]; NIH [GM067777]; EMBO ALTF [986-2011]; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067777, F32GM096483] Funding Source: NIH RePORTER	UCLA; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO ALTF; HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R.Y., S. H., X.N., and F. B. were funded by Temasek Life Sciences Laboratory. Sequencing was performed at the UCLA BSCRC BioSequencing Core facility. We thank Meredith Calvert for help with imaging and Mahnaz Akhavan for Illumina sequencing. We thank Dr. Maruyama for his comments and support with the graphical abstract. H. S. was supported by a Dissertation Year Fellowship from UCLA. X.Z. is a research fellow of Ruth L. Kirschstein National Research Service Award (F32GM096483-01). S. F. is a Special Fellow of the Leukemia & Lymphoma Society. Work in the Jacobsen lab was supported by NSF grant 1121245. K. L., U. M., and K.Z. are supported by NIH-GM067777. M. G. is supported by EMBO ALTF 986-2011 and HHMI. S.E.J. and K. L. are Investigators of the Howard Hughes Medical Institute.	Aceituno FF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-438; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Bian Q, 2012, CURR OPIN CELL BIOL, V24, P359, DOI 10.1016/j.ceb.2012.03.003; Bonisch C, 2012, NUCLEIC ACIDS RES, V40, P10719, DOI 10.1093/nar/gks865; BRUTLAG DL, 1980, ANNU REV GENET, V14, P121, DOI 10.1146/annurev.ge.14.120180.001005; Buttinelli M, 1999, GENETICA, V106, P117, DOI 10.1023/A:1003745315540; Chakravarthy S, 2012, NUCLEIC ACIDS RES, V40, P8285, DOI 10.1093/nar/gks645; CHURCHILL MEA, 1989, EMBO J, V8, P4189, DOI 10.1002/j.1460-2075.1989.tb08604.x; Coleman-Derr D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002988; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; De Rop V, 2012, CHROMOSOMA, V121, P527, DOI 10.1007/s00412-012-0386-5; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fang YD, 2005, MOL BIOL CELL, V16, P5710, DOI 10.1091/mbc.E05-08-0706; Filipescu D, 2013, TRENDS GENET, V29, P630, DOI 10.1016/j.tig.2013.06.002; FINNEGAN EJ, 1993, NUCLEIC ACIDS RES, V21, P2383, DOI 10.1093/nar/21.10.2383; Fransz P, 2002, P NATL ACAD SCI USA, V99, P14584, DOI 10.1073/pnas.212325299; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Gaspar-Maia A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2582; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Ingouff M, 2010, CURR BIOL, V20, P2137, DOI 10.1016/j.cub.2010.11.012; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kalashnikova AA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1022; Khadake JR, 1997, BIOCHEMISTRY-US, V36, P1041, DOI 10.1021/bi961617p; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lindhout BI, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm618; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; LINDSEY GG, 1991, J MOL BIOL, V218, P805, DOI 10.1016/0022-2836(91)90268-B; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Loyola A, 2007, TRENDS BIOCHEM SCI, V32, P425, DOI 10.1016/j.tibs.2007.08.004; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 2012, NAT REV MOL CELL BIO, V13, P436, DOI 10.1038/nrm3382; Lysak Martin, 2006, V323, P173; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2013, BIOCHEM J, V449, P567, DOI 10.1042/BJ20121646; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Muthurajan UM, 2011, J BIOL CHEM, V286, P23852, DOI 10.1074/jbc.M111.244871; POCCIA DL, 1992, TRENDS BIOCHEM SCI, V17, P223, DOI 10.1016/0968-0004(92)90382-J; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Stroud H, 2014, NAT STRUCT MOL BIOL, V21, P64, DOI 10.1038/nsmb.2735; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Stroud H, 2012, P NATL ACAD SCI USA, V109, P5370, DOI 10.1073/pnas.1203145109; SUZUKI M, 1989, EMBO J, V8, P797, DOI 10.1002/j.1460-2075.1989.tb03440.x; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Talbert PB, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-7; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Talbert Paul B., 2009, P193, DOI 10.1007/978-0-387-69076-6_7; Talbert PB, 2002, PLANT CELL, V14, P1053, DOI 10.1105/tpc.010425; Vaillant I, 2008, PLANT J, V54, P299, DOI 10.1111/j.1365-313X.2008.03413.x; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Wollmann H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002658; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	62	148	155	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					98	109		10.1016/j.cell.2014.06.006	http://dx.doi.org/10.1016/j.cell.2014.06.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995981	Green Accepted, Bronze			2022-12-01	WOS:000340943100010
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Overprescribing antidepressants: where's the evidence?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Gotzsche P., 2014, GUARDIAN; Health and Social Care Information Centre, 2012, PRESCR DISP COMM STA; Health Foundation Nuffield Trust; QualityWatch, 2014, FOC ANT PRESCR; Moberly T., 2011, GP              0705; Moore M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3999; Siddique H., 2014, GUARDIAN; Thompson S., 2014, DAILY TELEGRAPH	8	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2014	348								g4218	10.1136/bmj.g4218	http://dx.doi.org/10.1136/bmj.g4218			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YU	24982509	Bronze, Green Published			2022-12-01	WOS:000338644600002
J	Gupta, S				Gupta, Sujata			MENTAL HEALTH Ups and downs	NATURE			English	Editorial Material							POSTSTROKE DEPRESSION; CONTROLLED-TRIAL; MOOD DISORDER; COMPLICATION; MORTALITY; STROKE											Carson AJ, 2012, J NEUROL NEUROSUR PS, V83, P859, DOI 10.1136/jnnp-2011-301854; Casal S. L., 2014, STROKE, V45, pANS3; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; El Husseini N, 2012, STROKE, V43, P1609, DOI 10.1161/STROKEAHA.111.643130; FOLSTEIN MF, 1977, J NEUROL NEUROSUR PS, V40, P1018, DOI 10.1136/jnnp.40.10.1018; Jorge RE, 2003, AM J PSYCHIAT, V160, P1823, DOI 10.1176/appi.ajp.160.10.1823; MORRIS PLP, 1993, AM J PSYCHIAT, V150, P124; ROBINSON RG, 1975, NATURE, V255, P332, DOI 10.1038/255332a0; Robinson RG, 2008, JAMA-J AM MED ASSOC, V299, P2391, DOI 10.1001/jama.299.20.2391	9	0	0	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S10	S11		10.1038/510S10a	http://dx.doi.org/10.1038/510S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24964021	Bronze			2022-12-01	WOS:000337806300007
J	Belluz, J				Belluz, Julia			FEATURE The Truvada wars	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTIRETROVIRAL PROPHYLAXIS		MIT, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT)	Belluz, J (corresponding author), MIT, Cambridge, MA 02142 USA.	jbelluz@gmail.com						Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Centers for Disease Control and Prevention, PREEXP PROPH PREP; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Crary DT, 2014, HUFFINGTON POST; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Mascolini M., 2013, 53 ICAAC INT C ANT A; Okwundu CI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007189.pub3; Public Health England, PROUD STUD EX IMP GA	8	12	12	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2014	348								g3811	10.1136/bmj.g3811	http://dx.doi.org/10.1136/bmj.g3811			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK1UG	24961949				2022-12-01	WOS:000338201800003
J	Poelstra, JW; Vijay, N; Bossu, CM; Lantz, H; Ryll, B; Muller, I; Baglione, V; Unneberg, P; Wikelski, M; Grabherr, MG; Wolf, JBW				Poelstra, J. W.; Vijay, N.; Bossu, C. M.; Lantz, H.; Ryll, B.; Mueller, I.; Baglione, V.; Unneberg, P.; Wikelski, M.; Grabherr, M. G.; Wolf, J. B. W.			The genomic landscape underlying phenotypic integrity in the face of gene flow in crows	SCIENCE			English	Article							HOODED CROWS; HYBRID ZONE; SPECIATION; DIVERGENCE; INVERSIONS; EXPRESSION; EVOLUTION; EXCHANGE	The importance, extent, and mode of interspecific gene flow for the evolution of species has long been debated. Characterization of genomic differentiation in a classic example of hybridization between all-black carrion crows and gray-coated hooded crows identified genome-wide introgression extending far beyond the morphological hybrid zone. Gene expression divergence was concentrated in pigmentation genes expressed in gray versus black feather follicles. Only a small number of narrow genomic islands exhibited resistance to gene flow. One prominent genomic region (<2 megabases) harbored 81 of all 82 fixed differences (of 8.4 million single-nucleotide polymorphisms in total) linking genes involved in pigmentation and in visual perception-a genomic signal reflecting color-mediated prezygotic isolation. Thus, localized genomic selection can cause marked heterogeneity in introgression landscapes while maintaining phenotypic divergence.	[Poelstra, J. W.; Vijay, N.; Bossu, C. M.; Wolf, J. B. W.] Uppsala Univ, Sci Life Lab, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; [Poelstra, J. W.; Vijay, N.; Bossu, C. M.; Wolf, J. B. W.] Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; [Lantz, H.] Uppsala Univ, S-75124 Uppsala, Sweden; [Lantz, H.; Grabherr, M. G.] Uppsala Univ, Sci Life Lab, S-75123 Uppsala, Sweden; [Lantz, H.; Grabherr, M. G.] Uppsala Univ, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; [Ryll, B.] Uppsala Univ, Dept Organismal Biol, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; [Mueller, I.; Wikelski, M.] Max Planck Inst Ornithol, D-78315 Radolfzell am Bodensee, Germany; [Mueller, I.; Wikelski, M.] Univ Konstanz, Dept Biol, D-78464 Constance, Germany; [Baglione, V.] Univ Valladolid, Dept Ciencias Agroforestales, Palencia 34004, Spain; [Unneberg, P.] Stockholm Univ, Sci Life Lab, S-17121 Solna, Sweden; [Unneberg, P.] Stockholm Univ, Dept Biochem & Biophys, S-17121 Solna, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University; Uppsala University; Uppsala University; Max Planck Society; University of Konstanz; Universidad de Valladolid; Stockholm University; Stockholm University	Wolf, JBW (corresponding author), Uppsala Univ, Sci Life Lab, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden.	jochen.wolf@ebc.uu.se	Baglione, Vittorio/D-6456-2014; Wolf, Jochen/U-2243-2017; Vijay, Nagarjun/AAI-9433-2020; Vijay, Nagarjun/AAM-7687-2021	Wolf, Jochen/0000-0002-2958-5183; Vijay, Nagarjun/0000-0002-8703-6991; Bossu, Christen/0000-0002-0458-9305; Unneberg, Per/0000-0001-5735-3315; Lantz, Henrik/0000-0003-2419-0075; Baglione, Vittorio/0000-0001-8464-7861; Grabherr, Manfred/0000-0001-8792-6508; Poelstra, Jelmer/0000-0002-3514-7462	VolkswagenStiftung grant [I/83 496]; Swedish Research Council [621-2010-5553]; Wallenberg Advanced Bioinformatics Infrastructure - (Knut and Alice Wallenberg Foundation); Carl Tryggers foundation [CTS11:517, CTS12:543]; European Research Council [ERCStG-336536]; Max Planck Society; SciLifeLab Uppsala; Knut and Alice Wallenberg Foundation; Swedish National Infrastructure for Computing; NCBI [PRJNA192205]	VolkswagenStiftung grant(Volkswagen); Swedish Research Council(Swedish Research CouncilEuropean Commission); Wallenberg Advanced Bioinformatics Infrastructure - (Knut and Alice Wallenberg Foundation); Carl Tryggers foundation; European Research Council(European Research Council (ERC)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); SciLifeLab Uppsala; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish National Infrastructure for Computing; NCBI	We thank W. Fiedler, K. Temnow, L. Vossen, M. Dopfner, T. Part, K.-H. Siebenrock, and the other staff of the Max Planck Institute for Ornithology for help with field work and animal husbandry. R. Burri assisted in population genetic analyses. Supported by VolkswagenStiftung grant I/83 496, Swedish Research Council grant 621-2010-5553, the Wallenberg Advanced Bioinformatics Infrastructure (funded by the Knut and Alice Wallenberg Foundation), Carl Tryggers foundation grant CTS11:517, CTS12:543, and European Research Council grant ERCStG-336536 (J.B.W.W.); the Max Planck Society (M. W., I. M.); and SciLifeLab Uppsala (M. G. G., H. L.). C. brachyrhynchos samples were provided by courtesy of the American Museum of Natural History, New York; Polish hooded crows by A. Kruszewicz and M. Gajownik, Warsaw Zoo. We thank the UPPMAX Next-Generation Sequencing Cluster and Storage (UPPNEX) project, funded by the Knut and Alice Wallenberg Foundation and the Swedish National Infrastructure for Computing, for access to computational resources. All sequencing data and the genome assembly are available in the NCBI short read archive under project PRJNA192205.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009; Guerrero RF, 2012, PHILOS T R SOC B, V367, P430, DOI 10.1098/rstb.2011.0246; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Hoogduijn MJ, 2006, PIGM CELL RES, V19, P58, DOI 10.1111/j.1600-0749.2005.00284.x; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kunte K, 2014, NATURE, V507, P229, DOI 10.1038/nature13112; Martemyanov KA, 2009, PROG MOL BIOL TRANSL, V86, P205, DOI 10.1016/S1877-1173(09)86007-9; Martin SH, 2013, GENOME RES, V23, P1817, DOI 10.1101/gr.159426.113; McLean CA, 2014, BIOL REV, V89, P860, DOI 10.1111/brv.12083; MEISE WILHELM, 1928, JOUR ORNITHOL [BERLIN], V76, P1; Moniot B, 2011, DEV DYNAM, V240, P2335, DOI 10.1002/dvdy.22726; Parkin David T, 2003, British Birds, V96, P274; Randler C, 2007, ARDEA, V95, P143, DOI 10.5253/078.095.0116; Renaut S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2833; SAINO N, 1991, B ZOOL, V58, P255, DOI 10.1080/11250009109355762; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Schnetkamp PPM, 2013, MOL ASPECTS MED, V34, P455, DOI 10.1016/j.mam.2012.07.008; THORNEYCROFT HB, 1975, EVOLUTION, V29, P611, DOI 10.1111/j.1558-5646.1975.tb00855.x; Wolf JBW, 2010, MOL ECOL, V19, P162, DOI 10.1111/j.1365-294X.2009.04471.x	24	347	357	3	260	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1410	1414		10.1126/science.1253226	http://dx.doi.org/10.1126/science.1253226			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948738	Green Submitted			2022-12-01	WOS:000337531700043
J	Kneussel, M; Triller, A; Choquet, D				Kneussel, Matthias; Triller, Antoine; Choquet, Daniel			SnapShot: Receptor Dynamics at Plastic Synapses	CELL			English	Article									[Kneussel, Matthias] Univ Med Ctr Hamburg Eppendorf, D-20251 Hamburg, Germany; [Triller, Antoine] Ecole Normale Super, Inst Biol IBENS, CNRS UMR 8197, Inserm 1024, F-75005 Paris, France; [Choquet, Daniel] Bordeaux Univ, CNRS, Interdisciplinary Inst Neurosci, UMR 5297, F-33077 Bordeaux, France	University of Hamburg; University Medical Center Hamburg-Eppendorf; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Kneussel, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Falkenried 94, D-20251 Hamburg, Germany.		Choquet, Daniel/K-7893-2018	Choquet, Daniel/0000-0003-4726-9763; Kneussel, Matthias/0000-0003-4900-366X; TRILLER, Antoine/0000-0002-7530-1233				Choquet D, 2013, NEURON, V80, P691, DOI 10.1016/j.neuron.2013.10.013; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; Kapitein LC, 2011, MOL CELL NEUROSCI, V46, P9, DOI 10.1016/j.mcn.2010.08.015; Kneussel M, 2013, NAT REV NEUROSCI, V14, P233, DOI 10.1038/nrn3445; Thomas P, 2005, NAT NEUROSCI, V8, P889, DOI 10.1038/nn1483; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022	6	18	18	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7							1738.e1	10.1016/j.cell.2014.06.002	http://dx.doi.org/10.1016/j.cell.2014.06.002			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CB3RL	24949980	Bronze			2022-12-01	WOS:000349545900001
J	Rodgers, JT; King, KY; Brett, JO; Cromie, MJ; Charville, GW; Maguire, KK; Brunson, C; Mastey, N; Liu, L; Tsai, CR; Goodell, MA; Rando, TA				Rodgers, Joseph T.; King, Katherine Y.; Brett, Jamie O.; Cromie, Melinda J.; Charville, Gregory W.; Maguire, Katie K.; Brunson, Christopher; Mastey, Namrata; Liu, Ling; Tsai, Chang-Ru; Goodell, Margaret A.; Rando, Thomas A.			mTORC1 controls the adaptive transition of quiescent stem cells from G(0) to G(Alert)	NATURE			English	Article							HEPATOCYTE GROWTH-FACTOR; SKELETAL-MUSCLE; MOLECULAR REGULATION; EXPRESSION DATA; REGENERATION; PROGENITORS; RENEWAL; EVENTS; SYSTEM; INJURY	A unique property of many adult stem cells is their ability to exist in a non-cycling, quiescent state(1). Although quiescence serves an essential role in preserving stem cell function until the stem cell is needed in tissue homeostasis or repair, defects in quiescence can lead to an impairment in tissue function(2). The extent to which stem cells can regulate quiescence is unknown. Here we show that the stem cell quiescent state is composed of two distinct functional phases, G(0) and an 'alert' phase we term G(Alert). Stem cells actively and reversibly transition between these phases in response to injury-induced systemic signals. Using genetic mouse models specific to muscle stem cells (or satellite cells), we show that mTORC1 activity is necessary and sufficient for the transition of satellite cells from G(0) into G(Alert) and that signalling through the HGF receptor cMet is also necessary. We also identify G(0)-to-G(Alert) transitions in several populations of quiescent stem cells. Quiescent stem cells that transition into GAlert possess enhanced tissue regenerative function. We propose that the transition of quiescent stem cells into G(Alert) functions as an 'alerting' mechanism, an adaptive response that positions stem cells to respond rapidly under conditions of injury and stress, priming them for cell cycle entry.	[Rodgers, Joseph T.; Brett, Jamie O.; Cromie, Melinda J.; Charville, Gregory W.; Maguire, Katie K.; Brunson, Christopher; Mastey, Namrata; Liu, Ling; Rando, Thomas A.] Stanford Univ, Sch Med, Paul F Glenn Labs Biol Aging, Stanford, CA 94305 USA; [Rodgers, Joseph T.; Brett, Jamie O.; Cromie, Melinda J.; Charville, Gregory W.; Maguire, Katie K.; Brunson, Christopher; Mastey, Namrata; Liu, Ling; Rando, Thomas A.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [King, Katherine Y.; Tsai, Chang-Ru; Goodell, Margaret A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [King, Katherine Y.; Tsai, Chang-Ru; Goodell, Margaret A.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA 94304 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Rehabil Res & Dev Ctr Excellence, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Sch Med, Paul F Glenn Labs Biol Aging, Stanford, CA 94305 USA.	rando@stanford.edu	King, Katherine/AAI-2436-2021	Rando, Thomas/0000-0001-5843-8564; Goodell, Margaret A./0000-0003-1111-2932; Rodgers, Joseph/0000-0002-6598-5520; King, Katherine/0000-0002-5093-6005	Glenn Foundation for Medical Research; Department of Veterans Affairs; National Institutes of Health [K99 AG041764, K08 HL098898, R01 DK092883, P01 AG036695, R01 AG23806, R01 AR062185]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL098898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023806, F30AG035521, P01AG036695, K99AG041764, R01AG047820, R37AG023806] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002324] Funding Source: NIH RePORTER	Glenn Foundation for Medical Research; Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	We would like to thank members of the Rando laboratory for discussions critical to the preparation of this manuscript, especially T. Cheung and S. Biressi. We thank L. Rott for providing assistance with FACS. This work was supported by The Glenn Foundation for Medical Research, by a grant from the Department of Veterans Affairs to T. A. R., and grants from the National Institutes of Health to J.T.R. (K99 AG041764), K.Y.K (K08 HL098898), M.A.G. (R01 DK092883) and to T.A.R. (P01 AG036695, R01 AG23806 and R01 AR062185).	Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Fontanillo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024289; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Mieczkowski J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-104; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Miyazawa K, 2010, FEBS J, V277, P2208, DOI 10.1111/j.1742-4658.2010.07637.x; Nakamura T, 2010, P JPN ACAD B-PHYS, V86, P588, DOI 10.2183/pjab.86.588; Nishijo K, 2009, FASEB J, V23, P2681, DOI 10.1096/fj.08-128116; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; SOPRANO KJ, 1994, J CELL BIOCHEM, V54, P405, DOI 10.1002/jcb.240540407; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Valentini G, 2006, BIOINFORMATICS, V22, P369, DOI 10.1093/bioinformatics/bti817; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yamada M, 2010, AM J PHYSIOL-CELL PH, V298, pC465, DOI 10.1152/ajpcell.00449.2009	35	400	417	3	40	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					393	+		10.1038/nature13255	http://dx.doi.org/10.1038/nature13255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24870234	Green Accepted			2022-12-01	WOS:000337350200034
J	Prasad, V				Prasad, Vinay			Statins, Primary Prevention, and Overall Mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LOW-RISK; MEN; DISEASE; PEOPLE		NCI, NIH, 10 Ctr Dr,Bldg 10,Room 12N226, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Prasad, V (corresponding author), NCI, NIH, 10 Ctr Dr,Bldg 10,Room 12N226, Bethesda, MD 20892 USA.	vinayak.prasad@nih.gov		Prasad, Vinayak/0000-0002-6110-8221				Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; National Conference of State Legislatures, 2010, AUT REC; Newman DH, 2012, LANCET, V380, P1814, DOI 10.1016/S0140-6736(12)62020-0; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Redberg RF, 2012, JAMA-J AM MED ASSOC, V307, P1491, DOI 10.1001/jama.2012.423; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Robinson JG, 2013, JAMA-J AM MED ASSOC, V310, P2405, DOI 10.1001/jama.2013.281355; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Zomer E, 2012, LANCET, V380, P1817, DOI 10.1016/S0140-6736(12)62026-1	11	4	4	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12					867	+		10.7326/M13-2974	http://dx.doi.org/10.7326/M13-2974			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24935491				2022-12-01	WOS:000337374900025
J	Koren, I; Dagan, G; Altaratz, O				Koren, Ilan; Dagan, Guy; Altaratz, Orit			From aerosol-limited to invigoration of warm convective clouds	SCIENCE			English	Article							CONDENSATION NUCLEI; CCN CONCENTRATIONS; PRECIPITATION; MODEL; UNCERTAINTY; ALGORITHM; PRODUCTS; RAIN	Among all cloud-aerosol interactions, the invigoration effect is the most elusive. Most of the studies that do suggest this effect link it to deep convective clouds with a warm base and cold top. Here, we provide evidence from observations and numerical modeling of a dramatic aerosol effect on warm clouds. We propose that convective-cloud invigoration by aerosols can be viewed as an extension of the concept of aerosol-limited clouds, where cloud development is limited by the availability of cloud-condensation nuclei. A transition from pristine to slightly polluted atmosphere yields estimated negative forcing of similar to 15 watts per square meter (cooling), suggesting that a substantial part of this anthropogenic forcing over the oceans occurred at the beginning of the industrial era, when the marine atmosphere experienced such transformation.	[Koren, Ilan; Dagan, Guy; Altaratz, Orit] Weizmann Inst Sci, Dept Earth & Planetary Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Koren, I (corresponding author), Weizmann Inst Sci, Dept Earth & Planetary Sci, IL-76100 Rehovot, Israel.	ilan.koren@weizmann.ac.il	Keyes, Dennis/AAZ-9285-2021; Dagan, Guy/ABH-4574-2020; Koren, Ilan/K-1417-2012	Dagan, Guy/0000-0002-8391-6334; Koren, Ilan/0000-0001-6759-6265	European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7)/ERC [306965]	European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC))	The research leading to these results received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. 306965 (CAPRI).	Altaratz O, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034025; Andreae MO, 2008, EARTH-SCI REV, V89, P13, DOI 10.1016/j.earscirev.2008.03.001; Andreae MO, 2009, ATMOS CHEM PHYS, V9, P543, DOI 10.5194/acp-9-543-2009; Andreae MO, 2007, SCIENCE, V315, P50, DOI 10.1126/science.1136529; Andreae MO, 2004, SCIENCE, V303, P1337, DOI 10.1126/science.1092779; BAKER MB, 1990, NATURE, V345, P142, DOI 10.1038/345142a0; Carslaw KS, 2013, NATURE, V503, P67, DOI 10.1038/nature12674; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; HEGG DA, 1991, J GEOPHYS RES-ATMOS, V96, P18727, DOI 10.1029/91JD01870; HINDMAN EE, 1994, ATMOS ENVIRON, V28, P3393, DOI 10.1016/1352-2310(94)00171-G; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Jiang HL, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006138; Kaufman YJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023125; Kaufman YJ, 2005, P NATL ACAD SCI USA, V102, P11207, DOI 10.1073/pnas.0505191102; Koren I, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023187; Koren I, 2010, ATMOS CHEM PHYS, V10, P8855, DOI 10.5194/acp-10-8855-2010; Koren I, 2010, ATMOS CHEM PHYS, V10, P5001, DOI 10.5194/acp-10-5001-2010; Koren I, 2009, ATMOS CHEM PHYS, V9, P155, DOI 10.5194/acp-9-155-2009; Koren I, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029253; Koren I, 2012, NAT GEOSCI, V5, P118, DOI [10.1038/NGEO1364, 10.1038/ngeo1364]; Lohmann U, 2005, ATMOS CHEM PHYS, V5, P715, DOI 10.5194/acp-5-715-2005; PARRISH DF, 1992, MON WEATHER REV, V120, P1747, DOI 10.1175/1520-0493(1992)120<1747:TNMCSS>2.0.CO;2; Pierce JR, 2009, ATMOS CHEM PHYS, V9, P1339, DOI 10.5194/acp-9-1339-2009; Platnick S, 2003, IEEE T GEOSCI REMOTE, V41, P459, DOI 10.1109/TGRS.2002.808301; Reisin T, 1996, J APPL METEOROL, V35, P1416, DOI 10.1175/1520-0450(1996)035<1416:SCCWIN>2.0.CO;2; Remer LA, 2005, J ATMOS SCI, V62, P947, DOI 10.1175/JAS3385.1; Reutter P, 2009, ATMOS CHEM PHYS, V9, P7067, DOI 10.5194/acp-9-7067-2009; Rosenfeld D., 2013, CLIMATE SCI SERVING, P105, DOI [DOI 10.1007/978-94-007-6692-1_5, 10.1007/978-94-007-6692-1_5]; Rosenfeld D, 2008, SCIENCE, V321, P1309, DOI 10.1126/science.1160606; Rosenfeld D, 2014, SCIENCE, V343, P379, DOI 10.1126/science.1247490; Tao WK, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000369; TRIPOLI GJ, 1980, J APPL METEOROL, V19, P1037, DOI 10.1175/1520-0450(1980)019<1037:ANIOSF>2.0.CO;2; TWOMEY S, 1959, TELLUS, V11, P408; TZIVION S, 1994, J APPL METEOROL, V33, P252, DOI 10.1175/1520-0450(1994)033<0252:NSOHSI>2.0.CO;2; Wang M, 2009, ATMOS CHEM PHYS, V9, P239, DOI 10.5194/acp-9-239-2009; Wen GY, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008267; Wielicki BA, 1998, IEEE T GEOSCI REMOTE, V36, P1127, DOI 10.1109/36.701020; Xue HW, 2008, J ATMOS SCI, V65, P392, DOI 10.1175/2007JAS2428.1; Yu HB, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010648; Yuan T, 2011, ATMOS CHEM PHYS, V11, P7119, DOI 10.5194/acp-11-7119-2011; Yum SS, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003864	41	152	154	6	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1143	1146		10.1126/science.1252595	http://dx.doi.org/10.1126/science.1252595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904161				2022-12-01	WOS:000336791200043
J	Mortensen, EM; Halm, EA; Pugh, MJ; Copeland, LA; Metersky, M; Fine, MJ; Johnson, CS; Alvarez, CA; Frei, CR; Good, C; Restrepo, MI; Downs, JR; Anzueto, A				Mortensen, Eric M.; Halm, Ethan A.; Pugh, Mary Jo; Copeland, Laurel A.; Metersky, Mark; Fine, Michael J.; Johnson, Christopher S.; Alvarez, Carlos A.; Frei, Christopher R.; Good, Chester; Restrepo, Marcos I.; Downs, John R.; Anzueto, Antonio			Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; EMPIRIC ANTIBIOTIC-THERAPY; ELDERLY-PATIENTS; ANTIMICROBIAL THERAPY; SECONDARY PREVENTION; VETERANS-AFFAIRS; BETA-LACTAM; MACROLIDE; OUTCOMES; QUALITY	IMPORTANCE Although clinical practice guidelines recommend combination therapy with macrolides, including azithromycin, as first-line therapy for patients hospitalized with pneumonia, recent research suggests that azithromycin may be associated with increased cardiovascular events. OBJECTIVE To examine the association of azithromycin use with all-cause mortality and cardiovascular events for patients hospitalized with pneumonia. DESIGN Retrospective cohort study comparing older patients hospitalized with pneumonia from fiscal years 2002 through 2012 prescribed azithromycin therapy and patients receiving other guideline-concordant antibiotic therapy. SETTING This study was conducted using national Department of Veterans Affairs administrative data of patients hospitalized at any Veterans Administration acute care hospital. PARTICIPANTS Patients were included if they were aged 65 years or older, were hospitalized with pneumonia, and received antibiotic therapy concordant with national clinical practice guidelines. MAIN OUTCOMES AND MEASURES Outcomes included 30- and 90-day all-cause mortality and 90-day cardiac arrhythmias, heart failure, myocardial infarction, and any cardiac event. Propensity score matching was used to control for the possible effects of known confounders with conditional logistic regression. RESULTS Of 73 690 patients from 118 hospitals identified, propensity-matched groups were composed of 31 863 patients exposed to azithromycin and 31 863 matched patients who were not exposed. There were no significant differences in potential confounders between groups after matching. Ninety-day mortality was significantly lower in those who received azithromycin (exposed, 17.4%, vs unexposed, 22.3%; odds ratio [On 0.73; 95% CI, 0.70-0.76). However, we found significantly increased odds of myocardial infarction (5.1% vs 4.4%; OR, 1.17; 95% CI,1.08-1.25) but not any cardiac event (43.0% vs 42.7%; OR, 1.01; 95% CI, 0.98-1.05), cardiac arrhythmias (25.8% vs 26.0%; OR, 0.99; 95% CI, 0.95-1.02), or heart failure (26.3% vs 26.2%; OR, 1.01; 95% CI, 0.97-1.04). CONCLUSIONS AND RELEVANCE Among older patients hospitalized with pneumonia, treatment that included azithromycin compared with other antibiotics was associated with a lower risk of 90-day mortality and a smaller increased risk of myocardial infarction. These findings are consistent with a net benefit associated with azithromycin use. Copyright 2014 American Medical Association. All rights reserved.	[Mortensen, Eric M.; Johnson, Christopher S.; Alvarez, Carlos A.] VA North Texas Hlth Care Syst, Dallas, TX USA; [Mortensen, Eric M.; Halm, Ethan A.; Johnson, Christopher S.; Alvarez, Carlos A.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Alvarez, Carlos A.] Texas Tech Univ, Hlth Sci Ctr, Dallas, TX USA; [Pugh, Mary Jo; Restrepo, Marcos I.; Downs, John R.; Anzueto, Antonio] South Texas Vet Hlth Care Syst, VERDICT Res Program, San Antonio, TX USA; [Pugh, Mary Jo; Frei, Christopher R.; Restrepo, Marcos I.; Downs, John R.; Anzueto, Antonio] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Fine, Michael J.; Good, Chester] Univ Pittsburgh, VA Ctr Hlth Equ Res & Promot, VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Copeland, Laurel A.] Cent Texas Vet Hlth Care Syst Jointly Scott & Whi, Ctr Appl Hlth Res, Temple, TX USA; [Metersky, Mark] Univ Connecticut, Med Ctr, Farmington, CT USA; [Frei, Christopher R.] Univ Texas Austin, Austin, TX 78712 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas Tech University System; Texas Tech University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; University of Connecticut; University of Texas System; University of Texas Austin	Mortensen, EM (corresponding author), Dallas VA Med Ctr, Gen Internal Med Sect, 4500 S Lancaster,Ste 111E, Dallas, TX 75216 USA.	eric.mortensen@utsouthwestern.edu	Pugh, Mary Jo/K-5336-2019; Copeland, Laurel A/C-3763-2017; Good, Chester B/K-2818-2019; Frei, Christopher/AAI-1421-2020; Mortensen, Eric/AAF-2713-2020; Restrepo, Marcos I/H-4442-2014	Pugh, Mary Jo/0000-0003-4196-7763; Copeland, Laurel A/0000-0002-9478-0209; Good, Chester B/0000-0003-4388-4558; Frei, Christopher/0000-0002-0692-4787; Mortensen, Eric/0000-0002-3880-5563	National Institute of Nursing Research [R01NR010828]; National Heart, Lung, and Blood Institute [K23HL096054]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120, UL1TR001105, KL2TR001118, KL2TR001103] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024983] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL096054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010828] Funding Source: NIH RePORTER	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was supported by a grant from the National Institute of Nursing Research (R01NR010828), and Dr Restrepo was supported by the National Heart, Lung, and Blood Institute (K23HL096054). This material is the result of work supported with resources and the use of facilities at the VA North Texas Health Care System.	Anderson JL, 1999, CIRCULATION, V99, P1540, DOI 10.1161/01.CIR.99.12.1540; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Asadi L, 2012, CLIN INFECT DIS, V55, P371, DOI 10.1093/cid/cis414; Ashitani J, 1998, EUR RESPIR J, V11, P104, DOI 10.1183/09031936.98.11010104; Battleman DS, 2002, ARCH INTERN MED, V162, P682, DOI 10.1001/archinte.162.6.682; Culic O, 2002, EUR J PHARMACOL, V450, P277, DOI 10.1016/S0014-2999(02)02042-3; Culic O, 2001, EUR J PHARMACOL, V429, P209, DOI 10.1016/S0014-2999(01)01321-8; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Frei CR, 2006, AM J MED, V119, P865, DOI 10.1016/j.amjmed.2006.02.014; Gleason PP, 1999, ARCH INTERN MED, V159, P2562, DOI 10.1001/archinte.159.21.2562; Heron Melonie, 2012, Natl Vital Stat Rep, V60, P1; Houck PM, 2001, CHEST, V119, P1420, DOI 10.1378/chest.119.5.1420; Huang BH, 2007, PACE, V30, P1579, DOI 10.1111/j.1540-8159.2007.00912.x; Ianaro A, 2000, J PHARMACOL EXP THER, V292, P156; Kadota J, 2003, RESP MED, V97, P844, DOI 10.1016/S0954-6111(03)00042-8; Kazis LE, 1998, ARCH INTERN MED, V158, P626, DOI 10.1001/archinte.158.6.626; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI 10.1056/NEJMc1207269; Kudoh S, 1998, AM J RESP CRIT CARE, V157, P1829, DOI 10.1164/ajrccm.157.6.9710075; Labro M. T., 1998, Journal of Antimicrobial Chemotherapy, V41, P37, DOI 10.1093/jac/41.suppl_2.37; Leuven E, PSMATCH2 STATA MODUL; Lodise TP, 2007, ANTIMICROB AGENTS CH, V51, P3977, DOI 10.1128/AAC.00006-07; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Martinez JA, 2003, CLIN INFECT DIS, V36, P389, DOI 10.1086/367541; Matsunaga Naohisa, 2003, N Z Med J, V116, pU666; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Meterky ML, 2007, CHEST, V131, P466, DOI 10.1378/chest.06-1426; Mortensen EM, 2004, AM J MED, V117, P726, DOI 10.1016/j.amjmed.2004.06.028; Mortensen EM, 2002, ARCH INTERN MED, V162, P1059, DOI 10.1001/archinte.162.9.1059; Mortensen EM, 2006, CRIT CARE, V10, DOI 10.1186/cc3934; Musher DM, 2007, CLIN INFECT DIS, V45, P158, DOI 10.1086/518849; O'Connor CM, 2003, JAMA-J AM MED ASSOC, V290, P1459, DOI 10.1001/jama.290.11.1459; Owens RC, 2006, CLIN INFECT DIS, V43, P1603, DOI 10.1086/508873; Perry TW, 2011, AM J MED, V124, P244, DOI 10.1016/j.amjmed.2010.11.014; Ramirez J, 2008, CLIN INFECT DIS, V47, P182, DOI 10.1086/589246; Restrepo MI, 2009, EUR RESPIR J, V33, P153, DOI 10.1183/09031936.00054108; Rodriguez A, 2007, CRIT CARE MED, V35, P1493, DOI 10.1097/01.CCM.0000266755.75844.05; Sehdev AES, 2001, ARCH INTERN MED, V161, P277, DOI 10.1001/archinte.161.2.277; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Stahl JE, 1999, ARCH INTERN MED, V159, P2576, DOI 10.1001/archinte.159.21.2576; Svanstrom H, 2013, NEW ENGL J MED, V368, P1704, DOI 10.1056/NEJMoa1300799; Tamaoki J, 2004, AM J MED, V117, P5, DOI 10.1016/j.amjmed.2004.07.023; Terza JV, 2008, J HEALTH ECON, V27, P531, DOI 10.1016/j.jhealeco.2007.09.009; Waterer GW, 2001, ARCH INTERN MED, V161, P1837, DOI 10.1001/archinte.161.15.1837; Wilson BZ, 2012, CRIT CARE MED, V40, P2310, DOI 10.1097/CCM.0b013e31825151a8; Yamamoto M, 1990, Nihon Kyobu Shikkan Gakkai Zasshi, V28, P1305	45	110	116	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2199	2208		10.1001/jama.2014.4304	http://dx.doi.org/10.1001/jama.2014.4304			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24893087	Bronze, Green Accepted			2022-12-01	WOS:000336668400021
J	Moynihan, R				Moynihan, Ray			REALITY CHECK Was the flu drug zanamivir a breakthrough or money for old rope?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Bond Univ, Southport, Qld 4229, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Southport, Qld 4229, Australia.	RayMoynihan@bond.edu.au	Moynihan, Ray/ABC-3010-2020					[Anonymous], 2003, FRONTLINE; [Anonymous], 2002, BMJ; Heneghan CJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2547; Loder E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2630; Moynihan R., 1999, BULLETIN	5	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2014	348								g3611	10.1136/bmj.g3611	http://dx.doi.org/10.1136/bmj.g3611			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7CA	24891329				2022-12-01	WOS:000337037500006
J	Marx, V				Marx, Vivien			TECHNOLOGY FEATURE AN ATLAS OF EXPRESSION	NATURE			English	Editorial Material																		Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319	4	12	13	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					645	649		10.1038/509645a	http://dx.doi.org/10.1038/509645a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870547	Bronze			2022-12-01	WOS:000336457100054
J	Ekstrand, MI; Nectow, AR; Knight, ZA; Latcha, KN; Pomeranz, LE; Friedman, JM				Ekstrand, Mats I.; Nectow, Alexander R.; Knight, Zachary A.; Latcha, Kaamashri N.; Pomeranz, Lisa E.; Friedman, Jeffrey M.			Molecular Profiling of Neurons Based on Connectivity	CELL			English	Article							CNS CELL-TYPES; NUCLEUS-ACCUMBENS; RABIES VIRUS; CRE RECOMBINASE; DOPAMINE; NANOBODIES; SYSTEM; REWARD; CONNECTOMICS; CIRCUITS	The complexity and cellular heterogeneity of neural circuitry presents a major challenge to understanding the role of discrete neural populations in controlling behavior. While neuroanatomical methods enable high- resolution mapping of neural circuitry, these approaches do not allow systematic molecular profiling of neurons based on their connectivity. Here, we report the development of an approach for molecularly profiling projective neurons. We show that ribosomes can be tagged with a camelid nanobody raised against GFP and that this system can be engineered to selectively capture translating mRNAs from neurons retrogradely labeled with GFP. Using this system, we profiled neurons projecting to the nucleus accumbens. We then used an AAV to selectively profile midbrain dopamine neurons projecting to the nucleus accumbens. By comparing the captured mRNAs from each experiment, we identified a number of markers specific to VTA dopaminergic projection neurons. The current method provides a means for profiling neurons based on their projections.	[Ekstrand, Mats I.; Nectow, Alexander R.; Knight, Zachary A.; Latcha, Kaamashri N.; Pomeranz, Lisa E.; Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Friedman, JM (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, 1230 York Ave, New York, NY 10065 USA.	friedj@rockefeller.edu	Core, Vector/CAF-4832-2022	Pomeranz, Lisa/0000-0002-8117-7355; Knight, Zachary/0000-0001-7621-1478	Howard Hughes Medical Institute; JPB Foundation; NIDA [1RO1DA018799-01]; New York Stem Cell Foundation; Klingenstein Fund; Sloan Foundation; McKnight Foundation; Brain and Behavior Research Foundations; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK083531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018799] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); JPB Foundation; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); New York Stem Cell Foundation; Klingenstein Fund(Klingenstein Philanthropies); Sloan Foundation(Alfred P. Sloan Foundation); McKnight Foundation; Brain and Behavior Research Foundations; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Howard Hughes Medical Institute, the JPB Foundation, and NIDA grant 1RO1DA018799-01 (J.M.F.). Z.A.K. acknowledges support from the New York Stem Cell Foundation, the Klingenstein Fund, Sloan Foundation, the McKnight Foundation, and the Brain and Behavior Research Foundations. We thank Scott Dewell and the Rockefeller University Genomics Core for help with RNA-seq and bioinformatics, and Ana Milosevic, Yong Kim, and Paul Greengard for contributing p11-EGFP mice. We thank Karl Deisseroth for contributing the plasmid pAAV-EF1a-DIO-hChR2(H134R)-mCherry (Addgene 20297), which was used in the creation of AAV-FLEX-NBL10. We also thank Eric F. Schmidt for helpful discussions. Imaging was performed at the Rockefeller University Bio-Imaging Resource Center. CAV-GFP was obtained from the Montpellier vector platform.	Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bru T, 2010, VIRUSES-BASEL, V2, P2134, DOI 10.3390/v2092134; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; Croizier S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015471; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Georgescu D, 2005, J NEUROSCI, V25, P2933, DOI 10.1523/JNEUROSCI.1714-04.2005; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Kempadoo KA, 2013, J NEUROSCI, V33, P7618, DOI 10.1523/JNEUROSCI.2588-12.2013; Knight ZA, 2012, CELL, V151, P1126, DOI 10.1016/j.cell.2012.10.039; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li XP, 2013, BRAIN STRUCT FUNCT, V218, P1159, DOI 10.1007/s00429-012-0452-z; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Lo LC, 2011, NEURON, V72, P938, DOI 10.1016/j.neuron.2011.12.002; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Ludwig DS, 2001, J CLIN INVEST, V107, P379, DOI 10.1172/JCI10660; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Morgan JL, 2013, NAT METHODS, V10, P494, DOI 10.1038/nmeth.2480; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Oh YS, 2013, CELL, V152, P831, DOI 10.1016/j.cell.2013.01.014; Osakada F, 2013, NAT PROTOC, V8, P1583, DOI 10.1038/nprot.2013.094; Ries J, 2012, NAT METHODS, V9, P582, DOI [10.1038/NMETH.1991, 10.1038/nmeth.1991]; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schmidt EF, 2012, CELL, V149, P1152, DOI 10.1016/j.cell.2012.03.038; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Silva JP, 2009, NATURE, V462, P646, DOI 10.1038/nature08589; Stanley S, 2013, CELL METAB, V18, P596, DOI 10.1016/j.cmet.2013.09.002; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Tang JCY, 2013, CELL, V154, P928, DOI 10.1016/j.cell.2013.07.021; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Wall NR, 2013, NEURON, V79, P347, DOI 10.1016/j.neuron.2013.05.014; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999	52	94	95	1	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1230	1242		10.1016/j.cell.2014.03.059	http://dx.doi.org/10.1016/j.cell.2014.03.059			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855954	Green Accepted, Bronze			2022-12-01	WOS:000336437200022
J	Srivastava, A; Yano, J; Hirozane, Y; Kefala, G; Gruswitz, F; Snell, G; Lane, W; Ivetac, A; Aertgeerts, K; Nguyen, J; Jennings, A; Okada, K				Srivastava, Ankita; Yano, Jason; Hirozane, Yoshihiko; Kefala, Georgia; Gruswitz, Franz; Snell, Gyorgy; Lane, Weston; Ivetac, Anthony; Aertgeerts, Kathleen; Nguyen, Jasmine; Jennings, Andy; Okada, Kengo			High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; FREE FATTY-ACIDS; CRYSTAL-STRUCTURE; ADRENERGIC-RECEPTOR; MOLECULAR-GRAPHICS; INSULIN-SECRETION; MEMBRANE-PROTEINS; OPIOID RECEPTOR; ACTIVATION; BINDING	Human GPR40 receptor (hGPR40), also known as free fatty-acid receptor 1 (FFAR1), is a G-protein-coupled receptor that binds long-chain free fatty acids to enhance glucose-dependent insulin secretion(1). Novel treatments for type-2 diabetes mellitus(2) are therefore possible by targeting hGPR40 with partial or full agonists. TAK-875, or fasiglifam, is an orally available, potent and selective partial agonist(3) of hGPR40 receptor, which reached phase III clinical trials for the potential treatment of type-2 diabetes mellitus(4). Data from clinical studies indicate that TAK-875, which is anago-allosteric modulator of hGPR40 (ref. 3), demonstrates improved glycaemic control and low hypoglycaemic risk in diabetic patients(5). Here we report the crystal structure of hGPR40 receptor bound to TAK-875 at 2.3 angstrom resolution. The co-complex structure reveals a unique binding mode of TAK-875 and suggests that entry to the non-canonical binding pocket most probably occurs via the lipid bilayer. The atomic details of the extensive charge network in the ligand binding pocket reveal additional interactions not identified in previous studies and contribute to a clear understanding of TAK-875 binding to the receptor. The hGPR40-TAK-875 structure also provides insights into the plausible binding of multiple ligands to the receptor, which has been observed in radioligand binding(6) and Ca2+ influx assay studies(3). Comparison of the transmembrane helix architecture with other G-protein-coupled receptors suggests that the crystallized TAK-875-bound hGPR40 complex is in an inactive-like state.	[Srivastava, Ankita; Yano, Jason; Kefala, Georgia; Gruswitz, Franz; Snell, Gyorgy; Lane, Weston; Ivetac, Anthony; Aertgeerts, Kathleen; Nguyen, Jasmine; Jennings, Andy] Takeda Calif, Dept Struct Biol & Core Sci & Technol, San Diego, CA 92121 USA; [Hirozane, Yoshihiko; Okada, Kengo] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Biomol Res Labs, Fujisawa, Kanagawa 2518555, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc; Takeda Pharmaceutical Company Ltd	Srivastava, A (corresponding author), Takeda Calif, Dept Struct Biol & Core Sci & Technol, 10410 Sci Ctr Dr, San Diego, CA 92121 USA.	ankita.srivastava@takeda.com		Gruswitz, Franz/0000-0002-9671-6788; Yano, Jason/0000-0002-9774-2611	National Institutes of Health and National Institute of General Medical Sciences; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; Office of Science, Office of Basic Energy Sciences of the US Department of Energy [DE-AC02-05CH11231, DE-AC02-06CH11357]	National Institutes of Health and National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE))	We thank K. P. Wilson, M. Hixon and K. Goodwill for review and feedback on the manuscript; T. Ho and S. Okubo for molecular cloning support; T. Sjoberg for membrane preparation; and C. Dillard for cell culture support. We also thank the staff of the Berkeley Center for Structural Biology, Lawrence Berkeley National Laboratory, which operates Advanced Light Source beamline 5.0.3, and the staff ofGM/CA, Argonne National Laboratory, which operates Advanced Photon Source beamline 23ID-D. The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health and National Institute of General Medical Sciences. The GM/CA has been funded in whole or in part with Federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Sciences (Y1-GM-1104). The Advanced Light Source and Advanced Photon Source are supported by the Director, Office of Science, Office of Basic Energy Sciences of the US Department of Energy under contract numbers DE-AC02-05CH11231 and DE-AC02-06CH11357, respectively.	Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Choe HW, 2011, NEUROPHARMACOLOGY, V60, P52, DOI 10.1016/j.neuropharm.2010.07.018; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fischetti RF, 2009, J SYNCHROTRON RADIAT, V16, P217, DOI 10.1107/S0909049508040612; Flodgren E, 2007, BIOCHEM BIOPH RES CO, V354, P240, DOI 10.1016/j.bbrc.2006.12.193; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Hansen MC, 2013, SCIENCE, V342, P850, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Hirozane Y., MOL MEM BIO IN PRESS; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kotarsky K, 2003, BIOCHEM BIOPH RES CO, V301, P406, DOI 10.1016/S0006-291X(02)03064-4; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lin DCH, 2012, MOL PHARMACOL, V82, P843, DOI 10.1124/mol.112.079640; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mercier RW, 2010, CHEM BIOL, V17, P1132, DOI 10.1016/j.chembiol.2010.08.010; Negoro N, 2012, J MED CHEM, V55, P3960, DOI 10.1021/jm300170m; Negoro N, 2010, ACS MED CHEM LETT, V1, P290, DOI 10.1021/ml1000855; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Sum CS, 2007, J BIOL CHEM, V282, P29248, DOI 10.1074/jbc.M705077200; Sum CS, 2009, J BIOL CHEM, V284, P3529, DOI 10.1074/jbc.M806987200; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yabuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076280; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701	41	256	265	0	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					124	+		10.1038/nature13494	http://dx.doi.org/10.1038/nature13494			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25043059				2022-12-01	WOS:000341174800043
J	Khan, MS; Coker, RJ				Khan, Mishal S.; Coker, Richard J.			How to hinder tuberculosis control: five easy steps	LANCET			English	Editorial Material							MULTIDRUG-RESISTANT TUBERCULOSIS; EXTENSIVELY DRUG-RESISTANT; PRIVATE PHARMACIES; RUSSIA; CHINA; TB		[Khan, Mishal S.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Communicable Dis Policy Res Grp, London WC1, England; Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore	University of London; London School of Hygiene & Tropical Medicine; National University of Singapore	Khan, MS (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Communicable Dis Policy Res Grp, London WC1, England.	mishal.khan@lshtm.ac.uk						Auer C, 2000, TROP MED INT HEALTH, V5, P648, DOI 10.1046/j.1365-3156.2000.00615.x; Bosman MCJ, 2000, INT J TUBERC LUNG D, V4, P606; Chuc NTK, 1999, EUR J CLIN PHARMACOL, V55, P325, DOI 10.1007/s002280050636; Coker R, 2000, EUR J PUBLIC HEALTH, V10, P148, DOI 10.1093/eurpub/10.2.148; Coker RJ, 2004, TROP MED INT HEALTH, V9, P25, DOI 10.1046/j.1365-3156.2003.01156.x; Dheda K, 2014, LANCET RESP MED, V2, P321, DOI 10.1016/S2213-2600(14)70031-1; Farmer PE, 2000, EUR J PUBLIC HEALTH, V10, P150, DOI 10.1093/eurpub/10.2.150; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Hazarika I, 2011, J GLOB INFECT DIS, V3, P19, DOI 10.4103/0974-777X.77291; Hu D, 2008, HEALTH POLICY PLANN, V23, P43, DOI 10.1093/heapol/czm038; Hurtig AK, 2000, INT J TUBERC LUNG D, V4, P730; Macfie N, 2014, MED AID GROUP MSF AL; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Pietersen E, 2014, LANCET, V383, P1230, DOI 10.1016/S0140-6736(13)62675-6; Reintjes R., 2008, HLTH SYSTEMS CHALLEN, P141; Shah S K, 2003, East Mediterr Health J, V9, P776; Sharma SK, 2006, CHEST, V130, P261, DOI [10.1378/chest.130.1.261, 10.1016/S0012-3692(15)50981-1]; Tesh S.N., 1988, HIDDEN ARGUMENTS POL; The Global Fund to Fight AIDS, 2014, PERF BAS FUND; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Wang LX, 2014, LANCET, V383, P2057, DOI 10.1016/S0140-6736(13)62639-2; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yadav A, 2012, Indian J Chest Dis Allied Sci, V54, P161	23	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2014	384	9944					646	648		10.1016/S0140-6736(14)61175-2	http://dx.doi.org/10.1016/S0140-6736(14)61175-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5CJ	25064593				2022-12-01	WOS:000341359100010
J	Lingaraju, GM; Bunker, RD; Cavadini, S; Hess, D; Hassiepen, U; Renatus, M; Fischer, ES; Thoma, NH				Lingaraju, Gondichatnahalli M.; Bunker, Richard D.; Cavadini, Simone; Hess, Daniel; Hassiepen, Ulrich; Renatus, Martin; Fischer, Eric S.; Thomae, Nicolas H.			Crystal structure of the human COP9 signalosome	NATURE			English	Article							PCI DOMAIN; NEDD8 MODIFICATION; ARABIDOPSIS COP9; ARCHITECTURE; COMPLEX; INITIATION; SUBUNIT; PROTEIN; MODEL; ACTIVATION	Ubiquitination is a crucial cellular signalling process, and is controlled on multiple levels. Cullin-RINGE3 ubiquitin ligases (CRLs) are regulated by the eight-subunit COP9 signalosome (CSN). CSN inactivates CRLs by removing their covalently attached activator, NEDD8. NEDD8 cleavage by CSN is catalysed by CSN5, a Zn2+-dependent isopeptidase that is inactive in isolation. Here we present the crystal structure of the entire similar to 350-kDa human CSN holoenzyme at 3.8 angstrom resolution, detailing the molecular architecture of the complex. CSN has two organizational centres: a horseshoe-shaped ring created by its six proteasome lid-CSN-initiation factor 3 (PCI) domain proteins, and a large bundle formed by the carboxy-terminal a-helices of every subunit. CSN5 and its dimerization partner, CSN6, are intricately embedded at the core of the helical bundle. In the substrate-free holoenzyme, CSN5 is autoinhibited, which precludes access to the active site. We find that neddylated CRL binding to CSN is sensed by CSN4, and communicated to CSN5 with the assistance of CSN6, resulting in activation of the deneddylase.	[Lingaraju, Gondichatnahalli M.; Bunker, Richard D.; Cavadini, Simone; Hess, Daniel; Fischer, Eric S.; Thomae, Nicolas H.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Lingaraju, Gondichatnahalli M.; Bunker, Richard D.; Cavadini, Simone; Fischer, Eric S.; Thomae, Nicolas H.] Univ Basel, CH-4003 Basel, Switzerland; [Hassiepen, Ulrich; Renatus, Martin] Novartis Pharma AG, Inst Biomed Res, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel; Novartis; Universita della Svizzera Italiana	Thoma, NH (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	nicolas.thoma@fmi.ch		Bunker, Richard/0000-0001-8866-5290; Thoma, Nicolas/0000-0003-2685-906X; Fischer, Eric S./0000-0001-7337-6306	Novartis Research Foundation; Swiss National Science Foundation [31003A_144020]; European Research Council (MoBa-CS) [260481]; Novartis (NIBR)	Novartis Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council (MoBa-CS); Novartis (NIBR)	This work was supported by the Novartis Research Foundation, the Swiss National Science Foundation (31003A_144020) and the European Research Council (MoBa-CS #260481). G. M. L. is the recipient of a Novartis (NIBR) presidential postdoctoral fellowship. Part of this work was performed at beamline X06DA and X10SA of the Swiss Light Source. We thank H. Wu for sharing the A. thaliana CSN1 coordinates before publication; H. Gut, J. Keusch and M. Jones for support; and C. Vonrhein and the BUSTER development group, R. Read, A. McCoy, T. Terwilliger, R. Nicholls, R. Kingston and K. Diederichs for technical advice. We are also grateful for the assistance of B. Martoglio, R. Assenberg, C. Logel and I. Bechtold in developing the PT22 CSN assays.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; Boehringer J, 2012, BIOCHEM J, V448, P55, DOI 10.1042/BJ20120542; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bricogne G., 2011, BUSTER VERSION 2 11; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Cronin CN, 2007, PROTEIN SCI, V16, P2023, DOI 10.1110/ps.072931407; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Dessau M, 2008, PLANT CELL, V20, P2815, DOI 10.1105/tpc.107.053801; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Echalier A, 2013, P NATL ACAD SCI USA, V110, P1273, DOI 10.1073/pnas.1209345110; Ellisdon Andrew M, 2012, Bioarchitecture, V2, P118, DOI 10.4161/bioa.21131; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enchev RI, 2012, CELL REPORTS, V2, P616, DOI 10.1016/j.celrep.2012.08.019; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; Estrin E, 2013, STRUCTURE, V21, P1624, DOI 10.1016/j.str.2013.06.023; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Guevara T, 2010, J BIOL CHEM, V285, P13958, DOI 10.1074/jbc.M109.097436; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Hashem Y, 2013, CELL, V153, P1108, DOI 10.1016/j.cell.2013.04.036; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.1218231, 10.1126/science.121823]; Khoshnevis S, 2014, NUCLEIC ACIDS RES, V42, P4123, DOI 10.1093/nar/gkt1369; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lee JHW, 2013, J HYDRO-ENVIRON RES, V7, P227, DOI 10.1016/j.jher.2013.10.003; Lee M. H., 2011, CELL CYCLE, V10, P3057, DOI [DOI 10.4161/CC.10.18, 10.4161/cc.10.18.17320, DOI 10.4161/CC.10.18.17320]; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173; Marks BD, 2005, ASSAY DRUG DEV TECHN, V3, P613, DOI 10.1089/adt.2005.3.613; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menon S, 2005, METHOD ENZYMOL, V398, P468, DOI 10.1016/S0076-6879(05)98038-5; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Pathare GR, 2014, P NATL ACAD SCI USA, V111, P2984, DOI 10.1073/pnas.1400546111; Pathare GR, 2012, P NATL ACAD SCI USA, V109, P149, DOI 10.1073/pnas.1117648108; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pick E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043980; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Querol-Audi J, 2013, STRUCTURE, V21, P920, DOI 10.1016/j.str.2013.04.002; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Tran HJTT, 2003, BIOCHEMISTRY-US, V42, P11460, DOI 10.1021/bi035033g; Tsuge T, 2001, J MOL BIOL, V305, P1, DOI 10.1006/jmbi.2000.4288; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; WEI N, 1994, CELL, V78, P117, DOI 10.1016/0092-8674(94)90578-9; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Wei ZY, 2004, J BIOL CHEM, V279, P34983, DOI 10.1074/jbc.M405158200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Worden EJ, 2014, NAT STRUCT MOL BIOL, V21, P220, DOI 10.1038/nsmb.2771; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Zhang H, 2012, FEBS LETT, V586, P1147, DOI 10.1016/j.febslet.2012.03.029; Zhao RY, 2011, J CLIN INVEST, V121, P851, DOI 10.1172/JCI44111; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou CS, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-7; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	72	141	145	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					161	+		10.1038/nature13566	http://dx.doi.org/10.1038/nature13566			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043011				2022-12-01	WOS:000340200700024
J	Moltke, I; Grarup, N; Jorgensen, ME; Bjerregaard, P; Treebak, JT; Fumagalli, M; Korneliussen, TS; Andersen, MA; Nielsen, TS; Krarup, NT; Gjesing, AP; Zierath, JR; Linneberg, A; Wu, XL; Sun, GQ; Jin, X; Al-Aama, J; Wang, J; Borch-Johnsen, K; Pedersen, O; Nielsen, R; Albrechtsen, A; Hansen, T				Moltke, Ida; Grarup, Niels; Jorgensen, Marit E.; Bjerregaard, Peter; Treebak, Jonas T.; Fumagalli, Matteo; Korneliussen, Thorfinn S.; Andersen, Marianne A.; Nielsen, Thomas S.; Krarup, Nikolaj T.; Gjesing, Anette P.; Zierath, Juleen R.; Linneberg, Allan; Wu, Xueli; Sun, Guangqing; Jin, Xin; Al-Aama, Jumana; Wang, Jun; Borch-Johnsen, Knut; Pedersen, Oluf; Nielsen, Rasmus; Albrechtsen, Anders; Hansen, Torben			A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes	NATURE			English	Article							GLYCEMIC TRAITS; GLUCOSE; POPULATION; DISCOVERY; FRAMEWORK; MUTATION	The Greenlandic population, a small and historically isolated founder population comprising about 57,000 inhabitants, has experienced a dramatic increase in type 2 diabetes (T2D) prevalence during the past 25 years(1). Motivated by this, we performed association mapping of T2D-related quantitative traits in up to 2,575 Greenlandic individuals without known diabetes. Using array-based genotyping and exome sequencing, we discovered a nonsense p.Arg684Ter variant (in which arginine is replaced by a termination codon) in the gene TBC1D4 with an allele frequency of 17%. Here we show that homozygous carriers of this variant have markedly higher concentrations of plasma glucose(beta=3.8 mmol l(-1), P = 2.5 X 10(-35)) and serum insulin (beta = 165 pmol l(-1), P = 1.5 X 10(-20)) 2 hours after an oral glucose load compared with individuals with other genotypes (both non-carriers and heterozygous carriers). Furthermore, homozygous carriers have marginally lower concentrations of fasting plasma glucose (beta = -0.18 mmol l(-1), P = 1.1 X 10(-6)) and fasting serum insulin (beta = -8.3 pmol l(-1), P = 0.0014), and their T2D risk is markedly increased (odds ratio (OR) = 10.3, P = 1.6 X 10(-24)). Heterozygous carriers have a moderately higher plasma glucose concentration 2 hours after an oral glucose load than non-carriers (beta = 0.43 mmol l(-1), P = 5.3 X 10(-5)). Analyses of skeletal muscle biopsies showed lower messenger RNA and protein levels of the long isoform of TBC1D4, and lower muscle protein levels of the glucose transporter GLUT4, with increasing number of p.Arg684Ter alleles. These findings are concomitant with a severely decreased insulin-stimulated glucose uptake in muscle, leading to postprandial hyperglycaemia, impaired glucose tolerance and T2D. The observed effect sizes are several times larger than any previous findings in large-scale genome-wide association studies of these traits(2-4) and constitute further proof of the value of conducting genetic association studies outside the traditional setting of large homogeneous populations.	[Moltke, Ida; Albrechtsen, Anders] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Moltke, Ida] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Grarup, Niels; Krarup, Nikolaj T.; Gjesing, Anette P.; Wang, Jun; Pedersen, Oluf; Hansen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, DK-2100 Copenhagen, Denmark; [Jorgensen, Marit E.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Bjerregaard, Peter] Univ Southern Denmark, Natl Inst Publ Hlth, DK-1353 Copenhagen, Denmark; [Treebak, Jonas T.; Andersen, Marianne A.; Nielsen, Thomas S.; Zierath, Juleen R.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth & Med Sci, Sect Integrat Physiol, DK-2200 Copenhagen, Denmark; [Fumagalli, Matteo; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Korneliussen, Thorfinn S.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Zierath, Juleen R.] Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden; [Linneberg, Allan] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Wu, Xueli; Sun, Guangqing; Jin, Xin; Al-Aama, Jumana; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Al-Aama, Jumana; Wang, Jun] King Abdulaziz Univ, Fac Med, Dept Med Genet, Jeddah 21589, Saudi Arabia; [Al-Aama, Jumana; Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Albrahim Ctr Excellence Res H, Jeddah 21589, Saudi Arabia; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Wang, Jun] Macau Univ Sci & Technol, Macau 999078, Peoples R China; [Borch-Johnsen, Knut] Holbaek Cent Hosp, DK-4300 Holbaek, Denmark; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, DK-5000 Odense, Denmark	University of Copenhagen; University of Chicago; Novo Nordisk Foundation; University of Copenhagen; Steno Diabetes Center; University of Southern Denmark; Novo Nordisk Foundation; University of Copenhagen; University of California System; University of California Berkeley; University of Copenhagen; Karolinska Institutet; University of Copenhagen; Beijing Genomics Institute (BGI); King Abdulaziz University; King Abdulaziz University; University of Copenhagen; Macau University of Science & Technology; Holbaek Hospital; University of California System; University of California Berkeley; University of Southern Denmark	Hansen, T (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, DK-2100 Copenhagen, Denmark.	albrecht@binf.ku.dk; torben.hansen@sund.ku.dk	Albrechtsen, Anders/K-4281-2013; Pedersen, Oluf/AAG-8015-2020; Korneliussen, Thorfinn Sand/F-6421-2014; Treebak, Jonas Thue/B-4521-2017; Korneliussen, Thorfinn Sand/ABB-7656-2021; Bjerregaard, Peter/ABD-8894-2020; Jin, Xin/ABF-1329-2020; Moltke, Ida/C-6158-2011; Al-aama, Jumana/AAA-8653-2021; Pedersen, Oluf/Z-1731-2019; Grarup, Niels/K-2807-2015; Gjesing, Anette/ACC-7521-2022; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016; Nielsen, Rasmus/D-4405-2009	Albrechtsen, Anders/0000-0001-7306-031X; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Treebak, Jonas Thue/0000-0003-1488-7012; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Bjerregaard, Peter/0000-0001-7153-8447; Jin, Xin/0000-0001-7554-4975; Moltke, Ida/0000-0001-7052-8554; Pedersen, Oluf/0000-0002-3321-3972; Grarup, Niels/0000-0001-5526-1070; Gjesing, Anette/0000-0003-4580-1576; Andersen, Marianne/0000-0002-4603-9504; Wang, Jun/0000-0002-8540-8931; Agerholm Jensen, Marianne/0000-0001-8687-1031; Wang, Jun/0000-0002-2113-5874; Jorgensen, Marit Eika/0000-0001-8356-5565; Nielsen, Rasmus/0000-0003-0513-6591; Krarup, Nikolaj Thure/0000-0001-6526-8663; Hansen, Torben/0000-0001-8748-3831; Nielsen, Thomas Svava/0000-0002-9457-8000; Linneberg, Allan/0000-0002-0994-0184; Zierath, Juleen/0000-0001-6891-7497; Fumagalli, Matteo/0000-0002-4084-2953	Novo Nordisk Foundation; Danish Council for Independent Research (Medical Sciences); Steno Diabetes Center; Villum Foundation; Karen Elise Jensen's Foundation; NunaFonden; Medical Research Council of Denmark; Medical Research Council of Greenland; Commission for Scientific Research in Greenland; NNF Center for Basic Metabolic Research [Treebak Group] Funding Source: researchfish; Villum Fonden [00007171] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); Steno Diabetes Center; Villum Foundation(Villum Fonden); Karen Elise Jensen's Foundation; NunaFonden; Medical Research Council of Denmark; Medical Research Council of Greenland; Commission for Scientific Research in Greenland; NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Villum Fonden(Villum Fonden)	We thank I. Kleist, as well as all colleagues at the Physician's Clinic, Nuuk, Greenland. We also thank J. F. Wojtaszewski for comments and X. Zhou for discussions about GEMMA. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research centre at the University of Copenhagen and is partly funded by an unrestricted donation from the Novo Nordisk Foundation. This project was also funded by the Danish Council for Independent Research (Medical Sciences), the Steno Diabetes Center and the Villum Foundation. The IHIT study was supported by Karen Elise Jensen's Foundation, NunaFonden, the Medical Research Council of Denmark, the Medical Research Council of Greenland and the Commission for Scientific Research in Greenland. None of the funding agencies had any role in the study design or in the collection or interpretation of the data.	Albrechtsen A, 2013, DIABETOLOGIA, V56, P298, DOI 10.1007/s00125-012-2756-1; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baus D, 2008, CELL SIGNAL, V20, P2237, DOI 10.1016/j.cellsig.2008.08.010; Bjerregaard P., 2003, INT J CIRCUMPOL HEAL, V62, P3, DOI [10.3402/ijch.v62i0.18212, DOI 10.3402/IJCH.V62I0.18212]; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Cederberg H, 2010, DIABETES CARE, V33, P2077, DOI 10.2337/dc10-0262; Dash S, 2009, P NATL ACAD SCI USA, V106, P9350, DOI 10.1073/pnas.0900909106; Gutt M, 2000, DIABETES RES CLIN PR, V47, P177, DOI 10.1016/S0168-8227(99)00116-3; Jorgensen ME, 2013, DIABETES CARE, V36, P2988, DOI 10.2337/dc12-2703; Jorgensen ME, 2002, DIABETES CARE, V25, P1766, DOI 10.2337/diacare.25.10.1766; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lohmueller KE, 2013, AM J HUM GENET, V93, P1072, DOI 10.1016/j.ajhg.2013.11.005; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moltke I, 2014, BIOINFORMATICS, V30, P1027, DOI 10.1093/bioinformatics/btt652; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Treebak JT, 2009, DIABETOLOGIA, V52, P891, DOI 10.1007/s00125-009-1294-y; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wang HY, 2013, BIOCHEM J, V449, P479, DOI 10.1042/BJ20120702; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	30	242	251	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					190	+		10.1038/nature13425	http://dx.doi.org/10.1038/nature13425			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043022	Green Published			2022-12-01	WOS:000340200700031
J	Ma, H; Morey, R; O'Neil, RC; He, YP; Daughtry, B; Schultz, MD; Hariharan, M; Nery, JR; Castanon, R; Sabatini, K; Thiagarajan, RD; Tachibana, M; Kang, EJ; Tippner-Hedges, R; Ahmed, R; Gutierrez, NM; Van Dyken, C; Polat, A; Sugawara, A; Sparman, M; Gokhale, S; Amato, P; Wolf, DP; Ecker, JR; Laurent, LC; Mitalipov, S				Ma, Hong; Morey, Robert; O'Neil, Ryan C.; He, Yupeng; Daughtry, Brittany; Schultz, Matthew D.; Hariharan, Manoj; Nery, Joseph R.; Castanon, Rosa; Sabatini, Karen; Thiagarajan, Rathi D.; Tachibana, Masahito; Kang, Eunju; Tippner-Hedges, Rebecca; Ahmed, Riffat; Gutierrez, Nuria Marti; Van Dyken, Crystal; Polat, Alim; Sugawara, Atsushi; Sparman, Michelle; Gokhale, Sumita; Amato, Paula; Wolf, Don P.; Ecker, Joseph R.; Laurent, Louise C.; Mitalipov, Shoukhrat			Abnormalities in human pluripotent cells due to reprogramming mechanisms	NATURE			English	Article							EMBRYONIC STEM-CELLS; CODING MUTATIONS; DNA METHYLATION; DYNAMIC CHANGES; SOMATIC-CELLS; X-CHROMOSOME; COPY NUMBER; MEMORY; LINES; DIFFERENTIATION	Human pluripotent stem cells hold potential for regenerative medicine, but available cell types have significant limitations. Although embryonic stemcells (ES cells) from in vitro fertilized embryos (IVFES cells) represent the 'gold standard', they are allogeneic to patients. Autologous induced pluripotent stem cells (iPS cells) are prone to epigenetic and transcriptional aberrations. To determine whether such abnormalities are intrinsic to somatic cell reprogramming or secondary to the reprogramming method, genetically matched sets of human IVF ES cells, iPS cells and nuclear transfer ES cells (NT ES cells) derived by somatic cell nuclear transfer (SCNT) were subjected to genome-wide analyses. Both NT ES cells and iPS cells derived from the same somatic cells contained comparable numbers of de novo copy number variations. In contrast, DNA methylation and transcriptome profiles of NT ES cells corresponded closely to those of IVF ES cells, whereas iPS cells differed and retained residual DNA methylation patterns typical of parental somatic cells. Thus, human somatic cells can be faithfully reprogrammed to pluripotency by SCNT and are therefore ideal for cell replacement therapies.	[Ma, Hong; Daughtry, Brittany; Kang, Eunju; Tippner-Hedges, Rebecca; Ahmed, Riffat; Gutierrez, Nuria Marti; Van Dyken, Crystal; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, Portland, OR 97239 USA; [Ma, Hong; Daughtry, Brittany; Tachibana, Masahito; Kang, Eunju; Tippner-Hedges, Rebecca; Ahmed, Riffat; Gutierrez, Nuria Marti; Van Dyken, Crystal; Polat, Alim; Sugawara, Atsushi; Sparman, Michelle; Wolf, Don P.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR 97006 USA; [Morey, Robert; Sabatini, Karen; Thiagarajan, Rathi D.; Laurent, Louise C.] Univ Calif San Diego, Dept Reprod Med, Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA; [O'Neil, Ryan C.; He, Yupeng; Schultz, Matthew D.; Hariharan, Manoj; Nery, Joseph R.; Castanon, Rosa; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [O'Neil, Ryan C.; He, Yupeng] Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA; [Gokhale, Sumita] Boston Univ, Sch Med, Roger Williams Med Ctr, Univ Pathologists LLC, Providence, RI 02918 USA; [Amato, Paula; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Div Reprod Endocrinol, Portland, OR 97239 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego; Boston University; Roger Williams Medical Center; Oregon Health & Science University; Howard Hughes Medical Institute; Salk Institute	Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, 3303 Southwest Bond Ave, Portland, OR 97239 USA.	ecker@salk.edu; llaurent@ucsd.edu; mitalipo@ohsu.edu	Hariharan, Manoj/N-2855-2015; Nery, Joseph/AAE-8422-2019; Ecker, Joseph R/B-9144-2008	Hariharan, Manoj/0000-0002-1006-5372; Nery, Joseph/0000-0003-0153-5659; Ecker, Joseph R/0000-0001-5799-5895; Laurent, Louise/0000-0002-2095-7534	Leducq Foundation; OHSU; UCSD Department of Reproductive Medicine; Salk International Council Chair fund endowment; Mary K. Chapman Foundation; Swedish Research Council; Collins Medical Trust	Leducq Foundation(Leducq Foundation); OHSU; UCSD Department of Reproductive Medicine; Salk International Council Chair fund endowment; Mary K. Chapman Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Collins Medical Trust	The authors acknowledge the OHSU Embryonic Stem Cell Research Oversight Committee and the Institutional Review Board for providing oversight and guidance. We thank oocyte and sperm donors and the Women's Health Research Unit staff at the Center for Women's Health, University Fertility Consultants and the Reproductive Endocrinology and Infertility Division in the Department of Obstetrics and Gynecology of Oregon Health and Science University for their support and procurement of human gametes. We are grateful to C. Penedo for microsatellite analysis and W. Sanger and D. Zaleski for karyotyping services. We are also indebted to Y. Li, H. Sritanaudomchai and D. Melguizo Sanchis for their technical support. We thank the staff at the Institute for Genomic Medicine Genomics Facility at UCSD for running the Infinium HumanMethylation450 BeadChips and sequencing of the RNA-seq libraries. The authors acknowledge the Texas Advanced Computing Center (TACC) at The University of Texas at Austin (http://www.tacc.utexas.edu) and the San Diego Supercomputing Center (through an allocation from the eXtreme Science and Engineering Discovery Environment (XSEDE)) for providing HPC resources that have contributed to the research results reported within this paper. SCNT and iPS cell studies were supported by grants from the Leducq Foundation and OHSU institutional funds. R. M., K. S., R. T. and L. C. L. were supported by the UCSD Department of Reproductive Medicine. Methylome studies were supported by the Salk International Council Chair fund endowment and the Mary K. Chapman Foundation to J.R.E. J.R.E. is an investigator of the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation (GMBF3034). A. P. received a fellowship fromthe Swedish Research Council, Vetenskapsra det. E. K. was partially funded by a fellowship from the Collins Medical Trust.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bancroft T, 2013, BIOMETRICS, V69, P1, DOI 10.1111/j.1541-0420.2012.01825.x; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Martin M, 2011, EMBNET J, V17; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Newman AM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-117; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Perkins W, 2011, APPL MATH COMPUT, V217, P9072, DOI 10.1016/j.amc.2011.03.124; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Price EM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-4; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Ruiz S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2381; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schultz MD, 2012, TRENDS GENET, V28, P583, DOI 10.1016/j.tig.2012.10.012; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Stelzer Y, 2013, STEM CELL REP, V1, P79, DOI 10.1016/j.stemcr.2013.03.005; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallot C, 2013, NAT GENET, V45, P239, DOI 10.1038/ng.2530; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	43	236	242	2	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					177	+		10.1038/nature13551	http://dx.doi.org/10.1038/nature13551			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008523	Green Accepted, Green Published			2022-12-01	WOS:000338649800035
J	Popow, J; Jurkin, J; Schleiffer, A; Martinez, J				Popow, Johannes; Jurkin, Jennifer; Schleiffer, Alexander; Martinez, Javier			Analysis of orthologous groups reveals archease and DDX1 as tRNA splicing factors	NATURE			English	Article							3,5-PHOSPHODIESTER LINKAGE; M(5)C METHYLTRANSFERASE; SUBSTRATE-SPECIFICITY; JUNCTION PHOSPHATE; SEQUENCE ALIGNMENT; VIRUS-REPLICATION; CELL EXTRACT; LIGASE; PROTEINS; COMPLEX	RNA ligases have essential roles in many cellular processes in eukaryotes, archaea and bacteria, including in RNA repair(1,2) and stress-induced splicing of messenger RNA(3). In archaea and eukaryotes, RNA ligases also have a role in transfer RNA splicing to generate functional tRNAs required for protein synthesis(4-7). We recently identified the human tRNA splicing ligase, a multimeric protein complex with RTCB (also known as HSPC117, C22orf28, FAAP and D10Wsu52e) as the essential subunit(8). The functions of the additional complex components ASW (also known as C2orf49), CGI-99 (also known as C14orf166), FAM98B and the DEAD-box helicase DDX1 in the context of RNA ligation have remained unclear. Taking advantage of clusters of eukaryotic orthologous groups, here we find that archease (ARCH; also known as ZBTB8OS), a protein of unknown function, is required for full activity of the human tRNA ligase complex and, in cooperation with DDX1, facilitates the formation of an RTCB-guanylate intermediate central to mammalian RNA ligation. Our findings define a role for DDX1 in the context of the human tRNA ligase complex and suggest that the widespread co-occurrence of archease and RtcB proteins implies evolutionary conservation of their functional interplay.	[Popow, Johannes; Jurkin, Jennifer; Martinez, Javier] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Popow, Johannes] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Schleiffer, Alexander] Res Inst Mol Pathol IMP, IMP IMBA Bioinformat Core Facil, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); European Molecular Biology Laboratory (EMBL); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Martinez, J (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria.	javier.martinez@imba.oeaw.ac.at		Popow, Johannes/0000-0002-1093-0936; Martinez, Javier/0000-0001-9152-7323; Schleiffer, Alexander/0000-0001-6251-2747	Fonds zur Forderung der wissenschaftlichen Forschung [P24687]; GEN-AU 3 research programme [820982]; Institute of Molecular Biotechnology of the Austrian Academy of Sciences; Austrian Science Fund (FWF) [P 24687] Funding Source: researchfish	Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); GEN-AU 3 research programme; Institute of Molecular Biotechnology of the Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We would like to thank S. Ameres, B. Beckmann, R. Hartmann, M. Hentze, M. Jantsch, B. Klaus, B. Mair, A.F. Nielsen, J.-M. Peters, T. Rapoport, R. Schroeder and S. Weitzer for help and advice, S. Bandini for the preparation of Flag-TSEN2 cell lines and critical discussions and J. Dammann and T. Lendl for technical assistance. This work has been funded by the Fonds zur Forderung der wissenschaftlichen Forschung (P24687), the GEN-AU 3 research programme (820982 Non-coding RNAs) (J.P.) and the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (J.M.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Auxilien S, 2007, J BIOL CHEM, V282, P18711, DOI 10.1074/jbc.M607459200; Brzezicha B, 2006, NUCLEIC ACIDS RES, V34, P6034, DOI 10.1093/nar/gkl765; Canaves JM, 2004, PROTEINS, V56, P19, DOI 10.1002/prot.20141; Cao D, 2009, RNA, V15, P1971, DOI 10.1261/rna.1782209; Chakravarty AK, 2012, P NATL ACAD SCI USA, V109, P6072, DOI 10.1073/pnas.1201207109; Chan CM, 2009, SCIENCE, V326, P247, DOI 10.1126/science.1179480; Ciria R, 2004, BIOINFORMATICS, V20, P2307, DOI 10.1093/bioinformatics/bth216; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Desai K. K., 2014, NUCL ACIDS RES; Edgcomb SP, 2012, J MOL BIOL, V415, P61, DOI 10.1016/j.jmb.2011.10.032; Englert M, 2005, NUCLEIC ACIDS RES, V33, P388, DOI 10.1093/nar/gki174; FILIPOWICZ W, 1983, CELL, V32, P547, DOI 10.1016/0092-8674(83)90474-9; Godbout R, 1998, J BIOL CHEM, V273, P21161, DOI 10.1074/jbc.273.33.21161; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KONARSKA M, 1982, P NATL ACAD SCI-BIOL, V79, P1474, DOI 10.1073/pnas.79.5.1474; KONARSKA M, 1981, NATURE, V293, P112, DOI 10.1038/293112a0; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; LASKI FA, 1983, J BIOL CHEM, V258, P1974; Nandakumar J, 2008, MOL CELL, V31, P278, DOI 10.1016/j.molcel.2008.05.019; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; PERKINS KK, 1985, P NATL ACAD SCI USA, V82, P684, DOI 10.1073/pnas.82.3.684; PHIZICKY EM, 1992, J BIOL CHEM, V267, P4577; Popow J, 2012, CELL MOL LIFE SCI, V69, P2657, DOI 10.1007/s00018-012-0944-2; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Tanaka N, 2011, J BIOL CHEM, V286, P43134, DOI 10.1074/jbc.M111.302133; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Yee A, 2002, P NATL ACAD SCI USA, V99, P1825, DOI 10.1073/pnas.042684599; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027; Zofallova L, 2000, RNA, V6, P1019, DOI 10.1017/S1355838200000613	36	67	73	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					104	U508		10.1038/nature13284	http://dx.doi.org/10.1038/nature13284			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24870230	Green Accepted			2022-12-01	WOS:000338199400045
J	Rivera, LB; Bergers, G				Rivera, Lee B.; Bergers, Gabriele			Targeting vascular sprouts	SCIENCE			English	Editorial Material							ENDOTHELIAL-CELLS; GLYCOLYSIS; ANGIOGENESIS; PGC-1-ALPHA; CANCER		[Rivera, Lee B.; Bergers, Gabriele] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Brain Tumor Res Ctr, Dept Neurol Surg, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Rivera, LB (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Brain Tumor Res Ctr, Dept Neurol Surg, San Francisco, CA 94158 USA.	gabriele.bergers@ucsf.edu	Bergers, Gabriele/AAJ-5535-2020	Bergers, Gabriele/0000-0003-3545-5171				Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; DOBRINA A, 1983, BIOCHIM BIOPHYS ACTA, V762, P295, DOI 10.1016/0167-4889(83)90084-8; Granchi C, 2012, CHEMMEDCHEM, V7, P1318, DOI 10.1002/cmdc.201200176; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; KRUTZFELDT A, 1990, J MOL CELL CARDIOL, V22, P1393, DOI 10.1016/0022-2828(90)90984-A; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Sawada N, 2014, CELL METAB, V19, P246, DOI 10.1016/j.cmet.2013.12.014; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008	12	21	22	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1449	1450		10.1126/science.1257071	http://dx.doi.org/10.1126/science.1257071			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970064				2022-12-01	WOS:000337889900020
J	Hatziioannou, T; Del Prete, GQ; Keele, BF; Estes, JD; McNatt, MW; Bitzegeio, J; Raymond, A; Rodriguez, A; Schmidt, F; Mac Trubey, C; Smedley, J; Piatak, M; KewalRamani, VN; Lifson, JD; Bieniasz, PD				Hatziioannou, Theodora; Del Prete, Gregory Q.; Keele, Brandon F.; Estes, Jacob D.; McNatt, Matthew W.; Bitzegeio, Julia; Raymond, Alice; Rodriguez, Anthony; Schmidt, Fabian; Mac Trubey, C.; Smedley, Jeremy; Piatak, Michael, Jr.; KewalRamani, Vineet N.; Lifson, Jeffrey D.; Bieniasz, Paul D.			HIV-1-induced AIDS in monkeys	SCIENCE			English	Article							IMMUNODEFICIENCY; INFECTION; HIV/AIDS; MODELS	Primate lentiviruses exhibit narrow host tropism, reducing the occurrence of zoonoses but also impairing the development of optimal animal models of AIDS. To delineate the factors limiting cross-species HIV-1 transmission, we passaged a modified HIV-1 in pigtailed macaques that were transiently depleted of CD8(+) cells during acute infection. During adaptation over four passages in macaques, HIV-1 acquired the ability to antagonize the macaque restriction factor tetherin, replicated at progressively higher levels, and ultimately caused marked CD4(+) T cell depletion and AIDS-defining conditions. Transient treatment with an antibody to CD8 during acute HIV-1 infection caused rapid progression to AIDS, whereas untreated animals exhibited an elite controller phenotype. Thus, an adapted HIV-1 can cause AIDS in macaques, and stark differences in outcome can be determined by immunological perturbations during early infection.	[Hatziioannou, Theodora; McNatt, Matthew W.; Bitzegeio, Julia; Raymond, Alice; Rodriguez, Anthony; Schmidt, Fabian; Bieniasz, Paul D.] Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; [Del Prete, Gregory Q.; Keele, Brandon F.; Estes, Jacob D.; Mac Trubey, C.; Piatak, Michael, Jr.; Lifson, Jeffrey D.] Frederick Natl Lab, AIDS & Canc Virus Program, Leidos Biomed Res, Frederick, MD 21702 USA; [McNatt, Matthew W.; Bitzegeio, Julia; Schmidt, Fabian; Bieniasz, Paul D.] Rockefeller Univ, Lab Retrovirol, New York, NY 10016 USA; [Smedley, Jeremy] Frederick Natl Lab, Lab Anim Sci Program, Leidos Biomed Res, Frederick, MD 21702 USA; [KewalRamani, Vineet N.] NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA; [Bieniasz, Paul D.] Howard Hughes Med Inst, New York, NY 10016 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute	Hatziioannou, T (corresponding author), Aaron Diamond AIDS Res Ctr, 455 First Ave, New York, NY 10016 USA.	thatziio@adarc.org; vineet.kewalramani@nih.gov; lifsonj@mail.nih.gov; pbienias@adarc.org	KewalRamani, Vineet/V-5084-2019	Smedley, Jeremy/0000-0003-3369-4662	NIH [R37AI64003, R01AI50111, R01AI078788]; Deutsche Forschungsgemeinschaft [BI1540/1-1]; Howard Hughes Medical Institute; National Cancer Institute, NIH [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC010488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050111, R01AI078788, R37AI064003] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The data presented in this paper are tabulated in the main paper and in the supplementary materials. HIV-1 Env sequences used in Fig. 3 have been deposited in GenBank (accession numbers KJ201545 through KJ201764). Sequences encompassing the full-length viral genome for P5 and P6 have also been deposited in GenBank (accession numbers KJ767573 through KJ767592). This work was supported by NIH grants R37AI64003 and R01AI50111 (to P. D. B.) and R01AI078788 (to T. H.); Deutsche Forschungsgemeinschaft fellowship BI1540/1-1 (to J.B.); the Howard Hughes Medical Institute; and in part with federal funds from the National Cancer Institute, NIH, under contract no. HHSN261200800001E. We thank V. Coalter, A. Wiles, R. Wiles, and D. Johnson for assistance with study coordination and sample processing. Histology support was provided by the Pathology/Histotechnology Laboratory core service located at the Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.	Ambrose Z, 2007, TRENDS BIOTECHNOL, V25, P333, DOI 10.1016/j.tibtech.2007.05.004; Blanco-Melo D, 2012, IMMUNITY, V37, P399, DOI 10.1016/j.immuni.2012.08.013; Brennan G, 2008, P NATL ACAD SCI USA, V105, P3569, DOI 10.1073/pnas.0709511105; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Hatziioannou T, 2012, NAT REV MICROBIOL, V10, P852, DOI 10.1038/nrmicro2911; Hatziioannou T, 2009, P NATL ACAD SCI USA, V106, P4425, DOI 10.1073/pnas.0812587106; Hirsch VM, 2004, J VIROL, V78, P275, DOI 10.1128/JVI.78.1.275-284.2004; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Liao CH, 2007, AIDS, V21, pS19, DOI 10.1097/01.aids.0000304692.09143.1b; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Newman RM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000003; Orzechowska BU, 2008, BLOOD, V112, P4227, DOI 10.1182/blood-2008-04-151498; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; RAO TKS, 1991, ANNU REV MED, V42, P391, DOI 10.1146/annurev.med.42.1.391; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; SIMMONDS P, 1990, J VIROL, V64, P5840, DOI 10.1128/JVI.64.12.5840-5850.1990; Sina ST, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S7; Stephens EB, 1998, J VIROL, V72, P8820, DOI 10.1128/JVI.72.11.8820-8832.1998; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Veazey RS, 2008, J VIROL, V82, P5618, DOI 10.1128/JVI.02748-07; Virgen CA, 2008, P NATL ACAD SCI USA, V105, P3563, DOI 10.1073/pnas.0709258105; Virgen CA, 2007, J VIROL, V81, P13932, DOI 10.1128/JVI.01760-07	24	65	65	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1401	1405		10.1126/science.1250761	http://dx.doi.org/10.1126/science.1250761			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948736	Green Accepted			2022-12-01	WOS:000337531700041
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION Unit of observation versus unit of analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIALS; RANDOMIZATION		Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE; Pickett KE, 2007, BMJ-BRIT MED J, V335, P1080, DOI 10.1136/bmj.39377.580162.55; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3297; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2979; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2820; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1215; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1816; Sedgwick P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4654; Sedgwick P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4670	9	6	6	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2014	348								g3840	10.1136/bmj.g3840	http://dx.doi.org/10.1136/bmj.g3840			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1IW	24927764				2022-12-01	WOS:000337410400002
J	Lipska, KJ; Ross, JS; Van Houten, HK; Beran, D; Yudkin, JS; Shah, ND				Lipska, Kasia J.; Ross, Joseph S.; Van Houten, Holly K.; Beran, David; Yudkin, John S.; Shah, Nilay D.			Use and Out-of-Pocket Costs of Insulin for Type 2 Diabetes Mellitus From 2000 Through 2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Lipska, Kasia J.; Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Beran, David] Univ Geneva, Fac Med, Geneva, Switzerland; [Yudkin, John S.] UCL, London, England; [Van Houten, Holly K.; Shah, Nilay D.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA	Yale University; University of Geneva; University of London; University College London; Mayo Clinic	Lipska, KJ (corresponding author), Yale Univ, Sch Med, Dept Internal Med, POB 208020, New Haven, CT 06520 USA.	kasia.lipska@yale.edu	Beran, David/E-4422-2013; Yudkin, John S/C-1988-2008	Beran, David/0000-0001-7229-3920; Ross, Joseph/0000-0002-9218-3320	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R21HS017628] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021342, K23AG048359, K08AG032886, R03AG045086] Funding Source: NIH RePORTER; AHRQ HHS [R21HS17628] Funding Source: Medline; NCATS NIH HHS [UL1 TR000142] Funding Source: Medline; NIA NIH HHS [K08 AG032886, R03 AG045086, R03AG045086, P30 AG21342, P30 AG021342, K23 AG048359] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Gale EAM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4611; Gill GV, 2011, DIABETOLOGIA, V54, P19, DOI 10.1007/s00125-010-1897-3; Ginde Adit A, 2008, BMC Endocr Disord, V8, P4, DOI 10.1186/1472-6823-8-4; Holden SE, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000258; Horvath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005613.pub3	5	62	63	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2331	2333		10.1001/jama.2014.6316	http://dx.doi.org/10.1001/jama.2014.6316			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915266	Green Accepted, Bronze			2022-12-01	WOS:000336972600026
J	Zhang, QF; Siegel, TN; Martins, RM; Wang, F; Cao, J; Gao, Q; Cheng, X; Jiang, LB; Hon, CC; Scheidig-Benatar, C; Sakamoto, H; Turner, L; Jensen, ATR; Claes, A; Guizetti, J; Malmquist, NA; Scherf, A				Zhang, Qingfeng; Siegel, T. Nicolai; Martins, Rafael M.; Wang, Fei; Cao, Jun; Gao, Qi; Cheng, Xiu; Jiang, Lubin; Hon, Chung-Chau; Scheidig-Benatar, Christine; Sakamoto, Hiroshi; Turner, Louise; Jensen, Anja T. R.; Claes, Aurelie; Guizetti, Julien; Malmquist, Nicholas A.; Scherf, Artur			Exonuclease-mediated degradation of nascent RNA silences genes linked to severe malaria	NATURE			English	Article							MUTUALLY EXCLUSIVE EXPRESSION; ANTIGENIC VARIATION; VIRULENCE GENES; PLASMODIUM; EXORIBONUCLEASE; TRANSCRIPTION; DOMAINS; BINDING; SUBSET; SHOWS	Antigenic variation of the Plasmodium falciparum multicopy vargene family enables parasite evasion of immune destruction by host antibodies(1),(2). Expression of a particularvar subgroup, termed upsA, is linked to the obstruction of blood vessels in the brain and to the pathogenesis of human cerebralmalaria(3-6). The mechanism determining upsA activation remains unknown. Here we show that an entirely new type of gene silencing mechanism involving an exonuclease-mediated degradation of nascent RNA controls the silencing of genes linked to severe malaria. We identify a novel chromatin-associated exoribonuclease, termed PfR Nase II, that controls the silencing of upsA var genes by marking their transcription start site and intron-promoter regions leading to short-lived cryptic RNA. Parasites carrying a deficient PfRNase II gene produce full-lengthups Avar transcripts and intron-derived antisense longnon-coding RNA. The presence of stable upsA var transcripts overcomes monoallelic expression, resulting in the simultaneous expression of both upsA and upsC type PfEMP1 proteins on the surface of individual infected red blood cells. In addition, we observe an inverse relationship between transcript levels of PfRNase II andupsA-type var genes in parasites from severe malaria patients, implying a crucial role of PfRNase II in severe malaria. Our results uncover a previously unknown type of post-transcriptional gene silencing mechanism in malaria parasites with repercussions for other organisms. Additionally, the identification of RNase II as a parasite protein controlling the expression of virulence genes involved in pathogenesis in patients with severe malaria may provide new strategies for reducing malaria mortality.	[Zhang, Qingfeng; Wang, Fei] Tongji Univ Sch Med, Shanghai East Hosp, Res Ctr Translat Med, Shanghai 200120, Peoples R China; [Zhang, Qingfeng; Wang, Fei] Tongji Univ Sch Med, Inst Infect Dis & Vaccine Dev, Shanghai 200120, Peoples R China; [Zhang, Qingfeng; Siegel, T. Nicolai; Martins, Rafael M.; Scheidig-Benatar, Christine; Sakamoto, Hiroshi; Claes, Aurelie; Guizetti, Julien; Malmquist, Nicholas A.; Scherf, Artur] Inst Pasteur, Unite Biol Interact Hote Paras, F-75724 Paris, France; [Zhang, Qingfeng; Siegel, T. Nicolai; Martins, Rafael M.; Scheidig-Benatar, Christine; Sakamoto, Hiroshi; Claes, Aurelie; Guizetti, Julien; Malmquist, Nicholas A.; Scherf, Artur] CNRS, URA 2581, F-75724 Paris, France; [Cao, Jun; Gao, Qi] Jiangsu Inst Parasit Dis, Key Lab Parasit Dis Control & Prevent, Minist Hlth, Wuxi 214064, Peoples R China; [Cao, Jun; Gao, Qi] Jiangsu Prov Key Lab Parasite Mol Biol, Wuxi 214064, Peoples R China; [Cheng, Xiu; Jiang, Lubin] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China; [Hon, Chung-Chau] Inst Pasteur, Cell Biol Parasitism Unit, F-75724 Paris, France; [Hon, Chung-Chau] Inst Pasteur, INSERM, U786, F-75724 Paris, France; [Turner, Louise; Jensen, Anja T. R.] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Turner, Louise; Jensen, Anja T. R.] Rigshosp, Copenhagen Univ Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark	Tongji University; Tongji University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Copenhagen; Rigshospitalet; University of Copenhagen	Scherf, A (corresponding author), Inst Pasteur, Unite Biol Interact Hote Paras, F-75724 Paris, France.	qfzhangsh@aliyun.com; artur.scherf@pasteur.fr	Jensen, Anja Tatiana TR Ramstedt/T-3583-2017; Jensen, Anja Ramstedt/AAL-3119-2021; Guizetti, Julien/AAF-3793-2020; Siegel, Tim Nicolai/F-2502-2013; Cao, Jun/AAR-7268-2020	Jensen, Anja Tatiana TR Ramstedt/0000-0002-4004-7554; Jensen, Anja Ramstedt/0000-0002-4004-7554; Guizetti, Julien/0000-0002-8762-4259; Siegel, Tim Nicolai/0000-0002-1715-7907; Cao, Jun/0000-0001-5298-9234; Malmquist, Nicholas/0000-0003-2822-8245; Scherf, Artur/0000-0003-2411-3328; ZHANG, Qingfeng/0000-0002-8759-9102; miyazawa martins, rafael/0000-0001-7449-0696; Turner, Louise/0000-0003-4494-2289; Guizetti, Julien/0000-0002-7735-4689; Sakamoto, Hiroshi/0000-0002-8767-2111; Hon, Chung-Chau/0000-0002-3741-7577	European Research Council [250320]; French Parasitology consortium ParaFrap [ANR-11-LABX0024]; National Natural Science Foundation of China (NSFC) [31271388]; French National Research Agency-NSFC [13-ISV3-0003-01, 81361130411]; Fundamental Research Funds for the Central Universities of China [20123283]; Human Frontier Science Program; European Molecular Biology Organization long-term fellowship; NSFC [81271870]; Novo Nordisk Fonden [NNF13OC0006249] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); French Parasitology consortium ParaFrap; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); French National Research Agency-NSFC(French National Research Agency (ANR)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Human Frontier Science Program(Human Frontier Science Program); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); NSFC(National Natural Science Foundation of China (NSFC)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank T. Wandless for providing Shld1 compound. This work was supported by a European Research Council Advanced Grant (PlasmoEscape 250320), the French Parasitology consortium ParaFrap (ANR-11-LABX0024), the National Natural Science Foundation of China (NSFC; no. 31271388), the French National Research Agency (13-ISV3-0003-01)-NSFC (no. 81361130411) International Collaboration Project, and the Fundamental Research Funds for the Central Universities of China (20123283). T.N.S. was supported by the Human Frontier Science Program and a European Molecular Biology Organization long-term fellowship. J.C. was supported by the NSFC (no. 81271870). J.G. was supported by the Human Frontier Science Program.	Amblar M, 2006, J MOL BIOL, V360, P921, DOI 10.1016/j.jmb.2006.05.043; Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; Deitsch KW, 2012, P NATL ACAD SCI USA, V109, P10130, DOI 10.1073/pnas.1207174109; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Epp C, 2009, RNA, V15, P116, DOI 10.1261/rna.1080109; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Frank M, 2007, MOL MICROBIOL, V64, P1486, DOI 10.1111/j.1365-2958.2007.05736.x; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gudipati RK, 2012, EMBO J, V31, P2427, DOI 10.1038/emboj.2012.81; Horrocks P, 2004, P NATL ACAD SCI USA, V101, P11129, DOI 10.1073/pnas.0402347101; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Jiang LB, 2013, NATURE, V499, P223, DOI 10.1038/nature12361; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; Kiss DL, 2011, RNA, V17, P1, DOI 10.1261/rna.2364811; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Kyes SA, 2003, MOL MICROBIOL, V48, P1339, DOI 10.1046/j.1365-2958.2003.03505.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Mancio-Silva Liliana, 2013, Methods Mol Biol, V923, P335; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mourier T, 2008, GENOME RES, V18, P281, DOI 10.1101/gr.6836108; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Ralph SA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r93; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Scherf A, 2008, CELL, V134, P190, DOI 10.1016/j.cell.2008.06.042; Staals RHJ, 2010, EMBO J, V29, P2358, DOI 10.1038/emboj.2010.122; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Zhang QF, 2011, CELL HOST MICROBE, V10, P451, DOI 10.1016/j.chom.2011.09.013	39	51	54	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					431	+		10.1038/nature13468	http://dx.doi.org/10.1038/nature13468			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043062				2022-12-01	WOS:000341814900063
J	Wang, F; Chan, C; Weir, NR; Denic, V				Wang, Fei; Chan, Charlene; Weir, Nicholas R.; Denic, Vladimir			The Get1/2 transmembrane complex is an endoplasmic-reticulum membrane protein insertase	NATURE			English	Article							ER MEMBRANE; TAIL; MECHANISM; BIOGENESIS	Hundreds of tail-anchored proteins, including soluble N-ethylmaleimide-sensitive factor attachment receptors (SNAREs) involved in vesicle fusion, are inserted post-translationally into the endoplasmic reticulum membrane by a dedicated protein-targeting pathway(1-4). Before insertion, the carboxy-terminal transmembrane domains of tail-anchored proteins are shielded in the cytosol by the conserved targeting factor Get3 (in yeast; TRC40 inmammals)(5-7). The Get3 endoplasmic-reticulum receptor comprises the cytosolic domains of the Get1/2 (WRB/CAML) transmembrane complex, which interact individually with the targeting factor to drive a conformational change that enables substrate release and, as a consequence, insertion(8-11). Because tail-anchored protein insertion is not associated with significant translocation of hydrophilic protein sequences across the membrane, it remains possible that Get1/2 cytosolic domains are sufficient to place Get3 in proximity with the endoplasmic-reticulum lipid bilayer and permit spontaneous insertion to occur(12,13). Here we use cell reporters and biochemical reconstitution to define mutations in the Get1/2 transmembrane domain that disrupt tail-anchored protein insertion without interfering with Get1/2 cytosolic domain function. These mutations reveal a novel Get1/2 insertase function, in the absence of which substrates stay bound to Get3 despite their proximity to the lipid bilayer; as a consequence, the notion of spontaneous transmembrane domain insertion is a non sequitur. Instead, the Get1/2 transmembrane domain helps to release substrates from Get3 by capturing their transmembrane domains, and these transmembrane interactions define a bona fide pre-integrated intermediate along a facilitated route for tail-anchor entry into the lipid bilayer. Our work sheds light on the fundamental point of convergence between co-translational and post-translational endoplasmic-reticulum membrane protein targeting and insertion: a mechanism for reducing the ability of a targeting factor to shield its substrates enables substrate handover to a transmembrane-domain-docking site embedded in the endoplasmic-reticulum membrane.	[Wang, Fei; Chan, Charlene; Weir, Nicholas R.; Denic, Vladimir] Harvard Univ, Dept Mol & Cellular Biol, Northwest Labs, Cambridge, MA 02138 USA	Harvard University	Denic, V (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Northwest Labs, Cambridge, MA 02138 USA.	vdenic@mcb.harvard.edu		Chan, Charlene/0000-0002-0479-3373	National Institutes of Health [RO1GM0999943-01]; Sara Elizabeth O'Brien Trust Postdoctoral Fellowship Program, Bank of America; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sara Elizabeth O'Brien Trust Postdoctoral Fellowship Program, Bank of America; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Brandman and R. Hegde for reagents, members of the Denic laboratory for scientific advice, and J. Weissman, A. Murray, B. Stern and C. Patil for comments on the manuscript. This work was supported by the National Institutes of Health (RO1GM0999943-01) and a postdoctoral fellowship from the Sara Elizabeth O'Brien Trust Postdoctoral Fellowship Program, Bank of America, Co-Trustee (to F.W.).	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Brachmann CB, 1998, YEAST, V14, P115; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Chartron JW, 2012, CURR OPIN STRUC BIOL, V22, P217, DOI 10.1016/j.sbi.2012.03.001; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; Denic V, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013334; Denic V, 2012, TRENDS BIOCHEM SCI, V37, P411, DOI 10.1016/j.tibs.2012.07.004; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Joglekar AP, 2008, METHOD CELL BIOL, V85, P127, DOI 10.1016/S0091-679X(08)85007-8; Kubota K, 2012, J MOL BIOL, V422, P366, DOI 10.1016/j.jmb.2012.05.045; Leznicki P, 2011, BIOCHEM J, V436, P719, DOI 10.1042/BJ20101737; Li J, 2002, P NATL ACAD SCI USA, V99, P11605, DOI 10.1073/pnas.192439299; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-402312, 10.1146/annurev-biophys-050511-102312]; RICHARDS FM, 1959, J BIOL CHEM, V234, P1459; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Stefer S, 2011, SCIENCE, V333, P758, DOI 10.1126/science.1207125; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038	24	76	76	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					441	U486		10.1038/nature13471	http://dx.doi.org/10.1038/nature13471			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25043001	Green Accepted			2022-12-01	WOS:000340840600036
J	Oye, KA; Esvelt, K; Appleton, E; Catteruccia, F; Church, G; Kuiken, T; Lightfoot, SBY; McNamara, J; Smidler, A; Collins, JP				Oye, Kenneth A.; Esvelt, Kevin; Appleton, Evan; Catteruccia, Flaminia; Church, George; Kuiken, Todd; Lightfoot, Shlomiya Bar-Yam; McNamara, Julie; Smidler, Andrea; Collins, James P.			BIOTECHNOLOGY Regulating gene drives	SCIENCE			English	Editorial Material									[Oye, Kenneth A.] MIT, Polit Sci Dept, Cambridge, MA 02139 USA; [Oye, Kenneth A.; Lightfoot, Shlomiya Bar-Yam; McNamara, Julie] MIT, Engn Syst Div, Cambridge, MA 02139 USA; [Esvelt, Kevin; Church, George] Harvard Univ, Wyss Inst, Cambridge, MA 02138 USA; [Appleton, Evan] Boston Univ, Boston, MA 02215 USA; [Catteruccia, Flaminia; Smidler, Andrea] Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA; [Catteruccia, Flaminia] Univ Perugia, I-06100 Perugia, Italy; [Kuiken, Todd] Woodrow Wilson Int Ctr Scholars, Washington, DC USA; [Smidler, Andrea] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Collins, James P.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; University of Perugia; Harvard University; Arizona State University; Arizona State University-Tempe	Oye, KA (corresponding author), MIT, Polit Sci Dept, Cambridge, MA 02139 USA.	oye@mit.edu	Kuiken, Todd/A-3784-2016; Kuiken, Todd/U-3476-2019	Kuiken, Todd/0000-0001-7851-6232; Kuiken, Todd/0000-0001-7851-6232; Catteruccia, Flaminia/0000-0003-3295-6683; Smidler, Andrea/0000-0002-3281-1161; church, george/0000-0001-6232-9969; Esvelt, Kevin/0000-0001-8797-3945	Direct For Biological Sciences [1337431] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		[Anonymous], 1972, PROD STOCKP BACT BIO; Australia Group, 2012, GUID TRANSF SENS CHE; Bar Yam S., 2012, REGULATION SYNTHETIC; Benedict M, 2008, VECTOR-BORNE ZOONOT, V8, P127, DOI 10.1089/vbz.2007.0273; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Center for Veterinary Medicine (CVM) Food and Drug Administration U. S. Department of Health and Human Services, 2009, REG GEN ENG AN CONT; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Drinkwater K, 2014, CREATING RES AGENDA; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Kuiken T., 2014, J ENVIRON STUD SCI, V4, P191, DOI [10.1007/s13412-014-0171-2, DOI 10.1007/S13412-014-0171-2]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Reeves RG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001502; U. S. Science and Technology Office, 2013, US GOV POL I OV LIF; United Nations, 2003, CART PROT BIOS CONV; United Nations, 1925, 1925 GEN PROT; World Health Organization, 2009, PROGR PROSP US GEN M	16	211	222	0	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					626	628		10.1126/science.1254287	http://dx.doi.org/10.1126/science.1254287			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25035410				2022-12-01	WOS:000339962800022
J	Marcussen, T; Sandve, SR; Heier, L; Spannagl, M; Pfeifer, M; Jakobsen, KS; Wulff, BBH; Steuernagel, B; Mayer, KFX; Olsen, OA; Rogers, J; Dolezel, J; Pozniak, C; Eversole, K; Feuillet, C; Gill, B; Friebe, B; Lukaszewski, AJ; Sourdille, P; Endo, TR; Kubalakova, M; Cihalikova, J; Dubska, Z; Vrana, J; Sperkova, R; Simkova, H; Febrer, M; Clissold, L; Mclay, K; Singh, K; Chhuneja, P; Singh, NK; Khurana, J; Akhunov, E; Choulet, F; Alberti, A; Barbe, V; Wincker, P; Kanamori, H; Kobayashi, F; Itoh, T; Matsumoto, T; Sakai, H; Tanaka, T; Wu, JZ; Ogihara, Y; Handa, H; Maclachlan, PR; Sharpe, A; Klassen, D; Edwards, D; Batley, J; Lien, S; Caccamo, M; Ayling, S; Ramirez-Gonzalez, RH; Clavijo, BJ; Wright, J; Martis, MM; Mascher, M; Chapman, J; Poland, JA; Scholz, U; Barry, K; Waugh, R; Rokhsar, DS; Muehlbauer, GJ; Stein, N; Gundlach, H; Zytnicki, M; Jamilloux, V; Quesneville, H; Wicker, T; Faccioli, P; Colaiacovo, M; Stanca, AM; Budak, H; Cattivelli, L; Glover, N; Pingault, L; Paux, E; Sharma, S; Appels, R; Bellgard, M; Chapman, B; Nussbaumer, T; Bader, KC; Rimbert, H; Wang, SC; Knox, R; Kilian, A; Alaux, M; Alfama, F; Couderc, L; Guilhot, N; Viseux, C; Loaec, M; Keller, B; Praud, S				Marcussen, Thomas; Sandve, Simen R.; Heier, Lise; Spannagl, Manuel; Pfeifer, Matthias; Jakobsen, Kjetill S.; Wulff, Brande B. H.; Steuernagel, Burkhard; Mayer, Klaus F. X.; Olsen, Odd-Arne; Rogers, Jane; Dolezel, Jaroslav; Pozniak, Curtis; Eversole, Kellye; Feuillet, Catherine; Gill, Bikram; Friebe, Bernd; Lukaszewski, Adam J.; Sourdille, Pierre; Endo, Takashi R.; Kubalakova, Marie; Cihalikova, Jarmila; Dubska, Zdenka; Vrana, Jan; Sperkova, Romana; Simkova, Hana; Febrer, Melanie; Clissold, Leah; McLay, Kirsten; Singh, Kuldeep; Chhuneja, Parveen; Singh, Nagendra K.; Khurana, Jitendra; Akhunov, Eduard; Choulet, Frederic; Alberti, Adriana; Barbe, Valerie; Wincker, Patrick; Kanamori, Hiroyuki; Kobayashi, Fuminori; Itoh, Takeshi; Matsumoto, Takashi; Sakai, Hiroaki; Tanaka, Tsuyoshi; Wu, Jianzhong; Ogihara, Yasunari; Handa, Hirokazu; Maclachlan, P. Ron; Sharpe, Andrew; Klassen, Darrin; Edwards, David; Batley, Jacqueline; Lien, Sigbjorn; Caccamo, Mario; Ayling, Sarah; Ramirez-Gonzalez, Ricardo H.; Clavijo, Bernardo J.; Wright, Jonathan; Martis, Mihaela M.; Mascher, Martin; Chapman, Jarrod; Poland, Jesse A.; Scholz, Uwe; Barry, Kerrie; Waugh, Robbie; Rokhsar, Daniel S.; Muehlbauer, Gary J.; Stein, Nils; Gundlach, Heidrun; Zytnicki, Matthias; Jamilloux, Veronique; Quesneville, Hadi; Wicker, Thomas; Faccioli, Primetta; Colaiacovo, Moreno; Stanca, Antonio Michele; Budak, Hikmet; Cattivelli, Luigi; Glover, Natasha; Pingault, Lise; Paux, Etienne; Sharma, Sapna; Appels, Rudi; Bellgard, Matthew; Chapman, Brett; Nussbaumer, Thomas; Bader, Kai Christian; Rimbert, Helene; Wang, Shichen; Knox, Ron; Kilian, Andrzej; Alaux, Michael; Alfama, Francoise; Couderc, Loic; Guilhot, Nicolas; Viseux, Claire; Loaec, Mikael; Keller, Beat; Praud, Sebastien		Int Wheat Genome Sequencing	Ancient hybridizations among the ancestral genomes of bread wheat	SCIENCE			English	Article							AEGILOPS-TAUSCHII; DRAFT GENOME; A-GENOME; EVOLUTION; TRITICUM; DOMESTICATION; ALIGNMENT; PACKAGE; GENES	The allohexaploid bread wheat genome consists of three closely related subgenomes (A, B, and D), but a clear understanding of their phylogenetic history has been lacking. We used genome assemblies of bread wheat and five diploid relatives to analyze genome-wide samples of gene trees, as well as to estimate evolutionary relatedness and divergence times. We show that the A and B genomes diverged from a common ancestor similar to 7 million years ago and that these genomes gave rise to the D genome through homoploid hybrid speciation 1 to 2 million years later. Our findings imply that the present-day bread wheat genome is a product of multiple rounds of hybrid speciation (homoploid and polyploid) and lay the foundation for a new framework for understanding the wheat genome as a multilevel phylogenetic mosaic.	[Marcussen, Thomas; Sandve, Simen R.; Olsen, Odd-Arne] Norwegian Univ Life Sci, Dept Plant Sci, N-1432 As, Norway; [Spannagl, Manuel; Pfeifer, Matthias; Mayer, Klaus F. X.] Helmholtz Ctr Munich, D-85764 Neuherberg, Germany; [Jakobsen, Kjetill S.] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, N-0316 Oslo, Norway; [Wulff, Brande B. H.; Steuernagel, Burkhard] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Spannagl, Manuel; Pfeifer, Matthias; Mayer, Klaus F. X.; Martis, Mihaela M.; Gundlach, Heidrun; Sharma, Sapna; Nussbaumer, Thomas; Bader, Kai Christian] Helmholtz Zentrum Munich, Plant Genome & Syst Biol, Ingolstadter Landstrasse 1, D-85764 Neuherberg, Germany; [Rogers, Jane; Eversole, Kellye] Eversole Associates, IWGSC, 5207 Wyoming Rd, Bethesda 20816, MD USA; [Dolezel, Jaroslav; Kubalakova, Marie; Cihalikova, Jarmila; Dubska, Zdenka; Vrana, Jan; Sperkova, Romana; Simkova, Hana] Inst Expt Bot, Ctr Plant Struct & Funct Genom, Slechtitelu 31, Olomouc 78371, Czech Republic; [Pozniak, Curtis; Maclachlan, P. Ron] Univ Saskatchewan, Coll Agr & Bioresources, Dept Plant Sci, Ctr Crop Dev, 51 Campus Dr, Saskatoon, SK, Canada; [Feuillet, Catherine] Bayer Crop Sci, 3500 Paramount Pkwy, Morrisville, NC 27560 USA; [Gill, Bikram; Friebe, Bernd; Akhunov, Eduard; Wang, Shichen] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA; [Lukaszewski, Adam J.] Univ Calif, Coll Nat & Agr Sci Bot & Plant Sci, Riverside, CA 92521 USA; [Endo, Takashi R.] Kyoto Univ, Grad Sch Agr, Lab Plant Genet, Kyoto 6068502, Japan; [Febrer, Melanie] Univ Dundee, Genom Sequenc Unit, Dow St, Dundee DD1 5EH, Scotland; [Clissold, Leah; McLay, Kirsten; Caccamo, Mario; Ayling, Sarah; Ramirez-Gonzalez, Ricardo H.; Clavijo, Bernardo J.; Wright, Jonathan] Genome Anal Ctr, Res Pk, Norwich NR4 7UH, Norfolk, England; [Singh, Kuldeep; Chhuneja, Parveen] Punjab Agr Univ, Sch Agrictural Biotechnol, Ludhiana 141004, Punjab, India; [Singh, Nagendra K.] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; [Khurana, Jitendra] Univ Delhi, Dept Plant Mol, Interdisciplinary Ctr Plant Genom, South Campus, New Delhi 110021, India; [Sourdille, Pierre; Choulet, Frederic; Glover, Natasha; Pingault, Lise; Paux, Etienne; Guilhot, Nicolas] INRA Univers Blaise Pascal UMR1095 Genet, Div & Ecophysiol Cereals, 5 Chemin Beaulieu, F-63039 Clermont Ferrand, France; [Alberti, Adriana; Barbe, Valerie; Wincker, Patrick] Ctr Natl Sequencage, Commissariat IEnergie Atom Genoscope, 2 rue Gaston Cremieux, F-91057 Evry, France; [Kanamori, Hiroyuki; Kobayashi, Fuminori; Itoh, Takeshi; Matsumoto, Takashi; Sakai, Hiroaki; Tanaka, Tsuyoshi; Wu, Jianzhong; Handa, Hirokazu] Natl Inst Agrobiol Sci, Plant Genome Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan; [Ogihara, Yasunari] Yokohama City Univ, Kihara Inst Biol Res, Maioka cho 641-12 Totsuka Ku, Yokohama, Kanagawa 2440813, Japan; [Sharpe, Andrew; Klassen, Darrin] Natl Res Council Canada, 110 Gymnasium Pl, Saskatoon, SK S7N 0W9, Canada; [Edwards, David; Batley, Jacqueline] Univ Queensland, Sch Agr & Food Sci, Australian Ctr Plant Funct Genom, St Lucia, Qld 4072, Australia; [Edwards, David; Batley, Jacqueline] Univ Western Australia, Sch Plant Biol, Nedlands, WA 6009, Australia; [Sandve, Simen R.; Olsen, Odd-Arne] Norwegian Univ Life Sci, Dept Plant Sci, Ctr Integrat Genet CIGENE, N-1432 As, Norway; [Olsen, Odd-Arne] Hedmark Univ Coll, Dept Nat Sci & Technol, N-2318 Oslo, Norway; [Wulff, Brande B. H.; Steuernagel, Burkhard] Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Mascher, Martin; Scholz, Uwe] Leibniz Inst Plant Genet & Crop Plant Res IPK, Bioinformat & Informat Technol, D-06466 Seeland OT Gatersleben, Germany; [Chapman, Jarrod; Barry, Kerrie; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, 2800 Mitchell Dr, Walnut Creek, CA 94598 USA; [Poland, Jesse A.] Kansas State Univ, Dept Agron, USDA ARS Hard Winter Wheat Genet Res Unit, Manhattan, KS 66506 USA; [Waugh, Robbie] James Hutton Inst, Invergowrie, Dundee DD2 5DA, Scotland; [Muehlbauer, Gary J.] Univ Minnesota, Dept Agron & Plant Genet, Dept Plant Biol, St Paul, MN 55108 USA; [Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res IPK, Genome Div, D-06466 Seeland OT Gatersleben, Germany; [Jamilloux, Veronique; Quesneville, Hadi; Alaux, Michael; Alfama, Francoise; Couderc, Loic; Viseux, Claire; Loaec, Mikael] INRA Versailles, UR1164 URGI Research Unit Genom Info, INRA, Route Saint Cyr, F-78026 Versailles, France; [Wicker, Thomas; Keller, Beat] Univ Zurich, Inst Plant Biol, Zollikerstrasse 107, CH-8008 Zurich, Switzerland; [Faccioli, Primetta; Colaiacovo, Moreno; Stanca, Antonio Michele; Cattivelli, Luigi] Consiglio Ric Sperimentazione Agricoltura Gen Res, Via San Protaso 302, I-29017 Fjorenzuola dArda, Italy; [Budak, Hikmet] Sabanci Univ, Biol Sci & Bioengn Program, TR-34956 Istanbul, Turkey; [Appels, Rudi; Bellgard, Matthew; Chapman, Brett] Murdoch Univ, Ctr Comparat Genom, Perth, WA 6150, Australia; [Knox, Ron] Semiarid Prairie Agr Res Ctr, Post Off Box 1030, Swift Current, SK S9H 3X2, Canada; [Kilian, Andrzej] Div Arrays Technol Pty Ltd, 1 Wilf Crane Crescent, Yarralumla ACT2600, Australia; [Rimbert, Helene] Ctr Rech Chappes, Biogemma, Route dEnnezat, F-63720 Chappes, France; [Lien, Sigbjorn] Norwegian Univ Life Sci, Dept Anim & Aquicultural Sci, CIGENE, Arboretvelen 6, N-1432 As, Norway	Norwegian University of Life Sciences; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Oslo; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of Saskatchewan; Bayer AG; Bayer CropScience; Kansas State University; University of California System; University of California Riverside; Kyoto University; University of Dundee; The Genome Analysis Centre (TGAC); Punjab Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); University of Delhi; INRAE; UDICE-French Research Universities; Universite Paris Saclay; National Institute of Agrobiological Sciences - Japan; Yokohama City University; National Research Council Canada; University of Queensland; University of Western Australia; Norwegian University of Life Sciences; Inland Norway University of Applied Sciences; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Kansas State University; James Hutton Institute; University of Minnesota System; University of Minnesota Twin Cities; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Zurich; Sabanci University; Murdoch University; Norwegian University of Life Sciences	Sandve, SR (corresponding author), Norwegian Univ Life Sci, Dept Plant Sci, N-1432 As, Norway.	simen.sandve@nmbu.no	Dolezel, Jaroslav/B-7716-2008; Sourdille, Pierre/CAF-2780-2022; Marcussen, Thomas/I-7768-2019; Batley, Jacqueline/A-5723-2008; Ramírez, Ricardo/H-4808-2019; Simkova, Hana/F-7734-2014; Wu, Jian/AAU-5221-2020; Edwards, David/H-3710-2015; Kubaláková, Marie/F-8269-2014; Wulff, Brande B/N-4273-2013; Mayer, Klaus FX/M-7941-2015; Stein, Nils/F-7507-2017; Budak, Hikmet/U-8517-2019; Pingault, Lise/AAQ-8602-2020; Wang, Shichen/E-6213-2012; Budak, Hikmet/S-5835-2017; cattivelli, luigi/AAE-7046-2020; Wicker, Thomas/Z-1978-2019; Wulff, Brande BH/C-7465-2013; Sharma, Sapna/N-6357-2017; Pfeifer, Matthias/GRJ-4579-2022; Eversole, Kellye/AAN-6141-2020; Barry, Kerrie Whitelaw/AAA-5500-2020; Quesneville, Hadi/AAG-1048-2020; Wu, Jian/AAU-5221-2020	Dolezel, Jaroslav/0000-0002-6263-0492; Batley, Jacqueline/0000-0002-5391-5824; Ramírez, Ricardo/0000-0001-5745-7085; Simkova, Hana/0000-0003-4159-7619; Wu, Jian/0000-0001-9933-7364; Edwards, David/0000-0001-7599-6760; Mayer, Klaus FX/0000-0001-6484-1077; Stein, Nils/0000-0003-3011-8731; Budak, Hikmet/0000-0002-2556-2478; Pingault, Lise/0000-0002-6149-1267; Wang, Shichen/0000-0003-1441-2252; Budak, Hikmet/0000-0002-2556-2478; cattivelli, luigi/0000-0002-6067-4600; Wulff, Brande BH/0000-0003-4044-4346; Eversole, Kellye/0000-0002-8784-4913; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Quesneville, Hadi/0000-0003-3001-4908; Steuernagel, Burkhard/0000-0002-8284-7728; Wu, Jian/0000-0002-3394-1507; Bellgard, Matthew/0000-0002-6303-9469; Spannagl, Manuel/0000-0003-0701-7035; Sourdille, Pierre/0000-0002-1027-2224; Singh, Kuldeep/0000-0001-5239-6586; Marcussen, Thomas/0000-0002-1960-9508; Jamilloux, Veronique/0000-0002-6898-4910; Keller, Beat/0000-0003-2379-9225; Colaiacovo, Moreno/0000-0003-1320-0506; Martis, Mihaela-Maria/0000-0001-7509-2446; Scholz, Uwe/0000-0001-6113-3518; Kilian, Andrzej/0000-0002-2730-7462; Gundlach, Heidrun/0000-0002-6757-0943; Alaux, Michael/0000-0001-9356-4072; , Thomas/0000-0002-6777-7135	Norwegian Research Council [199387]; Biotechnology and Biological Sciences Research Council [BB/J003166/1, BBS/E/T/000PR6193] Funding Source: researchfish; BBSRC [BB/J003166/1, BBS/E/T/000PR6193] Funding Source: UKRI; Division Of Computer and Network Systems [1126709] Funding Source: National Science Foundation	Norwegian Research Council(Research Council of NorwayEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was financed by Norwegian Research Council grant 199387 to Norwegian University of Life Sciences and Graminor AS to O.-A.O. The phylogenetic analyses were run, in part, on the Bioportal supercomputing facility at the University of Oslo. We thank C.-P. Antoine and two anonymous reviewers for valuable comments on the manuscript and S. Saebo for help on implementation of the OpenBUGS analyses in R. Ortholog alignments, gene trees, and the OpenBUGS model used for multispecies coalescent modeling can be downloaded from Dryad (data available from the Dryad Digital Repository: http://doi.org/10.5061/dryad.f6c34).	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Akhunov ED, 2005, THEOR APPL GENET, V111, P1617, DOI 10.1007/s00122-005-0093-1; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Doyle JJ, 2010, NEW PHYTOL, V186, P73, DOI 10.1111/j.1469-8137.2009.03118.x; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Dvorak J, 2005, GENETICS, V171, P323, DOI 10.1534/genetics.105.041632; Eroukhmanoff F, 2013, CURR ZOOL, V59, P667, DOI 10.1093/czoolo/59.5.667; Escobar JS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-181; Fan X, 2013, BIOCHEM SYST ECOL, V50, P346, DOI 10.1016/j.bse.2013.05.010; Heun M, 1997, SCIENCE, V278, P1312, DOI 10.1126/science.278.5341.1312; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Lev-Yadun S, 2000, SCIENCE, V288, P1602, DOI 10.1126/science.288.5471.1602; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lotsy J. P., 1916, EVOLUTION BY MEANS O; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; MCFADDEN ES, 1946, J HERED, V37, P81, DOI 10.1093/oxfordjournals.jhered.a105590; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Pfeifer M, 2014, SCIENCE, V345, DOI 10.1126/science.1250091; Riehl S, 2013, SCIENCE, V341, P65, DOI 10.1126/science.1236743; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Stromberg CAE, 2011, ANNU REV EARTH PL SC, V39, P517, DOI 10.1146/annurev-earth-040809-152402; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Than C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-322; Vigeland MD, 2013, NEW PHYTOL, V199, P1060, DOI 10.1111/nph.12337; Yu Y, 2013, SYST BIOL, V62, P738, DOI 10.1093/sysbio/syt037	35	413	441	15	264	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194			SI				1250092	10.1126/science.1250092	http://dx.doi.org/10.1126/science.1250092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR2MB	25035499				2022-12-01	WOS:000343420300003
J	Jones, C; Pollit, V; Fitzmaurice, D; Cowan, C				Jones, Clare; Pollit, Vicki; Fitzmaurice, David; Cowan, Campbell		Guideline Dev Grp	The management of atrial fibrillation: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTICOAGULANTS; STROKE; RISK		[Jones, Clare; Pollit, Vicki] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Fitzmaurice, David] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Cowan, Campbell] Leeds Gen Infirm, Dept Cardiol, Leeds, W Yorkshire, England	Royal College of Physicians; University of Birmingham; Leeds General Infirmary; University of Leeds	Jones, C (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	clare.jones@rcplondon.ac.uk						Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Cowan C, 2013, HEART, V99, P1166, DOI 10.1136/heartjnl-2012-303472; GRADE Working Group, GRAD REC ASS DEV EV; Holt TA, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X656856; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lord J, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17580; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; National Institute for Health and Care Excellence, 2012, RIV PREV STROK SYST, V256; National Institute for Health and Care Excellence, 2012, DAB ET PREV STROK SY; National Institute for Health and Care Excellence, 2013, DEV NICE CLIN GUID; National Institute for Health and Care Excellence, 2013, SUPP COMM ANT THER; National Institute for Health and Care Excellence, 2012, VEN THROMB DIS MAN V, VCG144; National Institute for Health and Care Excellence, 2014, NICE CLIN GUID; National Institute for Health and Care Excellence, 2013, AP PREV STROK SYST E; National Institute for Health and Care Excellence, 2012, PAT EXP AD NHS SERV; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236	18	55	61	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2014	348								g3655	10.1136/bmj.g3655	http://dx.doi.org/10.1136/bmj.g3655			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6LH	24948694	Green Published			2022-12-01	WOS:000337805800007
J	Grady, JM; Enquist, BJ; Dettweiler-Robinson, E; Wright, NA; Smith, FA				Grady, John M.; Enquist, Brian J.; Dettweiler-Robinson, Eva; Wright, Natalie A.; Smith, Felisa A.			DINOSAUR PHYSIOLOGY Evidence for mesothermy in dinosaurs	SCIENCE			English	Article							BODY TEMPERATURES; GROWTH-RATES; THERMOREGULATION; EVOLUTION; PATTERNS	Were dinosaurs ectotherms or fast-metabolizing endotherms whose activities were unconstrained by temperature? To date, some of the strongest evidence for endothermy comes from the rapid growth rates derived from the analysis of fossil bones. However, these studies are constrained by a lack of comparative data and an appropriate energetic framework. Here we compile data on ontogenetic growth for extant and fossil vertebrates, including all major dinosaur clades. Using a metabolic scaling approach, we find that growth and metabolic rates follow theoretical predictions across clades, although some groups deviate. Moreover, when the effects of size and temperature are considered, dinosaur metabolic rates were intermediate to those of endotherms and ectotherms and closest to those of extant mesotherms. Our results suggest that the modern dichotomy of endothermic versus ectothermic is overly simplistic.	[Grady, John M.; Dettweiler-Robinson, Eva; Wright, Natalie A.; Smith, Felisa A.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Enquist, Brian J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Enquist, Brian J.] Santa Fe Inst, Santa Fe, NM 87501 USA	University of New Mexico; University of Arizona; The Santa Fe Institute	Grady, JM (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	jgrady@unm.edu	Smith, Felisa/ABE-6160-2021; Enquist, Brian J/B-6436-2008	Smith, Felisa/0000-0001-6262-436X; Enquist, Brian J/0000-0002-6124-7096; Grady, John/0000-0001-6444-3300; Dettweiler-Robinson, Eva/0000-0002-9742-3434	Program in Interdisciplinary Biological and Biomedical Sciences at the University of New Mexico (grant from the National Institute of Biomedical Imaging and Bioengineering) [T32EB009414]; NSF CAREER; NSF ATB [EF 0742800]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009414] Funding Source: NIH RePORTER	Program in Interdisciplinary Biological and Biomedical Sciences at the University of New Mexico (grant from the National Institute of Biomedical Imaging and Bioengineering); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF ATB; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by a fellowship from the Program in Interdisciplinary Biological and Biomedical Sciences at the University of New Mexico (grant no. T32EB009414 from the National Institute of Biomedical Imaging and Bioengineering to F.A.S. and J. H. Brown). B.J.E. was supported by an NSF CAREER and ATB Award (EF 0742800). We thank C. White and two anonymous reviewers for valuable feedback on our manuscript and N. Milan for assistance with the figures. Data are available in the supplementary materials.	Bernal D, 2001, COMP BIOCHEM PHYS A, V129, P695, DOI 10.1016/S1095-6433(01)00333-6; Brice PH, 2002, AUST J ZOOL, V50, P461, DOI 10.1071/ZO01080; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Charnov Eric L., 1993, Evolutionary Anthropology, V1, P191, DOI 10.1002/evan.1360010604; Chinsamy Anusuya, 2002, P421; Eagle RA, 2011, SCIENCE, V333, P443, DOI 10.1126/science.1206196; ELSE PL, 1981, AM J PHYSIOL, V240, pR3, DOI 10.1152/ajpregu.1981.240.1.R3; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Hou C, 2008, SCIENCE, V322, P736, DOI 10.1126/science.1162302; Isler K, 2009, J HUM EVOL, V57, P392, DOI 10.1016/j.jhevol.2009.04.009; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Reid R., 2012, COMPLETE DINOSAUR, P873; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Seebacher F, 1999, J EXP BIOL, V202, P77; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; White CR, 2006, BIOL LETTERS, V2, P125, DOI 10.1098/rsbl.2005.0378	23	104	105	7	250	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1268	1272		10.1126/science.1253143	http://dx.doi.org/10.1126/science.1253143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926017				2022-12-01	WOS:000337077500037
J	Woyach, JA; Furman, RR; Liu, TM; Ozer, HG; Zapatka, M; Ruppert, AS; Xue, L; Li, DHH; Steggerda, SM; Versele, M; Dave, SS; Zhang, J; Yilmaz, AS; Jaglowski, SM; Blum, KA; Lozanski, A; Lozanski, G; James, DF; Barrientos, JC; Lichter, P; Stilgenbauer, S; Buggy, JJ; Chang, BY; Johnson, AJ; Byrd, JC				Woyach, Jennifer A.; Furman, Richard R.; Liu, Ta-Ming; Ozer, Hatice Gulcin; Zapatka, Marc; Ruppert, Amy S.; Xue, Ling; Li, Daniel Hsieh-Hsin; Steggerda, Susanne M.; Versele, Matthias; Dave, Sandeep S.; Zhang, Jenny; Yilmaz, Ayse Selen; Jaglowski, Samantha M.; Blum, Kristie A.; Lozanski, Arletta; Lozanski, Gerard; James, Danelle F.; Barrientos, Jacqueline C.; Lichter, Peter; Stilgenbauer, Stephan; Buggy, Joseph J.; Chang, Betty Y.; Johnson, Amy J.; Byrd, John C.			Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ACQUIRED-RESISTANCE; CLINICAL RESISTANCE; THERAPEUTIC TARGET; MYELOID-LEUKEMIA; MUTATION; CANCER; SURVIVAL; IMATINIB; GENOME	BACKGROUND Ibrutinib is an irreversible inhibitor of Bruton's tyrosine kinase (BTK) and is effective in chronic lymphocytic leukemia (CLL). Resistance to irreversible kinase inhibitors and resistance associated with BTK inhibition have not been characterized. Although only a small proportion of patients have had a relapse during ibrutinib therapy, an understanding of resistance mechanisms is important. We evaluated patients with relapsed disease to identify mutations that may mediate ibrutinib resistance. METHODS We performed whole-exome sequencing at baseline and the time of relapse on samples from six patients with acquired resistance to ibrutinib therapy. We then performed functional analysis of identified mutations. In addition, we performed Ion Torrent sequencing for identified resistance mutations on samples from nine patients with prolonged lymphocytosis. RESULTS We identified a cysteine-to-serine mutation in BTK at the binding site of ibrutinib in five patients and identified three distinct mutations in PLC gamma 2 in two patients. Functional analysis showed that the C481S mutation of BTK results in a protein that is only reversibly inhibited by ibrutinib. The R665W and L845F mutations in PLC gamma 2 are both potentially gain-of-function mutations that lead to autonomous B-cell-receptor activity. These mutations were not found in any of the patients with prolonged lymphocytosis who were taking ibrutinib. CONCLUSIONS Resistance to the irreversible BTK inhibitor ibrutinib often involves mutation of a cysteine residue where ibrutinib binding occurs. This finding, combined with two additional mutations in PLC gamma 2 that are immediately downstream of BTK, underscores the importance of the B-cell-receptor pathway in the mechanism of action of ibrutinib in CLL.	[Woyach, Jennifer A.; Liu, Ta-Ming; Ruppert, Amy S.; Jaglowski, Samantha M.; Blum, Kristie A.; Lozanski, Arletta; Johnson, Amy J.; Byrd, John C.] Ohio State Univ, Div Hematol, Dept Internal Med, Columbus, OH 43210 USA; [Ozer, Hatice Gulcin; Yilmaz, Ayse Selen] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Lozanski, Gerard] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Furman, Richard R.] Weill Cornell Med Coll, Dept Med, Div Hematol Oncol, New York, NY USA; [Zapatka, Marc; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany; [Stilgenbauer, Stephan] Univ Ulm, Dept Internal Med 3, D-89069 Ulm, Germany; [Xue, Ling; Li, Daniel Hsieh-Hsin; Steggerda, Susanne M.; James, Danelle F.; Buggy, Joseph J.; Chang, Betty Y.] Pharmacycl Sunnyvale, Sunnyvale, CA USA; [Dave, Sandeep S.; Zhang, Jenny] Duke Univ, Duke Canc Inst, Durham, NC USA; [Barrientos, Jacqueline C.] Hofstra North Shore LIJ Sch Med, Div Hematol Oncol, Dept Med, New Hyde Pk, NY USA; [Versele, Matthias] Janssen Res & Dev, Beerse, Belgium	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Cornell University; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; Duke University; Hofstra University; Northwell Health; Johnson & Johnson; Janssen Pharmaceuticals	Byrd, JC (corresponding author), Ohio State Univ, Div Hematol, Dept Internal Med, Columbus, OH 43210 USA.	john.byrd@osumc.edu	Barrientos, Jacqueline/AAE-6683-2022; Woyach, Jennifer Ann/F-1087-2015; Zapatka, Marc/G-9896-2013; Zhang, Jenny/GXV-4980-2022; Stilgenbauer, Stephan/ABE-6609-2020	Zapatka, Marc/0000-0001-8287-5967; Barrientos, Jacqueline Claudia/0000-0001-6018-5535	National Cancer Institute [P50 CA140158, R01 CA177292, K23 CA178183]; Four Winds Foundation; D. Warren Brown Foundation; Harry T. Mangurian Jr. Foundation; Leukemia and Lymphoma Society; Pharmacyclics; Conquer Cancer Foundation; American Society of Hematology Scholar Award; Else Kroner-Fresenius-Stiftung [2010_Kolleg24, 2012_A146]; Helmholtz Virtual Institute [VH-VI-404, TP2]; German Research Foundation (SFB) [1074, B2]; NATIONAL CANCER INSTITUTE [P01CA081534, R01CA183444, K23CA178183, P01CA095426, P30CA016058, P30CA014236, K12CA133250, R01CA177292, P50CA140158] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Four Winds Foundation; D. Warren Brown Foundation; Harry T. Mangurian Jr. Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Pharmacyclics; Conquer Cancer Foundation; American Society of Hematology Scholar Award; Else Kroner-Fresenius-Stiftung; Helmholtz Virtual Institute; German Research Foundation (SFB)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the National Cancer Institute (P50 CA140158, R01 CA177292, and K23 CA178183), the Four Winds Foundation, the D. Warren Brown Foundation, Mr. and Mrs. Michael Thomas, Mr. and Mrs. Al Lipkin, the Harry T. Mangurian Jr. Foundation, the Leukemia and Lymphoma Society, Pharmacyclics, the Conquer Cancer Foundation, an American Society of Hematology Scholar Award, Else Kroner-Fresenius-Stiftung (2010_Kolleg24, Project 2012_A146), Helmholtz Virtual Institute (VH-VI-404, TP2), and the German Research Foundation (SFB 1074 Project B2).	Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Awad MM, 2013, NEW ENGL J MED, V368, P2395, DOI 10.1056/NEJMoa1215530; Bernal A, 2001, BLOOD, V98, P3050, DOI 10.1182/blood.V98.10.3050; Burger JA, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.866.866; Byrd JC, 2014, NEW ENGL J MED, V370, P786, DOI 10.1056/NEJMx130049; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cortes J, 2007, BLOOD, V110, P4005, DOI 10.1182/blood-2007-03-080838; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Deglesne PA, 2006, CANCER RES, V66, P7158, DOI 10.1158/0008-5472.CAN-06-0085; Dubovsky JA, 2013, BLOOD, V122, P2539, DOI 10.1182/blood-2013-06-507947; Furman RR, 2014, NEW ENGL J MED, V370, P2352, DOI 10.1056/NEJMc1402716; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Herman SEM, 2011, BLOOD, V117, P6287, DOI 10.1182/blood-2011-01-328484; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Quintes-Cardama A, 2009, CANCER CONTROL, V16, P122, DOI 10.1177/107327480901600204; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Stoklosa T, 2008, CANCER RES, V68, P2576, DOI 10.1158/0008-5472.CAN-07-6858; Valiaho J, 2006, HUM MUTAT, V27, P1209, DOI 10.1002/humu.20410; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Woyach JA, 2014, BLOOD, V123, P1810, DOI 10.1182/blood-2013-09-527853; Zhou Q, 2012, AM J HUM GENET, V91, P713, DOI 10.1016/j.ajhg.2012.08.006	33	826	896	10	137	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2014	370	24					2286	2294		10.1056/NEJMoa1400029	http://dx.doi.org/10.1056/NEJMoa1400029			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7BB	24869598	Green Accepted, Bronze			2022-12-01	WOS:000337033700008
J	Ni, WM; Xu, SL; Tepperman, JM; Stanley, DJ; Maltby, DA; Gross, JD; Burlingame, AL; Wang, ZY; Quail, PH				Ni, Weimin; Xu, Shou-Ling; Tepperman, James M.; Stanley, David J.; Maltby, Dave A.; Gross, John D.; Burlingame, Alma L.; Wang, Zhi-Yong; Quail, Peter H.			A mutually assured destruction mechanism attenuates light signaling in Arabidopsis	SCIENCE			English	Article							BHLH TRANSCRIPTION FACTORS; PHYTOCHROME B; INDUCED PHOSPHORYLATION; UBIQUITIN LIGASES; DEGRADATION; PIF3; PROTEINS; ACTS; LOOP	After light-induced nuclear translocation, phytochrome photoreceptors interact with and induce rapid phosphorylation and degradation of basic helix-loop-helix transcription factors, such as PHYTOCHROME-INTERACTING FACTOR 3 (PIF3), to regulate gene expression. Concomitantly, this interaction triggers feedback reduction of phytochrome B (phyB) levels. Light-induced phosphorylation of PIF3 is necessary for the degradation of both proteins. We report that this PIF3 phosphorylation induces, and is necessary for, recruitment of LRB [Light-Response Bric-a-Brack/Tramtrack/Broad (BTB)] E3 ubiquitin ligases to the PIF3-phyB complex. The recruited LRBs promote concurrent polyubiqutination and degradation of both PIF3 and phyB in vivo. These data reveal a linked signal-transmission and attenuation mechanism involving mutually assured destruction of the receptor and its immediate signaling partner.	[Ni, Weimin; Tepperman, James M.; Quail, Peter H.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Ni, Weimin; Tepperman, James M.; Quail, Peter H.] ARS, Plant Gene Express Ctr, USDA, Albany, CA 94710 USA; [Xu, Shou-Ling; Stanley, David J.; Maltby, Dave A.; Gross, John D.; Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Xu, Shou-Ling; Wang, Zhi-Yong] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	University of California System; University of California Berkeley; United States Department of Agriculture (USDA); University of California System; University of California San Francisco; Carnegie Institution for Science	Quail, PH (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	quail@berkeley.edu	Wang, Zhi-Yong/E-3810-2012	Wang, Zhi-Yong/0000-0003-4602-3390; xu, shouling/0000-0002-6741-9506	National Institutes of Health (NIH) [2R01 GM-047475]; U.S. Department of Energy (DOE) [DEFG03-87ER13742]; USDA ARS Current Research Information System [5335-21000-032-00D]; NIH [5R01GM066258, 8P41GM103481, P50 GM082250]; DOE [DEFG02-08ER15973]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066258, P50GM082250, T32GM008284, R01GM047475, P41GM103481] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); USDA ARS Current Research Information System(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. J. Chalkley, A. Pfeiffer, M. Zhuang, and B. A. Schulman for materials and technical assistance and S. McCormick for comments on the manuscript. We also thank the Salk Institute and Arabidopsis Biological Resource Center for the Arabidopsis T-DNA insertion lines. The plasmid pGEX-CUL3 (split 'n' coexpress)-Rbx1 used in the in vitro ubiquitination assays was provided by B. A. Schulman under a materials transfer agreement with St. Jude Children's Research Hospital. For access to this reagent, contact B. A. Schulman. The supplementary materials contain additional data. This work was supported by the National Institutes of Health (NIH) (2R01 GM-047475), the U.S. Department of Energy (DOE) (DEFG03-87ER13742), and USDA ARS Current Research Information System (5335-21000-032-00D) to P. H. Q; by NIH (5R01GM066258) and DOE (DEFG02-08ER15973) to Z.Y.W.; by NIH (8P41GM103481) to A. L. B; and by NIH (P50 GM082250) to J.D.G.	Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; Al-Sady B, 2008, P NATL ACAD SCI USA, V105, P2232, DOI 10.1073/pnas.0711675105; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bae G, 2008, ANNU REV PLANT BIOL, V59, P281, DOI 10.1146/annurev.arplant.59.032607.092859; Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; Christians MJ, 2012, PLANT PHYSIOL, V160, P118, DOI 10.1104/pp.112.199109; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Hua ZH, 2011, ANNU REV PLANT BIOL, V62, P299, DOI 10.1146/annurev-arplant-042809-112256; Jang IC, 2010, PLANT CELL, V22, P2370, DOI 10.1105/tpc.109.072520; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Khanna R, 2007, PLANT CELL, V19, P3915, DOI 10.1105/tpc.107.051508; Leivar P, 2008, CURR BIOL, V18, P1815, DOI 10.1016/j.cub.2008.10.058; Leivar P, 2012, MOL PLANT, V5, P734, DOI 10.1093/mp/sss031; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Lorrain S, 2008, PLANT J, V53, P312, DOI 10.1111/j.1365-313X.2007.03341.x; Monte E, 2004, P NATL ACAD SCI USA, V101, P16091, DOI 10.1073/pnas.0407107101; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Ni WM, 2013, PLANT CELL, V25, P2679, DOI 10.1105/tpc.113.112342; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Shen H, 2008, PLANT CELL, V20, P1586, DOI 10.1105/tpc.108.060020; Shen Y, 2007, PLANT PHYSIOL, V145, P1043, DOI 10.1104/pp.107.105601; Tang XJ, 2012, P NATL ACAD SCI USA, V109, P3287, DOI 10.1073/pnas.1116455109; Yarden Y, 2010, ONCOLOGIST, V15, P1, DOI 10.1634/theoncologist.2010-S5-01; Zhang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003244	25	181	191	4	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1160	1164		10.1126/science.1250778	http://dx.doi.org/10.1126/science.1250778			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904166	Green Accepted			2022-12-01	WOS:000336791200048
J	Yimlamai, D; Christodoulou, C; Galli, GG; Yanger, K; Pepe-Mooney, B; Gurung, B; Shrestha, K; Cahan, P; Stanger, BZ; Camargo, FD				Yimlamai, Dean; Christodoulou, Constantina; Galli, Giorgio G.; Yanger, Kilangsungla; Pepe-Mooney, Brian; Gurung, Basanta; Shrestha, Kriti; Cahan, Patrick; Stanger, Ben Z.; Camargo, Fernando D.			Hippo Pathway Activity Influences Liver Cell Fate	CELL			English	Article							BILE-DUCT DEVELOPMENT; EPITHELIAL-CELLS; TEAD/TEF FAMILY; YAP ONCOPROTEIN; ORGAN SIZE; STEM-CELLS; HEPATOCYTES; PROTEIN; GROWTH; INACTIVATION	The Hippo-signaling pathway is an important regulator of cellular proliferation and organ size. However, little is known about the role of this cascade in the control of cell fate. Employing a combination of lineage tracing, clonal analysis, and organoid culture approaches, we demonstrate that Hippo pathway activity is essential for the maintenance of the differentiated hepatocyte state. Remarkably, acute inactivation of Hippo pathway signaling in vivo is sufficient to dedifferentiate, at very high efficiencies, adult hepatocytes into cells bearing progenitor characteristics. These hepatocyte-derived progenitor cells demonstrate self-renewal and engraftment capacity at the single-cell level. We also identify the NOTCH-signaling pathway as a functional important effector downstream of the Hippo transducer YAP. Our findings uncover a potent role for Hippo/YAP signaling in controlling liver cell fate and reveal an unprecedented level of phenotypic plasticity in mature hepatocytes, which has implications for the understanding and manipulation of liver regeneration.	[Yimlamai, Dean; Christodoulou, Constantina; Galli, Giorgio G.; Pepe-Mooney, Brian; Gurung, Basanta; Shrestha, Kriti; Cahan, Patrick; Camargo, Fernando D.] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Yimlamai, Dean] Boston Childrens Hosp, Dept Med, Div Gastroenterol & Nutr, Boston, MA 02115 USA; [Christodoulou, Constantina; Galli, Giorgio G.; Pepe-Mooney, Brian; Gurung, Basanta; Camargo, Fernando D.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Christodoulou, Constantina; Galli, Giorgio G.; Pepe-Mooney, Brian; Gurung, Basanta; Camargo, Fernando D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Yanger, Kilangsungla; Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Camargo, FD (corresponding author), Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA.	fernando.camargo@childrens.harvard.edu	Yanger, Kilang/N-2888-2015; Yimlamai, Dean/AAA-6607-2020	Yanger, Kilang/0000-0002-1710-5306; Yimlamai, Dean/0000-0002-7936-7168; Galli, Giorgio/0000-0002-9401-060X; camargo, fernando/0000-0002-5630-5909; Cahan, Patrick/0000-0003-3652-2540; Christodoulou, Constantina/0000-0001-5371-2210; Gurung, Basanta/0000-0003-3196-7495	Stand Up to Cancer-AACR initiative; National Institutes of Health [AR064036, DK099559, DK083355]; Department of Defense [W81XWH-9]; Harvard Stem Cell Institute; National Institute of Diabetes and Digestive and Kidney Diseases [5T32 DK007477-27]; Boston Children's Hospital Career Development Award; American-Italian Cancer Foundation postdoctoral research fellowship; National Science Foundation Graduate Research Fellowship Program [DGE1144152]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, K08DK105351, R01DK083355, R01DK099559, T32DK007477] Funding Source: NIH RePORTER	Stand Up to Cancer-AACR initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Harvard Stem Cell Institute; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Boston Children's Hospital Career Development Award; American-Italian Cancer Foundation postdoctoral research fellowship; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful for stimulating discussions with the Camargo lab members, Barbara Trejo for help with IHC, Roderick Bronson for reviewing mouse liver pathology, and Ron Mathieu of the Stem Cell Program FACS facility. We thank G. Gu, T. Honjo, and M. Giovannini for use of Ck19-CreERT, RPBJ, and Nf2 mice, respectively. V. Factor generously donated A6 antibody for our use. This study was supported by awards from the Stand Up to Cancer-AACR initiative (FDC), grants from the National Institutes of Health (AR064036 and DK099559 to F. D. C.; DK083355 to B.Z.S.), a Department of Defense award (W81XWH-9) (to F. D. C.), and Junior Investigator funds from the Harvard Stem Cell Institute (to F. D. C.). D.Y. is supported by the National Institute of Diabetes and Digestive and Kidney Diseases (5T32 DK007477-27) and a Boston Children's Hospital Career Development Award and is a George Ferry Young Investigator (NASPGHAN). G. G. G. is supported by an American-Italian Cancer Foundation postdoctoral research fellowship. B.P.-M. is supported by the National Science Foundation Graduate Research Fellowship Program (DGE1144152). F. D. C. is a Pew Scholar in the Biomedical Sciences.	Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Demetris AJ, 1996, AM J PATHOL, V149, P439; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; ENGELHARDT NV, 1993, DIFFERENTIATION, V55, P19, DOI 10.1111/j.1432-0436.1993.tb00029.x; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; Fan B, 2012, J CLIN INVEST, V122, P2911, DOI 10.1172/JCI63212; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Geisler F, 2008, HEPATOLOGY, V48, P607, DOI 10.1002/hep.22381; Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613; Greenbaum LE, 2011, GASTROENTEROLOGY, V141, P1152, DOI 10.1053/j.gastro.2011.08.023; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hofmann JJ, 2010, DEVELOPMENT, V137, P4061, DOI 10.1242/dev.052118; Home P, 2012, P NATL ACAD SCI USA, V109, P7362, DOI 10.1073/pnas.1201595109; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Kohler C, 2004, HEPATOLOGY, V39, P1056, DOI 10.1002/hep.20156; Komuta M, 2012, HEPATOLOGY, V55, P1876, DOI 10.1002/hep.25595; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Li H, 2012, LIVER INT, V32, P38, DOI 10.1111/j.1478-3231.2011.02646.x; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; McCright B, 2002, DEVELOPMENT, V129, P1075; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Michalopoulos George K, 2012, Hepatology, V55, P2024, DOI 10.1002/hep.25703; Michalopoulos GK, 2005, HEPATOLOGY, V41, P535, DOI 10.1002/hep.20600; Mohseni M, 2014, NAT CELL BIOL, V16, P108, DOI 10.1038/ncb2884; Oertel M, 2008, BBA-MOL BASIS DIS, V1782, P61, DOI 10.1016/j.bbadis.2007.12.004; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Sekiya S, 2012, J CLIN INVEST, V122, P3914, DOI 10.1172/JCI63065; Tanigawa H, 2007, CIRCULATION, V116, P1267, DOI 10.1161/CIRCULATIONAHA.107.704254; Tschaharganeh DF, 2013, GASTROENTEROLOGY, V144, P1530, DOI 10.1053/j.gastro.2013.02.009; Turner R, 2011, HEPATOLOGY, V53, P1035, DOI 10.1002/hep.24157; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Zender S, 2013, CANCER CELL, V23, P784, DOI 10.1016/j.ccr.2013.04.019; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	45	523	543	9	120	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1324	1338		10.1016/j.cell.2014.03.060	http://dx.doi.org/10.1016/j.cell.2014.03.060			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906150	Green Accepted, Bronze			2022-12-01	WOS:000340881400010
J	Eisenstein, M				Eisenstein, Michael			CLINICAL TRIALS More trials, fewer tribulations	NATURE			English	Editorial Material							CELL LUNG-CANCER; GEFITINIB											Hoos WA, 2013, J CLIN ONCOL, V31, P3432, DOI 10.1200/JCO.2013.49.4823; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Prowell TM, 2012, NEW ENGL J MED, V366, P2438, DOI 10.1056/NEJMp1205737; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8	6	1	1	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S55	S57		10.1038/509S55a	http://dx.doi.org/10.1038/509S55a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870821	Bronze			2022-12-01	WOS:000336457100004
J	Trotta, F; Da Cas, R; Alegiani, SS; Gramegna, M; Venegoni, M; Zocchetti, C; Traversa, G				Trotta, Francesco; Da Cas, Roberto; Alegiani, Stefania Spila; Gramegna, Maria; Venegoni, Mauro; Zocchetti, Carlo; Traversa, Giuseppe			Evaluation of safety of A/H1N1 pandemic vaccination during pregnancy: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							H1N1 INFLUENZA; CONGENITAL-ABNORMALITIES; FETAL-DEATH; RISK; OUTCOMES; WOMEN	Objective To assess the risk of maternal, fetal, and neonatal outcomes associated with the administration of an MF59 adjuvanted A/H1N1 vaccine during pregnancy. Design Historical cohort study. Setting Singleton pregnancies of the resident population of the Lombardy region of Italy. Participants All deliveries between 1 October 2009 and 30 September 2010. Data on exposure to A/H1N1 pandemic vaccine, pregnancy, and birth outcomes were retrieved from regional databases. Vaccinated and non-vaccinated women were compared in a propensity score matched analysis to estimate risks of adverse outcomes. Main outcome measures Main maternal outcomes included type of delivery, admission to intensive care unit, eclampsia, and gestational diabetes; fetal and neonatal outcomes included perinatal deaths, small for gestational age births, and congenital malformations. Results Among the 86 171 eligible pregnancies, 6246 women were vaccinated (3615 (57.9%) in the third trimester and 2557 (40.9%) in the second trimester). No difference was observed in terms of spontaneous deliveries (adjusted odds ratio 1.02, 95% confidence interval 0.96 to 1.08) or admissions to intensive care units (0.95, 0.47 to 1.88), whereas a limited increase in the prevalence of gestational diabetes (1.26, 1.04 to 1.53) and eclampsia (1.19, 1.04 to 1.39) was seen in vaccinated women. Rates of fetal and neonatal outcomes were similar in vaccinated and non-vaccinated women. A slight increase in congenital malformations, although not statistically significant, was present in the exposed cohort (1.14, 0.99 to 1.31). Conclusions Our findings add relevant information about the safety of the MF59 adjuvanted A/H1N1 vaccine in pregnancy. Residual confounding may partly explain the increased risk of some maternal outcomes. Meta-analysis of published studies should be conducted to further clarify the risk of infrequent outcomes, such as specific congenital malformations.	[Trotta, Francesco; Da Cas, Roberto; Alegiani, Stefania Spila; Traversa, Giuseppe] Natl Inst Hlth, Natl Ctr Epidemiol, Pharmacoepidemiol Unit, I-00161 Rome, Italy; [Trotta, Francesco] Italian Med Agcy AIFA, Pharmacovigilance Unit, I-00187 Rome, Italy; [Gramegna, Maria] Gen Directorate Hlth, Unit Prevent Med, I-20124 Milan, Italy; [Venegoni, Mauro] Gen Directorate Hlth, Reg Ctr Pharmacovigilance, I-20124 Milan, Italy; [Zocchetti, Carlo] Gen Directorate Hlth, Unit Local Hlth Serv Governance, I-20124 Milan, Italy	Istituto Superiore di Sanita (ISS)	Traversa, G (corresponding author), Natl Inst Hlth, Natl Ctr Epidemiol, Pharmacoepidemiol Unit, Viale Regina Elena 299, I-00161 Rome, Italy.	giuseppe.traversa@iss.it	Trotta, Francesco/G-8702-2013; Venegoni, Mauro/H-3416-2019	Trotta, Francesco/0000-0001-6889-8484; Venegoni, Mauro/0000-0002-5462-5327				Acs N, 2005, BIRTH DEFECTS RES A, V73, P989, DOI 10.1002/bdra.20195; [Anonymous], MALF COD GUID; Chan M., 2009, WORLD NOW START 2009; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Conlin AMS, 2013, OBSTET GYNECOL, V121, P511, DOI 10.1097/AOG.0b013e318280d64e; Czeizel AE, 2008, BIRTH DEFECTS RES A, V82, P139, DOI 10.1002/bdra.20431; European Medicines Agency European Centre for Disease Prevention and Control, 2009, EUR STRAT INFL A H1N; Fell Deshayne B, 2012, Am J Public Health, V102, pe33, DOI 10.2105/AJPH.2011.300606; GRIFFITH GW, 1972, BMJ-BRIT MED J, V3, P553, DOI 10.1136/bmj.3.5826.553; Haberg SE, 2013, NEW ENGL J MED, V368, P333, DOI 10.1056/NEJMoa1207210; Heikkinen T, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.007; Jamieson DJ, 2012, AM J OBSTET GYNECOL, V207, P145, DOI 10.1016/j.ajog.2012.07.011; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kallen B, 2012, BJOG-INT J OBSTET GY, V119, P1583, DOI 10.1111/j.1471-0528.2012.03470.x; Laibl VR, 2005, CLIN PERINATOL, V32, P727, DOI 10.1016/j.clp.2005.04.009; Ludvigsson JF, 2013, EUR J EPIDEMIOL, V28, P579, DOI 10.1007/s10654-013-9813-z; Mak TK, 2008, LANCET INFECT DIS, V8, P44, DOI 10.1016/S1473-3099(07)70311-0; Mereckiene J, 2012, EURO SURVEILL, V17; Ministero del Lavoro della Salute e delle Politiche Sociali, 2009, MIS URG MAT PROT VIR; Nishiura H, 2009, EUR J OBSTET GYN R B, V147, P115, DOI 10.1016/j.ejogrb.2009.07.009; Oppermann M, 2012, VACCINE, V30, P4445, DOI 10.1016/j.vaccine.2012.04.081; Pasternak B, 2012, JAMA-J AM MED ASSOC, V308, P165, DOI 10.1001/jama.2012.6131; Pasternak B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2794; Richards JL, 2013, CLIN INFECT DIS, V56, P1216, DOI 10.1093/cid/cit045; Rubinstein F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f393; Sammon CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051734; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; Steinhoff MC, 2012, JAMA-J AM MED ASSOC, V308, P184, DOI 10.1001/jama.2012.7911; VAILLANT L, 2009, EURO SURVEILL, V14	29	31	31	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2014	348								g3361	10.1136/bmj.g3361	http://dx.doi.org/10.1136/bmj.g3361			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EK	24874845	Green Published, hybrid			2022-12-01	WOS:000336742400003
J	Browne, KM; Murphy, O; Clover, AJP				Browne, Katherine M.; Murphy, Olive; Clover, A. James P.			UNCERTAINTIES PAGE Should we advise patients with sutures not to swim?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RECREATIONAL WATER; UNITED-STATES; HEALTH EVENTS; SURVEILLANCE; OUTBREAKS; DISEASE		[Browne, Katherine M.; Clover, A. James P.] Cork Univ Hosp, Dept Plast Surg, Cork, Ireland; [Murphy, Olive] Bon Secour Hosp, Dept Pathol, Cork, Ireland	University College Cork	Browne, KM (corresponding author), Cork Univ Hosp, Dept Plast Surg, Cork, Ireland.	katheribrowne@rcsi.ie						AUERBACH PS, 1987, ANN EMERG MED, V16, P643, DOI 10.1016/S0196-0644(87)80061-6; Barna Z, 2012, ANN I SUPER SANITA, V48, P374, DOI 10.4415/ANN_12_04_05; Bross MH, 2007, AM FAM PHYSICIAN, V76, P539; Cappello MA, 2011, J ENVIRON HEALTH, V73, P19; Fernandez R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003861.pub3; Finkelstein Renato, 2011, Curr Infect Dis Rep, V13, P470, DOI 10.1007/s11908-011-0199-3; GOLD WL, 1993, CLIN INFECT DIS, V16, P69, DOI 10.1093/clinids/16.1.69; Hlavsa Michele C., 2011, Morbidity and Mortality Weekly Report, V60, P1; NHS, 2012, SOON CAN I GO SWIMM; NHS, 2013, ADV PAT UND FRAM SUR; Rich L, 2012, WIDE LOCAL EXCISION; SCHLECH WF, 1986, CAN MED ASSOC J, V134, P909; Toon CD, 2013, COCHRANE DB SYST REV, V10; WHO, 2003, GUID SAF RECR WAT EN; Women's N.C.C.f. and C.s. Health., 2008, SURG SIT INF PREV TR; Yoder Jonathan S, 2008, MMWR Surveill Summ, V57, P1	16	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2014	348								g3171	10.1136/bmj.g3171	http://dx.doi.org/10.1136/bmj.g3171			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH9AC	24859900				2022-12-01	WOS:000336429700001
J	Steen, R; Jana, S; Reza-Paul, S; Richter, M				Steen, Richard; Jana, Smarajit; Reza-Paul, Sushena; Richter, Marlise			Trafficking, sex work, and HIV: efforts to resolve conflicts	LANCET			English	Editorial Material							HARM REDUCTION; PREVENTION; PROSTITUTION; POLICY		[Steen, Richard] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 Rotterdam, Netherlands; [Steen, Richard; Jana, Smarajit] Durbar Mahila Samanwaya Comm, Kolkata, W Bengal, India; [Reza-Paul, Sushena] Univ Manitoba, Community Hlth Serv, Winnipeg, MB R3T 2N2, Canada; [Reza-Paul, Sushena] Ashodaya Samithi, Mysore, Karnataka, India; [Richter, Marlise] Univ Witwatersrand, African Ctr Migrat & Soc, Johannesburg, South Africa; [Richter, Marlise] Sonke Gender Justice, Cape Town, South Africa; [Richter, Marlise] Univ Cape Town, Dept Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa	Erasmus University Rotterdam; Erasmus MC; University of Manitoba; University of Witwatersrand; University of Cape Town	Steen, R (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 Rotterdam, Netherlands.	steenr7@gmail.com						Brandt AM., 1985, NO MAGIC BULLET SOCI; Busza J, 2006, HEALTH POLICY PLANN, V21, P329, DOI 10.1093/heapol/czl016; Busza Joanna, 2004, HLTH HUMAN RIGHTS, V7, P231, DOI DOI 10.2307/4065357; Butcher K, 2003, LANCET, V361, P1983, DOI 10.1016/S0140-6736(03)13596-9; Decker MR, 2014, LANCET; Ditmore MH, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17354; Jana S, 2006, LANCET, V367, P814, DOI 10.1016/S0140-6736(06)68331-1; Jana S, 2013, J PUBLIC HLTH OXF; Pearshouse Richard, 2008, HIV AIDS Policy Law Rev, V13, P21; Rekart ML, 2005, LANCET, V366, P2123, DOI 10.1016/S0140-6736(05)67732-X; Reza-Paul S, 2012, INDIAN J MED RES, V135, P98, DOI 10.4103/0971-5916.93431; Richter M, 2014, J IMMIGR MINOR HEALT, V16, P7, DOI 10.1007/s10903-012-9758-4; Richter ML, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-1; Shahmanesh M, 2009, SOC SCI MED, V69, P604, DOI 10.1016/j.socscimed.2009.06.020; Thomson N, 2012, HARM REDUCT J, V9, DOI 10.1186/1477-7517-9-31; Weitzer R, 2014, ANN AM ACAD POLIT SS, V653, P6, DOI 10.1177/0002716214521562	16	15	15	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2015	385	9963					94	96		10.1016/S0140-6736(14)60966-1	http://dx.doi.org/10.1016/S0140-6736(14)60966-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY7BI	25059945				2022-12-01	WOS:000347715900006
J	Xu, H; Yang, JL; Gao, WQ; Li, L; Li, P; Zhang, L; Gong, YN; Peng, XL; Xi, JZJ; Chen, S; Wang, FC; Shao, F				Xu, Hao; Yang, Jieling; Gao, Wenqing; Li, Lin; Li, Peng; Zhang, Li; Gong, Yi-Nan; Peng, Xiaolan; Xi, Jianzhong Jeff; Chen, She; Wang, Fengchao; Shao, Feng			Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome	NATURE			English	Article							FAMILIAL MEDITERRANEAN FEVER; GTP-BINDING PROTEINS; CLOSTRIDIUM-DIFFICILE; BURKHOLDERIA-CENOCEPACIA; TOXIN-B; ACTIN CYTOSKELETON; VIBRIO-CHOLERAE; RTX TOXIN; ACTIVATION; SYSTEM	Cytosolic inflammasome complexes mediated by a pattern recognition receptor (PRR) defend against pathogen infection by activating caspase 1. Pyrin, a candidate PRR, can bind to the inflammasome adaptor ASC to form a caspase 1-activating complex(1,2). Mutations in the Pyrin-encoding gene, MEFV, cause a human autoinflammatory disease known as familial Mediterranean fever(3-5). Despite important roles in immunity and disease, the physiological function of Pyrin remains unknown. Here we show that Pyrin mediates caspase 1 inflammasome activation in response to Rho-glucosylation activity of cytotoxin TcdB(6-8), a major virulence factor of Clostridium difficile, which causes most cases of nosocomial diarrhoea. The glucosyltransferase-inactive TcdB mutant loses the inflammasome-stimulating activity. Other Rho-inactivating toxins, including FIC-domain adenylyltransferases (Vibrioparahaemolyticus VopS and Histophilus somnilbpA) and Clostridium botulinum ADP-ribosylating C3 toxin, can also biochemically activate the Pyrin inflammasome in their enzymatic activitydependent manner. These toxins all target the Rho subfamily and modify a switch-I residue. We further demonstrate that Burkholderia cenocepacia inactivates RHOA by deamidating Asn 41, also in the switch-I region, and thereby triggers Pyrin inflammasome activation, both of which require the bacterial type VI secretion system (T6SS). Loss of the Pyrin inflammasome causes elevated intra-macrophage growth of B. cenocepacia and diminished lung inflammation in mice. Thus, Pyrin functions to sense pathogen modification and inactivation of Rho GTPases, representing a new paradigm in mammalian innate immunity.	[Xu, Hao; Yang, Jieling; Gao, Wenqing; Li, Lin; Li, Peng; Zhang, Li; Gong, Yi-Nan; Peng, Xiaolan; Chen, She; Wang, Fengchao; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Yang, Jieling; Shao, Feng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Xi, Jianzhong Jeff] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China; [Shao, Feng] Collaborat Innovat Ctr Canc Med, Beijing 102206, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Biophysics, CAS; Peking University	Shao, F (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	shaofeng@nibs.ac.cn	Xi, Jianzhong/J-1420-2014	Xu, Hao/0000-0003-3286-0710	International Early Career Scientist grant from the Howard Hughes Medical Institute; National Basic Research Program of China 973 Program [2012CB518700]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08020202]; China National Science Foundation Program for Distinguished Young Scholars [31225002]	International Early Career Scientist grant from the Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Basic Research Program of China 973 Program(National Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); China National Science Foundation Program for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC))	We thank V. Dixit for providing knockout mice and anti-ASC antibody, D. Lyras for C. sordellii genomic DNA, J. Xiao for IbpA-Fic constructs, T. Iida for V. parahaemolyticus strain, M. Valvano for pDAI-Scel vector and H. Feng for TcdB B. megaterium expression system. We thank members of the Shao laboratory for discussions. The research was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute to F.S. This work was also supported by the National Basic Research Program of China 973 Program (2012CB518700), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB08020202) and China National Science Foundation Program for Distinguished Young Scholars (31225002) to F.S.	AKTORIES K, 1989, TRENDS PHARMACOL SCI, V10, P415, DOI 10.1016/0165-6147(89)90191-0; Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; [Anonymous], 1997, CELL, V90, P797; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Boyer L, 2011, IMMUNITY, V35, P536, DOI 10.1016/j.immuni.2011.08.015; Bruno VM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000538; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; Flannagan RS, 2008, ENVIRON MICROBIOL, V10, P1652, DOI 10.1111/j.1462-2920.2008.01576.x; Flannagan RS, 2012, CELL MICROBIOL, V14, P239, DOI 10.1111/j.1462-5822.2011.01715.x; French FMF Consortium, 1997, NATURE GENET, V17, P25; Fukazawa A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000228; Gavrilin MA, 2012, J IMMUNOL, V188, P3469, DOI 10.4049/jimmunol.1102272; Gong YN, 2010, CELL RES, V20, P1289, DOI 10.1038/cr.2010.135; Higa N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003142; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Jank T, 2007, J BIOL CHEM, V282, P35222, DOI 10.1074/jbc.M703138200; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Just I, 1996, J BIOL CHEM, V271, P10149, DOI 10.1074/jbc.271.17.10149; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Keestra AM, 2013, NATURE, V496, P233, DOI 10.1038/nature12025; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Mattoo S, 2011, J BIOL CHEM, V286, P32834, DOI 10.1074/jbc.M111.227603; Ng J., 2010, GASTROENTEROLOGY, V139; Popoff MR, 1996, J BIOL CHEM, V271, P10217, DOI 10.1074/jbc.271.17.10217; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Richards N, 2001, J BIOL CHEM, V276, P39320, DOI 10.1074/jbc.M104730200; Rosales-Reyes R, 2012, CELL MICROBIOL, V14, P255, DOI 10.1111/j.1462-5822.2011.01716.x; Seshadri S, 2007, J IMMUNOL, V179, P1274, DOI 10.4049/jimmunol.179.2.1274; Sheahan KL, 2007, CELL MICROBIOL, V9, P1324, DOI 10.1111/j.1462-5822.2006.00876.x; Waite AL, 2009, EXP BIOL MED, V234, P40, DOI 10.3181/0806-RM-184; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192; Yang JL, 2013, P NATL ACAD SCI USA, V110, P14408, DOI 10.1073/pnas.1306376110; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	39	495	513	7	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					237	+		10.1038/nature13449	http://dx.doi.org/10.1038/nature13449			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	24919149	Bronze			2022-12-01	WOS:000341362800051
J	Gostin, LO				Gostin, Lawrence O.			The ACA's Contraceptive Mandate Religious Freedom, Women's Health, and Corporate Personhood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], NONCONTRACEPTIVE BEN; Cohen IG, 2014, NEW ENGL J MED, V371, P596, DOI 10.1056/NEJMp1407965; Gemzell-Danielsson K, 2013, CONTRACEPTION, V87, P300, DOI 10.1016/j.contraception.2012.08.021; Gossett DR, 2013, JAMA-J AM MED ASSOC, V309, P1997, DOI 10.1001/jama.2013.4262; LIPTAK A, 2013, NY TIMES, pA1; Wiley Lindsay F., 2016, PUBL HLTH LAW POW, V3rd	6	8	8	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2014	312	8					785	786		10.1001/jama.2014.9455	http://dx.doi.org/10.1001/jama.2014.9455			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7NX	25014562				2022-12-01	WOS:000340788500015
J	Belew, AT; Meskauskas, A; Musalgaonkar, S; Advani, VM; Sulima, SO; Kasprzak, WK; Shapiro, BA; Dinman, JD				Belew, Ashton Trey; Meskauskas, Arturas; Musalgaonkar, Sharmishtha; Advani, Vivek M.; Sulima, Sergey O.; Kasprzak, Wojciech K.; Shapiro, Bruce A.; Dinman, Jonathan D.			Ribosomal frameshifting in the CCR5 mRNA is regulated by miRNAs and the NMD pathway	NATURE			English	Article							TRANSLATIONAL FIDELITY; SEQUENCE ALIGNMENT; GENE; MODEL; EFFICIENCY; DATABASE; BINDING; VERSION; SIGNAL; CELLS	Programmed -1 ribosomal frameshift (-1 PRF) signals redirect translating ribosomes to slip back one base on messenger RNAs. Although well characterizedin viruses, how these elements may regulate cellular gene expression is not understood. Here we describe a -1 PRF signal in the human mRNA encoding CCR5, the HIV-1 co-receptor. CCR5 mRNA-mediated -1 PRF is directed by an mRNA pseudoknot, and is stimulated by at least two microRNAs. Mapping the mRNA-miRNA interaction suggests that formation of a triplex RNA structure stimulates -1 PRF. A -1 PRF event on the CCR5 mRNA directs translating ribosomes to a premature termination codon, destabilizing it through the nonsense-mediated mRNA decay pathway. At least one additional mRNA decay pathway is also involved. Functional -1 PRF signals that seem to be regulated by miRNAs are also demonstrated in mRNAs encoding six other cytokine receptors, suggesting a novel mode through which immune responses may be fine-tuned in mammalian cells.	[Belew, Ashton Trey; Meskauskas, Arturas; Musalgaonkar, Sharmishtha; Advani, Vivek M.; Sulima, Sergey O.; Dinman, Jonathan D.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Meskauskas, Arturas] Vilnius State Univ, Dept Biotechnol & Microbiol, LT-03101 Vilnius, Lithuania; [Kasprzak, Wojciech K.] Leidos Biomed Res Inc, Basic Sci Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Shapiro, Bruce A.] NCI, Basic Res Lab, Frederick, MD 21702 USA	University System of Maryland; University of Maryland College Park; Vilnius University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dinman, JD (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	dinman@umd.edu	Advani, Vivek/L-1827-2019	Advani, Vivek/0000-0002-0584-8989; Dinman, Jonathan/0000-0002-2402-9698	National Institutes of Health [5 R01GM058859, R21GM068123]; National Science Foundation [MCB-0084559]; University of Maryland College of CMNS Hockmeyer Fellowship; NIH/NIGMS [T32GM080201]; Frederick National Laboratory for Cancer Research, NIH [HHSN261200800001E]; Intramural Research Program of the National Institutes of Health, Center for Cancer Research;  [NIH/NIAIDT32AI051967]; NATIONAL CANCER INSTITUTE [ZIABC008382] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI051967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117177, T32GM080201, R21GM068123, R01GM058859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of Maryland College of CMNS Hockmeyer Fellowship; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Frederick National Laboratory for Cancer Research, NIH; Intramural Research Program of the National Institutes of Health, Center for Cancer Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants to J.D.D. from the National Institutes of Health (5 R01GM058859, R21GM068123) and from the National Science Foundation(MCB-0084559). A. T. B. was supported by NIH/NIAID T32AI051967, and a University of Maryland College of CMNS Hockmeyer Fellowship. S.O.S. was supported by NIH/NIGMS T32GM080201. This publication has also been funded in part with federal funds from the Frederick National Laboratory for Cancer Research, NIH, under Contract HHSN261200800001E to W. K. K. This research was supported in part by the Intramural Research Program of the National Institutes of Health, Center for Cancer Research to B. A. S. The content of this publication does not necessarily reflect the views or policies of the DHHS, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Advani VM, 2013, TRANSLATION, V1, DOI 10.4161/trla.24418; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Belew AT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-339; Belew AT, 2011, NUCLEIC ACIDS RES, V39, P2799, DOI 10.1093/nar/gkq1220; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Case D.A., 2014, AMBER 2014; Clark MB, 2007, J BIOL CHEM, V282, P37359, DOI 10.1074/jbc.M705676200; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; de Messieres M, 2014, BIOPHYS J, V106, P244, DOI 10.1016/j.bpj.2013.09.036; DINMAN JD, 1992, J VIROL, V66, P3669, DOI 10.1128/JVI.66.6.3669-3676.1992; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Dinman JD, 2010, NUCLEIC ACIDS MOL BI, V24, P321, DOI 10.1007/978-0-387-89382-2_15; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grentzmann G, 1998, RNA, V4, P479; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hekman KE, 2012, HUM MOL GENET, V21, P5472, DOI 10.1093/hmg/dds392; Houck-Loomis B, 2011, NATURE, V480, P561, DOI 10.1038/nature10657; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; HU JC, 1983, NUCLEIC ACIDS RES, V11, P4823, DOI 10.1093/nar/11.14.4823; Jack K, 2011, MOL CELL, V44, P660, DOI 10.1016/j.molcel.2011.09.017; Jacobs JL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh157; Jin H, 2009, MOL CELL BIOL, V29, P5789, DOI 10.1128/MCB.00653-09; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Manktelow E, 2005, NUCLEIC ACIDS RES, V33, P1553, DOI 10.1093/nar/gki299; Martinez HM, 2008, J BIOMOL STRUCT DYN, V25, P669, DOI 10.1080/07391102.2008.10531240; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Orom UA, 2007, METHODS, V43, P162, DOI 10.1016/j.ymeth.2007.04.007; PEATTIE DA, 1980, P NATL ACAD SCI-BIOL, V77, P4679, DOI 10.1073/pnas.77.8.4679; Plant EP, 2005, NUCLEIC ACIDS RES, V33, P1825, DOI 10.1093/nar/gki329; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Popenda M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks339; Popenda M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-231; Ritchie DB, 2012, P NATL ACAD SCI USA, V109, P16167, DOI 10.1073/pnas.1204114109; Staple DW, 2005, J MOL BIOL, V349, P1011, DOI 10.1016/j.jmb.2005.03.038; Sulima SO, 2014, P NATL ACAD SCI USA, V111, P5640, DOI 10.1073/pnas.1400247111; Temple G, 2009, GENOME RES, V19, P2324, DOI 10.1101/gr.095976.109; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wills NM, 2006, J BIOL CHEM, V281, P7082, DOI 10.1074/jbc.M511629200; Ysla RM, 2008, METHOD ENZYMOL, V449, P47, DOI 10.1016/S0076-6879(08)02403-8; Zhang YW, 1999, MOL BIOL EVOL, V16, P1145, DOI 10.1093/oxfordjournals.molbev.a026205	48	102	105	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					265	+		10.1038/nature13429	http://dx.doi.org/10.1038/nature13429			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25043019	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000340508200025
J	Dore, AS; Okrasa, K; Patel, JC; Serrano-Vega, M; Bennett, K; Cooke, RM; Errey, JC; Jazayeri, A; Khan, S; Tehan, B; Weir, M; Wiggin, GR; Marshall, FH				Dore, Andrew S.; Okrasa, Krzysztof; Patel, Jayesh C.; Serrano-Vega, Maria; Bennett, Kirstie; Cooke, Robert M.; Errey, James C.; Jazayeri, Ali; Khan, Samir; Tehan, Ben; Weir, Malcolm; Wiggin, Giselle R.; Marshall, Fiona H.			Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; ALLOSTERIC MODULATORS; HEPTAHELICAL DOMAIN; CRYSTAL-STRUCTURE; BINDING POCKETS; ACTIVATION; FAMILY; THERMOSTABILIZATION; ANTAGONISTS; MUTATIONS	Metabotropic glutamate receptors are class C G-protein-coupled receptors which respond to the neurotransmitter glutamate. Structural studies have been restricted to the amino-terminal extracellular domain, providing little understanding of the membrane-spanning signal transduction domain. Metabotropic glutamate receptor 5 is of considerable interest as a drug target in the treatment of fragile X syndrome, autism, depression, anxiety, addiction and movement disorders. Here we report the crystal structure of the transmembrane domain of the human receptor in complex with the negative allosteric modulator, mavoglurant. The structure provides detailed insight into the architecture of the transmembrane domain of class C receptors including the precise location of the allosteric binding site within the transmem-branedomain and key micro-switches which regulate receptor signalling. This structure also provides a model for all class CG-protein-coupled receptors and may aid in the design of new small-molecule drugs for the treatment of brain disorders.	[Dore, Andrew S.; Okrasa, Krzysztof; Patel, Jayesh C.; Serrano-Vega, Maria; Bennett, Kirstie; Cooke, Robert M.; Errey, James C.; Jazayeri, Ali; Khan, Samir; Tehan, Ben; Weir, Malcolm; Wiggin, Giselle R.; Marshall, Fiona H.] Heptares Therapeut Ltd, Welwyn Garden City AL7 3AX, Herts, England	Heptares Therapeutics Ltd.	Marshall, FH (corresponding author), Heptares Therapeut Ltd, BioPk,Broadwater Rd, Welwyn Garden City AL7 3AX, Herts, England.	fiona.marshall@heptares.com	Marshall, Fiona/AAZ-9626-2020	Wiggin, Giselle/0000-0003-4436-9208; Marshall, Fiona/0000-0002-8681-005X				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI DOI 10.1016/S1043-9471(05)80049-7; Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Beqollari D, 2009, MOL PHARMACOL, V76, P992, DOI 10.1124/mol.109.058628; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Brauner-Osborne H, 2007, CURR DRUG TARGETS, V8, P169, DOI 10.2174/138945007779315614; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chang WH, 2000, J BIOL CHEM, V275, P19955, DOI 10.1074/jbc.M909613199; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; El Moustaine D, 2012, P NATL ACAD SCI USA, V109, P16342, DOI 10.1073/pnas.1205838109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gasparini F, 2002, BIOORG MED CHEM LETT, V12, P407, DOI 10.1016/S0960-894X(01)00767-3; Goudet C, 2004, P NATL ACAD SCI USA, V101, P378, DOI 10.1073/pnas.0304699101; Gregory KJ, 2013, MOL PHARMACOL, V83, P991, DOI 10.1124/mol.112.083949; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Hu JX, 2007, J CELL MOL MED, V11, P908, DOI 10.1111/j.1582-4934.2007.00096.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lebon G, 2011, J MOL BIOL, V409, P298, DOI 10.1016/j.jmb.2011.03.075; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Levenga J, 2011, NEUROBIOL DIS, V42, P311, DOI 10.1016/j.nbd.2011.01.022; Li GY, 2013, PHARM PAT ANAL, V2, P767, DOI [10.4155/PPA.13.58, 10.4155/ppa.13.58]; Malherbe P, 2003, MOL PHARMACOL, V64, P823, DOI 10.1124/mol.64.4.823; Malherbe P, 2006, J NEUROCHEM, V98, P601, DOI 10.1111/j.1471-4159.2006.03886.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; O'Brien JA, 2003, MOL PHARMACOL, V64, P731, DOI 10.1124/mol.64.3.731; Pagano A, 2000, J BIOL CHEM, V275, P33750, DOI 10.1074/jbc.M006230200; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Robertson N, 2011, NEUROPHARMACOLOGY, V60, P36, DOI 10.1016/j.neuropharm.2010.07.001; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; SHIGEMOTO R, 1993, NEUROSCI LETT, V163, P53, DOI 10.1016/0304-3940(93)90227-C; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stauffer SR, 2011, ACS CHEM NEUROSCI, V2, P450, DOI 10.1021/cn2000519; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489	50	315	327	7	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					557	+		10.1038/nature13396	http://dx.doi.org/10.1038/nature13396			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25042998				2022-12-01	WOS:000339566300027
J	Kelly, BT; Graham, SC; Liska, N; Dannhauser, PN; Honing, S; Ungewickell, EJ; Owen, DJ				Kelly, Bernard T.; Graham, Stephen C.; Liska, Nicole; Dannhauser, Philip N.; Hoening, Stefan; Ungewickell, Ernst J.; Owen, David J.			AP2 controls clathrin polymerization with a membrane-activated switch	SCIENCE			English	Article							ADAPTER COMPLEX; COATED VESICLES; PROTEINS; CARGO; RECRUITMENT; PIT; ENDOCYTOSIS; DYNAMIN	Clathrin-mediated endocytosis (CME) is vital for the internalization of most cell-surface proteins. In CME, plasma membrane-binding clathrin adaptors recruit and polymerize clathrin to form clathrin-coated pits into which cargo is sorted. Assembly polypeptide 2 (AP2) is the most abundant adaptor and is pivotal to CME. Here, we determined a structure of AP2 that includes the clathrin-binding beta 2 hinge and developed an AP2-dependent budding assay. Our findings suggest that an autoinhibitory mechanism prevents clathrin recruitment by cytosolic AP2. A large-scale conformational change driven by the plasma membrane phosphoinositide phosphatidylinositol 4,5-bisphosphate and cargo relieves this autoinhibition, triggering clathrin recruitment and hence clathrin-coated bud formation. This molecular switching mechanism can couple AP2's membrane recruitment to its key functions of cargo and clathrin binding.	[Kelly, Bernard T.; Liska, Nicole; Owen, David J.] Univ Cambridge, CIMR, Dept Clin Biochem, Cambridge CB2 0XY, England; [Graham, Stephen C.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Dannhauser, Philip N.; Ungewickell, Ernst J.] Hannover Med Sch, Dept Cell Biol, Ctr Anat, D-30625 Hannover, Germany; [Hoening, Stefan] Univ Cologne, Inst Biochem 1, D-50931 Cologne, Germany; [Hoening, Stefan] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	University of Cambridge; University of Cambridge; Hannover Medical School; University of Cologne; University of Cologne	Kelly, BT (corresponding author), Univ Cambridge, CIMR, Dept Clin Biochem, Hills Rd, Cambridge CB2 0XY, England.	btk1000@cam.ac.uk; djo30@cam.ac.uk	Dannhauser, Philip/A-5675-2018	Dannhauser, Philip/0000-0002-6749-7678; Graham, Stephen/0000-0003-4547-4034	Wellcome Trust [090909/Z/09/Z, 079895]; German Science Foundation [SFB 635, TP A3]; Royal Society [098406/Z/12/Z]	Wellcome Trust(Wellcome Trust); German Science Foundation(German Research Foundation (DFG)); Royal Society(Royal Society of London)	We would like to thank the I02, I03, and I04-1 beamline staff at the Diamond Lightsource; A. McCoy and P. Evans for crystallographic advice; C. Oubridge for advice and assistance with SeMet mapping of the hinge residues; N. Bright, C. Savva, and S. Miller for advice and assistance with EM; C. Smith for reagents; and H. B ning and H. Ungewickell for expert technical assistance. D.J.O. and B. T. K. are supported by a Wellcome Trust Principal Research fellowship (090909/Z/09/Z). S. H. is supported by a grant of the German Science Foundation (SFB 635, TP A3). S. C. G. is supported by a Sir Henry Dale fellowship from the Wellcome Trust and the Royal Society (098406/Z/12/Z). CIMR is supported by a Wellcome Trust Strategic Award (079895). Coordinates have been deposited in the Protein Data Bank with PDB ID 4uqi.	Aguet F, 2013, DEV CELL, V26, P279, DOI 10.1016/j.devcel.2013.06.019; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Borner GHH, 2012, J CELL BIOL, V197, P141, DOI 10.1083/jcb.201111049; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Dannhauser PN, 2012, NAT CELL BIOL, V14, P634, DOI 10.1038/ncb2478; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Hirst J, 2013, MOL BIOL CELL, V24, P2558, DOI 10.1091/mbc.E13-03-0170; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; LINDNER R, 1992, J BIOL CHEM, V267, P16567; Liu AP, 2010, J CELL BIOL, V191, P1381, DOI 10.1083/jcb.201008117; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Ren XF, 2013, CELL, V152, P755, DOI 10.1016/j.cell.2012.12.042; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Traub LM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001037; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; ZAREMBA S, 1983, J CELL BIOL, V97, P1339, DOI 10.1083/jcb.97.5.1339	24	138	139	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					459	463		10.1126/science.1254836	http://dx.doi.org/10.1126/science.1254836			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061211	Green Accepted			2022-12-01	WOS:000339655100045
J	Fauci, AS; Marston, HD; Folkers, GK				Fauci, Anthony S.; Marston, Hilary D.; Folkers, Gregory K.			An HIV Cure Feasibility, Discovery, and Implementation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CCR5		[Fauci, Anthony S.; Marston, Hilary D.; Folkers, Gregory K.] NIAID, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov						Balazs AB, 2014, NAT MED, V20, P296, DOI 10.1038/nm.3471; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; UN Joint Programme on HIV/AIDS (UNAIDS), GLOB REP UN REP GLOB; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052	8	25	25	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					335	336		10.1001/jama.2014.4754	http://dx.doi.org/10.1001/jama.2014.4754			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038345				2022-12-01	WOS:000339257800013
J	Edenhofer, O; Minx, J				Edenhofer, Ottmar; Minx, Jan			Mapmakers and navigators, facts and values	SCIENCE			English	Editorial Material													Edenhofer, Ottmar/E-1886-2013; Minx, Jan C/AAC-5948-2019	Edenhofer, Ottmar/0000-0001-6029-5208; Minx, Jan C/0000-0002-2862-0178				Intergovernmental Panel Climate Change Working Grp III, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P1	1	44	44	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					37	38		10.1126/science.1255998	http://dx.doi.org/10.1126/science.1255998			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2XU	24994640				2022-12-01	WOS:000338284400039
J	Foth, C; Tischlinger, H; Rauhut, OWM				Foth, Christian; Tischlinger, Helmut; Rauhut, Oliver W. M.			New specimen of Archaeopteryx provides insights into the evolution of pennaceous feathers	NATURE			English	Article							LONG FEATHERS; CHINA; DINOSAUR; FLIGHT; THEROPOD; PLUMAGE; ORIGIN; BIRDS	Discoveries of bird-like theropod dinosaurs and basal avialans in recent decades have helped to put the iconic 'Urvogel' Archaeopteryx(1) into context(2-6) and have yielded important new data on the origin and early evolution of feathers(7). However, the biological context under which pennaceous feathers evolved is still debated. Here we describe a new specimen of Archaeopteryx with extensive feather preservation, not only on the wings and tail, but also on the body and legs. The new specimen shows that the entire body was covered in pennaceous feathers, and that the hindlimbs had long, symmetrical feathers along the tibiotarsus but short feathers on the tarsometatarsus. Furthermore, the wing plumage demonstrates that several recent interpretations(8,9) are problematic. An analysis of the phylogenetic distribution of pennaceous feathers on the tail, hindlimb and arms of advanced maniraptorans and basal avialans strongly indicates that these structures evolved in a functional context other than flight, most probably in relation to display, as suggested by some previous studies(10-12). Pennaceous feathers thus represented an exaptation and were later, in several lineages and following different patterns, recruited for aerodynamic functions. This indicates that the origin of flight in avialans was more complex than previously thought and might have involved several convergent achievements of aerial abilities.	[Foth, Christian; Rauhut, Oliver W. M.] Bayer Staatssammlung Palaontol & Geol, Staatliche Nat Wissenschaftliche Sammlungen Bayer, D-80333 Munich, Germany; [Foth, Christian; Rauhut, Oliver W. M.] Univ Munich, Dept Earth & Environm Sci, D-80333 Munich, Germany; [Foth, Christian; Rauhut, Oliver W. M.] Univ Munich, GeoBioCtr, D-80333 Munich, Germany	University of Munich; University of Munich	Rauhut, OWM (corresponding author), Bayer Staatssammlung Palaontol & Geol, Staatliche Nat Wissenschaftliche Sammlungen Bayer, Richard Wagner Str 10, D-80333 Munich, Germany.	o.rauhut@lrz.uni-muenchen.de	Rauhut, Oliver/AAG-1029-2020	Rauhut, Oliver/0000-0003-3958-603X	Volkswagen Foundation [I/84 640]	Volkswagen Foundation(Volkswagen)	We thank B. Pohl for making the specimen available for study, C. Keilmann and R. Albersdorfer for assistance, Xu X. for access to material, and R. Carney, G. Mayr and A. Lopez-Arbarello for discussions. This study was supported by the Volkswagen Foundation under grant I/84 640 (to O.W.M.R.).	Chiappe LM, 2002, ANNU REV ECOL SYST, V33, P91, DOI 10.1146/annurev.ecolsys.33.010802.150517; Chiappe LM, 2014, PEERJ, V2, DOI 10.7717/peerj.234; Chiappe Luis M, 2008, Biol Lett, V4, P719, DOI 10.1098/rsbl.2008.0409; Foth C, 2012, PALAEONTOL Z, V86, P91, DOI 10.1007/s12542-011-0111-3; Gatesy SM, 1996, EVOLUTION, V50, P2037, DOI 10.1111/j.1558-5646.1996.tb03590.x; Godefroit Pascal, 2013, Nature Communications, V4, P1; Godefroit P, 2013, NATURE, V498, P359, DOI 10.1038/nature12168; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Ji Q, 2001, NATURE, V410, P1084, DOI 10.1038/35074079; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Ji Qiang, 2005, Dizhi Tongbao, V24, P197; Li QG, 2012, SCIENCE, V335, P1215, DOI 10.1126/science.1213780; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Longrich NR, 2012, CURR BIOL, V22, P2262, DOI 10.1016/j.cub.2012.09.052; Longrich N, 2006, PALEOBIOLOGY, V32, P417, DOI 10.1666/04014.1; Lucas A. M., 1972, AVIAN ANATOMY INTEGU, P197; Meseguer Jose, 2012, Spanish Journal of Palaeontology, V27, P125; NACHTIGALL W, 1971, Z VERGL PHYSIOL, V71, P326, DOI 10.1007/BF00298144; Nudds RL, 2010, SCIENCE, V328, P887, DOI 10.1126/science.1188895; O'Connor J, 2013, P NATL ACAD SCI USA, V110, P17404, DOI 10.1073/pnas.1316979110; O'Connor JK, 2012, GEOSCIENCES, V2, P157, DOI 10.3390/geosciences2030157; Prum RO, 2002, Q REV BIOL, V77, P261, DOI 10.1086/341993; Turner AH, 2012, B AM MUS NAT HIST, P5; Wellnhofer P., 2008, ARCHAEOPTERYX URVOGE; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Xu X, 2010, NATURE, V464, P1338, DOI 10.1038/nature08965; Xu Xing, 2009, Vertebrata Palasiatica, V47, P311; Zheng XT, 2013, SCIENCE, V339, P1309, DOI 10.1126/science.1228753	30	138	143	0	228	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					79	U421		10.1038/nature13467	http://dx.doi.org/10.1038/nature13467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990749				2022-12-01	WOS:000338199400039
J	Kong, XX; Banks, A; Liu, T; Kazak, L; Rao, RR; Cohen, P; Wang, X; Yu, S; Lo, JC; Tseng, YH; Cypess, AM; Xue, R; Kleiner, S; Kang, S; Spiegelman, BM; Rosen, ED				Kong, Xingxing; Banks, Alexander; Liu, Tiemin; Kazak, Lawrence; Rao, Rajesh R.; Cohen, Paul; Wang, Xun; Yu, Songtao; Lo, James C.; Tseng, Yu-Hua; Cypess, Aaron M.; Xue, Ruidan; Kleiner, Sandra; Kang, Sona; Spiegelman, Bruce M.; Rosen, Evan D.			IRF4 Is a Key Thermogenic Transcriptional Partner of PGC-1 alpha	CELL			English	Article							BROWN ADIPOSE-TISSUE; REGULATORY FACTOR 4; UNCOUPLING PROTEIN GENE; RECEPTOR-ALPHA; COLD-EXPOSURE; FAT; EXPRESSION; CELL; COACTIVATOR; EXPANSION	Brown fat can reduce obesity through the dissipation of calories as heat. Control of thermogenic gene expression occurs via the induction of various coactivators, most notably PGC-1 alpha. In contrast, the transcription factor partner(s) of these cofactors are poorly described. Here, we identify interferon regulatory factor 4 (IRF4) as a dominant transcriptional effector of thermogenesis. IRF4 is induced by cold and cAMP in adipocytes and is sufficient to promote increased thermogenic gene expression, energy expenditure, and cold tolerance. Conversely, knockout of IRF4 in UCP1(+) cells causes reduced thermogenic gene expression and energy expenditure, obesity, and cold intolerance. IRF4 also induces the expression of PGC-1 alpha and PRDM16 and interacts with PGC-1 alpha, driving Ucp1 expression. Finally, cold, beta-agonists, or forced expression of PGC-1 alpha are unable to cause thermogenic gene expression in the absence of IRF4. These studies establish IRF4 as a transcriptional driver of a program of thermogenic gene expression and energy expenditure.	[Kong, Xingxing; Liu, Tiemin; Wang, Xun; Kang, Sona; Rosen, Evan D.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol, Boston, MA 02215 USA; [Kong, Xingxing; Liu, Tiemin; Wang, Xun; Kang, Sona; Rosen, Evan D.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA; [Banks, Alexander; Kazak, Lawrence; Rao, Rajesh R.; Cohen, Paul; Lo, James C.; Kleiner, Sandra; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; [Banks, Alexander; Kazak, Lawrence; Rao, Rajesh R.; Cohen, Paul; Lo, James C.; Kleiner, Sandra; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA; [Yu, Songtao] Northwestern Univ, Childrens Mem Res Ctr, Sch Med, Dept Pediat, Chicago, IL 60614 USA; [Tseng, Yu-Hua; Cypess, Aaron M.; Xue, Ruidan] Harvard Univ, Joslin Diabet Ctr, Sch Med, Sect Integrat Physiol & Metab, Boston, MA 02215 USA; [Rosen, Evan D.] Broad Inst, Cambridge, MA 02142 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Northwestern University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Rosen, ED (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol, Boston, MA 02215 USA.	erosen@bidmc.harvard.edu	Banks, Alexander/B-4832-2012; Tseng, Yu-Hua/AAE-6471-2021; Lo, James/GYR-1149-2022; ç, æ /AAU-6965-2020	Banks, Alexander/0000-0003-1787-6925; Tseng, Yu-Hua/0000-0003-2053-9559; Lo, James/0000-0003-0244-1670; 	American Heart Association (AHA) postdoctoral fellowship; NIH [R01 DK31405, R01 DK085171]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, R01DK054477, K08DK097303, R01DK031405, T32DK007516, R01DK085171, ZIADK075112, R01DK102170, R01DK077097] Funding Source: NIH RePORTER	American Heart Association (AHA) postdoctoral fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors gratefully acknowledge Ulf Klein (Columbia University) for the Irf4<SUP>flox</SUP> mice. PGC-1 alpha constructs were the gift of Pere Puigserver; other plasmids were from Lisa Madisen and Hongkui Zeng. The Electron Microscopy core of the Beth Israel Deaconess Medical Center (BIDMC) performed the EM analysis. We thank members of the E. D. R. and B. M. S. laboratories, and Saverio Cinti, for helpful discussions and technical advice. This work was funded by an American Heart Association (AHA) postdoctoral fellowship to X. K., NIH R01 DK31405 to B. M. S., and NIH R01 DK085171 to E. D. R. B. M. S. is a founder of and shareholder in Ember Therapeutics, and S. K. is an employee of the Genomics Institute of the Novartis Research Foundation.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; BOYER BB, 1991, MOL CELL BIOL, V11, P4147, DOI 10.1128/MCB.11.8.4147; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Eguchi J, 2008, CELL METAB, V7, P86, DOI 10.1016/j.cmet.2007.11.002; Eguchi J, 2013, DIABETES, V62, P3394, DOI 10.2337/db12-1327; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Ferrer MD, 2009, J SPORT SCI, V27, P49, DOI 10.1080/02640410802409683; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Guerra C, 2001, J CLIN INVEST, V108, P1205, DOI 10.1172/JCI13103; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Jiang DS, 2013, HYPERTENSION, V61, P1193, DOI 10.1161/HYPERTENSIONAHA.111.00614; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109; KOZAK UC, 1994, MOL CELL BIOL, V14, P59, DOI 10.1128/MCB.14.1.59; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Larose M, 1996, J BIOL CHEM, V271, P31533, DOI 10.1074/jbc.271.49.31533; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liew CW, 2013, NAT MED, V19, P217, DOI 10.1038/nm.3056; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Manfredi LH, 2013, J APPL PHYSIOL, V115, P1496, DOI 10.1152/japplphysiol.00474.2013; Meirhaeghe A, 2003, BIOCHEM J, V373, P155, DOI 10.1042/BJ20030200; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Odegaard JI, 2013, IMMUNITY, V38, P644, DOI 10.1016/j.immuni.2013.04.001; Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Raczkowski F, 2013, P NATL ACAD SCI USA, V110, P15019, DOI 10.1073/pnas.1309378110; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; RICQUIER D, 1986, J BIOL CHEM, V261, P13905; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; TOKUYAMA K, 1986, AM J PHYSIOL, V251, pE407, DOI 10.1152/ajpendo.1986.251.4.E407; Vijgen GHEJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017247; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wu ZD, 2007, EXPERT OPIN THER TAR, V11, P1329, DOI 10.1517/14728222.11.10.1329; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Ye L, 2013, P NATL ACAD SCI USA, V110, P12480, DOI 10.1073/pnas.1310261110; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	57	173	177	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					69	83		10.1016/j.cell.2014.04.049	http://dx.doi.org/10.1016/j.cell.2014.04.049			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995979	Green Accepted, Bronze			2022-12-01	WOS:000340943100008
J	Lo, JC; Ljubicic, S; Leibiger, B; Kern, M; Leibiger, IB; Moede, T; Kelly, ME; Bhowmick, DC; Murano, I; Cohen, P; Banks, AS; Khandekar, MJ; Dietrich, A; Flier, JS; Cinti, S; Blueher, M; Danial, NN; Berggren, PO; Spiegelman, BM				Lo, James C.; Ljubicic, Sanda; Leibiger, Barbara; Kern, Matthias; Leibiger, Ingo B.; Moede, Tilo; Kelly, Molly E.; Bhowmick, Diti Chatterjee; Murano, Incoronata; Cohen, Paul; Banks, Alexander S.; Khandekar, Melin J.; Dietrich, Arne; Flier, Jeffrey S.; Cinti, Saverio; Blueher, Matthias; Danial, Nika N.; Berggren, Per-Olof; Spiegelman, Bruce M.			Adipsin Is an Adipokine that Improves beta Cell Function in Diabetes	CELL			English	Article							COMPLEMENT FACTOR-D; ADIPOSE-TISSUE; INSULIN-RESISTANCE; MACROPHAGE INFILTRATION; OBESITY; SECRETION; INFLAMMATION; PATHWAY; ADIPONECTIN; ADIPOCYTE	A hallmark of type 2 diabetes mellitus (T2DM) is the development of pancreatic beta cell failure, which results in insulinopenia and hyperglycemia. We show that the adipokine adipsin has a beneficial role in maintaining beta cell function. Animals genetically lacking adipsin have glucose intolerance due to insulinopenia; isolated islets from these mice have reduced glucose-stimulated insulin secretion. Replenishment of adipsin to diabetic mice treated hyperglycemia by boosting insulin secretion. We identify C3a, a peptide generated by adipsin, as a potent insulin secretagogue and show that the C3a receptor is required for these beneficial effects of adipsin. C3a acts on islets by augmenting ATP levels, respiration, and cytosolic free Ca2+. Finally, we demonstrate that T2DM patients with b cell failure are deficient in adipsin. These findings indicate that the adipsin/C3a pathway connects adipocyte function to b cell physiology, and manipulation of this molecular switch may serve as a therapy in T2DM.	[Lo, James C.; Ljubicic, Sanda; Kelly, Molly E.; Bhowmick, Diti Chatterjee; Cohen, Paul; Banks, Alexander S.; Khandekar, Melin J.; Danial, Nika N.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Lo, James C.; Ljubicic, Sanda; Kelly, Molly E.; Bhowmick, Diti Chatterjee; Cohen, Paul; Banks, Alexander S.; Khandekar, Melin J.; Danial, Nika N.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA; [Lo, James C.; Cohen, Paul] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Leibiger, Barbara; Leibiger, Ingo B.; Moede, Tilo; Berggren, Per-Olof] Rolf Luft Res Ctr Diabet & Endocrinol, Karolinska Inst, S-17176 Stockholm, Sweden; [Kern, Matthias; Blueher, Matthias] Univ Leipzig, Dept Med, D-04103 Leipzig, Germany; [Murano, Incoronata; Cinti, Saverio] Univ Ancona, Dept Expt & Clin Med, I-60020 Ancona, Italy; [Dietrich, Arne] Univ Leipzig, Dept Surg, D-04103 Leipzig, Germany; [Flier, Jeffrey S.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Karolinska Institutet; Leipzig University; Marche Polytechnic University; Leipzig University; Harvard University; Harvard Medical School	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Flier, jeffrey/AAG-6223-2019; Banks, Alexander/B-4832-2012; Lo, James/GYR-1149-2022	Banks, Alexander/0000-0003-1787-6925; Lo, James/0000-0003-0244-1670; Berggren, Per-Olof/0000-0001-8991-413X; Moede, Tilo/0000-0002-2045-9244; CINTI, Saverio/0000-0003-0362-5017	Swiss National Science Foundation postdoctoral fellowship; Swedish Research Council; Family Erling-Persson Foundation; Novo Nordisk Foundation; Stichting af Jochnick Foundation; Strategic Research Program in Diabetes at Karolinska Institutet; Knut and Alice Wallenberg Foundation; DIABAT [HEALTH-F2-2011-278373]; Deutsche Forschungsgemeinschaft "Obesity mechanisms'' [SFB 1052/1, B01]; NIH [DK097303, DK078081, DK031405];  [ERC-2013-AdG 338936-BetaImage]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031405, R37DK031405, K08DK097303, P30DK043351, R01DK078081] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF12OC1016557] Funding Source: researchfish	Swiss National Science Foundation postdoctoral fellowship(Swiss National Science Foundation (SNSF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Family Erling-Persson Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Stichting af Jochnick Foundation; Strategic Research Program in Diabetes at Karolinska Institutet; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); DIABAT; Deutsche Forschungsgemeinschaft "Obesity mechanisms''(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank Dr. Gregory L. Stahl (Brigham and Women's Hospital) for generously providing Adipsin<SUP>-/-</SUP> mice. We are grateful to Drs. Rana Gupta, Shingo Kajimura, Jennifer Estall, Christiane Wrann, Linus Tsai, Susan Bonner-Weir, Pere Puigserver, and Evan Rosen for helpful discussions. We thank Jennifer Hollister-Lock and the Islet Isolation Core at Joslin Diabetes Center for help with islet perfusions. Fluorescence images were acquired in the Confocal and Light Microscopy Core Facility at the Dana-Farber Cancer Institute. S. L. was supported by a Swiss National Science Foundation postdoctoral fellowship. This work was supported by the Swedish Research Council, the Family Erling-Persson Foundation, the Novo Nordisk Foundation, the Stichting af Jochnick Foundation, the Strategic Research Program in Diabetes at Karolinska Institutet, the ERC-2013-AdG 338936-BetaImage, the Knut and Alice Wallenberg Foundation, DIABAT HEALTH-F2-2011-278373 (S. C.), Deutsche Forschungsgemeinschaft the SFB 1052/1: "Obesity mechanisms'' (project B01 to M. B.), and NIH grants DK097303 (J.C.L.), DK078081 (N.N.D.), and DK031405 (B. M. S.).	Ahren B, 2003, INT J OBESITY, V27, P1037, DOI 10.1038/sj.ijo.0802369; Ames RS, 2001, J IMMUNOL, V166, P6341, DOI 10.4049/jimmunol.166.10.6341; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; BALDO A, 1993, J CLIN INVEST, V92, P1543, DOI 10.1172/JCI116733; Bluher M, 2009, J CLIN ENDOCR METAB, V94, P2507, DOI 10.1210/jc.2009-0002; CHOY LN, 1992, J BIOL CHEM, V267, P12736; COOK KS, 1987, SCIENCE, V237, P402, DOI 10.1126/science.3299705; Dahlke K, 2011, J IMMUNOL, V186, P3066, DOI 10.4049/jimmunol.1002741; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Dunmore SJ, 2013, J ENDOCRINOL, V216, pT37, DOI 10.1530/JOE-12-0278; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Enerback L., 1986, MAST CELL DIFFERENTI, P167; Ferrannini E, 2010, CELL METAB, V11, P349, DOI 10.1016/j.cmet.2010.04.009; Festa A, 2006, DIABETES, V55, P1114, DOI 10.2337/diabetes.55.04.06.db05-1100; FLIER JS, 1987, SCIENCE, V237, P405, DOI 10.1126/science.3299706; Henquin JC, 2011, DIABETES RES CLIN PR, V93, pS27, DOI 10.1016/S0168-8227(11)70010-9; Homo-Delarche F, 2006, DIABETES, V55, P1625, DOI 10.2337/db05-1526; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kitamura T, 2013, NAT REV ENDOCRINOL, V9, P615, DOI 10.1038/nrendo.2013.157; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Lim J, 2013, FASEB J, V27, P822, DOI 10.1096/fj.12-220582; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Maechler P, 2013, MOL CELL ENDOCRINOL, V379, P12, DOI 10.1016/j.mce.2013.06.019; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; NAPOLITANO A, 1994, INT J OBESITY, V18, P213; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Okamoto M, 2008, DIABETOLOGIA, V51, P827, DOI 10.1007/s00125-008-0944-9; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; PLATT KA, 1994, J BIOL CHEM, V269, P28558; Pomeroy C, 1997, CLIN EXP IMMUNOL, V108, P507, DOI 10.1046/j.1365-2249.1997.3921287.x; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Primeau V, 2011, INT J OBESITY, V35, P971, DOI 10.1038/ijo.2010.216; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rorsman P, 2012, CELL CALCIUM, V51, P300, DOI 10.1016/j.ceca.2011.11.006; ROSEN BS, 1989, SCIENCE, V244, P1483, DOI 10.1126/science.2734615; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Shu CJ, 2012, SEMIN IMMUNOL, V24, P436, DOI 10.1016/j.smim.2012.12.001; Stahl GL, 2003, AM J PATHOL, V162, P449, DOI 10.1016/S0002-9440(10)63839-4; Staiger K, 2005, J CLIN ENDOCR METAB, V90, P6707, DOI 10.1210/jc.2005-0467; Tarasov AI, 2012, CELL CALCIUM, V52, P28, DOI 10.1016/j.ceca.2012.03.003; Turner R, 1996, ANN INTERN MED, V124, P136, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00011; TURNER RC, 1995, DIABETES, V44, P1249; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Weir GC, 2009, DIABETES OBES METAB, V11, P82, DOI 10.1111/j.1463-1326.2009.01113.x; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wetsel RA, 1999, J BIOL CHEM, V274, P19429, DOI 10.1074/jbc.274.27.19429; WHITE RT, 1992, J BIOL CHEM, V267, P9210; Winzell MS, 2004, BIOCHEM BIOPH RES CO, V321, P154, DOI 10.1016/j.bbrc.2004.06.130; Xu YY, 2001, P NATL ACAD SCI USA, V98, P14577, DOI 10.1073/pnas.261428398; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Zhang JH, 2007, AM J PHYSIOL-ENDOC M, V292, pE1433, DOI 10.1152/ajpendo.00664.2006	61	214	226	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					41	53		10.1016/j.cell.2014.06.005	http://dx.doi.org/10.1016/j.cell.2014.06.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995977	Bronze, Green Accepted			2022-12-01	WOS:000340943100006
J	Bingol, B; Tea, JS; Phu, L; Reichelt, M; Bakalarski, CE; Song, QH; Foreman, O; Kirkpatrick, DS; Sheng, MG				Bingol, Baris; Tea, Joy S.; Phu, Lilian; Reichelt, Mike; Bakalarski, Corey E.; Song, Qinghua; Foreman, Oded; Kirkpatrick, Donald S.; Sheng, Morgan			The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy	NATURE			English	Article							DOPAMINERGIC NEURON DEGENERATION; DROSOPHILA MODEL; DISEASE; UBIQUITINATION; MUTATIONS; PINK1; PHOSPHORYLATION; DEPOLARIZATION; DYSFUNCTION; P62/SQSTM1	Cells maintain healthy mitochondria by degrading damaged mitochondria through mitophagy; defective mitophagy is linked to Parkinson's disease. Here we report that USP30, a deubiquitinase localized to mitochondria, antagonizes mitophagy driven by the ubiquitin ligase parkin (also known as PARK2) and protein kinase PINK1, which are encoded by two genes associated with Parkinson's disease. Parkin ubiquitinates and tags damaged mitochondria for clearance. Overexpression of USP 30 removes ubiquitin attached by parkin onto damaged mitochondria and blocks parkin's ability to drive mitophagy, whereas reducing USP30 activity enhances mitochondrial degradation in neurons. Global ubiquitination site profiling identified multiple mitochondrial substrates oppositely regulated by parkin and USP30. Knockdown of USP30 rescues the defective mitophagy caused by pathogenic mutations in parkin and improves mitochondrial integrity in parkin-or PINK1-deficient flies. Knockdown of USP30 in dopaminergic neurons protects flies against paraquat toxicity in vivo, ameliorating defects in dopamine levels, motor function and organismal survival. Thus USP30 inhibition is potentially beneficial for Parkinson's disease by promoting mitochondrial clearance and quality control.	[Bingol, Baris; Tea, Joy S.; Sheng, Morgan] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Phu, Lilian; Kirkpatrick, Donald S.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Reichelt, Mike; Foreman, Oded] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Bakalarski, Corey E.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Song, Qinghua] Genentech Inc, Dept Nonclin Biostat, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Bingol, B (corresponding author), Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA.	bingol.baris@gene.com		Sheng, Morgan/0000-0002-8703-5366; Kirkpatrick, Donald/0000-0003-3091-2804; Tea, Joy/0000-0002-3395-149X; Bakalarski, Corey/0000-0003-1085-7828				Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; BRAND AH, 1993, DEVELOPMENT, V118, P401; Burchell VS, 2013, NAT NEUROSCI, V16, P1257, DOI 10.1038/nn.3489; Bustos D, 2012, MOL CELL PROTEOMICS, V11, P1529, DOI 10.1074/mcp.R112.019117; Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Guo M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009944; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Nakamura N, 2008, MOL BIOL CELL, V19, P1903, DOI 10.1091/mbc.E07-11-1103; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pinheiro J, 2011, NLME LINEAR NONLINEA; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Sang TK, 2007, J NEUROSCI, V27, P981, DOI 10.1523/JNEUROSCI.4810-06.2007; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Seeburg DP, 2008, J NEUROSCI, V28, P6583, DOI 10.1523/JNEUROSCI.1853-08.2008; Seyfried NT, 2008, ANAL CHEM, V80, P4161, DOI 10.1021/ac702516a; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang C, 2007, J NEUROSCI, V27, P8563, DOI 10.1523/JNEUROSCI.0218-07.2007; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338	41	513	543	7	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					370	+		10.1038/nature13418	http://dx.doi.org/10.1038/nature13418			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24896179				2022-12-01	WOS:000337350200029
J	Myburg, AA; Grattapaglia, D; Tuskan, GA; Hellsten, U; Hayes, RD; Grimwood, J; Jenkins, J; Lindquist, E; Tice, H; Bauer, D; Goodstein, DM; Dubchak, I; Poliakov, A; Mizrachi, E; Kullan, ARK; Hussey, SG; Pinard, D; Van der Merwe, K; Singh, P; Van Jaarsveld, I; Silva, OB; Togawa, RC; Pappas, MR; Faria, DA; Sansaloni, CP; Petroli, CD; Yang, XH; Ranjan, P; Tschaplinski, TJ; Ye, CY; Li, T; Sterck, L; Vanneste, K; Murat, F; Soler, M; Clemente, HS; Saidi, N; Cassan-Wang, H; Dunand, C; Hefer, CA; Bornberg-Bauer, E; Kersting, AR; Vining, K; Amarasinghe, V; Ranik, M; Naithani, S; Elser, J; Boyd, AE; Liston, A; Spatafora, JW; Dharmwardhana, P; Raja, R; Sullivan, C; Romanel, E; Alves-Ferreira, M; Lheim, CK; Foley, W; Carocha, V; Paiva, J; Kudrna, D; Brommonschenkel, SH; Pasquali, G; Byrne, M; Rigault, P; Tibbits, J; Spokevicius, A; Jones, RC; Steane, DA; Vaillancourt, RE; Potts, BM; Joubert, F; Barry, K; Pappas, GJ; Strauss, SH; Jaiswal, P; Grima-Pettenati, J; Salse, J; Van de Peer, Y; Rokhsar, DS; Schmutz, J				Myburg, Alexander A.; Grattapaglia, Dario; Tuskan, Gerald A.; Hellsten, Uffe; Hayes, Richard D.; Grimwood, Jane; Jenkins, Jerry; Lindquist, Erika; Tice, Hope; Bauer, Diane; Goodstein, David M.; Dubchak, Inna; Poliakov, Alexandre; Mizrachi, Eshchar; Kullan, Anand R. K.; Hussey, Steven G.; Pinard, Desre; Van der Merwe, Karen; Singh, Pooja; Van Jaarsveld, Ida; Silva-Junior, Orzenil B.; Togawa, Roberto C.; Pappas, Marilia R.; Faria, Danielle A.; Sansaloni, Carolina P.; Petroli, Cesar D.; Yang, Xiaohan; Ranjan, Priya; Tschaplinski, Timothy J.; Ye, Chu-Yu; Li, Ting; Sterck, Lieven; Vanneste, Kevin; Murat, Florent; Soler, Maral; Clemente, Helene San; Saidi, Naijib; Cassan-Wang, Hua; Dunand, Christophe; Hefer, Charles A.; Bornberg-Bauer, Erich; Kersting, Anna R.; Vining, Kelly; Amarasinghe, Vindhya; Ranik, Martin; Naithani, Sushma; Elser, Justin; Boyd, Alexander E.; Liston, Aaron; Spatafora, Joseph W.; Dharmwardhana, Palitha; Raja, Rajani; Sullivan, Christopher; Romanel, Elisson; Alves-Ferreira, Marcio; Lheim, Carsten Ku; Foley, William; Carocha, Victor; Paiva, Jorge; Kudrna, David; Brommonschenkel, Sergio H.; Pasquali, Giancarlo; Byrne, Margaret; Rigault, Philippe; Tibbits, Josquin; Spokevicius, Antanas; Jones, Rebecca C.; Steane, Dorothy A.; Vaillancourt, Rene E.; Potts, Brad M.; Joubert, Fourie; Barry, Kerrie; Pappas, Georgios J., Jr.; Strauss, Steven H.; Jaiswal, Pankaj; Grima-Pettenati, Jacqueline; Salse, Jerome; Van de Peer, Yves; Rokhsar, Daniel S.; Schmutz, Jeremy			The genome of Eucalyptus grandis	NATURE			English	Article							WHOLE-GENOME; NUCLEAR-DNA; PLANT; ALIGNMENT; TOOLS; GENE; DIVERSITY; EVOLUTION; DATABASE; TANDEM	Eucalypts are the world's most widely planted hardwood trees. Their outstanding diversity, adaptability and growth have made them a global renewable resource of fibre and energy. We sequenced and assembled >94% of the 640-megabase genome of Eucalyptus grandis. Of 36,376 predicted protein-coding genes, 34% occur in tandem duplications, the largest proportion thus far in plant genomes. Eucalyptus also shows the highest diversity of genes for specialized metabolites such as terpenes that act as chemical defence and provide unique pharmaceutical oils. Genome sequencing of the E. grandis sister species E. globulus and a set of inbred E. grandis tree genomes reveals dynamic genome evolution and hotspots of inbreeding depression. The E. grandis genome is the first reference for the eudicot order Myrtales and is placed here sister to the eurosids. This resource expands our understanding of the unique biology of large woody perennials and provides a powerful tool to accelerate comparative biology, breeding and biotechnology.	[Myburg, Alexander A.; Mizrachi, Eshchar; Kullan, Anand R. K.; Hussey, Steven G.; Pinard, Desre; Van der Merwe, Karen; Singh, Pooja] Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst FABI, ZA-0028 Pretoria, South Africa; [Myburg, Alexander A.; Mizrachi, Eshchar; Kullan, Anand R. K.; Hussey, Steven G.; Pinard, Desre; Van der Merwe, Karen; Singh, Pooja; Joubert, Fourie; Van de Peer, Yves] Univ Pretoria, Genom Res Inst GRI, ZA-0028 Pretoria, South Africa; [Grattapaglia, Dario; Pappas, Marilia R.; Faria, Danielle A.; Sansaloni, Carolina P.; Petroli, Cesar D.] EPQB Final W5 Norte, EMBRAPA Recursos Genet & Biotecnol, Lab Genet Vegetal, BR-70770917 Brasilia, DF, Brazil; [Grattapaglia, Dario] Univ Catolica Brasilia SGAN 916, Programa Ciencias Genom & Biotecnol, BR-70790160 Brasilia, DF, Brazil; [Tuskan, Gerald A.; Hellsten, Uffe; Hayes, Richard D.; Lindquist, Erika; Tice, Hope; Bauer, Diane; Goodstein, David M.; Dubchak, Inna; Poliakov, Alexandre; Barry, Kerrie; Rokhsar, Daniel S.; Schmutz, Jeremy] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Tuskan, Gerald A.; Yang, Xiaohan; Ranjan, Priya; Tschaplinski, Timothy J.; Ye, Chu-Yu; Li, Ting] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Grimwood, Jane; Jenkins, Jerry; Schmutz, Jeremy] HudsonAlpha Inst Biotechnol, Huntsville, AL 35801 USA; [Van Jaarsveld, Ida; Hefer, Charles A.; Joubert, Fourie] Univ Pretoria, Dept Biochem, Bioinformat & Computat Biol Unit, ZA-0028 Pretoria, South Africa; [Silva-Junior, Orzenil B.; Togawa, Roberto C.] EPQB Final W5 Norte, EMBRAPA Recursos Genet & Biotecnol, Lab Bioinformat, BR-70770917 Brasilia, DF, Brazil; [Sterck, Lieven; Vanneste, Kevin; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Murat, Florent; Salse, Jerome] INRA UBP UMR 1095, F-63100 Clermont Ferrand, France; [Soler, Maral; Clemente, Helene San; Saidi, Naijib; Cassan-Wang, Hua; Dunand, Christophe; Carocha, Victor; Grima-Pettenati, Jacqueline] Univ Toulouse 3, Lab Rech Sci Vegetales, UMR 5546, CNRS, F-31326 Castanet Tolosan, France; [Hefer, Charles A.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Bornberg-Bauer, Erich; Kersting, Anna R.] Univ Munster, Inst Evolut & Biodivers, D-48149 Munster, Germany; [Kersting, Anna R.] Univ Dusseldorf, Inst Comp Sci, Dept Bioinformat, D-40225 Dusseldorf, Germany; [Vining, Kelly; Amarasinghe, Vindhya; Ranik, Martin; Strauss, Steven H.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Naithani, Sushma; Elser, Justin; Liston, Aaron; Spatafora, Joseph W.; Dharmwardhana, Palitha; Raja, Rajani; Jaiswal, Pankaj] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Naithani, Sushma; Boyd, Alexander E.; Liston, Aaron; Spatafora, Joseph W.; Sullivan, Christopher; Jaiswal, Pankaj] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Romanel, Elisson] Univ Fed Rio de Janeiro, Dept Genet, Lab Biol Evolut Teor & Aplicada, BR-21949900 Rio de Janeiro, Brazil; [Romanel, Elisson] EEL USP, Dept Biotecnol, BR-12602810 Lorena, SP, Brazil; [Romanel, Elisson; Alves-Ferreira, Marcio] Univ Fed Rio de Janeiro, Dept Genet, LGMV, BR-21949900 Rio de Janeiro, Brazil; [Lheim, Carsten Ku; Foley, William] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Carocha, Victor; Paiva, Jorge] IICT MNE, P-1349007 Lisbon, Portugal; [Carocha, Victor; Paiva, Jorge] IBET ITQB, P-2781901 Oeiras, Portugal; [Kudrna, David] Univ Arizona, Arizona Genom Inst, Tucson, AZ 85721 USA; [Brommonschenkel, Sergio H.] Univ Fed Vicosa, Dep Fitopatol, BR-36570000 Vicosa, MG, Brazil; [Pasquali, Giancarlo] Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil; [Byrne, Margaret] Dept Parks & Wildlife, Sci & Conservat Div, Bentley, WA 6983, Australia; [Rigault, Philippe] GYDLE, Quebec City, PQ G1T 1Z2, Canada; [Tibbits, Josquin] Victorian Govt, Dept Environm & Primary Ind, Yallambie, Vic 3085, Australia; [Spokevicius, Antanas] Univ Melbourne, Melbourne Sch Land & Environm, Melbourne, Vic 3010, Australia; [Jones, Rebecca C.; Steane, Dorothy A.; Vaillancourt, Rene E.; Potts, Brad M.] Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia; [Jones, Rebecca C.; Steane, Dorothy A.; Vaillancourt, Rene E.; Potts, Brad M.] Univ Tasmania, Natl Ctr Future Forest Ind, Hobart, Tas 7001, Australia; [Steane, Dorothy A.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Sippy Downs, Qld 4558, Australia; [Pappas, Georgios J., Jr.] Univ Brasilia, Dept Biol Celular, BR-70910900 Brasilia, DF, Brazil	University of Pretoria; University of Pretoria; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Oak Ridge National Laboratory; HudsonAlpha Institute for Biotechnology; University of Pretoria; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Flanders Institute for Biotechnology (VIB); Ghent University; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of British Columbia; University of Munster; Heinrich Heine University Dusseldorf; Oregon State University; Oregon State University; Oregon State University; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Australian National University; University of Arizona; Universidade Federal de Vicosa; Universidade Federal do Rio Grande do Sul; University of Melbourne; University of Tasmania; University of Tasmania; University of the Sunshine Coast; Universidade de Brasilia	Myburg, AA (corresponding author), Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst FABI, Private Bag X20, ZA-0028 Pretoria, South Africa.	zander.myburg@up.ac.za	Tschaplinski, Timothy/D-6382-2018; Van de Peer, Yves/D-4388-2009; Alves-Ferreira, Marcio/C-5849-2009; Vaillancourt, Rene E/C-6123-2013; Jones, Rebecca C/J-7901-2014; Yang, Xiaohan/AAM-2449-2020; Jaiswal, Pankaj/H-7599-2016; Barry, Kerrie Whitelaw/AAA-5500-2020; Naithani, Sushma/AAU-1450-2021; Wang, Hua Cassan/AAF-5966-2021; Romanel, Elisson AC/F-1933-2013; Dunand, Christophe/I-6424-2012; Paiva, Jorge A P/C-2858-2008; Grattapaglia, Dario/B-5864-2014; Schmutz, Jeremy/N-3173-2013; Van de Peer, Yves/AAE-7666-2019; Byrne, Margaret/H-8198-2015; Steane, Dorothy/N-9940-2013; Bornberg-Bauer, Erich/A-1563-2013; Hussey, Steven/AAM-6245-2021; Jenkins, Jerry/ABE-6479-2020; Potts, Brad M/C-6489-2013; Mizrachi, Eshchar/N-3179-2014; Tuskan, Gerald/A-6225-2011; Yang, Xiaohan/A-6975-2011; Pappas, Georgios J./N-8071-2019; Foley, William J/C-8069-2009; Sterck, Lieven/A-9439-2016; Silva-Junior, Orzenil/B-3488-2013; Myburg, Alexander A/C-5426-2008; Kulheim, Carsten/AAR-2734-2021; Romanel, Elisson AC/E-5888-2019; Kulheim, Carsten/F-4720-2010; Grimwood, Jane/ABD-5737-2021; Pasquali, Giancarlo/L-6421-2013; Jaiswal, Pankaj/R-4214-2019; Grattapaglia, Dario/AAB-6805-2020; Hefer, Charles/A-6093-2011; Soler, Marçal/G-3522-2016; Pappas, Georgios J/D-5933-2016; Vaillancourt, Rene E/J-7456-2014	Tschaplinski, Timothy/0000-0002-9540-6622; Van de Peer, Yves/0000-0003-4327-3730; Alves-Ferreira, Marcio/0000-0002-6107-3700; Vaillancourt, Rene E/0000-0002-1159-9149; Jones, Rebecca C/0000-0002-6491-1423; Yang, Xiaohan/0000-0001-5207-4210; Jaiswal, Pankaj/0000-0002-1005-8383; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Naithani, Sushma/0000-0001-7819-4552; Wang, Hua Cassan/0000-0002-7395-9285; Romanel, Elisson AC/0000-0002-4794-4215; Dunand, Christophe/0000-0003-1637-4042; Paiva, Jorge A P/0000-0003-3162-4396; Grattapaglia, Dario/0000-0002-0050-970X; Schmutz, Jeremy/0000-0001-8062-9172; Van de Peer, Yves/0000-0003-4327-3730; Byrne, Margaret/0000-0002-7197-5409; Bornberg-Bauer, Erich/0000-0002-1826-3576; Hussey, Steven/0000-0002-1079-8373; Jenkins, Jerry/0000-0002-7943-3997; Potts, Brad M/0000-0001-6244-289X; Tuskan, Gerald/0000-0003-0106-1289; Yang, Xiaohan/0000-0001-5207-4210; Pappas, Georgios J./0000-0002-1100-976X; Foley, William J/0000-0001-8587-1814; Sterck, Lieven/0000-0001-7116-4000; Silva-Junior, Orzenil/0000-0002-2104-2010; Myburg, Alexander A/0000-0003-0644-5003; Romanel, Elisson AC/0000-0002-4794-4215; Pasquali, Giancarlo/0000-0003-1256-544X; Jaiswal, Pankaj/0000-0002-1005-8383; Grattapaglia, Dario/0000-0002-0050-970X; Hefer, Charles/0000-0001-7527-5461; Soler, Marçal/0000-0002-9138-9394; Pappas, Georgios J/0000-0002-1100-976X; Vaillancourt, Rene E/0000-0002-1159-9149; Rokhsar, Daniel/0000-0002-8704-2224; Saidi, Mohamed Najib/0000-0002-7692-4643; Kulheim, Carsten/0000-0002-0798-3324; Goodstein, David/0000-0001-6287-2697; Ranjan, Priya/0000-0002-0357-1939; Mizrachi, Eshchar/0000-0002-3126-9593; Spokevicius, Antanas/0000-0003-3507-9583; Togawa, Roberto/0000-0001-7179-3210; Singh, Pooja/0000-0001-6576-400X; Pappas, Marilia/0000-0002-4680-0199; Murat, Florent/0000-0003-2116-2511; Steane, Dorothy/0000-0002-8061-8454; Hayes, Richard/0000-0002-5236-7918; Pinard, Desre/0000-0001-5600-0139	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Office of Biological and Environmental Research in the US Department of Energy Office of Science, US DOE Bioenergy Center [DE-AC05-00OR22725]; Brazilian Ministry of Science, Technology and Innovation (MCTI) through (CNPq); Brazilian Ministry of Science, Technology and Innovation (MCTI) through (FINEP); Brazilian Federal District Research Foundation (FAP-DF); Technology and Human Resources for Industry Programme (THRIP) [UID 80118]; South African Department of Science and Technology (DST); National Research Foundation (NRF) [UID 18312, 86936]; Laboratoire d'Excellence [LABEX TULIP ANR-10-LABX-41]; Agence Nationale pour la Recherche (Project Tree For Joules) [ANR-2010-KBBE-007-01]; Fundacao para a Ciencia e Tecnologia (FCT) [P-KBBE/AGR_GPL/0001/2010]; Centre National pour la Recherche Scientifique (CNRS); University Paul Sabatier Toulouse III (UPS); Ghent University; Hercules Foundation; Flemish Government-department EWI; Div Of Industrial Innovation & Partnersh [1238305] Funding Source: National Science Foundation	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Office of Biological and Environmental Research in the US Department of Energy Office of Science, US DOE Bioenergy Center(United States Department of Energy (DOE)); Brazilian Ministry of Science, Technology and Innovation (MCTI) through (CNPq); Brazilian Ministry of Science, Technology and Innovation (MCTI) through (FINEP); Brazilian Federal District Research Foundation (FAP-DF); Technology and Human Resources for Industry Programme (THRIP); South African Department of Science and Technology (DST); National Research Foundation (NRF); Laboratoire d'Excellence; Agence Nationale pour la Recherche (Project Tree For Joules)(French National Research Agency (ANR)); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Paul Sabatier Toulouse III (UPS); Ghent University(Ghent University); Hercules Foundation; Flemish Government-department EWI; Div Of Industrial Innovation & Partnersh(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under Contract No. DE-AC02-05CH11231. The research and writing of the manuscript was supported, in part, by the Office of Biological and Environmental Research in the US Department of Energy Office of Science under contract DE-AC05-00OR22725 as part of the US DOE Bioenergy Center. Funding for additional components of the study was provided by the Brazilian Ministry of Science, Technology and Innovation (MCTI) through its research funding agencies (CNPq and FINEP), the Brazilian Federal District Research Foundation (FAP-DF), the public-private Genolyptus network of Brazilian forestry companies, the Tree Biosafety and Genomics Research Cooperative (TBGRC, Oregon State University), South African forestry companies Sappi and Mondi, the Technology and Human Resources for Industry Programme (THRIP, UID 80118), the South African Department of Science and Technology (DST) and National Research Foundation (NRF, UID 18312 and 86936), the Laboratoire d'Excellence (LABEX TULIP ANR-10-LABX-41), the Agence Nationale pour la Recherche (Project Tree For Joules ANR-2010-KBBE-007-01; Fundacao para a Ciencia e Tecnologia (FCT, P-KBBE/AGR_GPL/0001/2010), the Centre National pour la Recherche Scientifique (CNRS), the University Paul Sabatier Toulouse III (UPS). Part of this work was carried out using the Stevin Supercomputer Infrastructure at Ghent University, funded by Ghent University, the Hercules Foundation, and the Flemish Government-department EWI. We also acknowledge S. Oda and E. Gonzalez of Suzano Paper and Pulp for providing genetic material of E. grandis genotypes BRASUZ1, G7J1, M35D2 and their progeny used for genome sequencing and resequencing, Forestal Mininco (Chile) for genetic material of X46, the E. globulus genotype used for genome resequencing, M. Hinchee and W. Rottmann of ArborGen for EST sequences used to support gene annotation, Sappi (South Africa) for genetic material of the population used for genetic linkage mapping, and Sappi and Mondi (South Africa) for E. grandis tissues used for RNA sequencing. We acknowledge M. O'Neill of the University of Pretoria for technical assistance with E. grandis RNA sequencing.	Agren JA, 2011, CHROMOSOME RES, V19, P777, DOI 10.1007/s10577-011-9229-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bauhus J., 2010, ECOSYSTEM GOODS SERV; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Brooker MIH, 2000, AUST SYST BOT, V13, P79, DOI 10.1071/SB98008; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Buljan M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r74; Byrne M., 2008, PLANT GENOME BIODI E, V1, P303; Silva JCE, 2011, HEREDITY, V107, P50, DOI 10.1038/hdy.2010.154; Crisp MD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1191; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Dubchak I, 2009, GENOME RES, V19, P682, DOI 10.1101/gr.081778.108; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; Eschler BM, 2000, BIOCHEM SYST ECOL, V28, P813, DOI 10.1016/S0305-1978(99)00123-4; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Forslund K, 2008, MOL BIOL EVOL, V25, P254, DOI 10.1093/molbev/msm254; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Gardner Paul P, 2011, Nucleic Acids Res, V39, pD141, DOI 10.1093/nar/gkq1129; Goodger JQD, 2011, PHYTOCHEMISTRY, V72, P2259, DOI 10.1016/j.phytochem.2011.08.026; GRATTAPAGLIA D, 1994, CAN J FOREST RES, V24, P1074, DOI 10.1139/x94-142; Grattapaglia D, 2012, TREE GENET GENOMES, V8, P463, DOI 10.1007/s11295-012-0491-x; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Groover AT, 2005, TRENDS PLANT SCI, V10, P210, DOI 10.1016/j.tplants.2005.03.001; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hanada K, 2008, PLANT PHYSIOL, V148, P993, DOI 10.1104/pp.108.122457; House Susan M., 1997, P30; Hudson CJ, 2012, TREE GENET GENOMES, V8, P339, DOI 10.1007/s11295-011-0444-9; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Iglesias I., EUCALYPTOLOGICS INFO; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jaiswal P, 2011, METHODS MOL BIOL, V678, P247, DOI 10.1007/978-1-60761-682-5_18; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kulheim C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-452; Kullan ARK, 2012, TREE GENET GENOMES, V8, P163, DOI 10.1007/s11295-011-0430-2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Martin W, 2005, TRENDS PLANT SCI, V10, P203, DOI 10.1016/j.tplants.2005.03.007; Mizrachi E, 2012, NEW PHYTOL, V194, P54, DOI 10.1111/j.1469-8137.2011.03971.x; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Peterson DG, 1997, PLANT MOL BIOL REP, V15, P148, DOI 10.1007/BF02812265; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Petroli CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044684; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Resende MDV, 2012, NEW PHYTOL, V194, P116, DOI 10.1111/j.1469-8137.2011.04038.x; Robbertse B, 2011, PLOS CURR-TREE LIFE, DOI 10.1371/currents.RRN1213; Salse J, 2012, CURR OPIN PLANT BIOL, V15, P122, DOI 10.1016/j.pbi.2012.01.001; Salse J, 2009, BRIEF BIOINFORM, V10, P619, DOI 10.1093/bib/bbp037; Salse J, 2009, P NATL ACAD SCI USA, V106, P14908, DOI 10.1073/pnas.0902350106; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tibbits JFG, 2006, PLANT MOL BIOL REP, V24, P81, DOI 10.1007/BF02914048; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Youens-Clark K, 2011, NUCLEIC ACIDS RES, V39, pD1085, DOI 10.1093/nar/gkq1148	70	525	559	15	310	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					356	+		10.1038/nature13308	http://dx.doi.org/10.1038/nature13308			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24919147	Green Published, hybrid			2022-12-01	WOS:000337350200027
J	Churcher, TS; Cohen, JM; Novotny, J; Ntshalintshali, N; Kunene, S; Cauchemez, S				Churcher, Thomas S.; Cohen, Justin M.; Novotny, Joseph; Ntshalintshali, Nyasatu; Kunene, Simon; Cauchemez, Simon			PUBLIC HEALTH Measuring the path toward malaria elimination	SCIENCE			English	Editorial Material									[Churcher, Thomas S.; Cauchemez, Simon] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Cohen, Justin M.; Novotny, Joseph; Ntshalintshali, Nyasatu] Clinton Hlth Access Initiat, Boston, MA 02127 USA; [Novotny, Joseph; Ntshalintshali, Nyasatu] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Kunene, Simon] Natl Malaria Control Program, Manzini, Swaziland; [Cauchemez, Simon] Inst Pasteur, Math Modelling Infect Dis Unit, Paris, France	Imperial College London; University of California System; University of California San Francisco; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cauchemez, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	simon.cauchemez@pasteur.fr		Cohen, Justin/0000-0003-4481-6784; Churcher, Thomas/0000-0002-8442-0525	MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1B] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER; Medical Research Council [MR/K010174/1] Funding Source: Medline; NIGMS NIH HHS [U54 GM088491] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cauchemez S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001399; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; Dureau J, 2013, BIOSTATISTICS, V14, P541, DOI 10.1093/biostatistics/kxs052; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hsiang MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029550; Kunene S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-313; Smith DL, 2009, TRENDS PARASITOL, V25, P511, DOI 10.1016/j.pt.2009.08.002; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organization, 2012, DIS SURV MAL EL OP M	9	52	52	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1230	1232		10.1126/science.1251449	http://dx.doi.org/10.1126/science.1251449			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI7ND	24926005	Green Accepted, Green Submitted			2022-12-01	WOS:000337077500021
J	Venn, O; Turner, I; Mathieson, I; de Groot, N; Bontrop, R; McVean, G				Venn, Oliver; Turner, Isaac; Mathieson, Iain; de Groot, Natasja; Bontrop, Ronald; McVean, Gil			NONHUMAN GENETICS Strong male bias drives germline mutation in chimpanzees	SCIENCE			English	Article							HUMAN-EVOLUTION; GENOME; HUMANS; NUCLEOTIDE; RATES; APES; MAP; DNA	Germline mutation determines rates of molecular evolution, genetic diversity, and fitness load. In humans, the average point mutation rate is 1.2 x 10(-8) per base pair per generation, with every additional year of father's age contributing two mutations across the genome and males contributing three to four times as many mutations as females. To assess whether such patterns are shared with our closest living relatives, we sequenced the genomes of a nine-member pedigree of Western chimpanzees, Pan troglodytes verus. Our results indicate a mutation rate of 1.2 x 10(-8) per base pair per generation, but a male contribution seven to eight times that of females and a paternal age effect of three mutations per year of father's age. Thus, mutation rates and patterns differ between closely related species.	[Venn, Oliver; Turner, Isaac; Mathieson, Iain; McVean, Gil] Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England; [de Groot, Natasja; Bontrop, Ronald] Biomed Primate Res Ctr, NL-2288 GJ Rijswijk, Netherlands	University of Oxford; Wellcome Centre for Human Genetics	McVean, G (corresponding author), Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	mcvean@well.ox.ac.uk	Bontrop, Ronald E/J-3628-2012; Turner, Isaac/T-1092-2019	Bontrop, Ronald E/0000-0003-0874-6467; McVean, Gil/0000-0002-5012-4162; Turner, Isaac/0000-0002-2378-4886	Wellcome Trust [086786/Z/08/Z, 090532/Z/09/Z]; MRC hub grant [G0900747 91070]; Medical Research Council [G0900747] Funding Source: researchfish; MRC [G0900747] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC hub grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by Wellcome Trust grants 086786/Z/08/Z to O.V. and 090532/Z/09/Z to the Wellcome Trust Centre for Human Genetics and by MRC hub grant G0900747 91070. We thank M. Przeworski and D. Reich for discussion and comments on the manuscript and A. Kong for providing data on request from reference (6). Samples were provided through the Transnational Access Activity in the European Primate Network (EUPRIM-NET) under the Convention on International Trade of Endangered Species (CITES) authorization and a Material Transfer Agreement between the University of Oxford and the Foundation Biomedical Primate Research Centre. Read-level data are accessible under SRA Study accession no. PRJEB5937 from www.ebi.ac.uk/ena/data/view/PRJEB5937. All other project data are available from ftp://birch.well.ox.ac.uk.	Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Hvilsom C, 2012, P NATL ACAD SCI USA, V109, P2054, DOI 10.1073/pnas.1106877109; IJDO JW, 1991, P NATL ACAD SCI USA, V88, P9051, DOI 10.1073/pnas.88.20.9051; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Kondrashov FA, 2010, PHILOS T R SOC B, V365, P1169, DOI 10.1098/rstb.2009.0286; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; MARSON J, 1991, BIOL REPROD, V44, P448, DOI 10.1095/biolreprod44.3.448; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; MOLLER AP, 1988, J HUM EVOL, V17, P479, DOI 10.1016/0047-2484(88)90037-1; Nachman MW, 2000, GENETICS, V156, P297; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Perry GH, 2010, MOL ECOL, V19, P5332, DOI 10.1111/j.1365-294X.2010.04888.x; Presgraves DC, 2009, TRENDS ECOL EVOL, V24, P533, DOI 10.1016/j.tree.2009.04.007; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Short R.V., 1979, Advances in the Study of Behavior, V9, P131, DOI 10.1016/S0065-3454(08)60035-2; Taylor F, 2006, MOL BIOL EVOL, V23, P565, DOI 10.1093/molbev/msj060	24	86	86	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1272	1275		10.1126/science.344.6189.1272	http://dx.doi.org/10.1126/science.344.6189.1272			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926018	Green Accepted			2022-12-01	WOS:000337077500038
J	Martin, E; Palmic, N; Sanquer, S; Lenoir, C; Hauck, F; Mongellaz, C; Fabrega, S; Nitschke, P; Degli Esposti, M; Schwartzentruber, J; Taylor, N; Majewski, J; Jabado, N; Wynn, RF; Picard, C; Fischer, A; Arkwright, PD; Latour, S				Martin, Emmanuel; Palmic, Noe; Sanquer, Sylvia; Lenoir, Christelle; Hauck, Fabian; Mongellaz, Cedric; Fabrega, Sylvie; Nitschke, Patrick; Degli Esposti, Mauro; Schwartzentruber, Jeremy; Taylor, Naomi; Majewski, Jacek; Jabado, Nada; Wynn, Robert F.; Picard, Capucine; Fischer, Alain; Arkwright, Peter D.; Latour, Sylvain			CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation	NATURE			English	Article							NOVO PYRIMIDINE SYNTHESIS; EPSTEIN-BARR-VIRUS; KILLER T-CELLS; DE-NOVO; SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; VIRAL-INFECTION; SYNTHETASE; ACTIVATION; PATHWAY	Lymphocyte functions triggered by antigen recognition and costimulation signals are associated with a rapid and intense cell division, and hence with metabolism adaptation(1). The nucleotide cytidine 5' triphosphate (CTP) is a precursor required for the metabolism of DNA, RNA and phospholipids(2-4). CTP originates from two sources: a salvage pathway and a de novo synthesis pathway that depends on two enzymes, the CTP synthases (or synthetases) 1 and 2 (CTPS1 with CTPS2); the respective roles of these two enzymes are not known(5-7). CTP synthase activity is a potentially important step for DNA synthesis in lymphocytes(8,9). Here we report the identification of a loss-of- function homozygous mutation (rs145092287) in CTPS1 in humans that causes a novel and life-threatening immunodeficiency, characterized by an impaired capacity of activated T and B cells to proliferate in response to antigen receptor-mediated activation. In contrast, proximal and distal T-cell receptor (TCR) signalling events and responses were only weakly affected by the absence of CTPS1. Activated CTPS1-deficient cells had decreased levels of CTP. Normal T-cell proliferation was restored in CTPS1-deficient cells by expressing wild-type CTPS1 or by addition of exogenous CTP or its nucleoside precursor, cytidine. CTPS1 expression was found to be low in resting T cells, but rapidly upregulated following TCR activation. These results highlight a key and specific role of CTPS1 in the immune system by its capacity to sustain the proliferation of activated lymphocytes during the immune response. CTPS1 may therefore represent a therapeutic target of immunosuppressive drugs that could specifically dampen lymphocyte activation.	[Martin, Emmanuel; Palmic, Noe; Lenoir, Christelle; Hauck, Fabian; Fischer, Alain; Latour, Sylvain] Hop Necker Enfants Malad, Lab Activat Lymphocytaire & Susceptibilite EBV, INSERM, UMR 1163, F-75015 Paris, France; [Martin, Emmanuel; Palmic, Noe; Lenoir, Christelle; Hauck, Fabian; Fabrega, Sylvie; Nitschke, Patrick; Picard, Capucine; Fischer, Alain; Latour, Sylvain] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, F-75015 Paris, France; [Sanquer, Sylvia; Latour, Sylvain] Hop Necker Enfants Malad, Lab Biochim Metabol & Proteom, F-75015 Paris, France; [Mongellaz, Cedric; Taylor, Naomi] Inst Genet Mol Montpellier, CNRS, UMR 5535, F-34293 Montpellier, France; [Fabrega, Sylvie] Hop Necker Enfants Malad, Plateforme Vecteurs Viraux & Transfert Genes, IFR94, F-75015 Paris, France; [Nitschke, Patrick] Hop Necker Enfants Malad, Serv Bioinformat, F-75015 Paris, France; [Degli Esposti, Mauro; Wynn, Robert F.; Arkwright, Peter D.] Univ Manchester, Royal Manchester Childrens Hosp, Manchester M13 0WL, Lancs, England; [Degli Esposti, Mauro] Italian Inst Technol, I-16163 Genoa, Italy; [Schwartzentruber, Jeremy; Majewski, Jacek; Jabado, Nada] McGill Univ, Montreal, PQ H3A 0G1, Canada; [Schwartzentruber, Jeremy; Majewski, Jacek; Jabado, Nada] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada; [Jabado, Nada] McGill Univ, Hlth Ctr Res Inst, Dept Pediat, Montreal, PQ H3H 1P3, Canada; [Picard, Capucine] Hop Necker Enfants Malad, AP HP, Ctr Etude Deficits Immunitaires, F-75015 Paris, France; [Picard, Capucine] Hop Necker Enfants Malad, INSERM, Lab Genet Humaine Malad Infect, UMR 1163, F-75015 Paris, France; [Fischer, Alain] Hop Necker Enfants Malad, AP HP, Unite Immunol & Hematol Pediat, F-75015 Paris, France; [Fischer, Alain] Coll France, F-75005 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Royal Manchester Children's Hospital; University of Manchester; Istituto Italiano di Tecnologia - IIT; McGill University; McGill University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France	Latour, S (corresponding author), Hop Necker Enfants Malad, Lab Activat Lymphocytaire & Susceptibilite EBV, INSERM, UMR 1163, F-75015 Paris, France.	sylvain.latour@inserm.fr	Hauck, Fabian/H-5556-2016; Picard, Capucine/H-3914-2017; Taylor, Naomi/H-4016-2014; Martin, Emmanuel/F-9743-2016; Jabado, Nada/AAN-4026-2020; Latour, Sylvain/H-3652-2017	Picard, Capucine/0000-0001-8788-5056; Martin, Emmanuel/0000-0003-4211-7373; Wynn, robert/0000-0002-6046-8428; Degli Esposti, Mauro/0000-0002-0977-119X; Latour, Sylvain/0000-0001-8238-4391; Schwartzentruber, Jeremy/0000-0002-6183-2092; Arkwright, Peter/0000-0002-7411-5375; Hauck, Fabian/0000-0001-9644-2003	INSERM; ANR [ANR-08-MIEN-012-01, ANR-2010-MIDI-005-02, ANR-10-IAHU-01]; Fondation ARC (France); European Research Council [ERC-2009-AdG_20090506, FP7-249816]; Rare Diseases Fondation (France); ANR (France); Ligue contre le cancer (France); Wellcome Trust; Medical Research Council [WT095219MA, G1001799]; MRC [G1001799] Funding Source: UKRI	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR(French National Research Agency (ANR)); Fondation ARC (France); European Research Council(European Research Council (ERC)European Commission); Rare Diseases Fondation (France); ANR (France)(French National Research Agency (ANR)); Ligue contre le cancer (France); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the patients, their families and the healthy donors for cooperation. We thank S. Rigaud, S. Gerart, C. Synaeve and R. Rodriguez for help with experiments and P. Revy for discussion. This work was supported by grants from INSERM, ANR (ANR-08-MIEN-012-01, ANR-2010-MIDI-005-02 and ANR-10-IAHU-01), Fondation ARC (France), the European Research Council (ERC-2009-AdG_20090506 noFP7-249816) and the Rare Diseases Fondation (France). S. L. is a senior scientist of CNRS (France). E. M. is supported by ANR (France) and Ligue contre le cancer (France). We are also grateful to the UK 1958 Birth Cohort (http://www2.le.ac.uk/projects/birthcohort) for providing DNA from 752 individuals born in the northwest of England. Access to these resources was enabled via the 58READIE Project funded by the Wellcome Trust and Medical Research Council (grant numbers WT095219MA and G1001799). A full list of the financial, institutional and personal contributions to the development of the 1958 Birth Cohort Biomedical resource is available at (http://www2.le.ac.uk/projects/birthcohort).	Austin WR, 2012, J EXP MED, V209, P2215, DOI 10.1084/jem.20121061; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Chung BK, 2013, BLOOD, V122, P2600, DOI 10.1182/blood-2013-01-480665; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; FAIRBANKS LD, 1995, J BIOL CHEM, V270, P29682; Gulow K, 2005, J IMMUNOL, V174, P5249, DOI 10.4049/jimmunol.174.9.5249; Higgins MJ, 2007, J BIOL CHEM, V282, P29493, DOI 10.1074/jbc.M703948200; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Huang M, 2003, CELL MOL LIFE SCI, V60, P321, DOI 10.1007/s000180300027; Kassel KM, 2010, J BIOL CHEM, V285, P33727, DOI 10.1074/jbc.M110.178566; Kursula P, 2006, ACTA CRYSTALLOGR F, V62, P613, DOI 10.1107/S1744309106018136; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Le Bourhis L, 2013, CURR OPIN IMMUNOL, V25, P174, DOI 10.1016/j.coi.2013.01.005; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; MARIJNEN YMT, 1989, BIOCHIM BIOPHYS ACTA, V1012, P148, DOI 10.1016/0167-4889(89)90088-8; MCPARTLAND RP, 1974, CANCER RES, V34, P3107; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; NADKARNI AK, 1995, J BIOL CHEM, V270, P24982, DOI 10.1074/jbc.270.42.24982; Notarangelo LD, 2013, ANNU REV IMMUNOL, V31, P195, DOI 10.1146/annurev-immunol-032712-095927; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; Picard C, 2009, EUR J IMMUNOL, V39, P1966, DOI 10.1002/eji.200939385; Qiu Y, 2000, TRANSPLANTATION, V69, P890; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; SCAVENNEC J, 1982, CANCER RES, V42, P1326; Toy G, 2010, P NATL ACAD SCI USA, V107, P5551, DOI 10.1073/pnas.0913900107; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; van Kuilenburg ABP, 2000, BBA-GENE STRUCT EXPR, V1492, P548, DOI 10.1016/S0167-4781(00)00141-X; VANDENBERG AA, 1994, LEUKEMIA, V8, P1375; VANDENBERG AA, 1995, EUR J CANCER, V31A, P108, DOI 10.1016/0959-8049(94)00442-8; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wynn RF, 2005, LANCET ONCOL, V6, P344, DOI 10.1016/S1470-2045(05)70171-6	33	125	137	3	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					288	+		10.1038/nature13386	http://dx.doi.org/10.1038/nature13386			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24870241	Green Accepted			2022-12-01	WOS:000337032400054
J	Lee, YS; Kim, JW; Osborne, O; Oh, DY; Sasik, R; Schenk, S; Chen, A; Chung, H; Murphy, A; Watkins, SM; Quehenberger, O; Johnson, RS; Olefsky, JM				Lee, Yun Sok; Kim, Jung-whan; Osborne, Olivia; Oh, Da Young; Sasik, Roman; Schenk, Simon; Chen, Ai; Chung, Heekyung; Murphy, Anne; Watkins, Steven M.; Quehenberger, Oswald; Johnson, Randall S.; Olefsky, Jerrold M.			Increased Adipocyte O-2 Consumption Triggers HIF-1 alpha, Causing Inflammation and Insulin Resistance in Obesity	CELL			English	Article							ADENINE-NUCLEOTIDE TRANSLOCASE; WHITE ADIPOSE-TISSUE; NITRIC-OXIDE; MITOCHONDRIAL RESPIRATION; ENERGY-EXPENDITURE; HYPOXIA; MICE; FAT; MACROPHAGES; INHIBITION	Adipose tissue hypoxia and inflammation have been causally implicated in obesity-induced insulin resistance. Here, we report that, early in the course of high-fat diet (HFD) feeding and obesity, adipocyte respiration becomes uncoupled, leading to increased oxygen consumption and a state of relative adipocyte hypoxia. These events are sufficient to trigger HIF-1 alpha induction, setting off the chronic adipose tissue inflammatory response characteristic of obesity. At the molecular level, these events involve saturated fatty acid stimulation of the adenine nucleotide translocase 2 (ANT2), an inner mitochondrial membrane protein, which leads to the uncoupled respiratory state. Genetic or pharmacologic inhibition of either ANT2 or HIF-1 alpha can prevent or reverse these pathophysiologic events, restoring a state of insulin sensitivity and glucose tolerance. These results reveal the sequential series of events in obesity-induced inflammation and insulin resistance.	[Lee, Yun Sok; Osborne, Olivia; Oh, Da Young; Sasik, Roman; Chen, Ai; Chung, Heekyung; Quehenberger, Oswald; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Kim, Jung-whan; Johnson, Randall S.] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Schenk, Simon] Univ Calif San Diego, Dept Orthopaed Surg, La Jolla, CA 92093 USA; [Murphy, Anne] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Watkins, Steven M.] Lipomics Technol Inc, West Sacramento, CA 95691 USA; [Johnson, Randall S.] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Johnson, Randall S.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Karolinska Institutet; University of Cambridge	Johnson, RS (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.	rsj33@cam.ac.uk; jolefsky@ucsd.edu	Johnson, Randall/AAM-1189-2021; Lee, Yun Sok/B-3265-2015; Lee, Yun Sok/ABC-9195-2021; Murphy, Anne N/H-3217-2016	Johnson, Randall/0000-0002-4084-6639; Lee, Yun Sok/0000-0001-7967-4734; Lee, Yun Sok/0000-0001-7967-4734; Murphy, Anne N/0000-0002-5222-9902; Schenk, Simon/0000-0002-8224-3203; Kim, Jung-whan/0000-0002-7829-1480	National Institutes of Health (NIH) [DK-033651, DK-074868, DK-063491, P01-DK054441]; American Diabetes Association; National Institute of Aging; National Institute of Child Health and Human Development of the NIH [R01AG043120, R24HD050837]; Wellcome Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303, U54HD012303, R24HD050837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033651, T32DK007494, R37DK033651, R01DK101395, P01DK074868, P01DK054441, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043120] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Child Health and Human Development of the NIH; Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (NIH) grants DK-033651, DK-074868, DK-063491, and P01-DK054441. Y.S.L. was supported by a Mentor-Based Postdoctoral Fellowship Award from the American Diabetes Association. S. S. is supported by the National Institute of Aging and National Institute of Child Health and Human Development of the NIH under award numbers R01AG043120 and R24HD050837. R.S.J. is supported by a Principal Research Fellowship from the Wellcome Trust.	Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; ANDREYEV AY, 1988, FEBS LETT, V226, P265, DOI 10.1016/0014-5793(88)81436-4; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Branco-Price C, 2012, CANCER CELL, V21, P52, DOI 10.1016/j.ccr.2011.11.017; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Deng T, 2013, CELL METAB, V17, P411, DOI 10.1016/j.cmet.2013.02.009; DIGIROLAMO M, 1992, FASEB J, V6, P2405, DOI 10.1096/fasebj.6.7.1563593; Doege K, 2005, BLOOD, V106, P2311, DOI 10.1182/blood-2005-03-1138; Garcia-Arcos I, 2013, J BIOL CHEM, V288, P14046, DOI 10.1074/jbc.M113.469270; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Gonsalves CS, 2010, J IMMUNOL, V184, P3878, DOI 10.4049/jimmunol.0902594; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Lee KY, 2011, CELL METAB, V14, P491, DOI 10.1016/j.cmet.2011.08.006; Lee YS, 2008, MOL ENDOCRINOL, V22, P2176, DOI 10.1210/me.2008-0023; Lee YS, 2013, CELL, V153, P413, DOI 10.1016/j.cell.2013.03.001; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Lee YS, 2010, J BIOL CHEM, V285, P22174, DOI 10.1074/jbc.M109.085464; LEIBEL RL, 1985, AM J CLIN NUTR, V42, P198, DOI 10.1093/ajcn/42.2.198; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Melillo G, 1996, J IMMUNOL, V157, P2638; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI 10.1172/JCI21047; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Qvisth V, 2007, AM J PHYSIOL-ENDOC M, V292, pE709, DOI 10.1152/ajpendo.00104.2006; Rohm M, 2013, CELL METAB, V17, P575, DOI 10.1016/j.cmet.2013.02.010; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Shu CJ, 2012, SEMIN IMMUNOL, V24, P436, DOI 10.1016/j.smim.2012.12.001; Sims K, 2010, J BIOL CHEM, V285, P38568, DOI 10.1074/jbc.M110.170621; Spite M, 2011, J IMMUNOL, V187, P1942, DOI 10.4049/jimmunol.1100196; Sridharan V, 2008, AM J PHYSIOL-CELL PH, V295, pC29, DOI 10.1152/ajpcell.00466.2007; Sun K, 2013, MOL CELL BIOL, V33, P904, DOI 10.1128/MCB.00951-12; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Zhang XM, 2010, J BIOL CHEM, V285, P32869, DOI 10.1074/jbc.M110.135509; Zhivotovsky B, 2009, CELL DEATH DIFFER, V16, P1419, DOI 10.1038/cdd.2009.118	46	310	314	2	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1339	1352		10.1016/j.cell.2014.05.012	http://dx.doi.org/10.1016/j.cell.2014.05.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906151	Green Accepted, Bronze			2022-12-01	WOS:000340881400011
J	Liberali, P; Snijder, B; Pelkmans, L				Liberali, Prisca; Snijder, Berend; Pelkmans, Lucas			A Hierarchical Map of Regulatory Genetic Interactions in Membrane Trafficking	CELL			English	Article							ORGANIZATION; ENDOCYTOSIS; RNAI; ENDOSOME; KINASES; PATHWAY; SCREEN; YEAST	Endocytosis is critical for cellular physiology and thus is highly regulated. To identify regulatory interactions controlling the endocytic membrane system, we conducted 13 RNAi screens on multiple endocytic activities and their downstream organelles. Combined with image analysis of thousands of single cells per perturbation and their cell-to-cell variability, this created a high-quality and cross-comparable quantitative data set. Unbiased analysis revealed emergent properties of the endocytic membrane system and how its complexity evolved and distinct programs of regulatory control that coregulate specific subsets of endocytic uptake routes and organelle abundances. We show that these subset effects allow the mapping of functional regulatory interactions and their interaction motifs between kinases, membrane-trafficking machinery, and the cytoskeleton at a large scale, some of which we further characterize. Our work presents a powerful approach to identify regulatory interactions in complex cellular systems from parallel single-gene or double-gene perturbation screens in human cells and yeast.	[Liberali, Prisca; Snijder, Berend; Pelkmans, Lucas] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland	University of Zurich	Liberali, P (corresponding author), Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	prisca.liberali@uzh.ch; lucas.pelkmans@imls.uzh.ch	Snijder, Berend/M-2998-2017; Snijder, Berend/O-9206-2019	Snijder, Berend/0000-0003-3386-6583; Liberali, Prisca/0000-0003-0695-6081; Pelkmans, Lucas/0000-0002-6754-9730	FEBS; SystemsX.ch Research, Technology, and Development project PhosphoNetX; SystemsX.ch Research, Technology, and Development project LipidX; University of Zurich	FEBS; SystemsX.ch Research, Technology, and Development project PhosphoNetX; SystemsX.ch Research, Technology, and Development project LipidX; University of Zurich	We thank Y. Heer, N. Battich, B. Thijssen, M. Stark, C. von Meering, and K. Mench for help with experiments and computation, Y. Yakimovich for IT support, and lab members for comments on the manuscript. P. L. is supported by a FEBS. L. P. acknowledges financial support from the SystemsX.ch Research, Technology, and Development projects PhosphoNetX and LipidX and the University of Zurich.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brunner Y, 2007, MOL CELL PROTEOMICS, V6, P1007, DOI 10.1074/mcp.M600443-MCP200; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Galvez T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r142; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Kozik P, 2013, NAT CELL BIOL, V15, P50, DOI 10.1038/ncb2652; Laufer C, 2013, NAT METHODS, V10, P427, DOI [10.1038/NMETH.2436, 10.1038/nmeth.2436]; Liberali P, 2008, ANNU REV CELL DEV BI, V24, P501, DOI 10.1146/annurev.cellbio.041008.145637; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Moustakas A, 1999, J CELL SCI, V112, P1169; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Ramo P, 2009, BIOINFORMATICS, V25, P3028, DOI 10.1093/bioinformatics/btp524; Richardson SCW, 2004, MOL BIOL CELL, V15, P1197, DOI 10.1091/mbc.E03-06-0358; Roguev A, 2013, NAT METHODS, V10, P432, DOI [10.1038/NMETH.2398, 10.1038/nmeth.2398]; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Snijder B, 2013, NAT METHODS, V10, P1089, DOI [10.1038/NMETH.2655, 10.1038/nmeth.2655]; Snijder B, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.9; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Tsujita K, 2004, J BIOL CHEM, V279, P13817, DOI 10.1074/jbc.M312294200; Walz HA, 2010, J BIOL CHEM, V285, P14101, DOI 10.1074/jbc.M110.110536	38	66	66	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1473	1487		10.1016/j.cell.2014.04.029	http://dx.doi.org/10.1016/j.cell.2014.04.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906158	Bronze			2022-12-01	WOS:000340881400021
J	McCall, AS; Cummings, CF; Bhave, G; Vanacore, R; Page-McCaw, A; Hudson, BG				McCall, A. Scott; Cummings, Christopher F.; Bhave, Gautam; Vanacore, Roberto; Page-McCaw, Andrea; Hudson, Billy G.			Bromine Is an Essential Trace Element for Assembly of Collagen IV Scaffolds in Tissue Development and Architecture	CELL			English	Article							BASEMENT-MEMBRANE; EXTRACELLULAR-MATRIX; DROSOPHILA; THIOCYANATE; MUTATIONS; ACIDS; INTERMEDIATE; REACTIVITY; OXIDATION; ELEGANS	Bromine is ubiquitously present in animals as ionic bromide (Br-) yet has no known essential function. Herein, we demonstrate that Br- is a required cofactor for peroxidasin-catalyzed formation of sulfilimine crosslinks, a posttranslational modification essential for tissue development and architecture found within the collagen IV scaffold of basement membranes (BMs). Bromide, converted to hypobromous acid, forms a bromosulfonium-ion intermediate that energetically selects for sulfilimine formation. Dietary Br deficiency is lethal in Drosophila, whereas Br replenishment restores viability, demonstrating its physiologic requirement. Importantly, Br-deficient flies phenocopy the developmental and BM defects observed in peroxidasin mutants and indicate a functional connection between Br-, collagen IV, and peroxidasin. We establish that Br- is required for sulfilimine formation within collagen IV, an event critical for BM assembly and tissue development. Thus, bromine is an essential trace element for all animals, and its deficiency may be relevant to BM alterations observed in nutritional and smoking-related disease.	[McCall, A. Scott] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; [Cummings, Christopher F.; Hudson, Billy G.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Cummings, Christopher F.; Bhave, Gautam; Vanacore, Roberto; Hudson, Billy G.] Vanderbilt Univ, Sch Med, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37232 USA; [Vanacore, Roberto; Hudson, Billy G.] Vanderbilt Univ, Sch Med, Ctr Matrix Biol, Nashville, TN 37232 USA; [Page-McCaw, Andrea] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Page-McCaw, Andrea] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Page-McCaw, Andrea; Hudson, Billy G.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc3, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Hudson, BG (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 607 Light Hall, Nashville, TN 37232 USA.	billy.hudson@vanderbilt.edu	Vanacore, Roberto/AAD-6399-2020	Vanacore, Roberto/0000-0002-2886-0606; Hudson, Billy/0000-0002-5420-4100	NIH [R01 DK18381, F30 DK100094-01, KO8 DK097306, R01 GM073883]; NIGMS [T32 GM07347]; Canby Robinson Society; Vanderbilt Physician Scientist Development Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK097306, F30DK100094, R01DK018381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073883, T32GM007347] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canby Robinson Society; Vanderbilt Physician Scientist Development Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following: NIH R01 DK18381 to B. G. H.; NIH F30 DK100094-01 to A. S. M.; NIGMS T32 GM07347 to the Vanderbilt Medical-Scientist Training Program and the Canby Robinson Society in support of A. S. M.; NIH KO8 DK097306 and the Vanderbilt Physician Scientist Development Award to G. B.; and NIH R01 GM073883 to A.P.-M. We are grateful to K. L. Rose at Vanderbilt Mass Spectrometry Resource Center; J. Clanton, X. Wang, and E. Shannon for assistance with Drosophila; J. Williams and W. G. Jerome for assistance with Electron Microscopy and sample preparation, performed with use of the VUMC Cell Imaging Shared Resource; and the Bloomington Drosophila Stock Center, Yale FlyTrap, and the VDRC for fly stocks. The technical assistance of P. Todd and M. Rafi is appreciated. We acknowledge S. Kraft for helpful chemistry discussions. C. F. C. and B. G. H. are cofounders of SULFILATEC, INC. C. F. C. is a director and officer without salary of SULFILATEC, INC.	ANKE M, 1990, Acta Agronomica Hungarica, V39, P297; Armesto XL, 2000, TETRAHEDRON, V56, P1103, DOI 10.1016/S0040-4020(99)01066-2; ASMUSSEN I, 1979, Clinical Cardiology, V2, P246; BARRATT TM, 1969, J CLIN INVEST, V48, P56, DOI 10.1172/JCI105974; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/nchembio.1038, 10.1038/NCHEMBIO.1038]; Borchiellini C, 1996, MECH DEVELOP, V58, P179, DOI 10.1016/S0925-4773(96)00574-6; BOZEMAN PM, 1990, J IMMUNOL METHODS, V126, P125, DOI 10.1016/0022-1759(90)90020-V; Brodie BB, 1939, J BIOL CHEM, V130, P555; Chmutova G., 1999, RUSS J ORG CHEM+, V35, P56; DAHLSTROM KA, 1986, J PEDIATR-US, V109, P625, DOI 10.1016/S0022-3476(86)80225-6; Daley WP, 2013, CURR OPIN GENET DEV, V23, P408, DOI 10.1016/j.gde.2013.05.005; Gotenstein JR, 2010, DEVELOPMENT, V137, P3603, DOI 10.1242/dev.049189; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Groos S, 2003, J SURG RES, V109, P74, DOI 10.1016/S0022-4804(02)00094-X; Gupta MC, 1997, J CELL BIOL, V137, P1185, DOI 10.1083/jcb.137.5.1185; Haigo SL, 2011, SCIENCE, V331, P1071, DOI 10.1126/science.1199424; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; KLOPMAN G, 1968, J AM CHEM SOC, V90, P223, DOI 10.1021/ja01004a002; LANGEVELD JPM, 1988, J BIOL CHEM, V263, P10481; LIN CQ, 1993, FASEB J, V7, P737, DOI 10.1096/fasebj.7.9.8330681; MAYENO AN, 1989, J BIOL CHEM, V264, P5660; MERTZ W, 1981, SCIENCE, V213, P1332, DOI 10.1126/science.7022654; Miura Y, 2002, NUCL INSTRUM METH B, V189, P443, DOI 10.1016/S0168-583X(01)01122-3; Nagy P, 2006, CHEM RES TOXICOL, V19, P587, DOI 10.1021/tx050338c; Nielsen FH, 1998, J TRACE ELEM EXP MED, V11, P251, DOI 10.1002/(SICI)1520-670X(1998)11:2/3&lt;251::AID-JTRA15&gt;3.0.CO;2-Q; Oe P., 1981, TRACE ELEMENT METABO, P526; Olszowy HA, 1998, J ANAL TOXICOL, V22, P225, DOI 10.1093/jat/22.3.225; Pastor-Pareja JC, 2011, DEV CELL, V21, P245, DOI 10.1016/j.devcel.2011.06.026; Pavelka S, 2005, PHYSIOL RES, V54, P639; PEARSON RG, 1968, J CHEM EDUC, V45, P581, DOI 10.1021/ed045p581; Peskin AV, 2009, BIOCHEMISTRY-US, V48, P10175, DOI 10.1021/bi901266w; PIEDADEGUERREIRO J, 1987, J RADIOAN NUCL CH AR, V110, P531, DOI 10.1007/BF02035542; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Rodriguez A, 1996, GENETICS, V143, P929; SEEMAN JI, 1983, CHEM REV, V83, P83, DOI 10.1021/cr00054a001; Shanbhag S, 2009, J EXP BIOL, V212, P1731, DOI 10.1242/jeb.029306; Soltani A, 2012, HISTOPATHOLOGY, V60, P964, DOI 10.1111/j.1365-2559.2011.04147.x; Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005; TRAUTNER M, 1968, ACTA PHYSIOL SCAND, V74, P606, DOI 10.1111/j.1748-1716.1968.tb04271.x; Tsuge K, 2000, J HEALTH SCI, V46, P343; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; VANLEEUWEN FXR, 1987, CRIT REV TOXICOL, V18, P189, DOI 10.3109/10408448709089861; VANLOGTEN MJ, 1974, TOXICOLOGY, V2, P257, DOI 10.1016/0300-483X(74)90017-1; VRACKO R, 1974, AM J PATHOL, V77, P314; WALLAEYS B, 1986, KIDNEY INT, V30, P599, DOI 10.1038/ki.1986.227; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; WEISS SJ, 1986, SCIENCE, V234, P200, DOI 10.1126/science.3018933; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; WOLF RL, 1950, AM J PHYSIOL, V163, P436, DOI 10.1152/ajplegacy.1950.163.2.436; WOODS AE, 1979, B ENVIRON CONTAM TOX, V23, P179, DOI 10.1007/BF01769938; YOUNG PR, 1978, J AM CHEM SOC, V100, P7121, DOI 10.1021/ja00490a082; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911	53	222	224	5	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1380	1392		10.1016/j.cell.2014.05.009	http://dx.doi.org/10.1016/j.cell.2014.05.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906154	Bronze, Green Accepted			2022-12-01	WOS:000340881400014
J	Zumla, A; Hui, DS				Zumla, Alimuddin; Hui, David S.			Infection control and MERS-CoV in health-care workers	LANCET			English	Editorial Material							ACUTE RESPIRATORY SYNDROME; HONG-KONG; CORONAVIRUS; SARS; OUTBREAK		[Zumla, Alimuddin] UCL, Dept Infect, Div Infect & Immun, Ctr Clin Microbiol, London, England; [Zumla, Alimuddin] Univ Coll London Hosp, NIHR Biomed Res Ctr, London, England; [Hui, David S.] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Hui, David S.] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Chinese University of Hong Kong; Chinese University of Hong Kong	Hui, DS (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	dschui@cuhk.edu.hk	Hui, David Shu-Cheong/O-2754-2015; ZUMLA, Alimuddin/ABA-8208-2020	Hui, David Shu-Cheong/0000-0003-4382-2445; ZUMLA, Alimuddin/0000-0002-5111-5735				Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Booth TF, 2005, J INFECT DIS, V191, P1472, DOI 10.1086/429634; CDC, 2014, INT INF PREV CONTR R; Hijawi B, 2013, E MEDITERR HEALTH J, V19, pS12; Hui DS, 2014, CURR OPIN PULM MED, V20, P233, DOI 10.1097/MCP.0000000000000046; Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Sehulster Lynne, 2003, MMWR Recomm Rep, V52, P1; Seto WH, 2013, E MEDITERR HEALTH J, V19, pS39; SIEGEL JD, 2007, 2007 GUID IS PREC PR; Tomlinson B, 2003, LANCET, V361, P1486, DOI 10.1016/S0140-6736(03)13218-7; WHO, 2014, GLOB AL RESP MIDD E; WHO (World Health Organization), 2016, ASS RISK ASS INFL A; World Health Organization, 2014, WHO STAT 5 M IHR EM; Yu IT, 2007, CLIN INFECT DIS, V44, P1017, DOI 10.1086/512819; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	17	58	59	2	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1869	1871		10.1016/S0140-6736(14)60852-7	http://dx.doi.org/10.1016/S0140-6736(14)60852-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PR	24857701	Green Published, Bronze			2022-12-01	WOS:000336847800011
J	Birnbaum, ME; Mendoza, JL; Sethi, DK; Dong, S; Glanville, J; Dobbins, J; Ozkan, E; Davis, MM; Wucherpfennig, KW; Garcia, KC				Birnbaum, Michael E.; Mendoza, Juan L.; Sethi, Dhruv K.; Dong, Shen; Glanville, Jacob; Dobbins, Jessica; Oezkan, Engin; Davis, Mark M.; Wucherpfennig, Kai W.; Garcia, K. Christopher			Deconstructing the Peptide-MHC Specificity of T Cell Recognition	CELL			English	Article							CROSS-REACTIVITY; RECEPTOR RECOGNITION; DIRECTED EVOLUTION; SURFACE DISPLAY; ANTIGEN; BINDING; TCR; DEGENERACY; SELF; IDENTIFICATION	In order to survey a universe of major histocompatibility complex (MHC)-presented peptide antigens whose numbers greatly exceed the diversity of the T cell repertoire, T cell receptors (TCRs) are thought to be cross- reactive. However, the nature and extent of TCR cross- reactivity has not been conclusively measured experimentally. We developed a system to identify MHC-presented peptide ligands by combining TCR selection of highly diverse yeast-displayed peptide-MHC libraries with deep sequencing. Although we identified hundreds of peptides reactive with each of five different mouse and human TCRs, the selected peptides possessed TCR recognition motifs that bore a close resemblance to their known antigens. This structural conservation of the TCR interaction surface allowed us to exploit deep-sequencing information to computationally identify activating microbial and self-ligands for human autoimmune TCRs. The mechanistic basis of TCR cross- reactivity described here enables effective surveillance of diverse self and foreign antigens without necessitating degenerate recognition of nonhomologous peptides.	[Birnbaum, Michael E.; Mendoza, Juan L.; Dong, Shen; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Birnbaum, Michael E.; Mendoza, Juan L.; Dong, Shen; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Glanville, Jacob; Davis, Mark M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Birnbaum, Michael E.; Glanville, Jacob; Davis, Mark M.; Garcia, K. Christopher] Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; [Oezkan, Engin; Davis, Mark M.; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Sethi, Dhruv K.; Dobbins, Jessica; Wucherpfennig, Kai W.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Dobbins, Jessica; Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Program Immunol, Boston, MA 02115 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Dong, Shen/ABC-2875-2020	Davis, Mark/0000-0001-6868-657X; dong, Shen/0000-0001-8839-7046; Kohler, Jessica/0000-0002-6074-5595; Ozkan, Engin/0000-0002-0263-6729; Mendoza, Juan/0000-0001-6972-7476; Birnbaum, Michael/0000-0002-2281-3518	Regina Casper Stanford Graduate Fellowship; Gerald J. Lieberman Fellowship; National Science Foundation; Helen Hay Whitney Foundation; NIH [PO1 AI045757, R01 AI03867, R01 AI022511, U19 4100041120, P41GM103393]; HHMI; U.S. Department of Energy [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; NCI-K01CA175127; NATIONAL CANCER INSTITUTE [K01CA175127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103867, R01AI048540, U19AI057229, R01AI022511, P01AI045757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK097681] Funding Source: NIH RePORTER	Regina Casper Stanford Graduate Fellowship; Gerald J. Lieberman Fellowship; National Science Foundation(National Science Foundation (NSF)); Helen Hay Whitney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); U.S. Department of Energy(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NCI-K01CA175127; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Suzanne Fischer, Gary Mantalas, and Nelida Prado for technical assistance and Jarrett Adams, Lauren Ely, and Evan Newell for helpful discussions. M.E.B. was supported by a Regina Casper Stanford Graduate Fellowship, a Gerald J. Lieberman Fellowship, and a National Science Foundation Graduate Fellowship. J.L.M. was supported by NCI-K01CA175127 and a Helen Hay Whitney Foundation postdoctoral fellowship. This work was supported by the NIH (PO1 AI045757 to K.W.W., R01 AI03867 to K. C. G., R01 AI022511 to M. M. D., and U19 4100041120 to M. M. D. and K. C. G.) and HHMI (to M. M. D. and K. C. G.). Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health (including P41GM103393).	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Basu D, 2000, J IMMUNOL, V164, P5788, DOI 10.4049/jimmunol.164.11.5788; Benoist C, 2001, NAT IMMUNOL, V2, P797, DOI 10.1038/ni0901-797; Birnbaum ME, 2012, IMMUNOL REV, V250, P82, DOI 10.1111/imr.12006; Boder ET, 2005, BIOTECHNOL BIOENG, V92, P485, DOI 10.1002/bit.20616; Borbulevych OY, 2011, J IMMUNOL, V186, P2950, DOI 10.4049/jimmunol.1003150; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; COCKCROFT VB, 1991, FEBS LETT, V293, P149, DOI 10.1016/0014-5793(91)81173-6; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Crawford F, 2006, IMMUNOL REV, V210, P156, DOI 10.1111/j.0105-2896.2006.00365.x; Crawford F, 2004, PLOS BIOL, V2, P523, DOI 10.1371/journal.pbio.0020090; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; De la Herran-Arita AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007762; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; EHRICH EW, 1993, J EXP MED, V178, P713, DOI 10.1084/jem.178.2.713; Esteban O, 2004, J MOL BIOL, V340, P81, DOI 10.1016/j.jmb.2004.04.054; EVAVOLD BD, 1995, IMMUNITY, V2, P655, DOI 10.1016/1074-7613(95)90010-1; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Harkiolaki M, 2009, IMMUNITY, V30, P348, DOI 10.1016/j.immuni.2009.01.009; Hausmann S, 1999, J IMMUNOL, V162, P338; Hemmer B, 1997, J EXP MED, V185, P1651, DOI 10.1084/jem.185.9.1651; Hemmer B, 1998, J IMMUNOL, V160, P3631; Hemmer B, 1998, IMMUNOL TODAY, V19, P163, DOI 10.1016/S0167-5699(97)01217-6; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Jiang W, 2010, P NATL ACAD SCI USA, V107, P13258, DOI 10.1073/pnas.1006344107; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; Krishnamoorthy G, 2009, NAT MED, V15, P626, DOI 10.1038/nm.1975; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Lo WL, 2009, NAT IMMUNOL, V10, P1155, DOI 10.1038/ni.1796; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Madsen LS, 1999, NAT GENET, V23, P343, DOI 10.1038/15525; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; Morris GP, 2011, P NATL ACAD SCI USA, V108, P3695, DOI 10.1073/pnas.1017015108; Newell EW, 2011, J IMMUNOL, V186, P5823, DOI 10.4049/jimmunol.1100197; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; REAY PA, 1994, J IMMUNOL, V152, P3946; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Shann F, 2010, PEDIATR INFECT DIS J, V29, P457, DOI 10.1097/INF.0b013e3181c91361; Shih FF, 2004, MOL IMMUNOL, V40, P1041, DOI 10.1016/j.molimm.2003.11.008; Starwalt SE, 2003, PROTEIN ENG, V16, P147, DOI 10.1093/proeng/gzg018; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Wang YB, 2005, P NATL ACAD SCI USA, V102, P2476, DOI 10.1073/pnas.0409798102; Welsh RM, 2010, IMMUNOL REV, V235, P244, DOI 10.1111/j.0105-2896.2010.00897.x; Wen F, 2008, J IMMUNOL METHODS, V336, P37, DOI 10.1016/j.jim.2008.03.008; Wen F, 2011, PROTEIN ENG DES SEL, V24, P701, DOI 10.1093/protein/gzr035; Wilson DB, 1999, J IMMUNOL, V163, P6424; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wucherpfennig KW, 2007, SEMIN IMMUNOL, V19, P216, DOI 10.1016/j.smim.2007.02.012; WUCHERPFENNIG KW, 1994, J IMMUNOL, V152, P5581; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279; Yin YY, 2009, IMMUNITY, V31, P849, DOI 10.1016/j.immuni.2009.12.002; Zhao R, 1999, J EXP MED, V189, P359, DOI 10.1084/jem.189.2.359; Zhao YD, 2001, J IMMUNOL, V167, P2130, DOI 10.4049/jimmunol.167.4.2130	68	332	342	5	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1073	1087		10.1016/j.cell.2014.03.047	http://dx.doi.org/10.1016/j.cell.2014.03.047			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855945	Green Accepted, Bronze			2022-12-01	WOS:000336437200011
J	Lu, M; Zak, J; Chen, SO; Sanchez-Pulido, L; Severson, DT; Endicott, J; Ponting, CP; Schofield, CJ; Lu, X				Lu, Min; Zak, Jaroslav; Chen, Shuo; Sanchez-Pulido, Luis; Severson, David T.; Endicott, Jane; Ponting, Chris P.; Schofield, Christopher J.; Lu, Xin			A Code for RanGDP Binding in Ankyrin Repeats Defines a Nuclear Import Pathway	CELL			English	Article							CRYSTAL-STRUCTURE; TUMOR-SUPPRESSOR; TRANSPORT FACTOR; PROTEIN IMPORT; LOCALIZATION; P53; CELLS; ASPP1; INHIBITOR; APOPTOSIS	Regulation of nuclear import is fundamental to eukaryotic biology. The majority of nuclear import pathways are mediated by importin-cargo interactions. Yet not all nuclear proteins interact with importins, necessitating the identification of a general importin-independent nuclear import pathway. Here, we identify a code that determines importin-independent nuclear import of ankyrin repeats (ARs), a structural motif found in over 250 human proteins with diverse functions. AR-containing proteins (ARPs) with a hydrophobic residue at the 13th position of two consecutive ARs bind RanGDP efficiently, and consequently enter the nucleus. This code, experimentally tested in 17 ARPs, predicts the nuclear-cytoplasmic localization of over 150 annotated human ARPs with high accuracy and is acquired by the most common familial melanoma-associated CDKN2A mutation, leading to nuclear accumulation of mutant p16ink4a. The RaDAR (RanGDP/AR) pathway represents a general importin-independent nuclear import pathway and is frequently used by AR-containing transcriptional regulators, especially those regulating NF-kappa B/p53.	[Lu, Min; Zak, Jaroslav; Chen, Shuo; Severson, David T.; Lu, Xin] Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res, Oxford OX3 7DQ, England; [Sanchez-Pulido, Luis; Ponting, Chris P.] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford OX1 3PT, England; [Endicott, Jane] Univ Newcastle, Northern Inst Canc Res, Newcastle NE2 4HH, Tyne & Wear, England; [Schofield, Christopher J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England	Ludwig Institute for Cancer Research; University of Oxford; University of Oxford; Newcastle University - UK; University of Oxford	Lu, X (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res, Oxford OX3 7DQ, England.	xin.lu@ludwig.ox.ac.uk	Ponting, Chris/AAV-2621-2021; lu, min/E-5407-2014	Zak, Jaroslav/0000-0002-8135-856X; Schofield, Christopher/0000-0002-0290-6565; Ponting, Chris/0000-0003-0202-7816; Lu, Xin/0000-0002-6587-1152; lu, min/0000-0001-6902-3751; Sanchez Pulido, Luis/0000-0002-2300-8502; Endicott, Jane/0000-0003-4868-0116; Severson, David T/0000-0002-1750-8332	Ludwig Institute for Cancer Research Ltd.; BBSRC [BB/L009846/1] Funding Source: UKRI; MRC [MC_UU_12021/1, MC_U137761446, G0901526] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L009846/1] Funding Source: researchfish; Medical Research Council [MC_UU_12021/1, MC_U137761446, G0901526] Funding Source: researchfish	Ludwig Institute for Cancer Research Ltd.; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Ludwig Institute for Cancer Research Ltd. We thank Andrew Wilde, Katrien Van Impe, Paul Clarke, Svitlana Korolchuk, Ming Yang, Vann Bennett, Matthew Cockman, and Mark Hannink for the generous gift of plasmids or proteins. We thank Yvonne Jones for generous access to facilities for protein production. We thank Claire Beveridge and Kimberley Bryon-Dodd for critical reading of the manuscript.	Adams RL, 2013, CELL, V152, P1218, DOI 10.1016/j.cell.2013.02.042; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Aylon Y, 2010, GENE DEV, V24, P2420, DOI 10.1101/gad.1954410; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Chaillan-Huntington C, 2000, J BIOL CHEM, V275, P5874, DOI 10.1074/jbc.275.8.5874; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dreier B, 2013, P NATL ACAD SCI USA, V110, pE869, DOI 10.1073/pnas.1213653110; Eber SW, 1996, NAT GENET, V13, P214, DOI 10.1038/ng0696-214; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Ghiorzo P, 2004, HUM PATHOL, V35, P25, DOI 10.1016/j.humpath.2003.08.017; Goldstein AM, 2006, CANCER RES, V66, P9818, DOI 10.1158/0008-5472.CAN-06-0494; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Kim S, 2013, BIOPHYS J, V105, P565, DOI 10.1016/j.bpj.2013.04.025; Kohl A, 2003, P NATL ACAD SCI USA, V100, P1700, DOI 10.1073/pnas.0337680100; Kose S, 2012, CELL, V149, P578, DOI 10.1016/j.cell.2012.02.058; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lu M, 2013, CANCER CELL, V23, P618, DOI 10.1016/j.ccr.2013.03.013; McConnell BB, 1999, MOL CELL BIOL, V19, P1981; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Morrison J, 2003, J MOL BIOL, V333, P587, DOI 10.1016/j.jmb.2003.08.050; Notari M, 2011, P NATL ACAD SCI USA, V108, P16645, DOI 10.1073/pnas.1102292108; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Slee EA, 2004, ONCOGENE, V23, P9007, DOI 10.1038/sj.onc.1208088; Sottocornola R, 2010, DEV CELL, V19, P126, DOI 10.1016/j.devcel.2010.06.003; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Van Impe K, 2008, TRAFFIC, V9, P695, DOI 10.1111/j.1600-0854.2008.00720.x; Vigneron AM, 2010, GENE DEV, V24, P2430, DOI 10.1101/gad.1954310; Vives V, 2006, GENE DEV, V20, P1262, DOI 10.1101/gad.374006; Wang Y, 2013, CELL DEATH DIFFER, V20, P525, DOI 10.1038/cdd.2013.3; Yang JP, 1999, J BIOL CHEM, V274, P15662, DOI 10.1074/jbc.274.22.15662	46	50	51	3	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1130	1145		10.1016/j.cell.2014.05.006	http://dx.doi.org/10.1016/j.cell.2014.05.006			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855949	Bronze			2022-12-01	WOS:000336437200015
J	Shimizu, H; Woodcock, SA; Wilkin, MB; Trubenova, B; Monk, NAM; Baron, M				Shimizu, Hideyuki; Woodcock, Simon A.; Wilkin, Marian B.; Trubenova, Barbora; Monk, Nicholas A. M.; Baron, Martin			Compensatory Flux Changes within an Endocytic Trafficking Network Maintain Thermal Robustness of Notch Signaling	CELL			English	Article							OF-DELTEX GENE; DROSOPHILA-MELANOGASTER; ACTIVATION; RECEPTOR; PATHWAY; SUPPRESSOR; REGULATOR; REQUIRES; COMPLEX	Developmental signaling is remarkably robust to environmental variation, including temperature. For example, in ectothermic animals such as Drosophila, Notch signaling is maintained within functional limits across a wide temperature range. We combine experimental and computational approaches to show that temperature compensation of Notch signaling is achieved by an unexpected variety of endocytic-dependent routes to Notch activation which, when superimposed on ligand-induced activation, act as a robustness module. Thermal compensation arises through an altered balance of fluxes within competing trafficking routes, coupled with temperature-dependent ubiquitination of Notch. This flexible ensemble of trafficking routes supports Notch signaling at low temperature but can be switched to restrain Notch signaling at high temperature and thus compensates for the inherent temperature sensitivity of ligand-induced activation. The outcome is to extend the physiological range over which normal development can occur. Similar mechanisms may provide thermal robustness for other developmental signals.	[Shimizu, Hideyuki; Woodcock, Simon A.; Wilkin, Marian B.; Trubenova, Barbora; Baron, Martin] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Monk, Nicholas A. M.] Univ Sheffield, Sch Math & Stat, Sheffield S3 7RH, S Yorkshire, England	University of Manchester; University of Sheffield	Baron, M (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	mbaron@manchester.ac.uk	Trubenova, Barbora/GQB-4224-2022	Trubenova, Barbora/0000-0002-6873-2967; Monk, Nick/0000-0002-5465-4857; Love, Marian/0000-0003-2203-3551	Manchester Fly Facility; Biotechnology and Biological Sciences Research Council [H000976]; Wellcome Trust [087928]; BBSRC [BB/E002285/1, BB/H000976/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H000976/1, BB/E002285/1, BB/C503162/1] Funding Source: researchfish	Manchester Fly Facility; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Sarah Bray, Gunter Merdes, Spyros Artavanis-Tsakonas, Matthew Scott, Helmut Kramer, Suzanne Eaton, Stephen Brown, Michael Cornell, Bezhad Rowshanravan, David Hughes, the Bloomington Drosophila Stock Center (University of Indiana), and the Developmental Studies Hybridoma Bank (University of Iowa) for reagents, constructs, and fly lines, and the University of Sheffield RNAi Screening Facility, (Wellcome Trust-084757) for RNAi. We also acknowledge technical support from Deborah Ashworth, Sanjai Patel and the Manchester Fly Facility, and the Biotechnology and Biological Sciences Research Council (H000976) and Wellcome Trust (087928) for funding. We thank Shane Herbert for critical discussion. Research materials generated in this work are available on request.	Allgood AG, 2011, J MOL BIOL, V414, P243, DOI 10.1016/j.jmb.2011.09.050; Baron M, 2012, SEMIN CELL DEV BIOL, V23, P437, DOI 10.1016/j.semcdb.2012.01.008; Bishop SA, 1999, DEVELOPMENT, V126, P2993; Christian AE, 1997, J LIPID RES, V38, P2264; Cornell M, 1999, GENETICS, V152, P567; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Fortini ME, 2009, CURR OPIN GENET DEV, V19, P323, DOI 10.1016/j.gde.2009.04.005; Fostier M, 1998, GENETICS, V150, P1477; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Hori K, 2011, J CELL BIOL, V195, P1005, DOI 10.1083/jcb.201104146; Hortsch R, 2010, MOL BIOL CELL, V21, P778, DOI 10.1091/mbc.E09-01-0005; Katkere B, 2010, J IMMUNOL, V185, P5032, DOI 10.4049/jimmunol.1001653; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Mazaleyrat SL, 2003, DEV BIOL, V255, P363, DOI 10.1016/S0012-1606(02)00086-6; Saj A, 2010, DEV CELL, V18, P862, DOI 10.1016/j.devcel.2010.03.013; Salvat C, 2004, J BIOL CHEM, V279, P18935, DOI 10.1074/jbc.M312201200; Schmid SL, 2013, NATURE, V499, P161, DOI 10.1038/nature12408; Schneider M, 2013, J CELL SCI, V126, P645, DOI 10.1242/jcs.116590; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Venkatachalam K, 2013, AUTOPHAGY, V9, P98, DOI 10.4161/auto.22260; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Whiteman P, 2013, J BIOL CHEM, V288, P7305, DOI 10.1074/jbc.M112.428854; Wilkin M, 2008, DEV CELL, V15, P762, DOI 10.1016/j.devcel.2008.09.002; XU T, 1990, GENETICS, V126, P665; Zheng L, 2013, MOL BIOL CELL, V24, P297, DOI 10.1091/mbc.E12-02-0081	30	44	46	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1160	1174		10.1016/j.cell.2014.03.050	http://dx.doi.org/10.1016/j.cell.2014.03.050			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855951	hybrid, Green Published			2022-12-01	WOS:000336437200017
J	Shamian, J				Shamian, Judith			Interprofessional collaboration, the only way to Save Every Woman and Every Child	LANCET			English	Editorial Material									Int Council Nurses, CH-1201 Geneva, Switzerland		Shamian, J (corresponding author), Int Council Nurses, Pl Jean Marteau, CH-1201 Geneva, Switzerland.	shamianjudith@gmail.com							0	14	14	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					E41	E42		10.1016/S0140-6736(14)60858-8	http://dx.doi.org/10.1016/S0140-6736(14)60858-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ2PU	24965821				2022-12-01	WOS:000342630600002
J	Ghany, MG; Gara, N				Ghany, Marc G.; Gara, Naveen			QUEST for a cure for hepatitis C virus: the end is in sight	LANCET			English	Editorial Material							HCV GENOTYPE 1; PLUS SOFOSBUVIR; ABT-450/R-OMBITASVIR; TELAPREVIR; LEDIPASVIR; RIBAVIRIN; DASABUVIR; SIMEPREVIR; BOCEPREVIR; VARIANTS		[Ghany, Marc G.] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA; [Gara, Naveen] Washington Hosp Ctr, Dept Gastroenterol, Washington, DC 20010 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); MedStar Washington Hospital Center	Ghany, MG (corresponding author), NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA.	marcg@intra.niddk.nih.gov	Ghany, Marc/AAU-4238-2021	Ghany, Marc/0000-0003-2837-0188	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075009] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DK075009] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P18; Barnard RJO, 2013, VIROLOGY, V444, P329, DOI 10.1016/j.virol.2013.06.029; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Forns X, 2014, GASTROENTEROLOGY, V146, P1669, DOI 10.1053/j.gastro.2014.02.051; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hezode C, 2014, GASTROENTEROLOGY, V147, P132, DOI 10.1053/j.gastro.2014.03.051; Jacobson IM, 2014, LANCET; Jacobson IM, 2013, HEPATOLOGY, V58, p1379A; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Janssen Therapeutics, 2013, OL SIM CAPS OR US FU; Kieffer TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034372; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lawitz E, 2014, J HEPATOL, V60, pS524, DOI 10.1016/S0168-8278(14)61460-4; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Manns M, 2014, LANCET; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sullivan JC, 2013, CLIN INFECT DIS, V57, P221, DOI 10.1093/cid/cit226; Susser S, 2011, J CLIN VIROL, V52, P321, DOI 10.1016/j.jcv.2011.08.015; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; World Health Organization, 2014, GUID SCREEN CAR TREA; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	28	6	6	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2014	384	9941					381	383		10.1016/S0140-6736(14)60807-2	http://dx.doi.org/10.1016/S0140-6736(14)60807-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9IV	24907223	Green Accepted			2022-12-01	WOS:000340195800006
J	Ghosh, R; Wang, L; Wang, ES; Perera, BGK; Igbaria, A; Morita, S; Prado, K; Thamsen, M; Caswell, D; Macias, H; Weiberth, KF; Gliedt, MJ; Alavi, MV; Hari, SB; Mitra, AK; Bhhatarai, B; Schurer, SC; Snapp, EL; Gould, DB; German, MS; Backes, BJ; Maly, DJ; Oakes, SA; Papa, FR				Ghosh, Rajarshi; Wang, Likun; Wang, Eric S.; Perera, B. Gayani K.; Igbaria, Aeid; Morita, Shuhei; Prado, Kris; Thamsen, Maike; Caswell, Deborah; Macias, Hector; Weiberth, Kurt F.; Gliedt, Micah J.; Alavi, Marcel V.; Hari, Sanjay B.; Mitra, Arinjay K.; Bhhatarai, Barun; Schuerer, Stephan C.; Snapp, Erik L.; Gould, Douglas B.; German, Michael S.; Backes, Bradley J.; Maly, Dustin J.; Oakes, Scott A.; Papa, Feroz R.			Allosteric Inhibition of the IRE1 alpha RNase Preserves Cell Viability and Function during Endoplasmic Reticulum Stress	CELL			English	Article							UNFOLDED PROTEIN RESPONSE; ER STRESS; TRANSCRIPTION FACTOR; MAMMALIAN-CELLS; NLRP3 INFLAMMASOME; MESSENGER-RNAS; IRE1; KINASE; DEATH; TRANSLATION	Depending on endoplasmic reticulum (ER) stress levels, the ER transmembrane multidomain protein IRE1 alpha promotes either adaptation or apoptosis. Unfolded ER proteins cause IRE1a lumenal domain homo-oligomerization, inducing trans autophosphorylation that further drives homo-oligomerization of its cytosolic kinase/endoribonuclease (RNase) domains to activatem RNA splicing of adaptive XBP1 transcription factor. However, under high/chronic ER stress, IRE1a surpasses an oligomerization threshold that expands RNase substrate repertoire to many ER-localized mRNAs, leading to apoptosis. To modulate these effects, we developed ATP-competitive IRE1a Kinase-Inhibiting RNase Attenuators-KIRAs-that allosterically inhibit IRE1 alpha's RNase by breaking oligomers. One optimized KIRA, KIRA6, inhibits IRE1a in vivo and promotes cell survival under ER stress. Intravitreally, KIRA6 preserves photoreceptor functional viability in rat models of ER stress-induced retinal degeneration. Systemically, KIRA6 preserves pancreatic beta cells, increases insulin, and reduces hyperglycemia in Akita diabetic mice. Thus, IRE1a powerfully controls cell fate but can itself be controlled with small molecules to reduce cell degeneration.	[Ghosh, Rajarshi; Wang, Likun; Igbaria, Aeid; Morita, Shuhei; Prado, Kris; Thamsen, Maike; Macias, Hector; Weiberth, Kurt F.; Gliedt, Micah J.; German, Michael S.; Backes, Bradley J.; Papa, Feroz R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Ghosh, Rajarshi; Wang, Eric S.; Caswell, Deborah; Oakes, Scott A.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Alavi, Marcel V.; Gould, Douglas B.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Gould, Douglas B.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Ghosh, Rajarshi; Wang, Likun; Igbaria, Aeid; Morita, Shuhei; Prado, Kris; Thamsen, Maike; Macias, Hector; Weiberth, Kurt F.; German, Michael S.; Oakes, Scott A.; Papa, Feroz R.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Ghosh, Rajarshi; Wang, Likun; Igbaria, Aeid; Morita, Shuhei; Prado, Kris; Thamsen, Maike; Weiberth, Kurt F.; Gliedt, Micah J.; Backes, Bradley J.; Papa, Feroz R.] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA; [Ghosh, Rajarshi; Wang, Likun; Igbaria, Aeid; Morita, Shuhei; Prado, Kris; Thamsen, Maike; Weiberth, Kurt F.; Papa, Feroz R.] Univ Calif San Francisco, California Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Perera, B. Gayani K.; Hari, Sanjay B.; Mitra, Arinjay K.; Maly, Dustin J.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Schuerer, Stephan C.] Univ Miami, Miller Sch Med, Ctr Computat Sci, Miami, FL 33136 USA; [Bhhatarai, Barun; Schuerer, Stephan C.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Snapp, Erik L.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; University of Miami; University of Miami; Yeshiva University; Albert Einstein College of Medicine	Oakes, SA (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	scott.oakes@ucsf.edu; frpapa@medicine.ucsf.edu	Igbaria, Aeid/S-6871-2019	Alavi, Marcel/0000-0002-1319-3062; Ghosh, Rajarshi/0000-0002-5780-8241; Bhhatarai, Barun/0000-0002-0109-7487; Snapp, Erik/0000-0001-9482-2272; Maly, Dustin/0000-0003-0094-0177; Papa, Feroz/0000-0002-3684-9108; /0000-0003-0606-9896; Igbaria, Aeid/0000-0003-3940-1824	National Institutes of Health [DP2OD001925, RO1 CA136577, RO1 DK080955, RO1 DK095306, RO1 DK100623, PO1 HL108794, P30 DK063720, UO1 DK089541, RO1 DK021344, RO1 GM086858, R21 CA177402, EY019504, EY01919, EY06842, F31-NS083323]; HHMI Physician-Scientist Early Career Award; American Cancer Society Research Scholar Award; Burroughs Wellcome Foundation; Juvenile Diabetes Research Foundation; Harrington Discovery Institute Scholar-Innovator Award; Alfred P. Sloan Foundation; Camille and Henry Dreyfus Foundation; National Science Foundation; American Diabetes Association [ADA-7-07-MN-22]; NATIONAL CANCER INSTITUTE [R01CA136577, R21CA177402] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY001919, R01EY006842, F32EY006842, R37EY001919] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080955, P30DK063720, R01DK100623, R01DK021344, R01DK095306, U01DK089541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS083323] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI Physician-Scientist Early Career Award(Howard Hughes Medical Institute); American Cancer Society Research Scholar Award(American Cancer Society); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Harrington Discovery Institute Scholar-Innovator Award; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Camille and Henry Dreyfus Foundation; National Science Foundation(National Science Foundation (NSF)); American Diabetes Association(American Diabetes Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Michael Matthes and Doug Yasumura for technical assistance with rat models, Vinh Nguyen for islet isolation, and Oakes and Papa lab members for discussions. The work was supported by National Institutes of Health grants DP2OD001925 (F. R. P.), RO1 CA136577 (S. A. O.), RO1 DK080955 (F. R. P.), RO1 DK095306 (S. A. O. and F. R. P.), RO1 DK100623 (D.J.M. and F. R. P.), PO1 HL108794 (F. R. P.), P30 DK063720 (F. R. P. and M. S. G.), UO1 DK089541 (F. R. P. and M. S. G.), RO1 DK021344 (M. S. G.), RO1 GM086858 (D.J.M.), R21 CA177402 (D.J.M.), EY019504 (D. B. G.), EY01919 (D. B. G.), EY06842 (D. B. G.), and F31-NS083323 (E. S. W.); HHMI Physician-Scientist Early Career Award (S. A. O.); American Cancer Society Research Scholar Award (S. A. O.); Burroughs Wellcome Foundation (F. R. P.); Juvenile Diabetes Research Foundation (F. R. P. and S. A. O.); Harrington Discovery Institute Scholar-Innovator Award (S. A. O. and F. R. P.); Alfred P. Sloan Foundation (D.J.M.); Camille and Henry Dreyfus Foundation (D.J.M.); National Science Foundation (E. S. W.); and American Diabetes Association ADA-7-07-MN-22 (H. M. S.).	Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Dan H, 2008, BIOCHEM BIOPH RES CO, V365, P777, DOI 10.1016/j.bbrc.2007.11.040; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Kohno K, 2007, ANTIOXID REDOX SIGN, V9, P2295, DOI 10.1089/ars.2007.1819; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Pennesi ME, 2008, EXP EYE RES, V87, P561, DOI 10.1016/j.exer.2008.09.004; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Shimazawa M, 2007, MOL VIS, V13, P578; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Szot Gregory L, 2007, J Vis Exp, P255, DOI 10.3791/255; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang LK, 2012, NAT CHEM BIOL, V8, P982, DOI [10.1038/NCHEMBIO.1094, 10.1038/nchembio.1094]; Xue Z, 2011, J BIOL CHEM, V286, P30859, DOI 10.1074/jbc.M111.273714; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848; Zhang SX, 2014, EXP EYE RES, V125, P30, DOI 10.1016/j.exer.2014.04.015; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	38	305	318	2	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					534	548		10.1016/j.cell.2014.07.002	http://dx.doi.org/10.1016/j.cell.2014.07.002			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25018104	Bronze, Green Accepted			2022-12-01	WOS:000340944300008
J	Johnson, AS; Hall, HI; Hu, XH; Lansky, A; Holtgrave, DR; Mermin, J				Johnson, Anna Satcher; Hall, H. Irene; Hu, Xiaohong; Lansky, Amy; Holtgrave, David R.; Mermin, Jonathan			Trends in Diagnoses of HIV Infection in the United States. 2002-2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Johnson, Anna Satcher; Hall, H. Irene; Hu, Xiaohong; Lansky, Amy] Ctr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Atlanta, GA USA; [Holtgrave, David R.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Mermin, Jonathan] CDC, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA	Johnson, AS (corresponding author), CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, 1600 Clifton Rd NE, Atlanta, GA 30329 USA.	ats5@cdc.gov		Holtgrave, David/0000-0002-4321-7395	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Centers for Disease Control and Prevention, MONITORING SELECTED; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Paz-Bailey G, 2013, MMWR-MORBID MORTAL W, V62, P958; Ries LAG, 2002, SEER CANCER STATISTI; Whitmore Suzanne K., 2012, Morbidity and Mortality Weekly Report, V61, P971	6	110	110	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					432	434		10.1001/jama.2014.8534	http://dx.doi.org/10.1001/jama.2014.8534			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038362	Green Accepted, Bronze			2022-12-01	WOS:000339257800030
J	Pena, LD; Goldstein, SL				Pena, Leopoldo D.; Goldstein, Steven L.			Thermohaline circulation crisis and impacts during the mid-Pleistocene transition	SCIENCE			English	Article							MIDDLE PLEISTOCENE TRANSITION; CARBON-DIOXIDE CONCENTRATION; OCEAN CIRCULATION; DEEP-WATER; ICE; EVOLUTION; CLIMATE; TEMPERATURE; NEODYMIUM; SEA	The mid-Pleistocene transition (MPT) marked a fundamental change in glacial-interglacial periodicity, when it increased from similar to 41-thousand-year to 100-thousand-year cycles and developed higher-amplitude climate variability without substantial changes in the Milankovitch forcing. Here, we document, by using Nd isotopes, a major disruption of the ocean thermohaline circulation (THC) system during the MPT between marine isotope stages (MISs) 25 and 21 at similar to 950 to 860 thousand years ago, which effectively marks the first 100-thousand-year cycle, including an exceptional weakening through a critical interglacial (MIS 23) at similar to 900 thousand years ago. Its recovery into the post-MPT 100-thousand-year world is characterized by continued weak glacial THC. The MPT ocean circulation crisis facilitated the coeval drawdown of atmospheric CO2 and high-latitude ice sheet growth, generating the conditions that stabilized 100-thousand-year cycles.	[Pena, Leopoldo D.; Goldstein, Steven L.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Goldstein, Steven L.] Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA	Columbia University; Columbia University	Pena, LD (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, 61 Route 9W, Palisades, NY 10964 USA.	leopoldo@ldeo.columbia.edu	Pena, Leopoldo/A-7085-2015; Pena, Leopoldo/B-8140-2013	Pena, Leopoldo/0000-0001-6414-6293; Pena, Leopoldo/0000-0001-6414-6293	NSF [OCE-10-31198]; Storke Endowment of the Department of Earth and Environmental Sciences, Columbia University; Directorate For Geosciences [1031198] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Storke Endowment of the Department of Earth and Environmental Sciences, Columbia University; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We acknowledge support from NSF grant OCE-10-31198. We also thank two anonymous reviewers for valuable comments. This study was partly supported by the Storke Endowment of the Department of Earth and Environmental Sciences, Columbia University. Samples were provided by the ODP, which is sponsored by the NSF and participating countries under management of Joint Oceanographic Institutions. R. Lupien helped with sample processing. The data in this paper will be available in the supplementary materials and deposited with National Oceanic and Atmospheric Administration-National Climate Data Center at www.ncdc.noaa.gov. This is LDEO contribution number 7809.	Abouchami W, 1997, GEOCHIM COSMOCHIM AC, V61, P3957, DOI 10.1016/S0016-7037(97)00218-4; Berger W.H., 1994, GEOPHYS MONOGR SER, P295, DOI DOI 10.1029/GM085P0295; Bintanja R, 2008, NATURE, V454, P869, DOI 10.1038/nature07158; Broecker W.S., 1991, OCEANOGRAPHY, V4, P79, DOI [DOI 10.5670/0CEAN0G.1991.07, 10.5670/oceanog.1991.07, DOI 10.5670/OCEANOG.1991.07]; Broecker WS, 1992, GLOBAL BIOGEOCHEM CY, V6, P315, DOI 10.1029/92GB01672; Burton KW, 1999, EARTH PLANET SC LETT, V171, P149, DOI 10.1016/S0012-821X(99)00138-7; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; Clark PU, 1998, PALEOCEANOGRAPHY, V13, P1, DOI 10.1029/97PA02660; Curry WB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001021; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; Ganachaud A, 2000, NATURE, V408, P453, DOI 10.1038/35044048; Gildor H, 2000, PALEOCEANOGRAPHY, V15, P605, DOI 10.1029/1999PA000461; Goldstein S.L., 2003, TREATISE GEOCHEMISTR, V6, P453, DOI [10.1016/B0-08-043751-6/06179-X, DOI 10.1016/B0-08-043751-6/06179-X]; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Hodell DA, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000367; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; Huybers P, 2007, QUATERNARY SCI REV, V26, P37, DOI 10.1016/j.quascirev.2006.07.013; Kohler P, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2008PA001703; Kohler P, 2008, CLIM PAST, V4, P311, DOI 10.5194/cp-4-311-2008; Ling HF, 2005, EARTH PLANET SC LETT, V232, P345, DOI 10.1016/j.epsl.2004.12.009; Lisiecki LE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045109; Lisiecki L. E., 2005, PALEOCEANOGRAPHY, V20, DOI [10.1029/2004PA001071, DOI 10.1029/2004PA001071]; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; MACKENSEN A, 1993, PALEOCEANOGRAPHY, V8, P587, DOI 10.1029/93PA01291; Martinez-Garcia A, 2010, SCIENCE, V328, P1550, DOI 10.1126/science.1184480; McClymont EL, 2013, EARTH-SCI REV, V123, P173, DOI 10.1016/j.earscirev.2013.04.006; Piotrowski AM, 2005, SCIENCE, V307, P1933, DOI 10.1126/science.1104883; PISIAS NG, 1981, EARTH PLANET SC LETT, V52, P450, DOI 10.1016/0012-821X(81)90197-7; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P577, DOI 10.1029/97PA01169; RAYMO ME, 1990, EARTH PLANET SC LETT, V97, P353, DOI 10.1016/0012-821X(90)90051-X; Schmitt J, 2012, SCIENCE, V336, P711, DOI 10.1126/science.1217161; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Stichel T, 2012, EARTH PLANET SC LETT, V317, P282, DOI 10.1016/j.epsl.2011.11.025; Tachikawa K, 1999, EARTH PLANET SC LETT, V170, P433, DOI 10.1016/S0012-821X(99)00127-2; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033; Venz KA, 2002, PALAEOGEOGR PALAEOCL, V182, P197, DOI 10.1016/S0031-0182(01)00496-5	36	91	94	0	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					318	322		10.1126/science.1249770	http://dx.doi.org/10.1126/science.1249770			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	24968939				2022-12-01	WOS:000339400700049
J	Belcheva, A; Irrazabal, T; Robertson, SJ; Streutker, C; Maughan, H; Rubino, S; Moriyama, EH; Copeland, JK; Kumar, S; Green, B; Geddes, K; Pezo, RC; Navarre, WW; Milosevic, M; Wilson, BC; Girardin, SE; Wolever, TMS; Edelmann, W; Guttman, DS; Philpott, DJ; Martin, A				Belcheva, Antoaneta; Irrazabal, Thergiory; Robertson, Susan J.; Streutker, Catherine; Maughan, Heather; Rubino, Stephen; Moriyama, Eduardo H.; Copeland, Julia K.; Kumar, Sachin; Green, Blerta; Geddes, Kaoru; Pezo, Rossanna C.; Navarre, William W.; Milosevic, Michael; Wilson, Brian C.; Girardin, Stephen E.; Wolever, Thomas M. S.; Edelmann, Winfried; Guttman, David S.; Philpott, Dana J.; Martin, Alberto			Gut Microbial Metabolism Drives Transformation of Msh2-Deficient Colon Epithelial Cells	CELL			English	Article							MULTIPLE INTESTINAL NEOPLASIA; DIETARY GLYCEMIC LOAD; COLORECTAL-CANCER; MISMATCH-REPAIR; DNA-DAMAGE; BUTYRATE; TUMORIGENESIS; INFLAMMATION; DEFICIENCY; ACTIVATION	The etiology of colorectal cancer (CRC) has been linked to deficiencies in mismatch repair and adenomatous polyposis coli (APC) proteins, diet, inflammatory processes, and gut microbiota. However, the mechanism through which the microbiota synergizes with these etiologic factors to promote CRC is not clear. We report that altering the microbiota composition reduces CRC in APC(Min/+) MSH2(-/-) mice, and that a diet reduced in carbohydrates phenocopies this effect. Gut microbes did not induce CRC in these mice through an inflammatory response or the production of DNA mutagens but rather by providing carbohydrate-derived metabolites such as butyrate that fuel hyperproliferation of MSH2(-/-) colon epithelial cells. Further, we provide evidence that the mismatch repair pathway has a role in regulating beta-catenin activity and modulating the differentiation of transit-amplifying cells in the colon. These data thereby provide an explanation for the interaction between microbiota, diet, and mismatch repair deficiency in CRC induction.	[Belcheva, Antoaneta; Irrazabal, Thergiory; Robertson, Susan J.; Kumar, Sachin; Green, Blerta; Geddes, Kaoru; Philpott, Dana J.; Martin, Alberto] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Streutker, Catherine] St Michaels Hosp, Dept Lab Med, Toronto, ON M5S 1W8, Canada; [Maughan, Heather] Ronin Inst, Montclair, NJ 07043 USA; [Rubino, Stephen; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON M5S 1A8, Canada; [Moriyama, Eduardo H.; Wilson, Brian C.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Copeland, Julia K.; Guttman, David S.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON M5S 3B2, Canada; [Pezo, Rossanna C.] Univ Toronto, Dept Med Oncol, Toronto, ON M5S 1A8, Canada; [Navarre, William W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Milosevic, Michael] Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada; [Wolever, Thomas M. S.] Univ Toronto, Dept Nutr Sci, Toronto, ON M5S 3E2, Canada; [Edelmann, Winfried] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Yeshiva University; Albert Einstein College of Medicine	Martin, A (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada.	alberto.martin@utoronto.ca	Wolever, Thomas/AAC-8066-2022	Milosevic, Michael/0000-0002-9620-6876; Kumar, Sachin/0000-0002-4853-3864; Wilson, Brian C./0000-0001-5543-666X; Navarre, William/0000-0002-9293-9220; Martin, Alberto/0000-0002-0795-0418; Belcheva, Antoaneta/0000-0001-5061-7533; Irrazabal, Thergiory/0000-0003-0388-131X	Becas Chile; DFATD Canada; CIHR [MOP-86683, MSH-87729]; Cancer Research Society [MOP66965]; Lotte & John Hecht Memorial Foundation grant of the Canadian Cancer Society [702027]; Canada Research Chair award	Becas Chile; DFATD Canada; CIHR(Canadian Institutes of Health Research (CIHR)); Cancer Research Society; Lotte & John Hecht Memorial Foundation grant of the Canadian Cancer Society; Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	We are thankful to Drs. M. Shulman, M. Ohh, J. Mogridge, J. Danska, J. Carlyle, J. Gommerman, R. Bruce, and the Martin laboratory for helpful discussions and for reading the manuscript. We thank Maribel Berru and Kervan Rivera-Rufner for technical help. We acknowledge Becas Chile and DFATD Canada for sponsoring T.I. This research is supported by a CIHR grant to D.S.G. and to W.W.N. (MOP-86683, MSH-87729) and by a Cancer Research Society grant (MOP66965) and the Lotte & John Hecht Memorial Foundation grant of the Canadian Cancer Society (#702027) to A.M., who is supported by a Canada Research Chair award.	Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Arthur JC, 2011, INFLAMM BOWEL DIS, V17, P396, DOI 10.1002/ibd.21354; BARTHOLD SW, 1977, CANCER RES, V37, P4352; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chen GY, 2008, CANCER RES, V68, P10060, DOI 10.1158/0008-5472.CAN-08-2061; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033; Donohoe DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046589; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Dove WF, 1997, CANCER RES, V57, P812; Fernandes J, 2011, EUR J CLIN NUTR, V65, P1279, DOI 10.1038/ejcn.2011.116; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Franceschi S, 2001, ANN ONCOL, V12, P173, DOI 10.1023/A:1008304128577; FREEMAN HJ, 1986, GASTROENTEROLOGY, V91, P596, DOI 10.1016/0016-5085(86)90628-1; Gnagnarella P, 2008, AM J CLIN NUTR, V87, P1793, DOI 10.1093/ajcn/87.6.1793; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Heijmans J, 2013, CELL REP, V3, P1128, DOI 10.1016/j.celrep.2013.02.031; HERR R, 1990, AM J HEMATOL, V34, P1, DOI 10.1002/ajh.2830340102; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; KLEIN RS, 1977, NEW ENGL J MED, V297, P800, DOI 10.1056/NEJM197710132971503; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kucherlapati MH, 2010, GASTROENTEROLOGY, V138, P993, DOI 10.1053/j.gastro.2009.11.009; Lazarova DL, 2004, INT J CANCER, V110, P523, DOI 10.1002/ijc.20152; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Lupton JR, 2004, J NUTR, V134, P479, DOI 10.1093/jn/134.2.479; Magalhaes B, 2012, EUR J CANCER PREV, V21, P15, DOI 10.1097/CEJ.0b013e3283472241; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Meyerhardt JA, 2012, JNCI-J NATL CANCER I, V104, P1702, DOI 10.1093/jnci/djs399; Miller PE, 2010, NUTR CANCER, V62, P413, DOI 10.1080/01635580903407114; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Olive PL, 2005, CYTOM PART A, V66A, P1, DOI 10.1002/cyto.a.20154; Peters AC, 2003, DNA REPAIR, V2, P427, DOI 10.1016/S1568-7864(03)00003-X; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x; Reitmair AH, 1996, CANCER RES, V56, P2922; ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793; Roy Claude C, 2006, Nutr Clin Pract, V21, P351, DOI 10.1177/0115426506021004351; Senda T, 2007, MED MOL MORPHOL, V40, P68, DOI 10.1007/s00795-006-0352-5; Shoemaker AR, 2000, ONCOGENE, V19, P2774, DOI 10.1038/sj.onc.1203574; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Sohn KJ, 2003, CARCINOGENESIS, V24, P217, DOI 10.1093/carcin/24.2.217; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van den Abbeele P, 2013, ISME J, V7, P949, DOI 10.1038/ismej.2012.158; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Wang XM, 2008, CANCER RES, V68, P9909, DOI 10.1158/0008-5472.CAN-08-1551; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015	54	271	281	1	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					288	299		10.1016/j.cell.2014.04.051	http://dx.doi.org/10.1016/j.cell.2014.04.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036629	Bronze			2022-12-01	WOS:000340943600010
J	Hom, EFY; Murray, AW				Hom, Erik F. Y.; Murray, Andrew W.			Niche engineering demonstrates a latent capacity for fungal-algal mutualism	SCIENCE			English	Article							EVOLUTION; TRANSITIONS; SYMBIOSIS; LICHENS	Mutualistic symbioses shape the evolution of species and ecosystems and catalyze the emergence of biological complexity, yet how such symbioses first form is unclear. We show that an obligate mutualism between the yeast Saccharomyces cerevisiae and the alga Chlamydomonas reinhardtii-two model eukaryotes with very different life histories-can arise spontaneously in an environment requiring reciprocal carbon and nitrogen exchange. This capacity for mutualism is phylogenetically broad, extending to other Chlamydomonas and fungal species. Furthermore, we witnessed the spontaneous association of Chlamydomonas algal cells physically interacting with filamentous fungi. These observations demonstrate that under specific conditions, environmental change induces free-living species to become obligate mutualists and establishes a set of experimentally tractable, phylogenetically related, synthetic systems for studying the evolution of symbiosis.	[Hom, Erik F. Y.; Murray, Andrew W.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Hom, Erik F. Y.; Murray, Andrew W.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Hom, EFY (corresponding author), Univ Mississippi, Dept Biol, University, MS 38677 USA.	erik@fyhom.com; amurray@mcb.harvard.edu	Hom, Erik/B-3889-2008	Hom, Erik/0000-0003-0964-0031	Jane Coffin Childs postdoctoral fellowship; National Institute of General Medical Sciences Center for Modular Biology (NIH) [P50-GM068763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	Jane Coffin Childs postdoctoral fellowship; National Institute of General Medical Sciences Center for Modular Biology (NIH); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Q. Justman, B. Stern, A. Pringle, S. Sasso, M. Dayel, N. Collins, J. Hess, M. Mueller, G. Frenkel, S. Kryazhimskiy, M. McDonald, D. Van Dyken, E. Wallace, K. Zimmerman, P. Boynton, J. Calarco, D. Chiang, Y. Eun, K. Foster, R. Losick, W. Tong, Y. Katz, and members of the Murray and Nelson labs for helpful feedback. We thank D. Thompson, M. Dunham, F. Winston, and N. Rhind for yeast strains; T. Schinko and J. Strauss for A. nidulans strains; and the Fungal Genetics Stock Center (Kansas City, MO) for fungal strains. We thank P. Rogers, M. Tam, and B. Tilton (Faculty of Arts and Sciences Center for Systems Biology FACS Core); B. Goetze, C. Kraft, and D. Richardson (Harvard Center for Biological Imaging); M. Yankova and S. King (Central Electron Microscopy Facility, University of Connecticut Health Center) for their resources and assistance; and U. Goodenough for her help in interpreting electron micrographs. Supported in part by a Jane Coffin Childs postdoctoral fellowship to E.F.Y.H. and by the National Institute of General Medical Sciences Center for Modular Biology (NIH grant P50-GM068763). Additional data described in this work can be found in the online supplementary materials. E.F.Y.H. conceived the project, performed the experiments, and analyzed the data. E.F.Y.H. and A.W.M. devised the research and wrote the manuscript. A.W.M. supported and provided input throughout all stages of this work.	Agosta SJ, 2008, ECOL LETT, V11, P1123, DOI 10.1111/j.1461-0248.2008.01237.x; AZUARA MP, 1983, PLANT PHYSIOL, V71, P286, DOI 10.1104/pp.71.2.286; Bronstein J.L., 2009, PRINCETON GUIDE ECOL, P233, DOI DOI 10.1515/9781400833023.233; Brucker RM, 2012, TRENDS ECOL EVOL, V27, P443, DOI 10.1016/j.tree.2012.03.011; Douglas AE., 2010, SYMBIOTIC HABIT; Gomez JM, 2010, NATURE, V465, P918, DOI 10.1038/nature09113; Harcombe W, 2010, EVOLUTION, V64, P2166, DOI 10.1111/j.1558-5646.2010.00959.x; HAWKSWORTH DL, 1988, BOT J LINN SOC, V96, P3, DOI 10.1111/j.1095-8339.1988.tb00623.x; Hillesland KL, 2010, P NATL ACAD SCI USA, V107, P2124, DOI 10.1073/pnas.0908456107; Holland JN, 2010, ECOLOGY, V91, P1286, DOI 10.1890/09-1163.1; HONEGGER R, 1986, NEW PHYTOL, V103, P785, DOI 10.1111/j.1469-8137.1986.tb00853.x; Honegger R., 2012, FUNGAL ASS, P287, DOI DOI 10.1007/978-3-642-30826-0_15; JANZEN DH, 1985, OIKOS, V45, P308, DOI 10.2307/3565565; Klitgord N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001002; Kohlmeyer J, 1979, MARINE MYCOLOGY HIGH, P70; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Momeni B, 2011, CELL MOL LIFE SCI, V68, P1353, DOI 10.1007/s00018-011-0649-y; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Muller MJI, 2014, P NATL ACAD SCI USA, V111, P1037, DOI 10.1073/pnas.1313285111; Paracer S., 2000, SYMBIOSIS INTRO BIOL; Sachs JL, 2011, P NATL ACAD SCI USA, V108, P10800, DOI 10.1073/pnas.1100304108; Slot JC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001097; Thompson JN, 1999, SCIENCE, V284, P2116, DOI 10.1126/science.284.5423.2116; Wade MJ, 2007, NAT REV GENET, V8, P185, DOI 10.1038/nrg2031	24	132	135	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					94	98		10.1126/science.1253320	http://dx.doi.org/10.1126/science.1253320			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994654	Green Accepted			2022-12-01	WOS:000338284400058
J	Dong, HH; Xiang, QJ; Gu, YH; Wang, ZS; Paterson, NG; Stansfeld, PJ; He, C; Zhang, YZ; Wang, WJ; Dong, CJ				Dong, Haohao; Xiang, Quanju; Gu, Yinghong; Wang, Zhongshan; Paterson, Neil G.; Stansfeld, Phillip J.; He, Chuan; Zhang, Yizheng; Wang, Wenjian; Dong, Changjiang			Structural basis for outer membrane lipopolysaccharide insertion	NATURE			English	Article							TRANSENVELOPE PROTEIN COMPLEX; BETA-BARREL; MOLECULAR SIMULATION; FUNCTIONAL-ANALYSIS; CRYSTAL-STRUCTURE; CELL-ENVELOPE; TRANSPORT; BIOGENESIS; LPTD; TRANSLOCON	Lipopolysaccharide (LPS) is essential for most Gram-negative bacteria and has crucial roles in protection of the bacteria fromharsh environments and toxic compounds, including antibiotics. Seven LPS transport proteins (that is, LptA-LptG) form a trans-envelope protein complex responsible for the transport of LPS from the inner membrane to the outer membrane, the mechanism for which is poorly understood. Here we report the first crystal structure of the unique integral membrane LPS translocon LptD-LptE complex. LptD forms a novel 26-stranded beta-barrel, which is to our knowledge the largest beta-barrel reported so far. LptE adopts a roll-like structure located inside the barrel of LptD to form an unprecedented two-protein 'barrel and plug' architecture. The structure, molecular dynamics simulations and functional assays suggest that the hydrophilic O-antigen and the core oligosaccharide of the LPS may pass through the barrel and the lipid A of the LPS may be inserted into the outer leaflet of the outer membrane through a lateral opening between strands beta 1 and beta 26 of LptD. These findings not only help us to understand important aspects of bacterial outer membrane biogenesis, but also have significant potential for the development of novel drugs against multi-drug resistant pathogenic bacteria.	[Dong, Haohao; Gu, Yinghong; Wang, Zhongshan; Dong, Changjiang] Univ E Anglia, Norwich Med Sch, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England; [Dong, Haohao; Xiang, Quanju; Wang, Zhongshan; He, Chuan] Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland; [Xiang, Quanju] Sichuan Agr Univ, Dept Microbiol, Coll Resource & Environm Sci, Yaan 625000, Peoples R China; [Wang, Zhongshan; Zhang, Yizheng] Sichuan Univ, Coll Life Sci, Chengdu 610065, Peoples R China; [Paterson, Neil G.] Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Stansfeld, Phillip J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [He, Chuan] Wuhan Tech Coll Commun, Sch Elect & Informat, Wuhan 430065, Hubei, Peoples R China; [Wang, Wenjian] Sun Yat Sen Univ, Affiliated Hosp 1, Lab Dept Surg, Guangzhou 510080, Guangdong, Peoples R China	University of East Anglia; University of St Andrews; Sichuan Agricultural University; Sichuan University; Diamond Light Source; University of Oxford; Sun Yat Sen University	Dong, CJ (corresponding author), Univ E Anglia, Norwich Med Sch, Biomed Res Ctr, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	wenjian166@googlemail.com; c.dong@uea.ac.uk	GU, Yinghong/D-2433-2010; xiang, quanju/AAI-3042-2020; Stansfeld, Phillip James/AAA-9228-2020	GU, Yinghong/0000-0002-9364-1389; Stansfeld, Phillip James/0000-0001-8800-7669; Paterson, Neil/0000-0003-4292-6971; Wang, Zhongshan/0000-0002-1321-3916	China Scholarship Council; BBSRC [BB/I019855/1, BB/H000267/1, BB/L002558/1] Funding Source: UKRI; EPSRC [EP/J010421/1] Funding Source: UKRI; MRC [G1100110] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I019855/1, BB/L002558/1, BEP17032, BB/H000267/1, BBS/B/16011, B19456] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J010421/1] Funding Source: researchfish; Medical Research Council [G1100110] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank T. J. Silhavy for providing AM689 and AM661 cells, J. Naismith and C. Whitfield for support, and R. Field, A. Johnston and X. Tang for critical reading of the manuscript. We thank the staff at I24, I02, I03 and I04 of Diamond Light Source UK for beamtime (proposal mx7641) and their assistance with data collection. C.D. is a Wellcome Trust career development fellow (083501/Z/07/Z). Q.X. and Z.W. are the receipts of the Chinese overseas study scholarships of The China Scholarship Council.	Bos MP, 2011, J BIOL CHEM, V286, P28688, DOI 10.1074/jbc.M111.239673; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chng SS, 2012, SCIENCE, V337, P1665, DOI 10.1126/science.1227215; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Colombo G, 2003, BIOPHYS J, V84, P2331, DOI 10.1016/S0006-3495(03)75038-3; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005; Freinkman E, 2012, BIOCHEMISTRY-US, V51, P4800, DOI 10.1021/bi300592c; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Grabowicz M, 2013, J BACTERIOL, V195, P1327, DOI 10.1128/JB.02142-12; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khan MA, 2009, BIOCHEMISTRY-US, V48, P9745, DOI 10.1021/bi9013566; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Monticelli L, 2008, J COMPUT CHEM, V29, P1740, DOI 10.1002/jcc.20935; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Okuda S, 2012, SCIENCE, V338, P1214, DOI 10.1126/science.1228984; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PARRINELLO M, 1981, J CHEM PHYS, V74, P1990, DOI 10.1063/1.441242; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Sperandeo P, 2011, J BACTERIOL, V193, P1042, DOI 10.1128/JB.01037-10; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Stansfeld PJ, 2013, STRUCTURE, V21, P810, DOI 10.1016/j.str.2013.03.005; Stansfeld PJ, 2011, J CHEM THEORY COMPUT, V7, P1157, DOI 10.1021/ct100569y; Suits MDL, 2008, J MOL BIOL, V380, P476, DOI 10.1016/j.jmb.2008.04.045; Tran AX, 2010, J BIOL CHEM, V285, P33529, DOI 10.1074/jbc.M110.144709; van den Berg B, 2004, SCIENCE, V304, P1506, DOI 10.1126/science.1097524; Villa R, 2013, J BACTERIOL, V195, P1100, DOI 10.1128/JB.02057-12; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Whitney JC, 2011, P NATL ACAD SCI USA, V108, P13083, DOI 10.1073/pnas.1104984108; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103	44	173	176	1	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					52	U569		10.1038/nature13464	http://dx.doi.org/10.1038/nature13464			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990744	Green Accepted			2022-12-01	WOS:000338199400033
J	Jorgensen, AB; Frikke-Schmidt, R; Nordestgaard, BG; Tybjaerg-Hansen, A				Jorgensen, Anders Berg; Frikke-Schmidt, Ruth; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne			Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							APOLIPOPROTEIN-C-III; TRIGLYCERIDE-RICH LIPOPROTEINS; HIGH-DENSITY-LIPOPROTEIN; NONFASTING TRIGLYCERIDES; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; REMNANT CHOLESTEROL; ARTERIAL INTIMA; IN-VIVO; PLASMA	Background High plasma levels of nonfasting triglycerides are associated with an increased risk of ischemic cardiovascular disease. Whether lifelong low levels of nonfasting triglycerides owing to mutations in the gene encoding apolipoprotein C3 (APOC3) are associated with a reduced risk of ischemic cardiovascular disease in the general population is unknown. Methods Using data from 75,725 participants in two general-population studies, we first tested whether low levels of nonfasting triglycerides were associated with reduced risks of ischemic vascular disease and ischemic heart disease. Second, we tested whether loss-of-function mutations in APOC3, which were associated with reduced levels of nonfasting triglycerides, were also associated with reduced risks of ischemic vascular disease and ischemic heart disease. During follow-up, ischemic vascular disease developed in 10,797 participants, and ischemic heart disease developed in 7557 of these 10,797 participants. Results Participants with nonfasting triglyceride levels of less than 1.00 mmol per liter (90 mg per deciliter) had a significantly lower incidence of cardiovascular disease than those with levels of 4.00 mmol per liter (350 mg per deciliter) or more (hazard ratio for ischemic vascular disease, 0.43; 95% confidence interval [CI], 0.35 to 0.54; hazard ratio for ischemic heart disease, 0.40; 95% CI, 0.31 to 0.52). Heterozygosity for loss-of-function mutations in APOC3, as compared with no APOC3 mutations, was associated with a mean reduction in nonfasting triglyceride levels of 44% (P<0.001). The cumulative incidences of ischemic vascular disease and ischemic heart disease were reduced in heterozygotes as compared with noncarriers of APOC3 mutations (P = 0.009 and P = 0.05, respectively), with corresponding risk reductions of 41% (hazard ratio, 0.59; 95% CI, 0.41 to 0.86; P = 0.007) and 36% (hazard ratio, 0.64; 95% CI, 0.41 to 0.99; P = 0.04). Conclusions Loss-of-function mutations in APOC3 were associated with low levels of triglycerides and a reduced risk of ischemic cardiovascular disease. (Funded by the European Union and others.)	[Jorgensen, Anders Berg; Frikke-Schmidt, Ruth; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Univ Copenhagen Hosp, DK-2100 Copenhagen O, Denmark; [Jorgensen, Anders Berg; Frikke-Schmidt, Ruth; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Jorgensen, Anders Berg; Frikke-Schmidt, Ruth; Tybjaerg-Hansen, Anne] Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Nordestgaard, Borge G.] Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Frikke-Schmidt, Ruth; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Herlev Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark; [Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Frederiksberg Univ Hosp, Copenhagen City Heart Study, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital	Tybjaerg-Hansen, A (corresponding author), Univ Copenhagen Hosp, Dept Clin Chem KB 3011, Mol Genet Sect, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark.	anne.tybjaerg.hansen@regionh.dk	Girelli, Domenico/B-1183-2008; Nordestgaard, Borge Gronne/ABF-1310-2020	Girelli, Domenico/0000-0001-9684-1899; Nordestgaard, Borge/0000-0002-1954-7220; Frikke-Schmidt, Ruth/0000-0003-4084-5027	European Union	European Union(European Commission)	Funded by the European Union and others.	AIM- HIGH Investigators, 2012, NEW ENGL J MED, V367, P189; Atzmon G, 2006, PLOS BIOL, V4, P562, DOI 10.1371/journal.pbio.0040113; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bochem AE, 2014, CLIN GENET, V85, P433, DOI 10.1111/cge.12201; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; CLAVEY V, 1995, ARTERIOSCL THROM VAS, V15, P963, DOI 10.1161/01.ATV.15.7.963; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Freiberg JJ, 2008, JAMA-J AM MED ASSOC, V300, P2142, DOI 10.1001/jama.2008.621; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; GINSBERG HN, 1986, J CLIN INVEST, V78, P1287, DOI 10.1172/JCI112713; Graham MJ, 2013, CIRC RES, V112, P1479, DOI 10.1161/CIRCRESAHA.111.300367; Haase CL, 2012, J CLIN ENDOCR METAB, V97, pE248, DOI 10.1210/jc.2011-1846; Johannsen TH, 2009, J CLIN ENDOCR METAB, V94, P1264, DOI 10.1210/jc.2008-1342; Jorgensen AB, 2013, EUR HEART J, V34, P1826, DOI 10.1093/eurheartj/ehs431; Kamstrup PR, 2008, CIRCULATION, V117, P176, DOI 10.1161/CIRCULATIONAHA.107.715698; Kozlitina J, 2011, HEPATOLOGY, V53, P467, DOI 10.1002/hep.24072; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; Liu HQ, 2000, J LIPID RES, V41, P1760; NORDESTGAARD BG, 1995, ARTERIOSCL THROM VAS, V15, P534, DOI 10.1161/01.ATV.15.4.534; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Novelli V, 2008, BIOGERONTOLOGY, V9, P85, DOI 10.1007/s10522-007-9116-4; Ooi EMM, 2008, CLIN SCI, V114, P611, DOI 10.1042/CS20070308; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Qin W, 2011, J BIOL CHEM, V286, P27769, DOI 10.1074/jbc.M110.203679; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; SEHAYEK E, 1991, J BIOL CHEM, V266, P18259; SHAIKH M, 1991, ARTERIOSCLER THROMB, V11, P569, DOI 10.1161/01.ATV.11.3.569; Sundaram M, 2010, J LIPID RES, V51, P150, DOI [10.1194/jlr.M900346-JLR200, 10.1194/M900346-JLR200]; Sundaram M, 2010, J LIPID RES, V51, P1524, DOI 10.1194/jlr.M005108; Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026; Varbo A, 2011, ANN NEUROL, V69, P628, DOI 10.1002/ana.22384; Voight BF, 2012, LANCET, V380, P564; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; WINDLER E, 1985, J LIPID RES, V26, P556; Yao ZM, 2012, CURR OPIN LIPIDOL, V23, P206, DOI 10.1097/MOL.0b013e328352dc70	41	605	647	4	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2014	371	1					32	41		10.1056/NEJMoa1308027	http://dx.doi.org/10.1056/NEJMoa1308027			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK2RA	24941082				2022-12-01	WOS:000338265700007
J	Rodriguez, A; Laio, A				Rodriguez, Alex; Laio, Alessandro			Clustering by fast search and find of density peaks	SCIENCE			English	Article								a Cluster analysis is aimed at classifying elements into categories on the basis of their similarity. Its applications range from astronomy to bioinformatics, bibliometrics, and pattern recognition. We propose an approach based on the idea that cluster centers are characterized by a higher density than their neighbors and by a relatively large distance from points with higher densities. This idea forms the basis of a clustering procedure in which the number of clusters arises intuitively, outliers are automatically spotted and excluded fromthe analysis, and clusters are recognized regardless of their shape and of the dimensionality of the space inwhich they are embedded. We demonstrate the power of the algorithm on several test cases.	[Rodriguez, Alex; Laio, Alessandro] SISSA, I-34136 Trieste, Italy	International School for Advanced Studies (SISSA)	Rodriguez, A (corresponding author), SISSA, Via Bonomea 265, I-34136 Trieste, Italy.	alexrod@sissa.it; laio@sissa.it	Laio, Alessandro/K-2117-2012	Laio, Alessandro/0000-0001-9164-7907; Rodriguez, Alex/0000-0002-0213-6695	grant Associazione Italiana per la Ricerca sul Cancro 5 per mille [12214]; Fondo per gli Investimenti della Ricerca di Base-Accordo di programma [RBAP11ETKA]	grant Associazione Italiana per la Ricerca sul Cancro 5 per mille(Fondazione AIRC per la ricerca sul cancro); Fondo per gli Investimenti della Ricerca di Base-Accordo di programma(Ministry of Education, Universities and Research (MIUR))	We thank E. Tosatti, D. Amati, F. Laio, F. Marinelli, A. Maritan, R. Allen, J. Nasica, and M. d'Errico for stimulating discussion. We acknowledge financial support from the grant Associazione Italiana per la Ricerca sul Cancro 5 per mille, Rif. 12214, and Fondo per gli Investimenti della Ricerca di Base-Accordo di programma, Rif. RBAP11ETKA.	Chang H, 2008, PATTERN RECOGN, V41, P191, DOI 10.1016/j.patcog.2007.04.010; Charytanowicz M, 2010, ADV INTEL SOFT COMPU, V69, P15; CHENG YZ, 1995, IEEE T PATTERN ANAL, V17, P790, DOI 10.1109/34.400568; Dueck D, 2007, IEEE I CONF COMP VIS, P198; Ester M., 1996, PROC 2 INT C KNOWL D, V96, P226, DOI DOI 10.5555/3001460.3001507; Franti P, 2006, PATTERN RECOGN, V39, P761, DOI 10.1016/j.patcog.2005.09.012; Franti P, 2006, IEEE T PATTERN ANAL, V28, P1875, DOI 10.1109/TPAMI.2006.227; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Fu LM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-3; FUKUNAGA K, 1975, IEEE T INFORM THEORY, V21, P32, DOI 10.1109/TIT.1975.1055330; Gionis A., 2007, ACM T KNOWL DISCOV D, DOI [DOI 10.1145/1217299.1217303, 10.1145/1217299.1217303]; Hoppner F., 1999, FUZZY CLUSTER ANAL M; Horenko I, 2006, MULTISCALE MODEL SIM, V5, P802, DOI 10.1137/050623310; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Kaufman L., 2009, FINDING GROUPS DATA, V344; MacQueen JB., 1967, PROC 5 BERKELEY S MA, V1, P281, DOI DOI 10.1007/S11665-016-2173-6; Marinelli F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000452; MCLACHLAN G. J., 2007, WILEY SERIES PROBABI, V382; Samaria F. S., 1994, Proceedings of the Second IEEE Workshop on Applications of Computer Vision (Cat. No.94TH06742), P138, DOI 10.1109/ACV.1994.341300; Sampat MP, 2009, IEEE T IMAGE PROCESS, V18, P2385, DOI 10.1109/TIP.2009.2025923; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141	22	2682	3241	148	1714	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1492	1496		10.1126/science.1242072	http://dx.doi.org/10.1126/science.1242072			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970081				2022-12-01	WOS:000337889900044
J	Palen, WJ; Sisk, TD; Ryan, ME; Arvai, JL; Jaccard, M; Salomon, AK; Homer-Dixon, T; Lertzman, KP				Palen, Wendy J.; Sisk, Thomas D.; Ryan, Maureen E.; Arvai, Joseph L.; Jaccard, Mark; Salomon, Anne K.; Homer-Dixon, Thomas; Lertzman, Ken P.			Consider the global impacts of oil pipelines	NATURE			English	Editorial Material									[Palen, Wendy J.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Sisk, Thomas D.] No Arizona Univ, Sch Earth Sci & Environm Sustainabil, Flagstaff, AZ 86011 USA; [Ryan, Maureen E.; Jaccard, Mark; Salomon, Anne K.; Lertzman, Ken P.] Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada; [Arvai, Joseph L.] Univ Calgary, Dept Geog, Calgary, AB T2N 1N4, Canada; [Homer-Dixon, Thomas] Univ Waterloo, Balsillie Sch Int Affairs, Waterloo, ON N2L 3G1, Canada	Simon Fraser University; Northern Arizona University; Simon Fraser University; University of Calgary; University of Waterloo	Palen, WJ (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	wpalen@sfu.ca						[Anonymous], 2013, CAN EM TRENDS; Arvai J., 2014, J ENV PLAN MAGMT; Arvai J, 2012, ISSUES SCI TECHNOL, V28, P43; Canadian Association of Petroleum Producers, 2014, 2014 CAPP CRUD OIL F; Chen, 2009, CANC INCIDENCE FORT; Kelly EN, 2009, P NATL ACAD SCI USA, V106, P22346, DOI 10.1073/pnas.0912050106; Kurek J, 2013, P NATL ACAD SCI USA, V110, P1761, DOI 10.1073/pnas.1217675110; Office of the Auditor General of Canada, 2012, 2012 SPRING REP COMM; Rooney RC, 2012, P NATL ACAD SCI USA, V109, P4933, DOI 10.1073/pnas.1117693108	9	19	19	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					465	467		10.1038/510465a	http://dx.doi.org/10.1038/510465a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24971438	Bronze			2022-12-01	WOS:000337806300021
J	Chang, YQ; Bruni, R; Kloss, B; Assur, Z; Kloppmann, E; Rost, B; Hendrickson, WA; Liu, Q				Chang, Yanqi; Bruni, Renato; Kloss, Brian; Assur, Zahra; Kloppmann, Edda; Rost, Burkhard; Hendrickson, Wayne A.; Liu, Qun			Structural basis for a pH-sensitive calcium leak across membranes	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM CA2+; BAX INHIBITOR-1; CELL-DEATH; CRYSTAL-STRUCTURE; APOPTOSIS; TOPOLOGY; HOMEOSTASIS; EXPRESSION; PREDICTION; MECHANISM	Calcium homeostasis balances passive calcium leak and active calcium uptake. Human Bax inhibitor-1 (hBI-1) is an antiapoptotic protein that mediates a calcium leak and is representative of a highly conserved and widely distributed family, the transmembrane Bax inhibitor motif (TMBIM) proteins. Here, we present crystal structures of a bacterial homolog and characterize its calcium leak activity. The structure has a seven-transmembrane-helix fold that features two triple-helix sandwiches wrapped around a central C-terminal helix. Structures obtained in closed and open conformations are reversibly interconvertible by change of pH. A hydrogen-bonded, pK(a) (where K-a is the acid dissociation constant)-perturbed pair of conserved aspartate residues explains the pH dependence of this transition, and biochemical studies show that pH regulates calcium influx in proteoliposomes. Homology models for hBI-1 provide insights into TMBIM-mediated calcium leak and cytoprotective activity.	[Chang, Yanqi; Bruni, Renato; Kloss, Brian; Kloppmann, Edda; Rost, Burkhard; Hendrickson, Wayne A.; Liu, Qun] New York Struct Biol Ctr, New York Consortium Membrane Prot Struct, New York, NY 10027 USA; [Assur, Zahra; Hendrickson, Wayne A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Kloppmann, Edda; Rost, Burkhard] Tech Univ Munich, Fak Informat, Dept Bioinformat & Computat Biol, Garching, Germany; [Hendrickson, Wayne A.; Liu, Qun] Brookhaven Natl Lab, Natl Synchrotron Light Source NSLS X4, New York Struct Biol Ctr, Upton, NY 11973 USA; [Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Technical University of Munich; United States Department of Energy (DOE); Brookhaven National Laboratory; Columbia University	Liu, Q (corresponding author), New York Struct Biol Ctr, New York Consortium Membrane Prot Struct, New York, NY 10027 USA.	qunliu@bnl.gov	Liu, Qun/A-8757-2011; Rost, Burkhard/A-1908-2016	Liu, Qun/0000-0002-1179-290X; Rost, Burkhard/0000-0003-0179-8424; Kloss, Brian/0000-0003-0130-8739; Bruni, Renato/0000-0002-2312-0254	NIH [GM095315, GM107462]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM095315, R01GM107462] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Schwanof and R. Abramowitz at NSLS beamlines X4A and X4C for their assistance in data collection, J. Love for help in initial high-throughput screening, M. Punta for help in initial target selection, M. Su for help with the phylogenetic presentation, and F. Mancia and L. Shapiro for discussions. This work was supported in part by NIH grants GM095315 and GM107462. Beamlines X4A and X4C of the NSLS at Brookhaven National Laboratory, a U. S. Department of Energy facility, is supported by the New York Structural Biology Center. Atomic coordinates and structure factor files have been deposited in the Protein Data Bank (PDB) under the accession codes 4PGR for closed-form at pH 8, 4PGS for open-form at pH 6 by soaking, 4PGU for closed/open-form at pH 7 by back-soaking, 4PGV for closed-form at pH 8 by back-soaking, and 4PGW for open-form in C222<INF>1</INF> lattice. Q. L., Y.C., and W. A. H. are inventors on a patent application filed by the New York Structural Biology Center on uses of the three-dimensional structures of BsYetJ and homology models of hBI-1.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bultynck G, 2012, J BIOL CHEM, V287, P2544, DOI 10.1074/jbc.M111.275354; Carrara G, 2012, J BIOL CHEM, V287, P15896, DOI 10.1074/jbc.M111.336149; de Mattia F, 2009, MOL BIOL CELL, V20, P3638, DOI 10.1091/mbc.E09-05-0385; Distelhorst CW, 2011, CELL CALCIUM, V50, P234, DOI 10.1016/j.ceca.2011.05.011; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Grzmil M, 2006, J PATHOL, V208, P340, DOI 10.1002/path.1902; Grzmil M, 2003, AM J PATHOL, V163, P543, DOI 10.1016/S0002-9440(10)63682-6; Henke N, 2011, CELL CALCIUM, V50, P251, DOI 10.1016/j.ceca.2011.05.005; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Ihara-Ohori Y, 2007, PLANT PHYSIOL, V143, P650, DOI 10.1104/pp.106.090878; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kim HR, 2008, J BIOL CHEM, V283, P15946, DOI 10.1074/jbc.M800075200; Kiviluoto S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.103; Kiviluoto S, 2013, CELL CALCIUM, V54, P186, DOI 10.1016/j.ceca.2013.06.002; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Liu Q, 2012, SCIENCE, V336, P1033, DOI 10.1126/science.1218753; Nishizawa T, 2013, SCIENCE, V341, P168, DOI 10.1126/science.1239002; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Pryor EE, 2013, SCIENCE, V339, P1600, DOI 10.1126/science.1232048; Quigley A, 2013, SCIENCE, V339, P1604, DOI 10.1126/science.1231513; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Sano R, 2012, GENE DEV, V26, P1041, DOI 10.1101/gad.184325.111; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Smaili SS, 2013, CURR MOL MED, V13, P252; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Tanaka R, 2006, CANCER-AM CANCER SOC, V106, P648, DOI 10.1002/cncr.21639; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Waight AB, 2013, NATURE, V499, P107, DOI 10.1038/nature12233; Westphalen BC, 2005, CELL DEATH DIFFER, V12, P304, DOI 10.1038/sj.cdd.4401547; Wu MS, 2013, P NATL ACAD SCI USA, V110, P11367, DOI 10.1073/pnas.1302515110; Xu CY, 2008, J BIOL CHEM, V283, P11477, DOI 10.1074/jbc.M708385200; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9	40	68	70	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1131	1135		10.1126/science.1252043	http://dx.doi.org/10.1126/science.1252043			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904158	Green Accepted			2022-12-01	WOS:000336791200040
J	Kim, MS; Pinto, SM; Getnet, D; Nirujogi, RS; Manda, SS; Chaerkady, R; Madugundu, AK; Kelkar, DS; Isserlin, R; Jain, S; Thomas, JK; Muthusamy, B; Leal-Rojas, P; Kumar, P; Sahasrabuddhe, NA; Balakrishnan, L; Advani, J; George, B; Renuse, S; Selvan, LDN; Patil, AH; Nanjappa, V; Radhakrishnan, A; Prasad, S; Subbannayya, T; Raju, R; Kumar, M; Sreenivasamurthy, SK; Marimuthu, A; Sathe, GJ; Chavan, S; Datta, KK; Subbannayya, Y; Sahu, A; Yelamanchi, SD; Jayaram, S; Rajagopalan, P; Sharma, J; Murthy, KR; Syed, N; Goel, R; Khan, AA; Ahmad, S; Dey, G; Mudgal, K; Chatterjee, A; Huang, TC; Zhong, J; Wu, XY; Shaw, PG; Freed, D; Zahari, MS; Mukherjee, KK; Shankar, S; Mahadevan, A; Lam, H; Mitchell, CJ; Shankar, SK; Satishchandra, P; Schroeder, JT; Sirdeshmukh, R; Maitra, A; Leach, SD; Drake, CG; Halushka, MK; Prasad, TSK; Hruban, RH; Kerr, CL; Bader, GD; Iacobuzio-Donahue, CA; Gowda, H; Pandey, A				Kim, Min-Sik; Pinto, Sneha M.; Getnet, Derese; Nirujogi, Raja Sekhar; Manda, Srikanth S.; Chaerkady, Raghothama; Madugundu, Anil K.; Kelkar, Dhanashree S.; Isserlin, Ruth; Jain, Shobhit; Thomas, Joji K.; Muthusamy, Babylakshmi; Leal-Rojas, Pamela; Kumar, Praveen; Sahasrabuddhe, Nandini A.; Balakrishnan, Lavanya; Advani, Jayshree; George, Bijesh; Renuse, Santosh; Selvan, Lakshmi Dhevi N.; Patil, Arun H.; Nanjappa, Vishalakshi; Radhakrishnan, Aneesha; Prasad, Samarjeet; Subbannayya, Tejaswini; Raju, Rajesh; Kumar, Manish; Sreenivasamurthy, Sreelakshmi K.; Marimuthu, Arivusudar; Sathe, Gajanan J.; Chavan, Sandip; Datta, Keshava K.; Subbannayya, Yashwanth; Sahu, Apeksha; Yelamanchi, Soujanya D.; Jayaram, Savita; Rajagopalan, Pavithra; Sharma, Jyoti; Murthy, Krishna R.; Syed, Nazia; Goel, Renu; Khan, Aafaque A.; Ahmad, Sartaj; Dey, Gourav; Mudgal, Keshav; Chatterjee, Aditi; Huang, Tai-Chung; Zhong, Jun; Wu, Xinyan; Shaw, Patrick G.; Freed, Donald; Zahari, Muhammad S.; Mukherjee, Kanchan K.; Shankar, Subramanian; Mahadevan, Anita; Lam, Henry; Mitchell, Christopher J.; Shankar, Susarla Krishna; Satishchandra, Parthasarathy; Schroeder, John T.; Sirdeshmukh, Ravi; Maitra, Anirban; Leach, Steven D.; Drake, Charles G.; Halushka, Marc K.; Prasad, T. S. Keshava; Hruban, Ralph H.; Kerr, Candace L.; Bader, Gary D.; Iacobuzio-Donahue, Christine A.; Gowda, Harsha; Pandey, Akhilesh			A draft map of the human proteome	NATURE			English	Article							IDENTIFICATION; DATABASE; KNOWLEDGE; PROTEINS; PROJECT; TANDEM	The availability of human genome sequence has transformed biomedical research over the past decade. However, an equivalent map for the human proteome with direct measurements of proteins and peptides does not exist yet. Here we present a draft map of the human proteome using high-resolution Fourier-transform mass spectrometry. In-depth proteomic profiling of 30 histologically normal human samples, including 17 adult tissues, 7 fetal tissues and 6 purified primary haematopoietic cells, resulted in identification of proteins encoded by 17,294 genes accounting for approximately 84% of the total annotated protein-coding genes in humans. A unique and comprehensive strategy for proteogenomic analysis enabled us to discover a number of novel protein-coding regions, which includes translated pseudogenes, non-coding RNAs and upstream open reading frames. This large human proteome catalogue ( available as an interactive web-based resource at http://www.humanproteomemap.org) will complement available human genome and transcriptome data to accelerate biomedical research in health and disease.	[Kim, Min-Sik; Getnet, Derese; Chaerkady, Raghothama; Leal-Rojas, Pamela; Prasad, Samarjeet; Huang, Tai-Chung; Zhong, Jun; Wu, Xinyan; Shaw, Patrick G.; Freed, Donald; Mitchell, Christopher J.; Leach, Steven D.; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Kim, Min-Sik; Chaerkady, Raghothama; Wu, Xinyan; Zahari, Muhammad S.; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Pinto, Sneha M.; Nirujogi, Raja Sekhar; Manda, Srikanth S.; Madugundu, Anil K.; Kelkar, Dhanashree S.; Thomas, Joji K.; Muthusamy, Babylakshmi; Kumar, Praveen; Sahasrabuddhe, Nandini A.; Balakrishnan, Lavanya; Advani, Jayshree; George, Bijesh; Renuse, Santosh; Selvan, Lakshmi Dhevi N.; Patil, Arun H.; Nanjappa, Vishalakshi; Radhakrishnan, Aneesha; Subbannayya, Tejaswini; Raju, Rajesh; Kumar, Manish; Sreenivasamurthy, Sreelakshmi K.; Marimuthu, Arivusudar; Sathe, Gajanan J.; Chavan, Sandip; Datta, Keshava K.; Subbannayya, Yashwanth; Sahu, Apeksha; Yelamanchi, Soujanya D.; Jayaram, Savita; Rajagopalan, Pavithra; Sharma, Jyoti; Murthy, Krishna R.; Syed, Nazia; Goel, Renu; Khan, Aafaque A.; Ahmad, Sartaj; Dey, Gourav; Chatterjee, Aditi; Sirdeshmukh, Ravi; Prasad, T. S. Keshava; Gowda, Harsha; Pandey, Akhilesh] Inst Bioinformat, Bangalore 560066, Karnataka, India; [Getnet, Derese; Pandey, Akhilesh] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA 70130 USA; [Isserlin, Ruth; Jain, Shobhit; Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Leal-Rojas, Pamela] Univ La Frontera, Dept Pathol, Ctr Genet & Immunol Studies Sci & Technol Bioreso, Temuco 4811230, Chile; [Mudgal, Keshav] Univ London Imperial Coll Sci Technol & Med, Sch Med, London SW7 2AZ, England; [Mukherjee, Kanchan K.] Postgrad Inst Med Educ & Res, Dept Neurosurg, Chandigarh 160012, India; [Shankar, Subramanian] Armed Forces Med Coll, Dept Internal Med, Pune 411040, Maharashtra, India; [Mahadevan, Anita; Shankar, Susarla Krishna] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India; [Mahadevan, Anita; Shankar, Susarla Krishna] Natl Inst Mental Hlth & Neurosci, Neurobiol Res Ctr, Bangalore 560029, Karnataka, India; [Lam, Henry] Hong Kong Univ Sci & Technol, Dept Chem & Biomol Engn, Hong Kong, Hong Kong, Peoples R China; [Lam, Henry] Hong Kong Univ Sci & Technol, Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Satishchandra, Parthasarathy] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore 560029, Karnataka, India; [Schroeder, John T.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21224 USA; [Maitra, Anirban; Halushka, Marc K.; Hruban, Ralph H.; Iacobuzio-Donahue, Christine A.; Pandey, Akhilesh] Johns Hopkins Univ, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Sch Med, Baltimore, MD 21231 USA; [Maitra, Anirban; Drake, Charles G.; Hruban, Ralph H.; Iacobuzio-Donahue, Christine A.; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA; [Leach, Steven D.; Iacobuzio-Donahue, Christine A.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21231 USA; [Drake, Charles G.] Johns Hopkins Univ, Sch Med, Dept Immunol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Drake, Charles G.] Johns Hopkins Univ, Sch Med, Dept Urol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Kerr, Candace L.] Johns Hopkins Univ, Sch Med, Dept Obstet & Gynecol, Baltimore, MD 21205 USA; [Pandey, Akhilesh] Diana Helis Henry Med Res Fdn, New Orleans, LA 70130 USA	Johns Hopkins University; Johns Hopkins University; University of Toronto; Universidad de La Frontera; Imperial College London; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Armed Forces Medical College; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; National Institute of Mental Health & Neurosciences - India; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Gowda, H (corresponding author), Inst Bioinformat, Bangalore 560066, Karnataka, India.	harsha@ibioinformatics.org; pandey@jhmi.edu	RENUSE, SANTOSH/A-2072-2010; Pinto, Sneha/Q-7308-2018; John, Arivusudar Everad/ABB-1691-2020; Kim, Min-Sik/N-5010-2018; Lam, Henry/D-8629-2011; Subbannayya, Yashwanth/A-7796-2012; Bader, Gary/C-1176-2009; Chavan, Sandip/K-6889-2015; Zhong, Jun/D-1662-2010; Subbannayya, Tejaswini/A-5524-2012; Madugundu, Anil Kumar/ABE-2128-2021; Sreenivasamurthy, Sreelakshmi K/ABD-4253-2021; Iacobuzio-Donahue, Christine/ABF-1295-2020; Sreenivasamurthy, Sreelakshmi Kenkere/W-1942-2019; Khan, Aafaque/AFA-0670-2022; Prasad, Keshava/F-7631-2010; Kim, Min-Sik/M-3488-2016; M., Srikanth/H-7457-2012; Gowda, Harsha/A-8526-2011; Muthusamy, Babylakshmi/AAS-8226-2020; Manda, Srinivas Srikanth/AAC-1376-2022; Hanumana Gouda Patil, Arun Kumar/GLU-6821-2022; Renuse, Santosh/ABA-6792-2020; Raju, Rajesh/E-1104-2014; Mir, Sartaj Ahmad/J-8933-2014; Huang, Tai-Chung/I-3730-2013	RENUSE, SANTOSH/0000-0002-4051-5637; Pinto, Sneha/0000-0001-8541-8761; Kim, Min-Sik/0000-0001-7317-5360; Lam, Henry/0000-0001-7928-0364; Subbannayya, Yashwanth/0000-0002-3885-3514; Bader, Gary/0000-0003-0185-8861; Chavan, Sandip/0000-0002-8469-7882; Zhong, Jun/0000-0003-3148-4143; Subbannayya, Tejaswini/0000-0002-5384-0631; Madugundu, Anil Kumar/0000-0003-4274-7316; Sreenivasamurthy, Sreelakshmi K/0000-0002-8891-3714; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Prasad, Keshava/0000-0002-6206-2384; Kim, Min-Sik/0000-0001-7317-5360; M., Srikanth/0000-0003-1690-8403; Gowda, Harsha/0000-0002-4118-6855; Manda, Srinivas Srikanth/0000-0003-1690-8403; Hanumana Gouda Patil, Arun Kumar/0000-0002-3125-8958; Nirujogi, Raja Sekhar/0000-0002-3177-8566; Dey, Gourav/0000-0002-2703-699X; Raju, Rajesh/0000-0003-2319-121X; Mukherjee, Kanchan Kumar/0000-0001-7525-6172; Syed, Nazia/0000-0002-0396-9357; Mir, Sartaj Ahmad/0000-0001-6032-0936; Yelamanchi, Soujanya D./0000-0002-8477-9618; Sathe, Gajanan/0000-0002-6239-5365; Halushka, Marc/0000-0002-7112-7389; Huang, Tai-Chung/0000-0002-1625-7295; Mudgal, Keshav/0000-0002-6065-0617; Freed, Donald/0000-0003-4534-7254; Sharma, Jyoti/0000-0003-3299-9907; Khan, Aafaque Ahmad/0000-0002-8127-9677	NIH [U54GM103520]; NCI's Clinical Proteomic Tumor Analysis Consortium initiative [U24CA160036]; National Heart, Lung and Blood Institute [HHSN268201000032C]; Sol Goldman Pancreatic Cancer Research Center; National Resource for Network Biology [P41GM103504]; DBT Program Support on Neuroproteomics [BT/01/COE/08/05]; NIMHANS; Council of Scientific and Industrial Research; University Grants Commission; Department of Science and Technology, Government of India; NATIONAL CANCER INSTITUTE [U24CA160036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814, P41GM103504, U54GM103520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI's Clinical Proteomic Tumor Analysis Consortium initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Sol Goldman Pancreatic Cancer Research Center; National Resource for Network Biology; DBT Program Support on Neuroproteomics; NIMHANS; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission(University Grants Commission, India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to acknowledge the National Development and Research Institutes for some of the tissues. We acknowledge the assistance of V. Sandhya, V. Puttamallesh, U. Guha and B. Cole for help with analysis of some of the samples. We thank L. Lane and B. Amos for their assistance with the list of missing genes. This work was supported by an NIH roadmap grant for Technology Centers of Networks and Pathways (U54GM103520), NCI's Clinical Proteomic Tumor Analysis Consortium initiative (U24CA160036), a contract (HHSN268201000032C) from the National Heart, Lung and Blood Institute and the Sol Goldman Pancreatic Cancer Research Center. The authors acknowledge the joint participation by the Adrienne Helis Malvin Medical Research Foundation and the Diana Helis Henry Medical Research Foundation through its direct engagement in the continuous active conduct of medical research in conjunction with The Johns Hopkins Hospital and the Johns Hopkins University School of Medicine and the Foundation's Parkinson's Disease Programs. The analysis work was partially supported by the National Resource for Network Biology (P41GM103504). A.Mah., S.K.Sh., P. S. and T. S. K. P. are supported by DBT Program Support on Neuroproteomics (BT/01/COE/08/05) to IOB and NIMHANS. H. G. is a Wellcome Trust-DBT India Alliance Early Career Fellow. We thank Council of Scientific and Industrial Research, University Grants Commission and Department of Science and Technology, Government of India for research fellowships for S. M. P., R.S.N., A. R., M. K., G.J.S., S. C., P. R., J.S., S. S. M., D. S. K., S. R., S.K.Sr., K. K. D., Y.S., A. S., S.D.Y., N.S., S. A. and G.D.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bensimon A, 2012, ANNU REV BIOCHEM, V81, P379, DOI 10.1146/annurev-biochem-072909-100424; Branca RMM, 2014, NAT METHODS, V11, P59, DOI [10.1038/NMETH.2732, 10.1038/nmeth.2732]; Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Farrah T, 2013, J PROTEOME RES, V12, P162, DOI [10.1021/Pr301012j, 10.1021/pr301012j]; Ferrington DA, 2012, PROG MOL BIOL TRANSL, V109, P75, DOI 10.1016/B978-0-12-397863-9.00003-1; Fountoulakis M, 2002, PROTEOMICS, V2, P1547, DOI 10.1002/1615-9861(200211)2:11<1547::AID-PROT1547>3.0.CO;2-M; Gaudet P, 2013, J PROTEOME RES, V12, P293, DOI 10.1021/pr300830v; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kalyana-Sundaram S, 2012, CELL, V149, P1622, DOI 10.1016/j.cell.2012.04.041; Kelkar DS, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011627, 10.1074/mcp.M111.011445]; Lane L, 2014, J PROTEOME RES, V13, P15, DOI 10.1021/pr401144x; Legrain P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009993; Marko-Varga G, 2013, J PROTEOME RES, V12, P1, DOI [10.1021/pr301183aIJ, 10.1021/pr301183a]; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Mosley AL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000687; Nagaraj N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013722; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Paik YK, 2012, NAT BIOTECHNOL, V30, P221, DOI 10.1038/nbt.2152; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Peri S, 2001, TRENDS GENET, V17, P685, DOI 10.1016/S0168-9525(01)02493-3; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Picotti P, 2013, NATURE, V494, P266, DOI 10.1038/nature11835; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Sugimoto J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01462; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Ying WT, 2006, MOL CELL PROTEOMICS, V5, P1703, DOI 10.1074/mcp.M500344-MCP200; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	44	1424	1453	16	515	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					575	+		10.1038/nature13302	http://dx.doi.org/10.1038/nature13302			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870542	Green Accepted			2022-12-01	WOS:000336457100040
J	Cai, DF; Chen, SC; Prasad, M; He, L; Wang, XB; Choesmel-Cadamuro, V; Sawyer, JK; Danuser, G; Montell, DJ				Cai, Danfeng; Chen, Shann-Ching; Prasad, Mohit; He, Li; Wang, Xiaobo; Choesmel-Cadamuro, Valerie; Sawyer, Jessica K.; Danuser, Gaudenz; Montell, Denise J.			Mechanical Feedback through E-Cadherin Promotes Direction Sensing during Collective Cell Migration	CELL			English	Article							VE-CADHERIN; RAC; GUIDANCE; TENSION; ACTIVATION; EXPRESSION; MOVEMENT; REVEALS; GROWTH	E-cadherin is a major homophilic cell-cell adhesion molecule that inhibits motility of individual cells on matrix. However, its contribution to migration of cells through cell-rich tissues is less clear. We developed an in vivo sensor of mechanical tension across E-cadherin molecules, which we combined with cell-type-specific RNAi, photoactivatable Rac, and morphodynamic profiling, to interrogate how E-cadherin contributes to collective migration of cells between other cells. Using the Drosophila ovary as a model, we found that adhesion between border cells and their substrate, the nurse cells, functions in a positive feedback loop with Rac and actin assembly to stabilize forward-directed protrusion and directionally persistent movement. Adhesion between individual border cells communicates direction from the lead cell to the followers. Adhesion between motile cells and polar cells holds the cluster together and polarizes each individual cell. Thus, E-cadherin is an integral component of the guidance mechanisms that orchestrate collective chemotaxis in vivo.	[Cai, Danfeng; Chen, Shann-Ching; Prasad, Mohit; He, Li; Wang, Xiaobo; Sawyer, Jessica K.; Montell, Denise J.] Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Cai, Danfeng; Montell, Denise J.] Univ Calif Santa Barbara, Mol Cellular & Dev Biol Dept, Santa Barbara, CA 93106 USA; [Chen, Shann-Ching; Danuser, Gaudenz] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Wang, Xiaobo] Univ P Sabatier Toulouse III, F-31062 Toulouse 9, France; [Wang, Xiaobo] CNRS, LBCMCP, F-31062 Toulouse 9, France	Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California Santa Barbara; Scripps Research Institute; Centre National de la Recherche Scientifique (CNRS)	Montell, DJ (corresponding author), Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	denise.montell@lifesci.ucsb.edu	Cai, Danfeng/E-7509-2016	Cai, Danfeng/0000-0003-1623-5077; HE, LI/0000-0003-2155-606X; Danuser, Gaudenz/0000-0001-8583-2014; Sawyer, Jessica/0000-0001-9026-0559; Wang, Xiaobo/0000-0002-3311-1378	Cell Migration Consortium [GM73164, GM46425, GM64346, GM71868]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073164, R01GM046425, R29GM046425, R01GM071868, U54GM064346] Funding Source: NIH RePORTER	Cell Migration Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the D.J.M. lab for helpful discussions and Craig Montell for insightful comments on the manuscript. We thank the Erika Matunis laboratory and Bloomington Stock Center for generous sharing of fly stocks. Peter Allen produced the artwork in Figure 7 as well as the cover art. This work was supported by grants GM73164 and GM46425 (to D.J.M.), GM64346 (Cell Migration Consortium; to D.J.M. and G.D.), and GM71868 (to G.D.).	Arboleda-Estudillo Y, 2010, CURR BIOL, V20, P161, DOI 10.1016/j.cub.2009.11.036; Birukova AA, 2012, J CELL PHYSIOL, V227, P3405, DOI 10.1002/jcp.24041; Borghi N, 2012, P NATL ACAD SCI USA, V109, P19034, DOI 10.1073/pnas.1217417109; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Conway DE, 2013, CURR BIOL, V23, P1024, DOI 10.1016/j.cub.2013.04.049; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Fernandez-Espartero CH, 2013, J CELL SCI, V126, P2285, DOI 10.1242/jcs.124438; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Fulga TA, 2002, NAT CELL BIOL, V4, P715, DOI 10.1038/ncb848; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; He L, 2010, NAT CELL BIOL, V12, P1133, DOI 10.1038/ncb2124; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Iglesias PA, 2012, CURR OPIN CELL BIOL, V24, P245, DOI 10.1016/j.ceb.2011.11.009; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kardash E, 2010, NAT CELL BIOL, V12, P47, DOI 10.1038/ncb2003; Kunwar PS, 2008, J CELL BIOL, V183, P157, DOI 10.1083/jcb.200807049; McDonald JA, 2006, DEV BIOL, V296, P94, DOI 10.1016/j.ydbio.2006.04.438; McDonald Jocelyn A., 2004, V294, P175; Meinhardt H, 1999, J CELL SCI, V112, P2867; Montell DJ, 2012, NAT REV MOL CELL BIO, V13, P631, DOI 10.1038/nrm3433; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; Murphy AM, 1996, J CELL BIOL, V133, P617, DOI 10.1083/jcb.133.3.617; Ng MR, 2012, J CELL BIOL, V199, P545, DOI 10.1083/jcb.201207148; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Prasad M, 2007, NAT PROTOC, V2, P2467, DOI 10.1038/nprot.2007.363; Prasad M, 2007, DEV CELL, V12, P997, DOI 10.1016/j.devcel.2007.03.021; Rakshit S, 2012, P NATL ACAD SCI USA, V109, P18815, DOI 10.1073/pnas.1208349109; Ramel D, 2013, NAT CELL BIOL, V15, P317, DOI 10.1038/ncb2681; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Shih WT, 2012, J CELL SCI, V125, P3661, DOI 10.1242/jcs.103861; Theveneau E, 2012, CURR OPIN CELL BIOL, V24, P677, DOI 10.1016/j.ceb.2012.08.002; Van Doren M, 1998, CURR BIOL, V8, P243; Vitorino P, 2008, GENE DEV, V22, P3268, DOI 10.1101/gad.1725808; Wang XB, 2010, NAT CELL BIOL, V12, P591, DOI 10.1038/ncb2061; Wang XJ, 2006, DEV CELL, V10, P483, DOI 10.1016/j.devcel.2006.02.003; Weber GF, 2012, DEV CELL, V22, P104, DOI 10.1016/j.devcel.2011.10.013	42	301	305	1	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1146	1159		10.1016/j.cell.2014.03.045	http://dx.doi.org/10.1016/j.cell.2014.03.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855950	Green Accepted, Bronze			2022-12-01	WOS:000336437200016
J	Chang, LF; Zhang, ZG; Yang, J; McLaughlin, SH; Barford, D				Chang, Leifu; Zhang, Ziguo; Yang, Jing; McLaughlin, Stephen H.; Barford, David			Molecular architecture and mechanism of the anaphase-promoting complex	NATURE			English	Article							MITOTIC CHECKPOINT COMPLEX; UBIQUITIN CHAIN ELONGATION; EM STRUCTURE DETERMINATION; CULLIN-RING LIGASES; CRYSTAL-STRUCTURE; ELECTRON-MICROSCOPY; CRYOELECTRON MICROSCOPY; STRUCTURAL INSIGHTS; DEGRON RECOGNITION; SUBSTRATE-BINDING	The ubiquitination of cell cycle regulatory proteins by the anaphase-promoting complex/cyclosome(APC/C) controls sister chromatid segregation, cytokinesis and the establishment of the G1 phase of the cell cycle. The APC/C is an unusually large multimeric cullin-RING ligase. Its activity is strictly dependent on regulatory coactivator subunits that promote APC/C-substrate interactions and stimulate its catalytic reaction. Because the structures of many APC/C subunits and their organization within the assembly are unknown, the molecular basis for these processes is poorly understood. Here, from a cryo-electron microscopy reconstruction of a human APC/C-coactivator-substrate complex at 7.4 angstrom resolution, we have determined the complete secondary structural architecture of the complex. With this information we identified protein folds for structurally uncharacterized subunits, and the definitive location of all 20 APC/C subunits within the 1.2 MDa assembly. Comparison with apo APC/C shows that the coactivator promotes a profound allosteric transition involving displacement of the cullin-RING catalytic subunits relative to the degron-recognition module of coactivator and APC10. This transition is accompanied by increased flexibility of the cullin-RING subunits and enhanced affinity for UBCH10-ubiquitin, changes which may contribute to coactivator-mediated stimulation of APC/C E3 ligase activity.	[Chang, Leifu; Zhang, Ziguo; Yang, Jing; Barford, David] Inst Canc Res, Div Struct Biol, London SW3 6JB, England; [Chang, Leifu; Zhang, Ziguo; Yang, Jing; McLaughlin, Stephen H.; Barford, David] MRC Lab Mol Biol, Cambridge CB2 0QH, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; MRC Laboratory Molecular Biology	Barford, D (corresponding author), MRC Lab Mol Biol, Cambridge CB2 0QH, England.	dbarford@mrc-lmb.cam.ac.uk		Zhang, Ziguo/0000-0002-7268-9631; Barford, David/0000-0001-8810-950X; Yang, Jing/0000-0002-8984-4503; McLaughlin, Stephen/0000-0001-9135-6253	Cancer Research UK; MRC [MC_UP_1201/6] Funding Source: UKRI; Cancer Research UK [14109] Funding Source: researchfish; Medical Research Council [MC_UP_1201/6] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank P. da Fonseca for her guidance preparing cryo electron microscopy grids and X. Bai and S. Scheres for help with the use of RELION and A. Plechanovova for advice in preparing stable UBCH10-Ub conjugates. We thank D. Morgan and W. Chao for their comments on the manuscript and D. Morgan for communicating data before publication. This work was funded by a Cancer Research UK grant to D.B.	Au SWN, 2002, J MOL BIOL, V316, P955, DOI 10.1006/jmbi.2002.5399; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Buschhorn BA, 2011, NAT STRUCT MOL BIOL, V18, P6, DOI 10.1038/nsmb.1979; Calabrese MF, 2011, NAT STRUCT MOL BIOL, V18, P947, DOI 10.1038/nsmb.2086; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzgerald DJ, 2007, STRUCTURE, V15, P275, DOI 10.1016/j.str.2007.01.016; Frye JJ, 2013, NAT STRUCT MOL BIOL, V20, P827, DOI 10.1038/nsmb.2593; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hall MC, 2003, J BIOL CHEM, V278, P16698, DOI 10.1074/jbc.M213109200; Han D, 2009, J BIOL CHEM, V284, P15137, DOI 10.1074/jbc.M804887200; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; He J, 2012, STRUCTURE, V20, P513, DOI 10.1016/j.str.2011.12.015; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Li YF, 2012, PROTEIN EXPRES PURIF, V82, P162, DOI 10.1016/j.pep.2011.12.008; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Matyskiela ME, 2009, MOL CELL, V34, P68, DOI 10.1016/j.molcel.2009.02.027; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Pfleger CM, 2000, GENE DEV, V14, P655; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schreiber A, 2011, NATURE, V470, P227, DOI 10.1038/nature09756; Summers MK, 2008, MOL CELL, V31, P544, DOI 10.1016/j.molcel.2008.07.014; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Tian W, 2012, P NATL ACAD SCI USA, V109, P18419, DOI 10.1073/pnas.1213438109; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Uzunova K, 2012, NAT STRUCT MOL BIOL, V19, P1116, DOI 10.1038/nsmb.2412; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Wang J, 2009, NAT STRUCT MOL BIOL, V16, P987, DOI 10.1038/nsmb.1645; Wang WP, 2013, NAT CELL BIOL, V15, P797, DOI 10.1038/ncb2755; Wendt KS, 2001, NAT STRUCT BIOL, V8, P784, DOI 10.1038/nsb0901-784; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Zhang ZG, 2013, J MOL BIOL, V425, P4236, DOI 10.1016/j.jmb.2013.04.004; Zhang ZG, 2013, BIOCHEM J, V449, P365, DOI 10.1042/BJ20121374; Zhang ZG, 2010, EMBO J, V29, P3733, DOI 10.1038/emboj.2010.247; Zhang ZG, 2010, J MOL BIOL, V397, P1316, DOI 10.1016/j.jmb.2010.02.045; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	68	147	164	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					388	+		10.1038/nature13543	http://dx.doi.org/10.1038/nature13543			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043029	Green Accepted			2022-12-01	WOS:000341814900053
J	Wolfe, AL; Singh, K; Zhong, Y; Drewe, P; Rajasekhar, VK; Sanghvi, VR; Mavrakis, KJ; Jiang, M; Roderick, JE; Van der Meulen, J; Schatz, JH; Rodrigo, CM; Zhao, CY; Rondou, P; de Stanchina, E; Teruya-Feldstein, J; Kelliher, MA; Speleman, F; Porco, JA; Pelletier, J; Ratsch, G; Wendel, HG				Wolfe, Andrew L.; Singh, Kamini; Zhong, Yi; Drewe, Philipp; Rajasekhar, Vinagolu K.; Sanghvi, Viraj R.; Mavrakis, Konstantinos J.; Jiang, Man; Roderick, Justine E.; Van der Meulen, Joni; Schatz, Jonathan H.; Rodrigo, Christina M.; Zhao, Chunying; Rondou, Pieter; de Stanchina, Elisa; Teruya-Feldstein, Julie; Kelliher, Michelle A.; Speleman, Frank; Porco, John A., Jr.; Pelletier, Jerry; Raetsch, Gunnar; Wendel, Hans-Guido			RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; OF-FUNCTION MUTATIONS; C-MYC; INITIATION; EIF4E; CAP; AKT; TRANSCRIPTION; INHIBITION; MOTIF	The translational control of oncoprotein expression is implicated in many cancers. Here we report an eIF4A RNA helicase-dependent mechanism of translational control that contributes to oncogenesis and underlies the anticancer effects of silvestrol and related compounds. For example, eIF4A promotes T-cell acute lymphoblastic leukaemia development in vivo and is required for leukaemia maintenance. Accordingly, inhibition of eIF4A with silvestrol has powerful therapeutic effects against murine and human leukaemic cells in vitro and in vivo. We use transcriptome-scale ribosome footprinting to identify the hallmarks of eIF4A-dependent transcripts. These include 5' untranslated region (UTR) sequences such as the 12-nucleotide guanine quartet (CGG)(4) motif that can form RNA G-quadruplex structures. Notably, among the most eIF4A-dependent and silvestrol-sensitive transcripts are a number of oncogenes, superenhancer-associated transcription factors, and epigenetic regulators. Hence, the 5' UTRs of select cancer genes harbour a targetable requirement for the eIF4A RNA helicase.	[Wolfe, Andrew L.; Singh, Kamini; Sanghvi, Viraj R.; Mavrakis, Konstantinos J.; Jiang, Man; Van der Meulen, Joni; Schatz, Jonathan H.; Zhao, Chunying; Wendel, Hans-Guido] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Wolfe, Andrew L.] Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Zhong, Yi; Drewe, Philipp; Raetsch, Gunnar] Mem Sloan Kettering Canc Ctr, Computat Biol Dept, New York, NY 10065 USA; [Rajasekhar, Vinagolu K.] Mem Sloan Kettering Canc Ctr, Stem Cell Ctr, New York, NY 10065 USA; [Rajasekhar, Vinagolu K.] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Roderick, Justine E.; Kelliher, Michelle A.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Van der Meulen, Joni; Rondou, Pieter; Speleman, Frank] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Schatz, Jonathan H.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Rodrigo, Christina M.; Porco, John A., Jr.] Boston Univ, Dept Chem, Ctr Chem Methodol & Lib Dev, Boston, MA 02215 USA; [de Stanchina, Elisa] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, New York, NY 10065 USA; [Teruya-Feldstein, Julie] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Pelletier, Jerry] McGill Univ, Dept Oncol, Montreal, PQ H3G 1Y6, Canada; [Pelletier, Jerry] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada	Memorial Sloan Kettering Cancer Center; Cornell University; Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Massachusetts System; University of Massachusetts Worcester; Ghent University; Memorial Sloan Kettering Cancer Center; Boston University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; McGill University; McGill University; McGill University	Wendel, HG (corresponding author), Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA.	Ratschg@mskcc.org; wendelh@mskcc.org	speleman, frank/AAR-5184-2020; Rätsch, Gunnar/O-5914-2017; Van der Meulen, Joni/AFS-1616-2022	speleman, frank/0000-0002-6628-8559; Rätsch, Gunnar/0000-0001-5486-8532; Van der Meulen, Joni/0000-0002-1916-2769; Wolfe, Andrew/0000-0003-0418-716X; Sanghvi, Viraj/0000-0001-6526-7820; Schatz, Jonathan/0000-0003-1842-228X; van der Meulen, Jan/0000-0002-9451-2335; Boss, Philipp/0000-0002-5459-9771; Vinagolu, Rajasekhar/0000-0002-7364-2675	National Cancer Institute [R01-CA142798-01]; Leukemia Research Foundation; Experimental Therapeutics Center; American Cancer Society [10284, PF-11-077-01-CDD]; European Union [PITN-GA-2012-316861]; Fund for Scientific Research FWO Flanders [G.0198.08, G.0869.10N]; GOA-UGent [12051203]; Stichting tegen Kanker; Belgian Program of Interuniversity Poles of Attraction; Belgian Foundation Against Cancer; Lymphoma Research Foundation; National Institutes of Health [GM-067041, GM-073855]; Canadian Institutes of Health Research [MOP-10653]; NATIONAL CANCER INSTITUTE [R01CA142798, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM067041, R01GM073855] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia Research Foundation; Experimental Therapeutics Center; American Cancer Society(American Cancer Society); European Union(European Commission); Fund for Scientific Research FWO Flanders(FWO); GOA-UGent; Stichting tegen Kanker; Belgian Program of Interuniversity Poles of Attraction; Belgian Foundation Against Cancer; Lymphoma Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of A.L.W.'s thesis committee: N. Rosen, A. M. Brown and S. W. Lowe. For reagents and advice we thank J. T. Barata, W. S. Pear, R. Cencic, S. Shuman, J. Cools, A. A. Ferrando, C. S. Fraser, N. J. Lajkiewicz, A. Luz, J. F. Glickman, C. Y. Park, P. Yellen, A. Heguy, K. Huberman and A. Viale. H.-G. W. is a Scholar of the Leukemia and Lymphoma Society. This research was supported by National Cancer Institute R01-CA142798-01 (H.-G. W.), the Leukemia Research Foundation (H.-G. W.), the Experimental Therapeutics Center (H.-G. W.), the American Cancer Society 10284 (H.-G. W.), European Union grant no. PITN-GA-2012-316861 (Y.Z.), the Fund for Scientific Research FWO Flanders (J.V.d.M. and P. R.), grants G.0198.08 and G.0869.10N (F. S.), the GOA-UGent 12051203 (F. S.), Stichting tegen Kanker (F. S.), the Belgian Program of Interuniversity Poles of Attraction (F. S.), the Belgian Foundation Against Cancer (F. S.), the American Cancer Society PF-11-077-01-CDD (C. M. R.), the Lymphoma Research Foundation (J. H. S.), National Institutes of Health grants GM-067041 and GM-073855 (J. A. P.), and the Canadian Institutes of Health Research MOP-10653 (J.P.).	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Chakraborty P, 2011, DNA REPAIR, V10, P654, DOI 10.1016/j.dnarep.2011.04.013; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drewe P, 2013, NUCLEIC ACIDS RES, V41, P5189, DOI 10.1093/nar/gkt211; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; Galicia-Vazquez G, 2012, RNA, V18, P1373, DOI 10.1261/rna.033209.112; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Huppert JL, 2008, NUCLEIC ACIDS RES, V36, P6260, DOI 10.1093/nar/gkn511; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jean G., 2010, BIOINFORMATICS, V32; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kentsis A, 2004, P NATL ACAD SCI USA, V101, P18105, DOI 10.1073/pnas.0406927102; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Mavrakis KJ, 2008, GENE DEV, V22, P2178, DOI 10.1101/gad.1690808; Mavrakis KJ, 2011, NAT GENET, V43, P673, DOI 10.1038/ng.858; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Menten B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-124; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Morris MJ, 2010, J AM CHEM SOC, V132, P17831, DOI 10.1021/ja106287x; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Rodrigo CM, 2012, J MED CHEM, V55, P558, DOI 10.1021/jm201263k; Rong L, 2008, RNA, V14, P1318, DOI 10.1261/rna.950608; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Sadlish H, 2013, ACS CHEM BIOL, V8, P1519, DOI 10.1021/cb400158t; Schatz JH, 2011, J EXP MED, V208, P1799, DOI 10.1084/jem.20110846; Shahid R, 2010, BIOCHEMISTRY-US, V49, P8300, DOI 10.1021/bi100957h; Shochat C, 2011, J EXP MED, V208, P901, DOI 10.1084/jem.20110580; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Van Vlierberghe P, 2011, J EXP MED, V208, P2571, DOI 10.1084/jem.20112239; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Zenatti PP, 2011, NAT GENET, V43, P932, DOI 10.1038/ng.924; Zuurbier L, 2012, HAEMATOL-HEMATOL J, V97, P1405, DOI 10.3324/haematol.2011.059030	56	375	382	3	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					65	+		10.1038/nature13485	http://dx.doi.org/10.1038/nature13485			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25079319	Green Accepted			2022-12-01	WOS:000341174800030
J	Schumacher, T; Bunse, L; Pusch, S; Sahm, F; Wiestler, B; Quandt, J; Menn, O; Osswald, M; Oezen, I; Ott, M; Keil, M; Balss, J; Rauschenbach, K; Grabowska, AK; Vogler, I; Diekmann, J; Trautwein, N; Eichmuller, SB; Okun, J; Stevanovic, S; Riemer, AB; Sahin, U; Friese, MA; Beckhove, P; von Deimling, A; Wick, W; Platten, M				Schumacher, Theresa; Bunse, Lukas; Pusch, Stefan; Sahm, Felix; Wiestler, Benedikt; Quandt, Jasmin; Menn, Oliver; Osswald, Matthias; Oezen, Iris; Ott, Martina; Keil, Melanie; Balss, Joerg; Rauschenbach, Katharina; Grabowska, Agnieszka K.; Vogler, Isabel; Diekmann, Jan; Trautwein, Nico; Eichmueller, Stefan B.; Okun, Juergen; Stevanovic, Stefan; Riemer, Angelika B.; Sahin, Ugur; Friese, Manuel A.; Beckhove, Philipp; von Deimling, Andreas; Wick, Wolfgang; Platten, Michael			A vaccine targeting mutant IDH1 induces antitumour immunity	NATURE			English	Article							BRAIN-TUMORS; MUTATIONS; CELLS; DIFFERENTIATION; PHENOTYPE; MELANOMA; GLIOMAS; MICE	Monoallelic point mutations of isocitrate dehydrogenase type 1 (IDH1) are an early and defining event in the development of a subgroup of gliomas(1-3) and other types of tumour(4-6). They almost uniformly occur in the critical arginine residue (Arg 132) in the catalytic pocket, resulting in a neomorphic enzymatic function, production of the oncometabolite 2-hydroxyglutarate (2-HG)(7,8), genomic hypermethylation9-11, genetic instability and malignant transformation(12). More than 70% of diffuse grade II and grade III gliomas carry the most frequent mutation, IDH1(R132H) (ref. 3). From an immunological perspective, IDH1(R132H) represents a potential target for immunotherapy as it is a tumour-specific potential neoantigen with high uniformity and penetrance expressed in all tumour cells(13,14). Here we demonstrate that IDH1(R132H) contains an immunogenic epitope suitable formutation-specific vaccination. Peptides encompassing the mutated region are presented on major histocompatibility complexes (MHC) class II and induce mutation-specific CD4(+) T-helper-1 (TH1) responses. CD41 TH1 cells and antibodies spontaneously occurring in patients with IDH1(R132H)-mutated gliomas specifically recognize IDH1(R132H). Peptide vaccination of mice devoid of mouse MHC and transgenic for human MHC class I and II with IDH1(R132H) p123-142 results in an effective MHC class II-restrictedmutation-specific antitumourimmune response and control of pre-established syngeneic IDH1(R132H)-expressing tumours in a CD4(+)T-cell-dependent manner. As IDH1(R132H) is present in all tumour cells of these slow-growing gliomas(15), a mutation-specific anti-IDH1(R132H) vaccine may represent a viable novel therapeutic strategy for IDH1(R132H)-mutated tumours.	[Schumacher, Theresa; Bunse, Lukas; Wiestler, Benedikt; Menn, Oliver; Osswald, Matthias; Oezen, Iris; Ott, Martina; Keil, Melanie; Rauschenbach, Katharina; Wick, Wolfgang; Platten, Michael] Univ Heidelberg Hosp, Dept Neurooncol, D-69120 Heidelberg, Germany; [Schumacher, Theresa; Bunse, Lukas; Wiestler, Benedikt; Menn, Oliver; Osswald, Matthias; Oezen, Iris; Ott, Martina; Keil, Melanie; Rauschenbach, Katharina; Wick, Wolfgang; Platten, Michael] Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [Schumacher, Theresa; Bunse, Lukas; Oezen, Iris; Ott, Martina; Keil, Melanie; Balss, Joerg; Rauschenbach, Katharina; Platten, Michael] German Canc Res Ctr, German Canc Consortium DKTK Clin Cooperat Unit Ne, D-69120 Heidelberg, Germany; [Pusch, Stefan; Sahm, Felix; von Deimling, Andreas] Univ Heidelberg Hosp, Dept Neuropathol, D-69120 Heidelberg, Germany; [Pusch, Stefan; Sahm, Felix; von Deimling, Andreas] Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [Pusch, Stefan; Sahm, Felix; Balss, Joerg; von Deimling, Andreas] German Canc Res Ctr, German Canc Consortium DKTK Clin Cooperat Unit Ne, D-69120 Heidelberg, Germany; [Wiestler, Benedikt; Osswald, Matthias; Wick, Wolfgang] German Canc Res Ctr, German Canc Consortium DKTK Clin Cooperat Unit Ne, D-69120 Heidelberg, Germany; [Quandt, Jasmin; Eichmueller, Stefan B.; Beckhove, Philipp] German Canc Res Ctr, Dept Translat Immunol, D-69120 Heidelberg, Germany; [Grabowska, Agnieszka K.; Riemer, Angelika B.] German Canc Res Ctr, Dept Immunotherapy & Prevent Grp, D-69120 Heidelberg, Germany; [Vogler, Isabel] Ribological GmbH, D-55131 Mainz, Germany; [Diekmann, Jan; Sahin, Ugur] Translat Oncol, D-55131 Mainz, Germany; [Trautwein, Nico; Stevanovic, Stefan] Univ Tubingen, Dept Immunol, D-72076 Tubingen, Germany; [Okun, Juergen] Univ Childrens Hosp, Metab Ctr Heidelberg, D-69120 Heidelberg, Germany; [Friese, Manuel A.] Univ Med Ctr, Ctr Mol Neurobiol, D-20251 Hamburg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Platten, M (corresponding author), Univ Heidelberg Hosp, Dept Neurooncol, D-69120 Heidelberg, Germany.	m.platten@dkfz.de	Bunse, Lukas/L-2975-2016; Pusch, Stefan/H-3152-2019; Sahm, Felix/GQY-8202-2022; Sahin, Ugur/L-4818-2017; von Deimling, Andreas/F-7774-2013; Wick, Wolfgang/AAA-2545-2020; Eichmüller, Stefan B/A-5053-2008; Bunse, Theresa/AAD-1719-2019; Platten, Michael/F-2902-2013	Bunse, Lukas/0000-0002-4490-7574; Pusch, Stefan/0000-0002-3407-4249; Sahm, Felix/0000-0001-5441-1962; Sahin, Ugur/0000-0003-0363-1564; von Deimling, Andreas/0000-0002-5863-540X; Wick, Wolfgang/0000-0002-6171-634X; Eichmüller, Stefan B/0000-0002-3497-6904; Platten, Michael/0000-0002-4746-887X; Riemer, Angelika/0000-0002-5865-0714; Friese, Manuel A./0000-0001-6380-2420; Wiestler, Benedikt/0000-0002-2963-7772	DKFZ Light Microscopy and Genomics and Proteomics Facilities; NIH; Interdisciplinary Research Program of the National Center for Tumor Diseases Heidelberg [IFP III/2]; Wilhelm Sander Foundation [2012.118.1]; Helmholtz Foundation [VH-NG-306]; Andreas Zimprich Foundation; German Research Foundation [SFB938]; Helmholtz International Graduate School; Heinrich F. C. Behr Foundation; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology MD/PhD program, University Heidelberg; University Hospital Heidelberg	DKFZ Light Microscopy and Genomics and Proteomics Facilities; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interdisciplinary Research Program of the National Center for Tumor Diseases Heidelberg; Wilhelm Sander Foundation; Helmholtz Foundation(Helmholtz Association); Andreas Zimprich Foundation; German Research Foundation(German Research Foundation (DFG)); Helmholtz International Graduate School; Heinrich F. C. Behr Foundation; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology MD/PhD program, University Heidelberg; University Hospital Heidelberg	We are indebted to the patients and their relatives who agreed to participate in this study. We thank A. Gardyan, T. Lanz and W. Osen for technical advice, T. Lanz and A. Hertenstein for providing patient blood samples, S. Hundt for cloning, A. Habel and D. Krunic for technical support, W. Nicklas for pathological analysis, and J. Jung for graphics design. We acknowledge the support by the DKFZ Light Microscopy and Genomics and Proteomics Facilities. HLA-DRB1*01:01 MHC class II tetramer bound to IDH1(R132H) p123-142 was provided by NIH tetramer core facility. A2.DR1 mice were provided by Institut Pasteur. This work was supported by the Interdisciplinary Research Program of the National Center for Tumor Diseases Heidelberg (IFP III/2) to M. P. and A. V. D., the Wilhelm Sander Foundation (2012.118.1) to M. P and A. V. D., the Helmholtz Foundation (VH-NG-306) and the Andreas Zimprich Foundation to M. P. and the German Research Foundation (SFB938 TPK) to M. P. and W. W. T. S. and M. K. were supported by the Helmholtz International Graduate School, and L. B. was supported by the Heinrich F. C. Behr Foundation and the Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology MD/PhD program, University Heidelberg. F.S. was supported by a postdoctoral fellowship of the University Hospital Heidelberg.	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Balss J, 2012, ACTA NEUROPATHOL, V124, P883, DOI 10.1007/s00401-012-1060-y; Cairns RA, 2013, CANCER DISCOV, V3, P730, DOI 10.1158/2159-8290.CD-13-0083; Capper D, 2010, BRAIN PATHOL, V20, P245, DOI 10.1111/j.1750-3639.2009.00352.x; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Ito K, 1996, J EXP MED, V183, P2635, DOI 10.1084/jem.183.6.2635; Jansen M, 2010, LANCET NEUROL, V9, P717, DOI 10.1016/S1474-4422(10)70105-8; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Pajot A, 2004, EUR J IMMUNOL, V34, P3060, DOI 10.1002/eji.200425463; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	26	454	475	3	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					324	+		10.1038/nature13387	http://dx.doi.org/10.1038/nature13387			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25043048				2022-12-01	WOS:000340508200038
J	Schleich, S; Strassburger, K; Janiesch, PC; Koledachkina, T; Miller, KK; Haneke, K; Cheng, YS; Kuchler, K; Stoecklin, G; Duncan, KE; Teleman, AA				Schleich, Sibylle; Strassburger, Katrin; Janiesch, Philipp Christoph; Koledachkina, Tatyana; Miller, Katharine K.; Haneke, Katharina; Cheng, Yong-Sheng; Kuechler, Katrin; Stoecklin, Georg; Duncan, Kent E.; Teleman, Aurelio A.			DENR-MCT-1 promotes translation re-initiation downstream of uORFs to control tissue growth	NATURE			English	Article							MSL-2 MESSENGER-RNA; OPEN READING FRAMES; CANDIDATE ONCOGENE; INSULIN-RECEPTOR; GENE-EXPRESSION; SEX-LETHAL; DROSOPHILA; MECHANISM; PROTEIN; MCT-1	During cap-dependent eukaryotic translation initiation, ribosomes scan messenger RNA from the 5' end to the first AUG start codon with favourable sequence context(1,2). For many mRNAs this AUG belongs to a short upstream open reading frame (uORF)(3), and translation of the main downstream ORF requires re-initiation, an incompletely understood process(1,4-6). Re-initiation is thought to involve the same factors as standard initiation(1,5,7). It is unknown whether any factors specifically affect translation re-initiation without affecting standard cap-dependent translation. Here we uncover the non-canonical initiation factors density regulated protein (DENR) and multiple copies in T-cell lymphoma-1(MCT-1; also called MCTS1 inhumans) as the first selective regulators of eukaryotic re-initiation. mRNAs containing upstream ORFs with strong Kozak sequences selectively require DENR-MCT-1 for their proper translation, yielding a novel class of mRNAs that can be co-regulated and that is enriched for regulatory proteins such as oncogenic kinases. Collectively, our data reveal that cells have a previously unappreciated translational control system with a key role in supporting proliferation and tissue growth.	[Schleich, Sibylle; Strassburger, Katrin; Haneke, Katharina; Cheng, Yong-Sheng; Stoecklin, Georg; Teleman, Aurelio A.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Schleich, Sibylle; Janiesch, Philipp Christoph; Koledachkina, Tatyana; Miller, Katharine K.; Kuechler, Katrin; Duncan, Kent E.] Univ Med Ctr Hamburg Eppendorf UKE, Ctr Mol Neurobiol ZMNH, D-20251 Hamburg, Germany; [Haneke, Katharina; Stoecklin, Georg] Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Duncan, KE (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, Ctr Mol Neurobiol ZMNH, Falkenried 94, D-20251 Hamburg, Germany.	kent.duncan@zmnh.uni-hamburg.de; a.teleman@dkfz.de	Teleman, Aurelio A/E-6864-2013; Teleman, Aurelio/V-8470-2019; Miller, Katharine K/O-6804-2015; kuchler, karl/AAL-6937-2020	Teleman, Aurelio A/0000-0002-4237-9368; Teleman, Aurelio/0000-0002-4237-9368; Miller, Katharine K/0000-0002-0690-7426; kuchler, karl/0000-0003-2719-5955; Stoecklin, Georg/0000-0001-9284-9834; Hoerth, Katharina/0000-0002-6676-3583; Duncan, Kent/0000-0003-4290-2670; Cheng, Yong-Sheng/0000-0002-4586-8116	Hans und Ilse Breuer Foundation; Fritz Thyssen Foundation; Deutsche Forschungsgemeinschaft (DFG); ERC	Hans und Ilse Breuer Foundation; Fritz Thyssen Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission)	We thank B. Bukau, R. Green and P. Soba for suggestions on the manuscript, V. Benes and T. Bahr-Ivacevic (EMBL Genomics Core Facility) for assistance with microarray experiments, S. Abmayr for anti-Mbc antibody, T. Hsu for anti-Awd antibody, C. Strein and M. Hentze for Drosophila DENR antibodies, P. Jakob for help with testing conditions for S2 in vitro translation extracts, L. Schibalski and J. Grawe for help with cloning, S. Hofmann for help with polysome analysis, and S. Lerch, A. Haffner and M. Schroder for technical assistance. K.K.M. is the recipient of an Alzheimer's Research Scholarship from the Hans und Ilse Breuer Foundation. P.C.J. is supported in part by a grant from the Fritz Thyssen Foundation to K.E.D. This work was supported in part by a Deutsche Forschungsgemeinschaft (DFG) grant and ERC Starting Grant to A.A.T.	Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Bodenmiller B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100182; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Dierov J, 1999, J CELL BIOCHEM, V74, P544, DOI 10.1002/(SICI)1097-4644(19990915)74:4<544::AID-JCB4>3.0.CO;2-4; Dmitriev SE, 2010, J BIOL CHEM, V285, P26779, DOI 10.1074/jbc.M110.119693; Duncan K, 2006, GENE DEV, V20, P368, DOI 10.1101/gad.371406; Duncan KE, 2009, MOL CELL, V36, P571, DOI 10.1016/j.molcel.2009.09.042; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gebauer F, 1999, EMBO J, V18, P6146, DOI 10.1093/emboj/18.21.6146; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; HAYASHI S, 1993, DEVELOPMENT, V118, P105; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang J, 2008, GENETICS, V180, P703, DOI 10.1534/genetics.108.090563; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jackson RJ, 2012, ADV PROTEIN CHEM STR, V86, P45, DOI [10.1016/B978-0-12.386497.000002-5, 10.1016/B978-0-12-386497-0.00002-5]; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kong J, 2012, NAT REV GENET, V13, P383, DOI 10.1038/nrg3184; KONGSUWAN K, 1985, NATURE, V317, P555, DOI 10.1038/317555a0; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Mazan-Mamczarz K, 2009, LEUKEMIA RES, V33, P474, DOI 10.1016/j.leukres.2008.08.012; Nandi S, 2007, ONCOGENE, V26, P2283, DOI 10.1038/sj.onc.1210030; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Prosniak M, 1998, CANCER RES, V58, P4233; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Skabkin MA, 2013, MOL CELL, V51, P249, DOI 10.1016/j.molcel.2013.05.026; Skabkin MA, 2010, GENE DEV, V24, P1787, DOI 10.1101/gad.1957510; Somers J, 2013, INT J BIOCHEM CELL B, V45, P1690, DOI 10.1016/j.biocel.2013.04.020; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Valasek LS, 2012, CURR PROTEIN PEPT SC, V13, P305; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wilson TG, 2006, GENETICS, V172, P253, DOI 10.1534/genetics.105.046631; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	103	106	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					208	+		10.1038/nature13401	http://dx.doi.org/10.1038/nature13401			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043021	Green Accepted			2022-12-01	WOS:000340200700035
J	Ghavi-Helm, Y; Klein, FA; Pakozdi, T; Ciglar, L; Noordermeer, D; Huber, W; Furlong, EEM				Ghavi-Helm, Yad; Klein, Felix A.; Pakozdi, Tibor; Ciglar, Lucia; Noordermeer, Daan; Huber, Wolfgang; Furlong, Eileen E. M.			Enhancer loops appear stable during development and are associated with paused polymerase	NATURE			English	Article							GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; ABDOMINAL-B; TRANSCRIPTION; ORGANIZATION; BINDING; RANGE; TRANSFORMATION; CONSERVATION; ELEMENTS	Developmental enhancers initiate transcription and are fundamental to our understanding of developmental networks, evolution and disease. Despite their importance, the properties governing enhancer-promoter interactions and their dynamics during embryogenesis remain unclear. At the beta-globin locus, enhancer-promoter interactions appear dynamic and cell-type specific(1,2), whereas at the HoxD locus they are stable and ubiquitous, being present in tissues where the target genes are not expressed(3,4). The extent to which preformed enhancer-promoter conformations exist at other, more typical, loci and how transcription is eventually triggered is unclear. Here we generated a high-resolution map of enhancer three-dimensional contacts during Drosophila embryogenesis, covering two developmental stages and tissue contexts, at unprecedented resolution. Although local regulatory interactions are common, long-range interactions are highly prevalent within the compact Drosophila genome. Each enhancer contacts multiple enhancers, and promoters with similar expression, suggesting a role in their co-regulation. Notably, most interactions appear unchanged between tissue context and across development, arising before gene activation, and are frequently associated with paused RNA polymerase. Our results indicate that the general topology governing enhancer contacts is conserved from flies to humans and suggest that transcription initiates from preformed enhancer-promoter loops through release of paused polymerase.	[Ghavi-Helm, Yad; Klein, Felix A.; Pakozdi, Tibor; Ciglar, Lucia; Huber, Wolfgang; Furlong, Eileen E. M.] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Noordermeer, Daan] Swiss Fed Inst Technol, Sch Life Sci, CH-1015 Lausanne, Switzerland	European Molecular Biology Laboratory (EMBL); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Furlong, EEM (corresponding author), European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany.	furlong@embl.de	; Noordermeer, Daan/F-3306-2011	Furlong, Eileen/0000-0002-9544-8339; Ghavi-Helm, Yad/0000-0003-2397-9576; Pakozdi, Tibor/0000-0002-7633-7529; Noordermeer, Daan/0000-0002-9296-7002; Huber, Wolfgang/0000-0002-0474-2218	DFG [FU 750]; EMBO; EC	DFG(German Research Foundation (DFG)); EMBO(European Molecular Biology Organization (EMBO)); EC(European CommissionEuropean Commission Joint Research Centre)	This work was technically supported by the EMBL Genomics Core and FACS core facilities. We thank all members of the Furlong laboratory for discussions and comments, in particular D. Garfield, J. Reddington and I. Schor for important suggestions. Embryo images in Fig. 3c were used with permission from Development<SUP>27</SUP> and Nature Publishing Group<SUP>26</SUP> as these fly strains no longer exist. This work was supported by a DFG (FU 750) grant to E.E.M.F., an EMBO post-doctoral fellowship to Y.G.-H., and the EC FP7 project 'Radiant' grant to F.A.K. and W.H.	Albrecht S, 2011, DEV BIOL, V350, P89, DOI 10.1016/j.ydbio.2010.11.016; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Bonn S, 2012, NAT PROTOC, V7, P978, DOI 10.1038/nprot.2012.049; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; BUSTURIA A, 1993, EMBO J, V12, P1415, DOI 10.1002/j.1460-2075.1993.tb05785.x; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Capovilla M, 2001, DEVELOPMENT, V128, P1221; Chen K, 2013, ELIFE, V2, DOI 10.7554/eLife.00861; Chopra VS, 2009, GENE DEV, V23, P1505, DOI 10.1101/gad.1807309; Cleard F, 2006, NAT GENET, V38, P931, DOI 10.1038/ng1833; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Fanucchi S, 2013, CELL, V155, P606, DOI 10.1016/j.cell.2013.09.051; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; Gaertner B, 2012, CELL REP, V2, P1670, DOI 10.1016/j.celrep.2012.11.024; Gallo SM, 2011, NUCLEIC ACIDS RES, V39, pD118, DOI 10.1093/nar/gkq999; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Lai WKM, 2012, BIOINFORMATICS, V28, P1021, DOI 10.1093/bioinformatics/bts063; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Saunders A, 2013, GENE DEV, V27, P1146, DOI 10.1101/gad.215459.113; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Scuderi A, 2006, DEV BIOL, V291, P110, DOI 10.1016/j.ydbio.2005.12.014; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Thomas S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r43; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tolhuis B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001343; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/nmeth.2173, 10.1038/NMETH.2173]; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Wilczynski B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002798; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716; Zhou JM, 1999, DEVELOPMENT, V126, P3057; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	55	322	323	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					96	+		10.1038/nature13417	http://dx.doi.org/10.1038/nature13417			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043061				2022-12-01	WOS:000339908000039
J	Tseng, YY; Moriarity, BS; Gong, WM; Akiyama, R; Tiwari, A; Kawakami, H; Ronning, P; Reuland, B; Guenther, K; Beadnell, TC; Essig, J; Otto, GM; O'Sullivan, MG; Largaespada, DA; Schwertfeger, KL; Marahrens, Y; Kawakami, Y; Bagchi, A				Tseng, Yuen-Yi; Moriarity, Branden S.; Gong, Wuming; Akiyama, Ryutaro; Tiwari, Ashutosh; Kawakami, Hiroko; Ronning, Peter; Reuland, Brian; Guenther, Kacey; Beadnell, Thomas C.; Essig, Jaclyn; Otto, George M.; O'Sullivan, M. Gerard; Largaespada, David A.; Schwertfeger, Kathryn L.; Marahrens, York; Kawakami, Yasuhiko; Bagchi, Anindya			PVT1 dependence in cancer with MYC copy-number increase	NATURE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; BREAST-CANCER; C-MYC; TRANSCRIPTION FACTORS; MAMMARY-GLAND; CHROMOSOME 8Q; CELL-LINES; EXPRESSION; AMPLIFICATION; MICE	'Gain' of supernumerary copies of the 8q24.21 chromosomal region has been shown to be common in many human cancers(1-13) and is associated with poor prognosis(7,10,14). The well-characterized myelocytomatosis (MYC) oncogene resides in the 8q24.21 region and is consistently co-gained with an adjacent 'gene desert' of approximately 2 megabases that contains the long non-coding RNA gene PVT1, the CCDC26 gene candidate and the GSDMC gene. Whether low copy-number gain of one or more of these genes drives neoplasia is not known. Here we use chromosome engineering in mice to show that a single extra copy of either the Myc gene or the region encompassing Pvt1, Ccdc26 and Gsdmc fails to advance cancer measurably, whereas a single supernumerary segment encompassing all four genes successfully promotes cancer. Gain of PVT1 long non-coding RNA expression was required for high MYC protein levels in 8q24-amplified human cancer cells. PVT1 RNA and MYC protein expression correlated in primary human tumours, and copy number of PVT1 was co-increased in more than 98% of MYC-copy-increase cancers. Ablation of PVT1 from MYC-driven colon cancer line HCT116 diminished its tumorigenic potency. As MYC protein has been refractory to small-molecule inhibition, the dependence of high MYC protein levels on PVT1 long non-coding RNA provides a much needed therapeutic target.	[Tseng, Yuen-Yi; Gong, Wuming; Akiyama, Ryutaro; Kawakami, Hiroko; Ronning, Peter; Reuland, Brian; Guenther, Kacey; Essig, Jaclyn; Largaespada, David A.; Marahrens, York; Kawakami, Yasuhiko; Bagchi, Anindya] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Moriarity, Branden S.; Gong, Wuming; Tiwari, Ashutosh; Otto, George M.; O'Sullivan, M. Gerard; Largaespada, David A.; Schwertfeger, Kathryn L.; Bagchi, Anindya] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Akiyama, Ryutaro; Kawakami, Hiroko; Kawakami, Yasuhiko] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; [Beadnell, Thomas C.; Schwertfeger, Kathryn L.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bagchi, A (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	bagch005@umn.edu	Tiwari, Ashutosh/ABG-9394-2020; Gong, Wuming/GQH-1435-2022; Tseng, Yuen-Yi/C-2148-2015; Gong, Wuming/GQH-9157-2022	Gong, Wuming/0000-0002-3147-4028; Tseng, Yuen-Yi/0000-0002-8757-4087; Kawakami, Yasuhiko/0000-0002-0043-9705; Tiwari, Ashutosh/0000-0003-3404-8881	Masonic Cancer Center Laboratory; Institute of Prostate and Urologic Cancer, University of Minnesota; American Cancer Society [118198-IRG-58-001-52-IRG92]; Indo-US fellowship from the Indo-US Science and Technology Forum; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064195] Funding Source: NIH RePORTER	Masonic Cancer Center Laboratory; Institute of Prostate and Urologic Cancer, University of Minnesota; American Cancer Society(American Cancer Society); Indo-US fellowship from the Indo-US Science and Technology Forum; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. T. Vogel for writing statistical analysis scripts; Research Animal Resources, University of Minnesota, for maintaining the mouse colony; S. Horn and L. Oseth for embryonic stem cell blastocyst injection and FISH analysis respectively. This work was supported by Masonic Cancer Center Laboratory start-up funds (to A.B.), and by grants from the Masonic Scholar Award (to A.B.), the Karen Wyckoff Rein in Sarcoma Fund (to A.B.), Translational Workgroup Pilot Project Awards by the Institute of Prostate and Urologic Cancer, University of Minnesota (to A.B.) and an American Cancer Society Institutional Research Grant (award 118198-IRG-58-001-52-IRG92, to A.B.). A.T. was supported by an Indo-US fellowship from the Indo-US Science and Technology Forum.	Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; BORG A, 1992, INT J CANCER, V51, P687, DOI 10.1002/ijc.2910510504; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Douglas EJ, 2004, CANCER RES, V64, P4817, DOI 10.1158/0008-5472.CAN-04-0328; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; Huppi Konrad, 2012, Frontiers in Genetics, V3, P69, DOI 10.3389/fgene.2012.00069; Itou J, 2012, DEVELOPMENT, V139, P4133, DOI 10.1242/dev.079756; Jain AN, 2001, P NATL ACAD SCI USA, V98, P7952, DOI 10.1073/pnas.151241198; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; Le Beau MM, 2002, BLOOD, V99, P2985, DOI 10.1182/blood.V99.8.2985; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lin MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023356; Moriarity BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096114; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Park K, 2005, HUM PATHOL, V36, P634, DOI 10.1016/j.humpath.2005.04.016; Rahrmann EP, 2013, NAT GENET, V45, P756, DOI 10.1038/ng.2641; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Reed JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045877; Saji S, 2000, P NATL ACAD SCI USA, V97, P337, DOI 10.1073/pnas.97.1.337; Sato K, 1999, JNCI-J NATL CANCER I, V91, P1574, DOI 10.1093/jnci/91.18.1574; Schwertfeger KL, 2006, CANCER RES, V66, P5676, DOI 10.1158/0008-5472.CAN-05-3781; van Duin M, 2007, CYTOGENET GENOME RES, V118, P130, DOI 10.1159/000108293; Wang XY, 2011, CANCER RES, V71, P925, DOI 10.1158/0008-5472.CAN-10-1032; Yamada T, 2000, CANCER GENET CYTOGEN, V120, P11, DOI 10.1016/S0165-4608(99)00240-X; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P2790, DOI 10.1073/pnas.1100764108; Zitterbart K, 2011, J NEURO-ONCOL, V102, P25, DOI 10.1007/s11060-010-0289-3	37	515	539	3	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					82	+		10.1038/nature13311	http://dx.doi.org/10.1038/nature13311			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043044	Green Accepted			2022-12-01	WOS:000339908000036
J	Goodrich, JK; Di Rienzi, SC; Poole, AC; Koren, O; Walters, WA; Caporaso, JG; Knight, R; Ley, RE				Goodrich, Julia K.; Di Rienzi, Sara C.; Poole, Angela C.; Koren, Omry; Walters, William A.; Caporaso, J. Gregory; Knight, Rob; Ley, Ruth E.			Conducting a Microbiome Study	CELL			English	Article							HUMAN GUT MICROBIOTA; INTESTINAL MICROBIOTA; BACTERIAL; HOST; CLASSIFICATION; IMPACT; MICE; IDENTIFICATION; AMPLIFICATION; DIVERSITY	Human microbiome research is an actively developing area of inquiry, with ramifications for our lifestyles, our interactions with microbes, and how we treat disease. Advances depend on carefully executed, controlled, and reproducible studies. Here, we provide a Primer for researchers from diverse disciplines interested in conducting microbiome research. We discuss factors to be considered in the design, execution, and data analysis of microbiome studies. These recommendations should help researchers to enter and contribute to this rapidly developing field.	[Goodrich, Julia K.; Di Rienzi, Sara C.; Poole, Angela C.; Koren, Omry; Ley, Ruth E.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Goodrich, Julia K.; Di Rienzi, Sara C.; Poole, Angela C.; Koren, Omry; Ley, Ruth E.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Walters, William A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Walters, William A.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Caporaso, J. Gregory] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	Cornell University; Cornell University; University of Colorado System; University of Colorado Boulder; Northern Arizona University; United States Department of Energy (DOE); Argonne National Laboratory; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Ley, RE (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	rel222@cornell.edu	Knight, Rob/D-1299-2010; Koren, Omry/A-5222-2016; Goodrich, Julia/ABD-8368-2021; Di Rienzi, Sara C./U-1035-2019; Ley, Ruth E/M-8542-2014	Koren, Omry/0000-0002-7738-1337; Di Rienzi, Sara C./0000-0002-6188-663X; Ley, Ruth E/0000-0002-9087-1672; Caporaso, Greg/0000-0002-8865-1670; Knight, Rob/0000-0002-0975-9019; Poole, Angela/0000-0003-0278-7655	NHGRI NIH HHS [R01 HG004872] Funding Source: Medline; NIDDK NIH HHS [P01 DK078669] Funding Source: Medline; NIGMS NIH HHS [T32 GM008759, T32 GM142607] Funding Source: Medline; NIMHD NIH HHS [R01 MD011389] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD011389] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bai GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036934; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016900; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Chassaing B, 2012, ADV IMMUNOL, V116, P93, DOI 10.1016/B978-0-12-394300-2.00003-X; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Di Rienzi SC, 2013, ELIFE, V2, DOI 10.7554/eLife.01102; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goff SA, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00034; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI [10.1038/nmeth.1184, 10.1038/NMETH.1184]; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Hurwitz BL, 2013, ENVIRON MICROBIOL, V15, P1428, DOI 10.1111/j.1462-2920.2012.02836.x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jack PJM, 2009, VET MICROBIOL, V133, P145, DOI 10.1016/j.vetmic.2008.05.030; Karlsson F, 2013, DIABETES, V62, P3341, DOI 10.2337/db13-0844; Knight R, 2012, NAT BIOTECHNOL, V30, P513, DOI 10.1038/nbt.2235; Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/nmeth.1499, 10.1038/NMETH.1499]; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Lasken RS, 2007, CURR OPIN MICROBIOL, V10, P510, DOI 10.1016/j.mib.2007.08.005; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sergeant MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038094; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Smith Birgitte, 2011, Open Microbiol J, V5, P14, DOI 10.2174/1874285801105010014; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Tanner MA, 1998, APPL ENVIRON MICROB, V64, P3110; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	98	423	433	1	178	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					250	262		10.1016/j.cell.2014.06.037	http://dx.doi.org/10.1016/j.cell.2014.06.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036628	Green Accepted, Bronze			2022-12-01	WOS:000340943600007
J	Hallmann, CA; Foppen, RPB; van Turnhout, CAM; de Kroon, H; Jongejans, E				Hallmann, Caspar A.; Foppen, Ruud P. B.; van Turnhout, Chris A. M.; de Kroon, Hans; Jongejans, Eelke			Declines in insectivorous birds are associated with high neonicotinoid concentrations	NATURE			English	Article							FARMLAND BIRDS; INSECTICIDES; PESTICIDES; SCALE; BEES	Recent studies have shown that neonicotinoid insecticides have adverse effects on non-target invertebrate species(1-6). Invertebrates constitute a substantial part of the diet of many bird species during the breeding season and are indispensable for raising offspring(7). We investigated the hypothesis that the most widely used neonicotinoid insecticide, imidacloprid, has a negative impact on insectivorous bird populations. Here we show that, in the Netherlands, local population trends were significantly more negative in areas with higher surface-water concentrations of imidacloprid. At imidacloprid concentrations of more than 20 nanograms per litre, bird populations tended to decline by 3.5 per cent on average annually. Additional analyses revealed that this spatial pattern of decline appeared only after the introduction of imidacloprid to the Netherlands, in the mid-1990s. We further show that the recent negative relationship remains after correcting for spatial differences in land-use changes that are known to affect bird populations in farmland. Our results suggest that the impact of neonicotinoids on the natural environment is even more substantial than has recently been reported and is reminiscent of the effects of persistent insecticides in the past. Future legislation should take into account the potential cascading effects of neonicotinoidson ecosystems.	[Hallmann, Caspar A.; de Kroon, Hans; Jongejans, Eelke] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Expt Plant Ecol, NL-6500 GL Nijmegen, Netherlands; [Hallmann, Caspar A.; de Kroon, Hans; Jongejans, Eelke] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Anim Ecol & Ecophysiol, NL-6500 GL Nijmegen, Netherlands; [Hallmann, Caspar A.; Foppen, Ruud P. B.; van Turnhout, Chris A. M.] Dutch Ctr Field Ornithol, Sovon, NL-6503 GA Nijmegen, Netherlands; [Foppen, Ruud P. B.] Birdlife Netherlands, NL-3700 AX Zeist, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Hallmann, CA (corresponding author), Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Expt Plant Ecol, POB 9100 Mail Box 31, NL-6500 GL Nijmegen, Netherlands.	c.hallmann@science.ru.nl	de Kroon, Hans/B-3359-2009; Jongejans, Eelke/B-4832-2008; Serrano, Jose/A-2854-2009	de Kroon, Hans/0000-0001-6151-3561; Jongejans, Eelke/0000-0003-1148-7419; Serrano, Jose/0000-0002-1565-5216	Dutch Ministry of EZ; NWO [840.11.001, 841.11.007]	Dutch Ministry of EZ; NWO(Netherlands Organization for Scientific Research (NWO))	We thank A. J. van Dijk, H. Sierdsema and D. Zoetebier for processing the bird data sets and J. P. van der Sluijs for sharing the database with imidacloprid concentration measurements. The Breeding Bird Monitoring Program is organised in close collaboration with Statistics Netherlands and provinces and is funded by the Dutch Ministry of EZ. We thank Sovon volunteers for their efforts in the field. The study was supported by NWO grants 840.11.001 and 841.11.007 and was the result of a collaboration within the Center for Avian Population Studies.	[Anonymous], 2011, FINE CHEM IND BUSINE, DOI DOI 10.1002/9780470946404; Bibby C.J., 1992, BIRD CENSUS TECHNIQU; Boatman ND, 2004, IBIS, V146, P131, DOI 10.1111/j.1474-919X.2004.00347.x; Chamberlain DE, 2000, AGR ECOSYST ENVIRON, V78, P1, DOI 10.1016/S0167-8809(99)00105-X; Cramp S., 1994, BIRDS W PALEARCTIC; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Easton AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054819; Fuller RJ, 2000, ECOLOGY AND CONSERVATION OF LOWLAND FARMLAND BIRDS, P5; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Institute of Environmental Sciences Leiden University and Rijkswaterstaat-Water Services, 2009, DUTCH PEST ATL; Kampichler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035272; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Mineau P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057457; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Newton I., 1998, POPULATION LIMITATIO; Poulin B, 2010, J APPL ECOL, V47, P884, DOI 10.1111/j.1365-2664.2010.01821.x; Roessink I, 2013, ENVIRON TOXICOL CHEM, V32, P1096, DOI 10.1002/etc.2201; Statistics Netherlands, 2013, STATLINE DAT; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; Van Turnhout CAM, 2007, BIOL CONSERV, V134, P505, DOI 10.1016/j.biocon.2006.09.011; Van Turnhout CAM, 2010, BIOL CONSERV, V143, P173, DOI 10.1016/j.biocon.2009.09.023; VANDIJK AJ, 2004, HANDLEIDING BROEDVOG; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025	28	544	586	36	769	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					341	+		10.1038/nature13531	http://dx.doi.org/10.1038/nature13531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030173				2022-12-01	WOS:000338992200034
J	Yudkin, JS; Montori, VM				Yudkin, John S.; Montori, Victor M.			The epidemic of pre-diabetes: the medicine and the politics	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTIONS; DIABETES PREVENTION; HEMOGLOBIN A1C; FOLLOW-UP; DEFINITIONS; PROGRESSION; PREVALENCE; REDUCTION; HBA(1C)		[Yudkin, John S.] UCL, Div Med, London, England; [Montori, Victor M.] Mayo Clin, Dept Med, Div Endocrinol & Diabet, Knowledge & Evaluat Res Unit, Rochester, MN USA; [Montori, Victor M.] Mayo Clin, Dept Hlth Sci Res, Div Endocrinol & Diabet, Knowledge & Evaluat Res Unit, Rochester, MN USA	University of London; University College London; Mayo Clinic; Mayo Clinic	Yudkin, JS (corresponding author), UCL, Div Med, London, England.	j.yudkin@ucl.ac.uk	Yudkin, John S/C-1988-2008	Montori, Victor/0000-0003-0595-2898	NCATS NIH HHS [UL1 TR000135] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; DiabetesPrev D. Prog Res. Group, 2002, NEW ENGL J MED, V346, P393, DOI [DOI 10.1056/NEJMOA012512, 10.1056/NEJMoa012512]; Droumaguet C, 2006, DIABETES CARE, V29, P1619, DOI 10.2337/dc05-2525; Dunkley AJ, 2014, DIABETES CARE, V37, P922, DOI 10.2337/dc13-2195; Edelman D, 2004, J GEN INTERN MED, V19, P1175, DOI 10.1111/j.1525-1497.2004.40178.x; Gale EAM, 2013, HEART, V99, P824, DOI 10.1136/heartjnl-2012-302763; Gavin JR, 1997, DIABETES CARE, V20, P1183; Genuth S, 2003, DIABETES CARE, V26, P3160; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gong Q, 2011, DIABETOLOGIA, V54, P300, DOI 10.1007/s00125-010-1948-9; HARRIS M, 1979, DIABETES, V28, P1039; Holman RR, 2011, DIABETES CARE, V34, P1265, DOI 10.2337/dc10-1567; Hopper I, 2011, EUR J CARDIOV PREV R, V18, P813, DOI 10.1177/1741826711421687; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V311, P463, DOI 10.1001/jama.2013.284657; James C, 2011, DIABETES CARE, V34, P387, DOI 10.2337/dc10-1314; Kahn R, 2014, DIABETES CARE, V37, P943, DOI 10.2337/dc13-1954; Knowler WC, 2003, DIABETES CARE, V26, P977; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Montori V, 2007, BMJ-BRIT MED J, V334, P882, DOI 10.1136/bmj.39169.447488.94; Morris DH, 2013, DIABETOLOGIA, V56, P1489, DOI 10.1007/s00125-013-2902-4; Moynihan RN, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001500; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; National Institute for Health and Care Excellence, 2012, PREV TYP 2 DIAB RISK; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Pradhan AD, 2007, AM J MED, V120, P720, DOI 10.1016/j.amjmed.2007.03.022; Selvin E, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-5-201103010-00004; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Uusitupa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005656; W.H. Organization, 1999, DEFINITION DIAGNOSIS; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2006, DEF DIAGN DIAB MELL; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yudkin JS, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7995; Yudkin JS, 2011, LANCET, V377, P1220, DOI 10.1016/S0140-6736(10)61112-9; YUDKIN JS, 1990, BRIT MED J, V301, P397, DOI 10.1136/bmj.301.6749.397; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004	44	47	47	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 15	2014	349								g4485	10.1136/bmj.g4485	http://dx.doi.org/10.1136/bmj.g4485			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7OZ	25028385	Green Submitted, Green Published			2022-12-01	WOS:000339325400004
J	Carlson, JM; Schaefer, M; Monaco, DC; Batorsky, R; Claiborne, DT; Prince, J; Deymier, MJ; Ende, ZS; Klatt, NR; DeZiel, CE; Lin, TH; Peng, J; Seese, AM; Shapiro, R; Frater, J; Ndung'u, T; Tang, JM; Goepfert, P; Gilmour, J; Price, MA; Kilembe, W; Heckerman, D; Goulder, PJR; Allen, TM; Allen, S; Hunter, E				Carlson, Jonathan M.; Schaefer, Malinda; Monaco, Daniela C.; Batorsky, Rebecca; Claiborne, Daniel T.; Prince, Jessica; Deymier, Martin J.; Ende, Zachary S.; Klatt, Nichole R.; DeZiel, Charles E.; Lin, Tien-Ho; Peng, Jian; Seese, Aaron M.; Shapiro, Roger; Frater, John; Ndung'u, Thumbi; Tang, Jianming; Goepfert, Paul; Gilmour, Jill; Price, Matt A.; Kilembe, William; Heckerman, David; Goulder, Philip J. R.; Allen, Todd M.; Allen, Susan; Hunter, Eric			Selection bias at the heterosexual HIV-1 transmission bottleneck	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CLASS-I ALLELES; REPLICATION CAPACITY; DISCORDANT COUPLES; ESCAPE MUTATIONS; VIRAL-LOAD; SEXUAL TRANSMISSION; CHRONIC INFECTION; IMMUNE CONTROL; SH3 DOMAIN	Heterosexual transmission of HIV-1 typically results in one genetic variant establishing systemic infection. We compared, for 137 linked transmission pairs, the amino acid sequences encoded by non-envelope genes of viruses in both partners and demonstrate a selection bias for transmission of residues that are predicted to confer increased in vivo fitness on viruses in the newly infected, immunologically naive recipient. Although tempered by transmission risk factors, such as donor viral load, genital inflammation, and recipient gender, this selection bias provides an overall transmission advantage for viral quasispecies that are dominated by viruses with high in vivo fitness. Thus, preventative or therapeutic approaches that even marginally reduce viral fitness may lower the overall transmission rates and offer long-term benefits even upon successful transmission.	[Carlson, Jonathan M.; DeZiel, Charles E.; Lin, Tien-Ho; Peng, Jian] Microsoft Res, Redmond, WA 98052 USA; [Schaefer, Malinda; Monaco, Daniela C.; Claiborne, Daniel T.; Prince, Jessica; Deymier, Martin J.; Ende, Zachary S.; Klatt, Nichole R.; Hunter, Eric] Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Batorsky, Rebecca; Seese, Aaron M.; Ndung'u, Thumbi; Allen, Todd M.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02114 USA; [Shapiro, Roger] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Frater, John] Univ Oxford, Nuffield Dept Clin Med, Oxford OX1 7BN, England; [Frater, John] Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford OX3 7LE, England; [Frater, John] Univ Oxford, Oxford Martin Sch, Oxford OX1 3BD, England; [Ndung'u, Thumbi; Goulder, Philip J. R.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, ZA-4013 Durban, South Africa; [Ndung'u, Thumbi] Max Planck Inst Infekt Biol, D-10117 Berlin, Germany; [Tang, Jianming; Goepfert, Paul] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Gilmour, Jill] Int AIDS Vaccine Initiat, London SW10 9NH, England; [Gilmour, Jill] Univ London Imperial Coll Sci Technol & Med, London SW10 9NH, England; [Price, Matt A.] Int AIDS Vaccine Initiat, San Francisco, CA 94105 USA; [Price, Matt A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94105 USA; [Kilembe, William; Allen, Susan; Hunter, Eric] Zambia Emory HIV Res Project, Rwanda Zambia HIV Res Grp, Lusaka, Zambia; [Heckerman, David] Microsoft Res, Los Angeles, CA USA; [Goulder, Philip J. R.] Univ Oxford, Dept Paediat, Oxford OX1 3SY, England; [Allen, Susan; Hunter, Eric] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Allen, Susan] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA	Microsoft; Emory University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Beth Israel Deaconess Medical Center; University of Oxford; University of Oxford; University of Oxford; University of Kwazulu Natal; Max Planck Society; University of Alabama System; University of Alabama Birmingham; International AIDS Vaccine Initiative; Imperial College London; International AIDS Vaccine Initiative; University of California System; University of California San Francisco; Microsoft; University of Oxford; Emory University; Emory University; Rollins School Public Health	Carlson, JM (corresponding author), Univ Washington, Washington Natl Primate Res Ctr, Dept Pharmaceut, Seattle, WA 98121 USA.	carlson@microsoft.com; ehunte4@emory.edu	Allen, Todd/F-5473-2011; Ende, Zachary/AAD-3800-2019; Price, Matt/AAK-6881-2021; Tang, Jianming "James"/O-4980-2019	Allen, Todd/0000-0002-6609-1318; Price, Matt/0000-0002-2918-1373; Tang, Jianming "James"/0000-0003-0137-7486; Peng, Jian/0000-0002-1736-2978; Ndung'u, Thumbi/0000-0003-2962-3992; Frater, John/0000-0001-7163-7277	International AIDS Vaccine Initiative; American people through the U.S. Agency for International Development (USAID); Virology Core at the Emory Center for AIDS Research [P30 AI050409]; Yerkes National Primate Research Center through the National Center for Research Resources [2P51RR000165-51, P51RR165]; Office of Research Infrastructure Programs/OD [P51OD11132]; NIAID [P01-AI074415, U01 AI 66454]; Multidisciplinary AIDS Training Grant NIH [T32-AI007387]; Action Cycling Fellowships; South African Department of Science and Technology; National Research Foundation through the South Africa Research Chairs Initiative; Howard Hughes Medical Institute; Victor Daitz Foundation;  [R01 AI64060];  [R37 AI51231]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064060, U01AI066454, P30AI050409, T32AI007387, P01AI074415, R37AI051231, R01AI046995] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132, P51OD010425] Funding Source: NIH RePORTER; MRC [G108/626] Funding Source: UKRI; Medical Research Council [G108/626] Funding Source: researchfish	International AIDS Vaccine Initiative; American people through the U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); Virology Core at the Emory Center for AIDS Research; Yerkes National Primate Research Center through the National Center for Research Resources; Office of Research Infrastructure Programs/OD; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Multidisciplinary AIDS Training Grant NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Action Cycling Fellowships; South African Department of Science and Technology; National Research Foundation through the South Africa Research Chairs Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Victor Daitz Foundation; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank all the volunteers in Zambia who participated in this study and all the staff at the Zambia Emory HIV Research Project in Lusaka who made this study possible. We would like to thank J. Allen and M. Hurlston for technical assistance and sample management; P. Farmer, Ph.D., for database design and management; and I. Brill, K. Wall, X. Li, C. Lippert, N. Fusi, J. Listgarten, and Z. Brumme for helpful discussions. This study was funded by R01 AI64060 and R37 AI51231 (E. H.) and the International AIDS Vaccine Initiative (to S. A.), and made possible in part by the support of the American people through the U.S. Agency for International Development (USAID). The contents are the responsibility of the study authors and do not necessarily reflect the views of USAID or the U.S. government. This work was also supported, in part, by the Virology Core at the Emory Center for AIDS Research (grant P30 AI050409); the Yerkes National Primate Research Center base grant (2P51RR000165-51) through the National Center for Research Resources P51RR165 and by the Office of Research Infrastructure Programs/OD P51OD11132; NIAID grants P01-AI074415 (T. M. A.) and U01 AI 66454 (R. S.); and Multidisciplinary AIDS Training Grant NIH T32-AI007387 (R. B.). J. P., D. T. C., and M. S. were supported in part by Action Cycling Fellowships. T. N. was supported by the International AIDS Vaccine Initiative, the South African Department of Science and Technology and the National Research Foundation through the South Africa Research Chairs Initiative, by an International Early Career Scientist award from the Howard Hughes Medical Institute, and by the Victor Daitz Foundation. E. H. is a Georgia Eminent Scholar. All viral sequences not previously published have been submitted to GenBank-accession numbers JN014076-JN014465, JQ219842, and KM048382-KM050767. The data reported in this paper are tabulated in the supplementary online material.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Allen S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-349; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Bates D., 2014, R PACKAGE VERSION, V1, P1; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Boutwell CL, 2013, J VIROL, V87, P3952, DOI 10.1128/JVI.03233-12; Boutwell CL, 2009, J VIROL, V83, P2460, DOI 10.1128/JVI.01970-08; Brockman MA, 2010, J VIROL, V84, P11937, DOI 10.1128/JVI.01086-10; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Carlson JM, 2012, J VIROL, V86, P13202, DOI 10.1128/JVI.01998-12; Carlson JM, 2012, J VIROL, V86, P5230, DOI 10.1128/JVI.06728-11; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Cicala C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S2; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Cotton LA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004295; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; DEVINCENZI I, 1992, BRIT MED J, V304, P809; Efron B., 1981, CANADIAN J STATISTIC, V9, P139, DOI [10.1093/jtm/taab016, DOI 10.1093/jtm/taab016]; Etemad B, 2009, J VIROL, V83, P9694, DOI 10.1128/JVI.00925-09; Fenton-May AE, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-146; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Frater AJ, 2006, J VIROL, V80, P7226, DOI 10.1128/JVI.02014-05; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gnanakaran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002209; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Hecht FM, 2010, AIDS, V24, P941, DOI 10.1097/QAD.0b013e328337b12e; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Herbeck JT, 2006, J VIROL, V80, P1637, DOI 10.1128/JVI.80.4.1637-1644.2006; Hollingsworth TD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000876; Hsiou Y, 1996, STRUCTURE, V4, P853, DOI 10.1016/S0969-2126(96)00091-3; Huang KHG, 2009, ANTIVIR THER, V14, P975, DOI 10.3851/IMP1416; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kelly BN, 2006, BIOCHEMISTRY-US, V45, P11257, DOI 10.1021/bi060927x; Kempf MC, 2008, JAIDS-J ACQ IMM DEF, V47, P116, DOI 10.1097/QAI.0b013e31815d2f3f; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Listgarten J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000016; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Matthews PC, 2008, J VIROL, V82, P8548, DOI 10.1128/JVI.00580-08; Matthews PC, 2011, J IMMUNOL, V186, P5675, DOI 10.4049/jimmunol.1003711; McKenna SL, 1997, AIDS, V11, pS103; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; PIGUET V, 1999, HUMAN RETROVIRUSES A, P448; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Prince JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003041; Robbins AH, 2010, ACTA CRYSTALLOGR D, V66, P233, DOI 10.1107/S0907444909054298; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Sagar M, 2009, J INFECT DIS, V199, P580, DOI 10.1086/596557; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Shaw GM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006965; Song W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023469; Tang JM, 2008, J IMMUNOL, V181, P2626, DOI 10.4049/jimmunol.181.4.2626; Tang JM, 2002, J VIROL, V76, P8276, DOI 10.1128/JVI.76.16.8276-8284.2002; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WONG GY, 1985, J AM STAT ASSOC, V80, P513, DOI 10.2307/2288464; Wright JK, 2011, J VIROL, V85, P3996, DOI 10.1128/JVI.02520-10; Wright JK, 2010, J VIROL, V84, P10820, DOI 10.1128/JVI.01084-10; Yang X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-475; Yue L, 2013, J VIROL, V87, P708, DOI 10.1128/JVI.02118-12	72	170	176	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193							1254031	10.1126/science.1254031	http://dx.doi.org/10.1126/science.1254031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013080	Green Accepted			2022-12-01	WOS:000339409900043
J	Bessede, A; Gargaro, M; Pallotta, MT; Matino, D; Servillo, G; Brunacci, C; Bicciato, S; Mazza, EMC; Macchiarulo, A; Vacca, C; Iannitti, R; Tissi, L; Volpi, C; Belladonna, ML; Orabona, C; Bianchi, R; Lanz, TV; Platten, M; Della Fazia, MA; Piobbico, D; Zelante, T; Funakoshi, H; Nakamura, T; Gilot, D; Denison, MS; Guillemin, GJ; DuHadaway, JB; Prendergast, GC; Metz, R; Geffard, M; Boon, L; Pirro, M; Iorio, A; Veyret, B; Romani, L; Grohmann, U; Fallarino, F; Puccetti, P				Bessede, Alban; Gargaro, Marco; Pallotta, Maria T.; Matino, Davide; Servillo, Giuseppe; Brunacci, Cinzia; Bicciato, Silvio; Mazza, Emilia M. C.; Macchiarulo, Antonio; Vacca, Carmine; Iannitti, Rossana; Tissi, Luciana; Volpi, Claudia; Belladonna, Maria L.; Orabona, Ciriana; Bianchi, Roberta; Lanz, Tobias V.; Platten, Michael; Della Fazia, Maria A.; Piobbico, Danilo; Zelante, Teresa; Funakoshi, Hiroshi; Nakamura, Toshikazu; Gilot, David; Denison, Michael S.; Guillemin, Gilles J.; DuHadaway, James B.; Prendergast, George C.; Metz, Richard; Geffard, Michel; Boon, Louis; Pirro, Matteo; Iorio, Alfonso; Veyret, Bernard; Romani, Luigina; Grohmann, Ursula; Fallarino, Francesca; Puccetti, Paolo			Aryl hydrocarbon receptor control of a disease tolerance defence pathway	NATURE			English	Article							REGULATORY T-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; TRYPTOPHAN CATABOLISM; DENDRITIC CELLS; ENDOTOXIN TOLERANCE; LIGAND-BINDING; AH RECEPTOR; KYNURENINE; IDO; INFECTION	Disease tolerance is the ability of the host to reduce the effect of infection on host fitness. Analysis of disease tolerance pathways could provide new approaches for treating infections and other inflammatory diseases. Typically, an initial exposure to bacterial lipopolysaccharide (LPS) induces a state of refractoriness to further LPS challenge (endotoxin tolerance). We found that a first exposure of mice to LPS activated the ligand-operated transcription factor aryl hydrocarbon receptor (AhR) and the hepatic enzyme tryptophan 2,3-dioxygenase, which provided an activating ligand to the former, to down-regulate early inflammatory gene expression. However, on LPS rechallenge, AhR engaged in long-term regulation of systemic inflammation only in the presence of indoleamine 2,3-dioxygenase 1 (IDO1). AhR-complex-associated Src kinase activity promoted IDO1 phosphorylation and signalling ability. There sulting endotoxin-tolerant state was found to protect mice against immunopathology in Gram-negative and Gram-positive infections, pointing to a role for AhRin contributing to host fitness.	[Bessede, Alban; Gargaro, Marco; Pallotta, Maria T.; Matino, Davide; Servillo, Giuseppe; Brunacci, Cinzia; Vacca, Carmine; Iannitti, Rossana; Tissi, Luciana; Volpi, Claudia; Belladonna, Maria L.; Orabona, Ciriana; Bianchi, Roberta; Della Fazia, Maria A.; Piobbico, Danilo; Zelante, Teresa; Romani, Luigina; Grohmann, Ursula; Fallarino, Francesca; Puccetti, Paolo] Univ Perugia, Dept Expt Med, I-06132 Perugia, Italy; [Bessede, Alban; Geffard, Michel; Veyret, Bernard] Univ Bordeaux, IMS Lab, F-33607 Pessac, France; [Bicciato, Silvio; Mazza, Emilia M. C.] Univ Modena & Reggio Emilia, Ctr Genome Res, I-41125 Modena, Italy; [Macchiarulo, Antonio] Univ Perugia, Dept Chem & Technol Drugs, I-06123 Perugia, Italy; [Lanz, Tobias V.; Platten, Michael] German Canc Res Ctr, Expt Neuroimmunol Unit, D-69120 Heidelberg, Germany; [Lanz, Tobias V.; Platten, Michael] Univ Hosp, Dept Neurooncol, D-69120 Heidelberg, Germany; [Funakoshi, Hiroshi] Asahikawa Med Univ, Ctr Adv Res & Educ, Asahikawa, Hokkaido 0788510, Japan; [Nakamura, Toshikazu] Osaka Univ, Kringle Pharma Joint Res Div Regenerat Drug Disco, Ctr Adv Sci & Innovat, Suita, Osaka 5650871, Japan; [Gilot, David] Univ Rennes 1, CNRS UMR6290, Inst Genet & Dev Rennes, F-35043 Rennes, France; [Denison, Michael S.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Guillemin, Gilles J.] Macquarie Univ, ASAM, N Ryde, NSW 2109, Australia; [DuHadaway, James B.; Prendergast, George C.] Lankenau Inst Med Res, Wynnewood, PA 19096 USA; [Metz, Richard] New Link Genetics Corp, Ames, IA 50010 USA; [Boon, Louis] Bioceros, NL-3584 Utrecht, Netherlands; [Pirro, Matteo] Univ Perugia, Dept Med, I-06132 Perugia, Italy; [Iorio, Alfonso] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4K1, Canada	University of Perugia; UDICE-French Research Universities; Universite de Bordeaux; Universita di Modena e Reggio Emilia; University of Perugia; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Asahikawa Medical College; Osaka University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes 1; University of California System; University of California Davis; Macquarie University; Lankenau Medical Center; Lankenau Institute for Medical Research; University of Perugia; McMaster University	Puccetti, P (corresponding author), Univ Perugia, Dept Expt Med, I-06132 Perugia, Italy.	fllfnc@tin.it; plopcc@tin.it	Grohmann, Ursula/T-6545-2019; Pallotta, Maria Teresa/K-7021-2016; Pirro, Matteo/AAC-2318-2022; Gargaro, Marco/K-7077-2016; Orabona, Ciriana/L-8725-2015; Platten, Michael/F-2902-2013; Bicciato, Silvio/C-9825-2009; Matino, Davide/M-1426-2015; Matino, Davide/J-9576-2019; Macchiarulo, Antonio/L-2846-2017; Boon, Laurence/HCI-3629-2022; zelante, teresa/F-7933-2017; Iorio, Alfonso/B-9478-2013; BICCIATO, Silvio/J-4466-2019; Vacca, Carmine/AAE-7046-2019; Guillemin, Gilles J/C-3878-2015; Romani, Luigina/O-9987-2018; Fallarino, Francesca/O-3358-2013	Pallotta, Maria Teresa/0000-0002-0417-1638; Gargaro, Marco/0000-0003-0645-9800; Orabona, Ciriana/0000-0003-3113-0572; Platten, Michael/0000-0002-4746-887X; Bicciato, Silvio/0000-0002-1944-7078; Matino, Davide/0000-0002-9902-4074; Macchiarulo, Antonio/0000-0001-9535-4183; zelante, teresa/0000-0002-7071-0302; Iorio, Alfonso/0000-0002-3331-8766; BICCIATO, Silvio/0000-0002-1944-7078; Vacca, Carmine/0000-0002-3799-8164; Guillemin, Gilles J/0000-0001-8105-4470; VOLPI, CLAUDIA/0000-0002-3967-7954; Grohmann, Ursula/0000-0001-7952-1850; Bianchi, Roberta/0000-0001-5914-4701; Mazza, Emilia Maria Cristina/0000-0003-2424-3640; Pirro, Matteo/0000-0002-5527-4821; Boon, Louis/0000-0002-0937-9171; Servillo, Giuseppe/0000-0001-7960-7689; Romani, Luigina/0000-0002-1356-525X; Belladonna, Maria Laura/0000-0001-6522-0870; Piobbico, Danilo/0000-0003-4240-1526; Puccetti, Paolo/0000-0001-6674-2128; Della Fazia, Maria Agnese/0000-0002-5373-8477; Fallarino, Francesca/0000-0002-8501-2136	Italian Association for Cancer Research (AIRC); Fondazione Italiana Sclerosi Multipla [2010/R/17]; Associazione Umbra Contro il Cancro; Bayer Grants4Target Focus [2012-03-0630]; Bayer Early Career Investigator Award from the US National Institutes of Environmental Health Sciences [R01ES007685]; Specific Targeted Research Project FUNMETA; Regione dell'Umbria [GR-2008-1138004]; Italian Ministry of Health; NATIONAL CANCER INSTITUTE [R01CA109542, P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007685] Funding Source: NIH RePORTER	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); Associazione Umbra Contro il Cancro; Bayer Grants4Target Focus; Bayer Early Career Investigator Award from the US National Institutes of Environmental Health Sciences; Specific Targeted Research Project FUNMETA; Regione dell'Umbria(Regione Umbria); Italian Ministry of Health(Ministry of Health, Italy); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by funding from the Italian Association for Cancer Research (AIRC, to P. P.), Fondazione Italiana Sclerosi Multipla Project No. 2010/R/17 (to F. F.), Associazione Umbra Contro il Cancro (to G. S. & M. A. D. F.), Bayer Grants4Target Focus Grant no. 2012-03-0630 (to A. I., F. F. and D. M.), Bayer Early Career Investigator Award (to D. M.), Grant no. R01ES007685 from the US National Institutes of Environmental Health Sciences (to M. S. D.), the Specific Targeted Research Project FUNMETA (to L. R.), and the Italian Ministry of Health in association with Regione dell'Umbria (GR-2008-1138004 to C.O.) We thank D. Fuchs for serum kynurenine determinations. We also thank G. Andrielli for digital art and image editing and G. Ricci for histopathology.	Abdi K, 2012, J IMMUNOL, V188, P5981, DOI 10.4049/jimmunol.1102868; Backlund M, 2005, CELL SIGNAL, V17, P39, DOI 10.1016/j.cellsig.2004.05.010; Belladonna ML, 2009, TRENDS MOL MED, V15, P41, DOI 10.1016/j.molmed.2008.11.006; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Chambers MC, 2012, P NATL ACAD SCI USA, V109, P13886, DOI 10.1073/pnas.1211724109; Changsirivathanathamrong D, 2011, CRIT CARE MED, V39, P2678, DOI 10.1097/CCM.0b013e31822827f2; Chen WJ, 2011, NAT IMMUNOL, V12, P809, DOI 10.1038/ni.2088; De Luca A, 2007, J IMMUNOL, V179, P5999, DOI 10.4049/jimmunol.179.9.5999; Denison MS, 2002, CHEM-BIOL INTERACT, V141, P3, DOI 10.1016/S0009-2797(02)00063-7; Dong B, 2011, BBA-GEN SUBJECTS, V1810, P427, DOI 10.1016/j.bbagen.2010.11.007; Doreswamy V, 2011, CLIN EXP ALLERGY, V41, P9, DOI 10.1111/j.1365-2222.2010.03628.x; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino F, 2012, EUR J IMMUNOL, V42, P1932, DOI 10.1002/eji.201242572; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Howard G. J., 2009, ENV HLTH PERSPECT, V118, P666; Jung ID, 2009, J IMMUNOL, V182, P3146, DOI 10.4049/jimmunol.0803104; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Murray MF, 2007, CURR DRUG METAB, V8, P197, DOI 10.2174/138920007780362509; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Orabona C, 2006, BLOOD, V107, P2846, DOI 10.1182/blood-2005-10-4077; Orabona C, 2008, P NATL ACAD SCI USA, V105, P20828, DOI 10.1073/pnas.0810278105; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Pandini A, 2009, BIOCHEMISTRY-US, V48, P5972, DOI 10.1021/bi900259z; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Puliti M, 2009, INFECT IMMUN, V77, P1524, DOI 10.1128/IAI.00965-08; Quintana FJ, 2013, IMMUNOLOGY, V138, P183, DOI 10.1111/imm.12046; Randi AS, 2008, TOXICOL LETT, V177, P116, DOI 10.1016/j.toxlet.2008.01.003; Romani L, 2006, TRENDS MICROBIOL, V14, P183, DOI 10.1016/j.tim.2006.02.003; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Sekine H, 2009, MOL CELL BIOL, V29, P6391, DOI 10.1128/MCB.00337-09; Stejskalova L, 2011, CURR DRUG METAB, V12, P198, DOI 10.2174/138920011795016818; Stone TW, 2013, TRENDS PHARMACOL SCI, V34, P136, DOI 10.1016/j.tips.2012.09.006; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Volpi C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2874; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zelante T, 2009, MICROBES INFECT, V11, P133, DOI 10.1016/j.micinf.2008.10.007	50	418	443	4	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					184	+		10.1038/nature13323	http://dx.doi.org/10.1038/nature13323			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	24930766	Green Submitted, Green Accepted			2022-12-01	WOS:000338649800036
J	Power, SB				Power, Scott B.			Expulsion from history	NATURE			English	Editorial Material							UNCERTAINTIES		Bur Meteorol, Melbourne, Vic 3001, Australia	Bureau of Meteorology - Australia	Power, SB (corresponding author), Bur Meteorol, GPO Box 1289, Melbourne, Vic 3001, Australia.	s.power@bom.gov.au	Power, Scott Brendan/AAF-3370-2019	Power, Scott Brendan/0000-0002-9596-4368				Christensen JH, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1217; Field CB, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1; Hawkins E, 2014, NATURE, V511, pE3, DOI 10.1038/nature13523; IPCC, 2018, IPCC SPECIAL REPORT; Kirtman B, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P953; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Mahlstein I, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034009; Mora C, 2014, NATURE, V511, pE5, DOI 10.1038/nature13524; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Power SB, 2012, J CLIMATE, V25, P3792, DOI 10.1175/JCLI-D-11-00354.1; Settele J, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P271	11	8	8	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					38	39		10.1038/511038a	http://dx.doi.org/10.1038/511038a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK1TN	24990739				2022-12-01	WOS:000338199400027
J	Shin, J; Wallingford, MC; Gallant, J; Marcho, C; Jiao, BW; Byron, M; Bossenz, M; Lawrence, JB; Jones, SN; Mager, J; Bach, I				Shin, JongDae; Wallingford, Mary C.; Gallant, Judith; Marcho, Chelsea; Jiao, Baowei; Byron, Meg; Bossenz, Michael; Lawrence, Jeanne B.; Jones, Stephen N.; Mager, Jesse; Bach, Ingolf			RLIM is dispensable for X-chromosome inactivation in the mouse embryonic epiblast	NATURE			English	Article							FUNCTIONAL-ACTIVITY; RNF12; RNA; PLURIPOTENCY; RLIM/RNF12; NANOG; GENE; JPX	In female mice, two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Beginning at the four-cell stage, imprinted XCI (iXCI) exclusively silences the paternal X chromosome. Later, around implantation, epiblast cells of the inner cell mass that give rise to the embryo reactivate the paternal X chromosome and undergo a random form of XCI (rXCI)(1,2). Xist, a long non-coding RNA crucial for both forms of XCI, is activated by the ubiquitin ligase RLIM (also known as Rnf12)(3-5). Although RLIM is required for triggering iXCI in mice, its importance for rXCI has been controversial. Here we show that RLIM levels are downregulated in embryonic cells undergoing rXCI. Using mouse genetics we demonstrate that female cells lacking RLIM from pre-implantation stages onwards show hallmarks of XCI, including Xist clouds and H3K27me3 foci, and have full embryogenic potential. These results provide evidence that RLIM is dispensable for rXCI, indicating that in mice an RLIM-independent mechanism activates Xist in the embryo proper.	[Shin, JongDae; Jiao, Baowei; Bach, Ingolf] UMMS, Program Gene Funct & Express, Worcester, MA 01605 USA; [Wallingford, Mary C.; Marcho, Chelsea; Mager, Jesse] Univ Massachusetts, Amherst, MA 01003 USA; [Gallant, Judith; Byron, Meg; Lawrence, Jeanne B.; Jones, Stephen N.] UMMS, Dept Cell & Dev Biol, Worcester, MA 01605 USA; [Bossenz, Michael] Ortenau Klinikum Lahr Ettenheim, Inst Pathol, D-77933 Lahr, Germany; [Bach, Ingolf] UMMS, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Amherst	Bach, I (corresponding author), UMMS, Program Gene Funct & Express, Worcester, MA 01605 USA.	Ingolf.bach@umassmed.edu	Marcho, Chelsea/N-8230-2019	Marcho, Chelsea/0000-0003-0932-7416; Lawrence, Jeanne/0000-0001-6572-3128; JIAO, BAOWEI/0000-0001-8559-9160	National Institutes of Health grants [CA131158, CA077735, GM053234]; NATIONAL CANCER INSTITUTE [R01CA131158, R56CA077735, R01CA077735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053234] Funding Source: NIH RePORTER	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to H. Ma for help in the mouse facility, M. Keeler for culturing ES cells, T. Fazzio, N. Lawson and Y. Yoon for advice, and T. Fazzio for helpful discussions and reading of the manuscript. I.B. is a member of the University of Massachusetts Diabetes-Endocrinology Research Center (DK32520). This work was supported by National Institutes of Health grants CA131158 to I.B., CA077735 to S.N.J. and GM053234 to J.B.L.	Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Barakat TS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002001; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Dupont C, 2013, CURR OPIN CELL BIOL, V25, P314, DOI 10.1016/j.ceb.2013.03.001; Gontan C, 2012, NATURE, V485, P386, DOI 10.1038/nature11070; Griffith GJ, 2011, BIOL REPROD, V84, P654, DOI 10.1095/biolreprod.110.087213; Hadjantonakis AK, 2001, GENESIS, V29, P133, DOI 10.1002/gene.1016; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Hayashi S, 2003, GENESIS, V37, P51, DOI 10.1002/gene.10225; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Jiao BW, 2013, MOL BIOL CELL, V24, P3085, DOI 10.1091/mbc.E13-05-0239; Jiao BW, 2012, CELL, V149, P630, DOI 10.1016/j.cell.2012.02.056; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Lee JT, 2011, NAT REV MOL CELL BIO, V12, P815, DOI 10.1038/nrm3231; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagy A., 2003, MANIPULATING MOUSE E; Ostendorff HP, 2006, DEV DYNAM, V235, P786, DOI 10.1002/dvdy.20669; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Panning B, 2004, METHOD ENZYMOL, V376, P419; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Schulz EG, 2013, CURR OPIN GENET DEV, V23, P109, DOI 10.1016/j.gde.2013.01.008; Shin J, 2010, NATURE, V467, P977, DOI 10.1038/nature09457; Sun S, 2013, CELL, V153, P1537, DOI 10.1016/j.cell.2013.05.028; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Zhang L, 2012, MOL CELL, V46, P650, DOI 10.1016/j.molcel.2012.04.003	29	39	39	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					86	U443		10.1038/nature13286	http://dx.doi.org/10.1038/nature13286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24870238	Green Accepted			2022-12-01	WOS:000338199400041
J	King, AM; Reid-Yu, SA; Wang, WL; King, DT; De Pascale, G; Strynadka, NC; Walsh, TR; Coombes, BK; Wright, GD				King, Andrew M.; Reid-Yu, Sarah A.; Wang, Wenliang; King, Dustin T.; De Pascale, Gianfranco; Strynadka, Natalie C.; Walsh, Timothy R.; Coombes, Brian K.; Wright, Gerard D.			Aspergillomarasmine A overcomes metallo-beta-lactamase antibiotic resistance	NATURE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; KLEBSIELLA-PNEUMONIAE; MICROBIAL INHIBITORS	The emergence and spread of carbapenem-resistant Gram-negative pathogens is a global public health problem. The acquisition of metallo-beta-lactamases (MBLs) such as NDM-1 is a principle contributor to the emergence of carbapenem-resistant Gram-negative pathogens that threatens the use of penicillin, cephalosporin and carbapenem antibiotics to treat infections. To date, a clinical inhibitor of MBLs that could reverse resistance and re-sensitize resistant Gram-negative pathogens to carbapenems has not been found. Here we have identified a fungal natural product, aspergillomarasmine A (AMA), that is a rapid and potent inhibitor of the NDM-1 enzyme and another clinically relevant MBL, VIM-2. AMA also fully restored the activity of meropenem against Enterobacteriaceae, Acinetobacter spp. and Pseudomonas spp. possessing either VIM or NDM-type alleles. In mice infected with NDM-1-expressing Klebsiella pneumoniae, AMA efficiently restored meropenem activity, demonstrating that a combination of AMA and a carbapenem antibiotic has therapeutic potential to address the clinical challenge of MBL-positive carbapenem-resistant Gram-negative pathogens.	[King, Andrew M.; Wang, Wenliang; De Pascale, Gianfranco; Wright, Gerard D.] McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4K1, Canada; [King, Andrew M.; Wright, Gerard D.] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4K1, Canada; [Reid-Yu, Sarah A.; Coombes, Brian K.; Wright, Gerard D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [King, Dustin T.; Strynadka, Natalie C.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Walsh, Timothy R.] Cardiff Univ, Cardiff Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales	McMaster University; McMaster University; McMaster University; University of British Columbia; Cardiff University	Wright, GD (corresponding author), McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4K1, Canada.	wrightge@mcmaster.ca	Wright, G/ABB-7666-2021	Wright, Gerard/0000-0002-9129-7131; Coombes, Brian/0000-0001-9883-1010; King, Dustin/0000-0003-1775-2885; Walsh, Timothy/0000-0003-4315-4096	UK Medical Research Council [G1100135]; Canadian Institutes of Health Research [MT-13536]; Natural Sciences and Engineering Research Council [237480]; Canada Research Chair in Infectious Disease Pathogenesis; Antibiotic Biochemistry; MRC [G1100135] Funding Source: UKRI; Medical Research Council [G1100135] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair in Infectious Disease Pathogenesis; Antibiotic Biochemistry; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Mulvey (Public Health Agency of Canada) and R. Melano (Public Health Ontario) for clinical strains. We thank L. Rossi for her work in constructing the screening strain. AMA inhibition activity on clinical strains by T.R.W. was funded by the UK Medical Research Council (G1100135). This research was funded by a Canadian Institutes of Health Research Grant (MT-13536), Natural Sciences and Engineering Research Council Grant (237480), and by a Canada Research Chair in Infectious Disease Pathogenesis (to B.K.C.) and Antibiotic Biochemistry (to G.D.W.).	ARAI K, 1993, BIOSCI BIOTECH BIOCH, V57, P1944, DOI 10.1271/bbb.57.1944; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Bush K, 2013, ANN NY ACAD SCI, V1277, P84, DOI 10.1111/nyas.12023; Buynak JD, 2013, EXPERT OPIN THER PAT, V23, P1469, DOI 10.1517/13543776.2013.831071; Chang Y, 2013, LAB TRENDS DECEMBER; Docquier JD, 2003, J ANTIMICROB CHEMOTH, V51, P257, DOI 10.1093/jac/dkg067; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Edelstein MV, 2013, LANCET INFECT DIS, V13, P867, DOI 10.1016/S1473-3099(13)70168-3; Endimiani A, 2011, ANTIMICROB AGENTS CH, V55, P82, DOI 10.1128/AAC.01198-10; EUCAST, 2014, BREAKP TABL INT MICS; Fast W, 2013, BBA-PROTEINS PROTEOM, V1834, P1648, DOI 10.1016/j.bbapap.2013.04.024; Frere J. M., 2011, BETA LACTAMASES; Frias M, 2014, MMWR-MORBID MORTAL W, V62, P1051; HAENNI AL, 1965, HELV CHIM ACTA, V48, P729, DOI 10.1002/hlca.19650480409; HOLMQUIST B, 1979, ANAL BIOCHEM, V95, P540, DOI 10.1016/0003-2697(79)90769-3; King DT, 2012, J AM CHEM SOC, V134, P11362, DOI 10.1021/ja303579d; Lee M, 2005, J ORG CHEM, V70, P367, DOI 10.1021/jo0487395; Marra A, 2012, ANTIMICROB AGENTS CH, V56, P4671, DOI 10.1128/AAC.00276-12; MATSUURA A, 1993, JPN J PHARMACOL, V63, P187, DOI 10.1254/jjp.63.187; MIKAMI Y, 1983, AGR BIOL CHEM TOKYO, V47, P2693, DOI 10.1080/00021369.1983.10866020; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pillai SK., 2005, ANTIBIOTICS LAB MED, P365; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Ricci DP, 2012, BBA-BIOMEMBRANES, V1818, P1067, DOI 10.1016/j.bbamem.2011.08.020; Shlaes DM, 2013, ANN NY ACAD SCI, V1277, P105, DOI 10.1111/nyas.12010; US Centers for Disease Control and Prevention, 2013, ANTIBIOTIC RESISTANC; Valladares MH, 1997, BIOCHEMISTRY-US, V36, P11534, DOI 10.1021/bi971056h; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	30	357	375	1	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					503	+		10.1038/nature13445	http://dx.doi.org/10.1038/nature13445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24965651	Green Accepted			2022-12-01	WOS:000337806300039
J	Lee, YJ; Dominy, JE; Choi, YJ; Jurczak, M; Tolliday, N; Camporez, JP; Chim, H; Lim, JH; Ruan, HB; Yang, XY; Vazquez, F; Sicinski, P; Shulman, GI; Puigserver, P				Lee, Yoonjin; Dominy, John E.; Choi, Yoon Jong; Jurczak, Michael; Tolliday, Nicola; Camporez, Joao Paulo; Chim, Helen; Lim, Ji-Hong; Ruan, Hai-Bin; Yang, Xiaoyong; Vazquez, Francisca; Sicinski, Piotr; Shulman, Gerald I.; Puigserver, Pere			Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression	NATURE			English	Article							HEPATIC GLUCONEOGENESIS; INSULIN-RESISTANCE; MICE LACKING; PHOSPHORYLATION; INHIBITION; EXPRESSION; CDK4; PGC-1-ALPHA; ACTIVATION; RECEPTOR	Insulin constitutes a principal evolutionarily conserved hormonal axis for maintaining glucose homeostasis(1-3); dysregulation of this axis causes diabetes(2,4). PGC-1 alpha(peroxisome-proliferator-activated receptor-gamma coactivator-1 alpha) links insulin signalling to the expression of glucose and lipid metabolic genes(5-7). The histone acetyltransferase GCN5 (general control non-repressed protein 5) acetylates PGC-1 alpha and suppresses its transcriptional activity, whereas sirtuin 1 deacetylates and activates PGC-1 alpha(8,9). Although insulin is a mitogenic signal in proliferative cells(10,11), whether components of the cell cycle machinery contribute to its metabolic action is poorly understood. Here we report that in mice insulin activates cyclin D1-cyclin-dependent kinase 4 (Cdk4), which, in turn, increases GCN5 acetyltransferase activity and suppresses hepatic glucose production independently of cell cycle progression. Through a cell-based high-throughput chemical screen, we identify a Cdk4 inhibitor that potently decreases PGC-1 alpha acetylation. Insulin/GSK-3 beta (glycogen synthase kinase 3-beta) signalling induces cyclin D1 protein stability by sequestering cyclin D1 in the nucleus. In parallel, dietary amino acids increase hepatic cyclin D1 messenger RNA transcripts. Activated cyclin D1-Cdk4 kinase phosphorylates and activates GCN5, which then acetylates and inhibits PGC-1 alpha activity on gluconeogenic genes. Loss of hepatic cyclin D1 results in increased gluconeogenesis and hyperglycaemia. In diabetic models, cyclin D1-Cdk4 is chronically elevated and refractory to fasting/feeding transitions; nevertheless further activation of this kinase normalizes glycaemia. Our findings show that insulin uses components of the cell cycle machinery in post-mitotic cells to control glucose homeostasis independently of cell division.	[Lee, Yoonjin; Dominy, John E.; Choi, Yoon Jong; Chim, Helen; Lim, Ji-Hong; Vazquez, Francisca; Sicinski, Piotr; Puigserver, Pere] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Lee, Yoonjin; Dominy, John E.; Chim, Helen; Lim, Ji-Hong; Vazquez, Francisca; Puigserver, Pere] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Lee, Yoonjin] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Choi, Yoon Jong; Sicinski, Piotr] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Jurczak, Michael; Camporez, Joao Paulo; Ruan, Hai-Bin; Yang, Xiaoyong; Shulman, Gerald I.] Yale Univ, Sch Med, Yales Mouse Metab Phenotyping Ctr, New Haven, CT 06510 USA; [Jurczak, Michael; Camporez, Joao Paulo; Ruan, Hai-Bin; Yang, Xiaoyong; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Jurczak, Michael; Camporez, Joao Paulo; Ruan, Hai-Bin; Yang, Xiaoyong; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Tolliday, Nicola] Broad Inst Harvard & MIT, Chem Biol Platform, Cambridge Ctr 7, Cambridge, MA 02141 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Yale University; Yale University; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Puigserver, P (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	pere_puigserver@dfci.harvard.edu	Ruan, Hai-Bin/G-9907-2012; Shulman, Gerald I./P-7176-2019; Camporez, Joao Paulo G/B-9122-2015; Ruan, Hai-Bin/AAN-7777-2021; Vazquez, Francisca/AAA-3751-2020; Vazquez, Francisca/ABC-4620-2020	Ruan, Hai-Bin/0000-0002-3858-1272; Shulman, Gerald I./0000-0003-1529-5668; Ruan, Hai-Bin/0000-0002-3858-1272; Vazquez, Francisca/0000-0002-2857-4685; Jurczak, Michael/0000-0002-6335-6915; Camporez, Joao Paulo/0000-0003-3486-4301	Ewha Womans University; National Research Service Award Kirschstein Fellowship from the National Institutes of Health (NIH); Dana-Farber Cancer Institute; American Diabetes Association; Department of Defense; NIH/National Institute of Diabetes and Digestive and Kidney Diseases [R01069966, R24DK080261-06]; NIH [R03 MH092174, R01 CA108420, DK059635]; NATIONAL CANCER INSTITUTE [R01CA083688, R01CA108420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080261, U2CDK059635, F32DK083871, P30DK034989, U24DK059635, R01DK069966, R01DK089098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA032468] Funding Source: NIH RePORTER	Ewha Womans University; National Research Service Award Kirschstein Fellowship from the National Institutes of Health (NIH); Dana-Farber Cancer Institute; American Diabetes Association(American Diabetes Association); Department of Defense(United States Department of Defense); NIH/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank all the members of the Puigserver laboratory for discussions and suggestions about this project. We also appreciate the consultations with and efforts by M. Jedrychowski and S. Gygi for proteomic analysis. Y.L. was supported in part by a 21st Century Leaders scholarship from Ewha Womans University. J.E.D. was supported in part by a National Research Service Award Kirschstein Fellowship from the National Institutes of Health (NIH). The participating researchers were supported with funds from the Dana-Farber Cancer Institute and with grants from the American Diabetes Association, Department of Defense, NIH/National Institute of Diabetes and Digestive and Kidney Diseases (R01069966 and R24DK080261-06), NIH (R03 MH092174) awarded to P.P., NIH (R01 CA108420) awarded to P.S. and NIH (DK059635) awarded to Yale's Mouse Metabolic Phenotyping Center/G.I.S.	Abella A, 2005, CELL METAB, V2, P239, DOI 10.1016/j.cmet.2005.09.003; Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Boyer LA, 2002, MOL CELL, V10, P935, DOI 10.1016/S1097-2765(02)00634-2; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Choi YJ, 2012, CANCER CELL, V22, P438, DOI 10.1016/j.ccr.2012.09.015; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Estall JL, 2009, DIABETES, V58, P1499, DOI 10.2337/db08-1571; Fry DW, 2004, MOL CANCER THER, V3, P1427; HINDS PW, 1994, P NATL ACAD SCI USA, V91, P709, DOI 10.1073/pnas.91.2.709; IshShalom D, 1997, DIABETOLOGIA, V40, pS25, DOI 10.1007/s001250051393; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; KATO J, 1993, GENE DEV, V7, P331; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li DM, 2009, APPL BIOCHEM BIOTECH, V158, P253, DOI 10.1007/s12010-008-8391-0; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; MCKEEHAN WL, 1984, CANCER RES, V44, P1998; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2010, CELL METAB, V11, P23, DOI 10.1016/j.cmet.2009.11.006; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Schwartz GK, 2011, BRIT J CANCER, V104, P1862, DOI 10.1038/bjc.2011.177; Soni R, 2000, BIOCHEM BIOPH RES CO, V275, P877, DOI 10.1006/bbrc.2000.3349; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Wang YG, 2012, NATURE, V485, P128, DOI 10.1038/nature10988; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	35	167	173	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					547	+		10.1038/nature13267	http://dx.doi.org/10.1038/nature13267			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24870244	Green Accepted, Green Submitted			2022-12-01	WOS:000337806300049
J	Hernandez-Molina, FJ; Stow, DAV; Alvarez-Zarikian, CA; Acton, G; Bahr, A; Balestra, B; Ducassou, E; Flood, R; Flores, JA; Furota, S; Grunert, P; Hodell, D; Jimenez-Espejo, FJ; Kim, JK; Krissek, L; Kuroda, J; Li, BH; Llave, E; Lofi, J; Lourens, L; Miller, M; Nanayama, F; Nishida, N; Richter, C; Roque, C; Pereira, H; Goni, MFS; Sierro, FJ; Singh, AD; Sloss, C; Takashimizu, Y; Tzanova, A; Voelker, A; Williams, T; Xuan, C				Hernandez-Molina, F. Javier; Stow, Dorrik A. V.; Alvarez-Zarikian, Carlos A.; Acton, Gary; Bahr, Andre; Balestra, Barbara; Ducassou, Emmanuelle; Flood, Roger; Flores, Jose-Abel; Furota, Satoshi; Grunert, Patrick; Hodell, David; Jimenez-Espejo, Francisco J.; Kim, Jin Kyoung; Krissek, Lawrence; Kuroda, Junichiro; Li, Baohua; Llave, Estefania; Lofi, Johanna; Lourens, Lucas; Miller, Madeline; Nanayama, Futoshi; Nishida, Naohisa; Richter, Carl; Roque, Cristina; Pereira, Helder; Goni, Maria Fernanda Sanchez; Sierro, Francisco J.; Singh, Arun Deo; Sloss, Craig; Takashimizu, Yasuhiro; Tzanova, Alexandrina; Voelker, Antje; Williams, Trevor; Xuan, Chuang			Onset of Mediterranean outflow into the North Atlantic	SCIENCE			English	Article							DEEP-WATER CIRCULATION; HEMISPHERE GLACIATION; CONTOURITE DRIFTS; ALGARVE MARGIN; LATE PLIOCENE; ICE VOLUME; SEA-LEVEL; EVOLUTION; CLIMATE; CADIZ	Sediments cored along the southwestern Iberian margin during Integrated Ocean Drilling Program Expedition 339 provide constraints on Mediterranean Outflow Water (MOW) circulation patterns from the Pliocene epoch to the present day. After the Strait of Gibraltar opened (5.33 million years ago), a limited volume of MOW entered the Atlantic. Depositional hiatuses indicate erosion by bottom currents related to higher volumes of MOW circulating into the North Atlantic, beginning in the late Pliocene. The hiatuses coincide with regional tectonic events and changes in global thermohaline circulation (THC). This suggests that MOW influenced Atlantic Meridional Overturning Circulation (AMOC), THC, and climatic shifts by contributing a component of warm, saline water to northern latitudes while in turn being influenced by plate tectonics.	[Hernandez-Molina, F. Javier] Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England; [Stow, Dorrik A. V.] Heriot Watt Univ, Inst Petr Engn, Edinburgh EH14 4AS, Midlothian, Scotland; [Alvarez-Zarikian, Carlos A.] Texas A&M Univ, Dept Oceanog, Int Ocean Discovery Program, College Stn, TX 77845 USA; [Acton, Gary] Sam Houston State Univ, Dept Geog & Geol, Huntsville, TX 77341 USA; [Bahr, Andre] Goethe Univ Frankfurt, Inst Geosci, D-60438 Frankfurt, Germany; [Balestra, Barbara] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Ducassou, Emmanuelle] Univ Bordeaux, EPOC, F-33615 Pessac, France; [Flood, Roger] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Flores, Jose-Abel; Sierro, Francisco J.] Univ Salamanca, Dept Geol, Salamanca 3008, Spain; [Furota, Satoshi] Hokkaido Univ, Dept Nat Hist Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Grunert, Patrick] Graz Univ, Inst Earth Sci, A-8010 Graz, Austria; [Hodell, David] Univ Cambridge, Godwin Lab Palaeoclimate Res, Cambridge CB2 3EQ, England; [Jimenez-Espejo, Francisco J.] JAMSTEC, Dept Biogeochem, Yokosuka, Kanagawa 2370061, Japan; [Kim, Jin Kyoung] Korea Inst Ocean Sci & Technol, Ansan 426744, South Korea; [Krissek, Lawrence] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Kuroda, Junichiro] JAMSTEC, IFREE, Yokosuka, Kanagawa 2370061, Japan; [Li, Baohua] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, Dept Micropalaeontol, Nanjing 210008, Jiangsu, Peoples R China; [Llave, Estefania] Inst Geol & Minero Espana, Madrid 28003, Spain; [Lofi, Johanna] Univ Montpellier 2, Geosci Montpellier, F-34090 Montpellier, France; [Lofi, Johanna] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; [Lourens, Lucas] Univ Utrecht, Inst Earth Sci, NL-3584 CD Utrecht, Netherlands; [Miller, Madeline] CALTECH, Dept Mech Engn, Pasadena, CA 91125 USA; [Nanayama, Futoshi; Nishida, Naohisa] Geol Survey Japan AIST, Inst Geol & Geoinformat, Ibaraki 3058567, Japan; [Richter, Carl] Univ Louisiana, Sch Geosci, Lafayette, LA 70504 USA; [Roque, Cristina; Voelker, Antje] IPMA, Div Geol & Georecursos Marinhos, P-1749077 Lisbon, Portugal; [Pereira, Helder] Escola Secundaria Loule, Grp Biol & Geol, P-8100740 Loule, Portugal; [Goni, Maria Fernanda Sanchez] Univ Bordeaux, EPOC, Ecole Prat Hautes Etud, F-33615 Pessac, France; [Singh, Arun Deo] Banaras Hindu Univ, Dept Geol, Varanasi 221005, Uttar Pradesh, India; [Sloss, Craig] Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia; [Takashimizu, Yasuhiro] Niigata Univ, Dept Geol, Fac Educ, Niigata 9502181, Japan; [Tzanova, Alexandrina] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Williams, Trevor] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Xuan, Chuang] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England	University of London; Royal Holloway University London; Heriot Watt University; Texas A&M University System; Texas A&M University College Station; Texas State University System; Sam Houston State University; Goethe University Frankfurt; University of California System; University of California Santa Cruz; UDICE-French Research Universities; Universite de Bordeaux; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Salamanca; Hokkaido University; University of Graz; University of Cambridge; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Korea Institute of Ocean Science & Technology (KIOST); University System of Ohio; Ohio State University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Chinese Academy of Sciences; Universite de Montpellier; University of Leicester; Utrecht University; California Institute of Technology; National Institute of Advanced Industrial Science & Technology (AIST); University of Louisiana Lafayette; Instituto Portugues do Mar e da Atmosfera; UDICE-French Research Universities; Universite de Bordeaux; Banaras Hindu University (BHU); Queensland University of Technology (QUT); Niigata University; Brown University; Columbia University; NERC National Oceanography Centre; University of Southampton	Hernandez-Molina, FJ (corresponding author), Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England.	javier.hernandez-molina@rhul.ac.uk	Voelker, Antje H L/C-5427-2012; Lofi, Johanna/I-5159-2018; Xuan, Chuang/E-2039-2011; Acton, Gary/B-6108-2016; Jimenez-Espejo, Francisco J/F-4486-2016; Goñi, Maria Fernanda Sanchez/R-3699-2019; Nishida, Naohisa/I-7483-2016; Kuroda, Junichiro/A-3007-2016; Roque, Cristina/A-8146-2013; Nanayama, Futoshi/L-4453-2018; Flores, José-Abel/D-4218-2009; Jimenez-Espejo, Francisco J./AAR-2318-2020; Nanayama, Futoshi/K-2190-2019; Sierro, Francisco/A-4714-2008; Llave, Estefania/H-2232-2015	Voelker, Antje H L/0000-0001-6465-6023; Lofi, Johanna/0000-0002-0602-595X; Xuan, Chuang/0000-0003-4043-3073; Jimenez-Espejo, Francisco J/0000-0002-0335-8580; Goñi, Maria Fernanda Sanchez/0000-0001-8238-7488; Kuroda, Junichiro/0000-0002-2218-4854; Roque, Cristina/0000-0002-2583-594X; Nanayama, Futoshi/0000-0001-8693-4784; Flores, José-Abel/0000-0003-1909-293X; Nanayama, Futoshi/0000-0001-8693-4784; Sierro, Francisco/0000-0002-8647-456X; Llave, Estefania/0000-0001-7873-7211; Acton, Gary/0000-0002-3285-4022; Hodell, David/0000-0001-8537-1588; Bahr, Andre/0000-0001-5890-8773; Pereira, Helder/0000-0001-7664-7650; Miller, Madeline/0000-0003-2598-6518; Sloss, Craig/0000-0001-8694-6822; , barbara/0000-0001-7064-3173; Alvarez Zarikian, Carlos/0000-0002-3785-3336; Takashimizu, Yasuhiro/0000-0002-3840-9325	 [CTM 2008-06399-C04/MAR];  [CTM 2012-39599-C03];  [CGL2011-26493];  [CTM2012-38248];  [IGCP-619];  [INQUA 1204];  [FWF P25831-N29]; NERC [NE/J017922/1] Funding Source: UKRI; Austrian Science Fund (FWF) [P 25831] Funding Source: researchfish; Natural Environment Research Council [NE/J017922/1] Funding Source: researchfish	; ; ; ; ; ; ; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research used samples and data collected through the Integrated Ocean Drilling Program (IODP). The research was partially supported through the CTM 2008-06399-C04/MAR, CTM 2012-39599-C03, CGL2011-26493, CTM2012-38248, IGCP-619, INQUA 1204, and FWF P25831-N29 Projects. The Continental Margins Research Group at Royal Holloway, University of London, also contributed to the research. We thank REPSOL and TGS-NOPEC (Tomlinson Geophysical Services Inc. and Norwegian Petroleum Exploration Consultants) Geophysical Company ASA for use of an unpublished seismic record. We thank N. Khelifi (Springer, Germany) and M. Rogerson (University of Hull, UK) for discussing the changes in MOW density during the Pliocene and Quaternary, as well as the anonymous reviewers whose suggestions improved the final version of our manuscript. Data available at http://doi.pangaea.de/10.1594/PANGAEA.832885?format=html and at the IODP web page, http://iodp.tamu.edu/scienceops/expeditions/mediterranean_outflow.html.	Bailey I, 2013, QUATERNARY SCI REV, V75, P181, DOI 10.1016/j.quascirev.2013.06.004; Bartoli G, 2005, EARTH PLANET SC LETT, V237, P33, DOI 10.1016/j.epsl.2005.06.020; Billups K, 1998, PALEOCEANOGRAPHY, V13, P84, DOI 10.1029/97PA02995; Brackenridge RE, 2013, MAR PETROL GEOL, V46, P36, DOI 10.1016/j.marpetgeo.2013.05.015; CLOETINGH S, 1990, J GEOL SOC LONDON, V147, P495, DOI 10.1144/gsjgs.147.3.0495; deMenocal PB, 2011, SCIENCE, V331, P540, DOI 10.1126/science.1190683; Duarte JC, 2011, MAR GEOL, V289, P135, DOI 10.1016/j.margeo.2011.09.014; DWYER GS, 1995, SCIENCE, V270, P1347, DOI 10.1126/science.270.5240.1347; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; Esteras M., 2000, REV SOC GEOL ESPAN, V13, P539; Flinch JF, 1998, SEPM SPECIAL PUBLICA, V60, P199; Gutscher MA, 2002, GEOLOGY, V30, P1071, DOI 10.1130/0091-7613(2002)030<1071:EFASBG>2.0.CO;2; Hay WW, 1996, GEOL RUNDSCH, V85, P409, DOI 10.1007/BF02369000; Hernandez-Molina FJ, 2014, GEOLOGY, V42, P227, DOI 10.1130/G35083.1; Khelifi N, 2009, GEOLOGY, V37, P811, DOI 10.1130/G30058A.1; Knutz PC, 2008, DEVEL SEDIM, V60, P511, DOI 10.1016/S0070-4571(08)00224-0; LEDBETTER MT, 1978, NATURE, V272, P237, DOI 10.1038/272237a0; Llave E, 2007, GEOL SOC SPEC PUBL, V276, P49, DOI 10.1144/GSL.SP.2007.276.01.03; Martinez-Garcia P, 2013, BASIN RES, V25, P361, DOI 10.1111/bre.12005; Maslin MA, 1998, QUATERNARY SCI REV, V17, P411, DOI 10.1016/S0277-3791(97)00047-4; Medialdea T, 2004, MAR GEOL, V209, P173, DOI 10.1016/j.margeo.2004.05.029; Miller KG, 2011, OCEANOGRAPHY, V24, P40, DOI 10.5670/oceanog.2011.26; Nisancioglu KH, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000767; Potter PE, 2009, EARTH-SCI REV, V96, P279, DOI 10.1016/j.earscirev.2009.07.003; Rogerson M, 2012, CLIM DYNAM, V39, P589, DOI 10.1007/s00382-011-1148-4; Rogerson M, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000376; Rohling EJ, 2014, NATURE, V508, P477, DOI 10.1038/nature13230; Roque C, 2012, MAR GEOL, V303, P42, DOI 10.1016/j.margeo.2011.11.001; Roveri M, 2014, MAR GEOL, V352, P25, DOI 10.1016/j.margeo.2014.02.002; Serra N, 2010, OCEAN SCI, V6, P191, DOI 10.5194/os-6-191-2010; Summerhayes C. P., 1986, N ATLANTIC PALEOCEAN, P103; White N, 1997, NATURE, V387, P888, DOI 10.1038/43151; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zitellini N, 2009, EARTH PLANET SC LETT, V280, P13, DOI 10.1016/j.epsl.2008.12.005	34	119	122	0	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1244	1250		10.1126/science.1251306	http://dx.doi.org/10.1126/science.1251306			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926012	Green Published, Green Submitted			2022-12-01	WOS:000337077500031
J	Dunn, SJ; Martello, G; Yordanov, B; Emmott, S; Smith, AG				Dunn, S. -J.; Martello, G.; Yordanov, B.; Emmott, S.; Smith, A. G.			Defining an essential transcription factor program for naive pluripotency	SCIENCE			English	Article							SELF-RENEWAL; STEM-CELLS; DIFFERENTIATION; EXPRESSION; NETWORK; TARGET; NANOG	The gene regulatory circuitry through which pluripotent embryonic stem (ES) cells choose between self-renewal and differentiation appears vast and has yet to be distilled into an executive molecular program. We developed a data-constrained, computational approach to reduce complexity and to derive a set of functionally validated components and interaction combinations sufficient to explain observed ES cell behavior. This minimal set, the simplest version of which comprises only 16 interactions, 12 components, and three inputs, satisfies all prior specifications for self-renewal and furthermore predicts unknown and nonintuitive responses to compound genetic perturbations with an overall accuracy of 70%. We propose that propagation of ES cell identity is not determined by a vast interactome but rather can be explained by a relatively simple process of molecular computation.	[Dunn, S. -J.; Yordanov, B.; Emmott, S.] Microsoft Res, Computat Sci Lab, Cambridge CB1 2FB, England; [Martello, G.; Smith, A. G.] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 1QR, England; [Smith, A. G.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	Microsoft; University of Cambridge; University of Cambridge	Martello, G (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 1QR, England.	graziano.martello@unipd.it; austin.smith@cscr.cam.ac.uk	Martello, Graziano/AAM-3325-2021	Smith, Austin/0000-0002-3029-4682; Martello, Graziano/0000-0001-5520-085X	Human Frontier Science Program fellowship; Wellcome Trust; Medical Research Council [G19/38, MC_PC_12009, G1100526] Funding Source: researchfish	Human Frontier Science Program fellowship(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank T. Kalkan, H. Kugler, and S. Dupont for stimulating discussions and comments on this manuscript and B. Simons for reading the manuscript. G. M. was a recipient of a Human Frontier Science Program fellowship. A. G. S. is a Medical Research Council Professor and is also funded by the Wellcome Trust.	Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Lanner F, 2010, STEM CELLS, V28, P191, DOI 10.1002/stem.265; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Nichols J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008128; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Som A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015165; Tai CI, 2013, J CELL SCI, V126, P1093, DOI 10.1242/jcs.118273; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wilczynski B, 2009, BIOINFORMATICS, V25, P286, DOI 10.1093/bioinformatics/btn505; Yeo JC, 2013, CELL RES, V23, P20, DOI 10.1038/cr.2012.172; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yordanov Boyan, 2013, NASA Formal Methods. 5th International Symposium, NFM 2013. Proceedings, P78, DOI 10.1007/978-3-642-38088-4_6	20	250	256	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1156	1160		10.1126/science.1248882	http://dx.doi.org/10.1126/science.1248882			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904165	Green Accepted			2022-12-01	WOS:000336791200047
J	Youngs, H; Somerville, C				Youngs, Heather; Somerville, Chris			PLANT SCIENCE Best practices for biofuels	SCIENCE			English	Editorial Material							CROP RESIDUE; IMPACTS		[Youngs, Heather; Somerville, Chris] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Somerville, Chris] King Abdulaziz Univ, Fac Meteorol Environm & Arid Land Agr, Dept Arid Land Agr, Jeddah 21413, Saudi Arabia	University of California System; University of California Berkeley; King Abdulaziz University	Youngs, H (corresponding author), Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA.	crs@berkeley.edu						Anderson-Teixeira K. J., 2013, Ecosystems, V16, P508, DOI 10.1007/s10021-012-9628-x; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Bonner IJ, 2014, BIOENERG RES, V7, P576, DOI 10.1007/s12155-014-9423-y; Edenhofer O, 2011, IPCC SPECIAL REPORT; Hertel TW, 2013, GLOB FOOD SECUR-AGR, V2, P131, DOI 10.1016/j.gfs.2013.05.003; Karlen DL, 2014, BIOENERG RES, V7, P528, DOI [10.1007/s12155-014-9419-7, 10.1007/s12155-014-9407-y]; Liska AJ, 2014, NAT CLIM CHANGE, V4, P398, DOI [10.1038/nclimate2187, 10.1038/NCLIMATE2187]; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Scarlat N, 2011, ENERG POLICY, V39, P1630, DOI 10.1016/j.enpol.2010.12.039; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970	11	29	30	0	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1095	1096		10.1126/science.1255812	http://dx.doi.org/10.1126/science.1255812			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904145				2022-12-01	WOS:000336791200026
J	Qiu, YF; Nguyen, KD; Odegaard, JI; Cui, XJ; Tian, XY; Locksley, RM; Palmiter, RD; Chawla, A				Qiu, Yifu; Nguyen, Khoa D.; Odegaard, Justin I.; Cui, Xiaojin; Tian, Xiaoyu; Locksley, Richard M.; Palmiter, Richard D.; Chawla, Ajay			Eosinophils and Type 2 Cytokine Signaling in Macrophages Orchestrate Development of Functional Beige Fat	CELL			English	Article							BROWN ADIPOSE-TISSUE; NONSHIVERING THERMOGENESIS; ADAPTIVE THERMOGENESIS; GENE-EXPRESSION; IN-VIVO; ADULT HUMANS; WHITE; ACTIVATION; ADIPOCYTES; INFLAMMATION	Beige fat, which expresses the thermogenic protein UCP1, provides a defense against cold and obesity. Although a cold environment is the physiologic stimulus for inducing beige fat in mice and humans, the events that lead from the sensing of cold to the development of beige fat remain poorly understood. Here, we identify the efferent beige fat thermogenic circuit, consisting of eosinophils, type 2 cytokines interleukin (IL)-4/13, and alternatively activated macrophages. Genetic loss of eosinophils or IL-4/13 signaling impairs cold-induced biogenesis of beige fat. Mechanistically, macrophages recruited to cold-stressed subcutaneous white adipose tissue (scWAT) undergo alternative activation to induce tyrosine hydroxylase expression and catecholamine production, factors required for browning of scWAT. Conversely, administration of IL-4 to thermoneutral mice increases beige fat mass and thermogenic capacity to ameliorate pre-established obesity. Together, our findings have uncovered the efferent circuit controlling biogenesis of beige fat and provide support for its targeting to treat obesity.	[Qiu, Yifu; Nguyen, Khoa D.; Odegaard, Justin I.; Cui, Xiaojin; Tian, Xiaoyu; Chawla, Ajay] Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94158 USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94158 USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Locksley, Richard M.; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Dept Biochem, Seattle, WA 98195 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chawla, A (corresponding author), Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94158 USA.	ajay.chawla@ucsf.edu	Tian, Xiao Yu/P-1092-2016	Tian, Xiao Yu/0000-0003-3472-9898; Qiu, Yifu/0000-0001-5645-3189; Nguyen, Khoa/0000-0002-6720-2470	NIH [HL076746, DK094641]; American Heart Association Innovative Science Award [12PILT11840038]; NIH Director's Pioneer Award [DP1AR064158]; AHA Postdoctoral Fellowship; AHA Predoctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107202, R01HL076746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030663, R37AI026918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP1AR064158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094641, P30DK026743] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006415] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Innovative Science Award; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Postdoctoral Fellowship(American Heart Association); AHA Predoctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Chawla laboratory, A. Loh for comments on the manuscript, P. Cohen for providing the protocol to measure oxygen consumption in isolated adipose tissues, and S. Kajimura for assistance with use of their Clark electrode. The authors' work was supported by grants from NIH (HL076746, DK094641), American Heart Association Innovative Science Award (12PILT11840038), and an NIH Director's Pioneer Award (DP1AR064158) to A. C. Y.Q was supported by an AHA Postdoctoral Fellowship, and K.D.N. was supported by an AHA Predoctoral Fellowship. All animal care and procedures were performed in accordance with UCSF's IACUC guidelines. The authors declare that they have no competing financial interests.	Cannon B, 2010, INT J OBESITY, V34, pS7, DOI 10.1038/ijo.2010.177; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DANIEL H, 1969, CAN J PHYSIOL PHARM, V47, P941, DOI 10.1139/y69-154; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Golozoubova V, 2006, AM J PHYSIOL-ENDOC M, V291, pE350, DOI 10.1152/ajpendo.00387.2005; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Jackson CR, 2012, J NEUROSCI, V32, P9359, DOI 10.1523/JNEUROSCI.0711-12.2012; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Liu WY, 2013, J CELL SCI, V126, P3527, DOI 10.1242/jcs.124321; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Maier E, 2012, EUR J IMMUNOL, V42, P2827, DOI 10.1002/eji.201242433; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Morrison Shaun F, 2012, Front Endocrinol (Lausanne), V3; Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; SLAVIN BG, 1978, ANAT REC, V191, P377, DOI 10.1002/ar.1091910310; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; TRAYHURN P, 1987, P NUTR SOC, V46, P135, DOI 10.1079/PNS19870017; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0	52	572	597	10	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1292	1308		10.1016/j.cell.2014.03.066	http://dx.doi.org/10.1016/j.cell.2014.03.066			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906148	Green Accepted, Bronze			2022-12-01	WOS:000340881400008
J	Qin, N; Yang, FL; Li, A; Prifti, E; Chen, YF; Shao, L; Guo, J; Le Chatelier, E; Yao, J; Wu, LJ; Zhou, JW; Ni, SJ; Liu, L; Pons, N; Batto, JM; Kennedy, SP; Leonard, P; Yuan, CH; Ding, WC; Chen, YT; Hu, XJ; Zheng, BW; Qian, GR; Xu, W; Ehrlich, SD; Zheng, SS; Li, LJ				Qin, Nan; Yang, Fengling; Li, Ang; Prifti, Edi; Chen, Yanfei; Shao, Li; Guo, Jing; Le Chatelier, Emmanuelle; Yao, Jian; Wu, Lingjiao; Zhou, Jiawei; Ni, Shujun; Liu, Lin; Pons, Nicolas; Batto, Jean Michel; Kennedy, Sean P.; Leonard, Pierre; Yuan, Chunhui; Ding, Wenchao; Chen, Yuanting; Hu, Xinjun; Zheng, Beiwen; Qian, Guirong; Xu, Wei; Ehrlich, S. Dusko; Zheng, Shusen; Li, Lanjuan			Alterations of the human gut microbiome in liver cirrhosis	NATURE			English	Article							BACTERIAL TRANSLOCATION; INTESTINAL MICROBIOTA; OBESITY; CATALOG; GENOMES; IMPACT; LONG	Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Here we characterize the gut microbiome in liver cirrhosis by comparing 98 patients and 83 healthy control individuals. We build a reference gene set for the cohort containing 2.69 million genes, 36.1% of which are novel. Quantitative metagenomics reveals 75,245 genes that differ in abundance between the patients and healthy individuals (false discovery rate < 0.0001) and can be grouped into 66 clusters representing cognate bacterial species; 28 are enriched in patients and 38 in control individuals. Most (54%) of the patient-enriched, taxonomically assigned species are of buccal origin, suggesting an invasion of the gut from the mouth in liver cirrhosis. Biomarkers specific to liver cirrhosis at gene and function levels are revealed by a comparison with those for type 2 diabetes and inflammatory bowel disease. On the basis of only 15 biomarkers, a highly accurate patient discrimination index is created and validated on an independent cohort. Thus microbiota-targeted biomarkers may be a powerful tool for diagnosis of different diseases.	[Qin, Nan; Yang, Fengling; Li, Ang; Chen, Yanfei; Shao, Li; Guo, Jing; Yao, Jian; Wu, Lingjiao; Zhou, Jiawei; Ni, Shujun; Liu, Lin; Yuan, Chunhui; Ding, Wenchao; Chen, Yuanting; Hu, Xinjun; Zheng, Beiwen; Qian, Guirong; Xu, Wei; Li, Lanjuan] Zhejiang Univ, Affiliated Hosp 1, Coll Med, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Qin, Nan; Shao, Li; Yao, Jian; Zheng, Beiwen; Zheng, Shusen; Li, Lanjuan] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Prifti, Edi; Le Chatelier, Emmanuelle; Pons, Nicolas; Batto, Jean Michel; Kennedy, Sean P.; Leonard, Pierre; Ehrlich, S. Dusko] INRA, Metagenopolis, F-78350 Jouy En Josas, France; [Ehrlich, S. Dusko] Kings Coll London, Dent Inst Cent Off, Guys Hosp, Ctr Host Microbiome Interact, London SE1 9RT, England; [Zheng, Shusen] Zhejiang Univ, Affiliated Hosp 1, Minist Publ Hlth, Key Lab Combined Multiorgan Transplantat, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Zhejiang University	Li, LJ (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Coll Med, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	dusko.ehrlich@jouy.inra.fr; zyzsss@zju.edu.cn; ljli@zju.edu.cn	Prifti, Edi/F-3967-2019; Ehrlich, S./Y-2423-2019; LE CHATELIER, Emmanuelle/O-1243-2017; Jian, YAO/AAT-4231-2021	Prifti, Edi/0000-0001-8861-1305; Ehrlich, S./0000-0002-7563-4046; LE CHATELIER, Emmanuelle/0000-0002-2724-0536; Jian, YAO/0000-0002-3746-1279; Kennedy, Sean/0000-0002-3932-8922; LI, Lanjuan/0000-0001-6945-0593; Yuan, Chunhui/0000-0002-0922-4209	National Program on Key Basic Research Project [2013CB531401]; National Natural Science Foundation of China [81301475, 81330011]; Science Fund for Creative Research Groups of the National Natural Science Foundation of China [81121002]; Technology Group Project for Infectious Disease Control of Zhejiang Province [2009R50041]; Metagenopolis [ANR-11-DPBS-0001]	National Program on Key Basic Research Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Creative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Group Project for Infectious Disease Control of Zhejiang Province; Metagenopolis	This work was supported by the National Program on Key Basic Research Project (2013CB531401), the National Natural Science Foundation of China (81301475 and 81330011), the Science Fund for Creative Research Groups of the National Natural Science Foundation of China (81121002), the Technology Group Project for Infectious Disease Control of Zhejiang Province (2009R50041) and the Metagenopolis grant ANR-11-DPBS-0001. We thank Q. Cao, K. Su, J. Shao and A. Ghozlane for help with data computation, and H. Zhang, H. Lu, Q. Bao, J. Ge, J. Jiang, Z. Ren and M. Ye for assistance with sample collection. We are thankful to the MetaHIT consortium for generating the gut gene set and the Human Microbiome Project for generating the reference genomes from human gut microbes.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Bass NM, 2010, NEW ENGL J MED, V362, P1071, DOI 10.1056/NEJMoa0907893; Bauer TM, 2002, AM J GASTROENTEROL, V97, P2364; Benten D, 2012, J HEPATOL, V56, P1221, DOI 10.1016/j.jhep.2012.03.003; Cesaro C, 2011, DIGEST LIVER DIS, V43, P431, DOI 10.1016/j.dld.2010.10.015; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; FERENCI P, 1983, LANCET, V2, P811; Fouts DE, 2012, J HEPATOL, V56, P1283, DOI 10.1016/j.jhep.2012.01.019; Garcia-Tsao G, 2004, BEST PRACT RES CL GA, V18, P353, DOI 10.1016/j.bpg.2003.10.005; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hwang Jow-Jyh, 2002, Journal of Microbiology Immunology and Infection, V35, P65; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; KRIEGER D, 1995, LANCET, V346, P270, DOI 10.1016/S0140-6736(95)92164-8; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Marchandin H, 2001, EUR J CLIN MICROBIOL, V20, P340, DOI 10.1007/s10096-001-8116-6; Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; MINUK GY, 1985, HEPATO-GASTROENTEROL, V32, P171; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nielsen H. B., 2014, NATURE BIOTECHNOL; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Nolan JP, 2010, HEPATOLOGY, V52, P1829, DOI 10.1002/hep.23917; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Saarela M, 2000, J BIOTECHNOL, V84, P197, DOI 10.1016/S0168-1656(00)00375-8; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632; Wiest R, 2012, GUT, V61, P297, DOI 10.1136/gutjnl-2011-300779; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xu M, 2012, MICROB ECOL, V63, P304, DOI 10.1007/s00248-011-9925-5; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	55	1132	1233	18	470	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					59	+		10.1038/nature13568	http://dx.doi.org/10.1038/nature13568			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25079328				2022-12-01	WOS:000341174800029
J	Karasov, TL; Kniskern, JM; Gao, LP; DeYoung, BJ; Ding, J; Dubiella, U; Lastra, RO; Nallu, S; Roux, F; Innes, RW; Barrett, LG; Hudson, RR; Bergelson, J				Karasov, Talia L.; Kniskern, Joel M.; Gao, Liping; DeYoung, Brody J.; Ding, Jing; Dubiella, Ullrich; Lastra, Ruben O.; Nallu, Sumitha; Roux, Fabrice; Innes, Roger W.; Barrett, Luke G.; Hudson, Richard R.; Bergelson, Joy			The long-term maintenance of a resistance polymorphism through diffuse interactions	NATURE			English	Article							DISEASE RESISTANCE; ARABIDOPSIS; COEVOLUTION; SPECIFICITY; EVOLUTION; SELECTION; VARIANCE	Plant resistance (R) genes are a crucial component in plant defence against pathogens(1). Although R genes often fail to provide durable resistance in an agricultural context, they frequently persist as long-lived balanced polymorphisms in nature(2-4). Standard theory explains the maintenance of such polymorphisms through a balance of the costs and benefits of resistance and virulence in a tightly coevolving host-pathogen pair(5,6). However, many plant-pathogen interactions lack such specificity(7). Whether, and how, balanced polymorphisms are maintained in diffusely interacting species(8) is unknown. Here we identify a naturally interacting R gene and effector pair in Arabidopsis thaliana and its facultative plant pathogen, Pseudomonas syringae. The protein encoded by the R gene RPS5 recognizes an AvrPphB homologue (AvrPphB2) and exhibits a balanced polymorphism that has been maintained for over 2 million years (ref. 3). Consistent with the presence of an ancient balanced polymorphism, the R gene confers a benefit when plants are infected with P. syringae carrying avrPphB2 but also incurs a large cost in the absence of infection. RPS5 alleles are maintained at intermediate frequencies in populations globally, suggesting ubiquitous selection for resistance. However, the presence of P. syringae carrying avrPphB is probably insufficient to explain the RPS5 polymorphism. First, avrPphB homologues occur at very low frequencies in P. syringae populations on A. thaliana. Second, AvrPphB only rarely confers a virulence benefit to P. syringae on A. thaliana. Instead, we find evidence that selection for RPS5 involves multiple non-homologous effectors and multiple pathogen species. These results and an associated model suggest that the R gene polymorphism in A. thaliana may not be maintained through a tightly coupled interaction involving a single coevolved R gene and effector pair. More likely, the stable polymorphism is maintained through complex and diffuse community-wide interactions.	[Karasov, Talia L.; Kniskern, Joel M.; Gao, Liping; Ding, Jing; Lastra, Ruben O.; Nallu, Sumitha; Barrett, Luke G.; Hudson, Richard R.; Bergelson, Joy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Karasov, Talia L.] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [DeYoung, Brody J.; Dubiella, Ullrich; Innes, Roger W.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Roux, Fabrice] INRA, LIPM, F-31326 Castanet Tolosan, France; [Roux, Fabrice] CNRS, LIPM, F-31326 Castanet Tolosan, France; [Roux, Fabrice] Univ Sci & Technol Lille Lille 1, Lab Genet & Evolut Populat Vegetales, UMR CNRS 8198, F-59655 Villeneuve Dascq, France	University of Chicago; University of Chicago; Indiana University System; Indiana University Bloomington; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille	Bergelson, J (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	jbergels@uchicago.edu	Barrett, Luke G/I-5711-2015; Nallu, Sumitha/D-5382-2017; Dubiella, Ullrich/AAF-6499-2019	Barrett, Luke G/0000-0001-6530-0731; Dubiella, Ullrich/0000-0001-9854-9795; Bergelson, Joy/0000-0001-7893-7387; Innes, Roger/0000-0001-9634-1413; Fabrice, Roux/0000-0001-8059-5638; Karasov, Talia/0000-0002-3592-6597	Department of Education GAANN fellowship; Dropkin Foundation; National Institutes of Health (NIH) Postbaccalaureate Research Education Program award; Laboratory of Excellence (Labex) TULIP [ANR-10-LABX-41, ANR-11-IDEX-0002-02]; NIH-NIGMS [R01 GM046451, R01 GM057994, R01 GM083068]; NSF [MCB0603515]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083068, R01GM046451, T32GM007197, R01GM057994, R01GM062504] Funding Source: NIH RePORTER	Department of Education GAANN fellowship(US Department of Education); Dropkin Foundation; National Institutes of Health (NIH) Postbaccalaureate Research Education Program award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laboratory of Excellence (Labex) TULIP; NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Dwyer, M. Kreitman, L. Merwin, C. Morris and M. Nordborg for discussions, D. Baltrus, D. Dahlbeck, J. Greenberg and B. Vinatzer for supplying plasmids, N. Faure for help collecting the French isolates of P. syringae, C. Gode, J. Higgins and A. Stathos for contributions to genotyping RPS5 presence/absence, G. Sperone for mapping, and T. Morton and the staff of the University of Chicago greenhouse for planting and maintaining A. thaliana. T.L.K. was supported by a Department of Education GAANN fellowship, J.M.K. and L.G.B. were supported by postdoctoral fellowships from the Dropkin Foundation, and R.L. was supported by a National Institutes of Health (NIH) Postbaccalaureate Research Education Program award. F.R. was supported by the Laboratory of Excellence (Labex) TULIP (ANR-10-LABX-41; ANR-11-IDEX-0002-02). This work was supported by grants NIH-NIGMS R01 GM046451 to R.W.I., and grants NSF MCB0603515, NIH-NIGMS R01 GM057994 and NIH-NIGMS R01 GM083068 to J.B.	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Barrett LG, 2011, ECOL LETT, V14, P1149, DOI 10.1111/j.1461-0248.2011.01687.x; Barrett LG, 2009, NEW PHYTOL, V183, P513, DOI 10.1111/j.1469-8137.2009.02927.x; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Brown JKM, 2011, ANNU REV PHYTOPATHOL, V49, P345, DOI 10.1146/annurev-phyto-072910-095301; FRANK SA, 1992, TRENDS GENET, V8, P213, DOI 10.1016/0168-9525(92)90236-W; Gao LP, 2009, NEW PHYTOL, V184, P485, DOI 10.1111/j.1469-8137.2009.02959.x; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; HALDANE JBS, 1992, CURR SCI INDIA, V63, P599; Hudson RR, 2007, J MOL EVOL, V64, P702, DOI 10.1007/s00239-006-0261-1; Jakob K, 2002, MOL PLANT MICROBE IN, V15, P1195, DOI 10.1094/MPMI.2002.15.12.1195; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kniskern JM, 2011, EVOLUTION, V65, P818, DOI 10.1111/j.1558-5646.2010.01157.x; Lockett SF, 2001, J ACQ IMMUN DEF SYND, V27, P277, DOI 10.1097/00126334-200107010-00010; Lorang J, 2012, SCIENCE, V338, P659, DOI 10.1126/science.1226743; Morris CE, 2010, MBIO, V1, DOI 10.1128/mBio.00107-10; Paterson S, 1998, P NATL ACAD SCI USA, V95, P3714, DOI 10.1073/pnas.95.7.3714; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Stinchcombe JR, 2001, AM NAT, V158, P376, DOI 10.1086/321990; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Thrall PH, 2012, ECOL LETT, V15, P425, DOI 10.1111/j.1461-0248.2012.01749.x; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Warren RF, 1999, GENETICS, V152, P401	30	111	111	0	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					436	U472		10.1038/nature13439	http://dx.doi.org/10.1038/nature13439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25043057	Green Accepted			2022-12-01	WOS:000340840600035
J	Ducat, L; Philipson, LH; Anderson, BJ				Ducat, Lee; Philipson, Louis H.; Anderson, Barbara J.			The Mental Health Comorbidities of Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ducat, Lee] Mental Hlth Issues Diabet Fdn, Philadelphia, PA USA; [Philipson, Louis H.] Univ Chicago, Chicago, IL 60637 USA; [Anderson, Barbara J.] Baylor Coll Med, Houston, TX 77030 USA	University of Chicago; Baylor College of Medicine	Anderson, BJ (corresponding author), Baylor Coll Med, Dept Pediat, 1102 Bates Ave,Ste 940, Houston, TX 77030 USA.	bja@bcm.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595, T32DK064582] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK064582, P30 DK020595] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Anderson B.J., 2007, JOSLINS DIABETES DES, V2nd ed., P641; Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464; Goebel-Fabbri A.E., 2013, TYPE 1 DIABETES SOUR, P180; Gonzalez JS, 2013, TYPE 1 DIABETES SOUR, P169; Katon W., 2010, DEPRESSION DIABETES, P81; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593	7	151	156	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2014	312	7					691	692		10.1001/jama.2014.8040	http://dx.doi.org/10.1001/jama.2014.8040			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN2TR	25010529	Green Accepted			2022-12-01	WOS:000340438700012
J	Attaran, A				Attaran, Amir			A modest but meaningful decision for Indian drug patents	LANCET			English	Editorial Material									Univ Ottawa, Fac Law & Med, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Attaran, A (corresponding author), Univ Ottawa, Fac Law & Med, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada.	aattaran@uottawa.ca						[Anonymous], 2013, HINDU BUSINESS  0605; Eban K, LATEST CLAIM FRAUD G; Eban K, 2013, DIRTY MED; Hitchings AW, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7941; India-Parliamentary Standing Committee on Health and Family Welfare, 59 IND PARL STAND CO; Laxminarayan P, 2013, India Patent, Patent No. 255388; United States Department of Justice, GEN DRUG MAN RANB PL	7	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2014	384	9942					477	479		10.1016/S0140-6736(13)60845-4	http://dx.doi.org/10.1016/S0140-6736(13)60845-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9JR	24976117				2022-12-01	WOS:000340198300008
J	Michaletz, ST; Cheng, DL; Kerkhoff, AJ; Enquist, BJ				Michaletz, Sean T.; Cheng, Dongliang; Kerkhoff, Andrew J.; Enquist, Brian J.			Convergence of terrestrial plant production across global climate gradients	NATURE			English	Article							NET PRIMARY PRODUCTION; GENERAL QUANTITATIVE THEORY; TROPICAL FORESTS; TREE SIZE; TEMPERATURE-DEPENDENCE; USE EFFICIENCY; GROWTH; ECOSYSTEM; RESPIRATION; PRECIPITATION	Variation in terrestrial net primary production (NPP) with climate is thought to originate from a direct influence of temperature and precipitation on plant metabolism. However, variation in NPP may also result from an indirect influence of climate by means of plant age, stand biomass, growing season length and local adaptation. To identify the relative importance of direct and indirect climate effects, we extend metabolic scaling theory to link hypothesized climate influences with NPP, and assess hypothesized relationships using a global compilation of ecosystem woody plant biomass and production data. Notably, age and biomass explained most of the variation in production whereas temperature and precipitation explained almost none, suggesting that climate indirectly (not directly) influences production. Furthermore, our theory shows that variation in NPP is characterized by a common scaling relationship, suggesting that global change models can incorporate the mechanisms governing this relationship to improve predictions of future ecosystem function.	[Michaletz, Sean T.; Enquist, Brian J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Cheng, Dongliang] Fujian Normal Univ, Minist Educ, Key Lab Humid Subtrop Ecogeog Proc, Fuzhou 350007, Fujian, Peoples R China; [Kerkhoff, Andrew J.] Kenyon Coll, Dept Biol, Gambier, OH 43022 USA; [Enquist, Brian J.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Enquist, Brian J.] The iPlant Collaborat, Tucson, AZ 85721 USA; [Enquist, Brian J.] Aspen Ctr Environm Studies, Aspen, CO 81611 USA	University of Arizona; Fujian Normal University; Kenyon College; The Santa Fe Institute	Enquist, BJ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	chengdl@fjnu.edu.cn; benquist@email.arizona.edu	Enquist, Brian J/B-6436-2008; Michaletz, Sean/AAO-8175-2021	Enquist, Brian J/0000-0002-6124-7096; Michaletz, Sean/0000-0003-2158-6525; Kerkhoff, Andrew/0000-0001-9617-8687	NSF [1065861]; Aspen Center for Environmental Studies; National Natural Science Foundation of China [31170374, 31370589]; Fujian Natural Science Funds for Distinguished Young Scholar [2013J06009]; National Science Foundation [1065861]; Emerging Frontiers [1065861] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Aspen Center for Environmental Studies; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Natural Science Funds for Distinguished Young Scholar; National Science Foundation(National Science Foundation (NSF)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	S.T.M. and B.J.E. were supported by an NSF MacroSystems award (1065861) and a fellowship from the Aspen Center for Environmental Studies. D.C. was supported by the National Natural Science Foundation of China (31170374 and 31370589) and Fujian Natural Science Funds for Distinguished Young Scholar (2013J06009). A.J.K. was supported by a sabbatical supplement from Kenyon College, and by a National Science Foundation ROA supplement (1065861) to the NSF MacroSystems award (1065861) to B.J.E.	Allen AP, 2005, FUNCT ECOL, V19, P202, DOI 10.1111/j.1365-2435.2005.00952.x; [Anonymous], 2011, R LANG ENV STAT COMP; Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; BONAN GB, 1993, TELLUS B, V45, P397, DOI 10.1034/j.1600-0889.1993.t01-4-00001.x; Brett MT, 2004, OIKOS, V105, P647, DOI 10.1111/j.0030-1299.2004.12777.x; Brooks JR, 2010, NAT GEOSCI, V3, P100, DOI 10.1038/NGEO722; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; Campos GEP, 2013, NATURE, V494, P349, DOI 10.1038/nature11836; Cannell MGR, 1982, WORLD FOREST BIOMASS; Chapin FS, 2003, ANN BOT-LONDON, V91, P455, DOI 10.1093/aob/mcg041; Clark DA, 2001, ECOL APPL, V11, P371, DOI 10.1890/1051-0761(2001)011[0371:NPPITF]2.0.CO;2; DeLucia EH, 2007, GLOBAL CHANGE BIOL, V13, P1157, DOI 10.1111/j.1365-2486.2007.01365.x; Enquist B.J., 2012, METAB ECOL SCALING A, P164, DOI [10.1002/, DOI 10.1002/9781119968535.CH14]; Enquist BJ, 2007, NATURE, V449, P218, DOI 10.1038/nature06061; Enquist BJ, 2007, GLOBAL CHANGE BIOL, V13, P591, DOI 10.1111/j.1365-2486.2006.01222.x; Enquist BJ, 2009, P NATL ACAD SCI USA, V106, P7046, DOI 10.1073/pnas.0812303106; FAO, 2012, HARMONIZED WORLD SOI; Fredlund D. G., 2012, EKONOMI POLITIK PEMB; Gates DM, 1980, BIOPHYSICAL ECOLOGY; Gower ST, 1996, TRENDS ECOL EVOL, V11, P378, DOI 10.1016/0169-5347(96)10042-2; Hasler R, 1999, PHYTON-ANN REI BOT A, V39, P47; Helliker BR, 2008, NATURE, V454, P511, DOI 10.1038/nature07031; Huston MA, 2012, ECOL MONOGR, V82, P277, DOI 10.1890/11-1927.1; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Kempes CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020551; Kerkhoff AJ, 2006, ECOL LETT, V9, P419, DOI 10.1111/j.1461-0248.2006.00888.x; Kerkhoff AJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P585, DOI 10.1111/j.1466-822x.2005.00187.x; Larjavaara M, 2010, FUNCT ECOL, V24, P701, DOI 10.1111/j.1365-2435.2010.01698.x; Lieth H, 1975, PRIMARY PRODUCTIVITY; Luo T., 1996, THESIS CHINESE ACAD; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; MONTEITH JL, 1977, PHILOS T ROY SOC B, V281, P277, DOI 10.1098/rstb.1977.0140; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Niklas KJ, 2003, ECOL LETT, V6, P405, DOI 10.1046/j.1461-0248.2003.00440.x; Ryan MG, 1997, BIOSCIENCE, V47, P235, DOI 10.2307/1313077; Ryan T. P., 1997, MODERN REGRESSION ME; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Schuur EAG, 2003, ECOLOGY, V84, P1165, DOI 10.1890/0012-9658(2003)084[1165:PAGCRT]2.0.CO;2; Stegen JC, 2011, GLOBAL ECOL BIOGEOGR, V20, P744, DOI 10.1111/j.1466-8238.2010.00645.x; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Vieira S, 2005, P NATL ACAD SCI USA, V102, P18502, DOI 10.1073/pnas.0505966102; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; West GB, 2009, P NATL ACAD SCI USA, V106, P7040, DOI 10.1073/pnas.0812294106; Whittaker R., 1970, COMMUNITIES ECOSYSTE; Wright IJ, 1999, J ECOL, V87, P85, DOI 10.1046/j.1365-2745.1999.00330.x; Yvon-Durocher G, 2012, NATURE, V487, P472, DOI 10.1038/nature11205	49	203	222	21	314	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					39	+		10.1038/nature13470	http://dx.doi.org/10.1038/nature13470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043056				2022-12-01	WOS:000339908000026
J	Keranen, KM; Weingarten, M; Abers, GA; Bekins, BA; Ge, S				Keranen, K. M.; Weingarten, M.; Abers, G. A.; Bekins, B. A.; Ge, S.			Sharp increase in central Oklahoma seismicity since 2008 induced by massive wastewater injection	SCIENCE			English	Article							EARTHQUAKE SEQUENCE; STRESS; FLUID; MAGNITUDE; FAULT	Unconventional oil and gas production provides a rapidly growing energy source; however, high-production states in the United States, such as Oklahoma, face sharply rising numbers of earthquakes. Subsurface pressure data required to unequivocally link earthquakes to wastewater injection are rarely accessible. Here we use seismicity and hydrogeological models to show that fluid migration from high-rate disposal wells in Oklahoma is potentially responsible for the largest swarm. Earthquake hypocenters occur within disposal formations and upper basement, between 2- and 5-kilometer depth. The modeled fluid pressure perturbation propagates throughout the same depth range and tracks earthquakes to distances of 35 kilometers, with a triggering threshold of similar to 0.07 megapascals. Although thousands of disposal wells operate aseismically, four of the highest-rate wells are capable of inducing 20% of 2008 to 2013 central U.S. seismicity.	[Keranen, K. M.] Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14850 USA; [Weingarten, M.; Ge, S.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Abers, G. A.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Bekins, B. A.] US Geol Survey, Menlo Pk, CA 94025 USA	Cornell University; University of Colorado System; University of Colorado Boulder; Columbia University; United States Department of the Interior; United States Geological Survey	Keranen, KM (corresponding author), Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14850 USA.	keranen@cornell.edu			USGS National Earthquake Hazards Reduction Program (NEHRP) [G13AP00025]; USGS Powell Center [G13AC00023]; NEHRP [G13AP00024]; National Science Foundation	USGS National Earthquake Hazards Reduction Program (NEHRP)(United States Geological Survey); USGS Powell Center; NEHRP(United States Geological Survey); National Science Foundation(National Science Foundation (NSF))	This research benefited from discussion with E. Cochran, W. Ellsworth, and participants in a U.S. Geological Survey (USGS) Powell Center Working Group on Understanding Fluid Injection Induced Seismicity (M. W., B. A. B., and S. G. are part of this group). C. Hogan identified many P and S phases. K. M. K was partially supported by USGS National Earthquake Hazards Reduction Program (NEHRP) grant G13AP00025, M. W. was partially supported by the USGS Powell Center grant G13AC00023, and G. A. A. was partially supported by NEHRP grant G13AP00024. This project used seismic data from EarthScope's Transportable Array, a facility funded by the National Science Foundation. Seismic waveforms are from the Incorporated Research Institutions for Seismology Data Management Center and the USGS CWB Query. Well data are from the Oklahoma Corporation Commission and the Oklahoma Geological Survey. Lists of wells and the local earthquake catalog are available as supplementary materials on Science Online.	[Anonymous], 2013, J GEOPHYS RES, V118, P3506; Chernicky D., 2000, WORLD OIL; Davis S. D., 1993, Seismological Research Letters, V64, P207; Ellsworth WL, 2013, SCIENCE, V341, P142, DOI 10.1126/science.1225942; Frohlich C, 2012, P NATL ACAD SCI USA, V109, P13934, DOI 10.1073/pnas.1207728109; Frohlich C, 2011, B SEISMOL SOC AM, V101, P327, DOI 10.1785/0120100131; Gatewood L. E., 1970, AAPG MEMOIR, V14; Gay S.P., 2003, SHALE SHAKER, V54, P39; Holland AA, 2013, SEISMOL RES LETT, V84, P876, DOI 10.1785/0220120153; Horton S, 2012, SEISMOL RES LETT, V83, P250, DOI 10.1785/gssrl.83.2.250; Justinic AH, 2013, B SEISMOL SOC AM, V103, P3083, DOI 10.1785/0120120336; Keranen KM, 2013, GEOLOGY, V41, P699, DOI 10.1130/G34045.1; Luza K. V., 1981, OKLAHOMA GEOLOGICAL, V81-3, P1; McGarr A, 2014, J GEOPHYS RES-SOL EA, V119, P1008, DOI 10.1002/2013JB010597; Murray KE, 2013, ENVIRON SCI TECHNOL, V47, P4918, DOI 10.1021/es4000593; REASENBERG PA, 1992, SCIENCE, V255, P1687, DOI 10.1126/science.255.5052.1687; Seeber L, 2000, NATURE, V407, P69, DOI 10.1038/35024055; Stein RS, 1999, NATURE, V402, P605, DOI 10.1038/45144; Sumy DF, 2014, J GEOPHYS RES-SOL EA, V119, P1904, DOI 10.1002/2013JB010612; van der Elst NJ, 2013, SCIENCE, V341, P164, DOI 10.1126/science.1238948; Waldhauser F, 2000, B SEISMOL SOC AM, V90, P1353, DOI 10.1785/0120000006; WELLS DL, 1994, B SEISMOL SOC AM, V84, P974; Zoback MD, 2002, INT GEOL REV, V44, P383, DOI 10.2747/0020-6814.44.5.383; ZOBACK ML, 1992, J GEOPHYS RES-SOL EA, V97, P11703, DOI 10.1029/92JB00221	24	499	506	13	210	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					448	451		10.1126/science.1255802	http://dx.doi.org/10.1126/science.1255802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	24993347				2022-12-01	WOS:000339655100042
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED "Case finding" in dementia is simply screening with no evidence of benefit	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Andermann A, 2008, B WORLD HEALTH ORGAN, V86, P241; [Anonymous], 2010, UK NSC POLICY ALZHEI; Brunet MD, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8588; Burns A, RE THERE NO EVIDENCE; WHO, 2011, GUID INT TUB CAS FIN; Wilson JMG, 1968, PRINCIPLES ORACTICE	6	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2014	349								g4791	10.1136/bmj.g4791	http://dx.doi.org/10.1136/bmj.g4791			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VS	25059715	Green Published, Bronze			2022-12-01	WOS:000339566200006
J	Cohen, D				Cohen, Deborah			ANTICOAGULANTS Concerns over data in key dabigatran trial	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NONVALVULAR ATRIAL-FIBRILLATION; STROKE PREVENTION; WARFARIN; XIMELAGATRAN; EVENTS					dcohen@bmj.com						Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690; Albers GW, 2003, LANCET, V362, P1691; [Anonymous], 2011, THERAPEUTICS LETT, V80; Center for Drug Evaluation and Research, 2010, APPL NUMB 22 512; Chatterjee S, 2014, JAMA NEUROL, V71, P371, DOI 10.1001/jamaneurol.2013.6003; Cohen D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4670; Connolly SJ, 2010, NEW ENGL J MED, V363, P1875, DOI 10.1056/NEJMc1007378; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Hohnloser SH, 2012, CIRCULATION, V125, P669, DOI 10.1161/CIRCULATIONAHA.111.055970	9	20	20	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2014	349								g4747	10.1136/bmj.g4747	http://dx.doi.org/10.1136/bmj.g4747			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VP	25055831	Green Published, Bronze			2022-12-01	WOS:000339565900009
J	Muller, PA; Koscso, B; Rajani, GM; Stevanovic, K; Berres, ML; Hashimoto, D; Mortha, A; Leboeuf, M; Li, XM; Mucida, D; Stanley, ER; Dahan, S; Margolis, KG; Gershon, MD; Merad, M; Bogunovic, M				Muller, Paul Andrew; Koscso, Balazs; Rajani, Gaurav Manohar; Stevanovic, Korey; Berres, Marie-Luise; Hashimoto, Daigo; Mortha, Arthur; Leboeuf, Marylene; Li, Xiu-Min; Mucida, Daniel; Stanley, E. Richard; Dahan, Stephanie; Margolis, Kara Gross; Gershon, Michael David; Merad, Miriam; Bogunovic, Milena			Crosstalk between Muscularis Macrophages and Enteric Neurons Regulates Gastrointestinal Motility	CELL			English	Article							IRRITABLE-BOWEL-SYNDROME; INTERSTITIAL-CELLS; SYNAPTIC GROWTH; NERVOUS-SYSTEM; BACTERIAL OVERGROWTH; LANGERHANS CELLS; DENDRITIC CELL; RECEPTOR; MICE; 5-HYDROXYTRYPTAMINE	Intestinal peristalsis is a dynamic physiologic process influenced by dietary and microbial changes. It is tightly regulated by complex cellular interactions; however, our understanding of these controls is incomplete. A distinct population of macrophages is distributed in the intestinal muscularis externa. We demonstrate that, in the steady state, muscularis macrophages regulate peristaltic activity of the colon. They change the pattern of smooth muscle contractions by secreting bone morphogenetic protein 2 (BMP2), which activates BMP receptor (BMPR) expressed by enteric neurons. Enteric neurons, in turn, secrete colony stimulatory factor 1 (CSF1), a growth factor required for macrophage development. Finally, stimuli from microbial commensals regulate BMP2 expression by macrophages and CSF1 expression by enteric neurons. Our findings identify a plastic, microbiotadriven crosstalk between muscularis macrophages and enteric neurons that controls gastrointestinal motility.	[Muller, Paul Andrew; Berres, Marie-Luise; Hashimoto, Daigo; Mortha, Arthur; Leboeuf, Marylene; Merad, Miriam; Bogunovic, Milena] Mt Sinai Hosp, Icahn Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Muller, Paul Andrew; Berres, Marie-Luise; Hashimoto, Daigo; Mortha, Arthur; Leboeuf, Marylene; Merad, Miriam; Bogunovic, Milena] Mt Sinai Hosp, Icahn Sch Med, Tisch Canc Inst, New York, NY 10029 USA; [Muller, Paul Andrew; Berres, Marie-Luise; Hashimoto, Daigo; Mortha, Arthur; Leboeuf, Marylene; Merad, Miriam; Bogunovic, Milena] Mt Sinai Hosp, Icahn Sch Med, Inst Immunol, New York, NY 10029 USA; [Dahan, Stephanie] Mt Sinai Hosp, Icahn Sch Med, Dept Med, Div Clin Immunol, New York, NY 10029 USA; [Li, Xiu-Min] Mt Sinai Hosp, Icahn Sch Med, Dept Pediat, Div Allergy & Immunol, New York, NY 10029 USA; [Li, Xiu-Min] Mt Sinai Hosp, Icahn Sch Med, Jaffe Food Allergy Inst, New York, NY 10029 USA; [Koscso, Balazs; Rajani, Gaurav Manohar; Bogunovic, Milena] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; [Koscso, Balazs; Rajani, Gaurav Manohar; Bogunovic, Milena] Milton S Hershey Med Ctr, Hershey, PA 17033 USA; [Stevanovic, Korey; Margolis, Kara Gross] Columbia Univ, Morgan Stanley Childrens Hosp, Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; [Gershon, Michael David] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Muller, Paul Andrew; Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10065 USA; [Stanley, E. Richard] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Columbia University; NewYork-Presbyterian Hospital; Morgan Stanley Children's Hospital; Columbia University; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine	Merad, M (corresponding author), Mt Sinai Hosp, Icahn Sch Med, Dept Oncol Sci, New York, NY 10029 USA.	miriam.merad@mssm.edu; mbogunovich@hmc.psu.edu	Rajani, Gaurav Manohar/AAX-9919-2021; Berres, Marie-Luise/AAN-5351-2021; Mortha, Arthur/ABE-6250-2020; Stanley, Evan R/J-9154-2013; Hashimoto, Daigo/O-1013-2013	Stanley, Evan R/0000-0002-2910-2065; Hashimoto, Daigo/0000-0001-9489-9704; Muller, Paul/0000-0002-1957-4763; Stevanovic, Korey/0000-0003-4453-1631; Mucida, Daniel/0000-0002-0000-0452; Koscso, Balazs/0000-0001-9676-2066; Mortha, Arthur/0000-0003-2673-0485	NIH [AI09561, CA173861, AI104848, CA32551, R21-AI105047]; Career Development Award from the CCFA; PCARS from the NIAID; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA154947, R01CA173861, R01CA032551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104848, R21AI105047, U01AI095611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK093786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015547] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award from the CCFA; PCARS from the NIAID; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Immgen Project (http://www.immgen.org) for performing a whole-mouse genome microarray and the Penn State Hershey Flow Cytometry Core Facility and the Mount Sinai Flow Cytometry Core for assistance with our experiments. We also thank Frederico Costa Pinta (Rockefeller University, New York, NY, and School of Veterinary Medicine, University of Sao Paulo, Brazil), Hongyan Zou (Icahn School of Medicine at Mount Sinai Hospital, New York, NY), and Florent Ginhoux (Singapore Immunology Network and Agency for Science, Technology and Research, Singapore) for productive discussions regarding the study, and Aron Lukacher (Penn State University College of Medicine, Hershey, PA) for help with the manuscript. This work was supported in part by grants from the NIH (AI09561, CA173861, and AI104848 to M.M.; CA32551 to E.R.S; and R21-AI105047 to D.M.), as well as a Career Development Award from the CCFA and PCARS from the NIAID (M.B.).	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; ABRAMS GD, 1967, P SOC EXP BIOL MED, V126, P301; Anderson L, 2010, AM J PHYSIOL-REG I, V298, pR833, DOI 10.1152/ajpregu.00534.2009; Anitha M, 2012, GASTROENTEROLOGY, V143, P1006, DOI 10.1053/j.gastro.2012.06.034; Boeckxstaens GE, 2009, GUT, V58, P1300, DOI 10.1136/gut.2008.169250; Bogunovic M, 2007, AM J PHYSIOL-GASTR L, V292, pG1770, DOI 10.1152/ajpgi.00249.2006; Bogunovic M, 2012, IMMUNOL RES, V54, P37, DOI 10.1007/s12026-012-8323-5; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; BULBRING E, 1959, J PHYSIOL-LONDON, V146, P29; BULBRING E, 1959, J PHYSIOL-LONDON, V146, P18; Chalazonitis A, 2004, J NEUROSCI, V24, P4266, DOI 10.1523/JNEUROSCI.3688-03.2004; Chalazonitis A, 2008, J COMP NEUROL, V509, P474, DOI 10.1002/cne.21770; Chalazonitis A, 2011, DEV BIOL, V350, P64, DOI 10.1016/j.ydbio.2010.11.017; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Dahan S, 2011, GASTROENTEROLOGY, V140, P550, DOI 10.1053/j.gastro.2010.10.057; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Faure C, 2007, DEV DYNAM, V236, P44, DOI 10.1002/dvdy.20943; Flores-Langarica A, 2005, P NATL ACAD SCI USA, V102, P19039, DOI 10.1073/pnas.0504253102; FRIGO GM, 1970, BRIT J PHARMACOL, V39, P346, DOI 10.1111/j.1476-5381.1970.tb12898.x; Fu M, 2006, DEV BIOL, V299, P137, DOI 10.1016/j.ydbio.2006.07.016; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Goldstein AM, 2005, MECH DEVELOP, V122, P821, DOI 10.1016/j.mod.2005.03.003; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; GUSTAFSSON BE, 1970, SCAND J GASTROENTERO, V5, P309; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Helbing T, 2011, BLOOD, V118, P5040, DOI 10.1182/blood-2011-03-339762; Heredia DJ, 2013, J PHYSIOL-LONDON, V591, P5939, DOI 10.1113/jphysiol.2013.256230; Hoffman SM, 2010, CELL BIOCHEM FUNCT, V28, P686, DOI 10.1002/cbf.1709; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Huynh D, 2009, GASTROENTEROLOGY, V137, P136, DOI 10.1053/j.gastro.2009.03.004; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; Li ZS, 2006, J NEUROSCI, V26, P2798, DOI 10.1523/JNEUROSCI.4720-05.2006; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Mikkelsen HB, 2010, J CELL MOL MED, V14, P818, DOI 10.1111/j.1582-4934.2010.01025.x; MIKKELSEN HB, 1985, ANAT REC, V213, P77, DOI 10.1002/ar.1092130111; Mikkelsen HB, 1999, CELL TISSUE RES, V295, P485, DOI 10.1007/s004410051254; MIKKELSEN HB, 1992, CELL TISSUE RES, V270, P273, DOI 10.1007/BF00328013; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Nahm M, 2013, NEURON, V77, P680, DOI 10.1016/j.neuron.2012.12.015; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Peralta S, 2009, WORLD J GASTROENTERO, V15, P2628, DOI 10.3748/wjg.15.2628; Pimentel M, 2003, AM J GASTROENTEROL, V98, P412, DOI 10.1016/S0002-9270(02)05902-6; Pimentel M, 2002, DIGEST DIS SCI, V47, P2639, DOI 10.1023/A:1021039032413; Pimentel M, 2000, AM J GASTROENTEROL, V95, P3503, DOI 10.1111/j.1572-0241.2000.03368.x; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reigstad CS, 2013, NEUROGASTROENT MOTIL, V25, P358, DOI 10.1111/nmo.12134; Rumessen JJ, 2003, INT REV CYTOL, V229, P115, DOI 10.1016/S0074-7696(03)29004-5; Sudo T, 1995, ONCOGENE, V11, P2469; Swapna I, 2012, P NATL ACAD SCI USA, V109, P16336, DOI 10.1073/pnas.1202818109; Tornblom H, 2002, GASTROENTEROLOGY, V123, P1972, DOI 10.1053/gast.2002.37059; Uramatsu M, 2010, MICROBIOL IMMUNOL, V54, P330, DOI 10.1111/j.1348-0421.2010.00217.x; Wang XN, 2007, NAT NEUROSCI, V10, P177, DOI 10.1038/nn1841; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wehner S, 2007, GUT, V56, P176, DOI 10.1136/gut.2005.089615; Wiktor-Jedrzejczak W., 1991, NATURE, V19, P1049; YEUNG YG, 1987, P NATL ACAD SCI USA, V84, P1268, DOI 10.1073/pnas.84.5.1268; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang HB, 1996, DEVELOPMENT, V122, P2977	65	336	343	3	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					300	313		10.1016/j.cell.2014.04.050	http://dx.doi.org/10.1016/j.cell.2014.04.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036630	Green Accepted, Bronze			2022-12-01	WOS:000340943600011
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED The BMJ is wrong: doctor assisted dying would overmedicalise death	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Bingham J., 2014, DAILY TELEGRAPH, DOI [10674267/Family-breakdowncouldcost-taxpayers-46bn.htmlhttp://www.telegraph.co.uk/women/sex/divorce/10674267/Familybreakdown-could-cost-taxpayers-46bn.html, DOI 10674267/FAMILY-BREAKDOWNCOULDCOST-TAXPAYERS-46BN.HTMLHTTP://WWW.TELEGRAPH.CO.UK/WOMEN/SEX/DIVORCE/10674267/FAMILYBREAKDOWN-COULD-COST-TAXPAYERS-46BN.HTML]; Delamothe T, 2014, BMJ-BRIT MED J, V348, pg4094; Heath I, 2013, JAMA INTERN MED, V173, P956, DOI 10.1001/jamainternmed.2013.970; Marmot M., 2010, MARMOT REPORT; McPherson K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3106; The Royal College of Midwives, CAMP NORM BIRTH	6	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2014	349								g4502	10.1136/bmj.g4502	http://dx.doi.org/10.1136/bmj.g4502			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZB	25005033	Bronze, Green Published			2022-12-01	WOS:000338993300013
J	Lu, M; Lawrence, DA; Marsters, S; Acosta-Alvear, D; Kimmig, P; Mendez, AS; Paton, AW; Paton, JC; Walter, P; Ashkenazi, A				Lu, Min; Lawrence, David A.; Marsters, Scot; Acosta-Alvear, Diego; Kimmig, Philipp; Mendez, Aaron S.; Paton, Adrienne W.; Paton, James C.; Walter, Peter; Ashkenazi, Avi			Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM STRESS; DEPENDENT UP-REGULATION; ER STRESS; DOWN-REGULATION; CELL-DEATH; PATHWAY; ACTIVATION; EXPRESSION; CASPASE-2; TRAIL	Protein folding by the endoplasmic reticulum (ER) is physiologically critical; its disruption causes ER stress and augments disease. ER stress activates the unfolded protein response (UPR) to restore homeostasis. If stress persists, the UPR induces apoptotic cell death, but the mechanisms remain elusive. Here, we report that unmitigated ER stress promoted apoptosis through cell-autonomous, UPR-controlled activation of death receptor 5 (DR5). ER stressors induced DR5 transcription via the UPR mediator CHOP; however, the UPR sensor IRE1 alpha transiently catalyzed DR5 mRNA decay, which allowed time for adaptation. Persistent ER stress built up intracellular DR5 protein, driving ligand-independent DR5 activation and apoptosis engagement via caspase-8. Thus, DR5 integrates opposing UPR signals to couple ER stress and apoptotic cell fate.	[Lu, Min; Lawrence, David A.; Marsters, Scot; Ashkenazi, Avi] Genentech Inc, Canc Immunol, San Francisco, CA 94080 USA; [Acosta-Alvear, Diego; Kimmig, Philipp; Mendez, Aaron S.; Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Acosta-Alvear, Diego; Kimmig, Philipp; Mendez, Aaron S.; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Res Ctr Infect Dis, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Roche Holding; Genentech; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Adelaide	Walter, P (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	peter@walterlab.ucsf.edu; aa@gene.com	Ashkenazi, Avi/ABG-2712-2020; Acosta-Alvear, Diego/V-8048-2019	Ashkenazi, Avi/0000-0002-6890-4589; Acosta-Alvear, Diego/0000-0002-1139-8486	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM032384, T32 GM064337] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032384, T32GM064337] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Korennykh A, 2012, ANNU REV CELL DEV BI, V28, P251, DOI 10.1146/annurev-cellbio-101011-155826; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Martin-Perez R, 2012, APOPTOSIS, V17, P349, DOI 10.1007/s10495-011-0673-2; Niederreiter L, 2013, J EXP MED, V210, P2041, DOI 10.1084/jem.20122341; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Salvesen GS, 2011, CELL, V147, DOI 10.1016/j.cell.2011.09.030; Sandow JJ, 2014, CELL DEATH DIFFER, V21, P475, DOI 10.1038/cdd.2013.168; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	25	377	398	0	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					98	101		10.1126/science.1254312	http://dx.doi.org/10.1126/science.1254312			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994655	Green Accepted			2022-12-01	WOS:000338284400059
J	Shao, DD; Xue, W; Krall, EB; Bhutkar, A; Piccioni, F; Wang, XX; Schinzel, AC; Sood, S; Rosenbluh, J; Kim, JW; Zwang, Y; Roberts, TM; Root, DE; Jacks, T; Hahn, WC				Shao, Diane D.; Xue, Wen; Krall, Elsa B.; Bhutkar, Arjun; Piccioni, Federica; Wang, Xiaoxing; Schinzel, Anna C.; Sood, Sabina; Rosenbluh, Joseph; Kim, Jong W.; Zwang, Yaara; Roberts, Thomas M.; Root, David E.; Jacks, Tyler; Hahn, William C.			KRAS and YAP1 Converge to Regulate EMT and Tumor Survival	CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION SIGNATURE; ONCOGENIC RAS; C-FOS; CANDIDATE ONCOGENE; CONTACT INHIBITION; HIPPO PATHWAY; BETA-CATENIN; ORGAN SIZE; ACTIVATION	Cancer cells that express oncogenic alleles of RAS typically require sustained expression of the mutant allele for survival, but the molecular basis of this oncogene dependency remains incompletely understood. To identify genes that can functionally substitute for oncogenic RAS, we systematically expressed 15,294 open reading frames in a human KRAS-dependent colon cancer cell line engineered to express an inducible KRAS-specific shRNA. We found 147 genes that promoted survival upon KRAS suppression. In particular, the transcriptional coactivator YAP1 rescued cell viability in KRAS-dependent cells upon suppression of KRAS and was required for KRAS-induced cell transformation. Acquired resistance to Kras suppression in a Kras-driven murine lung cancer model also involved increased YAP1 signaling. KRAS and YAP1 converge on the transcription factor FOS and activate a transcriptional program involved in regulating the epithelial-mesenchymal transition (EMT). Together, these findings implicate transcriptional regulation of EMT by YAP1 as a significant component of oncogenic RAS signaling.	[Shao, Diane D.; Krall, Elsa B.; Wang, Xiaoxing; Schinzel, Anna C.; Rosenbluh, Joseph; Kim, Jong W.; Zwang, Yaara; Roberts, Thomas M.; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Shao, Diane D.; Krall, Elsa B.; Piccioni, Federica; Wang, Xiaoxing; Schinzel, Anna C.; Rosenbluh, Joseph; Kim, Jong W.; Zwang, Yaara; Root, David E.; Jacks, Tyler; Hahn, William C.] Harvard & MIT, Broad Inst, Cambridge, MA 02142 USA; [Xue, Wen; Bhutkar, Arjun; Sood, Sabina; Jacks, Tyler] Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Jacks, Tyler] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Jacks, T (corresponding author), Harvard & MIT, Broad Inst, Cambridge, MA 02142 USA.	tjacks@mit.edu; william_hahn@dfci.harvard.edu	Shao, Diane/GRO-3470-2022	Rosenbluh, Joseph/0000-0001-9815-8049; Shao, Diane/0000-0003-2087-4082	U.S. National Institutes of Health [R01 CA140545, U01 CA176058, P01 CA050661, K99 CA169512, T32 GM007753]; National Cancer Institute [P30-CA14051]; Howard Hughes Medical Institute; Daniel K. Ludwig Fund for Cancer Research; American Association for Cancer Research; Leukemia Lymphoma Society; Svenson Family Foundation; Department of Defense [W81XWH-10-1-0062, W81XWH-12-1-0115]; Hope Funds for Cancer Research [HFCR-11-03-03]; NATIONAL CANCER INSTITUTE [P01CA154303, U01CA176058, K99CA169512, R01CA140545, P30CA014051, R00CA169512, P01CA050661, P50CA127003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Daniel K. Ludwig Fund for Cancer Research; American Association for Cancer Research; Leukemia Lymphoma Society(Leukemia and Lymphoma Society); Svenson Family Foundation; Department of Defense(United States Department of Defense); Hope Funds for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by R01 CA140545 (W.C.H.), U01 CA176058 (W.C.H.), P01 CA050661 (W.C.H. and T.M.R.), K99 CA169512 (W.X.), and T32 GM007753 (D.S.) from the U.S. National Institutes of Health; and Koch Institute Support Grant P30-CA14051 (T.J.) from the National Cancer Institute. Additional support was provided by Howard Hughes Medical Institute (T.J.), Daniel K. Ludwig Fund for Cancer Research (T.J.), American Association for Cancer Research (W.X.), the Leukemia Lymphoma Society (W.X.), the Svenson Family Foundation (J.R.), fellowships W81XWH-10-1-0062 (X.W.) and W81XWH-12-1-0115 (Y.Z.) from the Department of Defense, and fellowship HFCR-11-03-03 from Hope Funds for Cancer Research (E.B.K.). T.M.R. and W.C.H. are consultants for Novartis.	Baez MV, 2005, J BIOL CHEM, V280, P43131, DOI 10.1074/jbc.M508374200; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; DENG TL, 1994, NATURE, V371, P171, DOI 10.1038/371171a0; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Eger A, 2000, J CELL BIOL, V148, P173, DOI 10.1083/jcb.148.1.173; Ehrenreiter K, 2009, CANCER CELL, V16, P149, DOI 10.1016/j.ccr.2009.06.008; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Fuchs IB, 2002, ANTICANCER RES, V22, P3415; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Jechlinger M, 2009, GENE DEV, V23, P1677, DOI 10.1101/gad.1801809; Kajiyama H, 2007, INT J ONCOL, V31, P277; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kielbasa SM, 2010, NUCLEIC ACIDS RES, V38, pW275, DOI 10.1093/nar/gkq438; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Lau KS, 2009, MOL CELLS, V28, P315, DOI 10.1007/s10059-009-0143-7; LEDWITH BJ, 1990, MOL CELL BIOL, V10, P1545, DOI 10.1128/MCB.10.4.1545; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Mechta F, 1997, ONCOGENE, V14, P837, DOI 10.1038/sj.onc.1200900; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; O'Donnell A, 2012, BIOCHEM SOC T, V40, P58, DOI 10.1042/BST20110636; Oka T, 2009, GENES CELLS, V14, P607, DOI 10.1111/j.1365-2443.2009.01292.x; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Reddy BVVG, 2013, DEV CELL, V24, P459, DOI 10.1016/j.devcel.2013.01.020; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUDOL M, 1994, ONCOGENE, V9, P2145; Sudol M, 2013, ONCOGENE, V32, P3922, DOI 10.1038/onc.2012.520; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; To MD, 2013, ONCOGENE, V32, P4028, DOI 10.1038/onc.2012.404; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Wang Y, 2010, ONCOGENE, V29, P4658, DOI 10.1038/onc.2010.218; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Wong CE, 2013, GENE DEV, V27, P670, DOI 10.1101/gad.210427.112; Xue W, 2011, CANCER DISCOV, V1, P236, DOI 10.1158/2159-8290.CD-11-0073; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031994; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	59	505	517	6	116	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					171	184		10.1016/j.cell.2014.06.004	http://dx.doi.org/10.1016/j.cell.2014.06.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24954536	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000340943100016
J	van Loosdrecht, MCM; Brdjanovic, D				van Loosdrecht, Mark C. M.; Brdjanovic, Damir			Anticipating the next century of wastewater treatment	SCIENCE			English	Editorial Material							RECOVERY		[van Loosdrecht, Mark C. M.] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands; [Brdjanovic, Damir] UNESCO IHE Inst Water Educ, NL-2611 AX Delft, Netherlands	Delft University of Technology; IHE Delft Institute for Water Education	van Loosdrecht, MCM (corresponding author), Delft Univ Technol, Dept Biotechnol, Julianalaan 67, NL-2628 BC Delft, Netherlands.	m.c.m.vanLoosdrecht@tudelft.nl	van Loosdrecht, Mark C.M./B-2738-2009; van Loosdrecht, Mark/AAA-9997-2019	van Loosdrecht, Mark C.M./0000-0003-0658-4775; 				[Anonymous], [No title captured]; Ardern E., 1914, J SOC CHEM IND LOND, V33, P523, DOI [DOI 10.1002/JCTB.50003, DOI 10.1002/JCTB.5000331005]; Daims H, 2006, TRENDS BIOTECHNOL, V24, P483, DOI 10.1016/j.tibtech.2006.09.002; de Kreuk M, 2005, BIOTECHNOL BIOENG, V90, P761, DOI 10.1002/bit.20470; du Pisani PL, 2006, DESALINATION, V188, P79, DOI 10.1016/j.desal.2005.04.104; Giesen A., 2012, WATER-SUI, V4, P28; Grant SB, 2012, SCIENCE, V337, P681, DOI 10.1126/science.1216852; Guest JS, 2009, ENVIRON SCI TECHNOL, V43, P6126, DOI 10.1021/es9010515; Judd S, 2008, TRENDS BIOTECHNOL, V26, P109, DOI 10.1016/j.tibtech.2007.11.005; Kartal B, 2010, SCIENCE, V328, P702, DOI 10.1126/science.1185941; Law I. B., 2003, WATER J AUST WATER A, V30, P31; Lin Y, 2010, WATER RES, V44, P3355, DOI 10.1016/j.watres.2010.03.019; Loosdrecht M. van, 2012, Water 21, P17; Ruiken CJ, 2013, WATER RES, V47, P43, DOI 10.1016/j.watres.2012.08.023; Siezen RJ, 2008, MICROB BIOTECHNOL, V1, P333, DOI 10.1111/j.1751-7915.2008.00059.x; Vairavamoorthy K., 2010, UNESCO REPORT ENG IS	16	401	411	53	671	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1452	1453		10.1126/science.1255183	http://dx.doi.org/10.1126/science.1255183			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970066				2022-12-01	WOS:000337889900022
J	Seaquist, ER				Seaquist, Elizabeth R.			Addressing the Burden of Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HYPOGLYCEMIA; MORTALITY		Univ Minnesota, Div Endocrinol & Diabet, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Seaquist, ER (corresponding author), Univ Minnesota, Div Endocrinol & Diabet, MMC101,420 Delaware St SE, Minneapolis, MN 55455 USA.	seaqu001@umn.edu						Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Centers for Disease Control and Prevention, DIABETES IN THE UNIT; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Geller AI, 2014, JAMA INTERN MED, V174, P678, DOI 10.1001/jamainternmed.2014.136; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278	10	24	24	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2267	2268		10.1001/jama.2014.6451	http://dx.doi.org/10.1001/jama.2014.6451			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915253				2022-12-01	WOS:000336972600013
J	Pe'er, G; Dicks, LV; Visconti, P; Arlettaz, R; Baldi, A; Benton, TG; Collins, S; Dieterich, M; Gregory, RD; Hartig, F; Henle, K; Hobson, PR; Kleijn, D; Neumann, RK; Robijns, T; Schmidt, J; Shwartz, A; Sutherland, WJ; Turbe, A; Wulf, F; Scott, AV				Pe'er, G.; Dicks, L. V.; Visconti, P.; Arlettaz, R.; Baldi, A.; Benton, T. G.; Collins, S.; Dieterich, M.; Gregory, R. D.; Hartig, F.; Henle, K.; Hobson, P. R.; Kleijn, D.; Neumann, R. K.; Robijns, T.; Schmidt, J.; Shwartz, A.; Sutherland, W. J.; Turbe, A.; Wulf, F.; Scott, A. V.			AGRICULTURE POLICY EU agricultural reform fails on biodiversity	SCIENCE			English	Editorial Material							AGRI-ENVIRONMENT SCHEMES; FARMLAND BIODIVERSITY; HABITAT HETEROGENEITY; POPULATION TRENDS; CONSERVATION; EUROPE; MANAGEMENT; BIRDS; INTENSIFICATION; POLLINATORS		[Pe'er, G.; Henle, K.; Neumann, R. K.] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, D-04318 Leipzig, Germany; [Pe'er, G.; Visconti, P.; Arlettaz, R.; Baldi, A.; Dieterich, M.] Soc Conservat Biol Europe Sect, Washington, DC 20001 USA; [Dicks, L. V.; Sutherland, W. J.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Visconti, P.] Microsoft Res, Computat Sci Lab Cambridge, Cambridge CB1 2FB, England; [Arlettaz, R.] Univ Bern, Inst Ecol & Evolut, Dept Conservat Biol, Bern, Switzerland; [Baldi, A.] MTA Ctr Ecol Res, H-2163 Vacratot, Hungary; [Benton, T. G.] Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; [Collins, S.] Butterfly Conservat Europe, Wageningen, Netherlands; [Dieterich, M.] Univ Hohenheim, Inst Landscape & Plant Ecol, D-70599 Stuttgart, Germany; [Gregory, R. D.] The Lodge, RSPB Ctr Conservat Sci, Sandy SG19 2DL, Beds, England; [Hartig, F.] Univ Freiburg, Dept Biometry & Environm Syst Anal, D-79085 Freiburg, Germany; [Hobson, P. R.] Eberswalde Univ Sustainable Dev, Ctr Econ & Ecosyst Management, D-16225 Eberswalde, Germany; [Kleijn, D.] Wageningen Univ, Resource Ecol Grp, NL-6708 PB Wageningen, Netherlands; [Kleijn, D.] Alterra, Anim Ecol Team, NL-6700 AA Wageningen, Netherlands; [Robijns, T.] Stichting BirdLife Europe, B-1060 Brussels, Belgium; [Schmidt, J.] UFZ Helmholtz Ctr Environm Res, Dept Environm Polit, D-04318 Leipzig, Germany; [Shwartz, A.] Technion Israel Inst Technol, Fac Architecture & Town Planning, IL-32000 Haifa, Israel; [Shwartz, A.] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NZ, Kent, England; [Turbe, A.] BIO Intelligence Serv, F-9200 Neuilly Sur Seine, France; [Wulf, F.] Pro Natura Friends Earth Switzerland, CH-4018 Basel, Switzerland; [Scott, A. V.] Univ Reading, Sch Agr Policy & Dev, CAER, Reading RG6 6AR, Berks, England	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Cambridge; Microsoft; University of Bern; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; University of Leeds; University Hohenheim; Royal Society for Protection of Birds; University of Freiburg; Eberswalde University for Sustainable Development; Wageningen University & Research; Wageningen University & Research; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technion Israel Institute of Technology; University of Kent; University of Reading	Pe'er, G (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, D-04318 Leipzig, Germany.	guy.peer@ufz.de; guy.peer@ufz.de	Kleijn, David/HCH-3477-2022; Baldi, Andras/A-7501-2008; Benton, Tim G/C-6493-2009; Henle, Klaus/I-6837-2013; Hartig, Florian/G-4510-2010; Arlettaz, Raphaël/O-2182-2016; Dicks, Lynn V./AFH-5289-2022; Visconti, Piero/A-3253-2009	Baldi, Andras/0000-0001-6063-3721; Benton, Tim G/0000-0002-7448-1973; Henle, Klaus/0000-0002-6647-5362; Hartig, Florian/0000-0002-6255-9059; Arlettaz, Raphaël/0000-0001-6360-5339; Visconti, Piero/0000-0001-6823-2826; Sutherland, William/0000-0002-6498-0437; Dicks, Lynn/0000-0002-8304-4468; Kleijn, David/0000-0003-2500-7164; Gregory, Richard/0000-0002-7419-5053	BBSRC [BB/J005851/1] Funding Source: UKRI; NERC [NE/K015419/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J005851/1] Funding Source: researchfish; Natural Environment Research Council [NE/K015419/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		[Anonymous], 2011, OUR NAT CAP EU BIOD; AVIRON S, 2005, EVAL OKOMASS BER BIO; Babai D, 2014, AGR ECOSYST ENVIRON, V182, P123, DOI 10.1016/j.agee.2013.08.018; Baker DJ, 2012, J APPL ECOL, V49, P871, DOI 10.1111/j.1365-2664.2012.02161.x; Batary P, 2011, P ROY SOC B-BIOL SCI, V278, P1894, DOI 10.1098/rspb.2010.1923; Batary P, 2011, FRONT ECOL ENVIRON, V9, P152, DOI 10.1890/11.WB.006; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; *BIRDLIFE INT, 2003, BIRDS EUR POP EST TR; Bommarco R, 2013, TRENDS ECOL EVOL, V28, P230, DOI 10.1016/j.tree.2012.10.012; *BTO, 2013, BIRD IND IND UPD OCT; Buri P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085635; Buri P, 2013, AGR ECOSYST ENVIRON, V181, P22, DOI 10.1016/j.agee.2013.09.003; Burton RJF, 2013, LAND USE POLICY, V30, P628, DOI 10.1016/j.landusepol.2012.05.002; Butler SJ, 2010, AGR ECOSYST ENVIRON, V137, P348, DOI 10.1016/j.agee.2010.03.005; Carvalheiro LG, 2013, ECOL LETT, V16, P870, DOI 10.1111/ele.12121; Cizek O, 2012, J INSECT CONSERV, V16, P215, DOI 10.1007/s10841-011-9407-6; COLLINS S, 2014, IMPROVING MANAGEMENT; Dicks LV, 2014, CONSERV LETT, V7, P119, DOI 10.1111/conl.12046; Dicks LV, 2013, INSECT CONSERV DIVER, V6, P435, DOI 10.1111/j.1752-4598.2012.00221.x; DIETERICH M, 2012, DEFIZIT NAT 2000 SIT; Dover JW, 2011, J INSECT CONSERV, V15, P129, DOI 10.1007/s10841-010-9332-0; Emery SB, 2012, J RURAL STUD, V28, P218, DOI 10.1016/j.jrurstud.2012.02.004; *EUR COMM, 2010, CAP TOW 2020 MEET FO; *EUR COMM, 2013, 6 FIN REP COMM EUR P; *EUR COMM, 2012, EU BUDG 2012 500 MIL; *EUR COMM, 2012, NAT BIOD LIFE PROJ 2; *EUR ENV AG, 2010, 122010 EEA TECH REP; *EUR ENV AG, 2013, 112013 EEA TECH REP; European Environment Agency, 2004, EEA SIGN 2004 EUR EN; European Parliament, 2013, DIR GEN INT POL POL; FAO (Food and Agriculture Organization of the United Nations), 2013, FAO STAT YB 2013; *FED OFF AGR BLW, 2013, BUND LANDW 2013 AGR; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Fischer J, 2012, CONSERV LETT, V5, P167, DOI 10.1111/j.1755-263X.2012.00227.x; GEROWITT B., 2011, CHANCEN BIOL VIELFAL; Gilroy JJ, 2011, ANIM CONSERV, V14, P620, DOI 10.1111/j.1469-1795.2011.00480.x; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Gregory RD, 2010, ORNITHOL SCI, V9, P3, DOI 10.2326/osj.9.3; Hartel T, 2013, BIOL CONSERV, V166, P267, DOI 10.1016/j.biocon.2013.06.020; Helberg N, 2012, CAN J PLANT SCI, V92, P981, DOI [10.4141/cjps2012-035, 10.4141/CJPS2012-035]; Henle K, 2008, AGR ECOSYST ENVIRON, V124, P60, DOI 10.1016/j.agee.2007.09.005; Henle K, 2013, ECOL INDIC, V33, P5, DOI 10.1016/j.ecolind.2013.03.028; Hole DG, 2005, BIOL CONSERV, V122, P113, DOI 10.1016/j.biocon.2004.07.018; IEEP, 2012, BACKGR STUD BIOD PRO; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Kleijn D, 2011, TRENDS ECOL EVOL, V26, P474, DOI 10.1016/j.tree.2011.05.009; Knight AT, 2008, CONSERV BIOL, V22, P610, DOI 10.1111/j.1523-1739.2008.00914.x; Konvicka M, 2008, J INSECT CONSERV, V12, P519, DOI 10.1007/s10841-007-9092-7; MCCULLAGH P, 1989, GENERAL LINEAR MODEL; Merckx T, 2009, AGR ECOSYST ENVIRON, V130, P177, DOI 10.1016/j.agee.2009.01.006; Mikulcak F, 2013, ENVIRON CONSERV, V40, P129, DOI 10.1017/S0376892912000392; Oppermann R., 2012, COMMON AGR POLICY 20; Pannekoek J., 2003, TRIM 3 MANUAL TRENDS; PARACCHINI ML, 2008, HIGH NAT VALUE FARML; Pe'er G, 2014, BIOL CONSERV, V170, P92, DOI 10.1016/j.biocon.2013.12.011; Pe'er G, 2011, DIVERS DISTRIB, V17, P1186, DOI 10.1111/j.1472-4642.2011.00795.x; POLAKOVA J, 2011, REP DF AGR RURAL DEV; Pywell RF, 2012, BIOL LETTERS, V8, P772, DOI 10.1098/rsbl.2012.0367; RIBBE L, 2011, EINE OKOL ERSTE EINE; Rutz C., 2013, SOCIOL RURAL; *SOC CONS BIOL EUR, 2013, EVID GRASSL MAPP MEM; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Sutherland LA, 2012, LAND USE POLICY, V29, P502, DOI 10.1016/j.landusepol.2011.09.003; Sutherland LA, 2010, LAND USE POLICY, V27, P415, DOI 10.1016/j.landusepol.2009.06.003; *TEEB, 2010, EC EC BIOD EC EC FOU; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Tscharntke T, 2011, AGR ECOSYST ENVIRON, V143, P37, DOI 10.1016/j.agee.2010.11.025; TUCK SL, 2014, J APPL ECOL; Tzanopoulos J, 2013, GLOBAL ENVIRON CHANG, V23, P167, DOI 10.1016/j.gloenvcha.2012.09.002; *UBA, 2014, OKOL VORR UNVERZ BIO; Van Herzele A, 2013, J ENVIRON MANAGE, V131, P110, DOI 10.1016/j.jenvman.2013.09.030; Van Strien AJ, 2001, BIRD STUDY, V48, P200, DOI 10.1080/00063650109461219; Vickery J., 2012, BIRDS HABITAT RELATI, P177, DOI DOI 10.1017/CBO9781139021654.009; Winqvist C, 2011, J APPL ECOL, V48, P570, DOI 10.1111/j.1365-2664.2010.01950.x; World Resources Institute, 2005, ECOS HUM WELL BEING	78	398	417	7	308	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1090	1092		10.1126/science.1253425	http://dx.doi.org/10.1126/science.1253425			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904142				2022-12-01	WOS:000336791200023
J	Burke, JE; Inglis, AJ; Perisic, O; Masson, GR; McLaughlin, SH; Rutaganira, F; Shokat, KM; Williams, RL				Burke, John E.; Inglis, Alison J.; Perisic, Olga; Masson, Glenn R.; McLaughlin, Stephen H.; Rutaganira, Florentine; Shokat, Kevan M.; Williams, Roger L.			Structures of PI4KIII beta complexes show simultaneous recruitment of Rab11 and its effectors	SCIENCE			English	Article							PHOSPHATIDYLINOSITOL 4-KINASES; MEMBRANE RECRUITMENT; RECYCLING ENDOSOME; GOLGI-COMPLEX; REPLICATION; FAMILY; P110-ALPHA; COMPONENTS; PROTEINS; PATHWAY	Phosphatidylinositol 4-kinases (PI4Ks) and small guanosine triphosphatases (GTPases) are essential for processes that require expansion and remodeling of phosphatidylinositol 4-phosphate (PI4P)-containing membranes, including cytokinesis, intracellular development of malarial pathogens, and replication of a wide range of RNA viruses. However, the structural basis for coordination of PI4K, GTPases, and their effectors is unknown. Here, we describe structures of PI4K beta (PI4KIII beta) bound to the small GTPase Rab11a without and with the Rab11 effector protein FIP3. The Rab11-PI4KIII beta interface is distinct compared with known structures of Rab complexes and does not involve switch regions used by GTPase effectors. Our data provide a mechanism for how PI4KIII beta coordinates Rab11 and its effectors on PI4P-enrichedmembranes and also provide strategies for the design of specific inhibitors that could potentially target plasmodial PI4KIII beta to combat malaria.	[Burke, John E.; Inglis, Alison J.; Perisic, Olga; Masson, Glenn R.; McLaughlin, Stephen H.; Williams, Roger L.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Rutaganira, Florentine; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Rutaganira, Florentine; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	MRC Laboratory Molecular Biology; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Burke, JE (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.	jeburke@uvic.ca; rlw@mrc-lmb.cam.ac.uk	Burke, John/H-3922-2019; Masson, Glenn/AAD-6546-2022	Burke, John/0000-0001-7904-9859; McLaughlin, Stephen/0000-0001-9135-6253; Williams, Roger/0000-0001-7754-4207; Inglis, Alison/0000-0002-9008-8565; Perisic, Olga/0000-0002-3842-2896; Masson, Glenn/0000-0002-1386-4719	British Heart Foundation [PG11/109/29247]; NSF; NIH [RO1AI099245]; UK MRC [MC_U105184308]; MRC [MC_U105184308] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM064337] Funding Source: NIH RePORTER; British Heart Foundation [PG/11/109/29247] Funding Source: researchfish; Medical Research Council [1358691, MC_U105184308] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C. Mueller-Dieckmann and D. De Sanctis at the European Synchrotron Radiation Facility and C. Lobley at Diamond Light Source for assistance with beamlines ID23-EH2, ID29, and I04-1; S. Maslen, M. Skehel, and S. Y. Peak-Chew for help with HDX-MS setup; and M. Yu for help with x-ray data collection. J.E.B. was supported by a grant from the British Heart Foundation (PG11/109/29247) and F. Rutaganira by an NSF predoctoral fellowship. This work was funded by the NIH (RO1AI099245 to K. M. S.) and the UK MRC (MC_U105184308 to R. L. W). K. M. S. has filed for patent protection on PIK93 analogs in the following application between UCSF and Stanford University: PCT/US2012/059023. Coordinates and structure factors have been deposited in the Protein Data Bank with accession numbers 4D0L and 4D0M, for PI4KIII beta/Rab11a and PI4KIII beta/Rab11a/FIP3 complexes, respectively. Author contributions: J.E.B., O.P., and R. L. W. initiated the project and designed the experiments; J.E.B., A.J.I., G. R. M., and O.P. performed the experiments; J.E.B. and R. L. W. carried out the structure determination and analysis; S. H. M. performed SPR analysis; F. R. and K. M. S. synthesized PI4K inhibitors; and J.E.B., O.P., and R. L. W. wrote the manuscript.	Altan-Bonnet N, 2012, TRENDS BIOCHEM SCI, V37, P293, DOI 10.1016/j.tibs.2012.03.004; Arita M, 2011, J VIROL, V85, P2364, DOI 10.1128/JVI.02249-10; Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Balla A, 2008, BIOCHEMISTRY-US, V47, P1599, DOI 10.1021/bi7017927; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; D'Angelo G, 2013, NATURE, V501, DOI 10.1038/nature12423; de Graaf P, 2004, MOL BIOL CELL, V15, P2038, DOI 10.1091/mbc.e03-12-0862; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Horgan CP, 2007, TRAFFIC, V8, P414, DOI 10.1111/j.1600-0854.2007.00543.x; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Jagoe WN, 2006, STRUCTURE, V14, P1273, DOI 10.1016/j.str.2006.06.010; Jean S, 2012, NAT REV MOL CELL BIO, V13, P463, DOI 10.1038/nrm3379; Kelly EE, 2012, BIOCHEM SOC T, V40, P1360, DOI 10.1042/BST20120157; Khan AR, 2013, STRUCTURE, V21, P1284, DOI 10.1016/j.str.2013.06.016; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; McNamara CW, 2013, NATURE, V504, P248, DOI 10.1038/nature12782; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Mizuno-Yamasaki E, 2010, DEV CELL, V18, P828, DOI 10.1016/j.devcel.2010.03.016; Polevoy G, 2009, J CELL BIOL, V187, P847, DOI 10.1083/jcb.200908107; Santiago-Tirado FH, 2011, TRENDS CELL BIOL, V21, P515, DOI 10.1016/j.tcb.2011.05.005; Sciorra VA, 2005, MOL BIOL CELL, V16, P776, DOI 10.1091/mbc.E04-08-0700; Shiba T, 2006, P NATL ACAD SCI USA, V103, P15416, DOI 10.1073/pnas.0605357103; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; van der Schaar HM, 2013, ANTIMICROB AGENTS CH, V57, P4971, DOI 10.1128/AAC.01175-13; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927	30	96	99	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1035	1038		10.1126/science.1253397	http://dx.doi.org/10.1126/science.1253397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876499	Green Accepted			2022-12-01	WOS:000336495800047
J	Dail, M; Wong, J; Lawrence, J; O'Connor, D; Nakitandwe, J; Chen, SC; Xu, J; Lee, LB; Akagi, K; Li, Q; Aster, JC; Pear, WS; Downing, JR; Sampath, D; Shannon, K				Dail, Monique; Wong, Jason; Lawrence, Jessica; O'Connor, Daniel; Nakitandwe, Joy; Chen, Shann-Ching; Xu, Jin; Lee, Leslie B.; Akagi, Keiko; Li, Qing; Aster, Jon C.; Pear, Warren S.; Downing, James R.; Sampath, Deepak; Shannon, Kevin			Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; PTEN; MUTATIONS; FREQUENCY	Mutations that deregulate Notch1 and Ras/phosphoinositide 3 kinase (PI3K)/Akt signalling are prevalent in T-cell acute lymphoblastic leukaemia (T-ALL), and often coexist. Here we show that the PI3K inhibitor GDC-0941 is active against primary T-ALLs from wild-type and Kras(G12D) mice, and addition of the MEK inhibitor PD0325901 increases its efficacy. Mice invariably relapsed after treatment with drug-resistant clones, most of which unexpectedly had reduced levels of activated Notch1 protein, downregulated many Notch1 target genes, and exhibited cross-resistance to gamma-secretase inhibitors. Multiple resistant primary T-ALLs that emerged in vivo did not contain somatic Notch1 mutations present in the parental leukaemia. Importantly, resistant clones upregulated PI3K signalling. Consistent with these data, inhibiting Notch1 activated the PI3K pathway, providing a likely mechanism for selection against oncogenic Notch1 signalling. These studies validate PI3K as a therapeutic target in T-ALL and raise the unexpected possibility that dual inhibition of PI3K and Notch1 signalling could promote drug resistance in T-ALL.	[Dail, Monique; Wong, Jason; Lawrence, Jessica; O'Connor, Daniel; Xu, Jin; Shannon, Kevin] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Dail, Monique; Wong, Jason; Lawrence, Jessica; O'Connor, Daniel; Xu, Jin; Shannon, Kevin] Univ Calif San Francisco, Benniof Childrens Hosp, San Francisco, CA 94143 USA; [Nakitandwe, Joy; Chen, Shann-Ching; Downing, James R.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Lee, Leslie B.; Sampath, Deepak] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Akagi, Keiko] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Li, Qing] Univ Michigan, Dept Med, Div Haematol Oncol, Ann Arbor, MI 48109 USA; [Aster, Jon C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Pear, Warren S.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Pear, Warren S.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; St Jude Children's Research Hospital; Roche Holding; Genentech; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Shannon, K (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	shannonk@peds.ucsf.edu	Downing, James R./N-8102-2018		William Lawrence and Blanche Hughes Foundation; Specialized Center of Research (SCOR) from the Leukaemia and Lymphoma Society of America [7019, 7703]; National Institutes of Health [R37 CA72614, R01 CA180037, K99 CA157950, K08 CA134649, P01 CA119070]; ALSAC of St. Jude Children's Research Hospital; Ohio Supercomputer Center [PAS0425]; Ohio Cancer Research Associate [GRT00024299]; American Cancer Society (ACS); NATIONAL CANCER INSTITUTE [K08CA134649, T32CA128583, K99CA157950, P01CA119070, R37CA072614, U01CA084221, R01CA180037, P30CA021765] Funding Source: NIH RePORTER	William Lawrence and Blanche Hughes Foundation; Specialized Center of Research (SCOR) from the Leukaemia and Lymphoma Society of America; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALSAC of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Ohio Supercomputer Center; Ohio Cancer Research Associate; American Cancer Society (ACS)(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the William Lawrence and Blanche Hughes Foundation to J.C.A. and K. S.; by Specialized Center of Research (SCOR) awards 7019 and 7703 from the Leukaemia and Lymphoma Society of America; by National Institutes of Health grants R37 CA72614 and R01 CA180037 (to K. S.), K99 CA157950 (to M. D.), K08 CA134649 (to Q. L.) and P01 CA119070 (to J.C.A. and W. S. P.), and by the ALSAC of St. Jude Children's Research Hospital (J.R.D.). K. A. is supported by the Ohio Supercomputer Center (#PAS0425) and is an Ohio Cancer Research Associate (#GRT00024299); and J.X received a Research Fellowship from the American Cancer Society (ACS). K. S. is an ACS Research Professor. We are grateful to T. Jacks and D. Tuveson for Kras<SUP>G12D</SUP> mice; to L. Wolff for the MOL4070 virus; and to D. Largaespada and G. Narla for sharing their advice and expertise.	Aster JC, 1997, J BIOL CHEM, V272, P11336; Aster JC, 2012, J CLIN ONCOL, V30, P2418, DOI 10.1200/JCO.2012.42.0992; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Blackburn JS, 2014, CANCER CELL, V25, P366, DOI 10.1016/j.ccr.2014.01.032; Brown AP, 2007, CANCER CHEMOTH PHARM, V59, P671, DOI 10.1007/s00280-006-0323-5; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Corcoran RB, 2011, ONCOTARGET, V2, P336; Dail M, 2010, P NATL ACAD SCI USA, V107, P5106, DOI 10.1073/pnas.1001064107; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gutierrez A, 2007, CANCER CELL, V12, P411, DOI 10.1016/j.ccr.2007.10.027; Gutierrez A, 2011, J EXP MED, V208, P1595, DOI 10.1084/jem.20101691; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Hales EC, 2013, J BIOL CHEM, V288, P22836, DOI 10.1074/jbc.M113.451625; HAWLEY RG, 1994, GENE THER, V1, P136; Jotta PY, 2010, LEUKEMIA, V24, P239, DOI 10.1038/leu.2009.209; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lauchle JO, 2009, NATURE, V461, P411, DOI 10.1038/nature08279; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Mansour MR, 2007, CLIN CANCER RES, V13, P6964, DOI 10.1158/1078-0432.CCR-07-1474; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; Shieh A., 2013, BLOOD; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Tosello V, 2013, THER ADV HEMATOL, V4, P199, DOI 10.1177/2040620712471368; Trinquand A, 2013, J CLIN ONCOL, V31, P4333, DOI 10.1200/JCO.2012.48.5292; Tzoneva G, 2013, NAT MED, V19, P368, DOI 10.1038/nm.3078; Wendorff AA, 2010, IMMUNITY, V33, P671, DOI 10.1016/j.immuni.2010.11.014; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zuber J, 2011, GENE DEV, V25, P1628, DOI 10.1101/gad.17269211	33	47	49	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					512	+		10.1038/nature13495	http://dx.doi.org/10.1038/nature13495			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25043004	Green Accepted			2022-12-01	WOS:000342075800032
J	Zhang, B; Wang, J; Wang, X; Zhu, J; Liu, Q; Shi, Z; Chambers, MC; Zimmerman, LJ; Shaddox, KF; Kim, S; Davies, SR; Wang, S; Wang, P; Kinsinger, CR; Rivers, RC; Rodriguez, H; Townsend, RR; Ellis, MJC; Carr, SA; Tabb, DL; Coffey, RJ; Slebos, RJC; Liebler, DC				Zhang, Bing; Wang, Jing; Wang, Xiaojing; Zhu, Jing; Liu, Qi; Shi, Zhiao; Chambers, Matthew C.; Zimmerman, Lisa J.; Shaddox, Kent F.; Kim, Sangtae; Davies, Sherri R.; Wang, Sean; Wang, Pei; Kinsinger, Christopher R.; Rivers, Robert C.; Rodriguez, Henry; Townsend, R. Reid; Ellis, Matthew J. C.; Carr, Steven A.; Tabb, David L.; Coffey, Robert J.; Slebos, Robbert J. C.; Liebler, Daniel C.		NCI CPTAC	Proteogenomic characterization of human colon and rectal cancer	NATURE			English	Article							RNA-SEQ DATA; PROTEIN EXPRESSION; COLORECTAL-CANCER; PEPTIDE IDENTIFICATION; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY; ANALYSIS REVEALS; GENE; ABUNDANCE; HNF4-ALPHA	Extensive genomic characterization of human cancers presents the problem of inference from genomic abnormalities to cancer phenotypes. To address this problem, we analysed proteomes of colon and rectal tumours characterized previously by The Cancer Genome Atlas (TCGA) and perform integrated proteogenomic analyses. Somatic variants displayed reduced protein abundance compared to germline variants. Messenger RNA transcript abundance did not reliably predict protein abundance differences between tumours. Proteomics identified five proteomic subtypes in the TCGA cohort, two of which overlapped with the TCGA 'microsatellite instability/CpG island methylation phenotype' transcriptomic subtype, but had distinct mutation, methylation and protein expression patterns associated with different clinical outcomes. Although copy number alterations showed strong cis- and trans-effects on mRNA abundance, relatively few of these extend to the protein level. Thus, proteomics data enabled prioritization of candidate driver genes. The chromosome 20q amplicon was associated with the largest global changes at both mRNA and protein levels; proteomics data highlighted potential 20q candidates, including HNF4A(hepatocyte nuclear factor 4, alpha), TOMM34 (translocase of outer mitochondrial membrane 34) and SRC (SRC proto-oncogene, non-receptor tyrosine kinase). Integrated proteogenomic analysis provides functional context to interpret genomic abnormalities and affords a new paradigm for understanding cancer biology.	[Zhang, Bing; Wang, Jing; Wang, Xiaojing; Zhu, Jing; Liu, Qi; Chambers, Matthew C.; Tabb, David L.] Vanderbilt Univ Sch Med, Dept Biomed Informat, Nashville, TN 37232 USA; [Zhang, Bing; Slebos, Robbert J. C.] Vanderbilt Univ Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Shi, Zhiao] Vanderbilt Univ, Adv Comp Ctr Res & Educ, Nashville, TN 37232 USA; [Shi, Zhiao] Vanderbilt Univ, Dept Elect Engn & Comp Sci, Nashville, TN 37232 USA; [Zimmerman, Lisa J.; Liebler, Daniel C.] Vanderbilt Univ Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Zimmerman, Lisa J.; Shaddox, Kent F.; Slebos, Robbert J. C.; Liebler, Daniel C.] Vanderbilt Ingram Canc Ctr, Jim Ayers Inst Precanc Detect & Diag, Nashville, TN 37232 USA; [Kim, Sangtae] Pacific NW Natl Lab, Directorate Fundamental & Computat Sci, Richland, WA 99352 USA; [Davies, Sherri R.; Townsend, R. Reid; Ellis, Matthew J. C.] Washington Univ Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Wang, Sean] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Wang, Pei] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA; [Kinsinger, Christopher R.; Rivers, Robert C.; Rodriguez, Henry] NCI, Off Canc Clin Prote Res, Bethesda, MD 20892 USA; [Carr, Steven A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Coffey, Robert J.] Vanderbilt Univ Sch Med, Dept Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Washington University (WUSTL); Fred Hutchinson Cancer Center; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Vanderbilt University	Liebler, DC (corresponding author), Vanderbilt Univ Sch Med, Dept Biochem, Nashville, TN 37232 USA.	daniel.liebler@vanderbilt.edu	Carr, Steven A./AAH-8366-2019; Smith, Richard D/J-3664-2012	Smith, Richard D/0000-0002-2381-2349; Tabb, David/0000-0001-7223-578X; Mani, D. R./0000-0003-3914-133X; McGarvey, Peter/0000-0002-8312-6017; White, Forest/0000-0002-1545-1651; Payne, Samuel/0000-0002-8351-1994; Davies, Sherri/0000-0002-7141-8354; Liebler, Daniel/0000-0002-7873-3031; McDermott, Jason/0000-0003-2961-2572; Fenyo, David/0000-0001-5049-3825; Wang, Pei/0000-0002-6890-6453; Levine, Douglas/0000-0003-1038-8232	National Cancer Institute (NCI) CPTAC awards [U24CA159988, U24CA160035, U24CA160034]; NCI SPORE award [P50CA095103]; NCI Cancer Center Support Grant [P30CA068485]; National Institutes of Health [GM088822]; Leidos Biomedical Research, Inc. [13XS029]; NATIONAL CANCER INSTITUTE [U24CA160035, P30CA068485, U24CA160034, U24CA160019, P50CA095103, R01CA046413, U24CA159988] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088822] Funding Source: NIH RePORTER	National Cancer Institute (NCI) CPTAC awards; NCI SPORE award; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leidos Biomedical Research, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Cancer Institute (NCI) CPTAC awards U24CA159988, U24CA160035, and U24CA160034; by NCI SPORE award P50CA095103 and NCI Cancer Center Support Grant P30CA068485; by National Institutes of Health grant GM088822; and by contract 13XS029 from Leidos Biomedical Research, Inc. Genomics data for this study were generated by The Cancer Genome Atlas pilot project established by the NCI and the National Human Genome Research Institute. Information about TCGA and the investigators and institutions comprising the TCGA research network can be found at http://cancergenome.nih.gov/.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cancer Genome Atlas Res. Netw, 2012, NATURE, V490, P292; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chellappa K, 2012, BIOMARK MED, V6, P297, DOI [10.2217/bmm.12.23, 10.2217/BMM.12.23]; Chellappa K, 2012, P NATL ACAD SCI USA, V109, P2302, DOI 10.1073/pnas.1106799109; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Darsigny M, 2010, CANCER RES, V70, P9423, DOI 10.1158/0008-5472.CAN-10-1697; Dasari S, 2012, J PROTEOME RES, V11, P1686, DOI 10.1021/pr200874e; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Foss EJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001144; Fu J, 2009, NAT GENET, V41, P166, DOI 10.1038/ng.308; Gallien S, 2012, MOL CELL PROTEOMICS, V11, P1709, DOI 10.1074/mcp.O112.019802; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Geiger T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001574; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Halvey PJ, 2014, CANCER RES, V74, P387, DOI 10.1158/0008-5472.CAN-13-2488; Halvey PJ, 2012, J PROTEOME RES, V11, P1184, DOI 10.1021/pr2009109; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Kiemer AK, 2001, ONCOGENE, V20, P6679, DOI 10.1038/sj.onc.1204872; Kim S, 2010, MOL CELL PROTEOMICS, V9, P2840, DOI 10.1074/mcp.M110.003731; Kim WK, 2013, CLIN CANCER RES, V19, P3369, DOI 10.1158/1078-0432.CCR-13-0684; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li M, 2010, J PROTEOME RES, V9, P4295, DOI 10.1021/pr100527g; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Licklider LJ, 2002, ANAL CHEM, V74, P3076, DOI 10.1021/ac025529o; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu Q, 2013, MOL CELL PROTEOMICS, V12, P1900, DOI 10.1074/mcp.M112.025783; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Ma ZQ, 2011, BIOINFORMATICS, V27, P3214, DOI 10.1093/bioinformatics/btr544; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ning K, 2012, J PROTEOME RES, V11, P2261, DOI 10.1021/pr201052x; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Peng J, 2010, ANN APPL STAT, V4, P53, DOI 10.1214/09-AOAS271; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Saandi T, 2013, ONCOGENE, V32, P3782, DOI 10.1038/onc.2012.401; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwartz B, 2009, INT J CANCER, V124, P1081, DOI 10.1002/ijc.24041; Shi ZA, 2013, NAT METHODS, V10, P597, DOI 10.1038/nmeth.2517; Shimokawa T, 2006, INT J ONCOL, V29, P381; Slebos RJC, 2013, INT J CANCER, V132, P568, DOI 10.1002/ijc.27699; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Turner B, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq023; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang J, 2012, BRIEF BIOINFORM, V13, P216, DOI 10.1093/bib/bbr041; Wang P., 2010, STAT METHODS CGH ARR; Wang XJ, 2013, BIOINFORMATICS, V29, P3235, DOI 10.1093/bioinformatics/btt543; Wang XJ, 2012, J PROTEOME RES, V11, P1009, DOI 10.1021/pr200766z; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273; Zhou JY, 2010, J PROTEOME RES, V9, P5698, DOI 10.1021/pr100508p; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	82	899	916	10	308	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					382	+		10.1038/nature13438	http://dx.doi.org/10.1038/nature13438			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043054	Green Submitted, Green Accepted			2022-12-01	WOS:000341814900052
J	Zhang, YN; Nicholatos, J; Dreier, JR; Ricoult, SJH; Widenmaier, SB; Hotamisligil, GS; Kwiatkowski, DJ; Manning, BD				Zhang, Yinan; Nicholatos, Justin; Dreier, John R.; Ricoult, Stephane J. H.; Widenmaier, Scott B.; Hotamisligil, Goekhan S.; Kwiatkowski, David J.; Manning, Brendan D.			Coordinated regulation of protein synthesis and degradation by mTORC1	NATURE			English	Article							ACTIVATION; HOMEOSTASIS; AUTOPHAGY; SREBP-1A; PATHWAY; COMPLEX; TARGET; GENES	Eukaryotic cells coordinately control anabolic and catabolic processes to maintain cell and tissue homeostasis. Mechanistic target of rapamycin complex 1 (mTORC1) promotes nutrient-consuming anabolic processes, such as protein synthesis(1). Here we show that as well as increasing protein synthesis, mTORC1 activation in mouse and human cells also promotes an increased capacity for protein degradation. Cells with activated mTORC1 exhibited elevated levels of intact and active proteasomes through a global increase in the expression of genes encoding proteasome subunits. The increase in proteasome gene expression, cellular proteasome content, and rates of protein turnover downstream of mTORC1 were all dependent on induction of the transcription factor nuclear factor erythroid-derived 2-related factor 1 (NRF1; also known as NFE2L1). Genetic activation of mTORC1 through loss of the tuberous sclerosis complex tumour suppressors, TSC1 or TSC2, or physiological activation of mTORC1 in response to growth factors or feeding resulted in increased NRF1 expression in cells and tissues. We find that this NRF1-dependent elevation in proteasome levels serves to increase the intracellular pool of amino acids, which thereby influences rates of new protein synthesis. Therefore, mTORC1 signalling increases the efficiency of proteasome-mediated protein degradation for both quality control and as a mechanism to supply substrate for sustained protein synthesis.	[Zhang, Yinan; Nicholatos, Justin; Ricoult, Stephane J. H.; Widenmaier, Scott B.; Hotamisligil, Goekhan S.; Manning, Brendan D.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Dreier, John R.; Kwiatkowski, David J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Translat Med Div,Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Manning, BD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	bmanning@hsph.harvard.edu	Manning, Brendan/ABD-6528-2021; Zhang, Yinan/N-6432-2014	Manning, Brendan/0000-0003-3895-5956; Zhang, Yinan/0000-0002-3471-6598; Widenmaier, Scott/0000-0001-5684-2707; Nicholatos, Justin/0000-0002-5433-3041	Department of Defense Tuberous Sclerosis Complex Research Program [W81XWH-10-1-0861]; National Institutes of Health [CA122617, CA120964]; Ellison Medical Foundation; National Science Foundation [DGE-1144152]; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [P01CA120964, R01CA122617] Funding Source: NIH RePORTER	Department of Defense Tuberous Sclerosis Complex Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Science Foundation(National Science Foundation (NSF)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank I. Ben-Sahra and L. Yang for technical assistance. This work was supported in part by Department of Defense Tuberous Sclerosis Complex Research Program grant W81XWH-10-1-0861 (B. D. M.), National Institutes of Health grants CA122617 (B. D. M.) and CA120964 (B. D. M. and D.J.K.), the Ellison Medical Foundation (B. D. M.), National Science Foundation fellowship DGE-1144152 (S.J.H.R.), and a Canadian Institutes of Health Research fellowship (S.B.W.).	Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; El-Hashemite N, 2003, LANCET, V361, P1348, DOI 10.1016/S0140-6736(03)13044-9; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CS, 2013, FEBS J, V280, P3609, DOI 10.1111/febs.12350; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Radhakrishnan SK, 2014, ELIFE, V3, DOI [10.7554/elife.01856, 10.7554/eLife.01856]; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yuan E, 2012, HUM MOL GENET, V21, P4286, DOI 10.1093/hmg/dds262; Zerenturk EJ, 2012, BBA-MOL CELL BIOL L, V1821, P1350, DOI 10.1016/j.bbalip.2012.07.006; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	27	206	210	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					440	+		10.1038/nature13492	http://dx.doi.org/10.1038/nature13492			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043031	Green Accepted			2022-12-01	WOS:000341814900065
J	Perkins, RB; Stier, EA				Perkins, Rebecca B.; Stier, Elizabeth A.			Should U.S. Women Be Screened for Cervical Cancer With Pap Tests, HPV Tests, or Both?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HUMAN-PAPILLOMAVIRUS; ABNORMALITIES; CYTOLOGY		[Perkins, Rebecca B.; Stier, Elizabeth A.] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University	Perkins, RB (corresponding author), Boston Univ, Sch Med, 85 East Concord St,6th Floor, Boston, MA 02118 USA.	rbperkin@bu.edu		Stier, Elizabeth/0000-0003-3526-0032; Perkins, Rebecca/0000-0002-7054-3014				Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; Gertig DM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-227; Katki HA, 2011, LANCET ONCOL, V12, P663, DOI 10.1016/S1470-2045(11)70145-0; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Murphy J, 2012, J OBSTET GYNAECOL CA, V34, P443, DOI 10.1016/S1701-2163(16)35241-0; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Schiffman M, 2003, ARCH PATHOL LAB MED, V127, P946; U.S. Department of Health and Human Services, 2014, BRIEF SUMM MICR DEV; Zhao C, 2014, ARCH PATHOL LAB MED	11	4	5	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4					295	+		10.7326/M14-1043	http://dx.doi.org/10.7326/M14-1043			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RU	24912666				2022-12-01	WOS:000342347300021
J	Shukla, AK; Westfield, GH; Xiao, KH; Reis, RI; Huang, LY; Tripathi-Shukla, P; Qian, J; Li, S; Blanc, A; Oleskie, AN; Dosey, AM; Su, M; Liang, CR; Gu, LL; Shan, JM; Chen, X; Hanna, R; Choi, MJ; Yao, XJ; Klink, BU; Kahsai, AW; Sidhu, SS; Koide, S; Penczek, PA; Kossiakoff, AA; Woods, VL; Kobilka, BK; Skiniotis, G; Lefkowitz, RJ				Shukla, Arun K.; Westfield, Gerwin H.; Xiao, Kunhong; Reis, Rosana I.; Huang, Li-Yin; Tripathi-Shukla, Prachi; Qian, Jiang; Li, Sheng; Blanc, Adi; Oleskie, Austin N.; Dosey, Anne M.; Su, Min; Liang, Cui-Rong; Gu, Ling-Ling; Shan, Jin-Ming; Chen, Xin; Hanna, Rachel; Choi, Minjung; Yao, Xiao Jie; Klink, Bjoern U.; Kahsai, Alem W.; Sidhu, Sachdev S.; Koide, Shohei; Penczek, Pawel A.; Kossiakoff, Anthony A.; Woods, Virgil L., Jr.; Kobilka, Brian K.; Skiniotis, Georgios; Lefkowitz, Robert J.			Visualization of arrestin recruitment by a G-protein-coupled receptor	NATURE			English	Article							BETA(2) ADRENERGIC-RECEPTOR; CONFORMATIONAL-CHANGES; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; VISUAL ARRESTIN; ACTIVATION; COMPLEX; BETA-ARRESTIN1; IMAGES; DOMAIN	G-protein-coupled receptors (GPCRs) are critically regulated by beta-arrestins, which not only desensitize G-protein signalling but also initiate a G-protein-independent wave of signalling(1-5). A recent surge of structural data on a number of GPCRs, including the beta(2) adrenergic receptor (beta(2)AR)-G-proteincomplex, has provided novel insights into the structural basis of receptor activation(6-11). However, complementary information has been lacking on the recruitment of beta-arrestins to activated GPCRs, primarily owing to challenges in obtaining stable receptor-beta-arrestin complexes for structural studies. Here we devised a strategy for forming and purifying a functional human beta(2)AR-beta-arrestin-1 complex that allowed us to visualize its architecture by single-particle negative-stain electron microscopy and to characterize the interactions between beta(2)AR and beta-arrestin 1 using hydrogen-deuterium exchange mass spectrometry (HDX-MS) and chemical crosslinking. Electron microscopy two-dimensional averages and three dimensional reconstructions reveal bimodal binding of beta-arrestin 1 to the beta(2)AR, involving two separate sets of interactions, one with the phosphorylated carboxy terminus of the receptor and the other with its seven-transmembrane core. Areas of reduced HDX together with identification of crosslinked residues suggest engagement of the finger loop of beta-arrestin 1 with the seven-transmembrane core of the receptor. In contrast, focal areas of raised HDX levels indicate regions of increased dynamics in both the N and C domains of beta-arrestin 1 when coupled to the beta(2)AR. A molecular model of the beta(2)AR-beta-arrestin signalling complex was made by docking activated beta-arrestin 1 and beta(2)AR crystal structures into the electron microscopymap densities with constraints provided by HDX-MS and crosslinking, allowing us to obtain valuable insights into the overall architecture of a receptor-arrestin complex. The dynamic and structural information presented here provides a framework for better understanding the basis of GPCR regulation by arrestins.	[Shukla, Arun K.; Xiao, Kunhong; Reis, Rosana I.; Huang, Li-Yin; Tripathi-Shukla, Prachi; Qian, Jiang; Blanc, Adi; Yao, Xiao Jie; Klink, Bjoern U.; Kahsai, Alem W.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Westfield, Gerwin H.; Oleskie, Austin N.; Dosey, Anne M.; Su, Min; Skiniotis, Georgios] Univ Michigan, Sch Med, Life Sci Inst, Ann Arbor, MI 48109 USA; [Westfield, Gerwin H.; Oleskie, Austin N.; Dosey, Anne M.; Su, Min; Skiniotis, Georgios] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; [Liang, Cui-Rong; Gu, Ling-Ling; Shan, Jin-Ming; Chen, Xin] Changzhou Univ, Sch Pharmaceut & Life Sci, Changzhou 213164, Jiangsu, Peoples R China; [Hanna, Rachel; Sidhu, Sachdev S.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Choi, Minjung; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Koide, Shohei; Kossiakoff, Anthony A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Penczek, Pawel A.] Univ Texas Houston, Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX 77054 USA; [Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego; Changzhou University; University of Toronto; Duke University; University of Chicago; University of Texas System; University of Texas Health Science Center Houston; Stanford University; Duke University; Howard Hughes Medical Institute	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	kobilka@stanford.edu; skinioti@umich.edu; lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021; Xiao, Kunhong/AAG-4275-2020; dos Reis, Rosana Maria/E-3346-2012	Xiao, Kunhong/0000-0002-1069-1226; Westfield, Gerwin/0000-0001-9634-2336; Kobilka, Brian/0000-0001-5958-3990; shukla, arun/0000-0003-2910-8288; Skiniotis, Georgios/0000-0003-0238-7846; Reis, Rosana/0000-0002-0465-8331; Koide, Shohei/0000-0001-5473-4358; dos Reis, Rosana Maria/0000-0001-9631-4167; Choi, Minjung/0000-0002-2601-107X	National Institutes of Health [DK090165, NS028471, GM072688, GM087519, HL075443, HL16037, HL70631]; Mathers Foundation [GM60635]; Pew Scholars Program in Biomedical Sciences; Canadian Institutes of Health Research [MOP-93725]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL016037, R01HL070631, P01HL075443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060635, R01GM072688, U54GM087519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Pew Scholars Program in Biomedical Sciences; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Capel for technical assistance, V. Ronk, D. Addison and Q. Lennon for administrative support, R. K. Sunahara for stimulating discussions and Alex R. B. Thomsen for critical reading of the manuscript. We acknowledge support from the National Institutes of Health Grants DK090165 (G. S.), NS028471 (B. K. K.), GM072688 and GM087519 (A. A. K. and S. K.), HL075443 (K. X.), HL16037 and HL70631 (R.J.L.), from the Mathers Foundation (B. K. K.), GM60635 (P. A. P.) and from the Pew Scholars Program in Biomedical Sciences (G. S.). R. H. and S. S. S. were supported by a research grant from the Canadian Institutes of Health Research (MOP-93725). R. I. R is supported by a postdoctoral fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. R.J.L. is an investigator with the Howard Hughes Medical Institute.	Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gimenez LE, 2012, J BIOL CHEM, V287, P29495, DOI 10.1074/jbc.M112.366674; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Gurevich VV, 2013, PROG MOL BIOL TRANSL, V118, P57, DOI 10.1016/B978-0-12-394440-5.00003-6; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Kang DS, 2009, J BIOL CHEM, V284, P29860, DOI 10.1074/jbc.M109.023366; Kim KM, 2008, BIOCHEM BIOPH RES CO, V366, P42, DOI 10.1016/j.bbrc.2007.11.055; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lohse Martin J, 2014, Handb Exp Pharmacol, V219, P15, DOI 10.1007/978-3-642-41199-1_2; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Nobles KN, 2007, J BIOL CHEM, V282, P21370, DOI 10.1074/jbc.M611483200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Weis WI, 2008, CURR OPIN STRUC BIOL, V18, P734, DOI 10.1016/j.sbi.2008.09.010; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110	36	336	338	9	210	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					218	+		10.1038/nature13430	http://dx.doi.org/10.1038/nature13430			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043026	Green Accepted, Green Submitted			2022-12-01	WOS:000340200700037
J	Rao, JN; Madasu, Y; Dominguez, R				Rao, Jampani Nageswara; Madasu, Yadaiah; Dominguez, Roberto			Mechanism of actin filament pointed-end capping by tropomodulin	SCIENCE			English	Article							BACTERIAL EFFECTOR VOPL; TROPOMYOSIN BINDING; THIN-FILAMENTS; F-ACTIN; MUSCLE; DOMAIN; CELLS; NUCLEATION; MODEL	Proteins that cap the ends of the actin filament are essential regulators of cytoskeleton dynamics. Whereas several proteins cap the rapidly growing barbed end, tropomodulin (Tmod) is the only protein known to cap the slowly growing pointed end. The lack of structural information severely limits our understanding of Tmod's capping mechanism. We describe crystal structures of actin complexes with the unstructured amino-terminal and the leucine-rich repeat carboxy-terminal domains of Tmod. The structures and biochemical analysis of structure-inspired mutants showed that one Tmod molecule interacts with three actin subunits at the pointed end, while also contacting two tropomyosin molecules on each side of the filament. We found that Tmod achieves high-affinity binding through several discrete low-affinity interactions, which suggests a mechanism for controlled subunit exchange at the pointed end.	[Rao, Jampani Nageswara; Madasu, Yadaiah; Dominguez, Roberto] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Dominguez, R (corresponding author), Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA.	droberto@mail.med.upenn.edu		Dominguez, Roberto/0000-0003-3186-5229	NIH [R01 GM073791, GM-0080]; U.S. Department of Energy [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073791] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grant R01 GM073791. X-ray data collection at beamline X6A of the National Synchrotron Light Source was supported by NIH grant GM-0080 and U.S. Department of Energy contract DE-AC02-98CH10886. We thank G. Rebowski for the preparation of actin and TM for this study and W. Lehman and M. Orzechowski for providing the TM models. The structures have been deposited in the Protein Data Bank under codes 4PKG, 4PKH, and 4PKI.	Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Fowler VM, 2003, J BIOL CHEM, V278, P40000, DOI 10.1074/jbc.M306895200; FOWLER VM, 1993, J CELL BIOL, V120, P411, DOI 10.1083/jcb.120.2.411; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Greenfield NJ, 2005, BIOPHYS J, V88, P372, DOI 10.1529/biophysj.104.051128; Kostyukova AS, 2006, BIOCHEMISTRY-US, V45, P12068, DOI 10.1021/bi060899i; Kostyukova AS, 2005, BIOCHEMISTRY-US, V44, P4905, DOI 10.1021/bi047468p; Krieger I, 2002, BIOPHYS J, V83, P2716, DOI 10.1016/S0006-3495(02)75281-8; Li XC, 2011, BIOPHYS J, V100, P1005, DOI 10.1016/j.bpj.2010.12.3697; Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517; Moyer JD, 2010, BLOOD, V116, P2590, DOI 10.1182/blood-2010-02-268458; Nag S, 2013, CYTOSKELETON, V70, P360, DOI 10.1002/cm.21117; Namgoong S, 2011, NAT STRUCT MOL BIOL, V18, P1060, DOI 10.1038/nsmb.2109; Tsukada T, 2011, J BIOL CHEM, V286, P2194, DOI 10.1074/jbc.M110.186924; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Weber A, 1999, J BIOL CHEM, V274, P34637, DOI 10.1074/jbc.274.49.34637; WEBER A, 1994, J CELL BIOL, V127, P1627, DOI 10.1083/jcb.127.6.1627; Yamashiro S, 2012, CYTOSKELETON, V69, P337, DOI 10.1002/cm.21031; Yamashiro S, 2010, J BIOL CHEM, V285, P33265, DOI 10.1074/jbc.M110.144873; Yao WJ, 2010, J BIOL CHEM, V285, P31408, DOI 10.1074/jbc.M110.130278; Yu BK, 2011, NAT STRUCT MOL BIOL, V18, P1068, DOI 10.1038/nsmb.2110; Zahm JA, 2013, CELL, V155, P423, DOI 10.1016/j.cell.2013.09.019	27	69	70	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					463	467		10.1126/science.1256159	http://dx.doi.org/10.1126/science.1256159			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061212	Green Accepted			2022-12-01	WOS:000339655100046
J	Ripke, S; Neale, BM; Corvin, A; Walters, JTR; Farh, KH; Holmans, PA; Lee, P; Bulik-Sullivan, B; Collier, DA; Huang, HL; Pers, TH; Agartz, I; Agerbo, E; Albus, M; Alexander, M; Amin, F; Bacanu, SA; Begemann, M; Belliveau, RA; Bene, J; Bergen, SE; Bevilacqua, E; Bigdeli, TB; Black, DW; Bruggeman, R; Buccola, NG; Buckner, RL; Byerley, W; Cahn, W; Cai, GQ; Campion, D; Cantor, RM; Carr, VJ; Carrera, N; Catts, SV; Chambert, KD; Chan, RCK; Chen, RYL; Chen, EYH; Cheng, W; Cheung, EFC; Chong, SA; Cloninger, CR; Cohen, D; Cohen, N; Cormican, P; Craddock, N; Crowley, JJ; Curtis, D; Davidson, M; Davis, KL; Degenhardt, F; Del Favero, J; Demontis, D; Dikeos, D; Dinan, T; Djurovic, S; Donohoe, G; Drapeau, E; Duan, J; Dudbridge, F; Durmishi, N; Eichhammer, P; Eriksson, J; Escott-Price, V; Essioux, L; Fanous, AH; Farrell, MS; Frank, J; Franke, L; Freedman, R; Freimer, NB; Friedl, M; Friedman, JI; Fromer, M; Genovese, G; Georgieva, L; Giegling, I; Giusti-Rodriguez, P; Godard, S; Goldstein, JI; Golimbet, V; Gopal, S; Gratten, J; de Haan, L; Hammer, C; Hamshere, ML; Hansen, M; Hansen, T; Haroutunian, V; Hartmann, AM; Henskens, FA; Herms, S; Hirschhorn, JN; Hoffmann, P; Hofman, A; Hollegaard, MV; Hougaard, DM; Ikeda, M; Joa, I; Julia, A; Kahn, RS; Kalaydjieva, L; Karachanak-Yankova, S; Karjalainen, J; Kavanagh, D; Keller, MC; Kennedy, JL; Khrunin, A; Kim, Y; Klovins, J; Knowles, JA; Konte, B; Kucinskas, V; Kucinskiene, ZA; Kuzelova-Ptackova, H; Kahler, AK; Laurent, C; Keong, JLC; Lee, SH; Legge, SE; Lerer, B; Li, MX; Li, T; Liang, KY; Lieberman, J; Limborska, S; Loughland, CM; Lubinski, J; Lonnqvist, J; Macek, M; Magnusson, PKE; Maher, BS; Maier, W; Mallet, J; Marsal, S; Mattheisen, M; Mattingsdal, M; McCarley, RW; McDonald, C; McIntosh, AM; Meier, S; Meijer, CJ; Melegh, B; Melle, I; Mesholam-Gately, RI; Metspalu, A; Michie, PT; Milani, L; Milanova, V; Mokrab, Y; Morris, DW; Mors, O; Murphy, KC; Murray, RM; Myin-Germeys, I; Muller-Myhsok, B; Nelis, M; Nenadic, I; Nertney, DA; Nestadt, G; Nicodemus, KK; Nikitina-Zake, L; Nisenbaum, L; Nordin, A; O'Callaghan, E; O'Dushlaine, C; O'Neill, FA; Oh, SY; Olincy, A; Olsen, L; Van Os, J; Pantelis, C; Papadimitriou, GN; Papiol, S; Parkhomenko, E; Pato, MT; Paunio, T; Pejovic-Milovancevic, M; Perkins, DO; Pietilainen, O; Pimm, J; Pocklington, AJ; Powell, J; Price, A; Pulver, AE; Purcell, SM; Quested, D; Rasmussen, HB; Reichenberg, A; Reimers, MA; Richards, AL; Roffman, JL; Roussos, P; Ruderfer, DM; Salomaa, V; Sanders, AR; Schall, U; Schubert, CR; Schulze, TG; Schwab, SG; Scolnick, EM; Scott, RJ; Seidman, LJ; Shi, JX; Sigurdsson, E; Silagadze, T; Silverman, JM; Sim, K; Slominsky, P; Smoller, JW; So, HC; Spencer, CCA; Stahl, EA; Stefansson, H; Steinberg, S; Stogmann, E; Straub, RE; Strengman, E; Strohmaier, J; Stroup, TS; Subramaniam, M; Suvisaari, J; Svrakic, DM; Szatkiewicz, JP; Soderman, E; Thirumalai, S; Toncheva, D; Tosato, S; Veijola, J; Waddington, J; Walsh, D; Wang, D; Wang, Q; Webb, BT; Weiser, M; Wildenauer, DB; Williams, NM; Williams, S; Witt, SH; Wolen, AR; Wong, EHM; Wormley, BK; Xi, HS; Zai, CC; Zheng, XB; Zimprich, F; Wray, NR; Stefansson, K; Visscher, PM; Adolfsson, R; Andreassen, OA; Blackwood, DHR; Bramon, E; Buxbaum, JD; Borglum, AD; Cichon, S; Darvasi, A; Domenici, E; Ehrenreich, H; Esko, T; Gejman, PV; Gill, M; Gurling, H; Hultman, CM; Iwata, N; Jablensky, AV; Jonsson, EG; Kendler, KS; Kirov, G; Knight, J; Lencz, T; Levinson, DF; Li, QQS; Liu, JJ; Malhotra, AK; McCarroll, SA; McQuillin, A; Moran, JL; Mortensen, PB; Mowry, BJ; Nothen, MM; Ophoff, RA; Owen, MJ; Palotie, A; Pato, CN; Petryshen, TL; Posthuma, D; Rietschel, M; Riley, BP; Rujescu, D; Sham, PC; Sklar, P; St Clair, D; Weinberger, DR; Wendland, JR; Werge, T; Daly, MJ; Sullivan, PF; O'Donovan, MC				Ripke, Stephan; Neale, Benjamin M.; Corvin, Aiden; Walters, James T. R.; Farh, Kai-How; Holmans, Peter A.; Lee, Phil; Bulik-Sullivan, Brendan; Collier, David A.; Huang, Hailiang; Pers, Tune H.; Agartz, Ingrid; Agerbo, Esben; Albus, Margot; Alexander, Madeline; Amin, Farooq; Bacanu, Silviu A.; Begemann, Martin; Belliveau, Richard A., Jr.; Bene, Judit; Bergen, Sarah E.; Bevilacqua, Elizabeth; Bigdeli, Tim B.; Black, Donald W.; Bruggeman, Richard; Buccola, Nancy G.; Buckner, Randy L.; Byerley, William; Cahn, Wiepke; Cai, Guiqing; Campion, Dominique; Cantor, Rita M.; Carr, Vaughan J.; Carrera, Noa; Catts, Stanley V.; Chambert, Kimberly D.; Chan, Raymond C. K.; Chen, Ronald Y. L.; Chen, Eric Y. H.; Cheng, Wei; Cheung, Eric F. C.; Chong, Siow Ann; Cloninger, C. Robert; Cohen, David; Cohen, Nadine; Cormican, Paul; Craddock, Nick; Crowley, James J.; Curtis, David; Davidson, Michael; Davis, Kenneth L.; Degenhardt, Franziska; Del Favero, Jurgen; Demontis, Ditte; Dikeos, Dimitris; Dinan, Timothy; Djurovic, Srdjan; Donohoe, Gary; Drapeau, Elodie; Duan, Jubao; Dudbridge, Frank; Durmishi, Naser; Eichhammer, Peter; Eriksson, Johan; Escott-Price, Valentina; Essioux, Laurent; Fanous, Ayman H.; Farrell, Martilias S.; Frank, Josef; Franke, Lude; Freedman, Robert; Freimer, Nelson B.; Friedl, Marion; Friedman, Joseph I.; Fromer, Menachem; Genovese, Giulio; Georgieva, Lyudmila; Giegling, Ina; Giusti-Rodriguez, Paola; Godard, Stephanie; Goldstein, Jacqueline I.; Golimbet, Vera; Gopal, Srihari; Gratten, Jacob; de Haan, Lieuwe; Hammer, Christian; Hamshere, Marian L.; Hansen, Mark; Hansen, Thomas; Haroutunian, Vahram; Hartmann, Annette M.; Henskens, Frans A.; Herms, Stefan; Hirschhorn, Joel N.; Hoffmann, Per; Hofman, Andrea; Hollegaard, Mads V.; Hougaard, David M.; Ikeda, Masashi; Joa, Inge; Julia, Antonio; Kahn, Rene S.; Kalaydjieva, Luba; Karachanak-Yankova, Sena; Karjalainen, Juha; Kavanagh, David; Keller, Matthew C.; Kennedy, James L.; Khrunin, Andrey; Kim, Yunjung; Klovins, Janis; Knowles, James A.; Konte, Bettina; Kucinskas, Vaidutis; Kucinskiene, Zita Ausrele; Kuzelova-Ptackova, Hana; Kahler, Anna K.; Laurent, Claudine; Keong, Jimmy Lee Chee; Lee, S. Hong; Legge, Sophie E.; Lerer, Bernard; Li, Miaoxin; Li, Tao; Liang, Kung-Yee; Lieberman, Jeffrey; Limborska, Svetlana; Loughland, Carmel M.; Lubinski, Jan; Lonnqvist, Jouko; Macek, Milan, Jr.; Magnusson, Patrik K. E.; Maher, Brion S.; Maier, Wolfgang; Mallet, Jacques; Marsal, Sara; Mattheisen, Manuel; Mattingsdal, Morten; McCarley, Robert W.; McDonald, Colm; McIntosh, Andrew M.; Meier, Sandra; Meijer, Carin J.; Melegh, Bela; Melle, Ingrid; Mesholam-Gately, Raquelle I.; Metspalu, Andres; Michie, Patricia T.; Milani, Lili; Milanova, Vihra; Mokrab, Younes; Morris, Derek W.; Mors, Ole; Murphy, Kieran C.; Murray, Robin M.; Myin-Germeys, Inez; Mueller-Myhsok, Bertram; Nelis, Mari; Nenadic, Igor; Nertney, Deborah A.; Nestadt, Gerald; Nicodemus, Kristin K.; Nikitina-Zake, Liene; Nisenbaum, Laura; Nordin, Annelie; O'Callaghan, Eadbhard; O'Dushlaine, Colm; O'Neill, F. Anthony; Oh, Sang-Yun; Olincy, Ann; Olsen, Line; Van Os, Jim; Pantelis, Christos; Papadimitriou, George N.; Papiol, Sergi; Parkhomenko, Elena; Pato, Michele T.; Paunio, Tiina; Pejovic-Milovancevic, Milica; Perkins, Diana O.; Pietilainen, Olli; Pimm, Jonathan; Pocklington, Andrew J.; Powell, John; Price, Alkes; Pulver, Ann E.; Purcell, Shaun M.; Quested, Digby; Rasmussen, Henrik B.; Reichenberg, Abraham; Reimers, Mark A.; Richards, Alexander L.; Roffman, Joshua L.; Roussos, Panos; Ruderfer, Douglas M.; Salomaa, Veikko; Sanders, Alan R.; Schall, Ulrich; Schubert, Christian R.; Schulze, Thomas G.; Schwab, Sibylle G.; Scolnick, Edward M.; Scott, Rodney J.; Seidman, Larry J.; Shi, Jianxin; Sigurdsson, Engilbert; Silagadze, Teimuraz; Silverman, Jeremy M.; Sim, Kang; Slominsky, Petr; Smoller, Jordan W.; So, Hon-Cheong; Spencer, Chris C. A.; Stahl, Eli A.; Stefansson, Hreinn; Steinberg, Stacy; Stogmann, Elisabeth; Straub, Richard E.; Strengman, Eric; Strohmaier, Jana; Stroup, T. Scott; Subramaniam, Mythily; Suvisaari, Jaana; Svrakic, Dragan M.; Szatkiewicz, Jin P.; Soderman, Erik; Thirumalai, Srinivas; Toncheva, Draga; Tosato, Sarah; Veijola, Juha; Waddington, John; Walsh, Dermot; Wang, Dai; Wang, Qiang; Webb, Bradley T.; Weiser, Mark; Wildenauer, Dieter B.; Williams, Nigel M.; Williams, Stephanie; Witt, Stephanie H.; Wolen, Aaron R.; Wong, Emily H. M.; Wormley, Brandon K.; Xi, Hualin Simon; Zai, Clement C.; Zheng, Xuebin; Zimprich, Fritz; Wray, Naomi R.; Stefansson, Kari; Visscher, Peter M.; Adolfsson, Rolf; Andreassen, Ole A.; Blackwood, Douglas H. R.; Bramon, Elvira; Buxbaum, Joseph D.; Borglum, Anders D.; Cichon, Sven; Darvasi, Ariel; Domenici, Enrico; Ehrenreich, Hannelore; Esko, Tonu; Gejman, Pablo V.; Gill, Michael; Gurling, Hugh; Hultman, Christina M.; Iwata, Nakao; Jablensky, Assen V.; Jonsson, Erik G.; Kendler, Kenneth S.; Kirov, George; Knight, Jo; Lencz, Todd; Levinson, Douglas F.; Li, Qingqin S.; Liu, Jianjun; Malhotra, Anil K.; McCarroll, Steven A.; McQuillin, Andrew; Moran, Jennifer L.; Mortensen, Preben B.; Mowry, Bryan J.; Noethen, Markus M.; Ophoff, Roel A.; Owen, Michael J.; Palotie, Aarno; Pato, Carlos N.; Petryshen, Tracey L.; Posthuma, Danielle; Rietschel, Marcella; Riley, Brien P.; Rujescu, Dan; Sham, Pak C.; Sklar, Pamela; St Clair, David; Weinberger, Daniel R.; Wendland, Jens R.; Werge, Thomas; Daly, Mark J.; Sullivan, Patrick F.; O'Donovan, Michael C.		Psychiat Genomics Consortium; Psychosis Endophenotypes Int Conso; Wellcome Trust Case-Control Consor	Biological insights from 108 schizophrenia-associated genetic loci	NATURE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; CONFERRING RISK; MUTATIONS	Schizophrenia is a highly heritable disorder. Genetic risk is conferred by a large number of alleles, including common alleles of small effect that might be detected by genome-wide association studies. Here we report a multi-stage schizophrenia genome-wide association study of up to 36,989 cases and 113,075 controls. We identify 128 independent associations spanning 108 conservatively defined loci that meet genome-wide significance, 83 of which have not been previously reported. Associations were enriched among genes expressed in brain, providing biological plausibility for the findings. Many findings have the potential to provide entirely new insights into aetiology, but associations at DRD2 and several genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses. Independent of genes expressed in brain, associations were enriched among genes expressed in tissues that have important roles in immunity, providing support for the speculated link between the immune system and schizophrenia.	[Ripke, Stephan; Neale, Benjamin M.; Farh, Kai-How; Lee, Phil; Bulik-Sullivan, Brendan; Huang, Hailiang; Fromer, Menachem; Goldstein, Jacqueline I.; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ripke, Stephan; Neale, Benjamin M.; Lee, Phil; Bulik-Sullivan, Brendan; Belliveau, Richard A., Jr.; Bergen, Sarah E.; Bevilacqua, Elizabeth; Chambert, Kimberly D.; Fromer, Menachem; Genovese, Giulio; O'Dushlaine, Colm; Scolnick, Edward M.; Smoller, Jordan W.; McCarroll, Steven A.; Moran, Jennifer L.; Palotie, Aarno; Petryshen, Tracey L.; Daly, Mark J.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Neale, Benjamin M.; Huang, Hailiang; Pers, Tune H.; Goldstein, Jacqueline I.; Hirschhorn, Joel N.; Price, Alkes; Stahl, Eli A.; Esko, Tonu; Daly, Mark J.] Broad Inst MIT & Harvard, Med & Populat Genet Program, Cambridge, MA 02142 USA; [Neale, Benjamin M.; Lee, Phil; Fromer, Menachem; Smoller, Jordan W.; Palotie, Aarno] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Corvin, Aiden; Cormican, Paul; Donohoe, Gary; Morris, Derek W.; Gill, Michael] Univ Ireland Trinity Coll, Dept Psychiat, Neuropsychiat Genet Res Grp, Dublin 8, Ireland; [Walters, James T. R.; Holmans, Peter A.; Carrera, Noa; Craddock, Nick; Escott-Price, Valentina; Georgieva, Lyudmila; Hamshere, Marian L.; Kavanagh, David; Legge, Sophie E.; Pocklington, Andrew J.; Richards, Alexander L.; Ruderfer, Douglas M.; Williams, Nigel M.; Kirov, George; Owen, Michael J.; O'Donovan, Michael C.] Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Genom, Inst Psychol Med & Clin Neurosci, Cardiff CF24 4HQ, S Glam, Wales; [Holmans, Peter A.; Craddock, Nick; Owen, Michael J.; O'Donovan, Michael C.] Cardiff Univ, Natl Ctr Mental Hlth, Cardiff CF24 4HQ, S Glam, Wales; [Collier, David A.; Mokrab, Younes] Eli Lilly & Co Ltd, Erl Wood Manor, Windlesham GU20 6PH, Surrey, England; [Collier, David A.] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London SE5 8AF, England; [Pers, Tune H.] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Pers, Tune H.; Hirschhorn, Joel N.; Esko, Tonu] Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Pers, Tune H.; Hirschhorn, Joel N.; Esko, Tonu] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Agartz, Ingrid; Soderman, Erik; Jonsson, Erik G.] Karolinska Inst, Psychiat Sect, Dept Clin Neurosci, SE-17176 Stockholm, Sweden; [Agartz, Ingrid] Diakonhjemmet Hosp, Dept Psychiat, N-0319 Oslo, Norway; [Agartz, Ingrid; Djurovic, Srdjan; Mattingsdal, Morten; Melle, Ingrid; Andreassen, Ole A.; Jonsson, Erik G.] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, N-0424 Oslo, Norway; [Agerbo, Esben; Mortensen, Preben B.] Aarhus Univ, CIRRAU, Ctr Integrat Register Based Res, DK-8210 Aarhus, Denmark; [Agerbo, Esben; Mortensen, Preben B.] Aarhus Univ, Natl Ctr Register Based Res, DK-8210 Aarhus, Denmark; [Agerbo, Esben; Demontis, Ditte; Hansen, Thomas; Mattheisen, Manuel; Mors, Ole; Olsen, Line; Rasmussen, Henrik B.; Borglum, Anders D.; Mortensen, Preben B.; Werge, Thomas] Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Aarhus, Denmark; [Albus, Margot] State Mental Hosp, D-85540 Haar, Germany; [Alexander, Madeline; Laurent, Claudine; Levinson, Douglas F.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Amin, Farooq] Atlanta Vet Affairs Med Ctr, Dept Psychiat & Behav Sci, Atlanta, GA 30033 USA; [Amin, Farooq] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Bacanu, Silviu A.; Bigdeli, Tim B.; Webb, Bradley T.; Wormley, Brandon K.] Virginia Commonwealth Univ, Dept Psychiat, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA; [Begemann, Martin; Hammer, Christian; Papiol, Sergi; Ehrenreich, Hannelore] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Bene, Judit; Melegh, Bela] Univ Pecs, Dept Med Genet, H-7624 Pecs, Hungary; [Bene, Judit; Melegh, Bela] Univ Pecs, Szentagothai Res Ctr, H-7624 Pecs, Hungary; [Bergen, Sarah E.; Kahler, Anna K.; Magnusson, Patrik K. E.; Hultman, Christina M.; Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Black, Donald W.] Univ Iowa, Carver Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; [Bruggeman, Richard] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9700 RB Groningen, Netherlands; [Buccola, Nancy G.] Louisiana State Univ, Hlth Sci Ctr, Sch Nursing, New Orleans, LA 70112 USA; [Buckner, Randy L.; Roffman, Joshua L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr, Boston, MA 02129 USA; [Buckner, Randy L.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Buckner, Randy L.; Roffman, Joshua L.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Byerley, William] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Cahn, Wiepke; Kahn, Rene S.; Strengman, Eric; Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, NL-3584 Utrecht, Netherlands; [Cai, Guiqing; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Human Genet, New York, NY 10029 USA; [Cai, Guiqing; Davis, Kenneth L.; Drapeau, Elodie; Friedman, Joseph I.; Haroutunian, Vahram; Parkhomenko, Elena; Reichenberg, Abraham; Silverman, Jeremy M.; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Campion, Dominique] Ctr Hosp Rouvray, F-76301 Rouen, France; [Campion, Dominique] INSERM, U1079, Fac Med, F-76301 Rouen, France; [Cantor, Rita M.; Ophoff, Roel A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Carr, Vaughan J.; Catts, Stanley V.; Henskens, Frans A.; Loughland, Carmel M.; Michie, Patricia T.; Pantelis, Christos; Schall, Ulrich; Scott, Rodney J.; Jablensky, Assen V.] Schizophrenia Res Inst, Sydney, NSW 2010, Australia; [Carr, Vaughan J.] Univ New S Wales, Sch Psychiat, Sydney, NSW 2031, Australia; [Catts, Stanley V.] Univ Queensland, Royal Brisbane & Womens Hosp, St Lucia, Qld 4072, Australia; [Chan, Raymond C. K.] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Chen, Ronald Y. L.; Chen, Eric Y. H.; Li, Miaoxin; So, Hon-Cheong; Wong, Emily H. M.; Sham, Pak C.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Chen, Eric Y. H.; Li, Miaoxin; Sham, Pak C.] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Cheng, Wei] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27514 USA; [Cheung, Eric F. C.] Castle Peak Hosp, Hong Kong, Hong Kong, Peoples R China; [Chong, Siow Ann; Keong, Jimmy Lee Chee; Sim, Kang; Subramaniam, Mythily] Inst Mental Hlth, Singapore 539747, Singapore; [Cloninger, C. Robert; Svrakic, Dragan M.] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA; [Cohen, David] Assistance Publ Hop Paris, Dept Child & Adolescent Psychiat, Pierre & Marie Curie Fac Med, F-75013 Paris, France; [Cohen, David] Inst Intelligent Syst & Robot, F-75013 Paris, France; [Cohen, Nadine] Blue Note Biosci, Princeton, NJ 08540 USA; [Crowley, James J.; Farrell, Martilias S.; Giusti-Rodriguez, Paola; Kim, Yunjung; Szatkiewicz, Jin P.; Williams, Stephanie; Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Curtis, David] Queen Mary Univ London, Dept Psychol Med, London E1 1BB, England; [Curtis, David; Pimm, Jonathan; Gurling, Hugh; McQuillin, Andrew] UCL, Mol Psychiat Lab, Div Psychiat, London WC1E 6JJ, England; [Davidson, Michael; Weiser, Mark] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Degenhardt, Franziska; Herms, Stefan; Hoffmann, Per; Hofman, Andrea; Cichon, Sven; Noethen, Markus M.] Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Degenhardt, Franziska; Herms, Stefan; Hoffmann, Per; Hofman, Andrea; Cichon, Sven; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Del Favero, Jurgen] Univ Antwerp VIB, Dept Mol Genet, Appl Mol Genom Unit, B-2610 Antwerp, Belgium; [Demontis, Ditte; Mattheisen, Manuel; Mors, Ole; Borglum, Anders D.] Aarhus Univ, iSEQ, Ctr Integrat Sequencing, DK-8000 Aarhus C, Denmark; [Demontis, Ditte; Mattheisen, Manuel; Borglum, Anders D.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Dikeos, Dimitris; Papadimitriou, George N.] Univ Athens, Sch Med, Dept Psychiat 1, Athens 11528, Greece; [Dinan, Timothy] Univ Coll Cork, Dept Psychiat, Cork, Ireland; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, N-0424 Oslo, Norway; [Donohoe, Gary; Morris, Derek W.] Natl Univ Ireland Galway, Cognit Genet & Therapy Grp, Sch Psychol, Galway, Ireland; [Donohoe, Gary; Morris, Derek W.] Natl Univ Ireland Galway, Discipline Biochem, Galway, Ireland; [Duan, Jubao; Sanders, Alan R.; Gejman, Pablo V.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Duan, Jubao; Sanders, Alan R.; Gejman, Pablo V.] NorthShore Univ HealthSyst, Dept Psychiat & Biobehav Sci, Evanston, IL 60201 USA; [Dudbridge, Frank] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Durmishi, Naser] Univ Clin Psychiat, Dept Child & Adolescent Psychiat, Skopje 1000, North Macedonia; [Eichhammer, Peter] Univ Regensburg, Dept Psychiat, D-93053 Regensburg, Germany; [Eriksson, Johan] Univ Helsinki, Cent Hosp, Dept Gen Practice, FI-00014 Helsinki, Finland; [Eriksson, Johan] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan] Biomedicum Helsinki 1, FI-00290 Helsinki, Finland; [Eriksson, Johan; Salomaa, Veikko] Natl Inst Hlth & Welf, FI-00271 Helsinki, Finland; [Essioux, Laurent] F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Translat Technol & Bioinformat, CH-4070 Basel, Switzerland; [Fanous, Ayman H.] Georgetown Univ, Sch Med, Dept Psychiat, Washington, DC 20057 USA; [Fanous, Ayman H.] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90033 USA; [Fanous, Ayman H.] Virginia Commonwealth Univ, Sch Med, Dept Psychiat, Richmond, VA 23298 USA; [Fanous, Ayman H.] Washington VA Med Ctr, Washington, DC 20422 USA; [Frank, Josef; Meier, Sandra; Schulze, Thomas G.; Strohmaier, Jana; Witt, Stephanie H.; Rietschel, Marcella] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, D-68159 Mannheim, Germany; [Franke, Lude; Karjalainen, Juha] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Freedman, Robert; Olincy, Ann] Univ Colorado Denver, Dept Psychiat, Aurora, CO 80045 USA; [Freimer, Nelson B.; Ophoff, Roel A.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; [Friedl, Marion; Giegling, Ina; Hartmann, Annette M.; Konte, Bettina; Rujescu, Dan] Univ Halle Wittenberg, Dept Psychiat, D-06112 Halle, Germany; [Fromer, Menachem; Purcell, Shaun M.; Roussos, Panos; Ruderfer, Douglas M.; Stahl, Eli A.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Psychiat, Div Psychiat Genom, New York, NY USA; [Giegling, Ina; Rujescu, Dan] Univ Munich, Dept Psychiat, D-80336 Munich, Germany; [Godard, Stephanie] Hop La Pitie Salpetriere, Dept Psychiat, INSERM, Inst Myol, F-75013 Paris, France; [Godard, Stephanie] Hop La Pitie Salpetriere, Dept Human & Mol Genet, INSERM, Inst Myol, F-75013 Paris, France; [Golimbet, Vera] Russian Acad Med Sci, Mental Hlth Res Ctr, Moscow 115522, Russia; [Gopal, Srihari; Wang, Dai; Li, Qingqin S.] Janssen Res & Dev, Neurosci Therapeut Area, Raritan, NJ 08869 USA; [Gratten, Jacob; Lee, S. Hong; Wray, Naomi R.; Visscher, Peter M.; Mowry, Bryan J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [de Haan, Lieuwe; Meijer, Carin J.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Hansen, Mark] Illumina, La Jolla, CA 92122 USA; [Hansen, Thomas; Olsen, Line; Rasmussen, Henrik B.; Werge, Thomas] Mental Hlth Serv Copenhagen, Mental Hlth Ctr Sct Hans, Inst Biol Psychiat, DK-4000 Roskilde, Denmark; [Haroutunian, Vahram; Buxbaum, Joseph D.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Haroutunian, Vahram] JJ Peters VA Med Ctr, Bronx, NY 10468 USA; [Henskens, Frans A.] Univ Newcastle, Prior Res Ctr Hlth Behav, Newcastle, NSW 2308, Australia; [Henskens, Frans A.] Univ Newcastle, Sch Elect Engn & Comp Sci, Newcastle, NSW 2308, Australia; [Herms, Stefan; Hoffmann, Per; Cichon, Sven] Univ Basel, Dept Biomed, Div Med Genet, CH-4058 Basel, Switzerland; [Hirschhorn, Joel N.; Esko, Tonu; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Hollegaard, Mads V.; Hougaard, David M.] Statens Serum Inst, Dept Clin Biochem Immunol & Genet, Sect Neonatal Screening & Hormones, DK-2300 Copenhagen, Denmark; [Ikeda, Masashi; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 4701192, Japan; [Joa, Inge] Stavanger Univ Hosp, Dept Psychiat, Reg Ctr Clin Res Psychosis, N-4011 Stavanger, Norway; [Julia, Antonio; Marsal, Sara] Vall dHebron Res Inst, Rheumatol Res Grp, Barcelona 08035, Spain; [Kalaydjieva, Luba] Univ Western Australia, Ctr Med Res, Perth, WA 6009, Australia; [Kalaydjieva, Luba; Jablensky, Assen V.] Univ Western Australia, Perkins Inst Med Res, Perth, WA 6009, Australia; [Karachanak-Yankova, Sena; Toncheva, Draga] Med Univ, Dept Med Genet, Sofia 1431, Bulgaria; [Keller, Matthew C.] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Kennedy, James L.; Zai, Clement C.; Knight, Jo] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON M5T 1R8, Canada; [Kennedy, James L.; Zai, Clement C.; Knight, Jo] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada; [Kennedy, James L.; Knight, Jo] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Khrunin, Andrey; Limborska, Svetlana; Slominsky, Petr] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia; [Klovins, Janis; Nikitina-Zake, Liene] Latvian Biomed Res & Study Ctr, LV-1067 Riga, Latvia; [Knowles, James A.; Pato, Michele T.; Pato, Carlos N.] Univ So Calif, Dept Psychiat, Los Angeles, CA 90089 USA; [Knowles, James A.; Pato, Michele T.; Pato, Carlos N.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Kucinskas, Vaidutis; Kucinskiene, Zita Ausrele] Vilnius State Univ, Fac Med, LT-01513 Vilnius, Lithuania; [Kuzelova-Ptackova, Hana; Macek, Milan, Jr.] 2nd Fac Med, Dept Biol & Med Genet, Prague 15006, Czech Republic; [Kuzelova-Ptackova, Hana; Macek, Milan, Jr.] Univ Hosp Motol, Prague 15006, Czech Republic; [Laurent, Claudine] Pierre & Marie Curie Fac Med, Dept Child & Adolescent Psychiat, F-75013 Paris, France; [Keong, Jimmy Lee Chee] Duke NUS Grad Med Sch, Singapore 169857, Singapore; [Lerer, Bernard] Hadassah Hebrew Univ, Med Ctr, Dept Psychiat, IL-91120 Jerusalem, Israel; [Li, Miaoxin; Sham, Pak C.] Univ Hong Kong, Ctr Genom Sci, Hong Kong, Hong Kong, Peoples R China; [Li, Tao; Wang, Qiang] Sichuan Univ, Mental Hlth Ctr, Chengdu 610041, Sichuan, Peoples R China; [Li, Tao; Wang, Qiang] Sichuan Univ, West China Hosp, Psychiat Lab, Chengdu 610041, Sichuan, Peoples R China; [Liang, Kung-Yee] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Lieberman, Jeffrey; Stroup, T. Scott] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Loughland, Carmel M.; Schall, Ulrich] Univ Newcastle, Prior Ctr Translat Neurosci & Mental Hlth, Newcastle, NSW 2300, Australia; [Lubinski, Jan] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, PL-70453 Szczecin, Poland; [Lonnqvist, Jouko; Suvisaari, Jaana] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, FI-00271 Helsinki, Finland; [Maher, Brion S.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA; [Maier, Wolfgang] Univ Bonn, Dept Psychiat, D-53127 Bonn, Germany; [Mallet, Jacques] Hop La Pitie Salpetriere, CNRS, Lab Genet Mol Neurotransmiss & Proc Neurodegenera, F-75013 Paris, France; [Mattheisen, Manuel] Univ Bonn, Dept Genom Math, D-53127 Bonn, Germany; [Mattingsdal, Morten] Sorlandet Hosp, Res Unit, N-4604 Kristiansand, Norway; [McCarley, Robert W.; Mesholam-Gately, Raquelle I.; Seidman, Larry J.; Petryshen, Tracey L.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [McCarley, Robert W.] VA Boston Hlth Care Syst, Brockton, MA 02301 USA; [McDonald, Colm] Natl Univ Ireland Galway, Dept Psychiat, Galway, Ireland; [McIntosh, Andrew M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH16 4SB, Midlothian, Scotland; [McIntosh, Andrew M.; Blackwood, Douglas H. R.] Univ Edinburgh, Div Psychiat, Edinburgh EH16 4SB, Midlothian, Scotland; [Melle, Ingrid; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, N-0424 Oslo, Norway; [Mesholam-Gately, Raquelle I.; Seidman, Larry J.] Beth Israel Deaconess Med Ctr, Publ Psychiat Div, Massachusetts Mental Hlth Ctr, Boston, MA 02114 USA; [Metspalu, Andres; Milani, Lili; Nelis, Mari; Esko, Tonu] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Michie, Patricia T.] Univ Newcastle, Sch Psychol, Callaghan, NSW 2308, Australia; [Milanova, Vihra] Med Univ, Psychiat Clin 1, Sofia 1431, Bulgaria; [Mors, Ole; Borglum, Anders D.] Aarhus Univ Hosp, Dept P, DK-8240 Risskov, Denmark; [Murphy, Kieran C.] Royal Coll Surgeons Ireland, Dept Psychiat, Dublin 2, Ireland; [Murray, Robin M.; Powell, John] Kings Coll London, London SE5 8AF, England; [Myin-Germeys, Inez; Van Os, Jim] Maastricht Univ, Med Ctr, South Limburg Mental Hlth Res & Teaching Network, EURON, NL-6229 HX Maastricht, Netherlands; [Mueller-Myhsok, Bertram] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80336 Munich, Germany; [Mueller-Myhsok, Bertram] Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany; [Nenadic, Igor] Jena Univ Hosp, Dept Psychiat & Psychotherapy, D-07743 Jena, Germany; [Nertney, Deborah A.] Univ Queensland, Queensland Brain Inst, Dept Psychiat, St Lucia, Qld 4072, Australia; [Nertney, Deborah A.] Univ Queensland, Queensland Ctr Mental Hlth Res, St Lucia, Qld 4072, Australia; [Nestadt, Gerald; Pulver, Ann E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Nicodemus, Kristin K.] Univ Dublin Trinity Coll, Dept Psychiat, Dublin 2, Ireland; [Nisenbaum, Laura] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; [Nordin, Annelie; Adolfsson, Rolf] Umea Univ, Dept Clin Sci, SE-90187 Umea, Sweden; [O'Callaghan, Eadbhard] DETECT Early Intervent Serv Psychosis, Blackrock, Dublin, Ireland; [O'Neill, F. Anthony] Queens Univ Belfast, Inst Clin Sci, Ctr Publ Hlth, Belfast BT12 6AB, Antrim, North Ireland; [Oh, Sang-Yun] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Van Os, Jim] Kings Coll London, Inst Psychiat, London SE5 8AF, England; [Pantelis, Christos] Univ Melbourne, Melbourne Neuropsychiat Ctr, Melbourne, Vic 3053, Australia; [Pantelis, Christos] Melbourne Hlth, Melbourne, Vic 3053, Australia; [Paunio, Tiina] Univ Helsinki, Dept Psychiat, FI-00029 Helsinki, Finland; [Paunio, Tiina; Pietilainen, Olli] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, FI-00271 Helsinki, Finland; [Pejovic-Milovancevic, Milica] Univ Belgrade, Fac Med, Belgrade 11000, Serbia; [Perkins, Diana O.; Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [Pietilainen, Olli; Palotie, Aarno] Univ Helsinki, FIMM, FI-00014 Helsinki, Finland; [Price, Alkes] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Quested, Digby] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Reimers, Mark A.; Wolen, Aaron R.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA; [Roussos, Panos; Sklar, Pamela] Icahn Sch Med Mt Sinai, Inst Multiscale Biol, New York, NY 10029 USA; [Schubert, Christian R.; Wendland, Jens R.] Pfizer Worldwide Res & Dev, Pharma Therapeut Clin Res, Cambridge, MA 02139 USA; [Schulze, Thomas G.] Univ Gottingen, Dept Psychiat & Psychotherapy, D-37073 Gottingen, Germany; [Schwab, Sibylle G.] Univ Erlangen Nurnberg, Psychiat & Psychotherapy Clin, D-91054 Erlangen, Germany; [Scott, Rodney J.] Hunter New England Hlth Serv, Newcastle, NSW 2308, Australia; [Scott, Rodney J.] Univ Newcastle, Sch Biomed Sci, Newcastle, NSW 2308, Australia; [Shi, Jianxin] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Sigurdsson, Engilbert] Univ Iceland, Natl Univ Hosp, Landspitali, IS-101 Reykjavik, Iceland; [Silagadze, Teimuraz] Tbilisi State Med Univ TSMU, Dept Psychiat & Drug Addict, GE-0177 Tbilisi, Georgia; [Silverman, Jeremy M.] Bronx Vet Affairs Med Ctr, New York, NY 10468 USA; [Spencer, Chris C. A.] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Stefansson, Hreinn; Steinberg, Stacy; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Stogmann, Elisabeth; Zimprich, Fritz] Med Univ Vienna, Dept Clin Neurol, A-1090 Vienna, Austria; [Straub, Richard E.; Weinberger, Daniel R.] Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Strengman, Eric] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CG Utrecht, Netherlands; [Thirumalai, Srinivas] Berkshire Healthcare NHS Fdn Trust, Bracknell RG12 1BQ, Berks, England; [Tosato, Sarah] Univ Verona, Sect Psychiat, I-37134 Verona, Italy; [Veijola, Juha] Univ Oulu, Dept Psychiat, Oulu 90014, Finland; [Veijola, Juha] Univ Hosp Oulu, Oys 90029, Finland; [Waddington, John] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Walsh, Dermot] Hlth Res Board, Dublin 2, Ireland; [Wildenauer, Dieter B.; Jablensky, Assen V.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Xi, Hualin Simon] Pfizer Worldwide Res & Dev, Computat Sci CoE, Cambridge, MA 02139 USA; [Zheng, Xuebin; Liu, Jianjun] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore; [Bramon, Elvira] UCL, London WC1E 6BT, England; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Cichon, Sven] Res Ctr Juelich, Inst Neurosci & Med INM 1, D-52428 Julich, Germany; [Darvasi, Ariel] Hebrew Univ Jerusalem, Dept Genet, IL-91905 Jerusalem, Israel; [Domenici, Enrico] F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Neurosci Discovery & Translat Area, CH-4070 Basel, Switzerland; [Jablensky, Assen V.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Ctr Clin Res Neuropsychiat, Perth, WA 6000, Australia; [Kendler, Kenneth S.; Riley, Brien P.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA 23298 USA; [Kendler, Kenneth S.; Riley, Brien P.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Lencz, Todd; Malhotra, Anil K.] Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Lencz, Todd; Malhotra, Anil K.] Hofstra NS LIJ Sch Med, Hempstead, NY 11549 USA; [Lencz, Todd; Malhotra, Anil K.] Zucker Hillside Hosp, Glen Oaks, NY 11004 USA; [Liu, Jianjun] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; [Mowry, Bryan J.] Univ Queensland, Queensland Ctr Mental Hlth Res, Brisbane, Qld 4076, Australia; [Petryshen, Tracey L.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Petryshen, Tracey L.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Posthuma, Danielle] Erasmus Univ, Med Ctr, Dept Child & Adolescent Psychiat, NL-3000 Rotterdam, Netherlands; [Posthuma, Danielle] Vrije Univ Amsterdam, Med Ctr Amsterdam, Dept Complex Trait Genet, NL-1081 Amsterdam, Netherlands; [Posthuma, Danielle] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Funct Genom, NL-1081 Amsterdam, Netherlands; [St Clair, David] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Werge, Thomas] Univ Copenhagen, Dept Clin Med, DK-2200 Copenhagen, Denmark	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Trinity College Dublin; Cardiff University; Cardiff University; Eli Lilly; University of London; King's College London; Technical University of Denmark; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Karolinska Institutet; Diakonhjemmet Hospital; University of Oslo; Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; Virginia Commonwealth University; Max Planck Society; University of Pecs; University of Pecs; Karolinska Institutet; University of Iowa; University of Groningen; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; Utrecht University; Utrecht University Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of New South Wales Sydney; Royal Brisbane & Women's Hospital; University of Queensland; Chinese Academy of Sciences; Institute of Psychology, CAS; University of Hong Kong; University of Hong Kong; University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of North Carolina; University of North Carolina Chapel Hill; University of London; Queen Mary University London; University of London; University College London; Chaim Sheba Medical Center; University of Bonn; University of Bonn; Flanders Institute for Biotechnology (VIB); University of Antwerp; Aarhus University; Aarhus University; Athens Medical School; National & Kapodistrian University of Athens; University College Cork; University of Oslo; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; University of Chicago; NorthShore University Health System; University of London; London School of Hygiene & Tropical Medicine; University of Regensburg; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Finland National Institute for Health & Welfare; Roche Holding; Georgetown University; University of Southern California; Virginia Commonwealth University; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Groningen; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Los Angeles; Martin Luther University Halle Wittenberg; Icahn School of Medicine at Mount Sinai; University of Munich; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Russian Academy of Medical Sciences; Johnson & Johnson; Janssen Pharmaceuticals; University of Queensland; University of Amsterdam; Academic Medical Center Amsterdam; Illumina; Icahn School of Medicine at Mount Sinai; University of Newcastle; University of Newcastle; University of Basel; Harvard University; Harvard Medical School; Statens Serum Institut; Fujita Health University; Stavanger University Hospital; University of Western Australia; University of Western Australia; Medical University Sofia; University of Colorado System; University of Colorado Boulder; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; Russian Academy of Sciences; Latvian Biomedical Research & Study Centre; University of Southern California; University of Southern California; Vilnius University; Charles University Prague; Motol University Hospital; UDICE-French Research Universities; Sorbonne Universite; National University of Singapore; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Hong Kong; Sichuan University; Sichuan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Columbia University; University of Newcastle; Pomeranian Medical University; Finland National Institute for Health & Welfare; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Bonn; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Bonn; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Ollscoil na Gaillimhe-University of Galway; University of Edinburgh; University of Edinburgh; University of Oslo; Harvard University; Beth Israel Deaconess Medical Center; University of Tartu; University of Newcastle; Medical University Sofia; Aarhus University; Royal College of Surgeons - Ireland; University of London; King's College London; Maastricht University; University of Liverpool; Max Planck Society; University of Munich; Friedrich Schiller University of Jena; University of Queensland; Queensland Centre for Mental Health Research; University of Queensland; Johns Hopkins University; Trinity College Dublin; Eli Lilly; Umea University; Queens University Belfast; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of London; King's College London; University of Melbourne; University of Helsinki; Finland National Institute for Health & Welfare; University of Belgrade; University of North Carolina; University of North Carolina Chapel Hill; University of Helsinki; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; Virginia Commonwealth University; Icahn School of Medicine at Mount Sinai; Pfizer; University of Gottingen; University of Erlangen Nuremberg; University of Newcastle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Iceland; Tbilisi State Medical University; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of Oxford; Wellcome Centre for Human Genetics; Medical University of Vienna; Utrecht University; Utrecht University Medical Center; University of Verona; University of Oulu; Royal College of Surgeons - Ireland; Health Research Board - Ireland; University of Western Australia; Pfizer; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of London; University College London; Icahn School of Medicine at Mount Sinai; Helmholtz Association; Research Center Julich; Hebrew University of Jerusalem; Roche Holding; University of Western Australia; Virginia Commonwealth University; Virginia Commonwealth University; Northwell Health; Hofstra University; Northwell Health; National University of Singapore; Queensland Centre for Mental Health Research; University of Queensland; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Aberdeen; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Copenhagen	O'Donovan, MC (corresponding author), Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Genom, Inst Psychol Med & Clin Neurosci, Cardiff CF24 4HQ, S Glam, Wales.	odonovanmc@cardiff.ac.uk	Chan, Raymond CK/B-6717-2009; Bigdeli, Tim B./AAX-7761-2020; van Os, Jim/V-8884-2019; Karjalainen, Juha/P-8624-2016; Lee, Sang Hong/A-2569-2011; Lencz, Todd/J-3418-2014; Slominsky, Petr A/B-4640-2016; McDonald, Colm/C-1430-2009; Morris, Derek/AAW-8343-2021; Powell, John F/G-4412-2011; Limborska, Svetlana/A-5633-2016; Jablensky, Assen/H-5116-2014; Donohoe, Gary/J-6481-2013; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Hougaard, David/AAD-6368-2019; Milani, Lili/N-1097-2019; Mattheisen, Manuel/S-3725-2019; Bramon, Elvira/A-9463-2011; Visscher, Peter/ABB-6151-2020; Lieberman, Jeffrey/AAY-8239-2020; Pantelis, Christos/H-7722-2014; Stroup, Thomas/AAB-7780-2019; Golimbet, V/E-2328-2016; Zimprich, Fritz/W-1738-2017; Wray, Naomi/C-8639-2015; Klovins, Janis/C-5695-2011; Konte, Bettina/AAT-1142-2021; Roffman, Joshua/G-8228-2012; Fanous, Ayman H/O-1263-2017; Reichenberg, Abraham/GQB-1227-2022; Knight, Jo/F-4946-2011; Magnusson, Patrik KE/C-4458-2017; SCHALL, ULRICH ANDREAS/G-7452-2013; Ruderfer, Douglas M/M-5795-2016; Zai, Clement C/G-7379-2015; Daly, Mark J/B-2453-2017; Zai, Clement C/AAA-5431-2022; Cloninger, Claude/F-5357-2012; Mattingsdal, Morten/Q-9367-2016; Slominsky, Petr/AAO-1852-2020; O'Neill, Francis A/C-5582-2008; Ripke, Stephan/AAK-5486-2021; Buxbaum, Joseph D/G-6001-2010; Limborska, Svetlana/S-2961-2019; Giegling, Ina/ABA-3677-2021; Sigurdsson, Engilbert/D-2486-2014; Liu, Jianjun/AAK-4989-2020; Rujescu, Dan/GRS-3875-2022; So, Hon-Cheong/I-1100-2016; Kendler, Kenneth/AAF-2876-2019; Dinan, Timothy/ABA-8284-2020; Hansen, Thomas Folkmann/O-5965-2014; Hammer, Christian/C-5827-2014; Curtis, David/HGB-3921-2022; McQuillin, Andrew/C-1623-2008; Hartmann, Annette/AAS-6331-2021; Karachanak-Yankova, Sena/AAL-2721-2021; Mattheisen, Manuel/B-4949-2012; Stefansson, Kari/AAE-7187-2019; Mortensen, Preben B/D-2358-2015; Webb, Bradley T/B-1459-2009; McCarley, Robert W/N-5562-2014; Mortensen, Preben/F-6758-2015; Kennedy, James Lowery/AAZ-6947-2020; Nelis, Mari/ABG-7775-2020; Melle, Ingrid S/B-4858-2011; Silverman, Jeremy M./AAO-4268-2020; Agerbo, Esben/A-2645-2012; Zimprich, Fritz/O-1406-2019; Wang, Qiang/AAV-7131-2021; van Os, Jim/C-2113-2014; Collier, David A/D-1649-2011; Andreassen, Ole A./AAY-7531-2020; Degenhardt, Franziska/H-4169-2017; O'Donovan, Michael C/P-7005-2018; Catts, Stanley V/G-6917-2013; McIntosh, Andrew M/B-9379-2008; Tosato, Sarah/E-6045-2010; Gratten, Jacob/G-1485-2011; Petryshen, Tracey/X-5850-2019; Myin-Germeys, Inez/L-5106-2014; blackwood, douglas/AIB-8874-2022; Franke, Lude/P-7036-2016; Meier, Sandra/AAB-1242-2021; Hoffmann, Per/A-5149-2010; Herms, Stefan/J-1949-2014; St Clair, David/AAN-2412-2021; Lee, Jimmy/ABB-2919-2020; Perkins, Diana O/F-5213-2013; Shenton, Martha/V-8780-2019; Domenici, Enrico/K-8194-2016; Walters, James/HCH-8835-2022; Holmans, Peter/F-4518-2015; Bergen, Sarah/I-8313-2012; KUČINSKAS, Vaidutis/A-4798-2013; Ptackova, Hana/M-9763-2017; Cichon, Sven/B-9618-2014; Mowry, Bryan/G-5046-2010; murray, robin/F-8658-2012; Scott, Rodney/B-2827-2013	Chan, Raymond CK/0000-0002-3414-450X; Bigdeli, Tim B./0000-0003-2215-5946; van Os, Jim/0000-0002-7245-1586; Lee, Sang Hong/0000-0001-9701-2718; Lencz, Todd/0000-0001-8586-338X; Slominsky, Petr A/0000-0003-3530-0655; McDonald, Colm/0000-0003-1661-5192; Morris, Derek/0000-0002-3413-570X; Powell, John F/0000-0001-6124-439X; Jablensky, Assen/0000-0003-0602-6810; Donohoe, Gary/0000-0003-3037-7426; Milani, Lili/0000-0002-5323-3102; Mattheisen, Manuel/0000-0002-8442-493X; Visscher, Peter/0000-0002-2143-8760; Pantelis, Christos/0000-0002-9565-0238; Stroup, Thomas/0000-0002-3123-0672; Golimbet, V/0000-0002-9960-7114; Zimprich, Fritz/0000-0002-6998-5480; Wray, Naomi/0000-0001-7421-3357; Konte, Bettina/0000-0001-5287-308X; Roffman, Joshua/0000-0003-4073-532X; Magnusson, Patrik KE/0000-0002-7315-7899; SCHALL, ULRICH ANDREAS/0000-0001-9041-4562; Ruderfer, Douglas M/0000-0002-2365-386X; Daly, Mark J/0000-0002-0949-8752; Zai, Clement C/0000-0003-0496-7262; Cloninger, Claude/0000-0003-3096-4807; Mattingsdal, Morten/0000-0003-4440-0324; Slominsky, Petr/0000-0003-3530-0655; O'Neill, Francis A/0000-0002-7531-7657; Limborska, Svetlana/0000-0002-1697-6820; Sigurdsson, Engilbert/0000-0001-9404-7982; Liu, Jianjun/0000-0002-3255-3019; Hansen, Thomas Folkmann/0000-0001-6703-7762; Hammer, Christian/0000-0003-4548-7548; Curtis, David/0000-0002-4089-9183; McQuillin, Andrew/0000-0003-1567-2240; Karachanak-Yankova, Sena/0000-0001-6441-629X; Mattheisen, Manuel/0000-0002-8442-493X; Mortensen, Preben B/0000-0002-5230-9865; Webb, Bradley T/0000-0002-0576-5366; McCarley, Robert W/0000-0001-5705-7495; Mortensen, Preben/0000-0002-4782-1450; Kennedy, James Lowery/0000-0002-8733-3806; Nelis, Mari/0000-0001-9748-1020; Melle, Ingrid S/0000-0002-9783-548X; Agerbo, Esben/0000-0002-2849-524X; Zimprich, Fritz/0000-0002-6998-5480; Collier, David A/0000-0003-4087-1559; O'Donovan, Michael C/0000-0001-7073-2379; McIntosh, Andrew M/0000-0002-0198-4588; Tosato, Sarah/0000-0002-9665-7538; Gratten, Jacob/0000-0003-1293-409X; Petryshen, Tracey/0000-0002-7972-4612; Franke, Lude/0000-0002-5159-8802; Hoffmann, Per/0000-0002-6573-983X; Herms, Stefan/0000-0002-2786-8200; Lee, Jimmy/0000-0002-7724-7445; Domenici, Enrico/0000-0001-7436-6919; Holmans, Peter/0000-0003-0870-9412; Bergen, Sarah/0000-0002-5888-0034; Gill, Michael/0000-0003-0206-5337; Escott-Price, Valentina/0000-0003-1784-5483; Esko, Tonu/0000-0003-1982-6569; Giusti-Rodriguez, Paola/0000-0002-1921-1305; Nothen, Markus/0000-0002-8770-2464; McCarroll, Steven/0000-0002-6954-8184; Golimbet, Vera/0000-0002-0114-4300; Borglum, Anders/0000-0001-8627-7219; Moran, Jennifer/0000-0002-5664-4716; Henskens, Frans/0000-0003-2358-5630; Pejovic Milovancevic, Milica/0000-0001-8902-2668; Freedman, Robert/0000-0002-2181-2898; Walters, James/0000-0002-6980-4053; Milovancevic, Milos/0000-0002-7891-1010; Ptackova, Hana/0000-0002-5694-3695; Buxbaum, Joseph/0000-0001-8898-8313; Bruggeman, Richard/0000-0002-3238-8471; Ehrenreich, Hannelore/0000-0001-8371-5711; Gopal, Srihari/0000-0001-5254-2192; Chen, Eric/0000-0002-5247-3593; Stefansson, Hreinn/0000-0002-9331-6666; Papiol, Sergi/0000-0001-9366-8728; Murphy, Kieran/0000-0003-2930-4465; Knight, Joanne/0000-0002-7148-1660; Powell, Joseph/0000-0002-5070-4124; Julia Cano, Antonio/0000-0001-6064-3620; Stogmann, Elisabeth/0000-0003-4688-8482; Jonsson, Erik/0000-0001-8368-6332; Quested, Digby/0000-0001-6155-3336; Kirov, George/0000-0002-3427-3950; /0000-0002-8114-7615; ripke, stephan/0000-0003-3622-835X; Buccola, Nancy/0000-0003-1378-4636; Eriksson, Johan/0000-0002-2516-2060; Andreassen, Ole A./0000-0002-4461-3568; Toncheva, Draga/0000-0002-7451-6363; So, Hon-Cheong/0000-0002-7102-833X; Goldstein, Jacqueline/0000-0003-1902-6916; Bacanu, Silviu-Alin/0000-0002-4364-1583; Pers, Tune/0000-0003-0207-4831; Hollegaard, Mads Vilhelm/0000-0003-1061-0091; Klovins, Janis/0000-0001-8362-5505; Cichon, Sven/0000-0002-9475-086X; Myin-Germeys, Inez/0000-0002-3731-4930; IWATA, Nakao/0000-0003-3189-6076; Crowley, James/0000-0001-9051-1557; Mowry, Bryan/0000-0002-4115-5645; Palotie, Aarno/0000-0002-2527-5874; Dinan, Timothy/0000-0002-2316-7220; marsal, sara/0000-0001-5515-3854; Black, Donald/0000-0001-8038-1971; Perkins, Diana/0000-0001-9396-2206; Djurovic, Srdjan/0000-0002-8140-8061; Adolfsson, Rolf/0000-0001-9785-8473; Lubinski, Jan/0000-0003-2931-3003; Oh, Sang-Yun/0000-0002-0364-5109; Posthuma, Danielle/0000-0001-7582-2365; Suvisaari, Jaana/0000-0001-7167-0990; Pocklington, Andrew/0000-0002-2137-0452; Sim, Kang/0000-0003-3209-9626; Agartz, Ingrid/0000-0002-9839-5391; Huang, Hailiang/0000-0003-1461-5762; Joa, Inge/0000-0002-5516-2336; Legge, Sophie/0000-0001-6617-0289; murray, robin/0000-0003-0829-0519; Demontis, Ditte/0000-0001-9124-2766; Mors, Ole/0000-0002-5660-0393; Bramon, Elvira/0000-0003-1369-5983; Scott, Rodney/0000-0001-7724-3404; Corvin, Aiden/0000-0001-6717-4089	US National Institute of Mental Health [U01 MH094421]; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; Medical Research Council [G0801418, 1247950, G0601635, G1000718, MR/L010305/1, G1100583, G0800509, G0901310] Funding Source: researchfish; National Institute for Health Research [PDA/02/06/016] Funding Source: researchfish; Chief Scientist Office [SCD/12] Funding Source: researchfish; MRC [G0601635, G1100583, G0901310, G1000718, G0800509, G0801418] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100141, K99MH101367, U01MH094421, R01MH077139, U01MH094432, T32MH020030, R01MH040799, U01MH096296] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001356, I01BX002395] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Veterans Affairs(US Department of Veterans Affairs)	Core funding for the Psychiatric Genomics Consortium is from the US National Institute of Mental Health (U01 MH094421). We thank T. Lehner (NIMH). The work of the contributing groups was supported by numerous grants from governmental and charitable bodies as well as philanthropic donation. Details are provided in the Supplementary Notes. Membership of the Wellcome Trust Case Control Consortium and of the Psychosis Endophenotype International Consortium are provided in the Supplementary Notes.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], PREPRINT; [Anonymous], 2012, NATURE GENET; Begum F, 2012, NUCLEIC ACIDS RES, V40, P3777, DOI 10.1093/nar/gkr1255; Benros ME, 2012, ANN NY ACAD SCI, V1262, P56, DOI 10.1111/j.1749-6632.2012.06638.x; CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140; Cichon S, 2009, MOL PSYCHIATR, V14, P10, DOI 10.1038/mp.2008.126; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Hamshere ML, 2013, MOL PSYCHIATR, V18, P708, DOI 10.1038/mp.2012.67; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Knapp M, 2004, SCHIZOPHRENIA BULL, V30, P279, DOI 10.1093/oxfordjournals.schbul.a007078; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Lee SH, 2012, GENET EPIDEMIOL, V36, P214, DOI 10.1002/gepi.21614; Lencz T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3739; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lichtenstein P, 2006, PSYCHOL MED, V36, P1417, DOI 10.1017/S0033291706008385; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lips ES, 2012, MOL PSYCHIATR, V17, P996, DOI 10.1038/mp.2011.117; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Richards AL, 2012, MOL PSYCHIATR, V17, P193, DOI 10.1038/mp.2011.11; Rietschel M, 2012, MOL PSYCHIATR, V17, P906, DOI 10.1038/mp.2011.80; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steinberg S, 2011, HUM MOL GENET, V20, P4076, DOI 10.1093/hmg/ddr325; Strange A, 2012, BIOL PSYCHIAT, V72, P620, DOI 10.1016/j.biopsych.2012.05.035; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; VANROSSUM JM, 1966, ARCH INT PHARMACOD T, V160, P492; World Health Organization, 2008, The global burden of disease: 2004 update; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979	50	4838	4897	37	897	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					421	+		10.1038/nature13595	http://dx.doi.org/10.1038/nature13595			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25056061	Bronze, Green Submitted, Green Accepted, Green Published			2022-12-01	WOS:000339335700037
J	Boumahdi, S; Driessens, G; Lapouge, G; Rorive, S; Nassar, D; Le Mercier, M; Delatte, B; Caauwe, A; Lenglez, S; Nkusi, E; Brohee, S; Salmon, I; Dubois, C; del Marmol, V; Fuks, F; Beck, B; Blanpain, C				Boumahdi, Soufiane; Driessens, Gregory; Lapouge, Gaelle; Rorive, Sandrine; Nassar, Dany; Le Mercier, Marie; Delatte, Benjamin; Caauwe, Amelie; Lenglez, Sandrine; Nkusi, Erwin; Brohee, Sylvain; Salmon, Isabelle; Dubois, Christine; del Marmol, Veronique; Fuks, Francois; Beck, Benjamin; Blanpain, Cedric			SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma	NATURE			English	Article							SELF-RENEWAL; EXPRESSION; DIFFERENTIATION; MAINTENANCE; POPULATIONS; SURVIVAL; ABLATION; CATENIN; MARKER; GENES	Cancer stem cells (CSCs) have been reported in various cancers, including in skin squamous-cell carcinoma (SCC)(1-4). The molecular mechanisms regulating tumour initiation and stemness are still poorly characterized. Here we find that Sox2, a transcription factor expressed in various types of embryonic and adult stem cells(5,6), was the most upregulated transcription factor in the CSCs of squamous skin tumours in mice. SOX2 is absent in normal epidermis but begins to be expressed in the vast majority of mouse and human pre-neoplastic skin tumours, and continues to be expressed in a heterogeneous manner in invasive mouse and human SCCs. In contrast to other SCCs, in which SOX2 is frequently genetically amplified(7), the expression of SOX2 in mouse and human skin SCCs is transcriptionally regulated. Conditional deletion of Sox2 in the mouse epidermis markedly decreases skin tumour formation after chemical-induced carcinogenesis. Using green fluorescent protein (GFP) as a reporter of Sox2 transcriptional expression (SOX2-GFP knock-in mice), we showed that SOX2-expressing cells in invasive SCC are greatly enriched in tumour-propagating cells, which further increase upon serial transplantations. Lineage ablation of SOX2-expressing cells within primary benign and malignant SCCs leads to tumour regression, consistent with the critical role of SOX2-expressing cells in tumour maintenance. Conditional Sox2 deletion in pre-existing skin papilloma and SCC leads to tumour regression and decreases the ability of cancer cells to be propagated upon transplantation into immunodeficient mice, supporting the essential role of SOX2 in regulating CSC functions. Transcriptional profiling of SOX2-GFP expressing CSCs and of tumour epithelial cells upon Sox2 deletion uncovered a gene network regulated by SOX2 in primary tumour cells in vivo. Chromatin immunoprecipitation identified several direct SOX2 target genes controlling tumour stemness, survival, proliferation, adhesion, invasion and paraneoplastic syndrome. We demonstrate that SOX2, by marking and regulating the functions of skin tumour-initiating cells and CSCs, establishes a continuum between tumour initiation and progression in primary skin tumours.	[Boumahdi, Soufiane; Driessens, Gregory; Lapouge, Gaelle; Nassar, Dany; Caauwe, Amelie; Lenglez, Sandrine; Nkusi, Erwin; Dubois, Christine; Beck, Benjamin; Blanpain, Cedric] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Rorive, Sandrine; Le Mercier, Marie; Salmon, Isabelle] Univ Libre Bruxelles, Erasme Hosp, Dept Pathol, B-1070 Brussels, Belgium; [Rorive, Sandrine; Salmon, Isabelle] CMMI, DIAPATH, B-6041 Gosselies, Belgium; [Delatte, Benjamin; Fuks, Francois] Univ Libre Bruxelles, Lab Canc Epigenet, B-1070 Brussels, Belgium; [Brohee, Sylvain] Univ Libre Bruxelles, Fac Sci, Dept Comp Sci, Machine Learning Grp, B-1050 Brussels, Belgium; [del Marmol, Veronique] Univ Libre Bruxelles, Erasme Hosp, Dept Dermatol, B-1070 Brussels, Belgium; [Blanpain, Cedric] Univ Libre Bruxelles, WELBIO, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; WELBIO	Blanpain, C (corresponding author), Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium.	Cedric.Blanpain@ulb.ac.be	Delatte, Benjamin/AAE-9276-2020; del marmol, veronique/AAZ-8117-2020; Blanpain, Cedric/ABD-8392-2021	Delatte, Benjamin/0000-0002-6798-0600; Nassar, Dany/0000-0001-6780-0721; Beck, Benjamin/0000-0001-8162-7566	FNRS/FRIA; FNRS; TELEVIE; Brussels Region through the BB2B program; BB2B; IUAP; Fondation Contre le Cancer; ULB foundation; Fonds Yvonne Boel; Fonds Gaston Ithier; foundation Bettencourt Schueller; European Research Council	FNRS/FRIA(Fonds de la Recherche Scientifique - FNRS); FNRS(Fonds de la Recherche Scientifique - FNRS); TELEVIE; Brussels Region through the BB2B program; BB2B; IUAP; Fondation Contre le Cancer; ULB foundation; Fonds Yvonne Boel; Fonds Gaston Ithier; foundation Bettencourt Schueller; European Research Council(European Research Council (ERC)European Commission)	We thank our colleagues who provided us with reagents. We also thank the animal house facility of the Universite Libre de Bruxelles (ULB) (Erasme campus). C. B. is an investigator of WELBIO. S.Bo., B. B., B. D., S.Br., G. L. and D.N. are supported by a FNRS/FRIA, FNRS and TELEVIE fellowships. G. D. is supported by the Brussels Region through the BB2B program. This work was supported by the FNRS, TELEVIE, BB2B program, the IUAP program, a research grant from the Fondation Contre le Cancer, the ULB foundation, the Fonds Yvonne Boel, the Fonds Gaston Ithier, the foundation Bettencourt Schueller, and a starting grant from the European Research Council.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Bardot ES, 2013, EMBO J, V32, P1990, DOI 10.1038/emboj.2013.110; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Chuang WY, 2013, HISTOL HISTOPATHOL, V28, P293, DOI 10.14670/HH-28.293; Coletta A, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r104; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Esbrit P, 2001, Clin Lab, V47, P67; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Fang XF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-11; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Granter S. R., 2008, PATHOLOGY SKIN CLIN; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Himburg HA, 2012, CELL REP, V2, P964, DOI 10.1016/j.celrep.2012.09.002; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Laga AC, 2010, AM J PATHOL, V176, P903, DOI 10.2353/ajpath.2010.090495; Lapouge G, 2012, EMBO J, V31, P4563, DOI 10.1038/emboj.2012.312; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; Liborio TN, 2011, HISTOPATHOLOGY, V58, P225, DOI 10.1111/j.1365-2559.2011.03751.x; Liu KC, 2013, CELL SIGNAL, V25, P1264, DOI 10.1016/j.cellsig.2013.02.013; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Philip E., 2006, WHO CLASSIFICATION T, P20; Rorive S, 2010, MODERN PATHOL, V23, P1418, DOI 10.1038/modpathol.2010.136; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Soh BS, 2007, STEM CELLS, V25, P3029, DOI 10.1634/stemcells.2007-0372; Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; van de Wiel MA, 2007, BIOINFORMATICS, V23, P892, DOI 10.1093/bioinformatics/btm030; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646	53	439	455	7	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					246	+		10.1038/nature13305	http://dx.doi.org/10.1038/nature13305			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	24909994				2022-12-01	WOS:000338649800049
J	Dolgin, E				Dolgin, Elie			TECHNOLOGY Dressed to detect	NATURE			English	Editorial Material																		Poh MZ, 2012, NEUROLOGY, V78, P1868, DOI 10.1212/WNL.0b013e318258f7f1; Poh MZ, 2012, EPILEPSIA, V53, pe93, DOI 10.1111/j.1528-1167.2012.03444.x	2	16	16	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					S16	S17		10.1038/511S16a	http://dx.doi.org/10.1038/511S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25019131	Bronze			2022-12-01	WOS:000338649800008
J	Karayannis, T; Au, E; Patel, JC; Kruglikov, I; Markx, S; Delorme, R; Heron, D; Salomon, D; Glessner, J; Restituito, S; Gordon, A; Rodriguez-Murillo, L; Roy, NC; Gogos, JA; Rudy, B; Rice, ME; Karayiorgou, M; Hakonarson, H; Keren, B; Huguet, G; Bourgeron, T; Hoeffer, C; Tsien, RW; Peles, E; Fishell, G				Karayannis, T.; Au, E.; Patel, J. C.; Kruglikov, I.; Markx, S.; Delorme, R.; Heron, D.; Salomon, D.; Glessner, J.; Restituito, S.; Gordon, A.; Rodriguez-Murillo, L.; Roy, N. C.; Gogos, J. A.; Rudy, B.; Rice, M. E.; Karayiorgou, M.; Hakonarson, H.; Keren, B.; Huguet, G.; Bourgeron, T.; Hoeffer, C.; Tsien, R. W.; Peles, E.; Fishell, G.			Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission	NATURE			English	Article							CORTICAL INTERNEURONS; GABA(A) RECEPTORS; PREPULSE INHIBITION; TOURETTES-SYNDROME; SCHIZOPHRENIA; SYNAPSES; NUMBER; ASSOCIATION; LINKAGE; RELEASE	Although considerable evidence suggests that the chemical synapse is a lynchpin underlying affective disorders, how molecular insults differentially affect specific synaptic connections remains poorly understood. For instance, Neurexin 1a and 2 (NRXN1 and NRXN2) and CNTNAP2 (also known as CASPR2), all members of the neurexin superfamily of transmembrane molecules, have been implicated in neuropsychiatric disorders. However, their loss leads to deficits that have been best characterized with regard to their effect on excitatory cells(1,2). Notably, other disease-associated genes such as BDNF and ERBB4 implicate specific interneuron synapses in psychiatric disorders(3,4). Consistent with this, cortical interneuron dysfunction has been linked to epilepsy, schizophrenia and autism(5,6). Using a microarray screen that focused upon synapse-associated molecules, we identified Cntnap4 (contactin associated protein-like 4, also known as Caspr4) as highly enriched in developing murine interneurons. In this study we show that Cntnap4 is localized presynaptically and its loss leads to a reduction in the output of cortical parvalbumin (PV)-positive GABAergic (gamma-aminobutyric acid producing) basket cells. Paradoxically, the loss of Cntnap4 augments midbrain dopaminergic release in the nucleus accumbens. In Cntnap4 mutant mice, synaptic defects in these disease-relevant neuronal populations are mirrored by sensory-motor gating and grooming endophenotypes; these symptoms could be pharmacologically reversed, providing promise for therapeutic intervention in psychiatric disorders.	[Karayannis, T.; Au, E.; Kruglikov, I.; Restituito, S.; Roy, N. C.; Rudy, B.; Hoeffer, C.; Tsien, R. W.; Fishell, G.] NYU, Dept Neurosci & Physiol, Neurosci Inst, New York, NY 10016 USA; [Patel, J. C.; Rice, M. E.] NYU, Dept Neurosurg Neurosci & Physiol, Langone Med Ctr, New York, NY 10016 USA; [Markx, S.; Rodriguez-Murillo, L.; Karayiorgou, M.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Delorme, R.; Hakonarson, H.; Huguet, G.; Bourgeron, T.] Inst Pasteur, Human Genet & Cognit Funct Unit, F-75724 Paris, France; [Delorme, R.; Huguet, G.; Bourgeron, T.] Inst Pasteur, URA Genes Synapses & Cognit 2182, CNRS, F-75724 Paris, France; [Delorme, R.] Hop Robert Debre, AP HP, Dept Child & Adolescent Psychiat, F-75019 Paris, France; [Heron, D.] Grp Hosp Pitie Salpetriere, AP HP, Unite Fonct Genet Med, Dept Genet & Cytogenet,Ctr Reference,CRicm,UMR S9, F-75013 Paris, France; [Salomon, D.; Gordon, A.] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Glessner, J.] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Roy, N. C.] Natl Inst Deafness & Other Commun Disorders, Sect Synapt Transmiss, NIH, Bethesda, MD 20892 USA; [Gogos, J. A.] Columbia Univ, Med Ctr, Dept Physiol, New York, NY 10032 USA; [Gogos, J. A.] Columbia Univ, Med Ctr, Dept Cellular Biophys & Neurosci, New York, NY 10032 USA; [Keren, B.] Grp Hosp Pitie Salpetriere, AP HP, Unite Fonct Genet Chromosom, Dept Genet & Cytogenet,CRicm,UMR S975, F-75013 Paris, France; [Huguet, G.; Bourgeron, T.] Univ Paris Diderot, Sorbonne Paris Cite, F-75005 Paris, France; [Bourgeron, T.] FondaMental Fdn, F-94000 Creteil, France	New York University; New York University; NYU Langone Medical Center; Columbia University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Weizmann Institute of Science; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Columbia University; Columbia University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Fishell, G (corresponding author), NYU, Dept Neurosci & Physiol, Neurosci Inst, New York, NY 10016 USA.	gordon.fishell@med.nyu.edu	Karayannis, Theofanis/O-5194-2014; Karayannis, Theofanis/GRR-3982-2022; Huguet, Guillaume/GPX-3656-2022; Kruglikov, Ilya/AAC-9131-2020	Karayannis, Theofanis/0000-0002-3267-6254; Huguet, Guillaume/0000-0002-4746-6030; Kruglikov, Ilya/0000-0002-1575-4636; Delorme, Richard/0000-0002-5614-3663; Rice, Margaret/0000-0003-1793-2798; Patel, Jyoti/0000-0003-0295-6180; Peles, Elior/0000-0002-3325-0597; Fishell, Gordon/0000-0002-9640-9278; Au, Edmund/0000-0003-3190-9711; Rudy, Bernardo/0000-0001-5748-6900; Glessner, Joseph/0000-0001-5131-2811; Bourgeron, Thomas/0000-0001-8164-9220	NIH [R01 NS081297, R01 MH071679, R01 NS074972, P01 NS074972, R01 NS036362, R01 DA033811, NS30989, NS50220]; Simons Foundation [94534]; Attilio and Olympia Ricciardi Research Fund; Israel Science Foundation; Patterson Trust; Roche; New York State through its NYSTEM initiative [C024326]; Canadian Institutes of Health Research; NYU COE Addiction Seed Grant; Institut Pasteur; INSERM; AP-HP; University Paris Diderot; Bettencourt-Schueller foundation; Orange foundation; FondaMental foundation; Conny-Maeva foundation; Cognacq-Jay foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Attilio and Olympia Ricciardi Research Fund; Israel Science Foundation(Israel Science Foundation); Patterson Trust; Roche(Roche Holding); New York State through its NYSTEM initiative; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NYU COE Addiction Seed Grant; Institut Pasteur(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); AP-HP; University Paris Diderot; Bettencourt-Schueller foundation; Orange foundation; FondaMental foundation; Conny-Maeva foundation; Cognacq-Jay foundation	The authors are grateful to R. Froemke for critically reading the manuscript, to B. Benedetti, M. McKenzie Chang, L. Cobbs, B. A. Heller, T. Petros and N. Yumoto (all NYU) for help with experiments and analysis and to Charles Nicholson (NYU) for providing specialized software to analyse Vmax. Research in the Fishell laboratory is supported by the NIH (grants R01 NS081297, R01 MH071679, R01 NS074972, P01 NS074972 to B. R. and G. F.) and the Simons Foundation (94534). The Rice laboratory is supported by the NIH (grants R01 NS036362 and R01 DA033811) and the Attilio and Olympia Ricciardi Research Fund. The Rudy laboratory is supported by the NIH (NS30989). The Peles laboratory is supported by the NIH (grant NS50220) and the Israel Science Foundation. T. K. support was provided through postdoctoral fellowships from the Patterson Trust and Roche. E. A. support was provided by New York State through its NYSTEM initiative (C024326) and fellowship from Canadian Institutes of Health Research. J.C.P support was provided by NYU COE Addiction Seed Grant. This work was funded by the Institut Pasteur, INSERM, AP-HP, University Paris Diderot and the Bettencourt-Schueller, Orange, FondaMental, Conny-Maeva, Cognacq-Jay foundations.	Abecasis GR, 2004, AM J HUM GENET, V74, P403, DOI 10.1086/381713; Ashrafi S, 2014, NEURON, V81, P120, DOI 10.1016/j.neuron.2013.10.060; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; Belzil C, 2013, J BIOL CHEM, V288, P24452, DOI 10.1074/jbc.M113.483107; Berghuis P, 2004, EUR J NEUROSCI, V20, P1290, DOI 10.1111/j.1460-9568.2004.03561.x; Blatt GJ, 2011, ANAT REC, V294, P1646, DOI 10.1002/ar.21252; Brandon NJ, 2003, MOL CELL NEUROSCI, V22, P87, DOI 10.1016/S1044-7431(02)00017-9; Castellanos FX, 1996, BIOL PSYCHIAT, V39, P33, DOI 10.1016/0006-3223(95)00101-8; Cathala L, 2005, NAT NEUROSCI, V8, P1310, DOI 10.1038/nn1534; Champagne FA, 2004, J NEUROSCI, V24, P4113, DOI 10.1523/JNEUROSCI.5322-03.2004; Chang MC, 2010, NAT NEUROSCI, V13, P1090, DOI 10.1038/nn.2621; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Close J, 2012, J NEUROSCI, V32, P17690, DOI 10.1523/JNEUROSCI.3583-12.2012; CONDE F, 1994, J COMP NEUROL, V341, P95, DOI 10.1002/cne.903410109; Crowley JJ, 2012, PHARMACOGENOMICS J, V12, P147, DOI 10.1038/tpj.2010.82; Doischer D, 2008, J NEUROSCI, V28, P12956, DOI 10.1523/JNEUROSCI.2890-08.2008; Elia J, 2012, NAT GENET, V44, P78, DOI 10.1038/ng.1013; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; Foster AC, 2004, J PHARMACOL EXP THER, V311, P547, DOI 10.1124/jpet.103.063487; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Glessner JT, 2010, P NATL ACAD SCI USA, V107, P10584, DOI 10.1073/pnas.1000274107; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gonzalez MI, 2013, EPILEPSIA, V54, P616, DOI 10.1111/epi.12063; Grados MA, 2009, CURR PSYCHIAT REP, V11, P162, DOI 10.1007/s11920-009-0025-x; HAYCOCK JW, 1987, BRAIN RES BULL, V19, P619, DOI 10.1016/0361-9230(87)90046-3; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Ho A, 2003, P NATL ACAD SCI USA, V100, P1409, DOI 10.1073/pnas.252774899; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Hoon M, 2009, J NEUROSCI, V29, P8039, DOI 10.1523/JNEUROSCI.0534-09.2009; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Karayiorgou M, 2004, AM J MED GENET B, V124B, P20, DOI 10.1002/ajmg.b.20090; Klausberger T, 2002, J NEUROSCI, V22, P2513, DOI 10.1523/JNEUROSCI.22-07-02513.2002; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Labasque M, 2010, FEBS LETT, V584, P1787, DOI 10.1016/j.febslet.2009.08.025; Lewis DA, 2012, EUR J NEUROSCI, V35, P1871, DOI 10.1111/j.1460-9568.2012.08156.x; Li MY, 2006, AM J HUM GENET, V78, P778, DOI 10.1086/503711; Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Miyoshi G, 2012, NEURON, V74, P1045, DOI 10.1016/j.neuron.2012.04.025; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Nicholson C., 2010, P 13 INT C IN VIV ME, P328; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; Patel Jyoti C, 2013, Methods Mol Biol, V964, P243, DOI 10.1007/978-1-62703-251-3_15; Patel JC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2144; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Petroski RE, 2006, J PHARMACOL EXP THER, V317, P369, DOI 10.1124/jpet.105.096701; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Restituito S, 2011, J NEUROSCI, V31, P12083, DOI 10.1523/JNEUROSCI.2513-11.2011; Rice ME, 2011, NEUROSCIENCE, V198, P112, DOI 10.1016/j.neuroscience.2011.08.066; Spiegel I, 2002, MOL CELL NEUROSCI, V20, P283, DOI 10.1006/mcne.2002.1110; Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915; Stark KL, 2009, INT J NEUROPSYCHOPH, V12, P983, DOI 10.1017/S1461145709000492; Sylwestrak EL, 2012, SCIENCE, V338, P536, DOI 10.1126/science.1222482; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Xu B, 2009, P NATL ACAD SCI USA, V106, P16746, DOI 10.1073/pnas.0908584106	66	103	110	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					236	+		10.1038/nature13248	http://dx.doi.org/10.1038/nature13248			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	24870235	Green Accepted			2022-12-01	WOS:000338649800047
J	Kfoury, Y; Mercier, F; Scadden, DT				Kfoury, Youmna; Mercier, Francois; Scadden, David T.			SnapShot: The Hematopoietic Stem Cell Niche	CELL			English	Editorial Material							BONE-MARROW NICHE; LEUKEMIA		[Kfoury, Youmna; Mercier, Francois; Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Ctr Regenerat Med, Harvard Stem Cell Inst,Dept Stem Cell & Regenerat, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital	Kfoury, Y (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Ctr Regenerat Med, Harvard Stem Cell Inst,Dept Stem Cell & Regenerat, Cambridge, MA 02138 USA.							Arranz L, 2014, NATURE, V512, P78, DOI 10.1038/nature13383; Hartwell KA, 2013, NAT CHEM BIOL, V9, P840, DOI [10.1038/NCHEMBIO.1367, 10.1038/nchembio.1367]; Kode A, 2014, NATURE, V506, P240, DOI 10.1038/nature12883; Levesque JP, 2013, BIOESSAYS, V35, P183, DOI 10.1002/bies.201200111; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Motabi IH, 2012, BLOOD REV, V26, P267, DOI 10.1016/j.blre.2012.09.003; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034	10	13	14	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					228	U252		10.1016/j.cell.2014.06.019	http://dx.doi.org/10.1016/j.cell.2014.06.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995988	Bronze			2022-12-01	WOS:000340943100022
J	Xu, HT; Han, Z; Gao, P; He, SJ; Li, ZZ; Shi, W; Kodish, O; Shao, W; Brown, KN; Huang, K; Shi, SH				Xu, Hua-Tai; Han, Zhi; Gao, Peng; He, Shuijin; Li, Zhizhong; Shi, Wei; Kodish, Oren; Shao, Wei; Brown, Keith N.; Huang, Kun; Shi, Song-Hai			Distinct Lineage-Dependent Structural and Functional Organization of the Hippocampus	CELL			English	Article							RADIAL GLIAL-CELLS; IN-VIVO; EXCITATORY NEURONS; GABAERGIC NEURONS; PYRAMIDAL CELLS; PLACE CELLS; INTERNEURONS; MIGRATION; RAT; SPECIFICATION	The hippocampus, as part of the cerebral cortex, is essential for memory formation and spatial navigation. Although it has been extensively studied, especially as a model system for neurophysiology, the cellular processes involved in constructing and organizing the hippocampus remain largely unclear. Here, we show that clonally related excitatory neurons in the developing hippocampus are progressively organized into discrete horizontal, but not vertical, clusters in the stratum pyramidale, as revealed by both cell-type-specific retroviral labeling and mosaic analysis with double markers (MADM). Moreover, distinct from those in the neocortex, sister excitatory neurons in the cornu ammonis 1 region of the hippocampus rarely develop electrical or chemical synapses with each other. Instead, they preferentially receive common synaptic input from nearby fast-spiking (FS), but not non-FS, interneurons and exhibit synchronous synaptic activity. These results suggest that shared inhibitory input may specify horizontally clustered sister excitatory neurons as functional units in the hippocampus.	[Xu, Hua-Tai; Gao, Peng; He, Shuijin; Li, Zhizhong; Shi, Wei; Kodish, Oren; Shao, Wei; Brown, Keith N.; Shi, Song-Hai] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Han, Zhi] Nankai Univ, Coll Software, Tianjin 300071, Peoples R China; [Gao, Peng; Shi, Wei; Brown, Keith N.; Shi, Song-Hai] Weill Cornell Med Coll, Grad Program Neurosci, New York, NY 10065 USA; [Shi, Wei; Shi, Song-Hai] Weill Cornell Med Coll, Grad Program Biochem & Struct Biol Cell & Dev Bio, New York, NY 10065 USA; [Huang, Kun] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA	Memorial Sloan Kettering Cancer Center; Nankai University; Cornell University; Cornell University; University System of Ohio; Ohio State University	Shi, SH (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.	shis@mskcc.org	Huang, Kun/E-3272-2011	Han, Zhi/0000-0002-5603-8433	NIH [R01DA024681, R01MH101382, P01NS048120]; Simons Foundation [GC221194]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083624, R01MH101382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS048120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024681] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Drs. Nicoletta Tekki-Kessaris and Dieter Saur for providing the Emx1-CreER<SUP>T2</SUP> and R26<SUP>LSLTVA-iLacZ</SUP> mouse lines, Dr. Shaoyu Ge for sharing retroviral vectors, and Dr. Eric Holland for initially supporting our avian retroviral engineering. We are grateful to Drs. Yasunori Hayashi, Alexandra L. Joyner, Mary E. Hatten, and Mu-ming Poo and Ildiko Lily Erdy for critical reading of the manuscript. This work was supported by grants from the NIH (R01DA024681, R01MH101382, and P01NS048120) and the Simons Foundation (GC221194).	Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; EICHENBAUM H, 1989, J NEUROSCI, V9, P2764; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fiala JC, 1998, J NEUROSCI, V18, P8900; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gorski JA, 2002, J NEUROSCI, V22, P6309; GROVE EA, 1992, NEURON, V8, P217, DOI 10.1016/0896-6273(92)90289-P; Hampson RE, 1999, NATURE, V402, P610, DOI 10.1038/45154; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Hilscher MM, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00120; Hippenmeyer S, 2010, NEURON, V68, P695, DOI 10.1016/j.neuron.2010.09.027; KAWAGUCHI Y, 1987, BRAIN RES, V416, P369, DOI 10.1016/0006-8993(87)90921-8; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kitazawa A, 2014, J NEUROSCI, V34, P1115, DOI 10.1523/JNEUROSCI.2254-13.2014; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; KNOWLES WD, 1981, J NEUROSCI, V1, P318; LACAILLE JC, 1988, J NEUROSCI, V8, P1411; LACAILLE JC, 1987, J NEUROSCI, V7, P1979; Lee SMK, 2000, DEVELOPMENT, V127, P457; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Li LY, 2013, NAT NEUROSCI, V16, P1179, DOI 10.1038/nn.3493; Li YT, 2013, NAT NEUROSCI, V16, P1324, DOI 10.1038/nn.3494; Li Y, 2012, NATURE, V486, P118, DOI 10.1038/nature11110; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; MACVICAR BA, 1981, SCIENCE, V213, P782, DOI 10.1126/science.6266013; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Martin LA, 2002, J NEUROSCI, V22, P3520; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Nauta W., 1986, FUNDAMENTAL NEUROANA; Nielsen JV, 2007, DEVELOPMENT, V134, P1133, DOI 10.1242/dev.000265; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; NOWAKOWSKI RS, 1981, J COMP NEUROL, V196, P129, DOI 10.1002/cne.901960110; NOWAKOWSKI RS, 1979, J NEUROCYTOL, V8, P697, DOI 10.1007/BF01206671; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Seidler B, 2008, P NATL ACAD SCI USA, V105, P10137, DOI 10.1073/pnas.0800487105; SIK A, 1995, J NEUROSCI, V15, P6651; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Stancik EK, 2010, J NEUROSCI, V30, P7028, DOI 10.1523/JNEUROSCI.6131-09.2010; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Tole S, 1997, DEVELOPMENT, V124, P4959; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Xie ZF, 2010, P NATL ACAD SCI USA, V107, P6510, DOI 10.1073/pnas.0912315107; Yu YC, 2012, NATURE, V486, P113, DOI 10.1038/nature10958; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722; Zhao YU, 1999, SCIENCE, V284, P1155, DOI 10.1126/science.284.5417.1155; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	66	46	46	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1552	1564		10.1016/j.cell.2014.03.067	http://dx.doi.org/10.1016/j.cell.2014.03.067			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949968	Green Accepted, Bronze			2022-12-01	WOS:000340941900011
J	Mann, C				Mann, Clifford			World Cup's extended pub opening hours make no sense	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Coll Emergency Med, Taunton, Somerset, England		Mann, C (corresponding author), Coll Emergency Med, Taunton, Somerset, England.	cliff.mann@me.com						Alcohol Concern, 2010, FACTSH GRASP NETTL A; [Anonymous], 2001, J SUBST ABUSE, V6, P235; Galanter M., 1997, RECENT DEV ALCOHOLIS, V13; Home Office, 2014, CONS REL LIC HOURS F; National Treatment Agency for Substance Misuse, 2013, ALC TREATM ENGL 2011; Newton, 2007, EMJ, V24, P532	6	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2014	348								g3805	10.1136/bmj.g3805	http://dx.doi.org/10.1136/bmj.g3805			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1GY	24916687				2022-12-01	WOS:000337405200014
J	Caprio, J; Shimohara, M; Marui, T; Harada, S; Kiyohara, S				Caprio, John; Shimohara, Mami; Marui, Takayuki; Harada, Shuitsu; Kiyohara, Sadao			Marine teleost locates live prey through pH sensing	SCIENCE			English	Article							CHANNEL CATFISH; ION-CHANNEL; TASTE-BUDS; OCEAN; BEHAVIOR; CARBON; FISH; ABILITY; CELLS	We report that the Japanese sea catfish Plotosus japonicus senses local pH-associated increases in H+/CO2 equating to a decrease of <= 0.1 pH unit in ambient seawater. We demonstrated that these sensors, located on the external body of the fish, detect undamaged cryptic respiring prey, such as polychaete worms. Sensitivity is maximal at the natural pH of seawater (pH 8.1 to 8.2) and decreases dramatically in seawater with a pH <8.0.	[Caprio, John] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Shimohara, Mami; Kiyohara, Sadao] Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem & BioSci, Kagoshima 8900065, Japan; [Harada, Shuitsu] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Physiol, Kagoshima 8908544, Japan	Louisiana State University System; Louisiana State University; Kagoshima University; Kagoshima University	Caprio, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jcap@lsu.edu			NIH U.S.-Japan Brain Research Cooperative Program [NS-04-014]; Louisiana State University College of Science; Ministry of Education, Science, Sports, and Culture of Japan [22580205]	NIH U.S.-Japan Brain Research Cooperative Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana State University College of Science; Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank A. Nikonov, M. Brown, and J. Belanger for aid in preparation of Fig. 1; A. Kiyohara for Fig. 1A; C. Derby, A. Hansen, W. C. Michel, W. Silver, D. Mulkey, and T. Dietz for their constructive comments on the manuscript; and C. Derby for statistical aid. We also thank M. Kirino, T. Ikenaga, R. Kawabata and K. Kawano for assitance in the laboratory. Supported in part by the NIH U.S.-Japan Brain Research Cooperative Program (grant NS-04-014) and the George C. Kent Professorship (Louisiana State University College of Science) to J. C. and a grant (22580205) to S. K. from the Ministry of Education, Science, Sports, and Culture of Japan. All primary electrophysiological data (VCR tapes) are archived in the Department of Biological Sciences, Louisiana State University. The authors declare no competing financial interests. Readers are welcome to comment on the online version of the paper. Correspondence and requests for materials should be addressed to J. C. (jcap@lsu.edu).	ATEMA J, 1971, BRAIN BEHAV EVOLUT, V4, P273, DOI 10.1159/000125438; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Chen XM, 2007, J BIOL CHEM, V282, P30406, DOI 10.1074/jbc.M702229200; Clark Eugenie, 2011, Aqua, V17, P211; DAVENPORT CJ, 1982, J COMP PHYSIOL, V147, P217, DOI 10.1007/BF00609846; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Ferrari MCO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031478; FINGER TE, 1976, J COMP NEUROL, V165, P513, DOI 10.1002/cne.901650407; Finger TE, 1997, BRAIN BEHAV EVOLUT, V50, P234, DOI 10.1159/000113337; Finger TE, 1996, J COMP NEUROL, V373, P129, DOI 10.1002/(SICI)1096-9861(19960909)373:1<129::AID-CNE11>3.0.CO;2-F; FINGER TE, 1991, J COMP NEUROL, V314, P55, DOI 10.1002/cne.903140106; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Guyenet PG, 2010, J COMP NEUROL, V518, P3883, DOI 10.1002/cne.22435; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Kasai M, 2010, J COMP PHYSIOL A, V196, P901, DOI 10.1007/s00359-010-0572-y; KIYOHARA S, 1986, BRAIN RES, V379, P353, DOI 10.1016/0006-8993(86)90789-4; KOTRSCHAL K, 1992, ENVIRON BIOL FISH, V35, P273, DOI 10.1007/BF00001894; Kristensen E, 2001, Geochem Trans, V2, P92, DOI 10.1186/1467-4866-2-92; Meigh L, 2013, ELIFE, V2, DOI 10.7554/eLife.01213; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Perry SF, 2012, RESP PHYSIOL NEUROBI, V184, P309, DOI 10.1016/j.resp.2012.06.013; REUTTER K, 1974, CELL TISSUE RES, V149, P143; SCHARRER E, 1947, J COMP NEUROL, V86, P183, DOI 10.1002/cne.900860204; Service RF, 2012, SCIENCE, V337, P146, DOI 10.1126/science.337.6091.146; SILVER WL, 1984, J COMP PHYSIOL, V154, P167, DOI 10.1007/BF00604982; Simpson SD, 2011, BIOL LETTERS, V7, P917, DOI 10.1098/rsbl.2011.0293; Sorensen P. W., 1997, PHYSL FISHES, P375; Springauf A, 2010, J PHYSIOL-LONDON, V588, P809, DOI 10.1113/jphysiol.2009.182931; Wang S, 2013, J NEUROSCI, V33, P16033, DOI 10.1523/JNEUROSCI.2451-13.2013; Yoshino Tetsuo, 2008, Bulletin of the National Museum of Nature and Science Series A-Zoology, P1	31	27	27	3	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1154	1156		10.1126/science.1252697	http://dx.doi.org/10.1126/science.1252697			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904164				2022-12-01	WOS:000336791200046
J	Rao, RR; Long, JZ; White, JP; Svensson, KJ; Lou, J; Lokurkar, I; Jedrychowski, MP; Ruas, JL; Wrann, CD; Lo, JC; Camera, DM; Lachey, J; Gygi, S; Seehra, J; Hawley, JA; Spiegelman, BM				Rao, Rajesh R.; Long, Jonathan Z.; White, James P.; Svensson, Katrin J.; Lou, Jesse; Lokurkar, Isha; Jedrychowski, Mark P.; Ruas, Jorge L.; Wrann, Christiane D.; Lo, James C.; Camera, Donny M.; Lachey, Jenn; Gygi, Steven; Seehra, Jasbir; Hawley, John A.; Spiegelman, Bruce M.			Meteorin-like Is a Hormone that Regulates Immune-Adipose Interactions to Increase Beige Fat Thermogenesis	CELL			English	Article							SKELETAL-MUSCLE; WHITE FAT; EXERCISE; PGC-1-ALPHA; MACROPHAGES; COACTIVATOR; ACTIVATION; DYSFUNCTION; ADIPOCYTES; PREVENTION	Exercise training benefits many organ systems and offers protection against metabolic disorders such as obesity and diabetes. Using the recently identified isoform of PGC1-alpha (PGC1-alpha 4) as a discovery tool, we report the identification of meteorin-like (Metrnl), a circulating factor that is induced in muscle after exercise and in adipose tissue upon cold exposure. Increasing circulating levels of Metrnl stimulates energy expenditure and improves glucose tolerance and the expression of genes associated with beige fat thermogenesis and anti-inflammatory cytokines. Metrnl stimulates an eosinophil-dependent increase in IL-4 expression and promotes alternative activation of adipose tissue macrophages, which are required for the increased expression of the thermogenic and anti-inflammatory gene programs in fat. Importantly, blocking Metrnl actions in vivo significantly attenuates chronic cold-exposure-induced alternative macrophage activation and thermogenic gene responses. Thus, Metrnl links host-adaptive responses to the regulation of energy homeostasis and tissue inflammation and has therapeutic potential for metabolic and inflammatory diseases.	[Rao, Rajesh R.; Long, Jonathan Z.; White, James P.; Svensson, Katrin J.; Lou, Jesse; Lokurkar, Isha; Wrann, Christiane D.; Lo, James C.; Spiegelman, Bruce M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Rao, Rajesh R.; Long, Jonathan Z.; White, James P.; Svensson, Katrin J.; Lou, Jesse; Lokurkar, Isha; Jedrychowski, Mark P.; Wrann, Christiane D.; Lo, James C.; Gygi, Steven; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Ruas, Jorge L.] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Camera, Donny M.; Hawley, John A.] Australian Catholic Univ, Dept Exercise Sci, Exercise & Nutr Res Grp, Fitzroy, Vic 3065, Australia; [Hawley, John A.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 2AJ, Merseyside, England; [Lachey, Jenn; Seehra, Jasbir] Ember Therapeut Inc, Watertown, MA 02472 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Karolinska Institutet; Australian Catholic University; Liverpool John Moores University	Spiegelman, BM (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Hawley, John A/U-3814-2018; Lo, James/GYR-1149-2022; Camera, Donny/J-1571-2018; Ruas, Jorge/AAE-6094-2019; Svensson, Katrin J./AAA-4770-2021	Hawley, John A/0000-0002-0886-9881; Lo, James/0000-0003-0244-1670; Camera, Donny/0000-0002-6494-9472; Ruas, Jorge/0000-0002-1110-2606; Svensson, Katrin J./0000-0001-5376-5128; Long, Jonathan/0000-0003-2631-7463	National Institutes of Health [DK061562]; JPB foundation; Irvington Institute Fellowship Program of the Cancer Research Institute; American Diabetics Association/Canadian Diabetics Association (ADA/CDA) joint postdoctoral fellowship; Swedish Research Council; Novo Nordisk Fonden [NNF12OC1016062] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061562, P30DK043351, K08DK097303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS087096, R00NS087096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB foundation; Irvington Institute Fellowship Program of the Cancer Research Institute; American Diabetics Association/Canadian Diabetics Association (ADA/CDA) joint postdoctoral fellowship; Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Spiegelman laboratory for useful discussions and suggestions on the manuscript. This work was funded by National Institutes of Health grant (DK061562) to B. M. S. and a grant from the JPB foundation. R. R. R. is supported by Irvington Institute Fellowship Program of the Cancer Research Institute. J.Z.L. is supported by the American Diabetics Association/Canadian Diabetics Association (ADA/CDA) joint postdoctoral fellowship. K.J.S. was supported by a Swedish Research Council postdoctoral fellowship. B. M. S. is a consultant and shareholder in Ember Therapeutics.	Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Baynard T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/767953; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; COUSIN B, 1992, J CELL SCI, V103, P931; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Goh YPS, 2013, P NATL ACAD SCI USA, V110, P9914, DOI 10.1073/pnas.1304046110; Hawley JA, 2004, DIABETES-METAB RES, V20, P383, DOI 10.1002/dmrr.505; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Karamanlidis G, 2007, J BIOL CHEM, V282, P24660, DOI 10.1074/jbc.M703101200; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mathai AS, 2008, J APPL PHYSIOL, V105, P1098, DOI 10.1152/japplphysiol.00847.2007; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; PACY PJ, 1986, SPORTS MED, V3, P89, DOI 10.2165/00007256-198603020-00002; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xu XH, 2011, AM J PHYSIOL-REG I, V300, pR1115, DOI 10.1152/ajpregu.00806.2010; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	32	545	571	10	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1279	1291		10.1016/j.cell.2014.03.065	http://dx.doi.org/10.1016/j.cell.2014.03.065			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906147	Green Accepted, Bronze			2022-12-01	WOS:000340881400007
J	Rice, CM; Saeed, M				Rice, Charles M.; Saeed, Mohsan			Treatment triumphs	NATURE			English	Editorial Material							GENOTYPE 1 INFECTION; CHRONIC HEPATITIS-C; HCV; SOFOSBUVIR; LEDIPASVIR; ABT-450/R-OMBITASVIR; RIBAVIRIN; DASABUVIR; VIRUS		[Rice, Charles M.; Saeed, Mohsan] Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, New York, NY 10065 USA	Rockefeller University	Rice, CM (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, New York, NY 10065 USA.	ricec@rockefeller.edu	Saeed, Mohsan/AAM-8375-2021					Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; ALTER HJ, 1975, LANCET, V2, P838, DOI 10.1016/S0140-6736(75)90234-2; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Denniston MM, 2012, HEPATOLOGY, V55, P1652, DOI 10.1002/hep.25556; Dhaliwal HS, 2014, NEW ENGL J MED, V370, P1560, DOI 10.1056/NEJMc1401726; Dore GJ, 2014, J VIRAL HEPATITIS, V21, P1, DOI 10.1111/jvh.12253; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Heim MH, 2013, NAT REV IMMUNOL, V13, P535, DOI 10.1038/nri3463; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; PRINCE AM, 1974, LANCET, V2, P241; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	15	28	30	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					43	44		10.1038/510043a	http://dx.doi.org/10.1038/510043a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3NR	24899301				2022-12-01	WOS:000336768900028
J	Quackenbush, J				Quackenbush, John			PERSPECTIVE Learning to share	NATURE			English	Editorial Material									Dana Farber Canc Inst, Ctr Canc Computat Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute	Quackenbush, J (corresponding author), Dana Farber Canc Inst, Ctr Canc Computat Biol, Boston, MA 02115 USA.	johnq@jimmy.harvard.edu		Quackenbush, John/0000-0002-2702-5879	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111759] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL111759] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))			0	1	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S68	S68		10.1038/509S68a	http://dx.doi.org/10.1038/509S68a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870827	Green Accepted			2022-12-01	WOS:000336457100010
J	Glendenning, P; Bell, DA; Clifton-Bligh, RJ				Glendenning, Paul; Bell, Damon A.; Clifton-Bligh, Roderick J.			RATIONAL TESTING Investigating hypophosphataemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY HYPERPARATHYROIDISM; 25-HYDROXYVITAMIN D; VITAMIN-D; PHOSPHATE; MANAGEMENT; CALCIUM	This series of occasional articles provides an update on the best use of key diagnostic tests in the initial investigation of common or important clinical presentations. The series advisers are Steve Atkin, professor, head of department of academic endocrinology, diabetes, and metabolism, Hull York Medical School; and Eric Kilpatrick, honorary professor, department of clinical biochemistry, Hull Royal Infirmary, Hull York Medical School. To suggest a topic for this series, please email us at practice@bmj.com.	[Glendenning, Paul; Bell, Damon A.] Univ Western Australia, Royal Perth Hosp, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Glendenning, Paul; Bell, Damon A.] Royal Perth Hosp, Dept Clin Biochem, PathWest Lab Med, Perth, WA 6000, Australia; [Clifton-Bligh, Roderick J.] Kolling Inst Royal North Shore Hosp, St Leonards, NSW, Australia	Royal Perth Hospital; University of Western Australia; Royal Perth Hospital; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Glendenning, P (corresponding author), Royal Perth Hosp, Dept Clin Biochem, PathWest Lab Med, Perth, WA 6000, Australia.	Paul.Glendenning@health.wa.gov.au		Clifton-Bligh, Roderick/0000-0002-1545-0368; Bell, Damon/0000-0002-6592-6184				Bhattacharyya N, 2012, TRENDS ENDOCRIN MET, V23, P610, DOI 10.1016/j.tem.2012.07.002; Brunelli SM, 2007, J AM SOC NEPHROL, V18, P1999, DOI 10.1681/ASN.2007020143; Chong WH, 2011, ENDOCR-RELAT CANCER, V18, pR53, DOI 10.1530/ERC-11-0006; Felsenfeld AJ, 2012, AM J KIDNEY DIS, V60, P655, DOI 10.1053/j.ajkd.2012.03.024; Girgis CM, 2013, ENDOCR REV, V34, P33, DOI 10.1210/er.2012-1012; Glendenning P, 2013, ANN CLIN BIOCHEM, V50, P191, DOI 10.1177/0004563213482892; Gok DE, 2011, J ENDOCRINOL INVEST, V34, P3, DOI [10.1007/BF03346687, 10.3275/6902]; Jayasena CN, 2013, CLIN ENDOCRINOL, V78, P838, DOI 10.1111/cen.12062; Kim YJ, 2012, TRANSPL P, V44, P651, DOI 10.1016/j.transproceed.2011.12.050; Liamis G, 2010, QJM-INT J MED, V103, P449, DOI 10.1093/qjmed/hcq039; Moosgaard B, 2007, CLIN ENDOCRINOL, V66, P35, DOI 10.1111/j.1365-2265.2006.02680.x; Payne RB, 1998, ANN CLIN BIOCHEM, V35, P201, DOI 10.1177/000456329803500203; Priemel M, 2010, J BONE MINER RES, V25, P305, DOI 10.1359/jbmr.090728; RAANANI P, 1992, POSTGRAD MED J, V68, P283, DOI 10.1136/pgmj.68.798.283; Skipper A, 2012, NUTR CLIN PRACT, V27, P34, DOI 10.1177/0884533611427916; Witteveen JE, 2013, EUR J ENDOCRINOL, V168, pR45, DOI 10.1530/EJE-12-0528	16	11	11	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2014	348								g3172	10.1136/bmj.g3172	http://dx.doi.org/10.1136/bmj.g3172			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EH	24871308				2022-12-01	WOS:000336742000001
J	Vanholder, R; Van Biesen, W; Lameire, N				Vanholder, Raymond; Van Biesen, Wim; Lameire, Norbert			Renal replacement therapy: how can we contain the costs?	LANCET			English	Editorial Material							DIALYSIS; DISEASE		[Vanholder, Raymond; Van Biesen, Wim] Ghent Univ Hosp, Sect Internal Med, Div Renal, B-9000 Ghent, Belgium; [Lameire, Norbert] Ghent Univ Hosp, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital	Vanholder, R (corresponding author), Ghent Univ Hosp, Sect Internal Med, Div Renal, B-9000 Ghent, Belgium.	raymond.vanholder@ugent.be						Couchoud C, 2009, NEPHROL DIAL TRANSPL, V24, P1553, DOI 10.1093/ndt/gfn698; Desai AA, 2009, CLIN J AM SOC NEPHRO, V4, P772, DOI 10.2215/CJN.05661108; Icks A, 2010, NEPHROL DIAL TRANSPL, V25, P1647, DOI 10.1093/ndt/gfp672; Jassal SV, 2002, NEPHROL DIAL TRANSPL, V17, P474, DOI 10.1093/ndt/17.3.474; Kleophas Werner, 2007, Int J Health Care Finance Econ, V7, P185, DOI 10.1007/s10754-007-9020-0; Lameire N, 2010, NEW ENGL J MED, V363, P678, DOI 10.1056/NEJMe1006669; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; Murtagh FEM, 2007, NEPHROL DIAL TRANSPL, V22, P1955, DOI 10.1093/ndt/gfm153; Ponce P, 2012, BLOOD PURIF; Robinson BM, 2014, KIDNEY INT, V85, P158, DOI 10.1038/ki.2013.252; Rubin HR, 2004, JAMA-J AM MED ASSOC, V291, P697, DOI 10.1001/jama.291.6.697; Swanepoel CR, 2013, NAT REV NEPHROL, V9, P610, DOI 10.1038/nrneph.2013.168; Vanholder R, 2012, J AM SOC NEPHROL, V23, P1291, DOI 10.1681/ASN.2011111094	13	14	14	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 24	2014	383	9931					1783	1785		10.1016/S0140-6736(14)60721-2	http://dx.doi.org/10.1016/S0140-6736(14)60721-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH6US	24856012				2022-12-01	WOS:000336267800004
J	Schiering, C; Krausgruber, T; Chomka, A; Frohlich, A; Adelmann, K; Wohlfert, EA; Pott, J; Griseri, T; Bollrath, J; Hegazy, AN; Harrison, OJ; Owens, BMJ; Lohning, M; Belkaid, Y; Fallon, PG; Powrie, F				Schiering, Chris; Krausgruber, Thomas; Chomka, Agnieszka; Froehlich, Anja; Adelmann, Krista; Wohlfert, Elizabeth A.; Pott, Johanna; Griseri, Thibault; Bollrath, Julia; Hegazy, Ahmed N.; Harrison, Oliver J.; Owens, Benjamin M. J.; Loehning, Max; Belkaid, Yasmine; Fallon, Padraic G.; Powrie, Fiona			The alarmin IL-33 promotes regulatory T-cell function in the intestine	NATURE			English	Article							AMELIORATES EXPERIMENTAL COLITIS; INFLAMMATORY-BOWEL-DISEASE; TRANSCRIPTION FACTOR FOXP3; ULCERATIVE-COLITIS; DEPENDENT COLITIS; SOLUBLE ST2; CYTOKINE; MICE; RESPONSES; COMPLEX	FOXP3+ regulatory T cells (T-reg cells) are abundant in the intestine, where they prevent dysregulated inflammatory responses to self and environmental stimuli. It is now appreciated that T-reg cells acquire tissue-specific adaptations that facilitate their survival and function(1); however, key host factors controlling theT(reg) response in the intestine are poorly understood. The interleukin (IL)-1 family member IL-33 is constitutively expressed in epithelial cells at barrier sites(2), where it functions as an endogenous danger signal, or alarmin, in response to tissue damage(3). Recent studies in humans have described high levels of IL-33 in inflamed lesions of inflammatory bowel disease patients(4-7), suggesting a role for this cytokine in disease pathogenesis. In the intestine, both protective and pathological roles for IL-33 have been described in murine models of acute colitis(8-11), but its contribution to chronic inflammation remains ill defined. Here we show in mice that the IL-33 receptor ST2 is preferentially expressed on colonic T-reg cells, where it promotes T-reg function and adaptation to the inflammatory environment. IL-33 signalling in T cells stimulates T-reg responses in several ways. First, it enhances transforming growth factor (TGF)-beta 1-mediated differentiation of T-reg cells and, second, it provides a necessary signal for T-reg-cell accumulation and maintenance in inflamed tissues. Strikingly, IL-23, a key pro-inflammatory cytokine in the pathogenesis of inflammatory bowel disease, restrained T-reg responses through inhibition of IL-33 responsiveness. These results demonstrate a hitherto unrecognized link between an endogenous mediator of tissue damage and a major anti-inflammatory pathway, and suggest that the balance between IL-33 and IL-23 may be a key controller of intestinal immune responses.	[Schiering, Chris; Krausgruber, Thomas; Chomka, Agnieszka; Adelmann, Krista; Griseri, Thibault; Bollrath, Julia; Hegazy, Ahmed N.; Owens, Benjamin M. J.; Powrie, Fiona] Univ Oxford, John Radcliffe Hosp, Translat Gastroenterol Unit, Nuffield Dept Clin Med,Expt Med Div, Oxford OX3 9DU, England; [Froehlich, Anja; Loehning, Max] Charite, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany; [Froehlich, Anja; Loehning, Max] German Rheumatism Res Ctr DRFZ, D-10117 Berlin, Germany; [Wohlfert, Elizabeth A.; Belkaid, Yasmine] NIAID, Program Barrier Immun & Repair, Mucosal Immunol Sect, Lab Parasit Dis,NIH, Bethesda, MD 20892 USA; [Pott, Johanna; Harrison, Oliver J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Fallon, Padraic G.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Dublin 2, Ireland	University of Oxford; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oxford; Trinity College Dublin	Powrie, F (corresponding author), Univ Oxford, John Radcliffe Hosp, Translat Gastroenterol Unit, Nuffield Dept Clin Med,Expt Med Div, Oxford OX3 9DU, England.	fiona.powrie@path.ox.ac.uk	Löhning, Max/AAL-2967-2021; Krausgruber, Thomas/H-8490-2018; Fallon, Padraic/Y-2711-2019; wohlfert, beth/ABA-2255-2020	Löhning, Max/0000-0001-6382-7281; Krausgruber, Thomas/0000-0002-1374-0329; Fallon, Padraic/0000-0002-8401-7293; Harrison, Oliver/0000-0003-1515-9586; Stockenhuber, Krista/0000-0003-3608-064X; Hegazy, Ahmed N./0000-0002-2946-8251; Pott, Johanna/0000-0003-4439-725X; Owens, Benjamin/0000-0003-4710-6841; Schiering, Chris/0000-0001-7902-6024; Belkaid, Yasmine/0000-0001-9962-3571	Wellcome Trust; Fondation Louis Jeantet; European Molecular Biology Organization long-term fellowship [ALTF 116-2012]; Science Foundation Ireland; Volkswagen Foundation (Lichtenberg Program); BMBF (e:Bio/T-Sys); Oxford-UCB Pharma Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001133, ZIAAI001132] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/I005609/1] Funding Source: researchfish; Wellcome Trust [095688/Z/11/Z] Funding Source: researchfish; BBSRC [BB/I005609/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Fondation Louis Jeantet; European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Volkswagen Foundation (Lichtenberg Program); BMBF (e:Bio/T-Sys)(Federal Ministry of Education & Research (BMBF)); Oxford-UCB Pharma Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	C. S., K. A., A. C., O.J.H. and F. P. are supported by the Wellcome Trust. F. P. is also supported by the Fondation Louis Jeantet. A.N.H. is supported by a European Molecular Biology Organization long-term fellowship (ALTF 116-2012). P. G. F. is supported by Science Foundation Ireland. M. L. and A. F. are supported by the Volkswagen Foundation (Lichtenberg Program) and BMBF (e:Bio/T-Sys). B.M.J.O. is supported by an Oxford-UCB Pharma Postdoctoral Fellowship. We thank all members of the Oxford Translational Gastroenterology Unit for assistance and support. We are grateful to H. Ferry and K. Alford for essential flow cytometry support and the staff of the University of Oxford for animal care. We are also grateful to D. Baban for conducting microarray hybridizations.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Beltran CJ, 2010, INFLAMM BOWEL DIS, V16, P1097, DOI 10.1002/ibd.21175; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Diaz-Jimenez D, 2011, WORLD J GASTROENTERO, V17, P2181, DOI 10.3748/wjg.v17.i17.2181; Duan LH, 2012, MOL MED, V18, P753, DOI 10.2119/molmed.2011.00428; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Furusawa J, 2013, J IMMUNOL, V191, P1818, DOI 10.4049/jimmunol.1300379; Gross P, 2012, INFLAMM BOWEL DIS, V18, P1900, DOI 10.1002/ibd.22900; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hayakawa H, 2007, J BIOL CHEM, V282, P26369, DOI 10.1074/jbc.M704916200; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Kobori A, 2010, J GASTROENTEROL, V45, P999, DOI 10.1007/s00535-010-0245-1; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Maneechotesuwan K, 2007, J IMMUNOL, V178, P2491, DOI 10.4049/jimmunol.178.4.2491; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Palmer G, 2011, NAT REV RHEUMATOL, V7, P321, DOI 10.1038/nrrheum.2011.53; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sedhom MAK, 2013, GUT, V62, P1714, DOI 10.1136/gutjnl-2011-301785; Seidelin JB, 2010, IMMUNOL LETT, V128, P80, DOI 10.1016/j.imlet.2009.11.001; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wasserman A, 2012, ISR MED ASSOC J, V14, P620; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	36	635	649	6	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					564	+		10.1038/nature13577	http://dx.doi.org/10.1038/nature13577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25043027	Green Accepted			2022-12-01	WOS:000342075800044
J	Prue, G				Prue, Gillian			Vaccinate boys as well as girls against HPV: it works, and it may be cost effective	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HUMAN-PAPILLOMAVIRUS; GENITAL WARTS; MEN		Queens Univ Belfast, Sch Nursing & Midwifery, Belfast BT9 7BL, Antrim, North Ireland	Queens University Belfast	Prue, G (corresponding author), Queens Univ Belfast, Sch Nursing & Midwifery, Belfast BT9 7BL, Antrim, North Ireland.	g.prue@qub.ac.uk						Baandrup L, 2013, SEX TRANSM DIS, V40, P130, DOI 10.1097/OLQ.0b013e31827bd66b; Baio G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049699; Bowyer HL, 2014, J FAM PLAN REPROD H, V40, P14, DOI 10.1136/jfprhc-2013-100583; Boyce T., 2013, BR J SCH NURS, V8, P71, DOI [10.12968/bjsn.2013.8.2.71, DOI 10.12968/BJSN.2013.8.2.71]; Burger EA, 2009, PLOS ONE, V201420; Desai S, 2011, SEX TRANSM INFECT, V87, P464, DOI 10.1136/sti.2010.048421; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Marty R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-10; Newman PA, 2013, SEX TRANSM INFECT, V89, P568, DOI 10.1136/sextrans-2012-050980; Public Health England, 2013, ANN HPV VACC COV 201; Public Health England, 2014, HPV VACC PROGR SCHED; Zou HC, 2014, J INFECT DIS, V209, P642, DOI 10.1093/infdis/jit626	12	9	9	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2014	349								g4834	10.1136/bmj.g4834	http://dx.doi.org/10.1136/bmj.g4834			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NG	25073786	Green Published			2022-12-01	WOS:000339906000007
J	Gragert, L; Eapen, M; Williams, E; Freeman, J; Spellman, S; Baitty, R; Hartzman, R; Rizzo, JD; Horowitz, M; Confer, D; Maiers, M				Gragert, Loren; Eapen, Mary; Williams, Eric; Freeman, John; Spellman, Stephen; Baitty, Robert; Hartzman, Robert; Rizzo, J. Douglas; Horowitz, Mary; Confer, Dennis; Maiers, Martin			HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the US Registry	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORD BLOOD TRANSPLANTATION; UNRELATED DONOR; RETROSPECTIVE ANALYSIS; HAPLOTYPE FREQUENCIES; ACUTE-LEUKEMIA; BONE-MARROW; NATIONAL REGISTRY; OUTCOMES; IMPACT; ADULTS	BACKGROUND Hematopoietic stem-cell transplantation (HSCT) is a potentially lifesaving therapy for several blood cancers and other diseases. For patients without a suitable related HLA-matched donor, unrelated-donor registries of adult volunteers and banked umbilical cord-blood units, such as the Be the Match Registry operated by the National Marrow Donor Program (NMDP), provide potential sources of donors. Our goal in the present study was to measure the likelihood of finding a suitable donor in the U. S. registry. METHODS Using human HLA data from the NMDP donor and cord-blood-unit registry, we built population-based genetic models for 21 U. S. racial and ethnic groups to predict the likelihood of identifying a suitable donor (either an adult donor or a cord-blood unit) for patients in each group. The models incorporated the degree of HLA matching, adult-donor availability (i.e., ability to donate), and cord-blood-unit cell dose. RESULTS Our models indicated that most candidates for HSCT will have a suitable (HLA-matched or minimally mismatched) adult donor. However, many patients will not have an optimal adult donor - that is, a donor who is matched at high resolution at HLA-A, HLA-B, HLA-C, and HLA-DRB1. The likelihood of finding an optimal donor varies among racial and ethnic groups, with the highest probability among whites of European descent, at 75%, and the lowest probability among blacks of South or Central American descent, at 16%. Likelihoods for other groups are intermediate. Few patients will have an optimal cord-blood unit - that is, one matched at the antigen level at HLA-A and HLA-B and matched at high resolution at HLA-DRB1. However, cord-blood units mismatched at one or two HLA loci are available for almost all patients younger than 20 years of age and for more than 80% of patients 20 years of age or older, regardless of racial and ethnic background. CONCLUSIONS Most patients likely to benefit from HSCT will have a donor. Public investment in donor recruitment and cord-blood banks has expanded access to HSCT.	[Gragert, Loren; Williams, Eric; Freeman, John; Confer, Dennis; Maiers, Martin] Natl Marrow Donor Program Be Match, Minneapolis, MN 55413 USA; [Eapen, Mary; Spellman, Stephen; Rizzo, J. Douglas; Horowitz, Mary] Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI USA; [Eapen, Mary; Spellman, Stephen; Rizzo, J. Douglas; Horowitz, Mary] Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA; [Baitty, Robert] Hlth Resources & Serv Adm, Blood Stem Cell Transplantat Program, Div Transplantat, Washington, DC USA; [Hartzman, Robert] Dept Navy, CW Bill Young Marrow Donor Recruitment & Res Pro, Dept Def Marrow Donor Recruitment, Washington, DC USA; [Hartzman, Robert] Dept Navy, Res Program, Bone Marrow Res Directorate, Naval Med Res Ctr, Washington, DC USA	National Marrow Donor Program; Center for International Blood & Marrow Transplant Research; Center for International Blood & Marrow Transplant Research; United States Health Resources & Service Administration (HRSA); Naval Medical Research Center (NMRC)	Gragert, L (corresponding author), Natl Marrow Donor Program Be Match, 3001 Broadway St NE,Suite 100, Minneapolis, MN 55413 USA.	lgragert@nmdp.org	horowitz, Mary/ABH-2173-2021	Maiers, Martin/0000-0002-0198-2064; Eapen, Mary/0000-0001-6193-4243	Office of Naval Research, Department of the Navy; Health Resources and Services Administration, Department of Health and Human Services	Office of Naval Research, Department of the Navy; Health Resources and Services Administration, Department of Health and Human Services(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	Funded by the Office of Naval Research, Department of the Navy, and the Health Resources and Services Administration, Department of Health and Human Services.	Atsuta Y, 2009, BLOOD, V113, P1631, DOI 10.1182/blood-2008-03-147041; Beatty PG, 2000, HUM IMMUNOL, V61, P834, DOI 10.1016/S0198-8859(00)00138-5; BEATTY PG, 1995, TRANSPLANTATION, V60, P778, DOI 10.1097/00007890-199510270-00003; Brunstein CG, 2007, BLOOD, V110, P3064, DOI 10.1182/blood-2007-04-067215; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Eapen M, 2007, LANCET, V369, P1947, DOI 10.1016/S0140-6736(07)60915-5; Eapen M, 2014, BLOOD, V123, P133, DOI 10.1182/blood-2013-05-506253; Eapen M, 2011, LANCET ONCOL, V12, P1214, DOI 10.1016/S1470-2045(11)70260-1; Eapen M, 2010, LANCET ONCOL, V11, P653, DOI 10.1016/S1470-2045(10)70127-3; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Flomenberg N, 2004, BLOOD, V104, P1923, DOI 10.1182/blood-2004-03-0803; Furst D, 2013, BLOOD, V122, P3220, DOI 10.1182/blood-2013-02-482547; Gluckman E, 2004, EXP HEMATOL, V32, P397, DOI 10.1016/j.exphem.2004.01.002; Gragert L, 2013, HUM IMMUNOL, V74, P1313, DOI 10.1016/j.humimm.2013.06.025; Gratwohl A, 2009, CANCER-AM CANCER SOC, V115, P4715, DOI 10.1002/cncr.24531; Horan J, 2012, BLOOD, V120, P2918, DOI 10.1182/blood-2012-03-417758; Howard DH, 2008, MED DECIS MAKING, V28, P243, DOI 10.1177/0272989X07308750; Humes K. R., 2011, OVERVIEW RACE HISPAN; Kollman C, 2004, TRANSPLANTATION, V78, P89, DOI 10.1097/01.TP.0000132327.40702.97; Kollman C, 2007, HUM IMMUNOL, V68, P950, DOI 10.1016/j.humimm.2007.10.009; Kurtzberg J, 1996, NEW ENGL J MED, V335, P157, DOI 10.1056/NEJM199607183350303; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Mori M, 1996, Biol Blood Marrow Transplant, V2, P134; Pidala J, 2013, BONE MARROW TRANSPL, V48, P346, DOI 10.1038/bmt.2012.150; Rocha V, 2009, BRIT J HAEMATOL, V147, P262, DOI 10.1111/j.1365-2141.2009.07883.x; Scaradavou A, 2013, BLOOD, V121, P752, DOI 10.1182/blood-2012-08-449108; Schmidt AH, 2007, BONE MARROW TRANSPL, V40, P823, DOI 10.1038/sj.bmt.1705832; Spellman SR, 2012, BLOOD, V120, P259, DOI 10.1182/blood-2012-03-379032; Woolfrey A, 2011, BIOL BLOOD MARROW TR, V17, P885, DOI 10.1016/j.bbmt.2010.09.012	30	574	578	2	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					339	348		10.1056/NEJMsa1311707	http://dx.doi.org/10.1056/NEJMsa1311707			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7TY	25054717	Green Accepted			2022-12-01	WOS:000339339800010
J	Viros, A; Sanchez-Laorden, B; Pedersen, M; Furney, SJ; Rae, J; Hogan, K; Ejiama, S; Girotti, MR; Cook, M; Dhomen, N; Marais, R				Viros, Amaya; Sanchez-Laorden, Berta; Pedersen, Malin; Furney, Simon J.; Rae, Joel; Hogan, Kate; Ejiama, Sarah; Girotti, Maria Romina; Cook, Martin; Dhomen, Nathalie; Marais, Richard			Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53	NATURE			English	Article							MELANOCYTIC NEVI; SEQUENCING DATA; P53 GAIN; MUTATIONS; MICE; SUNSCREEN; CANCER; EXPRESSION; PREVENTION; EXPOSURE	Cutaneous melanoma is epidemiologically linked to ultraviolet radiation (UVR), but the molecular mechanisms by which UVR drives melanomagenesis remain unclear(1,2). The most common somatic mutation in melanoma is a V600E substitution in BRAF, which is an early event(3). To investigate how UVR accelerates oncogenic BRAF-driven melanomagenesis, we used a BRAF(V600E) mouse model. In mice expressing BRAF(V600E) in their melanocytes, a single dose of UVR that mimicked mild sunburn in humans induced clonal expansion of the melanocytes, and repeated doses of UVR increased melanoma burden. Here we show that sunscreen (UVA superior, UVB sun protection factor (SPF) 50) delayed the onset of UVR-driven melanoma, but only provided partial protection. The UVR-exposed tumours showed increased numbers of single nucleotide variants and we observed mutations (H39Y, S124F, R245C, R270C, C272G) in the Trp53 tumour suppressor in approximately 40% of cases. TP53 is an accepted UVR target in human non-melanoma skin cancer, but is not thought to have a major role in melanoma(4). However, we show that, in mice, mutant Trp53 accelerated BRAF(V600E)-driven melanomagenesis, and that TP53 mutations are linked to evidence of UVR-induced DNA damage inhuman melanoma. Thus, we provide mechanistic insight into epidemiological data linking UVR to acquired naevi in humans(5). Furthermore, we identify TP53/Trp53 as a UVR-target gene that cooperates with BRAF(V600E) to induce melanoma, providing molecular insight into how UVR accelerates melanomagenesis. Our study validates public health campaigns that promote sunscreen protection for individuals at risk of melanoma.	[Viros, Amaya; Sanchez-Laorden, Berta; Furney, Simon J.; Hogan, Kate; Ejiama, Sarah; Girotti, Maria Romina; Cook, Martin; Marais, Richard] Univ Manchester, Canc Res UK Manchester Inst, Mol Oncol Grp, Manchester M20 4BX, Lancs, England; [Pedersen, Malin; Rae, Joel; Dhomen, Nathalie; Marais, Richard] Inst Canc Res, Signal Transduct Team, London SW3 6JB, England; [Cook, Martin] Royal Surrey Cty Hosp, Guildford GU2 7XX, Surrey, England	Cancer Research UK; University of Manchester; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Surrey County Hospital	Marais, R (corresponding author), Univ Manchester, Canc Res UK Manchester Inst, Mol Oncol Grp, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	richard.marais@cruk.manchester.ac.uk	Sanchez-Laorden, Berta/T-2177-2017	Sanchez-Laorden, Berta/0000-0002-6499-6332; Viros, Amaya/0000-0001-5177-5015; Dhomen, Nathalie/0000-0003-1961-2173; Marais, Richard/0000-0001-7484-4183; Furney, Simon/0000-0002-8920-6800	Cancer Research UK [C107/A10433, C5759/A12328, A13540, A17240]; Wenner-Gren Foundations; Stockholm; Teggerstiftelsen; FEBS Long-Term Fellowship; Cancer Research UK [19279, 17240] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wenner-Gren Foundations; Stockholm; Teggerstiftelsen; FEBS Long-Term Fellowship; Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK (C107/A10433; C5759/A12328; A13540; A17240), the Wenner-Gren Foundations, Stockholm, Teggerstiftelsen (M.P.) and a FEBS Long-Term Fellowship (B.S.-L.). We thank G. Ashton for technical assistance and A. Young for helpful discussions. We would like to acknowledge the contribution of the melanoma specimen donors and research groups to The Cancer Genome Atlas.	Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Gilchrest BA, 1999, NEW ENGL J MED, V340, P1341, DOI 10.1056/NEJM199904293401707; Goel VK, 2009, ONCOGENE, V28, P2289, DOI 10.1038/onc.2009.95; Goldenhersh MA, 2011, J CLIN ONCOL, V29, pE557, DOI 10.1200/JCO.2011.35.5727; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; Green AC, 2011, J CLIN ONCOL, V29, P257, DOI 10.1200/JCO.2010.28.7078; HARRISON SL, 1994, LANCET, V344, P1529, DOI 10.1016/S0140-6736(94)90348-4; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo C, 2013, CANCER RES, V73, P4337, DOI 10.1158/0008-5472.CAN-12-4454; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Patton EE, 2005, ZEBRAFISH, V1, P363, DOI 10.1089/zeb.2005.1.363; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Planta MB, 2011, J AM BOARD FAM MED, V24, P735, DOI 10.3122/jabfm.2011.06.100178; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; PONTEN F, 1995, J INVEST DERMATOL, V105, P402, DOI 10.1111/1523-1747.ep12321071; Rudolph P, 1998, HUM PATHOL, V29, P1480, DOI 10.1016/S0046-8177(98)90019-3; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Thomas NE, 2007, CANCER EPIDEM BIOMAR, V16, P991, DOI 10.1158/1055-9965.EPI-06-1038; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Turajlic S, 2012, GENOME RES, V22, P196, DOI 10.1101/gr.125591.111; Viros A, 2008, PLOS MED, V5, P941, DOI 10.1371/journal.pmed.0050120; Vultur Adina, 2013, Cancer Cell, V23, P706, DOI 10.1016/j.ccr.2013.05.001; Whiteman DC, 2003, J NATL CANCER I, V95, P806, DOI 10.1093/jnci/95.11.806; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yeh I, 2013, JNCI-J NATL CANCER I, V105, P917, DOI 10.1093/jnci/djt119; Zaidi MR, 2011, NATURE, V469, P548, DOI 10.1038/nature09666	38	147	150	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					478	+		10.1038/nature13298	http://dx.doi.org/10.1038/nature13298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	24919155	Green Accepted			2022-12-01	WOS:000339335700049
J	Wasmuth, EV; Januszyk, K; Lima, CD				Wasmuth, Elizabeth V.; Januszyk, Kurt; Lima, Christopher D.			Structure of an Rrp6-RNA exosome complex bound to poly(A) RNA	NATURE			English	Article							CRYSTAL-STRUCTURE; DEGRADATION; RRP6P; CORE; RECONSTITUTION; EXONUCLEASE; COFACTOR; BINDING	The eukaryotic RNA exosome processes and degrades RNA by directing substrates to the distributive or processive 3' to 5' exoribonuclease activities of Rrp6 or Rrp44, respectively. The non-catalytic nine-subunit exosome core (Exo9) features a prominent central channel. Although RNA can pass through the channel to engage Rrp44, it is not clear how RNA is directed to Rrp6 or whether Rrp6 uses the central channel. Here we report a 3.3 angstrom crystal structure of a ten-subunit RNA exosome complex from Saccharomyces cerevisiae composed of the Exo9 core and Rrp6 bound to single-stranded poly(A) RNA. The Rrp6 catalytic domain rests on top of the Exo9 S1/KH ring above the central channel, the RNA 3' end is anchored in the Rrp6 active site, and the remaining RNA traverses the S1/KH ring in an opposite orientation to that observed in a structure of a Rrp44-containing exosome complex. Solution studies with human and yeast RNA exosome complexes suggest that the RNA path to Rrp6 is conserved and dependent on the integrity of the S1/KH ring. Although path selection to Rrp6 or Rrp44 is stochastic in vitro, the fate of a particular RNA may be determined in vivo by the manner in which cofactors present RNA to the RNA exosome.	[Wasmuth, Elizabeth V.; Januszyk, Kurt; Lima, Christopher D.] Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA; [Wasmuth, Elizabeth V.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Louis Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA; [Lima, Christopher D.] Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Lima, CD (corresponding author), Sloan Kettering Inst, Struct Biol Program, 1275 York Ave, New York, NY 10065 USA.	limac@mskcc.org		Lima, Christopher/0000-0002-9163-6092; Wasmuth, Elizabeth/0000-0003-1474-4935	US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; National Institute of General Medical Sciences of the National Institutes of Health [F31GM097910, R01GM079196]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408, P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, P41GM103473, F31GM097910, P41GM103403, R01GM079196] Funding Source: NIH RePORTER	US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank NE-CAT beamlines (Advanced Photon Source) supported by P41GM103403 (NIH NIGMS). APS is supported by the US Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Beamline X29 (National Synchrotron Light Source) supported by the US Department of Energy, the Office of Basic Energy Sciences and P41RR012408 (NIH NCRR) and P41GM103473 (NIH NIGMS). Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award numbers F31GM097910 (E.V.W.) and R01GM079196 (C.D.L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. C.D.L. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Assenholt J, 2008, RNA, V14, P2305, DOI 10.1261/rna.1108008; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Cha SS, 2010, EMBO J, V29, P3520, DOI 10.1038/emboj.2010.226; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Drazkowska K, 2013, NUCLEIC ACIDS RES, V41, P3845, DOI 10.1093/nar/gkt060; Effantin G, 2010, J BIOL CHEM, V285, P14834, DOI 10.1074/jbc.M109.090498; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Greimann JC, 2008, METHOD ENZYMOL, V448, P185, DOI 10.1016/S0076-6879(08)02610-4; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Januszyk K, 2011, RNA, V17, P1566, DOI 10.1261/rna.2763111; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Liu JJ, 2014, NAT STRUCT MOL BIOL, V21, P95, DOI 10.1038/nsmb.2736; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Makino DL, 2013, NAT REV MOL CELL BIO, V14, P654, DOI 10.1038/nrm3657; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Midtgaard SF, 2006, P NATL ACAD SCI USA, V103, P11898, DOI 10.1073/pnas.0604731103; Milligan L, 2008, MOL CELL BIOL, V28, P5446, DOI 10.1128/MCB.00463-08; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sen M, 2013, CELL, V155, P636, DOI 10.1016/j.cell.2013.09.022; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Wasmuth EV, 2012, ENZYMES, V31, P53, DOI 10.1016/B978-0-12-404740-2.00003-3; Wasmuth EV, 2012, MOL CELL, V48, P133, DOI 10.1016/j.molcel.2012.07.012; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013	36	101	102	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					435	+		10.1038/nature13406	http://dx.doi.org/10.1038/nature13406			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25043052	Green Accepted			2022-12-01	WOS:000339335700039
J	Bhutta, ZA				Bhutta, Zulfiqar Ahmed			Polio eradication hinges on child health in Pakistan	NATURE			English	Editorial Material									[Bhutta, Zulfiqar Ahmed] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Bhutta, Zulfiqar Ahmed] Sick Kids Ctr Global Child Hlth, Toronto, ON, Canada	Aga Khan University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Bhutta, ZA (corresponding author), Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan.	zulfiqar.bhutta@aku.edu						Bhutta ZA, 2013, LANCET, V381, P2207, DOI 10.1016/S0140-6736(12)61999-0; Bhutta ZA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f280; Blake I. M., 2014, P NATL ACAD SCI US; Independent Monitoring Board of the Global Polio Eradication Initiative, 2014, 9 GLOB POL ER IN IND; Mayer BT, 2013, AM J EPIDEMIOL, V177, P1236, DOI 10.1093/aje/kws378; National Institute of Population Studies, 2013, PAK DEM HLTH SURV 20; Rutter PD, 2014, LANCET, V383, P1695, DOI 10.1016/S0140-6736(14)60756-X	7	13	13	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					285	287		10.1038/511285a	http://dx.doi.org/10.1038/511285a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL2YR	25030151	Green Published, Bronze			2022-12-01	WOS:000338992200012
J	Ksander, BR; Kolovou, PE; Wilson, BJ; Saab, KR; Guo, Q; Ma, J; McGuire, SP; Gregory, MS; Vincent, WJB; Perez, VL; Cruz-Guilloty, F; Kao, WWY; Call, MK; Tucker, BA; Zhan, Q; Murphy, GF; Lathrop, KL; Alt, C; Mortensen, LJ; Lin, CP; Zieske, JD; Frank, MH; Frank, NY				Ksander, Bruce R.; Kolovou, Paraskevi E.; Wilson, Brian J.; Saab, Karim R.; Guo, Qin; Ma, Jie; McGuire, Sean P.; Gregory, Meredith S.; Vincent, William J. B.; Perez, Victor L.; Cruz-Guilloty, Fernando; Kao, Winston W. Y.; Call, Mindy K.; Tucker, Budd A.; Zhan, Qian; Murphy, George F.; Lathrop, Kira L.; Alt, Clemens; Mortensen, Luke J.; Lin, Charles P.; Zieske, James D.; Frank, Markus H.; Frank, Natasha Y.			ABCB5 is a limbal stem cell gene required for corneal development and repair	NATURE			English	Article							OCULAR SURFACE; CHEMORESISTANCE; MELANOMA; MICE; POPULATION; DEFICIENCY; MICROSCOPY; PHENOTYPE; THERAPY	Corneal epithelial homeostasis and regeneration are sustained by limbal stem cells (LSCs)(1-3), and LSC deficiency is a major cause of blindness worldwide(4). Transplantation is often the only therapeutic option available to patients with LSC deficiency. However, while transplant success depends foremost on LSC frequency within grafts(5), a gene allowing for prospective LSC enrichment has not been identified so far(5). Here we show that ATP-binding cassette, sub-family B, member(5) (ABCB5)(6,7) marks LSCs and is required for LSC maintenance, corneal development and repair. Furthermore, we demonstrate that prospectively isolated humanor murine ABCB5-positive LSCs possess the exclusive capacity to fully restore the cornea upon grafting to LSC-deficient mice in xenogeneic or syngeneic transplantation models. ABCB5 is preferentially expressed on label-retaining LSCs2 in mice and p63 alpha-positive LSCs8 in humans. Consistent with these findings, ABCB5-positive LSC frequency is reduced in LSC-deficient patients. Abcb5 loss of function in Abcb5 knockout mice causes depletion of quiescent LSCs due to enhanced proliferation and apoptosis, and results in defective corneal differentiation and wound healing. Our results from gene knockout studies, LSC tracing and transplantation models, as well as phenotypic and functional analyses of human biopsy specimens, provide converging lines of evidence that ABCB5 identifies mammalian LSCs. Identification and prospective isolation of molecularly defined LSCs with essential functions in corneal development and repair has important implications for the treatment of corneal disease, particularly corneal blindness due to LSC deficiency.	[Ksander, Bruce R.; Kolovou, Paraskevi E.; McGuire, Sean P.; Gregory, Meredith S.; Vincent, William J. B.; Zieske, James D.] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02114 USA; [Ksander, Bruce R.; Kolovou, Paraskevi E.; McGuire, Sean P.; Gregory, Meredith S.; Vincent, William J. B.; Alt, Clemens; Mortensen, Luke J.; Lin, Charles P.; Zieske, James D.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Wilson, Brian J.; Saab, Karim R.; Guo, Qin; Ma, Jie; Frank, Markus H.; Frank, Natasha Y.] Boston Childrens Hosp, Div Nephrol, Transplant Res Program, Boston, MA 02115 USA; [Wilson, Brian J.; Saab, Karim R.; Guo, Qin; Ma, Jie; Frank, Markus H.] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Wilson, Brian J.; Guo, Qin; Frank, Natasha Y.] VA Boston Healthcare Syst, Dept Med, Boston, MA 02130 USA; [Perez, Victor L.; Cruz-Guilloty, Fernando] Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Perez, Victor L.; Cruz-Guilloty, Fernando] Univ Miami, Miller Sch Med, Dept Ophthalmol, Miami, FL 33136 USA; [Kao, Winston W. Y.; Call, Mindy K.] Univ Cincinnati, Med Ctr, Dept Ophthalmol, Cincinnati, OH 45229 USA; [Tucker, Budd A.] Univ Iowa, Stephen A Wynn Inst Vis Res, Carver Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Zhan, Qian; Murphy, George F.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lathrop, Kira L.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15213 USA; [Lathrop, Kira L.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA 15213 USA; [Alt, Clemens; Mortensen, Luke J.; Lin, Charles P.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Alt, Clemens; Mortensen, Luke J.; Lin, Charles P.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Frank, Markus H.; Frank, Natasha Y.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02138 USA; [Frank, Natasha Y.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Bascom Palmer Eye Institute; University of Miami; University System of Ohio; University of Cincinnati; University of Iowa; Harvard University; Brigham & Women's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Frank, NY (corresponding author), Boston Childrens Hosp, Div Nephrol, Transplant Res Program, Boston, MA 02115 USA.	markus.frank@childrens.harvard.edu; nfrank@partners.org	Gregory-Ksander, Meredith/AAG-1413-2019; Mortensen, Luke/N-2640-2018; Perez, Victor L./AAY-8633-2020; Frank, Markus/O-1625-2014	Gregory-Ksander, Meredith/0000-0002-7193-0032; Mortensen, Luke/0000-0002-4331-4099; Frank, Markus/0000-0002-1312-0488; Zieske, James/0000-0002-3730-6180; Tucker, Budd/0000-0003-2178-1742	National Institutes of Health (NIH)/National Institutes of Neurological Disorders and Stroke [K08NS051349]; VA BLRD [1I01BX000516]; VA RRD [1I01RX000989]; Harvard Stem Cell Institute; NIH/National Cancer Institute [R01CA113796, R01CA158467, R01CA138231]; Department of Defense [PR0332453]; NIH [R01CA138231, R01EY018624, P30EY014801, R01EY021768, DP2OD007483, R01 EB017274, U01HL100402, P41EB015903]; Corley Research Foundation; Western Pennsylvania Medical Eye Bank Core Grant for Vision Research [EY08098]; NATIONAL CANCER INSTITUTE [R01CA113796, R01CA138231, R01CA158467] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY014801, R01EY018624, P30EY003790, P30EY008098, R01EY021768] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015903, R01EB017274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS051349] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007483] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000516, I01RX000989] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institutes of Neurological Disorders and Stroke; VA BLRD; VA RRD; Harvard Stem Cell Institute; NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Corley Research Foundation; Western Pennsylvania Medical Eye Bank Core Grant for Vision Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	We thank R. Maas for critical reading of the manuscript. We also thank P. Mallen for assistance with graphic illustrations; the Heartland Lions Eye Bank for providing clinical specimens; G. Berg for assistance with mouse colony maintenance; D. Dombkowski, F. Preffer and R. Huang for their assistance with cell sorting and viability studies. This work was supported by National Institutes of Health (NIH)/National Institutes of Neurological Disorders and Stroke grant K08NS051349, VA BLR&D 1I01BX000516 and VA RR&D 1I01RX000989 Merit Review Awards, and a Harvard Stem Cell Institute grant to N.Y.F., NIH/National Cancer Institute grants R01CA113796, R01CA158467 and R01CA138231 to M. H. F., Department of Defense grant PR0332453 to B. R. K., NIH R01EY018624 and P30EY014801 grants to V. L. P., NIH grant R01EY021768 to W. W. K., NIH New Innovator Award DP2OD007483 and a Corley Research Foundation grant to B. A. T., NIH R01CA138231 to G. F. M., Western Pennsylvania Medical Eye Bank Core Grant for Vision Research (EY08098) to K. L. L., and NIH grants R01 EB017274, U01HL100402 and P41EB015903 to C. P. L. F. C. G. is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation.	Cheung ST, 2011, GASTROENTEROLOGY, V140, P344, DOI 10.1053/j.gastro.2010.07.049; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Dua HS, 2003, EYE, V17, P877, DOI 10.1038/sj.eye.6700573; Frank NY, 2011, CANCER RES, V71, P1474, DOI 10.1158/0008-5472.CAN-10-1660; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Frank NY, 2003, J BIOL CHEM, V278, P47156, DOI 10.1074/jbc.M308700200; Hutcheon AEK, 2007, EXP EYE RES, V84, P32, DOI 10.1016/j.exer.2006.08.011; Hutcheson DA, 2009, CELL CYCLE, V8, P3675, DOI 10.4161/cc.8.22.9992; Kao WWY, 1996, INVEST OPHTH VIS SCI, V37, P2572; Klocke J, 2011, INVEST OPHTH VIS SCI, V52, P256, DOI 10.1167/iovs.10-5566; Krulova M, 2008, INVEST OPHTH VIS SCI, V49, P3903, DOI 10.1167/iovs.08-1987; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lathrop KL, 2012, INVEST OPHTH VIS SCI, V53, P1381, DOI 10.1167/iovs.11-8524; Lin JY, 2013, BIOCHEM BIOPH RES CO, V436, P536, DOI 10.1016/j.bbrc.2013.06.006; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Luo YC, 2012, J INVEST DERMATOL, V132, P2440, DOI 10.1038/jid.2012.161; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Meyer-Blazejewska EA, 2011, STEM CELLS, V29, P57, DOI 10.1002/stem.550; Meyer-Blazejewska EA, 2010, INVEST OPHTH VIS SCI, V51, P765, DOI 10.1167/iovs.09-4109; Notara M, 2008, CELL TISSUE RES, V331, P135, DOI 10.1007/s00441-007-0458-7; Pal-Ghosh S, 2008, EXP EYE RES, V87, P478, DOI 10.1016/j.exer.2008.08.013; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Rocco A, 2012, LAB INVEST, V92, P1407, DOI 10.1038/labinvest.2012.100; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751; Wang K, 2012, BIOMED OPT EXPRESS, V3, P1972, DOI 10.1364/BOE.3.001972; Wilson BJ, 2011, CANCER RES, V71, P5307, DOI 10.1158/0008-5472.CAN-11-0221	32	166	175	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					353	+		10.1038/nature13426	http://dx.doi.org/10.1038/nature13426			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030174	Green Accepted			2022-12-01	WOS:000338992200037
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Is Coca-Cola's antiobesity scheme the real thing?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2009, ASA ADJ COC COL GREA; [Anonymous], 2011, ASA ADJ COC COL GREA; [Anonymous], 2014, BIRMINGHAM NEWS 0526; [Anonymous], GLAC; [Anonymous], 2014, INDEPENDENT; Newham London, COC COL ZER PARKLIVE	6	3	3	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2014	349								g4340	10.1136/bmj.g4340	http://dx.doi.org/10.1136/bmj.g4340			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZD	25007793	Green Published			2022-12-01	WOS:000338993500008
J	Alcaide, M; Scordato, ESC; Price, TD; Irwin, DE				Alcaide, Miguel; Scordato, Elizabeth S. C.; Price, Trevor D.; Irwin, Darren E.			Genomic divergence in a ring species complex	NATURE			English	Article							PHYLLOSCOPUS-TROCHILOIDES; SPECIATION; EVOLUTION; ADAPTATION; COMPONENT; SYMPATRY; SOFTWARE; DISTANCE	Ring species provide particularly clear demonstrations of how one species can gradually evolve into two, but are rare in nature(1-3). In the greenish warbler (Phylloscopus trochiloides) species complex, a ring of populations wraps around Tibet. Two reproductively isolated forms co-exist in central Siberia, with a gradient of genetic and phenotypic characteristics through the southern chain of populations connecting them(4-6). Previous genetic evidence has proven inconclusive, however, regarding whether species divergence took place in the face of continuous gene flow and whether hybridization between the terminal forms of the ring ever occurred(7-9). Here we use genome-wide analyses to show that, although spatial patterns of genetic variation are currently mostly as expected of a ring species, historical breaks in gene flow have existed at more than one location around the ring, and the two Siberian forms have occasionally interbred. Substantial periods of geographical isolation occurred not only in the north but also in the western Himalayas, where there is now an extensive hybrid zone between genetically divergent forms. Limited asymmetric introgression has occurred directly between the Siberian forms, although it has not caused a blending of those forms, suggesting selection against introgressed genes in the novel genetic background. Levels of reproductive isolation and genetic introgression are consistent with levels of phenotypic divergence around the ring, with phenotypic similarity and extensive interbreeding across the southwestern contact zone and strong phenotypic divergence and nearly complete reproductive isolation across the northern contact zone. These results cast doubt on the hypothesis that the greenish warbler should be viewed as a rare example of speciation by distance(6), but demonstrate that the greenish warbler displays a continuum from slightly divergent neighbouring populations to almost fully reproductively isolated species.	[Alcaide, Miguel; Irwin, Darren E.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Alcaide, Miguel; Irwin, Darren E.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Alcaide, Miguel] CSIC, Dept Evolutionary Ecol, Estn Biol Donana, Seville 41092, Spain; [Scordato, Elizabeth S. C.; Price, Trevor D.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Scordato, Elizabeth S. C.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of British Columbia; University of British Columbia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Chicago; University of Colorado System; University of Colorado Boulder	Irwin, DE (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	irwin@zoology.ubc.ca	Irwin, Darren E./G-6183-2012	Irwin, Darren E./0000-0002-1050-5841; Alcaide, Miguel/0000-0001-6945-0972	Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme [273773]; NSERC discovery grant [311931]; US NSF	Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; NSERC discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); US NSF(National Science Foundation (NSF))	This research was supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (project no. 273773) and an NSERC discovery grant (no. 311931). Original collections were made with a grant from the US NSF. We thank Z. Benowitz-Fredericks, J. Gibson, S. Gross, J. Irwin, G. Kelberg, A. Knorre, K. Marchetti and B. Sheldon for assistance in the field. For additional samples we thank P. Alstrom, K. Marchetti, U. Olsson, A. Richman and J. Tiainen. We thank J. Irwin and L. Rieseberg for comments and discussion and A. Kuzmin for assistance during library preparation.	BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; Cacho NI, 2012, P ROY SOC B-BIOL SCI, V279, P3377, DOI 10.1098/rspb.2012.0498; Coyne J.A., 2004, SPECIATION; Dobzhansky T., 1958, CENTURY DARWIN, P19; Drummond AJ, 2011, GENEIOUS V5 4; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endler J.A., 1977, Monographs in Population Biology, pi; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Irwin DE, 2008, J EVOLUTION BIOL, V21, P435, DOI 10.1111/j.1420-9101.2007.01499.x; Irwin D.E., 2012, CREATING CONSILIENCE, P163; Irwin Darren E., 2005, P27; Irwin DE, 2012, AM NAT, V180, P35, DOI 10.1086/666002; Irwin DE, 2005, SCIENCE, V307, P414, DOI 10.1126/science.1105201; Irwin DE, 2001, GENETICA, V112, P223, DOI 10.1023/A:1013319217703; Irwin DE, 2001, NATURE, V409, P333, DOI 10.1038/35053059; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kovylov NS, 2012, BIOL BULL+, V39, P729, DOI 10.1134/S1062359012090038; Martins AB, 2013, P NATL ACAD SCI USA, V110, P5080, DOI 10.1073/pnas.1217034110; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; Mayr E, 1963, ANIMAL SPECIES EVOLU; McCarthy E.M., 2006, HDB AVIAN HYBRIDS WO; MORITZ C, 1992, SYST BIOL, V41, P273, DOI 10.2307/2992567; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Price T., 2008, SPECIATION BIRDS; Price TD, 2002, EVOLUTION, V56, P2083; Pritchard JK, 2000, GENETICS, V155, P945; Rheindt FE, 2011, AUK, V128, P620, DOI 10.1525/auk.2011.128.4.620; Ticehurst CB., 1938, SYSTEMATIC REV GENUS; Wake DB, 2001, NATURE, V409, P299, DOI 10.1038/35053264; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Weir JT, 2011, AM NAT, V177, P462, DOI 10.1086/658910	34	93	99	2	202	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					83	U433		10.1038/nature13285	http://dx.doi.org/10.1038/nature13285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24870239				2022-12-01	WOS:000338199400040
J	George, R				George, Rob			ASSISTED DYING BILL We must not deprive dying people of the most important protection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CROSS-SECTIONAL SURVEY; PREDICTING SURVIVAL; EUTHANASIA; DISEASE; NETHERLANDS; SUICIDE		[George, Rob] Kings Coll London, Cicely Saunders Inst, London WC2R 2LS, England; [George, Rob] Guys & St Thomas Hosp NHS Fdn Trust, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	George, R (corresponding author), Kings Coll London, Cicely Saunders Inst, London WC2R 2LS, England.	rob.george@kcl.ac.uk						Beckford M., 2008, TELEGRAPH; Butler-Schloss E, 2013, TELEGRAPH; Coventry PA, 2005, AGE AGEING, V34, P218, DOI 10.1093/ageing/afi054; Ganzini L, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1682; Glare P, 2008, EUR J CANCER, V44, P1146, DOI 10.1016/j.ejca.2008.02.030; Goeman JJ, 2004, STAT NEERL, V58, P21, DOI 10.1111/j.1467-9574.2004.00244.x; Groenewoud JH, 2000, NEW ENGL J MED, V342, P551, DOI 10.1056/NEJM200002243420805; Hendin H, 2008, MICH LAW REV, V106, P1613; House of Lords, 2005, ASS DYING TERM ILL B; Onwuteaka-Philipsen BD, 2012, LANCET, V380, P908, DOI 10.1016/S0140-6736(12)61034-4; Oregon Health Authority, DEATH DIGN ACT ANN R; Royal College of Physicians, 2014, NAT CAR DYING AUD HO; Tallis R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3532	13	3	3	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2014	349								g4311	10.1136/bmj.g4311	http://dx.doi.org/10.1136/bmj.g4311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7ZE	24994758				2022-12-01	WOS:000338646100007
J	Kapoor, A; Yao, WT; Ying, HQ; Hua, SJ; Liewen, A; Wang, QY; Zhong, Y; Wu, CJ; Sadanandam, A; Hu, BL; Chang, Q; Chu, GC; Al-Khalil, R; Jiang, S; Xia, HA; Fletcher-Sananikone, E; Lim, C; Horwitz, GI; Viale, A; Pettazzoni, P; Sanchez, N; Wang, HM; Protopopov, A; Zhang, JH; Heffernan, T; Johnson, RL; Chin, LD; Wang, YA; Draetta, G; DePinho, RA				Kapoor, Avnish; Yao, Wantong; Ying, Haoqiang; Hua, Sujun; Liewen, Alison; Wang, Qiuyun; Zhong, Yi; Wu, Chang-Jiun; Sadanandam, Anguraj; Hu, Baoli; Chang, Qing; Chu, Gerald C.; Al-Khalil, Ramsey; Jiang, Shan; Xia, Hongai; Fletcher-Sananikone, Eliot; Lim, Carol; Horwitz, Gillian I.; Viale, Andrea; Pettazzoni, Piergiorgio; Sanchez, Nora; Wang, Huamin; Protopopov, Alexei; Zhang, Jianhua; Heffernan, Timothy; Johnson, Randy L.; Chin, Lynda; Wang, Y. Alan; Draetta, Giulio; DePinho, Ronald A.			Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer	CELL			English	Article							HIPPO PATHWAY; GROWTH; ADENOCARCINOMA; PROLIFERATION; INACTIVATION; INHIBITION; RESISTANCE; INDUCTION; TARGET	Activating mutations in KRAS are among the most frequent events in diverse human carcinomas and are particularly prominent in human pancreatic ductal adenocarcinoma (PDAC). An inducible Kras(G12D) driven mouse model of PDAC has established a critical role for sustained Kras(G12D) expression in tumor maintenance, providing a model to determine the potential for and the underlying mechanisms of Kras(G12D)-independent PDAC recurrence. Here, we show that some tumors undergo spontaneous relapse and are devoid of Kras(G12D) expression and downstream canonical MAPK signaling and instead acquire amplification and overexpression of the transcriptional coactivator Yap1. Functional studies established the role of Yap1 and the transcriptional factor Tead2 in driving Kras(G12D)-independent tumor maintenance. The Yap1/Tead2 complex acts cooperatively with E2F transcription factors to activate a cell cycle and DNA replication program. Our studies, along with corroborating evidence from human PDAC models, portend a novel mechanism of escape from oncogenic Kras addiction in PDAC.	[DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Kapoor, Avnish; Yao, Wantong; Ying, Haoqiang; Hua, Sujun; Liewen, Alison; Wang, Qiuyun; Wu, Chang-Jiun; Hu, Baoli; Al-Khalil, Ramsey; Jiang, Shan; Xia, Hongai; Fletcher-Sananikone, Eliot; Lim, Carol; Horwitz, Gillian I.; Viale, Andrea; Pettazzoni, Piergiorgio; Sanchez, Nora; Chin, Lynda; Wang, Y. Alan; Draetta, Giulio] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Yao, Wantong; Ying, Haoqiang; Viale, Andrea; Pettazzoni, Piergiorgio; Sanchez, Nora; Draetta, Giulio] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Zhong, Yi; Chang, Qing; Protopopov, Alexei; Zhang, Jianhua; Heffernan, Timothy; Chin, Lynda; Draetta, Giulio] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Johnson, Randy L.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Sadanandam, Anguraj] Inst Canc Res, Sutton SM2 5NG, Surrey, England; [Sadanandam, Anguraj] Swiss Fed Inst Technol Lausanne EPFL, Swiss Inst Expt Canc Res ISREC, Stn 19, CH-1015 Lausanne, Switzerland; [Chu, Gerald C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of London; Institute of Cancer Research - UK; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Harvard University; Brigham & Women's Hospital	Ying, HQ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, 1515 Holcombe Blvd, Houston, TX 77030 USA.	hying@mdanderson.org; rdepinho@mdanderson.org	Pettazzoni, Piergiorgio/GRJ-3011-2022; Ying, Haoqiang/AAK-4325-2020	DePinho, Ronald/0000-0002-5625-577X; Sadanandam, Anguraj/0000-0001-8485-5150	Small Animal Imaging Facility, Flow Cytometry and Cellular Imaging Core, Histopathology Core, Sequencing and Non-Coding RNA Core Services at The University of Texas, MD Anderson Cancer Center [CA16672]; National Institutes of Health [5U01CA084313, P01CA117969, R56DK094865]; UT Star Award; American-Italian Cancer Foundation Award; NHS; Department of Defense [W81XWH-12-1-0459]; Sheikh Ahmed Center for Pancreatic Cancer Research at the University of Texas MD Anderson Cancer Center; Jane Coffin Childs Postdoctoral Fellowship [61-1512]; Damon Runyon Foundation Postdoctoral Fellowship; TRIUMPH Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [P01CA117969, U01CA084313, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102611, R56DK094865] Funding Source: NIH RePORTER	Small Animal Imaging Facility, Flow Cytometry and Cellular Imaging Core, Histopathology Core, Sequencing and Non-Coding RNA Core Services at The University of Texas, MD Anderson Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT Star Award; American-Italian Cancer Foundation Award; NHS; Department of Defense(United States Department of Defense); Sheikh Ahmed Center for Pancreatic Cancer Research at the University of Texas MD Anderson Cancer Center; Jane Coffin Childs Postdoctoral Fellowship; Damon Runyon Foundation Postdoctoral Fellowship; TRIUMPH Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the laboratory of Kun-Liang Guan, William Kaelin, Jiandie D. Lin, Hiroshi Sasaki, and Marius Sudol for sharing various reagents; Mien-Chie Hung and William Hahn for sharing unpublished data; Douglas Hanahan for helpful suggestions and support for PDAC subtype analysis; Shreya Malu for help with the graphical abstract; and Giannicola Genovese, Sharmistha Sarkar, Shruti Malu, Simona Colla, and other members of the DePinho laboratory for helpful suggestions and technical support. We would also like to thank the Small Animal Imaging Facility, Flow Cytometry and Cellular Imaging Core, Histopathology Core, Sequencing and Non-Coding RNA Core Services at The University of Texas, MD Anderson Cancer Center (Cancer Center Support grant, CA16672).; The project was supported by 5U01CA084313 (R.A.D.), P01CA117969 (R.A.D.), R56DK094865 (R.L.J.) from National Institutes of Health; UT Star Award (R.A.D.); American-Italian Cancer Foundation Award (G.D.); NHS funding to the National Institute for Health Research (NIHR) Biomedical Research Centre for Cancer (A.S.); and Discovery Award W81XWH-12-1-0459 from Department of Defense (H.Y.). G.D., H.Y., and T.H. were also supported by funds from the Sheikh Ahmed Center for Pancreatic Cancer Research at the University of Texas MD Anderson Cancer Center. Additional support was provided by the Jane Coffin Childs Postdoctoral Fellowship to A.K. (61-1512), Damon Runyon Foundation Postdoctoral Fellowship to S.H., and TRIUMPH Postdoctoral Fellowship to N.S.	Adams PD, 1996, CURR TOP MICROBIOL, V208, P79; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Berns K, 2012, DRUG RESIST UPDATE, V15, P268, DOI 10.1016/j.drup.2012.10.002; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Collisson EA, 2012, CANCER DISCOV, V2, P685, DOI 10.1158/2159-8290.CD-11-0347; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Eser S, 2013, CANCER CELL, V23, P406, DOI 10.1016/j.ccr.2013.01.023; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Gao T, 2013, GASTROENTEROLOGY, V144, P1543, DOI 10.1053/j.gastro.2013.02.037; George NM, 2012, MOL CELL BIOL, V32, P5116, DOI 10.1128/MCB.01034-12; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Guerra C, 2013, MOL ONCOL, V7, P232, DOI 10.1016/j.molonc.2013.02.002; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hill R, 2010, CANCER RES, V70, P7114, DOI 10.1158/0008-5472.CAN-10-1649; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Lauchle JO, 2009, NATURE, V461, P411, DOI 10.1038/nature08279; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; McCormick F, 2011, J SURG ONCOL, V103, P464, DOI 10.1002/jso.21749; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Pobbati AV, 2013, CANCER BIOL THER, V14, P390, DOI 10.4161/cbt.23788; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Stanger BZ, 2012, GENE DEV, V26, P1263, DOI 10.1101/gad.196501.112; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Torti D, 2011, EMBO MOL MED, V3, P623, DOI 10.1002/emmm.201100176; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303	45	441	451	0	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					185	197		10.1016/j.cell.2014.06.003	http://dx.doi.org/10.1016/j.cell.2014.06.003			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24954535	Green Accepted, Bronze			2022-12-01	WOS:000340943100017
J	Keung, AJ; Bashor, CJ; Kiriakov, S; Collins, JJ; Khalil, AS				Keung, Albert J.; Bashor, Caleb J.; Kiriakov, Szilvia; Collins, James J.; Khalil, Ahmad S.			Using Targeted Chromatin Regulators to Engineer Combinatorial and Spatial Transcriptional Regulation	CELL			English	Article							HISTONE MODIFICATIONS; SYNTHETIC BIOLOGY; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; YEAST; ACTIVATION; PROMOTER; CELLS; MAP; ACETYLATION	The transcription of genomic information in eukaryotes is regulated in large part by chromatin. How a diverse array of chromatin regulator (CR) proteins with different functions and genomic localization patterns coordinates chromatin activity to control transcription remains unclear. Here, we take a synthetic biology approach to decipher the complexity of chromatin regulation by studying emergent transcriptional behaviors from engineered combinatorial, spatial, and temporal patterns of individual CRs. We fuse 223 yeast CRs to programmable zinc finger proteins. Site-specific and combinatorial recruitment of CRs to distinct intralocus locations reveals a range of transcriptional logic and behaviors, including synergistic activation, long-range and spatial regulation, and gene expression memory. Comparing these transcriptional behaviors with annotated CR complex and function terms provides design principles for the engineering of transcriptional regulation. This work presents a bottom-up approach to investigating chromatin-mediated transcriptional regulation and introduces chromatin-based components and systems for synthetic biology and cellular engineering.	[Keung, Albert J.; Bashor, Caleb J.; Collins, James J.; Khalil, Ahmad S.] Boston Univ, Dept Biomed Engn & Ctr Synthet Biol, Boston, MA 02215 USA; [Kiriakov, Szilvia] Boston Univ, Program Mol Biol Cell Biol & Biochem, Boston, MA 02215 USA; [Keung, Albert J.; Bashor, Caleb J.; Collins, James J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Collins, James J.; Khalil, Ahmad S.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA	Boston University; Boston University; Howard Hughes Medical Institute; Harvard University	Khalil, AS (corresponding author), Boston Univ, Dept Biomed Engn & Ctr Synthet Biol, Boston, MA 02215 USA.	akhalil@bu.edu	Keung, Albert/AAU-3870-2021		NIH-NIGMS Ruth L. Kirschstein Postdoctoral Fellowship [1F32GM105272-01A1]; Boehringer Ingelheim Fonds PhD Fellowship; Defense Advanced Research Projects Agency [DARPA-BAA-11-23]; startup funds from the Department of Biomedical Engineering at Boston University; National Science Foundation CAREER Award [MCB-1350949]; Wyss Institute for Biologically Inspired Engineering [PRJ-0329]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM105272] Funding Source: NIH RePORTER; Direct For Biological Sciences [1350949] Funding Source: National Science Foundation	NIH-NIGMS Ruth L. Kirschstein Postdoctoral Fellowship; Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); startup funds from the Department of Biomedical Engineering at Boston University; National Science Foundation CAREER Award(National Science Foundation (NSF)); Wyss Institute for Biologically Inspired Engineering; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank members of the J.J.C. and A. S. K. laboratories for helpful discussions. Emily Egan and the Moazed laboratory provided valuable technical advice on ChIP experiments. We thank the Siggers laboratory for use of their sonicator. We thank Sylvain Meylan and Kwan T. Chow for engaging discussions and manuscript feedback. This work was supported by a NIH-NIGMS Ruth L. Kirschstein Postdoctoral Fellowship (1F32GM105272-01A1 to A.J.K.), a Boehringer Ingelheim Fonds PhD Fellowship (to S. K.), a Defense Advanced Research Projects Agency grant (DARPA-BAA-11-23 to A. S. K. and J.J.C.), startup funds from the Department of Biomedical Engineering at Boston University (to A. S. K.), a National Science Foundation CAREER Award (MCB-1350949 to A. S. K.), the Wyss Institute for Biologically Inspired Engineering (PRJ-0329 to J.J.C.), and the Howard Hughes Medical Institute (to J.J.C.).	Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Blount BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033279; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crews D, 2012, P NATL ACAD SCI USA, V109, P9143, DOI 10.1073/pnas.1118514109; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Fischbach MA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005568; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; GUARENTE L, 1984, CELL, V36, P503, DOI 10.1016/0092-8674(84)90243-5; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Martens C, 2001, MOL MICROBIOL, V40, P1009, DOI 10.1046/j.1365-2958.2001.02445.x; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Milbradt AG, 2011, NAT STRUCT MOL BIOL, V18, P410, DOI 10.1038/nsmb.1999; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Moazed D, 2011, CELL, V146, P510, DOI 10.1016/j.cell.2011.07.013; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; OLESEN J, 1987, CELL, V51, P953, DOI 10.1016/0092-8674(87)90582-4; Perez-Pinera P, 2013, NAT METHODS, V10, P239, DOI [10.1038/NMETH.2361, 10.1038/nmeth.2361]; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ptashne M, 2013, P NATL ACAD SCI USA, V110, P7101, DOI 10.1073/pnas.1305399110; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Raveh-Sadka T, 2012, NAT GENET, V44, P743, DOI 10.1038/ng.2305; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Weber W, 2010, CURR OPIN BIOTECH, V21, P690, DOI 10.1016/j.copbio.2010.07.006; Weinberger L, 2012, MOL CELL, V47, P193, DOI 10.1016/j.molcel.2012.05.008; Ye HF, 2013, CURR OPIN CHEM BIOL, V17, P910, DOI 10.1016/j.cbpa.2013.10.006; Zalatan JG, 2012, SCIENCE, V337, P1218, DOI 10.1126/science.1220683; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	46	88	95	3	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					110	120		10.1016/j.cell.2014.04.047	http://dx.doi.org/10.1016/j.cell.2014.04.047			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995982	Bronze, Green Accepted			2022-12-01	WOS:000340943100011
J	Rothwell, PE; Fuccillo, MV; Maxeiner, S; Hayton, SJ; Gokce, O; Lim, BK; Fowler, SC; Malenka, RC; Sudhof, TC				Rothwell, Patrick E.; Fuccillo, Marc V.; Maxeiner, Stephan; Hayton, Scott J.; Gokce, Ozgun; Lim, Byung Kook; Fowler, Stephen C.; Malenka, Robert C.; Suedhof, Thomas C.			Autism-Associated Neuroligin-3 Mutations Commonly Impair Striatal Circuits to Boost Repetitive Behaviors	CELL			English	Article							NUCLEUS-ACCUMBENS; SYNAPTIC PATHOPHYSIOLOGY; BASAL GANGLIA; SOCIAL REWARD; MOUSE MODEL; DE-NOVO; MICE; PLASTICITY; SKILL; ACQUISITION	In humans, neuroligin-3 mutations are associated with autism, whereas in mice, the corresponding mutations produce robust synaptic and behavioral changes. However, different neuroligin-3 mutations cause largely distinct phenotypes in mice, and no causal relationship links a specific synaptic dysfunction to a behavioral change. Using rotarod motor learning as a proxy for acquired repetitive behaviors in mice, we found that different neuroligin-3 mutations uniformly enhanced formation of repetitive motor routines. Surprisingly, neuroligin-3 mutations caused this phenotype not via changes in the cerebellum or dorsal striatum but via a selective synaptic impairment in the nucleus accumbens/ventral striatum. Here, neuroligin-3 mutations increased rotarod learning by specifically impeding synaptic inhibition onto D1-dopamine receptor-expressing but not D2-dopamine receptor-expressing medium spiny neurons. Our data thus suggest that different autism-associated neuroligin-3 mutations cause a common increase in acquired repetitive behaviors by impairing a specific striatal synapse and thereby provide a plausible circuit substrate for autism pathophysiology.	[Rothwell, Patrick E.; Fuccillo, Marc V.; Maxeiner, Stephan; Gokce, Ozgun; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Rothwell, Patrick E.; Fuccillo, Marc V.; Hayton, Scott J.; Lim, Byung Kook; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Fowler, Stephen C.] Univ Kansas, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; University of Kansas	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA.	malenka@stanford.edu; tcs1@stanford.edu	Maxeiner, Stephan/Y-7692-2019	Maxeiner, Stephan/0000-0002-4472-695X; gokce, ozgun/0000-0001-6319-404X; Fuccillo, Marc/0000-0002-6569-706X; Rothwell, Patrick/0000-0003-0514-2510; Lim, Byungkook/0000-0002-3766-5415	NIMH [P50 MH086403, K99 MH099243, F32 MH096491]; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH099243, P50MH086403, F32MH096491] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Darvishzadeh, A. Afjei, G. Sun, S. Ghosh, and N. Huang for technical assistance, C. Foldy for advice, and all Malenka and Sudhof lab members for helpful discussions. This work was supported by grants from the NIMH (P50 MH086403 to R.C.M. and T.C.S., K99 MH099243 to M.V.F., and F32 MH096491 to P.E.R.); initial stages were also supported by the Simons Foundation (to R.C.M. and T.C.S.).	Akil H, 2010, SCIENCE, V327, P1580, DOI 10.1126/science.1188654; Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Bateup HS, 2013, NEURON, V78, P510, DOI 10.1016/j.neuron.2013.03.017; Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Di Martino A, 2011, BIOL PSYCHIAT, V69, P847, DOI 10.1016/j.biopsych.2010.10.029; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Foldy C, 2013, NEURON, V78, P498, DOI 10.1016/j.neuron.2013.02.036; Fowler SC, 2001, J NEUROSCI METH, V107, P107, DOI 10.1016/S0165-0270(01)00359-4; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Groenewegen HJ, 1996, PROG BRAIN RES, V107, P485; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Haber SN, 2000, J NEUROSCI, V20, P2369; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Hollander E, 2005, BIOL PSYCHIAT, V58, P226, DOI 10.1016/j.biopsych.2005.03.040; Howes SR, 2000, PSYCHOPHARMACOLOGY, V151, P55, DOI 10.1007/s002130000451; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Langen M, 2009, BIOL PSYCHIAT, V66, P327, DOI 10.1016/j.biopsych.2009.03.017; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lin CW, 2010, NEURON, V65, P32, DOI 10.1016/j.neuron.2009.12.001; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Presti MF, 2004, PHARMACOL BIOCHEM BE, V77, P501, DOI 10.1016/j.pbb.2003.12.004; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Scott-Van Zeeland AA, 2010, AUTISM RES, V3, P53, DOI 10.1002/aur.122; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Trezza V, 2011, J NEUROSCI, V31, P6362, DOI 10.1523/JNEUROSCI.5492-10.2011; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	46	279	284	3	66	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					198	212		10.1016/j.cell.2014.04.045	http://dx.doi.org/10.1016/j.cell.2014.04.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995986	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000340943100018
J	Silver, J				Silver, Jonathan			Drugs for Macular Degeneration, Price Discrimination, and Medicare's Responsibility Not to Overpay	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									George Washington Univ, Washington, DC 20052 USA	George Washington University	Silver, J (corresponding author), George Washington Univ, 801 22nd St NW,Ste 739, Washington, DC 20052 USA.	jesilver@gwu.edu		Silver, Jonathan/0000-0001-9231-6368				[Anonymous], 2012, MED PAYM DRUGS US TE; [Anonymous], REV MED PART B AV LU; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Rodwin Marc, 2013, MANAGING OFF LABEL D	4	10	10	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					23	24		10.1001/jama.2014.6672	http://dx.doi.org/10.1001/jama.2014.6672			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK0UK	24860863				2022-12-01	WOS:000338131100012
J	Corbyn, Z				Corbyn, Zoe			A GROWING GLOBAL BURDEN	NATURE			English	Editorial Material																			0	40	48	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S2	S3		10.1038/510S2a	http://dx.doi.org/10.1038/510S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ6LK	24964023	Bronze			2022-12-01	WOS:000337806300002
J	Gunaydin, LA; Grosenick, L; Finkelstein, JC; Kauvar, IV; Fenno, LE; Adhikari, A; Lammel, S; Mirzabekov, JJ; Airan, RD; Zalocusky, KA; Tye, KM; Anikeeva, P; Malenka, RC; Deisseroth, K				Gunaydin, Lisa A.; Grosenick, Logan; Finkelstein, Joel C.; Kauvar, Isaac V.; Fenno, Lief E.; Adhikari, Avishek; Lammel, Stephan; Mirzabekov, Julie J.; Airan, Raag D.; Zalocusky, Kelly A.; Tye, Kay M.; Anikeeva, Polina; Malenka, Robert C.; Deisseroth, Karl			Natural Neural Projection Dynamics Underlying Social Behavior	CELL			English	Article							VENTRAL TEGMENTAL AREA; IN-VIVO CONTROL; NUCLEUS-ACCUMBENS; DOPAMINE RELEASE; CALCIUM INDICATOR; NEURONAL-ACTIVITY; INBRED STRAINS; PRAIRIE VOLES; REWARD; MICE	Social interaction is a complex behavior essential for many species and is impaired in major neuropsychiatric disorders. Pharmacological studies have implicated certain neurotransmitter systems in social behavior, but circuit-level understanding of endogenous neural activity during social interaction is lacking. We therefore developed and applied a new methodology, termed fiber photometry, to optically record natural neural activity in genetically and connectivity-defined projections to elucidate the realtime role of specified pathways in mammalian behavior. Fiber photometry revealed that activity dynamics of a ventral tegmental area (VTA)-to-nucleus accumbens (NAc) projection could encode and predict key features of social, but not novel object, interaction. Consistent with this observation, optogenetic control of cells specifically contributing to this projection was sufficient to modulate social behavior, which was mediated by type 1 dopamine receptor signaling downstream in the NAc. Direct observation of deep projection-specific activity in this way captures a fundamental and previously inaccessible dimension of mammalian circuit dynamics.	[Gunaydin, Lisa A.; Grosenick, Logan; Finkelstein, Joel C.; Kauvar, Isaac V.; Fenno, Lief E.; Adhikari, Avishek; Mirzabekov, Julie J.; Airan, Raag D.; Zalocusky, Kelly A.; Tye, Kay M.; Anikeeva, Polina; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Grosenick, Logan; Fenno, Lief E.; Zalocusky, Kelly A.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Lammel, Stephan; Malenka, Robert C.; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Fenno, Lief/AAF-9638-2019; Adhikari, Avishek/N-1284-2015; Lammel, Stephan/O-8295-2018; Adhikari, Avishek/A-3339-2012; Fenno, Lief/AAK-2924-2020; Adhikari, Avishek/AAF-4444-2021	Adhikari, Avishek/0000-0002-9187-9211; Lammel, Stephan/0000-0002-3350-3208; Adhikari, Avishek/0000-0002-9187-9211; Adhikari, Avishek/0000-0002-9187-9211; Airan, Raag/0000-0001-5259-5606	Stanford Bio-X Fellowship; NSF [0801700]; Stanford Medical Scientist Training Program; Simons Foundation Autism Research Initiative; NIMH; NIDA; DARPA; Gatsby Charitable Foundation; James Doty; CCARE center at Stanford; Stanford Institute for Neuroinnovation and Translational Neurosciences; Wiegers Family Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086373, R01MH075957, T32MH020016, R00MH106649, R01MH099647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA035377, R01DA020794] Funding Source: NIH RePORTER	Stanford Bio-X Fellowship; NSF(National Science Foundation (NSF)); Stanford Medical Scientist Training Program; Simons Foundation Autism Research Initiative; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Gatsby Charitable Foundation; James Doty; CCARE center at Stanford; Stanford Institute for Neuroinnovation and Translational Neurosciences; Wiegers Family Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the entire Deisseroth lab for helpful discussions and T. Jardetzky for use of a Biotek Synergy4 plate reader. L.A.G. is supported by a Stanford Bio-X Fellowship. L.G. is supported by NSF 0801700. L.E.F. is supported by the Stanford Medical Scientist Training Program. K.D. is supported by the Simons Foundation Autism Research Initiative, a Conte Center grant from NIMH, and NIDA, DARPA, the Gatsby Charitable Foundation, James Doty and the CCARE center at Stanford, the Stanford Institute for Neuroinnovation and Translational Neurosciences, and the Wiegers Family Fund. R.C.M. and S.L. were supported by a grant from the Simons Foundation Autism Research Initiative and a Conte Center grant from NIMH. All optogenetic tools and methods described are distributed and supported freely (http://www.optogenetics.org).	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Aragona BJ, 2006, NAT NEUROSCI, V9, P133, DOI 10.1038/nn1613; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Benoit-Marand M, 2001, J NEUROSCI, V21, P9134, DOI 10.1523/JNEUROSCI.21-23-09134.2001; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Budygin EA, 2012, NEUROSCIENCE, V201, P331, DOI 10.1016/j.neuroscience.2011.10.056; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Curtis JT, 2005, PHYSIOL BEHAV, V86, P338, DOI 10.1016/j.physbeh.2005.08.022; Deisseroth K, 2014, NATURE, V505, P309, DOI 10.1038/nature12982; Dong YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025615; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761; Kalivas PW, 1999, CURR OPIN NEUROBIOL, V9, P223, DOI 10.1016/S0959-4388(99)80031-2; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Linden H, 2011, NEURON, V72, P859, DOI 10.1016/j.neuron.2011.11.006; Liu Y, 2003, NEUROSCIENCE, V121, P537, DOI 10.1016/S0306-4522(03)00555-4; Lobo MK, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00041; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Lutcke H, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00009; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Moratalla R, 1996, P NATL ACAD SCI USA, V93, P14928, DOI 10.1073/pnas.93.25.14928; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; PALIJ P, 1990, BRAIN RES, V509, P172, DOI 10.1016/0006-8993(90)90329-A; Panksepp JB, 2007, GENES BRAIN BEHAV, V6, P661, DOI 10.1111/j.1601-183X.2006.00295.x; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Perez MF, 2006, J NEUROPHYSIOL, V96, P2217, DOI 10.1152/jn.00254.2006; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Podda MV, 2010, NEUROSCIENCE, V167, P678, DOI 10.1016/j.neuroscience.2010.02.075; PuglisiAllegra S, 1997, PROG NEUROBIOL, V51, P637, DOI 10.1016/S0301-0082(97)00008-7; Robinson DL, 2011, NEUROSCIENCE, V176, P296, DOI 10.1016/j.neuroscience.2010.12.016; Robinson DL, 2002, J NEUROSCI, V22, P10477; Schulz K, 2012, NAT METHODS, V9, P597, DOI [10.1038/NMETH.2013, 10.1038/nmeth.2013]; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Winslow James T, 2003, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0816s22; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Young LJ, 2001, HORM BEHAV, V40, P133, DOI 10.1006/hbeh.2001.1691; Yuan KX, 2011, J NEUROSCI, V31, P13333, DOI 10.1523/JNEUROSCI.1000-11.2011	50	710	720	11	130	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1535	1551		10.1016/j.cell.2014.05.017	http://dx.doi.org/10.1016/j.cell.2014.05.017			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949967	Green Accepted, Bronze			2022-12-01	WOS:000340941900010
J	Li, PY; Qian, H; Wu, JH				Li, Peiyue; Qian, Hui; Wu, Jianhua			Accelerate research on land creation	NATURE			English	Editorial Material									[Li, Peiyue; Qian, Hui; Wu, Jianhua] Changan Univ, Sch Environm Sci & Engn, Xian, Peoples R China	Chang'an University	Li, PY (corresponding author), Changan Univ, Sch Environm Sci & Engn, Xian, Peoples R China.	lipy2@163.com	Li, Peiyue/F-3831-2011; Wu, Jianhua/G-4389-2017; Qian, Hui/B-9558-2019	Li, Peiyue/0000-0001-8771-3369; Wu, Jianhua/0000-0001-6423-1762; Qian, Hui/0000-0002-9354-4060				Allen F, 2005, J FINANC ECON, V77, P57, DOI 10.1016/j.jfineco.2004.06.010; Burns S. S., 2007, BRINGING MOUNTAINS I; Crotty M.G., 2002, VILLANOVA ENV LAW J, V13, P287; Li M., 1992, POPULATION MODERN CH, P83; Qian W., 2013, NEWSWEEK, V2, P26; Song Q., 2013, CHINA CONSTRUCTION, V20, P21; Sun JZ, 2005, LOESSOLOGY, V1; [张明泉 ZHANG Ming-quan], 2009, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V23, P77; Zhao F., 2013, CHINA BUS J A, VA13, P1	9	174	200	21	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					29	31		10.1038/510029a	http://dx.doi.org/10.1038/510029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3NR	24910868	Bronze			2022-12-01	WOS:000336768900015
J	Bourzac, K				Bourzac, Katherine			BIOLOGY Three known unknowns	NATURE			English	Editorial Material																		Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543	1	32	34	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S69	S71		10.1038/509S69a	http://dx.doi.org/10.1038/509S69a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870828	Bronze			2022-12-01	WOS:000336457100011
J	Chivukula, RR; Shi, GL; Acharya, A; Mills, EW; Zeitels, LR; Anandam, JL; Abdelnaby, AA; Balch, GC; Mansour, JC; Yopp, AC; Maitra, A; Mendell, JT				Chivukula, Raghu R.; Shi, Guanglu; Acharya, Asha; Mills, Eric W.; Zeitels, Lauren R.; Anandam, Joselin L.; Abdelnaby, Abier A.; Balch, Glen C.; Mansour, John C.; Yopp, Adam C.; Maitra, Anirban; Mendell, Joshua T.			An Essential Mesenchymal Function for miR-143/145 in Intestinal Epithelial Regeneration	CELL			English	Article							SMOOTH-MUSCLE-CELLS; GENE-EXPRESSION; STEM-CELLS; IN-VIVO; MICRORNAS; CANCER; MYOFIBROBLASTS; GROWTH; COLON; CRYPT	Downregulation of the miR-143/145 microRNA (miRNA) cluster has been repeatedly reported in colon cancer and other epithelial tumors. In addition, overexpression of these miRNAs inhibits tumorigenesis, leading to broad consensus that they function as cell-autonomous epithelial tumor suppressors. We generated mice with deletion of miR-143/145 to investigate the functions of these miRNAs in intestinal physiology and disease in vivo. Although intestinal development proceeded normally in the absence of these miRNAs, epithelial regeneration after injury was dramatically impaired. Surprisingly, we found that miR-143/145 are expressed and function exclusively within the mesenchymal compartment of intestine. Defective epithelial regeneration in miR-143/145-deficient mice resulted from the dysfunction of smooth muscle and myofibroblasts and was associated with derepression of the miR-143 target Igfbp5, which impaired IGF signaling after epithelial injury. These results provide important insights into the regulation of epithelial wound healing and argue against a cell-autonomous tumor suppressor role for miR-143/145 in colon cancer.	[Chivukula, Raghu R.; Mills, Eric W.; Zeitels, Lauren R.] Johns Hopkins Univ, Sch Med, Med Scientist Training Program, Baltimore, MD 21205 USA; [Shi, Guanglu; Acharya, Asha; Mendell, Joshua T.] UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; [Anandam, Joselin L.; Abdelnaby, Abier A.; Balch, Glen C.; Mansour, John C.; Yopp, Adam C.] UT Southwestern Med Ctr, Dept Surg, Dallas, TX 75390 USA; [Maitra, Anirban] UT MD Anderson Canc Ctr, Sheikh Ahmed Bin Zayed Al Nahyan Ctr Pancreat Can, Houston, TX 77030 USA; [Mendell, Joshua T.] UT Southwestern Med Ctr, Harold C Simmons Canc Ctr, Dallas, TX 75390 USA	Johns Hopkins University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mendell, JT (corresponding author), UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.	joshua.mendell@utsouthwestern.edu	Shi, Guanglu/G-1641-2013	Shi, Guanglu/0000-0001-5562-111X; Balch, Glen/0000-0002-1575-9170	CPRIT [R1008]; NIH [R01CA120185, P01CA134292, 5P30CA142543, 5T32GM007309]; NATIONAL CANCER INSTITUTE [P01CA134292, P30CA016672, R01CA120185, P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814, T32GM007309] Funding Source: NIH RePORTER	CPRIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Chip Hawkins in the Johns Hopkins Transgenic Core for assistance with generation of miR-143/145<SUP>Neo/+</SUP> mice, John Shelton in the UT Southwestern Molecular Pathology Core for assistance with histopathology, Cheryl Lewis in the UT Southwestern Tissue Resource Core for assistance with human tissue specimens, Jose Cabrera for assistance with figures, and Eric Olson and Kathryn O'Donnell for helpful suggestions on the manuscript. This work was supported by grants from CPRIT (R1008 to J.T.M.) and the NIH (R01CA120185 to J.T.M., P01CA134292 to J.T.M. and A. M., 5P30CA142543 to the UTSW Simmons Cancer Center, and 5T32GM007309 to R.R.C., L.R.Z., and E.M.).	Acharya A, 2012, DEVELOPMENT, V139, P2139, DOI 10.1242/dev.079970; Andoh A, 2007, PHARMACOL THERAPEUT, V114, P94, DOI 10.1016/j.pharmthera.2006.12.004; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Clapper ML, 2007, ACTA PHARMACOL SIN, V28, P1450, DOI 10.1111/j.1745-7254.2007.00695.x; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Geske MJ, 2008, DEVELOPMENT, V135, P2959, DOI 10.1242/dev.020453; Haigis KM, 2002, P NATL ACAD SCI USA, V99, P8927, DOI 10.1073/pnas.132275099; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Howarth GS, 1998, SCAND J GASTROENTERO, V33, P180; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Lamlum H, 2000, P NATL ACAD SCI USA, V97, P2225, DOI 10.1073/pnas.040564697; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Michael MZ, 2003, MOL CANCER RES, V1, P882; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Otte JM, 2003, GASTROENTEROLOGY, V124, P1866, DOI 10.1016/S0016-5085(03)00403-7; Papaconstantinou IG, 2013, PANCREAS, V42, P67, DOI 10.1097/MPA.0b013e3182592ba7; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Shaker A, 2010, J CLIN INVEST, V120, P2081, DOI 10.1172/JCI40676; Shao JY, 2006, CANCER RES, V66, P846, DOI 10.1158/0008-5472.CAN-05-2606; Shi GL, 2009, GASTROENTEROLOGY, V136, P1368, DOI 10.1053/j.gastro.2008.12.066; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zeng L, 2012, DEV BIOL, V367, P178, DOI 10.1016/j.ydbio.2012.05.009; Zhu HY, 2011, MOL CANCER RES, V9, P960, DOI 10.1158/1541-7786.MCR-10-0531; Zhu WD, 2008, NATURE, V454, P345, DOI 10.1038/nature07027	59	160	164	2	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1104	1116		10.1016/j.cell.2014.03.055	http://dx.doi.org/10.1016/j.cell.2014.03.055			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855947	Green Accepted, Bronze			2022-12-01	WOS:000336437200013
J	Strathdee, SA; Crago, AL; Butler, J; Bekker, LG; Beyrer, C				Strathdee, Steffanie A.; Crago, Anna-Louise; Butler, Jenny; Bekker, Linda-Gail; Beyrer, Chris			Dispelling myths about sex workers and HIV	LANCET			English	Editorial Material							CONDOM USE; RISK; INTERVENTION		[Strathdee, Steffanie A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Crago, Anna-Louise] Univ Toronto, Toronto, ON, Canada; [Butler, Jenny] United Nations Populat Fund, New York, NY USA; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Res Ctr, ZA-7925 Cape Town, South Africa; [Beyrer, Chris] Johns Hopkins Univ, Ctr Publ Hlth & Human Rights, Baltimore, MD USA	University of California System; University of California San Diego; University of Toronto; United Nations Population Fund; University of Cape Town; Johns Hopkins University	Strathdee, SA (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	sstrathdee@ucsd.edu	Bekker, Linda-Gail/AAZ-8929-2020; Strathdee, Steffanie A/B-9042-2009	BEKKER, LINDA-GAIL/0000-0002-0755-4386; Strathdee, Steffanie/0000-0002-7724-691X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI094189] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; [Anonymous], 2010, REC HIV AIDS WORLD W; [Anonymous], 2001, 42914044992001 ALM R; Baral S, 2013, EXAMINING PREVALENCE; Baral SD, 2014, LANCET; Beckham S. W., 2013, ANY OTHER WOMAN PREG; DODILLET SUSANNE, 2011, INT WORKSHOP DECRIMI; Ghose T, 2011, QUAL HEALTH RES, V21, P587, DOI 10.1177/1049732310395328; Harcourt C, 2005, SEX TRANSM INFECT, V81, P201, DOI 10.1136/sti.2004.012468; International Labor Organization, 2012, 21 MILL PEOPL AR NOW; International Labour Organization, 2012, ILO 2012 GLOB EST FO; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; Kerrigan DL, 2013, AIDS BEHAV, V17, P1926, DOI 10.1007/s10461-013-0458-4; Nemoto T, 1999, AIDS CARE, V11, P297, DOI 10.1080/09540129947938; Patterson TL, 2008, AM J PUBLIC HEALTH, V98, P2051, DOI 10.2105/AJPH.2007.130096; Poteat T, 2014, LANCET; RFSL,, 2011, OS SYNL AKT HBT PERS; *SOC, 2000, KANN PROST 1998 1999; Stachowiak JA, 2005, SIECUS REPORT, V22, P18; Steinfatt T. M., 2008, MEASURING EXTENT SEX; Strathdee SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065812; Stridbeck U., 2004, PURCHASING SEXUAL SE; The Global Alliance Against Traffic in Women, 2011, MOV SUPPL DEM CATCHP; Ulibarri MD, 2012, INT J STD AIDS, V23, P229, DOI 10.1258/ijsa.2011.011184; *UN, PROT PREV SUPPR PUN; UNAIDS, 2012, UNAIDS GUID NOT HIV; United Nations Office on Drugs and Crime, 2014, UN CONV TRANSN ORG C; Wagner Jamie., 2013, WEBCOMIC HOMESTUCK G	28	16	16	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2015	385	9962					4	7		10.1016/S0140-6736(14)60980-6	http://dx.doi.org/10.1016/S0140-6736(14)60980-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX8IW	25059948				2022-12-01	WOS:000347154200007
J	Cohen, D				Cohen, Deborah			ANTICOAGULANTS Dabigatran: how the drug company withheld important analyses	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ATRIAL-FIBRILLATION					dcohen@bmj.com						[Anonymous], 2014, J AM COLL CARDIOL; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Cohen D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4747; Committee for Medicinal Products for Human Use (CHMP), 2011, EMACHMP2034682011; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Heneghan C, 2014, BMJ-BRIT MED J, V349, pg4560; Moore T. J., 2012, QUARTERWATCH; Moore TJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4517; Moore TJ, 2012, JAMA-J AM MED ASSOC, V308, P869, DOI 10.1001/jama.2012.9658; NICE Implementation Collaborative, CONS SUPP LOCAL IMPL; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Reilly PA, 2014, J AM COLL CARDIOL, V63, P2885, DOI 10.1016/j.jacc.2014.04.012; Reilly PA, 2014, J AM COLL CARDIOL, V63, P321, DOI 10.1016/j.jacc.2013.07.104; Skanes AC, 2012, CAN J CARDIOL, V28, P125, DOI 10.1016/j.cjca.2012.01.021; Stangier J, 2012, BLOOD COAGUL FIBRIN, V23, P138, DOI 10.1097/MBC.0b013e32834f1b0c; Staton T, 2012, PRADAXA HITS BLOCKBU	16	91	93	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2014	349								g4670	10.1136/bmj.g4670	http://dx.doi.org/10.1136/bmj.g4670			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VP	25055829	Green Published, Bronze			2022-12-01	WOS:000339565900003
J	Couzin-Frankel, J				Couzin-Frankel, Jennifer			The elusive heart fix	SCIENCE			English	Editorial Material																			0	10	10	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					252	257		10.1126/science.345.6194.252	http://dx.doi.org/10.1126/science.345.6194.252			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035469				2022-12-01	WOS:000339400700015
J	Mayer, KFX; Rogers, J; Dolezel, J; Pozniak, C; Eversole, K; Feuillet, C; Gill, B; Friebe, B; Lukaszewski, AJ; Sourdille, P; Endo, TR; Dolezel, J; Kubalakova, M; Cihalikova, J; Dubska, Z; Vrana, J; Sperkova, R; Simkova, H; Rogers, J; Febrer, M; Clissold, L; McLay, K; Singh, K; Chhuneja, P; Singh, NK; Khurana, J; Akhunov, E; Choulet, F; Sourdille, P; Feuillet, C; Alberti, A; Barbe, V; Wincker, P; Kanamori, H; Kobayashi, F; Itoh, T; Matsumoto, T; Sakai, H; Tanaka, T; Wu, JZ; Ogihara, Y; Handa, H; Pozniak, C; Maclachlan, PR; Sharpe, A; Klassen, D; Edwards, D; Batley, J; Olsen, OA; Sandve, SR; Lien, S; Steuernagel, B; Wulff, B; Caccamo, M; Ayling, S; Ramirez-Gonzalez, RH; Clavijo, BJ; Steuernagel, B; Wright, J; Pfeifer, M; Spannagl, M; Mayer, KFX; Martis, MM; Akhunov, E; Choulet, F; Mayer, KFX; Mascher, M; Chapman, J; Poland, JA; Scholz, U; Barry, K; Waugh, R; Rokhsar, DS; Muehlbauer, GJ; Stein, N; Gundlach, H; Zytnicki, M; Jamilloux, V; Quesneville, H; Wicker, T; Mayer, KFX; Faccioli, P; Colaiacovo, M; Pfeifer, M; Stanca, AM; Budak, H; Cattivelli, L; Glover, N; Martis, MM; Choulet, F; Feuillet, C; Mayer, KFX; Pfeifer, M; Pingault, L; Mayer, KFX; Paux, E; Spannagl, M; Sharma, S; Mayer, KFX; Pozniak, C; Appels, R; Bellgard, M; Chapman, B; Pfeifer, M; Pfeifer, M; Sandve, SR; Nussbaumer, T; Bader, KC; Choulet, F; Feuillet, C; Mayer, KFX; Akhunov, E; Paux, E; Rimbert, H; Wang, SC; Poland, JA; Knox, R; Kilian, A; Pozniak, C; Alaux, M; Alfama, F; Couderc, L; Jamilloux, V; Guilhot, N; Viseux, C; Loaec, M; Quesneville, H; Rogers, J; Dolezel, J; Eversole, K; Feuillet, C; Keller, B; Mayer, KFX; Olsen, OA; Praud, S				Mayer, Klaus F. X.; Rogers, Jane; Dolezel, Jaroslav; Pozniak, Curtis; Eversole, Kellye; Feuillet, Catherine; Gill, Bikram; Friebe, Bernd; Lukaszewski, Adam J.; Sourdille, Pierre; Endo, Takashi R.; Dolezel, Jaroslav; Kubalakova, Marie; Cihalikova, Jarmila; Dubska, Zdenka; Vrana, Jan; Sperkova, Romana; Simkova, Hana; Rogers, Jane; Febrer, Melanie; Clissold, Leah; McLay, Kirsten; Singh, Kuldeep; Chhuneja, Parveen; Singh, Nagendra K.; Khurana, Jitendra; Akhunov, Eduard; Choulet, Frederic; Sourdille, Pierre; Feuillet, Catherine; Alberti, Adriana; Barbe, Valerie; Wincker, Patrick; Kanamori, Hiroyuki; Kobayashi, Fuminori; Itoh, Takeshi; Matsumoto, Takashi; Sakai, Hiroaki; Tanaka, Tsuyoshi; Wu, Jianzhong; Ogihara, Yasunari; Handa, Hirokazu; Pozniak, Curtis; Maclachlan, P. Ron; Sharpe, Andrew; Klassen, Darrin; Edwards, David; Batley, Jacqueline; Olsen, Odd-Arne; Sandve, Simen Rod; Lien, Sigbjorn; Steuernagel, Burkhard; Wulff, Brande; Caccamo, Mario; Ayling, Sarah; Ramirez-Gonzalez, Ricardo H.; Clavijo, Bernardo J.; Steuernagel, Burkhard; Wright, Jonathan; Pfeifer, Matthias; Spannagl, Manuel; Mayer, Klaus F. X.; Martis, Mihaela M.; Akhunov, Eduard; Choulet, Frederic; Mayer, Klaus F. X.; Mascher, Martin; Chapman, Jarrod; Poland, Jesse A.; Scholz, Uwe; Barry, Kerrie; Waugh, Robbie; Rokhsar, Daniel S.; Muehlbauer, Gary J.; Stein, Nils; Gundlach, Heidrun; Zytnicki, Matthias; Jamilloux, Veronique; Quesneville, Hadi; Wicker, Thomas; Mayer, Klaus F. X.; Faccioli, Primetta; Colaiacovo, Moreno; Pfeifer, Matthias; Stanca, Antonio Michele; Budak, Hikmet; Cattivelli, Luigi; Glover, Natasha; Martis, Mihaela M.; Choulet, Frederic; Feuillet, Catherine; Mayer, Klaus F. X.; Pfeifer, Matthias; Pingault, Lise; Mayer, Klaus F. X.; Paux, Etienne; Spannagl, Manuel; Sharma, Sapna; Mayer, Klaus F. X.; Pozniak, Curtis; Appels, Rudi; Bellgard, Matthew; Chapman, Brett; Pfeifer, Matthias; Pfeifer, Matthias; Sandve, Simen Rod; Nussbaumer, Thomas; Bader, Kai Christian; Choulet, Frederic; Feuillet, Catherine; Mayer, Klaus F. X.; Akhunov, Eduard; Paux, Etienne; Rimbert, Helene; Wang, Shichen; Poland, Jesse A.; Knox, Ron; Kilian, Andrzej; Pozniak, Curtis; Alaux, Michael; Alfama, Francoise; Couderc, Loic; Jamilloux, Veronique; Guilhot, Nicolas; Viseux, Claire; Loaec, Mikael; Quesneville, Hadi; Rogers, Jane; Dolezel, Jaroslav; Eversole, Kellye; Feuillet, Catherine; Keller, Beat; Mayer, Klaus F. X.; Olsen, Odd-Arne; Praud, Sebastien		IWGSC	A chromosome-based draft sequence of the hexaploid bread wheat (Triticum aestivum) genome	SCIENCE			English	Article							GENE-EXPRESSION; AEGILOPS-TAUSCHII; A-GENOME; EVOLUTION; REVEALS; TRANSCRIPTOME; ANNOTATION; DOMINANCE; RICE; POLYPLOIDIZATION	An ordered draft sequence of the 17-gigabase hexaploid bread wheat (Triticum aestivum) genome has been produced by sequencing isolated chromosome arms. We have annotated 124,201 gene loci distributed nearly evenly across the homeologous chromosomes and subgenomes. Comparative gene analysis of wheat subgenomes and extant diploid and tetraploid wheat relatives showed that high sequence similarity and structural conservation are retained, with limited gene loss, after polyploidization. However, across the genomes there was evidence of dynamic gene gain, loss, and duplication since the divergence of the wheat lineages. A high degree of transcriptional autonomy and no global dominance was found for the subgenomes. These insights into the genome biology of a polyploid crop provide a springboard for faster gene isolation, rapid genetic marker development, and precise breeding to meet the needs of increasing food demand worldwide.	[Mayer, Klaus F. X.; Pfeifer, Matthias; Spannagl, Manuel; Martis, Mihaela M.; Gundlach, Heidrun; Sharma, Sapna; Nussbaumer, Thomas; Bader, Kai Christian] Helmholtz Zentrum Munich, D-85764 Neuherberg, Germany; [Rogers, Jane; Eversole, Kellye] Eversole Associates, IWGSC, Bethesda, MD 20816 USA; [Dolezel, Jaroslav; Kubalakova, Marie; Cihalikova, Jarmila; Dubska, Zdenka; Vrana, Jan; Sperkova, Romana; Simkova, Hana] Ctr Plant Struct & Funct Genom, Inst Expt Bot, Olomouc 78371, Czech Republic; [Pozniak, Curtis; Maclachlan, P. Ron] Univ Saskatchewan, Ctr Crop Dev, Dept Plant Sci, Coll Agr & Bioresources, Saskatoon, SK S7N 0W0, Canada; [Feuillet, Catherine] Bayer Crop Sci, Morrisville, NC 27560 USA; [Gill, Bikram; Friebe, Bernd; Akhunov, Eduard; Wang, Shichen] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Lukaszewski, Adam J.] Univ Calif Riverside, Coll Nat & Agr Sci Bot & Plant Sci, Riverside, CA 92521 USA; [Endo, Takashi R.] Kyoto Univ, Grad Sch Agr, Lab Plant Genet, Kyoto 6068502, Japan; [Febrer, Melanie] Univ Dundee, Genom Sequencing Unit, Dundee DD1 5EH, Scotland; [Clissold, Leah; McLay, Kirsten; Caccamo, Mario; Ayling, Sarah; Ramirez-Gonzalez, Ricardo H.; Clavijo, Bernardo J.; Wright, Jonathan] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Singh, Kuldeep; Chhuneja, Parveen] Punjab Agr Univ, Sch Agrictural Biotechnol, Ludhiana 141004, Punjab, India; [Singh, Nagendra K.] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; [Khurana, Jitendra] Univ Delhi, Interdisciplinary Ctr Plant Genom, New Delhi 110021, India; [Khurana, Jitendra] Univ Delhi, Dept Plant Mol Biol, New Delhi 110021, India; [Sourdille, Pierre; Choulet, Frederic; Glover, Natasha; Pingault, Lise; Paux, Etienne; Guilhot, Nicolas] Univ Blaise Pascal, INRA, Genet Divers & Ecophysiol Cereals UMR1095, F-63039 Clermont Ferrand, France; [Alberti, Adriana; Barbe, Valerie; Wincker, Patrick] Commissariat Energie Atom Genoscope, Ctr Natl Sequencage, F-91057 Evry, France; [Kanamori, Hiroyuki; Kobayashi, Fuminori; Itoh, Takeshi; Matsumoto, Takashi; Sakai, Hiroaki; Tanaka, Tsuyoshi; Wu, Jianzhong; Handa, Hirokazu] Natl Inst Agrobiol Sci, Plant Genome Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Ogihara, Yasunari] Yokohama City Univ, Kihara Inst Biol Res, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan; [Sharpe, Andrew; Klassen, Darrin] Natl Res Council Canada, Saskatoon, SK S7N 0W9, Canada; [Edwards, David; Batley, Jacqueline] Univ Queensland, Australian Ctr Plant Funct Genom, Sch Agr & Food Sci, St Lucia, Qld 4072, Australia; [Edwards, David; Batley, Jacqueline] Univ Western Australia, Sch Plant Biol, Nedlands, WA 6009, Australia; [Olsen, Odd-Arne; Sandve, Simen Rod] Norwegian Univ Life Sci, Dept Plant Sci, Ctr Integrat Genet CIGENE, N-1432 As, Norway; [Olsen, Odd-Arne] Hedmark Univ Coll, Dept Nat Sci & Technol, N-2318 Elverum, Norway; [Steuernagel, Burkhard; Wulff, Brande] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Mascher, Martin; Scholz, Uwe] Leibniz Inst Plant Genet & Crop Plant Res IPK, D-06466 Seeland Ot Gatersleben, Germany; [Chapman, Jarrod; Barry, Kerrie; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Poland, Jesse A.] Kansas State Univ, USDA ARS, Hard Winter Wheat Genet Res Unit, Manhattan, KS 66506 USA; [Poland, Jesse A.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Waugh, Robbie] James Hutton Inst, Dundee DD2 5DA, Scotland; [Muehlbauer, Gary J.] Univ Minnesota, Dept Plant Biol, Dept Agron & Plant Genet, St Paul, MN 55108 USA; [Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res IPK, D-06466 Seeland Ot Gatersleben, Germany; [Zytnicki, Matthias; Jamilloux, Veronique; Quesneville, Hadi; Alaux, Michael; Alfama, Francoise; Couderc, Loic; Viseux, Claire; Loaec, Mikael] INRA, URGI Res Unit Genom Info UR1164, F-78026 Versailles, France; [Wicker, Thomas; Keller, Beat] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Faccioli, Primetta; Colaiacovo, Moreno; Stanca, Antonio Michele; Cattivelli, Luigi] Genom Res Ctr, Consiglio Ric & Sperimentaz Agr, I-29017 Fiorenzuola Darda, Italy; [Budak, Hikmet] Sabanci Univ, Biol Sci & Bioengn Program, TR-34956 Istanbul, Turkey; [Appels, Rudi; Bellgard, Matthew; Chapman, Brett] Murdoch Univ, Ctr Comparat Genom, Perth, WA 6150, Australia; [Knox, Ron] Semiarid Prairie Agr Res Ctr, Swift Current, SK S9H 3X2, Canada; [Kilian, Andrzej] Divers Arrays Technol Pty Ltd, Yarralumla, ACT 2600, Australia; [Rimbert, Helene; Praud, Sebastien] Biogemma, Ctr Rech Chappes, F-63720 Chappes, France; [Lien, Sigbjorn] Norwegian Univ Life Sci, CIGENE, Dept Anim & Aquicultural Sci, N-1432 As, Norway	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of Saskatchewan; Bayer AG; Bayer CropScience; Kansas State University; University of California System; University of California Riverside; Kyoto University; University of Dundee; The Genome Analysis Centre (TGAC); Punjab Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); University of Delhi; University of Delhi; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite Clermont Auvergne (UCA); UDICE-French Research Universities; Universite Paris Saclay; National Institute of Agrobiological Sciences - Japan; Yokohama City University; National Research Council Canada; University of Queensland; University of Western Australia; Norwegian University of Life Sciences; Inland Norway University of Applied Sciences; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Kansas State University; United States Department of Agriculture (USDA); Kansas State University; James Hutton Institute; University of Minnesota System; University of Minnesota Twin Cities; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Zurich; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Sabanci University; Murdoch University; Norwegian University of Life Sciences	Mayer, KFX (corresponding author), Helmholtz Zentrum Munich, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	k.mayer@helmholtz-muenchen.de; janerogersh@gmail.com; dolezel@ueb.cas.cz; curtis.pozniak@usask.ca; eversole@eversoleassociates.com; catherine.feuillet@bayer.com	Budak, Hikmet/F-4708-2010; Wicker, Thomas/Z-1978-2019; SAB, Parveen Chhuneja -/H-5456-2019; Edwards, David/H-3710-2015; Keller, Beat/K-3093-2019; Sourdille, Pierre/CAF-2780-2022; Wulff, Brande BH/C-7465-2013; Dolezel, Jaroslav/B-7716-2008; Wulff, Brande B/N-4273-2013; cattivelli, luigi/AAE-7046-2020; Stein, Nils/F-7507-2017; Mayer, Klaus FX/M-7941-2015; Ramírez, Ricardo/H-4808-2019; Budak, Hikmet/S-5835-2017; HANDA, Hirokazu/C-9781-2009; Barry, Kerrie Whitelaw/AAA-5500-2020; Kubaláková, Marie/F-8269-2014; Pfeifer, Matthias/GRJ-4579-2022; Budak, Hikmet/U-8517-2019; Wang, Shichen/E-6213-2012; Wu, Jian/AAU-5221-2020; Singh, Nouratan/N-9377-2017; Simkova, Hana/F-7734-2014; Quesneville, Hadi/AAG-1048-2020; Eversole, Kellye/AAN-6141-2020; Pingault, Lise/AAQ-8602-2020; Sharma, Sapna/N-6357-2017; Batley, Jacqueline/A-5723-2008; , 叮当๑/AAZ-9709-2020; Vrana, Jan/F-7306-2014; Wu, Jian/AAU-5221-2020	Budak, Hikmet/0000-0002-2556-2478; Edwards, David/0000-0001-7599-6760; Keller, Beat/0000-0003-2379-9225; Wulff, Brande BH/0000-0003-4044-4346; Dolezel, Jaroslav/0000-0002-6263-0492; cattivelli, luigi/0000-0002-6067-4600; Stein, Nils/0000-0003-3011-8731; Mayer, Klaus FX/0000-0001-6484-1077; Ramírez, Ricardo/0000-0001-5745-7085; Budak, Hikmet/0000-0002-2556-2478; HANDA, Hirokazu/0000-0003-2985-2883; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Budak, Hikmet/0000-0002-2556-2478; Wang, Shichen/0000-0003-1441-2252; Wu, Jian/0000-0001-9933-7364; Singh, Nouratan/0000-0002-8063-8375; Simkova, Hana/0000-0003-4159-7619; Quesneville, Hadi/0000-0003-3001-4908; Eversole, Kellye/0000-0002-8784-4913; Pingault, Lise/0000-0002-6149-1267; Batley, Jacqueline/0000-0002-5391-5824; Vrana, Jan/0000-0001-6171-8516; Dyer, Sarah/0000-0001-5690-9633; Itoh, Takeshi/0000-0002-6291-4233; Steuernagel, Burkhard/0000-0002-8284-7728; Bellgard, Matthew/0000-0002-6303-9469; Poland, Jesse/0000-0002-7856-1399; Jamilloux, Veronique/0000-0002-6898-4910; Sourdille, Pierre/0000-0002-1027-2224; Wu, Jian/0000-0002-3394-1507; Colaiacovo, Moreno/0000-0003-1320-0506; Martis, Mihaela-Maria/0000-0001-7509-2446; Gundlach, Heidrun/0000-0002-6757-0943; Tanaka, Tsuyoshi/0000-0003-3740-6832; Knox, Ron/0000-0002-2030-3899; Singh, Kuldeep/0000-0001-5239-6586; Spannagl, Manuel/0000-0003-0701-7035; Paux, Etienne/0000-0002-3094-7129; Kilian, Andrzej/0000-0002-2730-7462; Rokhsar, Daniel/0000-0002-8704-2224; Wright, Jonathan/0000-0001-6471-8749; Clavijo, Bernardo J./0000-0002-7597-2774; Mascher, Martin/0000-0001-6373-6013; Alaux, Michael/0000-0001-9356-4072; , Thomas/0000-0002-6777-7135; Choulet, Frederic/0000-0003-1788-7288; Scholz, Uwe/0000-0001-6113-3518	Institut National de la Recherche Agronomique (INRA); International Center for Agricultural Research in the Dry Areas; Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/IWGSC/03/TF/2008]; Biotechnology and Biological Sciences Research Council (BBSRC UK); 3A-U.S. Department of Agriculture Agriculture and Food Research Initiative (USDA AFRI) Triticeae-CAP [2011-68002-30029]; Kansas Wheat Commission; French National Research Agency [ANR-09-GENM-025 3BSEQ]; France Agrimer; Ministry of Agriculture, Forestry and Fisheries of Japan [KGS-1003,1004, NGB-1003]; Nisshin Flour Milling Incorporated; Genome Canada; Genome Prairie; University of Saskatchewan Ministry of Agriculture, Western Grains Research Foundation; Norwegian Research Council [199387]; Graminor AS; Czech Science foundation [P501/12/G090, P501/12/2554]; BBSRC (UK); German Ministry for Education and Research (BMBF) Plant2030; TRITEX; Deutsche Forschungsgemeinschaft (DFG) [SFB 924]; EC Transplant; IWGSC; Arcadia Biosciences; Australian Centre for Plant Functional Genomics; Biogemma; Bayer CropScience; Commonwealth Science and Industrial Research Organisation; Centro Internacional de Mejoramiento de Maiz y Trigo; Cereales Vallee; Dow AgroSciences; Dupont; Evogene; Florimond Desprez; Grains Research and Development Corporation; Graminor; Heartland Plant Innovation; INRA; KWS; Limagrain; Monsanto; RAGT; Syngenta; European Commission Marie Curie Actions (FP7-MC-IIF-Noncollinear Genes); BBSRC [BB/I00663X/1, BB/I026030/1, BB/J003166/1, BB/J003743/1, BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J003743/1, BB/J003166/1, BB/I00663X/1, BB/I026030/1, BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: researchfish; Division Of Computer and Network Systems [1126709] Funding Source: National Science Foundation	Institut National de la Recherche Agronomique (INRA); International Center for Agricultural Research in the Dry Areas; Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Biotechnology and Biological Sciences Research Council (BBSRC UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); 3A-U.S. Department of Agriculture Agriculture and Food Research Initiative (USDA AFRI) Triticeae-CAP; Kansas Wheat Commission; French National Research Agency(French National Research Agency (ANR)); France Agrimer; Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Nisshin Flour Milling Incorporated; Genome Canada(Genome Canada); Genome Prairie; University of Saskatchewan Ministry of Agriculture, Western Grains Research Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); Graminor AS; Czech Science foundation(Grant Agency of the Czech Republic); BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); German Ministry for Education and Research (BMBF) Plant2030(Federal Ministry of Education & Research (BMBF)); TRITEX; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EC Transplant; IWGSC; Arcadia Biosciences; Australian Centre for Plant Functional Genomics; Biogemma; Bayer CropScience(Bayer AG); Commonwealth Science and Industrial Research Organisation; Centro Internacional de Mejoramiento de Maiz y Trigo; Cereales Vallee; Dow AgroSciences; Dupont; Evogene; Florimond Desprez; Grains Research and Development Corporation(Grains R&D Corp); Graminor; Heartland Plant Innovation; INRA; KWS; Limagrain; Monsanto; RAGT; Syngenta(Syngenta); European Commission Marie Curie Actions (FP7-MC-IIF-Noncollinear Genes); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The authors would like to thank Graminor AS; Biogemma; Institut National de la Recherche Agronomique (INRA); International Center for Agricultural Research in the Dry Areas; Department of Biotechnology, Ministry of Science and Technology, Government of India (chr. 2A; grant no. BT/IWGSC/03/TF/2008); and the Biotechnology and Biological Sciences Research Council (BBSRC UK) for funding the chromosome sequencing at the Genome Analysis Centre. Chromosome sequencing at other centers was funded by the following: chr. 3A-U.S. Department of Agriculture Agriculture and Food Research Initiative (USDA AFRI) Triticeae-CAP (2011-68002-30029) and the Kansas Wheat Commission; chr. 3B-grants from the French National Research Agency (ANR-09-GENM-025 3BSEQ) and France Agrimer; chr. 6B-grants from the Ministry of Agriculture, Forestry and Fisheries of Japan "Genomics for agricultural innovation KGS-1003,1004", "Genomics based technology for agricultural improvement, NGB-1003," and Nisshin Flour Milling Incorporated; chr. 6D and Triticum durum cv. Strongfield-grants from Genome Canada, Genome Prairie, University of Saskatchewan Ministry of Agriculture, Western Grains Research Foundation; chr. 7B-grant no. 199387 from the Norwegian Research Council and from Graminor AS; chr. 7A and 7D sequence reads were provided by D. E.. Chromosome flow sorting and DNA preparation was supported through grants P501/12/G090 and P501/12/2554 from the Czech Science foundation. Chromosome sequence assembly was supported by the BBSRC (UK). K. F. X. M. acknowledges grants from the German Ministry for Education and Research (BMBF) Plant2030, TRITEX, Deutsche Forschungsgemeinschaft (DFG) SFB 924, and EC Transplant. K. E. and J.R. are supported by sponsors of the IWGSC, which include Arcadia Biosciences, Australian Centre for Plant Functional Genomics, Biogemma, Bayer CropScience, Commonwealth Science and Industrial Research Organisation, Centro Internacional de Mejoramiento de Maiz y Trigo, Cereales Vallee, Dow AgroSciences, Dupont, Evogene, Florimond Desprez, Grains Research and Development Corporation, Graminor, Heartland Plant Innovation, INRA, KWS, Kansas Wheat Commission, Limagrain, Monsanto, RAGT, and Syngenta. N. G. is supported by European Commission Marie Curie Actions (FP7-MC-IIF-Noncollinear Genes). T. W. is supported by the Swiss National Foundation and P. F., M. C., A. M. S., and L. C. are supported by the Italian Ministry of Agriculture special project "MAPPA-5A." H. B. acknowledges funding from Sabanci University and the Scientific and Technological Research Council of Turkey. B. W. and B. S. were funded by the Gatsby Charitable Foundation and the BBSRC (UK) Grant BB/J003166/1. R. W. is a Trustee Director of TGAC, Norwich, UK, and A. K. is a shareholder of Diversity Arrays Technology Pty Ltd. The POPSeq analysis carried out by the U. S. Department of Energy Joint Genome Institute was supported by the Office of Science of the U. S. Department of Energy under contract no. DE-AC02-05CH11231. Additional support for the work was funded from the Triticeae-CAP, USDA AFRI (2011-68002-30029) to G.J.M.; the Scottish Government Rural and Environment Science and Analytical Services Division Research Programme to R. W.; and the German Ministry of Research and Education (BMBF TRITEX 0315954) to N.S. Sequence reads and assembled sequences are available at European Molecular Biology Laboratory/GenBank/DNA Data Bank of Japan short read archives and sequence repositories, respectively (PRJEB3955-whole-genome sequences of T. aestivum 'Chinese Spring,' T. urartu, Ae. speltoides, Ae.; tauschii, T. turgidum; SRP004490.3-whole-genome sequencing of T. monococcum; SRP004490-whole-genome sequencing of Ae. tauschii; PRJEB4849 -whole-genome sequences of Ae. sharonensis; PRJEB4750-T. aestivum RNA-seq data; SRP037990-T. aestivum SynOpDH mapping population; SRP037781-T. aestivum synthetic opata M85; SRP037994-T. aestivum synthetic W7984). All data can be accessed via the IWGSC repository at Unite de Rercherche Genomique Info: http://wheat-urgi.versailles.inra.fr/Seq-Repository/.	Adams KL, 2007, J HERED, V98, P136, DOI 10.1093/jhered/esl061; Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Akhunov ED, 2013, PLANT PHYSIOL, V161, P252, DOI 10.1104/pp.112.205161; Allen AM, 2013, PLANT BIOTECHNOL J, V11, P279, DOI 10.1111/pbi.12009; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Berkman PJ, 2012, THEOR APPL GENET, V124, P423, DOI 10.1007/s00122-011-1717-2; Berkman PJ, 2011, PLANT BIOTECHNOL J, V9, P768, DOI 10.1111/j.1467-7652.2010.00587.x; Bernardo AN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-251; Borchert Glen M, 2011, Mob Genet Elements, V1, P8; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Buggs RJA, 2012, CURR BIOL, V22, P248, DOI 10.1016/j.cub.2011.12.027; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chaudhary B, 2009, GENETICS, V182, P503, DOI 10.1534/genetics.109.102608; Chelaifa H, 2013, NEW PHYTOL, V197, P730, DOI 10.1111/nph.12108; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Cheng F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036442; Choulet F, 2014, SCIENCE, V345, DOI 10.1126/science.1249721; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Civan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081955; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Coram TE, 2008, THEOR APPL GENET, V117, P401, DOI 10.1007/s00122-008-0784-5; Diaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033234; Eilam T, 2007, GENOME, V50, P1029, DOI 10.1139/G07-083; Escobar JS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-181; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Food and Agriculture Organization (FAO) of the United Nations, 2013, FAO CER SUPPL DEM BR; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Griffiths S, 2006, NATURE, V439, P749, DOI 10.1038/nature04434; Hernandez P, 2012, PLANT J, V69, P377, DOI 10.1111/j.1365-313X.2011.04808.x; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; KANTAR M, 2012, GENOMICS, V12, P465, DOI DOI 10.1007/S10142-012-0285-0; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Knox RE, 2009, GENOME, V52, P741, DOI [10.1139/G09-042, 10.1139/g09-042]; Koszul R, 2004, EMBO J, V23, P234, DOI 10.1038/sj.emboj.7600024; Krasileva KV, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r66; Kurtz S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-517; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Lucas SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040859; Luo MC, 2013, P NATL ACAD SCI USA, V110, P7940, DOI 10.1073/pnas.1219082110; Ma J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079329; Marcussen T, 2014, SCIENCE, V345, DOI 10.1126/science.1250092; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Martinez-Perez E, 2001, NATURE, V411, P204, DOI 10.1038/35075597; Martis MM, 2013, PLANT CELL, V25, P3685, DOI 10.1105/tpc.113.114553; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Mayer KFX, 2009, PLANT PHYSIOL, V151, P496, DOI 10.1104/pp.109.142612; Mochida K, 2009, PLANT PHYSIOL, V150, P1135, DOI 10.1104/pp.109.138214; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; Nesbitt M., HULLED WHEATS PROMOT, P41; OECD/Food and Agriculture Organization of the United Nations, 2013, OECD FAO AGR OUTL 20, DOI [10.1787/agr_outlook-2013-en, DOI 10.1787/AGR_OUTLOOK-2013-EN]; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Pfeifer M, 2014, SCIENCE, V345, DOI 10.1126/science.1250091; Pumphrey M, 2009, GENETICS, V181, P1147, DOI 10.1534/genetics.108.096941; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Rapp RA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-18; Safar J, 2010, CYTOGENET GENOME RES, V129, P211, DOI 10.1159/000313072; Saintenac C, 2013, G3-GENES GENOM GENET, V3, P1105, DOI 10.1534/g3.113.005819; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sears E. R., 1978, Proceedings of the fifth international wheat genetics symposium. Volume 1. Session IV. Cytogenetics., P389; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sorrells ME, 2011, GENOME, V54, P875, DOI [10.1139/g11-054, 10.1139/G11-054]; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Tanaka T, 2014, DNA RES, V21, P103, DOI 10.1093/dnares/dst041; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang JL, 2004, GENETICS, V167, P1961, DOI 10.1534/genetics.104.027896; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Wiebe K, 2010, THEOR APPL GENET, V121, P1047, DOI 10.1007/s00122-010-1370-1; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yoo MJ, 2013, HEREDITY, V110, P171, DOI 10.1038/hdy.2012.94; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	86	1113	1133	32	437	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194			SI				1251788	10.1126/science.1251788	http://dx.doi.org/10.1126/science.1251788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR2MB	25035500				2022-12-01	WOS:000343420300004
J	Cohen, RL; Settleman, J				Cohen, Robert L.; Settleman, Jeff			From Cancer Genomics to Precision Oncology-Tissue's Still an Issue	CELL			English	Article							ABL TYROSINE KINASE; CELL LUNG-CANCER; TARGETED THERAPY; INHIBITION; MULTICENTER; SORAFENIB; MELANOMA; SURVIVAL; LABEL	Rapidly evolving genome technology has enabled extensive molecular analysis of limited tumor biopsy material, thereby facilitating the broader implementation of personalized cancer medicine. However, genomics-based patient stratification across diverse tumor types is unlikely to supplant tissue-of-origin considerations in addressing clinical needs, including the development and application of novel "rationally targeted" cancer therapies.	[Cohen, Robert L.] Calico Life Sci, San Francisco, CA 94080 USA; [Settleman, Jeff] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Settleman, J (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	settleman.jeffrey@gene.com						AACR Cancer Progress Report Writing Committee, 2013, Clin Cancer Res, V19, pS4, DOI 10.1158/1078-0432.CCR-13-2107; Bauml J, 2013, CLIN LUNG CANCER, V14, P581, DOI 10.1016/j.cllc.2013.05.002; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Crowther M, 2013, HEMATOL-AM SOC HEMAT, P15, DOI 10.1182/asheducation-2013.1.15; Custodio A, 2013, CRIT REV ONCOL HEMAT, V85, P45, DOI 10.1016/j.critrevonc.2012.05.001; Dancey JE, 2012, CELL, V148, P409, DOI 10.1016/j.cell.2012.01.014; Dietrich S, 2012, NEW ENGL J MED, V366, P2038, DOI 10.1056/NEJMc1202124; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Eifert C, 2012, NAT REV CANCER, V12, P572, DOI 10.1038/nrc3299; Eisen T, 2006, BRIT J CANCER, V95, P581, DOI 10.1038/sj.bjc.6603291; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Figueroa-Magalhaes MC, 2014, BREAST, V23, P128, DOI 10.1016/j.breast.2013.11.011; Garraway LA, 2013, J CLIN ONCOL, V31, P1803, DOI 10.1200/JCO.2013.49.4799; Heng DYC, 2008, CURR CANCER DRUG TAR, V8, P676, DOI 10.2174/156800908786733450; Horning SJ, 2013, CLIN CANCER RES, V19, P4297, DOI 10.1158/1078-0432.CCR-13-0523; Iyer R, 2010, EXPERT OPIN PHARMACO, V11, P1943, DOI 10.1517/14656566.2010.496453; Minuti G, 2013, EXPERT OPIN BIOL TH, V13, P1401, DOI 10.1517/14712598.2013.827657; Monzon FA, 2009, J CLIN ONCOL, V27, P2503, DOI 10.1200/JCO.2008.17.9762; Mullighan CG, 2012, J CLIN INVEST, V122, P3407, DOI 10.1172/JCI61203; Mullins CD, 2012, J CLIN ONCOL, V30, P661, DOI 10.1200/JCO.2011.35.5198; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sauter G, 2009, J CLIN ONCOL, V27, P1323, DOI 10.1200/JCO.2007.14.8197; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Willyard C, 2013, NAT MED, V19, P655, DOI 10.1038/nm0613-655	28	21	26	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1509	1514		10.1016/j.cell.2014.05.027	http://dx.doi.org/10.1016/j.cell.2014.05.027			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949964	Bronze			2022-12-01	WOS:000340941900007
J	Kirschke, E; Goswami, D; Southworth, D; Griffin, PR; Agard, DA				Kirschke, Elaine; Goswami, Devrishi; Southworth, Daniel; Griffin, Patrick R.; Agard, David A.			Glucocorticoid Receptor Function Regulated by Coordinated Action of the Hsp90 and Hsp70 Chaperone Cycles	CELL			English	Article							LIGAND-BINDING DOMAIN; SHOCK-PROTEIN 90; CONFORMATIONAL DYNAMICS; PROGESTERONE-RECEPTOR; SIGNAL-TRANSDUCTION; ELECTRON-MICROSCOPY; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ATP HYDROLYSIS	The glucocorticoid receptor (GR), like many signaling proteins, depends on the Hsp90 molecular chaperone for in vivo function. Although Hsp90 is required for ligand binding in vivo, purified apo GR is capable of binding ligand with no enhancement from Hsp90. We reveal that Hsp70, known to facilitate client delivery to Hsp90, inactivates GR through partial unfolding, whereas Hsp90 reverses this inactivation. Full recovery of ligand binding requires ATP hydrolysis on Hsp90 and the Hop and p23 cochaperones. Surprisingly, Hsp90 ATP hydrolysis appears to regulate client transfer from Hsp70, likely through a coupling of the two chaperone's ATP cycles. Such coupling is embodied in contacts between Hsp90 and Hsp70 in the GR: Hsp70: Hsp90: Hop complex imaged by cryoelectron microscopy. Whereas GR released from Hsp70 is aggregation prone, release from Hsp90 protects GR from aggregation and enhances its ligand affinity. Together, this illustrates how coordinated chaperone interactions can enhance stability, function, and regulation.	[Kirschke, Elaine; Southworth, Daniel; Agard, David A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Kirschke, Elaine; Southworth, Daniel; Agard, David A.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Goswami, Devrishi; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Scripps Research Institute	Agard, DA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	agard@msg.ucsf.edu			PSI-Biology grant [U01 GM098254]; UCSF Quantitative Biosciences Consortium; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284, U01GM098254] Funding Source: NIH RePORTER	PSI-Biology grant; UCSF Quantitative Biosciences Consortium; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Liao and Y. Cheng for help with the initial model for EM refinement and members of the D.A.A. lab for helpful discussions. Support for this work was provided by the PSI-Biology grant U01 GM098254 (to D.A.A.), the UCSF Quantitative Biosciences Consortium (to E.K.), and the Howard Hughes Medical Institute.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Chrousos GP, 2009, ANN NY ACAD SCI, V1179, P153, DOI 10.1111/j.1749-6632.2009.04988.x; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Dittmar KD, 1998, J BIOL CHEM, V273, P7358, DOI 10.1074/jbc.273.13.7358; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; Fang L, 2006, P NATL ACAD SCI USA, V103, P18487, DOI 10.1073/pnas.0609163103; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Freeman BC, 2001, TRENDS BIOCHEM SCI, V26, P285, DOI 10.1016/S0968-0004(01)01834-5; Genest O, 2013, MOL CELL, V49, P464, DOI 10.1016/j.molcel.2012.11.017; Goswami D, 2013, J AM SOC MASS SPECTR, V24, P1584, DOI 10.1007/s13361-013-0669-y; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; HOWARD KJ, 1990, J BIOL CHEM, V265, P11928; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Johnson JL, 2007, MOL CELL BIOL, V27, P768, DOI 10.1128/MCB.01034-06; KIMURA Y, 1995, SCIENCE, V268, P1362, DOI 10.1126/science.7761857; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Lorenz OR, 2014, MOL CELL, V53, P941, DOI 10.1016/j.molcel.2014.02.003; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McLaughlin SH, 2002, PROTEIN SCI, V11, P1926, DOI 10.1110/ps.5000102; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; Morishima Y, 2000, J BIOL CHEM, V275, P6894, DOI 10.1074/jbc.275.10.6894; Morishima Y, 2001, BIOCHEMISTRY-US, V40, P1109, DOI 10.1021/bi002399+; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Pfaff SJ, 2010, J BIOL CHEM, V285, P15256, DOI 10.1074/jbc.M110.108118; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Ricketson D, 2007, J MOL BIOL, V368, P729, DOI 10.1016/j.jmb.2007.02.057; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; SMITH DF, 1992, J BIOL CHEM, V267, P1350; SMITH DF, 1993, MOL ENDOCRINOL, V7, P1418, DOI 10.1210/me.7.11.1418; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Stankiewicz M, 2010, FEBS J, V277, P3353, DOI 10.1111/j.1742-4658.2010.07737.x; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19307, DOI 10.1074/jbc.270.33.19307; Wegele H, 2003, J BIOL CHEM, V278, P39303, DOI 10.1074/jbc.M305751200; Whitesell L, 1996, MOL ENDOCRINOL, V10, P705, DOI 10.1210/me.10.6.705; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	51	255	263	2	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1685	1697		10.1016/j.cell.2014.04.038	http://dx.doi.org/10.1016/j.cell.2014.04.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949977	Green Accepted, Bronze			2022-12-01	WOS:000340941900021
J	Ball, P				Ball, Philip			The art of medicine Unnatural reactions	LANCET			English	Editorial Material																			0	7	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2014	383	9933					1964	1965		10.1016/S0140-6736(14)60945-4	http://dx.doi.org/10.1016/S0140-6736(14)60945-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PV	24936628				2022-12-01	WOS:000336848200014
J	Laganowsky, A; Reading, E; Allison, TM; Ulmschneider, MB; Degiacomi, MT; Baldwin, AJ; Robinson, CV				Laganowsky, Arthur; Reading, Eamonn; Allison, Timothy M.; Ulmschneider, Martin B.; Degiacomi, Matteo T.; Baldwin, Andrew J.; Robinson, Carol V.			Membrane proteins bind lipids selectively to modulate their structure and function	NATURE			English	Article							MOBILITY-MASS SPECTROMETRY; ATOM FORCE-FIELD; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR-DYNAMICS; ION-CHANNEL; COMPLEXES; MODEL; MSCL; PURIFICATION; WATER	Previous studies have established that the folding, structure and function of membrane proteins are influenced by their lipid environments(1-7) and that lipids can bind to specific sites, for example, in potassium channels(8). Fundamental questions remain however regarding the extent of membrane protein selectivity towards lipids. Here we report a mass spectrometry approach designed to determine the selectivity of lipid binding to membrane protein complexes. We investigate the mechanosensitive channel of large conductance (MscL) from Myco-bacterium tuberculosis and aquaporin Z (AqpZ) and the ammonia channel (AmtB) from Escherichia coli, using ion mobility mass spectrometry (IM-MS), which reports gas-phase collision cross-sections. We demonstrate that folded conformations of membrane protein complexes can exist in the gas phase. By resolving lipid-bound states, we then rank bound lipids on the basis of their ability to resist gas phase unfolding and thereby stabilize membrane protein structure. Lipids bind non-selectively and with high avidity to MscL, all imparting comparable stability; however, the highest-ranking lipid is phosphatidylinositol phosphate, in line with its proposed functional role in mechanosensation(9). AqpZ is also stabilized by many lipids, with cardiolipin imparting the most significant resistance to unfolding. Subsequently, through functional assays we show that cardiolipin modulates AqpZ function. Similar experiments identify AmtB as being highly selective for phosphatidylglycerol, prompting us to obtain an X-ray structure in this lipid membrane-like environment. The 2.3 angstrom resolution structure, when compared with others obtained without lipid bound, reveals distinct conformational changes that re-position AmtB residues to interact with the lipid bilayer. Our results demonstrate that resistance to unfolding correlates with specific lipid-binding events, enabling a distinction to be made between lipids that merely bind from those that modulate membrane protein structure and/or function. We anticipate that these findings will be important not only for defining the selectivity of membrane proteins towards lipids, but also for understanding the role of lipids in modulating protein function or drug binding.	[Laganowsky, Arthur; Reading, Eamonn; Allison, Timothy M.; Degiacomi, Matteo T.; Baldwin, Andrew J.; Robinson, Carol V.] Univ Oxford, Dept Chem, Oxford OX1 5QY, England; [Ulmschneider, Martin B.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA	University of Oxford; Johns Hopkins University	Laganowsky, A (corresponding author), Univ Oxford, Dept Chem, S Parks Rd, Oxford OX1 5QY, England.	art.laganowsky@chem.ox.ac.uk; carol.robinson@chem.ox.ac.uk	Degiacomi, Matteo/M-4342-2017; Ulmschneider, Martin/J-4374-2012; Baldwin, Andrew/A-5830-2015	Degiacomi, Matteo/0000-0003-4672-471X; Baldwin, Andrew/0000-0001-7579-8844; Ulmschneider, Martin/0000-0001-8103-0516; Reading, Eamonn/0000-0001-8219-0052; robinson, carol/0000-0001-7829-5505; Laganowsky, Arthur/0000-0001-5012-5547	Medical Research Council (MRC); BBSRC; ERC; BBSRC [BB/J014346/1] Funding Source: UKRI; MRC [MC_PC_12020, G1000819] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J014346/1] Funding Source: researchfish; Medical Research Council [MC_PC_12020, G1000819] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Hobman and D. Lee for providing gene-doctoring plasmids, Z. Guan and C. Li for providing E. coli strains and plasmids containing cardiolipin genes. We also thank D. Staunton and N. Housden for training on the stopped-flow apparatus; and T. Mize, J. Benesch, M. McDonough, T. Walton and D. Rees for discussions. We also gratefully acknowledge E. Lowe and S. Lea for organizing synchrotron proposals and Diamond Light Source beam line I04 and staff, the Medical Research Council (MRC), BBSRC and ERC advanced grant (IMPRESS) for funding. A.L. is a Nicholas Kurti Junior Research Fellow of Brasenose College, A. J. B. is a BBSRC David Phillip's Fellow and C.V.R. is a Royal Society Professor.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baldwin AJ, 2011, STRUCTURE, V19, P1855, DOI 10.1016/j.str.2011.09.015; Barrera NP, 2008, SCIENCE, V321, P243, DOI 10.1126/science.1159292; Benesch JLP, 2011, CURR OPIN STRUC BIOL, V21, P641, DOI 10.1016/j.sbi.2011.08.002; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blakey D, 2002, BIOCHEM J, V364, P527, DOI 10.1042/BJ20011761; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; Bush MF, 2010, ANAL CHEM, V82, P9557, DOI 10.1021/ac1022953; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cantor RS, 1999, CHEM PHYS LIPIDS, V101, P45, DOI 10.1016/S0009-3084(99)00054-7; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Contreras FX, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004705; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; FINE JB, 1982, J LIPID RES, V23, P660; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gandhi CS, 2011, PROTEIN SCI, V20, P313, DOI 10.1002/pro.562; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Hall Z, 2012, STRUCTURE, V20, P1596, DOI 10.1016/j.str.2012.07.001; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hite RK, 2010, EMBO J, V29, P1652, DOI 10.1038/emboj.2010.68; Hong H, 2009, METHOD ENZYMOL, V455, P213, DOI 10.1016/S0076-6879(08)04208-0; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Hyung SJ, 2009, CHEM BIOL, V16, P382, DOI 10.1016/j.chembiol.2009.02.008; Iscla I, 2012, BIOPHYS J, V103, P169, DOI 10.1016/j.bpj.2012.06.021; Izzo D., 2012, P ICATT; Izzo D, 2012, STUD COMPUT INTELL, V415, P151; Jones E, 2001, SCIPY OPEN SOURCE SC; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Laganowsky A, 2013, NAT PROTOC, V8, P639, DOI 10.1038/nprot.2013.024; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lee AG, 2011, TRENDS BIOCHEM SCI, V36, P493, DOI 10.1016/j.tibs.2011.06.007; Lee DJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-252; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; MASON EA, 1958, ANN PHYS-NEW YORK, V4, P233, DOI 10.1016/0003-4916(58)90049-6; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mesleh MF, 1996, J PHYS CHEM-US, V100, P16082, DOI 10.1021/jp961623v; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newby ZER, 2009, NAT PROTOC, V4, P619, DOI 10.1038/nprot.2009.27; Pace C N, 1986, Methods Enzymol, V131, P266; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Powl AM, 2003, BIOCHEMISTRY-US, V42, P14306, DOI 10.1021/bi034995k; Romantsov T, 2010, J BACTERIOL, V192, P912, DOI 10.1128/JB.00967-09; Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; Sanders CR, 2011, BIOCHEMISTRY-US, V50, P7858, DOI 10.1021/bi2011527; Savage DF, 2010, P NATL ACAD SCI USA, V107, P17164, DOI 10.1073/pnas.1009864107; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrodinger L. L. C., 2010, PYMOL MOL GRAPHICS S; Shvartsburg AA, 1996, CHEM PHYS LETT, V261, P86, DOI 10.1016/0009-2614(96)00941-4; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Stengel F, 2012, CHEM BIOL, V19, P599, DOI 10.1016/j.chembiol.2012.04.007; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; Ulmschneider JP, 2009, J CHEM THEORY COMPUT, V5, P1803, DOI 10.1021/ct900086b; Whitelegge JP, 2013, ANAL CHEM, V85, P2558, DOI 10.1021/ac303064a; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zhong DL, 2013, BIOCHEMISTRY-US, V52, P5415, DOI 10.1021/bi400790j	70	493	503	15	513	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					172	+		10.1038/nature13419	http://dx.doi.org/10.1038/nature13419			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24899312	Green Accepted, Green Submitted			2022-12-01	WOS:000336768900051
J	Al-Khatib, SM; Hellkamp, AS; Fonarow, GC; Mark, DB; Curtis, LH; Hernandez, AF; Anstrom, KJ; Peterson, ED; Sanders, GD; Al-Khalidi, HR; Hammill, BG; Heidenreich, PA; Hammill, SC				Al-Khatib, Sana M.; Hellkamp, Anne S.; Fonarow, Gregg C.; Mark, Daniel B.; Curtis, Lesley H.; Hernandez, Adrian F.; Anstrom, Kevin J.; Peterson, Eric D.; Sanders, Gillian D.; Al-Khalidi, Hussein R.; Hammill, Bradley G.; Heidenreich, Paul A.; Hammill, Stephen C.			Association Between Prophylactic Implantable Cardioverter-Defibrillators and Survival in Patients With Left Ventricular Ejection Fraction Between 30% and 35%	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONGESTIVE-HEART-FAILURE; MYOCARDIAL-INFARCTION; PREVENTION; PROGRAM; DISEASE; HF	IMPORTANCE Clinical trials of prophylactic implantable cardioverter-defibrillators (ICDs) have included a minority of patients with a left ventricular ejection fraction (LVEF) between 30% and 35%. Because a large number of ICDs in the United States are implanted in such patients, it is important to study survival associated with this therapy. OBJECTIVE To characterize patients with LVEF between 30% and 35% and compare the survival of those with and without ICDs. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of Medicare beneficiaries in the National Cardiovascular Data Registry ICD registry (January 1, 2006, through December 31, 2007) with an LVEF between 30% and 35% who received an ICD during a heart failure hospitalization and similar patients in the Get With The Guidelines-Heart Failure (GWTG-HF) database (January 1, 2005, through December 31, 2009) with no ICD. The analysis was repeated in patients with an LVEF less than 30%. There were 3120 patients with an LVEF between 30% and 35% (816 in matched cohorts) and 4578 with an LVEF less than 30% (2176 in matched cohorts). Propensity score matching and Cox models were applied. MAIN OUTCOMES AND MEASURES The primary outcome was all-cause mortality; data were obtained from Medicare claims through December 31, 2011. RESULTS There were no significant differences in the baseline characteristics of the matched groups (n = 408 for both groups). Among patients with an LVEF between 30% and 35%, there were 248 deaths in the ICD Registry group, within a median follow-up of 4.4 years (interquartile range, 2.7-4.9) and 249 deaths in the GWTG HF group, within a median follow-up of 2.9 years (interquartile range, 2.1-4.4). The risk of all-cause mortality in patients with an LVEF between 30% and 35% and an ICD was significantly lower than that in matched patients without an ICD (3-year mortality rates: 51.4% vs 55.0%; hazard ratio, 0.83 [95% CI, 0.69-0.991; P = .04). Presence of an ICD also was associated with better survival in patients with an LVEF less than 30% (3-year mortality rates: 45.0% vs 57.6%; 634 and 660 total deaths; hazard ratio, 0.72 [95% CI, 0.65-0.811; P < .001) (P = .20 for interaction). CONCLUSIONS AND RELEVANCE Among Medicare beneficiaries hospitalized for heart failure and with an LVEF between 30% and 35% and less than 30%, survival at 3 years was better in patients who received a prophylactic ICD than in comparable patients with no ICD. These findings support guideline recommendations to implant prophylactic ICDs in eligible patients with an LVEF of 35% or less. Copyright 2014 American Medical Association. All rights reserved.	[Al-Khatib, Sana M.; Hellkamp, Anne S.; Mark, Daniel B.; Curtis, Lesley H.; Hernandez, Adrian F.; Anstrom, Kevin J.; Peterson, Eric D.; Sanders, Gillian D.; Al-Khalidi, Hussein R.; Hammill, Bradley G.; Hammill, Stephen C.] Duke Univ, Med Ctr, Dept Med, Duke Clin Res Inst, Durham, NC 27710 USA; [Curtis, Lesley H.; Hammill, Stephen C.] Duke Univ, Med Ctr, Dept Med, Ctr Clin & Genet Econ, Durham, NC 27710 USA; [Al-Khatib, Sana M.; Mark, Daniel B.; Hernandez, Adrian F.; Peterson, Eric D.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Curtis, Lesley H.] Duke Univ, Med Ctr, Dept Med, Div Gen Internal Med, Durham, NC 27710 USA; [Fonarow, Gregg C.] Ronald Reagan UCLA Med Ctr, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA; [Heidenreich, Paul A.] Stanford Univ, Palo Alto Vet Hlth Care Syst, Palo Alto, CA 94304 USA; [Hammill, Stephen C.] Mayo Clin, Rochester, MN USA	Duke University; Duke University; Duke University; Duke University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Ronald Reagan UCLA Medical Center; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Mayo Clinic	Al-Khatib, SM (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	alkha001@mc.duke.edu	Hernandez, Adrian F/A-7818-2016; Fonarow, Gregg C/D-5988-2014; Peterson, Eric David/ABF-5033-2021; Heidenreich, Paul/AAU-6864-2021	Hernandez, Adrian F/0000-0003-3387-9616; Fonarow, Gregg C/0000-0002-3192-8093; Heidenreich, Paul/0000-0001-7730-8490; Mark, Daniel/0000-0001-6340-8087	National Heart, Lung, and Blood Institute [1R01-HL093071-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093071] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This analysis was funded by grant 1R01-HL093071-01A1 from the National Heart, Lung, and Blood Institute.	Al-Khatib SM, 2014, INT J CARDIOL, V172, P253, DOI 10.1016/j.ijcard.2013.12.278; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Curtis LH, 2008, ARCH INTERN MED, V168, P2481, DOI 10.1001/archinte.168.22.2481; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; Fonarow GC, 2004, AM HEART J, V148, P43, DOI 10.1016/j.ahj.2004.03.004; Gustafsson F, 2003, EUR HEART J, V24, P863, DOI 10.1016/S0195-668X(02)00845-X; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; Hammill SC, 2007, HEART RHYTHM, V4, P1260, DOI 10.1016/j.hrthm.2007.07.021; Hammill SC, 2009, HEART RHYTHM, V6, P1397, DOI 10.1016/j.hrthm.2009.07.015; Hellermann JP, 2005, EUR J HEART FAIL, V7, P119, DOI 10.1016/j.ejheart.2004.04.011; Hjalmarson A, 1999, LANCET, V353, P2001; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Kremers MS, 2013, HEART RHYTHM, V10, pE59, DOI 10.1016/j.hrthm.2013.01.035; Messenger JC, 2012, J AM COLL CARDIOL, V60, P1484, DOI 10.1016/j.jacc.2012.07.020; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Weir Robin A P, 2006, Curr Heart Fail Rep, V3, P175, DOI 10.1007/s11897-006-0019-5	20	23	23	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2209	2215		10.1001/jama.2014.5310	http://dx.doi.org/10.1001/jama.2014.5310			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24893088	Green Accepted, Bronze			2022-12-01	WOS:000336668400022
J	Gravitz, L				Gravitz, Lauren			THERAPY This time it's personal	NATURE			English	Editorial Material							CANCER; IMMUNOTHERAPY											Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Fan XZ, 2014, J EXP MED, V211, P715, DOI 10.1084/jem.20130590; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Welch JS, 2011, JAMA-J AM MED ASSOC, V305, P1577, DOI 10.1001/jama.2011.497	6	8	9	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S52	S54		10.1038/509S52a	http://dx.doi.org/10.1038/509S52a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870820	Bronze			2022-12-01	WOS:000336457100003
J	Pape, JW; Rouzier, V				Pape, Jean William; Rouzier, Vanessa			Embracing Oral Cholera Vaccine - The Shifting Response to Cholera	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pape, Jean William; Rouzier, Vanessa] Ctr GHESKIO, Port Au Prince, Haiti; [Pape, Jean William] Weill Cornell Med Coll, Ctr Global Hlth, Div Infect Dis, New York, NY USA	Cornell University	Pape, JW (corresponding author), Ctr GHESKIO, Port Au Prince, Haiti.							Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Date KA, 2011, EMERG INFECT DIS, V17, P2105, DOI 10.3201/eid1711.110822; Ivers LC, 2013, AM J TROP MED HYG, V89, P617, DOI 10.4269/ajtmh.13-0183; Rouzier V, 2013, AM J TROP MED HYG, V89, P671, DOI 10.4269/ajtmh.13-0171; World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P289	5	10	11	2	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					2067	2069		10.1056/NEJMp1402837	http://dx.doi.org/10.1056/NEJMp1402837			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH9BM	24869720	Bronze			2022-12-01	WOS:000336434000004
J	Engineer, CB; Ghassemian, M; Anderson, JC; Peck, SC; Hu, HH; Schroeder, JI				Engineer, Cawas B.; Ghassemian, Majid; Anderson, Jeffrey C.; Peck, Scott C.; Hu, Honghong; Schroeder, Julian I.			Carbonic anhydrases, EPF2 and a novel protease mediate CO2 control of stomatal development	NATURE			English	Article							ASYMMETRIC CELL-DIVISION; SIGNAL-TRANSDUCTION; SECRETORY PEPTIDE; ABSCISIC-ACID; DENSITY; KINASE; DIFFERENTIATION; REVEALS	Environmental stimuli, including elevated carbon dioxide levels, regulate stomatal development(1-3); however, the key mechanisms mediating the perception and relay of the CO2 signal to the stomatal development machinery remain elusive. To adapt CO2 intake to water loss, plants regulate the development of stomatal gas exchange pores in the aerial epidermis. A diverse range of plant species show a decrease in stomatal density in response to the continuing rise in atmospheric CO2 (ref. 4). To date, one mutant that exhibits deregulation of this CO2-controlled stomatal development response, hic (which is defective in cell-wall wax biosynthesis, ref. 5), has been identified. Here we show that recently isolated Arabidopsis thaliana beta-carbonic anhydrase double mutants (cal ca4)(6) exhibit an inversion in their response to elevated CO2, showing increased stomatal development at elevated CO2 levels. We characterized the mechanisms mediating this response and identified an extracellular signalling pathway involved in the regulation of CO2-controlled stomatal development by carbonic anhydrases. RNA-seq analyses of transcripts show that the extracellular pro-peptide-encoding gene EPIDERMAL PATTERNING FACTOR 2 (EPF2)(7,8), but not EPFI (ref. 9), is induced in wild-type leaves but not in cal ca4 mutant leaves at elevated CO2 levels. Moreover, EPF2 is essential for CO2 control of stomatal development. Using cell-wall proteomic analyses and CO2-dependent transcriptomic analyses, we identified a novel CO2-induced extracellular protease, CRSP (CO2 RESPONSE SECRETED PROTEASE), as a mediator of CO2-controlled stomatal development. Our results identify mechanisms and genes that function in the repression of stomatal development in leaves during atmospheric CO2 elevation, including the carbonic-anhydrase-encoding genes CA1 and CA4 and the secreted protease CRSP, which cleaves the pro-peptide EPF2, in turn repressing stomatal development. Elucidation of these mechanisms advances the understanding of how plants perceive and relay the elevated CO2 signal and provides a framework to guide future research into how environmental challenges can modulate gas exchange in plants.	[Engineer, Cawas B.; Hu, Honghong; Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Ghassemian, Majid] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Anderson, Jeffrey C.; Peck, Scott C.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Missouri System; University of Missouri Columbia	Schroeder, JI (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	jischroeder@ucsd.edu	Anderson, Jeff/I-1316-2017	Anderson, Jeff/0000-0001-9446-7100	National Science Foundation [MCB0918220, MCB1414339, IOS-1025837]; National Institutes of Health [GM060396-ES010337]; BAYER-UC Discovery grant; seed grant from the UCSD-SDCSB [GM085764]; Systems Biology Center; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy [DE-FG02-03ER15449]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764, R01GM060396] Funding Source: NIH RePORTER; Direct For Biological Sciences [1414339] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BAYER-UC Discovery grant; seed grant from the UCSD-SDCSB; Systems Biology Center; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank K. Knepper for conducting independent CO<INF>2</INF>-dependent stomatal development analyses. We thank A. Ries for help with generating the CA-YFP-fusion complementation lines. We thank D. Bergmann for providing the epfl6 mutant line and DNA constructs for MUTEpro::nucGFP expression; K. Toni for providing DNA constructs for MUTEpro::MUTE-GFP expression, erecta mutants and the oestradiol-inducible EPF constructs; T. Altmann for providing the sdd1-1 mutant; and M. Estelle, Y. Zhao, A. Stephan and M. Facette for comments on the manuscript. This project was funded by grants from the National Science Foundation (MCB0918220 and MCB1414339 to J.I.S. and IOS-1025837 to S.C.P.) and the National Institutes of Health (GM060396-ES010337 to J.I.S.), a BAYER-UC Discovery grant (J.I.S.) and a seed grant from the UCSD-SDCSB (GM085764) Systems Biology Center (C.B.E.). A grant from the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DE-FG02-03ER15449) to J.I.S. funded complementation and localization analyses.	Abrash EB, 2010, DEVELOPMENT, V137, P447, DOI 10.1242/dev.040931; Anderson JC, 2008, PLANT J, V55, P881, DOI 10.1111/j.1365-313X.2008.03550.x; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Berger D, 2000, GENE DEV, V14, P1119; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Gray JE, 2000, NATURE, V408, P713, DOI 10.1038/35047071; Guttman M, 2009, PROTEOMICS, V9, P5016, DOI 10.1002/pmic.200900457; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; Hara K, 2009, PLANT CELL PHYSIOL, V50, P1019, DOI 10.1093/pcp/pcp068; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hu HH, 2010, NAT CELL BIOL, V12, P87, DOI 10.1038/ncb2009; Hunt L, 2009, CURR BIOL, V19, P864, DOI 10.1016/j.cub.2009.03.069; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Kondo T, 2010, PLANT CELL PHYSIOL, V51, P1, DOI 10.1093/pcp/pcp180; Lake JA, 2008, NEW PHYTOL, V179, P397, DOI 10.1111/j.1469-8137.2008.02485.x; Lee JS, 2012, GENE DEV, V26, P126, DOI 10.1101/gad.179895.111; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Niehl A, 2013, J PROTEOME RES, V12, P2491, DOI 10.1021/pr3010698; Ohki S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1520; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Pillitteri LJ, 2012, ANNU REV PLANT BIOL, V63, P591, DOI 10.1146/annurev-arplant-042811-105451; Pillitteri LJ, 2011, PLANT CELL, V23, P3260, DOI 10.1105/tpc.111.088583; Rautengarten C, 2008, PLANT J, V54, P466, DOI 10.1111/j.1365-313X.2008.03437.x; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sellers PJ, 1997, SCIENCE, V275, P502, DOI 10.1126/science.275.5299.502; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Sugano SS, 2010, NATURE, V463, P241, DOI 10.1038/nature08682; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Uchida N, 2013, J EXP BOT, V64, P5335, DOI 10.1093/jxb/ert196; Woodward FI, 2002, NEW PHYTOL, V153, P477, DOI 10.1046/j.0028-646X.2001.00338.x; Woodward FI, 2002, CURR OPIN PLANT BIOL, V5, P207, DOI 10.1016/S1369-5266(02)00253-4; WOODWARD FI, 1987, NATURE, V327, P617, DOI 10.1038/327617a0; Xue SW, 2011, EMBO J, V30, P1645, DOI 10.1038/emboj.2011.68; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6	40	142	164	4	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					246	+		10.1038/nature13452	http://dx.doi.org/10.1038/nature13452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25043023	Green Accepted			2022-12-01	WOS:000341362800053
J	Arranz, L; Sanchez-Aguilera, A; Martin-Perez, D; Isern, J; Langa, X; Tzankov, A; Lundberg, P; Muntion, S; Tzeng, YS; Lai, DM; Schwaller, J; Skoda, RC; Mendez-Ferrer, S				Arranz, Lorena; Sanchez-Aguilera, Abel; Martin-Perez, Daniel; Isern, Joan; Langa, Xavier; Tzankov, Alexandar; Lundberg, Pontus; Muntion, Sandra; Tzeng, Yi-Shiuan; Lai, Dar-Ming; Schwaller, Juerg; Skoda, Radek C.; Mendez-Ferrer, Simon			Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms	NATURE			English	Article							TYROSINE KINASE JAK2; ACTIVATING MUTATION; POLYCYTHEMIA-VERA; BONE; JAK2-V617F	Myeloproliferative neoplasms (MPNs) are diseases caused by mutations in the haematopoietic stem cell (HSC) compartment. Most MPN patients have a common acquired mutation of Janus kinase 2 (JAK2) gene in HSCs1-4 that renders this kinase constitutively active, leading to uncontrolled cell expansion. The bone marrow microenvironment might contribute to the clinical outcomes of this common event. We previously showed that bone marrow nestin(+) mesenchymal stem cells (MSCs) innervated by sympathetic nerve fibres regulate normal HSCs5,6. Here we demonstrate that abrogation of this regulatory circuit is essential for MPN pathogenesis. Sympathetic nerve fibres, supporting Schwann cells and nestin(+) MSCs are consistently reduced in the bone marrow of MPN patients and mice expressing the human JAK2(V617F) mutation in HSCs. Unexpectedly, MSC reduction is not due to differentiation but is caused by bone marrow neural damage and Schwann cell death triggered by interleukin-1 beta produced by mutant HSCs. In turn, in vivo depletion of nestin(+) cells or their production of CXCL12 expanded mutant HSC number and accelerated MPN progression. In contrast, administration of neuroprotective or sympathomimetic drugs prevented mutant HSC expansion. Treatment with beta(3)-adrenergic agonists that restored the sympathetic regulation of nestin(+) MSCs5,6 prevented the loss of these cells and blocked MPN progression by indirectly reducing the number of leukaemic stem cells. Our results demonstrate that mutant-HSC-driven niche damage critically contributes to disease manifestation in MPN and identify niche-forming MSCs and their neural regulation as promising therapeutic targets.	[Arranz, Lorena; Sanchez-Aguilera, Abel; Martin-Perez, Daniel; Isern, Joan; Langa, Xavier; Mendez-Ferrer, Simon] CNIC, Stem Cell Niche Pathophysiol Grp, Madrid 28029, Spain; [Tzankov, Alexandar; Lundberg, Pontus; Schwaller, Juerg; Skoda, Radek C.] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Muntion, Sandra] IBSAL Hosp Univ Salamanca, Dept Haematol, Salamanca 37007, Spain; [Tzeng, Yi-Shiuan; Lai, Dar-Ming] Natl Taiwan Univ, Taipei 10002, Taiwan	Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Basel; National Taiwan University	Mendez-Ferrer, S (corresponding author), CNIC, Stem Cell Niche Pathophysiol Grp, Madrid 28029, Spain.	smendez@cnic.es	Méndez-Ferrer, Simón/ABG-8547-2020; Pérez, Daniel Martín/M-4264-2018; Schwaller, Juerg/A-3044-2016; Isern, Joan/C-1250-2017; Martín Pérez, Daniel/AFW-0499-2022; Tzankov, Alexandar/H-5656-2019; Méndez-Ferrer, Simón/L-8088-2014; Arranz, Lorena/Z-3635-2019	Méndez-Ferrer, Simón/0000-0002-9805-9988; Pérez, Daniel Martín/0000-0001-6125-2955; Schwaller, Juerg/0000-0001-8616-0096; Isern, Joan/0000-0002-1401-9779; Martín Pérez, Daniel/0000-0001-6125-2955; Tzankov, Alexandar/0000-0002-1100-3819; Méndez-Ferrer, Simón/0000-0002-9805-9988; Arranz, Lorena/0000-0002-5896-4238; Muntion Olave, Sandra/0000-0001-7164-0767	Fundacion CNIC; Spanish Ministry of Economy and Competitiveness (TerCel, Spanish Cell Therapy Network) [SAF-2011-30308]; ConSEPOC-Comunidad de Madrid [S2010/BMD-2542]; Ramon y Cajal Program [RYC-2009-04703/2011-09726]; Marie Curie grants [FP7-PEOPLE-2011-RG-294262/294096]; Swiss National Science Foundation [310000-120724/1, 32003BB_135712/1]; Swiss Cancer League [KLS-02398-02-2009]; European Hematology Association; Howard Hughes Medical Institute	Fundacion CNIC; Spanish Ministry of Economy and Competitiveness (TerCel, Spanish Cell Therapy Network); ConSEPOC-Comunidad de Madrid; Ramon y Cajal Program(Spanish Government); Marie Curie grants(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; European Hematology Association; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank S. Martin-Salamanca, A. M. Martin, A. B. Ricote, J. M. Ligos, S. Bartlett and the CNIC Comparative Medicine, Genomics and Bioinformatics Units for assistance; members of S.M.-F. and B. Ibanez groups and M. Garcia-Fernandez for data discussion; G. Enikolopov, G. Fishell and D. Riethmacher for providing mice. This work was supported by Fundacion CNIC, Spanish Ministry of Economy and Competitiveness (TerCel, Spanish Cell Therapy Network; Plan Nacional SAF-2011-30308) and ConSEPOC-Comunidad de Madrid S2010/BMD-2542 grants to S.M.-F.; Ramon y Cajal Program grants RYC-2009-04703/2011-09726 and Marie Curie grants FP7-PEOPLE-2011-RG-294262/294096 to A.S.-A. and S.M.-F.; Swiss National Science Foundation 310000-120724/1, 32003BB_135712/1 and Swiss Cancer League KLS-02398-02-2009 grants to R.C.S.; A.S.-A. received a Research Fellowship from the European Hematology Association. S.M.-F. is supported in part by an International Early Career Scientist grant of the Howard Hughes Medical Institute.	Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Biernaskie JA, 2006, NAT PROTOC, V1, P2803, DOI 10.1038/nprot.2006.422; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Irichishima H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030557; Isern J, 2013, CELL REP, V3, P1714, DOI 10.1016/j.celrep.2013.03.041; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kubovcakova L, 2013, BLOOD, V121, P1188, DOI 10.1182/blood-2012-03-415646; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Pajtler Kristian, 2010, J Vis Exp, DOI 10.3791/2380; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; RAMESHWAR P, 1994, J IMMUNOL, V153, P2819; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Vannucchi AM, 2013, LEUKEMIA, V27, P1861, DOI 10.1038/leu.2013.119; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053	35	287	296	3	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					78	+		10.1038/nature13383	http://dx.doi.org/10.1038/nature13383			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043017				2022-12-01	WOS:000339908000035
J	Taipale, M; Tucker, G; Peng, J; Krykbaeva, I; Lin, ZY; Larsen, B; Choi, H; Berger, B; Gingras, AC; Lindquist, S				Taipale, Mikko; Tucker, George; Peng, Jian; Krykbaeva, Irina; Lin, Zhen-Yuan; Larsen, Brett; Choi, Hyungwon; Berger, Bonnie; Gingras, Anne-Claude; Lindquist, Susan			A Quantitative Chaperone Interaction Network Reveals the Architecture of Cellular Protein Homeostasis Pathways	CELL			English	Article							E3 UBIQUITIN LIGASE; HSP90 CO-CHAPERONE; KINASE; CANCER; EVOLUTION; COMPLEX; DOMAIN; DEGRADATION; SPECIFICITY; RECOGNITION	Chaperones are abundant cellular proteins that promote the folding and function of their substrate proteins (clients). In vivo, chaperones also associate with a large and diverse set of cofactors (cochaperones) that regulate their specificity and function. However, how these cochaperones regulate protein folding and whether they have chaperone-independent biological functions is largely unknown. We combined mass spectrometry and quantitative high-throughput LUMIER assays to systematically characterize the chaperone-cochaperone-client interaction network in human cells. We uncover hundreds of chaperone clients, delineate their participation in specific cochaperone complexes, and establish a surprisingly distinct network of protein-protein interactions for cochaperones. As a salient example of the power of such analysis, we establish that NUDC family cochaperones specifically associate with structurally related but evolutionarily distinct beta-propeller folds. We provide a framework for deciphering the proteostasis network and its regulation in development and disease and expand the use of chaperones as sensors for drug-target engagement.	[Taipale, Mikko; Krykbaeva, Irina; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02114 USA; [Tucker, George; Peng, Jian; Berger, Bonnie] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Tucker, George; Peng, Jian; Berger, Bonnie] MIT, Dept Math, Cambridge, MA 02139 USA; [Lin, Zhen-Yuan; Larsen, Brett; Gingras, Anne-Claude] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Ctr Syst Biol,Dept Mol Genet, Toronto, ON M5G 1X5, Canada; [Choi, Hyungwon] Natl Univ Singapore, Singapore 117597, Singapore; [Choi, Hyungwon] Natl Univ Hlth Syst, Singapore 117597, Singapore; [Gingras, Anne-Claude] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lindquist, Susan] Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; National University of Singapore; National University of Singapore; University of Toronto; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Gingras, AC (corresponding author), Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Ctr Syst Biol,Dept Mol Genet, Toronto, ON M5G 1X5, Canada.	gingras@lunenfeld.ca; lindquist_admin@wi.mit.edu	Gingras, Anne-Claude/ABA-8341-2020; Choi, Hyungwon/S-8824-2019; Gingras, Anne-Claude/E-9982-2010	Gingras, Anne-Claude/0000-0002-6090-4437; Choi, Hyungwon/0000-0002-6687-3088; Gingras, Anne-Claude/0000-0002-6090-4437; Krykbaeva, Irina/0000-0003-1380-7607; Taipale, Mikko/0000-0003-3811-1761; Peng, Jian/0000-0002-1736-2978	Canadian Institutes of Health Research [MOP-84314]; NIH [5R01GM94231, GM081871]; HFSP; Margaret and Herman Sokol Postdoctoral Award; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081871, R01GM094231] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HFSP(Human Frontier Science Program); Margaret and Herman Sokol Postdoctoral Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Freyzon and M. Fischer for technical help, M. Shair for OSW-1, and A. Nesvizhskii and members of S. L. and A.-C.G.'s labs for comments and suggestions. We are grateful to M. Vidal and D. Hill for providing the human ORFeome. The website http://prohits-web.lunenfeld.ca is designed and maintained by J. Zhang and G. Liu. This work was supported by the Canadian Institutes of Health Research (MOP-84314 to A.-C.G.) and the NIH (5R01GM94231 to A.-C.G. and GM081871 to B.B.). M.T. was supported by the HFSP and a Margaret and Herman Sokol Postdoctoral Award. A.-C.G. holds the Canada Chair in Functional Proteomics and the Lea Reichmann Chair in Cancer Proteomics. S.L. is an investigator of the Howard Hughes Medical Institute.	Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Briknarova K, 2002, J BIOL CHEM, V277, P31172, DOI 10.1074/jbc.M202792200; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Chadli A, 2008, J BIOL CHEM, V283, P9509, DOI 10.1074/jbc.C800017200; Chaudhuri I, 2008, PROTEINS, V71, P795, DOI 10.1002/prot.21764; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; Echtenkamp FJ, 2012, BBA-MOL CELL RES, V1823, P668, DOI 10.1016/j.bbamcr.2011.08.011; Echtenkamp FJ, 2011, MOL CELL, V43, P229, DOI 10.1016/j.molcel.2011.05.029; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Fuchs M, 2010, BIOCHEM J, V425, P245, DOI 10.1042/BJ20090907; Gano JJ, 2010, MOL CELL PROTEOMICS, V9, P255, DOI 10.1074/mcp.M900261-MCP200; Hudson Andrew M., 2008, V48, P6, DOI 10.1007/978-0-387-09595-0_2; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Jagannathan M, 2012, J CELL SCI, V125, P133, DOI 10.1242/jcs.089938; Jarosz DF, 2010, ANNU REV GENET, V44, P189, DOI 10.1146/annurev.genet.40.110405.090412; Kadota Y, 2010, TRENDS BIOCHEM SCI, V35, P199, DOI 10.1016/j.tibs.2009.12.005; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kean MJ, 2012, METHODS, V57, P400, DOI 10.1016/j.ymeth.2012.06.002; Kundrat L, 2010, BIOCHEMISTRY-US, V49, P7428, DOI 10.1021/bi100386w; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lukov GL, 2006, J BIOL CHEM, V281, P22261, DOI 10.1074/jbc.M601590200; Lundin VF, 2010, TRENDS BIOCHEM SCI, V35, P288, DOI 10.1016/j.tibs.2009.12.007; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Powers ET, 2013, NAT REV MOL CELL BIO, V14, P237, DOI 10.1038/nrm3542; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Scholz GM, 2001, J BIOL CHEM, V276, P30971, DOI 10.1074/jbc.M103889200; Schuyler SC, 2012, J CELL SCI, V125, P4197, DOI 10.1242/jcs.107037; Shao JY, 2003, BIOCHEMISTRY-US, V42, P12577, DOI 10.1021/bi035138j; Taipale M, 2013, NAT BIOTECHNOL, V31, P630, DOI 10.1038/nbt.2620; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Teo GC, 2014, J PROTEOMICS, V100, P37, DOI 10.1016/j.jprot.2013.10.023; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsukahara F, 2010, BLOOD, V116, P3582, DOI 10.1182/blood-2009-10-249623; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Ying WW, 2012, MOL CANCER THER, V11, P475, DOI 10.1158/1535-7163.MCT-11-0755; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zheng MY, 2011, J MOL BIOL, V409, P722, DOI 10.1016/j.jmb.2011.04.018	50	253	253	0	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					434	448		10.1016/j.cell.2014.05.039	http://dx.doi.org/10.1016/j.cell.2014.05.039			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036637	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000340943600021
J	Law, KL; Thompson, RC				Law, Kara Lavender; Thompson, Richard C.			Microplastics in the seas	SCIENCE			English	Editorial Material							MARINE DEBRIS; ACCUMULATION; POLLUTANTS; CHEMICALS; WORMS		[Law, Kara Lavender] Sea Educ Assoc, Dept Oceanog, Woods Hole, MA 02543 USA; [Thompson, Richard C.] Univ Plymouth, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England	University of Plymouth	Law, KL (corresponding author), Sea Educ Assoc, Dept Oceanog, Woods Hole, MA 02543 USA.	klavender@sea.edu	Thompson, Richard C/J-8879-2014	Thompson, Richard/0000-0003-2262-6621; Law, Kara/0000-0002-5298-6751	Division Of Ocean Sciences [1260403] Funding Source: National Science Foundation	Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Bakir A, 2014, ENVIRON POLLUT, V185, P16, DOI 10.1016/j.envpol.2013.10.007; Browne MA, 2008, ENVIRON SCI TECHNOL, V42, P5026, DOI 10.1021/es800249a; Browne MA, 2013, CURR BIOL, V23, P2388, DOI 10.1016/j.cub.2013.10.012; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s; Collignon A, 2012, MAR POLLUT BULL, V64, P861, DOI 10.1016/j.marpolbul.2012.01.011; Law KL, 2014, ENVIRON SCI TECHNOL, V48, P4732, DOI 10.1021/es4053076; Law KL, 2010, SCIENCE, V329, P1185, DOI 10.1126/science.1192321; Maximenko N, 2012, MAR POLLUT BULL, V65, P51, DOI 10.1016/j.marpolbul.2011.04.016; Obbard R. W., 2014, EARTHS FUTURE; Ogata Y, 2009, MAR POLLUT BULL, V58, P1437, DOI 10.1016/j.marpolbul.2009.06.014; Rochman CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03263; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Wright SL, 2013, CURR BIOL, V23, pR1031, DOI 10.1016/j.cub.2013.10.068; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	15	680	761	80	906	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					144	145		10.1126/science.1254065	http://dx.doi.org/10.1126/science.1254065			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013051				2022-12-01	WOS:000339409900026
J	Naganuma, M; Sekine, S; Chong, YE; Guo, M; Yang, XL; Gamper, H; Hou, YM; Schimmel, P; Yokoyama, S				Naganuma, Masahiro; Sekine, Shun-ichi; Chong, Yeeting Esther; Guo, Min; Yang, Xiang-Lei; Gamper, Howard; Hou, Ya-Ming; Schimmel, Paul; Yokoyama, Shigeyuki			The selective tRNA aminoacylation mechanism based on a single G center dot U pair	NATURE			English	Article							CRYSTAL-STRUCTURE; ACCEPTOR-STEM; MAJOR DETERMINANT; SYNTHETASE; RECOGNITION; IDENTITY; TRNA(ALA); SEQUENCE; CRYSTALLOGRAPHY; SPECIFICITY	Ligation of tRNAs with their cognate amino acids, by aminoacyl-tRNA synthetases, establishes the genetic code. Throughout evolution, tRNA(Ala) selection by alanyl-tRNAsynthetase (AlaRS) has depended predominantly on a single wobble base pair in the acceptor stem, G3 center dot U70, mainly on the k(cat) level. Here we report the crystal structures of an archaeal AlaRS in complex with tRNAAla with G3 center dot U70 and its A3 center dot U70 variant. AlaRS interacts with both the minor-and the major-groove sides of G3 center dot U70, widening the major groove. The geometry difference between G3 center dot U70 and A3 center dot U70 is transmitted along the acceptor stemto the 3'-CCA region. Thus, the 3'-CCA region of tRNA(Ala) with G3 center dot U70 is oriented to the reactive route that reaches the active site, whereas that of the A3 center dot U70 variant is folded back into the non-reactive route. This novel mechanism enables the single wobble pair to dominantly determine the specificity of tRNA selection, by an approximate 100-fold difference in k(cat) .	[Naganuma, Masahiro; Sekine, Shun-ichi; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Naganuma, Masahiro; Sekine, Shun-ichi; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem & Lab Struct Biol, Bunkyo Ku, Tokyo 1130033, Japan; [Naganuma, Masahiro; Yokoyama, Shigeyuki] RIKEN Struct Biol Lab, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Sekine, Shun-ichi] RIKEN Ctr Life Sci Technol, Div Struct & Synthet Biol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Chong, Yeeting Esther; Guo, Min; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Chong, Yeeting Esther; Guo, Min; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Gamper, Howard; Hou, Ya-Ming] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Schimmel, Paul] Scripps Florida Res Inst, Jupiter, FL 33458 USA	RIKEN; University of Tokyo; RIKEN; RIKEN; Scripps Research Institute; Scripps Research Institute; Jefferson University; State University System of Florida; University of Florida	Yokoyama, S (corresponding author), RIKEN Syst & Struct Biol Ctr, Tsurumi Ku, 1-7-22 Suehiro cho, Yokohama, Kanagawa 2300045, Japan.	yokoyama@riken.jp	Yokoyama, Shigeyuki/N-6911-2015; Sekine, Shun-ichi/N-5450-2015; Yang, Xiang-Lei/AAR-7107-2020; Chong, Yeeting/AAE-3792-2020	Yokoyama, Shigeyuki/0000-0003-3133-7338; Sekine, Shun-ichi/0000-0001-8174-8704; Yang, Xiang-Lei/0000-0003-2554-084X; Hou, Ya-Ming/0000-0001-6546-2597	Targeted Proteins Research Program; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science [20247008]; MEXT; Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT; National Institutes of Health [GM015539, GM023562, NS085092]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023562, R01GM100136, R37GM015539, R01GM015539, R01GM108972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085092] Funding Source: NIH RePORTER	Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the staff of the beam line AR-NW12A at the Photon Factory and the beam lines BL32XU and BL41XU at SPring-8 for their assistance during data collection. This work was supported by the Targeted Proteins Research Program, and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. This work was also supported by a Grant-in-Aid for Scientific Research (No. 20247008) from the Japan Society for the Promotion of Science and MEXT, and the Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT. Research support was also provided by National Institutes of Health grants GM015539 and GM023562 to P.S. and NS085092 to X.-L.Y.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beuning PJ, 1999, BIOPOLYMERS, V52, P1; Beuning PJ, 2002, RNA, V8, P659, DOI 10.1017/S1355838202020277; Beuning PJ, 1997, J AM CHEM SOC, V119, P8397, DOI 10.1021/ja971020c; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chang KY, 1999, P NATL ACAD SCI USA, V96, P11764, DOI 10.1073/pnas.96.21.11764; CUSACK S, 1995, NAT STRUCT BIOL, V2, P824, DOI 10.1038/nsb1095-824; DEDUVE C, 1988, NATURE, V333, P117, DOI 10.1038/333117a0; Dignam JD, 2011, BIOCHEMISTRY-US, V50, P9886, DOI 10.1021/bi2012004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FRANCKLYN C, 1989, NATURE, V337, P478, DOI 10.1038/337478a0; FRANCKLYN C, 1992, SCIENCE, V255, P1121, DOI 10.1126/science.1546312; Fukunaga R, 2007, NAT STRUCT MOL BIOL, V14, P272, DOI 10.1038/nsmb1219; Fukunaga R, 2007, ACTA CRYSTALLOGR F, V63, P224, DOI 10.1107/S1744309107006264; Gabriel K, 1996, SCIENCE, V271, P195, DOI 10.1126/science.271.5246.195; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612; Guo M, 2009, SCIENCE, V325, P744, DOI 10.1126/science.1174343; Guth E, 2005, BIOCHEMISTRY-US, V44, P3785, DOI 10.1021/bi047923h; HOU YM, 1989, BIOCHEMISTRY-US, V28, P6800, DOI 10.1021/bi00443a003; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; JASIN M, 1983, NATURE, V306, P441, DOI 10.1038/306441a0; KIM SH, 1974, SCIENCE, V185, P435, DOI 10.1126/science.185.4149.435; MCCLAIN WH, 1988, SCIENCE, V242, P1681, DOI 10.1126/science.2462282; MCCLAIN WH, 1988, SCIENCE, V240, P793, DOI 10.1126/science.2452483; McClain WH, 1999, J MOL BIOL, V290, P391, DOI 10.1006/jmbi.1999.2884; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER WT, 1991, BIOCHEMISTRY-US, V30, P2635, DOI 10.1021/bi00224a011; Mueller U, 1999, RNA, V5, P670, DOI 10.1017/S1355838299982304; MUSIERFORSYTH K, 1992, NATURE, V357, P513, DOI 10.1038/357513a0; MUSIERFORSYTH K, 1991, SCIENCE, V253, P784, DOI 10.1126/science.1876835; Naganuma M, 2009, P NATL ACAD SCI USA, V106, P8489, DOI 10.1073/pnas.0901572106; Nakagawa H, 2013, PROTEINS, V81, P1232, DOI 10.1002/prot.24273; Nozawa K, 2009, NATURE, V457, P1163, DOI 10.1038/nature07611; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARK SJ, 1989, BIOCHEMISTRY-US, V28, P2740, DOI 10.1021/bi00432a056; PUTZ J, 1993, EMBO J, V12, P2949, DOI 10.1002/j.1460-2075.1993.tb05957.x; Ramos A, 1997, NUCLEIC ACIDS RES, V25, P2083, DOI 10.1093/nar/25.11.2083; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; ROGERS MJ, 1994, P NATL ACAD SCI USA, V91, P291, DOI 10.1073/pnas.91.1.291; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Sekine S, 2003, EMBO J, V22, P676, DOI 10.1093/emboj/cdg053; SHI JP, 1990, BIOCHEMISTRY-US, V29, P3621, DOI 10.1021/bi00467a005; Sokabe M, 2009, P NATL ACAD SCI USA, V106, P11028, DOI 10.1073/pnas.0904645106; Swairjo MA, 2004, MOL CELL, V13, P829, DOI 10.1016/S1097-2765(04)00126-1; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; UEDA H, 1991, BIOCHIM BIOPHYS ACTA, V1080, P126, DOI 10.1016/0167-4838(91)90138-P; Uter NT, 2004, P NATL ACAD SCI USA, V101, P14396, DOI 10.1073/pnas.0404017101; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; WEYGANDDURASEVIC I, 1994, J MOL BIOL, V240, P111, DOI 10.1006/jmbi.1994.1425; Yamashita S, 2011, PROTEIN SCI, V20, P118, DOI 10.1002/pro.543; Yaremchuk A, 2001, J MOL BIOL, V309, P989, DOI 10.1006/jmbi.2001.4712; Zhang CM, 2006, J MOL BIOL, V361, P300, DOI 10.1016/j.jmb.2006.06.015	61	57	60	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					507	511		10.1038/nature13440	http://dx.doi.org/10.1038/nature13440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24919148	Green Accepted			2022-12-01	WOS:000337806300040
J	Arie, S				Arie, Sophie			Would today's international agreements prevent another outbreak like SARS?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarie@bmj.com						[Anonymous], 2014, LANCET RESP MED, V2, P436; [Anonymous], 2014, NEWSWEEK; Heymann DL, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1499; MacKenzie D., 2014, NEW SCI; McCarthy M, 2014, BMJ-BRIT MED J, V348, pg1589; Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004; Sridhar D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3841; WHO, 2020, MIDDL E RESP SYNDR C; World Bank, PEOPL PATH OUR PLAN, V2; World Health Organization (WHO), AL RESP CAP BUILD IN	10	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2014	348								g4123	10.1136/bmj.g4123	http://dx.doi.org/10.1136/bmj.g4123			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK1UE	24957245				2022-12-01	WOS:000338201400010
J	Yang, G; Lai, CSW; Cichon, J; Ma, L; Li, W; Gan, WB				Yang, Guang; Lai, Cora Sau Wan; Cichon, Joseph; Ma, Lei; Li, Wei; Gan, Wen-Biao			Sleep promotes branch-specific formation of dendritic spines after learning	SCIENCE			English	Article							SYNAPTIC HOMEOSTASIS; PLASTICITY; NEURONS; REPLAY; OSCILLATIONS; HIPPOCAMPUS; CORTEX; STATE	How sleep helps learning and memory remains unknown. We report in mouse motor cortex that sleep after motor learning promotes the formation of postsynaptic dendritic spines on a subset of branches of individual layer V pyramidal neurons. New spines are formed on different sets of dendritic branches in response to different learning tasks and are protected from being eliminated when multiple tasks are learned. Neurons activated during learning of a motor task are reactivated during subsequent non-rapid eye movement sleep, and disrupting this neuronal reactivation prevents branch-specific spine formation. These findings indicate that sleep has a key role in promoting learning-dependent synapse formation and maintenance on selected dendritic branches, which contribute to memory storage.	[Yang, Guang; Lai, Cora Sau Wan; Cichon, Joseph; Ma, Lei; Gan, Wen-Biao] NYU, Sch Med, Dept Neurosci & Physiol, Skirball Inst, New York, NY 10016 USA; [Yang, Guang] NYU, Sch Med, Dept Anesthesiol, New York, NY 10016 USA; [Ma, Lei; Li, Wei] Peking Univ, Shenzhen Grad Sch, Key Lab Chem Genom, Drug Discovery Ctr, Shenzhen 518055, Peoples R China	New York University; New York University; Peking University; University Town of Shenzhen	Gan, WB (corresponding author), NYU, Sch Med, Dept Neurosci & Physiol, Skirball Inst, New York, NY 10016 USA.	gan@saturn.med.nyu.edu	, 0000-0002-5721-4259/K-3037-2019; ma, Lei/GOV-5903-2022	, 0000-0002-5721-4259/0000-0002-5721-4259; Yang, Guang/0000-0002-5739-9126	NIH [R01 NS047325, P01 NS074972]; Whitehall Foundation research grant; American Federation for Aging Research grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074972, R01NS047325] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation research grant; American Federation for Aging Research grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all the members in the Gan laboratory and T. Franke for comments on the manuscript. This work was supported by NIH R01 NS047325 and P01 NS074972 to W.-B.G. and by a Whitehall Foundation research grant and an American Federation for Aging Research grant to G.Y.	Aton SJ, 2009, NEURON, V61, P454, DOI 10.1016/j.neuron.2009.01.007; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Benington JH, 2003, PROG NEUROBIOL, V69, P71, DOI 10.1016/S0301-0082(03)00018-2; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Born J, 2012, NEURON, V75, P933, DOI 10.1016/j.neuron.2012.09.007; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Campbell IG, 1996, J NEUROPHYSIOL, V76, P3714, DOI 10.1152/jn.1996.76.6.3714; Chauvette S, 2012, NEURON, V75, P1105, DOI 10.1016/j.neuron.2012.08.034; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cirelli C, 1999, ANN MED, V31, P117, DOI 10.3109/07853899908998787; Crunelli V, 2010, NAT NEUROSCI, V13, P10, DOI 10.1038/nn.2445; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Frank MG, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/264378; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Jouvet-Mounier D, 1970, Dev Psychobiol, V2, P216; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Liston C, 2013, NAT NEUROSCI, V16, P698, DOI 10.1038/nn.3387; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Maret S, 2011, NAT NEUROSCI, V14, P1418, DOI 10.1038/nn.2934; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; ROFFWARG HP, 1966, SCIENCE, V152, P604, DOI 10.1126/science.152.3722.604; Seibt J, 2012, CURR BIOL, V22, P676, DOI 10.1016/j.cub.2012.02.016; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Timofeev I, 2011, PROG BRAIN RES, V193, P121, DOI 10.1016/B978-0-444-53839-0.00009-0; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Wang G, 2011, TRENDS NEUROSCI, V34, P452, DOI 10.1016/j.tins.2011.07.005; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Yang Guang, 2013, Methods Mol Biol, V1010, P35, DOI 10.1007/978-1-62703-411-1_3; Yang G, 2012, DEV NEUROBIOL, V72, P1391, DOI 10.1002/dneu.20996; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Zelenin PV, 2011, J NEUROPHYSIOL, V105, P2698, DOI 10.1152/jn.00120.2011	40	354	366	5	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1173	1178		10.1126/science.1249098	http://dx.doi.org/10.1126/science.1249098			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904169	Green Accepted			2022-12-01	WOS:000336791200051
J	Beura, LK; Masopust, D				Beura, Lalit K.; Masopust, David			SnapShot: Resident Memory T Cells	CELL			English	Editorial Material							CUTTING EDGE; TISSUE; INFECTION; DIFFERENTIATION; PROTECTION; IMMUNITY; VIRUS; SKIN		[Beura, Lalit K.; Masopust, David] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Beura, Lalit K.; Masopust, David] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Beura, LK (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.		masopust, david/B-5027-2008; Beura, Lalit/W-6281-2019					Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Lee YT, 2011, J VIROL, V85, P4085, DOI 10.1128/JVI.02493-10; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243	10	23	24	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1488	+	1488.e1	10.1016/j.cell.2014.05.026	http://dx.doi.org/10.1016/j.cell.2014.05.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906159	Bronze			2022-12-01	WOS:000340881400022
J	Pezzella, F; Harris, AL				Pezzella, Francesco; Harris, Adrian L.			When Cancer Co-opts the Vasculature	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							METASTASIS		[Pezzella, Francesco] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford OX3 9DU, England; [Harris, Adrian L.] Univ Oxford, Mol Oncol Labs, Dept Med Oncol, Weatherall Inst Mol Med, Oxford, England	University of Oxford; University of Oxford	Pezzella, F (corresponding author), Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford OX3 9DU, England.		Harris, Adrian L/ABA-3343-2020	Harris, Adrian L/0000-0003-1376-8409	National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish; Cancer Research UK [11359] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK)		Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302; Hu JT, 2005, ONCOGENE, V24, P1212, DOI 10.1038/sj.onc.1208242; Pezzella F, 1997, AM J PATHOL, V151, P1417; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Van den Eynden GG, 2013, CANCER RES, V73, P2031, DOI 10.1158/0008-5472.CAN-12-3931	5	5	5	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					2146	2147		10.1056/NEJMcibr1402407	http://dx.doi.org/10.1056/NEJMcibr1402407			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH9BM	24869725				2022-12-01	WOS:000336434000015
J	Wiener, RS				Wiener, Renda Soylemez			Balancing the Benefits and Harms of Low-Dose Computed Tomography Screening for Lung Cancer: Medicare's Options for Coverage	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MORTALITY; NODULE; RISK		Boston Univ, Sch Med, Boston, MA 02118 USA; Edith Nourse Rogers Mem Vet Hosp, Bedford, MA USA	Boston University	Wiener, RS (corresponding author), Boston Univ, Sch Med, Ctr Pulm, 72 East Concord St,R-304, Boston, MA 02118 USA.	rwiener@bu.edu	Wiener, Renda/AAO-1557-2020	Wiener, Renda/0000-0001-7712-2135	NATIONAL CANCER INSTITUTE [K07CA138772] Funding Source: NIH RePORTER; NCI NIH HHS [K07 CA138772] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Arenberg D, 2012, J NATL COMPR CANC NE, V10, P277, DOI 10.6004/jnccn.2012.0024; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Kozower BD, 2010, ANN THORAC SURG, V90, P875, DOI 10.1016/j.athoracsur.2010.03.115; Mazzone P, 2012, CLEV CLIN J MED, V79, P337, DOI 10.3949/ccjm.79a.12018; Mckee BJ, 2013, J AM COLL RADIOL, V10, P586, DOI 10.1016/j.jacr.2013.02.015; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Pinsky PF, 2013, RADIOLOGY, V268, P865, DOI 10.1148/radiol.13121530; Roth JA, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.7_suppl.77; Wiener RS, 2011, ANN INTERN MED, V155, P137, DOI 10.7326/0003-4819-155-3-201108020-00003	10	13	13	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6					445	U107		10.7326/M14-1352	http://dx.doi.org/10.7326/M14-1352			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	24957566				2022-12-01	WOS:000343894400021
J	Gonzalez-Munoz, E; Arboleda-Estudillo, Y; Otu, HH; Cibelli, JB				Gonzalez-Munoz, Elena; Arboleda-Estudillo, Yohanna; Otu, Hasan H.; Cibelli, Jose B.			Histone chaperone ASF1A is required for maintenance of pluripotency and cellular reprogramming	SCIENCE			English	Article							ACETYLATION; H3; OOCYTES	Unfertilized oocytes have the intrinsic capacity to remodel sperm and the nuclei of somatic cells. The discoveries that cells can change their phenotype from differentiated to embryonic state using oocytes or specific transcription factors have been recognized as two major breakthroughs in the biomedical field. Here, we show that ASF1A, a histone-remodeling chaperone specifically enriched in the metaphase II human oocyte, is necessary for reprogramming of human adult dermal fibroblasts (hADFs) into undifferentiated induced pluripotent stem cell. We also show that overexpression of just ASF1A and OCT4 in hADFs exposed to the oocyte-specific paracrine growth factor GDF9 can reprogram hADFs into pluripotent cells. Our Report underscores the importance of studying the unfertilized MII oocyte as a means to understand the molecular pathways governing somatic cell reprogramming.	[Gonzalez-Munoz, Elena; Arboleda-Estudillo, Yohanna; Cibelli, Jose B.] Ctr Andaluz Nanomed & Biotecnol Andalucia, BIONAND, LARCEL, Lab Andaluz Reprogramac Celular, Seville 29590, Spain; [Otu, Hasan H.] Istanbul Bilgi Univ, Dept Genet & Bioengn, TR-34060 Istanbul, Turkey; [Otu, Hasan H.] Univ Nebraska, Dept Elect Engn, Lincoln, NE 68588 USA; [Cibelli, Jose B.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Cibelli, Jose B.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	Istanbul Bilgi University; University of Nebraska System; University of Nebraska Lincoln; Michigan State University; Michigan State University	Cibelli, JB (corresponding author), Ctr Andaluz Nanomed & Biotecnol Andalucia, BIONAND, LARCEL, Lab Andaluz Reprogramac Celular, Seville 29590, Spain.	cibelli@msu.edu	Gonzalez-Munoz, Elena/AAY-4658-2020	Gonzalez-Munoz, Elena/0000-0001-8291-1518; Otu, Hasan/0000-0002-9253-8152; Cibelli, Jose/0000-0002-2176-3854	Fundacion Progreso y Salud, Sevilla, Andalucia, Spain; Michigan State University AgBioResearch, East Lansing, Michigan, USA; Naylor Family Foundation, York, Pennsylvania, USA	Fundacion Progreso y Salud, Sevilla, Andalucia, Spain; Michigan State University AgBioResearch, East Lansing, Michigan, USA; Naylor Family Foundation, York, Pennsylvania, USA	We thank members of LARCEL laboratory for comments and support, A. Wittgreen and N. Lopez Corrales for intellectual input and discussion, and Biobanco del Sistema Sanitario Publico de Andalucia for karyotyping and teratoma assay service. This work was supported by Fundacion Progreso y Salud, Sevilla, Andalucia, Spain; Michigan State University AgBioResearch, East Lansing, Michigan, USA; and the Naylor Family Foundation, York, Pennsylvania, USA. The Gene Expression Omnibus (GEO) accession number for the oocyte transcriptome is GSE12034. E. G.-M. and J.B.C. are listed as inventors on a patent application filed by Fundacion Progreso y Salud, Sevilla, Andalucia, Spain, and Michigan State University, East Lansing, Michigan, USA.	Assou S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-10; Awe JP, 2013, CELL REPROGRAM, V15, P126, DOI 10.1089/cell.2012.0060; Battu A, 2011, NUCLEIC ACIDS RES, V39, P7931, DOI 10.1093/nar/gkr523; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; GURDON JB, 1967, SCI PROG, V55, P259; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Houlard M, 2006, PLOS GENET, V2, P1686, DOI 10.1371/journal.pgen.0020181; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Miyamoto K, 2013, SCIENCE, V341, P1002, DOI 10.1126/science.1240376; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Mousson F, 2007, CHROMOSOMA, V116, P79, DOI 10.1007/s00412-006-0087-z; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan YL, 2013, P NATL ACAD SCI USA, V110, P11493, DOI 10.1073/pnas.1309914110; Wakayama S, 2006, STEM CELLS, V24, P2023, DOI 10.1634/stemcells.2005-0537; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620	20	53	56	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					822	825		10.1126/science.1254745	http://dx.doi.org/10.1126/science.1254745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25035411				2022-12-01	WOS:000340593100047
J	Xue, MS; Atallah, BV; Scanziani, M				Xue, Mingshan; Atallah, Bassam V.; Scanziani, Massimo			Equalizing excitation-inhibition ratios across visual cortical neurons	NATURE			English	Article							RECTIFYING POTASSIUM CHANNELS; IN-VIVO ELECTROPORATION; NETWORK ACTIVITY; GENE-TRANSFER; CORTEX; MOUSE; CHANNELRHODOPSIN-2; CONNECTIVITY; INTERNEURONS; MODULATION	The relationship between synaptic excitation and inhibition (E/I ratio), two opposing forces in the mammalian cerebral cortex, affects many cortical functions such as feature selectivity and gain(1,2). Individual pyramidal cells show stable E/I ratios in time despite fluctuating cortical activity levels. This is because when excitation increases, inhibition increases proportionally through the increased recruitment of inhibitory neurons, a phenomenon referred to as excitation-inhibition balance(3-9). However, little is known about the distribution of E/I ratios across pyramidal cells. Through their highly divergent axons, inhibitory neurons indiscriminately contact most neighbouring pyramidal cells(10,11). Is inhibition homogeneously distributed(12) or is it individually matched to the different amounts of excitation received by distinct pyramidal cells? Here we discover that pyramidal cells in layer 2/3 of mouse primary visual cortex each receive inhibition in a similar proportion to their excitation. As a consequence, E/I ratios are equalized across pyramidal cells. This matched inhibition is mediated by parvalbumin-expressing but not somatostatin-expressing inhibitory cells and results from the independent adjustment of synapses originating from individual parvalbumin-expressing cells targeting different pyramidal cells. Furthermore, this match is activity-dependent as it is disrupted by perturbing pyramidal cell activity. Thus, the equalization of E/I ratios across pyramidal cells reveals an unexpected degree of order in the spatial distribution of synaptic strengths and indicates that the relationship between the cortex's two opposing forces is stabilized not only in time but also in space.	[Xue, Mingshan; Scanziani, Massimo] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Xue, Mingshan; Scanziani, Massimo] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Atallah, Bassam V.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, P-1400038 Lisbon, Portugal; [Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Fundacao Champalimaud; Howard Hughes Medical Institute; University of California System; University of California San Diego	Xue, MS (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	mingshanxue@gmail.com; massimo@ucsd.edu		Atallah, Bassam/0000-0003-2315-7126; Xue, Mingshan/0000-0003-1463-8884	Jane Coffin Childs Memorial Fund for Medical Research; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund for Medical Research; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Chan, J. Evora, A. Linder and P. Abelkop for technical assistance; M. S. Caudill and S. R. Olsen for help with the in vivo physiology recording programme; E. Kim and A. Ghosh for pCAG-Kir2.1-T2A-tdTomato plasmid; J. Isaacson and H. Y. Zoghbi for comments on earlier versions of the manuscript; D. N. Hill, G. I. Allen, E. Arias-Castro and M. Wang for advice on statistical analysis; the members of the Scanziani and Isaacson laboratories for suggestions; and the University of California, San Diego Neuroscience Microscopy Facility (P30 N5047101) for imaging equipment. M.X. was supported by a fellowship from Jane Coffin Childs Memorial Fund for Medical Research. M.S. is an investigator of the Howard Hughes Medical Institute. This work was also supported by the Gatsby Charitable Foundation.	Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Benedetti BL, 2013, CEREB CORTEX, V23, P2690, DOI 10.1093/cercor/bhs257; Bloodgood BL, 2013, NATURE, V503, P121, DOI 10.1038/nature12743; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/cne.20256; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Kranz A, 2010, GENESIS, V48, P512, DOI 10.1002/dvg.20641; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Manent JB, 2009, NAT MED, V15, P84, DOI 10.1038/nm.1897; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Peng YR, 2010, J NEUROSCI, V30, P16220, DOI 10.1523/JNEUROSCI.3085-10.2010; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Sim SY, 2013, J NEUROSCI, V33, P7928, DOI 10.1523/JNEUROSCI.1571-12.2013; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; Tong YH, 2001, J GEN PHYSIOL, V117, P103, DOI 10.1085/jgp.117.2.103; Turan S, 2010, J MOL BIOL, V402, P52, DOI 10.1016/j.jmb.2010.07.015; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Vogels TP, 2009, NAT NEUROSCI, V12, P483, DOI 10.1038/nn.2276; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2004, J NEUROSCI, V24, P3985, DOI 10.1523/JNEUROSCI.5782-03.2004; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699	50	383	385	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					596	+		10.1038/nature13321	http://dx.doi.org/10.1038/nature13321			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043046	Green Accepted			2022-12-01	WOS:000339566300036
J	Zhou, W; Yuan, JY				Zhou, Wen; Yuan, Junying			SnapShot: Necroptosis	CELL			English	Editorial Material									[Zhou, Wen; Yuan, Junying] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Zhou, W (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.							Christofferson DE, 2014, ANNU REV PHYSIOL, V76, P129, DOI 10.1146/annurev-physiol-021113-170259; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Zhou ZR, 2012, PROTEIN CELL, V3, P811, DOI 10.1007/s13238-012-2083-9	3	48	51	1	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					464	U262		10.1016/j.cell.2014.06.041	http://dx.doi.org/10.1016/j.cell.2014.06.041			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036639	Bronze			2022-12-01	WOS:000340943600025
J	Soroldoni, D; Jorg, DJ; Morelli, LG; Richmond, DL; Schindelin, J; Julicher, F; Oates, AC				Soroldoni, Daniele; Joerg, David J.; Morelli, Luis G.; Richmond, David L.; Schindelin, Johannes; Juelicher, Frank; Oates, Andrew C.			A Doppler effect in embryonic pattern formation	SCIENCE			English	Article							SEGMENTATION CLOCK; VERTEBRATE SEGMENTATION; DYNAMICS; SOMITOGENESIS	During embryonic development, temporal and spatial cues are coordinated to generate a segmented body axis. In sequentially segmenting animals, the rhythm of segmentation is reported to be controlled by the time scale of genetic oscillations that periodically trigger new segment formation. However, we present real-time measurements of genetic oscillations in zebrafish embryos showing that their time scale is not sufficient to explain the temporal period of segmentation. A second time scale, the rate of tissue shortening, contributes to the period of segmentation through a Doppler effect. This contribution is modulated by a gradual change in the oscillation profile across the tissue. We conclude that the rhythm of segmentation is an emergent property controlled by the time scale of genetic oscillations, the change of oscillation profile, and tissue shortening.	[Soroldoni, Daniele; Morelli, Luis G.; Richmond, David L.; Schindelin, Johannes; Oates, Andrew C.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Soroldoni, Daniele; Oates, Andrew C.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Soroldoni, Daniele; Oates, Andrew C.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Joerg, David J.; Juelicher, Frank] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Morelli, Luis G.] Univ Buenos Aires, Dept Fis, Fac Ciencias Exactas & Nat, RA-1428 Buenos Aires, DF, Argentina; [Morelli, Luis G.] Consejo Nacl Invest Cient & Tecn, Inst Fis Buenos Aires, RA-1428 Buenos Aires, DF, Argentina; [Schindelin, Johannes] Univ Wisconsin, Lab Opt & Computat Instrumentat, Madison, WI 53706 USA	Max Planck Society; MRC National Institute for Medical Research; University of London; University College London; Max Planck Society; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Wisconsin System; University of Wisconsin Madison	Oates, AC (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	aoates@nimr.mrc.ac.uk	Zebrafish, UCL/A-3125-2009; Jörg, David/I-3905-2012; Julicher, Frank/B-1828-2009; Morelli, Luis G/A-6345-2009	Jörg, David/0000-0001-5960-0260; Julicher, Frank/0000-0003-4731-9185; Morelli, Luis G/0000-0001-5614-073X; Oates, Andrew/0000-0002-3015-3978	Max Planck Society; Medical Research Council [MC_UP_1202/3]; European Research Council (ERC) under European Communities 7th Framework Programme [207634]; European Molecular Biology Organization fellowship [ALTF1402-2011]; Wellcome Trust [WT098025MA]; MRC [MC_UP_1202/3] Funding Source: UKRI	Max Planck Society(Max Planck SocietyFoundation CELLEX); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council (ERC) under European Communities 7th Framework Programme(European Research Council (ERC)); European Molecular Biology Organization fellowship(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank L. Wetzel, L. Rohde, C. Poulet, C. Eugster, M. Gonzales-Gaitan, and J. Firmino, for comments on the manuscript; D. Hasselhoff for mental support; and the fish and light microscopy facilities of the Max Planck Institute of Molecular Cell Biology and Genetics. This work was supported by the Max Planck Society and the Medical Research Council (MC_UP_1202/3); D. S., L. G. M., and A.C.O. by the European Research Council (ERC) under the European Communities 7th Framework Programme (FP7/2007-2013)/(ERC grant 207634); D. L. R. by a European Molecular Biology Organization fellowship [ALTF1402-2011]; and A.C.O. and D. S. by the Wellcome Trust (WT098025MA). The original time-lapse recordings in this study are available for anonymous download via the Web site www.nimr.mrc.ac.uk/supplementary/oaties. The ROI and LOI are available as plugins via the Fiji website www.fiji.sc/Fiji. D. S., D. J. J., L. G. M., and A.C.O. designed experiments; D. S. performed experiments; J. S. developed analysis tools; D. S., D. J. J., L. G. M., F. J., and A.C.O. analyzed data; D. S., D. J. J., D. L. R., L. G. M., F. J., and A.C.O. developed the concepts and wrote the paper.	Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Benazeraf B, 2013, ANNU REV CELL DEV BI, V29, P1, DOI 10.1146/annurev-cellbio-101011-155703; Delaune EA, 2012, DEV CELL, V23, P995, DOI 10.1016/j.devcel.2012.09.009; Giudicelli F, 2007, PLOS BIOL, V5, P1309, DOI 10.1371/journal.pbio.0050150; Lauschke VM, 2013, NATURE, V493, P101, DOI 10.1038/nature11804; Mara A, 2007, NAT CELL BIOL, V9, P523, DOI 10.1038/ncb1578; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Morelli LG, 2009, HFSP J, V3, P55, DOI 10.2976/1.3027088; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Sarrazin AF, 2012, SCIENCE, V336, P338, DOI 10.1126/science.1218256; Schroter C, 2008, DEV DYNAM, V237, P545, DOI 10.1002/dvdy.21458; Soroldoni D, 2011, CURR OPIN GENET DEV, V21, P600, DOI 10.1016/j.gde.2011.09.006	13	75	75	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					222	225		10.1126/science.1253089	http://dx.doi.org/10.1126/science.1253089			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013078	Green Accepted			2022-12-01	WOS:000339409900056
J	Tian, XY; Hu, TY; Zhang, H; He, LJ; Huang, XZ; Liu, QZ; Yu, W; He, L; Yang, Z; Yan, Y; Yang, X; Zhong, TP; Pu, WT; Zhou, B				Tian, Xueying; Hu, Tianyuan; Zhang, Hui; He, Lingjuan; Huang, Xiuzhen; Liu, Qiaozhen; Yu, Wei; He, Liang; Yang, Zhen; Yan, Yan; Yang, Xiao; Zhong, Tao P.; Pu, William T.; Zhou, Bin			De novo formation of a distinct coronary vascular population in neonatal heart	SCIENCE			English	Article							ENDOTHELIAL-CELLS; ENDOCARDIAL CELLS; ARTERIES; FORM; BIOLOGY	The postnatal coronary vessels have been viewed as developing through expansion of vessels formed during the fetal period. Using genetic lineage tracing, we found that a substantial portion of postnatal coronary vessels arise de novo in the neonatal mouse heart, rather than expanding from preexisting embryonic vasculature. Our data show that lineage conversion of neonatal endocardial cells during trabecular compaction generates a distinct compartment of the coronary circulation located within the inner half of the ventricular wall. This lineage conversion occurs within a brief period after birth and provides an efficient means of rapidly augmenting the coronary vasculature. This mechanism of postnatal coronary vascular growth provides avenues for understanding and stimulating cardiovascular regeneration following injury and disease.	[Tian, Xueying; Hu, Tianyuan; Zhang, Hui; He, Lingjuan; Huang, Xiuzhen; Liu, Qiaozhen; Yu, Wei; He, Liang; Zhou, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Grad Sch, Shanghai 200031, Peoples R China; [Yang, Zhen; Yan, Yan] Fudan Univ, Zhongshan Hosp, Shanghai 200032, Peoples R China; [Yang, Xiao] Inst Biotechnol, State Key Lab Prote, Beijing 100071, Peoples R China; [Zhong, Tao P.] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Pu, William T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Pu, William T.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Fudan University; Harvard University; Harvard University; Boston Children's Hospital	Zhou, B (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Grad Sch, Shanghai 200031, Peoples R China.	zhoubin@sibs.ac.cn	Pu, William/AAJ-8301-2020	Pu, William/0000-0002-4551-8079; Zhou, Bin/0000-0001-5278-5522	National Basic Research Program of China [2012CB945102, 2013CB945302]; National Natural Science Foundation of China [91339104, 31271552, 31222038, 31301188]; Chinese Academy of Sciences [KSCX2-EW-R-09]; Shanghai Pujiang Program [11PJ1411400]; Basic Research Key Project [14JC1407400]; Organization Department of the CPC Central Committee Bajian Talents Program; AstraZeneca; Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) Fellowship; NIH [2 R01 HL094683]; American Heart Association Established Investigator Award;  [SIBS-2013KIP311];  [2013M541561]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094683, R01HL116461] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Pujiang Program(Shanghai Pujiang Program); Basic Research Key Project; Organization Department of the CPC Central Committee Bajian Talents Program; AstraZeneca(AstraZeneca); Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Established Investigator Award(American Heart Association); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank K. Red-Horse, Y. Chen, and N. Jin for insightful discussions and R. Adams, H. Zeng, Z. Yang, T. Quertermous, J. Rossant, and A. Nagy for mouse strains. This work was supported by National Basic Research Program of China (2012CB945102 and 2013CB945302), National Natural Science Foundation of China (91339104, 31271552, 31222038, 31301188), Chinese Academy of Sciences (Hundred Talents Program and KSCX2-EW-R-09), Shanghai Pujiang Program (11PJ1411400) and Basic Research Key Project (14JC1407400), Organization Department of the CPC Central Committee Bajian Talents Program, AstraZeneca, Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) Fellowship, Postdoc Fund (SIBS-2013KIP311, China-2013M541561), NIH (2 R01 HL094683), and American Heart Association Established Investigator Award to W.T.P.	Bennett HS, 1936, AM J ANAT, V60, P27, DOI 10.1002/aja.1000600103; del Monte G, 2012, CELL, V151, P932, DOI 10.1016/j.cell.2012.11.004; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Katz TC, 2012, DEV CELL, V22, P639, DOI 10.1016/j.devcel.2012.01.012; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Riley P, 2010, NATURE, V464, P498, DOI 10.1038/464498a; Riley PR, 2011, CARDIOVASC RES, V91, P260, DOI 10.1093/cvr/cvr035; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Tian XY, 2013, CELL RES, V23, P1075, DOI 10.1038/cr.2013.83; Wu BR, 2012, CELL, V151, P1083, DOI 10.1016/j.cell.2012.10.023; Yi BA, 2010, J CLIN INVEST, V120, P20, DOI 10.1172/JCI40820; Zhou B, 2005, DEVELOPMENT, V132, P1137, DOI 10.1242/dev.01640	14	131	142	4	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					90	94		10.1126/science.1251487	http://dx.doi.org/10.1126/science.1251487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994653	Green Accepted			2022-12-01	WOS:000338284400057
J	Victor, DG; Gerlagh, R; Baiocchi, G				Victor, David G.; Gerlagh, Reyer; Baiocchi, Giovanni			Getting serious about categorizing countries	SCIENCE			English	Editorial Material									[Victor, David G.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Gerlagh, Reyer] Tilburg Univ, NL-5037 AB Tilburg, Netherlands; [Baiocchi, Giovanni] Univ Maryland, College Pk, MD 20742 USA; Ctr Policy Res, New Delhi 110021, DL, India; Princeton Univ, Princeton, NJ 08544 USA; Stockholm Environm Inst, S-10451 Stockholm, Sweden; Potsdam Inst Climate Impact Res, D-14473 Potsdam, Germany; Mercator Res Inst Global Commons & Climate Change, D-10829 Berlin, Germany	University of California System; University of California San Diego; Tilburg University; University System of Maryland; University of Maryland College Park; Princeton University; Stockholm Environment Institute; Potsdam Institut fur Klimafolgenforschung	Victor, DG (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.		baiocchi, giovanni/AAN-4104-2021	baiocchi, giovanni/0000-0002-0319-7561; Gerlagh, Reyer/0000-0001-9781-9212					0	28	28	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					34	36		10.1126/science.1255302	http://dx.doi.org/10.1126/science.1255302			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2XU	24994638				2022-12-01	WOS:000338284400037
J	Jais, A; Einwallner, E; Sharif, O; Gossens, K; Lu, TTH; Soyal, SM; Medgyesi, D; Neureiter, D; Paier-Pourani, J; Dalgaard, K; Duvigneau, JC; Lindroos-Christensen, J; Zapf, TC; Amann, S; Saluzzo, S; Jantscher, F; Stiedl, P; Todoric, J; Martins, R; Oberkofler, H; Muller, S; Hauser-Kronberger, C; Kenner, L; Casanova, E; Sutterluty-Fall, H; Bilban, M; Miller, K; Kozlov, AV; Krempler, F; Knapp, S; Lumeng, CN; Patsch, W; Wagner, O; Pospisilik, JA; Esterbauer, H				Jais, Alexander; Einwallner, Elisa; Sharif, Omar; Gossens, Klaus; Lu, Tess Tsai-Hsiu; Soyal, Selma M.; Medgyesi, David; Neureiter, Daniel; Paier-Pourani, Jamile; Dalgaard, Kevin; Duvigneau, J. Catharina; Lindroos-Christensen, Josefine; Zapf, Thea-Christin; Amann, Sabine; Saluzzo, Simona; Jantscher, Florian; Stiedl, Patricia; Todoric, Jelena; Martins, Rui; Oberkofler, Hannes; Mueller, Simone; Hauser-Kronberger, Cornelia; Kenner, Lukas; Casanova, Emilio; Sutterluety-Fall, Hedwig; Bilban, Martin; Miller, Karl; Kozlov, Andrey V.; Krempler, Franz; Knapp, Sylvia; Lumeng, Carey N.; Patsch, Wolfgang; Wagner, Oswald; Pospisilik, J. Andrew; Esterbauer, Harald			Heme Oxygenase-1 Drives Metaflammation and Insulin Resistance in Mouse and Man	CELL			English	Article							ADIPOSE-TISSUE; UP-REGULATION; IKK-BETA; MACROPHAGE POLARIZATION; MITOCHONDRIAL-FUNCTION; COBALT PROTOPORPHYRIN; METABOLIC HOMEOSTASIS; GENE-EXPRESSION; OBESITY; INFLAMMATION	Obesity and diabetes affect more than half a billion individuals worldwide. Interestingly, the two conditions do not always coincide and the molecular determinants of "healthy" versus "unhealthy" obesity remain ill-defined. Chronic metabolic inflammation (metaflammation) is believed to be pivotal. Here, we tested a hypothesized anti-inflammatory role for heme oxygenase-1 (HO-1) in the development of metabolic disease. Surprisingly, in matched biopsies from "healthy" versus insulin-resistant obese subjects we find HO-1 to be among the strongest positive predictors of metabolic disease in humans. We find that hepatocyte and macrophage conditional HO-1 deletion in mice evokes resistance to diet-induced insulin resistance and inflammation, dramatically reducing secondary disease such as steatosis and liver toxicity. Intriguingly, cellular assays show that HO-1 defines prestimulation thresholds for inflammatory skewing and NF-kappa B amplification in macrophages and for insulin signaling in hepatocytes. These findings identify HO-1 inhibition as a potential therapeutic strategy for metabolic disease.	[Jais, Alexander; Einwallner, Elisa; Sharif, Omar; Lindroos-Christensen, Josefine; Zapf, Thea-Christin; Amann, Sabine; Saluzzo, Simona; Jantscher, Florian; Todoric, Jelena; Martins, Rui; Kenner, Lukas; Casanova, Emilio; Sutterluety-Fall, Hedwig; Bilban, Martin; Knapp, Sylvia; Wagner, Oswald; Esterbauer, Harald] Med Univ Vienna, A-1090 Vienna, Austria; [Sharif, Omar; Saluzzo, Simona; Martins, Rui; Knapp, Sylvia] Austrian Acad Sci, Res Ctr Mol Med, CeMM, A-1090 Vienna, Austria; [Gossens, Klaus; Lu, Tess Tsai-Hsiu; Medgyesi, David; Dalgaard, Kevin; Pospisilik, J. Andrew] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Soyal, Selma M.; Neureiter, Daniel; Oberkofler, Hannes; Hauser-Kronberger, Cornelia; Patsch, Wolfgang] Paracelsus Med Univ, A-5020 Salzburg, Austria; [Medgyesi, David] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Paier-Pourani, Jamile; Kozlov, Andrey V.] Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria; [Duvigneau, J. Catharina; Mueller, Simone; Kenner, Lukas] Univ Vet Med Vienna, A-1210 Vienna, Austria; [Stiedl, Patricia; Kenner, Lukas; Casanova, Emilio] Ludwig Boltzmann Inst Canc Res, A-1090 Vienna, Austria; [Miller, Karl; Krempler, Franz] Gen Hosp Hallein, A-5400 Hallein, Austria; [Lumeng, Carey N.] Univ Michigan, Ann Arbor, MI 48109 USA	Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Max Planck Society; Paracelsus Private Medical University; University of Freiburg; Ludwig Boltzmann Institute; University of Veterinary Medicine Vienna; Ludwig Boltzmann Institute; University of Michigan System; University of Michigan	Pospisilik, JA (corresponding author), Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany.	pospisilik@ie-freiburg.mpg.de; harald.esterbauer@meduniwien.ac.at	Duvigneau, J. Catharina/AAE-6992-2019; Martins, Rui/M-9606-2016; Casanova, Emilio/Y-6553-2019; Knapp, Sylvia/J-3973-2013; Jais, Alexander/AAQ-9102-2021	Martins, Rui/0000-0001-8106-6324; Casanova, Emilio/0000-0001-7992-5361; Knapp, Sylvia/0000-0001-9016-5244; Jais, Alexander/0000-0002-9897-4983; Sharif, Omar/0000-0001-7899-2343; Kozlov, Andrey/0000-0002-0834-4997; Sutterluty-Fall, Hedwig/0000-0001-9249-9299; Duvigneau, Johanna Catharina/0000-0002-2433-3120; Bilban, Martin/0000-0001-7043-7142; Saluzzo, Simona/0000-0003-2675-4014; Esterbauer, Harald/0000-0001-7343-7455; Kenner, Lukas/0000-0003-2184-1338	Vienna Science and Technology Fund; Max-Planck Society; Austrian Diabetes Association; Medical Scientific Fund of the Mayor of the City of Vienna; Osterreichische Gesellschaft fur Laboratoriumsmedizin und Klinische Chemie; National Institutes of Health [DK090262]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090262] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [V 344] Funding Source: researchfish	Vienna Science and Technology Fund; Max-Planck Society(Max Planck Society); Austrian Diabetes Association; Medical Scientific Fund of the Mayor of the City of Vienna; Osterreichische Gesellschaft fur Laboratoriumsmedizin und Klinische Chemie; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by the Vienna Science and Technology Fund (J.A.P. and H.E.), the Max-Planck Society (J.A.P.), the Austrian Diabetes Association (H.E.), the Medical Scientific Fund of the Mayor of the City of Vienna (E.E.), the Osterreichische Gesellschaft fur Laboratoriumsmedizin und Klinische Chemie (E.E.), and a grant from the National Institutes of Health (DK090262, C.N.L.). The authors are grateful to J. Husa, J. Kacerovsky, I. Miller, G. Mitterer, M. Ozsvar Kozma, and M. Ruf for critical technical and theoretical help.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Bao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012371; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Burcelin R, 2012, SEMIN IMMUNOL, V24, P67, DOI 10.1016/j.smim.2011.11.011; Calay ES, 2013, NAT MED, V19, P265, DOI 10.1038/nm.3114; Capel F, 2009, DIABETES, V58, P1558, DOI 10.2337/db09-0033; Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055369; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kapturczak MH, 2004, AM J PATHOL, V165, P1045, DOI 10.1016/S0002-9440(10)63365-2; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Koliaraki V, 2011, ADV EXP MED BIOL, V780, P101, DOI 10.1007/978-1-4419-5632-3_9; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Liu XF, 2013, UNIVERSITAS-TAIWAN, V40, P1; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mailloux RJ, 2013, TRENDS BIOCHEM SCI, V38, P592, DOI 10.1016/j.tibs.2013.09.001; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Ndisang JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE1029, DOI 10.1152/ajpendo.90241.2008; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Pihlajamaki J, 2009, J CLIN ENDOCR METAB, V94, P3521, DOI 10.1210/jc.2009-0212; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Qatanani M, 2013, DIABETES, V62, P855, DOI 10.2337/db12-0399; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Shakeri-Manesch S, 2009, INT J OBESITY, V33, P1257, DOI 10.1038/ijo.2009.160; Shan Y, 2006, FASEB J, V20, P2651, DOI 10.1096/fj.06-6346fje; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340; Stefan N, 2013, LANCET DIABETES ENDO, V1, P152, DOI 10.1016/S2213-8587(13)70062-7; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Teperino R, 2012, CELL, V151, P414, DOI 10.1016/j.cell.2012.09.021; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Tiganis T, 2011, TRENDS PHARMACOL SCI, V32, P82, DOI 10.1016/j.tips.2010.11.006; Tzima S, 2009, J EXP MED, V206, P1167, DOI 10.1084/jem.20081582; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zheng JY, 2008, MOL CELL BIOCHEM, V319, P153, DOI 10.1007/s11010-008-9888-0	59	189	193	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					25	40		10.1016/j.cell.2014.04.043	http://dx.doi.org/10.1016/j.cell.2014.04.043			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995976	Green Accepted, Bronze			2022-12-01	WOS:000340943100005
J	Ali, K; Soond, DR; Pineiro, R; Hagemann, T; Pearce, W; Lim, EL; Bouabe, H; Scudamore, CL; Hancox, T; Maecker, H; Friedman, L; Turner, M; Okkenhaug, K; Vanhaesebroeck, B				Ali, Khaled; Soond, Dalya R.; Pineiro, Roberto; Hagemann, Thorsten; Pearce, Wayne; Lim, Ee Lyn; Bouabe, Hicham; Scudamore, Cheryl L.; Hancox, Timothy; Maecker, Heather; Friedman, Lori; Turner, Martin; Okkenhaug, Klaus; Vanhaesebroeck, Bart			Inactivation of PI(3)K p110 delta breaks regulatory T-cell-mediated immune tolerance to cancer	NATURE			English	Article							PHOSPHOINOSITIDE 3-KINASE; SUPPRESSOR-CELLS; INFLAMMATION; IDELALISIB; INHIBITION; ISOFORM; DELTA; PI3K	Inhibitors against thep110 delta isoform of phosphoinositide-3-OH kinase (PI(3) K) have shown remarkable therapeutic efficacy in some human leukaemias(1,2). As p110 delta is primarily expressed in leukocytes(3), drugs against p110 delta have not been considered for the treatment of solid tumours(4). Here we report that p110 delta inactivation in mice protects against a broad range of cancers, including non-haematological solid tumours. We demonstrate that p110 delta inactivation in regulatory T cells unleashes CD8(+) cytotoxic T cells and induces tumour regression. Thus, p110 delta inhibitors can break tumour-induced immune tolerance and should be considered for wider use in oncology.	[Ali, Khaled; Pineiro, Roberto; Pearce, Wayne; Vanhaesebroeck, Bart] UCL, UCL Canc Inst, London WC1E 6DD, England; [Soond, Dalya R.; Lim, Ee Lyn; Bouabe, Hicham; Turner, Martin; Okkenhaug, Klaus] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England; [Hagemann, Thorsten] Queen Mary Univ London, Barts Canc Inst, Ctr Canc & Inflammat, London EC1M 6BQ, England; [Scudamore, Cheryl L.] MRC Harwell, Mary Lyon Ctr, Harwell OX11 0RD, Berks, England; [Hancox, Timothy] Piramed Pharma, Slough SL1 4NL, Berks, England; [Maecker, Heather; Friedman, Lori] Genentech Inc, Canc Signaling & Translat Oncol, San Francisco, CA 94080 USA	University of London; University College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of London; Queen Mary University London; MRC Harwell; Roche Holding; Genentech	Ali, K (corresponding author), Amgen Inc, Oncol Res, 1120 Vet Blvd, San Francisco, CA 94080 USA.	khaleda@amgen.com; klaus.okkenhaug@babraham.ac.uk; bart.vanh@ucl.ac.uk	Piñeiro, Roberto/AAN-5561-2020; Okkenhaug, Klaus/H-3154-2019; Turner, Martin/N-9976-2014	Piñeiro, Roberto/0000-0001-9479-139X; Okkenhaug, Klaus/0000-0002-9432-4051; Scudamore, Cheryl/0000-0002-7101-1714; Lim, Ee Lyn/0000-0002-5173-2979; , Dalya/0000-0001-9326-0896; Turner, Martin/0000-0002-3801-9896; Pearce, Wayne/0000-0001-5407-4767; Maecker, Heather/0000-0002-5378-1141	Cancer Research UK [C23338/A10200, C23338/A15965, C18270/A12888]; Biotechnology and Biological Sciences Research Council [BB/E009867/1]; Wellcome Trust [095691/Z/11/Z]; BBSRC [BBS/E/B/000C0407, BB/I007806/2, BB/E009867/1] Funding Source: UKRI; MRC [MC_UP_1502/1, G0901338] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I007806/2, BBS/B/02010, BBS/E/B/000C0407] Funding Source: researchfish; Cancer Research UK [12888, 14355, 15965] Funding Source: researchfish; Medical Research Council [MC_UP_1502/1, G0901338] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by Cancer Research UK (C23338/A10200; C23338/A15965 to B. V. and C18270/A12888 to T. Hagemann), Biotechnology and Biological Sciences Research Council (BB/E009867/1 to K.O.) and Wellcome Trust (095691/Z/11/Z) (to K.O.). We thank D. Sutherlin, J. Nonomiya, J. Lesnick and K. Reif (Genentech) for technical assistance, M. Whitehead, D. Dubuisson, D. Patton, E. Slack, N. Harrington, G. Rosignoli, W. P. Day, A. Brown, P. Depledge, F. Leenders, J. Pang, L. Salphati and X. Zhang for experimental help, D. Fearon and J. Arnold for LLC-OVA cells, and A. Rudensky for FoxP3<SUP>YFP-Cre</SUP> mice.	Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Curiel TJ, 2008, CURR OPIN IMMUNOL, V20, P241, DOI 10.1016/j.coi.2008.04.008; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gopal AK, 2014, NEW ENGL J MED, V370, P1008, DOI 10.1056/NEJMoa1314583; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Murray JM, 2012, J MED CHEM, V55, P7686, DOI 10.1021/jm300717c; Okkenhaug K, 2002, SCIENCE, V297, P1031; Okkenhaug K, 2006, J IMMUNOL, V177, P5122, DOI 10.4049/jimmunol.177.8.5122; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Patton DT, 2006, J IMMUNOL, V177, P6598, DOI 10.4049/jimmunol.177.10.6598; Patton DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017359; Pulaski BA, 2002, CANCER RES, V62, P4406; Putz EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040852; Safina BS, 2012, J MED CHEM, V55, P5887, DOI 10.1021/jm3003747; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Soler A, 2013, J EXP MED, V210, P1937, DOI 10.1084/jem.20121571; Soond DR, 2012, J IMMUNOL, V188, P5935, DOI 10.4049/jimmunol.1102116; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	23	357	373	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					407	+		10.1038/nature13444	http://dx.doi.org/10.1038/nature13444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24919154	Green Accepted			2022-12-01	WOS:000337350200037
J	Shalek, AK; Satija, R; Shuga, J; Trombetta, JJ; Gennert, D; Lu, DN; Chen, PL; Gertner, RS; Gaublomme, JT; Yosef, N; Schwartz, S; Fowler, B; Weaver, S; Wang, J; Wang, XH; Ding, RH; Raychowdhury, R; Friedman, N; Hacohen, N; Park, H; May, AP; Regev, A				Shalek, Alex K.; Satija, Rahul; Shuga, Joe; Trombetta, John J.; Gennert, Dave; Lu, Diana; Chen, Peilin; Gertner, Rona S.; Gaublomme, Jellert T.; Yosef, Nir; Schwartz, Schraga; Fowler, Brian; Weaver, Suzanne; Wang, Jing; Wang, Xiaohui; Ding, Ruihua; Raychowdhury, Raktima; Friedman, Nir; Hacohen, Nir; Park, Hongkun; May, Andrew P.; Regev, Aviv			Single-cell RNA-seq reveals dynamic paracrine control of cellular variation	NATURE			English	Article							GENE-EXPRESSION; I INTERFERON; IMMUNE; QUANTIFICATION; STOCHASTICITY; TRANSCRIPTOME; VARIABILITY; DETERMINES; ACTIVATION; PRINCIPLES	High-throughput single-cell transcriptomics offers an unbiased approach for understanding the extent, basis and function of gene expression variation between seemingly identical cells. Here we sequence single-cell RNA-seq libraries prepared from over 1,700 primary mouse bone-marrow-derived dendritic cells spanning several experimental conditions. We find substantial variation between identically stimulated dendritic cells, in both the fraction of cells detectably expressing a given messenger RNA and the transcript's level within expressing cells. Distinct gene modules are characterized by different temporal heterogeneity profiles. In particular, a 'core' module of antiviral genes is expressed very early by a few 'precocious' cells in response to uniform stimulation with a pathogenic component, but is later activated in all cells. By stimulating cells individually in sealed microfluidic chambers, analysing dendritic cells from knockout mice, and modulating secretion and extracellular signalling, we show that this response is coordinated by interferon-mediated paracrine signalling from these precocious cells. Notably, preventing cell-to-cell communication also substantially reduces variability between cells in the expression of an early-induced 'peaked' inflammatory module, suggesting that paracrine signalling additionally represses part of the inflammatory program. Our study highlights the importance of cell-to-cell communication in controlling cellular heterogeneity and reveals general strategies that multicellular populations can use to establish complex dynamic responses.	[Shalek, Alex K.; Gertner, Rona S.; Gaublomme, Jellert T.; Ding, Ruihua; Park, Hongkun] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Shalek, Alex K.; Gertner, Rona S.; Gaublomme, Jellert T.; Ding, Ruihua; Park, Hongkun] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Shalek, Alex K.; Satija, Rahul; Trombetta, John J.; Gennert, Dave; Lu, Diana; Yosef, Nir; Schwartz, Schraga; Raychowdhury, Raktima; Hacohen, Nir; Park, Hongkun; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Shuga, Joe; Chen, Peilin; Fowler, Brian; Weaver, Suzanne; Wang, Jing; Wang, Xiaohui; May, Andrew P.] Fluidigm Corp, San Francisco, CA 94080 USA; [Friedman, Nir] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91904 Jerusalem, Israel; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Dept Med, Charlestown, MA 02129 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02140 USA	Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Hebrew University of Jerusalem; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Satija, R (corresponding author), Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA.	rahuls@broadinstitute.org; Hongkun_Park@harvard.edu; apmay1@gmail.com	Shalek, Alex/Y-2434-2019; Satija, Rahul/AAF-9564-2019; Friedman, Nir/H-9692-2012; Park, Hongkun/R-9842-2019	Shalek, Alex/0000-0001-5670-8778; Friedman, Nir/0000-0002-9678-3550; Park, Hongkun/0000-0001-9576-8829; Schwartz, Schraga/0000-0002-3671-9709	NIH [1F32HD075541-01, U54 AI057159, DP2 OD002230, 5DP1OD003893-03, DP1OD003958-01]; NIH CEGS [1P50HG006193-01]; Broad Institute; Klarman Cell Observatory at the Broad Institute; ISF-Broad Grant; ERC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD075541] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [DP1CA174427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002230, DP1OD003893, DP1OD003958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH CEGS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Institute; Klarman Cell Observatory at the Broad Institute; ISF-Broad Grant; ERC(European Research Council (ERC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Tilton, T. Rogers and M. Tam for assistance with cell sorting; E. Shefler, C. Guiducci, D. Thompson, and O. Rozenblatt-Rosen for project management and discussions and the Broad Genomics Platform for sequencing. We thank J. West, R. Lebofsky, A. Leyrat, M. Thu, M. Wong, W. Yorza, D. Toppani, M. Norris and B. Clerkson for contributions to C<INF>1</INF> system development; B. Alvarado, M. Ray and L. Knuttson for assistance with C<INF>1</INF> experiments; and M. Unger for discussions. Work was supported by an NIH Postdoctoral Fellowship (1F32HD075541-01, R.S.), an NIH grant (U54 AI057159, N.H.), an NIH New Innovator Award (DP2 OD002230, N.H.), an NIH CEGS(1P50HG006193-01, H.P., N.H., A.R.), NIH Pioneer Awards (5DP1OD003893-03 to H.P., DP1OD003958-01 to A.R.), the Broad Institute (H.P. and A.R.), HHMI (A.R.), the Klarman Cell Observatory at the Broad Institute (A.R.), an ISF-Broad Grant (N.F.), and the ERC (N.F.).	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Benveniste E. N., 2007, SCI STKE, V416, ppe70, DOI DOI 10.1126/STKE.4162007PE70; Chalancon G, 2012, TRENDS GENET, V28, P221, DOI 10.1016/j.tig.2012.01.006; Fang MQ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001618; Feinerman O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.90; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Hall JC, 2010, NAT REV RHEUMATOL, V6, P40, DOI 10.1038/nrrheum.2009.237; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Islam S., 2012, NATURE PROTOCOLS, V7, P823; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Loewer A, 2011, CURR OPIN GENET DEV, V21, P753, DOI 10.1016/j.gde.2011.09.010; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Rand U, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.17; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Weibrecht I, 2012, NEW BIOTECHNOL, V29, P589, DOI 10.1016/j.nbt.2011.08.002; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Zhao MW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001249	36	566	590	5	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					363	+		10.1038/nature13437	http://dx.doi.org/10.1038/nature13437			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24919153	Green Submitted, Green Accepted			2022-12-01	WOS:000337350200028
J	Lu, CY; Zhang, F; Lakoma, MD; Madden, JM; Rusinak, D; Penfold, RB; Simon, G; Ahmedani, BK; Clarke, G; Hunkeler, EM; Waitzfelder, B; Owen-Smith, A; Raebel, MA; Rossom, R; Coleman, KJ; Copeland, LA; Soumerai, SB				Lu, Christine Y.; Zhang, Fang; Lakoma, Matthew D.; Madden, Jeanne M.; Rusinak, Donna; Penfold, Robert B.; Simon, Gregory; Ahmedani, Brian K.; Clarke, Gregory; Hunkeler, Enid M.; Waitzfelder, Beth; Owen-Smith, Ashli; Raebel, Marsha A.; Rossom, Rebecca; Coleman, Karen J.; Copeland, Laurel A.; Soumerai, Stephen B.			Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTERRUPTED TIME-SERIES; PEDIATRIC SUICIDALITY; E-CODES; RISK; DEPRESSION; ADOLESCENTS; FLUOXETINE; CHILDREN; DECLINE; TRENDS	Objective To investigate if the widely publicized warnings in 2003 from the US Food and Drug Administration about a possible increased risk of suicidality with antidepressant use in young people were associated with changes in antidepressant use, suicide attempts, and completed suicides among young people. Design Quasi-experimental study assessing changes in outcomes after the warnings, controlling for pre-existing trends. Setting Automated healthcare claims data (2000-10) derived from the virtual data warehouse of 11 health plans in the US Mental Health Research Network. Participants Study cohorts included adolescents (around 1.1 million), young adults (around 1.4 million), and adults (around 5 million). Main outcome measures Rates of antidepressant dispensings, psychotropic drug poisonings (a validated proxy for suicide attempts), and completed suicides. Results Trends in antidepressant use and poisonings changed abruptly after the warnings. In the second year after the warnings, relative changes in antidepressant use were -31.0% (95% confidence interval -33.0% to -29.0%) among adolescents, -24.3% (-25.4% to -23.2%) among young adults, and -14.5% (-16.0% to -12.9%) among adults. These reflected absolute reductions of 696, 1216, and 1621 dispensings per 100 000 people among adolescents, young adults, and adults, respectively. Simultaneously, there were significant, relative increases in psychotropic drug poisonings in adolescents (21.7%, 95% confidence interval 4.9% to 38.5%) and young adults (33.7%, 26.9% to 40.4%) but not among adults (5.2%, -6.5% to 16.9%). These reflected absolute increases of 2 and 4 poisonings per 100 000 people among adolescents and young adults, respectively (approximately 77 additional poisonings in our cohort of 2.5 million young people). Completed suicides did not change for any age group. Conclusions Safety warnings about antidepressants and widespread media coverage decreased antidepressant use, and there were simultaneous increases in suicide attempts among young people. It is essential to monitor and reduce possible unintended consequences of FDA warnings and media reporting.	[Lu, Christine Y.; Zhang, Fang; Lakoma, Matthew D.; Madden, Jeanne M.; Soumerai, Stephen B.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Lu, Christine Y.; Zhang, Fang; Lakoma, Matthew D.; Madden, Jeanne M.; Soumerai, Stephen B.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Penfold, Robert B.; Simon, Gregory] Grp Hlth Res Inst, Seattle, WA USA; [Penfold, Robert B.] Univ Washington, Dept Hlth Serv Res, Seattle, WA 98195 USA; [Simon, Gregory] Mental Hlth Res Network, Detroit, MI USA; [Ahmedani, Brian K.] Henry Ford Hlth Syst, Ctr Hlth Policy & Hlth Serv Res, Detroit, MI USA; [Clarke, Gregory] Kaiser Permanente Ctr Hlth Res, Portland, OR USA; [Hunkeler, Enid M.] Kaiser Permanente Med Care Program Northern Calif, Div Res, Oakland, CA USA; [Waitzfelder, Beth] Kaiser Permanente Ctr Hlth Res Hawaii, Honolulu, HI USA; [Owen-Smith, Ashli] Kaiser Permanente Georgia, Ctr Hlth Res Southeast, Atlanta, GA USA; [Raebel, Marsha A.] Kaiser Permanente Colorado Inst Hlth Res, Denver, CO USA; [Rossom, Rebecca] HealthPartners Inst Educ & Res, Bloomington, MN USA; [Coleman, Karen J.] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [Copeland, Laurel A.] Cent Texas Vet Hlth Care Syst Jointly Scott & Whi, Ctr Appl Hlth Res, Temple, TX USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Washington; University of Washington Seattle; Henry Ford Health System; Henry Ford Hospital; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; HealthPartners Institute for Education & Research; Kaiser Permanente	Lu, CY (corresponding author), 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	christine_lu@harvardpilgrim.org	Rossom, Rebecca/R-7103-2019; Copeland, Laurel A/C-3763-2017	Copeland, Laurel A/0000-0002-9478-0209; Rossom, Rebecca/0000-0002-9531-914X	US National Institute of Mental Health [U19MH092201]; Health Delivery Systems Center for Diabetes Translational Research (HDS-CDTR) (NIDDK) [1P30-DK092924]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH092201] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Health Delivery Systems Center for Diabetes Translational Research (HDS-CDTR) (NIDDK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding: This research was supported by a cooperative agreement (U19MH092201; principal investigator, GS) with the US National Institute of Mental Health; SBS was the study principal investigator. The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health. The sponsor had no role in the design and conduct of the study; analysis, and interpretation of the data; the preparation of the manuscript; and the decision to submit the manuscript for publication. SBS was supported in part by the Health Delivery Systems Center for Diabetes Translational Research (HDS-CDTR) (NIDDK grant 1P30-DK092924).	Baldessarini RJ, 2006, ARCH GEN PSYCHIAT, V63, P246, DOI 10.1001/archpsyc.63.3.246; Barry CL, 2010, PEDIATRICS, V125, P88, DOI 10.1542/peds.2009-0792; Busch SH, 2010, PSYCHIAT SERV, V61, P11, DOI 10.1176/appi.ps.61.1.11; Centers for Disease Control and Prevention, 2011, STRATEGIES PREVENT O, P60; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P321; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; FDA, 2007, QUEST ANSW ANT US CH; FDA, 2004, JOINT M PSYCH DRUGS; Gibbons RD, 2012, ARCH GEN PSYCHIAT, V69, P580, DOI 10.1001/archgenpsychiatry.2011.2048; Gibbons RD, 2011, DRUG SAFETY, V34, P375, DOI 10.2165/11589350-000000000-00000; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Harris G, 2004, NY TIMES; Hornbrook Mark C, 2005, J Natl Cancer Inst Monogr, P12; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; Kaizar EE, 2006, CLIN TRIALS, V3, P96; Kaizar EE, 2006, CLIN TRIALS, V3, P73, DOI 10.1191/1740774506cn139oa; Klein DF, 2006, NEUROPSYCHOPHARMACOL, V31, P689, DOI 10.1038/sj.npp.1300996; Leckman JF, 2007, AM J PSYCHIAT, V164, P1304, DOI 10.1176/appi.ajp.2007.07050880; Libby AM, 2007, AM J PSYCHIAT, V164, P884, DOI 10.1176/appi.ajp.164.6.884; Libby AM, 2009, ARCH GEN PSYCHIAT, V66, P633, DOI 10.1001/archgenpsychiatry.2009.46; Lu CY, 2014, PHARMACOEPIDEM DR S, V23, P218, DOI 10.1002/pds.3551; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; March JS, 2007, ARCH GEN PSYCHIAT, V64, P1132; Morrato EH, 2008, AM J PSYCHIAT, V165, P42, DOI 10.1176/appi.ajp.2007.07010205; National Institute of Mental Health, 2013, SUIC US STAT PREV; Olfson M, 2008, J CLIN PSYCHIAT, V69, P425, DOI 10.4088/JCP.v69n0313; Pamer CA, 2010, PHARMACOEPIDEM DR S, V19, P158, DOI 10.1002/pds.1886; Patrick AR, 2010, PHARMACOEPIDEM DR S, V19, P1263, DOI 10.1002/pds.2037; Schneeweiss S, 2010, ARCH GEN PSYCHIAT, V67, P497, DOI 10.1001/archgenpsychiatry.2010.39; Shadish W.R., 2002, EXPT QUASIEXPERIMENT; Simon GE, 2006, AM J PSYCHIAT, V163, P41, DOI 10.1176/appi.ajp.163.1.41; Simon GE, 2006, NEW ENGL J MED, V355, P2722, DOI 10.1056/NEJMp068270; SOUMERAI SB, 1992, MILBANK Q, V70, P155, DOI 10.2307/3350088; Spettell CM, 2003, HEALTH SERV RES, V38, P1081, DOI 10.1111/1475-6773.00164; Spiller HA, 2010, LEGAL MED, V12, P177, DOI 10.1016/j.legalmed.2010.04.005; Strom BL, 2012, PHARMACOEPIDEMIOLOGY, V5th, P163; Ting SA, 2012, GEN HOSP PSYCHIAT, V34, P557, DOI 10.1016/j.genhosppsych.2012.03.020; Townsend L, 2012, PHARMACOEPIDEM DR S, V21, P163, DOI 10.1002/pds.2310; Valuck RJ, 2007, AM J PSYCHIAT, V164, P1198, DOI 10.1176/appi.ajp.2007.07010007; Vedantam S, 2004, WASHINGTON POST; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wagner Edward H, 2005, J Natl Cancer Inst Monogr, P3, DOI 10.1093/jncimonographs/lgi032; Zhang F, 2009, J CLIN EPIDEMIOL, V62, P143, DOI 10.1016/j.jclinepi.2008.08.007	43	119	120	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 18	2014	348								g3596	10.1136/bmj.g3596	http://dx.doi.org/10.1136/bmj.g3596			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6LF	24942789	Green Published, hybrid			2022-12-01	WOS:000337805600001
J	Bushnell, C; McCullough, L				Bushnell, Cheryl; McCullough, Louise			Stroke Prevention in Women: Synopsis of the 2014 American Heart Association/American Stroke Association Guideline	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; HEALTH-CARE PROFESSIONALS; SEX-DIFFERENCES; ISCHEMIC-STROKE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; GENDER-DIFFERENCES; OUTCOMES	Description: In February 2014, the American Heart Association/American Stroke Association released their first guideline focused on stroke prevention in women. This new guideline highlights unique risk factors for stroke in women, including oral contraception and hormone therapy, and pregnancy-associated disorders, such as preeclampsia, that may have long-lasting consequences on a woman's health. It also addresses hypertension; atrial fibrillation; migraine headache with aura; and the epidemiology of types of stroke, such as aneurysmal subarachnoid hemorrhage and cerebral vein thrombosis, that are predominant in women. Methods: Members of a multidisciplinary expert panel searched, reviewed, and critiqued relevant English-language literature published between 1990 and May 2013. The panel devised evidence tables and developed recommendations using American Heart Association guideline procedures and levels of evidence. Recommendations: This synopsis of the guideline summarizes the evidence about risk factors for stroke in women and suggests prevention strategies. It also describes the new recommendations relevant to identifying and treating hypertensive disorders in pregnancy that increase risk for stroke.	[Bushnell, Cheryl] Wake Forest Baptist Med Ctr, Winston Salem, NC 27157 USA; Univ Connecticut, Ctr Hlth, Farmington, CT USA; Hartford Hosp, Stroke Ctr, Hartford, CT 06115 USA	Wake Forest University; Wake Forest Baptist Medical Center; University of Connecticut; Hartford Hospital	Bushnell, C (corresponding author), Wake Forest Baptist Med Ctr, Med Ctr Blvd, Winston Salem, NC 27157 USA.	cbushnel@wakehealth.edu	McCullough, Louise/R-2824-2019		Hazel K. Goddess Fund for Stroke Research in Women; World Federation of Neurology; National Institutes of Health [RO1 NS055215, RO1 NS077769, R21 NS082906]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077769, R21NS082906, R01NS055215] Funding Source: NIH RePORTER	Hazel K. Goddess Fund for Stroke Research in Women; World Federation of Neurology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. Bushnell is supported the Hazel K. Goddess Fund for Stroke Research in Women and the World Federation of Neurology. Dr. McCullough is supported by grants RO1 NS055215, RO1 NS077769, and R21 NS082906 from the National Institutes of Health.	Abalos E, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002252.pub3; Andersson HM, 2012, BLOOD, V119, P1555, DOI 10.1182/blood-2011-09-380618; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Berry JD, 2014, CIRCULATION, V129, P399, DOI DOI 10.1161/01.CIR.0000442015.53336.12; Bushnell C, 2014, STROKE, V45, P1545, DOI 10.1161/01.str.0000442009.06663.48; Bushnell CD, 2014, NEUROLOGY, V82, P922, DOI 10.1212/WNL.0000000000000208; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Fang MC, 2005, CIRCULATION, V112, P1687, DOI 10.1161/CIRCULATIONAHA.105.553438; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Gall SL, 2012, STROKE, V43, P1982, DOI 10.1161/STROKEAHA.111.632547; Gargano JW, 2007, STROKE, V38, P2541, DOI 10.1161/STROKEAHA.107.485482; Giralt D, 2012, ACTA NEUROL SCAND, V125, P83, DOI 10.1111/j.1600-0404.2011.01514.x; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Gray LJ, 2007, STROKE, V38, P2960, DOI 10.1161/STROKEAHA.107.488304; Howard VJ, 2011, LANCET NEUROL, V10, P530, DOI 10.1016/S1474-4422(11)70080-1; Jacobs AK, 2013, CIRCULATION, V127, P268, DOI 10.1161/CIR.0b013e31827e8e5f; James AH, 2005, OBSTET GYNECOL, V106, P509, DOI 10.1097/01.AOG.0000172428.78411.b0; Kamel H, 2014, NEW ENGL J MED, V370, P1307, DOI 10.1056/NEJMoa1311485; Kurth T, 2005, NEUROLOGY, V64, P1020, DOI 10.1212/01.WNL.0000154528.21485.3A; Kurth T, 2009, NEUROLOGY, V73, P581, DOI 10.1212/WNL.0b013e3181ab2c20; Lidegaard O, 2012, NEW ENGL J MED, V366, P2257, DOI 10.1056/NEJMoa1111840; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lloyd-Jones DM, 2005, JAMA-J AM MED ASSOC, V294, P466, DOI 10.1001/jama.294.4.466; Merikangas KR, 2013, HEADACHE, V53, P230, DOI 10.1111/head.12038; Mosca, 2011, CIRCULATION, V123, pE624, DOI 10.1161/CIR.0b013e318222b330; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pan A, 2011, STROKE, V42, P2770, DOI 10.1161/STROKEAHA.111.617043; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Peters SA, 2014, LANCET; Poisson SN, 2010, STROKE, V41, P1891, DOI 10.1161/STROKEAHA.110.580977; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; Sturm JW, 2004, STROKE, V35, P2340, DOI 10.1161/01.STR.0000141977.18520.3b; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	35	35	37	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12					853	U71		10.7326/M14-0762	http://dx.doi.org/10.7326/M14-0762			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24935489	Green Accepted			2022-12-01	WOS:000337374900020
J	Jampol, LM; Bressler, NM; Glassman, AR				Jampol, Lee M.; Bressler, Neil M.; Glassman, Adam R.			Revolution to a New Standard Treatment of Diabetic Macular Edema	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEFERRED LASER; RANIBIZUMAB; PROMPT		[Jampol, Lee M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Bressler, Neil M.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Glassman, Adam R.] Jaeb Ctr Hlth Res, Tampa, FL 33647 USA	Northwestern University; Feinberg School of Medicine; Johns Hopkins University; Johns Hopkins Medicine; JAEB Center For Health Research	Glassman, AR (corresponding author), Jaeb Ctr Hlth Res, 15310 Amberly Dr,Ste 350, Tampa, FL 33647 USA.	drcrstat2@jaeb.org		Glassman, Adam/0000-0003-0173-1684	NEI NIH HHS [U10 EY023207, U10 EY018817, EY18817, U10 EY014231, EY023207, U10 EY014229, EY14231] Funding Source: Medline; NATIONAL EYE INSTITUTE [U10EY014229, U10EY014231, U10EY018817, U10EY023207] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aiello LP, 2011, OPHTHALMOLOGY, V118, pE5, DOI 10.1016/j.ophtha.2011.09.058; Bressler NM, 2014, JAMA OPHTHALMOL, V132, P168, DOI 10.1001/jamaophthalmol.2013.6426; Centers for Disease Control and Prevention, 2011 NAT DIAB FACT S; Elman MJ, 2012, OPHTHALMOLOGY, V119, P2312, DOI 10.1016/j.ophtha.2012.08.022; Elman MJ, 2011, OPHTHALMOLOGY, V118, P609, DOI 10.1016/j.ophtha.2010.12.033; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Varma R, 2012, AM AC OPHTH 2012 ANN	8	32	33	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2269	2270		10.1001/jama.2014.2536	http://dx.doi.org/10.1001/jama.2014.2536			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915254	Green Accepted			2022-12-01	WOS:000336972600014
J	Chun, S; Westmoreland, JJ; Bayazitov, IT; Eddins, D; Pani, AK; Smeyne, RJ; Yu, J; Blundon, JA; Zakharenko, SS				Chun, Sungkun; Westmoreland, Joby J.; Bayazitov, Ildar T.; Eddins, Donnie; Pani, Amar K.; Smeyne, Richard J.; Yu, Jing; Blundon, Jay A.; Zakharenko, Stanislav S.			Specific disruption of thalamic inputs to the auditory cortex in schizophrenia models	SCIENCE			English	Article							DIGEORGE-SYNDROME REGION; HALLUCINATIONS; HYPOTHESIS; MICE	Auditory hallucinations in schizophrenia are alleviated by antipsychotic agents that inhibit D2 dopamine receptors (Drd2s). The defective neural circuits and mechanisms of their sensitivity to antipsychotics are unknown. We identified a specific disruption of synaptic transmission at thalamocortical glutamatergic projections in the auditory cortex in murine models of schizophrenia-associated 22q11 deletion syndrome (22q11DS). This deficit is caused by an aberrant elevation of Drd2 in the thalamus, which renders 22q11DS thalamocortical projections sensitive to antipsychotics and causes a deficient acoustic startle response similar to that observed in schizophrenic patients. Haploinsufficiency of the microRNA-processing gene Dgcr8 is responsible for the Drd2 elevation and hypersensitivity of auditory thalamocortical projections to antipsychotics. This suggests that Dgcr8-microRNA-Drd2-dependent thalamocortical disruption is a pathogenic event underlying schizophrenia-associated psychosis.	[Chun, Sungkun; Westmoreland, Joby J.; Bayazitov, Ildar T.; Eddins, Donnie; Pani, Amar K.; Smeyne, Richard J.; Yu, Jing; Blundon, Jay A.; Zakharenko, Stanislav S.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Zakharenko, SS (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	stanislav.zakharenko@stjude.org	Zakharenko, Stanislav/D-3287-2013; Chun, Sungkun/R-1614-2016	Zakharenko, Stanislav/0000-0001-8115-202X; Chun, Sungkun/0000-0001-9837-2299; Smeyne, Richard/0000-0002-8459-5472	NIH [R01 MH097742, R01 MH095810, R01 DC012833]; American Lebanese Syrian Associated Charities; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097742, R01MH095810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012833] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in part, by NIH grants R01 MH097742, R01 MH095810, and R01 DC012833 and the American Lebanese Syrian Associated Charities. We thank E. Illingworth, P. Scambler, A. Wynshaw-Boris, J. Gogos, S. Strittmatter, B. Morrow, and E. Fuchs for providing mutant mice; A. Lessard and the Maryland Brain Collection for providing postmortem human brain samples; K. J. Sample and P. Devaraju for technical assistance; and St. Jude Children's Research Hospital, University of Tennessee, University of North Carolina, and University of Pennsylvania Vector Cores for producing adeno-associated viruses and lentiviruses.	Behrendt RP, 2003, CONSCIOUS COGN, V12, P413, DOI 10.1016/S1053-8100(03)00017-5; CARLSSON A, 1988, NEUROPSYCHOPHARMACOL, V1, P179, DOI 10.1016/0893-133X(88)90012-7; Coyle JT, 1996, HARVARD REV PSYCHIAT, V3, P241, DOI 10.3109/10673229609017192; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; Hubl D, 2007, BRIT J PSYCHIAT, V190, P57, DOI 10.1192/bjp.bp.106.022954; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43903; Miyamoto S, 2012, MOL PSYCHIATR, V17, P1206, DOI 10.1038/mp.2012.47; Smith PH, 2001, J COMP NEUROL, V436, P508, DOI 10.1002/cne.1084; Snyder SH, 1999, PHILOS T ROY SOC B, V354, P1985, DOI 10.1098/rstb.1999.0538; Woodward ND, 2012, AM J PSYCHIAT, V169, P1092, DOI 10.1176/appi.ajp.2012.12010056; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498	13	81	82	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1178	1182		10.1126/science.1253895	http://dx.doi.org/10.1126/science.1253895			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904170	Green Accepted			2022-12-01	WOS:000336791200052
J	Collin, J; Johnson, E; Hill, S				Collin, Jeff; Johnson, Emma; Hill, Sarah			Government support for alcohol industry: promoting exports, jeopardising global health?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRADE AGREEMENTS		[Collin, Jeff; Hill, Sarah] Univ Edinburgh, Sch Social & Polit Sci, Global Publ Hlth Unit, Edinburgh EH8 9LD, Midlothian, Scotland; [Johnson, Emma] NHS Greater Glasgow & Clyde, Glasgow, Lanark, Scotland	University of Edinburgh	Collin, J (corresponding author), Univ Edinburgh, Sch Social & Polit Sci, Global Publ Hlth Unit, Edinburgh EH8 9LD, Midlothian, Scotland.	jeff.collin@ed.ac.uk		Hill, Sarah/0000-0003-3555-433X	ESRC [ES/L001284/1] Funding Source: UKRI; Economic and Social Research Council [ES/L001284/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA160695] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA160695, R01 CA160695] Funding Source: Medline	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2011, HEALTH IS GLOBAL AN; Australian Government, 2011, TRADE POLICY STATEME; Department of Health, 2011, THE PUBLIC HEALTH RE; Department of Health, 2011, HEALTHY LIVES HEALTH; Department of Health, 2007, UK GOVERNMENT SIDE S; Department of Health Foreign and Commonwealth Office, 2013, UNITED KINGDOMS REVI; Diageo, ANNUAL REPORT 2013; Diageo, 2011, GENERATING PROSPERIT; Donaldson L., 2007, HEALTH IS GLOBAL; Euromonitor, 2012, LEGISLATION IN ALCOH; Euromonitor, 2013, ALCOHOLIC DRINKS IN; Euromonitor, 2012, ALCOHOLIC DRINKS FOR; Euromonitor, 2012, ALCOHOLIC DRINKS IN; Euromonitor, 2012, NEW PRODUCT DEVELOPM; Euromonitor, 2012, WHISKIES GROWTH OPPO; European Commission, 2013, FREE TRADE AGREEMENT; Gornall J., 2014, BMJ-BRIT MED J, V348, pf7646, DOI DOI 10.1136/BMJ.F7646; Hague W., 2011, PREFECT POLICE F PEC; HM Government, 2008, HEALTH IS GLOBAL A U; HM Government, 2011, TECHNICAL DOCUMENT D; HM Government, 2012, THE GOVERNMENTS ALCO; Jernigan D., 2008, ADDICTION.S, V104, P6; Kelsey J, 2012, ADDICTION, V107, P1719, DOI 10.1111/j.1360-0443.2012.03874.x; Lawrence F., 2012, GUARDIAN        0913; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McCambridge J, 2014, ADDICTION, V109, P519, DOI 10.1111/add.12356; Nair S, 2014, MONEYCONTROL; O'Brien P, 2013, DRUG ALCOHOL REV, V32, P5, DOI 10.1111/j.1465-3362.2012.00485.x; Pomfret J, 2011, REUTERS         0624; SABMiller, 2013, SABMILLER PLC QUARTE; SABMiller, 2012, INVESTOR RELATIONS Q; SABMiller, 2013, FIRST HALF RESULTS S; SABMiller, 2013, INVESTOR RELATIONS Q; SABMiller. Company snapshot, 2013, COMPANY SNAPSHOT 201; Scotch Whisky Association, 2013, TRADE MATTERS INTERN; The Scottish Government, 2009, CHANGING SCOTLANDS R; UK Trade and Investment, 2012, EXPANDING IN ETHIOPI; UK Trade and Investment Department for Environment and Rural Affairs, 2013, UK FOOD AND DRINK IN; United Nations, 2011, DRAFT POLITICAL DECL; United Nations, 2011, LIST OF CIVIL SOCIET; United Nations, 2013, NEW GLOB PARTN ER PO; WHO, 2011, GLOBAL STATUS REPORT; WHO, 2009, 2008 2013 ACTION PLA; World Health Organization, 2009, GLOB HLTH RISKS MORT; World Trade Organization, 2010, TAXES ON ALCOHOLIC B; World Trade Organization, 2013, PHILIPPINES TAXES ON; World Trade Organization, 2010, INDIA MEASURES AFFEC; Zeigler DW, 2009, ADDICTION, V104, P13, DOI 10.1111/j.1360-0443.2008.02431.x	48	14	14	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2014	348								g3648	10.1136/bmj.g3648	http://dx.doi.org/10.1136/bmj.g3648			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI7CE	24906713	Green Published			2022-12-01	WOS:000337038000011
J	Bender, E				Bender, Eric			DEVELOPING WORLD Global warning	NATURE			English	Editorial Material																		Safaeian M, 2013, CANCER PREV RES, V6, P1242, DOI 10.1158/1940-6207.CAPR-13-0203; Shastri SS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju009; Stewart B., 2019, WORLD CANC REPORT 20	3	12	12	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S64	S65		10.1038/509S64a	http://dx.doi.org/10.1038/509S64a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870825	Bronze			2022-12-01	WOS:000336457100008
J	Schmid, M; Jensen, TH				Schmid, Manfred; Jensen, Torben Heick			SnapShot: Nuclear RNAPII Transcript Modification	CELL			English	Editorial Material									[Schmid, Manfred; Jensen, Torben Heick] Aarhus Univ, Dept Mol Biol & Genet, Ctr mRNP Biogenesis & Metab, DK-8000 Aarhus, Denmark	Aarhus University	Schmid, M (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Ctr mRNP Biogenesis & Metab, DK-8000 Aarhus, Denmark.		Schmid, Manfred/E-6725-2012; Jensen, Torben H/G-2954-2017	Schmid, Manfred/0000-0003-0516-3055; Jensen, Torben Heick/0000-0001-5127-1239	Novo Nordisk Fonden [NNF12OC0001211] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation)			0	0	0	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5							1244.e1	10.1016/j.cell.2014.05.003	http://dx.doi.org/10.1016/j.cell.2014.05.003			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855955	Bronze, Green Accepted			2022-12-01	WOS:000336437200024
J	ten Hoope-Bender, P; de Bernis, L; Campbell, J; Downe, S; Fauveau, V; Fogstad, H; Homer, CSE; Kennedy, HP; Matthews, Z; McFadden, A; Renfrew, MJ; Van Lerberghe, W				ten Hoope-Bender, Petra; de Bernis, Luc; Campbell, James; Downe, Soo; Fauveau, Vincent; Fogstad, Helga; Homer, Caroline S. E.; Kennedy, Holly Powell; Matthews, Zoe; McFadden, Alison; Renfrew, Mary J.; Van Lerberghe, Wim			Improvement of maternal and newborn health through midwifery	LANCET			English	Article							EFFECTIVE COVERAGE; GLOBAL HEALTH; CARE; INTERVENTIONS; AFGHANISTAN; STRENGTHEN; RETENTION; FRAMEWORK; POST-2015; MORTALITY	In the concluding paper of this Series about midwifery, we look at the policy implications from the framework for quality maternal and newborn care, the potential effect of life-saving interventions that fall within the scope of practice of midwives, and the historic sequence of health system changes that made a reduction in maternal mortality possible in countries that have expanded their midwifery workforce. Achievement of better health outcomes for women and newborn infants is possible, but needs improvements in the quality of reproductive, maternal, and newborn care, alongside necessary increases in universal coverage. In this report, we propose three priority research areas and outline how national investment in midwives and in their work environment, education, regulation, and management can improve quality of care. Midwifery and midwives are crucial to the achievement of national and international goals and targets in reproductive, maternal, newborn, and child health; now and beyond 2015.	[ten Hoope-Bender, Petra; Campbell, James] Inst Cooperac Social Integrare, Barcelona 08007, Spain; [de Bernis, Luc] UN Populat Fund, Geneva, Switzerland; [Downe, Soo] Univ Cent Lancashire, Sch Hlth, Preston PR1 2HE, Lancs, England; [Fauveau, Vincent] Holist Sante, Montpellier, France; [Fogstad, Helga] Norwegian Agcy Dev Cooperat, Oslo, Norway; [Homer, Caroline S. E.] Univ Technol, Fac Hlth, Sydney, NSW, Australia; [Kennedy, Holly Powell] Yale Univ, Sch Nursing, New Haven, CT 06536 USA; [Matthews, Zoe] Univ Southampton, Southampton, Hants, England; [McFadden, Alison; Renfrew, Mary J.] Univ Dundee, Coll Med Dent & Nursing, Sch Nursing & Midwifery, Mother & Infant Res Unit, Dundee, Scotland; [Van Lerberghe, Wim] WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark	United Nations Population Fund; University of Central Lancashire; University of Technology Sydney; Yale University; University of Southampton; University of Dundee; World Health Organization	ten Hoope-Bender, P (corresponding author), Inst Cooperac Social Integrare, Barcelona 08007, Spain.	petra.tenhoope@integrare.es	; Homer, Caroline/J-2101-2014	Matthews, Zoe/0000-0003-1533-6618; McFadden, Alison/0000-0002-5164-2025; Renfrew, Mary/0000-0003-2905-403X; Homer, Caroline/0000-0002-7454-3011	Bill & Melinda Gates Foundation [OPP1042500]; University of Dundee; Instituto de Cooperacion Social Integrare	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); University of Dundee; Instituto de Cooperacion Social Integrare	The work on this paper was supported partly through a grant from the Bill & Melinda Gates Foundation (grant number OPP1042500). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of their employers or the Bill & Melinda Gates Foundation. MJR's work was supported by the University of Dundee. PtH-B's work was supported by the Instituto de Cooperacion Social Integrare. Maria Guerra Arias managed and checked all the references. Thomson Prentice edited sections of the first draft. Joanne McManus edited the second draft. Administrative support was provided by Jenny Brown and Tracy Sparey, and Natalie Muir provided project support. We thank all series co-authors, dose readers, and the reviewers from ICM, FIGO, WHO, and the Bill & Melinda Gates Foundation for their contributions and support.	Abe Eghe, 2008, Afr J Reprod Health, V12, P17; [Anonymous], 1986, WHO CHRON, V40, P175; [Anonymous], 2011, GLOB REV KEY INT REL; [Anonymous], 2008, PRIM HLTH CAR NOW MO; [Anonymous], 2010, TRENDS MAT MORT 1990; Bailey PE, 2011, INT J GYNECOL OBSTET, V115, P300, DOI 10.1016/j.ijgo.2011.09.004; Bhutta Z, 2010, LANCET, V376, P1375; Bowser D, 2010, EXPLORING EVIDENCE D; Bustreo F, 2013, LANCET GLOB HEALTH, V1, pE176, DOI 10.1016/S2214-109X(13)70059-7; Campbell, 2013, UNIVERSAL TRUTH NO H; Campbell J, 2013, B WORLD HEALTH ORGAN, V91, P853, DOI 10.2471/BLT.13.118729; Campbell J, 2013, LANCET, V381, P725, DOI 10.1016/S0140-6736(13)60579-6; Colston J., 2011, USE EFFECTIVE COVERA; Ebener S, 2013, 5 INT C HLTH BANGK T; Evans T., 2013, VAL MON ASS COMM BAS; Family Planning 2020, 2012, LOND SUMM FAM PLANN; Gibbons L, 2010, GLOBAL NUMBERS COSTS; Global Alliance for Vaccine and Immunization (GAVI), IMM IS ON MOST COST; Hassan-Bitar S, 2011, MIDWIFERY, V27, P154, DOI 10.1016/j.midw.2009.05.007; High-Level Panel of Eminent Persons on the Post-2015 Development Agenda, 2013, NEW GLOB PARTN ER PO; Homer CSE, 2014, LANCET; Horton R, 2013, LANCET, V382, P382, DOI 10.1016/S0140-6736(13)61641-4; ICM, 2011, ICM INT DEF MIDW; ILO, 2012, INT STAND CLASS OCC, V1; Independent Expert Review Group (iERG), 2013, EV WOM EV CHILD STRE; Info MME, 2013, MAL MAT MORT EST 201; International Confederation of midwives (ICM), 2013, ESS COMP BAS MIDW PR; Jaffre Y, 2003, B AMADES, V56, P639; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kruk ME, 2014, B WORLD HEALTH ORGAN, V92, P246, DOI 10.2471/BLT.13.126417; Kruk ME, 2014, BUSTING MYTHS DO HLT; Kyei NNA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046475; Langer A, 2013, LANCET, V381, P601, DOI 10.1016/S0140-6736(13)60259-7; Lawn JE, 2011, LANCET; Leap N., 2009, BR J MIDWIFERY, V17, P12, DOI [10.12968/bjom.2009.17.1.37646, DOI 10.12968/BJOM.2009.17.1.37646]; Lemiere C, 2011, WOR BANK WORK PAPER, P1, DOI 10.1596/978-0-8213-8599-9; Lemiere C, 2014, PRINC MAH AW C 2014; Mansoor GF, 2013, MIDWIFERY, V29, P1088, DOI 10.1016/j.midw.2013.07.021; Montenegro H, 2012, INT J PERS CENT MED, V2, P93; Ngwenya BN, 2011, HEALTH CARE WOMEN IN, V32, P917, DOI 10.1080/07399332.2011.603860; Rath AD, 2007, REPROD HEALTH MATTER, V15, P72, DOI 10.1016/S0968-8080(07)30329-7; Renfrew MJ, 2014, LANCET; Sandall J, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004667.pub3, 10.1002/14651858.CD004667.pub5]; Schaaf M, 2013, HLTH POLICY PLAN, DOI [10.1093/heapol/czt09, DOI 10.1093/HEAPOL/CZT09]; Scheffler R., 2012, LABOUR MARKET HUMAN; Shaban I, 2012, MIDWIFERY, V28, P106, DOI 10.1016/j.midw.2010.11.012; Shengelia B, 2005, SOC SCI MED, V61, P97, DOI 10.1016/j.socscimed.2004.11.055; Soucat A, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9555-4; Sousa A, 2013, B WORLD HEALTH ORGAN, V91, P892, DOI 10.2471/BLT.13.118927; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Tatem AJ, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-2; ten Hoope-Bender P, 2011, INT J GYNECOL OBSTET, V114, P211, DOI 10.1016/j.ijgo.2011.06.002; UNAIDS, 2011, COUNTD ZER GLOB PLAN; UNFPA, 2011, STAT WORLDS MIDW 201; UNFPA, 2014, STAT WORLDS MIDW 201; UNICEF, 2012, COMM CHILD SURV PROM; United Nations Fund for Population Activities (UNFPA), 2014, FRAM ACT FOLL UP PRO; United Nations Human Rights Council, 2011, PRACT AD HUM RIGHTS; United Nations - Department of Economic and Social Affairs - Population Division, 2012, WORLD POP PROSP 2012; Van Lerberghe W, 2014, LANCET; van Teijlingen E, 2014, MIDWIFERY, V30, P1, DOI 10.1016/j.midw.2013.10.022; Vega J, 2013, LANCET, V381, P179, DOI 10.1016/S0140-6736(13)60062-8; Vujicic M, 2009, MEASURING HLTH WORKF; Walker N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S1; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; WHO, 2014, MAK FAIR CHOIC PATH; WHO, 2014, EV NEWB DRAFT ACT PL; WHO, 2010, FRAM ACT INT ED COLL; WHO, 2005, MAK EV MOTH CHILD CO; Wood ME, 2013, MIDWIFERY, V29, P1137, DOI 10.1016/j.midw.2013.07.004; World Health Organisation, 2010, WORKL IND STAFF NEED; World Health Organization, 2011, WHO GUID PREV EARL P; World Health Organization, 2000, HLTH SYSTEMS IMPROVI; World Health Organization, 2001, BACKGR PAP TECHN CON; World Health Organization, 2013, TRANSF SCAL HLTH PRO; World Health Organization, 2007, EV BUS STRENGTH HLTH; World Health Organization & World Bank, 2013, MON PROGR UN HLTH CO	78	250	251	5	43	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 27	2014	384	9949					1226	1235		10.1016/S0140-6736(14)60930-2	http://dx.doi.org/10.1016/S0140-6736(14)60930-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7MT	24965818				2022-12-01	WOS:000343002600029
J	Praetorius, SK; Mix, AC				Praetorius, Summer K.; Mix, Alan C.			Synchronization of North Pacific and Greenland climates preceded abrupt deglacial warming	SCIENCE			English	Article							LAST DEGLACIATION; OCEAN CIRCULATION; SEA-ICE; ATLANTIC; ACCUMULATION; OSCILLATIONS; VARIABILITY; ANTARCTICA; TOPOGRAPHY; HOLOCENE	Some proposed mechanisms for transmission of major climate change events between the North Pacific and North Atlantic predict opposing patterns of variations; others suggest synchronization. Resolving this conflict has implications for regulation of poleward heat transport and global climate change. New multidecadal-resolution foraminiferal oxygen isotope records from the Gulf of Alaska (GOA) reveal sudden shifts between intervals of synchroneity and asynchroneity with the North Greenland Ice Core Project (NGRIP) delta O-18 record over the past 18,000 years. Synchronization of these regions occurred 15,500 to 11,000 years ago, just prior to and throughout the most abrupt climate transitions of the last 20,000 years, suggesting that dynamic coupling of North Pacific and North Atlantic climates may lead to critical transitions in Earth's climate system.	[Praetorius, Summer K.; Mix, Alan C.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Oregon State University	Praetorius, SK (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	spraetor@coas.oregonstate.edu			NSF [AGS-0602395, OCE-1204204]; Division Of Ocean Sciences [0962077, 1204204] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank B. Jensen and D. Froese for the tephra analyses; J. Southon for assistance with radiocarbon samples; A. Ross, J. Padman, and J. McKay of the College of Earth, Ocean and Atmospheric Sciences Stable Isotope Lab; and five anonymous reviewers. This work was supported by NSF grants AGS-0602395 (Project PALEOVAR) and OCE-1204204 to A. C. M., and an NSF graduate research fellowship to S. K. P. The data can be found in the supplementary online materials and at the National Oceanic and Atmospheric Administration Paleoclimate Database.	ALLEY RB, 1993, NATURE, V362, P527, DOI 10.1038/362527a0; Asahi H, 2007, PROG OCEANOGR, V72, P343, DOI 10.1016/j.pocean.2006.03.021; Bakke J, 2009, NAT GEOSCI, V2, P202, DOI 10.1038/NGEO439; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Barron JA, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000768; Broecker W, 2012, QUATERNARY SCI REV, V57, P17, DOI 10.1016/j.quascirev.2012.09.024; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; BROECKER WS, 1985, NATURE, V315, P21, DOI 10.1038/315021a0; Caissie BE, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2008PA001671; Chang EKM, 2004, J CLIMATE, V17, P4230, DOI 10.1175/JCLI3195.1; Clark PU, 2001, SCIENCE, V293, P283, DOI 10.1126/science.1062517; Cronin TM, 2010, QUATERNARY SCI REV, V29, P3415, DOI 10.1016/j.quascirev.2010.05.024; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Davies MH, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002051; Davies-Walczak M, 2014, EARTH PLANET SC LETT, V397, P57, DOI 10.1016/j.epsl.2014.04.004; Dyke AS, 2004, DEV QUA SCI, V2, P373, DOI 10.1016/S1571-0866(04)80209-4; Gebhardt H, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001513; Justino F, 2005, J CLIMATE, V18, P2826, DOI 10.1175/JCLI3403.1; KENNETT JP, 1995, NATURE, V377, P510, DOI 10.1038/377510a0; Lemieux-Dudon B, 2010, QUATERNARY SCI REV, V29, P8, DOI 10.1016/j.quascirev.2009.11.010; Lenton TM, 2012, CLIM PAST, V8, P1127, DOI 10.5194/cp-8-1127-2012; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Li C, 2009, CLIM DYNAM, V32, P753, DOI 10.1007/s00382-009-0529-4; Livina VN, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028672; Lund DC, 1998, PALEOCEANOGRAPHY, V13, P10, DOI 10.1029/97PA02984; Max L, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002292; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Mix AC, 1999, GEOPH MONOG SERIES, V112, P127; Monnin E, 2004, EARTH PLANET SC LETT, V224, P45, DOI 10.1016/j.epsl.2004.05.007; Okazaki Y, 2010, SCIENCE, V329, P200, DOI 10.1126/science.1190612; Okumura YM, 2009, J CLIMATE, V22, P1424, DOI 10.1175/2008JCLI2511.1; Pausata FSR, 2011, CLIM PAST, V7, P1089, DOI 10.5194/cp-7-1089-2011; Pedro JB, 2011, CLIM PAST, V7, P671, DOI 10.5194/cp-7-671-2011; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Saenko OA, 2004, J CLIMATE, V17, P2033, DOI 10.1175/1520-0442(2004)017<2033:TAS>2.0.CO;2; Sarnthein M, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000771; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; SHAFFER G, 1994, NATURE, V367, P354, DOI 10.1038/367354a0; Steffensen JP, 2008, SCIENCE, V321, P680, DOI 10.1126/science.1157707; Timmermann A, 2004, CLIM DYNAM, V23, P353, DOI 10.1007/s00382-004-0434-9; Ullman DJ, 2014, CLIM PAST, V10, P487, DOI 10.5194/cp-10-487-2014; Waelbroeck C, 2001, NATURE, V412, P724, DOI 10.1038/35089060; Weaver AJ, 2003, SCIENCE, V299, P1709, DOI 10.1126/science.1081002; Wu LX, 2005, J CLIMATE, V18, P331, DOI 10.1175/JCLI-3264.1	46	63	63	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					444	448		10.1126/science.1252000	http://dx.doi.org/10.1126/science.1252000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061208				2022-12-01	WOS:000339655100041
J	Rohr, RP; Saavedra, S; Bascompte, J				Rohr, Rudolf P.; Saavedra, Serguei; Bascompte, Jordi			On the structural stability of mutualistic systems	SCIENCE			English	Article							FACILITATE BIODIVERSITY MAINTENANCE; GENERALIZED VOLTERRA TYPE; COEVOLUTIONARY NETWORKS; GLOBAL STABILITY; DISENTANGLING NESTEDNESS; ECOLOGICAL-SYSTEMS; ECOSYSTEMS; MODEL; COMMUNITIES; COMPETITION	In theoretical ecology, traditional studies based on dynamical stability and numerical simulations have not found a unified answer to the effect of network architecture on community persistence. Here, we introduce a mathematical framework based on the concept of structural stability to explain such a disparity of results. We investigated the range of conditions necessary for the stable coexistence of all species in mutualistic systems. We show that the apparently contradictory conclusions reached by previous studies arise as a consequence of overseeing either the necessary conditions for persistence or its dependence on model parameterization. We show that observed network architectures maximize the range of conditions for species coexistence. We discuss the applicability of structural stability to study other types of interspecific interactions.	[Rohr, Rudolf P.; Saavedra, Serguei; Bascompte, Jordi] CSIC, EBD, Integrat Ecol Grp, E-41092 Seville, Spain; [Rohr, Rudolf P.] Univ Fribourg, Dept Biol, Unit Ecol & Evolut, CH-1700 Fribourg, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Fribourg	Bascompte, J (corresponding author), CSIC, EBD, Integrat Ecol Grp, Calle Americo Vespucio S-N, E-41092 Seville, Spain.	bascompte@ebd.csic.es	Rohr, Rudolf Philippe/K-9232-2015; Bascompte, Jordi/B-7596-2008	Rohr, Rudolf Philippe/0000-0002-6440-2696; Bascompte, Jordi/0000-0002-0108-6411	European Research Council; FP7-REGPOT-2010-1 program [264125 EcoGenes]	European Research Council(European Research Council (ERC)European Commission); FP7-REGPOT-2010-1 program	We thank U. Bastolla, L.-F. Bersier, V. Dakos, A. Ferrera, M. A. Fortuna, L. J. Gilarranz, S. Kefi, J. Lever, B. Luque, A. M. Neutel, A. Pascual-Garcia, D. B. Stouffer, and J. Tylianakis for insightful discussions. We thank S. Baigent for pointing out the counter-example in (53). Funding was provided by the European Research Council through an Advanced Grant (J. B.) and FP7-REGPOT-2010-1 program under project 264125 EcoGenes (R.P.R.). The data are publicly available at www.web-of-life.es.	ALBERCH P, 1985, EVOLUTION, V39, P8, DOI 10.1111/j.1558-5646.1985.tb04076.x; Alberch P., 1989, GEOBIOS, V12, P21, DOI DOI 10.1016/S0016-6995(89)80006-3; Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Arnold V.I., 1988, GEOMETRICAL METHODS, V2nd; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bastolla U, 2005, J THEOR BIOL, V235, P521, DOI 10.1016/j.jtbi.2005.02.005; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Case T. J., 2000, AN ILLUSTRATED GUIDE; CASE TJ, 1990, P NATL ACAD SCI USA, V87, P9610, DOI 10.1073/pnas.87.24.9610; CASE TJ, 1979, AM NAT, V113, P705, DOI 10.1086/283427; GOH BS, 1979, AM NAT, V113, P261, DOI 10.1086/283384; GOH BS, 1977, AM NAT, V111, P135, DOI 10.1086/283144; Holland JN, 2006, SCIENCE, V313, P1887, DOI 10.1126/science.1129547; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; James A, 2012, NATURE, V487, P227, DOI 10.1038/nature11214; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kolmogorov A., 1936, GIORNALE ISTITUTO DE, V7, P74; Kuznetsov Yu. A., 2004, ELEMENTS OF APPLIED; Logofet D. O., 1992, MATRICES AND GRAPHS; Logofet DO, 2005, LINEAR ALGEBRA APPL, V398, P75, DOI 10.1016/j.laa.2003.04.001; MACARTHUR R, 1970, Theoretical Population Biology, V1, P1, DOI 10.1016/0040-5809(70)90039-0; Margalef R, 1968, PERSPECTIVES IN ECOL; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McCullagh P. N., 1989, GENERALIZED LINEAR M; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; Ollerton J, 2003, ANN BOT-LONDON, V92, P807, DOI 10.1093/aob/mcg206; Pimm SL, 2002, FOOD WEBS; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; ROBERTS A, 1974, NATURE, V251, P607, DOI 10.1038/251607a0; Rohr R. P., 2013, ARXIV 1310 4633; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Saavedra S, 2013, NATURE, V500, pE1, DOI 10.1038/nature12380; Saavedra S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3350; SOLE RV, 1992, J THEOR BIOL, V155, P87, DOI 10.1016/S0022-5193(05)80550-8; Suweis S, 2013, NATURE, V500, P449, DOI 10.1038/nature12438; Svirezhev Y. M., 1982, STABILITY OF BIOLOGI; TAKEUCHI Y, 1980, J MATH BIOL, V10, P401, DOI 10.1007/BF00276098; TAKEUCHI Y, 1978, MATH BIOSCI, V42, P119, DOI 10.1016/0025-5564(78)90010-X; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thom R., 1994, STRUCTURAL STABILITY; Thompson D. A. W., 1992, ON GROWTH AND FORM; Thompson JN, 2005, THE GEOGRAPHIC MOSAI; Turchin P, 1997, AM NAT, V149, P842, DOI 10.1086/286027; VANDERMEER J H, 1970, American Naturalist, V104, P73, DOI 10.1086/282641; VANDERMEER JH, 1975, SCIENCE, V188, P253, DOI 10.1126/science.1118725; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; WRIGHT DH, 1989, AM NAT, V134, P664, DOI 10.1086/285003	52	292	298	13	247	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					416	+		10.1126/science.1253497	http://dx.doi.org/10.1126/science.1253497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7PY	25061214	Green Submitted			2022-12-01	WOS:000349821000001
J	Hickman, AB; Ewis, HE; Li, XH; Knapp, JA; Laver, T; Doss, AL; Tolun, G; Steven, AC; Grishaev, A; Bax, A; Atkinson, PW; Craig, NL; Dyda, F				Hickman, Alison B.; Ewis, Hosam E.; Li, Xianghong; Knapp, Joshua A.; Laver, Thomas; Doss, Anna-Louise; Tolun, Goekhan; Steven, Alasdair C.; Grishaev, Alexander; Bax, Ad; Atkinson, Peter W.; Craig, Nancy L.; Dyda, Fred			Structural Basis of hAT Transposon End Recognition by Hermes, an Octameric DNA Transposase from Musca domestica	CELL			English	Article							X-RAY-SCATTERING; BINDING DOMAIN; SUBTERMINAL SEQUENCES; PUTATIVE TRANSPOSASE; V(D)J RECOMBINATION; AC ELEMENT; HOBO; ARABIDOPSIS; DROSOPHILA; REVEALS	Hermes is a member of the hAT transposon superfamily that has active representatives, including McClintock's archetypal Ac mobile genetic element, in many eukaryotic species. The crystal structure of the Hermes transposase-DNA complex reveals that Hermes forms an octameric ring organized as a tetramer of dimers. Although isolated dimers are active in vitro for all the chemical steps of transposition, only octamers are active in vivo. The octamer can provide not only multiple specific DNA-binding domains to recognize repeated subterminal sequences within the transposon ends, which are important for activity, but also multiple nonspecific DNA binding surfaces for target capture. The unusual assembly explains the basis of bipartite DNA recognition at hAT transposon ends, provides a rationale for transposon end asymmetry, and suggests how the avidity provided by multiple sites of interaction could allow a transposase to locate its transposon ends amidst a sea of chromosomal DNA.	[Hickman, Alison B.; Dyda, Fred] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Ewis, Hosam E.; Li, Xianghong; Craig, Nancy L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Knapp, Joshua A.; Atkinson, Peter W.] Univ Calif Riverside, Grad Program Biochem & Mol Biol, Riverside, CA 92521 USA; [Laver, Thomas; Atkinson, Peter W.] Univ Calif Riverside, Grad Program Genet Genom & Bioinformat, Riverside, CA 92521 USA; [Doss, Anna-Louise; Atkinson, Peter W.] Univ Calif Riverside, Grad Program Cell Mol & Dev Biol, Riverside, CA 92521 USA; [Atkinson, Peter W.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Atkinson, Peter W.] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Tolun, Goekhan; Steven, Alasdair C.] NIAMSD, Struct Biol Res Lab, NIH, Bethesda, MD 20892 USA; [Grishaev, Alexander; Bax, Ad] NIDDK, Phys Chem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Howard Hughes Medical Institute; Johns Hopkins University; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Dyda, F (corresponding author), NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	fred.dyda@nih.gov	TOLUN, Gökhan/D-1971-2012; Wilson, Matthew H/K-3193-2013; Tolun, Gokhan/AAG-9606-2021	TOLUN, Gökhan/0000-0001-6166-9451; Tolun, Gokhan/0000-0001-6166-9451; Grishaev, Alexander/0000-0002-9347-2327	NIH Intramural Programs of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Public Health Service (PHS) award [A1045741]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036153] Funding Source: NIH RePORTER	NIH Intramural Programs of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Public Health Service (PHS) award; US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partially funded by the NIH Intramural Programs of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (F.D. and A.B.) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (A.C.S.). P.W.A. and N.L.C. were funded by Public Health Service (PHS) award A1045741. Crystallographic data were collected at the SER-CAT 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory (ANL). For the SAXS experiments, we gratefully acknowledge use of the shared scattering beamline 12-IDC resource allocated under the PUP-77 agreement between the National Cancer Institute and ANL and thank Soenke Seifert (ANL) for his support. Use of the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract W-31-109-Eng-38. We thank Sriram Subramaniam and members of his laboratory for their preliminary EM efforts. We also thank Nadine Samara for critical reading of the manuscript, Primrose Musingarimi for help with Sf9-expressed Hermes, Robert Hice for assistance with EMSA and insect cell culture experiments, and Susan Chacko of the Helix systems group, CIT, NIH for advice and help with fuzznuc.	Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P421, DOI 10.1016/S0968-0004(00)01620-0; Arensburger P, 2011, GENETICS, V188, P45, DOI 10.1534/genetics.111.126813; ATKINSON PW, 1993, P NATL ACAD SCI USA, V90, P9693, DOI 10.1073/pnas.90.20.9693; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Becker HA, 1997, MOL GEN GENET, V254, P219, DOI 10.1007/s004380050410; Biemont C, 2010, GENETICS, V186, P1085, DOI 10.1534/genetics.110.124180; BLACKMAN RK, 1989, EMBO J, V8, P211, DOI 10.1002/j.1460-2075.1989.tb03366.x; Cherepanov P, 2011, CURR OPIN STRUC BIOL, V21, P249, DOI 10.1016/j.sbi.2010.12.005; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Dawson A, 2003, MOL CELL, V11, P225, DOI 10.1016/S1097-2765(02)00798-0; Gangadharan S, 2010, P NATL ACAD SCI USA, V107, P21966, DOI 10.1073/pnas.1016382107; Gao J, 2006, INSECT MOL BIOL, V15, P835, DOI 10.1111/j.1365-2583.2006.00690.x; Grishaev A, 2010, J AM CHEM SOC, V132, P15484, DOI 10.1021/ja106173n; Grundy GJ, 2009, MOL CELL, V35, P217, DOI 10.1016/j.molcel.2009.06.022; HALLET B, 1994, MOL MICROBIOL, V14, P131, DOI 10.1111/j.1365-2958.1994.tb01273.x; Hashida SN, 2006, PLANT CELL, V18, P104, DOI 10.1105/tpc.105.037655; HEHL R, 1991, PLANT MOL BIOL, V16, P369, DOI 10.1007/BF00020572; Hickman AB, 2010, CRIT REV BIOCHEM MOL, V45, P50, DOI 10.3109/10409230903505596; Huang CRL, 2012, ANNU REV GENET, V46, P651, DOI 10.1146/annurev-genet-110711-155616; Kahlon AS, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-9; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kim YJ, 2011, GENETICA, V139, P985, DOI 10.1007/s10709-011-9600-2; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; KUNZE R, 1989, EMBO J, V8, P3177, DOI 10.1002/j.1460-2075.1989.tb08476.x; Kunze R., 2002, MOBILE DNA, P565, DOI DOI 10.1128/9781555817954.CH24; LAVOIE BD, 1991, EMBO J, V10, P3051, DOI 10.1002/j.1460-2075.1991.tb07856.x; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Liu D, 1998, GENETICS, V149, P693; Liu D, 2001, GENETICS, V157, P817; Mack AM, 2001, PLANT CELL, V13, P2319, DOI 10.1105/tpc.13.10.2319; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; Montano SP, 2012, NATURE, V491, P413, DOI 10.1038/nature11602; Oh J, 2006, J VIROL, V80, P451, DOI 10.1128/JVI.80.1.451-459.2006; Pribil PA, 2003, J MOL BIOL, V330, P247, DOI 10.1016/S0022-2836(03)00588-6; Rambo RP, 2013, ANNU REV BIOPHYS, V42, P415, DOI 10.1146/annurev-biophys-083012-130301; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Rubin E, 2001, GENETICS, V158, P949; Sarkar A, 1997, GENETICA, V99, P15, DOI 10.1023/A:1018349803656; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; STRECK RD, 1986, EMBO J, V5, P3615, DOI 10.1002/j.1460-2075.1986.tb04690.x; VandenDriessche T, 2009, BLOOD, V114, P1461, DOI 10.1182/blood-2009-04-210427; WARREN WD, 1994, GENET RES, V64, P87, DOI 10.1017/S0016672300032699; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Yin FF, 2009, NAT STRUCT MOL BIOL, V16, P499, DOI 10.1038/nsmb.1593; Yuan YW, 2011, P NATL ACAD SCI USA, V108, P7884, DOI 10.1073/pnas.1104208108; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157	52	47	52	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					353	367		10.1016/j.cell.2014.05.037	http://dx.doi.org/10.1016/j.cell.2014.05.037			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036632	Bronze, Green Accepted			2022-12-01	WOS:000340943600015
J	Jae, LT; Raaben, M; Herbert, AS; Kuehne, AI; Wirchnianski, AS; Soh, TK; Stubbs, SH; Janssen, H; Damme, M; Saftig, P; Whelan, SP; Dye, JM; Brummelkamp, TR				Jae, Lucas T.; Raaben, Matthijs; Herbert, Andrew S.; Kuehne, Ana I.; Wirchnianski, Ariel S.; Soh, Timothy K.; Stubbs, Sarah H.; Janssen, Hans; Damme, Markus; Saftig, Paul; Whelan, Sean P.; Dye, John M.; Brummelkamp, Thijn R.			Lassa virus entry requires a trigger-induced receptor switch	SCIENCE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; ALPHA-DYSTROGLYCAN; HUMAN AIRWAY; MEMBRANE; BINDING; SPECIFICITY; INHIBITORS; COMPLEX; FEVER; CELLS	Lassa virus spreads from a rodent to humans and can lead to lethal hemorrhagic fever. Despite its broad tropism, chicken cells were reported 30 years ago to resist infection. We found that Lassa virus readily engaged its cell-surface receptor a-dystroglycan in avian cells, but virus entry in susceptible species involved a pH-dependent switch to an intracellular receptor, the lysosome-resident protein LAMP1. Iterative haploid screens revealed that the sialyltransferase ST3GAL4 was required for the interaction of the virus glycoprotein with LAMP1. A single glycosylated residue in LAMP1, present in susceptible species but absent in birds, was essential for interaction with the Lassa virus envelope protein and subsequent infection. The resistance of Lamp1-deficient mice to Lassa virus highlights the relevance of this receptor switch in vivo.	[Jae, Lucas T.; Raaben, Matthijs; Janssen, Hans; Brummelkamp, Thijn R.] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Raaben, Matthijs; Soh, Timothy K.; Stubbs, Sarah H.; Whelan, Sean P.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Herbert, Andrew S.; Kuehne, Ana I.; Wirchnianski, Ariel S.; Dye, John M.] US Army, Med Res Inst Infect Dis, Frederick, MD 21702 USA; [Damme, Markus; Saftig, Paul] Univ Kiel, Inst Biochem, D-24118 Kiel, Germany; [Brummelkamp, Thijn R.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Brummelkamp, Thijn R.] Cancer Genom Ctr CGC Nl, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Harvard University; Harvard Medical School; University of Kiel; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Brummelkamp, TR (corresponding author), Netherlands Canc Inst, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	sean_whelan@hms.harvard.edu; john.m.dye1.civ@mail.mil; t.brummelkamp@nki.nl	Jae, Lucas/AAH-5342-2020; Jae, Lucas/AAY-3438-2021; Saftig, Paul/A-7966-2010	Jae, Lucas/0000-0002-3531-1760; Dye, John/0000-0002-0883-5016; Raaben, Matthijs/0000-0001-5989-289X; Whelan, Sean/0000-0003-1564-8590; Stubbs, Sarah Hulsey/0000-0002-3261-191X	CGC.nl; Nederlandse Organisatie voor Wetenschappelijk Onderzoek Vidi grant [91711316]; European Research Council (ERC) Starting Grant [ERC-2012-StG 309634]; Deutsche Forschungsgemeinschaft [DFG SPP1580, GRK1459]; NIH [AI081842, AI109740]; Defense Threat Reduction Agency [CB3947]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007245, R56AI081842, R01AI081842, U19AI109740] Funding Source: NIH RePORTER	CGC.nl; Nederlandse Organisatie voor Wetenschappelijk Onderzoek Vidi grant; European Research Council (ERC) Starting Grant(European Research Council (ERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Sixma, A. Perrakis, E. von Castelmur, D. Lefeber, and members of the Brummelkamp group for discussion; M. Rusch for mouse breeding; S. Kunz for a plasmid encoding Lassa-GP; E. Ollmann-Saphire for an Fc-fusion vector; R. Schoepp for GP1 antibodies; and M. Verheije for DF1 cells. This work was supported by CGC.nl, Nederlandse Organisatie voor Wetenschappelijk Onderzoek Vidi grant 91711316, and European Research Council (ERC) Starting Grant (ERC-2012-StG 309634) to T. R. B.; Deutsche Forschungsgemeinschaft (DFG SPP1580 and GRK1459) to P. S.; and NIH grants AI081842 and AI109740 to S. P. W. J.M.D was supported by the Defense Threat Reduction Agency (CB3947). The HAP1 cells that were used are distributed under a materials transfer agreement. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the U.S. Army. T. R. B. is a cofounder and shareholder of Haplogen GmbH, a company involved in haploid genetics. Sequencing data are accessible at www.ncbi.nlm.nih.gov/sra (accession SRP041566).	Andrejewski N, 1999, J BIOL CHEM, V274, P12692, DOI 10.1074/jbc.274.18.12692; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; CARLSSON SR, 1993, ARCH BIOCHEM BIOPHYS, V304, P65, DOI 10.1006/abbi.1993.1322; Cosset FL, 2009, J VIROL, V83, P3228, DOI 10.1128/JVI.01711-08; de Graaf M, 2014, EMBO J, V33, P823, DOI 10.1002/embj.201387442; DISIMONE C, 1995, VIROLOGY, V209, P3, DOI 10.1006/viro.1995.1225; Haas WH, 2003, CLIN INFECT DIS, V36, P1254, DOI 10.1086/374853; HEFFERNAN M, 1989, CANCER RES, V49, P6077; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Kunz S, 2005, J VIROL, V79, P14282, DOI 10.1128/JVI.79.22.14282-14296.2005; Lozach PY, 2011, CURR OPIN VIROL, V1, P35, DOI 10.1016/j.coviro.2011.05.004; LUKASHEVICH IS, 1983, ACTA VIROL, V27, P282; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nunberg JH, 2012, VIRUSES-BASEL, V4, P83, DOI 10.3390/v4010083; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Saito F, 2005, FEBS LETT, V579, P2359, DOI 10.1016/j.febslet.2005.03.033; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; WANG WC, 1988, J BIOL CHEM, V263, P4576; York J, 2008, J VIROL, V82, P10932, DOI 10.1128/JVI.01140-08; Zhu WY, 2011, BIOMED ENVIRON SCI, V24, P81, DOI 10.3967/0895-3988.2011.01.011	23	169	175	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1506	1510		10.1126/science.1252480	http://dx.doi.org/10.1126/science.1252480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970085	Green Accepted			2022-12-01	WOS:000337889900048
J	Cathomen, T; Ehl, S				Cathomen, Toni; Ehl, Stephan			Translating the Genomic Revolution - Targeted Genome Editing in Primates	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GENE; CELLS		[Cathomen, Toni; Ehl, Stephan] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany; [Cathomen, Toni] Univ Med Ctr Freiburg, Inst Cell & Gene Therapy, Freiburg, Germany; [Ehl, Stephan] Univ Med Ctr Freiburg, Dept Pediat & Adolescent Med, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Cathomen, T (corresponding author), Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany.		Ehl, Stephan/AAM-6006-2020; Cathomen, Toni/ABG-8410-2021; Cathomen, Toni/GZL-2702-2022	Cathomen, Toni/0000-0002-7757-4630; Cathomen, Toni/0000-0002-7757-4630; Ehl, Stephan/0000-0002-9265-2721				[Anonymous], 2013, SCIENCE, V342, P1434; de Souza N, 2012, NAT METHODS, V9, P27, DOI 10.1038/nmeth.1848; Garate Z, 2013, HUM GENE THER, V24, P571, DOI 10.1089/hum.2012.251; Liu HL, 2014, CELL STEM CELL, V14, P323, DOI 10.1016/j.stem.2014.01.018; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662	6	15	15	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2014	370	24					2342	2345		10.1056/NEJMcibr1403629	http://dx.doi.org/10.1056/NEJMcibr1403629			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7BB	24918378				2022-12-01	WOS:000337033700015
J	Pellissier, L; Leprieur, F; Parravicini, V; Cowman, PF; Kulbicki, M; Litsios, G; Olsen, SM; Wisz, MS; Bellwood, DR; Mouillot, D				Pellissier, Loic; Leprieur, Fabien; Parravicini, Valeriano; Cowman, Peter F.; Kulbicki, Michel; Litsios, Glenn; Olsen, Steffen M.; Wisz, Mary S.; Bellwood, David R.; Mouillot, David			Quaternary coral reef refugia preserved fish diversity	SCIENCE			English	Article							GLOBAL PATTERNS; ASSEMBLY RULES; BIODIVERSITY; HOTSPOTS; CRADLES; MUSEUMS; AREAS	The most prominent pattern in global marine biogeography is the biodiversity peak in the Indo-Australian Archipelago. Yet the processes that underpin this pattern are still actively debated. By reconstructing global marine paleoenvironments over the past 3 million years on the basis of sediment cores, we assessed the extent to which Quaternary climate fluctuations can explain global variation in current reef fish richness. Comparing global historical coral reef habitat availability with the present-day distribution of 6316 reef fish species, we find that distance from stable coral reef habitats during historical periods of habitat loss explains 62% of the variation in fish richness, outweighing present-day environmental factors. Our results highlight the importance of habitat persistence during periods of climate change for preserving marine biodiversity.	[Pellissier, Loic] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Pellissier, Loic; Wisz, Mary S.] Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark; [Leprieur, Fabien; Mouillot, David] UM1, UM2, Inst Francais Rech Exploitat Mer, IRD,CNRS,Lab Ecol Syst Marins Cotiers UMR 5119,Cc, Pl E Bataillon, FR-34095 Montpellier 5, France; [Parravicini, Valeriano; Kulbicki, Michel] IRD, UR CoReUs 227, LABEX Lab Excellence Corail, Lab Arago, FR-66651 Banyuls Sur Mer, France; [Parravicini, Valeriano] FRB, CESAB Ctr Synth & Anal Biodiversite, FR-13857 Aix En Provence 3, France; [Cowman, Peter F.] Australian Natl Univ, Res Sch Biol, Ctr Macroevolut & Macroecol, Canberra, ACT 0200, Australia; [Litsios, Glenn] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Litsios, Glenn] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Olsen, Steffen M.] Danish Meteorol Inst, Ctr Ocean & Ice, DK-2100 Copenhagen, Denmark; [Wisz, Mary S.] DHI Water & Environm, Dept Ecol & Environm, DK-2970 Horsholm, Denmark; [Bellwood, David R.; Mouillot, David] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Bellwood, David R.; Mouillot, David] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	University of Fribourg; Aarhus University; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Australian National University; University of Lausanne; Swiss Institute of Bioinformatics; Danish Meteorological Institute DMI; James Cook University; James Cook University	Mouillot, D (corresponding author), UM1, UM2, Inst Francais Rech Exploitat Mer, IRD,CNRS,Lab Ecol Syst Marins Cotiers UMR 5119,Cc, Pl E Bataillon, FR-34095 Montpellier 5, France.	david.mouillot@univ-montp2.fr	Leprieur, Fabien/ABA-4433-2020; Pellissier, Loïc/J-2563-2015; Cowman, Peter Francis/G-9998-2017; Pellissier, Loïc/AAG-1013-2020; Parravicini, Valeriano/A-8539-2011	Pellissier, Loïc/0000-0002-2289-8259; Cowman, Peter Francis/0000-0001-5977-5327; Pellissier, Loïc/0000-0002-2289-8259; Parravicini, Valeriano/0000-0002-3408-1625; Kulbicki, Michel/0000-0003-1258-5061; Wisz, Mary S./0000-0002-5357-6367	Danish Council for Independent Research [12-126430]; Marie Curie [IOF-GA-2009-236316]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Marie Curie(European Commission)	This study was supported by grants from the Danish Council for Independent Research no. 12-126430 to L. P., Marie Curie IOF-GA-2009-236316 to D. M., FRB CESAB-General Approach to Species-Abundance Relationships in a context of global change, reef fish species as a model, and the Australian Research Council. We thank three anonymous reviewers for valuable comments on the manuscript. We thank J. P. Krajewski and S. Gingins for the fish images. Data are available in the supplementary materials.	Barber PH, 2005, MOL PHYLOGENET EVOL, V35, P235, DOI 10.1016/j.ympev.2004.10.004; Bellwood D. R., 2002, CORAL REEF FISHES DY, P5; Bellwood DR, 2009, J BIOGEOGR, V36, P569, DOI 10.1111/j.1365-2699.2008.02029.x; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bonin MC, 2011, ECOLOGY, V92, P1503, DOI 10.1890/10-0627.1; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Chown SL, 2000, TRENDS ECOL EVOL, V15, P311, DOI 10.1016/S0169-5347(00)01910-8; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Cowman PF, 2013, J BIOGEOGR, V40, P209, DOI 10.1111/jbi.12003; Fjeldsa J, 1997, BIODIVERS CONSERV, V6, P325, DOI 10.1023/A:1018356506390; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Herbert TD, 2010, SCIENCE, V328, P1530, DOI 10.1126/science.1185435; Hughes TP, 2012, CURR BIOL, V22, P736, DOI 10.1016/j.cub.2012.02.068; Kiessling W, 2012, P NATL ACAD SCI USA, V109, P21378, DOI 10.1073/pnas.1214037110; Kleypas JA, 1999, AM ZOOL, V39, P146; Kohn A. J., 1995, P 5 INT COR REEF C, V4, P139; Luiz OJ, 2013, P NATL ACAD SCI USA, V110, P16498, DOI 10.1073/pnas.1304074110; McKenna DD, 2006, P NATL ACAD SCI USA, V103, P10947, DOI 10.1073/pnas.0602712103; McManus J. W., 1985, PROC 5 INT CORAL REE, V4, P133; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Mora C, 2003, NATURE, V421, P933, DOI 10.1038/nature01393; Mora C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001682; O'Dea A, 2007, P NATL ACAD SCI USA, V104, P5501, DOI 10.1073/pnas.0610947104; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parravicini V, 2013, ECOGRAPHY, V36, P1254, DOI 10.1111/j.1600-0587.2013.00291.x; PAULAY G, 1990, PALEOBIOLOGY, V16, P415, DOI 10.1017/S0094837300010162; Potts D. C., 1985, PROC 5 INT CORAL REE, V4, P127; Price SA, 2011, ECOL LETT, V14, P462, DOI 10.1111/j.1461-0248.2011.01607.x; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Veron J.E.N., 2000, CORALS WORLD, V1-3	33	127	130	1	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1016	1019		10.1126/science.1249853	http://dx.doi.org/10.1126/science.1249853			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876495	Green Submitted			2022-12-01	WOS:000336495800042
J	Wilhelm, BG; Mandad, S; Truckenbrodt, S; Krohnert, K; Schafer, C; Rammner, B; Koo, SJ; Classen, GA; Krauss, M; Haucke, V; Urlaub, H; Rizzoli, SO				Wilhelm, Benjamin G.; Mandad, Sunit; Truckenbrodt, Sven; Kroehnert, Katharina; Schaefer, Christina; Rammner, Burkhard; Koo, Seong Joo; Classen, Gala A.; Krauss, Michael; Haucke, Volker; Urlaub, Henning; Rizzoli, Silvio O.			Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins	SCIENCE			English	Article							NEUROTRANSMITTER RELEASE; SYNTAXIN CLUSTERS; MEMBRANE; FUSION; POOL; QUANTIFICATION; EXOCYTOSIS; SYNAPSES; ENDOCYTOSIS; SUFFICIENT	Synaptic vesicle recycling has long served as a model for the general mechanisms of cellular trafficking. We used an integrative approach, combining quantitative immunoblotting and mass spectrometry to determine protein numbers; electron microscopy to measure organelle numbers, sizes, and positions; and super-resolution fluorescence microscopy to localize the proteins. Using these data, we generated a three-dimensional model of an "average" synapse, displaying 300,000 proteins in atomic detail. The copy numbers of proteins involved in the same step of synaptic vesicle recycling correlated closely. In contrast, copy numbers varied over more than three orders of magnitude between steps, from about 150 copies for the endosomal fusion proteins to more than 20,000 for the exocytotic ones.	[Wilhelm, Benjamin G.; Truckenbrodt, Sven; Kroehnert, Katharina; Schaefer, Christina; Rammner, Burkhard; Rizzoli, Silvio O.] Univ Gottingen, European Neurosci Inst, Cluster Excellence Nanoscale Microscopy & Mol Phy, Med Ctr,Dept Neuro & Sensory Physiol, D-37073 Gottingen, Germany; [Wilhelm, Benjamin G.] Int Max Planck Res Sch Neurosci, D-37077 Gottingen, Germany; [Mandad, Sunit; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Dept Clin Chem, D-37075 Gottingen, Germany; [Truckenbrodt, Sven] Int Max Planck Res Sch Mol Biol, D-37077 Gottingen, Germany; [Koo, Seong Joo; Classen, Gala A.; Krauss, Michael; Haucke, Volker] Leibniz Inst Mol Pharmacol, Dept Mol Pharmacol & Cell Biol, D-13125 Berlin, Germany	University of Gottingen; Max Planck Society; Max Planck Society; University of Gottingen; Max Planck Society; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Rizzoli, SO (corresponding author), Univ Gottingen, European Neurosci Inst, Cluster Excellence Nanoscale Microscopy & Mol Phy, Med Ctr,Dept Neuro & Sensory Physiol, D-37073 Gottingen, Germany.	srizzol@gwdg.de	Rizzoli, Silvio/ABG-2227-2020; 889, CRC/L-1607-2018	889, CRC/0000-0002-6678-3138; Rizzoli, Silvio/0000-0002-1667-7839; Krauss, Michael/0000-0003-1010-9723; Truckenbrodt, Sven/0000-0002-7741-3837; Haucke, Volker/0000-0003-3119-6993	Boehringer Ingelheim Fonds PhD Fellowship; Excellence Stipend of the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB); European Research Council (FP7 NANOMAP and ERC-CoG NeuroMolAnatomy); Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain; DFG [RI 1967 2/1, RI 1967 3/1, SFB 889/A5, Exc-257-Neurocure, SFB 958/A01, SFB 889, SFB 958/A11]	Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); Excellence Stipend of the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB); European Research Council (FP7 NANOMAP and ERC-CoG NeuroMolAnatomy); Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	We thank the following collaborators for providing purified proteins and antibodies: R. Jahn, C. Griesinger, B. Shwaller, and A. Roux. We thank H. Martens for technical help and support, B. Rizzoli for helpful comments on the manuscript, and T. Sargeant for providing the carve source code for creation of the voltage-dependent anion channel (VDAC)-based mitochondrial membrane cut-outs. B. G. W. was supported by a Boehringer Ingelheim Fonds PhD Fellowship. S. T. was supported by an Excellence Stipend of the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB). The work was supported by grants to S.O.R. from the European Research Council (FP7 NANOMAP and ERC-2013-CoG NeuroMolAnatomy) and from the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain, as well as from DFG grants RI 1967 2/1, RI 1967 3/1, and SFB 889/A5. We acknowledge support by the DFG to V. H. (Exc-257-Neurocure and SFB 958/A01), H. U. (SFB 889), and M. K. (SFB 958/A11). Author contributions: B. G. W. prepared the synaptosomes and performed all immunoblotting experiments. K. K. performed the electron microscopy imaging and all neuromuscular junction imaging. C. S. performed the hippocampal culture imaging. S. T. performed the synaptosome imaging. B. R. generated the synapse model. S.J.K., G. A. C., and M. K. participated in the biochemistry experiments. S. M. and H. U. designed and performed all mass spectrometry experiments. S.O.R., B. G. W., and V. H. designed the experiments. All authors analyzed the data and contributed to writing the manuscript.	Bar-On D, 2012, J BIOL CHEM, V287, P27158, DOI 10.1074/jbc.M112.353250; Bonanomi D, 2006, PROG NEUROBIOL, V80, P177, DOI 10.1016/j.pneurobio.2006.09.002; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; Cohen LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063191; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Darna M, 2009, J BIOL CHEM, V284, P4300, DOI 10.1074/jbc.M805480200; Denker A, 2011, P NATL ACAD SCI USA, V108, P17183, DOI 10.1073/pnas.1112690108; Denker A, 2011, P NATL ACAD SCI USA, V108, P17177, DOI 10.1073/pnas.1112688108; Haucke V, 2011, NAT REV NEUROSCI, V12, P127, DOI 10.1038/nrn2948; Hoopmann P, 2010, P NATL ACAD SCI USA, V107, P19055, DOI 10.1073/pnas.1007037107; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Marra V, 2012, NEURON, V76, P579, DOI 10.1016/j.neuron.2012.08.042; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Mutch SA, 2011, J NEUROSCI, V31, P1461, DOI 10.1523/JNEUROSCI.3805-10.2011; NICHOLLS DG, 1986, NATURE, V321, P772, DOI 10.1038/321772a0; Opazo F, 2010, TRAFFIC, V11, P800, DOI 10.1111/j.1600-0854.2010.01058.x; Rizzoli SO, 2006, TRAFFIC, V7, P1163, DOI 10.1111/j.1600-0854.2006.00466.x; Rizzoli SO, 2014, EMBO J, V33, P788, DOI 10.1002/embj.201386357; Rose T, 2013, NEURON, V77, P1109, DOI 10.1016/j.neuron.2013.01.021; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shnyrova AV, 2013, SCIENCE, V339, P1433, DOI 10.1126/science.1233920; Shupliakov O, 2009, NEUROSCIENCE, V158, P204, DOI 10.1016/j.neuroscience.2008.03.035; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Sinha R, 2011, P NATL ACAD SCI USA, V108, P14318, DOI 10.1073/pnas.1101818108; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Uytterhoeven V, 2011, CELL, V145, P117, DOI 10.1016/j.cell.2011.02.039; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592	34	429	435	5	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1023	1028		10.1126/science.1252884	http://dx.doi.org/10.1126/science.1252884			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876496				2022-12-01	WOS:000336495800044
J	Woolhouse, M; Farrar, J				Woolhouse, Mark; Farrar, Jeremy			An intergovernmental panel on antimicrobial resistance	NATURE			English	Editorial Material							ANTIBIOTIC-RESISTANCE		[Woolhouse, Mark] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh EH8 9YL, Midlothian, Scotland; [Farrar, Jeremy] Wellcome Trust Res Labs, London, England	University of Edinburgh	Woolhouse, M (corresponding author), Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh EH8 9YL, Midlothian, Scotland.	mark.woolhouse@ed.ac.uk; j.farrar@wellcome.ac.uk	Farrar, Jeremy J./HGA-7610-2022	Farrar, Jeremy/0000-0002-2700-623X				Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Vernet G, 2014, EMERG INFECT DIS, V20, P434, DOI [10.3201/eid2003.121157, 10.3201/EID2003.121157]; Wertheim HFL, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001429; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; WHO, 2020, ANT RES GLOB REP SUR	8	106	110	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					555	557		10.1038/509555a	http://dx.doi.org/10.1038/509555a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24877180	Bronze			2022-12-01	WOS:000336457100023
J	Li, J; Li, X; Wang, Q; Hu, S; Wang, YF; Masoudi, FA; Spertus, JA; Krumholz, HM; Jiang, LX				Li, Jing; Li, Xi; Wang, Qing; Hu, Shuang; Wang, Yongfei; Masoudi, Frederick A.; Spertus, John A.; Krumholz, Harlan M.; Jiang, Lixin		China PEACE Collaborative Grp	RETRACTED: ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data (Retracted article. See vol. 385, pg. 402, 2015)	LANCET			English	Article; Retracted Publication							ACUTE CORONARY SYNDROMES; STANDARDIZED MORTALITY-RATES; QUALITY-OF-CARE; REPERFUSION THERAPY; PRACTICE PATTERNS; IMPROVEMENT; TRANSITION; TRENDS; REFORM	Background Despite the importance of ST-segment elevation myocardial infarction (STEMI) in China, no nationally representative studies have characterised the clinical profiles, management, and outcomes of this cardiac event during the past decade. We aimed to assess trends in characteristics, treatment, and outcomes for patients with STEMI in China between 2001 and 2011. Methods In a retrospective analysis of hospital records, we used a two-stage random sampling design to create a nationally representative sample of patients in China admitted to hospital for STEMI in 3 years (2001, 2006, and 2011). In the first stage, we used a simple random-sampling procedure stratified by economic-geographical region to generate a list of participating hospitals. In the second stage we obtained case data for rates of STEMI, treatments, and baseline characteristics from patients attending each sampled hospital with a systematic sampling approach. We weighted our findings to estimate nationally representative rates and assess changes from 2001 to 2011. This study is registered with ClinicalTrials.gov, number NCT01624883. Findings We sampled 175 hospitals (162 participated in the study) and 18 631 acute myocardial infarction admissions, of which 13 815 were STEMI admissions. 12 264 patients were included in analysis of treatments, procedures, and tests, and 11 986 were included in analysis of in-hospital outcomes. Between 2001 and 2011, estimated national rates of hospital admission for STEMI per 100 000 people increased (from 3.5 in 2001, to 7.9 in 2006, to 15.4 in 2011; p(trend)<0.0001) and the prevalence of risk factors-including smoking, hypertension, diabetes, and dyslipidaemia-increased. We noted significant increases in use of aspirin within 24 h (79.7% [95% CI 77.9-81.5] in 2001 vs 91.2% [90.5-91.8] in 2011, p(trend)<0.0001) and clopidogrel (1.5% [95% CI 1.0-2.1] in 2001 vs 82.1% [81.1-83.0] in 2011, p(trend)<0.0001) in patients without documented contraindications. Despite an increase in the use of primary percutaneous coronary intervention (10.6% [95% CI 8.6-12.6] in 2001 vs 28.1% [26.6-29.7] in 2011, p(trend)<0.0001), the proportion of patients who did not receive reperfusion did not significantly change (45.3% [95% CI 42.1-48.5] in 2001 vs 44.8% [43.1-46.5] in 2011, p(trend)=0.69). The median length of hospital stay decreased from 12 days (IQR 7-18) in 2001 to 10 days (6-14) in 2011 (p(trend)<0.0001). Adjusted in-hospital mortality did not significantly change between 2001 and 2011 (odds ratio 0.82, 95% CI 0.62-1.10, p(trend)=0.07). Interpretation During the past decade in China, hospital admissions for STEMI have risen; in these patients, comorbidities and the intensity of testing and treatment have increased. Quality of care has improved for some treatments, but important gaps persist and in-hospital mortality has not decreased. National efforts are needed to improve the care and outcomes for patients with STEMI in China.	[Li, Jing; Li, Xi; Wang, Qing; Hu, Shuang; Jiang, Lixin] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Natl Clin Res Ctr Cardiovasc Dis,Fuwai Hosp, Beijing 100730, Peoples R China; [Li, Jing; Li, Xi; Wang, Qing; Hu, Shuang; Jiang, Lixin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Yongfei; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Wang, Yongfei; Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Dept Hlth Policy & Management, Sch Publ Hlth, New Haven, CT USA; [Masoudi, Frederick A.] Univ Colorado, Div Cardiol, Aurora, CO USA; [Spertus, John A.] Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, MO 64110 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Yale University; Yale University; Yale University; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City	Jiang, LX (corresponding author), Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Natl Clin Res Ctr Cardiovasc Dis, Beijing 100037, Peoples R China.	jiangl@fwoxford.org	Spertus, John/ABD-3075-2021; Masoudi, Frederick/Q-7467-2019; , Harlan/AAI-2875-2020	Normand, Sharon-Lise/0000-0001-7027-4769; Li, Xi/0000-0003-2249-688X	National Health and Family Planning Commission of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	National Health and Family Planning Commission of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Health and Family Planning Commission of China.	[Anonymous], 2010, LANCET, V376, P657, DOI 10.1016/S0140-6736(10)61315-3; [Anonymous], 2007, CHIN STAT YB; [Anonymous], 2012, CHIN STAT YB; [Anonymous], 2000, 5 CENSUS DATA COUNTY; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Bradley EH, 2005, MED CARE, V43, P282, DOI 10.1097/00005650-200503000-00011; Chen J, 2010, CIRCULATION, V121, P1322, DOI 10.1161/CIRCULATIONAHA.109.862094; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; China Society of Cardiology of Chinese Medical Association, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P675; Chung SC, 2014, LANCET, V383, P1305, DOI 10.1016/S0140-6736(13)62070-X; COLLINS R, 1995, LANCET, V345, P669; Dharmarajan K, 2013, CIRC-CARDIOVASC QUAL, V6, P732, DOI 10.1161/CIRCOUTCOMES.113.000441; Drye EE, 2012, ANN INTERN MED, V156, P19, DOI 10.7326/0003-4819-156-1-201201030-00004; Du X, 2014, CIRC-CARDIOVASC QUAL, V7, P217, DOI 10.1161/CIRCOUTCOMES.113.000526; [Editorial Board of Chinese Journal of Circulation Editorial Board of Chinese Journal of Cardiology China Society of Cardiology of Chinese Medical Association], 2001, CHIN J CIRC, V16, P407; Gale CP, 2012, EUR HEART J, V33, P630, DOI 10.1093/eurheartj/ehr381; Gao R, 2008, HEART, V94, P554, DOI 10.1136/hrt.2007.119750; Gershlick AH, 2013, LANCET, V382, P624, DOI 10.1016/S0140-6736(13)61454-3; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Li J, 2007, Cochrane Database Syst Rev, pCD002755; Liu Qun, 2009, Zhonghua Xinxueguanbing Zazhi, V37, P213, DOI 10.3760/cma.j.issn.0253-3758.2009.03.004; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; Masoudi FA, 2013, J AM COLL CARDIOL, V62, P1931, DOI 10.1016/j.jacc.2013.05.099; Mehta RH, 2004, J AM COLL CARDIOL, V43, P2166, DOI 10.1016/j.jacc.2003.08.067; Ministry of Health of the People's Republic of China, QUAL STAND TERT GEN; Ministry of Health of the People's Republic of China, 2012, CHIN PUBL HLTH STAT; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Ranasinghe I, 2014, CIRC-CARDIOVASC QUAL, V7, P209, DOI 10.1161/CIRCOUTCOMES.113.000527; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Rubin D.B., 1987, MULTIPLE IMPUTATION, P1; *SAS I, MI PROC; Simms AD, 2013, HEART, V99, P35, DOI 10.1136/heartjnl-2012-302632; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; The World Bank, HLTH HARM LIF CHIN S; Thygesen K, 2007, EUR HEART J, V28, P2525; Widimsky P, 2010, EUR HEART J, V31, P943, DOI 10.1093/eurheartj/ehp492; Wu TX, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004465.pub2; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1	41	271	365	4	98	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2015	385	9966					441	451		10.1016/S0140-6736(14)60921-1	http://dx.doi.org/10.1016/S0140-6736(14)60921-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CT	24969506	Green Accepted			2022-12-01	WOS:000348509900031
J	Brennan, T; Shrank, W				Brennan, Troyen; Shrank, William			New Expensive Treatments for Hepatitis C Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VIRUS-INFECTION; HCV		[Brennan, Troyen; Shrank, William] CVS Caremark, Woonsocket, RI USA		Brennan, T (corresponding author), CVS Caremark, 1 CVS Dr, Woonsocket, RI USA.	troyen.brennan@cvscaremark.com						[Anonymous], SUPP PATH SOV; [Anonymous], 2014, MED MAST DRUG DAT BA; California Technology Assessment Forum, 2014, COMP CLIN EFF VAL SI; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Gounder C., 2013, NEW YORKER; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Ozaras R, 2013, NEW ENGL J MED, V369, P679, DOI 10.1056/NEJMc1307589; Staton T., 2014, EXPRESS SCRIPTS ASSE	9	82	83	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2014	312	6					593	594		10.1001/jama.2014.8897	http://dx.doi.org/10.1001/jama.2014.8897			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM8OU	25038617				2022-12-01	WOS:000340136400013
J	Hawkes, N				Hawkes, Nigel			Mixed messages on progress against HIV	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						McCarthy M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4614; Mills E, 2008, HIV MED, V9, P332, DOI 10.1111/j.1468-1293.2008.00596.x	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 25	2014	349								g4763	10.1136/bmj.g4763	http://dx.doi.org/10.1136/bmj.g4763			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VU	25062743				2022-12-01	WOS:000339566400006
J	Pfeifer, M; Kugler, KG; Sandve, SR; Zhan, BJ; Rudi, H; Hvidsten, TR; Mayer, KFX; Olsen, OA; Rogers, J; Dolezel, J; Pozniak, C; Eversole, K; Feuillet, C; Gill, B; Friebe, B; Lukaszewski, AJ; Sourdille, P; Endo, TR; Kubalakova, M; Cihalikova, J; Dubska, Z; Vrana, J; Sperkova, R; Simkova, H; Febrer, M; Clissold, L; Mclay, K; Singh, K; Chhuneja, P; Singh, NK; Khurana, J; Akhunov, E; Choulet, F; Alberti, A; Barbe, V; Wincker, P; Kanamori, H; Kobayashi, F; Itoh, T; Matsumoto, T; Sakai, H; Tanaka, T; Wu, JZ; Ogihara, Y; Handa, H; Maclachlan, PR; Sharpe, A; Klassen, D; Edwards, D; Batley, J; Lien, S; Steuernagel, B; Wulff, B; Caccamo, M; Ayling, S; Ramirez-Gonzalez, RH; Clavijo, BJ; Wright, J; Spannagl, M; Martis, MM; Mascher, M; Chapman, J; Poland, JA; Scholz, U; Barry, K; Waugh, R; Rokhsar, DS; Muehlbauer, GJ; Stein, N; Gundlach, H; Zytnicki, M; Jamilloux, V; Quesneville, H; Wicker, T; Faccioli, P; Colaiacovo, M; Stanca, AM; Budak, H; Cattivelli, L; Glover, N; Pingault, L; Paux, E; Sharma, S; Appels, R; Bellgard, M; Chapman, B; Nussbaumer, T; Bader, KC; Rimbert, H; Wang, SC; Knox, R; Kilian, A; Alaux, M; Alfama, F; Couderc, L; Guilhot, N; Viseux, C; Loaec, M; Keller, B; Praud, S				Pfeifer, Matthias; Kugler, Karl G.; Sandve, Simen R.; Zhan, Bujie; Rudi, Heidi; Hvidsten, Torgeir R.; Mayer, Klaus F. X.; Olsen, Odd-Arne; Rogers, Jane; Dolezel, Jaroslav; Pozniak, Curtis; Eversole, Kellye; Feuillet, Catherine; Gill, Bikram; Friebe, Bernd; Lukaszewski, Adam J.; Sourdille, Pierre; Endo, Takashi R.; Kubalakova, Marie; Cihalikova, Jarmila; Dubska, Zdenka; Vrana, Jan; Sperkova, Romana; Simkova, Hana; Febrer, Melanie; Clissold, Leah; McLay, Kirsten; Singh, Kuldeep; Chhuneja, Parveen; Singh, Nagendra K.; Khurana, Jitendra; Akhunov, Eduard; Choulet, Frederic; Alberti, Adriana; Barbe, Valerie; Wincker, Patrick; Kanamori, Hiroyuki; Kobayashi, Fuminori; Itoh, Takeshi; Matsumoto, Takashi; Sakai, Hiroaki; Tanaka, Tsuyoshi; Wu, Jianzhong; Ogihara, Yasunari; Handa, Hirokazu; Maclachlan, P. Ron; Sharpe, Andrew; Klassen, Darrin; Edwards, David; Batley, Jacqueline; Lien, Sigbjorn; Steuernagel, Burkhard; Wulff, Brande; Caccamo, Mario; Ayling, Sarah; Ramirez-Gonzalez, Ricardo H.; Clavijo, Bernardo J.; Wright, Jonathan; Spannagl, Manuel; Martis, Mihaela M.; Mascher, Martin; Chapman, Jarrod; Poland, Jesse A.; Scholz, Uwe; Barry, Kerrie; Waugh, Robbie; Rokhsar, Daniel S.; Muehlbauer, Gary J.; Stein, Nils; Gundlach, Heidrun; Zytnicki, Matthias; Jamilloux, Veronique; Quesneville, Hadi; Wicker, Thomas; Faccioli, Primetta; Colaiacovo, Moreno; Stanca, Antonio Michele; Budak, Hikmet; Cattivelli, Luigi; Glover, Natasha; Pingault, Lise; Paux, Etienne; Sharma, Sapna; Appels, Rudi; Bellgard, Matthew; Chapman, Brett; Nussbaumer, Thomas; Bader, Kai Christian; Rimbert, Helene; Wang, Shichen; Knox, Ron; Kilian, Andrzej; Alaux, Michael; Alfama, Francoise; Couderc, Loic; Guilhot, Nicolas; Viseux, Claire; Loaec, Mikael; Keller, Beat; Praud, Sebastien		Int Wheat Genome Sequencing	Genome interplay in the grain transcriptome of hexaploid bread wheat	SCIENCE			English	Article							STARCHY ENDOSPERM; GENE-EXPRESSION; RNA; PROTEIN; IDENTIFICATION; GERMINATION; ALIGNMENT; PROFILES; TRITICUM; REVEALS	Allohexaploid bread wheat (Triticum aestivum L.) provides approximately 20% of calories consumed by humans. Lack of genome sequence for the three homeologous and highly similar bread wheat genomes (A, B, and D) has impeded expression analysis of the grain transcriptome. We used previously unknown genome information to analyze the cell type-specific expression of homeologous genes in the developing wheat grain and identified distinct co-expression clusters reflecting the spatiotemporal progression during endosperm development. We observed no global but cell type-and stage-dependent genome dominance, organization of the wheat genome into transcriptionally active chromosomal regions, and asymmetric expression in gene families related to baking quality. Our findings give insight into the transcriptional dynamics and genome interplay among individual grain cell types in a polyploid cereal genome.	[Pfeifer, Matthias; Kugler, Karl G.; Mayer, Klaus F. X.] Helmholtz Ctr Munich, D-85764 Neuherberg, Germany; [Sandve, Simen R.; Zhan, Bujie; Rudi, Heidi; Olsen, Odd-Arne] Norwegian Univ Life Sci NMBU, Ctr Integrat Genet, Dept Plant Sci, N-1432 As, Norway; [Hvidsten, Torgeir R.] NMBU, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Pfeifer, Matthias; Mayer, Klaus F. X.; Spannagl, Manuel; Martis, Mihaela M.; Gundlach, Heidrun; Sharma, Sapna; Nussbaumer, Thomas; Bader, Kai Christian] Helmholtz Zentrum Munich, Plant Genome & Syst Biol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Rogers, Jane; Eversole, Kellye] Eversole Associates, IWGSC, 5207 Wyoming Rd, Bethesda, MD 20816 USA; [Dolezel, Jaroslav; Kubalakova, Marie; Cihalikova, Jarmila; Dubska, Zdenka; Vrana, Jan; Sperkova, Romana; Simkova, Hana] Inst Expt Bot, Ctr Plant Struct & Funct Genom, Slechtitelu 31, Olomouc 78371, Czech Republic; [Pozniak, Curtis; Maclachlan, P. Ron] Univ Saskatchewan, Dept Plant Sci, Coll Agr & Bioresources, Ctr Crop Dev, 51 Campus Dr, Saskatoon, SK, Canada; [Feuillet, Catherine] Bayer Crop Sci, 3500 Paramount Pkwy, Morrisville, NC 27560 USA; [Gill, Bikram; Friebe, Bernd; Akhunov, Eduard; Wang, Shichen] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA; [Lukaszewski, Adam J.] Univ Calif Riverside, Coll Nat & Agr Sci, Bot & Plant Sci, Riverside, CA 92521 USA; [Endo, Takashi R.] Kyoto Univ, Grad Sch Agr, Lab Plant Genet, Kyoto 6068502, Japan; [Febrer, Melanie] Univ Dundee, Genom Sequencing Unit, Dow St, Dundee DD1 5EH, Scotland; [Clissold, Leah; McLay, Kirsten; Caccamo, Mario; Ayling, Sarah; Ramirez-Gonzalez, Ricardo H.; Clavijo, Bernardo J.; Wright, Jonathan] Norwich Res Pk, Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Singh, Kuldeep] Punjab Agr Univ, Sch Agr Biotechnol, Ludhiana 141004, Punjab, India; [Singh, Nagendra K.] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; [Khurana, Jitendra] Univ Delhi, Interdisciplinary Ctr Plant Genom, South Campus, New Delhi 110021, India; [Khurana, Jitendra] Univ Delhi, Dept Plant Mol Biol, South Campus, New Delhi 110021, India; [Sourdille, Pierre; Choulet, Frederic; Glover, Natasha; Pingault, Lise; Paux, Etienne; Guilhot, Nicolas] Univ Blaise Pascal, INRA, UMR Genet Divers & Ecophysiol Cereals 1095, 5 Chemin Beaulieu, F-63039 Clermont Ferrand, France; [Alberti, Adriana; Barbe, Valerie; Wincker, Patrick] Commissariat Energie Atom Genoscope, Ctr Natl Sequencage, 2 Rue Gaston Cremieux, F-91057 Evry, France; [Kanamori, Hiroyuki; Kobayashi, Fuminori; Itoh, Takeshi; Matsumoto, Takashi; Sakai, Hiroaki; Tanaka, Tsuyoshi; Wu, Jianzhong; Handa, Hirokazu] Natl Inst Agrobiol Sci, Plant Genome Res Unit, 2-1-2 Kan Non Dai, Tsukuba, Ibaraki 3058602, Japan; [Ogihara, Yasunari] Yokohama City Univ, Kihara Inst Biol Res, Totsuka Ku, Maioka Cho 641-12, Yokohama, Kanagawa 2440813, Japan; [Sharpe, Andrew; Klassen, Darrin] Natl Res Council Canada, 110 Gymnasium Pl, Saskatoon, SK S7N 0W9, Canada; [Edwards, David; Batley, Jacqueline] Univ Queensland, Australian Ctr Plant Funct Genom, Sch Agr & Food Sci, St Lucia, Qld 4072, Australia; [Edwards, David; Batley, Jacqueline] Univ Western Australia, Sch Plant Biol, Nedlands, WA 6009, Australia; [Sandve, Simen R.; Olsen, Odd-Arne] Norwegian Univ Life Sci, Dept Plant Sci, Ctr Integrat Genet CIGENE, N-1432 As, Norway; [Olsen, Odd-Arne] Hedmark Univ Coll, Dept Nat Sci & Technol, N-2318 Elverum, Norway; [Steuernagel, Burkhard; Wulff, Brande] Norwich Res Pk, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Mascher, Martin; Scholz, Uwe] Leibniz Inst Plant Genet & Crop Plant Res IPK, Bioinformat & Informat Technol, D-06466 Seeland Ot Gatersleben, Germany; [Chapman, Jarrod; Barry, Kerrie; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, 2800 Mitchell Dr, Walnut Creek, CA 94598 USA; [Poland, Jesse A.] USDA ARS, Hard Winter Wheat Genet Res Unit, Manhattan, KS 66506 USA; [Poland, Jesse A.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Waugh, Robbie] James Hutton Inst, Dundee DD2 5DA, Scotland; [Muehlbauer, Gary J.] Univ Minnesota, Dept Agron & Plant Genet, Dept Plant Biol, St Paul, MN 55108 USA; [Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res IPK, Genome Divers, D-06466 Seeland Ot Gatersleben, Germany; [Zytnicki, Matthias; Jamilloux, Veronique; Quesneville, Hadi; Alaux, Michael; Alfama, Francoise; Couderc, Loic; Viseux, Claire; Loaec, Mikael] INRA Versailles, URGI Res Unit Genom Info UR1164, Route St Cyr, F-78026 Versailles, France; [Wicker, Thomas; Keller, Beat] Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland; [Faccioli, Primetta; Colaiacovo, Moreno; Stanca, Antonio Michele; Cattivelli, Luigi] Consiglio Ric Sperimentaz Agr, Genom Res Ctr, Via San Protaso 302, I-29017 Fjorenzuola Darda, Italy; [Budak, Hikmet] Sabanci Univ, Biol Sci & Bioengn Program, TR-34956 Istanbul, Turkey; [Appels, Rudi; Bellgard, Matthew; Chapman, Brett] Murdoch Univ, Ctr Comparat Genom, Perth, WA 6150, Australia; [Knox, Ron] Semiarid Prairie Agr Res Ctr, POB 1030, Swift Current, SK S9H 3X2, Canada; [Kilian, Andrzej] Divers Arrays Technol Pty Ltd, 1 Wilf Crane Crescent, Yarralumla, ACT 2600, Australia; [Rimbert, Helene; Praud, Sebastien] Biogemma, Ctr Rech Chappes, Route Ennezat, F-63720 Chappes, France; [Lien, Sigbjorn] Norwegian Univ Life Sci, Dept Anim & Aquicultural Sci, CIGENE, Arboretvelen 6, N-1432 As, Norway	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Norwegian University of Life Sciences; Norwegian University of Life Sciences; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of Saskatchewan; Bayer AG; Bayer CropScience; Kansas State University; University of California System; University of California Riverside; Kyoto University; University of Dundee; The Genome Analysis Centre (TGAC); Punjab Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); University of Delhi; University of Delhi; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite Clermont Auvergne (UCA); UDICE-French Research Universities; Universite Paris Saclay; National Institute of Agrobiological Sciences - Japan; Yokohama City University; National Research Council Canada; University of Queensland; University of Western Australia; Norwegian University of Life Sciences; Inland Norway University of Applied Sciences; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Agriculture (USDA); Kansas State University; James Hutton Institute; University of Minnesota System; University of Minnesota Twin Cities; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; INRAE; University of Zurich; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Sabanci University; Murdoch University; Norwegian University of Life Sciences	Olsen, OA (corresponding author), Norwegian Univ Life Sci NMBU, Ctr Integrat Genet, Dept Plant Sci, N-1432 As, Norway.	odd-arne.olsen@nmbu.no	Stein, Nils/F-7507-2017; cattivelli, luigi/AAE-7046-2020; Edwards, David/H-3710-2015; Budak, Hikmet/S-5835-2017; Eversole, Kellye/AAN-6141-2020; Sourdille, Pierre/CAF-2780-2022; Wu, Jian/AAU-5221-2020; Simkova, Hana/F-7734-2014; Mayer, Klaus FX/M-7941-2015; Pingault, Lise/AAQ-8602-2020; Batley, Jacqueline/A-5723-2008; Wang, Shichen/E-6213-2012; Budak, Hikmet/U-8517-2019; Pfeifer, Matthias/GRJ-4579-2022; Kubaláková, Marie/F-8269-2014; Kugler, Karl G/B-8406-2015; Wicker, Thomas/Z-1978-2019; Hvidsten, Torgeir R./A-3409-2009; Ramírez, Ricardo/H-4808-2019; Quesneville, Hadi/AAG-1048-2020; Dolezel, Jaroslav/B-7716-2008; Barry, Kerrie Whitelaw/AAA-5500-2020; Wu, Jian/AAU-5221-2020	Stein, Nils/0000-0003-3011-8731; cattivelli, luigi/0000-0002-6067-4600; Edwards, David/0000-0001-7599-6760; Budak, Hikmet/0000-0002-2556-2478; Eversole, Kellye/0000-0002-8784-4913; Wu, Jian/0000-0001-9933-7364; Simkova, Hana/0000-0003-4159-7619; Mayer, Klaus FX/0000-0001-6484-1077; Pingault, Lise/0000-0002-6149-1267; Batley, Jacqueline/0000-0002-5391-5824; Wang, Shichen/0000-0003-1441-2252; Budak, Hikmet/0000-0002-2556-2478; Kugler, Karl G/0000-0003-2342-7472; Hvidsten, Torgeir R./0000-0001-6097-2539; Ramírez, Ricardo/0000-0001-5745-7085; Quesneville, Hadi/0000-0003-3001-4908; Dolezel, Jaroslav/0000-0002-6263-0492; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Gundlach, Heidrun/0000-0002-6757-0943; Kilian, Andrzej/0000-0002-2730-7462; Colaiacovo, Moreno/0000-0003-1320-0506; Singh, Kuldeep/0000-0001-5239-6586; Wu, Jian/0000-0002-3394-1507; Paux, Etienne/0000-0002-3094-7129; Keller, Beat/0000-0003-2379-9225; Martis, Mihaela-Maria/0000-0001-7509-2446; Alaux, Michael/0000-0001-9356-4072; , Thomas/0000-0002-6777-7135; Scholz, Uwe/0000-0001-6113-3518; Spannagl, Manuel/0000-0003-0701-7035; Jamilloux, Veronique/0000-0002-6898-4910; Bellgard, Matthew/0000-0002-6303-9469	Norwegian Research Council [199387]; Deutsche Forschungsgemeinschaft (DFG) [SFB924]; German Federal Ministry of Education and Research (BMBF); European Commission's 7th Framework Program	Norwegian Research Council(Research Council of NorwayEuropean Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Commission's 7th Framework Program	This work was supported by research grant 199387 from the Norwegian Research Council to the Norwegian University of Life Sciences and Graminor AS to O.A.O. K. F. X. M. acknowledges generous funding by the Deutsche Forschungsgemeinschaft (DFG) to project SFB924 "Molecular mechanisms regulating yield and yield stability in plants," the German Federal Ministry of Education and Research (BMBF) in frame of the Synbreed project, and the European Commission's 7th Framework Program in frame of the TransPLANT project. The data reported in this paper are tabulated in the supplementary materials and archived at the ArrayExpress database www.ebi.ac.uk/arrayexpress, accession no. E-MTAB-2137. No conflict of interest is known for the authors of this manuscript regarding data reported herein. S. I. Chi, E. I. Ako, A. Maharajan, and O. Jorgensen are thankfully acknowledged for grain dissection and plant cultivation. We thank P. Langridge, P. Shewry, B. Keller, and two anonymous reviewers for helpful suggestions on the manuscript. The RNA-seq was carried out at the Norwegian Sequencing Centre of University of Oslo. Graminor AS is acknowledged for generous support throughout this work.	Akhunova AR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-505; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson OD, 2013, FUNCT INTEGR GENOMIC, V13, P261, DOI 10.1007/s10142-013-0321-8; Anderson OD, 2009, FUNCT INTEGR GENOMIC, V9, P397, DOI 10.1007/s10142-009-0122-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Belmonte MF, 2013, P NATL ACAD SCI USA, V110, pE435, DOI 10.1073/pnas.1222061110; Bolot S, 2009, CURR OPIN PLANT BIOL, V12, P119, DOI 10.1016/j.pbi.2008.10.011; Chantret N, 2005, PLANT CELL, V17, P1033, DOI 10.1105/tpc.104.029181; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Darzentas N, 2010, BIOINFORMATICS, V26, P2620, DOI 10.1093/bioinformatics/btq484; Drea S, 2005, PLANT CELL, V17, P2172, DOI 10.1105/tpc.105.034058; Dupont FM, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-10; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Feldman M, 2012, J EXP BOT, V63, P5045, DOI 10.1093/jxb/ers192; Finnegan EJ, 2004, CURR BIOL, V14, P911, DOI 10.1016/j.cub.2004.04.045; Gillies SA, 2012, PLANT BIOTECHNOL J, V10, P668, DOI 10.1111/j.1467-7652.2012.00705.x; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Hu ZR, 2013, NEW PHYTOL, V197, P1344, DOI 10.1111/nph.12131; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Marcussen T, 2014, SCIENCE, V345, DOI 10.1126/science.1250092; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; MOORE G, 1995, TRENDS GENET, V11, P81, DOI 10.1016/S0168-9525(00)89005-8; Morris CF, 2002, PLANT MOL BIOL, V48, P633, DOI 10.1023/A:1014837431178; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Olsen OA, 2004, PLANT CELL, V16, pS214, DOI 10.1105/tpc.017111; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Payne P. I., 1983, Cereal Research Communications, V11, P29; Pellny TK, 2012, PLANT PHYSIOL, V158, P612, DOI 10.1104/pp.111.189191; Ravel C, 2009, PLANT PHYSIOL, V151, P2133, DOI 10.1104/pp.109.146076; Rustenholz C, 2011, PLANT PHYSIOL, V157, P1596, DOI 10.1104/pp.111.183921; Serna A, 2001, PLANT J, V25, P687, DOI 10.1046/j.1365-313x.2001.01004.x; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Shitsukawa N, 2007, PLANT CELL, V19, P1723, DOI 10.1105/tpc.107.051813; Sreenivasulu N, 2008, PLANT PHYSIOL, V146, P1738, DOI 10.1104/pp.107.111781; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; THOMPSON RD, 1983, THEOR APPL GENET, V67, P87, DOI 10.1007/BF00303930; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vensel WH, 2005, PROTEOMICS, V5, P1594, DOI 10.1002/pmic.200401034; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wilkinson M, 2008, J CEREAL SCI, V48, P722, DOI 10.1016/j.jcs.2008.03.007; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	53	225	236	6	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194			SI				1250091	10.1126/science.1250091	http://dx.doi.org/10.1126/science.1250091			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR2MB	25035498	Green Published			2022-12-01	WOS:000343420300002
J	Spiegelhalter, DJ				Spiegelhalter, D. J.			STATISTICS The future lies in uncertainty	SCIENCE			English	Editorial Material									Univ Cambridge, Stat Lab, Ctr Math Sci, Cambridge CB3 0WB, England	University of Cambridge	Spiegelhalter, DJ (corresponding author), Univ Cambridge, Stat Lab, Ctr Math Sci, Cambridge CB3 0WB, England.	david@statslab.cam.ac.uk						Aalen OO, 2012, J R STAT SOC A STAT, V175, P831, DOI 10.1111/j.1467-985X.2011.01030.x; Aberdein J, 2013, SIGNIFICANCE, V10, P46; Andrieu C, 2010, J R STAT SOC B, V72, P269, DOI 10.1111/j.1467-9868.2009.00736.x; Aydin B, 2009, ANN APPL STAT, V3, P1597, DOI 10.1214/09-AOAS263; Berry CC, 2014, BIOINFORMATICS, V30, P1493, DOI 10.1093/bioinformatics/btu035; Davidian M, 2013, J AM STAT ASSOC, V108, P1141, DOI 10.1080/01621459.2013.844019; Efron B, 2013, SCIENCE, V340, P1177, DOI 10.1126/science.1236536; Fan JQ, 2012, J AM STAT ASSOC, V107, P1019, DOI 10.1080/01621459.2012.720478; Gaydos B, 2009, DRUG INF J, V43, P539, DOI 10.1177/009286150904300503; Li B, 2012, J AM STAT ASSOC, V107, P152, DOI 10.1080/01621459.2011.644498; Macilwain C, 2014, SCIENCE, V344, P1221, DOI 10.1126/science.344.6189.1221; National Academy of Sciences, 2013, FRONT MASS DAT AN	12	24	25	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					264	265		10.1126/science.1251122	http://dx.doi.org/10.1126/science.1251122			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035471				2022-12-01	WOS:000339400700025
J	West, PC; Gerber, JS; Engstrom, PM; Mueller, ND; Brauman, KA; Carlson, KM; Cassidy, ES; Johnston, M; MacDonald, GK; Ray, DK; Siebert, S				West, Paul C.; Gerber, James S.; Engstrom, Peder M.; Mueller, Nathaniel D.; Brauman, Kate A.; Carlson, Kimberly M.; Cassidy, Emily S.; Johnston, Matt; MacDonald, Graham K.; Ray, Deepak K.; Siebert, Stefan			Leverage points for improving global food security and the environment	SCIENCE			English	Article							CLIMATE-CHANGE; DEFORESTATION; EMISSIONS; DEMAND; YIELD	Achieving sustainable global food security is one of humanity's contemporary challenges. Here we present an analysis identifying key "global leverage points" that offer the best opportunities to improve both global food security and environmental sustainability. We find that a relatively small set of places and actions could provide enough new calories to meet the basic needs for more than 3 billion people, address many environmental impacts with global consequences, and focus food waste reduction on the commodities with the greatest impact on food security. These leverage points in the global food system can help guide how nongovernmental organizations, foundations, governments, citizens' groups, and businesses prioritize actions.	[West, Paul C.; Gerber, James S.; Engstrom, Peder M.; Brauman, Kate A.; Carlson, Kimberly M.; Johnston, Matt; MacDonald, Graham K.; Ray, Deepak K.] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA; [Mueller, Nathaniel D.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA; [Cassidy, Emily S.] Environm Working Grp, Washington, DC 20009 USA; [Siebert, Stefan] Univ Bonn, Inst Crop Sci & Resource Conservat, D-53115 Bonn, Germany	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; University of Bonn	West, PC (corresponding author), Univ Minnesota, Inst Environm, St Paul, MN 55108 USA.	pcwest@umn.edu	West, Paul C./J-1665-2015; MacDonald, Graham/L-5648-2019; Mueller, Nathan D/E-5864-2010; Brauman, Kate A/ABD-5349-2021; Ray, Deepak K/F-7720-2012; Siebert, Stefan/B-8621-2009	West, Paul C./0000-0001-9024-1657; MacDonald, Graham/0000-0002-7120-1366; Mueller, Nathan D/0000-0003-1857-5104; Brauman, Kate A/0000-0002-8099-285X; Siebert, Stefan/0000-0002-9998-0672; Ray, Deepak/0000-0002-2856-9608; Gerber, James/0000-0002-6890-0481; Cassidy, Emily/0000-0003-4405-0264	Gordon and Betty Moore Foundation; Institute on the Environment; NASA's Interdisciplinary Earth Science program; Laurel Salton Clark Memorial Fellowship; McKnight Foundation; Grantham Foundation; World Wildlife Fund; Nature Conservancy; Stanford University; NSF; The Natural Sciences and Engineering Research Council of Canada	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Institute on the Environment; NASA's Interdisciplinary Earth Science program; Laurel Salton Clark Memorial Fellowship; McKnight Foundation; Grantham Foundation; World Wildlife Fund; Nature Conservancy; Stanford University(Stanford University); NSF(National Science Foundation (NSF)); The Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research greatly benefited from discussions with J. Foley. S. Carpenter, and E. Bennett, and three anonymous reviewers provided critical feedback that strengthened this paper. Research support was primarily provided by the Gordon and Betty Moore Foundation. Additional research support was from the Institute on the Environment, NASA's Interdisciplinary Earth Science program and Laurel Salton Clark Memorial Fellowship, the McKnight Foundation, the Grantham Foundation, the World Wildlife Fund, the Nature Conservancy, and Stanford University. NSF provided support for N.D.M. The Natural Sciences and Engineering Research Council of Canada provided support for G. K. M. Contributions by General Mills, Mosaic, Cargill, Pentair, Google, Kellogg's, Mars, and PepsiCo supported stakeholder outreach and public engagement. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional data and method details are provided in the supplementary materials.	Brauman KA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024030; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Cassidy ES, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034015; Cassman KG, 2003, ANNU REV ENV RESOUR, V28, P315, DOI 10.1146/annurev.energy.28.040202.122858; Challinor AJ, 2014, NAT CLIM CHANGE, V4, P287, DOI [10.1038/nclimate2153, 10.1038/NCLIMATE2153]; De Klein C., 2006, 2006 IPCC GUIDELINES, pV4; FAO, 2011, FOOD BAL SHEETS; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Gleick P.H., 2009, WORLDS WATER 2008 20, P402; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gustavsson J., 2011, Global food losses and food waste: extent, causes and prevention; Hansen MC, 2013, SCIENCE, V342, P850, DOI [10.1126/science.1215904, 10.1126/science.1244693]; International Assessment of Agricultural Knowledge Science and Technology for Development, 2009, AGR CROSSROADS; Kastner T, 2012, P NATL ACAD SCI USA, V109, P6868, DOI 10.1073/pnas.1117054109; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Macedo MN, 2012, P NATL ACAD SCI USA, V109, P1341, DOI 10.1073/pnas.1111374109; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Royal Society, 2009, REAP BEN SCI SUST IN; Siebert S, 2010, J HYDROL, V384, P198, DOI 10.1016/j.jhydrol.2009.07.031; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Venterea RT, 2012, FRONT ECOL ENVIRON, V10, P562, DOI 10.1890/120062; Vermeulen SJ, 2012, ANNU REV ENV RESOUR, V37, P195, DOI 10.1146/annurev-environ-020411-130608; West PC, 2010, P NATL ACAD SCI USA, V107, P19645, DOI 10.1073/pnas.1011078107; Yan XY, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003299; Zhang WF, 2013, P NATL ACAD SCI USA, V110, P8375, DOI 10.1073/pnas.1210447110	30	418	433	33	540	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					325	328		10.1126/science.1246067	http://dx.doi.org/10.1126/science.1246067			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035492	Green Submitted			2022-12-01	WOS:000339400700051
J	Stingele, J; Schwarz, MS; Bloemeke, N; Wolf, PG; Jentsch, S				Stingele, Julian; Schwarz, Michael S.; Bloemeke, Nicolas; Wolf, Peter G.; Jentsch, Stefan			A DNA-Dependent Protease Involved in DNA-Protein Crosslink Repair	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; TOPOISOMERASE-I; HOMOLOGOUS RECOMBINATION; DVC1 C1ORF124; UBIQUITIN; SUMO; REPLICATION; CDC48; P97; REGULATOR	Toxic DNA-protein crosslinks (DPCs) arise by ionizing irradiation and UV light, are particularly caused by endogenously produced reactive compounds such as formaldehyde, and also occur during compromised topoisomerase action. Although nucleotide excision repair and homologous recombination contribute to cell survival uponDPCs, hardly anything is known about mechanisms that target the protein component of DPCs directly. Here, we identify the metalloprotease Wss1 as being crucial for cell survival upon exposure to formaldehyde and topoisomerase 1-dependent DNA damage. Yeast mutants lacking Wss1 accumulate DPCs and exhibit gross chromosomal rearrangements. Notably, in vitro assays indicate that substrates such as topoisomerase 1 are processed by the metalloprotease directly and in a DNA-dependent manner. Thus, our data suggest that Wss1 contributes to survival of DPC-harboring cells by acting on DPCs proteolytically. We propose that DPC proteolysis enables repair of these unique lesions via downstream canonical DNA repair pathways.	[Stingele, Julian; Schwarz, Michael S.; Bloemeke, Nicolas; Wolf, Peter G.; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	jentsch@biochem.mpg.de	Stingele, Julian/K-7490-2012	Stingele, Julian/0000-0001-6020-2075	Max Planck Society; Deutsche Forschungsgemeinschaft; Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence; ERC Advanced Grant; Louis-Jeantet Foundation	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence; ERC Advanced Grant; Louis-Jeantet Foundation	We thank A. Strasser for technical assistance, J. Rech for help with robot-based techniques, the MPIB Microchemistry Core Facility for help with protein purification, and S. Bergink, M. Kern, C. Lademann, B. Pfander, I. Psakhye, and J. Renkawitz for discussions. S.J. is supported by the Max Planck Society, Deutsche Forschungsgemeinschaft, Center for Integrated Protein Science Munich, RUBICON EU Network of Excellence, ERC Advanced Grant, and the Louis-Jeantet Foundation.	Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Bergink S, 2013, NAT CELL BIOL, V15, P526, DOI 10.1038/ncb2729; Biggins S, 2001, GENETICS, V159, P453; BJORNSTI MA, 1989, CANCER RES, V49, P6318; Centore RC, 2012, MOL CELL, V46, P625, DOI 10.1016/j.molcel.2012.05.020; Chen SH, 2013, ANNU REV BIOCHEM, V82, P139, DOI 10.1146/annurev-biochem-061809-100002; Davis EJ, 2012, NAT STRUCT MOL BIOL, V19, P1093, DOI 10.1038/nsmb.2394; de Graaf B, 2009, DNA REPAIR, V8, P1207, DOI 10.1016/j.dnarep.2009.06.007; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Friedberg EC, 2014, DNA REPAIR MUTAGENES; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Ghosal G, 2012, J BIOL CHEM, V287, P34225, DOI 10.1074/jbc.M112.400135; Grogan D, 2012, MUTAT RES-FUND MOL M, V731, P92, DOI 10.1016/j.mrfmmm.2011.12.004; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Iyer LM, 2004, CELL CYCLE, V3, P1440, DOI 10.4161/cc.3.11.1206; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Jentsch S, 2013, ANNU REV GENET, V47, P167, DOI 10.1146/annurev-genet-111212-133453; Juhasz S, 2012, NUCLEIC ACIDS RES, V40, P10795, DOI 10.1093/nar/gks850; Kanellis P, 2007, PLOS GENET, V3, P1438, DOI 10.1371/journal.pgen.0030134; Kim MS, 2013, NUCLEIC ACIDS RES, V41, P1661, DOI 10.1093/nar/gks1267; Kohn KW, 2000, CELL BIOCHEM BIOPHYS, V33, P175, DOI 10.1385/CBB:33:2:175; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Mao Y, 2000, P NATL ACAD SCI USA, V97, P4046, DOI 10.1073/pnas.080536597; Mieczkowski PA, 2006, DNA REPAIR, V5, P1010, DOI 10.1016/j.dnarep.2006.05.027; Minko IG, 2002, P NATL ACAD SCI USA, V99, P1905, DOI 10.1073/pnas.042700399; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Mullen JR, 2011, GENETICS, V187, P73, DOI 10.1534/genetics.110.124347; Mullen JR, 2010, MOL CELL BIOL, V30, P3737, DOI 10.1128/MCB.01649-09; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; Nakano T, 2013, J BIOL CHEM, V288, P4649, DOI 10.1074/jbc.M112.419358; Nie MH, 2012, J BIOL CHEM, V287, P29610, DOI 10.1074/jbc.M112.379768; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Pourquier P, 1997, J BIOL CHEM, V272, P7792, DOI 10.1074/jbc.272.12.7792; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Regairaz M, 2011, J CELL BIOL, V195, P739, DOI 10.1083/jcb.201104003; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; Sale JE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012708; Stapf C, 2011, J BIOL CHEM, V286, P38670, DOI 10.1074/jbc.M111.274472; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Su D, 2010, MOL CELL BIOL, V30, P3734, DOI 10.1128/MCB.00673-10; Swenberg JA, 2011, TOXICOL SCI, V120, pS130, DOI 10.1093/toxsci/kfq371; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Vaz Bruno, 2013, Frontiers in Genetics, V4, P60, DOI 10.3389/fgene.2013.00060; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	55	169	176	2	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					327	338		10.1016/j.cell.2014.04.053	http://dx.doi.org/10.1016/j.cell.2014.04.053			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	24998930	Bronze			2022-12-01	WOS:000340943600013
J	Kesselheim, AS; Bykov, K; Avorn, J; Tong, A; Doherty, M; Choudhry, NK				Kesselheim, Aaron S.; Bykov, Katsiaryna; Avorn, Jerry; Tong, Angela; Doherty, Michael; Choudhry, Niteesh K.			Burden of Changes in Pill Appearance for Patients Receiving Generic Cardiovascular Medications After Myocardial Infarction Cohort and Nested Case-Control Studies	ANNALS OF INTERNAL MEDICINE			English	Article							BRAND-NAME DRUGS; STATIN THERAPY; ADHERENCE; NONADHERENCE; EQUIVALENCE; PREVENTION; MORTALITY; DISEASE; RISK	Background: Generic prescription drugs made by different manufacturers may vary in color or shape, and switching among these drug products may interrupt medication use. Objective: To determine whether nonpersistent use of generic drugs among patients with cardiovascular disease after myocardial infarction (MI) is associated with inconsistent appearance of their medications. Design: Cohort and nested case-control studies. Setting: Claims from a commercial health insurance database in the United States. Patients: Patients discharged after hospitalization for MI between 2006 and 2011 who initiated treatment with a generic beta-blocker, angiotensin-converting enzyme inhibitor, angiotensin II-receptor blocker, or statin. Case patients discontinued their index medication for at least 1 month; control patients continued treatment. Control patients were matched to case patients on therapeutic class, number of dispensings before nonpersistence, sex, and age. Measurements: Rates of changes in pill color and shape during the year after MI were calculated. Next, 2 refills preceding nonpersistence were evaluated to determine whether pill color or shape had changed. Odds of discordance among case and control patients were compared using conditional logistic regression. Results: A total of 29% of patients (3286 of 11 513) had a change in pill shape or color during the study. Statins had the most changes in appearance, whereas beta-blockers had the fewest. A total of 4573 episodes of nonpersistence was matched to 19 881 control episodes. The odds of nonpersistence in case patients increased by 34% after a change in pill color (adjusted odds ratio, 1.34 [95% CI, 1.12 to 1.59]) and 66% after a change in pill shape (adjusted odds ratio, 1.66 [CI, 1.43 to 1.94]). Limitation: Only 3 categories of drugs indicated after MI were evaluated, and clinical outcomes were not addressed. Conclusion: Variation in the appearance of generic pills is associated with nonpersistent use of these essential drugs after MI among patients with cardiovascular disease.	Brigham & Womens Hosp, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Bykov, Katsiaryna/0000-0003-3336-5412	Agency for Healthcare Research and Quality [K08HS18465-01]; Greenwall Faculty Scholars Program in Bioethics; Harvard Program in Therapeutic Science; Robert Wood Johnson Foundation Investigator Award in Health Policy Research; FDA Office of Generic Drugs; CVS Caremark; Commonwealth Fund; Robert Wood Johnson Foundation; Aetna	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Greenwall Faculty Scholars Program in Bioethics; Harvard Program in Therapeutic Science; Robert Wood Johnson Foundation Investigator Award in Health Policy Research(Robert Wood Johnson Foundation (RWJF)); FDA Office of Generic Drugs; CVS Caremark; Commonwealth Fund; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Aetna	Dr. Kesselheim was supported by a career development award from the Agency for Healthcare Research and Quality (K08HS18465-01), the Greenwall Faculty Scholars Program in Bioethics, the Harvard Program in Therapeutic Science, and a Robert Wood Johnson Foundation Investigator Award in Health Policy Research. Dr. Kesselheim and Dr. Avorn receive research support from the FDA Office of Generic Drugs. Dr. Choudhry was supported by unrestricted research grants from CVS Caremark, Aetna, The Commonwealth Fund, and the Robert Wood Johnson Foundation.	Akincigil A, 2008, J GEN INTERN MED, V23, P115, DOI 10.1007/s11606-007-0351-9; [Anonymous], 2010, CBS NEWS; [Anonymous], 2011, CLOS LOOK PRESCR BOT; BIRON P, 1974, CAN MED ASSOC J, V110, P1346; Boh M, 2011, INT ANGIOL, V30, P366; Brookhart MA, 2007, ARCH INTERN MED, V167, P847, DOI 10.1001/archinte.167.8.847; Center for Drug Evaluation and Research, 2013, GUID IND SI IN PRESS; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Choudhry NK, 2011, ARCH INTERN MED, V171, P814, DOI 10.1001/archinternmed.2010.495; Cohen M, 2011, PHILLY COM      0808; Colivicchi F, 2007, STROKE, V38, P2652, DOI 10.1161/STROKEAHA.107.487017; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; Cutler C, 2011, BIOL BLOOD MARROW TR, V17, P285, DOI 10.1016/j.bbmt.2010.11.006; Cutler DM, 2010, NEW ENGL J MED, V362, P1553, DOI 10.1056/NEJMp1002305; Dicken JE, 2012, GAO12371R; Engelberg AB, 2011, J MANAGE CARE PHARM, V17, P321, DOI 10.18553/jmcp.2011.17.4.321; Faasse K, 2013, PSYCHOSOM MED, V75, P90, DOI 10.1097/PSY.0b013e3182738826; Fischer MA, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2011.05.028; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; Green JB, 2013, JAMA INTERN MED, V173, P229, DOI 10.1001/jamainternmed.2013.1529; Greene JA, 2011, NEW ENGL J MED, V365, P83, DOI 10.1056/NEJMhle1101722; Haas JS, 2005, ANN INTERN MED, V142, P891, DOI 10.7326/0003-4819-142-11-200506070-00006; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Ho PM, 2008, AM HEART J, V155, P772, DOI 10.1016/j.ahj.2007.12.011; Ho P Michael, 2006, BMC Cardiovasc Disord, V6, P48, DOI 10.1186/1471-2261-6-48; Kenagy JW, 2001, AM J HEALTH-SYST PH, V58, P2033, DOI 10.1093/ajhp/58.21.2033; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Kesselheim AS, 2013, JAMA INTERN MED, V173, P202, DOI 10.1001/2013.jamainternmed.997; Kronish IM, 2013, PROG CARDIOVASC DIS, V55, P590, DOI 10.1016/j.pcad.2013.02.001; Nightingale SL, 1998, THERAPEUTIC EQUIVALE; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Rasmussen JN, 2007, JAMA-J AM MED ASSOC, V297, P177, DOI 10.1001/jama.297.2.177; Roullet B, 2005, ADV CONSUM RES, V32, P164; Shah ND, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2008.12.021; Shrank WH, 2011, HEALTH AFFAIR, V30, P1351, DOI 10.1377/hlthaff.2010.0431; Smith DH, 2008, ARCH INTERN MED, V168, P477, DOI 10.1001/archinternmed.2007.132; Sundar RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038819; World Health Organization (WHO), 2013, ADHERENCE LONG TERM; Yu LX, 2013, JAMA INTERN MED, V173, P208, DOI 10.1001/jamainternmed.2013.2283; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	41	63	63	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2					96	+		10.7326/M13-2381	http://dx.doi.org/10.7326/M13-2381			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	25023248				2022-12-01	WOS:000339764600018
J	Hwang, TJ; Bourgeois, FT; Seeger, JD				Hwang, Thomas J.; Bourgeois, Florence T.; Seeger, John D.			Drug Safety in the Digital Age	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							WIKIPEDIA; INFORMATION		[Hwang, Thomas J.] Blackstone Grp, London, England; [Bourgeois, Florence T.] Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA USA; [Bourgeois, Florence T.] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Bourgeois, Florence T.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Seeger, John D.] Harvard Univ, Sch Med, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA USA; [Seeger, John D.] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Hwang, TJ (corresponding author), Blackstone Grp, London, England.		Bourgeois, Florence/H-6710-2016	Bourgeois, Florence/0000-0001-7798-4560; Hwang, Thomas/0000-0003-0717-1497				Bould MD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1585; Epstein RM, 2009, JAMA-J AM MED ASSOC, V302, P195, DOI 10.1001/jama.2009.984; Heilman JM, 2011, J MED INTERNET RES, V13, P153, DOI 10.2196/jmir.1589; Hwang TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071966; Kupferberg N, 2011, J MED LIBR ASSOC, V99, P310, DOI 10.3163/1536-5050.99.4.010	5	16	17	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					2460	2462		10.1056/NEJMp1401767	http://dx.doi.org/10.1056/NEJMp1401767			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KY	24963564				2022-12-01	WOS:000337804400002
J	Greenwood, B				Greenwood, Brian			The use of a placebo in vaccine trials	LANCET			English	Editorial Material							CONJUGATE VACCINE; MENINGITIS; PNEUMONIA; DISEASE		London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Greenwood, B (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England.	brian.greenwood@lshtm.ac.uk						Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Daugla DM, 2014, LANCET, V383, P40, DOI 10.1016/S0140-6736(13)61612-8; Feikin DR, 2014, LANCET, V383, P1762, DOI 10.1016/S0140-6736(13)61682-7; Gessner BD, 2005, LANCET, V365, P43, DOI 10.1016/S0140-6736(04)17664-2; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7; Rid A, 2014, VACCINE, V32, P4708, DOI 10.1016/j.vaccine.2014.04.022; WHO, 2013, EXP CONS USE PLAC VA	10	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2014	383	9935					2101	2102		10.1016/S0140-6736(14)60926-0	http://dx.doi.org/10.1016/S0140-6736(14)60926-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ7VG	24953464				2022-12-01	WOS:000337906600004
J	Xiol, J; Spinelli, P; Laussmann, MA; Homolka, D; Yang, Z; Cora, E; Coute, Y; Conn, S; Kadlec, J; Sachidanandam, R; Kaksonen, M; Cusack, S; Ephrussi, A; Pillai, RS				Xiol, Jordi; Spinelli, Pietro; Laussmann, Maike A.; Homolka, David; Yang, Zhaolin; Cora, Elisa; Coute, Yohann; Conn, Simon; Kadlec, Jan; Sachidanandam, Ravi; Kaksonen, Marko; Cusack, Stephen; Ephrussi, Anne; Pillai, Ramesh S.			RNA Clamping by Vasa Assembles a piRNA Amplifier Complex on Transposon Transcripts	CELL			English	Article							PIWI-INTERACTING RNAS; MESSENGER-RNA; DROSOPHILA; PROTEIN; GERMLINE; HELICASE; ELEMENTS; AMPLIFICATION; MACHINERY; MECHANISM	Germline-specific Piwi-interacting RNAs (piRNAs) protect animal genomes against transposons and are essential for fertility. piRNAs targeting active transposons are amplified by the ping-pong cycle, which couples Piwi endonucleolytic slicing of target RNAs to biogenesis of new piRNAs. Here, we describe the identification of a transient Amplifier complex that mediates biogenesis of secondary piRNAs in insect cells. Amplifier is nucleated by the DEAD box RNA helicase Vasa and contains the two Piwi proteins participating in the ping-pong loop, the Tudor protein Qin/Kumo and antisense piRNA guides. These components assemble on the surface of Vasa's helicase domain, which functions as an RNA clamp to anchor Amplifier onto transposon transcripts. We show that ATP-dependent RNP remodeling by Vasa facilitates transfer of 50 sliced piRNA precursors between ping-pong partners, and loss of this activity causes sterility in Drosophila. Our results reveal the molecular basis for the small RNA amplification that confers adaptive immunity against transposons.	[Xiol, Jordi; Spinelli, Pietro; Laussmann, Maike A.; Homolka, David; Yang, Zhaolin; Cora, Elisa; Conn, Simon; Kadlec, Jan; Cusack, Stephen; Pillai, Ramesh S.] Univ Grenoble Alpes, CNRS, EMBL, Grenoble Outstn, F-38042 Grenoble, France; [Xiol, Jordi; Spinelli, Pietro; Laussmann, Maike A.; Homolka, David; Yang, Zhaolin; Cora, Elisa; Conn, Simon; Kadlec, Jan; Cusack, Stephen; Pillai, Ramesh S.] Univ Grenoble Alpes, CNRS, EMBL, Unit Virus Host Cell Interact, F-38042 Grenoble, France; [Laussmann, Maike A.; Kaksonen, Marko] EMBL, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Coute, Yohann] CEA, IRTSV, Lab Biol Grande Echelle, F-38054 Grenoble, France; [Sachidanandam, Ravi] Icahn Sch Med Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Ephrussi, Anne] EMBL, Dev Biol Unit, D-69117 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Icahn School of Medicine at Mount Sinai; European Molecular Biology Laboratory (EMBL)	Pillai, RS (corresponding author), Univ Grenoble Alpes, CNRS, EMBL, Grenoble Outstn, 71 Ave Martyrs, F-38042 Grenoble, France.	pillai@embl.fr	Ephrussi, Anne/AAG-4075-2020; sachidanandam, ravi/Q-6916-2019; Ephrussi, Anne/ABD-4393-2021; Couté, Yohann/G-2695-2015	sachidanandam, ravi/0000-0001-9844-4459; Ephrussi, Anne/0000-0002-5061-4620; Couté, Yohann/0000-0003-3896-6196; Conn, Simon/0000-0002-1376-4515; Cusack, Stephen/0000-0002-9324-0796; Kadlec, Jan/0000-0002-4853-6918; Kaksonen, Marko/0000-0003-3645-7689	European Union (European Research Council); EMBL Interdisciplinary Postdoc Programme (EIPOD); Region Rhone Alp; EMBL	European Union (European Research Council)(European Research Council (ERC)European Commission); EMBL Interdisciplinary Postdoc Programme (EIPOD); Region Rhone Alp; EMBL	We thank Paul Lasko, Hugo Bellen, and Beat Suter for fly stocks/reagents. We are grateful to Sanjay Ghosh, Andrea Picco, Enrico Zamattia, Sandra Muller, and Anna Cyrklaff for help with data analysis and experiments. We thank the following EMBL core facilities: Advanced Light Microscopy, Genomics, Protein Expression and Purification, and High-Throughput Crystallization. Crystallographic data collection was at European Synchrotron Radiation Facility (ESRF), Grenoble, France. This work was supported by grants from European Union (European Research Council; "pisilence") to R.S.P. We are grateful for fellowships from the EMBL Interdisciplinary Postdoc Programme (EIPOD) under Marie Curie COFUND Actions (M.A.L), EMBO (D.H), and Region Rhone Alp (E.C.). This work was supported by the EMBL.	Anand A, 2012, EMBO J, V31, P870, DOI 10.1038/emboj.2011.449; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; De Fazio S, 2011, NATURE, V480, P259, DOI 10.1038/nature10547; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; de Vanssay A, 2012, NATURE, V490, P112, DOI 10.1038/nature11416; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grentzinger T, 2012, GENOME RES, V22, P1877, DOI 10.1101/gr.136614.111; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Johnstone O, 2004, DEVELOPMENT, V131, P4167, DOI 10.1242/dev.01286; Kawaoka S, 2013, NUCLEIC ACIDS RES, V41, P1581, DOI 10.1093/nar/gks1275; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Kawaoka S, 2009, RNA, V15, P1258, DOI 10.1261/rna.1452209; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kirino Y, 2010, J BIOL CHEM, V285, P8148, DOI 10.1074/jbc.M109.089821; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Kuramochi-Miyagawa S, 2010, GENE DEV, V24, P887, DOI 10.1101/gad.1902110; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; LEHMANN R, 1991, DEVELOPMENT, V112, P679; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106; Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Mathioudakis N, 2012, RNA, V18, P2056, DOI 10.1261/rna.034181.112; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; SCHUPBACH T, 1986, DEV BIOL, V113, P443, DOI 10.1016/0012-1606(86)90179-X; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Shoji M, 2009, DEV CELL, V17, P775, DOI 10.1016/j.devcel.2009.10.012; Xiol J, 2012, MOL CELL, V47, P970, DOI 10.1016/j.molcel.2012.07.019; Zhang F, 2012, CELL, V151, P871, DOI 10.1016/j.cell.2012.09.040; Zhang Z, 2011, MOL CELL, V44, P572, DOI 10.1016/j.molcel.2011.10.011	44	144	151	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1698	1711		10.1016/j.cell.2014.05.018	http://dx.doi.org/10.1016/j.cell.2014.05.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24910301	Bronze			2022-12-01	WOS:000340941900022
J	Vvedenskaya, IO; Vahedian-Movahed, H; Bird, JG; Knoblauch, JG; Goldman, SR; Zhang, Y; Ebright, RH; Nickels, BE				Vvedenskaya, Irina O.; Vahedian-Movahed, Hanif; Bird, Jeremy G.; Knoblauch, Jared G.; Goldman, Seth R.; Zhang, Yu; Ebright, Richard H.; Nickels, Bryce E.			TRANSCRIPTION Interactions between RNA polymerase and the "core recognition element" counteract pausing	SCIENCE			English	Article							STRUCTURAL BASIS; SINGLE-MOLECULE; REVEALS	Transcription elongation is interrupted by sequences that inhibit nucleotide addition and cause RNA polymerase (RNAP) to pause. Here, by use of native elongating transcript sequencing (NET-seq) and a variant of NET-seq that enables analysis of mutant RNAP derivatives in merodiploid cells (mNET-seq), we analyze transcriptional pausing genome-wide in vivo in Escherichia coli. We identify a consensus pause-inducing sequence element, G(-10)Y(-1)G(+1) (where -1 corresponds to the position of the RNA 3' end). We demonstrate that sequence-specific interactions between RNAP core enzyme and a core recognition element (CRE) that stabilize transcription initiation complexes also occur in transcription elongation complexes and facilitate pause read-through by stabilizing RNAP in a posttranslocated register. Our findings identify key sequence determinants of transcriptional pausing and establish that RNAP-CRE interactions modulate pausing.	[Vvedenskaya, Irina O.; Bird, Jeremy G.; Knoblauch, Jared G.; Goldman, Seth R.; Nickels, Bryce E.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Vvedenskaya, Irina O.; Vahedian-Movahed, Hanif; Bird, Jeremy G.; Knoblauch, Jared G.; Goldman, Seth R.; Zhang, Yu; Ebright, Richard H.; Nickels, Bryce E.] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Vahedian-Movahed, Hanif; Bird, Jeremy G.; Zhang, Yu; Ebright, Richard H.] Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Ebright, RH (corresponding author), Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA.	ebright@waksman.rutgers.edu; bnickels@waksman.rutgers.edu	Zhang, Yu/J-5225-2014; Nickels, Bryce/AAF-2549-2020; Zhang, Yu/AAV-5722-2021; Ebright, Richard/O-3321-2019	Zhang, Yu/0000-0002-1778-8389; Ebright, Richard/0000-0001-8915-7140; Nickels, Bryce/0000-0001-7449-8831; Bird, Jeremy/0000-0003-2690-8474	NIH grants [GM041376, GM088343, GM096454]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041376, R01GM096454, R01GM088343, R37GM041376] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM041376 (R.H.E.), GM088343 (B.E.N.), and GM096454 (B.E.N.). Reads are deposited in the Sequence Read Archive (accession SRP039384).	AIVAZASHVILI V A, 1981, Molekulyarnaya Biologiya (Moscow), V15, P915; Bai L, 2004, J MOL BIOL, V344, P335, DOI 10.1016/j.jmb.2004.08.107; CHAN CL, 1993, J MOL BIOL, V233, P25, DOI 10.1006/jmbi.1993.1482; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Dangkulwanich M, 2014, CHEM REV, V114, P3203, DOI 10.1021/cr400730x; Dangkulwanich M, 2013, ELIFE, V2, DOI 10.7554/eLife.00971; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; Hein PP, 2011, BIOCHEMISTRY-US, V50, P7002, DOI 10.1021/bi200437q; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Kireeva ML, 2009, P NATL ACAD SCI USA, V106, P8900, DOI 10.1073/pnas.0900407106; Kyzer S, 2007, J BIOL CHEM, V282, P19020, DOI 10.1074/jbc.M701483200; Landick R, 2009, P NATL ACAD SCI USA, V106, P8797, DOI 10.1073/pnas.0904373106; Larson MH, 2011, MOL CELL, V41, P249, DOI 10.1016/j.molcel.2011.01.008; LEE DN, 1990, J BIOL CHEM, V265, P15145; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; Weixlbaumer A, 2013, CELL, V152, P431, DOI 10.1016/j.cell.2012.12.020; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786; Zhou J, 2011, MOL CELL, V44, P635, DOI 10.1016/j.molcel.2011.09.018	20	114	115	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1285	1289		10.1126/science.1253458	http://dx.doi.org/10.1126/science.1253458			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926020	Green Accepted			2022-12-01	WOS:000337077500041
J	Dajani, R				Dajani, Rana			Jordan's stem-cell law can guide the Middle East	NATURE			English	Editorial Material									Hashemite Univ, Zarqa, Jordan	Hashemite University	Dajani, R (corresponding author), Hashemite Univ, Zarqa, Jordan.	rdajani@hu.edu.jo	Dajani, Rana/C-3466-2014	Dajani, Rana/0000-0002-4355-9977					0	10	10	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					189	189		10.1038/510189a	http://dx.doi.org/10.1038/510189a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24919888	Bronze			2022-12-01	WOS:000337032400004
J	van Hees, F; Habbema, JDF; Meester, RG; Lansdorp-Vogelaar, I; van Ballegooijen, M; Zauber, AG				van Hees, Frank; Habbema, J. Dik F.; Meester, Reinier G.; Lansdorp-Vogelaar, Iris; van Ballegooijen, Marjolein; Zauber, Ann G.			Should Colorectal Cancer Screening Be Considered in Elderly Persons Without Previous Screening? A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							LARGE-INTESTINE; LARGE-BOWEL; TASK-FORCE; COLONOSCOPY; POLYPS; PREVALENCE; GUIDELINES; SIGMOIDOSCOPY; NECROPSY; STATES	Background: The U.S. Preventive Services Task Force recommends against routine screening for colorectal cancer (CRC) in adequately screened persons older than 75 years but does not address the appropriateness of screening in elderly persons without previous screening. Objective: To determine at what ages CRC screening should be considered in unscreened elderly persons and to determine which test is indicated at each age. Design: Microsimulation modeling study. Data Sources: Observational and experimental studies. Target Population: Unscreened persons aged 76 to 90 years with no, moderate, and severe comorbid conditions. Time Horizon: Lifetime. Perspective: Societal. Intervention: One-time colonoscopy, sigmoidoscopy, or fecal immunochemical test (FIT) screening. Outcome Measures: Quality-adjusted life-years gained, costs, and costs per quality-adjusted life-year gained. Results of Base-Case Analysis: In unscreened elderly persons with no comorbid conditions, CRC screening was cost-effective up to age 86 years. Screening with colonoscopy was indicated up to age 83 years, sigmoidoscopy was indicated at age 84 years, and FIT was indicated at ages 85 and 86 years. In unscreened persons with moderate comorbid conditions, screening was cost-effective up to age 83 years (colonoscopy indicated up to age 80 years, sigmoidoscopy at age 81 years, and FIT at ages 82 and 83 years). In unscreened persons with severe comorbid conditions, screening was cost-effective up to age 80 years (colonoscopy indicated up to age 77 years, sigmoidoscopy at age 78 years, and FIT at ages 79 and 80 years). Results of Sensitivity Analyses: Results were most sensitive to assuming a lower willingness to pay per quality-adjusted life-year gained. Limitation: Only persons at average risk for CRC were considered. Conclusion: In unscreened elderly persons CRC screening should be considered well beyond age 75 years. A colonoscopy is indicated at most ages.	Erasmus Univ, Med Ctr, NL-3000 CA Rotterdam, Netherlands; Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA	Erasmus University Rotterdam; Erasmus MC; Memorial Sloan Kettering Cancer Center	van Hees, F (corresponding author), Erasmus Univ, Med Ctr, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	f.vanhees@erasmusmc.nl			National Cancer Institute as part of the Cancer Intervention and Surveillance Modeling Network [U01-CA152959]; NATIONAL CANCER INSTITUTE [P30CA008748, U01CA152959] Funding Source: NIH RePORTER	National Cancer Institute as part of the Cancer Intervention and Surveillance Modeling Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute (grant U01-CA152959) as part of the Cancer Intervention and Surveillance Modeling Network.	ARMINSKI T. C., 1964, DIS COLON RECTUM, V7, P249, DOI 10.1007/BF02630528; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Blatt LJ., 1961, DIS COLON RECTUM, V4, P277; BOMBI JA, 1988, CANCER-AM CANCER SOC, V61, P1472, DOI 10.1002/1097-0142(19880401)61:7<1472::AID-CNCR2820610734>3.0.CO;2-E; Bureau of Labor Statistics, 2013, CONS PRIC IND; Bureau of Labor Statistics, 2013, CURR EMPL STAT NAT; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; CHAPMAN I, 1963, ANN SURG, V157, P223, DOI 10.1097/00000658-196302000-00007; Cho H, 2013, ANN INTERN MED, V159, P667, DOI 10.7326/0003-4819-159-10-201311190-00005; CLARK JC, 1985, INT J CANCER, V36, P179, DOI 10.1002/ijc.2910360209; Freedman AN, 2009, J CLIN ONCOL, V27, P686, DOI 10.1200/JCO.2008.17.4797; Gatto NM, 2003, J NATL CANCER I, V95, P230, DOI 10.1093/jnci/95.3.230; Goodwin JS, 2011, ARCH INTERN MED, V171, P1335, DOI 10.1001/archinternmed.2011.212; Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; JASS JR, 1992, GUT, V33, P1508, DOI 10.1136/gut.33.11.1508; JOHANNSEN LGK, 1989, SCAND J GASTROENTERO, V24, P799, DOI 10.3109/00365528909089217; Jorgensen OD, 2002, GUT, V50, P29, DOI 10.1136/gut.50.1.29; Ko CW, 2005, GASTROENTEROLOGY, V129, P1163, DOI 10.1053/j.gastro.2005.07.027; Lansdorp-Vogelaar I, 2009, CANCER-AM CANCER SOC, V115, P2410, DOI 10.1002/cncr.24256; Lansdorp-Vogelaar I, 2009, GASTROINTEST ENDOSC, V70, P96, DOI 10.1016/j.gie.2008.08.040; Leffler DA, 2010, ARCH INTERN MED, V170, P1752, DOI 10.1001/archinternmed.2010.373; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Lin OS, 2006, JAMA-J AM MED ASSOC, V295, P2357, DOI 10.1001/jama.295.20.2357; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Ness RM, 1999, AM J GASTROENTEROL, V94, P1650; Painter J, 1999, ENDOSCOPY, V31, P227, DOI 10.1055/s-1999-13673; RICKERT RR, 1979, CANCER-AM CANCER SOC, V43, P1847, DOI 10.1002/1097-0142(197905)43:5<1847::AID-CNCR2820430538>3.0.CO;2-L; Rozen P, 2011, EUR J CANCER PREV, V20, P46, DOI 10.1097/CEJ.0b013e328341e309; Rutter CM, 2013, JNCI-J NATL CANCER I, V105, P1806, DOI 10.1093/jnci/djt299; Shapiro JA, 2012, CANCER EPIDEM BIOMAR, V21, P895, DOI 10.1158/1055-9965.EPI-12-0192; Shellnut JK, 2010, DIS COLON RECTUM, V53, P5, DOI 10.1007/DCR.0b013e3181bc01d1; Surveillance Epidemiology and End Results (SEER) Program, 2002, SEER STAT DAT INC SE; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Zauber AG, 2007, COST EFFECTIVENESS D; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	39	77	77	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 3	2014	160	11					750	+		10.7326/M13-2263	http://dx.doi.org/10.7326/M13-2263			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MT	24887616	Green Accepted			2022-12-01	WOS:000337348700002
J	Gilissen, C; Hehir-Kwa, JY; Thung, DT; van de Vorst, M; van Bon, BWM; Willemsen, MH; Kwint, M; Janssen, IM; Hoischen, A; Schenck, A; Leach, R; Klein, R; Tearle, R; Bo, T; Pfundt, R; Yntema, HG; de Vries, BBA; Kleefstra, T; Brunner, HG; Vissers, LELM; Veltman, JA				Gilissen, Christian; Hehir-Kwa, Jayne Y.; Thung, Djie Tjwan; van de Vorst, Maartje; van Bon, Bregje W. M.; Willemsen, Marjolein H.; Kwint, Michael; Janssen, Irene M.; Hoischen, Alexander; Schenck, Annette; Leach, Richard; Klein, Robert; Tearle, Rick; Bo, Tan; Pfundt, Rolph; Yntema, Helger G.; de Vries, Bert B. A.; Kleefstra, Tjitske; Brunner, Han G.; Vissers, Lisenka E. L. M.; Veltman, Joris A.			Genome sequencing identifies major causes of severe intellectual disability	NATURE			English	Article							DE-NOVO MUTATIONS; COPY-NUMBER VARIATION; MENTAL-RETARDATION; AUTISM; SCHIZOPHRENIA; VARIANTS; SPECTRUM; PROTEIN; PARADIGM; NETWORK	Severe intellectual disability (ID) occurs in 0.5% of newborns and is thought to be largely genetic in origin(1,2). The extensive genetic heterogeneity of this disorder requires a genome-wide detection of all types of genetic variation. Microarray studies and, more recently, exome sequencing have demonstrated the importance of de novo copy number variations (CNVs) and single-nucleotide variations (SNVs) in ID, but the majority of cases remain undiagnosed(3-6). Here we applied whole-genome sequencing to 50 patients with severe ID and their unaffected parents. All patients included had not received a molecular diagnosis after extensive genetic prescreening, including microarray-based CNV studies and exome sequencing. Notwithstanding this prescreening, 84 de novo SNVs affecting the coding region were identified, which showed a statistically significant enrichment of loss-of-function mutations as well as an enrichment for genes previously implicated in ID-related disorders. In addition, we identified eight de novo CNVs, including single-exon and intra-exonic deletions, as well as interchromosomal duplications. These CNVs affected known ID genes more frequently than expected. On the basis of diagnostic interpretation of all de novo variants, a conclusive genetic diagnosis was reached in 20 patients. Together with one compound heterozygous CNV causing disease in a recessive mode, this results in a diagnostic yield of 42% in this extensively studied cohort, and 62% as a cumulative estimate in an unselected cohort. These results suggest that de novo SNVs and CNVs affecting the coding region are a major cause of severe ID. Genome sequencing can be applied as a single genetic test to reliably identify and characterize the comprehensive spectrum of genetic variation, providing a genetic diagnosis in the majority of patients with severe ID.	[Gilissen, Christian; Hehir-Kwa, Jayne Y.; Thung, Djie Tjwan; van de Vorst, Maartje; van Bon, Bregje W. M.; Willemsen, Marjolein H.; Kwint, Michael; Janssen, Irene M.; Hoischen, Alexander; Schenck, Annette; Bo, Tan; Pfundt, Rolph; Yntema, Helger G.; de Vries, Bert B. A.; Kleefstra, Tjitske; Brunner, Han G.; Vissers, Lisenka E. L. M.; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Gilissen, Christian; Hehir-Kwa, Jayne Y.; Thung, Djie Tjwan; van de Vorst, Maartje; van Bon, Bregje W. M.; Willemsen, Marjolein H.; Kwint, Michael; Janssen, Irene M.; Hoischen, Alexander; Schenck, Annette; Bo, Tan; Pfundt, Rolph; Yntema, Helger G.; de Vries, Bert B. A.; Kleefstra, Tjitske; Brunner, Han G.; Vissers, Lisenka E. L. M.; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Donders Ctr Neurosci, NL-6525 GA Nijmegen, Netherlands; [Leach, Richard; Klein, Robert; Tearle, Rick] Complete Genom Inc, Mountain View, CA 94043 USA; [Bo, Tan] Cent S Univ, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Gilissen, Christian; Brunner, Han G.; Veltman, Joris A.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6229 ER Maastricht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Central South University; Maastricht University	Veltman, JA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, Geert Grootepl 10, NL-6525 GA Nijmegen, Netherlands.	joris.veltman@radboudumc.nl	Hoischen, Alexander/AGF-7293-2022; Brunner, Han/C-9928-2013; Hoischen, Alexander/D-1282-2013; Janssen, Irene M/V-3667-2018; Schenck, Annette/E-4514-2012; Pfundt, Rolph/L-4576-2015; Yntema, H.G./L-4771-2015; Kwint, Michael/AAC-9062-2019; Veltman, Joris A/F-5128-2010; Hehir, g. J.Y./L-4358-2015; Thung, Djie Tjwan/Q-2104-2015; Vissers, Lisenka ELM/A-2598-2015; Willemsen, Marjolein/R-5958-2019; van Bon, Bregje/Q-2445-2015; Gilissen, Christian/E-5246-2012; Kleefstra, Tjitske/G-2619-2012	Hoischen, Alexander/0000-0002-8072-4476; Hoischen, Alexander/0000-0002-8072-4476; Schenck, Annette/0000-0002-6918-3314; Veltman, Joris A/0000-0002-3218-8250; Vissers, Lisenka ELM/0000-0001-6470-5497; van Bon, Bregje/0000-0003-2234-0105; Gilissen, Christian/0000-0003-1693-9699; Tager-Flusberg, Helen/0000-0002-8768-5414; Hehir-Kwa, Jayne/0000-0003-0837-304X; Wagner, Jennifer/0000-0001-8174-0534; Keehn, Brandon/0000-0001-8796-2250	Netherlands Organization for Scientific Research [912-12-109, 916-14-043, 916-12-095, 907-00-365, SH-271-13]; European Research Council (ERC) [DENOVO 281964]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC)(European Research Council (ERC))	We thank R. Drmanac, K. Albers, J. Goeman, D. Lugtenberg and P. N. Robinson for useful discussions, and M. Steehouwer, P. de Vries and W. Nillesen for technical support. This work was in part financially supported by grants from the Netherlands Organization for Scientific Research (912-12-109 to J. A. V., A. S. and B.B.A.d.V., 916-14-043 to C. G., 916-12-095 to A. H., 907-00-365 to T. K. and SH-271-13 to C. G. and J. A. V.) and the European Research Council (ERC Starting grant DENOVO 281964 to J.A.V.).	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Bell J, 2007, PRACTICE GUIDELINES; Berg JS, 2011, GENET MED, V13, P499, DOI 10.1097/GIM.0b013e318220aaba; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Carnevali P, 2012, J COMPUT BIOL, V19, P279, DOI 10.1089/cmb.2011.0201; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Hehir-Kwa JY, 2013, CLIN GENET, V84, P415, DOI 10.1111/cge.12242; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Kolehmainen J, 2003, AM J HUM GENET, V72, P1359, DOI 10.1086/375454; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Mefford HC, 2012, NEW ENGL J MED, V366, P733, DOI 10.1056/NEJMra1114194; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Rippey C, 2013, AM J HUM GENET, V93, P697, DOI 10.1016/j.ajhg.2013.09.004; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Vulto-van Silfhout AT, 2013, HUM MUTAT, V34, P1679, DOI 10.1002/humu.22442; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902	30	763	790	4	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					344	+		10.1038/nature13394	http://dx.doi.org/10.1038/nature13394			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	23964223				2022-12-01	WOS:000338992200035
J	Savage, N				Savage, Neil			LOGISTICS Keeping cool	NATURE			English	Editorial Material																			0	30	31	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S8	S9		10.1038/507S8a	http://dx.doi.org/10.1038/507S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611169	Bronze			2022-12-01	WOS:000332224400004
J	Savage, N				Savage, Neil			BIOINFORMATICS Big data versus the big C	NATURE			English	Editorial Material																		Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; McNerney ME, 2013, BLOOD, V121, P975, DOI 10.1182/blood-2012-04-426965	2	25	28	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S66	S67		10.1038/509S66a	http://dx.doi.org/10.1038/509S66a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24860876	Bronze			2022-12-01	WOS:000336457100009
